PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Denoncin, K; Vertommen, D; Arts, IS; Goemans, CV; Rahuel-Clermont, S; Messens, J; Collet, JF				Denoncin, Katleen; Vertommen, Didier; Arts, Isabelle S.; Goemans, Camille V.; Rahuel-Clermont, Sophie; Messens, Joris; Collet, Jean-Francois			A New Role for Escherichia coli DsbC Protein in Protection against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Escherichia coli; Oxidative Stress; Protein Folding; Redox Regulation; Thioredoxin; DsbC; Sulfenic Acid	ARABINOSE-BINDING PROTEIN; DISULFIDE-ISOMERASE; IN-VIVO; SUGAR-BINDING; SUBSTRATE-SPECIFICITY; PERIPLASMIC PROTEIN; BOND; THIOREDOXIN; DIVERSITY; ELECTRONS	Background: DsbC is a protein-disulfide isomerase present in the periplasm of Gram-negative bacteria. Results: We discovered that DsbC also regulates the redox state of the single cysteine residue of the l-arabinose-binding protein AraF. Conclusion: DsbC is involved in the protection of single cysteine residues against oxidative stress. Significance: This finding reveals a new link between oxidative stress protection and oxidative protein folding. We report a new function for Escherichia coli DsbC, a protein best known for disulfide bond isomerization in the periplasm. We found that DsbC regulates the redox state of the single cysteine of the l-arabinose-binding protein AraF. This cysteine, which can be oxidized to a sulfenic acid, mediates the formation of a disulfide-linked homodimer under oxidative stress conditions, preventing l-arabinose binding. DsbC, unlike the homologous protein DsbG, reduces the intermolecular disulfide, restoring AraF binding properties. Thus, our results reveal a new link between oxidative protein folding and the defense mechanisms against oxidative stress.	[Denoncin, Katleen; Vertommen, Didier; Arts, Isabelle S.; Goemans, Camille V.; Collet, Jean-Francois] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Denoncin, Katleen; Arts, Isabelle S.; Goemans, Camille V.; Collet, Jean-Francois] WELBIO, B-1200 Brussels, Belgium; [Denoncin, Katleen; Arts, Isabelle S.; Goemans, Camille V.; Messens, Joris; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Messens, Joris] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Rahuel-Clermont, Sophie] Univ Lorraine, CNRS, F-54505 Vandoeuvre Les Nancy, France	Universite Catholique Louvain; WELBIO; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Collet, JF (corresponding author), Catholic Univ Louvain, Duve Inst, 75 Ave Hippocrate, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Rahuel-Clermont, Sophie/AAB-3451-2020; Messens, Joris/AAH-3008-2020	Rahuel-Clermont, Sophie/0000-0001-5143-0105; Messens, Joris/0000-0002-2128-8264; Vertommen, Didier/0000-0001-7648-8282; Collet, Jean-Francois/0000-0001-8069-7036; Goemans, Camille/0000-0002-5564-1644	European Research Council ERC [282335-Sulfenic]	European Research Council ERC(European Research Council (ERC))	This work was supported by the European Research Council (FP7/2007-2013) ERC Independent Researcher Starting Grant 282335-Sulfenic (to J.-F.C.).	Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Brot N, 2006, J BIOL CHEM, V281, P32668, DOI 10.1074/jbc.M604971200; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; DECLERCK N, 1994, PROTEIN ENG, V7, P997, DOI 10.1093/protein/7.8.997; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; HORAZDOVSKY BF, 1989, J BACTERIOL, V171, P3053, DOI 10.1128/jb.171.6.3053-3059.1989; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kawazu SI, 2010, PARASITOL INT, V59, P298, DOI 10.1016/j.parint.2010.03.005; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; MAO B, 1983, J BIOL CHEM, V258, P2543; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; MILLER DM, 1979, J BIOL CHEM, V254, P7521; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NEWCOMER ME, 1979, J BIOL CHEM, V254, P7529; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3213; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; VERMERSCH PS, 1990, J BIOL CHEM, V265, P16592; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x	35	20	21	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12356	12364		10.1074/jbc.M114.554055	http://dx.doi.org/10.1074/jbc.M114.554055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634211	hybrid, Green Published			2022-12-25	WOS:000335581400014
J	Attout, L; Fias, W; Salmon, E; Majerus, S				Attout, Lucie; Fias, Wim; Salmon, Eric; Majerus, Steve			Common Neural Substrates for Ordinal Representation in Short-Term Memory, Numerical and Alphabetical Cognition	PLOS ONE			English	Article							LEFT INTRAPARIETAL SULCUS; SERIAL-ORDER; WORKING-MEMORY; PARIETAL CIRCUITS; NEURONAL-ACTIVITY; MODEL; ATTENTION; ACTIVATION; MAGNITUDE; DISTANCE	The representation and maintenance of serial order information is one of the main functions of verbal short-term memory (STM) but its neural correlates remain poorly understood. We show here that the neural substrates allowing for coding of order information in STM are shared with those supporting ordinal processing in the numerical and alphabetical domains. We designed an fMRI experiment determining the neural substrates sensitive to ordinal distance effects in numerical judgment, alphabetical judgment and serial order STM tasks. Null conjunction analyses for parametric ordinal distance effects showed a common involvement of the horizontal segment of the left intraparietal sulcus over the three tasks; in addition, right intraparietal sulcus involvement was also observed for ordinal distance effects in the STM and numerical judgment tasks. These findings demonstrate that shared neural correlates in the intraparietal cortex support processing of order information in verbal STM, number and alphabetical domains, and suggest the existence of domain general, potentially ordinal, comparison processes supported by the left intraparietal sulcus.	[Attout, Lucie; Majerus, Steve] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium; [Fias, Wim] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Salmon, Eric] Univ Liege, Cyclotron Res Ctr, Liege, Belgium	University of Liege; Ghent University; University of Liege	Attout, L (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium.	Lucie.attout@ulg.ac.be	Fias, Wim/D-6861-2010; Salmon, Eric/AAE-4901-2020	Fias, Wim/0000-0002-5788-7306; Salmon, Eric/0000-0003-2520-9241; Majerus, Steve/0000-0002-8206-8097	Belgian National Fund for Scientific Research [F.R.S.-FNRS 1.5.056.10]; Belgian Inter-University Attraction Pole [P7/11]; University of Liege	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Belgian Inter-University Attraction Pole(Belgian Federal Science Policy Office); University of Liege(University of Liege)	This research was supported by the Belgian National Fund for Scientific Research (grant F.R.S.-FNRS 1.5.056.10), by a Belgian Inter-University Attraction Pole (P7/11) and by the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andres M, 2005, COGNITIVE BRAIN RES, V25, P283, DOI 10.1016/j.cogbrainres.2005.06.002; Ansari D, 2007, NEURON, V53, P165, DOI 10.1016/j.neuron.2007.01.001; Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Attout L, 2012, APHASIOLOGY, V26, P355, DOI 10.1080/02687038.2011.604303; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Bugden S, 2012, DEV COGN NEUROS-NETH, V2, P448, DOI 10.1016/j.dcn.2012.04.001; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Farrell S, 2002, PSYCHON B REV, V9, P59, DOI 10.3758/BF03196257; Fias W, 2007, J NEUROSCI, V27, P8952, DOI 10.1523/JNEUROSCI.2076-07.2007; Franklin MS, 2009, J COGNITIVE NEUROSCI, V21, P2114, DOI 10.1162/jocn.2008.21181; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Ischebeck A, 2008, HUM BRAIN MAPP, V29, P894, DOI 10.1002/hbm.20433; Jacob SN, 2008, TRENDS COGN SCI, V12, P41, DOI 10.1016/j.tics.2007.11.006; Jou J, 1999, J EXP PSYCHOL LEARN, V25, P680, DOI 10.1037/0278-7393.25.3.680; Kadosh RC, 2010, CEREB CORTEX, V20, P2166, DOI 10.1093/cercor/bhp273; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Kaufmann L, 2009, COGNITIVE DEV, V24, P486, DOI 10.1016/j.cogdev.2009.09.001; Knops A, 2014, NEUROIMAGE, V84, P786, DOI 10.1016/j.neuroimage.2013.09.037; LOVELACE EA, 1971, J EXP PSYCHOL, V88, P258, DOI 10.1037/h0030922; Majerus S, 2008, NEUROIMAGE, V42, P1698, DOI 10.1016/j.neuroimage.2008.06.003; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Majerus S, 2012, CEREB CORTEX, V22, P1086, DOI 10.1093/cercor/bhr174; Majerus S, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P244; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Marshuetz C, 2006, NEUROSCIENCE, V139, P311, DOI 10.1016/j.neuroscience.2005.04.071; Marshuetz C, 2005, PSYCHOL BULL, V131, P323, DOI 10.1037/0033-2909.131.3.323; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Reynvoet B, 2009, J EXP CHILD PSYCHOL, V103, P480, DOI 10.1016/j.jecp.2009.01.007; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Szucs D, 2004, NEUROSCI LETT, V360, P65, DOI 10.1016/j.neulet.2004.02.038; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Turconi E, 2004, COGNITIVE BRAIN RES, V21, P22, DOI 10.1016/j.cogbrainres.2004.05.003; van Dijck JP, 2013, PSYCHOL SCI, V24, P1854, DOI 10.1177/0956797613479610; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zorzi M, 2011, NEUROIMAGE, V56, P674, DOI 10.1016/j.neuroimage.2010.06.035	64	40	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92049	10.1371/journal.pone.0092049	http://dx.doi.org/10.1371/journal.pone.0092049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632823	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400134
J	Gil-Humanes, J; Piston, F; Barro, F; Rosell, CM				Gil-Humanes, Javier; Piston, Fernando; Barro, Francisco; Rosell, Cristina M.			The Shutdown of Celiac Disease-Related Gliadin Epitopes in Bread Wheat by RNAi Provides Flours with Increased Stability and Better Tolerance to Over-Mixing	PLOS ONE			English	Article							SDS-SEDIMENTATION TEST; PROTEIN FRACTIONS; TRANSGENIC WHEAT; GAMMA-GLIADINS; QUALITY; GLUTEN; DOUGH; INTERFERENCE; BREADMAKING; TEMPERATURE	Celiac disease is a food-sensitive enteropathy triggered by the ingestion of wheat gluten proteins and related proteins from barley, rye, and some varieties of oat. There are no interventional therapies and the only solution is a lifelong gluten-free diet. The down-regulation of gliadins by RNAi provides wheat lines with all the gliadin fractions strongly down-regulated (low-gliadin). The technological properties of doughs prepared from the low-gliadin lines indicated a general weakening effect, although some of the lines displayed similar properties to that of the wild-type lines. In contrast, the stability was increased significantly in some of the transgenic lines, indicating better tolerance to over-mixing. Results reported here are the first analyses of the mixing and bread-making quality of the wheat lines with all gliadin fractions strongly down-regulated. Flour from these lines may be an important breakthrough in the development of new products for the celiac community. These lines might be used directly or blended with other non-toxic cereals, as raw material for developing food products that can be safely tolerated by CD patients and others with gluten intolerance or gluten sensitivity, incrementing the range of available food products and enhancing their diet.	[Gil-Humanes, Javier; Piston, Fernando; Barro, Francisco] CSIC, Inst Agr Sostenible, Cordoba, Spain; [Rosell, Cristina M.] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Gil-Humanes, J (corresponding author), CSIC, Inst Agr Sostenible, Cordoba, Spain.	javigil@ias.csic.es	Piston, Fernando/AAD-6975-2020; Gil-Humanes, Javier/AAU-4381-2020; Barro, Francisco/E-8572-2017; Rosell, Cristina M/F-4888-2010; Barro, Francisco/J-3254-2014	Barro, Francisco/0000-0002-7652-229X; Rosell, Cristina M/0000-0001-7197-5874; Gil Humanes, Javier/0000-0002-7283-6945	Spanish Ministry of Economy and Competitiveness [AGL2010-19643-C02-02]; European Regional Development Fund (FEDER); Junta de Andalucia [P09AGR-4783]; Generalitat Valenciana [Prometeo 2012/064]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The Spanish Ministry of Economy and Competitiveness (Project AGL2010-19643-C02-02), the European Regional Development Fund (FEDER), and Junta de Andalucia (Project P09AGR-4783) supported this work. Authors also acknowledge the financial support of Generalitat Valenciana (Project Prometeo 2012/064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; AYOUB M, 1993, CAN J PLANT SCI, V73, P995, DOI 10.4141/cjps93-130; BRANLARD G, 1985, J CEREAL SCI, V3, P329, DOI 10.1016/S0733-5210(85)80006-0; Carter BP, 1999, CEREAL CHEM, V76, P907, DOI 10.1094/CCHEM.1999.76.6.907; Cato L, 2008, FOOD AUST, V60, P577; Codina GG, 2010, CZECH J FOOD SCI, V28, P185, DOI 10.17221/169/2008-CJFS; Collar C, 2003, EUR FOOD RES TECHNOL, V216, P505, DOI 10.1007/s00217-003-0686-3; Collar C, 2013, MIXOLAB NEW APPROACH, P23; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; ECKERT B, 1993, Z LEBENSM UNTERS FOR, V196, P122, DOI 10.1007/BF01185570; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; Gil-Humanes J, 2011, J EXP BOT IN PRESS; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045937; Gil-Humanes J, 2012, J CEREAL SCI, V56, P161, DOI 10.1016/j.jcs.2012.02.009; Gil-Humanes J, 2011, J EXP BOT, V62, P4203, DOI 10.1093/jxb/err119; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Gras PW, 2000, J CEREAL SCI, V31, P1, DOI 10.1006/jcrs.1999.0293; ICC, 1994, 1231 ICC INT ASS CER, V123/1; ICC, 1994, 1052 ICC INT ASS CER, V105/2; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; Khatkar BS, 2002, J CEREAL SCI, V35, P299, DOI 10.1006/jcrs.2001.0429; Koksel H, 2009, CEREAL CHEM, V86, P522, DOI 10.1094/CCHEM-86-5-0522; LORENZO A, 1987, CROP SCI, V27, P247, DOI 10.2135/cropsci1987.0011183X002700020025x; MACRITCHIE F, 1987, J CEREAL SCI, V6, P259, DOI 10.1016/S0733-5210(87)80063-2; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; MACRITCHIE F, 1991, CEREAL CHEM, V68, P122; METAKOVSKY EV, 1990, AUST J AGR RES, V41, P289, DOI 10.1071/AR9900289; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Piston F, 2011, PLOS ONE, V6; Piston F, 2008, EUPHYTICA, V162, P371, DOI 10.1007/s10681-007-9530-3; Piston F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-136; Piston F, 2009, MOL BREEDING, V23, P655, DOI 10.1007/s11032-009-9263-1; Rojas JA, 1999, FOOD HYDROCOLLOID, V13, P27, DOI 10.1016/S0268-005X(98)00066-6; Rosell CM, 2007, FOOD HYDROCOLLOID, V21, P452, DOI 10.1016/j.foodhyd.2006.05.004; Rosell CM, 2013, CEREAL CHEM, V90, P89, DOI 10.1094/CCHEM-05-12-0056-R; Rosell CM, 2010, EUR FOOD RES TECHNOL, V231, P535, DOI 10.1007/s00217-010-1310-y; Rosell CM, 2009, INT J FOOD SCI TECH, V44, P493, DOI 10.1111/j.1365-2621.2008.01758.x; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6; Wieser H, 2008, CEREAL CHEM, V85, P1, DOI 10.1094/CCHEM-85-1-0001; Williams R, 1988, TECHNICAL MANUAL, V4; Xie LH, 2011, CEREAL CHEM, V88, P333, DOI 10.1094/CCHEM-06-10-0090	56	53	54	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91931	10.1371/journal.pone.0091931	http://dx.doi.org/10.1371/journal.pone.0091931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633046	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400122
J	Jin, H; Liang, Q; Chen, TS; Wang, XP				Jin, Hua; Liang, Qian; Chen, Tongsheng; Wang, Xiaoping			Resveratrol Protects Chondrocytes from Apoptosis via Altering the Ultrastructural and Biomechanical Properties: An AFM Study	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; NITRIC-OXIDE; ARTICULAR CHONDROCYTES; ELASTIC PROPERTIES; KINASE; DEDIFFERENTIATION; INHIBITION; CARTILAGE; SURFACE; DIFFERENTIATION	Osteoarthritis (OA), a degenerative joint disease with high prevalence among older people, occurs from molecular or nanometer level and extends gradually to higher degrees of the ultrastructure of cartilage, finally resulting in irreversible structural and functional damages. This report aims to use atomic force microscopy (AFM) to investigate the protective effects of resveratrol (RV), a drug with good anti-inflammatory properties, on cellular morphology, membrane architecture, cytoskeleton, cell surface adhesion and stiffness at nanometer level in sodium nitroprusside (SNP)-induced apoptotic chondrocytes, a typical cellular OA model. CCK-8 assay showed that 100 mu M RV significantly prevented SNP-induced cytotoxicity. AFM imaging and quantitative analysis showed that SNP potently induced chondrocytes changes including shrunk, round, lamellipodia contraction and decrease in adherent junctions among cells, as well as the destruction of biomechanics: 90% decrease in elasticity and 30% decrease in adhesion. In addition, confocal imaging analysis showed that SNP induced aggregation of the cytoskeleton and decrease in the expression of cytoskeletal proteins. More importantly, these SNP-induced damages to chondrocytes could be potently prevented by RV pretreatment. Interestingly, the biomechanical changes occurred before morphological changes could be clearly observed during SNP-induced apoptosis, indicating that the biomechanics of cellular membrane may be a more robust indicator of cell function. Collectively, our data demonstrate that RV prevents SNP-induced apoptosis of chondrocytes by regulating actin organization, and that AFM-based technology can be developed into a powerful and sensitive method to study the interaction mechanisms between chondrocytes and drugs.	[Jin, Hua; Liang, Qian; Wang, Xiaoping] Jinan Univ, Affiliated Hosp 1, Dept Pain Management, Guangzhou, Guangdong, Peoples R China; [Chen, Tongsheng] S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Tongsheng] S China Normal Univ, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China	Jinan University; South China Normal University; South China Normal University	Wang, XP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Pain Management, Guangzhou, Guangdong, Peoples R China.	txp2938@jnu.edu.cn		jin, Hua/0000-0001-5478-4611	National Natural Science Foundation of China [81071491, 61178078]; Department of Education and Finance of Guangdong Province [cxzd115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education and Finance of Guangdong Province	This work was supported by the National Natural Science Foundation of China (Grant No. 81071491 and 61178078), and Key Project of the Department of Education and Finance of Guangdong Province (cxzd115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Cai XF, 2010, J PHYS CHEM B, V114, P3833, DOI 10.1021/jp910682q; Capella B, 1997, IEEE ENG MED BIOL, V16, P58, DOI 10.1109/51.582177; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dave M, 2008, ARTHRITIS RHEUM, V58, P2786, DOI 10.1002/art.23799; de Andres MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4295; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Del Carlo Marcello Jr, 2008, Curr Rheumatol Rep, V10, P37; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Eo SH, 2013, BIOMOL THER, V21, P364, DOI 10.4062/biomolther.2013.029; Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Hsieh CH, 2008, OSTEOARTHR CARTILAGE, V16, P480, DOI 10.1016/j.joca.2007.08.004; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/NNANO.2009.77, 10.1038/nnano.2009.77]; Kim JS, 2005, CELL DEATH DIFFER, V12, P201, DOI 10.1038/sj.cdd.4401511; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim SJ, 2003, J BIOL CHEM, V278, P42448, DOI 10.1074/jbc.M304887200; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kim SJ, 2002, J BIOL CHEM, V277, P30375, DOI 10.1074/jbc.M205193200; Laney DE, 1997, BIOPHYS J, V72, P806, DOI 10.1016/S0006-3495(97)78714-9; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Liang XM, 2004, COLLOID SURFACE B, V34, P41, DOI 10.1016/j.colsurfb.2003.10.017; Lim Teck Chwee, 2005, ASIA PACIFIC BIOTECH, V09, P674; Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nakagawa S, 2010, J ORTHOP RES, V28, P156, DOI 10.1002/jor.20976; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Radmacher M, 2002, METHOD CELL BIOL, V68, P67; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Tonomura H, 2006, OSTEOARTHR CARTILAGE, V14, P545, DOI 10.1016/j.joca.2005.12.008; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764; Yoon JB, 2003, J BIOL CHEM, V278, P15319, DOI 10.1074/jbc.M212520200; Zhuang CP, 2013, J INNOV OPT HEAL SCI, V6, DOI 10.1142/S1793545813500223	41	23	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91611	10.1371/journal.pone.0091611	http://dx.doi.org/10.1371/journal.pone.0091611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632762	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400073
J	Yano, CF; Poltronieri, J; Bertollo, LAC; Artoni, RF; Liehr, T; Cioffi, MD				Yano, Cassia Fernanda; Poltronieri, Juliana; Carlos Bertollo, Luiz Antonio; Artoni, Roberto Ferreira; Liehr, Thomas; Cioffi, Marcelo de Bello			Chromosomal Mapping of Repetitive DNAs in Triportheus trifurcatus (Characidae, Characiformes): Insights into the Differentiation of the Z and W Chromosomes	PLOS ONE			English	Article							FISH HOPLIAS-MALABARICUS; SEX-CHROMOSOMES; SYSTEM; ZZ/ZW; EVOLUTION; HETEROCHROMATIN; GENETICS; PISCES	Repetitive DNA sequences play an important role in the structural and functional organization of chromosomes, especially in sex chromosome differentiation. The genus Triportheus represents an interesting model for such studies because all of its species analyzed so far contain a ZZ/ZW sex chromosome system. A close relationship has been found between the differentiation of the W chromosome and heterochromatinization, with the involvement of different types of repetitive DNA in this process. This study investigated several aspects of this association in the W chromosome of Triportheus trifurcatus (2n = 52 chromosomes), including the cytogenetic mapping of repetitive DNAs such as telomeric sequences (TTAGGG)n, microsatellites and retrotransposons. A remarkable heterochromatic segment on the W chromosome was observed with a preferential accumulation of (CAC)(10), (CAG)(10), (CGG)(10), (GAA)(10) and (TA)(15). The retrotransposons Rex1 and Rex3 showed a general distribution pattern in the chromosomes, and Rex6 showed a different distribution on the W chromosome. The telomeric repeat (TTAGGG) n was highly evident in both telomeres of all chromosomes without the occurrence of ITS. Thus, the differentiation of the W chromosome of T. trifurcatus is clearly associated with the formation of heterochromatin and different types of repetitive DNA, suggesting that these elements had a prominent role in this evolutionary process.	[Yano, Cassia Fernanda; Poltronieri, Juliana; Carlos Bertollo, Luiz Antonio; Cioffi, Marcelo de Bello] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Artoni, Roberto Ferreira] Univ Jena, Jena Univ Hosp, Inst Human Genet, Jena, Thuringen, Germany; [Liehr, Thomas] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, PR, Brazil	Universidade Federal de Sao Carlos; Friedrich Schiller University of Jena; Universidade Estadual de Ponta Grossa	Cioffi, MD (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil.	mbcioffi@ufscar.br	Cioffi, Marcelo/AAG-4675-2022; Artoni, Roberto Ferreira/N-1693-2019; Artoni, Roberto F/H-6651-2013; Cioffi, Marcelo/AFK-6402-2022; Liehr, Thomas/H-2852-2019	Cioffi, Marcelo/0000-0003-4340-1464; Artoni, Roberto Ferreira/0000-0002-2528-9846; Artoni, Roberto F/0000-0002-2528-9846; Cioffi, Marcelo/0000-0003-4340-1464; Liehr, Thomas/0000-0003-1672-3054; Yano, Cassia Fernanda/0000-0002-8118-2867	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian agencies CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoni RF, 2002, HEREDITY, V89, P15, DOI 10.1038/sj.hdy.6800081; Artoni RF, 2001, CHROMOSOME RES, V9, P449, DOI 10.1023/A:1011620226348; Bellafronte E, 2012, GENET MOL BIOL, V35, P770, DOI 10.1590/S1415-47572012005000077; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; BERTOLLO LAC, 1992, CYTOGENET CELL GENET, V60, P60, DOI 10.1159/000133296; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Cioffi MB, 2012, J FISH BIOL, V80, P2125, DOI 10.1111/j.1095-8649.2012.03272.x; Cioffi MB, 2011, CYTOGENET GENOME RES, V132, P188, DOI 10.1159/000321571; Cioffi MB, 2009, CYTOGENET GENOME RES, V125, P132, DOI 10.1159/000227838; Cioffi MD, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-28; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Diniz D, 2008, CYTOGENET GENOME RES, V122, P163, DOI 10.1159/000163094; Diniz D, 2008, GENETICA, V133, P85, DOI 10.1007/s10709-007-9187-9; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Falcao JN, 1988, THESIS U SAO PAULO R; FELDBERG E, 1987, GENOME, V29, P1, DOI 10.1139/g87-001; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Malabarba Maria Claudia S. L., 2004, Neotrop. ichthyol., V2, P167, DOI 10.1590/S1679-62252004000400001; Marquioni V, 2013, MICRON, V45, P129, DOI 10.1016/j.micron.2012.11.008; Nirchio M, 2007, GENET MOL BIOL, V30, P25, DOI 10.1590/S1415-47572007000100007; Ohno S., 1967, SEX CHROMOSOMES SEX; Oliveira C, 2009, FISH PHYSIOL BIOCHEM, V35, P81, DOI 10.1007/s10695-008-9250-1; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; Poltronieri J, 2014, CYTOGENET GENOME RES, V142, P40, DOI 10.1159/000355908; Sanchez Sebastian, 1999, Cytologia (Tokyo), V64, P395; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Silva DS, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-74; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Vallender EJ, 2004, BIOESSAYS, V26, P159, DOI 10.1002/bies.10393; Venere PC, 2004, GENETICA, V121, P75, DOI 10.1023/B:GENE.0000019936.40970.7a; Volff JN, 1999, MOL BIOL EVOL, V16, P1427, DOI 10.1093/oxfordjournals.molbev.a026055	38	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90946	10.1371/journal.pone.0090946	http://dx.doi.org/10.1371/journal.pone.0090946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632562	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400026
J	Kimura, T; Watanabe, E; Sakamoto, T; Takasu, O; Ikeda, T; Ikeda, K; Kotani, J; Kitamura, N; Sadahiro, T; Tateishi, Y; Shinozaki, K; Oda, S				Kimura, Tomonori; Watanabe, Eizo; Sakamoto, Teruo; Takasu, Osamu; Ikeda, Toshiaki; Ikeda, Kazumi; Kotani, Joji; Kitamura, Nobuya; Sadahiro, Tomohito; Tateishi, Yoshihisa; Shinozaki, Koichiro; Oda, Shigeto			Autophagy-Related IRGM Polymorphism Is Associated with Mortality of Patients with Severe Sepsis	PLOS ONE			English	Article							CROHNS-DISEASE; ORGAN FAILURE; CRITICAL ILLNESS; CELL-DEATH; SOFA SCORE; MULTIPLE; MECHANISMS; IMMUNOSUPPRESSION; SUSCEPTIBILITY; DEFINITIONS	Objective Autophagy is the regulated catabolic process for recycling damaged or unnecessary organelles, which plays crucial roles in cell survival during nutrient deficiency, and innate immune defense against pathogenic microorganisms. Autophagy has been also reported to be involved in various conditions including inflammatory diseases. IRGM (human immunity-related GTPase) has an important function in eliminating Mycobacterium tuberculosis from host cells via autophagy. We examined the association between genetic polymorphism and clinical course/outcome in severely septic patients. Methods: The study included 125 patients with severe sepsis/septic shock (SS) and 104 non-sepsis patients who were admitted to the intensive care unit (ICU) of Chiba University Hospital between October 2001 and September 2008 (discovery cohort) and 268 SS patients and 454 non-sepsis patients who were admitted to ICUs of five Japanese institutions including Chiba University Hospital between October 2008 and September 2012 (multi-center validation cohort). Three hundred forty seven healthy volunteers who consented to this study were also included. Genotyping was performed for a single-nucleotide polymorphism (SNP) within the coding region of IRGM, IRGM(+313) (rs10065172). Lipopolysaccharide challenge of whole blood from randomly selected healthy volunteers (n = 70) was performed for comparison of IRGM mRNA expression among different genotypes. Results: No significant difference in genotypic distributions (CC/CT/TT) at the IRGM(+313) locus was observed among the three subject groups (SS, non-sepsis, and healthy volunteers) in either cohort. When mortality were compared, no significant difference was observed in the non-sepsis group, while TT homozygotes exhibited a significantly higher mortality than the CC+CT genotype category in the SS group for both cohorts (P = 0.043, 0.037). Lipopolysaccharide challenge to whole blood showed a significant suppression of IRGM mRNA expression in TT compared with the CC+CT genotype category (P = 0.019). Conclusions: The data suggest that the IRGM(+313), an autophagy-related polymorphic locus, influences outcome in severely septic patients, with the possible involvement of autophagy in sepsis exacerbation.	[Kimura, Tomonori; Watanabe, Eizo; Sadahiro, Tomohito; Tateishi, Yoshihisa; Shinozaki, Koichiro; Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chu Ku, Chiba, Japan; [Sakamoto, Teruo; Takasu, Osamu] Kurume Univ, Sch Med, Dept Emergency & Crit Care Med, Kurume, Fukuoka 830, Japan; [Ikeda, Toshiaki; Ikeda, Kazumi] Tokyo Med Univ, Hachioji Med Ctr, Div Crit Care & Emergency Med, Hachioji, Tokyo, Japan; [Kotani, Joji] Hyogo Coll Med, Dept Emergency Disaster & Crit Care Med, Nishinomiya, Hyogo 6638501, Japan; [Kitamura, Nobuya] Kimitsu Chuo Hosp, Dept Emergency & Crit Care Med, Kisarazu City, Chiba, Japan	Chiba University; Kurume University; Tokyo Medical University; Hyogo College of Medicine	Watanabe, E (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chu Ku, 1-8-1 Inohana, Chiba, Japan.	watanabee@faculty.chiba-u.jp	Watanabe, Eizo/AAO-4780-2021	Watanabe, Eizo/0000-0001-6731-909X	Ministry of Education, Culture, Sports Science, and Technology, Japan [23792070]; ZENKYOREN	Ministry of Education, Culture, Sports Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ZENKYOREN	This work was supported by the Grants-in-Aid for Young Scientists (B) of Grants-in-Aid for Scientific Research (#23792070) from the Ministry of Education, Culture, Sports Science, and Technology, Japan (TK). This work was also supported by ZENKYOREN (EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Frazier WJ, 2008, PEDIATR CLIN N AM, V55, P647, DOI 10.1016/j.pcl.2008.02.009; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2013, IMMUNITY, V39, P799, DOI 10.1016/j.immuni.2013.10.012; Oda S, 2000, INTENS CARE MED, V26, P1786, DOI 10.1007/s001340000710; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Silva E, 2012, MINERVA ANESTESIOL, V78, P1215; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	35	40	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91522	10.1371/journal.pone.0091522	http://dx.doi.org/10.1371/journal.pone.0091522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626347	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300098
J	Lou, J; Blevins, M; Ruan, YH; Vermund, SH; Tang, SY; Webb, GF; Shepherd, BE; He, X; Lu, HY; Shao, YM; Qian, HZ				Lou, Jie; Blevins, Meridith; Ruan, Yuhua; Vermund, Sten H.; Tang, Sanyi; Webb, Glenn F.; Shepherd, Bryan E.; He, Xiong; Lu, Hongyan; Shao, Yiming; Qian, Han-Zhu			Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION RISK; INFECTION; EPIDEMIC; RESISTANCE; BEHAVIOR; DONORS; COHORT; CARE	Objective: To project the HIV/AIDS epidemics among men who have sex with men (MSM) under different combinations of HIV testing and linkage to care (TLC) interventions including antiretroviral therapy (ART) in Beijing, China. Design: Mathematical modeling. Methods: Using a mathematical model to fit prevalence estimates from 2000-2010, we projected trends in HIV prevalence and incidence during 2011-2020 under five scenarios: (S1) current intervention levels by averaging 2000-2010 coverage; (S2) increased ART coverage with current TLC; (S3) increased TLC/ART coverage; (S4) increased condom use; and (S5) increased TLC/ART plus increased condom use. Results: The basic reproduction number based upon the current level of interventions is significantly higher than 1 (R-0 = 2.09; 95% confidence interval (CI), 1.83-2.35), suggesting that the HIV epidemic will continue to increase to 2020. Compared to the 2010 prevalence of 7.8%, the projected HIV prevalence in 2020 for the five prevention scenarios will be: (S1) Current coverage: 21.4% (95% CI, 9.9-31.7%); (S2) Increased ART: 19.9% (95% CI, 9.9-28.4%); (S3) Increased TLC/ART: 14.5% (95% CI, 7.0-23.8%); (S4) Increased condom use: 13.0% (95% CI, 9.8-28.4%); and (S5) Increased TLC/ART and condom use: 8.7% (95% CI, 5.4-11.5%). HIV epidemic will continue to rise (R-0 > 1) for S1-S4 even with hyperbolic coverage in the sensitivity analysis, and is expected to decline (R-0 = 0.93) for S5. Conclusion: Our transmission model suggests that Beijing MSM will have a rapidly rising HIV epidemic. Even enhanced levels of TLC/ART will not interrupt epidemic expansion, despite optimistic assumptions for coverage. Promoting condom use is a crucial component of combination interventions.	[Lou, Jie] Shanghai Univ, Dept Math, Shanghai, Peoples R China; [Blevins, Meridith; Vermund, Sten H.; Shepherd, Bryan E.; Qian, Han-Zhu] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Ruan, Yuhua; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Vermund, Sten H.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Tang, Sanyi] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Shaanxi Provinc, Peoples R China; [Webb, Glenn F.] Vanderbilt Univ, Dept Math, Nashville, TN USA; [He, Xiong; Lu, Hongyan] Beijing Municipal Ctr Dis Control & Prevent, Inst AIDS STD Prevent & Control, Beijing, Peoples R China; [Qian, Han-Zhu] Vanderbilt Univ, Div Epidemiol, Dept Med, Nashville, TN USA	Shanghai University; Vanderbilt University; Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Vanderbilt University; Shaanxi Normal University; Vanderbilt University; Vanderbilt University	Shao, YM (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	yshao08@gmail.com; han-zhu.qian@vanderbilt.edub	Webb, Glenn/AAW-7228-2021; Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Blevins, Meridith/0000-0002-3861-9859	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01AI094562, R34AI091446]; Natural Science Foundation of China [11271246, 11331009]; International Development Research Center of Canada [104519-010]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2012SKLID103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R34AI091446, R01AI094562] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Development Research Center of Canada; Chinese State Key Laboratory for Infectious Disease Develop Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was mainly supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers R01AI094562 and R34AI091446. This study was also in part sponsored by grants from the Natural Science Foundation of China (grants #11271246 & 11331009), the International Development Research Center of Canada (grant #104519-010) and Chinese State Key Laboratory for Infectious Disease Develop Grant (grant #2012SKLID103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusto FB, 2013, MATH BIOSCI, V243, P147, DOI 10.1016/j.mbs.2013.02.001; AHLGREN DJ, 1990, J ACQ IMMUN DEF SYND, V3, P631; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Buonomo B, 2012, J MATH ANAL APPL, V385, P709, DOI 10.1016/j.jmaa.2011.07.006; CDC C, 2010, ANN REP HIV AIDS BEI; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; Chow EPF, 2012, AIDS BEHAV, V16, P653, DOI 10.1007/s10461-011-9935-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; HELTON JC, 1985, ECOL MODEL, V28, P243, DOI 10.1016/0304-3800(85)90077-8; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jia Z, 2012, LANCET; Johnson LF, 2006, DEMOGR RES, V14, P541, DOI 10.4054/DemRes.2006.14.22; Li D-I, 2008, J PREVENTIVE MED INF, V6; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Liu H., 2001, CHIN J STD AIDS PREV, V7, P289; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Sullivan P, 2010, AIDS RES HUM RETROVI; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tan WY, 1999, J STAT PLAN INFER, V78, P71, DOI 10.1016/S0378-3758(98)00207-9; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; Vardavas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000152; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Wang JJ, 2010, NONLINEAR ANAL-REAL, V11, P2390, DOI 10.1016/j.nonrwa.2009.07.012; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Wirtz AL, 2013, INT J STD AIDS; Wu Z, 2013, HIV SYPHILIS PREVALE; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xu Juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P975; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050873; Yu M-R, 2011, CHINESE J PUBLIC HLT, V10; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang L, 2012, SEX HEALTH, V9, P261, DOI 10.1071/SH11104; Zhou Zhen-hai, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P273	60	29	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90985	10.1371/journal.pone.0090985	http://dx.doi.org/10.1371/journal.pone.0090985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626165	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300047
J	Steffener, J; Barulli, D; Habeck, C; O'Shea, D; Razlighi, Q; Stern, Y				Steffener, Jason; Barulli, Daniel; Habeck, Christian; O'Shea, Deirdre; Razlighi, Qolamreza; Stern, Yaakov			The Role of Education and Verbal Abilities in Altering the Effect of Age-Related Gray Matter Differences on Cognition	PLOS ONE			English	Article							BRAIN VOLUME DECLINE; MEDIATION ANALYSIS; RESERVE; MEMORY; INTELLIGENCE; MAINTENANCE; MODELS	Evidence suggests that individual variability in lifetime exposures influences how cognitive performance changes with advancing age. Brain maintenance and cognitive reserve are theories meant to account for preserved performance despite advancing age. These theories differ in their causal mechanisms. Brain maintenance predicts more advantageous lifetime exposures will reduce age-related neural differences. Cognitive reserve predicts that lifetime exposures will not directly reduce these differences but minimize their impact on cognitive performance. The present work used moderated-mediation modeling to investigate the contributions of these mechanisms at explaining variability in cognitive performance among a group of 39 healthy younger (mean age (standard deviation) 25.9 (2.92) and 45 healthy older adults (65.2 (2.79)). Cognitive scores were computed using composite measures from three separate domains (speed of processing, fluid reasoning, and memory), while their lifetime exposures were estimated using education and verbal IQ measures. T1-weighted MR images were used to measure cortical thickness and subcortical volumes. Results suggest a stronger role for cognitive reserve mechanisms in explaining age-related cognitive variability: even with age-related reduced gray matter, individuals with greater lifetime exposures could perform better given their quantity of brain measures.	[Steffener, Jason; Barulli, Daniel; Habeck, Christian; O'Shea, Deirdre; Razlighi, Qolamreza; Stern, Yaakov] Columbia Univ Coll Phys & Surg, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Steffener, Jason; Habeck, Christian; Razlighi, Qolamreza; Stern, Yaakov] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Barulli, Daniel] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Stern, Yaakov] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Steffener, J (corresponding author), Columbia Univ Coll Phys & Surg, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.	js2746@columbia.edu		Stern, Yaakov/0000-0001-7542-3241	NIH [K01AG035061]; NATIONAL INSTITUTE ON AGING [K01AG044467, R01AG026158, R01AG038465, K01AG035061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this study was from NIH grant: K01AG035061, titled "Age-Related Structural and Functional Neural Changes on Cognitive Measures'' and awarded to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Bartres-Faz D, 2009, BIOL PSYCHOL, V80, P256, DOI 10.1016/j.biopsycho.2008.10.005; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Benjamini Y, 1995, J R STAT SOC B; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Clymo RS, 2013, MANY DIGITS MEAN ARE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Hayes A.F, 2013, MEDIATION MODERATION; Hayes AF, 2013, INTRO MEDIAITON MODE; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Johnson PO, 1936, STAT RES MEMOIRS, V1; MacDonald P.A., 2013, BRAIN IMAGING BEHAV; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mattis S, 1988, DEMENTIA RATING SCAL; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Park Denise C, 2013, Dialogues Clin Neurosci, V15, P109; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Raven J.C., 1962, ADV PROGR MATRICES; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2008, INTELLIGENCE, V36, P464, DOI 10.1016/j.intell.2007.10.003; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Steffener J, 2012, HUM BRAIN MAPP; Steffener J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044421; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird	48	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91196	10.1371/journal.pone.0091196	http://dx.doi.org/10.1371/journal.pone.0091196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625888	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300062
J	Lim, SH; Wu, LX; Kiew, LV; Chung, LY; Burgess, K; Lee, HB				Lim, Siang Hui; Wu, Liangxing; Kiew, Lik Voon; Chung, Lip Yong; Burgess, Kevin; Lee, Hong Boon			Rosamines Targeting the Cancer Oxidative Phosphorylation Pathway	PLOS ONE			English	Article							DELOCALIZED LIPOPHILIC CATIONS; RAT-LIVER MITOCHONDRIA; CARDIAC TOXICITY; CARCINOMA-CELLS; INHIBITORS; DOXORUBICIN; RESISTANCE; ACIDOSIS; SCREEN; GROWTH	Reprogramming of energy metabolism is pivotal to cancer, so mitochondria are potential targets for anticancer therapy. A prior study has demonstrated the anti-proliferative activity of a new class of mitochondria-targeting rosamines. This present study describes in vitro cytotoxicity of second-generation rosamine analogs, their mode of action, and their in vivo efficacies in a tumor allografted mouse model. Here, we showed that these compounds exhibited potent cytotoxicity (average IC50<0.5 mu M), inhibited Complex II and ATP synthase activities of the mitochondrial oxidative phosphorylation pathway and induced loss of mitochondrial transmembrane potential. A NCI-60 cell lines screen further indicated that rosamine analogs 4 and 5 exhibited potent antiproliferative effects with Log(10)GI(50) = -7 (GI(50) = 0.1 mu M) and were more effective against a colorectal cancer sub-panel than other cell lines. Preliminary in vivo studies on 4T1 murine breast cancer-bearing female BALB/c mice indicated that treatment with analog 5 in a single dosing of 5 mg/kg or a schedule dosing of 3 mg/kg once every 2 days for 6 times (q2dx6) exhibited only minimal induction of tumor growth delay. Our results suggest that rosamine analogs may be further developed as mitochondrial targeting agents. Without a doubt proper strategies need to be devised to enhance tumor uptake of rosamines, i.e. by integration to carrier molecules for better therapeutic outcome.	[Lim, Siang Hui; Lee, Hong Boon] Canc Res Initiat Fdn CARIF, Drug Discovery Lab, Subang Jaya, Selangor, Malaysia; [Lim, Siang Hui; Chung, Lip Yong] Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia; [Wu, Liangxing; Burgess, Kevin] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Kiew, Lik Voon] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Texas A&M University System; Texas A&M University College Station; Universiti Malaya	Lee, HB (corresponding author), Canc Res Initiat Fdn CARIF, Drug Discovery Lab, Subang Jaya, Selangor, Malaysia.	hongboon.lee@carif.com.my	Burgess, Kevin/B-5372-2015; CHUNG, LIP YONG/B-7764-2010; Lim, Siang Hui/H-2804-2014; KIEW, LIK VOON/B-8789-2010	Burgess, Kevin/0000-0001-6597-1842; CHUNG, LIP YONG/0000-0002-3596-768X; KIEW, LIK VOON/0000-0002-6855-9631; , LEE/0000-0002-0768-2222	Cancer Research Initiatives Foundation; Malaysia Ministry of Higher Education's HIR-MOHE [UM.C/625/1/HIR/MOHE/MED/17, UM.C/625/1/HIR/MOHE/MED/33]; Universiti Malaya [PS204/2010B]; National Institutes of Health [GM087981]; Robert A. Welch Foundation [A-1121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087981] Funding Source: NIH RePORTER	Cancer Research Initiatives Foundation; Malaysia Ministry of Higher Education's HIR-MOHE; Universiti Malaya(Universiti Malaya); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Cancer Research Initiatives Foundation, Malaysia Ministry of Higher Education's HIR-MOHE grants (UM.C/625/1/HIR/MOHE/MED/17 and UM.C/625/1/HIR/MOHE/MED/33), Universiti Malaya Post Graduate Research Grant (PS204/2010B), and by grants to KB from The National Institutes of Health (GM087981) and The Robert A. Welch Foundation (A-1121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken MJ, 2009, CLIN NUCL MED, V34, P762, DOI 10.1097/RLU.0b013e3181b7d76f; Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Ayoola A, 2012, CANCER INVEST, V30, P433, DOI 10.3109/07357907.2012.666691; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Don AS, 2004, TRENDS MOL MED, V10, P372, DOI 10.1016/j.molmed.2004.06.005; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017; Hollingshead MG, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn351; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Kesterson JP, 2010, CHEMOTHERAPY, V56, P108, DOI 10.1159/000312644; Kowaltowski AJ, 1999, J BIOENERG BIOMEMBR, V31, P581, DOI 10.1023/A:1005421112345; Kraut JA, 2012, NAT REV NEPHROL, V8, P589, DOI 10.1038/nrneph.2012.186; Kurtoglu M, 2009, MOL NUTR FOOD RES, V53, P68, DOI 10.1002/mnfr.200700457; LAMPIDIS TJ, 1985, BIOMED PHARMACOTHER, V39, P220; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lim SH, 2009, ANTI-CANCER DRUG, V20, P461, DOI 10.1097/CAD.0b013e32832b7bee; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; MODICANAPOLITANO JS, 1984, BIOCHEM BIOPH RES CO, V118, P717, DOI 10.1016/0006-291X(84)91453-0; MORENO SNJ, 1988, J BIOL CHEM, V263, P12493; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Plowman J, 1997, ANTICANCER DRUG DEV, P101; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Renda F, 2013, EUR REV MED PHARMACO, V17, P45; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Toogood PL, 2008, CURR OPIN CHEM BIOL, V12, P457, DOI 10.1016/j.cbpa.2008.06.002; Wang F, 2010, MOL ASPECTS MED, V31, P75, DOI 10.1016/j.mam.2009.12.003; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu LX, 2008, J ORG CHEM, V73, P8711, DOI 10.1021/jo800902j	32	13	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e82934	10.1371/journal.pone.0082934	http://dx.doi.org/10.1371/journal.pone.0082934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622277	Green Submitted, gold, Green Published			2022-12-25	WOS:000332845300002
J	Loneragan, GH; Thomson, DU; Scott, HM				Loneragan, Guy H.; Thomson, Daniel U.; Scott, H. Morgan			Increased Mortality in Groups of Cattle Administered the beta-Adrenergic Agonists Ractopamine Hydrochloride and Zilpaterol Hydrochloride	PLOS ONE			English	Article							CARCASS CHARACTERISTICS; GROWTH-PERFORMANCE; FINISHING PIGS; ASTHMA; STEERS; METAANALYSIS; BEHAVIOR; TENDERNESS; HEIFERS; IMPACT	The United States Food and Drug Administration (FDA) approved two beta-adrenergic agonists (beta AA) for in-feed administration to cattle fed in confinement for human consumption. Anecdotal reports have generated concern that administration of beta AA might be associated with an increased incidence of cattle deaths. Our objectives, therefore, were to a) quantify the association between beta AA administration and mortality in feedlot cattle, and b) explore those variables that may confound or modify this association. Three datasets were acquired for analysis: one included information from randomized and controlled clinical trials of the beta AA ractopamine hydrochloride, while the other two were observational data on zilpaterol hydrochloride administration to large numbers of cattle housed, fed, and cared for using routine commercial production practices in the U. S. Various population and time at-risk models were developed to explore potential beta AA relationships with mortality, as well as the extent of confounding and effect modification. Measures of effect were relatively consistent across datasets and models in that the cumulative risk and incidence rate of death was 75 to 90% greater in animals administered the beta AA compared to contemporaneous controls. During the exposure period, 40 to 50% of deaths among groups administered the beta AA were attributed to administration of the drug. None of the available covariates meaningfully confounded the relationship between beta AA and increased mortality. Only month of slaughter, presumably a proxy for climate, consistently modified the effect in that the biological association was generally greatest during the warmer months of the year. While death is a rare event in feedlot cattle, the data reported herein provide compelling evidence that mortality is nevertheless increased in response to administration of FDA-approved beta AA and represents a heretofore unquantified adverse drug event.	[Loneragan, Guy H.] Texas Tech Univ, Int Ctr Food Ind Excellence, Dept Anim & Food Sci, Coll Agr & Nat Resources, Lubbock, TX 79409 USA; [Thomson, Daniel U.] Kansas State Univ, Coll Vet Med, Dept Clin Sci, Manhattan, KS 66506 USA; [Scott, H. Morgan] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Texas Tech University System; Texas Tech University; Kansas State University; Kansas State University	Loneragan, GH (corresponding author), Texas Tech Univ, Int Ctr Food Ind Excellence, Dept Anim & Food Sci, Coll Agr & Nat Resources, Lubbock, TX 79409 USA.	Guy.Loneragan@TTU.edu	Scott, Harvey/ABC-9935-2020	Scott, Harvey/0000-0002-0538-5961	Elanco Animal Health, Greenfield, IN	Elanco Animal Health, Greenfield, IN	Initial funding for the evaluation of an association of ractopamine hydrochloride with death loss was provided by Elanco Animal Health, Greenfield, IN. In preparation for manuscript development, further analyses of ractopamine hydrochloride data and all analyses of zilpaterol hydrochloride data were performed solely in the service of the first author's employment at Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano-Reyes L, 2011, J ANIM SCI, V89, P4188, DOI 10.2527/jas.2011-3904; Babcock AH, 2013, PREV VET MED, V108, P38, DOI 10.1016/j.prevetmed.2012.07.008; Baszczak JA, 2006, J ANIM SCI, V84, P3410, DOI 10.2527/jas.2006-167; Beasley R, 2006, J ALLERGY CLIN IMMUN, V117, P225, DOI 10.1016/j.jaci.2005.10.029; Bohrer BM, 2013, J ANIM SCI, V91, P1015, DOI 10.2527/jas.2012-5647; Brown, 2006, APPL MIXED MODELS ME; Bryant TC, 2010, J ANIM SCI, V88, P4102, DOI 10.2527/jas.2010-2901; Capper JL, 2012, J ANIM SCI, V90, P3527, DOI 10.2527/jas.2011-4870; GUZY PM, 1977, WESTERN J MED, V127, P455; Health and Human Services Food and Drug Administration website, FREED INF SUMM OR NE; Hilton GG, 2009, J ANIM SCI, V87, P1394, DOI 10.2527/jas.2008-1170; Kononoff PJ, 2013, J ANIM SCI, V91, P5011, DOI 10.2527/jas.2012-5229; Loneragan GH, 2001, J AM VET MED ASSOC, V219, P1122, DOI 10.2460/javma.2001.219.1122; Marchant-Forde JN, 2003, J ANIM SCI, V81, P416; MCDERMOTT JJ, 1994, PREV VET MED, V18, P155, DOI 10.1016/0167-5877(94)90073-6; MCDERMOTT JJ, 1994, PREV VET MED, V18, P175, DOI 10.1016/0167-5877(94)90074-4; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Poletto R, 2009, J ANIM SCI, V87, P304, DOI 10.2527/jas.2008-1188; Poletto R, 2010, J ANIM SCI, V88, P1184, DOI 10.2527/jas.2008-1576; Rathmann RJ, 2012, J ANIM SCI, V90, P3301, DOI 10.2527/jas.2011-4375; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2010, EXPERT OPIN DRUG SAF, V9, P407, DOI 10.1517/14740330903535852; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Scramlin SM, 2010, J ANIM SCI, V88, P1823, DOI 10.2527/jas.2009-2405; Stryhn H., 2009, VET EPIDEMIOLOGIC RE, V2nd; University of Bristol Centre for Multilevel Modeling website, US GUID MLWIN VERS 2; Wagner SA, 2008, J EQUINE VET SCI, V28, P238, DOI 10.1016/j.jevs.2008.02.006	28	33	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91177	10.1371/journal.pone.0091177	http://dx.doi.org/10.1371/journal.pone.0091177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621596	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300057
J	Hardy, S; Uetani, N; Wong, N; Kostantin, E; Labbe, DP; Begin, LR; Mes-Masson, A; Miranda-Saavedra, D; Tremblay, ML				Hardy, S.; Uetani, N.; Wong, N.; Kostantin, E.; Labbe, D. P.; Begin, L. R.; Mes-Masson, A.; Miranda-Saavedra, D.; Tremblay, M. L.			The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis	ONCOGENE			English	Article							REGENERATING LIVER; CELL-MIGRATION; CANCER; MG2+; METASTASIS; IDENTIFICATION; PROLIFERATION; PURIFICATION; STIMULATION; MECHANISMS	The three PRL (phosphatases of regenerating liver) protein tyrosine phosphatases (PRL-1, -2 and -3) have been identified as key contributors to metastasis in several human cancers, yet the molecular basis of their pro-oncogenic property is unclear. Among the subfamily of PRL phosphatases, overexpression of PRL-2 in breast cancer cells has been shown to promote tumor growth by a mechanism that remains to be uncovered. Here we show that PRL-2 regulates intracellular magnesium levels by forming a functional heterodimer with the magnesium transporter CNNM3. We further reveal that CNNM3 is not a phosphorylated substrate of PRL-2, and that the interaction occurs through a loop unique to the CBS pair domains of CNNM3 that exists only in organisms having PRL orthologs. Supporting the role of PRL-2 in cellular magnesium transport is the observation that PRL-2 knockdown results in a substantial decrease of cellular magnesium influx. Furthermore, in PRL-2 knockout mice, serum magnesium levels were significantly elevated as compared with control animals, indicating a pivotal role for PRL-2 in regulating cellular magnesium homeostasis. Although the expression levels of CNNM3 remained unchanged after magnesium depletion of various cancer cell lines, the interaction between endogenous PRL-2 and CNNM3 was markedly increased. Importantly, xenograft tumor assays with CNNM3 and a mutant form that does not associate with PRL-2 confirm that CNNM3 is itself pro-oncogenic, and that the PRL-2/CNNM3 association is important for conferring transforming activities. This finding is further confirmed from data in human breast cancer tissues showing that CNNM3 levels correlate positively with both PRL-2 expression and the tumor proliferative index. In summary, we demonstrate that oncogenic PRL-2 controls tumor growth by modulating intracellular magnesium levels through binding with the CNNM3 magnesium transporter.	[Hardy, S.; Uetani, N.; Wong, N.; Kostantin, E.; Labbe, D. P.; Tremblay, M. L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Wong, N.; Kostantin, E.; Tremblay, M. L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Labbe, D. P.; Tremblay, M. L.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Begin, L. R.] Hop Sacre Coeur, Serv Anatomopathol, Montreal, PQ H4J 1C5, Canada; [Mes-Masson, A.] Univ Montreal, CR CHUM, Inst Canc Montreal, Montreal, PQ, Canada; [Mes-Masson, A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Miranda-Saavedra, D.] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Miranda-Saavedra, D.] Newcastle Univ, Sch Med, Inst Cellular Med, Fibrosis Labs, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Osaka University; Newcastle University - UK	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Canc Res Bldg,1160 Pine Ave West, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca	Labbé, David P./C-2702-2009	Labbé, David P./0000-0001-8864-8765; Mes-Masson, Anne-Marie/0000-0002-6498-266X	Canadian Institute of Health Research (CIHR); CIHR/Fonds de recherche du Quebec-Sante Training Grant in Cancer Research [FRN53888]; Quebec Breast Cancer Foundation; Canadian Breast Cancer Research Alliance	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Fonds de recherche du Quebec-Sante Training Grant in Cancer Research; Quebec Breast Cancer Foundation; Canadian Breast Cancer Research Alliance	We thank Dr Laurent Lessard (J. Wayne Cancer Institute) for his technical help. Dr Kalle Gehring, biochemistry department, McGill University for helpful discussion and colleagues at the Goodman Cancer Research Centre Drs Jose Teodoro and Jerry Pelletier for their constructive comments on the manuscript. MLT is a Jeanne and Jean-Louis Levesque chair in Cancer Research. DPL is a recipient of Canadian Institute of Health Research (CIHR) Frederick Banting and Charles Best Doctoral Research award and of CIHR/Fonds de recherche du Quebec-Sante Training Grant in Cancer Research FRN53888 the McGill Integrated Cancer Research Training Program. This research is supported by an operating grant from the Quebec Breast Cancer Foundation and the Canadian Breast Cancer Research Alliance to MLT.	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Castiglioni S, 2011, MAGNESIUM RES, V24, pS92, DOI 10.1684/mrh.2011.0285; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Chen SD, 2010, CHINESE MED J-PEKING, V123, P1447, DOI 10.3760/cma.j.issn.0366-6999.2010.11.018; DAI LJ, 1991, J CLIN INVEST, V88, P1255, DOI 10.1172/JCI115429; Dai LJ, 1997, AM J PHYSIOL-RENAL, V272, pF249, DOI 10.1152/ajprenal.1997.272.2.F249; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Dumaual CM, 2006, J HISTOCHEM CYTOCHEM, V54, P1401, DOI 10.1369/jhc.6A7019.2006; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Gomez-Garcia I, 2012, ACTA CRYSTALLOGR F, V68, P1198, DOI 10.1107/S1744309112035348; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardy S, 2012, ANTI-CANCER AGENT ME, V12, P4, DOI 10.2174/187152012798764741; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Ikari A, 2010, LIFE SCI, V86, P766, DOI 10.1016/j.lfs.2010.03.016; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Krndija D, 2012, J CELL SCI, V125, P3883, DOI 10.1242/jcs.104885; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Skinner AL, 2009, BIOCHEMISTRY-US, V48, P4262, DOI 10.1021/bi900241k; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang JY, 2011, J BIOL CHEM, V286, P10177, DOI 10.1074/jbc.M110.163295; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Wolf FI, 2012, CLIN SCI, V123, P417, DOI 10.1042/CS20120086; Wolf FI, 2004, FRONT BIOSCI-LANDMRK, V9, P2056, DOI 10.2741/1389; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291	45	75	78	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					986	995		10.1038/onc.2014.33	http://dx.doi.org/10.1038/onc.2014.33			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632616				2022-12-25	WOS:000350121300005
J	Martin, Y; Cabrera, E; Amoedo, H; Hernandez-Perez, S; Dominguez-Kelly, R; Freire, R				Martin, Y.; Cabrera, E.; Amoedo, H.; Hernandez-Perez, S.; Dominguez-Kelly, R.; Freire, R.			USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination	ONCOGENE			English	Article							DNA-DAMAGE-RESPONSE; REPEATED PHOSPHOPEPTIDE MOTIFS; CELL-CYCLE; REPLICATION; CHK1; PHOSPHORYLATION; DESTRUCTION; DEGRADATION; ACTIVATION; BINDING	The DNA damage checkpoint is essential for the maintenance of genome integrity after genotoxic stress, and also for cell survival in eukaryotes. Claspin has a key role in the ATR (ATM and Rad3-related)-Chk1 branch of the DNA damage checkpoint and is also required for correct DNA replication. To achieve properly these functions, Claspin is tightly regulated by ubiquitinin-dependent proteasomal degradation, which controls Claspin levels in a DNA-damage- and cell-cycle-dependent manner. Here, we identified a new regulator of Claspin, the ubiquitin-specific peptidase 29, USP29. Downregulation of USP29 destabilizes Claspin, whereas its overexpression promotes an increase in Claspin levels. USP29 interacts with Claspin and is able to deubiquitinate it both in vivo and in vitro. Most importantly, USP29 knockdown results in an impaired phosphorylation of Chk1 after DNA damage and USP29-depleted cells show a major defect in the S-phase progression. With these results, we identified USP29 as a new player in the ATR-Chk1 pathway and the control of DNA replication.	[Martin, Y.; Cabrera, E.; Amoedo, H.; Hernandez-Perez, S.; Dominguez-Kelly, R.; Freire, R.] Hosp Univ Canarias, Unidad Invest, Inst Tecnol Biomed, Tenerife 38320, Spain	Universidad de la Laguna	Freire, R (corresponding author), Hosp Univ Canarias, Unidad Invest, Ofra S-N, Tenerife 38320, Spain.	rfreire@ull.es	Freire, Raimundo/Q-7660-2019; Cabrera, Elisa/GPX-3455-2022	Freire, Raimundo/0000-0003-4473-8894; 	Spanish MINECO [SAF2010-22357, CONSOLIDER-Ingenio 2010 CDS2007-0015]	Spanish MINECO(Spanish Government)	We are grateful to V Smits for careful reading of the manuscript. We thank G Marfany, JW Harper and D Bohmann for helpful reagents. This work was supported by grants from the Spanish MINECO (SAF2010-22357, CONSOLIDER-Ingenio 2010 CDS2007-0015).	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Freire R, 2006, CELL CYCLE, V5, P2831, DOI 10.4161/cc.5.24.3559; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Perez-Castro AJ, 2012, J CELL SCI, V125, P1152, DOI 10.1242/jcs.091124; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Meng Z, 2011, MOL BIOL CELL, V22, P2834, DOI 10.1091/mbc.E11-01-0048; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Refolio E, 2011, J CELL SCI, V124, P2488, DOI 10.1242/jcs.081711; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smits VAJ, 2010, FRONT BIOSCI-LANDMRK, V15, P840, DOI 10.2741/3649; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	37	47	49	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1058	1063		10.1038/onc.2014.38	http://dx.doi.org/10.1038/onc.2014.38			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632611				2022-12-25	WOS:000350121300012
J	Mayes, J; Tinker-Mill, C; Kolosov, O; Zhang, H; Tabner, BJ; Allsop, D				Mayes, Jennifer; Tinker-Mill, Claire; Kolosov, Oleg; Zhang, Hao; Tabner, Brian J.; Allsop, David			beta-Amyloid Fibrils in Alzheimer Disease Are Not Inert When Bound to Copper Ions but Can Degrade Hydrogen Peroxide and Generate Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Free Radicals; Hydrogen Peroxide; Oxidative Stress; Reactive Oxygen Species (ROS); -Amyloid; Copper Ions; Peptide Aggregation; Zinc Ions	A-BETA; HYDROXYL RADICALS; OXIDATIVE DAMAGE; ALPHA-SYNUCLEIN; PROTEIN; AGGREGATION; PEPTIDE; OLIGOMERS; MECHANISM; BINDING	Background: Metal-associated -amyloid (A) aggregates are implicated in the pathogenesis of Alzheimer disease. Results: Copper bound A(1-42) aggregates, including fibrils, degrade hydrogen peroxide, forming hydroxyl radicals and carbonyls. Conclusion: Copper-bound A fibrils can retain redox activity. Significance: A fibrils bound to copper are not inert end points and may be a source of oxidative stress in the Alzheimer brain. According to the amyloid cascade hypothesis of Alzheimer disease, the formation of A fibrils and senile plaques in the brain initiates a cascade of events leading to the formation of neurofibrillary tangles, neurodegeneration, and the symptom of dementia. Recently, however, emphasis has shifted away from amyloid fibrils as the predominant toxic form of A toward smaller aggregates, referred to as soluble oligomers. These oligomers have become one of the prime suspects for involvement in the early oxidative damage that is evident in this disease. This raises the question whether or not A fibrils are actually inert tombstones present at the end of the aggregation process. Here we show that, when A(1-42) aggregates, including fibrils, are bound to Cu(II) ions, they retain their redox activity and are able to degrade hydrogen peroxide (H2O2) with the formation of hydroxyl radicals and the consequent oxidation of the peptide (detected by formation of carbonyl groups). We find that this ability increases as the Cu(II):peptide ratio increases and is accompanied by changes in aggregate morphology, as determined by atomic force microscopy. When aggregates are prepared in the copresence of Cu(II) and Zn(II) ions, the ratio of Cu(II):Zn(II) becomes an important factor in the degeneration of H2O2, the formation of carbonyl groups in the peptide, and in aggregate morphology. We believe, therefore, that A fibrils can destroy H2O2 and generate damaging hydroxyl radicals and, so, are not necessarily inert end points.	[Mayes, Jennifer; Tabner, Brian J.; Allsop, David] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster LA1 4YQ, England; [Tinker-Mill, Claire; Kolosov, Oleg] Univ Lancaster, Dept Phys, Fac Sci & Technol, Lancaster LA1 4YQ, England; [Zhang, Hao] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England	Lancaster University; Lancaster University; Lancaster University	Allsop, D (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster LA1 4YQ, England.	d.allsop@lancaster.ac.uk	Kolosov, Oleg V/D-3815-2013; Allsop, David/B-9725-2008; Zhang, Hao/HHM-1940-2022; Zhang, Hao/E-5375-2010	Kolosov, Oleg V/0000-0003-3278-9643; Allsop, David/0000-0002-0513-5575; Tinker-Mill, Claire/0000-0002-1981-3111	Sir John Fisher Foundation; Engineering and Physical Sciences Research Council [1064552, EP/K023373/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish; EPSRC [EP/K023373/1] Funding Source: UKRI	Sir John Fisher Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by The Sir John Fisher Foundation.	Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dasgupta A, 2012, ASN NEURO, V4, DOI 10.1042/AN20110064; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hewitt N, 2009, J PHYS CHEM B, V113, P1202, DOI 10.1021/jp807327a; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kiselyova O., 2004, METH MOL B, V242, P217; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; Markesbery WR, 2005, ANN NEUROL, V58, P730, DOI 10.1002/ana.20629; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nunomura A, 2009, ACTA NEUROPATHOL, V118, P151, DOI 10.1007/s00401-009-0508-1; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Riederer BM, 2013, EXP BIOL MED, V238, P519, DOI 10.1177/1535370213488484; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Tabner B. J., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/546380; Tabner BJ, 2005, BIOCHEM SOC T, V33, P1082, DOI 10.1042/BST0331082; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Tabner Brian J., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P299, DOI 10.2174/1568013033483249; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Turnbull S, 2001, FREE RADICAL BIO MED, V30, P1163, DOI 10.1016/S0891-5849(01)00513-5; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	61	76	80	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12052	12062		10.1074/jbc.M113.525212	http://dx.doi.org/10.1074/jbc.M113.525212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619420	Green Published, hybrid			2022-12-25	WOS:000335010600043
J	Collins, IJ; Cairns, J; Ngo-Giang-Huong, N; Sirirungsi, W; Leechanachai, P; Le Coeur, S; Samleerat, T; Kamonpakorn, N; Mekmullica, J; Jourdain, G; Lallemant, M				Collins, Intira Jeannie; Cairns, John; Ngo-Giang-Huong, Nicole; Sirirungsi, Wasna; Leechanachai, Pranee; Le Coeur, Sophie; Samleerat, Tanawan; Kamonpakorn, Nareerat; Mekmullica, Jutarat; Jourdain, Gonzague; Lallemant, Marc		Programme For Hiv Prevention Treat	Cost-Effectiveness of Early Infant HIV Diagnosis of HIV-Exposed Infants and Immediate Antiretroviral Therapy in HIV-Infected Children under 24 Months in Thailand	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; DRIED BLOOD SPOTS; DISEASE PROGRESSION; NATIONAL GUIDELINES; ECONOMIC-EVALUATION; MORTALITY; TRANSMISSION; OUTCOMES; CARE	Background: HIV-infected infants have high risk of death in the first two years of life if untreated. WHO guidelines recommend early infant HIV diagnosis (EID) of all HIV-exposed infants and immediate antiretroviral therapy (ART) in HIV-infected children under 24-months. We assessed the cost-effectiveness of this strategy in HIV-exposed non-breastfed children in Thailand. Methods: A decision analytic model of HIV diagnosis and disease progression compared: EID using DNA PCR with immediate ART (Early-Early); or EID with deferred ART based on immune/clinical criteria (Early-Late); vs. clinical/serology based diagnosis and deferred ART (Reference). The model was populated with survival and cost data from a Thai observational cohort and the literature. Incremental cost-effectiveness ratio per life-year gained (LYG) was compared against the Reference strategy. Costs and outcomes were discounted at 3%. Results: Mean discounted life expectancy of HIV-infected children increased from 13.3 years in the Reference strategy to 14.3 in the Early-Late and 17.8 years in Early-Early strategies. The mean discounted lifetime cost was $17,335, $22,583 and $29,108, respectively. The cost-effectiveness ratio of Early-Late and Early-Early strategies was $5,149 and $2,615 per LYG, respectively as compared to the Reference strategy. The Early-Early strategy was most cost-effective at approximately half the domestic product per capita per LYG ($4,420 in Thailand 2011). The results were robust in deterministic and probabilistic sensitivity analyses including varying perinatal transmission rates. Conclusion: In Thailand, EID and immediate ART would lead to major survival benefits and is cost-effective. These findings strongly support the adoption of WHO recommendations as routine care.	[Collins, Intira Jeannie] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Collins, Intira Jeannie; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Jourdain, Gonzague; Lallemant, Marc] IRD PHPT, Chiang Mai, Thailand; [Collins, Intira Jeannie; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Jourdain, Gonzague; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Cairns, John] London Sch Hyg Trop Med, Fac Publ Hlth & Policy, London, England; [Ngo-Giang-Huong, Nicole; Sirirungsi, Wasna; Leechanachai, Pranee; Le Coeur, Sophie; Samleerat, Tanawan; Jourdain, Gonzague; Lallemant, Marc] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai, Thailand; [Le Coeur, Sophie] Univ Paris 05, INED IRD, Ctr Francais Populat & Dev, Unite Mixte Rech 196, Paris, France; [Kamonpakorn, Nareerat] Somdej Prapinklao Hosp, Dept Paediat, Bangkok, Thailand; [Mekmullica, Jutarat] Bhumibol Adulyadej Hosp, Dept Paediat, Bangkok, Thailand	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Chiang Mai University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Collins, IJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	jeannie.collins@ucl.ac.uk	Jourdain, Gonzague/F-9117-2017; Collins, Intira Jeannie/I-5048-2019; Cairns, John/AAD-1168-2020; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; Collins, Intira Jeannie/0000-0003-2132-6037; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234	Global Fund to fight AIDS, Tuberculosis and Malaria (Thailand Grant Round 1) [PR-A-N-008]; Institut de Recherche pour le Developpement (IRD), France; International Maternal Pediatric Adolescents Aids Clinical Trials Group (IMPAACT); National Institutes of Health, US [R01 HD 33326, R01 HD 39615]; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; United Kingdom Medical Research Council Doctoral Training Account Studentship for Intira Collins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039615, R01HD033326] Funding Source: NIH RePORTER	Global Fund to fight AIDS, Tuberculosis and Malaria (Thailand Grant Round 1); Institut de Recherche pour le Developpement (IRD), France; International Maternal Pediatric Adolescents Aids Clinical Trials Group (IMPAACT); National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; United Kingdom Medical Research Council Doctoral Training Account Studentship for Intira Collins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Grant support: The Global Fund to fight AIDS, Tuberculosis and Malaria (Thailand Grant Round 1 sub recipient PR-A-N-008); Institut de Recherche pour le Developpement (IRD), France; International Maternal Pediatric Adolescents Aids Clinical Trials Group (IMPAACT); The National Institutes of Health, US (R01 HD 33326; R01 HD 39615); Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; United Kingdom Medical Research Council Doctoral Training Account Studentship for Intira Collins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2012, 19 INT AIDS C WASH D; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Binagwaho A, 2013, J PUBLIC HEALTH POL, V34, P2, DOI 10.1057/jphp.2012.62; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Briggs A, 2006, DECISION MODELLING H; Chearskul S, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e25; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Clinton Foundation, 2009, HIV AIDS DIAGN PRIC; Collins I, 2013, JAIDS-J ACQ IMM DEF, V64, P95, DOI 10.1097/QAI.0b013e318298a309; Collins IJ, 2012, AIDS, V26, P1943, DOI 10.1097/QAD.0b013e328357f7b9; Collins IJ, 2010, CLIN INFECT DIS, V51, P1449, DOI 10.1086/657401; Deeks SG, 2013, LANCET; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Goetghebuer T, 2012, CLIN INFECT DIS, V54, P878, DOI 10.1093/cid/cir950; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Judd A, 2011, AIDS, V25, P2279, DOI 10.1097/QAD.0b013e32834d614c; Kim M, 2011, 6 IAS C HIV PATH TRE; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Meyer-Rath G, 2010, 18 INT AIDS C VIENN; Naiwatanakul T, 2012, 19 INT AIDS C WASH D; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ngo-Giang-Huong N, 2008, JAIDS-J ACQ IMM DEF, V49, P465, DOI 10.1097/QAI.0b013e31818e2531; Patel K, 2008, CLIN INFECT DIS, V46, P1751, DOI 10.1086/587900; Persaud D, 2013, 20 C RETR OPP INF CR; Phanuphak N, 2010, ASIAN BIOMED, V4, P529, DOI 10.2478/abm-2010-0067; Plipat T, 2007, AIDS, V21, P145, DOI 10.1097/QAD.0b013e328010e02d; Puthanakit T, 2013, PEDIAT INFECT DIS J; Puthanakit T, 2010, ASIAN BIOMED, V4, P505, DOI 10.2478/abm-2010-0065; Ruel TD, 2012, CLIN INFECT DIS, V54, P1001, DOI 10.1093/cid/cir1037; Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Schneider K, 2011, AIDS, V25, P1143, DOI 10.1097/QAD.0b013e3283466fab; Shapiro D, 2011, 18 INT AIDS C ROM IT; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Sirirungsi W, 2013, 5 INT WORKSH HIV PED; Smith R, 2012, PEDIATR INFECT DIS J, V31, P592, DOI 10.1097/INF.0b013e318253844b; Sturt AS, 2012, PEDIATR INFECT DIS J, V31, P53, DOI 10.1097/INF.0b013e31823515a2; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Teerawattananon Yot, 2005, Cost Eff Resour Alloc, V3, P7, DOI 10.1186/1478-7547-3-7; Teerawattananon Yot, 2008, J Med Assoc Thai, V91 Suppl 2, pS11; TOVO PA, 1992, LANCET, V339, P1249, DOI 10.1016/0140-6736(92)91592-V; UNAIDS, 2021, PREV HIV INF TIM NEW; UNAIDS, 2012, TOG WE WILL END AIDS; UNITAID, 2012, HIV AIDS DIAGN TECHN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; *WHO, 2008, WHO TECHN REF GROUP; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization, 2003, MAKING CHOICES HLTH	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91004	10.1371/journal.pone.0091004	http://dx.doi.org/10.1371/journal.pone.0091004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632750	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000332858400032
J	Halder, K; Banerjee, S; Bose, A; Majumder, S; Majumdar, S				Halder, Kuntal; Banerjee, Sayantan; Bose, Anamika; Majumder, Saikat; Majumdar, Subrata			Overexpressed PKC delta Downregulates the Expression of PKC alpha in B16F10 Melanoma: Induction of Apoptosis by PKC delta via Ceramide Generation	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHOLIPASE-D ACTIVITY; BREAST-CANCER CELLS; AKT DEPHOSPHORYLATION; ACID SPHINGOMYELINASE; SIGNAL-TRANSDUCTION; ISOFORMS; PROLIFERATION; ACTIVATION; PHOSPHORYLATION	In the present study, we observed a marked variation in the expression of PKC alpha and PKC delta isotypes in B16F10 melanoma tumor cells compared to the normal melanocytes. Interestingly, the tumor instructed expression or genetically manipulated overexpression of PKC alpha isotype resulted in enhanced G1 to S transition. This in turn promoted cellular proliferation by activating PLD1 expression and subsequent AKT phosphorylation, which eventually resulted in suppressed ceramide generation and apoptosis. On the other hand, B16F10 melanoma tumors preferentially blocked the expression of PKC delta isotype, which otherwise could exhibit antagonistic effects on PKC alpha-PLD1-AKT signaling and rendered B16F10 cells more sensitive to apoptosis via generating ceramide and subsequently triggering caspase pathway. Hence our data suggested a reciprocal PKC signaling operational in B16F10 melanoma cells, which regulates ceramide generation and provide important clues to target melanoma cancer by manipulating the PKC delta-ceramide axis.	[Halder, Kuntal; Banerjee, Sayantan; Bose, Anamika; Majumder, Saikat; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet.in	Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019	Majumder, Saikat/0000-0002-6591-9515; 				Bhattacharyya S, 2001, MOL CELL BIOCHEM, V216, P47, DOI 10.1023/A:1011048210691; Bieberich E, 2008, FUTURE LIPIDOL, V3, P273, DOI 10.2217/17460875.3.3.273; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENS MJ, 1992, J CELL SCI, V103, P881; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; da Rocha AB, 2002, ONCOLOGIST, V7, P17, DOI 10.1634/theoncologist.7-1-17; Dbaibo GS, 1998, APOPTOSIS, V3, P317, DOI 10.1023/A:1009668802718; Dey R, 2007, INFECT IMMUN, V75, P2136, DOI 10.1128/IAI.01589-06; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Foster DA, 2003, MOL CANCER RES, V1, P789; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; GOODNIGHT J, 1994, ADV CANCER RES, V64, P159, DOI 10.1016/S0065-230X(08)60838-6; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Haughian JM, 2006, ENDOCR-RELAT CANCER, V13, P1251, DOI 10.1677/erc.1.01278; Haughian JM, 2009, J CELL PHYSIOL, V220, P112, DOI 10.1002/jcp.21741; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Huang WC, 2011, J LIPIDS, V2011, DOI 10.1155/2011/565316; JONES MJ, 1995, J BIOL CHEM, V270, P5007, DOI 10.1074/jbc.270.10.5007; Kim NH, 2007, J CELL BIOCHEM, V102, P1160, DOI 10.1002/jcb.21344; Kim SW, 2010, J TOXICOL ENV HEAL A, V73, P1465, DOI 10.1080/15287394.2010.511553; Lahn MM, 2004, MELANOMA RES, V14, P85, DOI 10.1097/00008390-200404000-00002; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Mandil R, 2011, CANCER RES, V61, P4612; Marengo Barbara, 2011, Cancers (Basel), V3, P531, DOI 10.3390/cancers3010531; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Morse-Gaudio M, 1998, INT J ONCOL, V12, P1349; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oka M, 2003, J INVEST DERMATOL, V121, P69, DOI 10.1046/j.1523-1747.2003.12300.x; Osawa Y, 2013, J CLIN INVEST, V123, P834, DOI 10.1172/JCI65188; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Visnjic D, 1999, BIOCHEM J, V344, P921, DOI 10.1042/0264-6021:3440921; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	48	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91656	10.1371/journal.pone.0091656	http://dx.doi.org/10.1371/journal.pone.0091656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632809	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400075
J	van Hooren, KWEM; Spijkers, LJA; van Breevoort, D; Fernandez-Borja, M; Bierings, R; van Buul, JD; Alewijnse, AE; Peters, SLM; Voorberg, J				van Hooren, Kathinka W. E. M.; Spijkers, Leon J. A.; van Breevoort, Dorothee; Fernandez-Borja, Mar; Bierings, Ruben; van Buul, Jaap D.; Alewijnse, Astrid E.; Peters, Stephan L. M.; Voorberg, Jan			Sphingosine-1-Phosphate Receptor 3 Mediates Sphingosine-1-Phosphate Induced Release of Weibel-Palade Bodies from Endothelial Cells	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; CARDIOVASCULAR-SYSTEM; LYMPHOCYTE EGRESS; BODY EXOCYTOSIS; SECRETION; KINASE; S1P; PERMEABILITY; STIMULATION; VASOPRESSIN	Sphingosine-1-phosphate (S1P) is an agonist for five distinct G-protein coupled receptors, that is released by platelets, mast cells, erythrocytes and endothelial cells. S1P promotes endothelial cell barrier function and induces release of endothelial cell-specific storage-organelles designated Weibel-Palade bodies (WPBs). S1P-mediated enhancement of endothelial cell barrier function is dependent on S1P receptor 1 (S1PR1) mediated signaling events that result in the activation of the small GTPase Rac1. Recently, we have reported that Rac1 regulates epinephrine-induced WPB exocytosis following its activation by phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 (PREX1). S1P has also been described to induce WPB exocytosis. Here, we confirm that S1P induces release of WPBs using von Willebrand factor (VWF) as a marker. Using siRNA mediated knockdown of gene expression we show that S1PR1 is not involved in S1P-mediated release of WPBs. In contrast depletion of the S1PR3 greatly reduced S1P-induced release of VWF. S1P-mediated enhancement of endothelial barrier function was not affected by S1PR3-depletion whereas it was greatly impaired in cells lacking S1PR1. The Rho kinase inhibitor Y27632 completely abrogated S1P-mediated release of VWF. Also, the calcium chelator BAPTA-AM significantly reduced S1P-induced release of VWF. Our findings indicate that S1P-induced release of haemostatic, inflammatory and angiogenic components stored within WPBs depends on the S1PR3.	[van Hooren, Kathinka W. E. M.; van Breevoort, Dorothee; Bierings, Ruben; Voorberg, Jan] Sanquin AMC Landsteiner Lab, Dept Plasma Proteins, Amsterdam, Netherlands; [Spijkers, Leon J. A.; Alewijnse, Astrid E.; Peters, Stephan L. M.] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands; [Fernandez-Borja, Mar; van Buul, Jaap D.] Sanquin AMC Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Voorberg, J (corresponding author), Sanquin AMC Landsteiner Lab, Dept Plasma Proteins, Amsterdam, Netherlands.	j.voorberg@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021; Bierings, Ruben/AAQ-8854-2020	van Buul, Jaap D/0000-0003-0054-7949; Bierings, Ruben/0000-0002-1205-9689; Voorberg, Jan/0000-0003-4585-2621; van Breevoort, Dorothee/0000-0003-3122-0252	Landsteiner Foundation for Blood Transfusion Research [LSBR 08.19, LSBR 12.44]; European Hematology Association Research Fellowship	Landsteiner Foundation for Blood Transfusion Research; European Hematology Association Research Fellowship	This study was supported by grants from the Landsteiner Foundation for Blood Transfusion Research (LSBR 08.19, LSBR 12.44). RB was supported by a European Hematology Association Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewijnse AE, 2008, EUR J PHARMACOL, V585, P292, DOI 10.1016/j.ejphar.2008.02.089; An SZ, 1999, MOL PHARMACOL, V55, P787; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Brinkmann V, 2006, CURR OPIN PHARMACOL, V6, P244, DOI 10.1016/j.coph.2005.12.004; Curry FE, 2012, AM J PHYSIOL-HEART C, V303, pH825, DOI 10.1152/ajpheart.00181.2012; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hsieh HL, 2006, J CELL PHYSIOL, V207, P757, DOI 10.1002/jcp.20621; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Kozasa T, 1998, SEIKAGAKU, V70, P1418; Kumagai A, 2008, ATHEROSCLEROSIS, V200, P45, DOI 10.1016/j.atherosclerosis.2007.12.010; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsushita K, 2004, P NATL ACAD SCI USA, V101, P11483, DOI 10.1073/pnas.0400185101; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR; Nightingale TD, 2012, TRENDS CELL BIOL, V22, P329, DOI 10.1016/j.tcb.2012.03.003; Ono Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-20; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Ozaka T, 1997, ANAT REC, V247, P388, DOI 10.1002/(SICI)1097-0185(199703)247:3<388::AID-AR10>3.0.CO;2-L; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Russell FD, 1998, CIRC RES, V83, P314, DOI 10.1161/01.RES.83.3.314; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; STEL HV, 1984, BLOOD, V63, P1408; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tanski W, 2002, J SURG RES, V108, P98, DOI 10.1006/jsre.2002.6529; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; van Breevoort D, 2012, J PROTEOME RES, V11, P2925, DOI 10.1021/pr300010r; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; van Hooren KW, 2013, J THROMB HAEMOST; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Zhang L, 2013, BLOOD, V122, P791, DOI 10.1182/blood-2012-12-473884	48	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91346	10.1371/journal.pone.0091346	http://dx.doi.org/10.1371/journal.pone.0091346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632890	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400057
J	Wartolowska, K; Beard, DJ; Carr, AJ				Wartolowska, Karolina; Beard, David J.; Carr, Andrew J.			Attitudes and Beliefs about Placebo Surgery among Orthopedic Shoulder Surgeons in the United Kingdom	PLOS ONE			English	Article							CLINICAL-PRACTICE; SHAM SURGERY; QUESTIONNAIRE SURVEY; CONTROLLED TRIAL; INTERVENTIONS	Objectives: To survey surgeons on their beliefs and attitudes towards the use of placebo in surgery. Methods: British orthopedic shoulder surgeons, attending a national conference in the United Kingdom, were asked to complete a self-report online questionnaire about their beliefs and attitudes towards the use of placebo related to surgical intervention. The survey included questions about ethical issues, the mechanism of placebo effects, and any concerns regarding its use. Results: 100 surgeons who participated in the survey believed that placebo surgery is ethically acceptable (96%), especially as a part of a clinical trial (46%). Respondents thought that a placebo effect in surgery is real i.e. has a scientific basis (92%), that placebo can be therapeutically beneficial (77%), and that it involves psychological mechanisms (96%). Over half of the respondents (58%) have used a surgical procedure with a significant placebo component at least once in their professional career. Their main concern about placebo use in surgery was that it might involve an element of deception. Conclusions and Implications: Surgeons generally agreed that a placebo component to surgical intervention might exist. They also supported placebo use in clinical trials and considered it ethical, providing it does not involve deception of patients. More studies are needed, particularly among other surgical specialties and with larger numbers of participants, to better understand the use of placebo in surgery.	[Wartolowska, Karolina; Beard, David J.; Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Botnar Inst Musculoskeletal Sci, Oxford, England	University of Oxford	Wartolowska, K (corresponding author), Univ Oxford, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Botnar Inst Musculoskeletal Sci, Oxford, England.	karolina.wartolowska@ndorms.ox.ac.uk	Wartolowska, Karolina/D-3968-2015	Beard, David/0000-0001-7884-6389; Wartolowska, Karolina A./0000-0003-4049-2364	NIHR Musculoskeletal Biomedical Research Unit; National Institute for Health Research [NF-SI-0611-10216] Funding Source: researchfish	NIHR Musculoskeletal Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the NIHR Musculoskeletal Biomedical Research Unit. The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.	Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Campbell MK, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-50; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; England TRCoSo, 2011, SURG WORKF CENS REP; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Frank SA, 2008, MOVEMENT DISORD, V23, P63, DOI 10.1002/mds.21775; Gelijns AC, 2009, SURGERY, V145, P581, DOI 10.1016/j.surg.2009.04.003; Horng S, 2003, CRIT CARE MED, V31, pS126, DOI 10.1097/01.CCM.0000054906.49187.67; Howes N, 1997, BRIT J SURG, V84, P1220; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hull SC, 2013, BMJ, V347; Kim SYH, 2012, MOVEMENT DISORD, V27, P1461, DOI 10.1002/mds.25155; Macklin R, 1999, NEW ENGL J MED, V341, P992, DOI 10.1056/NEJM199909233411312; Miller FG, 2003, AM J BIOETHICS, V3, P41, DOI 10.1162/152651603322614580; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Raz A, 2011, CAN J PSYCHIAT, V56, P198, DOI 10.1177/070674371105600403; SHAPIRO AK, 1960, J NERV MENT DIS, V130, P200, DOI 10.1097/00005053-196003000-00003; SHAPIRO AK, 1973, COMPR PSYCHIAT, V14, P107, DOI 10.1016/0010-440X(73)90003-5; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Tenery R, 2002, ANN SURG, V235, P303, DOI 10.1097/00000658-200202000-00021; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Wenner DM, 2012, J AM COLL SURGEONS, V215, P722, DOI 10.1016/j.jamcollsurg.2012.06.018; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright JG, 2011, J BONE JOINT SURG AM, V93A, P510, DOI 10.2106/JBJS.J.01039	32	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91699	10.1371/journal.pone.0091699	http://dx.doi.org/10.1371/journal.pone.0091699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632880	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400079
J	Kovacik, J; Babula, P; Klejdus, B; Hedbavny, J; Jarosova, M				Kovacik, Jozef; Babula, Petr; Klejdus, Borivoj; Hedbavny, Josef; Jarosova, Marketa			Unexpected Behavior of Some Nitric Oxide Modulators under Cadmium Excess in Plant Tissue	PLOS ONE			English	Article							HEAVY-METALS; CROSS-TALK; COPPER; TOXICITY; OXYGEN; L.; QUANTIFICATION; PHYTOCHELATINS; COUNTERACTS; METABOLISM	Various nitric oxide modulators (NO donors - SNP, GSNO, DEA NONOate and scavengers - PTIO, cPTIO) were tested to highlight the role of NO under Cd excess in various ontogenetic stages of chamomile (Matricaria chamomilla). Surprisingly, compared to Cd alone, SNP and PTIO elevated Cd uptake (confirmed also by PhenGreen staining) but depleted glutathione (partially ascorbic acid) and phytochelatins PC2 and PC3 in both older plants (cultured hydroponically) and seedlings (cultured in deionised water). Despite these anomalous impacts, fluorescence staining of NO and ROS confirmed predictable assumptions and revealed reciprocal changes (decrease in NO but increase in ROS after PTIO addition and the opposite after SNP application). Subsequent tests using alternative modulators and seedlings confirmed changes to NO and ROS after application of GSNO and DEA NONOate as mentioned above for SNP while cPTIO altered only NO level (depletion). On the contrary to SNP and PTIO, GSNO, DEA NONOate and cPTIO did not elevate Cd content and phytochelatins (PC2, PC3) were rather elevated. These data provide evidence that various NO modulators are useful in terms of NO and ROS manipulation but interactions with intact plants affect metal uptake and must therefore be used with caution. In this view, cPTIO and DEA NONOate revealed the less pronounced side impacts and are recommended as suitable NO scavenger/donor in plant physiological studies under Cd excess.	[Kovacik, Jozef; Klejdus, Borivoj; Hedbavny, Josef; Jarosova, Marketa] Mendel Univ Brno, Fac Agron, Inst Chem & Biochem, Brno, Czech Republic; [Kovacik, Jozef; Klejdus, Borivoj] Mendel Univ Brno, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Babula, Petr] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Nat Drugs, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno; University of Veterinary Sciences Brno	Kovacik, J (corresponding author), Mendel Univ Brno, Fac Agron, Inst Chem & Biochem, Brno, Czech Republic.	jozkovacik@yahoo.com	Hedbavny, Josef/AAH-1368-2020; Klejdus, Borivoj/D-8490-2012; Kovacik, Jozef/E-1688-2012; Babula, Petr/AAL-6510-2020	Hedbavny, Josef/0000-0001-6769-3639; Klejdus, Borivoj/0000-0002-5557-5771; Kovacik, Jozef/0000-0002-5701-0598	European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; OP Education for Competitiveness (European Social Fund and the state budget of the Czech Republic) [CZ.1.07/2.3.00/30.0017]; Internal Grant Agency of Faculty of Agronomy, Mendel University [IP 17/2013]	European Regional Development Fund(European Commission); OP Education for Competitiveness (European Social Fund and the state budget of the Czech Republic); Internal Grant Agency of Faculty of Agronomy, Mendel University	This work was realized in CEITEC - Central European Institute of Technology with research infrastructure supported by the project CZ.1.05/1.1.00/02.0068 financed from European Regional Development Fund. The work was also supported by OP Education for Competitiveness (European Social Fund and the state budget of the Czech Republic) CZ.1.07/2.3.00/30.0017 Postdocs in Biological Sciences at MENDELU and partially by Internal Grant Agency of Faculty of Agronomy, Mendel University (project IP 17/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaki M, 2011, PLANT CELL PHYSIOL, V52, P2006, DOI 10.1093/pcp/pcr133; Akhter MF, 2012, J PLANT PHYSIOL, V169, P1821, DOI 10.1016/j.jplph.2012.07.011; Arasimowicz M, 2007, PLANT SCI, V172, P876, DOI 10.1016/j.plantsci.2007.02.005; Brautigam A, 2010, ANAL BIOANAL CHEM, V398, P877, DOI 10.1007/s00216-010-3970-7; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Gajewska E, 2010, ECOTOX ENVIRON SAFE, V73, P996, DOI 10.1016/j.ecoenv.2010.02.013; Hose E, 2001, J EXP BOT, V52, P2245, DOI 10.1093/jexbot/52.365.2245; Kazemi N, 2010, SCI HORTIC-AMSTERDAM, V126, P402, DOI 10.1016/j.scienta.2010.07.037; Kopyra M, 2003, PLANT PHYSIOL BIOCH, V41, P1011, DOI 10.1016/j.plaphy.2003.09.003; Kovacik J, 2008, ECOTOXICOLOGY, V17, P471, DOI 10.1007/s10646-008-0200-6; Kovacik J, 2014, PLANT SCI, V215, P1, DOI 10.1016/j.plantsci.2013.10.015; Kovacik J, 2013, J AGR FOOD CHEM, V61, P7864, DOI 10.1021/jf401575a; Kovacik J, 2012, J HAZARD MATER, V239, P175, DOI 10.1016/j.jhazmat.2012.08.062; Kovacik J, 2011, J PLANT PHYSIOL, V168, P576, DOI 10.1016/j.jplph.2010.09.011; Kovacik J, 2010, PLANT SCI, V179, P383, DOI 10.1016/j.plantsci.2010.06.014; Kovacik J, 2009, PLANT SOIL, V320, P231, DOI 10.1007/s11104-009-9889-0; Leterrier M, 2011, PLANT SIGNAL BEHAV, V6, P789, DOI 10.4161/psb.6.6.15161; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Ma WW, 2010, PLANTA, V232, P325, DOI 10.1007/s00425-010-1177-y; Murgia I, 2004, J PLANT PHYSIOL, V161, P777, DOI 10.1016/j.jplph.2003.12.004; Najmanova J, 2012, IND CROP PROD, V36, P536, DOI 10.1016/j.indcrop.2011.11.008; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Peng L, 2013, PLANT BIOLOGY, V15, P405, DOI 10.1111/j.1438-8677.2012.00630.x; Qiu ZB, 2013, ACTA PHYSIOL PLANT, V35, P65, DOI 10.1007/s11738-012-1048-1; Rodriguez-Serrano M, 2009, PLANT PHYSIOL, V150, P229, DOI 10.1104/pp.108.131524; Shingles R, 2004, PLANT PHYSIOL, V135, P145, DOI 10.1104/pp.103.037895; Simontacchi M, 2012, PLANT SCI, V183, P159, DOI 10.1016/j.plantsci.2011.08.006; Stork F, 2013, ENVIRON SCI POLLUT R, V20, P5502, DOI 10.1007/s11356-013-1541-0; Verma K, 2013, BIOMETALS, V26, P255, DOI 10.1007/s10534-013-9608-4; Vollenweider P, 2006, ENVIRON EXP BOT, V58, P25, DOI [10.1016/j.envexpbot.2005.06.012, 10.1016/j.envexpbot.2005.06.017]; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhang L, 2012, J ENVIRON SCI, V24, P940, DOI 10.1016/S1001-0742(11)60978-9; Zhang ZH, 2012, CELL CHEM TECHNOL, V46, P157	33	53	57	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91685	10.1371/journal.pone.0091685	http://dx.doi.org/10.1371/journal.pone.0091685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626462	Green Submitted, gold, Green Published			2022-12-25	WOS:000332851300120
J	Zhang, Q; Ran, X; Wang, DW				Zhang, Qin; Ran, Xiao; Wang, Dao Wen			Relation of Plasma Tissue Kallikrein Levels to Presence and Severity of Coronary Artery Disease in a Chinese Population	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HEART-DISEASE; BLOOD-PRESSURE; KININ SYSTEM; ISCHEMIC-STROKE; RENAL-DISEASES; GENE; DELIVERY; RISK; INFLAMMATION	Objectives: Tissue kallikrein (TK) has been shown to provide cardiovascular and cerebrovascular protective effects in animal models. The aim of this study was to investigate the relationship of plasma TK levels with the presence and severity of coronary artery disease (CAD) in the Chinese. Methods: The study involved 898 consecutive CAD patients and 905 ethnically and geographically matched controls. CAD was angiographically confirmed in all the patients, and the severity of CAD was expressed by the number of affected vessel and coronary artery stenosis scores. Plasma TK levels were measured using an enzyme-linked immunosorbent assay. Results: Plasma TK levels were significantly higher in CAD patients than controls (0.347+/-.082 vs. 0.256+/-0.087 mg/L, P<0.001), and elevated plasma TK levels were directly associated with a higher risk of CAD (OR = 3.49, 95% CI 2.90-4.19). One-way ANOVA and multivariable stepwise linear regression analysis demonstrated that TK levels were negatively associated with the severity of CAD according to vessel scores (P<0.001) and stenosis scores (r = 20.211, p<0.001). Conclusions: Our findings suggest that higher levels of TK in plasma are associated with the presence of CAD and are a predictor of mild coronary arteriosclerosis.	[Zhang, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Anesthesia, Tongji Hosp, Wuhan 430074, Peoples R China; [Ran, Xiao] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Emergency, Tongji Hosp, Wuhan 430074, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, DW (corresponding author), Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Med Coll, Wuhan 430074, Peoples R China.	dwwang@tjh.tjmu.edu.cn		Wang, Dao Wen/0000-0002-9774-3980	National "863'' projects [2006AA02A406]; Natural Science Foundation [81100864]; Ministry of Health of the People's Republic of China	National "863'' projects(National High Technology Research and Development Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Health of the People's Republic of China	This work was supported by grants from National "863'' projects (No. 2006AA02A406), Natural Science Foundation (No. 81100864) and 2010 Clinical Key Disciplines Construction Grant from the Ministry of Health of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson BL, 1999, CIRCULATION, V99, P1810, DOI 10.1161/01.CIR.99.14.1810; Agata J, 2002, HYPERTENSION, V40, P653, DOI 10.1161/01.HYP.0000036035.41122.99; Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Campbell DJ, 2010, DIABETOLOGIA, V53, P779, DOI 10.1007/s00125-009-1645-8; Chao J, 2005, EXP PHYSIOL, V90, P291, DOI 10.1113/expphysiol.2004.028464; Chao J, 2006, BIOL CHEM, V387, P665, DOI 10.1515/BC.2006.085; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Diamandis EP, 2000, CLIN CHEM, V46, P1855; Federico Cacciapuoti, 2010, Heart Views, V11, P10; FEILD DJ, 1987, J AM COLL CARDIOL, V10, P935, DOI 10.1016/S0735-1097(87)80294-2; GOTTO AM, 1986, AM J MED, V80, P48, DOI 10.1016/0002-9343(86)90160-9; Griol-Charhbili V, 2005, FASEB J, V19, P1172, DOI 10.1096/fj.04-3508fje; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HOLMES DR, 1981, CIRCULATION, V63, P293, DOI 10.1161/01.CIR.63.2.293; Kayashima Y, 2012, CURR OPIN NEPHROL HY, V21, P92, DOI 10.1097/MNH.0b013e32834d54b1; Koch M, 2006, EUR J PHARMACOL, V550, P143, DOI 10.1016/j.ejphar.2006.08.054; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Moran Andrew, 2008, BMC Public Health, V8, P394, DOI 10.1186/1471-2458-8-394; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Murakami H, 1999, HYPERTENSION, V34, P164, DOI 10.1161/01.HYP.34.2.164; PETTERSSON A, 1986, EUR HEART J, V7, P693, DOI 10.1093/oxfordjournals.eurheartj.a062124; Poulter N, 1999, AM J HYPERTENS, V12, p92S; Sharma JN, 2004, PHARMACOLOGY, V70, P201, DOI 10.1159/000075549; Smith S C Jr, 2000, Circulation, V101, pE12; SRINIVASAN SR, 1995, CLIN CHEM, V41, P159; Tu L, 2008, HUM GENE THER, V19, P318, DOI 10.1089/hum.2007.138; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; XIONG W, 1995, HYPERTENSION, V25, P715, DOI 10.1161/01.HYP.25.4.715; Xu YJ, 2011, PHARMACOGENET GENOM, V21, P489, DOI 10.1097/FPC.0b013e3283485eb2; Yin H, 2008, LIFE SCI, V82, P156, DOI 10.1016/j.lfs.2007.10.021; Yoshida H, 2000, HYPERTENSION, V35, P25, DOI 10.1161/01.HYP.35.1.25; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602; Zhang Q, 2011, ANN NEUROL, V70, P265, DOI 10.1002/ana.22404; ZINNER SH, 1978, CIRCULATION, V58, P908, DOI 10.1161/01.CIR.58.5.908	35	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91780	10.1371/journal.pone.0091780	http://dx.doi.org/10.1371/journal.pone.0091780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626253	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300133
J	Zhou, Y; Chen, LF; Fan, XZ; Bian, YB				Zhou, Yan; Chen, Lianfu; Fan, Xiuzhi; Bian, Yinbing			De Novo Assembly of Auricularia polytricha Transcriptome Using Illumina Sequencing for Gene Discovery and SSR Marker Identification	PLOS ONE			English	Article							COPRINUS-CINEREUS ENCODES; GENOME SEQUENCE; RNA-SEQ; MICROSATELLITE MARKERS; AGARICUS-BISPORUS; MUSHROOM; EXPRESSION; TOOL; PHOTORECEPTOR; EXPANSION	Auricularia polytricha (Mont.) Sacc., a type of edible black-brown mushroom with a gelatinous and modality-specific fruiting body, is in high demand in Asia due to its nutritional and medicinal properties. Illumina Solexa sequenceing technology was used to generate very large transcript sequences from the mycelium and the mature fruiting body of A. polytricha for gene discovery and molecular marker development. De novo assembly generated 36,483 ESTs with an N50 length of 636 bp. A total of 28,108 ESTs demonstrated significant hits with known proteins in the nr database, and 94.03% of the annotated ESTs showed the greatest similarity to A. delicata, a related species of A. polytricha. Functional categorization of the Gene Ontology (GO), Clusters of Orthologous Groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways revealed the conservation of genes involved in various biological processes in A. polytricha. Gene expression profile analysis indicated that a total of 2,057 ESTs were differentially expressed, including 1,020 ESTs that were up-regulated in the mycelium and 1,037 up-regulated in the fruiting body. Functional enrichment showed that the ESTs associated with biosynthesis, metabolism and assembly of proteins were more active in fruiting body development. The expression patterns of homologous transcription factors indicated that the molecular mechanisms of fruiting body formation and development were not exactly the same as for other agarics. Interestingly, an EST encoding tyrosinase was significantly up-regulated in the fruiting body, indicating that melanins accumulated during the processes of the formation of the black-brown color of the fruiting body in A. polytricha development. In addition, a total of 1,715 potential SSRs were detected in this transcriptome. The transcriptome analysis of A. polytricha provides valuable sequence resources and numerous molecular markers to facilitate further functional genomics studies and genetic researches on this fungus.	[Zhou, Yan; Chen, Lianfu; Fan, Xiuzhi; Bian, Yinbing] Huazhong Agr Univ, Inst Appl Mycol, Wuhan, Hubei, Peoples R China; [Zhou, Yan; Chen, Lianfu; Fan, Xiuzhi; Bian, Yinbing] Huazhong Agr Univ, Minist Agr, Key Lab Agromicrobial Resource Comprehens Utiliza, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Bian, YB (corresponding author), Huazhong Agr Univ, Inst Appl Mycol, Wuhan, Hubei, Peoples R China.	bianyinbinghzaucn@yahoo.com			National Natural Science Foundation of China [31200079]; Chinese Postdoctoral Research Fellowship [20110491164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Research Fellowship	This work was supported by the National Natural Science Foundation of China (31200079) and the Chinese Postdoctoral Research Fellowship (20110491164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Razak DL, 2013, APPL MICROBIOL BIOT, V97, P3207, DOI 10.1007/s00253-012-4135-8; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corrochano LM, 2011, IMA FUNGUS, V2, P25, DOI 10.5598/imafungus.2011.02.01.04; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; ENDO H, 1994, GENE, V139, P117, DOI 10.1016/0378-1119(94)90533-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gawlik-Dziki U, 2008, FOOD CHEM, V107, P129, DOI 10.1016/j.foodchem.2007.07.068; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kamada T, 2010, FUNGAL GENET BIOL, V47, P917, DOI 10.1016/j.fgb.2010.05.003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIRK PM, 2008, DICT FUNGI, P549; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Metzgar D, 2000, GENOME RES, V10, P72; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muraguchi H, 2008, FUNGAL GENET BIOL, V45, P890, DOI 10.1016/j.fgb.2007.11.004; Murata Y, 1998, GENETICS, V149, P1753; Ohm RA, 2011, MOL MICROBIOL, V81, P1433, DOI 10.1111/j.1365-2958.2011.07776.x; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Qian J, 2013, GENE, V512, P331, DOI 10.1016/j.gene.2012.09.127; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; RAPER CA, 1972, MYCOLOGIA, V64, P1088, DOI 10.2307/3758075; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sano H, 2007, BIOSCI BIOTECH BIOCH, V71, P2206, DOI 10.1271/bbb.70170; Sano H, 2009, FUNGAL GENET BIOL, V46, P333, DOI 10.1016/j.fgb.2009.01.001; Soler-Rivas C, 2001, PHYSIOL MOL PLANT P, V58, P95, DOI 10.1006/pmpp.2000.0312; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tang LH, 2013, APPL MICROBIOL BIOT, V97, P4977, DOI 10.1007/s00253-013-4832-y; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056686; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wichers HJ, 2003, APPL MICROBIOL BIOT, V61, P336, DOI 10.1007/s00253-002-1194-2; Wu Q, 2010, INT J BIOL MACROMOL, V46, P284, DOI 10.1016/j.ijbiomac.2010.01.016; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116; Zheng Y, 2008, FUNGAL GENET BIOL, V45, P1340, DOI 10.1016/j.fgb.2008.07.012; Zhong MT, 2013, BIOCHEM BIOPH RES CO, V431, P111, DOI 10.1016/j.bbrc.2012.12.065	53	34	43	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91740	10.1371/journal.pone.0091740	http://dx.doi.org/10.1371/journal.pone.0091740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626227	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300131
J	Acosta, SA; Tajiri, N; Shinozuka, K; Ishikawa, H; Sanberg, PR; Sanchez-Ramos, J; Song, SJ; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Sanberg, Paul R.; Sanchez-Ramos, Juan; Song, Shijie; Kaneko, Yuji; Borlongan, Cesar V.			Combination Therapy of Human Umbilical Cord Blood Cells and Granulocyte Colony Stimulating Factor Reduces Histopathological and Motor Impairments in an Experimental Model of Chronic Traumatic Brain Injury	PLOS ONE			English	Article							MARROW STROMAL CELLS; CEREBRAL-ARTERY OCCLUSION; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; FACTOR G-CSF; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTORS; COLLAGEN SCAFFOLDS; MILD HYPOTHERMIA; PROGENITOR CELLS	Traumatic brain injury (TBI) is associated with neuro-inflammation, debilitating sensory-motor deficits, and learning and memory impairments. Cell-based therapies are currently being investigated in treating neurotrauma due to their ability to secrete neurotrophic factors and anti-inflammatory cytokines that can regulate the hostile milieu associated with chronic neuroinflammation found in TBI. In tandem, the stimulation and mobilization of endogenous stem/progenitor cells from the bone marrow through granulocyte colony stimulating factor (G-CSF) poses as an attractive therapeutic intervention for chronic TBI. Here, we tested the potential of a combined therapy of human umbilical cord blood cells (hUCB) and G-CSF at the acute stage of TBI to counteract the progressive secondary effects of chronic TBI using the controlled cortical impact model. Four different groups of adult Sprague Dawley rats were treated with saline alone, G-CSF+saline, hUCB+saline or hUCB+G-CSF, 7-days post CCI moderate TBI. Eight weeks after TBI, brains were harvested to analyze hippocampal cell loss, neuroinflammatory response, and neurogenesis by using immunohistochemical techniques. Results revealed that the rats exposed to TBI treated with saline exhibited widespread neuroinflammation, impaired endogenous neurogenesis in DG and SVZ, and severe hippocampal cell loss. hUCB monotherapy suppressed neuroinflammation, nearly normalized the neurogenesis, and reduced hippocampal cell loss compared to saline alone. G-CSF monotherapy produced partial and short-lived benefits characterized by low levels of neuroinflammation in striatum, DG, SVZ, and corpus callosum and fornix, a modest neurogenesis, and a moderate reduction of hippocampal cells loss. On the other hand, combined therapy of hUCB+G-CSF displayed synergistic effects that robustly dampened neuroinflammation, while enhancing endogenous neurogenesis and reducing hippocampal cell loss. Vigorous and long-lasting recovery of motor function accompanied the combined therapy, which was either moderately or short-lived in the monotherapy conditions. These results suggest that combined treatment rather than monotherapy appears optimal for abrogating histophalogical and motor impairments in chronic TBI.	[Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Off Res & Innovat, Tampa, FL USA; [Sanchez-Ramos, Juan; Song, Shijie] James Haley Vet Affairs Med Ctr, Tampa, FL USA; [Sanchez-Ramos, Juan; Song, Shijie] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Sanchez-Ramos, Juan; Song, Shijie] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Borlongan, Cesar/I-5696-2012; Tajiri, Naoki/K-1230-2012; Sanchez-Ramos, Juan/A-1188-2009	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X; Sanberg, Paul/0000-0001-9130-4592; Sanchez-Ramos, Juan/0000-0002-3391-7857; Shinozuka, Kazutaka/0000-0002-6435-4460; Ishikawa, Hiroto/0000-0003-0760-7203	Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; SanBio Inc.; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001407] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Foundation; SanBio Inc.; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Financial support for this study was provided by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. CVB and PRS serve as consultant and founder, respectively, of Saneron CCEL Therapeutics, Inc. CVB is funded by the National Institutes of Health 1R01NS071956-01A1, James and Esther King Biomedical Research Foundation 1KG01-33966, SanBio Inc., KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bath PMW, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub4; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Campbell K, 2013, BRAIN RES, V1502, P47, DOI 10.1016/j.brainres.2013.01.038; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo XH, 2012, INT J NEUROSCI, V122, P723, DOI 10.3109/00207454.2012.716109; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Imamura K, 2005, ACTA NEUROPATHOL, V109, P141, DOI 10.1007/s00401-004-0919-y; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Joo YD, 2011, CYTOKINE, V54, P36, DOI 10.1016/j.cyto.2010.12.020; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P265, DOI 10.1007/978-3-7091-0693-8_44; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lewis FD, 2013, J SPEC OPER MED, V13, P56; Liu CY, 2008, NEUROSURGERY, V63, pN12, DOI 10.1227/01.NEU.0000339457.01711.3B; Lopes FRP, 2013, NEUROSCIENCE, V230, P184, DOI 10.1016/j.neuroscience.2012.10.025; Loving CL, 2013, BIOLOGICALS, V41, P368, DOI 10.1016/j.biologicals.2013.07.001; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lyman GH, 2013, ANN ONCOL, V24, P2475, DOI 10.1093/annonc/mdt226; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Maurer MH, 2008, CURR MED CHEM, V15, P1407, DOI 10.2174/092986708784567671; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Morita Y, 2007, NEUROSCI RES, V58, P356, DOI 10.1016/j.neures.2007.04.006; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Prakash A, 2013, PHARMACOL BIOCHEM BE, V110, P46, DOI 10.1016/j.pbb.2013.05.015; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sasaki A, 2008, BRAIN RES, V1214, P159, DOI 10.1016/j.brainres.2008.02.084; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shahaduzzaman M, 2013, AGE, V35, P2071, DOI 10.1007/s11357-012-9496-5; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Stachura DL, 2013, BLOOD; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tsuji T, 1999, GROWTH FACTORS, V16, P225, DOI 10.3109/08977199909002132; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Yang YN, 2013, PEDIATR NEONATOL, V54, P380, DOI 10.1016/j.pedneo.2013.04.011; Yasuda Y, 2007, BRAIN RES, V1138, P196, DOI 10.1016/j.brainres.2006.12.054; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhao Li R, 2013, Recent Pat CNS Drug Discov, V8, P2; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	83	72	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90953	10.1371/journal.pone.0090953	http://dx.doi.org/10.1371/journal.pone.0090953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621603	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300037
J	Arthanari, Y; Heintzen, C; Griffiths-Jones, S; Crosthwaite, SK				Arthanari, Yamini; Heintzen, Christian; Griffiths-Jones, Sam; Crosthwaite, Susan K.			Natural Antisense Transcripts and Long Non-Coding RNA in Neurospora crassa	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; FUNCTIONAL ANNOTATION; BUDDING YEAST; HUMAN GENOME; SEQUENCE; EXPRESSION; IDENTIFICATION; REVEALS; GENES; ARABIDOPSIS	The prevalence of long non-coding RNAs (lncRNA) and natural antisense transcripts (NATs) has been reported in a variety of organisms. While a consensus has yet to be reached on their global importance, an increasing number of examples have been shown to be functional, regulating gene expression at the transcriptional and post-transcriptional level. Here, we use RNA sequencing data from the ABI SOLiD platform to identify lncRNA and NATs obtained from samples of the filamentous fungus Neurospora crassa grown under different light and temperature conditions. We identify 939 novel lncRNAs, of which 477 are antisense to annotated genes. Across the whole dataset, the extent of overlap between sense and antisense transcripts is large: 371 sense/antisense transcripts are complementary over 500 nts or more and 236 overlap by more than 1000 nts. Most prevalent are 3' end overlaps between convergently transcribed sense/antisense pairs, but examples of divergently transcribed pairs and nested transcripts are also present. We confirm the expression of a subset of sense/antisense transcript pairs by qPCR. We examine the size, types of overlap and expression levels under the different environmental stimuli of light and temperature, and identify 11 lncRNAs that are up-regulated in response to light. We also find differences in transcript length and the position of introns between protein-coding transcripts that have antisense expression and transcripts with no antisense expression. These results demonstrate the ability of N. crassa lncRNAs and NATs to be regulated by different environmental stimuli and provide the scope for further investigation into the function of NATs.	[Arthanari, Yamini; Heintzen, Christian; Griffiths-Jones, Sam; Crosthwaite, Susan K.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Griffiths-Jones, S (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester, Lancs, England.	sam.griffiths-jones@manchester.ac.uk; susan.crosthwaite@manchester.ac.uk	Griffiths-Jones, Sam/H-2998-2014	Griffiths-Jones, Sam/0000-0001-6043-807X	Leverhulme Trust [RPG-091]; BBSRC [BB/F012055/1]; Biotechnology and Biological Sciences Research Council [BB/F012055/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to acknowledge the financial support of The Leverhulme Trust (RPG-091, to SKC and SG-J) and a BBSRC project grant awarded to CH (BB/F012055/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], NEUR CRASS SEQ PROJ; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Dang YK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003761; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Donaldson ME, 2012, MOL MICROBIOL, V85, P405, DOI 10.1111/j.1365-2958.2012.08125.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goodman AJ, 2013, MOL BIOL EVOL, V30, P409, DOI 10.1093/molbev/mss240; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li KG, 2010, ONCOTARGET, V1, P447, DOI 10.18632/oncotarget.178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McKinlay A, 2011, G3-GENES GENOM GENET, V1, P549, DOI 10.1534/g3.111.000810; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Palma-Guerrero J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003669; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Read ND., 1994, CELLULAR NATURE MULT, P254; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Salato VK, 2010, RNA BIOL, V7, P179, DOI 10.4161/rna.7.2.11182; Sasson A, 2010, BIOINFORMATICS, V26, P849, DOI 10.1093/bioinformatics/btq045; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Smith CA, 2008, CURR GENET, V54, P241, DOI 10.1007/s00294-008-0215-9; Steigele S, 2005, NUCLEIC ACIDS RES, V33, P5034, DOI 10.1093/nar/gki804; Sun M, 2005, NUCLEIC ACIDS RES, V33, P5533, DOI 10.1093/nar/gki852; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang DN, 2013, INT J MOL SCI, V14, P9018, DOI 10.3390/ijms14059018; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Yan B, 2012, DNA CELL BIOL, V31, pS34, DOI 10.1089/dna.2011.1544; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Young RS, 2013, ESSAYS BIOCHEM, V54, P113, DOI [10.1042/bse0540113, 10.1042/BSE0540113]; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	61	34	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91353	10.1371/journal.pone.0091353	http://dx.doi.org/10.1371/journal.pone.0091353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621812	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300080
J	Dessilly, G; Elens, L; Panin, N; Capron, A; Decottignies, A; Demoulin, JB; Haufroid, V				Dessilly, Geraldine; Elens, Laure; Panin, Nadtha; Capron, Arnaud; Decottignies, Anabelle; Demoulin, Jean-Baptiste; Haufroid, Vincent			ABCB1 1199G > A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; BINDING CASSETTE TRANSPORTERS; SOLID-ORGAN TRANSPLANTATION; MULTIDRUG-RESISTANCE GENE; BLOOD MONONUCLEAR-CELLS; HUMAN MDR1 GENE; P-GLYCOPROTEIN; DRUG DISPOSITION; EXPRESSION; IMPACT	Objective: ATP-binding cassette, subfamily B, member 1 (ABCB1) transporter, or P-glycoprotein, is an efflux protein implicated in the absorption and the distribution of various compounds, including tacrolimus and cyclosporine A. In vivo studies suggest an association between the ABCB1 1199G>A single nucleotide polymorphism (SNP) and tacrolimus intracellular accumulation. The aim of the present experimental study was to clarify in vitro the impact of the coding ABCB1 1199G>A SNP on ABCB1 transport activity towards both immunosuppressive drugs. Method: Two recombinant cell lines, i.e. Human Embryonic Kidney (HEK293) and Human Myelogenous Leukemia (K562) cells, overexpressing ABCB1 carrying either the wild-type allele (1199G) or its mutated counterpart (1199A), were generated. The impact of the 1199G>A SNP on ABCB1 activity towards rhodamine (Rh123), doxorubicin, vinblastine, tacrolimus and cyclosporine A was assessed by accumulation, cytotoxicity and/or kinetic experiments. Results: Tacrolimus accumulation was strongly decreased in cells overexpressing the wild-type protein (1199G) compared to control cells, confirming the ability of ABCB1 to transport tacrolimus. By contrast, overexpression of the variant protein (1199A) had nearly no effect on tacrolimus intracellular accumulation whatever the model used and the concentration tested. Unlike tacrolimus, our results also indicate that cyclosporine A, Rh123 and doxorubicin are transported in a similar extent by the wild-type and variant ABCB1 proteins while the variant protein seems to be more efficient for the transport of vinblastine. Conclusion: ABCB1 encoded by the 1199G wild-type allele transports more efficiently tacrolimus in comparison to the 1199A variant protein. This observation indicates that the amino-acid substitution (Ser400Asn) encoded by the 1199A allele drastically decreases the ability of ABCB1 to drive the efflux of tacrolimus in a substrate-specific manner, in agreement with our previously published clinical data. Our study emphasizes the importance of the ABCB1 1199G>A polymorphism for ABCB1 activity and its potential to explain differences in drug response.	[Dessilly, Geraldine; Panin, Nadtha; Haufroid, Vincent] Catholic Univ Louvain, Inst Rech Expt & Clin, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium; [Elens, Laure] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Capron, Arnaud; Haufroid, Vincent] Catholic Univ Louvain, Clin Univ St Luc, Dept Clin Chem, B-1200 Brussels, Belgium; [Decottignies, Anabelle; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Haufroid, V (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium.	vincent.haufroid@uclouvain.be		Demoulin, Jean-Baptiste/0000-0002-8016-6689; Elens, Laure/0000-0002-0039-3583	Fonds National de la Recherche Scientifique (FNRS)- Televie, Belgium [7.4539.13]	Fonds National de la Recherche Scientifique (FNRS)- Televie, Belgium(Fonds de la Recherche Scientifique - FNRS)	Geraldine Dessilly (GD) is a doctoral researcher with the Fonds National de la Recherche Scientifique (FNRS)- Televie, Belgium (credit no7.4539.13). Laure Elens (LE) is a post-doctoral researcher with the Fonds National de la Recherche Scientifique (FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringer PM, 2005, ANN PHARMACOTHER, V39, P1097, DOI 10.1345/aph.1E614; Bodor M, 2005, AAPS J, V7, pE1, DOI 10.1208/aapsj070101; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; Capron A, 2010, PHARMACOGENOMICS, V11, P703, DOI [10.2217/pgs.10.43, 10.2217/PGS.10.43]; Capron A, 2009, THER DRUG MONIT, V31, P178, DOI 10.1097/FTD.0b013e3181905aaa; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; CHIN JE, 1989, MOL CELL BIOL, V9, P3808, DOI 10.1128/MCB.9.9.3808; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; Crettol S, 2008, PHARMACOGENET GENOM, V18, P307, DOI 10.1097/FPC.0b013e3282f7046f; Crouthamel MH, 2006, J PHARM SCI-US, V95, P2767, DOI 10.1002/jps.20743; Czyzewski K, 2009, NEOPLASMA, V56, P202; Elens L, 2011, PHARMACOGENET GENOM, V21, P884, DOI 10.1097/FPC.0b013e32834d672b; Fardel O, 1996, GEN PHARMACOL, V27, P1283, DOI 10.1016/S0306-3623(96)00081-X; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haufroid V, 2011, CURR DRUG TARGETS, V12, P631, DOI 10.2174/138945011795378487; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; JUSKO WJ, 1995, THER DRUG MONIT, V17, P606, DOI 10.1097/00007691-199512000-00011; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Lepper ER, 2005, PHARMACOGENOMICS, V6, P115, DOI 10.1517/14622416.6.2.115; Li Yan-Hong, 2006, Acta Genetica Sinica, V33, P93, DOI 10.1016/S0379-4172(06)60027-9; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Salama NN, 2006, J PHARM SCI-US, V95, P2293, DOI 10.1002/jps.20717; Schwab M, 2003, ANNU REV PHARMACOL, V43, P285, DOI 10.1146/annurev.pharmtox.43.100901.140233; Scott LJ, 2003, DRUGS, V63, P1247, DOI 10.2165/00003495-200363120-00006; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Vallet CM, 2011, INT J ANTIMICROB AG, V38, P249, DOI 10.1016/j.ijantimicag.2011.05.011; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Woodahl EL, 2005, AIDS, V19, P1617, DOI 10.1097/01.aids.0000183626.74299.77; Woodahl EL, 2004, J PHARMACOL EXP THER, V310, P1199, DOI 10.1124/jpet.104.065383; Woodahl EL, 2009, CANCER CHEMOTH PHARM, V64, P183, DOI 10.1007/s00280-008-0906-4; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	38	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91555	10.1371/journal.pone.0091555	http://dx.doi.org/10.1371/journal.pone.0091555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621983	gold, Green Submitted, Green Published			2022-12-25	WOS:000332845300103
J	Han, DH; Yoo, HJ; Kim, BN; McMahon, W; Renshaw, PF				Han, Doug Hyun; Yoo, Hee Jeong; Kim, Bung Nyun; McMahon, William; Renshaw, Perry F.			Brain Activity of Adolescents with High Functioning Autism in Response to Emotional Words and Facial Emoticons	PLOS ONE			English	Article							FUSIFORM FACE AREA; COMPUTER-MEDIATED COMMUNICATION; NONVERBAL-COMMUNICATION; SPECTRUM DISORDERS; BIOLOGICAL MOTION; JOINT ATTENTION; PERCEPTION; CHILDREN; COMPREHENSION; LANGUAGE	Studies of social dysfunction in patients with autism spectrum disorder (ASD) have generally focused on the perception of emotional words and facial affect. Brain imaging studies have suggested that the fusiform gyrus is associated with both the comprehension of language and face recognition. We hypothesized that patients with ASD would have decreased ability to recognize affect via emotional words and facial emoticons, relative to healthy comparison subjects. In addition, we expected that this decreased ability would be associated with altered activity of the fusiform gyrus in patients with ASD. Ten male adolescents with ASDs and ten age and sex matched healthy comparison subjects were enrolled in this case-control study. The diagnosis of autism was further evaluated with the Autism Diagnostic Observation Schedule. Brain activity was assessed using functional magnetic resonance imaging (fMRI) in response to emotional words and facial emoticon presentation. Sixty emotional words (45 pleasant words +15 unpleasant words) were extracted from a report on Korean emotional terms and their underlying dimensions. Sixty emoticon faces (45 pleasant faces +15 unpleasant faces) were extracted and modified from on-line sites. Relative to healthy comparison subjects, patients with ASD have increased activation of fusiform gyrus in response to emotional aspects of words. In contrast, patients with ASD have decreased activation of fusiform gyrus in response to facial emoticons, relative to healthy comparison subjects. We suggest that patients with ASD are more familiar with word descriptions than facial expression as depictions of emotion.	[Han, Doug Hyun] Chung Ang Univ Hosp, Dept Psychiat, Seoul, South Korea; [Yoo, Hee Jeong] Seoul Natl Bundang Hosp, Dept Psychiat, Seoul, South Korea; [Kim, Bung Nyun] Seoul Natl Hosp, Dept Psychiat, Seoul, South Korea; [McMahon, William] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Renshaw, Perry F.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Han, DH (corresponding author), Chung Ang Univ Hosp, Dept Psychiat, Seoul, South Korea.	hduk@yahoo.com	Renshaw, Perry/O-1384-2018		Korean Game Culture Foundation; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120013]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	Korean Game Culture Foundation; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Korean Game Culture Foundation and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2013, SOC COGN AFFECT NEUR; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Buchsbaum MS, 2007, AM J PSYCHIAT, V164, P1072, DOI 10.1176/appi.ajp.164.7.1072; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Chugani DC, 1997, ANN NEUROL, V42, P666, DOI 10.1002/ana.410420420; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Derks D, 2008, CYBERPSYCHOL BEHAV, V11, P99, DOI 10.1089/cpb.2007.9926; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P215, DOI 10.1093/scan/nsp017; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Ghosh Shantanu, 2010, Indian J Radiol Imaging, V20, P182, DOI 10.4103/0971-3026.69352; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Hauck M, 1998, CHILD NEUROPSYCHOL, V4, P187, DOI 10.1076/chin.4.3.187.3174; Herrington JD, 2011, BRAIN COGNITION, V77, P372, DOI 10.1016/j.bandc.2011.09.001; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Huang J, 2008, BRAIN LANG, V104, P10, DOI 10.1016/j.bandl.2007.01.003; Kaiser MD, 2010, AUTISM RES, V3, P191, DOI 10.1002/aur.137; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kikuchi Y, 2011, J AUTISM DEV DISORD, V41, P629, DOI 10.1007/s10803-010-1082-z; Kim YS, 2004, YONSEI MED J, V45, P81, DOI 10.3349/ymj.2004.45.1.81; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Lo SK, 2008, CYBERPSYCHOL BEHAV, V11, P595, DOI 10.1089/cpb.2007.0132; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; 박인조, 2005, [Korean Journal of Social and Personality Psychology, 한국심리학회지: 사회및성격], V19, P109; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Rosset DB, 2008, J AUTISM DEV DISORD, V38, P919, DOI 10.1007/s10803-007-0465-2; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; SCOTT DW, 1985, PSYCHOL MED, V15, P683, DOI 10.1017/S0033291700031548; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; Talairach I., 1988, COPLANAR STEREOTACTI; Tesink CMJY, 2009, BRAIN, V132, P1941, DOI 10.1093/brain/awp103; van der Geest JN, 2002, J AUTISM DEV DISORD, V32, P69, DOI 10.1023/A:1014832420206; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Yeom TH, 1992, KOREAN VERSION WECHS; Yoo H. J, 2008, SOCIAL COMMUNICATION; Yuasa M, 2007, IEEJ T ELECT INFORM, V127, P1865; Yuasa M, 2006, EMOTICONS CONVEY EMO; Yuasa M, 2011, ELECTR COMMUN JPN, V94, P17, DOI 10.1002/ecj.10311	52	11	12	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91214	10.1371/journal.pone.0091214	http://dx.doi.org/10.1371/journal.pone.0091214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621866	gold, Green Submitted, Green Published			2022-12-25	WOS:000332845300065
J	Li, MM; Li, GS; Zhu, LY; Yin, YS; Zhao, XL; Xiang, C; Yu, GL; Wang, X				Li, Miaomiao; Li, Guangsheng; Zhu, Liying; Yin, Yeshi; Zhao, Xiaoliang; Xiang, Charlie; Yu, Guangli; Wang, Xin			Isolation and Characterization of an Agaro-Oligosaccharide (AO)-Hydrolyzing Bacterium from the Gut Microflora of Chinese Individuals	PLOS ONE			English	Article							IN-VITRO; POLYSACCHARIDES; IDENTIFICATION; BACTEROIDES; DIVERSITY; BIFIDOBACTERIUM; FERMENTATION; POPULATIONS; MICROBIOME; HYDROLYSIS	Agarose (AP) from red algae has a long history as food ingredients in East Asia. Agaro-oligosaccharides (AO) derived from AP have shown potential prebiotic effects. However, the human gut microbes responsible for the degradation of AO and AP have not yet been fully investigated. Here, we reported that AO and AP can be degraded and utilized at various rates by fecal microbiota obtained from different individuals. Bacteroides uniformis L8 isolated from human feces showed a pronounced ability to degrade AO and generate D-galactose as its final end product. PCR-DGGE analysis showed B. uniformis to be common in the fecal samples, but only B. uniformis L8 had the ability to degrade AO. A synergistic strain, here classified as Escherichia coli B2, was also identified because it could utilize the D-galactose as the growth substrate. The cross-feeding interaction between B. uniformis L8 and E. coli B2 led to exhaustion of the AO supply. Bifidobacterium infantis and Bifidobacterium adolescentis can utilize one of the intermediates of AO hydrolysis, agarotriose. Growth curves indicated that AO was the substrate that most favorably sustained the growth of B. uniformis L8. In contrast, kappa-carrageenan oligosaccharides (KCO), guluronic acid oligosaccharides (GO), and mannuronic acid oligosaccharides (MO) were found to be unusable to B. uniformis L8. Current results indicate that B. uniformis L8 is a special degrader of AO in the gut microbiota. Because B. uniformis can mitigate high-fat-diet-induced metabolic disorders, further study is required to determine the potential applications of AO.	[Li, Miaomiao; Li, Guangsheng; Zhao, Xiaoliang; Yu, Guangli] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Shandong, Peoples R China; [Li, Miaomiao; Li, Guangsheng; Zhao, Xiaoliang; Yu, Guangli] Ocean Univ China, Minist Educ, Key Lab Marine Drugs, Qingdao, Shandong, Peoples R China; [Zhu, Liying; Yin, Yeshi; Wang, Xin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Zhu, Liying; Yin, Yeshi; Wang, Xin] Zhejiang Acad Agr Sci, Key Lab Food Microbial Technol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xiang, Charlie] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Ocean University of China; Ocean University of China; Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Zhejiang University	Yu, GL (corresponding author), Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Shandong, Peoples R China.	glyu@ouc.edu.cn; xxww101@sina.com	Rui, Zhenhua/J-8195-2019	Rui, Zhenhua/0000-0001-6088-0845; Li, Miaomiao/0000-0003-4508-196X	 [31070724];  [31100097];  [2013BAB01B02];  [201005024];  [2013CB531404];  [2010R10095]	; ; ; ; ; 	1. 31070724, http://www.nsfc.gov.cn/, 2. 31100097, http://www.nsfc.gov.cn/, 3. 2013BAB01B02, http://program.most.gov.cn/, 4. 201005024, http://www.soa.gov.cn/, 5. 2013CB531404, http://program.most.gov.cn/, 6. 2010R10095, http://www.zjkjt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017; Chen HM, 2005, BBA-GEN SUBJECTS, V1722, P103, DOI 10.1016/j.bbagen.2004.11.016; Child MW, 2006, FEMS MICROBIOL ECOL, V55, P299, DOI 10.1111/j.1574-6941.2005.00016.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Dolci P, 2008, INT J FOOD MICROBIOL, V122, P302, DOI 10.1016/j.ijfoodmicro.2007.12.018; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Enoki T, 2012, BIOL PHARM BULL, V35, P1145, DOI 10.1248/bpb.b12-00188; Enoki T, 2010, BIOSCI BIOTECH BIOCH, V74, P766, DOI 10.1271/bbb.90803; Fan W, 2013, WORLD J MICROBIOL BI; FISCHER FG, 1955, H-S Z PHYSIOL CHEM, V302, P186, DOI 10.1515/bchm2.1955.302.1-2.186; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Franco W, 2012, APPL ENVIRON MICROB, V78, P1273, DOI 10.1128/AEM.06605-11; Fu WD, 2008, J IND MICROBIOL BIOT, V35, P915, DOI 10.1007/s10295-008-0365-2; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Higashimura Y, 2012, J GASTROENTEROL, P1; Higashimura Y, 2013, J GASTROENTEROL, V48, P897, DOI 10.1007/s00535-012-0719-4; Holben WE, 2004, APPL ENVIRON MICROB, V70, P2263, DOI 10.1128/AEM.70.4.2263-2270.2004; Hu B, 2006, ANAEROBE, V12, P260, DOI 10.1016/j.anaerobe.2006.07.005; Ishikawa E, 2013, J BIOSCI BIOENG, V116, P265, DOI 10.1016/j.jbiosc.2013.02.010; Jiao G, 2012, J OCEAN U CHINA ENGL, P1; Kim J, 2012, J MICROBIOL BIOTECHN, V22, P1621, DOI 10.4014/jmb.1209.08087; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Long MX, 2010, MAR BIOTECHNOL, V12, P62, DOI 10.1007/s10126-009-9200-7; Nakanishi H, 2013, FORENSIC SCI INT-GEN, V7, P176, DOI 10.1016/j.fsigen.2012.09.006; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramnani P, 2012, ANAEROBE, V18, P1, DOI 10.1016/j.anaerobe.2011.08.003; Rantsiou K, 2005, APPL ENVIRON MICROB, V71, P1977, DOI 10.1128/AEM.71.4.1977-1986.2005; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vera J, 1998, APPL ENVIRON MICROB, V64, P4378; Wang JX, 2006, APPL MICROBIOL BIOT, V71, P833, DOI 10.1007/s00253-005-0207-3; Wang PP, 2012, CARBOHYD POLYM, V89, P914, DOI 10.1016/j.carbpol.2012.04.034; Yang B, 2009, FEBS J, V276, P2125, DOI 10.1111/j.1742-4658.2009.06947.x; Yu GL, 2006, ANAL CHEM, V78, P8499, DOI 10.1021/ac061416j	39	59	63	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91106	10.1371/journal.pone.0091106	http://dx.doi.org/10.1371/journal.pone.0091106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622338	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300049
J	Lyver, PO; Barron, M; Barton, KJ; Ainley, DG; Pollard, A; Gordon, S; McNeill, S; Ballard, G; Wilson, PR				Lyver, Phil O'B.; Barron, Mandy; Barton, Kerry J.; Ainley, David G.; Pollard, Annie; Gordon, Shulamit; McNeill, Stephen; Ballard, Grant; Wilson, Peter R.			Trends in the Breeding Population of Adelie Penguins in the Ross Sea, 1981-2012: A Coincidence of Climate and Resource Extraction Effects	PLOS ONE			English	Article							PACIFIC SECTOR; SOUTHERN-OCEAN; ANTARCTICA; ECOSYSTEMS; COLONIES; IMPACTS; BIOMASS; SIZE	Measurements of the size of Adelie penguin (Pygoscelis adeliae) colonies of the southern Ross Sea are among the longest biologic time series in the Antarctic. We present an assessment of recent annual variation and trends in abundance and growth rates of these colonies, adding to the published record not updated for more than two decades. High angle oblique aerial photographic surveys of colonies were acquired and penguins counted for the breeding seasons 1981-2012. In the last four years the numbers of Adelie penguins in the Ross and Beaufort Island colonies (southern Ross Sea metapopulation) reached their highest levels since aerial counts began in 1981. Results indicated that 855,625 pairs of Adelie penguins established breeding territories in the western Ross Sea, with just over a quarter (28%) of those in the southern portion, constituting a semi-isolated metapopulation (three colonies on Ross Island, one on nearby Beaufort Island). The southern population had a negative per capita growth rate of -0.019 during 1981-2000, followed by a positive per capita growth rate of 0.067 for 2001-2012. Colony growth rates for this metapopulation showed striking synchrony through time, indicating that large-scale factors influenced their annual growth. In contrast to the increased colony sizes in the southern population, the patterns of change among colonies of the northern Ross Sea were difficult to characterize. Trends were similar to southern colonies until the mid-1990s, after which the signal was lost owing to significantly reduced frequency of surveys. Both climate factors and recovery of whale populations likely played roles in the trends among southern colonies until 2000, after which depletion of another trophic competitor, the Antarctic toothfish (Dissostichus mawsoni), may explain the sharp increasing trend evident since then.	[Lyver, Phil O'B.; Barron, Mandy; McNeill, Stephen] Landcare Res, Lincoln, New Zealand; [Barton, Kerry J.] Bartonk Solut, Nelson, New Zealand; [Ainley, David G.; Pollard, Annie] HT Harvey & Associates Ecol Consultants, Los Gatos, CA USA; [Gordon, Shulamit] Antarctica New Zealand, Christchurch, New Zealand; [Ballard, Grant] Point Blue Conservat Sci, Petaluma, CA USA	Landcare Research - New Zealand	Lyver, PO (corresponding author), Landcare Res, Lincoln, New Zealand.	lyverp@landcareresearch.co.nz	McNeill, Stephen JE/A-9939-2008	McNeill, Stephen JE/0000-0003-1288-4387	New Zealand's Foundation for Research, Science and Technology grants [C09527, C09X0510]; Ministry of Science and Innovation project [C01X1001, CONT-21216-BKBN]; National Science Foundation [OPP 0944411]; Office of Polar Programs (OPP) [0944141] Funding Source: National Science Foundation	New Zealand's Foundation for Research, Science and Technology grants; Ministry of Science and Innovation project; National Science Foundation(National Science Foundation (NSF)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was primarily funded by New Zealand's Foundation for Research, Science and Technology grants (C09527; C09X0510) and Ministry of Science and Innovation project (C01X1001; CONT-21216-BKBN). Funding for DA, AP, and GB came from the National Science Foundation (OPP 0944411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley D, 2007, ANTARCT SCI, V19, P283, DOI 10.1017/S095410200700051X; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley D, 2010, MAR MAMMAL SCI, V26, P482, DOI 10.1111/j.1748-7692.2009.00337.x; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2013, FISH FISH, V14, P343, DOI 10.1111/j.1467-2979.2012.00474.x; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Ainley DG, 1995, AUK, V112, P171, DOI 10.2307/4088776; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; AINLEY DG, 1981, DEEP-SEA RES, V28, P1173, DOI 10.1016/0198-0149(81)90054-6; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; Antarctic Treaty Consultative Meeting (ATCM), 2010, MAN PLAN ANT SPEC PR; Arrigo KR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017721; Arrigo KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014160; Ballance LT, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P215; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Ballard G, 2010, THESIS; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Barber-Meyer SM, 2008, ANTARCT SCI, V20, P3, DOI 10.1017/S0954102007000673; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; CCAMLR, 2004, CCAMLR EC MON PROGR; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; EASTMAN JT, 1985, POLAR BIOL, V4, P155, DOI 10.1007/BF00263878; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Emslie SD, 2007, GEOLOGY, V35, P61, DOI 10.1130/G23011A.1; HENTTONEN H, 1985, ANN ZOOL FENN, V22, P221; JACOBS SS, 1989, J GEOPHYS RES-OCEANS, V94, P18195, DOI 10.1029/JC094iC12p18195; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2006, POLAR BIOL, V29, P413, DOI 10.1007/s00300-005-0073-6; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Kooyman GL, 2007, ANTARCT SCI, V19, P31, DOI 10.1017/S0954102007000065; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lyver PO, 2011, POLAR BIOL, V34, P49, DOI 10.1007/s00300-010-0858-0; Marschoff ER, 2012, FISH RES, V125, P206, DOI 10.1016/j.fishres.2012.02.017; Martin S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006700; McNeill S, 2011, INT GEOSCI REMOTE SE, P4312, DOI 10.1109/IGARSS.2011.6050185; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson NJ, 2012, ANTARCT SCI, V24, P514, DOI 10.1017/S0954102012000296; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Siniff DB, 2008, ANTARCT SCI, V20, P425, DOI 10.1017/S0954102008001351; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Southwell C, 2013, ANTARCT SCI, V25, P531, DOI 10.1017/S0954102012001174; Stammerjohn S, 2012, REGIONS RAPID SEA IC; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; TAYLOR RH, 1990, NEW ZEAL J ECOL, V14, P25; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Williams TD, 1995, BIRD FAMILIES OF THE, V2; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	56	73	75	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91188	10.1371/journal.pone.0091188	http://dx.doi.org/10.1371/journal.pone.0091188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621601	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300058
J	Odman, AM; Olsson, PA				Odman, Anja Madelen; Olsson, Pal Axel			Conservation of Sandy Calcareous Grassland: What Can Be Learned from the Land Use History?	PLOS ONE			English	Article							WIND EROSION; NEW-ENGLAND; VEGETATION; RESTORATION; ACIDIFICATION; BIODIVERSITY; DISTURBANCE; LANDSCAPES; DYNAMICS; PATTERNS	Understanding the land use history has proven crucial for the conservation of biodiversity in the agricultural landscape. In southern Sweden, very small and fragmented areas of the disturbance-dependent habitat xeric sand calcareous grassland support a large number of threatened and rare plants and animals. In order to find out if historical land use could explain variation in present-day habitat quality, the land use on eight such sites was traced back to the 18th century and compared with key factors such as the amount of bare sand, lime content and P availability. There was no support for the common explanation of the decline in xeric sand calcareous grassland being caused by abandonment of agricultural fields during the last century. Instead, fertilization history was the main explanation for the difference in depletion depth of CaCO3 seen between the sites. The decline in xeric sand calcareous grassland since the 18th century is most probably the result of the drastic changes in land use during the 19th century, which put an end to the extensive sand drift. Since cultivation was shown to have played an important role in the historical land use of xeric sand calcareous grassland, grazing alone may not be the optimal management option for these grasslands. Instead more drastic measures are needed to restore the high calcium content and maintain proper disturbance levels.	[Odman, Anja Madelen; Olsson, Pal Axel] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Odman, AM (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Anja.Odman@biol.lu.se	Ödman, Anja/AGV-7196-2022; Zimmerman, Anja/CAA-7485-2022	Ödman, Anja/0000-0002-3556-7029; Zimmerman, Anja/0000-0002-3556-7029	County Administrative Board; Swedish Research Council; Gyllenstiernska Krapperup Foundation	County Administrative Board; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gyllenstiernska Krapperup Foundation	Financial support from The County Administrative Board, The Swedish Research Council, and the Gyllenstiernska Krapperup Foundation made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antrop M, 2005, LANDSCAPE URBAN PLAN, V70, P21, DOI 10.1016/j.landurbplan.2003.10.002; Bahr A, 2012, FLORA, V207, P379, DOI 10.1016/j.flora.2012.03.003; Bateman MD, 2004, HOLOCENE, V14, P579, DOI 10.1191/0959683604hl735rp; Berglund B.E., 1991, CULTURAL LANDSCAPE 6, P425; Bjorkman L, 2003, VEG HIST ARCHAEOBOT, V12, P61, DOI 10.1007/s00334-003-0004-9; Bolan NS, 2003, ADV AGRON, V78, P215, DOI 10.1016/S0065-2113(02)78006-1; Campbell A, 1929, THESIS UPPSALA U SWE; Carroll JA, 2003, ENVIRON POLLUT, V121, P363, DOI 10.1016/S0269-7491(02)00241-5; Dahl S, 1989, MEDDELANDE B, V69; Dahlstrom A., 2006, Environment and History, V12, P191, DOI 10.3197/096734006776680218; Eberhardt RW, 2003, ECOL APPL, V13, P68, DOI 10.1890/1051-0761(2003)013[0068:COCLVA]2.0.CO;2; Eichberg C, 2010, APPL VEG SCI, V13, P425, DOI 10.1111/j.1654-109X.2010.01082.x; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Emanuelsson U., 2002, SKANSKA KULTURLANDSK; FOSTER DR, 1992, J ECOL, V80, P753, DOI 10.2307/2260864; Gazenbeek A, 2005, LIFE FOCUS; Jentsch A, 2009, RESTOR ECOL, V17, P107, DOI 10.1111/j.1526-100X.2007.00339.x; Johansson LJ, 2008, LANDSCAPE URBAN PLAN, V84, P200, DOI 10.1016/j.landurbplan.2007.08.001; Kent M, 2001, PROG PHYS GEOG, V25, P455, DOI 10.1177/030913330102500401; Kent Martin, 2003, Botanical Journal of Scotland, V55, P161; Ljungberg H, 1999, SKALBAGGAR ANDRA INS, P1; Ljungberg KO, 1994, 390254094 SWED ENV P; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; Martensson LM, 2010, PLANT ECOL, V206, P127, DOI 10.1007/s11258-009-9629-9; Mattiasson G, 1974, MEDDELANDEN FRAN AVD, V2, P1; Motzkin G, 1996, ECOL MONOGR, V66, P345, DOI 10.2307/2963522; Odman AM, 2012, BIODIVERS CONSERV, V21, P1921, DOI 10.1007/s10531-012-0292-4; OENEMA O, 1990, FERT RES, V26, P217, DOI 10.1007/BF01048759; Olsson K-A, 1994, LUNDS BOT FORENING M, V2, P4; Olsson PA, 2014, RESTOR ECOL, V22, P49, DOI 10.1111/rec.12024; Olsson PA, 2010, FUNGAL ECOL, V3, P357, DOI 10.1016/j.funeco.2010.01.004; Olsson PA, 2009, APPL VEG SCI, V12, P350, DOI 10.1111/j.1654-109X.2009.01029.x; Owen NW, 2004, J VEG SCI, V15, P669, DOI 10.1111/j.1654-1103.2004.tb02309.x; Persson KM, 2000, DESCRIPTION QUATERNA; PIGOTT CD, 1954, J ECOL, V42, P95, DOI 10.2307/2256981; Poortinga A, 2011, AEOLIAN RES, V3, P81, DOI 10.1016/j.aeolia.2011.05.003; Poschlod P, 2002, BIOL CONSERV, V104, P361, DOI 10.1016/S0006-3207(01)00201-4; Poschlod P., 2009, GRASSLANDS EUROPE HI, P113; Poska A, 1999, VEG HIST ARCHAEOBOT, V8, P185, DOI 10.1007/BF02342719; Rehounkova K, 2008, RESTOR ECOL, V16, P305, DOI 10.1111/j.1526-100X.2007.00316.x; Riksen M, 2006, LANDSCAPE ECOL, V21, P431, DOI 10.1007/s10980-005-2895-6; Riksen M, 2008, J NAT CONSERV, V16, P26, DOI 10.1016/j.jnc.2007.07.002; Roem WJ, 2000, BIOL CONSERV, V92, P151, DOI 10.1016/S0006-3207(99)00049-X; Schnoor TK, 2010, AGR ECOSYST ENVIRON, V139, P714, DOI 10.1016/j.agee.2010.10.018; Smits NAC, 2008, APPL VEG SCI, V11, P279, DOI 10.3170/2008-7-18417; Snogerup S, 2000, FRAN SKANSKA RESA SK; Stroia C, 2011, SOIL SCI SOC AM J, V75, P112, DOI 10.2136/sssaj2009.0135; Tyler T., 2007, FLORAN SKANE ARTERNA; Tyler Torbjorn, 2003, Botaniska Notiser, V136, P1; Tyler Torbjorn, 2005, Lindbergia, V30, P11; VONLINNE C, 1751, C LINNAEI SKANSKA RE; Warren SD, 2007, RESTOR ECOL, V15, P606, DOI 10.1111/j.1526-100X.2007.00272.x; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; WELLS TCE, 1976, J ECOL, V64, P589, DOI 10.2307/2258775	55	11	11	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90998	10.1371/journal.pone.0090998	http://dx.doi.org/10.1371/journal.pone.0090998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621928	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300044
J	Gilan, O; Diesch, J; Amalia, M; Jastrzebski, K; Chueh, AC; Verrills, NM; Pearson, RB; Mariadason, J; Tulchinsky, E; Hannan, RD; Dhillon, AS				Gilan, O.; Diesch, J.; Amalia, M.; Jastrzebski, K.; Chueh, A. C.; Verrills, N. M.; Pearson, R. B.; Mariadason, J. M.; Tulchinsky, E.; Hannan, R. D.; Dhillon, A. S.			PR55 alpha-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FACTOR C-JUN; BETA-CATENIN; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; UP-REGULATION; DNA-BINDING; PP2A; FRA-1; PHOSPHORYLATION	The proto-oncogene c-Jun is a component of activator protein-1 (AP-1) transcription factor complexes that regulates processes essential for embryonic development, tissue homeostasis and malignant transformation. Induction of gene expression by c-Jun involves stimulation of its transactivation ability and upregulation of DNA binding capacity. While it is well established that the former requires JNK-mediated phosphorylation of S63/S73, the mechanism(s) through which binding of c-Jun to its endogenous target genes is regulated remains poorly characterized. Here we show that interaction of c-Jun with chromatin is positively regulated by protein phosphatase 2A (PP2A) complexes targeted to c-Jun by the PR55 alpha regulatory subunit. PR55 alpha-PP2A specifically dephosphorylates T239 of c-Jun, promoting its binding to genes regulating tumour cell migration and invasion. PR55 alpha-PP2A also enhanced transcription of these genes, without affecting phosphorylation of c-Jun on S63. These findings suggest a critical role for interplay between JNK and PP2A pathways determining the functional activity of c-Jun/AP-1 in tumour cells.	[Gilan, O.; Diesch, J.; Amalia, M.; Pearson, R. B.; Hannan, R. D.; Dhillon, A. S.] Peter MacCallum Canc Ctr, Div Res, East Melbourne, Vic, Australia; [Gilan, O.; Diesch, J.; Pearson, R. B.; Hannan, R. D.] Univ Melbourne, Inst Bio21, Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Chueh, A. C.; Mariadason, J. M.] Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Verrills, N. M.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Verrills, N. M.] Hunter Med Res Inst, New Lambton, NSW, Australia; [Pearson, R. B.; Hannan, R. D.; Dhillon, A. S.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, East Melbourne, Vic, Australia; [Pearson, R. B.; Hannan, R. D.] Monash Univ, Biochem & Mol Biol, Clayton, Vic, Australia; [Tulchinsky, E.] Univ Leicester, Canc Studies & Mol Med, Leicester, Leics, England; [Hannan, R. D.] Univ Queensland, SchBiomed Sci, St Lucia, Qld, Australia; [Dhillon, A. S.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; Ludwig Institute for Cancer Research; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Peter Maccallum Cancer Center; University of Melbourne; Monash University; University of Leicester; University of Queensland; University of Melbourne	Dhillon, AS (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.	Amardeep.Dhillon@petermac.org	Chueh, Anderly C./D-8615-2015; Tulchinsky, Eugene/ABD-7070-2021; Chüeh, Anderly C/AFC-2076-2022; Diesch, Jeannine/J-8558-2017; Pearson, Richard Bruce/I-1451-2013; Chueh, Anderly/AAF-9375-2022	Chueh, Anderly C./0000-0003-1140-5516; Chüeh, Anderly C/0000-0003-1140-5516; Diesch, Jeannine/0000-0002-4667-3468; Pearson, Richard Bruce/0000-0001-5919-5090; Dhillon, Amardeep/0000-0002-6065-663X; Verrills, Nicole/0000-0002-7894-0137; Hannan, Ross/0000-0002-2166-4493; Jastrzesbki, Katarzyna/0000-0002-3062-9016; Mariadason, John/0000-0001-9123-7684	National Health and Medical Research Council of Australia; Cancer Institute NSW	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	We thank Drs David Gillespie, Eisuke Nishida, Chunming Liu, Kanaga Sabapathy and William Kaelin for providing reagents used in this study. This work was supported by project grants (to ASD and RDH) and Research Fellowships (to RDH, RBP and JMM) from the National Health and Medical Research Council of Australia and the Cancer Institute NSW (to NMV).	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Al-Murrani SWK, 1999, BIOCHEM J, V341, P293, DOI 10.1042/0264-6021:3410293; ALBERTS AS, 1993, MOL CELL BIOL, V13, P2104, DOI 10.1128/MCB.13.4.2104; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Chen BK, 2007, MOL BIOL CELL, V18, P1118, DOI 10.1091/mbc.E06-09-0797; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; CHOU SY, 1992, MOL BIOL CELL, V3, P1117, DOI 10.1091/mbc.3.10.1117; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Francia G, 1999, INT J CANCER, V82, P709, DOI 10.1002/(SICI)1097-0215(19990827)82:5<709::AID-IJC14>3.3.CO;2-I; Fuchs SY, 1996, ONCOGENE, V13, P1531; Hartl M, 2003, CURR CANCER DRUG TAR, V3, P41, DOI 10.2174/1568009033333781; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Huang CC, 2008, ONCOGENE, V27, P2422, DOI 10.1038/sj.onc.1210888; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698	45	14	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1333	1339		10.1038/onc.2014.26	http://dx.doi.org/10.1038/onc.2014.26			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24632621				2022-12-25	WOS:000350687100013
J	Canesin, G; Cuevas, EP; Santos, V; Lopez-Menendez, C; Moreno-Bueno, G; Huang, Y; Csiszar, K; Portillo, F; Peinado, H; Lyden, D; Cano, A				Canesin, G.; Cuevas, E. P.; Santos, V.; Lopez-Menendez, C.; Moreno-Bueno, G.; Huang, Y.; Csiszar, K.; Portillo, F.; Peinado, H.; Lyden, D.; Cano, A.			Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SUPPRESSOR-CELLS; PROGENITOR CELLS; SNAIL; RECRUITMENT; REGULATOR; REQUIRES; POLARITY	Epithelial-mesenchymal transition (EMT) has been associated with increased aggressiveness and acquisition of migratory properties providing tumor cells with the ability to invade into adjacent tissues. Downregulation of E-cadherin, a hallmark of EMT, is mediated by several transcription factors (EMT-TFs) that act also as EMT inducers, among them, Snail1 and the bHLH transcription factor E47. We previously described lysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family, as a Snail1 regulator and EMT inducer. Here we show that LOXL2 is also an E47-interacting partner and functionally collaborates in the repression of E-cadherin promoter. Loss and gain of function analyses combined with in vivo studies in syngeneic breast cancer models demonstrate the participation of LOXL2 and E47 in tumor growth and their requirement for lung metastasis. Furthermore, LOXL2 and E47 contribute to early steps of metastatic colonization by cell and noncell autonomous functions regulating the recruitment of bone marrow progenitor cells to the lungs and by direct transcriptional regulation of fibronectin and cytokines TNFa, ANG-1 and GM-CSF. Moreover, fibronectin and GM-CSF proved to be necessary for LOXL2/E47-mediated modulation of tumor growth and lung metastasis.	[Canesin, G.; Cuevas, E. P.; Santos, V.; Lopez-Menendez, C.; Moreno-Bueno, G.; Portillo, F.; Cano, A.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, IdiPAZ,Dept Bioquim, Madrid 28029, Spain; [Moreno-Bueno, G.] Fdn MD Anderson Int Madrid, Madrid, Spain; [Huang, Y.; Peinado, H.; Lyden, D.] Weill Cornell Med Coll, Dept Pediat Cell & Dev Biol, New York, NY USA; [Csiszar, K.] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; Cornell University; University of Hawaii System	Cano, A (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Arzobispo Morcillo 2, Madrid 28029, Spain.	acano@iib.uam.es	Peinado, Hector/A-6417-2013; Canesin, Giacomo/H-4541-2019; Cuevas, Eva P./P-4533-2019; Moreno-Bueno, Gema/K-9354-2016; Menendez, Celia Lopez/ABG-7555-2020	Peinado, Hector/0000-0002-4256-3413; Canesin, Giacomo/0000-0002-3318-4550; Cuevas, Eva P./0000-0001-6477-1283; Moreno-Bueno, Gema/0000-0002-5030-6687; Menendez, Celia Lopez/0000-0002-5967-1955; Portillo Perez, Francisco/0000-0003-4922-346X	Spanish Ministry of Science and Innovation [SAF2010-21143, Consolider 2007-CS00017]; AICR [12-1057]; ISCIII [RETIC-RD12/0036/0007]; Comunidad de Madrid [S2010/BMD-2302]; Worldwide Cancer Research [12-1057] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AICR; ISCIII(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Worldwide Cancer Research	We thank members of A. Cano's group: Saleta Morales and Amalia Montes for technical support, Ana Villarejo and Fernando Salvador for help in flow cytometry and collagen crosslinking analyses, and Thomas Look, Manuel Fresno and Peter N. Cockerill for providing reagents, and Angela Nieto for reading the manuscript. The work was supported by the Spanish Ministry of Science and Innovation (SAF2010-21143; Consolider 2007-CS00017); AICR (12-1057) and ISCIII (RETIC-RD12/0036/0007) to AC, and Comunidad de Madrid (S2010/BMD-2302) to AC and GMB. EPC and VS are founded from the AICR grant.	Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bosiljcic M, 2011, CANCER RES, V71, P5050, DOI 10.1158/0008-5472.CAN-10-3982; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Cubillo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059948; Cuevas EP, 2014, BIOL OPEN, V3, P129, DOI 10.1242/bio.20146841; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Ewens A, 2005, ANTICANCER RES, V25, P3905; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Massari ME, 1996, MOL CELL BIOL, V16, P121; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Ye XZ, 2010, J GENET GENOMICS, V37, P423, DOI 10.1016/S1673-8527(09)60061-8	43	66	71	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					951	964		10.1038/onc.2014.23	http://dx.doi.org/10.1038/onc.2014.23			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632622	Green Submitted			2022-12-25	WOS:000350121300002
J	Damania, P; Sen, B; Dar, SB; Kumar, S; Kumari, A; Gupta, E; Sarin, SK; Venugopal, SK				Damania, Preeti; Sen, Bijoya; Dar, Sadaf Bashir; Kumar, Satendra; Kumari, Anupama; Gupta, Ekta; Sarin, Shiv Kumar; Venugopal, Senthil Kumar			Hepatitis B Virus Induces Cell Proliferation via HBx-Induced microRNA-21 in Hepatocellular Carcinoma by Targeting Programmed Cell Death Protein4 (PDCD4) and Phosphatase and Tensin Homologue (PTEN)	PLOS ONE			English	Article							X PROTEIN; REGULATES EXPRESSION; DOWN-REGULATION; UP-REGULATION; MIR-21; NUCLEAR; MIGRATION; SUPPRESSES; ACTIVATION; GROWTH	Hepatitis B viral infection-induced hepatocellular carcinoma is one of the major problems in the developing countries. One of the HBV proteins, HBx, modulates the host cell machinery via several mechanisms. In this study we hypothesized that HBV enhances cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma. HBx gene was over-expressed, and miRNA-21 expression and cell proliferation were measured in Huh 7 and Hep G2 cells. miRNA-21 was over-expressed in these cells, cell proliferation and the target proteins were analyzed. To confirm the role of miRNA-21 in HBx-induced proliferation, Hep G 2.2.1.5 cells (a cell line that expresses HBV stably) were used for miRNA-21 inhibition studies. HBx overexpression enhanced proliferation (3.7- and 4.5-fold increase; n = 3; p<0.01) and miRNA-21 expression (24- and 36-fold increase, normalized with 5S rRNA; p<0.001) in Huh 7 and Hep G2 cells respectively. HBx also resulted in the inhibition of miRNA-21 target proteins, PDCD4 and PTEN. miRNA-21 resulted in a significant increase in proliferation (2- and 2.3-fold increase over control cells; p<0.05 in Huh 7 and Hep G2 cells respectively) and decreased target proteins, PDCD4 and PTEN expression. Anti-miR-21 resulted in a significant decrease in proliferation (p<0.05) and increased miRNA-21 target protein expression. We conclude that HBV infection enhances cell proliferation, at least in part, via HBx-induced miRNA-21 expression during hepatocellular carcinoma progression.	[Damania, Preeti; Sen, Bijoya; Dar, Sadaf Bashir; Kumari, Anupama; Gupta, Ekta; Sarin, Shiv Kumar] Inst Liver & Biliary Sci, New Delhi, India; [Kumar, Satendra; Venugopal, Senthil Kumar] South Asian Univ, New Delhi, India	Institute of Liver & Biliary Sciences (ILBS); South Asian University (SAU)	Sarin, SK (corresponding author), Inst Liver & Biliary Sci, New Delhi, India.	shivsarin@gmail.com; drsenthil@sau.ac.in			Ramalingaswamy Fellowship, DBT, Government of Inida; Department of Biotechnology, Government of India	Ramalingaswamy Fellowship, DBT, Government of Inida; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was supported by the grants from Ramalingaswamy Fellowship, DBT, Government of Inida and Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chen XL, 2011, TRANSPLANTATION, V91, P293, DOI 10.1097/TP.0b013e318204756c; Chung TW, 2003, CANCER RES, V63, P3453; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023; Huang WC, 2012, J CELL PHYSIOL, V227, P1446, DOI 10.1002/jcp.22860; Kong GY, 2011, ACTA PHARMACOL SIN, V32, P1173, DOI 10.1038/aps.2011.52; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lara-Pezzi E, 2001, J HEPATOL, V34, P409, DOI 10.1016/S0168-8278(00)00090-8; Lee YI, 2001, J BIOL CHEM, V276, P16969, DOI 10.1074/jbc.M011263200; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; PATERLINI P, 1995, HEPATOLOGY, V21, P313, DOI 10.1002/hep.1840210208; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shih WL, 2000, J BIOL CHEM, V275, P25858, DOI 10.1074/jbc.M003578200; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Varnholt H, 2008, ANN HEPATOL, V7, P104, DOI 10.1016/S1665-2681(19)31864-2; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Wei XF, 2013, CELL SIGNAL, V25, P439, DOI 10.1016/j.cellsig.2012.10.013; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Yang B, 2012, J VIROL, V86, P313, DOI 10.1128/JVI.06442-11; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yoon S, 2010, LIVER INT, V30, P376, DOI 10.1111/j.1478-3231.2009.02181.x; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang F, 2010, J MED VIROL, V82, P920, DOI 10.1002/jmv.21753; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	37	62	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91745	10.1371/journal.pone.0091745	http://dx.doi.org/10.1371/journal.pone.0091745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633222	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400085
J	Feng, Y; Wang, Z; Bao, ZS; Yan, W; You, G; Wang, YY; Hu, HM; Zhang, W; Zhang, QG; Jiang, T				Feng, Ying; Wang, Zheng; Bao, Zhaoshi; Yan, Wei; You, Gan; Wang, Yinyan; Hu, Huimin; Zhang, Wei; Zhang, Quangeng; Jiang, Tao			SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; DNA METHYLATION; MULTIPLE GENES; SUPPRESSOR; INSTABILITY; CARCINOMAS; BIOMARKER; OVARIAN; GROWTH	Background: Hypermethylation of the suppressor of cytokine signaling 3(SOCS3) promoter has been reported to predict a poor prognosis in several cancers including glioblstoma multiforme (GBM). We explored the function of SOCS3 promoter hypermethylation in GBM cohorts, including analysis of the CpG island methylator phenotype (CIMP), when a large number of gene loci are simultaneously hypermethylated. Methods: A whole genome promoter methylation profile was performed in a cohort of 33 GBM samples, with 13 long-term survivors (LTS; overall survival >= 18 months) and 20 short-term survivors (STS; overall survival <= 9 months). The SOCS3 promoter methylation status was compared between the two groups. In addition, we investigated the relationship of SOCS3 promoter methylation and G-CIMP status. Results: Interestingly, in our present study, we found that SOCS3 promoter methylation was statistically significantly higher in the 13 LTS than that in the 20 STS. Furthermore, high SOCS3 promoter methylation detected via pyro-sequencing predicted a better prognosis in an independent cohort containing 62 GBM patients. This correlation was validated by the dataset from the Cancer Genome Atlas(TCGA) and the Chinese Cancer Genome Atlas(CGGA). In addition, we found that hypermethylation of the SOCS3 promoter was tightly associated with the G-CIMP-positive GBM patients. Conclusions: Using a total of 359 clinical samples, we demonstrate that SOCS3 promoter hypermethylation status has a favorable prognostic value in GBM patients because of whole genome methylation status. Particularly, the hypermethylation of the SOCS3 promoter indicates positive G-CIMP status.	[Feng, Ying; Zhang, Quangeng] Capital Med Univ, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Wang, Zheng; Bao, Zhaoshi; Yan, Wei; You, Gan; Zhang, Wei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Zheng; Bao, Zhaoshi; Yan, Wei; You, Gan; Wang, Yinyan; Hu, Huimin; Zhang, Wei; Jiang, Tao] Beijing Neurosurg Inst, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Beijing Neurosurgical Institute	Zhang, W (corresponding author), Capital Med Univ, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.	zhangwei_vincent@126.com; quangengzhang@163.com; taojiang1964@163.com	Jiang, Tao/N-8142-2014; Wang, Yinyan/AAJ-1160-2020; jiang, tao/GWC-7108-2022		National High Technology Research and Development Program [2012AA02A508]; National 973 program [2011CB707804]; National Nature Science Foundation of China [81201993, 81272804]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National 973 program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National High Technology Research and Development Program (No. 2012AA02A508), the National 973 program (No. 2011CB707804) and the National Nature Science Foundation of China (No. 81201993 and No. 81272804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We appreciate the patients' approval and cooperation.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Barreau O, 2013, J CLIN ENDOCR METAB, V98, pE174, DOI 10.1210/jc.2012-2993; Claus R, 2010, FUTURE ONCOL, V6, P1415, DOI 10.2217/FON.10.110; Eads CA, 2000, CANCER RES, V60, P5021; Fourouclas N, 2008, HAEMATOL-HEMATOL J, V93, P1635, DOI 10.3324/haematol.13043; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JPJ, 2001, CANCER RES, V61, P3573; Kang GH, 2002, AM J PATHOL, V160, P787, DOI 10.1016/S0002-9440(10)64901-2; Kloten V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3375; Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553; Kusano M, 2006, CANCER-AM CANCER SOC, V106, P1467, DOI 10.1002/cncr.21789; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Li Y, 2012, CARCINOGENESIS, V33, P1889, DOI 10.1093/carcin/bgs214; Lindemann C, 2011, ACTA NEUROPATHOL, V122, P241, DOI 10.1007/s00401-011-0832-0; Martini M, 2008, INT J CANCER, V123, P2955, DOI 10.1002/ijc.23805; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Strathdee G, 2001, AM J PATHOL, V158, P1121, DOI 10.1016/S0002-9440(10)64059-X; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang P, 2013, J NEUROONCOL; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	37	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91829	10.1371/journal.pone.0091829	http://dx.doi.org/10.1371/journal.pone.0091829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633048	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400102
J	Nardi, F; Lipina, C; Magill, D; Hassan, RH; Hajduch, E; Gray, A; Hundal, HS				Nardi, Francesca; Lipina, Christopher; Magill, David; Hassan, Rima Hage; Hajduch, Eric; Gray, Alexander; Hundal, Harinder S.			Enhanced Insulin Sensitivity Associated with Provision of Mono and Polyunsaturated Fatty Acids in Skeletal Muscle Cells Involves Counter Modulation of PP2A	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; PLECKSTRIN HOMOLOGY DOMAIN; KINASE-C-ZETA; MITOCHONDRIAL-FUNCTION; MONOUNSATURATED-FAT; DEPENDENT MECHANISM; SRC KINASE; PALMITATE; CERAMIDE; RESISTANCE	Aims/Hypothesis: Reduced skeletal muscle insulin sensitivity is a feature associated with sustained exposure to excess saturated fatty acids (SFA), whereas mono and polyunsaturated fatty acids (MUFA and PUFA) not only improve insulin sensitivity but blunt SFA-induced insulin resistance. The mechanisms by which MUFAs and PUFAs institute these favourable changes remain unclear, but may involve stimulating insulin signalling by counter-modulation/repression of protein phosphatase 2A (PP2A). This study investigated the effects of oleic acid (OA; a MUFA), linoleic acid (LOA; a PUFA) and palmitate (PA; a SFA) in cultured myotubes and determined whether changes in insulin signalling can be attributed to PP2A regulation. Principal Findings: We treated cultured skeletal myotubes with unsaturated and saturated fatty acids and evaluated insulin signalling, phosphorylation and methylation status of the catalytic subunit of PP2A. Unlike PA, sustained incubation of rat or human myotubes with OA or LOA significantly enhanced Akt- and ERK1/2-directed insulin signalling. This was not due to heightened upstream IRS1 or PI3K signalling nor to changes in expression of proteins involved in proximal insulin signalling, but was associated with reduced dephosphorylation/inactivation of Akt and ERK1/2. Consistent with this, PA reduced PP2Ac demethylation and tyrosine(307) phosphorylation - events associated with PP2A activation. In contrast, OA and LOA strongly opposed these PA-induced changes in PP2Ac thus exerting a repressive effect on PP2A. Conclusions/Interpretation: Beneficial gains in insulin sensitivity and the ability of unsaturated fatty acids to oppose palmitate-induced insulin resistance in muscle cells may partly be accounted for by counter-modulation of PP2A.	[Nardi, Francesca; Lipina, Christopher; Magill, David; Gray, Alexander; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland; [Hassan, Rima Hage; Hajduch, Eric] INSERM, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Hassan, Rima Hage; Hajduch, Eric] Univ Paris 06, UMR S 872, Paris, France; [Hassan, Rima Hage; Hajduch, Eric] Univ Paris 05, UMR S 872, Paris, France	University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland.	h.s.hundal@dundee.ac.uk	Hundal, Hari/A-8990-2008; Hajduch, Eric/B-7332-2008	Hundal, Hari/0000-0002-7621-4932; Hajduch, Eric/0000-0002-0125-7751; Gray, Alexander/0000-0001-9227-0363; Lipina, Christopher/0000-0001-7327-2857	BBSRC; Diabetes UK; Diabetes UK [10/0004146] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Diabetes UK(Diabetes UK)	This work was supported by grants from BBSRC and Diabetes UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Feng XT, 2012, BIOSCI BIOTECH BIOCH, V76, P1356, DOI 10.1271/bbb.120107; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kien CL, 2013, DIABETES, V62, P1054, DOI 10.2337/db12-0363; Kien CL, 2013, AM J CLIN NUTR, V97, P689, DOI 10.3945/ajcn.112.051730; Kien CL, 2011, OBESITY, V19, P305, DOI 10.1038/oby.2010.135; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Kowluru A, 2012, BIOCHEM PHARMACOL, V84, P591, DOI 10.1016/j.bcp.2012.05.003; Macrae K, 2013, J LIPID RES, V54, P2366, DOI 10.1194/jlr.M036996; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Soto-Guzman A, 2008, MOL CELL ENDOCRINOL, V294, P81, DOI 10.1016/j.mce.2008.08.003; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010	44	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92255	10.1371/journal.pone.0092255	http://dx.doi.org/10.1371/journal.pone.0092255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632852	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400156
J	Arai-Nunota, N; Mizobuchi, M; Ogata, H; Yamazaki-Nakazawa, A; Kumata, C; Kondo, F; Hosaka, N; Koiwa, F; Kinugasa, E; Shibata, T; Akizawa, T				Arai-Nunota, Noriko; Mizobuchi, Masahide; Ogata, Hiroaki; Yamazaki-Nakazawa, Ai; Kumata, Chiaki; Kondo, Fumiko; Hosaka, Nozomu; Koiwa, Fumihiko; Kinugasa, Eriko; Shibata, Takanori; Akizawa, Tadao			Intravenous Phosphate Loading Increases Fibroblast Growth Factor 23 in Uremic Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; VITAMIN-D METABOLISM; HEMODIALYSIS-PATIENTS; MINERAL METABOLISM; SERUM PHOSPHORUS; RENAL-FUNCTION; HEALTHY-MEN; FGF23; FIBROBLAST-GROWTH-FACTOR-23	Oral phosphate loading and calcitriol stimulate Fibroblast growth factor 23 (FGF23) secretion, but the mechanisms underlying the stimulation of FGF23 remain to be studied. We compared the effect of intravenous phosphate loading with that of oral loading on FGF23 levels in normal and 5/6 nephrectomized uremic rats. Uremic rats (Nx) and sham-operated rats were fed a normal phosphate diet for 2 weeks and then divided into 3 groups: 1) with the same phosphate diet (NP), 2) with a high phosphate diet (HP), and 3) NP rats with intravenous phosphate infusion using a microinfusion pump (IV). Blood and urine were obtained 1 day (early phase) and 7 days (late phase) after the interventions. In the early and late phases, serum phosphate levels and fractional excretion of phosphate (FEP) were comparable in the HP and IV groups in both Sham and Nx rats. Serum phosphate levels in the HP and IV groups were equally and significantly higher than those in the NP group only in the late phase in Nx rats. In the early phase, FGF23 levels were comparable in the NP, HP, and IV groups, but were significantly higher in the HP and IV groups compared to the NP group in the late phase in Nx rats. 1 alpha-hydroxylase and sodium dependent phosphate co-transporter 2a expression levels in the kidney in Nx rats were equally and significantly decreased in the HP and IV groups compared with the NP group, while 24-hydroxylase expression was equally and significantly increased. These results show that chronic intravenous phosphate loading increases bioactive FGF23, indicating that an alternative pathway for FGF23 regulation, in addition to the dietary route, may be present. This pathway is clearer under conditions produced by a kidney injury in which phosphate is easily overloaded.	[Arai-Nunota, Noriko; Mizobuchi, Masahide; Yamazaki-Nakazawa, Ai; Kondo, Fumiko; Hosaka, Nozomu; Shibata, Takanori; Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Ogata, Hiroaki; Kumata, Chiaki; Kinugasa, Eriko] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan; [Koiwa, Fumihiko] Showa Univ, Fujigaoka Hosp, Dept Med, Div Nephrol, Yokohama, Kanagawa 227, Japan	Showa University; Showa University; Showa University	Mizobuchi, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan.	mizobu@med.showa-u.ac.jp	Ogata, Hiroaki/A-7946-2011	Ogata, Hiroaki/0000-0002-0046-5575				Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Berndt T, 2007, P NATL ACAD SCI USA, V104, P11085, DOI 10.1073/pnas.0704446104; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Cancela ALE, 2011, NEPHRON CLIN PRACT, V117, pC74, DOI 10.1159/000319650; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; HUGHES MR, 1975, SCIENCE, V190, P578, DOI 10.1126/science.1188357; Imanishi Y, 2004, KIDNEY INT, V65, P1943, DOI 10.1111/j.1523-1755.2004.00604.x; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P948, DOI 10.1093/ndt/gfn571; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Krieger NS, 2012, AM J PHYSIOL-RENAL, V303, pF431, DOI 10.1152/ajprenal.00199.2012; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2013, SEMIN NEPHROL, V33, P130, DOI 10.1016/j.semnephrol.2012.12.014; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91096	10.1371/journal.pone.0091096	http://dx.doi.org/10.1371/journal.pone.0091096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625659	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300055
J	Bu, CF; Wu, SF; Yang, YS; Zheng, MG				Bu, Chongfeng; Wu, Shufang; Yang, Yongsheng; Zheng, Mingguo			Identification of Factors Influencing the Restoration of Cyanobacteria-Dominated Biological Soil Crusts	PLOS ONE			English	Article							GURBANTUNGGUT DESERT; NITROGENASE ACTIVITY; ALGAL CRUSTS; BIOMASS; STABILIZATION; INOCULATION; EROSION; SURFACE	Biological soil crusts (BSCs) cover >35% of the Earth's land area and contribute to important ecological functions in arid and semiarid ecosystems, including erosion reduction, hydrological cycling, and nutrient cycling. Artificial rapid cultivation of BSCs can provide a novel alternative to traditional biological methods for controlling soil and water loss such as the planting of trees, shrubs, and grasses. At present, little is known regarding the cultivation of BSCs in the field due to lack of knowledge regarding the influencing factors that control BSCs growth. Thus, we determined the effects of various environmental factors (shade; watering; N, P, K, and Ca concentrations) on the growth of cyanobacteria-dominated BSCs from the Sonoran Desert in the southwestern United States. The soil surface changes and chlorophyll a concentrations were used as proxies of BSC growth and development. After 4 months, five factors were found to impact BSC growth with the following order of importance: NH4NO3 approximate to watering frequency>shading>CaCO3 approximate to KH2PO4. The soil water content was the primary positive factor affecting BSC growth, and BSCs that were watered every 5 days harbored greater biomass than those watered every 10 days. Groups that received NH4NO3 consistently exhibited poor growth, suggesting that fixed N amendment may suppress BSC growth. The effect of shading on the BSC biomass was inconsistent and depended on many factors including the soil water content and availability of nutrients. KH2PO4 and CaCO3 had nonsignificant effects on BSC growth. Collectively, our results indicate that the rapid restoration of BSCs can be controlled and realized by artificial "broadcasting" cultivation through the optimization of environmental factors.	[Bu, Chongfeng; Wu, Shufang] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Bu, Chongfeng; Yang, Yongsheng] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Bu, Chongfeng; Yang, Yongsheng] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Wu, Shufang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China; [Zheng, Mingguo] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Bu, CF (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	buchongfeng@163.com	Lang, Ming/HIK-0758-2022		National Natural Science Foundation of China [41071192, 40701096]; West Light Foundation of the Chinese Academy of Sciences [B2008132]; 111 project [B12007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); 111 project(Ministry of Education, China - 111 Project)	The National Natural Science Foundation of China (Grant Nos 41071192 & 40701096), the West Light Foundation of the Chinese Academy of Sciences (No. B2008132), and the 111 project (No. B12007) provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; BELNAP J, 1994, ARID SOIL RES REHAB, V8, P1; Bowker MA, 2002, MICROB ECOL, V43, P13, DOI 10.1007/s00248-001-1013-9; Bowker MA, 2009, SOIL BIOL BIOCHEM, V42, P1; Bowker MA, 2008, SOIL BIOL BIOCHEM, V40, P2309, DOI 10.1016/j.soilbio.2008.05.008; Bu C, 2015, PLANT BIOSYST, V149, P364, DOI 10.1080/11263504.2013.819820; Bu CF, 2013, SOIL USE MA IN PRESS; Bu CF, 2013, CLEAN-SOIL AIR WATER, V41, P899, DOI 10.1002/clen.201100675; [卜崇峰 BU Chongfeng], 2008, [地理科学进展, Progress in Geography], V27, P26; Chen Lan-zhou, 2002, Acta Hydrobiologica Sinica, V26, P155; Chen YanQin, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P44; De Philippis R, 2003, REC RES DEV MICROBIO, V7, P13; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Hu CX, 2002, J APPL PHYCOL, V14, P281, DOI 10.1023/A:1021128530086; Institute of Soil Science Chinese Academic Sciences, 1978, AN PHYS CHEM PROP SO; [赵允格 Zhao Yunge], 2010, [生态学报, Acta Ecologica Sinica], V30, P4668; Kidron GJ, 2009, EARTH SURF PROC LAND, V34, P1594, DOI 10.1002/esp.1843; Lan SB, 2011, SOIL BIOL BIOCHEM, V43, P857, DOI 10.1016/j.soilbio.2010.12.007; Li XR, 2010, EARTH SURF PROC LAND, V35, P932, DOI 10.1002/esp.1963; Maestre FT, 2006, MICROB ECOL, V52, P365, DOI 10.1007/s00248-006-9017-0; Metting B., 1991, BIOL SURFACE FEATURE; Rao Ben-Qiang, 2009, Acta Hydrobiologica Sinica, V33, P937, DOI 10.3724/SP.J.0000.2009.50937; Rao Ben-Qiang, 2009, Acta Hydrobiologica Sinica, V33, P756, DOI 10.3724/SP.J.1035.2009.40756; Tang Dong-Shan, 2007, Acta Hydrobiologica Sinica, V31, P339; Tighe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048565; Tsujimura S, 2000, J APPL PHYCOL, V12, P1, DOI 10.1023/A:1008126232188; Wang WB, 2009, SOIL BIOL BIOCHEM, V41, P926, DOI 10.1016/j.soilbio.2008.07.001; [王雪芹 Wang Xueqin], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P632; Wei J. C., 2005, ARID ZONE RES, V2, P287; Wu N, 2009, J ARID ENVIRON, V73, P828, DOI 10.1016/j.jaridenv.2009.04.002; Wu N, 2006, CHINESE SCI BULL, V51, P124, DOI 10.1007/s11434-006-8216-x; Xie Zuo-Ming, 2008, Acta Hydrobiologica Sinica, V32, P272; Xie ZM, 2007, SOIL BIOL BIOCHEM, V39, P567, DOI 10.1016/j.soilbio.2006.09.004; Zhang YM, 2006, GEODERMA, V132, P441, DOI 10.1016/j.geoderma.2005.06.008	38	36	38	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90049	10.1371/journal.pone.0090049	http://dx.doi.org/10.1371/journal.pone.0090049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625498	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300013
J	Englund, E; Pattanaik, B; Ubhayasekera, SJK; Stensjo, K; Bergquist, J; Lindberg, P				Englund, Elias; Pattanaik, Bagmi; Ubhayasekera, Sarojini Jayantha K.; Stensjo, Karin; Bergquist, Jonas; Lindberg, Pia			Production of Squalene in Synechocystis sp PCC 6803	PLOS ONE			English	Article							THERMOSYNECHOCOCCUS-ELONGATUS BP-1; BACTERIUM PRODUCING HOPANOIDS; PENTOSE-PHOSPHATE CYCLE; NON-MEVALONATE PATHWAY; HOPENE CYCLASE; ISOPRENOID BIOSYNTHESIS; CHOLESTEROL-BIOSYNTHESIS; SEQUENCE-ANALYSIS; STRAIN PCC-6803; KEY ENZYME	In recent years, there has been an increased interest in the research and development of sustainable alternatives to fossil fuels. Using photosynthetic microorganisms to produce such alternatives is advantageous, since they can achieve direct conversion of carbon dioxide from the atmosphere into the desired product, using sunlight as the energy source. Squalene is a naturally occurring 30-carbon isoprenoid, which has commercial use in cosmetics and in vaccines. If it could be produced sustainably on a large scale, it could also be used instead of petroleum as a raw material for fuels and as feedstock for the chemical industry. The unicellular cyanobacterium Synechocystis PCC 6803 possesses a gene, slr2089, predicted to encode squalene hopene cyclase (Shc), an enzyme converting squalene into hopene, the substrate for forming hopanoids. Through inactivation of slr2089 (shc), we explored the possibility to produce squalene using cyanobacteria. The inactivation led to accumulation of squalene, to a level over 70 times higher than in wild type cells, reaching 0.67 mg OD750-1 L-1. We did not observe any significant growth deficiency in the Delta shc strain compared to the wild type Synechocystis, even at high light conditions, suggesting that the observed squalene accumulation was not detrimental to growth, and that formation of hopene by Shc is not crucial for growth under normal conditions, nor for high-light stress tolerance. Effects of different light intensities and growth stages on squalene accumulation in the Delta shc strain were investigated. We also identified a gene, sll0513, as a putative squalene synthase in Synechocystis, and verified its function by inactivation. In this work, we show that it is possible to use the cyanobacterium Synechocystis to generate squalene, a hydrocarbon of commercial interest and a potential biofuel. We also report the first identification of a squalene hopene cyclase, and the second identification of squalene synthase, in cyanobacteria.	[Englund, Elias; Pattanaik, Bagmi; Stensjo, Karin; Lindberg, Pia] Uppsala Univ, Dept Chem, Angstrom & Sci Life Lab, Uppsala, Sweden; [Ubhayasekera, Sarojini Jayantha K.; Bergquist, Jonas] BMC, Dept Chem, Uppsala, Sweden; [Ubhayasekera, Sarojini Jayantha K.; Bergquist, Jonas] Sci Life Lab, Uppsala, Sweden	Uppsala University	Lindberg, P (corresponding author), Uppsala Univ, Dept Chem, Angstrom & Sci Life Lab, Uppsala, Sweden.	pia.lindberg@kemi.uu.se	Stensjo, Karin/E-3801-2017; Bergquist, Jonas/C-5894-2015; Stensjö, Karin/D-3240-2009	Stensjo, Karin/0000-0001-6993-8476; Bergquist, Jonas/0000-0002-4597-041X	Swedish Energy Agency; Knut and Alice Wallenberg Foundation; Swedish Research Council [VR-621-2011-4423]; CF Lundstrom Foundation; Carl Trygger Foundation	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); CF Lundstrom Foundation; Carl Trygger Foundation	The research leading to these results has received funding from the Swedish Energy Agency, the Knut and Alice Wallenberg Foundation (project MoSE), the Swedish Research Council (grant no VR-621-2011-4423), the CF Lundstrom Foundation, and the Carl Trygger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley SJ, 2004, J BACTERIOL, V186, P8156, DOI 10.1128/JB.186.23.8156-8158.2004; Bentley FK, 2013, BIOENERG RES, V6, P917, DOI 10.1007/s12155-013-9325-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Feil C, 1996, EUR J BIOCHEM, V242, P51, DOI 10.1111/j.1432-1033.1996.0051r.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu PD, 1998, J BIOL CHEM, V273, P12515, DOI 10.1074/jbc.273.20.12515; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; JURGENS UJ, 1992, FEMS MICROBIOL LETT, V92, P285; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kannenberg EL, 1999, NATURWISSENSCHAFTEN, V86, P168, DOI 10.1007/s001140050592; KLEEMANN G, 1994, BBA-LIPID LIPID MET, V1210, P317, DOI 10.1016/0005-2760(94)90235-6; Kufryk GI, 2002, FEMS MICROBIOL LETT, V206, P215; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; Lichtenthaler HK, 2000, BIOCHEM SOC T, V28, P785, DOI 10.1042/BST0280785; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; OCHS D, 1992, J BACTERIOL, V174, P298, DOI 10.1128/jb.174.1.298-302.1992; Okada K, 2005, J BIOL CHEM, V280, P20672, DOI 10.1074/jbc.M500865200; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Pearson A, 2009, ISME J, V3, P352, DOI 10.1038/ismej.2008.116; Perzl M, 1997, MICROBIOL-UK, V143, P1235, DOI 10.1099/00221287-143-4-1235; Poliquin K, 2004, J BACTERIOL, V186, P4685, DOI 10.1128/JB.186.14.4685-4693.2004; REIPEN IG, 1995, MICROBIOL-SGM, V141, P155, DOI 10.1099/00221287-141-1-155; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Seipke RF, 2009, J BACTERIOL, V191, P5216, DOI 10.1128/JB.00390-09; Siedenburg G, 2011, APPL ENVIRON MICROB, V77, P3905, DOI 10.1128/AEM.00300-11; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; SUMMERS C, 1993, GENE, V136, P185, DOI 10.1016/0378-1119(93)90462-C; Tamagnini P, 1997, APPL ENVIRON MICROB, V63, P1801, DOI 10.1128/AEM.63.5.1801-1807.1997; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Tippelt A, 1998, BBA-LIPID LIPID MET, V1391, P223, DOI 10.1016/S0005-2760(97)00212-9; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470	40	66	70	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90270	10.1371/journal.pone.0090270	http://dx.doi.org/10.1371/journal.pone.0090270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625633	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300017
J	Li, Y; Liu, YY; Chen, XJ; Xiong, XH; Li, FS				Li, Yi; Liu, Yuan-Yuan; Chen, Xue-Jun; Xiong, Xiao-Hui; Li, Fang-Shi			Synthesis, Spectroscopic Characterization, X-Ray Structure, and DFT Calculations of Some New 1,4-Dihydro-2,6-Dimethyl-3,5-Pyridinedicarboxamides	PLOS ONE			English	Article							ANTITUBERCULAR ACTIVITY	A series of novel 1,4-dihydro-2,6- dimethyl-3,5-pyridinedicarboxamides were synthesized and characterized by infrared absorption spectrum (IR), proton nuclear magnetic resonance (H-1 NMR), elemental analysis, ultraviolet spectrum (UV), and fluorescence techniques, together with X-ray single crystal diffraction. The results of density functional theory (DFT) and time-dependent density functional theory (TDDFT) calculations provided a reasonable explanation on the molecular structures, the molecular frontier orbital, and the spectra of electronic absorption and emission. The present work will be helpful to systematically understanding of the structures and the optical properties of 1,4-dihydropyridines for studying the structure-activity relationship and to develop new drugs and their analytical methods.	[Li, Yi; Xiong, Xiao-Hui] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China; [Liu, Yuan-Yuan] Southeast Univ, ChengXian Coll, Dept Chem & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Chen, Xue-Jun; Li, Fang-Shi] Nanjing Tech Univ, Coll Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Southeast University - China; Nanjing Tech University	Liu, YY (corresponding author), Southeast Univ, ChengXian Coll, Dept Chem & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.	Liuyuanyuan1985419@163.com; Fangshi.li@njtech.edu.cn	liu, yuanyuan/GWZ-5838-2022		Natural Science Youth Foundation of Jiangsu Province, China [BK20130749]; Project of the Twelfth Five Year Plan of China [2012BAK17B09]; Project of Food Fast Detection Technology of Jiangsu Province, China [BM2012026]	Natural Science Youth Foundation of Jiangsu Province, China; Project of the Twelfth Five Year Plan of China; Project of Food Fast Detection Technology of Jiangsu Province, China	The Natural Science Youth Foundation of Jiangsu Province, China (BK20130749); The Project of the Twelfth Five Year Plan of China (2012BAK17B09); The Project of Food Fast Detection Technology of Jiangsu Province, China (BM2012026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desai B, 2001, BIOORGAN MED CHEM, V9, P1993, DOI 10.1016/S0968-0896(01)00141-9; Fassihi A, 2009, EUR J MED CHEM, V44, P3253, DOI 10.1016/j.ejmech.2009.03.027; Frisch M. J., 2009, GAUSSIAN 09 REVISION; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; GANIS P, 1971, J AM CHEM SOC, V93, P3328, DOI 10.1021/ja00743a004; Ghorai MK, 2010, J ORG CHEM, V75, P7061, DOI 10.1021/jo101680f; JANIS RA, 1983, J MED CHEM, V26, P775, DOI 10.1021/jm00360a001; Kemp William, 1996, ORGANIC SPECTROSCOPY, V3rd; Li Y, 2013, MOLECULES, V18, P877, DOI 10.3390/molecules18010877; Li Y, 2011, J MOL STRUCT, V997, P110, DOI 10.1016/j.molstruc.2011.05.006; Li Y, 2011, J MOL STRUCT, V987, P206, DOI 10.1016/j.molstruc.2010.12.023; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; Mojarrad JS, 2004, BIOORGAN MED CHEM, V12, P3215, DOI 10.1016/j.bmc.2004.03.063; Shafii B., 2008, Journal of Sciences-Islamic Republic of Iran, V19, P323; Shan RD, 2004, J MED CHEM, V47, P254, DOI 10.1021/jm030333h; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silverstein R., 1977, SPECTROMETRIC IDENTI; STOUT DM, 1982, CHEM REV, V82, P223, DOI 10.1021/cr00048a004; Suarez M, 2003, TETRAHEDRON, V59, P9179, DOI 10.1016/j.tet.2003.09.047; Zhang QM, 2010, TETRAHEDRON, V66, P8095, DOI 10.1016/j.tet.2010.07.043	20	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91361	10.1371/journal.pone.0091361	http://dx.doi.org/10.1371/journal.pone.0091361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625887	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300078
J	Liu, FF; Yu, H				Liu, Feifan; Yu, Hong			Learning to Rank Figures within a Biomedical Article	PLOS ONE			English	Article							RERANKING; SEARCH; ADAPTATION; ENGINE	Hundreds of millions of figures are available in biomedical literature, representing important biomedical experimental evidence. This ever-increasing sheer volume has made it difficult for scientists to effectively and accurately access figures of their interest, the process of which is crucial for validating research facts and for formulating or testing novel research hypotheses. Current figure search applications can't fully meet this challenge as the "bag of figures" assumption doesn't take into account the relationship among figures. In our previous study, hundreds of biomedical researchers have annotated articles in which they serve as corresponding authors. They ranked each figure in their paper based on a figure's importance at their discretion, referred to as "figure ranking". Using this collection of annotated data, we investigated computational approaches to automatically rank figures. We exploited and extended the state-of-the-art listwise learning-to-rank algorithms and developed a new supervised-learning model BioFigRank. The cross-validation results show that BioFigRank yielded the best performance compared with other state-of-the-art computational models, and the greedy feature selection can further boost the ranking performance significantly. Furthermore, we carry out the evaluation by comparing BioFigRank with three-level competitive domain-specific human experts: (1) First Author, (2) Non-Author-In-Domain-Expert who is not the author nor co-author of an article but who works in the same field of the corresponding author of the article, and (3) Non-Author-Out-Domain-Expert who is not the author nor co-author of an article and who may or may not work in the same field of the corresponding author of an article. Our results show that BioFigRank outperforms Non-Author-Out-Domain-Expert and performs as well as Non-Author-In-Domain-Expert. Although BioFigRank underperforms First Author, since most biomedical researchers are either in-or out-domain-experts for an article, we conclude that BioFigRank represents an artificial intelligence system that offers expert-level intelligence to help biomedical researchers to navigate increasingly proliferated big data efficiently.	[Liu, Feifan] Univ Wisconsin, Dept Comp Sci, Milwaukee, WI 53201 USA; [Yu, Hong] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA; [Yu, Hong] VA Cent Western Massachusetts, Northampton, MA USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Massachusetts System; University of Massachusetts Worcester	Yu, H (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA.	hongyubennett@gmail.com	Liu, Feifan/D-2478-2012	Liu, Feifan/0000-0003-0881-6365	National Institutes of Health [1R01GM095476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (http://www.nih.gov/) with the grant number 1R01GM095476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 2009, AMIA ANN S P; Agarwal Shashank, 2009, AMIA Annu Symp Proc, V2009, P6; Bockhorst JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039618; Braschler M, 2004, INFORM RETRIEVAL, V7, P7, DOI 10.1023/B:INRT.0000009438.69013.fa; Burges C., 2005, P 22 INT C MACH LEAR, V119, P89, DOI [10.1145/1102351.1102363, DOI 10.1145/1102351.1102363]; Burges C. J., 2007, P ADV NEUR INF PROC, V19, P193; Cao Z., 2007, P 24 INT C MACH LEAR, P129, DOI DOI 10.1145/1273496.1273513; Cass T, 1998, SCIENCE, V282, P636, DOI 10.1126/science.282.5389.636; Charniak E, 2005, P 43 ANN M ASS COMP, P180; Collins M, 2005, COMPUT LINGUIST, V31, P25, DOI 10.1162/0891201053630273; COLLINS M, 2002, P 40 ANN M ASS COMP; DEMNERFUSHMAN D, 2009, INT J MED INFORM; Esparza J, 2007, J EXP MED, V204, P701, DOI 10.1084/jem.20070073; Freund Y., 2003, J MACHINE LEARNING R, V4, P933, DOI DOI 10.1162/JMLR.2003.4.6.933; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; HUANG L, 2008, P ACL; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Joachims T, 2006, PROC 22 ACM SIGKDD I, P217, DOI DOI 10.1145/1150402.1150429; Jun Xu, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P391; Kahn CE, 2007, AM J ROENTGENOL, V188, P1475, DOI 10.2214/AJR.06.1740; LI Z, 2009, FOREST RERANKING MAC; Liu F, 2011, IEEE T AUDIO SPEECH, V19, P538, DOI 10.1109/TASL.2010.2052119; Liu Y, 2008, INT CONF ACOUST SPEE, P4921; Marcotte E, 2001, Brief Bioinform, V2, P363, DOI 10.1093/bib/2.4.363; Mervis J, 2012, SCIENCE, V336, P22, DOI 10.1126/science.336.6077.22; Murphy RF, 2001, 2ND ANNUAL IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P119, DOI 10.1109/BIBE.2001.974420; Nallapati R., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P64, DOI 10.1145/1008992.1009006; Pennisi E, 2005, SCIENCE, V309, P94, DOI 10.1126/science.309.5731.94; Qin T, 2008, INFORM PROCESS MANAG, V44, P838, DOI 10.1016/j.ipm.2007.07.016; Radev Dragomir, 2002, P 11 INT C WORLD WID, P408, DOI [10.1145/511446.511500, DOI 10.1145/511446.511500]; Rafkind B, 2006, EXPLORING TEXT IMAGE; Ranganathan S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S1; Shatkay H, 2006, BIOINFORMATICS, V22, pE446, DOI 10.1093/bioinformatics/btl235; Shen LB, 2005, MACH LEARN, V60, P73, DOI 10.1007/s10994-005-0918-9; Simon N, 2012, NAT BIOTECHNOL, V30, P334, DOI 10.1038/nbt.2182; Trelles O, 2011, NAT REV GENET, V12, DOI 10.1038/nrg2857-c1; Xia Fen, 2008, P 25 INT C MACH LEAR, P1192, DOI DOI 10.1145/1390156.1390306; Xu JX, 2000, ACM T INFORM SYST, V18, P79, DOI 10.1145/333135.333138; Xu SH, 2008, BIOINFORMATICS, V24, P1968, DOI 10.1093/bioinformatics/btn340; Yates R. B., 1999, MODERN INFORM RETRIE; Yisong Yue, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P271; Yu Hong, 2006, AMIA Annu Symp Proc, P834; Yu H, 2006, BIOINFORMATICS, V22, pE547, DOI 10.1093/bioinformatics/btl261; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012983; Yu Hong, 2009, J Biomed Discov Collab, V4, P1, DOI 10.1186/1747-5333-4-1; Zheng Z., 2010, P 2010 C N AM CHAPT, P483; Zhou ZY, 2006, INT CONF ACOUST SPEE, P141	47	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e61567	10.1371/journal.pone.0061567	http://dx.doi.org/10.1371/journal.pone.0061567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625719	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300001
J	Croci, R; Pezzullo, M; Tarantino, D; Milani, M; Tsay, SC; Sureshbabu, R; Tsai, YJ; Mastrangelo, E; Rohayem, J; Bolognesi, M; Hwu, JR				Croci, Romina; Pezzullo, Margherita; Tarantino, Delia; Milani, Mario; Tsay, Shwu-Chen; Sureshbabu, Radhakrishnan; Tsai, Yi-Jin; Mastrangelo, Eloise; Rohayem, Jacques; Bolognesi, Martino; Hwu, Jih Ru			Structural Bases of Norovirus RNA Dependent RNA Polymerase Inhibition by Novel Suramin-Related Compounds	PLOS ONE			English	Article							GROWTH-FACTOR; VACCINE; PATHOGENESIS; ANTAGONIST; INFECTION; RECEPTOR; PPNDS; DRUG	Noroviruses (NV) are +ssRNA viruses responsible for severe gastroenteritis; no effective vaccines/antivirals are currently available. We previously identified Suramin (9) as a potent inhibitor of NV-RNA dependent RNA polymerase (NV-RdRp). Despite significant in vitro activities versus several pharmacological targets, Suramin clinical use is hampered by pharmacokinetics/toxicity problems. To improve Suramin access to NV-RdRp in vivo, a Suramin-derivative, 8, devoid of two sulphonate groups, was synthesized, achieving significant anti-human-NV-RdRp activity (IC50 = 28 nM); the compound inhibits also murine NV (mNV) RdRp. The synthesis process led to the isolation/characterization of lower molecular weight intermediates (3-7) hosting only one sulphonate head. The crystal structures of both hNV/mNV-RdRps in complex with 6, were analyzed, providing new knowledge on the interactions that a small fragment can establish with NV-RdRps, and establishing a platform for structure-guided optimization of potency, selectivity and drugability.	[Croci, Romina; Pezzullo, Margherita; Tarantino, Delia; Milani, Mario; Mastrangelo, Eloise; Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy; [Milani, Mario; Tsai, Yi-Jin] CNR IBF, Ist Biofis, Milan, Italy; [Tsay, Shwu-Chen; Hwu, Jih Ru] Natl Cent Univ, Dept Chem, Jhongli, Taiwan; [Sureshbabu, Radhakrishnan; Tsai, Yi-Jin; Hwu, Jih Ru] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Sureshbabu, Radhakrishnan; Tsai, Yi-Jin; Hwu, Jih Ru] Natl Tsing Hua Univ, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu, Taiwan; [Rohayem, Jacques] Riboxx GmbH, Radebeul, Germany; [Rohayem, Jacques] Tech Univ Dresden, Inst Virol, Dresden, Germany	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); National Central University; National Tsing Hua University; National Tsing Hua University; Technische Universitat Dresden	Bolognesi, M (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	martino.bolognesi@unimi.it; jrhwu@mx.nthu.edu.tw	Mastrangelo, Eloise/AAX-1385-2020; Bolognesi, Martino/B-7924-2017; Milani, Mario/B-6446-2015	Bolognesi, Martino/0000-0002-9253-5170; Milani, Mario/0000-0001-6098-3991; Mastrangelo, Eloise/0000-0002-5968-8386; Hwu, Jih Ru/0000-0002-9225-8484	National Science Council [NSC 102-2923-I-008-001]; Ministry of Education of the R.O.C., Taiwan [102N2011E1, 102N2018E1]; National Central University [102G918]; European Commission [2606444]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education of the R.O.C., Taiwan(Ministry of Education, Taiwan); National Central University; European Commission(European CommissionEuropean Commission Joint Research Centre)	National Science Council (NSC 102-2923-I-008-001), Ministry of Education of the R.O.C., Taiwan (grants nos. 102N2011E1 and 102N2018E1), and National Central University (102G918). The work at University of Milano and CNR (Milano, Italy) and at Riboxx GmbH (Dresden Germany) was supported by the European Commission SILVER project, within the 7th Framework Program Cooperation Project Grant Agreement No. 2606444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2012, EXPERT REV VACCINES, V11, P1023, DOI [10.1586/erv.12.78, 10.1586/ERV.12.78]; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bookser BC, 2005, J MED CHEM, V48, P7808, DOI 10.1021/jm050394a; Camp D, 2012, J NAT PROD, V75, P72, DOI 10.1021/np200687v; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Clarke IN, 1997, J GEN VIROL, V78, P291, DOI 10.1099/0022-1317-78-2-291; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Eltahla AA, 2013, J BIOMOL SCREEN, V18, P1027, DOI 10.1177/1087057113489883; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; Hansman GS, 2005, ARCH VIROL, V150, P2529, DOI 10.1007/s00705-005-0599-5; Hansman GS, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P1; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; Jagielski AK, 2006, EUR J PHARMACOL, V537, P205, DOI 10.1016/j.ejphar.2006.03.029; KAPLAN LD, 1987, AM J MED, V82, P615, DOI 10.1016/0002-9343(87)90108-2; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Kaur M, 2002, INVEST NEW DRUG, V20, P209, DOI 10.1023/A:1015666024386; Kraszni M, 2003, J MED CHEM, V46, P2241, DOI 10.1021/jm030767c; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Lee S, 2012, J CHEM INF MODEL, V52, P440, DOI 10.1021/ci2004913; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lustberg MB, 2012, CANCER CHEMOTH PHARM, V70, P49, DOI 10.1007/s00280-012-1887-x; Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008; Mitsuya H, 1984, Princess Takamatsu Symp, V15, P277; Padiya KJ, 2012, ORG LETT, V14, P2814, DOI 10.1021/ol301009d; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pinnen F, 2007, J MED CHEM, V50, P2506, DOI 10.1021/jm070037v; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SOLA F, 1995, CANCER CHEMOTH PHARM, V36, P217, DOI 10.1007/BF00685849; Souza M, 2007, J VIROL, V81, P9183, DOI 10.1128/JVI.00558-07; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Suzuki E, 2004, MOL PHARMACOL, V66, P1738, DOI 10.1124/mol.104.003038; Tarantino D, 2013, ANTIVIR RES; Thomas G, MED CHEM; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wood CR, 2003, J EXP BIOL, V206, P627, DOI 10.1242/jeb.00105; Zamai M, 2002, BIOPHYS J, V82, P2652, DOI 10.1016/S0006-3495(02)75607-5; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200; Zamyatkin DF, 2009, J MOL BIOL, V390, P10, DOI 10.1016/j.jmb.2009.04.069	43	34	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91765	10.1371/journal.pone.0091765	http://dx.doi.org/10.1371/journal.pone.0091765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622391	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300125
J	Huang, BR; Chang, PC; Yeh, WL; Lee, CH; Tsai, CF; Lin, CJ; Lin, HY; Liu, YS; Wu, CYJ; Ko, PY; Huang, SS; Hsu, HC; Lu, DY				Huang, Bor-Ren; Chang, Pei-Chun; Yeh, Wei-Lan; Lee, Chih-Hao; Tsai, Cheng-Fang; Lin, Chingju; Lin, Hsiao-Yun; Liu, Yu-Shu; Wu, Caren Yu-Ju; Ko, Pei-Ying; Huang, Shiang-Suo; Hsu, Horng-Chaung; Lu, Dah-Yuu			Anti-Neuroinflammatory Effects of the Calcium Channel Blocker Nicardipine on Microglial Cells: Implications for Neuroprotection	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; FACTOR-KAPPA-B; SIGNALING PATHWAY; GLIOMA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE	Background/Objective: Nicardipine is a calcium channel blocker that has been widely used to control blood pressure in severe hypertension following events such as ischemic stroke, traumatic brain injury, and intracerebral hemorrhage. However, accumulating evidence suggests that inflammatory processes in the central nervous system that are mediated by microglial activation play important roles in neurodegeneration, and the effect of nicardipine on microglial activation remains unresolved. Methodology/Principal Findings: In the present study, using murine BV-2 microglia, we demonstrated that nicardipine significantly inhibits microglia-related neuroinflammatory responses. Treatment with nicardipine inhibited microglial cell migration. Nicardipine also significantly inhibited LPS plus IFN-gamma-induced release of nitric oxide (NO), and the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Furthermore, nicardipine also inhibited microglial activation by peptidoglycan, the major component of the Gram-positive bacterium cell wall. Notably, nicardipine also showed significant anti-neuroinflammatory effects on microglial activation in mice in vivo. Conclusion/Significance: The present study is the first to report a novel inhibitory role of nicardipine on neuroinflammation and provides a new candidate agent for the development of therapies for inflammation-related neurodegenerative diseases.	[Huang, Bor-Ren; Hsu, Horng-Chaung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Huang, Bor-Ren] Taichung Tzu Chi Hosp, Neurosurg Dept, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Huang, Bor-Ren] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chang, Pei-Chun] Asia Univ, Dept Bioinformat, Taichung, Taiwan; [Yeh, Wei-Lan] Changhua Christian Hosp, Dept Cell & Tissue Engn, Changhua, Taiwan; [Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Tsai, Cheng-Fang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Chingju] China Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan; [Lin, Hsiao-Yun] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yu-Shu; Wu, Caren Yu-Ju] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Ko, Pei-Ying] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Dept Pharmacol, Coll Med, Taichung, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Inst Med, Coll Med, Taichung, Taiwan; [Hsu, Horng-Chaung] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Lu, Dah-Yuu] China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan	China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Asia University Taiwan; Changhua Christian Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Asia University Taiwan; China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lu, DY (corresponding author), China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan.	dahyuu@mail.cmu.edu.tw	Liu, Yu-Shu/GQZ-6251-2022; Lu, Dah-Yuu/P-2563-2015		National Science Council [NSC 101-2320-B-039-048-MY2, NSC 102-2320-B-039-051-MY3, NSC 102-2320-B-039-026-MY3]; Taichung Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation [TTCRD 101-03]; China Medical University [CMU101-ASIA-10]; Asia University [99-A-01]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation; China Medical University(China Medical University); Asia University	This work was supported by grants from the National Science Council (NSC 101-2320-B-039-048-MY2, NSC 102-2320-B-039-051-MY3 and NSC 102-2320-B-039-026-MY3), Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TTCRD 101-03), China Medical University (CMU101-ASIA-10), and Asia University (99-A-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta F, 2004, CLIN EXP HYPERTENS, V26, P351, DOI 10.1081/CEH-120034139; Amenta F, 1996, J HYPERTENS, V14, pS29, DOI 10.1097/00004872-199610003-00006; Amenta F, 2008, CLIN EXP HYPERTENS, V30, P808, DOI 10.1080/10641960802580190; Babu CS, 2011, INT J DEV NEUROSCI, V29, P93, DOI 10.1016/j.ijdevneu.2010.08.001; Bal-Price A, 2001, J NEUROSCI, V21, P6480; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; Chen JH, 2012, INT IMMUNOPHARMACOL, V12, P94, DOI 10.1016/j.intimp.2011.10.019; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Cho S, 2005, J CEREBR BLOOD F MET, V25, P493, DOI 10.1038/sj.jcbfm.9600058; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; Degoute CS, 2007, DRUGS, V67, P1053, DOI 10.2165/00003495-200767070-00007; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gasior M, 1996, J NEURAL TRANSM, V103, P819, DOI 10.1007/BF01273360; Gianino John W, 2012, Mo Med, V109, P384; Guillot-Sestier MV, 2013, CNS NEUROL DISORD-DR, V12, P593; HALEY EC, 1994, J NEUROSURG, V80, P788, DOI 10.3171/jns.1994.80.5.0788; Hashioka S, 2012, NEUROPHARMACOLOGY, V63, P685, DOI 10.1016/j.neuropharm.2012.05.033; Hayashi M, 2000, HYPERTENS RES, V23, P521, DOI 10.1291/hypres.23.521; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Huang BR, 2013, TOXICOL APPL PHARM, V269, P43, DOI 10.1016/j.taap.2013.03.004; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Kim Sang Yong, 2012, J Cerebrovasc Endovasc Neurosurg, V14, P84, DOI 10.7461/jcen.2012.14.2.84; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Koizumi S, 2002, LIFE SCI, V72, P431, DOI 10.1016/S0024-3205(02)02273-7; Koizumi S, 2013, GLIA, V61, P47, DOI 10.1002/glia.22358; Komagiri Y, 2011, CELL CALCIUM, V49, P35, DOI 10.1016/j.ceca.2010.11.006; Leung YM, 2013, BIOMEDICINE-TAIWAN, V3, P130, DOI 10.1016/j.biomed.2012.11.003; Leung YM, 2011, BIOMEDICINE-TAIWAN, V1, P16, DOI 10.1016/j.biomed.2011.10.003; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lin C, 2013, NEUROSCIENCE, V231, P216, DOI 10.1016/j.neuroscience.2012.11.051; Lin HY, 2014, NEUROBIOL AGING, V35, P191, DOI 10.1016/j.neurobiolaging.2013.06.020; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Liu YX, 2011, NEUROPHARMACOLOGY, V60, P373, DOI 10.1016/j.neuropharm.2010.10.002; Loihl AK, 1998, PROG BRAIN RES, V118, P253; Lu DY, 2007, BRIT J PHARMACOL, V151, P396, DOI 10.1038/sj.bjp.0707187; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Lu DY, 2013, INT J NEUROPSYCHOPH, V16, P433, DOI 10.1017/S1461145712000338; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Lu DY, 2010, BIOCHEM PHARMACOL, V80, P1201, DOI 10.1016/j.bcp.2010.06.046; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Maa MC, 2013, BIOMEDICINE-TAIWAN, V3, P1, DOI 10.1016/j.biomed.2012.12.006; Matsui T, 2010, BIOCHEM BIOPH RES CO, V396, P566, DOI 10.1016/j.bbrc.2010.04.149; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Mikami C, 2001, CEREBROVASC DIS, V11, P44, DOI 10.1159/000047610; Narotam PK, 2008, J NEUROSURG, V109, P1065, DOI 10.3171/JNS.2008.109.12.1065; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Qureshi AI, 2006, CRIT CARE MED, V34, P1975, DOI 10.1097/01.CCM.0000220763.85974.E8; Qureshi Ai, 2012, J Vasc Interv Neurol, V5, P6; Rasmuson S., 2011, INT PSYCHOGERIATR, V18, P1; Saijonmaa Outi, 1997, Blood Pressure, V6, P24, DOI 10.3109/08037059709086442; Sanz JM, 2012, BRIT J PHARMACOL, V167, P1702, DOI 10.1111/j.1476-5381.2012.02112.x; Sato Shoichiro, 2012, Rinsho Shinkeigaku, V52, P642; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schut Ewout S, 2008, Pract Neurol, V8, P8, DOI 10.1136/jnnp.2007.139725; Su PY, 2013, BIOMEDICINE-TAIWAN, V3, P181, DOI 10.1016/j.biomed.2013.08.001; Tejada JG, 2007, AM J NEURORADIOL, V28, P844; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Uslu S, 2012, NEUROCHEM RES, V37, P1554, DOI 10.1007/s11064-012-0750-0; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Yermakova A, 2000, CURR PHARM DESIGN, V6, P1755, DOI 10.2174/1381612003398672; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang XL, 2012, J INT MED RES, V40, P1036, DOI 10.1177/147323001204000322; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	76	47	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91167	10.1371/journal.pone.0091167	http://dx.doi.org/10.1371/journal.pone.0091167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621589	Green Submitted, gold, Green Published			2022-12-25	WOS:000332845300055
J	Li, J; Liu, C; Guo, QP; Yang, HL; Li, B				Li, Jun; Liu, Chen; Guo, Qianping; Yang, Huilin; Li, Bin			Regional Variations in the Cellular, Biochemical, and Biomechanical Characteristics of Rabbit Annulus Fibrosus	PLOS ONE			English	Article							INTERVERTEBRAL DISC; ANULUS FIBROSUS; MECHANICAL-PROPERTIES; DEGENERATION; MATRIX; EXPRESSION; THERAPIES; CELLS; DIFFERENTIATION; FIBERS	Tissue engineering of annulus fibrosus (AF), the essential load-bearing disc component, remains challenging due to the intrinsic heterogeneity of AF tissue. In order to provide a set of characterization data of AF tissue, which serve as the benchmark for constructing tissue engineered AF, we analyzed tissues and cells from various radial zones of AF, i.e., inner AF (iAF), middle AF (mAF), and outer AF (oAF), using a rabbit model. We found that a radial gradient in the cellular, biochemical, and biomechanical characteristics of rabbit AF existed. Specifically, the iAF cells (iAFCs) had the highest expression of collagen-II and aggrecan genes, while oAF cells (oAFCs) had the highest collagen-I gene expression. The contents of DNA, total collagen and collagen-I sequentially increased from iAF, mAF to oAF, while glycosaminoglycan (GAG) and collagen-II levels decreased. The cell traction forces of primary AFCs gradually decreased from iAFCs, mAFCs to oAFCs, being 336.6 +/- 155.3, 199.0 +/- 158.8, and 123.8 +/- 76.1 Pa, respectively. The storage moduli of iAF, mAF, and oAF were 0.032 +/- 0.002, 2.121 +/- 0.656, and 4.130 +/- 0.159 MPa, respectively. These measurements have established a set of reference data for functional evaluation of the efficacy of AF tissue engineering strategies using a convenient and cost-effective rabbit model, the findings of which may be further translated to human research.	[Li, Jun; Liu, Chen; Yang, Huilin; Li, Bin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China; [Guo, Qianping; Yang, Huilin; Li, Bin] Soochow Univ, Inst Orthoped, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Li, B (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.	binli@suda.edu.cn	Li, Bin/B-7802-2012	Li, Jun/0000-0002-3257-9315	National Natural Science Foundation of China [81171479]; Natural Science Foundation of Jiangsu Province [BK2011291]; Graduate Research and Innovation Program of Jiangsu Province [CXZZ12_0843]; Jiangsu Provincial Special Program of Medical Science [BL2012004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Graduate Research and Innovation Program of Jiangsu Province; Jiangsu Provincial Special Program of Medical Science	This study was supported by grants from the National Natural Science Foundation of China (81171479), Natural Science Foundation of Jiangsu Province (BK2011291), the Graduate Research and Innovation Program of Jiangsu Province (CXZZ12_0843), and the Jiangsu Provincial Special Program of Medical Science(BL2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x; BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015; Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a; Cortes DH, 2013, J ORTHOP RES, V31, P1725, DOI 10.1002/jor.22430; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Driscoll TP, 2013, J ORTHOP RES, V31, P864, DOI 10.1002/jor.22312; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Guerin HL, 2007, J ORTHOP RES, V25, P508, DOI 10.1002/jor.20324; Hakkinen A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-2; Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777; Herbert EG, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/7/074021; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012; Hughes SPF, 2012, J BONE JOINT SURG BR, V94B, P1298, DOI 10.1302/0301-620X.94B10.28986; Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002; Iatridis JC, 2009, NAT MATER, V8, P923, DOI 10.1038/nmat2577; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216; Kroeber MW, 2002, SPINE, V27, P2684, DOI 10.1097/00007632-200212010-00007; Lewis NT, 2008, MICRON, V39, P1008, DOI 10.1016/j.micron.2007.08.009; Li B, 2010, SENSORS-BASEL, V10, P9948, DOI 10.3390/s101109948; Li B, 2008, J BIOMECH, V41, P3349, DOI 10.1016/j.jbiomech.2008.09.025; Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; MCNALLY DS, 1992, SPINE, V17, P66, DOI 10.1097/00007632-199201000-00011; Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001; Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414; Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; Smith LJ, 2006, J ANAT, V209, P359, DOI 10.1111/j.1469-7580.2006.00610.x; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; STOKES IAF, 1987, J ORTHOPAED RES, V5, P348, DOI 10.1002/jor.1100050306; Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031; Yu J, 2007, J ANAT, V210, P460, DOI 10.1111/j.1469-7580.2007.00707.x	41	19	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91799	10.1371/journal.pone.0091799	http://dx.doi.org/10.1371/journal.pone.0091799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622282	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300130
J	Liao, B; Li, Y; Jiang, Y; Cai, LJ				Liao, Bo; Li, Yun; Jiang, Yan; Cai, Lijun			Using Multi-Instance Hierarchical Clustering Learning System to Predict Yeast Gene Function	PLOS ONE			English	Article							PROTEIN FUNCTION; SCALE DATA; ANNOTATION; ALGORITHM; ONTOLOGY; TOOL	Time-course gene expression datasets, which record continuous biological processes of genes, have recently been used to predict gene function. However, only few positive genes can be obtained from annotation databases, such as gene ontology (GO). To obtain more useful information and effectively predict gene function, gene annotations are clustered together to form a learnable and effective learning system. In this paper, we propose a novel multi-instance hierarchical clustering (MIHC) method to establish a learning system by clustering GO and compare this method with other learning system establishment methods. Multi-label support vector machine classifier and multi-label K-nearest neighbor classifier are used to verify these methods in four yeast time-course gene expression datasets. The MIHC method shows good performance, which serves as a guide to annotators or refines the annotation in detail.	[Liao, Bo; Li, Yun; Jiang, Yan; Cai, Lijun] Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China	Hunan University	Liao, B (corresponding author), Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China.	dragonbw@163.com; in_ljcai@yeah.net			Program for New Century Excellent Talents in University [NCET-10-0365]; National Nature Science Foundation of China [60973082, 11171369, 61272395, 61370171]; National Nature Science Foundation of Hunan Province [12JJ2041]; Planned Science and Technology Project of Hunan Province [2009FJ3195, 2012FJ2012]; Fundamental Research Funds for the Central Universities, Hunan university	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Hunan Province; Planned Science and Technology Project of Hunan Province; Fundamental Research Funds for the Central Universities, Hunan university(Fundamental Research Funds for the Central Universities)	This work is supported by the Program for New Century Excellent Talents in University (Grant NCET-10-0365), National Nature Science Foundation of China (Grant 60973082, 11171369, 61272395,61370171), National Nature Science Foundation of Hunan Province (Grant 12JJ2041), the Planned Science and Technology Project of Hunan Province (Grant 2009FJ3195, 2012FJ2012) and supported by the Fundamental Research Funds for the Central Universities, Hunan university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Clare A, 2003, BIOINFORMATICS, V19, pII42, DOI 10.1093/bioinformatics/btg1058; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Eblen JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Hvidsten T R, 2001, Pac Symp Biocomput, P299; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Laegreid A, 2003, GENOME RES, V13, P965, DOI 10.1101/gr.1144503; Langfelder P, 2012, J STAT SOFTWARE, V46; Li YX, 2012, IEEE ACM T COMPUT BI, V9, P98, DOI 10.1109/TCBB.2011.73; Liang S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-61; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Magi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038767; Mitsakakis N, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-8; MURTAGH F, 1983, COMPUT J, V26, P354, DOI 10.1093/comjnl/26.4.354; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Ostergard PRJ, 2002, DISCRETE APPL MATH, V120, P197, DOI 10.1016/S0166-218X(01)00290-6; Punnen AP, 2012, DISCRETE OPTIM, V9, P205, DOI 10.1016/j.disopt.2012.05.002; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Schlkopf B., 2006, ADV NEURAL INFORM PR, V19, P1609; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tibshirani R, 1999, CLUSTERING METHODS A; Vapnik V.N., 2006, ESTIMATION DEPENDENC, VVolume 40; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhou Zhi-Hua, 2004, TECH REP	33	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90962	10.1371/journal.pone.0090962	http://dx.doi.org/10.1371/journal.pone.0090962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621610	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300038
J	Reddy, CA; Somepalli, V; Golakoti, T; Kanugula, AK; Karnewar, S; Rajendiran, K; Vasagiri, N; Prabhakar, S; Kuppusamy, P; Kotamraju, S; Kutala, VK				Reddy, Cheruku Apoorva; Somepalli, Venkateswarlu; Golakoti, Trimurtulu; Kanugula, Anantha KoteswaraRao; Karnewar, Santosh; Rajendiran, Karthikraj; Vasagiri, Nagarjuna; Prabhakar, Sripadi; Kuppusamy, Periannan; Kotamraju, Srigiridhar; Kutala, Vijay Kumar			Mitochondrial-Targeted Curcuminoids: A Strategy to Enhance Bioavailability and Anticancer Efficacy of Curcumin	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; OXIDATIVE STRESS; BREAST-CANCER; SUPPRESSES PROLIFERATION; STAT3 PHOSPHORYLATION; SIGNALING PATHWAYS; GENE-EXPRESSION; BNIP3 GENE; APOPTOSIS; PROTEIN	Although the anti-cancer effects of curcumin has been shown in various cancer cell types, in vitro, pre-clinical and clinical studies showed only a limited efficacy, even at high doses. This is presumably due to low bioavailability in both plasma and tissues, particularly due to poor intracellular accumulation. A variety of methods have been developed to achieve the selective targeting of drugs to cells and mitochondrion. We used a novel approach by conjugation of curcumin to lipophilic triphenylphosphonium (TPP) cation to facilitate delivery of curcumin to mitochondria. TPP is selectively taken up by mitochondria driven by the membrane potential by several hundred folds. In this study, three mitocurcuminoids (mitocurcuminoids-1, 2, and 3) were successfully synthesized by tagging TPP to curcumin at different positions. ESI-MS analysis showed significantly higher uptake of the mitocurcuminoids in mitochondria as compared to curcumin in MCF-7 breast cancer cells. All three mitocurcuminoids exhibited significant cytotoxicity to MCF-7, MDA-MB-231, SKNSH, DU-145, and HeLa cancer cells with minimal effect on normal mammary epithelial cells (MCF-10A). The IC50 was much lower for mitocurcuminoids when compared to curcumin. The mitocurcuminoids induced significant ROS generation, a drop in Delta circle divide m, cell-cycle arrest and apoptosis. They inhibited Akt and STAT3 phosphorylation and increased ERK phosphorylation. Mitocurcuminoids also showed upregulation of pro-apoptotic BNIP3 expression. In conclusion, the results of this study indicated that mitocurcuminoids show substantial promise for further development as a potential agent for the treatment of various cancers.	[Reddy, Cheruku Apoorva; Vasagiri, Nagarjuna; Kutala, Vijay Kumar] Nizams Inst Med Sci, Dept Clin Pharmacol & Therapeut, Hyderabad, AP, India; [Somepalli, Venkateswarlu; Golakoti, Trimurtulu] Laila Impex R&D Ctr, Vijayawada, AP, India; [Kanugula, Anantha KoteswaraRao; Karnewar, Santosh; Kotamraju, Srigiridhar] Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, AP, India; [Rajendiran, Karthikraj; Prabhakar, Sripadi] Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, AP, India; [Kuppusamy, Periannan] Dartmouth Coll, Geisel Sch Med, Dept Radiol, Hanover, NH 03755 USA	Nizam's Institute of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Dartmouth College	Kotamraju, S (corresponding author), Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, AP, India.	giridhar@iict.res.in; vijaykutala@gmail.com	Karnewar, Santosh/AAI-8536-2021; Kanugula, Anantha Koteswararao/H-8187-2019; RAJENDIRAN, KARTHIKRAJ/K-3571-2019	RAJENDIRAN, KARTHIKRAJ/0000-0001-9680-8079; Kutala, Vijay Kumar/0000-0002-7253-8999	DST [SR/SO/HS-110/2008, SR/SO/HS-0021/2010]; CSIR, India [CSC-0111]; CSIR; ICMR	DST(Department of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	This study was supported by the grants from DST (Grant No.: SR/SO/HS-110/2008, Grant No.: SR/SO/HS-0021/2010) and CSIR (Grant. No.: CSC-0111), India (as part ofthe SMiLE project). Senior research fellowship to AKK from CSIR and Junior reserach fellowship to NV from ICMR is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Biasutto L, 2008, BIOORG MED CHEM LETT, V18, P5594, DOI 10.1016/j.bmcl.2008.08.100; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; DAIRKEE SH, 1991, BREAST CANCER RES TR, V18, P57, DOI 10.1007/BF01975444; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Dayton A, 2010, CANCER BIOL THER, V10, P1027, DOI 10.4161/cbt.10.10.13250; Fu SQ, 2010, CANCER-AM CANCER SOC, V116, P4670, DOI 10.1002/cncr.25414; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Javvadi P, 2008, MOL PHARMACOL, V73, P1491, DOI 10.1124/mol.107.043554; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kubli DA, 2005, BIOCHEM J, V405, P407; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lakshmi SVV, 2013, MOL CELL BIOCHEM, V374, P203, DOI 10.1007/s11010-012-1520-7; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422; Murai M, 2005, CLIN CANCER RES, V11, P1021; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Naushad SM, 2011, CELL BIOCHEM BIOPHYS, V61, P715, DOI 10.1007/s12013-011-9245-x; Pandian RP, 2003, ARCH BIOCHEM BIOPHYS, V420, P169, DOI 10.1016/j.abb.2003.09.008; Porteous CM, 2010, BBA-GEN SUBJECTS, V1800, P1009, DOI 10.1016/j.bbagen.2010.06.001; Prakobwong S, 2011, CARCINOGENESIS, V32, P1372, DOI 10.1093/carcin/bgr032; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577	40	65	69	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89351	10.1371/journal.pone.0089351	http://dx.doi.org/10.1371/journal.pone.0089351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622734	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300008
J	Li, GR; Sun, CL; Wang, YJ; Liu, YJ; Gang, XK; Gao, Y; Li, F; Xiao, XC; Wang, GX				Li, Guangren; Sun, Chenglin; Wang, Yanjun; Liu, Yujia; Gang, Xiaokun; Gao, Ying; Li, Fei; Xiao, Xianchao; Wang, Guixia			A Clinical and Neuropathological Study of Chinese Patients with Diabetic Peripheral Neuropathy	PLOS ONE			English	Article							OXIDATIVE STRESS; ALDOSE REDUCTASE; POLYOL PATHWAY; SCHWANN-CELLS; PATHOGENESIS; SORBITOL; RETINOPATHY	Objective: To examine whether the neuropathological and metabolic changes of peripheral nerves are correlated to clinical features in diabetes mellitus type 2 patients with peripheral neuropathy. Methods: 147 type 2 diabetic patients with signs/symptoms of diabetic peripheralneuropathy (DPN) aged 53.4 +/- 12.3 years and 134 healthy volunteers aged 55.5 +/- 11.7 years were investigated for fasting plasma glucose (FPG), hemoglobin A1C (HbA1c), and red blood cell sorbitol (RBC sorbitol) in addition to nerve conduction velocity (NCV). Among the 147 diabetic patients, 10 patients underwent superficial peroneal nerve biopsy for light and electron microscopy. Results: In the experimental group, the levels of HbA1c and RBC sorbitol showed significant increase compared with the controlled group, whereas motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) both showed decline and SNCV decreased at a greater extent. Morphologically, there were various degrees of nerve fiber loss, associated with axon degeneration and capillary luminal narrowing in 10 patients undergone nerve biopsy. Conclusion: The metabolic change of sorbitol, the consequently observed changes in NCV and histopathology of peripheral nerves are positively correlated with the duration of diabetes and overall level of blood glucose.	[Sun, Chenglin; Liu, Yujia; Gang, Xiaokun; Gao, Ying; Li, Fei; Xiao, Xianchao; Wang, Guixia] Jilin Univ, Hosp Univ 1, Dept Endocrinol & Metab, Changchun 130023, Jilin, Peoples R China; [Li, Guangren] Jilin Univ, China Japan Union Hosp, Dept Neurol, Changchun 130023, Jilin, Peoples R China; [Wang, Yanjun] Jilin Univ, Hosp Univ 2, Dept Endocrinol & Metab, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, GX (corresponding author), Jilin Univ, Hosp Univ 1, Dept Endocrinol & Metab, Changchun 130023, Jilin, Peoples R China.	gxwang6688@yahoo.com	Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022					Ando H, 2006, J DIABETES COMPLICAT, V20, P367, DOI 10.1016/j.jdiacomp.2005.09.002; Askwith T, 2009, AM J PHYSIOL-ENDOC M, V297, pE620, DOI 10.1152/ajpendo.00287.2009; Beiswenger KK, 2008, ACTA HISTOCHEM, V110, P351, DOI 10.1016/j.acthis.2007.12.004; Chattopadhyay M, 2008, J NEUROSCI, V28, P6652, DOI 10.1523/JNEUROSCI.5530-07.2008; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Duby JJ, 2004, AM J HEALTH-SYST PH, V61, P160, DOI 10.1093/ajhp/61.2.160; Kempler Peter, 2002, Orv Hetil, V143, P1113; Miranda-Massari JR, 2011, CURR CLIN PHARMACOL, V6, P260, DOI 10.2174/157488411798375967; Morrison JFB, 2008, EXP PHYSIOL, V93, P213, DOI 10.1113/expphysiol.2007.039222; Obrosova IG, 2011, CURR PHARM BIOTECHNO, V12, P373; Reddy GB, 2008, MOL VIS, V14, P593; Reinisch CM, 2008, DIABETES CARE, V31, P1219, DOI 10.2337/dc07-1832; Said G, 2003, BRAIN, V126, P376, DOI 10.1093/brain/awg029; Sim HJ, 2009, J CHROMATOGR B, V877, P1607, DOI 10.1016/j.jchromb.2009.03.041; Spallone V, 2011, EUR J PAIN, V15, P153, DOI 10.1016/j.ejpain.2010.06.011; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Stavniichuk R, 2012, BIOCHEM PHARMACOL, V83, P932, DOI 10.1016/j.bcp.2012.01.015; Takizawa M, 2008, DIABETES RES CLIN PR, V82, P119, DOI 10.1016/j.diabres.2008.07.008; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Winkler Gabor, 2010, Orvosi Hetilap, V151, P971, DOI 10.1556/OH.2010.28898; Yagihashi S, 2007, DIABETES RES CLIN PR, V77, pS184, DOI 10.1016/j.diabres.2007.01.054; Younger DS, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/140379	22	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91772	10.1371/journal.pone.0091772	http://dx.doi.org/10.1371/journal.pone.0091772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618902	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400126
J	Edmond, V; Dufour, F; Poiroux, G; Shoji, K; Malleter, M; Fouque, A; Tauzin, S; Rimokh, R; Sergent, O; Penna, A; Dupuy, A; Levade, T; Theret, N; Micheau, O; Segui, B; Legembre, P				Edmond, V.; Dufour, F.; Poiroux, G.; Shoji, K.; Malleter, M.; Fouque, A.; Tauzin, S.; Rimokh, R.; Sergent, O.; Penna, A.; Dupuy, A.; Levade, T.; Theret, N.; Micheau, O.; Segui, B.; Legembre, P.			Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility	ONCOGENE			English	Article							GENE-EXPRESSION PATTERNS; BREAST-CANCER; IN-VITRO; RECEPTOR; TRANSFORMATION; INVASION; RAFTS; SPHINGOLIPIDS; GANGLIOSIDE; PHENOTYPE	Epithelial-to-mesenchymal transition (EMT) promotes cell motility, which is important for the metastasis of malignant cells, and blocks CD95-mediated apoptotic signaling triggered by immune cells and chemotherapeutic regimens. CD95L, the cognate ligand of CD95, can be cleaved by metalloproteases and released as a soluble molecule (cl-CD95L). Unlike transmembrane CD95L, cl-CD95L does not induce apoptosis but triggers cell motility. Electron paramagnetic resonance was used to show that EMT and cl-CD95L treatment both led to augmentation of plasma membrane fluidity that was instrumental in inducing cell migration. Compaction of the plasma membrane is modulated, among other factors, by the ratio of certain lipids such as sphingolipids in the membrane. An integrative analysis of gene expression in NCI tumor cell lines revealed that expression of ceramide synthase-6 (CerS6) decreased during EMT. Furthermore, pharmacological and genetic approaches established that modulation of CerS6 expression/activity in cancer cells altered the level of C16-ceramide, which in turn influenced plasma membrane fluidity and cell motility. Therefore, this study identifies CerS6 as a novel EMT-regulated gene that has a pivotal role in the regulation of cell migration.	[Edmond, V.; Shoji, K.; Malleter, M.; Fouque, A.; Tauzin, S.; Sergent, O.; Penna, A.; Theret, N.; Legembre, P.] Univ Rennes 1, F-35043 Rennes, France; [Edmond, V.; Shoji, K.; Malleter, M.; Fouque, A.; Tauzin, S.; Sergent, O.; Penna, A.; Theret, N.; Legembre, P.] INSERM, UMR 1085, IRSET, Rennes, France; [Edmond, V.; Shoji, K.; Malleter, M.; Fouque, A.; Tauzin, S.; Penna, A.; Legembre, P.] Equipe Labellisee Ligue Contre Le Canc, Rennes, France; [Dufour, F.; Micheau, O.] INSERM, UMR 866, Dijon, France; [Poiroux, G.; Levade, T.; Segui, B.] INSERM, UMR 1037, Toulouse, France; [Poiroux, G.; Levade, T.; Segui, B.] Univ Toulouse 3, Toulouse, France; [Poiroux, G.; Levade, T.; Segui, B.] Equipe Labellisee Ligue Contre Le Canc, Toulouse, France; [Rimokh, R.] Univ Lyon, Ctr Rech Cancerol Lyon, CNRS UMR 5286, Ctr Leon Berard Lyon,Inserm U1052, Lyon, France; [Dupuy, A.] INSERM, U1048, Toulouse, France; [Legembre, P.] Ctr Eugene Marquis, Rennes, France	Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Eugene Marquis	Legembre, P (corresponding author), Univ Rennes 1, IRSET, U1085, INSERM, 2 Av Prof Leon Bernard, F-35043 Rennes, France.	patrick.legembre@inserm.fr	Legembre, Patrick/U-1882-2019; legembre, patrick/L-3475-2016; penna, aubin/AAD-2550-2019; Levade, Thierry/O-8948-2014; Ségui, Bruno/O-8957-2014; Theret, Nathalie/I-2871-2015; PENNA, aubin/E-2208-2018; theret, nathalie/ABG-6780-2020; micheau, olivier/C-3574-2011; SERGENT, ODILE/K-1966-2015; Rimokh, Ruth/G-7506-2014; Guillaume, Poiroux/M-2854-2015	Legembre, Patrick/0000-0001-6649-8049; legembre, patrick/0000-0001-6649-8049; penna, aubin/0000-0002-1070-5990; Ségui, Bruno/0000-0002-6119-1889; Theret, Nathalie/0000-0002-5857-7828; PENNA, aubin/0000-0002-1070-5990; theret, nathalie/0000-0002-5857-7828; micheau, olivier/0000-0001-8499-7984; Guillaume, Poiroux/0000-0002-6769-3716; Sergent, Odile/0000-0002-9488-2141	French National Research Agency (ANR) [ANR-11-LABX-0021-01-LipSTIC Labex]; Conseil General d'Ille-et-Vilaine, project Membratox [32508]; European union (FEDER)	French National Research Agency (ANR)(French National Research Agency (ANR)); Conseil General d'Ille-et-Vilaine, project Membratox; European union (FEDER)(European Commission)	We are grateful to the L3 and microscopy facilities of the SFR Biosit (Universite de Rennes-1, Rennes, France) for their technical assistance. We thank Nicole Therville and Julia Rochotte for their technical assistance. We also acknowledge the assistance of Dr Pauline Le Faouder and Dr Justine Bertrand-Michel from the lipidomic facilities (INSERM U1048, Toulouse, France). This work was supported by grants from the French Government managed by the French National Research Agency (ANR) and under the program 'Investissements d'Avenir' with reference ANR-11-LABX-0021-01-LipSTIC Labex, INCa, ARC, Canceropole Grand Ouest, Region Bretagne, Region Bourgogne, Rennes Metropole, Ligue Contre le Cancer (Comites d'Ille-et-Vilaine/du Morbihan/des Cotes d'Armor/du Maine et Loire et les comites du Doubs/de l'Yonne), Conseil General d'Ille-et-Vilaine, project Membratox (Grant number 32508) and the European union (FEDER).	Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; ALONSO A, 1995, BBA-BIOMEMBRANES, V1237, P6, DOI 10.1016/0005-2736(95)00069-F; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; HANAI N, 1988, J BIOL CHEM, V263, P6296; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Hoogwater FJH, 2010, GASTROENTEROLOGY, V138, P2357, DOI 10.1053/j.gastro.2010.02.046; Jezequel P, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas060; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; LUCIANO L, 1989, CELL TISSUE RES, V258, P339; Malleter M, 2013, CANCER RES, V73, P6711, DOI 10.1158/0008-5472.CAN-13-1794; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; NAKAZAWA I, 1989, TOHOKU J EXP MED, V157, P193, DOI 10.1620/tjem.157.193; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sergent O, 2005, BIOMETALS, V18, P567, DOI 10.1007/s10534-005-8488-7; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; Silva LC, 2012, J LIPID RES, V53, P430, DOI 10.1194/jlr.M022715; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; TARABOLETTI G, 1989, INT J CANCER, V44, P707, DOI 10.1002/ijc.2910440426; Tauzin S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001090; VLASIC N, 1993, LIFE SCI, V53, P1053, DOI 10.1016/0024-3205(93)90258-5; WANG E, 1991, J BIOL CHEM, V266, P14486; Weinmann A, 2005, INT J MOL MED, V16, P905; Xu LJ, 2006, J BIOL CHEM, V281, P35567, DOI 10.1074/jbc.M607702200; Zeisig R, 2007, ARCH BIOCHEM BIOPHYS, V459, P98, DOI 10.1016/j.abb.2006.09.030	40	52	55	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					996	1005		10.1038/onc.2014.55	http://dx.doi.org/10.1038/onc.2014.55			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632610	Green Submitted			2022-12-25	WOS:000350121300006
J	Rupp, C; Scherzer, M; Rudisch, A; Unger, C; Haslinger, C; Schweifer, N; Artaker, M; Nivarthi, H; Moriggl, R; Hengstschlager, M; Kerjaschki, D; Sommergruber, W; Dolznig, H; Garin-Chesa, P				Rupp, C.; Scherzer, M.; Rudisch, A.; Unger, C.; Haslinger, C.; Schweifer, N.; Artaker, M.; Nivarthi, H.; Moriggl, R.; Hengstschlaeger, M.; Kerjaschki, D.; Sommergruber, W.; Dolznig, H.; Garin-Chesa, P.			IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction	ONCOGENE			English	Article							LASER CAPTURE MICRODISSECTION; GENE-EXPRESSION SIGNATURE; PROSTATE-CANCER; BREAST-CANCER; ADHESION FACTOR/MAC25; EPITHELIAL CANCERS; COLORECTAL-CANCER; POOR-PROGNOSIS; LUNG-CANCER; CELL-GROWTH	The activated tumor stroma participates in many processes that control tumorigenesis, including tumor cell growth, invasion and metastasis. Cancer-associated fibroblasts (CAFs) represent the major cellular component of the stroma and are the main source for connective tissue components of the extracellular matrix and various classes of proteolytic enzymes. The signaling pathways involved in the interactions between tumor and stromal cells and the molecular characteristics that distinguish normal 'resting' fibroblasts from cancer-associated or '-activated' fibroblasts remain poorly defined. Recent studies emphasized the prognostic and therapeutic significance of CAF-related molecular signatures and a number of those genes have been shown to serve as putative therapeutic targets. We have used immuno-laser capture microdissection and whole-genome Affymetrix GeneChip analysis to obtain transcriptional signatures from the activated tumor stroma of colon carcinomas that were compared with normal resting colonic fibroblasts. Several members of the Wnt-signaling pathway and gene sets related to hypoxia, epithelial-to-mesenchymal transition (EMT) and transforming growth factor-beta (TGF beta) pathway activation were induced in CAFs. The putative TGF beta-target IGFBP7 was identified as a tumor stroma marker of epithelial cancers and as a tumor antigen in mesenchyme-derived sarcomas. We show here that in contrast to its tumor-suppressor function in epithelial cells, IGFPB7 can promote anchorage-independent growth in malignant mesenchymal cells and in epithelial cells with an EMT phenotype when IGFBP7 is expressed by the tumor cells themselves and can induce colony formation in colon cancer cells co-cultured with IGFBP7-expressing CAFs by a paracrine tumor-stroma interaction.	[Rupp, C.; Kerjaschki, D.; Garin-Chesa, P.] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria; [Scherzer, M.; Unger, C.; Hengstschlaeger, M.; Dolznig, H.] Med Univ Vienna, Ctr Pathobiol & Genet, Inst Med Genet, A-1090 Vienna, Austria; [Rudisch, A.; Haslinger, C.; Schweifer, N.; Sommergruber, W.; Garin-Chesa, P.] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Artaker, M.] Med Univ Vienna, Max F Perutz Labs, A-1090 Vienna, Austria; [Nivarthi, H.; Moriggl, R.] Ludwig Boltzmann Inst Canc Res, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Boehringer Ingelheim; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Ludwig Boltzmann Institute	Garin-Chesa, P (corresponding author), Med Univ Vienna, Inst Med Genet, Wahringer Str 10, A-1090 Vienna, Austria.	helmut.dolznig@meduniwien.ac.at; pilar.garin-chesa@boehringer-ingelheim.com	Moriggl, Richard/H-8118-2019; Dolznig, Helmut/L-7005-2015	Moriggl, Richard/0000-0003-0918-9463; Dolznig, Helmut/0000-0002-6063-3585	Boehringer Ingelheim Austria	Boehringer Ingelheim Austria(Boehringer Ingelheim)	This work was supported by Boehringer Ingelheim Austria. We are grateful to Christina Puri, Daniela Milovanovic, Oliver Bergner and Jakob Schnabl for help with immunohistochemistry, cell culture and in vitro assays.	Adachi Y, 2001, INT J CANCER, V95, P216, DOI 10.1002/1097-0215(20010720)95:4<216::AID-IJC1037>3.0.CO;2-O; Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Ahmed S, 2003, BIOCHEM BIOPH RES CO, V310, P612, DOI 10.1016/j.bbrc.2003.09.058; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen Y, 2011, LUNG CANCER, V73, P38, DOI 10.1016/j.lungcan.2010.10.015; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; Degeorges A, 1999, CANCER RES, V59, P2787; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gallagher PG, 2005, CANCER RES, V65, P4134, DOI 10.1158/0008-5472.CAN-04-0415; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang W, 2008, NEOPLASIA, V10, P1335, DOI 10.1593/neo.08694; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Lin J, 2008, CANCER BIOL THER, V7, P1896, DOI 10.4161/cbt.7.12.6937; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massoner P, 2008, PROSTATE, V68, P1165, DOI 10.1002/pros.20785; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Ostermann E, 2008, CLIN CANCER RES, V14, P4584, DOI 10.1158/1078-0432.CCR-07-5211; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Pure E, 2009, EXPERT OPIN THER TAR, V13, P967, DOI 10.1517/14728220903103841; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Rupp C, 2006, DIAGN MOL PATHOL, V15, P35, DOI 10.1097/00019606-200603000-00006; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Sato Y, 2007, CANCER SCI, V98, P1055, DOI 10.1111/j.1349-7006.2007.00502.x; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan L, 2012, J UROLOGY, V188, P1354, DOI 10.1016/j.juro.2012.06.002; Tomimaru Y, 2012, INT J CANCER, V130, P319, DOI 10.1002/ijc.25994; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Vizioli MG, 2010, ONCOGENE, V29, P3835, DOI 10.1038/onc.2010.136	57	74	78	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					815	825		10.1038/onc.2014.18	http://dx.doi.org/10.1038/onc.2014.18			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24632618				2022-12-25	WOS:000349472000002
J	Dixon, AM; Drake, L; Hughes, KT; Sargent, E; Hunt, D; Harton, JA; Drake, JR				Dixon, Ann M.; Drake, Lisa; Hughes, Kelly T.; Sargent, Elizabeth; Hunt, Danielle; Harton, Jonathan A.; Drake, James R.			Differential Transmembrane Domain GXXXG Motif Pairing Impacts Major Histocompatibility Complex ( MHC) Class II Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Lipid Raft; Major Histocompatibility Complex (MHC); Molecular Modeling; Protein Conformation	MYASTHENIA-GRAVIS; ANTIGEN PRESENTATION; PEPTIDE COMPLEXES; B-CELLS; HLA-DQ; MOLECULES; ASSOCIATION; BINDING; SEGMENT	Background: Major histocompatibility complex class II molecules are structurally and functionally heterogeneous. Results: Combined mutagenesis and structural studies establish a role for pairing between conserved transmembrane (TM) GXXXG dimerization motifs in determining class II conformation. Conclusion: Differential pairing of highly conserved TM domain dimerization motifs contributes to class II structure and function. Significance: Global conformation contributes to the function of peptide-class II complexes. Major histocompatibility complex (MHC) class II molecules exhibit conformational heterogeneity, which influences their ability to stimulate CD4 T cells and drive immune responses. Previous studies suggest a role for the transmembrane domain of the class II heterodimer in determining molecular structure and function. Our previous studies identified an MHC class II conformer that is marked by the Ia.2 epitope. These Ia.2(+) class II conformers are lipid raft-associated and able to drive both tyrosine kinase signaling and efficient antigen presentation to CD4 T cells. Here, we establish that the Ia.2(+) I-A(k) conformer is formed early in the class II biosynthetic pathway and that differential pairing of highly conserved transmembrane domain GXXXG dimerization motifs is responsible for formation of Ia.2(+)versus Ia.2(-) I-A(k) class II conformers and controlling lipid raft partitioning. These findings provide a molecular explanation for the formation of two distinct MHC class II conformers that differ in their inherent ability to signal and drive robust T cell activation, providing new insight into the role of MHC class II in regulating antigen-presenting cell-T cell interactions critical to the initiation and control of multiple aspects of the immune response.	[Dixon, Ann M.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Drake, Lisa; Hughes, Kelly T.; Sargent, Elizabeth; Hunt, Danielle; Harton, Jonathan A.; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	University of Warwick; Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 151, Albany, NY 12208 USA.	drakej@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021; Dixon, Ann M/I-3696-2012	Harton, Jonathan A/0000-0002-0350-1877; Dixon, Ann M/0000-0002-5261-304X; Hughes, Kelly T/0000-0003-1546-6746	National Institutes of Health [AI-083922, AI-065773, PO1 AI-056321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI056321, R21AI083922, P01AI056320, R01AI065773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-083922 (to J. R. D. and J. A. H.), AI-065773 (to J. R. D.), and PO1 AI-056321 to the Center for Immunology and Microbial Disease.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Brosig B, 1998, PROTEIN SCI, V7, P1052; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busman-Sahay K, 2011, J IMMUNOL, V186, P6710, DOI 10.4049/jimmunol.1100336; Castellino F, 2001, EUR J IMMUNOL, V31, P841, DOI 10.1002/1521-4141(200103)31:3<841::AID-IMMU841>3.0.CO;2-D; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Deitiker PR, 2011, INT J IMMUNOGENET, V38, P55, DOI 10.1111/j.1744-313X.2010.00979.x; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Gondre-Lewis TA, 2001, J IMMUNOL, V166, P6657, DOI 10.4049/jimmunol.166.11.6657; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; Khalil H, 2003, INT IMMUNOL, V15, P1249, DOI 10.1093/intimm/dxg124; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Lee KW, 2006, TISSUE ANTIGENS, V68, P167, DOI 10.1111/j.1399-0039.2006.00645.x; Lovitch SB, 2005, IMMUNOL REV, V207, P293, DOI 10.1111/j.0105-2896.2005.00298.x; Morkowski S, 1999, J BIOMED SCI, V6, P53; Nashar TO, 2006, J IMMUNOL, V176, P827, DOI 10.4049/jimmunol.176.2.827; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Porter KA, 2010, J IMMUNOL, V185, P6480, DOI 10.4049/jimmunol.1000830; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sadegh-Nasseri S, 2010, IMMUNOL RES, V47, P56, DOI 10.1007/s12026-009-8138-1; Saruhan-Direskeneli G, 2006, HUM IMMUNOL, V67, P352, DOI 10.1016/j.humimm.2006.02.039; Zhu WH, 2012, J NEUROIMMUNOL, V247, P81, DOI 10.1016/j.jneuroim.2012.03.018	25	25	25	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11695	11703		10.1074/jbc.M113.516997	http://dx.doi.org/10.1074/jbc.M113.516997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619409	Green Published, hybrid			2022-12-25	WOS:000335010600012
J	Wang, XW; Xu, JD; Zhao, XF; Vasta, GR; Wang, JX				Wang, Xian-Wei; Xu, Ji-Dong; Zhao, Xiao-Fan; Vasta, Gerardo Raul; Wang, Jin-Xing			A Shrimp C-type Lectin Inhibits Proliferation of the Hemolymph Microbiota by Maintaining the Expression of Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Invertebrates; Lectin; Pattern Recognition Receptor; RNA Interference (RNAi); C-type Lectin; Hemolymph Microbiota; Shrimp	ANTILIPOPOLYSACCHARIDE FACTOR ALF; LITOPENAEUS-VANNAMEI; CALLINECTES-SAPIDUS; BACTERIAL-FLORA; MANDUCA-SEXTA; BLUE-CRAB; PROTEIN; HEPATOPANCREAS; DIVERSITY; BINDING	Background: The hemolymph of healthy shrimp contains low albeit stable numbers of bacteria. Results: Knockdown of C-type lectin MjHeCL led to suppressed expression of antimicrobial peptides, bacterial proliferation, and shrimp death. Conclusion: MjHeCL protects shrimp by inhibiting the proliferation of hemolymph microbiota. Significance: This study demonstrated a novel role for soluble C-type lectins in antibacterial response. Some aquatic invertebrates such as shrimp contain low albeit stable numbers of bacteria in the circulating hemolymph. The proliferation of this hemolymph microbiota in such a nutrient-rich environment is tightly controlled in healthy animals, but the mechanisms responsible had remained elusive. In the present study, we report a C-type lectin (MjHeCL) from the kuruma shrimp (Marsupenaeus japonicus) that participates in restraining the hemolymph microbiota. Although the expression of MjHeCL did not seem to be modulated by bacterial challenge, the down-regulation of its expression by RNA interference led to proliferation of the hemolymph microbiota, ultimately resulting in shrimp death. This phenotype was rescued by the injection of recombinant MjHeCL, which restored the healthy status of the knockdown shrimp. A mechanistic analysis revealed that MjHeCL inhibited bacterial proliferation by modulating the expression of antimicrobial peptides. The key function of MjHeCL in the shrimp immune homeostasis might be related to its broader recognition spectrum of the hemolymph microbiota components than other lectins. Our study demonstrates the role of MjHeCL in maintaining the healthy status of shrimp and provides new insight into the biological significance of C-type lectins, a diversified and abundant lectin family in invertebrate species.	[Wang, Xian-Wei; Xu, Ji-Dong; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Minist Educ,Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Vasta, Gerardo Raul] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21202 USA; [Vasta, Gerardo Raul] Inst Marine & Environm Technol, Baltimore, MD 21202 USA	Shandong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Wang, JX (corresponding author), Shandong Univ, Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Minist Educ,Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021	Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056, 31302217]; Provincial Natural Science Foundation of Shandong, China [ZR2011CM014]; Ph.D. Program Foundation of the Ministry of Education of China [20110131130003]; China Postdoctoral Science Foundation [2013M540553]; National Science Foundation [IOS-1050518, IOB-0618409, IOS-0822257]; National Institutes of Health [5R01GM070589-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong, China; Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (Grants 31130056 and 31302217), the Provincial Natural Science Foundation of Shandong, China (Grant ZR2011CM014), the Ph.D. Program Foundation of the Ministry of Education of China (Grant 20110131130003), and the China Postdoctoral Science Foundation (Grant 2013M540553) (to J.-X. W. and X.-W. W.) and by National Science Foundation Grants IOS-1050518, IOB-0618409, and IOS-0822257 (to G. R. V.). This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM070589-06 (to G. R. V.).	Amparyup P, 2012, J BIOL CHEM, V287, P10060, DOI 10.1074/jbc.M111.294744; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Cuthbertson BJ, 2005, J BIOL CHEM, V280, P16009, DOI 10.1074/jbc.M412420200; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; Dean MM, 2005, J CLIN IMMUNOL, V25, P346, DOI 10.1007/s10875-005-4702-1; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; GEWURZ H, 1982, ADV INTERNAL MED, V27, P345; Gomez-Gil B, 1998, AQUACULTURE, V163, P1, DOI 10.1016/S0044-8486(98)00162-8; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Kaizu A, 2011, J BIOL CHEM, V286, P44344, DOI 10.1074/jbc.M111.292672; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lin XH, 2011, BLOOD, V117, P6417, DOI 10.1182/blood-2010-11-320614; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OLAFSEN JA, 1993, APPL ENVIRON MICROB, V59, P1848, DOI 10.1128/AEM.59.6.1848-1854.1993; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rosa RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067937; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; SIZEMORE RK, 1975, APPL MICROBIOL, V29, P393, DOI 10.1177/0146167202250221; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Sun YD, 2008, MOL IMMUNOL, V45, P348, DOI 10.1016/j.molimm.2007.06.355; TUBIASH HS, 1975, APPL MICROBIOL, V29, P388, DOI 10.1128/AEM.29.3.388-392.1975; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; Wang XW, 2014, J BIOL CHEM, V289, P2405, DOI 10.1074/jbc.M113.528885; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Wu CL, 2013, IMMUNOBIOLOGY, V218, P159, DOI 10.1016/j.imbio.2012.02.011; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	49	108	111	8	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11779	11790		10.1074/jbc.M114.552307	http://dx.doi.org/10.1074/jbc.M114.552307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619414	Green Published, hybrid			2022-12-25	WOS:000335010600019
J	Amraoui, F; Spijkers, L; Lahsinoui, HH; Vogt, L; van der Post, J; Peters, S; Afink, G; Ris-Stalpers, C; van den Born, BJ				Amraoui, Fouad; Spijkers, Leon; Lahsinoui, Hajar Hassani; Vogt, Liffert; van der Post, Joris; Peters, Stephan; Afink, Gijs; Ris-Stalpers, Carrie; van den Born, Bert-Jan			SFlt-1 Elevates Blood Pressure by Augmenting Endothelin-1-Mediated Vasoconstriction in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PREGNANT RATS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; VASCULAR REACTIVITY; INHIBITOR SUNITINIB; CANCER-PATIENTS; MOUSE MODEL; PREECLAMPSIA; HYPERTENSION	Objective: Scavenging of vascular endothelial growth factor (VEGF) elevates blood pressure (BP) in patients receiving anti-angiogenic therapy. Similarly, inhibition of circulation VEGF by its soluble receptor fms-like tyrosine kinase-1 (sFlt-1) underlies BP elevation in pre-eclampsia. Both phenotypes are characterized by augmented production of endothelin-1 (ET-1), suggesting a role for ET-1 in anti-angiogenic hypertension. We aimed to assess the effect of VEGF inhibition on ET-1-induced contractility and downstream ET-1 signaling. Approach and Results: Male C57BL/6N mice were treated with either sFlt-1 or vehicle and BP was assessed via tail-cuff. Mean arterial pressure of sFlt-1-treated mice markedly increased compared to vehicle-treated controls (N = 11-12, p<0.05). After sacrifice, carotid and mesenteric arteries were isolated for isometric tension measurements. ET-1-induced contractions were similar in mesenteric arteries of vehicle and sFlt-1-treated mice, but augmented in carotid segments of sFlt-1-treated mice compared to controls (N = 9-10, p<0.05). The increased contraction in carotid segments could be completely abrogated by the cyclooxygenase (COX) inhibitor indomethacin (N = 9-10, p<0.05), indicating heightened prostaglandin-mediated vasoconstriction. This was associated with a shift towards procontractile ETB signaling in sFlt-1-treated mice, possibly explaining the increased ET-1-induced prostaglandin-mediated vasoconstriction. In line with the ex vivo findings, sFlt-1-induced BP elevation could be prevented in vivo by oral treatment with either a high-dose of the COX inhibitor aspirin (N = 7) or with picotamide (N = 9), a dual thromboxane A(2) synthase inhibitor and receptor antagonist. Conclusions: VEGF inhibition augments the pressor response to ET-1. The cyclooxygenase-thromboxane signaling route downstream of ET-1 might be a possible target to prevent BP elevation during VEGF inhibition.	[Amraoui, Fouad; Spijkers, Leon; Vogt, Liffert; Peters, Stephan; van den Born, Bert-Jan] Univ Amsterdam, Acad Med Ctr, Dept Internal & Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Lahsinoui, Hajar Hassani; van der Post, Joris; Ris-Stalpers, Carrie] Univ Amsterdam, Acad Med Ctr, Womens & Childrens Clin, NL-1105 AZ Amsterdam, Netherlands; [Lahsinoui, Hajar Hassani; van der Post, Joris; Afink, Gijs; Ris-Stalpers, Carrie] Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Born, BJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal & Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.j.vandenborn@amc.uva.nl	van der Post, Joris A M/A-8991-2008; Afink, Gijs/AAB-2832-2021; Vogt, Liffert/C-3168-2018; van den Born, Bert-Jan/E-4263-2017; Afink, Gijs/A-2025-2009	Vogt, Liffert/0000-0002-4585-7505; Afink, Gijs/0000-0002-2155-725X; van der Post, Joris/0000-0003-3311-2116; van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393	Netherlands Organization for Scientific Research/ZonMw, The Netherlands [90700310]	Netherlands Organization for Scientific Research/ZonMw, The Netherlands	This study was funded by a Clinical Fellowship awarded to B.J.H. van den Born (90700310) from the Netherlands Organization for Scientific Research/ZonMw, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalvand A, 2013, HYPERTENSION, V61, P488, DOI 10.1161/HYPERTENSIONAHA.111.00055; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Bridges JP, 2009, AM J HYPERTENS, V22, P564, DOI 10.1038/ajh.2009.24; Cardillo CM, 2000, HYPERTENSION, V35, P1237, DOI 10.1161/01.HYP.35.6.1237; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; DEKKER GA, 1991, EUR J OBSTET GYN R B, V40, P215, DOI 10.1016/0028-2243(91)90120-A; DORLEANSJUSTE P, 1994, BRIT J PHARMACOL, V113, P1257, DOI 10.1111/j.1476-5381.1994.tb17133.x; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Faxen M, 2000, ARCH GYNECOL OBSTET, V264, P143, DOI 10.1007/s004040000111; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; George EM, 2011, AM J HYPERTENS, V24, P964, DOI 10.1038/ajh.2011.99; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kandula P, 2011, KIDNEY INT, V80, P1271, DOI 10.1038/ki.2011.288; Kappers MHW, 2011, HYPERTENSION, V58, P295, DOI 10.1161/HYPERTENSIONAHA.111.173559; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; KARAKI H, 1994, BIOCHEM BIOPH RES CO, V205, P168, DOI 10.1006/bbrc.1994.2645; Lankhorst S, 2013, J HYPERTENS, V31, P444, DOI 10.1097/HJH.0b013e32835c1d1b; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mills JL, 1999, JAMA-J AM MED ASSOC, V282, P356, DOI 10.1001/jama.282.4.356; Mousa AA, 2012, HYPERTENSION, V59, P1249, DOI 10.1161/HYPERTENSIONAHA.111.188730; Murphy SR, 2012, AM J PHYSIOL-REG I, V302, pR259, DOI 10.1152/ajpregu.00319.2011; Murphy SR, 2010, HYPERTENSION, V55, P394, DOI 10.1161/HYPERTENSIONAHA.109.141473; NOVA A, 1991, AM J OBSTET GYNECOL, V165, P724, DOI 10.1016/0002-9378(91)90317-K; Pereg D, 2008, EUR HEART J, V29, P2325, DOI 10.1093/eurheartj/ehn384; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029222; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; TAKAYASUOKISHIO M, 1990, BIOCHEM PHARMACOL, V40, P2713; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; White RM, 1996, HYPERTENSION, V27, P1245, DOI 10.1161/01.HYP.27.6.1245; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	39	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91897	10.1371/journal.pone.0091897	http://dx.doi.org/10.1371/journal.pone.0091897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632840	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400118
J	Bertuccio, CA; Lee, SL; Wu, GY; Butterworth, MB; Hamilton, KL; Devor, DC				Bertuccio, Claudia A.; Lee, Shih-Liang; Wu, Guangyu; Butterworth, Michael B.; Hamilton, Kirk L.; Devor, Daniel C.			Anterograde Trafficking of KCa3.1 in Polarized Epithelia Is Rab1-and Rab8-Dependent and Recycling Endosome-Independent	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; CELL-SURFACE EXPRESSION; ANGIOTENSIN-II; PLASMA-MEMBRANE; INTERMEDIATE CONDUCTANCE; ENDOPLASMIC-RETICULUM; CHLORIDE SECRETION; GTP-BINDING; DEPENDENT REGULATION; PROTEIN TRAFFICKING	The intermediate conductance, Ca2+-activated K+ channel (KCa3.1) targets to the basolateral (BL) membrane in polarized epithelia where it plays a key role in transepithelial ion transport. However, there are no studies defining the anterograde and retrograde trafficking of KCa3.1 in polarized epithelia. Herein, we utilize Biotin Ligase Acceptor Peptide (BLAP)-tagged KCa3.1 to address these trafficking steps in polarized epithelia, using MDCK, Caco-2 and FRT cells. We demonstrate that KCa3.1 is exclusively targeted to the BL membrane in these cells when grown on filter supports. Following endocytosis, KCa3.1 degradation is prevented by inhibition of lysosomal/proteosomal pathways. Further, the ubiquitylation of KCa3.1 is increased following endocytosis from the BL membrane and PR-619, a deubiquitylase inhibitor, prevents degradation, indicating KCa3.1 is targeted for degradation by ubiquitylation. We demonstrate that KCa3.1 is targeted to the BL membrane in polarized LLC-PK1 cells which lack the mu 1B subunit of the AP-1 complex, indicating BL targeting of KCa3.1 is independent of mu 1B. As Rabs 1, 2, 6 and 8 play roles in ER/Golgi exit and trafficking of proteins to the BL membrane, we evaluated the role of these Rabs in the trafficking of KCa3.1. In the presence of dominant negative Rab1 or Rab8, KCa3.1 cell surface expression was significantly reduced, whereas Rabs 2 and 6 had no effect. We also co-immunoprecipitated KCa3.1 with both Rab1 and Rab8. These results suggest these Rabs are necessary for the anterograde trafficking of KCa3.1. Finally, we determined whether KCa3.1 traffics directly to the BL membrane or through recycling endosomes in MDCK cells. For these studies, we used either recycling endosome ablation or dominant negative RME-1 constructs and determined that KCa3.1 is trafficked directly to the BL membrane rather than via recycling endosomes. These results are the first to describe the anterograde and retrograde trafficking of KCa3.1 in polarized epithelia cells.	[Bertuccio, Claudia A.; Butterworth, Michael B.; Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Lee, Shih-Liang; Hamilton, Kirk L.] Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin, Otago, New Zealand; [Wu, Guangyu] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Otago; University System of Georgia; Augusta University	Hamilton, KL (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin, Otago, New Zealand.	kirk.hamilton@otago.ac.nz; dd2@pitt.edu		Butterworth, Michael/0000-0002-2173-8333; Lee, Shih-Liang/0000-0001-5882-8503	National Institute of Health [HL092157, GM076167, DK078917]; University of Otago (UoO); Department of Physiology; Department of Physiology at UoO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK078917, K99DK078917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Otago (UoO); Department of Physiology; Department of Physiology at UoO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health to DCD (HL092157), GW(GM076167) and MBB (DK078917). KLH was supported by an University of Otago (UoO) Research Grant and the Department of Physiology. SLL was supported by an MSc scholarship from the Department of Physiology at UoO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazza A, 2012, J PATHOL, V226, P463, DOI 10.1002/path.2994; Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; Balut CM, 2010, FUTURE MED CHEM, V2, P707, DOI [10.4155/fmc.10.182, 10.4155/FMC.10.182]; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Cancino J, 2007, MOL BIOL CELL, V18, P4872, DOI 10.1091/mbc.E07-06-0563; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; DEVOR DC, 1993, AM J PHYSIOL, V265, pC1271, DOI 10.1152/ajpcell.1993.265.5.C1271; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; DEVOR DC, 1990, AM J PHYSIOL, V258, pC318, DOI 10.1152/ajpcell.1990.258.2.C318; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Duffield A, 2004, TRAFFIC, V5, P449, DOI 10.1111/j.1398-9219.2004.00192.x; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; FUTTER CE, 1995, J BIOL CHEM, V270, P10999, DOI 10.1074/jbc.270.18.10999; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Hammad MM, 2012, BIOL CHEM, V393, P541, DOI 10.1515/hsz-2011-0284; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Orzech E, 2000, J BIOL CHEM, V275, P15207, DOI 10.1074/jbc.275.20.15207; Pilecka I, 2011, EXP CELL RES, V317, P1093, DOI 10.1016/j.yexcr.2011.02.002; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Simms LA, 2010, AM J GASTROENTEROL, V105, P2209, DOI 10.1038/ajg.2010.161; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wulf A, 2002, J MEMBRANE BIOL, V187, P71, DOI 10.1007/s00232-001-0149-3; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422	62	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92013	10.1371/journal.pone.0092013	http://dx.doi.org/10.1371/journal.pone.0092013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632741	Green Published, gold, Green Accepted			2022-12-25	WOS:000332858400130
J	Courcoul, A; Moyen, JL; Brugere, L; Faye, S; Henault, S; Gares, H; Boschiroli, ML				Courcoul, Aurelie; Moyen, Jean-Louis; Brugere, Laure; Faye, Sandy; Henault, Sylvie; Gares, Helene; Boschiroli, Maria-Laura			Estimation of Sensitivity and Specificity of Bacteriology, Histopathology and PCR for the Confirmatory Diagnosis of Bovine Tuberculosis Using Latent Class Analysis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; GOLD STANDARD; TESTS; SURVEILLANCE; ABSENCE; CATTLE; IS6110; ASSAY	Bacteriology and histopathology are the most commonly used tests used for official confirmatory diagnosis of bovine tuberculosis (bTB) in cattle in most countries. PCR is also being used increasingly because it allows a fast diagnosis. This test could be applied as a supplement to or replacement for current bTB confirmatory diagnostic tests but its characteristics have first to be evaluated. The aim of this study was to estimate and compare sensitivities and specificities of bacteriology, histopathology and PCR under French field conditions, in the absence of a gold standard using latent class analysis. The studied population consisted of 5,211 animals from which samples were subjected to bacteriology and PCR (LSI VetMAX (TM) Mycobacterium tuberculosis Complex PCR Kit, Life Technologies) as their herd of origin was either suspected or confirmed infected with bTB or because bTB-like lesions were detected during slaughterhouse inspection. Samples from 697 of these animals (all with bTB-like lesions) were subjected to histopathology. Bayesian models were developed, allowing for dependence between bacteriology and PCR, while assuming independence from histopathology. The sensitivity of PCR was higher than that of bacteriology (on average 87.7% [82.5-92.3%] versus 78.1% [72.9-82.8%]) while specificity of both tests was very good (on average 97.0% for PCR [94.3-99.0%] and 99.1% for bacteriology [97.1-100.0%]). Histopathology was at least as sensitive as PCR (on average 93.6% [89.9-96.9%]) but less specific than the two other tests (on average 83.3% [78.7-87.6%]). These results suggest that PCR has the potential to replace bacteriology to confirm bTB in samples submitted from suspect cattle.	[Courcoul, Aurelie] Paris Est Univ, Epidemiol Unit, Hlth Anim Lab, Anses, Maisons Alfort, France; [Moyen, Jean-Louis; Brugere, Laure; Faye, Sandy; Gares, Helene] Reg Anal & Res Lab Dordogne LDAR24, Coulounieix Chamiers, France; [Henault, Sylvie; Boschiroli, Maria-Laura] Paris Est Univ, Bacterial Zoonoses Unit, Bovine TB Reference Lab, Hlth Anim Lab,Anses, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Boschiroli, ML (corresponding author), Paris Est Univ, Bacterial Zoonoses Unit, Bovine TB Reference Lab, Hlth Anim Lab,Anses, Maisons Alfort, France.	Maria-laura.BOSCHIROLI@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021		French Ministry of Agriculture	French Ministry of Agriculture	This work was supported by the French Ministry of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Cardoso MA, 2009, ZOONOSES PUBLIC HLTH, V56, P465, DOI 10.1111/j.1863-2378.2008.01199.x; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Gardner IA, 2011, PREV VET MED, V101, P18, DOI 10.1016/j.prevetmed.2011.04.002; Henault S, 2006, DEV BIOLOGICALS, V126, P123; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Johnson WO, 2009, PREV VET MED, V91, P116, DOI 10.1016/j.prevetmed.2009.06.006; Jones G, 2010, BIOMETRICS, V66, P855, DOI 10.1111/j.1541-0420.2009.01330.x; Karolemeas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043217; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; [OIE OIE], 2012, MAN DIAGN TESTS VACC, P674; Parra A, 2008, VET MICROBIOL, V127, P315, DOI 10.1016/j.vetmic.2007.09.001; Paul S, 2013, PREV VET MED, V109, P258, DOI 10.1016/j.prevetmed.2012.10.007; Proano-Perez F, 2011, PREV VET MED, V101, P65, DOI 10.1016/j.prevetmed.2011.04.018; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Toft N, 2007, VET MICROBIOL, V120, P77, DOI 10.1016/j.vetmic.2006.10.025; Varello K, 2008, J VET DIAGN INVEST, V20, P164, DOI 10.1177/104063870802000204; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	26	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90334	10.1371/journal.pone.0090334	http://dx.doi.org/10.1371/journal.pone.0090334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625670	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300018
J	Gupta, R; Deswal, R				Gupta, Ravi; Deswal, Renu			Refolding of beta-Stranded Class I Chitinases of Hippophae rhamnoides Enhances the Antifreeze Activity during Cold Acclimation	PLOS ONE			English	Article							PROTEINS; PURIFICATION; DEGLYCOSYLATION; IDENTIFICATION; GLYCOPROTEINS; DYNAMICS; CLEAVAGE; SEQUENCE; ACID	Class I chitinases hydrolyse the beta-1,4-linkage of chitin and also acquire antifreeze activity in some of the overwintering plants during cold stress. Two chitinases, HrCHT1a of 31 kDa and HrCHT1b of 34 kDa, were purified from cold acclimated and non-acclimated seabuckthorn seedlings using chitin affinity chromatography. 2-D gels of HrCHT1a and HrCHT1b showed single spots with pIs 7.0 and 4.6 respectively. N-terminal sequence of HrCHT1b matched with the class I chitinase of rice and antifreeze proteins while HrCHT1a could not be sequenced as it was N-terminally blocked. Unlike previous reports, where antifreeze activity of chitinase was cold inducible, our results showed that antifreeze activity is constitutive property of class I chitinase as both HrCHT1a and HrCHT1b isolated even from non-acclimated seedlings, exhibited antifreeze activity. Interestingly, HrCHT1a and HrCHT1b purified from cold acclimated seedlings, exhibited 4 and 2 times higher antifreeze activities than those purified from non-acclimated seedlings, suggesting that antifreeze activity increased during cold acclimation. HrCHT1b exhibited 23-33% higher hydrolytic activity and 2-4 times lower antifreeze activity than HrCHT1a did. HrCHT1b was found to be a glycoprotein; however, its antifreeze activity was independent of glycosylation as even deglycosylated HrCHT1b exhibited antifreeze activity. Circular dichroism (CD) analysis showed that both these chitinases were rich in unusual beta-stranded conformation (36-43%) and the content of beta-strand increased (similar to 11%) during cold acclimation. Surprisingly, calcium decreased both the activities of HrCHT1b while in case of HrCHT1a, a decrease in the hydrolytic activity and enhancement in its antifreeze activity was observed. CD results showed that addition of calcium also increased the beta-stranded conformation of HrCHT1a and HrCHT1b. This is the first report, which shows that antifreeze activity is constitutive property of class I chitinase and cold acclimation and calcium regulate these activities of chitinases by changing the secondary structure.	[Gupta, Ravi; Deswal, Renu] Univ Delhi, Dept Bot, Mol Plant Physiol & Prote Lab, Delhi 110007, India	University of Delhi	Deswal, R (corresponding author), Univ Delhi, Dept Bot, Mol Plant Physiol & Prote Lab, Delhi 110007, India.	rdeswal@botany.du.ac.in	Gupta, Ravi/K-5977-2019; Deswal, Renu/P-7051-2019	Gupta, Ravi/0000-0001-5242-9528; Deswal, Renu/0000-0002-7298-1050	Department of Biotechnology, Government of India [BT/PR10799/NDB/51/171/2008]; University of Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi)	This work was supported by a grant (BT/PR10799/NDB/51/171/2008) from Department of Biotechnology, Government of India, and a small research grant provided by University of Delhi to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Fernandez-Caballero C, 2009, J AGR FOOD CHEM, V57, P8893, DOI 10.1021/jf9016543; Ghangal R, 2012, PLANT PHYSIOL BIOCH, V51, P123, DOI 10.1016/j.plaphy.2011.10.005; Graether SP, 2003, J MOL BIOL, V327, P1155, DOI 10.1016/S0022-2836(03)00235-3; Graether SP, 2001, BIOPHYS J, V81, P1677, DOI 10.1016/S0006-3495(01)75821-3; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gupta R, 2012, J PROTEOME RES, V11, P2684, DOI 10.1021/pr200944z; Hakim A, 2013, J BIOL CHEM, V288, P12295, DOI 10.1074/jbc.M113.450973; Hiilovaara-Teijo M, 1999, PLANT PHYSIOL, V121, P665, DOI 10.1104/pp.121.2.665; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Jarzabek M, 2009, CRYOBIOLOGY, V58, P268, DOI 10.1016/j.cryobiol.2009.01.007; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kang SC, 1999, J INVERTEBR PATHOL, V73, P276, DOI 10.1006/jipa.1999.4843; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Li N, 1998, ARCH BIOCHEM BIOPHYS, V360, P25, DOI 10.1006/abbi.1998.0930; MERRIL CR, 1983, METHOD ENZYMOL, V96, P230; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Nakamura T, 2008, PLANT PHYSIOL, V147, P391, DOI 10.1104/pp.106.081497; Perez-Iratxeta C, 2007, BMC STRUCT BIOL, P8; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Seebach D, 2004, CHEM BIODIVERS, V1, P1111, DOI 10.1002/cbdv.200490087; STICHER L, 1993, PLANT PHYSIOL, V101, P1239, DOI 10.1104/pp.101.4.1239; Stressmann M, 2004, PLANT PHYSIOL, V135, P364, DOI 10.1104/pp.103.038158; Sun YL, 2012, BIOCHEM GENET, V50, P600, DOI 10.1007/s10528-012-9504-6; Taira T, 2005, BIOSCI BIOTECH BIOCH, V69, P189, DOI 10.1271/bbb.69.189; TAMS JW, 1995, ANAL BIOCHEM, V228, P48, DOI 10.1006/abio.1995.1313; Thompson SE, 2001, APPL ENVIRON MICROB, V67, P4001, DOI 10.1128/AEM.67.9.4001-4008.2001; Tsvetkova NM, 2002, BIOPHYS J, V82, P464, DOI 10.1016/S0006-3495(02)75411-8; Wen CM, 2002, BIOTECHNOL APPL BIOC, V35, P213, DOI 10.1042/BA20020001; YAMAGAMI T, 1994, BIOSCI BIOTECH BIOCH, V58, P322, DOI 10.1271/bbb.58.322; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Yu XM, 2001, PLANT PHYSIOL, V126, P1232, DOI 10.1104/pp.126.3.1232; Yu XM, 2001, PHYSIOL PLANTARUM, V112, P78, DOI 10.1034/j.1399-3054.2001.1120111.x; Zhang DQ, 2004, BIOCHEM J, V377, P589, DOI 10.1042/BJ20031249; Zhang SH, 2011, BIOL PLANTARUM, V55, P141, DOI 10.1007/s10535-011-0019-5	38	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91723	10.1371/journal.pone.0091723	http://dx.doi.org/10.1371/journal.pone.0091723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626216	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300128
J	Robino, A; Mezzavilla, M; Pirastu, N; Dognini, M; Tepper, BJ; Gasparini, P				Robino, Antonietta; Mezzavilla, Massimo; Pirastu, Nicola; Dognini, Maddalena; Tepper, Beverly J.; Gasparini, Paolo			A Population-Based Approach to Study the Impact of PROP Perception on Food Liking in Populations along the Silk Road	PLOS ONE			English	Article							GENETIC TASTE SENSITIVITY; BITTER-TASTE; INDIVIDUAL-DIFFERENCES; 6-N-PROPYLTHIOURACIL PROP; TAS2R38; PHENYLTHIOCARBAMIDE; PTC; POLYMORPHISMS; SENSATIONS; PREFERENCE	Taste is one of the main factors determining food choices. Differences in PROP bitter taste perception have been implicated in individual differences in food preferences and selection. The present study examined associations between, PROP phenotypes, self-reported food liking and TAS2R38 polymorphisms, the major gene implicated in PROP bitterness, in six different populations of the Caucasus and Central Asia, located along the ancient Silk Road. Differences in the distribution of PROP phenotypes across populations were detected, with a higher frequency of super tasters in Tajikistan (31.3%) and Armenia (39.0%) and a higher frequency of non tasters in Georgia (50.9%). While no relationships were observed between PROP phenotypes and food liking using standard statistical tests, we used an approach based on comparison of distance matrices derived from these data. The first matrix compared the food liking ratings of each population to all others pairwise using the Kruskal-Wallis test (at p<0.00063), and the second one compared the distribution of PROP phenotypes across all populations in a similar manner calculating the chi-square statistic as a distance measure. A strong correlation between the two matrices was found (Mantel test: r = 0.67, p-value = 0.03), suggesting that the pattern of food liking across populations was closely related to the distribution of PROP phenotypes. This same relationship was not observed when TAS2R38 genotypes were substituted for PROP phenotypes in this analysis. Our data suggest that a population-based approach utilizing distance matrices is a useful technique for detecting PROP-related differences in food liking and can be applied to other taste phenotypes.	[Robino, Antonietta; Mezzavilla, Massimo; Pirastu, Nicola; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Robino, Antonietta; Mezzavilla, Massimo; Pirastu, Nicola; Gasparini, Paolo] Univ Trieste, Trieste, Italy; [Dognini, Maddalena] Condotta Slow Food, Trieste, Italy; [Tepper, Beverly J.] Rutgers State Univ, Dept Food Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	IRCCS Burlo Garofolo; University of Trieste; Rutgers State University New Brunswick	Robino, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	antonietta.robino@burlo.trieste.it	Pirastu, Nicola/AHB-6226-2022; Mezzavilla, Massimo/AAL-8225-2020; Mezzavilla, Massimo/J-2948-2018; Gasparini, Paolo/B-6173-2014; Robino, Antonietta/K-9398-2016	Mezzavilla, Massimo/0000-0002-9000-4595; Mezzavilla, Massimo/0000-0002-9000-4595; Pirastu, Nicola/0000-0002-5363-3886; Robino, Antonietta/0000-0003-2152-2353; Gasparini, Paolo/0000-0002-0859-0856	Ministry of Health (IRCCS-Burlo Garofolo - Ricerca Corrente)	Ministry of Health (IRCCS-Burlo Garofolo - Ricerca Corrente)	The study was funded by the sponsors of the scientific expedition Marcopolo 2010, and by Ministry of Health (IRCCS-Burlo Garofolo - Ricerca Corrente). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski JC, 2010, PUBLIC HEALTH NUTR, V13, P1587, DOI 10.1017/S1368980009993004; Baranowski T, 2011, NUTR RES, V31, P594, DOI 10.1016/j.nutres.2011.07.004; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Behrens M, 2013, CHEM SENSES, V38, P475, DOI 10.1093/chemse/bjt016; Bembich S, 2010, CHEM SENSES, V35, P801, DOI 10.1093/chemse/bjq080; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030962; Calo C, 2011, PHYSIOL BEHAV, V104, P1065, DOI 10.1016/j.physbeh.2011.06.013; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Carrai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020464; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Coletta A, 2013, EAT BEHAV, V14, P180, DOI 10.1016/j.eatbeh.2013.02.006; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1340, DOI 10.1016/j.jada.2007.05.013; EFRON B, 1992, J ROY STAT SOC B MET, V54, P83; Feeney E, 2011, P NUTR SOC, V70, P135, DOI 10.1017/S0029665110003976; Feeney E, 2011, NUTR B, V36, P20330; Ferrucci LM, 2010, ASIAN PAC J CANCER P, V11, P1621; Goldstein GL, 2007, PHYSIOL BEHAV, V90, P809, DOI 10.1016/j.physbeh.2007.01.004; Gorovic N, 2011, SCAND J CLIN LAB INV, V71, P274, DOI 10.3109/00365513.2011.559553; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Green BG, 2004, CHEM SENSES, V29, P617, DOI 10.1093/chemse/bjh065; Guo SW, 1998, ANN NY ACAD SCI, V855, P810, DOI 10.1111/j.1749-6632.1998.tb10664.x; Guo SW, 2001, ANN HUM BIOL, V28, P111; Hayes JE, 2008, PHYSIOL BEHAV, V95, P77, DOI 10.1016/j.physbeh.2008.04.023; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2013, FOOD QUAL PREFER, V30, P202, DOI 10.1016/j.foodqual.2013.05.013; Hayes JE, 2011, PHYSIOL BEHAV, V104, P1072, DOI 10.1016/j.physbeh.2011.08.003; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keller KL, 2002, APPETITE, V38, P3, DOI 10.1006/appe.2001.0441; Khataan NH, 2009, J NUTRIGENET NUTRIGE, V2, P251, DOI 10.1159/000297217; Kim UK, 2005, CLIN GENET, V67, P275, DOI 10.1111/j.1399-0004.2004.00361.x; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Lucock M, 2011, FOOD FUNCT, V2, P457, DOI 10.1039/c1fo10054h; Mangold JE, 2008, J MED GENET, V45, P578, DOI 10.1136/jmg.2008.057844; MANTEL N, 1967, CANCER RES, V27, P209; Melis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059810; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; Mennella JA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-60; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nenadic O, 2007, J STAT SOFTW, V20; Ooi SX, 2010, ASIA PAC J CLIN NUTR, V19, P491; Pemberton TJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-13; Pirastu N, 2012, J FOOD SCI, V77, pS413, DOI 10.1111/j.1750-3841.2012.02852.x; Prescott J, 2004, PHYSIOL BEHAV, V82, P459, DOI 10.1016/j.physbeh.2004.04.009; REYNOLDS J, 1983, GENETICS, V105, P767; Sacerdote C, 2007, AM J EPIDEMIOL, V166, P576, DOI 10.1093/aje/kwm113; Shafaie Y, 2013, AM J CLIN NUTR; TENENHAUS M, 1985, PSYCHOMETRIKA, V50, P91, DOI 10.1007/BF02294151; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2011, APPETITE, V56, P104, DOI 10.1016/j.appet.2010.11.144; Tepper BJ, 2009, ANN NY ACAD SCI, V1170, P126, DOI 10.1111/j.1749-6632.2009.03916.x; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tepper BJ, 2002, PHYSIOL BEHAV, V75, P305, DOI 10.1016/S0031-9384(01)00664-3; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Tsuji M, 2012, EUR J CLIN NUTR, V66, P47, DOI 10.1038/ejcn.2011.127; Ullrich NV, 2004, J AM DIET ASSOC, V104, P543, DOI 10.1016/j.jada.2004.01.011; Walker Christopher J., 1990, ARMENIA SURVIVAL NAT; Zhao LQ, 2003, PHYSIOL BEHAV, V78, P625, DOI 10.1016/S0031-9384(03)00057-X	66	27	27	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91716	10.1371/journal.pone.0091716	http://dx.doi.org/10.1371/journal.pone.0091716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626196	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300127
J	Graham, SL; Hunt, JE; Millard, P; McSeveny, T; Tylianakis, JM; Whitehead, D				Graham, Scott L.; Hunt, John E.; Millard, Peter; McSeveny, Tony; Tylianakis, Jason M.; Whitehead, David			Effects of Soil Warming and Nitrogen Addition on Soil Respiration in a New Zealand Tussock Grassland	PLOS ONE			English	Article							CARBON-CYCLE FEEDBACKS; ATMOSPHERIC CO2; ORGANIC-MATTER; TEMPERATURE SENSITIVITY; MICROBIAL BIOMASS; ROOT RESPIRATION; CLIMATE; AVAILABILITY; RESPONSES; FLUX	Soil respiration (R-S) represents a large terrestrial source of CO2 to the atmosphere. Global change drivers such as climate warming and nitrogen deposition are expected to alter the terrestrial carbon cycle with likely consequences for R-S and its components, autotrophic (R-A) and heterotrophic respiration (R-H). Here we investigate the impacts of a 3 degrees C soil warming treatment and a 50 kg ha(-1) y(-1) nitrogen addition treatment on R-S, R-H and their respective seasonal temperature responses in an experimental tussock grassland. Average respiration in untreated soils was 0.96 +/- 0.09 mu mol m(-2) s(-1) over the course of the experiment. Soil warming and nitrogen addition increased R-S by 41% and 12% respectively. These treatment effects were additive under combined warming and nitrogen addition. Warming increased R-H by 37% while nitrogen addition had no effect. Warming and nitrogen addition affected the seasonal temperature response of R-S by increasing the basal rate of respiration (R-10) by 14% and 20% respectively. There was no significant interaction between treatments for R10. The treatments had no impact on activation energy (E-0). The seasonal temperature response of R-H was not affected by either warming or nitrogen addition. These results suggest that the additional CO2 emissions from New Zealand tussock grassland soils as a result of warming-enhanced R-S constitute a potential positive feedback to rising atmospheric CO2 concentration.	[Graham, Scott L.; Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Graham, Scott L.; Hunt, John E.; Millard, Peter; McSeveny, Tony; Whitehead, David] Landcare Res, Lincoln, New Zealand; [Tylianakis, Jason M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England	University of Canterbury; Landcare Research - New Zealand; Imperial College London	Graham, SL (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	scott.graham@ucf.edu	Hunt, John/AAX-6121-2020; Whitehead, David/AAB-1608-2019; Millard, Peter/F-1048-2011; Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620; Millard, Peter/0000-0001-5114-6219; Hunt, John/0000-0002-8966-8773; Graham, Scott/0000-0002-4751-9868	Miss E.L. Hellaby Indigenous Grassland Research Trust; Ministry for Business, Innovation and Employment; Rutherford Discovery Fellowship; Marsden Fund [UOC-0705]	Miss E.L. Hellaby Indigenous Grassland Research Trust; Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Rutherford Discovery Fellowship; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	SLG was supported by a fellowship from the Miss E.L. Hellaby Indigenous Grassland Research Trust. JEH, PM, TM, and DW received funding from the Ministry for Business, Innovation and Employment. JMT was funded by a Rutherford Discovery Fellowship administered by the Royal Society of New Zealand. This work was funded by the Marsden Fund (UOC-0705) and the Miss E.L. Hellaby Indigenous Grassland Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Burton AJ, 2008, J INTEGR PLANT BIOL, V50, P1467, DOI 10.1111/j.1744-7909.2008.00750.x; Chen XW, 2011, CLIMATIC CHANGE, V107, P459, DOI 10.1007/s10584-010-9942-2; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craine JM, 2001, GLOBAL CHANGE BIOL, V7, P947, DOI 10.1046/j.1354-1013.2001.00455.x; Crawley M.J., 2007, R BOOK; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Graham SL, 2012, ANN BOT-LONDON, V110, P253, DOI 10.1093/aob/mcs073; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hartley IP, 2007, GLOBAL CHANGE BIOL, V13, P1761, DOI 10.1111/j.1365-2486.2007.01373.x; Hewitt A.E., 2010, NZ SOIL CLASSIFICATI, Vthird; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; JONG ED, 1974, CAN J SOIL SCI, V54, P299, DOI 10.4141/cjss74-039; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Norby RJ, 2004, NEW PHYTOL, V162, P281, DOI 10.1111/j.1469-8137.2004.01047.x; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Pinheiro J., 2021, NLME LINEAR NONLINEA; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANG ENV STAT COMP; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schindlbacher A, 2012, GLOBAL CHANGE BIOL, V18, P2270, DOI 10.1111/j.1365-2486.2012.02696.x; Schindlbacher A, 2009, GLOBAL CHANGE BIOL, V15, P901, DOI 10.1111/j.1365-2486.2008.01757.x; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Trotter CM, 2004, GLOBAL ENV CHANGE OC, P311; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Uchida Y, 2010, PLANT SOIL, V337, P375, DOI 10.1007/s11104-010-0533-9; USDA, 2006, KEYS SOIL TAX; Uselman SM, 2000, PLANT SOIL, V222, P191, DOI 10.1023/A:1004705416108; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Zhou YM, 2011, TREE PHYSIOL, V31, P707, DOI 10.1093/treephys/tpr066; Zhu BA, 2011, GLOBAL CHANGE BIOL, V17, P2172, DOI 10.1111/j.1365-2486.2010.02354.x	53	37	39	19	230	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91204	10.1371/journal.pone.0091204	http://dx.doi.org/10.1371/journal.pone.0091204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621790	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300063
J	Gubernator, J; Lipka, D; Korycinska, M; Kempinska, K; Milczarek, M; Wietrzyk, J; Hrynyk, R; Barnert, S; Suss, R; Kozubek, A				Gubernator, Jerzy; Lipka, Dominik; Korycinska, Mariola; Kempinska, Katarzyna; Milczarek, Magdalena; Wietrzyk, Joanna; Hrynyk, Rafal; Barnert, Sabine; Suess, Regine; Kozubek, Arkadiusz			Efficient Human Breast Cancer Xenograft Regression after a Single Treatment with a Novel Liposomal Formulation of Epirubicin Prepared Using the EDTA Ion Gradient Method	PLOS ONE			English	Article							LONG-CIRCULATING LIPOSOMES; TO-LIPID RATIO; THERMOSENSITIVE LIPOSOMES; DRUG-RELEASE; IN-VITRO; DOXORUBICIN; TUMOR; ANTHRACYCLINES; RETENTION; CISPLATIN	Liposomes act as efficient drug carriers. Recently, epirubicin (EPI) formulation was developed using a novel EDTA ion gradient method for drug encapsulation. This formulation displayed very good stability and drug retention in vitro in a two-year long-term stability experiment. The cryo-TEM images show drug precipitate structures different than ones formed with ammonium sulfate method, which is usually used to encapsulate anthracyclines. Its pharmacokinetic properties and its efficacy in the human breast MDA-MB-231 cancer xenograft model were also determined. The liposomal EPI formulation is eliminated slowly with an AUC of 7.6487, while the free drug has an AUC of only 0.0097. The formulation also had a much higher overall antitumor efficacy than the free drug.	[Gubernator, Jerzy; Lipka, Dominik; Korycinska, Mariola; Kozubek, Arkadiusz] Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, PL-50138 Wroclaw, Poland; [Kempinska, Katarzyna; Milczarek, Magdalena; Wietrzyk, Joanna] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Wroclaw, Poland; [Hrynyk, Rafal] Natl Res Inst, Cent Inst Labour Protect, Dept Personal Protect Equipment, Warsaw, Poland; [Barnert, Sabine; Suess, Regine] Univ Freiburg, Dept Pharmaceut Technol, D-79106 Freiburg, Germany	University of Wroclaw; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Central Institute for Labour Protection - National Research Institute; University of Freiburg	Gubernator, J (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, PL-50138 Wroclaw, Poland.	gubern@ibmb.uni.wroc.pl	Milczarek, Magdalena/AAC-5660-2020; Wietrzyk, Joanna/O-4392-2018	Wietrzyk, Joanna/0000-0003-4980-6606; Milczarek, Magdalena/0000-0001-6696-5305	Pharmaceutical Research Institute, Warsaw, Poland	Pharmaceutical Research Institute, Warsaw, Poland	This study was supported by the Pharmaceutical Research Institute, Warsaw, Poland. The funders had only role in drug and cancer type selection, but not on data collection and analysis, decision to publish, or preparation of the manuscript.	Banno B, 2010, J PHARM SCI-US, V99, P2295, DOI 10.1002/jps.21988; Birtle AJ, 2000, CLIN ONCOL-UK, V12, P146, DOI 10.1053/clon.2000.9141; Cern A, 2012, J CONTROL RELEASE, V160, P147, DOI 10.1016/j.jconrel.2011.11.029; Dos Santos N, 2002, BBA-BIOMEMBRANES, V1561, P188, DOI 10.1016/S0005-2736(02)00345-0; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1997, ADV DRUG DELIVER REV, V24, P337, DOI 10.1016/S0169-409X(96)00476-0; GABIZON AA, 1994, HEMATOL ONCOL CLIN N, V8, P431; GABIZON AA, 1992, CANCER RES, V52, P891; Gubernator J, 2010, J CONTROL RELEASE, V146, P68, DOI 10.1016/j.jconrel.2010.05.021; Ickenstein LM, 2003, BBA-BIOMEMBRANES, V1614, P135, DOI 10.1016/S0005-2736(03)00196-2; Johnston MJW, 2008, J LIPOSOME RES, V18, P145, DOI [10.1080/08982100802129372, 10.1080/08982100802129372 ]; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; Koning GA, 2010, PHARM RES-DORDR, V27, P1750, DOI 10.1007/s11095-010-0154-2; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lipka Dominik, 2013, Int J Nanomedicine, V8, P3573, DOI 10.2147/IJN.S47745; Lohr M, 2009, ANN ONCOL, V20, P9; MAYHEW EG, 1992, INT J CANCER, V51, P302, DOI 10.1002/ijc.2910510221; Mylonakis N, 2010, LUNG CANCER, V68, P240, DOI 10.1016/j.lungcan.2009.06.017; Nielsen D, 2000, CANCER CHEMOTH PHARM, V46, P459, DOI 10.1007/s002800000178; Popovic Z, 2010, ANGEW CHEM INT EDIT, V49, P8649, DOI 10.1002/anie.201003142; Riviere J.E., 2018, VET PHARM THERAPEUTI; Stathopoulos GP, 2010, ANTICANCER RES, V30, P1317; Stathopoulos GP, 2006, ANTICANCER RES, V26, P1489; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Tian W, 2010, EUR J PHARM SCI, V41, P232, DOI 10.1016/j.ejps.2010.06.008; TIDEFELT U, 1991, CANCER CHEMOTH PHARM, V29, P7, DOI 10.1007/BF00686328; TODOROV DK, 1995, J CANCER RES CLIN, V121, P164, DOI 10.1007/BF01198098; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	28	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91487	10.1371/journal.pone.0091487	http://dx.doi.org/10.1371/journal.pone.0091487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621591	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300094
J	Tamayo, T; Rathmann, W; Kramer, U; Sugiri, D; Grabert, M; Holl, RW				Tamayo, Teresa; Rathmann, Wolfgang; Kraemer, Ursula; Sugiri, Dorothea; Grabert, Matthias; Holl, Reinhard W.			Is Particle Pollution in Outdoor Air Associated with Metabolic Control in Type 2 Diabetes?	PLOS ONE			English	Article							LONG-TERM EXPOSURE; CARDIOVASCULAR-DISEASE; STATEMENT; MORTALITY; MELLITUS; OBESITY	Background: There is growing evidence that air pollutants are associated with the risk of type 2 diabetes. Subclinical inflammation may be a mechanism linking air pollution with diabetes. Information is lacking whether air pollution also contributes to worse metabolic control in newly diagnosed type 2 diabetes. We examined the hypothesis that residential particulate matter (PM10) is associated with HbA(1c) concentration in newly diagnosed type 2 diabetes. Methods: Nationwide regional levels of particulate matter with a diameter of <= 10 mu m (PM10) were obtained in 2009 from background monitoring stations in Germany (Federal Environmental Agency) and assigned to place of residency of 9,102 newly diagnosed diabetes patients registered in the DPV database throughout Germany (age 65.5 +/- 13.5 yrs; males: 52.1%). Mean HbA(1c) (%) levels stratified for air pollution quartiles (PM10 in mu g/m(3)) were estimated using linear regression models adjusting for age, sex, BMI, diabetes duration, geographic region, year of ascertainment, and social indicators. Findings: In both men and women, adjusted HbA(1c) was significantly lower in the lowest quartile of PM10 exposure in comparison to quartiles Q2-Q4. Largest differences in adjusted HbA(1c) (95% CI) were seen comparing lowest quartiles of exposure with highest quartiles (men %: -0.42 (-0.62; -0.23)/mmol/mol: -28.11 (-30.30; -26.04), women, %: -0.28 (-0.47; -0.09)/mmol/mol: -0.28 (-0.47; -0.09)). Interpretation: Air pollution may be associated with higher HbA(1c) levels in newly diagnosed type 2 diabetes patients. Further studies are warranted to examine this association.	[Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Kraemer, Ursula; Sugiri, Dorothea] Univ Dusseldorf, Leibniz Ctr, Inst Environm Med IUF, Dusseldorf, Germany; [Grabert, Matthias; Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Ulm University	Tamayo, T (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	teresa.tamayo@ddz.uni-duesseldorf.de		Holl, Reinhard/0000-0003-1395-4842	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research [01GI1110D/01GI1106]	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research	Data are part of the BMBF Diabetes Meta-Database project which was funded by the Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research (support codes 01GI1110D/01GI1106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awa WL, 2012, EUR J ENDOCRINOL, V167, P245, DOI 10.1530/EJE-12-0143; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70; Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chuang KJ, 2011, OCCUP ENVIRON MED, V68, P64, DOI 10.1136/oem.2009.052704; Cohen BE, 2009, DIABETES RES CLIN PR, V86, P67, DOI 10.1016/j.diabres.2009.07.006; Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753; Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76; Flemming J, 2002, ITM AIR POLLUTION MO; Kahn SE, 2013, DIABETES CARE, V36, P4, DOI 10.2337/dc12-1526; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Malmqvist E, 2013, ENVIRON HEALTH PERSP, V121, P488, DOI 10.1289/ehp.1205736; Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961; Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344; Raaschou-Nielsen O, 2013, DIABETOLOGIA, V56, P36, DOI 10.1007/s00125-012-2698-7; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; STERN R, 2004, FORMULATION CRITERIA; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Teichert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083042; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P588, DOI 10.1097/00001648-200209000-00016; Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1	28	33	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91639	10.1371/journal.pone.0091639	http://dx.doi.org/10.1371/journal.pone.0091639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619127	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400110
J	Miyagawa, S; Sato, M; Sudo, T; Yamada, G; Iguchi, T				Miyagawa, S.; Sato, M.; Sudo, T.; Yamada, G.; Iguchi, T.			Unique roles of estrogen-dependent Pten control in epithelial cell homeostasis of mouse vagina	ONCOGENE			English	Article							GROWTH-FACTOR-I; NF-KAPPA-B; RECEPTOR-ALPHA; ENDOMETRIAL CANCER; UTERINE EPITHELIUM; SIGNALING PATHWAYS; MTOR INHIBITION; PTEN(+/-) MICE; ACTIVATION; DIETHYLSTILBESTROL	Numerous studies support a role of phosphatase and tensin homolog deleted from chromosome 10 (Pten) as a tumor suppressor gene that controls epithelial cell homeostasis to prevent tumor formation. Mouse vaginal epithelium cyclically exhibits cell proliferation and differentiation in response to estrogen and provides a unique model for analyzing homeostasis of stratified squamous epithelia. We analyzed vaginal epithelium-specific Pten conditional knockout (CKO) mice to provide new insights into Pten/phosphoinositide-3-kinase (PI3K)/Akt function. The vaginal epithelium of ovariectomized (OVX) mice ( control) was composed of 1-2 layers of cuboidal cells, whereas OVX CKO mice exhibited epithelial hyperplasia in the suprabasal cells with increased cell mass and mucin production. This is possibly due to misactivation of mammalian target of rapamycin and mitogen-activated protein kinase. Intriguingly, estrogen administration to OVX Pten CKO mice induced stratification and keratinized differentiation in the vaginal epithelium, as in estrogen-treated controls. We found that Pten is exclusively expressed in the suprabasal cells in the absence of estrogens, whereas estrogen administration induced Pten expression in the basal cells. This suggests that Pten acts to prevent excessive cell proliferation as in the case of other squamous tissues. Thus, Pten exhibits a dual role on the control of vaginal homeostasis, depending on whether estrogens are present or absent. Our results provide new insights into how Pten functions in tissue homeostasis.	[Miyagawa, S.; Sato, M.; Iguchi, T.] Grad Univ Adv Studies, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Natl Inst Nat Sci, Okazaki, Aichi 4448787, Japan; [Miyagawa, S.; Sato, M.; Iguchi, T.] Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Sudo, T.] Hyogo Canc Ctr, Sect Translat Res, Akashi, Hyogo, Japan; [Sudo, T.] Hyogo Canc Ctr, Dept Gynecol Oncol, Akashi, Hyogo, Japan; [Yamada, G.] Wakayama Med Univ, Inst Adv Med, Dept Dev Genet, Wakayama, Wakayama, Japan; [Yamada, G.] Wakayama Med Univ, Inst Adv Med, Lab Anim Ctr, Wakayama, Wakayama, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Hyogo Cancer Center; Hyogo Cancer Center; Wakayama Medical University; Wakayama Medical University	Iguchi, T (corresponding author), Grad Univ Adv Studies, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Natl Inst Nat Sci, Okazaki, Aichi 4448787, Japan.	taisen@nibb.ac.jp	Iguchi, Taisen/AAL-4225-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	We thank Dr J Takeda, Osaka University, Suita, Japan, for providing K5-Cre mice. We also thank Dr Y Mikami, Kyoto University, Kyoto, Japan, and Dr Bruce Blumberg, University of California, Irvine, CA, USA, for their support. This study was supported by Grant-in-Aid for Young Scientists B, Grant-in-Aid for Scientific Research B from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Health Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan.	Blanco Veronica, 2006, Med Oral Patol Oral Cir Bucal, V11, pE12; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Buckanan DL, 1998, ENDOCRINOLOGY, V139, P4345, DOI 10.1210/en.139.10.4345; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Ebrahim S, 2001, GYNECOL ONCOL, V80, P89, DOI 10.1006/gyno.2000.5963; GHAHARY A, 1990, MOL ENDOCRINOL, V4, P191, DOI 10.1210/mend-4-2-191; GIMENEZCONTI IB, 1994, DIFFERENTIATION, V56, P143, DOI 10.1007/s002580050031; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; Joshi A, 2012, AM J PATHOL, V180, P2536, DOI 10.1016/j.ajpath.2012.03.006; Joshi A, 2011, EXP CELL RES, V317, P1580, DOI 10.1016/j.yexcr.2011.03.006; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Leao JC, 2005, ORAL SURG ORAL MED O, V99, P569, DOI 10.1016/j.tripleo.2004.08.032; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; McCluggage WG, 2001, INT J GYNECOL PATHOL, V20, P399, DOI 10.1097/00004347-200110000-00015; Memarzadeh S, 2010, P NATL ACAD SCI USA, V107, P17298, DOI 10.1073/pnas.1012548107; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Miyagawa S, 2004, J MOL ENDOCRINOL, V32, P663, DOI 10.1677/jme.0.0320663; Miyagawa S, 2004, ONCOGENE, V23, P340, DOI 10.1038/sj.onc.1207207; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Mudhar HS, 2001, INT J GYNECOL PATHOL, V20, P204, DOI 10.1097/00004347-200104000-00016; NELSON KG, 1994, CELL GROWTH DIFFER, V5, P595; NELSON KG, 1991, P NATL ACAD SCI USA, V88, P21, DOI 10.1073/pnas.88.1.21; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; OZAWA S, 1991, CANCER LETT, V58, P167, DOI 10.1016/0304-3835(91)90096-Z; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; PLATZ CE, 1995, CANCER, V75, P270, DOI 10.1002/1097-0142(19950101)75:1+<270::AID-CNCR2820751312>3.0.CO;2-D; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Squarize CH, 2008, CANCER RES, V68, P7066, DOI 10.1158/0008-5472.CAN-08-0922; Suzuki A, 2003, CANCER RES, V63, P674; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986	45	8	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1035	1043		10.1038/onc.2014.62	http://dx.doi.org/10.1038/onc.2014.62			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632614				2022-12-25	WOS:000350121300009
J	Masuda, T; Wahlin, K; Wan, J; Hu, JF; Maruotti, J; Yang, X; Iacovelli, J; Wolkow, N; Kist, R; Dunaief, JL; Qian, J; Zack, DJ; Esumi, N				Masuda, Tomohiro; Wahlin, Karl; Wan, Jun; Hu, Jianfei; Maruotti, Julien; Yang, Xue; Iacovelli, Jared; Wolkow, Natalie; Kist, Ralf; Dunaief, Joshua L.; Qian, Jiang; Zack, Donald J.; Esumi, Noriko			Transcription Factor SOX9 Plays a Key Role in the Regulation of Visual Cycle Gene Expression in the Retinal Pigment Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eye; Gene Expression; Gene Regulation; MicroRNA; Transcription; SOX9; Retinal Pigment Epithelium; Visual Cycle	GLIAL-CELL DEVELOPMENT; MYELIN PROTEIN ZERO; IN-VIVO; PHOTORECEPTOR DEGENERATION; VERTEBRATE RETINA; BEST1 EXPRESSION; DOWN-REGULATION; MESSENGER-RNA; MOUSE MODEL; STEM-CELLS	Background: The visual cycle is an enzymatic cascade that regenerates the visual chromophore. Results: Visual cycle gene expression is regulated by SOX9 in combination with OTX2 or LHX2 and can be modulated by common microRNAs. Conclusion: A core transcriptional network involving SOX9 regulates visual cycle genes. Significance: Understanding visual cycle gene regulation may have implications for treating retinal degenerative diseases. The retinal pigment epithelium (RPE) performs specialized functions to support retinal photoreceptors, including regeneration of the visual chromophore. Enzymes and carrier proteins in the visual cycle function sequentially to regenerate and continuously supply 11-cis-retinal to retinal photoreceptor cells. However, it is unknown how the expression of the visual cycle genes is coordinated at the transcriptional level. Here, we show that the proximal upstream regions of six visual cycle genes contain chromatin-accessible sex-determining region Y box (SOX) binding sites, that SOX9 and LIM homeobox 2 (LHX2) are coexpressed in the nuclei of mature RPE cells, and that SOX9 acts synergistically with orthodenticle homeobox 2 (OTX2) to activate the RPE65 and retinaldehyde binding protein 1 (RLBP1) promoters and acts synergistically with LHX2 to activate the retinal G protein-coupled receptor (RGR) promoter. ChIP reveals that SOX9 and OTX2 bind to the promoter regions of RPE65, RLBP1, and RGR and that LHX2 binds to those of RPE65 and RGR in bovine RPE. ChIP with human fetal RPE cells shows that SOX9 and OTX2 also bind to the human RPE65, RLBP1, and RGR promoters. Conditional inactivation of Sox9 in mouse RPE results in reduced expression of several visual cycle genes, most dramatically Rpe65 and Rgr. Furthermore, bioinformatic analysis predicts that multiple common microRNAs (miRNAs) regulate visual cycle genes, and cotransfection of miRNA mimics with luciferase reporter constructs validated some of the predicted miRNAs. These results implicate SOX9 as a key regulator of visual cycle genes, reveal for the first time the functional role of LHX2 in the RPE, and suggest the possible regulation of visual cycle genes by common miRNAs.	[Masuda, Tomohiro; Wahlin, Karl; Wan, Jun; Hu, Jianfei; Maruotti, Julien; Yang, Xue; Qian, Jiang; Zack, Donald J.; Esumi, Noriko] Johns Hopkins Univ, Wilmer Eye Inst, Sch Med, Baltimore, MD 21231 USA; [Iacovelli, Jared; Wolkow, Natalie; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Kist, Ralf] Newcastle Univ, Sch Dent Sci, Ctr Oral Hlth Res, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; [Zack, Donald J.] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Johns Hopkins Univ, Dept Mol Biol, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Johns Hopkins Univ, Dept Genet, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Johns Hopkins Univ, Inst Med Genet, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Univ Paris 06, Inst Vis, F-75012 Paris, France	Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; Newcastle University - UK; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite	Esumi, N (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Sch Med, Smith Bldg,Rm 3041,400 N Broadway, Baltimore, MD 21231 USA.	nesumi1@jhmi.edu	Wan, Jun/H-7132-2013; Kist, Ralf/B-4982-2008; Yang, xue/G-3626-2016; Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562; Kist, Ralf/0000-0003-3729-5693; Wan, Jun/0000-0001-9286-6562; Wolkow, Natalie/0000-0003-1524-115X; Zack, Don/0000-0002-7966-1973; Jianfei, Hu/0000-0001-8458-6683; Wahlin, Karl/0000-0002-0494-8304	National Institutes of Health [EY016398, EY009769, EY001765]; Foundation Fighting Blindness; Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016398, P30EY001765, R01EY009769, R01EY015240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016398 (to N.E.) and EY009769 (to (D.J.Z.) and National Institutes of Health Core Grant EY001765 (to the Wilmer Eye Institute). This work was also supported by Foundation Fighting Blindness, by an award from the Wilmer Pooled Professor Research Fund, by unrestricted funds from Research to Prevent Blindness, Inc., and by gifts from Mr. and Mrs. Robert and Clarice Smith and the Guerrieri Family Foundation.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beby F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011673; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bhutto IA, 2004, INVEST OPHTH VIS SCI, V45, P1544, DOI 10.1167/iovs.03-0862; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; de Melo J, 2012, P NATL ACAD SCI USA, V109, P4657, DOI 10.1073/pnas.1107488109; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Gamm DM, 2008, INVEST OPHTH VIS SCI, V49, P788, DOI 10.1167/iovs.07-0777; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Hu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037224; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; Kennedy BN, 1998, J BIOL CHEM, V273, P5591, DOI 10.1074/jbc.273.10.5591; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7; Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Maruotti J, 2013, STEM CELL TRANSL MED, V2, P341, DOI 10.5966/sctm.2012-0106; Maruotti J, 2012, PIGM CELL MELANOMA R, V25, P641, DOI 10.1111/j.1755-148X.2012.01033.x; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Mead TJ, 2013, NUCLEIC ACIDS RES, V41, P4459, DOI 10.1093/nar/gkt140; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miller AM, 2010, J COMP NEUROL, V518, P4825, DOI 10.1002/cne.22497; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nicoletti A, 1998, INVEST OPHTH VIS SCI, V39, P637; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Porter FD, 1997, DEVELOPMENT, V124, P2935; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vazquez-Chona FR, 2009, INVEST OPHTH VIS SCI, V50, P3996, DOI 10.1167/iovs.08-3189; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vogel JS, 2007, INVEST OPHTH VIS SCI, V48, P3872, DOI 10.1167/iovs.06-1523; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhang L, 2013, MOL VIS, V19, P1371; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	70	35	36	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12908	12921		10.1074/jbc.M114.556738	http://dx.doi.org/10.1074/jbc.M114.556738			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634209	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000335581400059
J	Stemberk, V; Jones, RPO; Moroz, O; Atkin, KE; Edwards, AM; Turkenburg, JP; Leech, AP; Massey, RC; Potts, JR				Stemberk, Vaclav; Jones, Richard P. O.; Moroz, Olga; Atkin, Kate E.; Edwards, Andrew M.; Turkenburg, Johan P.; Leech, Andrew P.; Massey, Ruth C.; Potts, Jennifer R.			Evidence for Steric Regulation of Fibrinogen Binding to Staphylococcus aureus Fibronectin-binding Protein A ( FnBPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrinogen; Fibronectin; Isothermal Titration Calorimetry; Staphylococcus aureus; Surface Plasmon Resonance (SPR); X-ray Crystallography; FnBPA	CLUMPING FACTOR; CRYSTAL-STRUCTURE; GAMMA-CHAIN; AFFINITY; MSCRAMM; SURFACE; DOMAIN; MODEL; VALIDATION; REFINEMENT	Background:Staphylococcus aureus fibronectin-binding protein A (FnBPA) binds fibronectin and fibrinogen at adjacent sites. Results: The fibrinogen-binding mechanism is similar but not identical to homologous bacterial proteins. Ternary complex formation by intact fibronectin and fibrinogen on adjacent FnBPA sites could not be demonstrated. Conclusion: Fibrinogen binding is sterically regulated by fibronectin binding. Significance: Steric regulation might result in targeting of S. aureus to fibrin clots. The adjacent fibrinogen (Fg)- and fibronectin (Fn)-binding sites on Fn-binding protein A (FnBPA), a cell surface protein from Staphylococcus aureus, are implicated in the initiation and persistence of infection. FnBPA contains a single Fg-binding site (that also binds elastin) and multiple Fn-binding sites. Here, we solved the structure of the N2N3 domains containing the Fg-binding site of FnBPA in the apo form and in complex with a Fg peptide. The Fg binding mechanism is similar to that of homologous bacterial proteins but without the requirement for latch strand residues. We show that the Fg-binding sites and the most N-terminal Fn-binding sites are nonoverlapping but in close proximity. Although Fg and a subdomain of Fn can form a ternary complex on an FnBPA protein construct containing a Fg-binding site and single Fn-binding site, binding of intact Fn appears to inhibit Fg binding, suggesting steric regulation. Given the concentrations of Fn and Fg in the plasma, this mechanism might result in targeting of S. aureus to fibrin-rich thrombi or elastin-rich tissues.	[Stemberk, Vaclav; Jones, Richard P. O.; Atkin, Kate E.; Leech, Andrew P.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Moroz, Olga; Turkenburg, Johan P.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Edwards, Andrew M.; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of York - UK; University of York - UK; University of Bath	Potts, JR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jennifer.potts@york.ac.uk	Massey, Ruth/AAT-6415-2021	Massey, Ruth/0000-0002-8154-4039; Moroz, Olga/0000-0002-0354-6119; Turkenburg, Johan/0000-0001-6992-6838; Edwards, Andrew/0000-0002-7173-7355	Biotechnology and Biological Sciences Research Council; MRC [MR/J006874/1] Funding Source: UKRI; British Heart Foundation [PG/09/079/28008, FS/07/034/22969, FS/12/36/29588] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was also supported by the Biotechnology and Biological Sciences Research Council through a doctoral training grant.	Ariens RAS, 2013, J THROMB HAEMOST, V11, P294, DOI 10.1111/jth.12229; Banachewicz W, 2011, P NATL ACAD SCI USA, V108, P5596, DOI 10.1073/pnas.1101752108; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BLUMENSTEIN M, 1992, BIOCHEMISTRY-US, V31, P10692, DOI 10.1021/bi00159a008; Bonsor D, 2006, ORG BIOMOL CHEM, V4, P1252, DOI 10.1039/b517338h; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Drenth Jan, 2007, P1, DOI 10.1007/0-387-33746-6_1; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Floyd CN, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012007; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Ganesh V. K., 2008, PLOS PATHOG, V4; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Matsuda M, 1978, Ann N Y Acad Sci, V312, P74, DOI 10.1111/j.1749-6632.1978.tb16794.x; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MAYO KH, 1990, BIOCHEMISTRY-US, V29, P3277, DOI 10.1021/bi00465a019; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	58	21	22	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12842	12851		10.1074/jbc.M113.543546	http://dx.doi.org/10.1074/jbc.M113.543546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627488	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000335581400053
J	Chesarino, NM; McMichael, TM; Hach, JC; Yount, JS				Chesarino, Nicholas M.; McMichael, Temet M.; Hach, Jocelyn C.; Yount, Jacob S.			Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 ( IFITM3) Dually Regulates Its Endocytosis and Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Influenza Virus; Innate Immunity; Interferon; Phosphorylation; Phosphotyrosine; Ubiquitination; IFITM; IFITM3; Posttranslational Modification	WEST NILE VIRUS; S-PALMITOYLATION; DENGUE VIRUS; NEGATIVE REGULATION; INFLUENZA; FAMILY; LOCALIZATION; REPLICATION; RESISTANCE; PROTEOMICS	Background: IFITM3 restricts the fusion of viruses within endolysosomes. Results: Phosphorylation of IFITM3 on Tyr(20) blocks IFITM3 endocytosis and ubiquitination. Conclusion: Tyr(20) of IFITM3 is part of a YXX endocytosis signal and has a dual role in regulating IFITM3 ubiquitination. Significance: Identifying mechanisms regulating IFITM3 trafficking and activity is crucial for understanding and manipulating IFITM3 biology for combating virus infections. Interferon-inducible transmembrane protein 3 (IFITM3) is essential for innate defense against influenza virus in mice and humans. IFITM3 localizes to endolysosomes where it prevents virus fusion, although mechanisms controlling its trafficking to this cellular compartment are not fully understood. We determined that both mouse and human IFITM3 are phosphorylated by the protein-tyrosine kinase FYN on tyrosine 20 (Tyr(20)) and that mouse IFITM3 is also phosphorylated on the non-conserved Tyr(27). Phosphorylation led to a cellular redistribution of IFITM3, including plasma membrane accumulation. Mutation of Tyr(20) caused a similar redistribution of IFITM3 and resulted in decreased antiviral activity against influenza virus, whereas Tyr(27) mutation of mouse IFITM3 showed minimal effects on localization or activity. Using FYN knockout cells, we also found that IFITM3 phosphorylation is not a requirement for its antiviral activity. Together, these results indicate that Tyr(20) is part of an endocytosis signal that can be blocked by phosphorylation or by mutation of this residue. Further mutagenesis narrowed this endocytosis-controlling region to four residues conforming to a YXX phi (where X is any amino acid and phi is Val, Leu, or Ile) endocytic motif that, when transferred to CD4, resulted in its internalization from the cell surface. Additionally, we found that phosphorylation of IFITM3 by FYN and mutagenesis of Tyr(20) both resulted in decreased IFITM3 ubiquitination. Overall, these results suggest that modification of Tyr(20) may serve in a cellular checkpoint controlling IFITM3 trafficking and degradation and demonstrate the complexity of posttranslational regulation of IFITM3.	[Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,790 Biomed Res Tower, Columbus, OH 43210 USA.	yount.37@osu.edu	Chesarino, Nicholas/AAC-3725-2020; Yount, Jacob/F-9905-2014	Chesarino, Nicholas/0000-0002-3582-8508; Yount, Jacob/0000-0002-6128-4575	NIAID, National Institutes of Health [R00AI095348]; Ohio State University Public Health Preparedness for Infectious Disease program; Ohio State University Systems and Integrative Biology Training Program (NIGMS, National Institutes of Health) [T32GM068412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI095348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ohio State University Public Health Preparedness for Infectious Disease program; Ohio State University Systems and Integrative Biology Training Program (NIGMS, National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIAID, National Institutes of Health Grant R00AI095348 (to J. S. Y.). This work was also supported by the Ohio State University Public Health Preparedness for Infectious Disease program.; Supported by The Ohio State University Systems and Integrative Biology Training Program (NIGMS, National Institutes of Health Grant T32GM068412).	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Ghosh AK, 2004, J BIOL CHEM, V279, P36132, DOI 10.1074/jbc.M404189200; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shan Z, 2013, J BIOL CHEM, V288, P35093, DOI 10.1074/jbc.M113.511949; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2012, BIOORGAN MED CHEM, V20, P650, DOI 10.1016/j.bmc.2011.03.062; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	32	83	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11986	11992		10.1074/jbc.M114.557694	http://dx.doi.org/10.1074/jbc.M114.557694			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627473	Green Published, hybrid			2022-12-25	WOS:000335010600037
J	Berrabah, F; Bourcy, M; Cayrel, A; Eschstruth, A; Mondy, S; Ratet, P; Gourion, B				Berrabah, Fathi; Bourcy, Marie; Cayrel, Anne; Eschstruth, Alexis; Mondy, Samuel; Ratet, Pascal; Gourion, Benjamin			Growth Conditions Determine the DNF2 Requirement for Symbiosis	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; RHIZOBIUM-MELILOTI; ARABIDOPSIS-THALIANA; PHOSPHOLIPASE-C; SALICYLIC-ACID; PLANT; RESISTANCE; NODULATION; EXPRESSION; INFECTION	Rhizobia and legumes are able to interact in a symbiotic way leading to the development of root nodules. Within nodules, rhizobia fix nitrogen for the benefit of the plant. These interactions are efficient because spectacularly high densities of nitrogen fixing rhizobia are maintained in the plant cells. DNF2, a Medicago truncatula gene has been described as required for nitrogen fixation, bacteroid's persistence and to prevent defense-like reactions in the nodules. This manuscript shows that a Rhizobium mutant unable to differentiate is not sufficient to trigger defense-like reactions in this organ. Furthermore, we show that the requirement of DNF2 for effective symbiosis can be overcome by permissive growth conditions. The dnf2 knockout mutants grown in vitro on agarose or Phytagel as gelling agents are able to produce nodules fixing nitrogen with the same efficiency as the wild-type. However, when agarose medium is supplemented with the plant defense elicitor ulvan, the dnf2 mutant recovers the fix(-) phenotype. Together, our data show that plant growth conditions impact the gene requirement for symbiotic nitrogen fixation and suggest that they influence the symbiotic suppression of defense reactions in nodules.	[Berrabah, Fathi; Bourcy, Marie; Cayrel, Anne; Eschstruth, Alexis; Mondy, Samuel; Ratet, Pascal; Gourion, Benjamin] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ratet, P (corresponding author), CNRS, Inst Sci Vegetal, Gif Sur Yvette, France.	pascal.ratet@isv.cnrs-gif.fr	Mondy, Samuel/AAG-8805-2019; Cayrel, Anne/A-5257-2016; Ratet, Pascal/GPP-3654-2022; Gourion, Benjamin/AAG-9063-2019	Mondy, Samuel/0000-0002-9203-6398; Ratet, Pascal/0000-0002-8621-1495; Gourion, Benjamin/0000-0001-5768-6961; Fathi, Berrabah/0000-0002-5710-8421	French State grant [ANR-10-LABX-0040-SPS]; French National Research Agency under an Investments for the Future program [ANR-11-IDEX-0003-02]; Centre National de la Recherche Scientifique (CNRS); grant Agence Nationale de la Recherche (ANR) Blanc International SVSE [6.2010.1]; French Ministry of Research	French State grant; French National Research Agency under an Investments for the Future program(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); grant Agence Nationale de la Recherche (ANR) Blanc International SVSE(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work has benefited from a French State grant (reference ANR-10-LABX-0040-SPS) managed by the French National Research Agency under an Investments for the Future program (reference noANR-11-IDEX-0003-02). This work was supported by the Centre National de la Recherche Scientifique (CNRS) and the grant Agence Nationale de la Recherche (ANR) Blanc International SVSE 6.2010.1 (LEGUMICS) to PR. MB was supported by a PhD fellowship from the French Ministry of Research. This work has benefited from the facilities and expertise of the Imagif Cell Biology Unit of the Gif campus (www.imagif.cnrs.fr) which is supported by the Conseil General de l'Essonne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bourcy M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23915; Bourcy M, 2013, NEW PHYTOL, V197, P1250, DOI 10.1111/nph.12091; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Cluzet S, 2004, PLANT CELL ENVIRON, V27, P917, DOI 10.1111/j.1365-3040.2004.01197.x; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Gellatly SA, 2012, BIOCHEM BIOPH RES CO, V424, P651, DOI 10.1016/j.bbrc.2012.06.079; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Gough C, 2013, TRENDS PLANT SCI; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Hoffmann B, 1997, MOL PLANT MICROBE IN, V10, P307, DOI 10.1094/MPMI.1997.10.3.307; HOWIESON JG, 1986, AUST J AGR RES, V37, P55, DOI 10.1071/AR9860055; Jaulneau V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525291; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KING EO, 1954, J LAB CLIN MED, V44, P301; KOCH B, 1966, PLANT PHYSIOL, V41, P1748, DOI 10.1104/pp.41.10.1748; KONDOROSI E, 1984, MOL GEN GENET, V193, P445, DOI 10.1007/BF00382082; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Limpens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064377; Lopez-Gomez M, 2012, J EXP BOT, V63, P393, DOI 10.1093/jxb/err291; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Menard R, 2004, PLANT CELL, V16, P3020, DOI 10.1105/tpc.104.024968; Mithofer A, 2002, TRENDS PLANT SCI, V7, P440, DOI 10.1016/S1360-1385(02)02336-1; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; Nars A, 2013, PLANT CELL REP, V32, P489, DOI 10.1007/s00299-012-1380-3; Paulert R, 2010, PLANT PATHOL, V59, P634, DOI 10.1111/j.1365-3059.2010.02300.x; Peleg-Grossman S, 2012, PLANT SIGNAL BEHAV, V7, P409, DOI 10.4161/psb.19217; Peleg-Grossman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008399; Pislariu CI, 2007, PLANT PHYSIOL, V144, P682, DOI 10.1104/pp.106.092494; Pislariu CI, 2012, PLANT PHYSIOL, V159, P1686, DOI 10.1104/pp.112.197061; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Reguera M, 2010, J PLANT PHYSIOL, V167, P625, DOI 10.1016/j.jplph.2009.11.017; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Rupwate SD, 2012, PLANT SIGNAL BEHAV, V7, P1281, DOI 10.4161/psb.21436; Samac DA, 2011, MOL PLANT PATHOL, V12, P786, DOI [10.1111/j.1364-3703.2011.00712.x, 10.1111/J.1364-3703.2011.00712.X]; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; Welchen E, 2005, PLANT PHYSIOL, V139, P88, DOI 10.1104/pp.105.065920; Weller DM, 2012, PHYTOPATHOLOGY, V102, P403, DOI 10.1094/PHYTO-08-11-0222; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	56	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91866	10.1371/journal.pone.0091866	http://dx.doi.org/10.1371/journal.pone.0091866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632747	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400111
J	Chaves, LD; Bao, L; Wang, Y; Chang, A; Haas, M; Quigg, RJ				Chaves, Lee Daniel; Bao, Lihua; Wang, Ying; Chang, Anthony; Haas, Mark; Quigg, Richard John			Loss of CD11b Exacerbates Murine Complement-Mediated Tubulointerstitial Nephritis	PLOS ONE			English	Article							TISSUE-RESIDENT MACROPHAGES; ACUTE-RENAL-FAILURE; DENDRITIC CELLS; ALTERNATIVE PATHWAY; MONOCLONAL-ANTIBODY; ACTIVATION; GLOMERULONEPHRITIS; INFLAMMATION; KIDNEY; MICE	Acute complement activation occurs in the tubulointerstitium (TI) of kidneys transplanted from Crry(-/-)C3(-/-) mice into complement-sufficient wildtype mice, followed by marked inflammatory cell infiltration, tubular damage and interstitial fibrosis. We postulated iC3b-CD11b interactions were critical in this TI nephritis model. We transplanted Crry(-/-)C3(-/-) mouse kidneys into CD11b(-/-) and wildtype C57BL/6 mice. Surprisingly, there was greater inflammation in Crry(-/-)C3(-/-) kidneys in CD11b(-/-) recipients compared to those in wildtype hosts. Kidneys in CD11b(-/-) recipients had large numbers of CD11b(-)Ly6C(hi)CCR2(hi)F4/80(+) cells consistent with inflammatory (M1) macrophages recruited from circulating monocytes of the host CD11b(-/-) animal. There was also an expanded population of CD11b(+)CD11c(+)Ly6C(-)F4/80(hi) cells. Since these cells were CD11b(+), they must have originated from the transplanted kidney; their surface protein expression and appearance within the kidney were consistent with the intrinsic renal mononuclear cellular population. These cells were markedly expanded relative to all relevant controls, including the contralateral donor kidney and Crry(-/-)C3(-/-) mouse kidneys in CD11b(+/+) wildtype recipients. Direct evidence for their in situ proliferation was the presence of nuclear Ki67 and PCNA in CD11b(+)F4/80(+) cells. Thus, in this experimental model in which there is unrestricted C3 activation, CD11b(+) monocytes limit their own infiltration into the kidney and prevent proliferation of endogenous mononuclear cells. This suggests a role for outside-in iC3b-CD11b signals in limiting intrinsic organ inflammation.	[Chaves, Lee Daniel; Quigg, Richard John] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Div Nephrol, Buffalo, NY 14260 USA; [Bao, Lihua; Wang, Ying] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Chang, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Haas, Mark] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Chicago; University of Chicago; Cedars Sinai Medical Center	Quigg, RJ (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Div Nephrol, Buffalo, NY 14260 USA.	rquigg@buffalo.edu		Chang, Anthony/0000-0002-6877-5510	National Institutes of Health (NIH) [R01DK041873]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant R01DK041873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2012, KIDNEY INT, V82, P961, DOI 10.1038/ki.2012.249; Bao LH, 2007, J AM SOC NEPHROL, V18, P811, DOI 10.1681/ASN.2006101176; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Barbour TD, 2013, NEPHROL DIAL TRANSPL, V28, P1685, DOI 10.1093/ndt/gfs430; Berger M, 2002, J LEUKOCYTE BIOL, V71, P798; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; FUNABASHI K, 1994, IMMUNOLOGY, V81, P444; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gottschalk C, 2013, J AM SOC NEPHROL, V24, P543, DOI 10.1681/ASN.2012101022; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; ICHIDA S, 1994, KIDNEY INT, V46, P89, DOI 10.1038/ki.1994.247; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342; KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; LI B, 1993, J IMMUNOL, V151, P4295; Lukacs-Kornek V, 2008, J IMMUNOL, V180, P706, DOI 10.4049/jimmunol.180.2.706; Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2; Means TK, 2010, NAT IMMUNOL, V11, P691, DOI 10.1038/ni0810-691; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naik A, 2013, SEMIN NEPHROL, V33, P575, DOI 10.1016/j.semnephrol.2013.08.008; NATH KA, 1985, J CLIN INVEST, V76, P667, DOI 10.1172/JCI112020; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; NOMURA A, 1995, J CLIN INVEST, V96, P2348, DOI 10.1172/JCI118291; Quigg RJ, 1998, KIDNEY INT, V53, P320, DOI 10.1046/j.1523-1755.1998.00723.x; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Shah SN, 2009, AM J KIDNEY DIS, V54, P270, DOI 10.1053/j.ajkd.2009.02.014; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Thurman JM, 2005, KIDNEY INT, V67, P524, DOI 10.1111/j.1523-1755.2005.67109.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Thurman JM, 2006, J AM SOC NEPHROL, V17, P707, DOI 10.1681/ASN.2005070698; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498	45	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92051	10.1371/journal.pone.0092051	http://dx.doi.org/10.1371/journal.pone.0092051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632830	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400135
J	Ghorbaniaghdam, A; Chen, JK; Henry, O; Jolicoeur, M				Ghorbaniaghdam, Atefeh; Chen, Jingkui; Henry, Olivier; Jolicoeur, Mario			Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform	PLOS ONE			English	Article							RECOMBINANT PROTEIN-PRODUCTION; YEAST PYRUVATE-CARBOXYLASE; HAMSTER OVARY CELLS; PROTEOMIC ANALYSIS; FLUX ANALYSIS; HIGH PRODUCTIVITY; MYELOMA CELLS; ENERGY-CHARGE; EXPRESSION; CULTURE	Monoclonal antibody producing Chinese hamster ovary (CHO) cells have been shown to undergo metabolic changes when engineered to produce high titers of recombinant proteins. In this work, we have studied the distinct metabolism of CHO cell clones harboring an efficient inducible expression system, based on the cumate gene switch, and displaying different expression levels, high and low productivities, compared to that of the parental cells from which they were derived. A kinetic model for CHO cell metabolism was further developed to include metabolic regulation. Model calibration was performed using intracellular and extracellular metabolite profiles obtained from shake flask batch cultures. Model simulations of intracellular fluxes and ratios known as biomarkers revealed significant changes correlated with clonal variation but not to the recombinant protein expression level. Metabolic flux distribution mostly differs in the reactions involving pyruvate metabolism, with an increased net flux of pyruvate into the tricarboxylic acid (TCA) cycle in the high-producer clone, either being induced or non-induced with cumate. More specifically, CHO cell metabolism in this clone was characterized by an efficient utilization of glucose and a high pyruvate dehydrogenase flux. Moreover, the high-producer clone shows a high rate of anaplerosis from pyruvate to oxaloacetate, through pyruvate carboxylase and from glutamate to a-ketoglutarate, through glutamate dehydrogenase, and a reduced rate of cataplerosis from malate to pyruvate, through malic enzyme. Indeed, the increase of flux through pyruvate carboxylase was not driven by an increased anabolic demand. It is in fact linked to an increase of the TCA cycle global flux, which allows better regulation of higher redox and more efficient metabolic states. To the best of our knowledge, this is the first time a dynamic in silico platform is proposed to analyze and compare the metabolomic behavior of different CHO clones.	[Ghorbaniaghdam, Atefeh; Chen, Jingkui; Jolicoeur, Mario] Ecole Polytech, Canada Res Chair Appl Metab Engn, Montreal, PQ H3C 3A7, Canada; [Ghorbaniaghdam, Atefeh; Chen, Jingkui; Henry, Olivier; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal	Jolicoeur, M (corresponding author), Ecole Polytech, Canada Res Chair Appl Metab Engn, Montreal, PQ H3C 3A7, Canada.	mario.jolicoeur@polymtl.ca			National Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Monoclonal Antibody Network (MabNet); Canadian Foundation for Innovation (CFI)	National Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Monoclonal Antibody Network (MabNet); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	The National Sciences and Engineering Research Council of Canada (NSERC) funded this research project through the Canadian Monoclonal Antibody Network (MabNet), in which MJ is a member. The Canadian Foundation for Innovation (CFI) has funded the analytical equipments used in this work as well as their operation. Viropro International Inc. (Montreal, Quebec, Canada) has only provided the cell lines used in this study. The funders, as well as Viropro International Inc., had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Alete DE, 2005, PROTEOMICS, V5, P4689, DOI 10.1002/pmic.200500019; Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; BEBBINGTON CR, 1992, BIO-TECHNOL, V10, P169, DOI 10.1038/nbt0292-169; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bonarius HPJ, 1998, BIOTECHNOL BIOENG, V57, P447, DOI 10.1002/(SICI)1097-0290(19980220)57:4<447::AID-BIT8>3.3.CO;2-C; Chong WPK, 2012, BIOTECHNOL BIOENG, V109, P3103, DOI 10.1002/bit.24580; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; CLARKE GD, 1965, BRIT J CANCER, V19, P840, DOI 10.1038/bjc.1965.97; Dahodwala H, 2012, CYTOTECHNOLOGY, V64, P27, DOI 10.1007/s10616-011-9388-z; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Davies SL, 2013, BIOTECHNOL BIOENG, V110, P260, DOI 10.1002/bit.24621; Dean J, 2013, BIOTECHNOL BIOENG, V110, P1735, DOI 10.1002/bit.24826; Dell'mour M, 2010, J SEP SCI, V33, P911, DOI 10.1002/jssc.200900743; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Dorka P, 2009, BIOPROC BIOSYST ENG, V32, P183, DOI 10.1007/s00449-008-0236-2; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Eppink MHM, 2009, BIOPHARM INT, P32; Europa AF, 2006, BIOTECHNOL BIOENG, V67, P25; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Gaillet B, 2010, BIOTECHNOL BIOENG, V106, P203, DOI 10.1002/bit.22698; GARREAU H, 1972, BIOCHIMIE, V54, P1103, DOI 10.1016/S0300-9084(72)80013-0; Ghorbaniaghdam A, 2013, BIOPROC BIOSYST ENG, V36, P469, DOI 10.1007/s00449-012-0804-3; Goudar C, 2010, METAB ENG, V12, P138, DOI 10.1016/j.ymben.2009.10.007; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Harper ME, 2002, J ANIM SCI, V80, P90; Hayduk EJ, 2005, BIOTECHNOL BIOENG, V90, P354, DOI 10.1002/bit.20438; Hayduk EJ, 2004, ELECTROPHORESIS, V25, P2545, DOI 10.1002/elps.200406010; HEINRICH R, 1977, PROG BIOPHYS MOL BIO, V32, P1; Heyland J, 2011, J BIOTECHNOL, V155, P178, DOI 10.1016/j.jbiotec.2011.06.016; Heyland J, 2011, BIOTECHNOL BIOENG, V108, P1942, DOI 10.1002/bit.23114; HUNDAL HS, 1989, J PHYSIOL-LONDON, V408, P93, DOI 10.1113/jphysiol.1989.sp017449; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; KONRAD MW, 1977, CELL, V10, P305, DOI 10.1016/0092-8674(77)90224-0; Lamboursain L, 2002, BIOTECHNOL PROGR, V18, P1377, DOI 10.1021/bp015511j; Lee YY, 2009, J BIOTECHNOL, V143, P34, DOI 10.1016/j.jbiotec.2009.05.013; Lehninger A. L., 1977, BIOCHEMISTRY; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-41; Link T, 2004, J BIOTECHNOL, V110, P51, DOI 10.1016/j.jbiotec.2003.12.008; Mailier J, 2011, BIOTECHNOL BIOENG, V108, P1108, DOI 10.1002/bit.23030; Martens D. E., 2007, SYSTEMS BIOL, P275; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mo ML, 2009, BMC SYSTEMS BIOL, V25, P3; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; Naderi S, 2011, BIOTECHNOL PROGR, V27, P1197, DOI 10.1002/btpr.647; Niklas J, 2011, BIOPROC BIOSYST ENG, V34, P533, DOI 10.1007/s00449-010-0502-y; Nissom PM, 2006, MOL BIOTECHNOL, V34, P125, DOI 10.1385/MB:34:2:125; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Oh MK, 2003, J CELL BIOCHEM, V90, P1068, DOI 10.1002/jcb.10712; Pavlou AK, 2005, EUR J PHARM BIOPHARM, V59, P389, DOI 10.1016/j.ejpb.2004.11.007; PETERSON JA, 1976, P NATL ACAD SCI USA, V73, P2056, DOI 10.1073/pnas.73.6.2056; Pincetich CA, 2005, COMP BIOCHEM PHYS C, V140, P103, DOI 10.1016/j.cca.2005.01.010; Preinerstorfer B, 2010, J CHROMATOGR A, V1217, P312, DOI 10.1016/j.chroma.2009.11.051; Pugin A, 1997, PLANT CELL, V9, P2077, DOI 10.1105/tpc.9.11.2077; Qian TX, 2004, ANAL BIOCHEM, V325, P77, DOI 10.1016/j.ab.2003.10.028; REICH JG, 1981, ENERGY METABOLISM CE; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Segel IH., 1993, ENZYME KINETICS BEHA; Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890; Seth G, 2007, BIOTECHNOL BIOENG, V97, P933, DOI 10.1002/bit.21234; Sheikholeslami Z, 2013, J BIOTECHNOL, V164, P469, DOI 10.1016/j.jbiotec.2013.01.025; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Stephanopoulos G., 1998, METAB ENG; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; WANG CS, 1977, EUR J BIOCHEM, V78, P569, DOI 10.1111/j.1432-1033.1977.tb11770.x; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021; Zamorano F., 2012, J BIOTECHNOL, P409; ZDZIENICKA MZ, 1985, SOMAT CELL MOLEC GEN, V11, P127, DOI 10.1007/BF01534701; Zomorrodi AR, 2012, METAB ENG, V14, P672, DOI 10.1016/j.ymben.2012.09.005	76	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90832	10.1371/journal.pone.0090832	http://dx.doi.org/10.1371/journal.pone.0090832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632968	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000332858400020
J	Li, XY; Zhang, LS; Wang, GJ				Li, Xiangyang; Zhang, Linshuang; Wang, Gejiao			Genomic Evidence Reveals the Extreme Diversity and Wide Distribution of the Arsenic-Related Genes in Burkholderiales	PLOS ONE			English	Article							HERMINIIMONAS-ARSENICOXYDANS; ALCALIGENES-FAECALIS; OXIDIZING BACTERIA; RICH ENVIRONMENTS; SEQUENCE; RESISTANCE; IDENTIFICATION; OXIDASE; METABOLISM; REDUCTASE	So far, numerous genes have been found to associate with various strategies to resist and transform the toxic metalloid arsenic (here, we denote these genes as "arsenic-related genes"). However, our knowledge of the distribution, redundancies and organization of these genes in bacteria is still limited. In this study, we analyzed the 188 Burkholderiales genomes and found that 95% genomes harbored arsenic-related genes, with an average of 6.6 genes per genome. The results indicated: a) compared to a low frequency of distribution for aio (arsenite oxidase) (12 strains), arr (arsenate respiratory reductase) (1 strain) and arsM (arsenite methytransferase)-like genes (4 strains), the ars (arsenic resistance system)-like genes were identified in 174 strains including 1,051 genes; b) 2/3 ars-like genes were clustered as ars operon and displayed a high diversity of gene organizations (68 forms) which may suggest the rapid movement and evolution for ars-like genes in bacterial genomes; c) the arsenite efflux system was dominant with ACR3 form rather than ArsB in Burkholderiales; d) only a few numbers of arsM and arrAB are found indicating neither As III biomethylation nor AsV respiration is the primary mechanism in Burkholderiales members; (e) the aio-like gene is mostly flanked with ars-like genes and phosphate transport system, implying the close functional relatedness between arsenic and phosphorus metabolisms. On average, the number of arsenic-related genes per genome of strains isolated from arsenic-rich environments is more than four times higher than the strains from other environments. Compared with human, plant and animal pathogens, the environmental strains possess a larger average number of arsenic-related genes, which indicates that habitat is likely a key driver for bacterial arsenic resistance.	[Li, Xiangyang; Zhang, Linshuang; Wang, Gejiao] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn	Li, Xiangyang/AAJ-3142-2020	Li, Xiangyang/0000-0003-1313-633X	National Natural Science Foundation of China [31010103903, 31170106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China 31010103903 and 31170106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Arsene-Ploetze F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000859; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Cai L, 2013, APPL MICROBIOL BIOT, V97, P9579, DOI 10.1007/s00253-012-4678-8; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Cavalca L, 2013, FUTURE MICROBIOL, V8, P753, DOI [10.2217/FMB.13.38, 10.2217/fmb.13.38]; Cleiss-Arnold J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-709; Dhuldhaj UP, 2013, REV ENVIRON CONTAM T, V224, P1, DOI 10.1007/978-1-4614-5882-1_1; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Escudero LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078890; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Heinrich-Salmeron A, 2011, APPL ENVIRON MICROB, V77, P4685, DOI 10.1128/AEM.02884-10; Huang YY, 2012, J BACTERIOL, V194, P1635, DOI 10.1128/JB.06814-11; Jackson CR, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-18; Jia Y, 2013, ENVIRON SCI TECHNOL, V47, P3141, DOI 10.1021/es303649v; Kang YS, 2012, ENVIRON MICROBIOL, V14, P3097, DOI 10.1111/j.1462-2920.2012.02881.x; Koechler S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-53; Kruger MC, 2013, APPL MICROBIOL BIOT, V97, P3827, DOI 10.1007/s00253-013-4838-5; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li XY, 2013, APPL MICROBIOL BIOT, V97, P6413, DOI 10.1007/s00253-013-5018-3; Li XY, 2012, J BACTERIOL, V194, P4473, DOI 10.1128/JB.00907-12; Li XY, 2012, J BACTERIOL, V194, P1243, DOI 10.1128/JB.06667-11; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; Muller D, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030053; Nagai F, 2009, INT J SYST EVOL MICR, V59, P1793, DOI 10.1099/ijs.0.002519-0; Oremland RS, 2009, GEOMICROBIOL J, V26, P522, DOI 10.1080/01490450903102525; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Phung LT, 2012, J BACTERIOL, V194, P5153, DOI 10.1128/JB.01185-12; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Plewniak F, 2013, MOL ECOL, V22, P4870, DOI 10.1111/mec.12432; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Shen ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058894; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trimble WL, 2012, J BACTERIOL, V194, P6355, DOI 10.1128/JB.01660-12; Villegas-Torres MF, 2011, INT BIODETER BIODEGR, V65, P147, DOI 10.1016/j.ibiod.2010.10.007; Wang LR, 2006, APPL ENVIRON MICROB, V72, P3738, DOI 10.1128/AEM.72.5.3738-3742.2006; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09; Weiss S, 2009, BIOCHIMIE, V91, P192, DOI 10.1016/j.biochi.2008.07.013; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005; Yin XX, 2011, PLANT PHYSIOL, V156, P1631, DOI 10.1104/pp.111.178947; Zargar K, 2012, ENVIRON MICROBIOL, V14, P1635, DOI 10.1111/j.1462-2920.2012.02722.x	54	39	40	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92236	10.1371/journal.pone.0092236	http://dx.doi.org/10.1371/journal.pone.0092236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632831	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400155
J	Skorheim, S; Lonjers, P; Bazhenov, M				Skorheim, Steven; Lonjers, Peter; Bazhenov, Maxim			A Spiking Network Model of Decision Making Employing Rewarded STDP	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; TOTAL SYNAPTIC WEIGHT; DENDRITIC SPINES; DOPAMINE; MODULATION; SPECIFICITY; NORMALIZATION; OSCILLATIONS	Reward-modulated spike timing dependent plasticity (STDP) combines unsupervised STDP with a reinforcement signal that modulates synaptic changes. It was proposed as a learning rule capable of solving the distal reward problem in reinforcement learning. Nonetheless, performance and limitations of this learning mechanism have yet to be tested for its ability to solve biological problems. In our work, rewarded STDP was implemented to model foraging behavior in a simulated environment. Over the course of training the network of spiking neurons developed the capability of producing highly successful decision-making. The network performance remained stable even after significant perturbations of synaptic structure. Rewarded STDP alone was insufficient to learn effective decision making due to the difficulty maintaining homeostatic equilibrium of synaptic weights and the development of local performance maxima. Our study predicts that successful learning requires stabilizing mechanisms that allow neurons to balance their input and output synapses as well as synaptic noise.	[Skorheim, Steven; Lonjers, Peter; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	maksim.bazhenov@ucr.edu			National Institutes of Health [R01 MH087631]; ONR [N00014-13-1-0672]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding from National Institutes of Health (R01 MH087631) and ONR (N00014-13-1-0672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Baker DA, 1998, PHARMACOL BIOCHEM BE, V61, P107, DOI 10.1016/S0091-3057(98)00070-7; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bazhenov M, 2013, J NEUROSCI, V33, P5686, DOI 10.1523/JNEUROSCI.4145-12.2013; Bazhenov M, 2010, NEURON, V67, P357, DOI 10.1016/j.neuron.2010.07.023; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chadderdon GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047251; Chen JY, 2013, J NEUROSCI, V33, P15915, DOI 10.1523/JNEUROSCI.5088-12.2013; CHENG B, 1994, STAT SCI, V9, P2, DOI 10.1214/ss/1177010638; Chistiakova M, 2009, EXP BRAIN RES, V199, P377, DOI 10.1007/s00221-009-1859-5; Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Delgado JY, 2010, J NEUROSCI, V30, P15713, DOI 10.1523/JNEUROSCI.3068-10.2010; Elliott T, 2002, NEURAL COMPUT, V14, P1311, DOI 10.1162/089976602753712954; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Finelli LA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000062; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gutig R, 2003, J NEUROSCI, V23, P3697; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; Hebb D.O., 1961, BRAIN MECH LEARNING, P37, DOI DOI 10.5962/BHL.TITLE.7220; Huerta R, 2004, NEURAL COMPUT, V16, P1601, DOI 10.1162/089976604774201613; Huerta R, 2009, NEURAL COMPUT, V21, P2123, DOI 10.1162/neco.2009.03-08-733; Hull C., 1943, PRINCIPLES BEHAV; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kawato M, 2011, CURR OPIN NEUROBIOL, V21, P791, DOI 10.1016/j.conb.2011.05.014; Kempter R, 2001, NEURAL COMPUT, V13, P2709, DOI 10.1162/089976601317098501; Kossel A, 1990, Neuroreport, V1, P115, DOI 10.1097/00001756-199010000-00008; Lee K, 2008, NEUROCOMPUTING, V71, P3037, DOI 10.1016/j.neucom.2007.09.009; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lotfi A, 2011, J ARTIFICIAL INTELLI, P288; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Miller P, 2010, J NEUROSCI, V30, P2559, DOI 10.1523/JNEUROSCI.3047-09.2010; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nitz DA, 2007, NEUROREPORT, V18, P1833, DOI 10.1097/WNR.0b013e3282f16d86; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rao RPN, 2001, NEURAL COMPUT, V13, P2221, DOI 10.1162/089976601750541787; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2008, J BIOL PHYS, V34, P279, DOI 10.1007/s10867-008-9079-y; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SEGAL DS, 1974, PHARMACOL BIOCHEM BE, V2, P249, DOI 10.1016/0091-3057(74)90060-4; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Timofeev I, 2005, TRENDS CHRONOBIOLOGY, P1; Turing A.M, 1948, TECH REP; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; White H, 1989, NEURAL COMPUT, V1, P425, DOI 10.1162/neco.1989.1.4.425; Wu ZH, 2006, NEURAL NETWORKS, V19, P547, DOI 10.1016/j.neunet.2005.06.048; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhang GQ, 1999, EUR J OPER RES, V116, P16, DOI 10.1016/S0377-2217(98)00051-4; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zhou YD, 2005, P NATL ACAD SCI USA, V102, P19121, DOI 10.1073/pnas.0509856103	85	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90821	10.1371/journal.pone.0090821	http://dx.doi.org/10.1371/journal.pone.0090821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632858	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400018
J	Speyer, CL; Hachem, AH; Assi, AA; Johnson, JS; DeVries, JA; Gorski, DH				Speyer, Cecilia L.; Hachem, Ali H.; Assi, Ali A.; Johnson, Jennifer S.; DeVries, John A.; Gorski, David H.			Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-COUPLED RECEPTORS; FACTOR-KAPPA-B; TUMORAL VASCULARITY; PROGNOSTIC-FACTOR; GENE-EXPRESSION; KINASE-C; ANGIOGENESIS; RILUZOLE; ACTIVATION	Metabotropic glutamate receptors (mGluRs) are normally expressed in the central nervous system, where they mediate neuronal excitability and neurotransmitter release. Certain cancers, including melanoma and gliomas, express various mGluR subtypes that have been implicated as playing a role in disease progression. Recently, we detected metabotropic glutamate receptor-1 (gene: GRM1; protein: mGluR1) in breast cancer and found that it plays a role in the regulation of cell proliferation and tumor growth. In addition to cancer cells, brain endothelial cells express mGluR1. In light of these studies, and because angiogenesis is both a prognostic indicator in cancer correlating with a poorer prognosis and a potential therapeutic target, we explored a potential role for mGluR1 in mediating endothelial cell (EC) proliferation and tumor-induced angiogenesis. GRM1 and mGluR1 were detected in various types of human ECs and, using mGluR1-specific inhibitors or shRNA silencing, we demonstrated that EC growth and Matrigel tube formation are dependent on mGluR1 signaling. In addition, loss of mGluR1 activity leads to reduced angiogenesis in a murine Matrigel sponge implant model as well as a murine tumor model. These results suggest a role for mGluR1 in breast cancer as a pro-angiogenic factor as well as a mediator of tumor progression. They also suggest mGluR1 as a potential new molecular target for the anti-angiogenic therapy of breast cancer.	[Speyer, Cecilia L.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Tumor Microenvironm Program, Detroit, MI USA; [Gorski, David H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA; [Speyer, Cecilia L.; DeVries, John A.; Gorski, David H.] Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; [Hachem, Ali H.; Assi, Ali A.] Univ Michigan, Dearborn, MI USA; [Johnson, Jennifer S.] Van Andel Res Inst, Grand Rapids, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Van Andel Institute	Gorski, DH (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA.	gorskid@med.wayne.edu	Gorski, David/AAE-6399-2022	Gorski, David/0000-0002-9805-6699	NIH [P30CA22453]; Wayne State University; Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University; Conquer Cancer Foundation of ASCO; Bayer Healthcare; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University; Conquer Cancer Foundation of ASCO; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MICR Core is supported, in part, by NIH Center grant P30CA22453 to The Karmanos Cancer Institute, Wayne State University and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University. This work was also supported by in part by grants from the Conquer Cancer Foundation of ASCO as well as a Grants-4Targets grant from Bayer Healthcare, as well as institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bonsi P, 2005, NEUROPHARMACOLOGY, V49, P104, DOI 10.1016/j.neuropharm.2005.05.012; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Chu ZG, 2000, BRAIN RES, V879, P88, DOI 10.1016/S0006-8993(00)02752-9; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Endoh T, 2004, BRAIN RES, V1024, P212, DOI 10.1016/j.brainres.2004.07.074; Festoff BW, 1996, DRUGS, V51, P28, DOI 10.2165/00003495-199651010-00004; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Gorski DH, 1998, CANCER RES, V58, P5686; Greenberg JI, 2009, EXPERT OPIN BIOL TH, V9, P1347, DOI 10.1517/14712590903208883; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris SL, 2004, MOL CELL NEUROSCI, V25, P275, DOI 10.1016/j.mcn.2003.10.018; HEBERT T, 1994, MOL PHARMACOL, V45, P1055; Higa GM, 2009, EXPERT REV ANTICANC, V9, P999, DOI 10.1586/ERA.09.68; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hsu JY, 2009, BIODRUGS, V23, P289, DOI 10.2165/11317600-000000000-00000; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Lin SH, 2001, NEUROSCI LETT, V298, P207, DOI 10.1016/S0304-3940(00)01766-3; Liu F, 2002, J BIOL CHEM, V277, P45393, DOI 10.1074/jbc.M204499200; Mabire D, 2005, J MED CHEM, V48, P2134, DOI 10.1021/jm049499o; Mao LM, 2003, EUR J NEUROSCI, V17, P741, DOI 10.1046/j.1460-9568.2003.02495.x; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MILLER FR, 1983, INVAS METAST, V3, P22; MILLER FR, 1983, INVAS METAST, V3, P234; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Mills CD, 2002, J NEUROTRAUM, V19, P23, DOI 10.1089/089771502753460213; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noh KM, 2000, NEUROBIOL DIS, V7, P375, DOI 10.1006/nbdi.2000.0297; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; Patel S, 2005, CANCER RES, V65, P1414, DOI 10.1158/0008-5472.CAN-04-3431; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Ribeiro FM, 2011, MOL NEUROBIOL, V43, P1, DOI 10.1007/s12035-010-8153-1; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; TEICHER BA, 1992, CANCER RES, V52, P6702; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Weidner Noel, 1996, P167; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yoo MH, 2005, INVEST OPHTH VIS SCI, V46, P4780, DOI 10.1167/iovs.05-0376; Zona C, 1998, NEUROSCIENCE, V85, P931, DOI 10.1016/S0306-4522(97)00604-0	55	39	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88830	10.1371/journal.pone.0088830	http://dx.doi.org/10.1371/journal.pone.0088830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633367	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400004
J	Taskinen, B; Airenne, TT; Janis, J; Rahikainen, R; Johnson, MS; Kulomaa, MS; Hytonen, VP				Taskinen, Barbara; Airenne, Tomi T.; Janis, Janne; Rahikainen, Rolle; Johnson, Mark S.; Kulomaa, Markku S.; Hytonen, Vesa P.			A Novel Chimeric Avidin with Increased Thermal Stability Using DNA Shuffling	PLOS ONE			English	Article							BIOTIN-BINDING PROTEIN; HIGH-AFFINITY; FAMILY; REFINEMENT; GENES	Avidins are a family of proteins widely employed in biotechnology. We have previously shown that functional chimeric mutant proteins can be created from avidin and avidin-related protein 2 using a methodology combining random mutagenesis by recombination and selection by a tailored biopanning protocol (phage display). Here, we report the crystal structure of one of the previously selected and characterized chimeric avidin forms, A/A2-1. The structure was solved at 1.8 angstrom resolution and revealed that the protein fold was not affected by the shuffled sequences. The structure also supports the previously observed physicochemical properties of the mutant. Furthermore, we improved the selection and screening methodology to select for chimeric avidins with slower dissociation rate from biotin than were selected earlier. This resulted in the chimeric mutant A/A2-B, which showed increased thermal stability as compared to A/A2-1 and the parental proteins. The increased stability was especially evident at conditions of extreme pH as characterized using differential scanning calorimetry. In addition, amino acid sequence and structural comparison of the chimeric mutants and the parental proteins led to the rational design of A/A2-B I109K. This mutation further decreased the dissociation rate from biotin and yielded an increase in the thermal stability.	[Taskinen, Barbara; Rahikainen, Rolle; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Taskinen, Barbara; Rahikainen, Rolle; Hytonen, Vesa P.] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Airenne, Tomi T.; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Kulomaa, Markku S.] Tampere Univ Hosp, Tampere, Finland	Tampere University; Pirkanmaa Hospital District; Abo Akademi University; University of Eastern Finland; Tampere University; Tampere University Hospital	Hytonen, VP (corresponding author), Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Jänis, Janne/B-7326-2014; Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Taskinen, Barbara/0000-0003-2989-7563; Rahikainen, Rolle/0000-0003-1265-862X	Academy of Finland [136288, 257814, 272283, 273192]; National Doctoral Programme in Informational and Structural Biology (ISB); Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Pirkanmaa Hospital District, Tampere University Hospital	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology (ISB); Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Pirkanmaa Hospital District, Tampere University Hospital	This work was funded by the Academy of Finland [projects 136288, 257814, 272283, 273192], the National Doctoral Programme in Informational and Structural Biology (ISB), the Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging), the Sigrid Juselius Foundation, and the Joe, Pentti and Tor Borg Memorial Fund. This study was financially supported by the Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital. The authors acknowledge the FIRI infrastructure support for structural biology from the Academy of Finland. Biocenter Finland is acknowledged for the infrastructure support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Humbert N, 2005, ELECTROPHORESIS, V26, P47, DOI 10.1002/elps.200406148; Hytonen VP, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-8; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEINANEN RA, 1994, EUR J BIOCHEM, V220, P615, DOI 10.1111/j.1432-1033.1994.tb18663.x; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leppiniemi J, 2013, PROTEIN SCI; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2012, J BIOL CHEM, V287, P17951, DOI 10.1074/jbc.M112.357186; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholas K.B., 1997, GENEDOC ANAL VISUALI; Niederhauser B, 2012, J BIOTECHNOL, V157, P38, DOI 10.1016/j.jbiotec.2011.10.014; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reznik GO, 1998, P NATL ACAD SCI USA, V95, P13525, DOI 10.1073/pnas.95.23.13525; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Taskinen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077207; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	47	8	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92058	10.1371/journal.pone.0092058	http://dx.doi.org/10.1371/journal.pone.0092058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632863	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400137
J	Allen, DK; Evans, BS; Libourel, IGL				Allen, Doug K.; Evans, Bradley S.; Libourel, Igor G. L.			Analysis of Isotopic Labeling in Peptide Fragments by Tandem Mass Spectrometry	PLOS ONE			English	Article							METABOLIC FLUX ANALYSIS; HIGHER-PLANT CELLS; CODED AFFINITY TAGS; AMINO-ACIDS; NONAQUEOUS FRACTIONATION; ARABIDOPSIS CELLS; HIGH-RESOLUTION; SOYBEAN SEEDS; ROOT-TIPS; C-13	Phenotype in multicellular organisms is the consequence of dynamic metabolic events that occur in a spatially dependent fashion. This spatial and temporal complexity presents challenges for investigating metabolism; creating a need for improved methods that effectively probe biochemical events such as amino acid biosynthesis. Isotopic labeling can provide a temporal-spatial recording of metabolic events through, for example, the description of enriched amino acids in the protein pool. Proteins are therefore an important readout of metabolism and can be assessed with modern mass spectrometers. We compared the measurement of isotopic labeling in MS2 spectra obtained from tandem mass spectrometry under either higher energy collision dissociation (HCD) or collision induced dissociation (CID) at varied energy levels. Developing soybean embryos cultured with or without C-13-labeled substrates, and Escherichia coli MG1655 enriched by feeding 7% uniformly labeled glucose served as a source of biological material for protein evaluation. CID with low energies resulted in a disproportionate amount of heavier isotopologues remaining in the precursor isotopic distribution. HCD resulted in fewer quantifiable products; however deviation from predicted distributions were small relative to the CID-based comparisons. Fragment ions have the potential to provide information on the labeling of amino acids in peptides, but our results indicate that without further development the use of this readout in quantitative methods such as metabolic flux analysis is limited.	[Allen, Doug K.] ARS, USDA, Plant Genet Res Unit, St Louis, MO USA; [Allen, Doug K.; Evans, Bradley S.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Libourel, Igor G. L.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	United States Department of Agriculture (USDA); Donald Danforth Plant Science Center; University of Minnesota System; University of Minnesota Twin Cities	Allen, DK (corresponding author), ARS, USDA, Plant Genet Res Unit, St Louis, MO USA.	doug.allen@ars.usda.gov	Evans, Bradley S/M-2842-2013; Allen, Doug K/M-2836-2013	Evans, Bradley S/0000-0002-1207-9006; Allen, Doug K/0000-0001-8599-8946	NSF [DBI-0922879]	NSF(National Science Foundation (NSF))	The authors acknowledge USDA facilities and resources, and technical expertise of Jim Gierse and Christine Diepenbrock along with the Donald Danforth Plant Science Center Proteomics and Mass Spectrometry Facility where the Orbitrap mass spectrometer was located (funded by NSF: DBI-0922879). Technical advice from Drs. Alisha Roberts and Jae Schwartz, Thermo-Fisher Scientific was also greatly appreciated.	Allen DK, 2009, PLANT METABOLIC NETWORKS, P105, DOI 10.1007/978-0-387-78745-9_5; Allen DK, 2007, PHYTOCHEMISTRY, V68, P2197, DOI 10.1016/j.phytochem.2007.04.010; Allen DK, 2014, ANAL CHEM, V86, P1894, DOI 10.1021/ac403985w; Allen DK, 2013, PLANT PHYSIOL, V161, P1458, DOI 10.1104/pp.112.203299; Allen DK, 2012, PLANT CELL ENVIRON, V35, P1232, DOI 10.1111/j.1365-3040.2012.02485.x; Allen DK, 2009, PLANT CELL ENVIRON, V32, P1241, DOI 10.1111/j.1365-3040.2009.01992.x; Allen DK, 2009, PLANT J, V58, P220, DOI 10.1111/j.1365-313X.2008.03771.x; Alonso AP, 2007, METAB ENG, V9, P419, DOI 10.1016/j.ymben.2007.06.002; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Aubert S, 1999, PLANT CELL ENVIRON, V22, P255, DOI 10.1046/j.1365-3040.1999.00421.x; Aubert S, 1998, PLANT PHYSIOL, V116, P547, DOI 10.1104/pp.116.2.547; Balbuena TS, 2011, J PROTEOME RES, V10, P2330, DOI 10.1021/pr101137q; Benkeblia N, 2007, METABOLOMICS, V3, P297, DOI 10.1007/s11306-007-0078-y; Blank LM, 2012, ANAL BIOANAL CHEM, V403, P2291, DOI 10.1007/s00216-012-6009-4; Borisjuk L, 2005, NEW PHYTOL, V167, P761, DOI 10.1111/j.1469-8137.2005.01474.x; Borisjuk L, 2013, PLANT CELL, V25, P1625, DOI 10.1105/tpc.113.111740; Chen XW, 2013, METAB ENG, V18, P78, DOI 10.1016/j.ymben.2013.04.006; Chen XW, 2012, J EXP BOT, V63, P2343, DOI 10.1093/jxb/ers057; Cheung CY, 2013, PLANT J; Colangelo Christopher M., 2006, V328, P151; Demartini DR, 2011, J PROTEOME RES, V10, P2226, DOI 10.1021/pr101047y; Ebert B, 2010, J EXP BOT, V61, P1321, DOI 10.1093/jxb/erq002; Fernie AR, 2013, PLANT CELL ENV; Geigenberger P, 2011, METHODS MOL BIOL, V775, P135, DOI 10.1007/978-1-61779-237-3_8; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; GERHARDT R, 1987, PLANT PHYSIOL, V83, P399, DOI 10.1104/pp.83.2.399; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; GOUT E, 1992, J BIOL CHEM, V267, P13903; GOUT E, 1993, J BIOL CHEM, V268, P3986; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Herbst FA, 2013, MOL CELL PROTEOMICS, V12, P2060, DOI 10.1074/mcp.M112.025627; HOOKS MA, 1989, PLANT PHYSIOL, V89, P963, DOI 10.1104/pp.89.3.963; Horn PJ, 2012, PLANT CELL, V24, P622, DOI 10.1105/tpc.111.094581; Horn PJ, 2011, J BIOL CHEM, V286, P3298, DOI 10.1074/jbc.M110.186353; HSU FC, 1982, PLANT SCI LETT, V27, P129, DOI 10.1016/0304-4211(82)90141-9; Huege J, 2012, MOL BIOSYST, V8, P2466, DOI 10.1039/c2mb25068c; Hughes C, 2012, TRENDS BIOTECHNOL, V30, P668, DOI 10.1016/j.tibtech.2012.09.007; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Jehmlich N, 2010, NAT PROTOC, V5, P1957, DOI 10.1038/nprot.2010.166; JOHNSON RS, 1988, INT J MASS SPECTROM, V86, P137, DOI 10.1016/0168-1176(88)80060-0; Koubaa M, 2012, ANAL BIOCHEM, V425, P183, DOI 10.1016/j.ab.2012.03.020; Kruger NJ, 2012, J EXP BOT, V63, P2309, DOI 10.1093/jxb/err382; Lee CP, 2012, J PROTEOME RES, V11, P3326, DOI 10.1021/pr3001157; Libourel IGL, 2006, PLANT PHYSIOL, V142, P1710, DOI 10.1104/pp.106.088898; Lonien J, 2009, PLANT PHYSIOL, V151, P1617, DOI 10.1104/pp.109.144121; Mandy DE, 2014, PLANT J, V77, P476, DOI 10.1111/tpj.12390; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Marco-Urrea E, 2012, J BACTERIOL, V194, P4169, DOI 10.1128/JB.00049-12; Martin SF, 2012, J PROTEOME RES, V11, P476, DOI 10.1021/pr2009302; Masakapalli SK, 2013, PLANT J, V74, P569, DOI 10.1111/tpj.12142; Nelson CJ, 2013, J PROTEOME RES, V12, P3449, DOI 10.1021/pr400304r; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PATTERSON BW, 1993, BIOL MASS SPECTROM, V22, P518, DOI 10.1002/bms.1200220905; Truong Q, 2013, J EXP BOT, V64, P2985, DOI 10.1093/jxb/ert138; RATCLIFFE RG, 1994, ADV BOT RES, V20, P43, DOI 10.1016/S0065-2296(08)60215-3; Rolletschek H, 2011, PLANT CELL, V23, P3041, DOI 10.1105/tpc.111.087015; Rosman KJR, 1998, PURE APPL CHEM, V70, P217, DOI 10.1351/pac199870010217; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shachar-Hill Y, 2013, CURR OPIN BIOTECH, V24, P247, DOI 10.1016/j.copbio.2013.01.004; Sobott F, 2009, J AM SOC MASS SPECTR, V20, P1652, DOI 10.1016/j.jasms.2009.04.023; Sriram G, 2007, METAB ENG, V9, P442, DOI 10.1016/j.ymben.2007.07.003; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Stitt M, 2013, CURR OPIN PLANT BIOL, V16, P381, DOI 10.1016/j.pbi.2013.02.012; STOCKING CR, 1959, PLANT PHYSIOL, V34, P56, DOI 10.1104/pp.34.1.56; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Taubert M, 2011, PROTEOMICS, V11, P2265, DOI 10.1002/pmic.201000788; THOMPSON JF, 1977, ANN BOT-LONDON, V41, P29, DOI 10.1093/oxfordjournals.aob.a085281; Verboven P, 2013, NEW PHYTOL, V199, P936, DOI 10.1111/nph.12342; Yoon JM, 2013, ANNU REV CHEM BIOMOL, V4, P211, DOI 10.1146/annurev-chembioeng-061312-103320; Zhang Y, 2010, MOL CELL PROTEOMICS, V9, P780, DOI 10.1074/mcp.M900452-MCP200	74	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91537	10.1371/journal.pone.0091537	http://dx.doi.org/10.1371/journal.pone.0091537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626471	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300101
J	Hertz, R; Ben Lulu, S; Shahi, P; Trebicz-Geffen, M; Benhar, M; Ankri, S				Hertz, Rivka; Ben Lulu, Shani; Shahi, Preeti; Trebicz-Geffen, Meirav; Benhar, Moran; Ankri, Serge			Proteomic Identification of S-Nitrosylated Proteins in the Parasite Entamoeba histolytica by Resin-Assisted Capture: Insights into the Regulation of the Gal/GalNAc Lectin by Nitric Oxide	PLOS ONE			English	Article							UNIQUE RAB GTPASE; CYSTEINE PROTEINASES; IN-VITRO; ALCOHOL-DEHYDROGENASE-2 EHADH2; ANTISENSE INHIBITION; AMEBICIDAL ACTIVITY; LIVER-ABSCESS; EXPRESSION; GENES; OVEREXPRESSION	Entamoeba histolytica is a gastrointestinal protozoan parasite that causes amebiasis, a disease which has a worldwide distribution with substantial morbidity and mortality. Nitrosative stress, which is generated by innate immune cells, is one of the various environmental challenges that E. histolytica encounters during its life cycle. Although the effects of nitric oxide (NO) on the regulation of gene expression in this parasite have been previously investigated, our knowledge on S-nitrosylated proteins in E. histolytica is lacking. In order to fill this knowledge gap, we performed a large-scale detection of S-nitrosylated (SNO) proteins in E. histolytica trophozoites that were treated with the NO donor, S-nitrosocysteine by resin-assisted capture (RAC). We found that proteins involved in glycolysis, gluconeogenesis, translation, protein transport, and adherence to target cells such as the heavy subunit of Gal/GalNac lectin are among the S-nitrosylated proteins that were enriched by SNO-RAC. We also found that the S-nitrosylated cysteine residues in the carbohydrate recognition domain (CRD) of Gal/GalNAc lectin impairs its function and contributes to the inhibition of E. histolytica adherence to host cells. Collectively, these results advance our understanding of the mechanism of reduced E. histolytica adherence to mammalian cells by NO and emphasize the importance of NO as a regulator of key physiological functions in E. histolytica.	[Hertz, Rivka; Shahi, Preeti; Trebicz-Geffen, Meirav; Ankri, Serge] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel; [Ben Lulu, Shani; Benhar, Moran] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ankri, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Mol Microbiol, POB 9649, IL-31096 Haifa, Israel.	sankri@tx.technion.ac.il	Shahi, Preeti/S-8197-2019; Benhar, Moran/AAV-5764-2020	Benhar, Moran/0000-0002-7094-3456	Israel Science Foundation [1218/10]; German Research Foundation [784/1-2]	Israel Science Foundation(Israel Science Foundation); German Research Foundation(German Research Foundation (DFG))	This study was supported by The Israel Science Foundation (grant number 1218/10) and The German Research Foundation (grant number 784/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MA, 2004, MOL BIOCHEM PARASIT, V133, P187, DOI 10.1016/j.molbiopara.2003.10.006; Ankri S, 1999, MOL MICROBIOL, V33, P327, DOI 10.1046/j.1365-2958.1999.01476.x; Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; [Anonymous], 1997, Epidemiol Bull, V18, P13; ARROYO R, 1987, MOL BIOCHEM PARASIT, V23, P151, DOI 10.1016/0166-6851(87)90150-2; Biller L, 2014, MOL CELL PROTEOMICS, V13, P132, DOI 10.1074/mcp.M113.031393; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Dodson JM, 1999, J INFECT DIS, V179, P460, DOI 10.1086/314610; Elnekave K, 2003, PARASITE IMMUNOL, V25, P597, DOI 10.1111/j.0141-9838.2004.00669.x; Espinosa A, 2004, J ANTIMICROB CHEMOTH, V54, P56, DOI 10.1093/jac/dkh280; Espinosa A, 2001, J BIOL CHEM, V276, P20136, DOI 10.1074/jbc.M101349200; Fares A, 2011, BIOCHEM BIOPH RES CO, V416, P331, DOI 10.1016/j.bbrc.2011.11.036; Faust DM, 2012, MICROBES INFECT, V14, P1428, DOI 10.1016/j.micinf.2012.05.013; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Hara MR, 2005, NATURE CELL BIOL, V7; Hellberg A, 2001, CELL MICROBIOL, V3, P13, DOI 10.1046/j.1462-5822.2001.00086.x; Holzmuller P, 2006, INFECT GENET EVOL, V6, P187, DOI 10.1016/j.meegid.2005.03.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Irmer H, 2009, MOL MICROBIOL, V72, P658, DOI 10.1111/j.1365-2958.2009.06672.x; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; Lam YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009075; Lavi T, 2006, MOL MICROBIOL, V62, P1373, DOI 10.1111/j.1365-2958.2006.05464.x; LIN JY, 1992, J IMMUNOL, V148, P3999; Makioka A, 2005, EXP PARASITOL, V109, P27, DOI 10.1016/j.exppara.2004.10.003; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matthiesen J, 2013, MBIO, V4, DOI 10.1128/mBio.00072-13; Nakada-Tsukui K, 2012, CELL MICROBIOL, V14, P1299, DOI 10.1111/j.1462-5822.2012.01800.x; Nakada-Tsukui K, 2010, EXP PARASITOL, V126, P337, DOI 10.1016/j.exppara.2010.04.014; NUNOSHIBA T, 1995, INFECT IMMUN, V63, P794, DOI 10.1128/IAI.63.3.794-798.1995; Petri WA, 1996, J INVEST MED, V44, P24; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Petri William A. Jr, 1993, Seminars in Cell Biology, V4, P305, DOI 10.1006/scel.1993.1037; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; RAVDIN JI, 1980, J EXP MED, V152, P377, DOI 10.1084/jem.152.2.377; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Santi-Rocca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031777; Seguin R, 1995, P NATL ACAD SCI USA, V92, P12175, DOI 10.1073/pnas.92.26.12175; Seguin R, 1997, INFECT IMMUN, V65, P2522; Siman-Tov R, 2003, PARASITOL RES, V89, P146, DOI 10.1007/s00436-002-0716-2; Stuart MK, 2003, ARCH INSECT BIOCHEM, V52, P17, DOI 10.1002/arch.10061; Teixeira JE, 2008, INFECT IMMUN, V76, P959, DOI 10.1128/IAI.01455-07; Tillack M, 2006, MOL BIOCHEM PARASIT, V149, P58, DOI 10.1016/j.molbiopara.2006.04.009; Venturini G, 2000, BIOCHEM BIOPH RES CO, V267, P190, DOI 10.1006/bbrc.1999.1922; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Wang L, 2013, ANTIOXID REDOX SIGNA; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Welter BH, 2005, MOL BIOCHEM PARASIT, V140, P161, DOI 10.1016/j.molbiopara.2004.12.011; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550	53	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91518	10.1371/journal.pone.0091518	http://dx.doi.org/10.1371/journal.pone.0091518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626316	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300096
J	Hiraoka, N; Kikuchi, J; Yamauchi, T; Koyama, D; Wada, T; Uesawa, M; Akutsu, M; Mori, S; Nakamura, Y; Ueda, T; Kano, Y; Furukawa, Y				Hiraoka, Nobuya; Kikuchi, Jiro; Yamauchi, Takahiro; Koyama, Daisuke; Wada, Taeko; Uesawa, Mitsuyo; Akutsu, Miyuki; Mori, Shigehisa; Nakamura, Yuichi; Ueda, Takanori; Kano, Yasuhiko; Furukawa, Yusuke			Purine Analog-Like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; PREVIOUSLY UNTREATED PATIENTS; REFRACTORY MULTIPLE-MYELOMA; PHASE-II MULTICENTER; INDOLENT B-CELL; IN-VITRO; PLUS RITUXIMAB; OPEN-LABEL	Bendamustine has shown considerable clinical activity against indolent lymphoid malignancies as a single agent or in combination with rituximab, but combination with additional anti-cancer drugs may be required for refractory and/or relapsed cases as well as other intractable tumors. In this study, we attempted to determine suitable anti-cancer drugs to be combined with bendamustine for the treatment of mantle cell lymphoma, diffuse large B-cell lymphoma, aggressive lymphomas and multiple myeloma, all of which are relatively resistant to this drug, and investigated the mechanisms underlying synergism. Isobologram analysis revealed that bendamustine had synergistic effects with alkylating agents (4-hydroperoxy-cyclophosphamide, chlorambucil and melphalan) and pyrimidine analogues (cytosine arabinoside, gemcitabine and decitabine) in HBL-2, B104, Namalwa and U266 cell lines, which represent the above entities respectively. In cell cycle analysis, bendamustine induced late S-phase arrest, which was enhanced by 4-hydroperoxy-cyclophosphamide, and potentiated early S-phase arrest by cytosine arabinoside (Ara-C), followed by a robust increase in the size of sub-G1 fractions. Bendamustine was able to elicit DNA damage response and subsequent apoptosis faster and with shorter exposure than other alkylating agents due to rapid intracellular incorporation via equilibrative nucleoside transporters (ENTs). Furthermore, bendamustine increased the expression of ENT1 at both mRNA and protein levels and enhanced the uptake of Ara-C and subsequent increase in Ara-C triphosphate (Ara-CTP) in HBL-2 cells to an extent comparable with the purine analog fludarabine. These purine analog-like properties of bendamustine may underlie favorable combinations with other alkylators and pyrimidine analogues. Our findings may provide a theoretical basis for the development of more effective bendamustine-based combination therapies.	[Hiraoka, Nobuya; Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi, Japan; [Yamauchi, Takahiro; Ueda, Takanori] Univ Fukui, Div Hematol & Oncol, Fac Med Sci, Eiheiji, Fukui, Japan; [Uesawa, Mitsuyo; Akutsu, Miyuki; Kano, Yasuhiko] Tochigi Canc Ctr, Dept Hematol, Utsunomiya, Tochigi, Japan; [Mori, Shigehisa] Saitama Med Univ, Med Educ Ctr, Moroyama, Saitama, Japan; [Nakamura, Yuichi] Saitama Med Univ, Dept Hematol, Moroyama, Saitama, Japan	Jichi Medical University; University of Fukui; Tochigi Prefectural Cancer Center; Saitama Medical University; Saitama Medical University	Furukawa, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT; JSPS; Japan Leukemia Research Fund; Takeda Science Foundation; Naito Foundation; Yasuda Medical Foundation; Uehara Memorial Foundation; Eisai Co.; Janssen Pharmaceutical K.K.; Novartis Pharmaceuticals Co.; Jichi Medical University; Grants-in-Aid for Scientific Research [25118721] Funding Source: KAKEN	High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Yasuda Medical Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Eisai Co.(Eisai Co Ltd); Janssen Pharmaceutical K.K.; Novartis Pharmaceuticals Co.; Jichi Medical University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT, a Grant-in-Aid for Scientific Research from JSPS (to J.K. and Y.F.), and research grants from Japan Leukemia Research Fund, Takeda Science Foundation (to J.K.), The Naito Foundation, The Yasuda Medical Foundation, and The Uehara Memorial Foundation (to Y.F.). YF received research funding from Eisai Co., Janssen Pharmaceutical K.K., and Novartis Pharmaceuticals Co. N.H. is a winner of the Young Scientist Award of Jichi Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1988, CANCER, V61, P483, DOI 10.1002/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L; Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; BOYD VL, 1986, J MED CHEM, V29, P1206, DOI 10.1021/jm00157a015; Cai B, 2013, CANCER LETT, V335, P343, DOI 10.1016/j.canlet.2013.02.046; Castegnaro S, 2012, LEUKEMIA LYMPHOMA, V53, P2262, DOI 10.3109/10428194.2012.688200; CHAN KK, 1994, CANCER RES, V54, P6421; Chow KU, 2003, BIOCHEM PHARMACOL, V66, P711, DOI 10.1016/S0006-2952(03)00410-6; Chow KU, 2003, LEUKEMIA LYMPHOMA, V44, P165, DOI 10.1080/1042819021000054670; Chow KU, 2001, HAEMATOLOGICA, V86, P485; Damaj G, 2013, J CLIN ONCOL, V31, P104, DOI 10.1200/JCO.2012.43.7285; Fernandez-Calotti PX, 2011, NUCLEOS NUCLEOT NUCL, V30, P1324, DOI 10.1080/15257770.2011.597372; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; Gandhi V, 1996, BLOOD, V87, P256, DOI 10.1182/blood.V87.1.256.bloodjournal871256; HARTMANN M, 1972, BIOCHIM BIOPHYS ACTA, V287, P386, DOI 10.1016/0005-2787(72)90282-1; Herold M, 2006, J CANCER RES CLIN, V132, P105, DOI 10.1007/s00432-005-0023-2; HILL BT, 1972, BIOCHEM PHARMACOL, V21, P495, DOI 10.1016/0006-2952(72)90322-X; Hiraoka N, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.66; Hitz F, 2013, ANN HEMATOL, V92, P1033, DOI 10.1007/s00277-013-1751-z; Kikuchi J, 2013, J BIOL CHEM, V288, P25593, DOI 10.1074/jbc.M113.480574; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; Koenigsmann M, 2004, LEUKEMIA LYMPHOMA, V45, P1821, DOI 10.1080/1042819042000223822; Koster W, 2004, CLIN DRUG INVEST, V24, P611; Koyama D, 2014, PROTEASOME INHIBITOR, DOI [10.1038/leu.2013.366, DOI 10.1038/LEU.2013.366]; Layman RM, 2013, CANCER CHEMOTH PHARM, V71, P1183, DOI 10.1007/s00280-013-2112-2; Lentzsch S, 2012, BLOOD, V119, P4608, DOI 10.1182/blood-2011-12-395715; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; McCloskey James K, 2013, Clin Adv Hematol Oncol, V11, P184; Offidani M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.58; Ogura M, 2010, CANCER SCI, V101, P2054, DOI 10.1111/j.1349-7006.2010.01633.x; Ohmachi K, 2013, J CLIN ONCOL, V31, P2103, DOI 10.1200/JCO.2012.46.5203; Pastor-Anglada M, 2004, LEUKEMIA, V18, P385, DOI 10.1038/sj.leu.2403271; Petersen AJ, 1996, EUR J HAEMATOL, V56, P213; Rasschaert M, 2007, BRIT J CANCER, V96, P1692, DOI 10.1038/sj.bjc.6603776; Robinson KS, 2008, J CLIN ONCOL, V26, P4473, DOI 10.1200/JCO.2008.17.0001; Roue G, 2008, CLIN CANCER RES, V14, P6907, DOI 10.1158/1078-0432.CCR-08-0388; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Schwanen C, 2002, LEUKEMIA, V16, P2096, DOI 10.1038/sj.leu.2402651; Staib P, 1999, BLOOD, V94, p63A; Strumberg D, 1996, ANTI-CANCER DRUG, V7, P415, DOI 10.1097/00001813-199606000-00007; Tageja N, 2010, CANCER CHEMOTH PHARM, V66, P413, DOI 10.1007/s00280-010-1317-x; Visani G, 2011, BLOOD, V118, P3419, DOI 10.1182/blood-2011-04-351924; Visco C, 2013, J CLIN ONCOL, V31, P1442, DOI 10.1200/JCO.2012.45.9842; Visco C, 2013, AM J HEMATOL, V88, P289, DOI 10.1002/ajh.23391; Visco C, 2012, BLOOD CELL MOL DIS, V48, P68, DOI 10.1016/j.bcmd.2011.09.007; Weide R, 2007, LEUKEMIA LYMPHOMA, V48, P1299, DOI 10.1080/10428190701361828; Wright AMP, 2000, LEUKEMIA, V14, P52, DOI 10.1038/sj.leu.2401633; Yamauchi T, 2005, BIOCHEM PHARMACOL, V69, P1795, DOI 10.1016/j.bcp.2005.03.013; Yamauchi T, 1996, CANCER RES, V56, P1800; Yamauchi T, 2009, BIOCHEM PHARMACOL, V77, P1780, DOI 10.1016/j.bcp.2009.03.011	50	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90675	10.1371/journal.pone.0090675	http://dx.doi.org/10.1371/journal.pone.0090675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626203	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300029
J	Johnbeck, CB; Jensen, MM; Nielsen, CH; Hag, AMF; Knigge, U; Kjaer, A				Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Knigge, Ulrich; Kjaer, Andreas			F-18-FDG and F-18-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SURROGATE MARKER; MAMMALIAN TARGET; IN-VIVO; PET; INHIBITION; PROLIFERATION; THERAPY; RECIST; VALIDATION	Introduction: The mTOR inhibitor everolimus has shown promising results in some but not all neuroendocrine tumors. Therefore, early assessment of treatment response would be beneficial. In this study, we investigated the in vivo and in vitro treatment effect of everolimus in neuroendocrine tumors and evaluated the performance of F-18-FDG and the proliferation tracer F-18-FLT for treatment response assessment by PET imaging. Methods: The effect of everolimus on the human carcinoid cell line H727 was examined in vitro with the MTT assay and in vivo on H727 xenograft tumors. The mice were scanned at baseline with F-18-FDG or F-18-FLT and then treated with either placebo or everolimus (5 mg/kg daily) for 10 days. PET/CT scans were repeated at day 1,3 and 10. Results: Everolimus showed significant inhibition of H727 cell proliferation in vitro at concentrations above 1 nM. In vivo tumor volumes measured relative to baseline were significantly lower in the everolimus group compared to the control group at day 3 (126 +/- 6% vs. 152 +/- 6%; p = 0.016), day 7 (164 +/- 7% vs. 226 +/- 13%; p<0.001) and at day 10 (194 +/- 10% vs. 281 +/- 18%; p<0.001). Uptake of F-18-FDG and F-18-FLT showed little differences between control and treatment groups, but individual mean uptake of F-18-FDG at day 3 correlated with tumor growth day 10(r(2) = 0.45; P = 0.034), F-18-FLT mean uptake at day 1 correlated with tumor growth day 7 (r(2) = 0.63; P = 0.019) and at day 3 F-18-FLT correlated with tumor growth day 7 (r(2) = 0.87; P<0.001) and day 10 (r(2) = 0.58; P = 0.027). Conclusion: Everolimus was effective in vitro and in vivo in human xenografts lung carcinoid NETs and especially early F-18-FLT uptake predicted subsequent tumor growth. We suggest that F-18-FLT PET can be used for tailoring therapy for neuroendocrine tumor patients through early identification of responders and non-responders.	[Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Kjaer, Andreas] Rigshosp, Fac Hlth Sci, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Knigge, Ulrich] Rigshosp, Dept Surg Gastroenterol C, DK-2100 Copenhagen, Denmark; [Knigge, Ulrich] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Johnbeck, CB (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.	Camillabj@sund.ku.dk	Kjaer, Andreas/E-8932-2015	Kjaer, Andreas/0000-0002-2706-5547	National Advances Technology Foundation; Danish Cancer Society; Lundbeck Foundation; Novo Nordic Foundation; Danish Medical Research Council; Svend Andersen Foundation; Research Council for Strategic Research; Rigshospitalets Research Council; Research Foundation of the Capital Region; Arvid Nilsson Foundation; John and Birthe Meyer Foundation; A. P. Moeller Foundation; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish; The Danish Cancer Society [R72-A4569] Funding Source: researchfish	National Advances Technology Foundation; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Svend Andersen Foundation; Research Council for Strategic Research; Rigshospitalets Research Council; Research Foundation of the Capital Region; Arvid Nilsson Foundation; John and Birthe Meyer Foundation; A. P. Moeller Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	The National Advances Technology Foundation, Danish Cancer Society, The Lundbeck Foundation, Novo Nordic Foundation, The Danish Medical Research Council, Svend Andersen Foundation, Research Council for Strategic Research, Rigshospitalets Research Council, the Research Foundation of the Capital Region, the Arvid Nilsson Foundation, the John and Birthe Meyer Foundation and A. P. Moeller Foundation supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide N, 2010, J NUCL MED, V51, P1559, DOI 10.2967/jnumed.109.073288; Benjamin RS, 2007, J CLIN ONCOL, V25, P1760, DOI 10.1200/JCO.2006.07.3411; Binderup T, 2011, CURR MED IMAGING REV, V7, P234, DOI 10.2174/157340511796411221; Binderup T, 2010, CLIN CANCER RES, V16, P978, DOI 10.1158/1078-0432.CCR-09-1759; Castellano D, 2012, ONCOLOGIST, DOI [10.1634/theoncologist.2012-0263, DOI 10.1634/THE0NC0L0GIST.2012-0263]; Cejka D, 2009, BRIT J CANCER, V100, P1739, DOI 10.1038/sj.bjc.6605076; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Ali HH, 2012, DIAGNOSTICS, V2, P42, DOI 10.3390/diagnostics2040042; Fazio N, 2013, CHEST, V143, P955, DOI 10.1378/chest.12-1108; Frilling A, 2012, ENDOCR-RELAT CANCER, V19, pR163, DOI 10.1530/ERC-12-0024; Fuereder T, 2011, CLIN CANCER RES, V17, P5322, DOI 10.1158/1078-0432.CCR-10-1659; Jensen MM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-168; Jensen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050618; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Li ZL, 2012, CANCER RES, V72, P5014, DOI 10.1158/0008-5472.CAN-12-0635; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Modlin IM, 2010, MED J AUSTRALIA, V193, P46, DOI 10.5694/j.1326-5377.2010.tb03742.x; Munk Jensen M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053410, DOI 10.1371/J0URNAL.P0NE.0053410.PUBMED:23308217]; Nogova L, 2009, J NUCL MED, V50, P1815, DOI 10.2967/jnumed.109.065367; Pavel M, 2013, NEUROENDOCRINOLOGY, V97, P99, DOI 10.1159/000336089; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Rasey JS, 2002, J NUCL MED, V43, P1210; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tehrani OS, 2013, J NUCL MED, V54, P903, DOI 10.2967/jnumed.112.112201; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; Van den Abbeele AD, 2008, ONCOLOGIST, V13, P8, DOI 10.1634/theoncologist.13-S2-8; Vanderhoek M, 2011, LEUKEMIA RES, V35, P310, DOI 10.1016/j.leukres.2010.06.010; von Wichert G, 2000, CANCER RES, V60, P4573; Weber WA, 2006, EUR J NUCL MED MOL I, V33, pS27, DOI 10.1007/s00259-006-0133-3; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2007, BEST PRACT RES CL EN, V21, P163, DOI 10.1016/j.beem.2007.01.006; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Zannetti A, 2012, J NUCL MED, V53, P443, DOI 10.2967/jnumed.111.096503; Zatelli MC, 2010, ENDOCR-RELAT CANCER, V17, P719, DOI 10.1677/ERC-10-0097	45	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91387	10.1371/journal.pone.0091387	http://dx.doi.org/10.1371/journal.pone.0091387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626055	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300080
J	Kerr, JE; Abramian, JR; Dao, DHV; Rigney, TW; Fritz, J; Pham, T; Gay, I; Parthasarathy, K; Wang, BY; Zhang, WJ; Tribble, GD				Kerr, Jennifer E.; Abramian, Jared R.; Dao, Doan-Hieu V.; Rigney, Todd W.; Fritz, Jamie; Tan Pham; Gay, Isabel; Parthasarathy, Kavitha; Wang, Bing-yan; Zhang, Wenjian; Tribble, Gena D.			Genetic Exchange of Fimbrial Alleles Exemplifies the Adaptive Virulence Strategy of Porphyromonas gingivalis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FIMA GENOTYPES; MEMBRANE-VESICLES; EPITHELIAL-CELLS; PERIODONTITIS; INVOLVEMENT; INVASION; PREVALENCE; COMPONENTS; EXPRESSION	Porphyromonas gingivalis is a gram-negative anaerobic bacterium, a member of the human oral microbiome, and a proposed "keystone" pathogen in the development of chronic periodontitis, an inflammatory disease of the gingiva. P. gingivalis is a genetically diverse species, and is able to exchange chromosomal DNA between strains by natural competence and conjugation. In this study, we investigate the role of horizontal DNA transfer as an adaptive process to modify behavior, using the major fimbriae as our model system, due to their critical role in mediating interactions with the host environment. We show that P. gingivalis is able to exchange fimbrial allele types I and IV into four distinct strain backgrounds via natural competence. In all recombinants, we detected a complete exchange of the entire fimA allele, and the rate of exchange varies between the different strain backgrounds. In addition, gene exchange within other regions of the fimbrial genetic locus was identified. To measure the biological implications of these allele swaps we compared three genotypes of fimA in an isogenic background, strain ATCC 33277. We demonstrate that exchange of fimbrial allele type results in profound phenotypic changes, including the quantity of fimbriae elaborated, membrane blebbing, auto-aggregation and other virulence-associated phenotypes. Replacement of the type I allele with either the type III or IV allele resulted in increased invasion of gingival fibroblast cells relative to the isogenic parent strain. While genetic variability is known to impact host-microbiome interactions, this is the first study to quantitatively assess the adaptive effect of exchanging genes within the pan genome cloud. This is significant as it presents a potential mechanism by which opportunistic pathogens may acquire the traits necessary to modify host-microbial interactions.	[Kerr, Jennifer E.; Abramian, Jared R.; Dao, Doan-Hieu V.; Rigney, Todd W.; Fritz, Jamie; Tan Pham; Gay, Isabel; Parthasarathy, Kavitha; Wang, Bing-yan; Tribble, Gena D.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont & Dent Hyg, Houston, TX 77030 USA; [Zhang, Wenjian] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Tribble, GD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont & Dent Hyg, Houston, TX 77030 USA.	gena.d.tribble@uth.tmc.edu	Tribble, Gena/A-8755-2011	Tribble, Gena/0000-0002-6468-2851; Kerr, Jennifer/0000-0002-3946-449X	Public Health Service from the National Institute for Dental and Craniofacial Research [DE-019634]; High Resolution Electron Microscopy Facility, UTMDACC [CA16672]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019634] Funding Source: NIH RePORTER	Public Health Service from the National Institute for Dental and Craniofacial Research; High Resolution Electron Microscopy Facility, UTMDACC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Public Health Service grant DE-019634 from the National Institute for Dental and Craniofacial Research to G.D.T., http://www.nidcr.nih.gov, and Institutional Core Grant #CA16672 High Resolution Electron Microscopy Facility, UTMDACC, http://www.mdanderson.org/education-andresearch/resources-for-professionals/scientific-resources/core-facilities-and-services/high-resolution-electron-microscopy-facility/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; Beikler T, 2003, EUR J ORAL SCI, V111, P390, DOI 10.1034/j.1600-0722.2003.00065.x; Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123; Choi YS, 2012, FEMS IMMUNOL MED MIC, V65, P497, DOI 10.1111/j.1574-695X.2012.00955.x; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Davila-Perez C, 2007, J CLIN PERIODONTOL, V34, P25, DOI 10.1111/j.1600-051X.2006.01011.x; Enersen M., 2011, J ORAL MICROBIOL, V3, P8487, DOI [10.3402/jom.v3i0.8487, DOI 10.3402/J0M.V3I0.8487]; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; Frandsen EVG, 2001, INFECT IMMUN, V69, P4479, DOI 10.1128/IAI.69.7.4479-4485.2001; Fujise O, 2005, J PERIODONTOL, V76, P1661, DOI 10.1902/jop.2005.76.10.1661; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Handfield M, 2008, J DENT RES, V87, P203, DOI 10.1177/154405910808700302; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kato T, 2007, CELL MICROBIOL, V9, P753, DOI 10.1111/j.1462-5822.2006.00825.x; Koehler A, 2003, MICROBIOL-SGM, V149, P2407, DOI 10.1099/mic.0.26267-0; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LEE JY, 1991, INFECT IMMUN, V59, P383, DOI 10.1128/IAI.59.1.383-389.1991; Lo A, 2010, J BACTERIOL, V192, P1332, DOI 10.1128/JB.01211-09; LOOS BG, 1993, INFECT IMMUN, V61, P204, DOI 10.1128/IAI.61.1.204-212.1993; Love RM, 2000, INFECT IMMUN, V68, P1359, DOI 10.1128/IAI.68.3.1359-1365.2000; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Missailidis CG, 2004, ORAL MICROBIOL IMMUN, V19, P224, DOI 10.1111/j.1399-302X.2004.00140.x; Miura M, 2005, J PERIODONTAL RES, V40, P147, DOI 10.1111/j.1600-0765.2005.00779.x; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; Nakano K, 2004, ORAL MICROBIOL IMMUN, V19, P205, DOI 10.1111/j.0902-0055.2004.00133.x; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishikawa K, 2004, MOL MICROBIOL, V54, P546, DOI 10.1111/j.1365-2958.2004.04291.x; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Onoe T, 1995, MICROB PATHOGENESIS, V19, P351, DOI 10.1016/S0882-4010(96)80006-4; Pierce DL, 2009, INFECT IMMUN, V77, P3294, DOI 10.1128/IAI.00262-09; Rocas IN, 2010, ORAL SURG ORAL MED O, V109, P474, DOI 10.1016/j.tripleo.2009.11.009; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; TAKAHASHI Y, 1992, J PERIODONTAL RES, V27, P599, DOI 10.1111/j.1600-0765.1992.tb01742.x; Teixeira SRL, 2009, J CLIN PERIODONTOL, V36, P482, DOI 10.1111/j.1600-051X.2009.01411.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; van der Ploeg JR, 2004, FEMS MICROBIOL LETT, V232, P31, DOI 10.1016/S0378-1097(04)00064-3; Wang QA, 2010, J ENDODONT, V36, P1790, DOI 10.1016/j.joen.2010.08.018; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Wong C, 2012, MBIO, DOI [10.1128/mBio.00231-11, DOI 10.1128/MBI0.00231-11]; Xia QW, 2007, PROTEOMICS, V7, P4323, DOI 10.1002/pmic.200700543; Xie H, 2000, INFECT IMMUN, V68, P6574, DOI 10.1128/IAI.68.12.6574-6579.2000; Xie HA, 1997, INFECT IMMUN, V65, P2265, DOI 10.1128/IAI.65.6.2265-2271.1997; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; YOSHIMURA F, 1993, INFECT IMMUN, V61, P5181, DOI 10.1128/IAI.61.12.5181-5189.1993; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; Zhang W, 2011, J PERIODONTOL, V82, P909, DOI 10.1902/jop.2010.100501; Zhang WJ, 2010, MICROBES INFECT, V12, P838, DOI 10.1016/j.micinf.2010.05.011; Zhao L, 2007, J PERIODONTAL RES, V42, P511, DOI 10.1111/j.1600-0765.2007.00975.x; Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x	74	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91696	10.1371/journal.pone.0091696	http://dx.doi.org/10.1371/journal.pone.0091696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626479	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300123
J	Sadoh, WE; Eregie, CO; Nwaneri, DU; Sadoh, AE				Sadoh, Wilson E.; Eregie, Charles O.; Nwaneri, Damian U.; Sadoh, Ayebo E.			The Diagnostic Value of Both Troponin T and Creatinine Kinase Isoenzyme (CK-MB) in Detecting Combined Renal and Myocardial Injuries in Asphyxiated Infants	PLOS ONE			English	Article							MARKERS; SERUM	Background: Troponin T (cTnT) and Creatinine Kinase Isoenzyme (CK-MB) are both markers of myocardial injuries. However, CK-MB is also elevated in acute kidney injury. Objective: The diagnostic value of both cTnT and cardiac CK-MB in combined myocardial and acute kidney injuries (AKI) in asphyxiated neonates was evaluated. Method: 40 asphyxiated infants and 40 non-asphyxiated controls were consecutively recruited. Serum levels of cTnT, CK-MB and creatinine were measured. Myocardial injury and AKI were defined as cTnT>95th percentile of the control and serum creatinine >1.0 mg/dl respectively. Results: Of the 40 subjects, 9 (22.50%), 8 (20.00%) and 4 (10.00%) had myocardial injury, AKI and combined AKI and myocardial injuries respectively. The mean cTnT and CK-MB values were highest in infants with combined AKI and myocardial injuries. The Mean cTnT in infants with AKI, myocardial injury and combined AKI and myocardial injuries were 0.010 +/- 0.0007 ng/ml, 0.067 +/- 0.040 ng/ml and 0.084 +/- 0.067 ng/ml respectively, p = 0.006. The mean CK-MB in infants with AKI, myocardial injury and combined AKI and myocardial injuries were 2.78 +/- 0.22 ng/ml, 1.28 +/- 0.11 ng/ml and 4.58 +/- 0.52 ng/ml respectively, p = <0.0001. Conclusion: In severe perinatal asphyxia, renal and myocardial injuries could co-exist. Elevated cTnT signifies the presence of myocardial injury. Elevated CK-MB indicates either myocardial injury, AKI or both. Therefore renal injury should be excluded in asphyxiated infants with elevated CK-MB.	[Sadoh, Wilson E.] Univ Benin, Teaching Hosp, Dept Child Hlth, Benin, Nigeria; [Eregie, Charles O.; Nwaneri, Damian U.; Sadoh, Ayebo E.] Univ Benin, Teaching Hosp, Inst Child Hlth, Benin, Nigeria	University of Benin; University of Benin	Sadoh, WE (corresponding author), Univ Benin, Teaching Hosp, Dept Child Hlth, Benin, Nigeria.	sadohehi@yahoo.com	Nwaneri, Damian/AAZ-1200-2020	Nwaneri, Damian/0000-0001-7860-3942				Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Azra Haider Batool, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P178; BEHRMAN RE, 1970, AM J OBSTET GYNECOL, V108, P956, DOI 10.1016/0002-9378(70)90341-8; BHAYANA V, 1995, CLIN BIOCHEM, V28, P1, DOI 10.1016/0009-9120(94)00065-4; Boo NY, 2005, J PAEDIATR CHILD H, V41, P331, DOI 10.1111/j.1440-1754.2005.00626.x; Clark SJ, 2001, ARCH DIS CHILD-FETAL, V84, pF34, DOI 10.1136/fn.84.1.F34; Correale Michele, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P270; Costello AM de L, 1994, ARCH DIS CHILD FETAL, V71, pF ; EREGIE CO, 1991, DEV MED CHILD NEUROL, V33, P146; Fahey J, 2005, J MIDWIFERY WOM HEAL, V50, P677; Finster M, 2005, ANESTHESIOLOGY, V102, P855, DOI 10.1097/00000542-200504000-00022; McIntosh N, 2003, FORFAR ARNEILS TXB P, P197; Moller JC, 1998, BIOL NEONATE, V73, P367, DOI 10.1159/000013999; Nicholson JP, 2004, NELSON TXB PAEDIAT, P2393; Ogunlesi TA, 2008, NIGER MED PRACT, V53, P40; Omoigberale AI, 2010, NIGER J CLIN PRACT, V13, P321; PRIMHAK RA, 1985, ACTA PAEDIATR SCAND, V74, P595, DOI 10.1111/j.1651-2227.1985.tb11036.x; Sadoh WE, 2012, PAEDIATR INT CHILD H, V32, P43, DOI 10.1179/1465328111Y.0000000046; Sanjay A, 2004, MANUAL NEONATAL CARE, P536; Sarafidis K, 2012, PEDIATR NEPHROL, V27, P1575, DOI 10.1007/s00467-012-2162-4; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Sobki SH, 2000, SAUDI MED J, V21, P843; Uzodimma CC, 2012, WORLD J PEDIATR CONG, V3, P330, DOI 10.1177/2150135112442693	23	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91338	10.1371/journal.pone.0091338	http://dx.doi.org/10.1371/journal.pone.0091338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625749	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300074
J	Sargent, B; Schweighofer, N; Kubo, M; Fetters, L				Sargent, Barbara; Schweighofer, Nicolas; Kubo, Masayoshi; Fetters, Linda			Infant Exploratory Learning: Influence on Leg Joint Coordination	PLOS ONE			English	Article							WHITE-MATTER DISORDER; MOTOR-PERCEPTUAL TASK; FULL-TERM INFANTS; 3-MONTH-OLD INFANTS; CEREBRAL-PALSY; SPONTANEOUS KICKING; PRETERM; MEMORY; DYNAMICS; CLASSIFICATION	A critical issue in the study of infant development is to identify the processes by which task-specific action emerges from spontaneous movement. Emergent leg action has been studied by providing contingent reinforcement to specific leg movements using an overhead infant-activated mobile, however, there is limited information on the strategies used by infants to support the emergence of task-specific leg action from spontaneous movement. The purpose of this study is to (1) determine the ability of 3 month old infants to learn, through discovery, the contingency between leg action and mobile activation using a virtual threshold, and (2) identify strategies, defined by variance of the end-effectors (feet) and hip-knee joint coordination, used by infants that learned the contingency. Fourteen 3 month old infants participated in 2 sessions of mobile reinforcement on consecutive days. As a group, infants increased the percentage of mobile activation to meet performance criteria on Day 2, but did not meet memory or learning criteria across days. However, five infants learned the contingency based on individual learning criteria. When interacting with the mobile on Day 2 as compared to spontaneous kicking on Day 1, infants who learned the contingency, but not infants who did not learn the contingency, increased variance of the end-effectors (feet) in the vertical, task-specific direction and demonstrated less in-phase hip-knee joint coordination. An important discovery is that infants can discover this very specific contingency, suggesting that this movement behavior (action) can be shaped in future work. This may have implications for the rehabilitation of infants with atypical leg action.	[Sargent, Barbara] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA; [Schweighofer, Nicolas] Univ So Calif, Dept Neurosci, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Schweighofer, Nicolas] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; [Kubo, Masayoshi] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan; [Fetters, Linda] Univ So Calif, Keck Sch Med, Div Biokinesiol & Phys Therapy, Dept Pediat, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; Niigata University; University of Southern California	Sargent, B (corresponding author), Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA.	bsargent@usc.edu	Sargent, Barbara/ABG-2160-2021; Schweighofer, Nicolas/A-3675-2008	Sargent, Barbara/0000-0002-2261-6610; Schweighofer, Nicolas/0000-0003-3362-6088	Foundation for Physical Therapy; Education Section of the American Physical Therapy Association	Foundation for Physical Therapy; Education Section of the American Physical Therapy Association	This research was supported by scholarships from the Foundation for Physical Therapy and the Education Section of the American Physical Therapy Association to Barbara Sargent (http://foundation4pt.org/;http://www.aptaeducation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph K. E., 1997, MONOGRAPHS SOC RES C, V62; Adolph KE, 2008, CURR DIR PSYCHOL SCI, V17, P213, DOI 10.1111/j.1467-8721.2008.00577.x; Angulo-Kinzler RM, 2001, INFANT BEHAV DEV, V24, P239, DOI 10.1016/S0163-6383(01)00083-2; Angulo-Kinzler RM, 2002, MOTOR CONTROL, V6, P52, DOI 10.1123/mcj.6.1.52; Angulo-Kinzler RM, 2001, J MOTOR BEHAV, V33, P363, DOI 10.1080/00222890109601920; Bayley N, 2006, MANUAL BAYLEY SCALES; Chen YP, 2002, INFANT BEHAV DEV, V25, P195, DOI 10.1016/S0163-6383(02)00121-2; Fetters L, 2004, HUM MOVEMENT SCI, V22, P729, DOI 10.1016/j.humov.2004.02.001; Fetters L, 2010, DEV PSYCHOBIOL, V52, P524, DOI 10.1002/dev.20455; Fowler EG, 2009, GAIT POSTURE, V29, P102, DOI 10.1016/j.gaitpost.2008.07.007; Garciaguirre JS, 2007, CHILD DEV, V78, P664, DOI 10.1111/j.1467-8624.2007.01020.x; GEKOSKI MJ, 1984, INFANT BEHAV DEV, V7, P267, DOI 10.1016/S0163-6383(84)80042-9; Gibson E. J., 2000, ECOLOGICAL APPROACH; Haley DW, 2006, PSYCHONEUROENDOCRINO, V31, P108, DOI 10.1016/j.psyneuen.2005.06.007; Heathcock JC, 2004, PHYS THER, V84, P808, DOI 10.1093/ptj/84.9.808; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; JENSEN JL, 1994, J MOTOR BEHAV, V26, P303, DOI 10.1080/00222895.1994.9941686; Kelso J. A., 1986, PHYS LETT A, V134, P8; Lobo MA, 2013, RES DEV DISABIL, V34, P1721, DOI 10.1016/j.ridd.2013.02.010; OHR PS, 1991, AM J MENT RETARD, V96, P151; Ostensjo S, 2004, DEV MED CHILD NEUROL, V46, P580; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; ROVEE CK, 1969, J EXP CHILD PSYCHOL, V8, P33, DOI 10.1016/0022-0965(69)90025-3; Rovee-Collier C K, 1979, Adv Child Dev Behav, V13, P195, DOI 10.1016/S0065-2407(08)60348-1; Sanger TD, 2006, PEDIATRICS, V118, P2159, DOI 10.1542/peds.2005-3016; SCHNEIDER K, 1990, J MOTOR BEHAV, V22, P493; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Thelen E, 1991, MONOGRAPHS SOC RES C, V56; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Tiernan CW, 2008, J MOTOR BEHAV, V40, P133, DOI 10.3200/JMBR.40.2.133-142; Vaal J, 2000, EXP BRAIN RES, V135, P94, DOI 10.1007/s002210000508; vanEmmerik REA, 1996, J BIOMECH, V29, P1175, DOI 10.1016/0021-9290(95)00128-X; Watanabe H, 2011, HUM MOVEMENT SCI, V30, P125, DOI 10.1016/j.humov.2010.07.003	33	30	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91500	10.1371/journal.pone.0091500	http://dx.doi.org/10.1371/journal.pone.0091500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626202	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300090
J	Xu, H; Mohtashami, M; Stewart, B; Boulianne, G; Trimble, WS				Xu, Hao; Mohtashami, Mahmood; Stewart, Bryan; Boulianne, Gabrielle; Trimble, William S.			Drosophila SNAP-29 Is an Essential SNARE That Binds Multiple Proteins Involved in Membrane Traffic	PLOS ONE			English	Article							APICAL PLASMA-MEMBRANE; CANINE KIDNEY-CELLS; EPITHELIAL-CELLS; MOLECULAR-MECHANISMS; EARLY ENDOSOMES; EPS15 HOMOLOGY; EH-DOMAIN; FUSION; EXOCYTOSIS; SYNTAXIN	Each membrane fusion event along the secretory and endocytic pathways requires a specific set of SNAREs to assemble into a 4-helical coiled-coil, the so-called trans-SNARE complex. Although most SNAREs contribute one helix to the trans-SNARE complex, members of the SNAP-25 family contribute two helixes. We report the characterization of the Drosophila homologue of SNAP-29 (dSNAP-29), which is expressed throughout development. Unlike the other SNAP-25 like proteins in fruit fly (i.e., dSNAP-25 and dSNAP-24), which form SDS-resistant SNARE complexes with their cognate SNAREs, dSNAP-29 does not participate in any SDS-resistant complexes, despite its interaction with dsyntaxin1 and dsyntaxin 16 in vitro. Immunofluorescence studies indicated that dSNAP-29 is distributed in various tissues, locating in small intracellular puncta and on the plasma membrane, where it associates with EH domain-containing proteins implicated in the endocytic pathway. Overexpression and RNAi studies suggested that dSNAP-29 mediates an essential process in Drosophila development.	[Xu, Hao] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Mohtashami, Mahmood] Sunnybrook Res Inst, Dept Immunol, Toronto, ON, Canada; [Stewart, Bryan] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Boulianne, Gabrielle] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Boulianne, Gabrielle] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Trimble, William S.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Southern Mississippi; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Xu, H (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	hao.xu@usm.edu	XU, HAO/B-3194-2011	XU, HAO/0000-0002-5776-0276; Stewart, Bryan/0000-0003-2520-3632	Canadian Institutes of Health Research (GLB); Natural Sciences and Engineering Research Council of Canada (WST)	Canadian Institutes of Health Research (GLB); Natural Sciences and Engineering Research Council of Canada (WST)	These studies were supported by grants from the Canadian Institutes of Health Research (GLB) and the Natural Sciences and Engineering Research Council of Canada (WST). GLB and WST are Canada Research Chair holders. HX is a USM intramural development grant recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kang J, 2011, DEV BIOL, V355, P77, DOI 10.1016/j.ydbio.2011.04.013; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Kwong J, 2000, J CELL SCI, V113, P2273; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mohtashami M, 2001, J NEUROCHEM, V77, P1407, DOI 10.1046/j.1471-4159.2001.00363.x; Niemeyer BA, 2000, J CELL SCI, V113, P4055; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Stewart BA, 2002, J NEUROBIOL, V51, P261, DOI 10.1002/neu.10059; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Vilinsky I, 2002, GENETICS, V162, P259; Wang GY, 1997, J CELL SCI, V110, P505; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Wesolowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049886; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830	60	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91471	10.1371/journal.pone.0091471	http://dx.doi.org/10.1371/journal.pone.0091471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626111	Green Submitted, gold, Green Published			2022-12-25	WOS:000332851300087
J	Gil-Humanes, J; Piston, F; Altamirano-Fortoul, R; Real, A; Comino, I; Sousa, C; Rosell, CM; Barro, F				Gil-Humanes, Javier; Piston, Fernando; Altamirano-Fortoul, Rossana; Real, Ana; Comino, Isabel; Sousa, Carolina; Rosell, Cristina M.; Barro, Francisco			Reduced-Gliadin Wheat Bread: An Alternative to the Gluten-Free Diet for Consumers Suffering Gluten-Related Pathologies	PLOS ONE			English	Article							CELIAC-DISEASE; OPAQUE-2 CORN; NUTRITIONAL-VALUE; ALPHA-GLIADIN; EPITOPES; MALIGNANCY; MODEL; INTEGRATION; PREVALENCE; EXPRESSION	Wheat flour cannot be tolerated by those who suffer allergies to gluten. Human pathologies associated with grain proteins have increased worldwide in recent years, and the only effective treatment available is a lifelong gluten-free diet, which is complicated to follow and detrimental to gut health. This manuscript describes the development of wheat bread potentially suitable for celiac patients and other gluten-intolerant individuals. We have made bread using wheat flour with very low content of the specific gluten proteins (near gliadin-free) that are the causal agents for pathologies such as celiac disease. Loaves were compared with normal wheat breads and rice bread. Organoleptic, nutritional, and immunotoxic properties were studied. The reduced-gliadin breads showed baking and sensory properties, and overall acceptance, similar to those of normal flour, but with up to 97% lower gliadin content. Moreover, the low-gliadin flour has improved nutritional properties since its lysine content is significantly higher than that of normal flour. Conservative estimates indicate that celiac patients could safely consume 67 grams of bread per day that is made with low-gliadin flour. However, additional studies, such as feeding trials with gluten-intolerant patients, are still needed in order to determine whether or not the product can be consumed by the general celiac population, as well as the actual tolerated amount that can be safely ingested. The results presented here offer a major opportunity to improve the quality of life for millions of sufferers of gluten intolerance throughout the world.	[Gil-Humanes, Javier; Piston, Fernando; Barro, Francisco] CSIC, Inst Agr Sostenible, Cordoba, Spain; [Altamirano-Fortoul, Rossana; Rosell, Cristina M.] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Real, Ana; Comino, Isabel; Sousa, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Sevilla	Gil-Humanes, J (corresponding author), CSIC, Inst Agr Sostenible, Cordoba, Spain.	javigil@ias.csic.es; fbarro@ias.csic.es	Rosell, Cristina M/F-4888-2010; Gil-Humanes, Javier/AAU-4381-2020; Barro, Francisco/E-8572-2017; Barro, Francisco/J-3254-2014; Piston, Fernando/AAD-6975-2020	Rosell, Cristina M/0000-0001-7197-5874; Barro, Francisco/0000-0002-7652-229X; Sousa Martin, Carolina/0000-0002-9235-9496; Gil Humanes, Javier/0000-0002-7283-6945; Altamirano-Fortoul, Rossana/0000-0002-5323-8931	Spanish Ministry of Economy and Competitiveness [AGL2010-19643-C02-02]; European Regional Development Fund (FEDER); Junta de Andalucia [P09AGR-4783]; Generalitat Valenciana [Prometeo 2012/064]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The Spanish Ministry of Economy and Competitiveness (Project AGL2010-19643-C02-02), the European Regional Development Fund (FEDER), and Junta de Andalucia (Project P09AGR-4783) supported this work. Authors also acknowledge the financial support of Generalitat Valenciana (Project Prometeo 2012/064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AACCI, 2000, APPR METH AN; Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Altenbach Susan B, 2011, GM Crops, V2, P66, DOI 10.4161/gmcr.2.1.15884; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Bethune MT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040034; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; CICLITIRA PJ, 1980, CLIN SCI, V59, pP25; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Perez LC, 2012, EUR J INTERN MED, V23, P9, DOI 10.1016/j.ejim.2011.08.030; CROMWELL GL, 1967, J ANIM SCI, V26, P1325, DOI 10.2527/jas1967.2661325x; De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767; Demirkesen I, 2010, J FOOD ENG, V96, P295, DOI 10.1016/j.jfoodeng.2009.08.004; DREWS JE, 1969, J NUTR, V97, P537, DOI 10.1093/jn/97.4.537; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; FRISONI M, 1995, GUT, V36, P375, DOI 10.1136/gut.36.3.375; Frizzi A, 2008, PLANT BIOTECHNOL J, V6, P13, DOI 10.1111/j.1467-7652.2007.00290.x; Gevers H. O., 1992, Quality protein maize., P49; Ghosh S, 2004, ECOL FOOD NUTR, V43, P107, DOI 10.1080/03670240490280267; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2011, J EXP BOT, V62, P4203, DOI 10.1093/jxb/err119; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Glover DV, 1992, QUALITY PROTEIN MAIZ, P49; GUPTA HO, 1979, J AGR FOOD CHEM, V27, P390, DOI 10.1021/jf60222a046; Hager AS, 2012, EUR FOOD RES TECHNOL, V235, P333, DOI 10.1007/s00217-012-1763-2; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; Hournard NM, 2007, PLANT BIOTECHNOL J, V5, P605, DOI 10.1111/j.1467-7652.2007.00265.x; ICC, 1994, 1161 ICC INT ASS CER; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; Kasarda DD, 2013, J AGR FOOD CHEM, V61, P1155, DOI 10.1021/jf305122s; KIES C, 1972, J NUTR, V102, P757, DOI 10.1093/jn/102.6.757; KLEIN RG, 1971, J ANIM SCI, V32, P256; Kupper C, 2005, GASTROENTEROLOGY, V128, pS121, DOI 10.1053/j.gastro.2005.02.024; LEONARD JN, 1983, BRIT MED J, V286, P16, DOI 10.1136/bmj.286.6358.16; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Marco C, 2008, EUR FOOD RES TECHNOL, V227, P1205, DOI 10.1007/s00217-008-0838-6; Mariani P, 1998, J PEDIATR GASTR NUTR, V27, P519, DOI 10.1097/00005176-199811000-00004; Segura MEM, 2011, PLANT FOOD HUM NUTR, V66, P224, DOI 10.1007/s11130-011-0244-2; MCCARTHY CF, 1991, EUR J GASTROEN HEPAT, V3, P125; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Murray JA, 2004, AM J CLIN NUTR, V79, P669; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Piston F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-136; Rojas JA, 2000, EUR FOOD RES TECHNOL, V212, P57, DOI 10.1007/s002170000209; Rosell CM, 2012, WOODHEAD PUBL FOOD S, P687; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Sciarini LS, 2012, J FOOD ENG, V111, P590, DOI 10.1016/j.jfoodeng.2012.03.011; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; Silvester JA, 2007, CAN J GASTROENTEROL, V21, P557, DOI 10.1155/2007/342685; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; van den Broeck HC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-41; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Wen SS, 2012, P NATL ACAD SCI USA, V109, P20543, DOI 10.1073/pnas.1217927109; Wenefrida Ida, 2009, Recent Pat DNA Gene Seq, V3, P219; WHO, 2003, E79832 WHO; Wu XR, 2007, PLANT J, V50, P627, DOI 10.1111/j.1365-313X.2007.03076.x; YOUNG VR, 1971, J NUTR, V101, P1475, DOI 10.1093/jn/101.11.1475; Zuidmeer L, 2008, J ALLERGY CLIN IMMUN, V121, P1210, DOI 10.1016/j.jaci.2008.02.019	74	56	58	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90898	10.1371/journal.pone.0090898	http://dx.doi.org/10.1371/journal.pone.0090898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621595	Green Published, gold			2022-12-25	WOS:000332845300035
J	Guedes, PT; de Oliveira, BCEPD; Manso, PPD; Caputo, LFG; Cotta-Pereira, G; Pelajo-Machado, M				Guedes, Priscila Tavares; Pereira Dias de Oliveira, Barbara Cristina Euzebio; de Abreu Manso, Pedro Paulo; Goncalves Caputo, Luzia Fatima; Cotta-Pereira, Gerson; Pelajo-Machado, Marcelo			Histological Analyses Demonstrate the Temporary Contribution of Yolk Sac, Liver, and Bone Marrow to Hematopoiesis during Chicken Development	PLOS ONE			English	Article							COLONY-FORMING CELLS; STEM-CELLS; DEFINITIVE ERYTHROPOIESIS; AVIAN DEVELOPMENT; EMBRYO AORTA; SIRIUS RED; MOUSE; ONTOGENY; ORIGIN; TISSUE	The use of avian animal models has contributed to the understanding of many aspects of the ontogeny of the hematopoietic system in vertebrates. However, specific events that occur in the model itself are still unclear. There is a lack of consensus, among previous studies, about which is the intermediate site responsible for expansion and differentiation of hematopoietic cells, and the liver's contribution to the development of this system. Here we aimed to evaluate the presence of hematopoiesis in the yolk sac and liver in chickens, from the stages of intra-aortic clusters in the aorta-genital ridges-mesonephros (AGM) region until hatching, and how it relates to the establishment of the bone marrow. Gallus gallus domesticus L. embryos and their respective yolk sacs at embryonic day 3 (E3) and up to E21 were collected and processed according to standard histological techniques for paraffin embedding. The slides were stained with hematoxylin-eosin, Lennert's Giemsa, and Sirius Red at pH 10.2, and investigated by light microscopy. This study demonstrated that the yolk sac was a unique hematopoietic site between E4 and E12. Hematopoiesis occurred in the yolk sac and bone marrow between E13 and E20. The liver showed granulocytic differentiation in the connective tissue of portal spaces at E15 and onwards. The yolk sac showed expansion of erythrocytic and granulocytic lineages from E6 to E19, and E7 to E20, respectively. The results suggest that the yolk sac is the major intermediate erythropoietic and granulopoietic site where expansion and differentiation occur during chicken development. The hepatic hematopoiesis is restricted to the portal spaces and represented by the granulocytic lineage.	[Guedes, Priscila Tavares; Pereira Dias de Oliveira, Barbara Cristina Euzebio; de Abreu Manso, Pedro Paulo; Goncalves Caputo, Luzia Fatima; Pelajo-Machado, Marcelo] Oswaldo Cruz Inst Fiocruz, Pathol Lab, Rio De Janeiro, Brazil; [Cotta-Pereira, Gerson] Santa Casa Misericordia Rio de Janeiro, Lab Immunochem & Histochem, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Pelajo-Machado, M (corresponding author), Oswaldo Cruz Inst Fiocruz, Pathol Lab, Rio De Janeiro, Brazil.	mpelajo@ioc.fiocruz.br	de Abreu Manso, Pedro Paulo/M-7326-2018; Machado, Marcelo Pelajo/I-5359-2012	de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Pelajo Machado, Marcelo/0000-0002-7295-7018	CNPq; Faperj; Fiocruz	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz	Priscila Tavares Guedes was a PhD fellow at the Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, Brazil. This study was supported by CNPq, Faperj, and Fiocruz grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Ayres-Silva JD, 2011, CELL TISSUE RES, V344, P455, DOI 10.1007/s00441-011-1170-1; BOGOMOLETZ W, 1980, ARCH ANAT CYTOL PATH, V28, P252; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; CARSON FL, 1973, AM J CLIN PATHOL, V59, P365; CORMIER F, 1986, DEV BIOL, V118, P167, DOI 10.1016/0012-1606(86)90084-9; CORMIER F, 1988, DEVELOPMENT, V102, P279; CUDENNEC CA, 1981, P NATL ACAD SCI-BIOL, V78, P2412, DOI 10.1073/pnas.78.4.2412; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dantschakoff W, 1909, ARCH MIKRO ANAT ENTW, V74, P855, DOI 10.1007/BF02979951; Dantschakoff Wera., 1908, Anatomische Hefte Wiesbaden Abt 1, V37; DIETERLENLIEVRE F, 1976, ANN INST PASTEUR IMM, VC127, P857; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DIETERLENLIEVRE F, 1984, DEV COMP IMMUNOL S, V3, P75; Godin I, 2005, INT J DEV BIOL, V49, P251, DOI 10.1387/ijdb.041945ig; GORDON MY, 1993, BLOOD REV, V7, P190, DOI 10.1016/0268-960X(93)90005-O; Haff R, 1914, ARCH MIKROSK ANAT, V84, P321, DOI 10.1007/BF02991372; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; Jordan HE, 1936, AM J ANAT, V59, P249, DOI 10.1002/aja.1000590204; JUURLINK BH, 1973, CAN J ZOOL, V51, P509, DOI 10.1139/z73-076; KARRER HE, 1961, J ULTRA MOL STRUCT R, V5, P116, DOI 10.1016/S0022-5320(61)90009-0; KAUFMAN MH, 1998, ATLAS MOUSE DEV; KINGSBURY JW, 1956, ANAT RECORD, V124, P165, DOI 10.1002/ar.1091240204; LASSILA O, 1978, NATURE, V272, P353, DOI 10.1038/272353a0; LENNERT K, 1978, MALIGNANT LYMPHOMAS; Marks P A, 1966, Curr Top Dev Biol, V1, P213, DOI 10.1016/S0070-2153(08)60014-9; MAYER P, 1903, Z WISSENSCHAFTLICHE, V20, P409; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nagai H, 2008, DEV DYNAM, V237, P3332, DOI 10.1002/dvdy.21746; NICOLA NA, 1982, BLOOD, V60, P1019; Niimi Gen, 2008, Italian Journal of Anatomy and Embryology, V113, P9; OGAWA M, 1983, BLOOD, V61, P823; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; Russel ES, 1966, BIOL LAB MOUSE; Schoenwolf G., 2020, LARSENS HUMAN EMBRYO, V6th edn; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; Stewart JR, 2000, J MORPHOL, V244, P81, DOI 10.1002/(SICI)1097-4687(200005)244:2<81::AID-JMOR1>3.0.CO;2-D; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TURPEN JB, 1982, DEV BIOL, V89, P138, DOI 10.1016/0012-1606(82)90302-5; VASSE J, 1981, J EMBRYOL EXP MORPH, V62, P129; Wehrend A, 2004, ANAT HISTOL EMBRYOL, V33, P180, DOI 10.1111/j.1439-0264.2004.00532.x; WONG GK, 1993, ANAT REC, V235, P131, DOI 10.1002/ar.1092350114; ZON LI, 1995, BLOOD, V86, P2876	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90975	10.1371/journal.pone.0090975	http://dx.doi.org/10.1371/journal.pone.0090975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621665	gold, Green Published			2022-12-25	WOS:000332845300040
J	Nakamura, Y; Bryan, J				Nakamura, Yumiko; Bryan, Joseph			Targeting SUR1/Abcc8-Type Neuroendocrine K-ATP Channels in Pancreatic Islet Cells	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; GLUCAGON-SECRETION; INTRAISLET INSULIN; ALPHA-CELL; BETA-CELLS; GLUCOSE; HYPOGLYCEMIA; MOUSE; MICE; LACKING	ATP-sensitive K+ (K-ATP) channels play a regulatory role in hormone-secreting pancreatic islet alpha-, beta- and delta-cells. Targeted channel deletion would assist analysis and dissection of the intraislet regulatory network. Toward this end Abcc8/Sur1 flox mice were generated and tested by crossing with glucagon-(GCG)-cre mice to target alpha-cell K-ATP channels selectively. Agonist resistance was used to quantify the percent of alpha-cells lacking channels. 41% of Sur1(loxP/loxP);GCG-cre(+) and similar to 64% of Sur1(loxP/-);GCG-cre(+) alpha-cells lacked K-ATP channels, while similar to 65% of alpha-cells expressed enhanced yellow fluorescent protein (EYFP) in ROSA-EYFP/GCG-cre matings. The results are consistent with a stochastic two-recombination event mechanism and a requirement that both floxed alleles are deleted.	[Nakamura, Yumiko; Bryan, Joseph] Pacific Northwest Diabet Res Inst, Seattle, WA 98122 USA	Pacific Northwest Diabetes Research Institute (PNDRI)	Nakamura, Y (corresponding author), Pacific Northwest Diabet Res Inst, Seattle, WA 98122 USA.	ynakamura@pnri.org		Brusgaard, Klaus/0000-0002-2096-4988	Pacific Northwest Diabetes Research Institute (PNDRI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647] Funding Source: NIH RePORTER	Pacific Northwest Diabetes Research Institute (PNDRI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by internal funds from the Pacific Northwest Diabetes Research Institute (PNDRI); but Drs. Nakamura and Bryan are employees of PNDRI. The funders, PNDRI, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoplan A, 2005, ADV GENET, V55, P1, DOI 10.1016/S0065-2660(05)55001-6; Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; De Leon DD, 2008, J BIOL CHEM, V283, P25786, DOI 10.1074/jbc.M804372200; Farhy LS, 2008, AM J PHYSIOL-ENDOC M, V295, pE575, DOI 10.1152/ajpendo.90372.2008; Farhy Leon S, 2010, J Diabetes Sci Technol, V4, P1345; Gosmanov NR, 2005, DIABETES CARE, V28, P1124, DOI 10.2337/diacare.28.5.1124; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Karimian N, 2013, DIABETES; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Larsson H, 1998, DIABETOLOGIA, V41, P772, DOI 10.1007/s001250050986; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Mohamed Z, 2012, J CLIN RES PEDIATR E, V4, P169, DOI [10.4274/jcrpe.821, 10.4274/Jcrpe.821]; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; Nyman LR, 2010, AM J PHYSIOL-ENDOC M, V298, pE807, DOI 10.1152/ajpendo.00715.2009; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; Robertson RP, 2011, DIABETES OBES METAB, V13, P106, DOI 10.1111/j.1463-1326.2011.01448.x; Rorsman P, 2008, TRENDS ENDOCRIN MET, V19, P277, DOI 10.1016/j.tem.2008.07.003; Rui CX, 2013, DIABETES, V62, P1612, DOI 10.2337/db12-0347; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; Szollosi A, 2007, J BIOL CHEM, V282, P1747, DOI 10.1074/jbc.M609875200; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91525	10.1371/journal.pone.0091525	http://dx.doi.org/10.1371/journal.pone.0091525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621811	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300100
J	Prentice, JR; Blackwell, CS; Raoof, N; Bacon, P; Ray, J; Hickman, SJ; Wilkinson, JM				Prentice, Jennifer R.; Blackwell, Christopher S.; Raoof, Naz; Bacon, Paul; Ray, Jaydip; Hickman, Simon J.; Wilkinson, J. Mark			Auditory and Visual Health after Ten Years of Exposure to Metal-on-Metal Hip Prostheses: A Cross-Sectional Study Follow Up	PLOS ONE			English	Article							RESURFACING ARTHROPLASTY; SIGHT	Case reports of patients with mal-functioning metal-on-metal hip replacement (MoMHR) prostheses suggest an association of elevated circulating metal levels with visual and auditory dysfunction. However, it is unknown if this is a cumulative exposure effect and the impact of prolonged low level exposure, relevant to the majority of patients with a well-functioning prosthesis, has not been studied. Twenty four male patients with a well-functioning MoMHR and an age and time since surgery matched group of 24 male patients with conventional total hip arthroplasty (THA) underwent clinical and electrophysiological assessment of their visual and auditory health at a mean of ten years after surgery. Median circulating cobalt and chromium concentrations were higher in patients after MoMHR versus those with THA (P<0.0001), but were within the Medicines and Healthcare Products Regulatory Agency (UK) investigation threshold. Subjective auditory tests including pure tone audiometric and speech discrimination findings were similar between groups (P>0.05). Objective assessments, including amplitude and signal-to-noise ratio of transient evoked and distortion product oto-acoustic emissions (TEOAE and DPOAE, respectively), were similar for all the frequencies tested (P>0.05). Auditory brainstem responses (ABR) and cortical evoked response audiometry (ACR) were also similar between groups (P>0.05). Ophthalmological evaluations, including self-reported visual function by visual functioning questionnaire, as well as binocular low contrast visual acuity and colour vision were similar between groups (P>0.05). Retinal nerve fibre layer thickness and macular volume measured by optical coherence tomography were also similar between groups (P>0.05). In the presence of moderately elevated metal levels associated with well-functioning implants, MoMHR exposure does not associate with clinically demonstrable visual or auditory dysfunction.	[Prentice, Jennifer R.; Blackwell, Christopher S.; Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Raoof, Naz] Sheffield Teaching Hosp NHS Fdn Trust, Dept Ophthalmol, Sheffield, S Yorkshire, England; [Bacon, Paul; Ray, Jaydip] Sheffield Teaching Hosp NHS Fdn Trust, Dept Otolaryngol, Sheffield, S Yorkshire, England; [Hickman, Simon J.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Wilkinson, JM (corresponding author), Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England.	j.m.wilkinson@sheffield.ac.uk	Raoof, Naz/AAL-4240-2020		Sheffield Musculoskeletal Biomedical Research Unit through National Institute of Health Research in the United Kingdom (NIHR)	Sheffield Musculoskeletal Biomedical Research Unit through National Institute of Health Research in the United Kingdom (NIHR)	This study was funded by Sheffield Musculoskeletal Biomedical Research Unit through its core grant from the National Institute of Health Research in the United Kingdom (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostoli P, 2013, EXP TOXICOL PATHOL, V65, P719, DOI 10.1016/j.etp.2012.09.006; BOOTHROYD A, 1968, J ACOUST SOC AM, V43, P362, DOI 10.1121/1.1910787; Clark MJ, 2014, AM J NEUROR IN PRESS; Daniel J, 2007, J BONE JOINT SURG BR, V89B, P169, DOI 10.1302/0301-620X.89B2.18519; HARTMANN A, 2012, CLIN ORTHOP RELAT RE; Heisel C, 2008, J BONE JOINT SURG AM, V90A, P125, DOI 10.2106/JBJS.H.00437; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Holland JP, 2012, J BONE JOINT SURG BR, V94B, P471, DOI 10.1302/0301-620X.94B4.27895; Ikeda T, 2010, MUSCLE NERVE, V42, P140, DOI 10.1002/mus.21638; JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; Katz B, 1995, Trans Am Ophthalmol Soc, V93, P685; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; MEECHAM HM, 1991, J NEUROL NEUROSUR PS, V54, P374, DOI 10.1136/jnnp.54.4.374; Oldenburg M., 2009, J ARTHROPLASTY, V24, P825, DOI [10.1016/j.arth.2008.07.017 e15-825.e20, DOI 10.1016/J.ARTH.2008.07.017]; Prentice JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066186; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rising JP, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMp1206794; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6; Steens W, 2006, ACTA ORTHOP, V77, P830, DOI 10.1080/17453670610013079; Tower SS, 2010, J BONE JOINT SURG AM, V92A, P2847, DOI 10.2106/JBJS.J.00125	20	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90838	10.1371/journal.pone.0090838	http://dx.doi.org/10.1371/journal.pone.0090838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621561	Green Published, Green Accepted, gold			2022-12-25	WOS:000332845300032
J	Sasson, M; Lee, M; Jan, C; Fontes, F; Motta, J				Sasson, Morris; Lee, Marcos; Jan, Carmen; Fontes, Flavia; Motta, Jorge			Prevalence and Associated Factors of Obesity among Panamanian Adults. 1982-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; MORTALITY; OVERWEIGHT; INCOME; COUNTRIES; EPIDEMIC; COHORT; RISK	Background: In Central America, there has been a marked increase in obesity in the last 30 years. Over this time frame, in Panama, there have been lifestyle changes associated with economic development and urbanization that may have facilitated increases in body weight. The aim of the study is to describe the change in the prevalence of obesity in the country since 1982 and to analyze the association of obesity with gender, place of residence and socioeconomic factors. Methods: We analyzed three nationally representative cross-sectional studies and one sub-national study of Panamanian adults that evaluated anthropometric and socioeconomic variables; ENPA-1982 (n = 11 611), ENV-II 2003 (n = 14 737), ENV-III 2008 (n = 15 484), PREFREC-2010 (n = 3 590). We also evaluated one nationally representative study that evaluated people's perception of their body weight, ENSCAVI-2007 (n = 25 748). Results: In 1982, the prevalence in males of a body mass index (BMI) >= 30 kg/m(2) was 3.8% (3.3 - 4.2) and in females 7.6% (6.9 - 8.2). In 2003, the prevalence in males increased to 14.4% (13.6 - 15.2) and in females to 21.8% (20.8 - 22.7). In 2008, the prevalence in males was 16.9% (16.0 - 17.7) and in females it was 23.8% (22.8 - 24.7). Nevertheless, in 2007, the national perception of being obese was only 4% among males and 6.7% among females. The highest prevalence of obesity was noted in urban areas. Female gender and higher income were found to be positively associated with obesity. Income level was positively associated with abdominal obesity in men but not in women. Conclusions: There has been a marked increase of obesity in Panama in the last 3 decades. Initiatives to control this problem will have to take into consideration the observed gender difference and the lifestyle changes that have contributed to the rise of this problem.	[Sasson, Morris; Lee, Marcos; Jan, Carmen; Motta, Jorge] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Fontes, Flavia] Minist Hlth, Dept Nutr, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; Ministerio de Salud de la Republica de Panama	Motta, J (corresponding author), Gorgas Mem Inst Hlth Studies, Panama City, Panama.	drjmotta@gmail.com	Motta, Jorge Alejandro/ABI-6006-2020					Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Akil L, 2011, ETHNIC DIS, V21, P58; Alvarez V, 2009, EXPERT REV CARDIOVAS, V7, P281; Barcelo A, 2012, DIABETES CARE, V35, P738, DOI 10.2337/dc11-1614; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Clark Ashley E., 2013, Yale Journal of Biology and Medicine, V86, P29; Contraloria Panama website, 2008, ENC NIV VID ENV; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Garcia-Garcia E, 2008, SALUD PUBLICA MEXICO, V50, P530, DOI 10.1590/S0036-36342008000600015; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Herman KM, 2013, QUALITY LIFE RES INT; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; ICGES website, 2010, PREV FACT RIESG AS E; ICGES website, TAS AJ MORT TOD ENF; ICGES website, 2007, ENC NAC SAL CAL VID; Kuchler F, 2003, INT J OBESITY, V27, P856, DOI 10.1038/sj.ijo.0802293; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Liu JK, 2013, OBESITY, V21, P644, DOI 10.1002/oby.20265; de Mola CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050252; Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6; MacDonald J, 2009, REV PANAM SALUD PUBL, V26, P290, DOI 10.1590/S1020-49892009001000002; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Monteiro CA, 2001, J NUTR, V131, p881S, DOI 10.1093/jn/131.3.881S; Motta J, 2012, ANALISIS MORTALIDAD; Motta JA, 2013, REV PANAM SALUD PUBL, V34, P114; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Pisabarro R, 2009, REV MED URUG, V25, P14; Popkin BM, 1998, NUTR REV, V56, P106; Rodriquez J RF, 2009, ENCUESTA NACL SALUD; Schulz LO, 2006, DIABETES CARE, V29, P1866, DOI 10.2337/dc06-0138; Seubsman SA, 2010, J EPIDEMIOL, V20, P13, DOI 10.2188/jea.JE20090014; Solomon CG, 1997, AM J CLIN NUTR, V66, P1044, DOI 10.1093/ajcn/66.4.1044S; Stoddard P, 2011, SOC SCI MED, V73, P1635, DOI 10.1016/j.socscimed.2011.09.006; The World Bank website, PAN ENC NIV VID 2008; The World Bank website, URB POP; The World Bank website, PAN OV; The World Bank website, LIV STAND MEAS STUD; The World Bank website, 2003, ENC NIV VID ENV; The World Bank website, GDP PER CAP; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; WHO website, OV OB MEAN BOD MASS; Xiao YY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-355	58	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91689	10.1371/journal.pone.0091689	http://dx.doi.org/10.1371/journal.pone.0091689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621825	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300119
J	Steen, DA; Hopkins, BC; Van Dyke, JU; Hopkins, WA				Steen, David A.; Hopkins, Brittney C.; Van Dyke, James U.; Hopkins, William A.			Prevalence of Ingested Fish Hooks in Freshwater Turtles from Five Rivers in the Southeastern United States	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; CHELYDRA-SERPENTINA; PELAGIC LONGLINES; SNAPPING TURTLE; MORTALITY; BYCATCH; CONSERVATION; MANAGEMENT; FISHERIES; PATTERNS	Freshwater turtles may ingest baited fish hooks because many are opportunistic scavengers. Although the ingestion of fish hooks is known to be a source of mortality in multiple vertebrate groups, the prevalence of hook ingestion by freshwater turtles has not been well studied. We trapped turtles from five rivers in the southeastern United States and used radiographs to examine over 600 individuals of four species. Depending on the species, sex, and age class, 0-33% of turtles contained ingested fish hooks. For some species, larger turtles were more likely to contain a fish hook than smaller individuals. Freshwater turtle demography suggests that even small increases in adult mortality may lead to population declines. If our study areas are representative of other aquatic systems that receive fishing pressure, this work likely identifies a potential conflict between a widespread, common recreational activity (i.e., fishing) and an imperiled taxonomic group.	[Steen, David A.; Hopkins, Brittney C.; Hopkins, William A.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Van Dyke, James U.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Virginia Polytechnic Institute & State University; University of Sydney	Steen, DA (corresponding author), Auburn Univ, Inst Environm, Alabama Nat Heritage Program, Auburn, AL 36849 USA.	davidasteen@gmail.com		Van Dyke, James/0000-0002-3933-111X	Tennessee Valley Authority [00050623]; E.I. DuPont de Nemours [LBIO-65967]; Fralin Life Sciences Institute (Virginia Tech); Virginia Tech's Open Access Subvention Fund	Tennessee Valley Authority; E.I. DuPont de Nemours; Fralin Life Sciences Institute (Virginia Tech); Virginia Tech's Open Access Subvention Fund	Research was funded by the Tennessee Valley Authority (grant # 00050623), E.I. DuPont de Nemours (grant # LBIO-65967), and the Fralin Life Sciences Institute (Virginia Tech). Publishing costs were provided by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barko VA, 2004, J WILDLIFE MANAGE, V68, P1145, DOI 10.2193/0022-541X(2004)068[1145:PFTACO]2.0.CO;2; Borkowski R, 1997, J ZOO WILDLIFE MED, V28, P109; Broadhurst MK, 2007, DIS AQUAT ORGAN, V74, P27, DOI 10.3354/dao074027; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Bulte G, 2010, AQUAT CONSERV, V20, P31, DOI [10.1002/aqc.1063, 10.1002/aqc.1089]; Casale P, 2008, AQUAT CONSERV, V18, P945, DOI 10.1002/aqc.894; Chaloupka M, 2004, MAR ECOL PROG SER, V280, P285, DOI 10.3354/meps280285; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CONGDON JD, 1994, AM ZOOL, V34, P397; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Dau BK, 2009, J WILDLIFE DIS, V45, P355, DOI 10.7589/0090-3558-45.2.355; Deflorio M, 2005, FISHERIES SCI, V71, P1010, DOI 10.1111/j.1444-2906.2005.01058.x; Elsey RM, 2006, SOUTHEAST NAT, V5, P443, DOI 10.1656/1528-7092(2006)5[443:FHOMTA]2.0.CO;2; Ernst CH, 2009, TURTLES US CANADA; Fratto ZW, 2008, J WILDLIFE MANAGE, V72, P1628, DOI 10.2193/2007-216; Galois P, 2007, CHELONIAN CONSERV BI, V6, P288, DOI 10.2744/1071-8443(2007)6[288:TIIESS]2.0.CO;2; GARBER SD, 1995, ECOL APPL, V5, P1151, DOI 10.2307/2269362; GIBBONS JW, 1979, HERPETOLOGICA, V35, P86; Grosse AM, 2011, J WILDLIFE MANAGE, V75, P762, DOI 10.1002/jwmg.104; Heinrich GL, 2012, HERPETOL CONSERV BIO, V7, P349; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hopkins BC, 2013, ENVIRON SCI TECHNOL, V47, P2416, DOI 10.1021/es304261s; Howey CAF, 2013, COPEIA, P58, DOI 10.1643/CE-12-040; Klemens MW., 2000, TURTLE CONSERVATION; Larocque SM, 2012, ANIM CONSERV, V15, P53, DOI 10.1111/j.1469-1795.2011.00487.x; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Lowry MB, 2005, AQUAT CONSERV, V15, P7, DOI 10.1002/aqc.639; McGrath SP, 2009, J FISH BIOL, V74, P220, DOI 10.1111/j.1095-8649.2008.02135.x; Meka JM, 2004, N AM J FISH MANAGE, V24, P1309, DOI 10.1577/M03-108.1; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Moore MJC, 2006, BIOL CONSERV, V130, P386, DOI 10.1016/j.biocon.2006.01.001; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; Nemoz M, 2004, BIOLOGIA, V59, P185; NUFER AJ, 1992, N AM J FISH MANAGE, V12, P634; Oros J, 2004, VET REC, V155, P169, DOI 10.1136/vr.155.6.169; Parga ML, 2012, B MAR SCI, V88, P731, DOI 10.5343/bms.2011.1063; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Read AJ, 2007, BIOL CONSERV, V135, P155, DOI 10.1016/j.biocon.2006.10.030; Rhodin AGJ, 2010, CHELONIANS RES MONOG, V5, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V3.2010; Steen DA, 2006, ANIM CONSERV, V9, P269, DOI 10.1111/j.1469-1795.2006.00032.x; Stokes Lesley W., 2011, Endangered Species Research, V14, P1, DOI 10.3354/esr00339; *TN WILDL RES AG, 2012, 2012 TENN FISH GUID; *VA DEP GAM INL FI, 2014, 2014 FRESHW FISH VIR; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Watson JW, 2005, CAN J FISH AQUAT SCI, V62, P965, DOI 10.1139/F05-004	49	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91368	10.1371/journal.pone.0091368	http://dx.doi.org/10.1371/journal.pone.0091368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621919	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300082
J	Wallace, LA; Li, J; McDaid, LM				Wallace, Lesley A.; Li, Jessica; McDaid, Lisa M.			HIV Prevalence and Undiagnosed Infection among a Community Sample of Gay and Bisexual Men in Scotland, 2005-2011: Implications for HIV Testing Policy and Prevention	PLOS ONE			English	Article							HOMOSEXUAL-MEN; SEX; SETTINGS; RISK; TRANSMISSION; BARRIERS; OUTREACH; UNAWARE; AWARE	Objective: To examine HIV prevalence, HIV testing behaviour, undiagnosed infection and risk factors for HIV positivity among a community sample of gay men in Scotland. Methods: Cross-sectional survey of gay and bisexual men attending commercial gay venues in Glasgow and Edinburgh, Scotland with voluntary anonymous HIV testing of oral fluid samples in 2011. A response rate of 65.2% was achieved (1515 participants). Results: HIV prevalence (4.8%, 95% confidence interval, CI 3.8% to 6.2%) remained stable compared to previous survey years (2005 and 2008) and the proportion of undiagnosed infection among HIV-positive men (25.4%) remained similar to that recorded in 2008. Half of the participants who provided an oral fluid sample stated that they had had an HIV test in the previous 12 months; this proportion is significantly higher when compared to previous study years (50.7% versus 33.8% in 2005, p<0.001). Older age (>25 years) was associated with HIV positivity (1.8% in those,25 versus 6.4% in older ages group) as was a sexually transmitted infection (STI) diagnosis within the previous 12 months (adjusted odds ratio 2.13, 95% CI 1.09-4.14). There was no significant association between age and having an STI or age and any of the sexual behaviours recorded. Conclusion: HIV transmission continues to occur among gay and bisexual men in Scotland. Despite evidence of recent testing within the previous six months, suggesting a willingness to test, the current opt-out policy may have reached its limit with regards to maximising HIV test uptake. Novel strategies are required to improve regular testing opportunities and more frequent testing as there are implications for the use of other biomedical HIV interventions.	[Wallace, Lesley A.] Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Li, Jessica] Univ Sheffield, Sect Publ Hlth, Sheffield, S Yorkshire, England; [McDaid, Lisa M.] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	NHS National Services Scotland; University of Sheffield; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Wallace, LA (corresponding author), Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland.	lesley.wallace@nhs.net		McDaid, Lisa/0000-0002-7711-8723	UK Medical Research Council (MRC) as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; Health Protection Scotland; MRC as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; MRC [MC_UU_12017/2, MC_U130031238] Funding Source: UKRI; Medical Research Council [MC_U130031238, MC_UU_12017/2] Funding Source: researchfish	UK Medical Research Council (MRC) as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; Health Protection Scotland; MRC as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The 2011 survey was funded by the UK Medical Research Council (MRC) as part of the Sexual Health programme (MC_U130031238/MC_UU_12017/2) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow and Health Protection Scotland. Jessica Li (at the time of conducting the analysis) and Dr. Lisa McDaid are funded by the MRC as part of the Sexual Health programme (MC_U130031238/MC_UU_12017/2) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], 2013, HIV UK 2013 REPORT D; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1233; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cullen B, 2010, HPS WEEKLY REPORT, V44, P72; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hart GJ, 2005, SEX TRANSM INFECT, V81, P367, DOI 10.1136/sti.2004.013995; Health Protection Agency, 2011, HLTH PROTECTION WEEK, V5, P24; Health Protection Agency, 2011, SEX TRANSM INF MEN W; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Knussen C, 2011, SEX TRANSM INFECT, V87, P257, DOI 10.1136/sti.2010.045047; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; McDaid LM, 2013, SEX TRANSM INFECT, V89, P223, DOI 10.1136/sextrans-2012-050605; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; McDonald SA, 2012, SEX TRANSM INFECT, V88, P194, DOI 10.1136/sextrans-2011-050132; National Institute for Health and Clinical Excellence, 2011, INCR UPT HIV TEST ME; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Platteau T, 2012, ACTA CLIN BELG, V67, P172, DOI 10.2143/ACB.67.3.2062651; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Prestage G, 2012, SEX HEALTH, V9, P453, DOI 10.1071/SH12033; Scottish Government, 2005, RESP RESP STRAT ACT; Sexual Health Epidemiology Group, 2009, SCOTL SEX HLTH INF 2; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Wallace L. A., 2012, HPS Weekly Report, V46, P265; Williamson LM, 2007, JAIDS-J ACQ IMM DEF, V45, P224, DOI 10.1097/QAI.0b013e318058a01e	31	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90805	10.1371/journal.pone.0090805	http://dx.doi.org/10.1371/journal.pone.0090805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621479	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000332845300030
J	Zaravinos, A; Lambrou, GI; Mourmouras, N; Katafygiotis, P; Papagregoriou, G; Giannikou, K; Delakas, D; Deltas, C				Zaravinos, Apostolos; Lambrou, George I.; Mourmouras, Nikos; Katafygiotis, Patroklos; Papagregoriou, Gregory; Giannikou, Krinio; Delakas, Dimitris; Deltas, Constantinos			New miRNA Profiles Accurately Distinguish Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas from the Normal Kidney	PLOS ONE			English	Article							MICRORNA EXPRESSION; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; CANCER; CLASSIFICATION; INHIBITION; SUBTYPES; TUMORS; IDENTIFICATION; PROLIFERATION	Background: Upper tract urothelial carcinomas (UT-UC) can invade the pelvicalyceal system making differential diagnosis of the various histologically distinct renal cell carcinoma (RCC) subtypes and UT-UC, difficult. Correct diagnosis is critical for determining appropriate surgery and post-surgical treatments. We aimed to identify microRNA (miRNA) signatures that can accurately distinguish the most prevalent RCC subtypes and UT-UC form the normal kidney. Methods and Findings: miRNA profiling was performed on FFPE tissue sections from RCC and UT-UC and normal kidney and 434 miRNAs were significantly deregulated in cancerous vs. the normal tissue. Hierarchical clustering distinguished UT-UCs from RCCs and classified the various RCC subtypes among them. qRT-PCR validated the deregulated expression profile for the majority of the miRNAs and ROC analysis revealed their capability to discriminate between tumour and normal kidney. An independent cohort of freshly frozen RCC and UT-UC samples was used to validate the deregulated miRNAs with the best discriminatory ability (AUC>0.8, p<0.001). Many of them were located within cytogenetic regions that were previously reported to be significantly aberrated. miRNA targets were predicted using the miRWalk algorithm and ingenuity pathway analysis identified the canonical pathways and curated networks of the deregulated miRNAs. Using the miRWalk algorithm, we further identified the top anti-correlated mRNA/miRNA pairs, between the deregulated miRNAs from our study and the top co-deregulated mRNAs among 5 independent ccRCC GEO datasets. The AB8/13 undifferentiated podocyte cells were used for functional assays using luciferase reporter constructs and the developmental transcription factor TFCP2L1 was proved to be a true target of miR-489, which was the second most upregulated miRNA in ccRCC. Conclusions: We identified novel miRNAs specific for each RCC subtype and UT-UC, we investigated their putative targets, the networks and pathways in which they participate and we functionally verified the true targets of the top deregulated miRNAs.	[Zaravinos, Apostolos; Papagregoriou, Gregory; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Mol Med Res Ctr, Nicosia, Cyprus; [Zaravinos, Apostolos; Papagregoriou, Gregory; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Lab Mol & Med Genet, Nicosia, Cyprus; [Lambrou, George I.] Univ Athens, Dept Pediat 1, Choremeio Res Lab, Athens, Greece; [Mourmouras, Nikos; Katafygiotis, Patroklos; Delakas, Dimitris] Asklipieio Gen Hosp, Dept Urol, Athens, Greece; [Giannikou, Krinio] Univ Athens, Sch Med, Dept Med Genet, GR-11527 Athens, Greece	University of Cyprus; University of Cyprus; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Zaravinos, A (corresponding author), Karolinska Inst Huddinge, Dept Lab Med, Stockholm, Sweden.	zaravinos.apostolos@ucy.ac.cy; Deltas@ucy.ac.cy	Giannikou, Krinio/AAC-9214-2022; Zaravinos, Apostolos/B-2528-2019; Deltas, Constantinos/A-4936-2013; Lambrou, George/F-9674-2011	Zaravinos, Apostolos/0000-0003-4625-5562; Deltas, Constantinos/0000-0001-5549-9169; Lambrou, George/0000-0001-8389-1360; Papagregoriou, Gregory/0000-0002-2440-9789	Cyprus Research Promotion Foundation [New Infrastructure/SigmaTPATH/0308/24]; EU	Cyprus Research Promotion Foundation; EU(European Commission)	This project was funded by the Cyprus Research Promotion Foundation, New Infrastructure/Sigma TPATH/0308/24 (co-funding by the EU Structural Funds) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Bratslavsky G, 2007, CLIN CANCER RES, V13, P4667, DOI 10.1158/1078-0432.CCR-06-2510; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng ZH, 2011, J MOL CELL BIOL, V3, P44, DOI 10.1093/jmcb/mjq040; Ficarra V, 2006, EUR UROL, V50, P786, DOI 10.1016/j.eururo.2006.04.009; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Girgis AH, 2012, CANCER RES, V72, P5273, DOI 10.1158/0008-5472.CAN-12-0656; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Izquierdo L, 2013, BJU INT; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kirkali Z, 2003, CRIT REV ONCOL HEMAT, V47, P155, DOI 10.1016/S1040-8428(03)00079-9; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; KOVACS G, 1991, GENE CHROMOSOME CANC, V3, P249, DOI 10.1002/gcc.2870030403; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Lopez-Beltran A, 2008, SEMIN DIAGN PATHOL, V25, P232, DOI 10.1053/j.semdp.2008.07.006; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meloni-Ehrig AM, 2002, AM J MED GENET, V115, P164, DOI 10.1002/ajmg.10697; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Roupret M, 2012, ACTAS UROL ESP, V36, P2, DOI 10.1016/j.acuro.2011.09.001; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Sato A, 2013, INT J ONCOL, V43, P1441, DOI 10.3892/ijo.2013.2073; Spector Y, 2013, MOL ONCOL, V7, P732, DOI 10.1016/j.molonc.2013.03.002; SPEICHER MR, 1994, AM J PATHOL, V145, P356; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tazi E, 2011, UROL J, V8, P1; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Thapa RJ, 2013, MOL CANCER THER, V12, P1568, DOI 10.1158/1535-7163.MCT-12-1010; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; vandenBerg E, 1997, CANCER GENET CYTOGEN, V95, P103, DOI 10.1016/S0165-4608(96)00289-0; Velickovic M, 2001, CANCER RES, V61, P4815; Wach S, 2013, BRIT J CANCER, V109, P714, DOI 10.1038/bjc.2013.313; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wu Y, 2011, J CANCER RES CLIN, V137, P887, DOI 10.1007/s00432-010-0951-3; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Yoshimoto T, 2007, J PATHOL, V213, P392, DOI 10.1002/path.2239; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zaravinos A, 2014, ONCOSCIENCE ADV PUBL; Zaravinos A, 2007, INT J ONCOL, V31, P1051; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122	51	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91646	10.1371/journal.pone.0091646	http://dx.doi.org/10.1371/journal.pone.0091646			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621579	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300111
J	Zhang, BC; Zhang, J; Sun, L				Zhang, Bao-cun; Zhang, Jian; Sun, Li			Streptococcus iniae SF1: Complete Genome Sequence, Proteomic Profile, and Immunoprotective Antigens	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; TURBOT SCOPHTHALMUS-MAXIMUS; BIOFILM FORMATION; BINDING-PROTEIN; ALPHA-ENOLASE; STAPHYLOCOCCUS-AUREUS; NEURAMINIDASE VACCINE; GENETIC COMPETENCE; BACILLUS-SUBTILIS; AQUATIC PATHOGEN	Streptococcus iniae is a Gram-positive bacterium that is reckoned one of the most severe aquaculture pathogens. It has a broad host range among farmed marine and freshwater fish and can also cause zoonotic infection in humans. Here we report for the first time the complete genome sequence as well as the host factor-induced proteomic profile of a pathogenic S. iniae strain, SF1, a serotype I isolate from diseased fish. SF1 possesses a single chromosome of 2,149,844 base pairs, which contains 2,125 predicted protein coding sequences (CDS), 12 rRNA genes, and 45 tRNA genes. Among the protein-encoding CDS are genes involved in resource acquisition and utilization, signal sensing and transduction, carbohydrate metabolism, and defense against host immune response. Potential virulence genes include those encoding adhesins, autolysins, toxins, exoenzymes, and proteases. In addition, two putative prophages and a CRISPR-Cas system were found in the genome, the latter containing a CRISPR locus and four cas genes. Proteomic analysis detected 21 secreted proteins whose expressions were induced by host serum. Five of the serum-responsive proteins were subjected to immunoprotective analysis, which revealed that two of the proteins were highly protective against lethal S. iniae challenge when used as purified recombinant subunit vaccines. Taken together, these results provide an important molecular basis for future study of S. iniae in various aspects, in particular those related to pathogenesis and disease control.	[Zhang, Bao-cun; Zhang, Jian; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Bao-cun; Zhang, Jian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Li] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn		Zhang, Bao-cun/0000-0001-6104-0848	National Natural Science Foundation of China [31025030]; Shandong Scientific and Technological Project [2010GHY10511]; Taishan Scholar Program of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Scientific and Technological Project; Taishan Scholar Program of Shandong Province	This work was supported by grants from the National Natural Science Foundation of China (31025030), the Shandong Scientific and Technological Project (2010GHY10511), and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian PV, 2004, VACCINE, V22, P2737, DOI 10.1016/j.vaccine.2004.01.042; Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Allen JP, 2012, INFECT IMMUN, V80, P1707, DOI 10.1128/IAI.00027-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amagai M, 2002, J INVEST DERMATOL, V118, P845, DOI 10.1046/j.1523-1747.2002.01751.x; Andrade MA, 2002, GENOME BIOL, V3; Aviles F, 2013, VET MICROBIOL, V162, P151, DOI 10.1016/j.vetmic.2012.08.018; Bachrach G, 2001, APPL ENVIRON MICROB, V67, P3756, DOI 10.1128/AEM.67.8.3756-3758.2001; Baiano JCF, 2009, EMERG INFECT DIS, V15, P1891, DOI 10.3201/eid1512.090232; Baiano JCF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-67; Barnes AC, 2003, DIS AQUAT ORGAN, V53, P241, DOI 10.3354/dao053241; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bose B, 2008, MOL MICROBIOL, V70, P570, DOI 10.1111/j.1365-2958.2008.06414.x; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chen C, 2013, FISH SHELLFISH IMMUN, V35, P1677, DOI 10.1016/j.fsi.2013.08.020; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cheng S, 2010, VACCINE, V28, P2636, DOI 10.1016/j.vaccine.2010.01.016; Coats MT, 2011, MICROB PATHOGENESIS, V50, P343, DOI 10.1016/j.micpath.2011.02.010; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dinis M, 2009, J INFECT DIS, V199, P116, DOI 10.1086/594372; Du J, 2001, MODERN FISHERIES, V5, P28; El Aamri F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00025-13; Emanuelsson C, 2007, MOL IMMUNOL, V44, P3256, DOI 10.1016/j.molimm.2007.01.019; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Eyngor M, 2008, APPL ENVIRON MICROB, V74, P6892, DOI 10.1128/AEM.00853-08; Eyngor M, 2010, FEMS MICROBIOL LETT, V305, P109, DOI 10.1111/j.1574-6968.2010.01919.x; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; GILSON E, 1988, EMBO J, V7, P3971, DOI 10.1002/j.1460-2075.1988.tb03284.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jedrzejas MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P891, DOI 10.2741/1299; Jiao XD, 2010, VACCINE, V28, P1832, DOI 10.1016/j.vaccine.2009.11.083; JURGENS D, 1987, J EXP MED, V165, P720, DOI 10.1084/jem.165.3.720; Kascakova S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038624; Kilbourne ED, 1995, VACCINE, V13, P1799, DOI 10.1016/0264-410X(95)00127-M; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Locke JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002824; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Long JP, 2004, INFECT IMMUN, V72, P4309, DOI 10.1128/IAI.72.7.4309-4313.2004; Lopez R, 2000, RES MICROBIOL, V151, P437, DOI 10.1016/S0923-2508(00)00172-8; Low D. E., 1999, Emerging infections 3., P53; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Lyon WR, 2003, J BACTERIOL, V185, P3661, DOI 10.1128/JB.185.12.3661-3667.2003; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; Milani CJE, 2010, MICROBIOL-SGM, V156, P543, DOI 10.1099/mic.0.028365-0; Millard CM, 2012, APPL ENVIRON MICROB, V78, P8219, DOI 10.1128/AEM.02216-12; Miller JD, 2005, INFECT IMMUN, V73, P921, DOI 10.1128/IAI.73.2.921-934.2005; Mills S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S7; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Nawawi RA, 2008, J FISH DIS, V31, P305, DOI 10.1111/j.1365-2761.2007.00880.x; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Qi FX, 2004, INFECT IMMUN, V72, P4895, DOI 10.1128/IAI.72.8.4895-4899.2004; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shibata Y, 2005, INFECT IMMUN, V73, P3512, DOI 10.1128/IAI.73.6.3512-3520.2005; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun Y, 2010, VACCINE, V28, P3905, DOI 10.1016/j.vaccine.2010.03.071; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; van der Ploeg JR, 2010, VIRUS GENES, V41, P450, DOI 10.1007/s11262-010-0525-0; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang J Y, 2002, BIOCHEMISTRY; Ware D, 2005, J MICROBIOL, V43, P398; Wen YT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007013; WILLIAMSON R, 1980, J BACTERIOL, V144, P105, DOI 10.1128/JB.144.1.105-113.1980; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zhang J, 2013, J PROTEOMICS, V91, P430, DOI 10.1016/j.jprot.2013.07.033; Zhang WW, 2007, APPL ENVIRON MICROB, V73, P2825, DOI 10.1128/AEM.02872-06; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	111	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91324	10.1371/journal.pone.0091324	http://dx.doi.org/10.1371/journal.pone.0091324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621602	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300076
J	Zhou, CH; Liu, L; Liu, L; Zhang, MX; Guo, H; Pan, J; Yin, XX; Ma, TF; Wu, YQ				Zhou, Cheng-Hua; Liu, Lian; Liu, Lu; Zhang, Ming-Xing; Guo, Hao; Pan, Jin; Yin, Xiao-Xing; Ma, Teng-Fei; Wu, Yu-Qing			Salusin-beta Not Salusin-alpha Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-kappa B alpha/NF-kappa B Pathway	PLOS ONE			English	Article							ATHEROSCLEROSIS; MECHANISMS; DISEASE; SERUM; RESPONSES	Objective: Vascular inflammation plays an important role in the development and progression of atherosclerosis. Recently, salusins (salusin-alpha and salusin-beta) have been reported to be associated wtih atherosclerosis. However, its underlying mechanism remains incompletely known. In this study, we observed the effects of salusins on vascular inflammation in apoE-deficient (apoE-/-) mice. Methods and Results: Six-week old male apoE-/- mice were infused with salusin-alpha, salusin-beta or vehicle for 8 weeks via osmotic mini-pumps. Our results showed that apoE-/- mice receiving vehicle alone developed severe atherosclerotic lesions and dyslipidemia, with significantly up-regulated levels of IL-6, TNF-alpha, VCAM-1 and MCP-1. For apoE-/- mice receiving 8 weeks of salusin-beta infusion, the atherosclerotic lesions were markedly aggravated, and the levels of IL-6, TNF-alpha, VCAM-1 and MCP-1 were substantially increased, despite a similar plasma lipid concentration with that of apoE-/- mice. However, after 8 week-infusion of salusin-alpha, apoE-/- mice presented significant amelioration in atherosclerotic lesions, along with remarkably up-regulated level of high-density lipoprotein-cholesterol (HDL-C) and down-regulated levels of IL-6 and TNF-alpha, but without any effect on the expressions of VCAM-1 and MCP-1. Furthermore, the activation of nuclear factor-kappa B (NF-kappa B), an important transcription factor essential for inflammatory molecules, and the degradation of I-kappa B alpha, an inhibitor of NF-kappa B, were markedly increased in apoE-/- mice receiving vehicle alone. Treatment with salusin-beta not salusin-alpha could remarkably accelerate the process of NF-kappa B nuclear translocation and I-kappa B alpha degradation. Conclusion: Salusin-beta, but not salusin-alpha, promotes vascular inflammation in apoE-deficient mice via the I-kappa B alpha/NF-kappa B pathway. These findings provide further insight into the mechanism of salusins in atherosclerosis and potential targets for the prevention and treatment of atherosclerosis.	[Zhou, Cheng-Hua; Liu, Lian; Zhang, Ming-Xing; Guo, Hao; Pan, Jin; Yin, Xiao-Xing; Ma, Teng-Fei] Xuzhou Med Coll, Sch Pharm, Xuzhou, Jiangsu, Peoples R China; [Liu, Lu; Wu, Yu-Qing] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Wu, Yu-Qing] Xuzhou Med Coll, Dept Anesthet Pharmacol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Zhou, CH (corresponding author), Xuzhou Med Coll, Sch Pharm, Xuzhou, Jiangsu, Peoples R China.	chzhou1212@163.com; xzmcyqwu@126.com	zhang, xu/GYE-3558-2022; Ma, Tengfei/B-6383-2017; Yin, Xiaoxing/AFS-9632-2022	Ma, Tengfei/0000-0002-8916-7370; 	National Natural Science Foundation of China [81001431]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [11KJB310014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions of China	This work is supported by National Natural Science Foundation of China (81001431,http://www.nsfc.gov.cn), Natural Science Foundation of Jiangsu Higher Education Institutions of China (11KJB310014,http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen F, 1999, CLIN CHEM, V45, P7; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Du SL, 2013, SCAND J CLIN LAB INV; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Fujimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076714; Gehrig SM, 2008, EXP PHYSIOL, V93, P1190, DOI 10.1113/expphysiol.2008.042838; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Koya T, 2012, AM J PHYSIOL-HEART C, V303, pH96, DOI 10.1152/ajpheart.00009.2012; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sato K, 2006, PEPTIDES, V27, P2561, DOI 10.1016/j.peptides.2006.06.005; Sato K, 2010, REGUL PEPTIDES, V162, P68, DOI 10.1016/j.regpep.2010.02.010; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; Ti Y, 2012, J HUM HYPERTENS, V26, P603, DOI 10.1038/jhh.2011.71; Watanabe T, 2008, HYPERTENS RES, V31, P463, DOI 10.1291/hypres.31.463; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Zhou CH, 2012, CAN J PHYSIOL PHARM, V90, P463, DOI 10.1139/Y2012-022	24	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91468	10.1371/journal.pone.0091468	http://dx.doi.org/10.1371/journal.pone.0091468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621517	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300090
J	Thibault, K; Calvino, B; Rivals, I; Marchand, F; Dubacq, S; McMahon, SB; Pezet, S				Thibault, Karine; Calvino, Bernard; Rivals, Isabelle; Marchand, Fabien; Dubacq, Sophie; McMahon, Stephen B.; Pezet, Sophie			Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain	PLOS ONE			English	Article							VINCRISTINE-INDUCED NEUROPATHY; CONTROLLED-RELEASE OXYCODONE; GENE-EXPRESSION; CANCER PAIN; SPINAL-CORD; RECEPTOR SUBUNITS; BRAIN-REGIONS; RAT MODEL; HYPERALGESIA; INHIBITION	Oxycodone is a m-opioid receptor agonist, used for the treatment of a large variety of painful disorders. Several studies have reported that oxycodone is a more potent pain reliever than morphine, and that it improves the quality of life of patients. However, the neurobiological mechanisms underlying the therapeutic action of these two opioids are only partially understood. The aim of this study was to define the molecular changes underlying the long-lasting analgesic effects of oxycodone and morphine in an animal model of peripheral neuropathy induced by a chemotherapic agent, vincristine. Using a behavioural approach, we show that oxycodone maintains an optimal analgesic effect after chronic treatment, whereas the effect of morphine dies down. In addition, using DNA microarray technology on dorsal root ganglia, we provide evidence that the long-term analgesic effect of oxycodone is due to an up-regulation in GABA(B) receptor expression in sensory neurons. These receptors are transported to their central terminals within the dorsal horn, and subsequently reinforce a presynaptic inhibition, since only the long-lasting (and not acute) anti-hyperalgesic effect of oxycodone was abolished by intrathecal administration of a GABA(B) receptor antagonist; in contrast, the morphine effect was unaffected. Our study demonstrates that the GABA(B) receptor is functionally required for the alleviating effect of oxycodone in neuropathic pain condition, thus providing new insight into the molecular mechanisms underlying the sustained analgesic action of oxycodone.	[Thibault, Karine; Calvino, Bernard; Dubacq, Sophie; Pezet, Sophie] ESPCI ParisTech, Brain Plast Unit, Paris, France; [Thibault, Karine; Calvino, Bernard; Dubacq, Sophie; Pezet, Sophie] CNRS, UMR 8249, Paris, France; [Thibault, Karine; McMahon, Stephen B.] Kings Coll London, Wolfson Ctr Age Related Dis, Neurorestorat Grp, London WC2R 2LS, England; [Rivals, Isabelle] ESPCI ParisTech, Equipe Stat Appl, Paris, France; [Marchand, Fabien] INSERM, U1107, NEURO DOL, Clermont Ferrand, France; [Marchand, Fabien] Univ Auvergne, Clermont Univ, Clermont Ferrand, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of London; King's College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Thibault, K (corresponding author), Paris Descartes Univ, CNRS, FR3636, Glia Glia & Glia Neuron Interact Neurophysiopatho, Paris, France.	karine.thibault@parisdescartes.fr	PEZET, sophie/AAR-1239-2021; MARCHAND, Fabien/K-1285-2015; Rivals, Isabelle/AAE-7971-2022	PEZET, sophie/0000-0002-3305-3315; Rivals, Isabelle/0000-0002-8736-7010; McMahon, Stephen/0000-0003-4656-5536	Institut UPSA de la douleur; "Centre National de la Recherche Scientifique", CNRS; Mundipharma laboratory (ML); Fondation pour la Recherche Medicale	Institut UPSA de la douleur; "Centre National de la Recherche Scientifique", CNRS(Centre National de la Recherche Scientifique (CNRS)); Mundipharma laboratory (ML); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the "Institut UPSA de la douleur" and the "Centre National de la Recherche Scientifique", CNRS. KT received a two year doctoral fellowship from Mundipharma laboratory (ML). KT received one year of post-doctoral fellowship from "Fondation pour la Recherche Medicale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016/0306-4522(96)00020-6; Ammon-Treiber S, 2005, ADDICT BIOL, V10, P81, DOI 10.1080/13556210412331308994; Authier N, 1999, NEUROREPORT, V10, P965, DOI 10.1097/00001756-199904060-00013; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Barrera-Chacon JM, 2011, SPINAL CORD, V49, P36, DOI 10.1038/sc.2010.101; Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Bruera E, 1998, J CLIN ONCOL, V16, P3222, DOI 10.1200/JCO.1998.16.10.3222; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; CASEY EB, 1973, BRAIN, V96, P69, DOI 10.1093/brain/96.1.69; Charles KJ, 2001, NEUROSCIENCE, V106, P447, DOI 10.1016/S0306-4522(01)00296-2; Chen YP, 2005, J PHARMACOL EXP THER, V315, P696, DOI 10.1124/jpet.105.091314; Courteix C, 1998, J PHARMACOL EXP THER, V285, P63; Curtis GB, 1999, EUR J CLIN PHARMACOL, V55, P425, DOI 10.1007/s002280050651; Dunbar SA, 2006, EUR J PHARMACOL, V535, P152, DOI 10.1016/j.ejphar.2006.02.007; Falk E., 1917, MUNCHEN MED WOCHEN, V20, P381; FOX S, 1978, NEUROSCIENCE, V3, P495, DOI 10.1016/0306-4522(78)90016-7; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Gatti A, 2009, CLIN DRUG INVEST, V29, P31, DOI 10.2165/0044011-200929001-00005; Goudet C, 2009, BRAIN RES REV, V60, P43, DOI 10.1016/j.brainresrev.2008.12.007; HOLZ GG, 1989, J NEUROSCI, V9, P657; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; Kaplan R, 1998, J CLIN ONCOL, V16, P3230, DOI 10.1200/JCO.1998.16.10.3230; Kato A, 2008, ONCOLOGY-BASEL, V74, P55, DOI 10.1159/000143220; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Kiraly KP, 2006, BRAIN RES BULL, V70, P233, DOI 10.1016/j.brainresbull.2006.05.005; Lenz H, 2009, ANESTH ANALG, V109, P1279, DOI 10.1213/ane.0b013e3181b0f0bb; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; MALCANGIO M, 1993, J PHARMACOL EXP THER, V266, P1490; Malcangio M, 1998, PAIN, V76, P151, DOI 10.1016/S0304-3959(98)00037-2; Marchand F, 2003, J PHARMACOL EXP THER, V307, P268, DOI 10.1124/jpet.103.052613; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; Mucci-LoRusso P, 1998, EUR J PAIN-LONDON, V2, P239, DOI 10.1016/S1090-3801(98)90020-9; Nakamura A, 2013, BRIT J PHARMACOL, V168, P375, DOI 10.1111/j.1476-5381.2012.02139.x; Nozaki-Taguchi N, 2001, PAIN, V93, P69, DOI 10.1016/S0304-3959(01)00294-9; Park JH, 2010, BRAIN RES, V1322, P24, DOI 10.1016/j.brainres.2010.02.001; Parkitna JMR, 2004, J NEUROCHEM, V91, P38, DOI 10.1111/j.1471-4159.2004.02697.x; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; SANDLER SG, 1969, NEUROLOGY, V19, P367, DOI 10.1212/WNL.19.4.367; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Tapocik JD, 2009, J NEUROSCI, V29, P5295, DOI 10.1523/JNEUROSCI.4020-08.2009; Thibault K, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.07.010; Thibault K, 2008, EUR J PHARMACOL, V600, P71, DOI 10.1016/j.ejphar.2008.10.004; Thibault K, 2008, PAIN, V140, P305, DOI 10.1016/j.pain.2008.09.006; Watson CPN, 2003, PAIN, V105, P71, DOI 10.1016/S0304-3959(03)00160-X; Watson CPN, 1998, NEUROLOGY, V50, P1837; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1	51	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91297	10.1371/journal.pone.0091297	http://dx.doi.org/10.1371/journal.pone.0091297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618941	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400069
J	Grahn, THM; Kaur, R; Yin, J; Schweiger, M; Sharma, VM; Lee, MJ; Ido, Y; Smas, CM; Zechner, R; Lass, A; Puri, V				Grahn, Tan Hooi Min; Kaur, Rajween; Yin, Jun; Schweiger, Martina; Sharma, Vishva Mitra; Lee, Mi-Jeong; Ido, Yasuo; Smas, Cynthia M.; Zechner, Rudolf; Lass, Achim; Puri, Vishwajeet			Fat-specific Protein 27 ( FSP27) Interacts with Adipose Triglyceride Lipase ( ATGL) to Regulate Lipolysis and Insulin Sensitivity in Human Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipose Tissue Metabolism; Adipose Triglyceride Lipase; Diabetes; Diacylglycerol; Fatty Acid; Fatty Acid Metabolism; Insulin Resistance; Obesity	LIPID DROPLETS; PERILIPIN-A; MEDIATED LIPOLYSIS; GENE-EXPRESSION; UP-REGULATION; RESISTANCE; ACIDS; BINDING; OBESITY; KINASE	Background: FSP27 depletion increases both basal and stimulated lipolysis. Results: FSP27 interacts with ATGL via amino acids 120-220 to regulate lipolysis and triglyceride storage in human adipocytes. Conclusion: FSP27 inhibits ATGL-mediated lipolysis and protects adipocytes against free fatty acid-impaired insulin signaling. Significance: The novel lipolytic regulation shown here may lead to new treatments for insulin resistance. In adipocytes, lipolysis is a highly regulated process involving hormonal signals, lipid droplet-associated proteins, and lipases. The discovery of new lipid droplet-associated proteins added complexity to the current model of lipolysis. In this study, we used cultured human adipocytes to demonstrate that fat-specific protein 27 (FSP27), an abundantly expressed protein in adipocytes, regulates both basal and stimulated lipolysis by interacting with adipose triglyceride lipase (ATGL, also called desnutrin or PNPLA2). We identified a core domain of FSP27, amino acids 120-220, that interacts with ATGL to inhibit its lipolytic function and promote triglyceride storage. We also defined the role of FSP27 in free fatty acid-induced insulin resistance in adipocytes. FSP27 depletion in human adipocytes increased lipolysis and inhibited insulin signaling by decreasing AKT phosphorylation. However, reducing lipolysis by either depletion of ATGL or expression of exogenous full-length FSP27 or amino acids 120-220 protected human adipocytes against the adverse effects of free fatty acids on insulin signaling. In embryonic fibroblasts derived from ATGL KO mice, exogenous free fatty acids did not affect insulin sensitivity. Our results demonstrate a crucial role for FSP27-ATGL interactions in regulating lipolysis, triglyceride accumulation, and insulin signaling in human adipocytes.	[Grahn, Tan Hooi Min; Kaur, Rajween; Yin, Jun; Sharma, Vishva Mitra; Lee, Mi-Jeong; Ido, Yasuo; Puri, Vishwajeet] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Schweiger, Martina; Zechner, Rudolf; Lass, Achim] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Smas, Cynthia M.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA	Boston University; University of Graz; University System of Ohio; University of Toledo	Puri, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, 650 Albany St, Boston, MA 02118 USA.	vpuri@bu.edu	Lass, Achim/C-3332-2008; Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lass, Achim/0000-0002-8190-7151; Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Grahn, Tan Hooi Min/0000-0002-4737-4320; Schweiger, Martina/0000-0002-3419-1007; Zechner, Rudolf/0000-0001-5483-1182	NIDDK, National Institutes of Health from Boston University Parent Clinical and Translational Science Institute [R56DK094815, P30DK046200, 8KL2TR000158, UL1-TR000157]; Wittgenstein Award [Z136]; Austrian Science Fund (FWF) [P25193]; Foundation Leducq [12CVD04];  [SFB Lipotox F30]; Austrian Science Fund (FWF) [F 3002, Z 136, P 25193] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000158, UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK094815, P30DK046200] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health from Boston University Parent Clinical and Translational Science Institute; Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Foundation Leducq(Leducq Foundation); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants R56DK094815, P30DK046200, and 8KL2TR000158 (to V. P.) from Boston University Parent Clinical and Translational Science Institute Grant UL1-TR000157. This work was also supported by Grant SFB Lipotox F30, Wittgenstein Award Z136 (to R. Z.), and Grant P25193 (to A. L.), which are funded by the Austrian Science Fund (FWF) and Grant 12CVD04 from the Foundation Leducq (to R. Z.).	Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee M. J., 2013, OBESITY IN PRESS; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; VanEppsFung M, 1997, ENDOCRINOLOGY, V138, P4338, DOI 10.1210/en.138.10.4338; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WILLIAMS PM, 1992, MOL ENDOCRINOL, V6, P1135, DOI 10.1210/me.6.7.1135; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	62	84	85	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12029	12039		10.1074/jbc.M113.539890	http://dx.doi.org/10.1074/jbc.M113.539890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627478	Green Published, hybrid			2022-12-25	WOS:000335010600041
J	Bartoszewski, R; Hering, A; Marszall, M; Hajduk, JS; Bartoszewska, S; Kapoor, N; Kochan, K; Ochocka, R				Bartoszewski, Rafal; Hering, Anna; Marszall, Marcin; Hajduk, Justyna Stefanowicz; Bartoszewska, Sylwia; Kapoor, Niren; Kochan, Kinga; Ochocka, Renata			Mangiferin Has an Additive Effect on the Apoptotic Properties of Hesperidin in Cyclopia sp. Tea Extracts	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; TIME PCR DATA; REAL-TIME; XCELLIGENCE SYSTEM; PROTEIN TRADD; RECEPTOR 1; ACTIVATION; PATHWAYS; GENE	A variety of biological pro-health activities have been reported for mangiferin and hesperidin, two major phenolic compounds of Honeybush (Cyclopia sp.) tea extracts. Given their increasing popularity, there is a need for understanding the mechanisms underlying the biological effects of these compounds. In this study, we used real-time cytotoxicity cellular analysis of the Cyclopia sp. extracts on HeLa cells and found that the higher hesperidin content in non-fermented "green" extracts correlated with their higher cytotoxicity compared to the fermented extracts. We also found that mangiferin had a modulatory effect on the apoptotic effects of hesperidin. Quantitative PCR analysis of hesperidin-induced changes in apoptotic gene expression profile indicated that two death receptor pathway members, TRADD and TRAMP, were up regulated. The results of this study suggest that hesperidin mediates apoptosis in HeLa cells through extrinsic pathway for programmed cell death.	[Bartoszewski, Rafal; Hering, Anna; Hajduk, Justyna Stefanowicz; Kochan, Kinga; Ochocka, Renata] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Bartoszewska, Sylwia] Med Univ Gdansk, Dept Inorgan Chem, Gdansk, Poland; [Kapoor, Niren] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Marszall, Marcin] Med Univ Gdansk, Dept Toxicol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk	Bartoszewski, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland.	rafalbar@gumed.edu.pl	Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019	Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272; hering, anna/0000-0003-1060-5380	National Science Center KBN Programme [66991/B/P01/2011/40]	National Science Center KBN Programme	This work has been supported by National Science Center KBN Programme under contract 66991/B/P01/2011/40 (to RO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Crnkovic-Mertens I, 2003, ONCOGENE, V22, P8330, DOI 10.1038/sj.onc.1206973; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; du Plessis-Stoman D, 2011, AFR J TRADIT COMPLEM, V8, P177; Erskine CL, 2012, JOVE-J VIS EXP, DOI 10.3791/3683; Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074; Ghorbani A, 2012, EUR J NUTR, V51, P39, DOI 10.1007/s00394-011-0187-2; Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240; Golke A, 2012, POL J VET SCI, V15, P151, DOI 10.2478/v10181-011-0126-4; Gong X, 2013, J NUTR BIOCHEM, V24, P1173, DOI 10.1016/j.jnutbio.2012.09.003; Guan N, 2013, MOL BIOSYST, V9, P1035, DOI 10.1039/c3mb25421f; Guha S, 1996, CHEMOTHERAPY, V42, P443, DOI 10.1159/000239478; Hellevik T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-59; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Joubert E, 2012, S AFR J BOT, V82, P113, DOI 10.1016/j.sajb.2012.07.019; Joubert E, 2003, EUR FOOD RES TECHNOL, V216, P270, DOI 10.1007/s00217-002-0644-5; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kamara BI, 2003, J AGR FOOD CHEM, V51, P3874, DOI 10.1021/jf0210730; KO FN, 1991, EUR J PHARMACOL, V192, P133; Kokotkiewicz A, 2012, Z NATURFORSCH C, V67, P65, DOI 10.5560/ZNC.2012.67c0065; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Leatherbarrow RJ, 2009, GRAFIT VERSION 7 7 0; Lee CJ, 2010, PHYTOTHER RES, V24, pS15, DOI 10.1002/ptr.2856; Lee KH, 2010, TOXICOL LETT, V194, P42, DOI 10.1016/j.toxlet.2010.01.021; Li HZ, 2013, TOXICOL APPL PHARM, V272, P180, DOI 10.1016/j.taap.2013.05.011; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Menkovic N, 2010, PHYTOTHER RES, V24, P1693, DOI 10.1002/ptr.3225; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Nandakumar N, 2011, BIOMED PREV NUTR, V1, P207; Nazari M, 2011, EUR J PHARMACOL, V650, P526, DOI 10.1016/j.ejphar.2010.10.053; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Pal PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056894; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Rajendran Peramaiyan, 2013, Int J Biomed Sci, V9, P68; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scrace S, 2013, METHODS MOL BIOL, V1046, P295, DOI 10.1007/978-1-62703-538-5_17; Shoji K, 2011, ARCH PHARM RES, V34, P469, DOI 10.1007/s12272-011-0316-8; TENG CM, 1989, BIOCHEM PHARMACOL, V38, P3791, DOI 10.1016/0006-2952(89)90587-X; Vanden Heuvel JP, 1999, TOXICOL SCI, V47, P1, DOI 10.1093/toxsci/47.1.1; Wang H, 2007, ACTA PHARMACOL SIN, V28, P1968, DOI 10.1111/j.1745-7254.2007.00724.x; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Xia J, 2006, J PHARMACEUT BIOMED, V41, P1401, DOI 10.1016/j.jpba.2006.02.030; ZHENG MS, 1990, CHINESE MED J-PEKING, V103, P160	48	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92128	10.1371/journal.pone.0092128	http://dx.doi.org/10.1371/journal.pone.0092128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633329	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400145
J	Chernyavsky, IL; Croisier, H; Chapman, LAC; Kimpton, LS; Hiorns, JE; Brook, BS; Jensen, OE; Billington, CK; Hall, IP; Johnson, SR				Chernyavsky, Igor L.; Croisier, Huguette; Chapman, Lloyd A. C.; Kimpton, Laura S.; Hiorns, Jonathan E.; Brook, Bindi S.; Jensen, Oliver E.; Billington, Charlotte K.; Hall, Ian P.; Johnson, Simon R.			The Role of Inflammation Resolution Speed in Airway Smooth Muscle Mass Accumulation in Asthma: Insight from a Theoretical Model	PLOS ONE			English	Article							CELL-PROLIFERATION; GROWTH; HYPERRESPONSIVENESS; EXACERBATIONS; HYPERTROPHY; PHENOTYPE	Despite a large amount of in vitro data, the dynamics of airway smooth muscle (ASM) mass increase in the airways of patients with asthma is not well understood. Here, we present a novel mathematical model that describes qualitatively the growth dynamics of ASM cells over short and long terms in the normal and inflammatory environments typically observed in asthma. The degree of ASM accumulation can be explained by an increase in the rate at which ASM cells switch between non-proliferative and proliferative states, driven by episodic inflammatory events. Our model explores the idea that remodelling due to ASM hyperplasia increases with the frequency and magnitude of these inflammatory events, relative to certain sensitivity thresholds. It highlights the importance of inflammation resolution speed by showing that when resolution is slow, even a series of small exacerbation events can result in significant remodelling, which persists after the inflammatory episodes. In addition, we demonstrate how the uncertainty in long-term outcome may be quantified and used to design an optimal low-risk individual anti-proliferative treatment strategy. The model shows that the rate of clearance of ASM proliferation and recruitment factors after an acute inflammatory event is a potentially important, and hitherto unrecognised, target for anti-remodelling therapy in asthma. It also suggests new ways of quantifying inflammation severity that could improve prediction of the extent of ASM accumulation. This ASM growth model should prove useful for designing new experiments or as a building block of more detailed multi-cellular tissue-level models.	[Chernyavsky, Igor L.; Croisier, Huguette; Hiorns, Jonathan E.; Brook, Bindi S.] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Chapman, Lloyd A. C.; Kimpton, Laura S.] Univ Oxford, Inst Math, Oxford OX1 3LB, England; [Jensen, Oliver E.] Univ Manchester, Sch Math, Manchester, Lancs, England; [Billington, Charlotte K.; Hall, Ian P.; Johnson, Simon R.] Univ Nottingham, Dept Therapeut & Mol Med, Nottingham NG7 2RD, England	University of Nottingham; University of Oxford; University of Manchester; University of Nottingham	Chernyavsky, IL (corresponding author), Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England.	Igor.Chernyavsky@nottingham.ac.uk	Brook, Bindi/O-6704-2016; Jensen, Oliver/B-5880-2008	Brook, Bindi/0000-0001-9883-4131; Jensen, Oliver/0000-0003-0172-6578; Hall, Ian/0000-0001-9933-3216; Johnson, Simon/0000-0002-9837-2763; Chernyavsky, Igor L./0000-0003-0284-9318; Chapman, Lloyd/0000-0001-7727-7102	AirPROM 7th European Framework Programme; Medical Research Council [G0901174]; National Centre for the Replacement, Refinement and Reduction of Animals in Research & EPSRC UK Research Council; MRC [G0400910, G0701390, G0901174] Funding Source: UKRI; Medical Research Council [G0400910, G0701390] Funding Source: researchfish; Asthma UK [05/007] Funding Source: researchfish	AirPROM 7th European Framework Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Refinement and Reduction of Animals in Research & EPSRC UK Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	AirPROM 7th European Framework Programme (www.airprom.eu; ILC), Medical Research Council New Investigator Grant G0901174 (www.mrc.ac.uk; BSB & HC), National Centre for the Replacement, Refinement and Reduction of Animals in Research & EPSRC UK Research Council (www.maths-in-medicine.org; all authors). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alkhouri H, 2011, ALLERGY, V66, P1231, DOI 10.1111/j.1398-9995.2011.02616.x; Allen JE, 2009, PULM PHARMACOL THER, V22, P455, DOI 10.1016/j.pupt.2009.04.001; Alrifai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085839; Baker M, 2011, MATH MODELLING AIRWA; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Bergeron C, 2005, J ALLERGY CLIN IMMUN, V116, P983, DOI 10.1016/j.jaci.2005.07.029; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brook BS, 2010, RESP PHYSIOL NEUROBI, V170, P44, DOI 10.1016/j.resp.2009.11.006; Byrne H, 2003, MATH MED BIOL, V20, P341; Contoli M, 2010, ALLERGY, V65, P141, DOI 10.1111/j.1398-9995.2009.02242.x; Dekkers BGJ, 2012, BRIT J PHARMACOL, V166, P359, DOI 10.1111/j.1476-5381.2011.01773.x; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Halayko AJ, 1999, AM J PHYSIOL-LUNG C, V276, pL197, DOI 10.1152/ajplung.1999.276.1.L197; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kariyawasam HH, 2007, AM J RESP CRIT CARE, V175, P896, DOI 10.1164/rccm.200609-1260OC; Kaur D, 2010, CLIN EXP ALLERGY, V40, P279, DOI 10.1111/j.1365-2222.2009.03423.x; Leclere M, 2012, AM J RESP CELL MOL, V47, P589, DOI 10.1165/rcmb.2011-0363OC; Louis R, 2002, ALLERGY, V57, P907, DOI 10.1034/j.1398-9995.2002.23608.x; Markwick LJ, 2012, CLIN EXP ALLERGY, V42, P1040, DOI 10.1111/j.1365-2222.2012.04019.x; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; Moulton DE, 2011, J APPL PHYSIOL, V110, P1003, DOI 10.1152/japplphysiol.00991.2010; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tattersfield AE, 1999, AM J RESP CRIT CARE, V160, P594, DOI 10.1164/ajrccm.160.2.9811100; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x	32	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90162	10.1371/journal.pone.0090162	http://dx.doi.org/10.1371/journal.pone.0090162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632688	Green Published, Green Accepted, gold			2022-12-25	WOS:000332858400010
J	Arnal, A; Gomez-Diaz, E; Cerda-Cuellar, M; Lecollinet, S; Pearce-Duvet, J; Busquets, N; Garcia-Bocanegra, I; Pages, N; Vittecoq, M; Hammouda, A; Samraoui, B; Garnier, R; Ramos, R; Selmi, S; Gonzalez-Solis, J; Jourdain, E; Boulinier, T				Arnal, Audrey; Gomez-Diaz, Elena; Cerda-Cuellar, Marta; Lecollinet, Sylvie; Pearce-Duvet, Jessica; Busquets, Nuria; Garcia-Bocanegra, Ignacio; Pages, Nonito; Vittecoq, Marion; Hammouda, Abdessalem; Samraoui, Boudjema; Garnier, Romain; Ramos, Rauel; Selmi, Slaheddine; Gonzalez-Solis, Jacob; Jourdain, Elsa; Boulinier, Thierry			Circulation of a Meaban-Like Virus in Yellow-Legged Gulls and Seabird Ticks in the Western Mediterranean Basin	PLOS ONE			English	Article							ORNITHODOROS ALECTOROBIUS MARITIMUS; BURGDORFERI-SENSU-LATO; NILE-VIRUS; LARUS-MICHAHELLIS; BORNE FLAVIVIRUSES; PHYLOGENETIC-RELATIONSHIPS; SOUTHERN FRANCE; BIRDS; EVOLUTION; DISEASE	In recent years, a number of zoonotic flaviviruses have emerged worldwide, and wild birds serve as their major reservoirs. Epidemiological surveys of bird populations at various geographical scales can clarify key aspects of the eco-epidemiology of these viruses. In this study, we aimed at exploring the presence of flaviviruses in the western Mediterranean by sampling breeding populations of the yellow-legged gull (Larus michahellis), a widely distributed, anthropophilic, and abundant seabird species. For 3 years, we sampled eggs from 19 breeding colonies in Spain, France, Algeria, and Tunisia. First, ELISAs were used to determine if the eggs contained antibodies against flaviviruses. Second, neutralization assays were used to identify the specific flaviviruses present. Finally, for colonies in which ELISA-positive eggs had been found, chick serum samples and potential vectors, culicid mosquitoes and soft ticks (Ornithodoros maritimus), were collected and analyzed using serology and PCR, respectively. The prevalence of flavivirus-specific antibodies in eggs was highly spatially heterogeneous. In northeastern Spain, on the Medes Islands and in the nearby village of L'Escala, 56% of eggs had antibodies against the flavivirus envelope protein, but were negative for neutralizing antibodies against three common flaviviruses: West Nile, Usutu, and tick-borne encephalitis viruses. Furthermore, little evidence of past flavivirus exposure was obtained for the other colonies. A subset of the Ornithodoros ticks from Medes screened for flaviviral RNA tested positive for a virus whose NS5 gene was 95% similar to that of Meaban virus, a flavivirus previously isolated from ticks of Larus argentatus in western France. All ELISA-positive samples subsequently tested positive for Meaban virus neutralizing antibodies. This study shows that gulls in the western Mediterranean Basin are exposed to a tick-borne Meaban-like virus, which underscores the need of exploring the spatial and temporal distribution of this flavivirus as well as its potential pathogenicity for animals and humans.	[Arnal, Audrey; Pearce-Duvet, Jessica; Garnier, Romain; Ramos, Rauel; Boulinier, Thierry] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Arnal, Audrey; Vittecoq, Marion] Ctr Rech Tour Valat, Arles, France; [Gomez-Diaz, Elena] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain; [Cerda-Cuellar, Marta] IRTA, Barcelona, Spain; [Cerda-Cuellar, Marta; Busquets, Nuria; Pages, Nonito] Univ Autonoma Barcelona, IRTA, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Cerdanyola Del, Spain; [Lecollinet, Sylvie] Virol INRA, Anim Hlth Lab ANSES, ENVA, ANSES,UMR1161, Maisons Alfort, France; [Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Garcia-Bocanegra, Ignacio] Univ Cordoba, Dept Sanidad Anim, Cordoba, Spain; [Hammouda, Abdessalem; Selmi, Slaheddine] Fac Sci Gabes, Dept Sci Vie, Gabes, Tunisia; [Samraoui, Boudjema] Univ Guelma, Lab Rech & Conservat Zones Humides, Guelma, Algeria; [Samraoui, Boudjema] King Saud Univ, Ctr Excellence Res Biodivers, Riyadh, Saudi Arabia; [Jourdain, Elsa] INRA, Unite Epidemiol Anim, UR346, F-63122 St Genes Champanelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; IRTA; Autonomous University of Barcelona; IRTA; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Barcelona; University of Barcelona; Universidad de Cordoba; Universite de Gabes; Universite 8 Mai 1945 de Guelma; King Saud University; INRAE	Jourdain, E (corresponding author), INRA, Unite Epidemiol Anim, UR346, F-63122 St Genes Champanelle, France.	elsa.jourdain@clermont.inra.fr	Gómez-Díaz, Elena/G-2503-2011; Pages, Nonito/Q-1274-2016; Ramos, Raül/S-3112-2016; Gonzalez-Solis, Jacob/AAZ-5338-2021; arnal, audrey/ABR-6358-2022; Gonzalez-Solis, Jacob/C-3942-2008; Busquets, Núria/T-8431-2017; Cerda, Marta/U-4534-2018; Lecollinet, Sylvie/AAV-5276-2021; Samraoui, Boudjéma/E-6761-2011; González-Solís, Jacob/AAB-1161-2019; Lecollinet, Sylvie/M-1728-2019; Gómez-Díaz, Elena/AAA-9141-2019; Slaheddine, Selmi/AAD-1495-2021; Bocanegra, Ignacio Garcia/G-1443-2016	Gómez-Díaz, Elena/0000-0002-4146-9003; Pages, Nonito/0000-0001-6020-7175; Ramos, Raül/0000-0002-0551-8605; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Cerda, Marta/0000-0001-6842-1299; Samraoui, Boudjéma/0000-0002-0608-9021; Gómez-Díaz, Elena/0000-0002-4146-9003; Slaheddine, Selmi/0000-0002-7204-9159; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; BOULINIER, Thierry/0000-0002-5898-7667; HAMMOUDA, Abdessalem/0000-0003-4078-7592; Lecollinet, Sylvie/0000-0001-8535-2133	Chateaubriand Postdoctoral Fellowship; National Science Foundation; Ministerio de Educacion y Ciencia, Spain; European Commission [PERG08-GA-ERG-2010- 276838]; Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique (DGRSDT/MESRS); DSFP program, King Saud University, Saudi Arabia; OSU OREME; ANR [11 BSV7 003 EVEMATA, 13 BSV7 018 ESPEVEC]; INIA [FAU2008-00012-C02-01]; AIRD; CNRS	Chateaubriand Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique (DGRSDT/MESRS); DSFP program, King Saud University, Saudi Arabia; OSU OREME; ANR(French National Research Agency (ANR)); INIA(Instituto de Investigacion Agropecuaria (INIA)); AIRD; CNRS(Centre National de la Recherche Scientifique (CNRS))	J. Pearce-Duvet was supported by a Chateaubriand Postdoctoral Fellowship and a National Science Foundation Postdoctoral Fellowship. E. Gomez-Diaz. was supported by a Juan de la Cierva contract from the Ministerio de Educacion y Ciencia, Spain, and a Marie Curie Reintegration Grant from the European Commission (PERG08-GA-ERG-2010- 276838). B. Samraoui was supported by the Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique (DGRSDT/MESRS) and by the DSFP program, King Saud University, Saudi Arabia. Support from the OSU OREME, ANR (11 BSV7 003 EVEMATA and 13 BSV7 018 ESPEVEC grants), INIA (FAU2008-00012-C02-01), AIRD, and CNRS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2011, EMERG INFECT DIS, V17, P1498, DOI 10.3201/eid1708.110077; Alba A, 2014, ZOONOSES PUBLIC HLTH, V61, P181, DOI 10.1111/zph.12048; Arens M, 1999, CLIN MICROBIOL REV, V12, P612, DOI 10.1128/CMR.12.4.612; Arizaga J, 2010, WATERBIRDS, V33, P444, DOI 10.1675/063.033.0403; Baaloudj A, 2012, ARDEOLA, V59, P137, DOI 10.13157/arla.59.1.2012.137; Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049; Berthold P, 2001, AUK, V2nd; Bofill D, 2006, EMERG INFECT DIS, V12, P1163, DOI 10.3201/eid1207.060164; Bosch M, 1999, ARDEA, V87, P83; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; CHASTEL C, 1988, CR ACAD SCI III-VIE, V307, P479; CHASTEL C, 1983, REV EPIDEMIOL SANTE, V31, P445; CHASTEL C, 1985, ARCH VIROL, V83, P129, DOI 10.1007/BF01309911; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; Cramp S., 1988, HDB BIRDS EUROPE; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; Dietrich M, 2011, VECTOR-BORNE ZOONOT, V11, P453, DOI 10.1089/vbz.2010.0009; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; EpiSouth, 2010, W NIL VIR CIRC EPISO; EstradaPena A, 1996, ACAROLOGIA, V37, P19; Figuerola J, 2007, EMERG INFECT DIS, V13, P1915, DOI 10.3201/eid1312.070343; Figuerola J, 2007, AVIAN PATHOL, V36, P209, DOI 10.1080/03079450701332329; Garcia-Bocanegra I, 2011, VECTOR-BORNE ZOONOT, V11, P1107, DOI 10.1089/vbz.2009.0237; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gibbs SEJ, 2005, CLIN DIAGN LAB IMMUN, V12, P665, DOI 10.1128/CDLI.12.5.665-667.2005; Gomez-Diaz E, 2012, BIOL LETTERS, V8, P616, DOI 10.1098/rsbl.2012.0179; Gomez-Diaz E, 2011, ENVIRON MICROBIOL, V13, P2453, DOI 10.1111/j.1462-2920.2011.02515.x; Gomez-Diaz E, 2010, EVOL APPL, V3, P391, DOI 10.1111/j.1752-4571.2010.00127.x; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Hammouda A, 2011, VECTOR-BORNE ZOONOT, V11, P1583, DOI 10.1089/vbz.2011.0639; Hars J, 2004, FAUNE SAUVAGE, V261, P54; Heinze DM, 2012, J VIROL, V86, P8663, DOI 10.1128/JVI.01013-12; Hobson-Peters J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/379738; Hofle U, 2000, EMERG INFECT DIS, V267, P1741; Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111; Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001; Jimenez-Clavero MA, 2010, VET REC, V167, P379, DOI 10.1136/vr.c3155; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P15, DOI 10.1089/vbz.2006.0543; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P448, DOI 10.1089/vbz.2006.0592; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; JUPP PG, 1972, J MED ENTOMOL, V9, P393, DOI 10.1093/jmedent/9.5.393; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Llorente F, 2013, EMERG INFECT DIS, V19, P1023, DOI 10.3201/eid1906.130122; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; McCoy KD, 2005, MOL ECOL, V14, P2825, DOI 10.1111/j.1365-294X.2005.02631.x; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Monaco F, 2011, RES VET SCI, V91, P321, DOI 10.1016/j.rvsc.2011.01.008; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murphy FA, 1998, EMERG INFECT DIS, V4, P429, DOI 10.3201/eid0403.980324; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; NUTTALL PA, 1984, ARCH VIROL, V79, P35, DOI 10.1007/BF01314301; Oliphant T, 2007, EXPERT OPIN BIOL TH, V7, P885, DOI 10.1517/14712598.7.6.885; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Pearce-Duvet JMC, 2009, EMERG INFECT DIS, V15, P1147, DOI 10.3201/eid1507.090036; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Peruski LF, 2003, BIOTECHNIQUES, V35, P840, DOI 10.2144/03354ss01; PORTERFIELD JS, 1975, MED BIOL, V53, P400; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Reed Kurt D, 2003, Clin Med Res, V1, P5; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; SOL D, 1995, BIRD STUDY, V42, P216, DOI 10.1080/00063659509477170; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vazquez A, 2011, EUROSURVEILLANCE, V16, P22; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578; Webster RG, 2007, J WILDLIFE DIS, V43, pS1; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	90	30	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89601	10.1371/journal.pone.0089601	http://dx.doi.org/10.1371/journal.pone.0089601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625959	Green Published, gold			2022-12-25	WOS:000332851300006
J	Guo, DG; Li, QX; Lv, Q; Wei, QJ; Cao, SY; Gu, JR				Guo, Donggeng; Li, Qiuxia; Lv, Qing; Wei, Qiujing; Cao, Shuangyan; Gu, Jieruo			MiR-27a Targets sFRP1 in hFOB Cells to Regulate Proliferation, Apoptosis and Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; ANIMAL DEVELOPMENT; WNT; EXPRESSION; ADIPOGENESIS; OSTEOGENESIS; MICRORNA-27A; CONTRIBUTES; INHIBITION	MicroRNAs (miRNAs) play a key role in the regulation of almost all the physiological and pathological processes, including bone metabolism. Recent studies have suggested that miR-27 might play a key role in osteoblast differentiation and bone formation. Increasing evidence indicates that the canonical Wnt signaling pathway contributes to different stages of bone formation. In this study, we identify miR-27a can promote osteoblast differentiation by repressing a new target, secreted frizzled-related proteins 1 (sFRP1) expression at the transcriptional level. Here, 21 candidate targets of miR-27a involved in canonical Wnt/beta-catenin signaling were predicted, and a significant decrease in sFRP1 luciferase activity was observed both in 293T and MG63 cells co-transfected with the matched luciferase reporter constructs and miR-27a mimic. Furthermore, the presence of exogenous miR-27a significantly decreased sFRP1 mRNA and protein expression in hFOB1.19 cells during both proliferation and osteogenic differentiation. The over-expression of miR-27a or knockdown sFRP1 significantly increased the percentage of apoptotic hFOBs, the percentage of cells in the G2-M phase of the cell cycle and the expression of key osteoblastic markers, including ALP, SPP1, RUNX2 and ALP activity. Over-expression of miR-27a or knockdown of endogenous sFRP1 led to an accumulation of beta-catenin in hFOBs. In the present study, we demonstrate that miR-27a induced gene silencing effect is a vital mechanism contributing to bone metabolism in hFOB cells in vitro, which is partly affected by the post-transcriptional regulation of sFRP1, during osteoblast proliferation, apoptosis and differentiation.	[Guo, Donggeng; Li, Qiuxia; Lv, Qing; Wei, Qiujing; Cao, Shuangyan; Gu, Jieruo] Sun Yat Sen Univ, Dept Rheumatol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Gu, JR (corresponding author), Sun Yat Sen Univ, Dept Rheumatol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	gujieruo@163.com			5010 Subject of Sun Yat-sen University	5010 Subject of Sun Yat-sen University	This work was financially supported by the 5010 Subject of Sun Yat-sen University (2007-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen XL, 2013, INT J MOL SCI, V14, P14076, DOI 10.3390/ijms140714076; Gong Y, 2013, MOL CELL BIOCH; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hicok KC, 1998, J BONE MINER RES, V13, P205, DOI 10.1359/jbmr.1998.13.2.205; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kang T, 2013, J BIOL CHEM; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075251; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	38	71	79	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91354	10.1371/journal.pone.0091354	http://dx.doi.org/10.1371/journal.pone.0091354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625818	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300076
J	Mi, H; Ho, SL; Lim, WK; Wong, EPY; Teoh, SC				Mi, Helen; Ho, Su L.; Lim, Wee K.; Wong, Elizabeth P. Y.; Teoh, Stephen C.			Trends in Patterns of Intermediate Uveitis in a Tertiary Institution in Singapore	PLOS ONE			English	Article							INTRAOCULAR INFLAMMATORY DISEASE; CLINICAL-FEATURES; REFERRAL CENTER; PARS PLANITIS; MULTIPLE-SCLEROSIS; CHANGING PATTERNS; TUBERCULOSIS; COMPLICATIONS	Purpose: The study aims to describe the characteristics and etiologic causes of intermediate uveitis (IU) patients seen by a tertiary eye center in Singapore over 8 years. Methods: This was a retrospective analysis of the clinical records of consecutive new cases of IU that presented to the uveitis subspecialty clinic from 2004-2011 at Tan Tock Seng Hospital. Data collected included demographics, clinical and laboratory findings. Diagnoses were based on standardized clinical history, ophthalmological examination and investigations. Results: There were 66 new cases of IU, comprising 5.7% of 1168 new uveitis patients. The median age of diagnosis was 40 years (mean 39.4 +/- 15.9), with largest subgroup of the patients in the age group of 41-60 years (36.4%). The majority was Chinese (57.6%), followed by Asian Indians (18.2%) and Malays (16.7%). The ethnicity distribution was dissimilar to our ethnic distribution in Singapore (p<0.001) with an increased incidence of IU in the Asian Indian population. Most were idiopathic (59.1%) in etiology, followed by tuberculosis (TB) (15.2%). Ocular complications developed in 21 patients (31.8%), with cystoid macular edema (CME) being the commonest (28.8%). Severe vitritis occurred in 9.1% of patients, and was significantly associated with TB-associated IU (p<0.001). There was a downward trend for the incidence of the proportion of IU patients over the total uveitis patients (p = 0.021), with Spearman's rho of -0.786. Conclusions: Despite the downward trend, TB-associated IU was still of higher prevalence compared to less endemic areas, emphasizing the need for increased TB surveillance. A high index of suspicion for TB-associated IU is required in patients with severe vitritis. Comparisons with other countries revealed disparities in the IU etiologies, indicating possible geographical differences. Prevalence of known immune-mediated etiologies of IU is less compared to the western population. Our study also suggests a probable predisposition of the Singapore local Indian population for IU.	[Mi, Helen] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Ho, Su L.; Lim, Wee K.; Wong, Elizabeth P. Y.; Teoh, Stephen C.] Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore, Singapore; [Lim, Wee K.; Teoh, Stephen C.] Eagle Eye Ctr, Singapore, Singapore	National University of Singapore; Tan Tock Seng Hospital	Teoh, SC (corresponding author), Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore, Singapore.	Stephen_Teoh@ttsh.com.sg		Wong, Elizabeth/0000-0001-5288-0546; Teoh, Stephen/0000-0002-9359-9694				Aguirre-Cruz L, 2011, AUTOIMMUNITY, V44, P571, DOI 10.3109/08916934.2011.592887; Al-Mezaine HS, 2010, OCUL IMMUNOL INFLAMM, V18, P424, DOI 10.3109/09273948.2010.502284; Ang M, 2012, CLIN EXP OPHTHALMOL, V40, P689, DOI 10.1111/j.1442-9071.2012.02766.x; Anonymous, 2005, International Ophthalmology Clinics, V45, P1, DOI 10.1097/01.iio.0000155938.83083.94; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bodaghi B, 2000, Curr Opin Ophthalmol, V11, P443, DOI 10.1097/00055735-200012000-00010; Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592; Chong HT, 2008, NEUROL ASIA, V13, P145; Cimino L., 2010, International Ophthalmology, V30, P521, DOI 10.1007/s10792-010-9359-y; Cimino Luca, 2009, International Ophthalmology, V29, P67, DOI 10.1007/s10792-007-9071-8; Communicable Disease Center Tan Tock Seng Hospital, 2002, TRENDS SEL INF DIS S; Cunningham ET, 2000, OCUL IMMUNOL INFLAMM, V8, P251; Davis EJ, 2012, J OPHTHALMIC INFLAMM, V2, P183, DOI 10.1007/s12348-012-0079-5; Department of Statistics Singapore, 2011, SING RES AG GROUP ET; Donaldson MJ, 2007, AM J OPHTHALMOL, V144, P812, DOI 10.1016/j.ajo.2007.08.023; Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015; Hamade IH, 2010, ACTA OPHTHALMOL, V88, P905, DOI 10.1111/j.1755-3768.2009.01579.x; Hamade IH, 2009, OCUL IMMUNOL INFLAMM, V17, P11, DOI 10.1080/09273940802491850; HENDERLY DE, 1987, AM J OPHTHALMOL, V103, P131, DOI 10.1016/S0002-9394(14)74217-5; Huang JJ., 2010, OCULAR INFLAMMATORY; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Keino H, 2009, CLIN EXP OPHTHALMOL, V37, P595, DOI 10.1111/j.1442-9071.2009.02102.x; Kempen JH, 2010, AM J OPHTHALMOL, V149, P550, DOI 10.1016/j.ajo.2009.11.019; Khairallah M, 2007, EYE, V21, P33, DOI 10.1038/sj.eye.6702111; MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P818; Parchand S, 2011, J OPHTHALMIC INFLAMM, V1, P65, DOI 10.1007/s12348-011-0020-3; PERKINS ES, 1984, OPHTHALMOLOGICA, V189, P36, DOI 10.1159/000309382; Raja SC, 1999, OPHTHALMOLOGY, V106, P594, DOI 10.1016/S0161-6420(99)90122-7; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Sengun A, 2005, OCUL IMMUNOL INFLAMM, V13, P45, DOI 10.1080/09273940590909121; Smit R L, 1995, Curr Opin Ophthalmol, V6, P57; SMIT RLMJ, 1993, INT OPHTHALMOL, V17, P71, DOI 10.1007/BF00942778; Soheilian M, 2004, OCUL IMMUNOL INFLAMM, V12, P297, DOI 10.1080/092739490500174; Tan WJ, 2013, OCUL IMMUNOL INFLAMM, V21, P270, DOI 10.3109/09273948.2013.779725; Wakabayashi T, 2003, OCUL IMMUNOL INFLAMM, V11, P277, DOI 10.1076/ocii.11.4.277.18260; ZIERHUT M, 1992, DEV OPHTHALMOL, V23, P41	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91533	10.1371/journal.pone.0091533	http://dx.doi.org/10.1371/journal.pone.0091533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626440	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300100
J	Ursekar, CP; Teo, SK; Hirata, H; Harada, I; Chiam, KH; Sawada, Y				Ursekar, Chaitanya Prashant; Teo, Soo-Kng; Hirata, Hiroaki; Harada, Ichiro; Chiam, Keng-Hwee; Sawada, Yasuhiro			Design and Construction of an Equibiaxial Cell Stretching System That Is Improved for Biochemical Analysis	PLOS ONE			English	Article							MECHANICAL STRAIN; IN-VITRO; BIAXIAL STRAIN; RESPONSES; UNIFORM; FIBROBLASTS; ACTIVATION; DEVICE	We describe the design and validation of an equibiaxial stretching device in which cells are confined to regions of homogeneous strain. Using this device, we seek to overcome a significant limitation of existing equibiaxial stretching devices, in which strains are not homogeneous over the entire region of cell culture. We cast PDMS in a mold to produce a membrane with a cylindrical wall incorporated in the center, which was used to confine cell monolayers to the central membrane region subjected to homogeneous equibiaxial strain. We demonstrated that the presence of the wall to hold the culture medium did not affect strain homogeneity over the majority of the culture surface and also showed that cells adhered well onto the PDMS membranes. We used our device in cyclic strain experiments and demonstrated strain-dependent changes in extracellular signal-regulated kinase (ERK) and tyrosine phosphorylation upon cell stretching. Furthermore, we examined cell responses to very small magnitudes of strain ranging from 1% to 6% and were able to observe a graduated increase in ERK phosphorylation in response to these strains. Collectively, we were able to study cellular biochemical response with a high degree of accuracy and sensitivity to fine changes in substrate strain. Because we have designed our device along the lines of existing equibiaxial stretching technologies, we believe that our innovations can be incorporated into existing systems. This device would provide a useful addition to the set of tools applied for in vitro studies of cell mechanobiology.	[Ursekar, Chaitanya Prashant; Hirata, Hiroaki; Chiam, Keng-Hwee; Sawada, Yasuhiro] Natl Univ Singapore, Mechanobiol Inst Singapore, Singapore 117548, Singapore; [Teo, Soo-Kng] Agcy Sci Technol & Res, Inst High Performance Comp, Singapore, Singapore; [Harada, Ichiro; Sawada, Yasuhiro] Nadogaya Hosp, Locomot Syndrome Res Inst, Lab Mech Med, Kashiwa, Chiba, Japan; [Harada, Ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Chiam, Keng-Hwee] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Sawada, Yasuhiro] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Tokyo Institute of Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Sawada, Y (corresponding author), Natl Univ Singapore, Mechanobiol Inst Singapore, Singapore 117548, Singapore.	dbssy@nus.edu.sg	Teo, Soo Kng/H-8212-2019; Sokabe, Masahiro/I-1565-2012; Sawada, Yasuhiro/H-8044-2012	Teo, Soo Kng/0000-0001-5659-3763; Sawada, Yasuhiro/0000-0003-0625-3335; Hirata, Hiroaki/0000-0002-2604-9158; Ursekar, Chaitanya/0000-0001-9253-0559	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore; Singapore Ministry of Education	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by the Seed Fund of the Mechanobiology Institute, Research Centre of Excellence financed by the National Research Foundation of Singapore (http://www.nrf.gov.sg/) and the Singapore Ministry of Education (http://www.science.nus.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Arold SP, 2007, ANN BIOMED ENG, V35, P1156, DOI 10.1007/s10439-007-9262-5; Arold SP, 2009, AM J PHYSIOL-LUNG C, V296, pL574, DOI 10.1152/ajplung.90454.2008; Brosig M, 2010, INT J BIOCHEM CELL B, V42, P1717, DOI 10.1016/j.biocel.2010.07.001; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Huang L, 2010, ANN BIOMED ENG, V38, P1728, DOI 10.1007/s10439-010-9968-7; Hull JL, 2005, HDB PLASTIC PROCESSE, P455, DOI DOI 10.1002/0471786586.CH7/SUMMARY.ACCESSED; HUNG CT, 1994, J BIOMECH, V27, P227, DOI 10.1016/0021-9290(94)90212-7; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Lammerding Jan, 2008, V464, P13; Lee AA, 1999, J MOL CELL CARDIOL, V31, P1833, DOI 10.1006/jmcc.1999.1017; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548; Masuda T, 2008, J BIOTECHNOL, V133, P231, DOI 10.1016/j.jbiotec.2007.08.007; Quaglino A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-55; Rana OR, 2008, AM J PHYSIOL-HEART C, V294, pH532, DOI 10.1152/ajpheart.00649.2007; SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Sotoudeh M, 1998, ANN BIOMED ENG, V26, P181, DOI 10.1114/1.88; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Wang JHC, 2004, J BIOMECH, V37, P573, DOI 10.1016/j.jbiomech.2003.09.011; Waters CM, 2001, J APPL PHYSIOL, V91, P1600, DOI 10.1152/jappl.2001.91.4.1600; Xie KY, 2012, MED ENG PHYS, V34, P826, DOI 10.1016/j.medengphy.2011.09.024	32	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90665	10.1371/journal.pone.0090665	http://dx.doi.org/10.1371/journal.pone.0090665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626190	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300028
J	Zimbone, M; Baeri, P; Calcagno, L; Musumeci, P; Contino, A; Barcellona, ML; Bonaventura, G				Zimbone, Massimo; Baeri, Pietro; Calcagno, Lucia; Musumeci, Paolo; Contino, Annalinda; Barcellona, Maria Luisa; Bonaventura, Gabriele			Dynamic Light Scattering on Bioconjugated Laser Generated Gold Nanoparticles	PLOS ONE			English	Article							ABLATION; DNA; COLLOIDS; DISSOCIATION; DEGRADATION; ADSORBATES; SIZE	Gold nanoparticles (AuNPs) conjugated to DNA are widely used for biomedical targeting and sensing applications. DNA functionalization is easily reached on laser generated gold nanoparticles because of their unique surface chemistry, not reproducible by other methods. In this context, we present an extensive investigation concerning the attachment of DNA to the surface of laser generated nanoparticles using Dynamic Light Scattering and UV-Vis spectroscopy. The DNA conjugation is highlighted by the increase of the hydrodynamic radius and by the UV-Vis spectra behavior. Our investigation indicates that Dynamic Light Scattering is a suitable analytical tool to evidence, directly and qualitatively, the binding between a DNA molecule and a gold nanoparticle, therefore it is ideal to monitor changes in the conjugation process when experimental conditions are varied.	[Zimbone, Massimo; Baeri, Pietro; Calcagno, Lucia; Musumeci, Paolo] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Contino, Annalinda] Univ Catania, Dipartimento Sci Chim, I-95125 Catania, Italy; [Barcellona, Maria Luisa; Bonaventura, Gabriele] Univ Catania, Dipartimento Sci Farmaco, Catania, Italy	University of Catania; University of Catania; University of Catania	Barcellona, ML (corresponding author), Univ Catania, Dipartimento Sci Farmaco, Catania, Italy.	marsirin@gmail.com	Musumeci, Paolo/ABE-8253-2020; Contino, Annalinda/A-2765-2012	Musumeci, Paolo/0000-0002-5160-1522; Contino, Annalinda/0000-0003-2443-9352; CALCAGNO, Lucia/0000-0003-0403-6708; ZIMBONE, MASSIMO/0000-0003-4539-3998				Berne B.J., 1976, DYNAMIC LIGHT SCATTE, P376, DOI 10.1002/bbpc.19770810123; Besner S, 2008, APPL PHYS A-MATER, V93, P955, DOI 10.1007/s00339-008-4773-y; Bhatt N, 2011, LANGMUIR, V27, P6132, DOI 10.1021/la200241d; BLATCHFORD CG, 1982, SURF SCI, V120, P435, DOI 10.1016/0039-6028(82)90161-3; Bohren C. F., 2008, ABSORPTION SCATTERIN; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Cuenca AG, 2006, CANCER-AM CANCER SOC, V107, P459, DOI 10.1002/cncr.22035; Le DV, 2013, TALANTA, V107, P233, DOI 10.1016/j.talanta.2013.01.016; Galletto P, 1999, J PHYS CHEM B, V103, P8706, DOI 10.1021/jp991937t; Garcia MA, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/28/283001; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Herdt AR, 2006, COLLOID SURFACE B, V51, P130, DOI 10.1016/j.colsurfb.2006.06.006; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hill HD, 2009, ACS NANO, V3, P418, DOI 10.1021/nn800726e; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Jans H, 2009, ANAL CHEM, V81, P9425, DOI 10.1021/ac901822w; Jin RC, 2003, J AM CHEM SOC, V125, P1643, DOI 10.1021/ja021096v; Kreibig U, 1908, SPRINGER SERIES MAT; Lin J, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-170; Liu J, 2006, NAT PROTOC, V1, P246, DOI 10.1038/nprot.2006.38; Mafune F, 2004, CHEM PHYS LETT, V397, P133, DOI 10.1016/j.cplett.2004.08.108; Mafune F, 2002, J PHYS CHEM B, V106, P7575, DOI 10.1021/jp020577y; Majzik A, 2009, GOLD BULL, V42, P2; Martin MN, 2010, LANGMUIR, V26, P7410, DOI 10.1021/la100591h; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Petersen S, 2009, J PHYS CHEM C, V113, P19830, DOI 10.1021/jp905962f; Philip D, 2008, SPECTROCHIM ACTA A, V71, P80, DOI 10.1016/j.saa.2007.11.012; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Sajti CL, 2010, APPL PHYS A-MATER, V101, P259, DOI 10.1007/s00339-010-5813-y; Sethi M, 2009, ACS APPL MATER INTER, V1, P1270, DOI 10.1021/am900157m; Shim JY, 2007, J COLLOID INTERF SCI, V316, P977, DOI 10.1016/j.jcis.2007.08.021; Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i; Sylvestre JP, 2004, J PHYS CHEM B, V108, P16864, DOI 10.1021/jp047134+; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Ullien D, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/42/424015; Walter Johanna G., 2010, Journal of Nanobiotechnology, V8, P21, DOI 10.1186/1477-3155-8-21; Wei F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373325; Yang GW, 2007, PROG MATER SCI, V52, P648, DOI 10.1016/j.pmatsci.2006.10.016; Zhang X, 2012, J AM CHEM SOC, V134, P7266, DOI 10.1021/ja3014055; Zhang YJ, 2012, CHINESE SCI BULL, V57, P238, DOI 10.1007/s11434-011-4747-x; Zimbone M, 2012, APPL SURF SCI, V258, P9246, DOI 10.1016/j.apsusc.2011.08.112; Zimbone M, 2011, MATER LETT, V65, P2906, DOI 10.1016/j.matlet.2011.06.054; Zu YB, 2009, ANAL CHEM, V81, P8523, DOI 10.1021/ac901459v	47	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89048	10.1371/journal.pone.0089048	http://dx.doi.org/10.1371/journal.pone.0089048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625863	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300005
J	Grieb, B; Engler, G; Sharott, A; von Nicolai, C; Streichert, T; Papageorgiou, I; Schulte, A; Westphal, M; Lamszus, K; Engel, AK; Moll, CKE; Hamel, W				Grieb, Benjamin; Engler, Gerhard; Sharott, Andrew; von Nicolai, Constantin; Streichert, Thomas; Papageorgiou, Ismini; Schulte, Alexander; Westphal, Manfred; Lamszus, Katrin; Engel, Andreas K.; Moll, Christian K. E.; Hamel, Wolfgang			High-Frequency Stimulation of the Subthalamic Nucleus Counteracts Cortical Expression of Major Histocompatibility Complex Genes in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; CLASS-II INDUCIBILITY; SUBSTANTIA-NIGRA; 6-HYDROXYDOPAMINE LESION; DOPAMINERGIC-NEURONS; BETA-OSCILLATIONS; CEREBRAL-CORTEX; MESSENGER-RNA; BASAL GANGLIA; MOTOR CORTEX	High-frequency stimulation of the subthalamic nucleus (STN-HFS) is widely used as therapeutic intervention in patients suffering from advanced Parkinson's disease. STN-HFS exerts a powerful modulatory effect on cortical motor control by orthodromic modulation of basal ganglia outflow and via antidromic activation of corticofugal fibers. However, STN-HFS-induced changes of the sensorimotor cortex are hitherto unexplored. To address this question at a genomic level, we performed mRNA expression analyses using Affymetrix microarray gene chips and real-time RT-PCR in sensorimotor cortex of parkinsonian and control rats following STN-HFS. Experimental parkinsonism was induced in Brown Norway rats by bilateral nigral injections of 6-hydroxydopamine and was assessed histologically, behaviorally, and electrophysiologically. We applied prolonged (23h) unilateral STN-HFS in awake and freely moving animals, with the non-stimulated hemisphere serving as an internal control for gene expression analyses. Gene enrichment analysis revealed strongest regulation in major histocompatibility complex (MHC) related genes. STN-HFS led to a cortical downregulation of several MHC class II (RT1-Da, Db1, Ba, and Cd74) and MHC class I (RT1CE) encoding genes. The same set of genes showed increased expression levels in a comparison addressing the effect of 6-hydroxydopamine lesioning. Hence, our data suggest the possible association of altered microglial activity and synaptic transmission by STN-HFS within the sensorimotor cortex of 6-hydroxydopamine treated rats.	[Grieb, Benjamin; Engler, Gerhard; Sharott, Andrew; von Nicolai, Constantin; Engel, Andreas K.; Moll, Christian K. E.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Papageorgiou, Ismini] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Gen Neurophysiol, Heidelberg, Germany; [Schulte, Alexander; Westphal, Manfred; Lamszus, Katrin; Hamel, Wolfgang] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Grieb, Benjamin] Heidelberg Univ, Ctr Psychosocial Med, Dept Gen Psychiat, Heidelberg, Germany; [von Nicolai, Constantin] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen	Grieb, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	benjamin.grieb@med.uni-heidelberg.de	Engel, Andreas K./AAH-6384-2019; Engel, Andreas K/C-7781-2012; Papageorgiou, Ismini/AAI-7329-2020; /H-8186-2012	Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466; Papageorgiou, Ismini/0000-0001-5810-0483; Sharott, Andrew/0000-0002-1594-3349	University Medical Center Hamburg-Eppendorf	University Medical Center Hamburg-Eppendorf	The study received intramural funding from the University Medical Center Hamburg-Eppendorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW WF, 1986, EXP NEUROL, V92, P162, DOI 10.1016/0014-4886(86)90132-9; AKIYAMA H, 1989, BRAIN RES, V489, P247, DOI 10.1016/0006-8993(89)90857-3; Alberts JL, 2008, EXP NEUROL, V214, P1, DOI 10.1016/j.expneurol.2008.07.019; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alla JA, 2009, BIOCHEM BIOPH RES CO, V387, P186, DOI 10.1016/j.bbrc.2009.07.011; Ashby P, 2001, CLIN NEUROPHYSIOL, V112, P431, DOI 10.1016/S1388-2457(00)00532-0; Baker KB, 2002, MOVEMENT DISORD, V17, P969, DOI 10.1002/mds.10206; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Chung SJ, 2006, EUR NEUROL, V56, P127, DOI 10.1159/000095704; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Darbaky Y, 2003, EUR J NEUROSCI, V18, P951, DOI 10.1046/j.1460-9568.2003.02803.x; Dejean C, 2009, CEREB CORTEX, V19, P1055, DOI 10.1093/cercor/bhn149; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Dymecki J, 1996, FOLIA NEUROPATHOL, V34, P102; Ferro MM, 2005, J NEUROSCI METH, V148, P78, DOI 10.1016/j.jneumeth.2005.04.005; Fox CM, 2001, BRAIN RES, V896, P56, DOI 10.1016/S0006-8993(00)03270-4; Gimsa U, 2006, J NEUROSCI METH, V150, P212, DOI 10.1016/j.jneumeth.2005.06.013; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grieb B, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00095; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Harnack D, 2004, J NEUROSCI METH, V138, P207, DOI 10.1016/j.jneumeth.2004.04.019; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Healy-Stoffel M, 2012, J NEUROSCI METH, V210, P187, DOI 10.1016/j.jneumeth.2012.07.013; Henning J, 2007, EUR J NEUROSCI, V25, P239, DOI 10.1111/j.1460-9568.2006.05264.x; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Kadar E, 2011, BRAIN RES, V1391, P1, DOI 10.1016/j.brainres.2011.03.059; Kemmel V, 2010, PHYSIOL GENOMICS, V41, P146, DOI 10.1152/physiolgenomics.00208.2009; KITAI ST, 1981, BRAIN RES, V214, P411, DOI 10.1016/0006-8993(81)91204-X; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Kuriakose R, 2010, CEREB CORTEX, V20, P1926, DOI 10.1093/cercor/bhp269; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Liu F, 2011, CURR NEUROPHARMACOL, V9, P260, DOI 10.2174/157015911795017155; MacKinnon CD, 2005, EUR J NEUROSCI, V21, P1394, DOI 10.1111/j.1460-9568.2005.03952.x; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; Monakow K H, 1978, Exp Brain Res, V33, P395; Nambu A, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-4002-y; Neumann H, 1998, P NATL ACAD SCI USA, V95, P5779, DOI 10.1073/pnas.95.10.5779; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PENNYPACKER KR, 1995, TRENDS PHARMACOL SCI, V16, P317, DOI 10.1016/S0165-6147(00)89061-6; Raz A, 2010, ANESTH ANALG, V111, P1285, DOI 10.1213/ANE.0b013e3181f565f2; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Sarro SM, 2010, LEUKEMIA RES, V34, P1670, DOI 10.1016/j.leukres.2010.06.031; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Schulte T, 2006, NEUROSCIENCE, V138, P1377, DOI 10.1016/j.neuroscience.2005.12.034; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Shen KZ, 2003, SYNAPSE, V50, P314, DOI 10.1002/syn.10274; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Strackx E, 2008, EXP NEUROL, V211, P413, DOI 10.1016/j.expneurol.2008.02.006; Tan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021328; Temel Y, 2004, NEUROSCI LETT, V367, P92, DOI 10.1016/j.neulet.2004.05.087; Temel Y, 2005, EXP NEUROL, V193, P43, DOI 10.1016/j.expneurol.2004.12.025; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Thobois S, 2010, BRAIN, V133, P1111, DOI 10.1093/brain/awq032; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walker HC, 2012, MOVEMENT DISORD, V27, P1404, DOI 10.1002/mds.25137; Walker HC, 2009, NEUROSURGERY, V65, P302, DOI 10.1227/01.NEU.0000349764.34211.74; Walker QD, 2012, NEUROPHARMACOLOGY, V62, P2267, DOI 10.1016/j.neuropharm.2012.01.029; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; Zaidel A, 2010, BRAIN, V133, P2007, DOI 10.1093/brain/awq144	85	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91663	10.1371/journal.pone.0091663	http://dx.doi.org/10.1371/journal.pone.0091663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621597	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300114
J	Moore, JA; Draheim, HM; Etter, D; Winterstein, S; Scribner, KT				Moore, Jennifer A.; Draheim, Hope M.; Etter, Dwayne; Winterstein, Scott; Scribner, Kim T.			Application of Large-Scale Parentage Analysis for Investigating Natal Dispersal in Highly Vagile Vertebrates: A Case Study of American Black Bears (Ursus americanus)	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; SPATIALLY-STRUCTURED POPULATIONS; SEX-BIASED DISPERSAL; INBREEDING AVOIDANCE; HABITAT SELECTION; GENOTYPING ERRORS; BROWN BEAR; MAMMALS; EVOLUTION; BIRDS	Understanding the factors that affect dispersal is a fundamental question in ecology and conservation biology, particularly as populations are faced with increasing anthropogenic impacts. Here we collected georeferenced genetic samples (n = 2,540) from three generations of black bears (Ursus americanus) harvested in a large (47,739 km(2)), geographically isolated population and used parentage analysis to identify mother-offspring dyads (n = 337). We quantified the effects of sex, age, habitat type and suitability, and local harvest density at the natal and settlement sites on the probability of natal dispersal, and on dispersal distances. Dispersal was male-biased (76% of males dispersed) but a small proportion (21%) of females also dispersed, and female dispersal distances (mean +/- SE = 48.9 +/- 7.7 km) were comparable to male dispersal distances (59.0 +/- 3.2 km). Dispersal probabilities and dispersal distances were greatest for bears in areas with high habitat suitability and low harvest density. The inverse relationship between dispersal and harvest density in black bears suggests that 1) intensive harvest promotes restricted dispersal, or 2) high black bear population density decreases the propensity to disperse. Multigenerational genetic data collected over large landscape scales can be a powerful means of characterizing dispersal patterns and causal associations with demographic and landscape features in wild populations of elusive and wide-ranging species.	[Moore, Jennifer A.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Draheim, Hope M.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Etter, Dwayne] Michigan Dept Nat Resources, Wildlife Div, E Lansing, MI USA; [Moore, Jennifer A.; Winterstein, Scott; Scribner, Kim T.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Grand Valley State University; Michigan State University; Michigan State University	Moore, JA (corresponding author), Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA.	moorejen@gvsu.edu			Michigan Department of Natural Resources through the Wildlife and Sportfish Restoration Program, Michigan State University Department of Fisheries and Wildlife [F11AF00640]	Michigan Department of Natural Resources through the Wildlife and Sportfish Restoration Program, Michigan State University Department of Fisheries and Wildlife	Michigan Department of Natural Resources through the Wildlife and Sportfish Restoration Program F11AF00640, Michigan State University Department of Fisheries and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bitume EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026927; Broseth H, 2005, J APPL ECOL, V42, P453, DOI 10.1111/j.1365-2664.2005.01031.x; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Costello CM, 2010, J MAMMAL, V91, P116, DOI 10.1644/09-MAMM-A-015R1.1; Czetwertynski SM, 2007, URSUS, V18, P1, DOI 10.2192/1537-6176(2007)18[1:EOHODP]2.0.CO;2; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Draheim H, WILDLIFE BI IN PRESS; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Epperson BK, 2005, HEREDITY, V95, P7, DOI 10.1038/sj.hdy.6800680; ETTER DR, 2002, BLACK BEAR POPULATIO; Frawley BJ, 2009, 2008 MICHIGAN BLACK; GARSHELIS DL, 1981, J WILDLIFE MANAGE, V45, P912, DOI 10.2307/3808099; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HESTBECK JB, 1982, OIKOS, V39, P157, DOI 10.2307/3544480; HORNER MA, 1990, J MAMMAL, V71, P402, DOI 10.2307/1381953; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; LAMBIN X, 1994, ECOLOGY, V75, P224, DOI 10.2307/1939396; Lambin Xavier, 2001, P110; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; MEAGHER TR, 1986, THEOR POPUL BIOL, V29, P87, DOI 10.1016/0040-5809(86)90006-7; Miller MA, 2003, URSUS, V14, P130; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; NOVAK JM, 1991, J WILDLIFE MANAGE, V55, P31, DOI 10.2307/3809238; Obbard ME, 2008, J WILDLIFE MANAGE, V72, P869, DOI 10.2193/2006-158; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peacock E, 2004, ESTIMATION BLACK BEA; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Team, 2006, R LANG ENV STAT COMP; Riester M, 2009, BIOINFORMATICS, V25, P2134, DOI 10.1093/bioinformatics/btp064; Rogers L. L., 1987, MAMMALIAN DISPERSAL, P75; ROGERS LL, 1987, WILDLIFE MONOGR, P1; Ronce Ophelie, 2001, P341; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Roy J, 2012, ECOL EVOL, V2, P525, DOI 10.1002/ece3.207; SCHWARTZ CC, 1992, J WILDLIFE MANAGE, V56, P426, DOI 10.2307/3808854; Shih CC, 2009, CONSERV GENET, V10, P1845, DOI 10.1007/s10592-009-9830-3; Silverman B.W., 1986, DENSITY ESTIMATION S; STAMPS JA, 1987, BEHAV ECOL SOCIOBIOL, V21, P273, DOI 10.1007/BF00299964; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Stamps JA, 2006, ANIM BEHAV, V72, P1279, DOI 10.1016/j.anbehav.2006.03.010; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WILLEY CH, 1974, J WILDLIFE MANAGE, V38, P97, DOI 10.2307/3800203; WOLFF JO, 1992, NATURE, V359, P409, DOI 10.1038/359409a0; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Wu H, 2010, CONSERV GENET, V11, P1215, DOI 10.1007/s10592-009-9922-0; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015; [No title captured]	65	28	28	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91168	10.1371/journal.pone.0091168	http://dx.doi.org/10.1371/journal.pone.0091168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621593	Green Published, gold			2022-12-25	WOS:000332845300056
J	Westmark, CJ				Westmark, Cara J.			Soy Infant Formula and Seizures in Children with Autism: A Retrospective Study	PLOS ONE			English	Article							FED BREAST-MILK; EPILEPSY; EXPOSURE; BEHAVIOR; GENDER; MODELS	Seizures are a common phenotype in many neurodevelopmental disorders including fragile X syndrome, Down syndrome and autism. We hypothesized that phytoestrogens in soy-based infant formula were contributing to lower seizure threshold in these disorders. Herein, we evaluated the dependence of seizure incidence on infant formula in a population of autistic children. Medical record data were obtained on 1,949 autistic children from the SFARI Simplex Collection. An autism diagnosis was determined by scores on the ADI-R and ADOS exams. The database included data on infant formula use, seizure incidence, the specific type of seizure exhibited and IQ. Soy-based formula was utilized in 17.5% of the study population. Females comprised 13.4% of the subjects. There was a 2.6-fold higher rate of febrile seizures [4.2% versus 1.6%, OR = 2.6, 95% CI = 1.3-5.3], a 2.1-fold higher rate of epilepsy comorbidity [3.6% versus 1.7%, OR = 2.2, 95% CI = 1.1-4.7] and a 4-fold higher rate of simple partial seizures [1.2% versus 0.3%, OR = 4.8, 95% CI = 1.0-23] in the autistic children fed soy-based formula. No statistically significant associations were found with other outcomes including: IQ, age of seizure onset, infantile spasms and atonic, generalized tonic clonic, absence and complex partial seizures. Limitations of the study included: infant formula and seizure data were based on parental recall, there were significantly less female subjects, and there was lack of data regarding critical confounders such as the reasons the subjects used soy formula, age at which soy formula was initiated and the length of time on soy formula. Despite these limitations, our results suggest that the use of soy-based infant formula may be associated with febrile seizures in both genders and with a diagnosis of epilepsy in males in autistic children. Given the lack of data on critical confounders and the retrospective nature of the study, a prospective study is required to confirm the association.	Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Westmark, CJ (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	westmark@wisc.edu	Westmark, Cara/AAX-4408-2020; Westmark, Cara J/L-4647-2019		FRAXA Research Foundation; National Institutes of Health (NIH) [1UL1RR025011, 9U54TR000021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	FRAXA Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by FRAXA Research Foundation (www.fraxa.org) and National Institutes of Health (NIH) (www.nih.gov) [1UL1RR025011 and 9U54TR000021]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgent MA, 2011, ENVIRON HEALTH PERSP, V119, P1811, DOI 10.1289/ehp.1103579; Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; Andres A, 2012, PEDIATRICS, V129, P1134, DOI 10.1542/peds.2011-3121; [Anonymous], 2008, ANN ICRP, V38, P1; Bernbaum JC, 2008, ENVIRON HEALTH PERSP, V116, P416, DOI 10.1289/ehp.10409; Berry-Kravis E, 2010, AJIDD-AM J INTELLECT, V115, P461, DOI 10.1352/1944-7558-115.6.461; Bhatia J, 2008, PEDIATRICS, V121, P1062, DOI 10.1542/peds.2008-0564; Brooks-Kayal A, 2010, BRAIN DEV-JPN, V32, P731, DOI 10.1016/j.braindev.2010.04.010; Brown NM, 2001, LAB INVEST, V81, P735, DOI 10.1038/labinvest.3780282; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gilchrist JM, 2010, J PEDIATR-US, V156, P215, DOI 10.1016/j.jpeds.2009.08.043; Hessl D, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e88; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Jing HK, 2010, EARLY HUM DEV, V86, P119, DOI 10.1016/j.earlhumdev.2010.02.001; Li JA, 2010, DEV NEUROPSYCHOL, V35, P762, DOI 10.1080/87565641.2010.508547; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; McCary LM, 2013, J INTELL DISABIL RES, V57, P803, DOI 10.1111/j.1365-2788.2012.01609.x; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Polack FP, 1999, CLIN PEDIATR, V38, P703, DOI 10.1177/000992289903801202; Ricci M., 2005, ANIM LAB NEWS, V4, P1; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1453S, DOI 10.1093/ajcn/68.6.1453S; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Shukla SK, 2010, NAT PROD RES, V24, P873, DOI 10.1080/14786410903417378; Soucy NV, 2006, TOXICOL SCI, V90, P230, DOI 10.1093/toxsci/kfj077; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Weber KS, 2001, DEV BRAIN RES, V126, P217, DOI 10.1016/S0165-3806(00)00138-3; Wei P, 2012, ASIAN PAC J TROP MED, V5, P243, DOI 10.1016/S1995-7645(12)60033-9; Yates JRW, 2011, ARCH DIS CHILD, V96, P1020, DOI 10.1136/adc.2011.211995	32	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e80488	10.1371/journal.pone.0080488	http://dx.doi.org/10.1371/journal.pone.0080488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622158	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300001
J	Bharti, RK; Srivastava, S; Thakur, IS				Bharti, Randhir K.; Srivastava, Shaili; Thakur, Indu Shekhar			Proteomic Analysis of Carbon Concentrating Chemolithotrophic Bacteria Serratia sp for Sequestration of Carbon Dioxide	PLOS ONE			English	Article							ESCHERICHIA-COLI; INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE; CO2; BIOSYNTHESIS; PROTEINS; ANHYDRASE; SEQUENCE; ENZYME; MICROCOMPARTMENTS; PURIFICATION	A chemolithotrophic bacterium enriched in the chemostat in presence of sodium bicarbonate as sole carbon source was identified as Serratia sp. by 16S rRNA sequencing. Carbon dioxide sequestering capacity of bacterium was detected by carbonic anhydrase enzyme and ribulose-1, 5-bisphosphate carboxylase/oxygenase (RuBisCO). The purified carbonic anhydrase showed molecular weight of 29 kDa. Molecular weight of RuBisCO was 550 kDa as determined by fast protein liquid chromatography (FPLC), however, sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) showed presence of two subunits whose molecular weights were 56 and 14 kDa. The Western blot analysis of the crude protein and purified sample cross reacted with RuBisCO large-subunit polypeptides antibodies showed strong band pattern at molecular weight around 56 kDa regions. Whole cell soluble proteins of Serratia sp. grown under autotrophic and heterotrophic conditions were resolved by two-dimensional gel electrophoresis and MALDI-TOF/MS for differential expression of proteins. In proteomic analysis of 63 protein spots, 48 spots were significantly up-regulated in the autotrophically grown cells; seven enzymes showed its utilization in autotrophic carbon fixation pathways and other metabolic activities of bacterium including lipid metabolisms indicated sequestration potency of carbon dioxide and production of biomaterials.	[Bharti, Randhir K.; Srivastava, Shaili; Thakur, Indu Shekhar] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Thakur, IS (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	isthakur@hotmail.com			Department of Biotechnology, Government of India, New Delhi, India; University Grants Commission	Department of Biotechnology, Government of India, New Delhi, India; University Grants Commission(University Grants Commission, India)	This research work was supported by the research grants of Department of Biotechnology, Government of India, New Delhi, India. One of the authors (Srivastava S.) is thankful to University Grants Commission for Dr. D. S Kothari post Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; BAHR J T, 1981, Photosynthesis Research, V2, P235, DOI 10.1007/BF00056260; Banfield JF, 2005, OMICS, V9, P301, DOI 10.1089/omi.2005.9.301; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Burns BP, 1995, MICROBIOL-UK, V141, P3113, DOI 10.1099/13500872-141-12-3113; CHAUDHURI S, 1985, BIOCHEM J, V226, P217, DOI 10.1042/bj2260217; DUNCAN K, 1984, FEBS LETT, V170, P59, DOI 10.1016/0014-5793(84)81368-X; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; HARRIS RA, 1986, ADV ENZYME REGUL, V25, P219, DOI 10.1016/0065-2571(86)90016-6; HILDITCH CM, 1991, PHYTOCHEMISTRY, V30, P745, DOI 10.1016/0031-9422(91)85245-U; Ho SH, 2011, BIOTECHNOL ADV, V29, P189, DOI 10.1016/j.biotechadv.2010.11.001; Innocenti A, 2008, BIOORG MED CHEM LETT, V18, P2267, DOI 10.1016/j.bmcl.2008.03.012; Jaiswal PK, 2011, J IND MICROBIOL BIOT, V38, P503, DOI 10.1007/s10295-010-0793-7; Jehmlich N, 2010, APPL MICROBIOL BIOT, V88, P575, DOI 10.1007/s00253-010-2753-6; Joseph P, 2011, BIOORGAN MED CHEM, V19, P1172, DOI 10.1016/j.bmc.2010.12.048; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kichise T, 1999, INT J BIOL MACROMOL, V25, P69, DOI 10.1016/S0141-8130(99)00017-3; Kim IG, 2012, CHEMOSPHERE, V87, P1091, DOI 10.1016/j.chemosphere.2012.02.003; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kumar A, 2010, TRENDS BIOTECHNOL, V28, P371, DOI 10.1016/j.tibtech.2010.04.004; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurian D, 2006, PROTEOMICS, V6, P1483, DOI 10.1002/pmic.200500413; LENNARZ WJ, 1961, BIOCHEM BIOPH RES CO, V6, P112, DOI 10.1016/0006-291X(61)90395-3; Liang XQ, 2000, ARCH BIOCHEM BIOPHYS, V380, P373, DOI 10.1006/abbi.2000.1941; LONG JJ, 1994, J BIOL CHEM, V269, P2827; Mehlan H, 2013, PROTEOMICS, V13, P2805, DOI 10.1002/pmic.201300167; Mishra M, 2011, INT BIODETER BIODEGR, V65, P301, DOI 10.1016/j.ibiod.2010.12.002; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Ozensoy O, 2004, BIOCHEMISTRY-MOSCOW+, V69, P216, DOI 10.1023/B:BIRY.0000018954.38006.9a; Palumbo AV, 2004, ADV ENVIRON RES, V8, P425, DOI 10.1016/S1093-0191(02)00124-7; PELROY RA, 1972, ARCH MIKROBIOL, V87, P303, DOI 10.1007/BF00409131; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; Qiao JJ, 2013, GENE, V512, P6, DOI 10.1016/j.gene.2012.10.004; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; SHARKEY TD, 1991, PHOTOSYNTH RES, V28, P41, DOI 10.1007/BF00027175; Shrestha RK, 2006, ENVIRON INT, V32, P781, DOI 10.1016/j.envint.2006.05.001; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Taneja S, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-5; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; THAKUR IS, 1995, WORLD J MICROB BIOT, V11, P643, DOI 10.1007/BF00361007; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wohlbrand L, 2013, PROTEOMIC TOOLS ENV, DOI [10.1002/pmic.201300175, DOI 10.1002/PMIC.201300175]; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Wu WW, 2007, J PROTEOME RES, V6, P2447, DOI 10.1021/pr060621c; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998; Zimmermann AG, 1998, PROG NUCLEIC ACID RE, V61, P181, DOI 10.1016/S0079-6603(08)60827-2	57	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91300	10.1371/journal.pone.0091300	http://dx.doi.org/10.1371/journal.pone.0091300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619032	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400070
J	Mackeh, R; Lorin, S; Ratier, A; Mejdoubi-Charef, N; Baillet, A; Bruneel, A; Hamai, A; Codogno, P; Pous, C; Perdiz, D				Mackeh, Rafah; Lorin, Severine; Ratier, Ameetha; Mejdoubi-Charef, Najet; Baillet, Anita; Bruneel, Arnaud; Hamai, Ahmed; Codogno, Patrice; Poues, Christian; Perdiz, Daniel			Reactive Oxygen Species, AMP-activated Protein Kinase, and the Transcription Cofactor p300 Regulate alpha- Tubulin Acetyltransferase-1 ( alpha TAT-1/MEC-17)- dependent Microtubule Hyperacetylation during Cell Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Microtubules; p300; Reactive Oxygen Species (ROS); Stress; Tubulin; AMPK; MEC-17; ATAT1; Acetylation	DYNAMIC INSTABILITY; AUTOPHAGY; STIMULATION; ACETYLATION; MITOCHONDRIA; INHIBITION; BINDING; MEC-17; GENE; ROS	Background: Tubulin acetylation is a hallmark of microtubule stabilization, which may modulate the binding of microtubule-associated proteins. Results: Microtubules are hyperacetylated because of stress-induced cellular signaling upstream of the tubulin acetyltransferase MEC-17/TAT1. Conclusion: MEC-17/TAT1 is regulated by p300, reactive oxygen species, and AMP-activated protein kinase. Significance: Microtubule hyperacetylation is important for cell adaptation to stress through autophagy induction and for cell survival. Beyond its presence in stable microtubules, tubulin acetylation can be boosted after UV exposure or after nutrient deprivation, but the mechanisms of microtubule hyperacetylation are still unknown. In this study, we show that this hyperacetylation is a common response to several cellular stresses that involves the stimulation of the major tubulin acetyltransferase MEC-17. We also demonstrate that the acetyltransferase p300 negatively regulates MEC-17 expression and is sequestered on microtubules upon stress. We further show that reactive oxygen species of mitochondrial origin are required for microtubule hyperacetylation by activating the AMP kinase, which in turn mediates MEC-17 phosphorylation upon stress. Finally, we show that preventing microtubule hyperacetylation by knocking down MEC-17 affects cell survival under stress conditions and starvation-induced autophagy, thereby pointing out the importance of this rapid modification as a broad cell response to stress.	[Mackeh, Rafah; Lorin, Severine; Ratier, Ameetha; Mejdoubi-Charef, Najet; Baillet, Anita; Bruneel, Arnaud; Poues, Christian; Perdiz, Daniel] Univ Paris 11, Fac Pharm, EA4530, F-92296 Chatenay Malabry, France; [Bruneel, Arnaud] Hop Bichat Claude Bernard, AP HP, Serv Biochim Metab & Cellulaire, F-75018 Paris, France; [Hamai, Ahmed; Codogno, Patrice] Univ Paris 05, INSERM, U845, F-75014 Paris, France; [Poues, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Pous, C (corresponding author), Univ Paris 11, UFR Pharm, EA4530, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.	christian.pous@u-psud.fr	POÜS, Christian/R-5089-2018; Baillet, Anita/R-6217-2018; Bruneel, Arnaud/AAD-1338-2021; Lorin, Séverine/R-4689-2018; Perdiz, Daniel/R-4471-2018; MEJDOUBI-CHAREF, Najet/R-4683-2018	Bruneel, Arnaud/0000-0001-8411-3309; Perdiz, Daniel/0000-0002-6804-5980; POUS, Christian/0000-0002-2502-7854	Ministere de l'Enseignement Superieur et de la Recherche [EA 4530]; INSERM [U845]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by Grant EA 4530 from the Ministere de l'Enseignement Superieur et de la Recherche and Grant U845 from INSERM.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen F, 2010, MOL CELL, V40, P175, DOI 10.1016/j.molcel.2010.10.008; Chen JH, 2007, EPIGENETICS-US, V2, P92, DOI 10.4161/epi.2.2.4326; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Giustiniani J, 2009, EXP CELL RES, V315, P3509, DOI 10.1016/j.yexcr.2009.07.018; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Mees ST, 2010, INT J CANCER, V126, P114, DOI 10.1002/ijc.24695; MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nunes P, 2013, AUTOPHAGY, V9, P550, DOI 10.4161/auto.23662; Park IJ, 2006, ANN NY ACAD SCI, V1091, P102, DOI 10.1196/annals.1378.059; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Sid B, 2013, BIOCHEM PHARMACOL, V86, P200, DOI 10.1016/j.bcp.2013.05.007; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Walter WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042218; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; Zhou XY, 2005, AM J PHYSIOL-RENAL, V289, pF871, DOI 10.1152/ajprenal.00129.2005	53	61	63	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11816	11828		10.1074/jbc.M113.507400	http://dx.doi.org/10.1074/jbc.M113.507400			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619423	Green Published, hybrid			2022-12-25	WOS:000335010600022
J	Cheng, YS; Chen, CC; Huang, CH; Ko, TP; Luo, WH; Huang, JW; Liu, JR; Guo, RT				Cheng, Ya-Shan; Chen, Chun-Chi; Huang, Chun-Hsiang; Ko, Tzu-Ping; Luo, Wenhua; Huang, Jian-Wen; Liu, Je-Ruei; Guo, Rey-Ting			Structural Analysis of a Glycoside Hydrolase Family 11 Xylanase from Neocallimastix patriciarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Mutation; Enzyme Structure; Glycoside Hydrolases; X-ray Crystallography; N-terminal Region; Disulfide Bond; Industrial Enzyme; Xylanase	TERMINAL DISULFIDE BRIDGE; PICHIA-PASTORIS; 3-DIMENSIONAL STRUCTURE; GH11 XYLANASE; THERMOMYCES-LANUGINOSUS; ANGSTROM RESOLUTION; TRICHODERMA-REESEI; PROTEIN-STRUCTURE; ESCHERICHIA-COLI; LOW PH	Background: Thermophilic xylanases are valuable in many industrial applications. Results: The structures of a xylanase XynCDBFV and its complex with xylooligosaccharides were determined, and its N-terminal region (NTR) contributes to thermostability. Conclusion: NTR may stabilize the overall protein folding of XynCDBFV. Significance: The structural and functional investigation of unprecedented NTR of XynCDBFV provides a new insight into the molecular basis of thermophilic xylanases. The catalytic domain of XynCDBFV, a glycoside hydrolase family 11 (GH11) xylanase from ruminal fungus Neocallimastix patriciarum previously engineered to exhibit higher specific activity and broader pH adaptability, holds great potential in commercial applications. Here, the crystal structures of XynCDBFV and its complex with substrate were determined to 1.27-1.43 resolution. These structures revealed a typical GH11 -jelly-roll fold and detailed interaction networks between the enzyme and ligands. Notably, an extended N-terminal region (NTR) consisting of 11 amino acids was identified in the XynCDBFV structure, which is found unique among GH11 xylanases. The NTR is attached to the catalytic core by hydrogen bonds and stacking forces along with a disulfide bond between Cys-4 and Cys-172. Interestingly, the NTR deletion mutant retained 61.5% and 19.5% enzymatic activity at 55 degrees C and 75 degrees C, respectively, compared with the wild-type enzyme, whereas the C4A/C172A mutant showed 86.8% and 23.3% activity. These results suggest that NTR plays a role in XynCDBFV thermostability, and the Cys-4/Cys-172 disulfide bond is critical to the NTR-mediated interactions. Furthermore, we also demonstrated that Pichia pastoris produces XynCDBFV with higher catalytic activity at higher temperature than Escherichia coli, in which incorrect NTR folding and inefficient disulfide bond formation might have occurred. In conclusion, these structural and functional analyses of the industrially favored XynCDBFV provide a molecular basis of NTR contribution to its thermostability.	Genozyme Biotechnol Inc, Taipei 106, Taiwan; [Cheng, Ya-Shan; Guo, Rey-Ting] AsiaPac Biotechnol Co Ltd, Dongguan 523808, Peoples R China; [Chen, Chun-Chi; Huang, Chun-Hsiang] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Ind Enzymes Natl Engn Lab, Tianjin 300308, Peoples R China; [Ko, Tzu-Ping] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Luo, Wenhua] South China Agr Univ, Coll Food Sci, Guangzhou 510642, Guangdong, Peoples R China; [Liu, Je-Ruei] Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Academia Sinica - Taiwan; South China Agricultural University; National Taiwan University	Guo, RT (corresponding author), 32 XiQiDao,Tianjin Airport Econ Pk, Tianjin 300308, Peoples R China.	guo_rt@tib.cas.cn		LIU, JE-RUEI/0000-0002-2152-7536; Guo, Rey-Ting/0000-0003-2942-7246; Chen, chun-chi/0000-0002-7459-5591	National High Technology Research and Development Program of China [2012AA022200]; Tianjin Municipal Science and Technology Commission [12ZCZDSY12500]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Tianjin Municipal Science and Technology Commission	This work was supported by the National High Technology Research and Development Program of China (2012AA022200) and the Tianjin Municipal Science and Technology Commission (12ZCZDSY12500).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Chen YL, 2001, CAN J MICROBIOL, V47, P1088, DOI 10.1139/cjm-47-12-1088; Cheng YF, 2005, ENZYME MICROB TECH, V37, P541, DOI 10.1016/j.enzmictec.2005.04.006; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumon C, 2008, J BIOL CHEM, V283, P22557, DOI 10.1074/jbc.M800936200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenel F, 2004, J BIOTECHNOL, V108, P137, DOI 10.1016/j.jbiotec.2003.11.002; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l; Guo RT, 2001, PROTEINS, V43, P499, DOI 10.1002/prot.1061; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Janis J, 2004, BIOCHEMISTRY-US, V43, P9556, DOI 10.1021/bi049597b; Khandeparker R, 2008, J IND MICROBIOL BIOT, V35, P635, DOI 10.1007/s10295-008-0342-9; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Konig J, 2002, ANAL BIOANAL CHEM, V374, P80, DOI 10.1007/s00216-002-1379-7; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Kumar PR, 2000, J MOL BIOL, V295, P581, DOI 10.1006/jmbi.1999.3348; LEE JMT, 1993, CAN J MICROBIOL, V39, P134, DOI 10.1139/m93-020; Li H, 2013, ENZYME MICROB TECH, V53, P414, DOI 10.1016/j.enzmictec.2013.09.004; Liu JH, 1999, CAN J MICROBIOL, V45, P970, DOI 10.1139/cjm-45-11-970; Liu MQ, 2006, PROTEIN EXPRES PURIF, V48, P292, DOI 10.1016/j.pep.2006.04.007; McCarthy AA, 2000, ACTA CRYSTALLOGR D, V56, P1367, DOI 10.1107/S0907444900009896; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaux C, 2010, BIOCHIMIE, V92, P1407, DOI 10.1016/j.biochi.2010.07.003; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Purmonen M, 2007, PROTEIN ENG DES SEL, V20, P551, DOI 10.1093/protein/gzm056; Ramalingam A. D. H. a. C., 2010, J EXP SCI, V1, P1; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sriyapai T, 2011, J BIOSCI BIOENG, V111, P528, DOI 10.1016/j.jbiosc.2010.12.024; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; Sygmund C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; van Bueren AL, 2012, ACTA CRYSTALLOGR F, V68, P141, DOI 10.1107/S1744309111049608; VIIKARI L, 1994, FEMS MICROBIOL REV, V13, P335, DOI 10.1016/0168-6445(94)90090-6; Wan Q, 2014, ACTA CRYSTALLOGR D, V70, P11, DOI 10.1107/S1399004713023626; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; You C, 2010, BIOTECHNOL BIOENG, V105, P861, DOI 10.1002/bit.22623	48	49	57	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11020	11028		10.1074/jbc.M114.550905	http://dx.doi.org/10.1074/jbc.M114.550905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619408	Green Published, hybrid			2022-12-25	WOS:000334638500008
J	Groeneweg, FL; van Royen, ME; Fenz, S; Keizer, VIP; Geverts, B; Prins, J; de Kloet, ER; Houtsmuller, AB; Schmidt, TS; Schaaf, MJM				Groeneweg, Femke L.; van Royen, Martin E.; Fenz, Susanne; Keizer, Veer I. P.; Geverts, Bart; Prins, Jurrien; de Kloet, E. Ron; Houtsmuller, Adriaan B.; Schmidt, Thomas S.; Schaaf, Marcel J. M.			Quantitation of Glucocorticoid Receptor DNA-Binding Dynamics by Single-Molecule Microscopy and FRAP	PLOS ONE			English	Article							NF-KAPPA-B; MINERALOCORTICOID RECEPTOR; CORRELATION SPECTROSCOPY; IN-VIVO; TRANSCRIPTION; REVEALS; PROTEIN; MOBILITY; CHROMATIN; MEMBRANE	Recent advances in live cell imaging have provided a wealth of data on the dynamics of transcription factors. However, a consistent quantitative description of these dynamics, explaining how transcription factors find their target sequences in the vast amount of DNA inside the nucleus, is still lacking. In the present study, we have combined two quantitative imaging methods, single-molecule microscopy and fluorescence recovery after photobleaching, to determine the mobility pattern of the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR), two ligand-activated transcription factors. For dexamethasone-activated GR, both techniques showed that approximately half of the population is freely diffusing, while the remaining population is bound to DNA. Of this DNA-bound population about half the GRs appeared to be bound for short periods of time (similar to 0.7 s) and the other half for longer time periods (similar to 2.3 s). A similar pattern of mobility was seen for the MR activated by aldosterone. Inactive receptors (mutant or antagonist-bound receptors) show a decreased DNA binding frequency and duration, but also a higher mobility for the diffusing population. Likely, very brief (<= 1 ms) interactions with DNA induced by the agonists underlie this difference in diffusion behavior. Surprisingly, different agonists also induce different mobilities of both receptors, presumably due to differences in ligand-induced conformational changes and receptor complex formation. In summary, our data provide a consistent quantitative model of the dynamics of GR and MR, indicating three types of interactions with DNA, which fit into a model in which frequent low-affinity DNA binding facilitates the search for high-affinity target sequences.	[Groeneweg, Femke L.; Prins, Jurrien; de Kloet, E. Ron] Leiden Univ, LUMC, Dept Med Pharmacol, Leiden, Netherlands; [van Royen, Martin E.; Geverts, Bart; Houtsmuller, Adriaan B.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Fenz, Susanne; Schmidt, Thomas S.] Leiden Univ, LION, Inst Phys, Leiden, Netherlands; [Fenz, Susanne] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Keizer, Veer I. P.; Prins, Jurrien; Schaaf, Marcel J. M.] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University - Excl LUMC; University of Wurzburg; Leiden University; Leiden University - Excl LUMC	Schaaf, MJM (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	m.j.m.schaaf@biology.leidenuniv.nl	Fenz, Susanne F/B-7969-2012; Schmidt, Thomas/B-6296-2009; prins, jurrien/AAK-9350-2020	Fenz, Susanne F/0000-0002-8395-0727; Schmidt, Thomas/0000-0002-0045-1851; prins, jurrien/0000-0001-6499-5076; Schaaf, Marcel/0000-0002-5859-8936; van Royen, Martin/0000-0002-6814-0996; de Kloet, Ron/0000-0001-9176-1830	Royal Netherlands Academy for Arts and Sciences; Netherlands Organization for Scientific Research (NWO-STW); Foundation for Fundamental Research on Matter (FOM); SmartMix Program of The Netherlands Ministry of Economic Affairs; Ministry of Education, Culture and Science	Royal Netherlands Academy for Arts and Sciences; Netherlands Organization for Scientific Research (NWO-STW)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); SmartMix Program of The Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	FLG and ERdK are supported by the Royal Netherlands Academy for Arts and Sciences, MvR by the Netherlands Organization for Scientific Research (NWO-STW), VIPK by the Foundation for Fundamental Research on Matter (FOM), and MJMS by the SmartMix Program of The Netherlands Ministry of Economic Affairs and the Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Biddie SC, 2009, STRESS, V12, P193, DOI 10.1080/10253890802506409; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; DEKLOET ER, 1994, ANN NY ACAD SCI, V746, P8; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P13, DOI 10.1113/expphysiol.2008.045914; Gorski SA, 2006, CURR OPIN CELL BIOL, V18, P284, DOI 10.1016/j.ceb.2006.03.002; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Grossmann C, 2004, EUR J ENDOCRINOL, V151, P397, DOI 10.1530/eje.0.1510397; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Li GW, 2009, FEBS LETT, V583, P3979, DOI 10.1016/j.febslet.2009.11.035; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Lind U, 2000, J BIOL CHEM, V275, P19041, DOI 10.1074/jbc.M000228200; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Lord SJ, 2010, ANAL CHEM, V82, P2192, DOI 10.1021/ac9024889; Mazza D, 2012, METHODS MOL BIOL, V833, P177, DOI 10.1007/978-1-61779-477-3_12; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2007, MOL CELL BIOL, V27, P2442, DOI 10.1128/MCB.01570-06; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; MUNCK A, 1976, J STEROID BIOCHEM, V7, P1117, DOI 10.1016/0022-4731(76)90042-X; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; Quinkler M, 2002, EUR J ENDOCRINOL, V146, P789, DOI 10.1530/eje.0.1460789; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; Saxton Michael J., 2007, V400, P295; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Schaaf MJM, 2005, MOL ENDOCRINOL, V19, P1501, DOI 10.1210/me.2005-0050; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Semrau S, 2007, BIOPHYS J, V92, P613, DOI 10.1529/biophysj.106.092577; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Speil J, 2011, BIOPHYS J, V101, P2592, DOI 10.1016/j.bpj.2011.10.006; Stasevich TJ, 2010, BIOPHYS J, V99, P3093, DOI 10.1016/j.bpj.2010.08.059; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; van den Broek B, 2008, P NATL ACAD SCI USA, V105, P15738, DOI 10.1073/pnas.0804248105; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; van Royen Martin E., 2009, V505, P69, DOI 10.1007/978-1-60327-575-0_5; van Royen Martin E., 2008, V464, P363, DOI 10.1007/978-1-60327-461-6_20; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, METHODS, V39, P316, DOI 10.1016/j.ymeth.2006.06.002	62	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90532	10.1371/journal.pone.0090532	http://dx.doi.org/10.1371/journal.pone.0090532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632838	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400016
J	Liao, KL; Bai, XF; Friedman, A				Liao, Kang-Ling; Bai, Xue-Feng; Friedman, Avner			Mathematical Modeling of Interleukin-27 Induction of Anti-Tumor T Cells Response	PLOS ONE			English	Article							COMPLETE REGRESSION; TUMOR-DEVELOPMENT; CANCER INVASION; IFN-GAMMA; IL-27; IL-10; GROWTH; EXPRESSION; EFFECTOR; PROMOTES	Interleukin-12 is a pro-inflammatory cytokine which promotes Th1 and cytotoxic T lymphocyte activities, such as Interferon-gamma secretion. For this reason Interleukin-12 could be a powerful therapeutic agent for cancer treatment. However, Interleukin-12 is also excessively toxic. Interleukin-27 is an immunoregulatory cytokine from the Interleukin-12 family, but it is not as toxic as Interleukin-12. In recent years, Interleukin-27 has been considered as a potential anti-tumor agent. Recent experiments in vitro and in vivo have shown that cancer cells transfected with IL-27 activate CD8(+) T cells to promote the secretion of anti-tumor cytokines Interleukin-10, although, at the same time, IL-27 inhibits the secretion of Interferon-gamma by CD8(+) T cells. In the present paper we develop a mathematical model based on these experimental results. The model involves a dynamic network which includes tumor cells, CD8(+) T cells and cytokines Interleukin-27, Interleukin-10 and Interferon-gamma. Simulations of the model show how Interleukin-27 promotes CD8(+) T cells to secrete Interleukin-10 to inhibit tumor growth. On the other hand Interleukin-27 inhibits the secretion of Interferon-gamma by CD8(+) T cells which somewhat diminishes the inhibition of tumor growth. Our numerical results are in qualitative agreement with experimental data. We use the model to design protocols of IL-27 injections for the treatment of cancer and find that, for some special types of cancer, with a fixed total amount of drug, within a certain range, continuous injection has better efficacy than intermittent injections in reducing the tumor load while the treatment is ongoing, although the decrease in tumor load is only temporary.	[Liao, Kang-Ling; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liao, KL (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	liao.92@mbi.osu.edu	Bai, Xue-Feng/H-5164-2013; Bai, Xue-feng/E-2681-2011	Bai, Xue-Feng/0000-0001-9476-8376; 	National Science Council of Taiwan, R.O.C [NSC 101-2917-I-564-062]; National Science Foundation [DMS 0931642]; National Cancer Institute [R01CA138427]; American Cancer Society [RSG-09-188-01-LIB]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA138427] Funding Source: NIH RePORTER	National Science Council of Taiwan, R.O.C(Ministry of Science and Technology, Taiwan); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in part, by the National Science Council of Taiwan, R.O.C (http://web1.nsc.gov.tw/) under No. NSC 101-2917-I-564-062; the National Science Foundation (http://www.nsf.gov/) under Agreement DMS 0931642; the National Cancer Institute (http://www.cancer.gov/) under R01CA138427; and the American Cancer Society (http://www.cancer.org/) under RSG-09-188-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Bresch D, 2010, SIAM J SCI COMPUT, V32, P2321, DOI 10.1137/070708895; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; BYRNE HM, 1995, MATH BIOSCI, V130, P151, DOI 10.1016/0025-5564(94)00117-3; Car BD, 1999, TOXICOL PATHOL, V27, P58, DOI 10.1177/019262339902700112; Cavallo F, 1997, J NATL CANCER I, V89, P1049, DOI 10.1093/jnci/89.14.1049; Chaplain MAJ, 2006, NETW HETEROG MEDIA, V1, P399; Chiyo M, 2004, ANTICANCER RES, V24, P3763; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Deakin NE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00070; Fujii S, 2001, BLOOD, V98, P2143, DOI 10.1182/blood.V98.7.2143; Groux H, 1999, J IMMUNOL, V162, P1723; Groux H, 1998, J IMMUNOL, V160, P3188; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Itakura E, 2011, MODERN PATHOL, V24, P801, DOI 10.1038/modpathol.2011.5; Lemech C, 2012, CLIN MED INSIGHTS-ON, V6, DOI 10.4137/CMO.S5855; Liao KL, 2013, J THEOR BIOL, V328, P65, DOI 10.1016/j.jtbi.2013.03.017; Liu ZZ, 2013, EUR J IMMUNOL, V43, P468, DOI 10.1002/eji.201242930; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marshall E, 1995, SCIENCE, V268, P1555; McGillen JB, 2013, J MATH BIOL; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Rakhmilevich AL, 1997, HUM GENE THER, V8, P1303, DOI 10.1089/hum.1997.8.11-1303; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; ROTH AD, 1991, CLIN EXP IMMUNOL, V86, P163; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Shinozaki Y, 2009, INT J CANCER, V124, P1372, DOI 10.1002/ijc.24107; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Swarbrick A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25409; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Szymanska Z, 2009, MATH MOD METH APPL S, V19, P257, DOI 10.1142/S0218202509003425; Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627; Wang R, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-62; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371; Zolochevska O, 2013, J CELL PHYSIOL, V228, P1127, DOI 10.1002/jcp.24265	49	41	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91844	10.1371/journal.pone.0091844	http://dx.doi.org/10.1371/journal.pone.0091844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633175	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400105
J	Mwafongo, AA; Rosenberg, NE; Ng'ambi, W; Werner, AB; Garneau, WM; Gumulira, J; Phiri, S; Hosseinipour, MC				Mwafongo, Albert A.; Rosenberg, Nora E.; Ng'ambi, Wingston; Werner, Alexandra B.; Garneau, William M.; Gumulira, Joe; Phiri, Sam; Hosseinipour, Mina C.			Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy	PLOS ONE			English	Article							IMMUNE-DEFICIENCY-SYNDROME; SUB-SAHARAN AFRICA; FOLLOW-UP; RISK-FACTORS; LOST; MORTALITY; CHEMOTHERAPY; COMBINATION; SETTINGS	Purpose: Despite Kaposi's sarcoma (KS) being the most prevalent AIDS-associated cancer in resource limited settings, optimal treatment options remain unknown. We assessed whether bleomycin/vincristine compared to vincristine monotherapy was associated with improved treatment outcomes for AIDS-associated KS among patients initiating combination antiretroviral therapy (cART) in Malawi. Methods: All patients initiating cART and chemotherapy for AIDS-related KS were identified from an electronic data system from the HIV Lighthouse Clinic from 2002 to 2011. Treatment responses were compared between patients receiving vincristine monotherapy and vincristine/bleomycin. Binomial regression models were implemented to assess probability of tumor improvement for patients receiving vincristine/bleomycin compared to vincristine monotherapy after a complete cycle of chemotherapy (9-10 months). A chi-squared test was used to compare changes in CD4 count after six months of chemotherapy. Results: Of 449 patients with AIDS-associated KS on chemotherapy, 94% received vincristine monotherapy and 6% received bleomycin/vincristine. Distribution of treatment outcomes was different: 29% of patients on vincristine experienced tumor improvement compared to 53% of patients on bleomycin/vincristine. Patients receiving bleomycin/vincristine were 2.25 (95% CI: 1.47, 3.44) times as likely to experience tumor improvement as to those on vincristine monotherapy. This value changed little after adjustment for age and baseline CD4 count: 2.46 (95% CI: 1.57, 3.86). Change in CD4 count was similar for patients receiving vincristine monotherapy and bleomycin/vincristine (p = 0.6). Conclusion: Bleomycin/vincristine for the treatment of AIDS-associated KS was associated with better tumor response compared to vincristine monotherapy without impairing CD4 count recovery. Replication in larger datasets and randomized controlled trials is necessary.	[Mwafongo, Albert A.; Rosenberg, Nora E.; Hosseinipour, Mina C.] Univ North Carolina Project, Lilongwe, Malawi; [Rosenberg, Nora E.; Werner, Alexandra B.; Garneau, William M.; Hosseinipour, Mina C.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Ng'ambi, Wingston; Gumulira, Joe; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mwafongo, AA (corresponding author), Univ North Carolina Project, Lilongwe, Malawi.	amwafongo@gmail.com	Garneau, William/GXV-3378-2022	Garneau, William/0000-0002-1849-1640	National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; NCC; NEI; NHBLI; NIDCR; NIDA; NIMH; NIAID; NIHOWH; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; University of North Carolina Center for AIDS Research [P30AI50410]; UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program [R25TW009340]; UNC Center for AIDS Research [P30 AI50410]; American Society of Tropical Medicine and Hygiene; FOGARTY INTERNATIONAL CENTER [R25TW009340, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCC; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHBLI; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIHOWH; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act; University of North Carolina Center for AIDS Research; UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program; UNC Center for AIDS Research; American Society of Tropical Medicine and Hygiene; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AM was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, NCC, NEI, NHBLI, NIDCR, NIDA, NIMH, NIAID, NIHOWH, Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988), the American Relief and Recovery Act, and the University of North Carolina Center for AIDS Research (P30AI50410). NR was supported by the UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program (R25TW009340), and the UNC Center for AIDS Research (P30 AI50410). WG was supported by the Benjamin H. Kean Traveling Fellowship in Tropical Medicine from the American Society of Tropical Medicine and Hygiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihl F, 2007, AIDS, V21, P1245, DOI 10.1097/QAD.0b013e328182df03; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chu K, 2010, INT HEALTH, V2, P99, DOI 10.1016/j.inhe.2010.04.001; Chu KM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-23; Cottrill C P, 1997, Clin Oncol (R Coll Radiol), V9, P365, DOI 10.1016/S0936-6555(97)80129-X; Dittmer DP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00141; Francis H, 2012, PROSPECTIVE STUDY AS, V2012; GILL P, 1990, AM J CLIN ONCOL-CANC, V13, P315, DOI 10.1097/00000421-199008000-00010; GILL PS, 1990, CANCER, V65, P1074, DOI 10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1; GILL PS, 1991, AM J MED, V90, P427, DOI 10.1016/0002-9343(91)80081-V; GOMPELS MM, 1992, AIDS, V6, P1175, DOI 10.1097/00002030-199210000-00018; HIV unit, 2003, TREATM AIDS GUID US; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Krown SE, 2004, J CLIN ONCOL, V22, P399, DOI 10.1200/JCO.2004.08.064; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Krown SE, 2011, CURR OPIN ONCOL, V23, P463, DOI 10.1097/CCO.0b013e328349428d; Makombe SD, 2008, TROP DOCT, V38, P5, DOI 10.1258/td.2007.060023; MINTZER DM, 1985, ANN INTERN MED, V102, P200, DOI 10.7326/0003-4819-102-2-200; Mlombe Y, 2008, MALAWI MED J, V20, P129; Mosam A, 2010, CURR OPIN INFECT DIS, V23, P119, DOI 10.1097/QCO.0b013e328335b01a; Mosam A, 2012, JAIDS-J ACQ IMM DEF, V60, P150, DOI 10.1097/QAI.0b013e318251aedd; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sissolak G, 2005, TROP MED INT HEALTH, V10, P981, DOI 10.1111/j.1365-3156.2005.01491.x; Stebbing J, 2006, LANCET, V367, P1495, DOI 10.1016/S0140-6736(06)68649-2; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; Vanni T, 2006, HIV CLIN TRIALS, V7, P194, DOI 10.1310/hct0704-194; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	31	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91020	10.1371/journal.pone.0091020	http://dx.doi.org/10.1371/journal.pone.0091020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632813	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400035
J	Jin, HY; Zhang, B; Yao, H; Du, YH; Wang, XF; Leng, Q				Jin, Heiying; Zhang, Bei; Yao, Hang; Du, Yonghong; Wang, Xiaofeng; Leng, Qiang			Smooth Muscle Enfoldment Internal Sphincter Construction after Intersphincteric Resection for Rectal Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; ANTERIOR	Objective: To assess smooth muscle enfoldment and internal sphincter construction (SMESC) for improvement of continence after intersphincteric resection (ISR) for rectal cancer. Methods: Twenty-four Bama miniature pigs were randomly divided into a conventional ISR group and experimental SMESC group, with 12 pigs in each group. The proximal sigmoid colon was anastomosed directly to the anus in the ISR group. In the SMESC group, internal sphincter construction was performed. At 12 weeks before and after surgery, rectal resting pressure and anal canal length were assessed. Three-dimensional ultrasound was used to determine the thickness of the internal sphincter. After the animals were sacrificed, the rectum and anus were resected and pathological examinations were performed to evaluate the differences in sphincter thickness and muscle fibers. Results: All 24 animals in the SMESC group and the ISR group survived the surgery. Twelve weeks post-surgery, the rectal resting pressure, length of the anal high-pressure zone and the postoperative internal sphincter thickness for the ISR group were significantly lower than for the SMESC group. There was a thickened area (about 2 cm) above the anastomotic stoma among animals from the SMESC group; in addition, the smooth muscles were significantly enlarged and enfolded when compared to the ISR group. Conclusion: This animal model study shows that the SMESC procedure achieved acceptable reconstruction of the internal anal neo-sphincter (IAN/S), without increasing surgical risk. However, the findings in this experimental animal model must be confirmed by clinical trials to determine the safety and efficacy of this procedure in clinical practice.	[Jin, Heiying; Zhang, Bei; Yao, Hang; Du, Yonghong; Wang, Xiaofeng; Leng, Qiang] Nanjing Univ Tradit Chinese Med, Affiliated Hosp 1, Natl Ctr Colorectal Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Jin, HY (corresponding author), Nanjing Univ Tradit Chinese Med, Affiliated Hosp 1, Natl Ctr Colorectal Surg, Nanjing, Jiangsu, Peoples R China.	jinheiying@hotmail.com			National Nature Science Foundation of China [30973837, 81273944]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is funded by the National Nature Science Foundation of China (No. 30973837, 81273944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi Y, 2013, SURG TODAY, V43, P838, DOI 10.1007/s00595-012-0394-3; Barisic G, 2011, COLORECTAL DIS, V13, P638, DOI 10.1111/j.1463-1318.2010.02244.x; Chamlou R, 2007, ANN SURG, V246, P916, DOI 10.1097/SLA.0b013e31815c29ff; Gong X, 2012, COLORECTAL DIS, V14, pe802, DOI 10.1111/j.1463-1318.2012.03177.x; Hirano A, 2011, AM J SURG, V201, P508, DOI 10.1016/j.amjsurg.2009.12.016; Kim JC, 2012, SURG TODAY, V42, P547, DOI 10.1007/s00595-011-0048-x; Konanz J, 2013, INT J COLORECTAL DIS, V28, P679, DOI 10.1007/s00384-013-1683-z; Laforest A, 2012, COLORECTAL DIS, V14, P1231, DOI 10.1111/j.1463-1318.2012.02956.x; Lim SW, 2011, WORLD J SURG, V35, P2811, DOI 10.1007/s00268-011-1277-2; Liu J, 2012, CHIN J GASTROINTEST, V15, P1312; Martin ST, 2012, BRIT J SURG, V99, P603, DOI 10.1002/bjs.8677; Rullier E, 2013, DIS COLON RECTUM, V56, P560, DOI 10.1097/DCR.0b013e31827c4a8c; Sato Yuichiro, 2008, Kurume Medical Journal, V55, P7, DOI 10.2739/kurumemedj.55.7; Zhuang CP, 2009, CHIN J GASTROINTEST, V12, P364	14	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91491	10.1371/journal.pone.0091491	http://dx.doi.org/10.1371/journal.pone.0091491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626174	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300089
J	Kooiman, J; Seth, M; Share, D; Dixon, S; Gurm, HS				Kooiman, Judith; Seth, Milan; Share, David; Dixon, Simon; Gurm, Hitinder S.			The Association between Contrast Dose and Renal Complications Post PCI across the Continuum of Procedural Estimated Risk	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CROSS-BLUE-SHIELD; INDUCED NEPHROPATHY; SAFE LIMITS; MEDIA; PREDICTION; INSIGHTS	Background: Prior studies have proposed to restrict the contrast volume (CV) to,3x calculated creatinine clearance (CCC), to prevent contrast induced nephropathy (CIN) post percutaneous coronary interventions (PCI). The predictive value of this algorithm for CIN and therefore the benefit of this approach in high risk patients has been questioned. The aim of our study was to assess the association between contrast dose and the occurrence of CIN in patients at varying predicted risks of CIN and baseline CCC following contemporary PCI. Methods: Consecutive patients undergoing PCI between 2010-2012 were included. Baseline risk of CIN was calculated using a previously validated risk tool. High contrast dose was defined as CV/CCC>3. Likelihood ratio tests were used to evaluate whether the effect of a high contrast dose on the risk of CIN and nephropathy requiring dialysis (NRD) varied across the spectrum of baseline predicted risk. Results: Of the 82,120 PCI included in our analysis, 25% were performed using a high contrast dose. Patients treated with a high compared with a low contrast dose were at increased risks of CIN and NRD, throughout the entire range of baseline predicted risk and CCC in our population. The effect size of a high contrast dose on risks of both outcomes varied significantly with baseline predicted CIN risk and CCC (CIN p = 0.004, NRD p<0.001 for adding interactions), and was largest for patients with predicted CIN risk <10% and pre-existing chronic kidney disease. Conclusions: The use of a high contrast dose is associated with increased risks of CIN and NRD across the continuum of baseline predicted risk and CCC. Efforts to reduce contrast dose may therefore be effective in preventing renal complications in all patients undergoing PCI.	[Kooiman, Judith] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Zuid Holland, Netherlands; [Kooiman, Judith] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Zuid Holland, Netherlands; [Seth, Milan; Gurm, Hitinder S.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Share, David] Blue Cross Blue Shield Michigan, Detroit, MI USA; [Dixon, Simon] Beaumont Hosp, Royal Oak, MI USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; Beaumont Health	Gurm, HS (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu		Gurm, Hitinder/0000-0002-1646-0218	Blue Cross Blue Shield of Michigan; National Institutes of Health; Agency for Healthcare Research and Quality	Blue Cross Blue Shield of Michigan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The BMC2 registry is funded by Blue Cross Blue Shield of Michigan. Hitinder S. Gurm receives research funding from the National Institutes of Health and Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JR, 2010, CIRC-CARDIOVASC INTE, V3, P346, DOI 10.1161/CIRCINTERVENTIONS.109.910638; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; Gupta R, 2005, CATHETER CARDIO INTE, V64, P442, DOI 10.1002/ccd.20316; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023; Kalra N, 2012, J AM COLL CARDIOL, V59, P432, DOI 10.1016/j.jacc.2011.09.060; Kline-Rogers Eva, 2002, J Interv Cardiol, V15, P387, DOI 10.1111/j.1540-8183.2002.tb01072.x; Marenzi G, 2009, ANN INTERN MED, V150, P170, DOI 10.7326/0003-4819-150-3-200902030-00006; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Nayak KR, 2010, CATHETER CARDIO INTE, V75, P1076, DOI 10.1002/ccd.22414; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002; Reed MC, 2010, J INVASIVE CARDIOL, V22, P467; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Slocum NK, 2012, AM HEART J, V163, P829, DOI 10.1016/j.ahj.2012.02.011; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0	22	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90233	10.1371/journal.pone.0090233	http://dx.doi.org/10.1371/journal.pone.0090233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625555	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300015
J	Lopez, CM; Wallich, R; Riesbeck, K; Skerka, C; Zipfel, PF				Lopez, Crisanto M.; Wallich, Reinhard; Riesbeck, Kristian; Skerka, Christine; Zipfel, Peter F.			Candida albicans Uses the Surface Protein Gpm1 to Attach to Human Endothelial Cells and to Keratinocytes via the Adhesive Protein Vitronectin	PLOS ONE			English	Article							FACTOR-H; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; STREPTOCOCCUS-PNEUMONIAE; COMPLEMENT INHIBITOR; EXTRACELLULAR-MATRIX; BINDING PROTEINS; YEAST; PLASMINOGEN; ADHERENCE; RECEPTOR	Candida albicans is a major cause of invasive fungal infections worldwide. Upon infection and when in contact with human plasma as well as body fluids the fungus is challenged by the activated complement system a central part of the human innate immune response. C. albicans controls and evades host complement attack by binding several human complement regulators like Factor H, Factor H-like protein 1 and C4BP to the surface. Gpm1 (Phosphoglycerate mutase 1) is one fungal Factor H/FHL1 -binding protein. As Gpm1 is surface exposed, we asked whether Gpm1 also contributes to host cell attachment. Here, we show by flow cytometry and by laser scanning microscopy that candida Gpm1 binds to human umbilical vein endothelial cells (HUVEC) to keratinocytes (HaCaT), and also to monocytic U937 cells. Wild type candida did bind, but the candida gpm1 Delta/Delta knock-out mutant did not bind to these human cells. In addition Gpm1when attached to latex beads also conferred attachment to human endothelial cells. When analyzing Gpm1-binding to a panel of extracellular matrix proteins, the human glycoprotein vitronectin was identified as a new Gpm1 ligand. Vitronectin is a component of the extracellular matrix and also a regulator of the terminal complement pathway. Vitronectin is present on the surface of HUVEC and keratinocytes and acts as a surface ligand for fungal Gpm1. Gpm1 and vitronectin colocalize on the surface of HUVEC and HaCaT as revealed by laser scanning microscopy. The Gpm1 vitronectin interaction is inhibited by heparin and the interaction is also ionic strength dependent. Taken together, Gpm1 the candida surface protein binds to vitronectin and mediates fungal adhesion to human endothelial cells. Thus fungal Gpm1 and human vitronectin represent a new set of proteins that are relevant for fungal attachment to human cells interaction. Blockade of the Gpm1 vitronectin interaction might provide a new target for therapy.	[Lopez, Crisanto M.; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Riesbeck, Kristian] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Ruprecht Karls University Heidelberg; Lund University; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany.	peter.zipfel@hki-jena.de	Lopez, Crisanto/AAO-3704-2020	Riesbeck, Kristian/0000-0001-6274-6965	Deutshce Forschungsgemeinschaft	Deutshce Forschungsgemeinschaft	Funding was provided by Deutshce Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Berends ETM, 2013, CELL MICROBIOL, V15, P1955, DOI 10.1111/cmi.12170; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; BRAMONO K, 1994, J MED VET MYCOL, V32, P473; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Ebanks RO, 2006, PROTEOMICS, V6, P2147, DOI 10.1002/pmic.200500100; Francois PP, 1999, J BIOL CHEM, V274, P37611, DOI 10.1074/jbc.274.53.37611; GilNavarro I, 1997, J BACTERIOL, V179, P4992, DOI 10.1128/jb.179.16.4992-4999.1997; GomezDuarte OG, 1997, INFECT IMMUN, V65, P3857; Gow NAR, CURRENT OPINION MICR, V15, P406; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Grubb SEW, 2008, INFECT IMMUN, V76, P4370, DOI 10.1128/IAI.00332-08; Hallstrom T, 2013, MOL BIOL, V13, P4, DOI DOI 10.1128/MBI0.00481-13; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Ifrim D. C., 2014, CLIN VACCINE IMMUNOL; JAKAB E, 1993, APMIS, V101, P187, DOI 10.1111/j.1699-0463.1993.tb00100.x; Jawhara S, 2012, J IMMUNOL, V189, P2468, DOI 10.4049/jimmunol.1200524; Karkowska-Kuleta J, 2011, PEPTIDES, V32, P2488, DOI 10.1016/j.peptides.2011.10.021; KLOTZ SA, 1993, MICROB PATHOGENESIS, V14, P133, DOI 10.1006/mpat.1993.1014; KLOTZ SA, 1990, FEMS MICROBIOL LETT, V68, P249, DOI 10.1016/S0378-1097(05)80049-7; Lesiak-Markowicz I, 2011, J INFECT DIS, V204, P802, DOI 10.1093/infdis/jir455; LIMPER AH, 1994, IMMUNOL LETT, V42, P139, DOI 10.1016/0165-2478(94)90077-9; Luo SS, 2013, MOL IMMUNOL, V56, P161, DOI 10.1016/j.molimm.2013.05.218; Luo SS, 2013, J INFECT DIS, V207, P594, DOI 10.1093/infdis/jis718; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; OLLERT MW, 1993, INFECT IMMUN, V61, P4560, DOI 10.1128/IAI.61.11.4560-4568.1993; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Roth-Ben Arie Z, 1998, FEMS MICROBIOL LETT, V163, P121, DOI 10.1111/j.1574-6968.1998.tb13035.x; Santoni G, 2002, INFECT IMMUN, V70, P3804, DOI 10.1128/IAI.70.7.3804-3815.2002; Santoni G, 2001, MICROB PATHOGENESIS, V31, P159, DOI 10.1006/mpat.2001.0459; SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Spreghini E, 1999, J INFECT DIS, V180, P156, DOI 10.1086/314822; Sturtevant Joy, 1997, Revista Iberoamericana de Micologia, V14, P90; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Szolnoky G, 2001, J INVEST DERMATOL, V117, P205, DOI 10.1046/j.1523-1747.2001.14071.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, COMPLEMENT REGULATOR	57	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90796	10.1371/journal.pone.0090796	http://dx.doi.org/10.1371/journal.pone.0090796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625558	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300034
J	Meier, RPH; Seebach, JD; Morel, P; Mahou, R; Borot, S; Giovannoni, L; Parnaud, G; Montanari, E; Bosco, D; Wandrey, C; Berney, T; Buhler, LH; Muller, YD				Meier, Raphael P. H.; Seebach, Joerg D.; Morel, Philippe; Mahou, Redouan; Borot, Sophie; Giovannoni, Laurianne; Parnaud, Geraldine; Montanari, Elisa; Bosco, Domenico; Wandrey, Christine; Berney, Thierry; Buehler, Leo H.; Muller, Yannick D.			Survival of Free and Encapsulated Human and Rat Islet Xenografts Transplanted into the Mouse Bone Marrow	PLOS ONE			English	Article							MEDIATED INFLAMMATORY REACTION; T-REGULATORY CELLS; PORCINE; XENOTRANSPLANTATION; REJECTION; MICE; BIOCOMPATIBILITY; MICROCAPSULES; MACROPHAGES; LANGERHANS	Bone marrow was recently proposed as an alternative and potentially immune-privileged site for pancreatic islet transplantation. The aim of the present study was to assess the survival and rejection mechanisms of free and encapsulated xenogeneic islets transplanted into the medullary cavity of the femur, or under the kidney capsule of streptozotocin-induced diabetic C57BL/6 mice. The median survival of free rat islets transplanted into the bone marrow or under the kidney capsule was 9 and 14 days, respectively, whereas that of free human islets was shorter, 7 days (bone marrow) and 10 days (kidney capsule). Infiltrating CD8(+) T cells and redistributed CD4(+) T cells, and macrophages were detected around the transplanted islets in bone sections. Recipient mouse splenocytes proliferated in response to donor rat stimulator cells. One month after transplantation under both kidney capsule or into bone marrow, encapsulated rat islets had induced a similar degree of fibrotic reaction and still contained insulin positive cells. In conclusion, we successfully established a small animal model for xenogeneic islet transplantation into the bone marrow. The rejection of xenogeneic islets was associated with local and systemic T cell responses and macrophage recruitment. Although there was no evidence for immune-privilege, the bone marrow may represent a feasible site for encapsulated xenogeneic islet transplantation.	[Meier, Raphael P. H.; Morel, Philippe; Borot, Sophie; Giovannoni, Laurianne; Parnaud, Geraldine; Montanari, Elisa; Bosco, Domenico; Berney, Thierry; Buehler, Leo H.; Muller, Yannick D.] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Meier, Raphael P. H.; Morel, Philippe; Borot, Sophie; Giovannoni, Laurianne; Parnaud, Geraldine; Montanari, Elisa; Bosco, Domenico; Berney, Thierry; Buehler, Leo H.; Muller, Yannick D.] Univ Geneva, Geneva, Switzerland; [Seebach, Joerg D.; Muller, Yannick D.] Univ Hosp, Dept Internal Med, Div Clin Immunol & Allergol, Geneva, Switzerland; [Seebach, Joerg D.; Muller, Yannick D.] Fac Med, Geneva, Switzerland; [Mahou, Redouan; Wandrey, Christine] Ecole Polytech Fed Lausanne, Inst Ingn Biol, Lausanne, Switzerland; [Mahou, Redouan; Wandrey, Christine] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Muller, YD (corresponding author), Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland.	yannick.muller@unige.ch	Seebach, Jörg/AAA-3746-2020; giovannoni, laurianne/AFM-0316-2022; giovannoni, laurianne/AAH-2648-2022; Meier, Raphaël P H/AAR-7882-2021; Berney, Thierry/ABE-9450-2021; Mahou, Redouan/AAH-5056-2021	Meier, Raphaël P H/0000-0001-9050-0436; Berney, Thierry/0000-0002-4230-9378; Buhler, Leo/0000-0002-9461-8498; Bosco, Domenico/0000-0003-3453-9613; Seebach, Jorg/0000-0001-5748-4577; Muller, Yannick/0000-0003-0513-7156	Swiss National Science Foundation [205321-116397/1, 205320_130572/1, 205321_141286/1]; Fondation Insuleman Geneva; Juvenile Diabetes Research Foundation [31-2008-416]; E. & L. Schmidheiny Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Insuleman Geneva; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); E. & L. Schmidheiny Foundation	This work was supported by grants from the Swiss National Science Foundation (grants 205321-116397/1, 205320_130572/1, 205321_141286/1), Fondation Insuleman Geneva, the Juvenile Diabetes Research Foundation (# 31-2008-416 to T. B.), the E. & L. Schmidheiny Foundation (to Y.D.M.), and by contributions of the Wilsdorf Foundation and the Swiss National Science Foundation (# 320030-138376) to J.D.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstoot HJ, 2007, PEDIATR DIABETES, V8, P8, DOI 10.1111/j.1399-5448.2007.00326.x; Andres A, 2005, TRANSPLANTATION, V79, P543, DOI 10.1097/01.TP.0000151764.39095.CA; [Anonymous], 2006, DIABET MED, V23, P857; Auchincloss H, 1998, ANNU REV IMMUNOL, V16, P433, DOI 10.1146/annurev.immunol.16.1.433; Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731; Bell GI, 2012, STEM CELLS DEV, V21, P97, DOI 10.1089/scd.2010.0583; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Cantarelli E, 2009, BLOOD, V114, P4566, DOI 10.1182/blood-2009-03-209973; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Ciceri F, 2010, CELL TRANSPLANT, V19, P1511, DOI 10.3727/096368910X514279; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Friedman T, 1999, DIABETES, V48, P2340, DOI 10.2337/diabetes.48.12.2340; Giraldo Jaime A, 2010, J Diabetes Sci Technol, V4, P1238; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; Hobbs HA, 2001, J INVEST MED, V49, P572, DOI 10.2310/6650.2001.33722; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Karsten V, 1999, HORM METAB RES, V31, P448, DOI 10.1055/s-2007-978773; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Loganathan G, 2013, TRANSPLANTATION, V95, P1439, DOI 10.1097/TP.0b013e318293b7b8; Luo JZQ, 2013, TRANSPLANTATION, V95, P801, DOI 10.1097/TP.0b013e31828235c7; Maffi P, 2013, DIABETES; Mahou R, 2012, J MATER SCI-MATER M, V23, P171, DOI 10.1007/s10856-011-4512-3; Merani S, 2006, TRANSPLANTATION, V82, P1472, DOI 10.1097/01.tp.0000243166.64244.3d; Mirenda V, 2005, DIABETES, V54, P1048, DOI 10.2337/diabetes.54.4.1048; Muller Yannick D, 2011, Self Nonself, V2, P26; Muller YD, 2012, CURR OPIN ORGAN TRAN, V17, P155, DOI 10.1097/MOT.0b013e3283508e17; Muller YD, 2011, DIABETES, V60, P2331, DOI 10.2337/db11-0159; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Niclauss N, 2008, TRANSPLANTATION, V86, P1603, DOI 10.1097/TP.0b013e31818f671a; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Oh BJ, 2013, AM J TRANSPLANT, V13, P1429, DOI 10.1111/ajt.12222; Pepper AR, 2009, XENOTRANSPLANTATION, V16, P502, DOI 10.1111/j.1399-3089.2009.00548.x; Salazar-Banuelos A, 2008, AM J SURG, V195, P674, DOI 10.1016/j.amjsurg.2007.12.040; SIEBERS U, 1993, INT J ARTIF ORGANS, V16, P96, DOI 10.1177/039139889301600207; Teramura Y, 2009, BIOMATERIALS, V30, P2270, DOI 10.1016/j.biomaterials.2009.01.036; Toso C, 2005, CELL TRANSPLANT, V14, P159, DOI 10.3727/000000005783983223; Toso C, 2003, TRANSPLANT INT, V16, P405, DOI 10.1007/s00147-003-0555-9; Vaithilingam V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059120; Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51; WOLF LA, 1995, TRANSPLANTATION, V60, P1164, DOI 10.1097/00007890-199511270-00018; WREN SM, 1993, TRANSPLANTATION, V56, P905, DOI 10.1097/00007890-199310000-00025; Yi SN, 2003, J IMMUNOL, V170, P2750, DOI 10.4049/jimmunol.170.5.2750; Yi SN, 2000, TRANSPLANTATION, V70, P896, DOI 10.1097/00007890-200009270-00007	43	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91268	10.1371/journal.pone.0091268	http://dx.doi.org/10.1371/journal.pone.0091268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625569	Green Submitted, gold, Green Published			2022-12-25	WOS:000332851300070
J	Olderoy, MO; Lilledahl, MB; Beckwith, MS; Melvik, JE; Reinholt, F; Sikorski, P; Brinchmann, JE				Olderoy, Magnus O.; Lilledahl, Magnus B.; Beckwith, Marianne Sandvold; Melvik, Jan Egil; Reinholt, Finn; Sikorski, Pawel; Brinchmann, Jan E.			Biochemical and Structural Characterization of Neocartilage Formed by Mesenchymal Stem Cells in Alginate Hydrogels	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; HYALURONIC-ACID HYDROGELS; PROCOLLAGEN C-PROTEINASE; ARTICULAR-CARTILAGE; ENGINEERED CARTILAGE; DEGRADATION; COLLAGEN; BONE; FIBRILLOGENESIS	A popular approach to make neocartilage in vitro is to immobilize cells with chondrogenic potential in hydrogels. However, functional cartilage cannot be obtained by control of cells only, as function of cartilage is largely dictated by architecture of extracellular matrix (ECM). Therefore, characterization of the cells, coupled with structural and biochemical characterization of ECM, is essential in understanding neocartilage assembly to create functional implants in vitro. We focused on mesenchymal stem cells (MSC) immobilized in alginate hydrogels, and used immunohistochemistry (IHC) and gene expression analysis combined with advanced microscopy techniques to describe properties of cells and distribution and organization of the forming ECM. In particular, we used second harmonic generation (SHG) microscopy and focused ion beam/scanning electron microscopy (FIB/SEM) to study distribution and assembly of collagen. Samples with low cell seeding density (1e7 MSC/ml) showed type II collagen molecules distributed evenly through the hydrogel. However, SHG microscopy clearly indicated only pericellular localization of assembled fibrils. Their distribution was improved in hydrogels seeded with 5e7 MSC/ml. In those samples, FIB/SEM with nm resolution was used to visualize distribution of collagen fibrils in a three dimensional network extending from the pericellular region into the ECM. In addition, distribution of enzymes involved in procollagen processing were investigated in the alginate hydrogel by IHC. It was discovered that, at high cell seeding density, procollagen processing and fibril assembly was also occurring far away from the cell surface, indicating sufficient transport of procollagen and enzymes in the intercellular space. At lower cell seeding density, the concentration of enzymes involved in procollagen processing was presumably too low. FIB/SEM and SHG microscopy combined with IHC localization of specific proteins were shown to provide meaningful insight into ECM assembly of neocartilage, which will lead to better understanding of cartilage formation and development of new tissue engineering strategies.	[Olderoy, Magnus O.; Brinchmann, Jan E.] Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Lilledahl, Magnus B.; Beckwith, Marianne Sandvold; Sikorski, Pawel] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; [Melvik, Jan Egil] NovaMatrix FMC Biopolymer, Sandvika, Norway; [Reinholt, Finn] Univ Oslo, Dept Pathol, Oslo, Norway; [Reinholt, Finn] Oslo Univ Hosp, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo	Olderoy, MO (corresponding author), Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Oslo, Norway.	magnus.ostgard.olderoy@rr-research.no	Sikorski, Pawel/A-2304-2009	Sikorski, Pawel/0000-0001-9413-1623; Beckwith, Marianne Sandvold/0000-0001-8235-3755	South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Bushby AJ, 2011, NAT PROTOC, V6, P845, DOI 10.1038/nprot.2011.332; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Fernandes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062994; Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024; Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Kadler KE, 1996, BIOCHEM J, V316, P1; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kundu J, 2015, J TISSUE ENG REGEN M, V9, P1286, DOI 10.1002/term.1682; Leal-Egana A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Melvik JE, 2011, US Patent Application, Patent No. 20110053886; Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d; Ng KW, 2009, OSTEOARTHR CARTILAGE, V17, P220, DOI 10.1016/j.joca.2008.06.013; Nicodemus GD, 2011, ACTA BIOMATER, V7, P492, DOI 10.1016/j.actbio.2010.08.021; Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0; Rice MA, 2007, TISSUE ENG, V13, P683, DOI 10.1089/ten.2006.0142; Roberts JJ, 2011, CLIN ORTHOP RELAT R, V469, P2725, DOI 10.1007/s11999-011-1823-0; Smith AM, 2012, BIOMACROMOLECULES, V13, P4032, DOI 10.1021/bm301321d; Trewenack AJ, 2009, MATH MED BIOL, V26, P241, DOI 10.1093/imammb/dqp013; Wong M, 2001, J ORTHOPAED RES, V19, P493, DOI 10.1016/S0736-0266(00)90023-8; Zehbe R, 2012, MICRON, V43, P1060, DOI 10.1016/j.micron.2012.05.001	33	29	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91662	10.1371/journal.pone.0091662	http://dx.doi.org/10.1371/journal.pone.0091662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626259	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300115
J	Rosjo, H; Dahl, MB; Bye, A; Andreassen, J; Jorgensen, M; Wisloff, U; Christensen, G; Edvardsen, T; Omland, T				Rosjo, Helge; Dahl, Mai Britt; Bye, Anja; Andreassen, Johanna; Jorgensen, Marit; Wisloff, Ulrik; Christensen, Geir; Edvardsen, Thor; Omland, Torbjorn			Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; BIOMARKERS; QUANTIFICATION; MIR-210; DISEASE; PLASMA; ISCHEMIA; RISK	Background: Circulating micro-RNAs have been proposed as a novel class of cardiovascular (CV) biomarkers, but whether they meet analytical requirements and provide additional information to establish risk indices have not been established. miR-210 levels are increased in subjects with low VO2 max, which is a recognized risk factor in patients with aortic stenosis (AS), and we hypothesized that circulating miR-210 levels may be increased in patients with AS and associated with a poor prognosis. Methods: We measured circulating miR-210 levels by real-time PCR in 57 patients with moderate to severe AS and in 10 age-and gender-matched healthy controls. The merit of miR-210 as a biomarker was assessed according to established criteria, including by comparing miR-210 levels with NT-proBNP and miR-22 levels, which is another miRNA biomarker candidate. Results: All patients and control subjects had miR-210 levels within the range of detection (Cq<35) and the analytical variability was low. Circulating miR-210 levels were 2.0+/-0.2 [mean+/-SEM] fold increased in AS patients compared to controls (p = 0.002), whereas miR-22 levels were not differently expressed in the AS patients (0.12+/-0.06 fold increase, p = 0.45). The increase in miR-210 levels in AS patients was comparable to the increment in NT-proBNP levels: [AUC] 0.82 (95% CI 0.70-0.90) vs. 0.85 (0.75-0.93), respectively, p = 0.71. During a median follow-up of 1287 days, 15 patients (26%) died. There was a significant association between higher circulating levels of miR-210 and increased mortality during follow-up: hazard ratio [supra- vs. inframedian levels] 3.3 (95% CI 1.1-10.5), p = 0.039. Adjusting for other risk indices in multivariate analysis did not attenuate the prognostic merit of circulating miR-210 levels. Conclusion: Circulating miR-210 levels are increased in patients with AS and provide independent prognostic information to established risk indices. Analytical characteristics were also excellent supporting the potential of micro-RNAs as novel CV biomarkers.	[Rosjo, Helge; Dahl, Mai Britt; Jorgensen, Marit; Omland, Torbjorn] Akershus Univ Hosp, Div Med, Lorenskog, Norway; [Rosjo, Helge; Dahl, Mai Britt; Jorgensen, Marit; Christensen, Geir; Edvardsen, Thor; Omland, Torbjorn] Univ Oslo, Inst Clin Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Rosjo, Helge; Dahl, Mai Britt; Jorgensen, Marit; Christensen, Geir; Edvardsen, Thor; Omland, Torbjorn] Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway; [Dahl, Mai Britt; Jorgensen, Marit] Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, UiO, Lorenskog, Norway; [Bye, Anja; Wisloff, Ulrik] Norwegian Inst Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Fac Med, Trondheim, Norway; [Andreassen, Johanna; Edvardsen, Thor] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo	Rosjo, H (corresponding author), Akershus Univ Hosp, Div Med, Lorenskog, Norway.	helge.rosjo@medisin.uio.no	Edvardsen, Thor/F-4079-2012; Bye, Anja/K-8041-2019; Wisloff, Ulrik/K-2899-2012	Edvardsen, Thor/0000-0002-3800-765X; Bye, Anja/0000-0003-1259-5542; Wisloff, Ulrik/0000-0002-7211-3587	Akershus University Hospital; University of Oslo	Akershus University Hospital; University of Oslo	This study was supported by Akershus University Hospital and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Coglianese EE, 2009, CIRCULATION, V120, P9, DOI 10.1161/CIRCULATIONAHA.109.875591; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Endo K, 2013, BIOL PHARM BULL, V36, P48, DOI 10.1248/bpb.b12-00578; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kaudewitz D, 2013, THROMB HAEMOSTASIS, V110, P609, DOI 10.1160/TH13-05-0368; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; McManus DD, 2011, CIRCULATION, V124, P1908, DOI 10.1161/CIRCULATIONAHA.111.062117; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Omland Torbjorn, 2008, Crit Care Med, V36, pS17, DOI 10.1097/01.CCM.0000296266.74913.85; Otto CM, 2006, J AM COLL CARDIOL, V47, P2141, DOI 10.1016/j.jacc.2006.03.002; Rosjo H, 2012, CLIN CHEM, V58, P1565, DOI 10.1373/clinchem.2012.190868; Rosjo H, 2011, AM J CARDIOL, V108, P88, DOI 10.1016/j.amjcard.2011.02.346; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Vahanian A, 2010, EUR HEART J, V31, P416, DOI 10.1093/eurheartj/ehp575; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; VINCENT WR, 1974, CIRCULATION, V49, P326, DOI 10.1161/01.CIR.49.2.326; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Zampetaki A, 2012, THROMB HAEMOSTASIS, V108, P592, DOI 10.1160/TH12-02-0097; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhao DS, 2013, CARDIOVASC PATHOL, V22, P444, DOI 10.1016/j.carpath.2013.04.001	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91812	10.1371/journal.pone.0091812	http://dx.doi.org/10.1371/journal.pone.0091812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626394	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300138
J	Serang, O				Serang, Oliver			The Probabilistic Convolution Tree: Efficient Exact Bayesian Inference for Faster LC-MS/MS Protein Inference	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CAUSAL INDEPENDENCE; SHOTGUN PROTEOMICS; MARGINALIZATION	Exact Bayesian inference can sometimes be performed efficiently for special cases where a function has commutative and associative symmetry of its inputs (called "causal independence''). For this reason, it is desirable to exploit such symmetry on big data sets. Here we present a method to exploit a general form of this symmetry on probabilistic adder nodes by transforming those probabilistic adder nodes into a probabilistic convolution tree with which dynamic programming computes exact probabilities. A substantial speedup is demonstrated using an illustration example that can arise when identifying splice forms with bottom-up mass spectrometry-based proteomics. On this example, even state-of-the-art exact inference algorithms require a runtime more than exponential in the number of splice forms considered. By using the probabilistic convolution tree, we reduce the runtime to O(k log(k)(2)) and the space to O(k log(k)) where k is the number of variables joined by an additive or cardinal operator. This approach, which can also be used with junction tree inference, is applicable to graphs with arbitrary dependency on counting variables or cardinalities and can be used on diverse problems and fields like forward error correcting codes, elemental decomposition, and spectral demixing. The approach also trivially generalizes to multiple dimensions.	Thermo Fisher Sci, Bremen, Germany	Thermo Fisher Scientific	Serang, O (corresponding author), Thermo Fisher Sci, Bremen, Germany.	orserang@uw.edu			Thermo Fisher Scientific	Thermo Fisher Scientific	This work was created as an employee of Thermo Fisher Scientific (http://www.thermofisher.com/) with no external funding. The funder provided support in the form of salaries for author OS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Andersen SK, 1990, HUGIN SHELL BUILDING, P332; Andrews G., 1998, THEORY PARTITIONS, V2; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Heckerman D, 1996, IEEE T SYST MAN CY A, V26, P826, DOI 10.1109/3468.541341; Heckerman D, 1993, P 9 C UNC ART INT, P122; Heckerman D, 1994, P 10 C UNC ART INT, P286, DOI DOI 10.1016/B978-1-55860-332-5.50041-9; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kelchtermans P, 2013, PROTEOMICS; Koller D., 2009, PROBABILISTIC GRAPHI; Li YF, 2008, LECT N BIOINFORMAT, V4955, P167; Li YF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S4; Li YF, 2012, STAT INTERFACE, V5, P21; McDowell GS, 2013, J PROTEOME RES, V12, P3809, DOI 10.1021/pr400032m; Minka T. P., 2001, PROC 17 C UNCERTAINT, P362; Murphy K, 1999, P 15 C UNC ART INT, P4067; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; NUSSBAUMER HJ, 1978, IBM J RES DEV, V22, P134, DOI 10.1147/rd.222.0134; Pearl J., 1982, P AM ASS ART INT NAT, P133; POTTIER L, 1991, LECT NOTES COMPUT SC, V488, P162; Rappsilber J, 2002, TRENDS BIOCHEM SCI, V27, P74, DOI 10.1016/S0968-0004(01)02021-7; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; ROBERTSON N, 1984, J COMB THEORY B, V36, P49, DOI 10.1016/0095-8956(84)90013-3; Serang O, 2012, J PROTEOME RES, V11, P5586, DOI 10.1021/pr300426s; Serang O, 2012, IEEE ACM T COMPUT BI, V9, P809, DOI 10.1109/TCBB.2012.26; Serang O, 2012, STAT INTERFACE, V5, P3; Serang O, 2010, J PROTEOME RES, V9, P5346, DOI 10.1021/pr100594k; Shokrollahi A, 2004, PROG COM SC, V23, P85; Zhang NL, 1996, J ARTIF INTELL RES, V5, P301, DOI 10.1613/jair.305	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91507	10.1371/journal.pone.0091507	http://dx.doi.org/10.1371/journal.pone.0091507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626234	gold, Green Submitted, Green Published			2022-12-25	WOS:000332851300093
J	Tapia, LI; Shaw, CA; Aideyan, LO; Jewell, AM; Dawson, BC; Haq, TR; Piedra, PA				Tapia, Lorena I.; Shaw, Chad A.; Aideyan, Letisha O.; Jewell, Alan M.; Dawson, Brian C.; Haq, Taha R.; Piedra, Pedro A.			Gene Sequence Variability of the Three Surface Proteins of Human Respiratory Syncytial Virus (HRSV) in Texas	PLOS ONE			English	Article							SMALL HYDROPHOBIC PROTEIN; CIRCULATION PATTERNS; FUSION PROTEIN; SUBGROUP-B; GROUP-A; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; CONSECUTIVE SEASONS; ATTACHMENT PROTEIN; STRUCTURAL BASIS	Human respiratory syncytial virus (HRSV) has three surface glycoproteins: small hydrophobic (SH), attachment (G) and fusion (F), encoded by three consecutive genes (SH-G-F). A 270-nt fragment of the G gene is used to genotype HRSV isolates. This study genotyped and investigated the variability of the gene and amino acid sequences of the three surface proteins of HRSV strains collected from 1987 to 2005 from one center. Sixty original clinical isolates and 5 prototype strains were analyzed. Sequences containing SH, F and G genes were generated, and multiple alignments and phylogenetic trees were analyzed. Genetic variability by protein domains comparing virus genotypes was assessed. Complete sequences of the SH-G-F genes were obtained for all 65 samples: HRSV-A = 35; HRSV-B = 30. In group A strains, genotypes GA5 and GA2 were predominant. For HRSV-B strains, the genotype GB4 was predominant from 1992 to 1994 and only genotype BA viruses were detected in 2004-2005. Different genetic variability at nucleotide level was detected between the genes, with G gene being the most variable and the highest variability detected in the 270-nt G fragment that is frequently used to genotype the virus. High variability (>10%) was also detected in the signal peptide and transmembrane domains of the F gene of HRSV A strains. Variability among the HRSV strains resulting in non-synonymous changes was detected in hypervariable domains of G protein, the signal peptide of the F protein, a not previously defined domain in the F protein, and the antigenic site empty set in the pre-fusion F. Divergent trends were observed between HRSV -A and -B groups for some functional domains. A diverse population of HRSV -A and -B genotypes circulated in Houston during an 18 year period. We hypothesize that diverse sequence variation of the surface protein genes provide HRSV strains a survival advantage in a partially immune-protected community.	[Tapia, Lorena I.; Aideyan, Letisha O.; Jewell, Alan M.; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tapia, Lorena I.] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Virol, Santiago 7, Chile; [Tapia, Lorena I.] Univ Chile, Fac Med, Dept Pediat & Cirugi Infantil Norte, Santiago 7, Chile; [Shaw, Chad A.; Dawson, Brian C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Haq, Taha R.] Baylor Coll Med, Sch Med, Houston, TX 77030 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Universidad de Chile; Universidad de Chile; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tapia, LI (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	ltapia@med.uchile.cl	Tapia, Lorena/I-5678-2016					Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; Carter SD, 2010, FEBS LETT, V584, P2786, DOI 10.1016/j.febslet.2010.05.006; Chen MD, 2000, J INFECT DIS, V182, P1228, DOI 10.1086/315829; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Cianci C, 2005, J ANTIMICROB CHEMOTH, V55, P289, DOI 10.1093/jac/dkh558; Collins P. L., 2006, FIELDS VIROLOGY, P1601; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; CONNORS M, 1995, VIROLOGY, V208, P478, DOI 10.1006/viro.1995.1178; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Day ND, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-34; Eckardt-Michel J, 2008, J VIROL, V82, P3236, DOI 10.1128/JVI.01887-07; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Gan SW, 2008, PROTEIN SCI, V17, P813, DOI 10.1110/ps.073366208; GARCIA O, 1994, J VIROL, V68, P5448; Hall CB, 2010, LANCET, V375, P1500, DOI 10.1016/S0140-6736(10)60401-1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Kim YK, 2007, J MED VIROL, V79, P820, DOI 10.1002/jmv.20891; Kochva U, 2003, PROTEIN SCI, V12, P2668, DOI 10.1110/ps.03151103; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; LAMBERT DM, 1988, VIROLOGY, V164, P458, DOI 10.1016/0042-6822(88)90560-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Li Z, 2011, J VIROL, V85, P32, DOI 10.1128/JVI.01673-10; Lima HN, 2012, VIRUS RES, V163, P82, DOI 10.1016/j.virusres.2011.08.013; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Moura FEA, 2004, J MED VIROL, V74, P156, DOI 10.1002/jmv.20159; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Piedra PA, 2003, VACCINE, V21, P2448, DOI 10.1016/S0264-410X(03)00098-7; Polack FP, 2005, P NATL ACAD SCI USA, V102, P8996, DOI 10.1073/pnas.0409478102; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaikh FY, 2012, MBIO, V3, DOI 10.1128/mBio.00270-11; Shingai M, 2008, INT IMMUNOL, V20, P1169, DOI 10.1093/intimm/dxn074; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; The Impact RSV Study Group, 1998, PEDIATRICS, V3, P531; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	67	45	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90786	10.1371/journal.pone.0090786	http://dx.doi.org/10.1371/journal.pone.0090786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625544	Green Submitted, gold, Green Published			2022-12-25	WOS:000332851300033
J	Tsai, YL; Wang, HC; Lo, CF; Tang-Nelson, K; Lightner, D; Ou, BR; Hour, AL; Tsai, CF; Yen, CC; Chang, HFG; Teng, PH; Lee, PY				Tsai, Yun-Long; Wang, Han-Ching; Lo, Chu-Fang; Tang-Nelson, Kathy; Lightner, Donald; Ou, Bor-Rung; Hour, Ai-Ling; Tsai, Chuan-Fu; Yen, Cheng-Chi; Chang, Hsiao-Fen Grace; Teng, Ping-Hua; Lee, Pei-Yu			Validation of a Commercial Insulated Isothermal PCR-based POCKIT Test for Rapid and Easy Detection of White Spot Syndrome Virus Infection in Litopenaeus vannamei	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYNDROME BACULOVIRUS WSBV; PENAEUS-MONODON; TISSUE TROPISM; NESTED PCR; AMPLIFICATION; SHRIMP; WSSV; CRABS; DNA	Timely pond-side detection of white spot syndrome virus (WSSV) plays a critical role in the implementation of bio-security measures to help minimize economic losses caused by white spot syndrome disease, an important threat to shrimp aquaculture industry worldwide. A portable device, namely POCKIT (TM), became available recently to complete fluorescent probe-based insulated isothermal PCR (iiPCR), and automatic data detection and interpretation within one hour. Taking advantage of this platform, the IQ Plus (TM) WSSV Kit with POCKIT system was established to allow simple and easy WSSV detection for on-site users. The assay was first evaluated for its analytical sensitivity and specificity performance. The 95% limit of detection (LOD) of the assay was 17 copies of WSSV genomic DNA per reaction (95% confidence interval [ CI], 13 to 24 copies per reaction). The established assay has detection sensitivity similar to that of OIE-registered IQ2000 (TM) WSSV Detection and Protection System with serial dilutions of WSSV-positive Litopenaeus vannamei DNA. No cross-reaction signals were generated from infectious hypodermal and haematopoietic necrosis virus (IHHNV), monodon baculovirus (MBV), and hepatopancreatic parvovirus (HPV) positive samples. Accuracy analysis using700 L. vannamei of known WSSV infection status shows that the established assayhassensitivity93.5% (95% CI: 90.61-95.56%) and specificity 97% (95% CI: 94.31-98.50%). Furthermore, no discrepancy was found between the two assays when 100 random L. vannamei samples were tested in parallel. Finally, excellent correlation was observed among test results of three batches of reagents with 64 samples analyzed in three different laboratories. Working in a portable device, IQ Plus (TM) WSSV Kit with POCKIT system allows reliable, sensitive and specific on-site detection of WSSV in L. vannamei.	[Tsai, Yun-Long; Tsai, Chuan-Fu; Yen, Cheng-Chi; Chang, Hsiao-Fen Grace; Teng, Ping-Hua; Lee, Pei-Yu] GeneReach Biotechnol Corp, Dept Res & Dev, Taichung, Taiwan; [Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Lo, Chu-Fang] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Tang-Nelson, Kathy; Lightner, Donald] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ USA; [Ou, Bor-Rung] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan; [Hour, Ai-Ling] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; University of Arizona; Tunghai University; Fu Jen Catholic University	Lee, PY (corresponding author), GeneReach Biotechnol Corp, Dept Res & Dev, Taichung, Taiwan.	pylee@genereachbiotech.com	Lo, Chu-Fang/G-3088-2014; Wang, Han-Ching/AAT-6086-2021	Lo, Chu-Fang/0000-0001-5136-8129; Wang, Han-Ching/0000-0001-7283-4942	Central Taiwan Science Park, National Science Council, Taiwan [302403501]	Central Taiwan Science Park, National Science Council, Taiwan	This work was supported in part by a grant from Central Taiwan Science Park, National Science Council, Taiwan, Grant no. 302403501 (http://www.ctspb.most.gov.tw/english/00home/home.aspx?v=20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Belcher CR, 1998, J VIROL METHODS, V74, P21, DOI 10.1016/S0166-0934(98)00067-6; Chaivisuthangkura P, 2009, J VIROL METHODS, V162, P188, DOI 10.1016/j.jviromet.2009.08.005; Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453; Chou PH, 2011, J VIROL METHODS, V173, P67, DOI 10.1016/j.jviromet.2011.01.009; Durand SV, 2002, J FISH DIS, V25, P381, DOI 10.1046/j.1365-2761.2002.00367.x; Hameed ASS, 2003, DIS AQUAT ORGAN, V57, P157, DOI 10.3354/dao057157; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Jian XF, 2005, DIS AQUAT ORGAN, V67, P171, DOI 10.3354/dao067171; Kasornchandra J, 1998, AQUACULTURE, V164, P243, DOI 10.1016/S0044-8486(98)00190-2; Kiatpathomchai W, 2001, DIS AQUAT ORGAN, V47, P235, DOI 10.3354/dao047235; Kono T, 2004, J VIROL METHODS, V115, P59, DOI 10.1016/j.jviromet.2003.09.015; Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lo CF, 1997, DIS AQUAT ORGAN, V30, P53, DOI 10.3354/dao030053; Lotz JM, 2002, DIS AQUAT ORGAN, V50, P199, DOI 10.3354/dao050199; Mekata T, 2009, LETT APPL MICROBIOL, V48, P25, DOI 10.1111/j.1472-765X.2008.02479.x; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Musthaq SS, 2006, J INVERTEBR PATHOL, V93, P75, DOI 10.1016/j.jip.2006.06.006; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Natividad KDT, 2008, J VIROL METHODS, V149, P28, DOI 10.1016/j.jviromet.2008.01.013; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nunan LM, 2011, J VIROL METHODS, V171, P318, DOI 10.1016/j.jviromet.2010.11.015; O.I.E, 2009, MAN DIAGN TESTS AQ A; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Seetang-Nun Y, 2013, MOL CELL PROBE, V27, P71, DOI 10.1016/j.mcp.2012.11.005; Teng PH, 2007, J VIROL METHODS, V146, P317, DOI 10.1016/j.jviromet.2007.07.027; Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278; Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017; Vaseeharan B, 2003, LETT APPL MICROBIOL, V37, P443, DOI 10.1046/j.1472-765X.2003.01428.x; Xie XX, 2005, VIRUS RES, V108, P63, DOI 10.1016/j.virusres.2004.08.002; Yuan L, 2007, J VIROL METHODS, V146, P96, DOI 10.1016/j.jviromet.2007.06.009	32	40	48	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90545	10.1371/journal.pone.0090545	http://dx.doi.org/10.1371/journal.pone.0090545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625894	Green Published, gold			2022-12-25	WOS:000332851300024
J	Zhu, JW; Loos, RJF; Lu, L; Zong, G; Gan, W; Ye, XW; Sun, L; Li, HX; Lin, X				Zhu, Jingwen; Loos, Ruth J. F.; Lu, Ling; Zong, Geng; Gan, Wei; Ye, Xingwang; Sun, Liang; Li, Huaixing; Lin, Xu			Associations of Genetic Risk Score with Obesity and Related Traits and the Modifying Effect of Physical Activity in a Chinese Han Population	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; FTO RS9939609 POLYMORPHISM; COMMON VARIANTS; LOCI; FAT; PREDISPOSITION; CHILDHOOD; CHILDREN	Background/Objectives: Recent large-scale genome-wide association studies have identified multiple loci robustly associated with BMI, predominantly in European ancestry (EA) populations. However, associations of these loci with obesity and related traits have not been well described in Chinese Hans. This study aimed to investigate whether BMI-associated loci are, individually and collectively, associated with adiposity-related traits and obesity in Chinese Hans and whether these associations are modified by physical activity (PA). Subjects/Methods: We genotyped 28 BMI-associated single nucleotide polymorphisms (SNPs) in a population-based cohort including 2,894 unrelated Han Chinese. Genetic risk score (GRS), EA and East Asian ancestry (EAA) GRSs were calculated by adding BMI-increasing alleles based on all, EA and EAA identified SNPs, respectively. Interactions of GRS and PA were examined by including the interaction-term in the regression model. Results: Individually, 26 of 28 SNPs showed directionally consistent effects on BMI, and associations of four loci (TMEM18, PCSK1, BDNF and MAP2K5) reached nominal significance(P<0.05). The GRS was associated with increased BMI, trunk fat and body fat percentages; and increased risk of obesity and overweight (all P<0.05). Effect sizes (0.11 vs. 0.17 kg/m(2)) and explained variance (0.90% vs. 1.45%) of GRS for BMI tended to be lower in Chinese Hans than in Europeans. The EA GRS and EAA GRS were associated with 0.11 and 0.13 kg/m(2) higher BMI, respectively. In addition, we found that PA attenuated the effect of the GRS on BMI (P-interaction = 0.022). Conclusions: Our observations suggest that the combined effect of obesity-susceptibility loci on BMI tended to be lower in Han Chinese than in EA. The overall, EA and EAA GRSs exert similar effects on adiposity traits. Genetic predisposition to increased BMI is attenuated by PA in this population of Han Chinese.	[Zhu, Jingwen; Lu, Ling; Zong, Geng; Gan, Wei; Ye, Xingwang; Sun, Liang; Li, Huaixing; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhu, Jingwen; Lu, Ling; Zong, Geng; Gan, Wei; Ye, Xingwang; Sun, Liang; Li, Huaixing; Lin, Xu] Chinese Acad Sci, Grad Univ, Shanghai, Peoples R China; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, Charles Bronfman Inst Personalized Med, Mindich Child Hlth & Dev Inst,Dept Prevent Med, New York, NY USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Icahn School of Medicine at Mount Sinai	Li, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	lihx@sibs.ac.cn; xlin@sibs.ac.cn	Loos, Ruth J F/Q-2862-2016; Zong, Geng/ABG-6946-2021; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; 	National High Technology Research and Development Program (863 Program) [2009AA022704]; National Basic Research Program of China (973 Program) [2012CB524900]; National Natural Science Foundation of China [30930081, 81170734, 81021002]; Chinese Academy of Sciences [KSCX2-EW-R-10, SIBS2008006]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National High Technology Research and Development Program (863 Program 2009AA022704), the National Basic Research Program of China (973 Program 2012CB524900), the National Natural Science Foundation of China (30930081, 81170734 and 81021002), and the Chinese Academy of Sciences (KSCX2-EW-R-10 and SIBS2008006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Browne W.J., 2009, GUIDE SAMPLE SIZE CA; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hong J, 2013, INT J OBESITY, V37, P673, DOI 10.1038/ijo.2012.87; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Ruiz JR, 2010, ARCH PEDIAT ADOL MED, V164, P328, DOI 10.1001/archpediatrics.2010.29; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tews D, 2011, HORM METAB RES, V43, P17, DOI 10.1055/s-0030-1265130; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2013, BIOMED ENVIRON SCI, V26, P787, DOI 10.3967/bes2013.001; Xi B, 2013, CLIN ENDOCRINOL, V79, P523, DOI 10.1111/cen.12091; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	39	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91442	10.1371/journal.pone.0091442	http://dx.doi.org/10.1371/journal.pone.0091442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626232	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300085
J	Bricard, Y; Ralliere, C; Lebret, V; Lefevre, F; Rescan, PY				Bricard, Yoann; Ralliere, Cecile; Lebret, Veronique; Lefevre, Florence; Rescan, Pierre-Yves			Early Fish Myoseptal Cells: Insights from the Trout and Relationships with Amniote Axial Tenocytes	PLOS ONE			English	Article							MYOTENDINOUS JUNCTION; MUSCLE DEVELOPMENT; DIFFERENTIAL EXPRESSION; TELEOST DERMOMYOTOME; MUSCULAR-DYSTROPHY; ZEBRAFISH EMBRYOS; COLLAGEN-XII; ADHESION; TENDON; GROWTH	The trunk muscle in fish is organized as longitudinal series of myomeres which are separated by sheets of connective tissue called myoseptum to which myofibers attach. In this study we show in the trout that the myoseptum separating two somites is initially acellular and composed of matricial components such as fibronectin, laminin and collagen I. However, myoseptal cells forming a continuum with skeletogenic cells surrounding axial structures are observed between adjacent myotomes after the completion of somitogenesis. The myoseptal cells do not express myogenic markers such as Pax3, Pax7 and myogenin but express several tendon-associated collagens including col1a1, col5a2 and col12a1 and angiopoietin-like 7, which is a secreted molecule involved in matrix remodelling. Using col1a1 as a marker gene, we observed in developing trout embryo an initial labelling in disseminating cells ventral to the myotome. Later, labelled cells were found more dorsally encircling the notochord or invading the intermyotomal space. This opens the possibility that the sclerotome gives rise not only to skeletogenic mesenchymal cells, as previously reported, but also to myoseptal cells. We furthermore show that myoseptal cells differ from skeletogenic cells found around the notochord by the specific expression of Scleraxis, a distinctive marker of tendon cells in amniotes. In conclusion, the location, the molecular signature and the possible sclerotomal origin of the myoseptal cells suggest that the fish myoseptal cells are homologous to the axial tenocytes in amniotes.	[Bricard, Yoann; Ralliere, Cecile; Lebret, Veronique; Lefevre, Florence; Rescan, Pierre-Yves] French Natl Inst Agr Res, Fish Physiol & Genom, Rennes, France	INRAE	Rescan, PY (corresponding author), French Natl Inst Agr Res, Fish Physiol & Genom, Rennes, France.	pierre-yves.rescan@rennes.inra.fr		, Florence/0000-0002-5573-8411	European Community [222719]; INRA PHASE department; Britany province (Region Bretagne)	European Community(European Commission); INRA PHASE department; Britany province (Region Bretagne)(Region Bretagne)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222719. YB received a PhD fellowship from the INRA PHASE department and the Britany province (Region Bretagne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDE.RM, 1969, J MAR BIOL ASSOC UK, V49, P263, DOI 10.1017/S0025315400035906; Ayala MD, 2013, FISH PHYSIOL BIOCHEM, V39, P807, DOI 10.1007/s10695-012-9742-x; Bader HL, 2009, MATRIX BIOL, V28, P32, DOI 10.1016/j.matbio.2008.09.580; BREMNER HA, 1985, J FOOD SCI, V50, P975, DOI 10.1111/j.1365-2621.1985.tb12993.x; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Charvet B, 2013, DEVELOPMENT, V140, P4602, DOI 10.1242/dev.096024; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Devoto SH, 2006, EVOL DEV, V8, P101, DOI 10.1111/j.1525-142X.2006.05079.x; Dumont E, 2008, J EXP BIOL, V211, P1163, DOI 10.1242/jeb.015461; Duran I, 2011, MICROSC RES TECHNIQ, V74, P440, DOI 10.1002/jemt.20929; Gabillard JC, 2003, MOL REPROD DEV, V64, P32, DOI 10.1002/mrd.10222; Gemballa S, 2003, P ROY SOC B-BIOL SCI, V270, P1229, DOI 10.1098/rspb.2003.2345; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Govoroun M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-196; Grotmol S, 2003, ANAT EMBRYOL, V207, P263, DOI 10.1007/s00429-003-0349-y; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kudo H, 2004, DEV BIOL, V267, P473, DOI 10.1016/j.ydbio.2003.12.007; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; MorinKensicki EM, 1997, DEVELOPMENT, V124, P159; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Rescan PY, 2008, J EXP ZOOL PART B, V310B, P541, DOI 10.1002/jez.b.21230; Rescan PY, 2005, DEV DYNAM, V233, P605, DOI 10.1002/dvdy.20337; Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x; Snow CJ, 2008, DEV DYNAM, V237, P2542, DOI 10.1002/dvdy.21670; Snow CJ, 2009, GENE EXPR PATTERNS, V9, P37, DOI 10.1016/j.gep.2008.08.003; Steinbacher P, 2008, DEV DYNAM, V237, P3233, DOI 10.1002/dvdy.21745; Stellabotte F, 2007, DEV DYNAM, V236, P2432, DOI 10.1002/dvdy.21253; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6; Sztal T, 2011, DEV DYNAM, V240, P422, DOI 10.1002/dvdy.22537; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Weber P, 1998, J NEUROBIOL, V35, P1	44	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91876	10.1371/journal.pone.0091876	http://dx.doi.org/10.1371/journal.pone.0091876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622730	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300136
J	Mia, MM; Boersema, M; Bank, RA				Mia, Masum M.; Boersema, Miriam; Bank, Ruud A.			Interleukin-1 beta Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-beta 1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TELOPEPTIDE LYSYL HYDROXYLASE; HEDGEHOG PATHWAY ACTIVATION; PYRIDINOLINE CROSS-LINKS; MUSCLE ACTIN EXPRESSION; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; COLLAGEN-SYNTHESIS; SONIC HEDGEHOG; CYTOSKELETAL FEATURES	One of the most potent pro-fibrotic cytokines is transforming growth factor (TGF beta). TGF beta is involved in the activation of fibroblasts into myofibroblasts, resulting in the hallmark of fibrosis: the pathological accumulation of collagen. Interleukin-1 beta (IL1 beta) can influence the severity of fibrosis, however much less is known about the direct effects on fibroblasts. Using lung and dermal fibroblasts, we have investigated the effects of IL1 beta, TGF beta 1, and IL1 beta in combination with TGF beta 1 on myofibroblast formation, collagen synthesis and collagen modification (including prolyl hydroxylase, lysyl hydroxylase and lysyl oxidase), and matrix metalloproteinases (MMPs). We found that IL1 beta alone has no obvious pro-fibrotic effect on fibroblasts. However, IL1 beta is able to inhibit the TGF beta 1-induced myofibroblast formation as well as collagen synthesis. Glioma-associated oncogene homolog 1 (GLI1), the Hedgehog transcription factor that is involved in the transformation of fibroblasts into myofibroblasts is upregulated by TGF beta 1. The addition of IL1 beta reduced the expression of GLI1 and thereby also indirectly inhibits myofibroblast formation. Other potentially anti-fibrotic effects of IL1 beta that were observed are the increased levels of MMP1, -2, -9 and -14 produced by fibroblasts exposed to TGF beta 1/IL1 beta in comparison with fibroblasts exposed to TGF beta 1 alone. In addition, IL1 beta decreased the TGF beta 1-induced upregulation of lysyl oxidase, an enzyme involved in collagen cross-linking. Furthermore, we found that lung and dermal fibroblasts do not always behave identically towards IL1 beta. Suppression of COL1A1 by IL1 beta in the presence of TGF beta 1 is more pronounced in lung fibroblasts compared to dermal fibroblasts, whereas a higher upregulation of MMP1 is seen in dermal fibroblasts. The role of IL1 beta in fibrosis should be reconsidered, and the differences in phenotypical properties of fibroblasts derived from different organs should be taken into account in future anti-fibrotic treatment regimes.	[Mia, Masum M.; Boersema, Miriam; Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands	University of Groningen	Bank, RA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands.	R.A.Bank@umcg.nl		Mia, Md Masum/0000-0001-8281-6377	Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]; Netherlands Organisation for Health Research and Development (ZonMW) [40-00506-98-9021]	Netherlands Institute for Regenerative Medicine (NIRM); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The authors thankfully acknowledge the financial support of the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908). Microscopical imaging was performed at the UMCG Imaging Center (UMIC), which is supported by the Netherlands Organisation for Health Research and Development (ZonMW grant 40-00506-98-9021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhordar RA, 2002, J ENDODONT, V28, P157, DOI 10.1097/00004770-200203000-00003; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Branski RC, 2007, J VOICE, V21, P651, DOI 10.1016/j.jvoice.2006.06.005; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chaudhuri V, 2007, J CUTAN PATHOL, V34, P146, DOI 10.1111/j.1600-0560.2006.00584.x; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; COUNTS DF, 1981, J PHARMACOL EXP THER, V219, P675; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1994, CELL MOTIL CYTOSKEL, V29, P195, DOI 10.1002/cm.970290302; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Furuyama A, 2008, MATRIX BIOL, V27, P429, DOI 10.1016/j.matbio.2008.02.005; GABBIANI G, 1994, PATHOL RES PRACT, V190, P851; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Guo J, 2013, ARCH TOXICO; Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559; HEINO J, 1990, BIOCHEM J, V271, P827, DOI 10.1042/bj2710827; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Hong HH, 2002, J PERIODONTOL, V73, P145, DOI 10.1902/jop.2002.73.2.145; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Horn A, 2012, ANN RHEUM DIS, V71, P785, DOI 10.1136/annrheumdis-2011-200883; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Kagan HM, 2000, ACTA TROP, V77, P147, DOI 10.1016/S0001-706X(00)00128-5; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P226, DOI 10.1097/00054725-200108000-00008; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; Li SF, 2012, RESPIRATION, V84, P509, DOI 10.1159/000340041; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Lu HK, 2010, J PERIODONTAL RES, V45, P451, DOI 10.1111/j.1600-0765.2009.01255.x; Maleszewska M, 2013, IMMUNOBIOLOGY, V218, P443, DOI 10.1016/j.imbio.2012.05.026; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Mirastschijski U, 2010, WOUND REPAIR REGEN, V18, P223, DOI 10.1111/j.1524-475X.2010.00574.x; Moon DO, 2010, INT IMMUNOPHARMACOL, V10, P605, DOI 10.1016/j.intimp.2010.02.011; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakayama S, 2008, LIFE SCI, V82, P210, DOI 10.1016/j.lfs.2007.11.003; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Philips GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023943; POOLE A, 1985, BRIT J EXP PATHOL, V66, P567; Pratap A, 2012, J DRUG TARGET, V20, P770, DOI 10.3109/1061186X.2012.719900; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Seth P, 2010, ARTHRITIS RHEUM-US, V62, P1167, DOI 10.1002/art.27315; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Swiderska-Syn M, 2013, HEPATOLOGY, V57, P1814, DOI 10.1002/hep.26230; Szauter KM, 2005, PATHOL BIOL, V53, P448, DOI 10.1016/j.patbio.2004.12.033; Thampatty BP, 2007, GENE, V386, P154, DOI 10.1016/j.gene.2006.08.027; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Usuki J, 2012, J NIPPON MED SCH, V79, P46, DOI 10.1272/jnms.79.46; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao Hua, 2008, Shengli Xuebao, V60, P355	75	63	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91559	10.1371/journal.pone.0091559	http://dx.doi.org/10.1371/journal.pone.0091559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622053	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300104
J	Nakamaru, M; Takada, T; Ohtsuki, A; Suzuki, SU; Miura, K; Tsuji, K				Nakamaru, Mayuko; Takada, Takenori; Ohtsuki, Akiko; Suzuki, Sayaki U.; Miura, Kanan; Tsuji, Kazuki			Ecological Conditions Favoring Budding in Colonial Organisms under Environmental Disturbance	PLOS ONE			English	Article							CONDITION-DEPENDENT DISPERSAL; GROUP SELECTION; INCLUSIVE FITNESS; EVOLUTION; DEMOGRAPHY; ALTRUISM; COALITIONS; PLANTS; CORAL; SIZE	Dispersal is a topic of great interest in ecology. Many organisms adopt one of two distinct dispersal tactics at reproduction: the production of small offspring that can disperse over long distances (such as seeds and spawned eggs), or budding. The latter is observed in some colonial organisms, such as clonal plants, corals and ants, in which (super) organisms split their body into components of relatively large size that disperse to a short distance. Contrary to the common dispersal viewpoint, short-dispersal colonial organisms often flourish even in environments with frequent disturbances. In this paper, we investigate the conditions that favor budding over long-distance dispersal of small offspring, focusing on the life history of the colony growth and the colony division ratio. These conditions are the relatively high mortality of very small colonies, logistic growth, the ability of dispersers to peacefully seek and settle unoccupied spaces, and small spatial scale of environmental disturbance. If these conditions hold, budding is advantageous even when environmental disturbance is frequent. These results suggest that the demography or life history of the colony underlies the behaviors of the colonial organisms.	[Nakamaru, Mayuko; Ohtsuki, Akiko; Suzuki, Sayaki U.; Miura, Kanan] Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 152, Japan; [Takada, Takenori] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Ohtsuki, Akiko; Suzuki, Sayaki U.] Grad Univ Adv Studies, Kanagawa, Japan; [Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 90301, Japan	Tokyo Institute of Technology; Hokkaido University; Graduate University for Advanced Studies - Japan; University of the Ryukyus	Nakamaru, M (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 152, Japan.	nakamaru@valdes.titech.ac.jp	Nakamaru, Mayuko/N-9127-2013; Tsuji, Kazuki/D-6607-2014	Nakamaru, Mayuko/0000-0003-2116-1711; Tsuji, Kazuki/0000-0002-2027-8582; Suzuki, Sayaki/0000-0002-6744-8139	JSPS KAKENHI [21770076, 23370006, 25340115, 20033015, 21247006]; Inamori Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Inamori Foundation	This work is supported by JSPS KAKENHI Grant Number 21770076 (M.N.), 23370006 (T. T.), 25340115 (T. T.), 20033015 (K. T.), 21247006 (K. T.), and Inamori Foundation (M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Bradley BJ, 2007, P ROY SOC B-BIOL SCI, V274, P2179, DOI 10.1098/rspb.2007.0407; Carpintero S, 2004, BIOL CONSERV, V115, P279, DOI 10.1016/S0006-3207(03)00147-2; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; Cronin AL, 2012, ANIM BEHAV, V84, P1243, DOI 10.1016/j.anbehav.2012.08.036; Gardner A, 2006, J EVOLUTION BIOL, V19, P1707, DOI 10.1111/j.1420-9101.2006.01104.x; Gardner A, 2009, J EVOLUTION BIOL, V22, P1036, DOI 10.1111/j.1420-9101.2009.01719.x; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; GOODNIGHT KF, 1992, AM NAT, V140, P1028, DOI 10.1086/285454; Gyllenberg M, 2008, J MATH BIOL, V57, P285, DOI 10.1007/s00285-008-0158-2; Gyllenberg M, 2011, THEOR POPUL BIOL, V79, P139, DOI 10.1016/j.tpb.2011.02.004; Gyllenberg Mats, 2011, Journal of Biological Dynamics, V5, P191, DOI 10.1080/17513758.2010.519403; Harper J. L, 1977, POPULATION BIOL PLAN; Heinsohn R, 2000, P ROY SOC B-BIOL SCI, V267, P243, DOI 10.1098/rspb.2000.0993; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Honnay O, 2010, EVOL ECOL, V24, P1393, DOI 10.1007/s10682-010-9408-z; Kummerli R, 2009, EVOLUTION, V63, P939, DOI 10.1111/j.1558-5646.2008.00548.x; Lehmann L, 2006, EVOLUTION, V60, P1137; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; Nakamaru M, 2007, J THEOR BIOL, V248, P288, DOI 10.1016/j.jtbi.2007.05.012; Nichols J., 2001, DISPERSAL; Ono S, 2003, J THEOR BIOL, V220, P55, DOI 10.1006/jtbi.2003.3144; PASSERA L, 1994, WESTV STUD, P23; Ronce Ophelie, 2001, P341; Sharp SP, 2008, P ROY SOC B-BIOL SCI, V275, P2125, DOI 10.1098/rspb.2008.0398; SLATKIN M, 1978, P NATL ACAD SCI USA, V75, P3531, DOI 10.1073/pnas.75.7.3531; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Suzuki JI, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P311; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Tsuji K, 2010, ENCY ANIMAL BEHAV, P469; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Williams DA, 2005, J ANIM ECOL, V74, P150, DOI 10.1111/j.1365-2656.2004.00907.x; Williams G. C., 1966, P307; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wynee-Edwards V, 1962, ANIMAL DISPERSION RE; Yamaguchi M., 1983, Galaxea, V2, P21	45	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91210	10.1371/journal.pone.0091210	http://dx.doi.org/10.1371/journal.pone.0091210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621824	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300064
J	Ren, DB; Kordis, AA; Sonenshine, DE; Daines, DA				Ren, Dabin; Kordis, Alexis A.; Sonenshine, Daniel E.; Daines, Dayle A.			The ToxAvapA Toxin-Antitoxin Locus Contributes to the Survival of Nontypeable Haemophilus influenzae during Infection	PLOS ONE			English	Article							OTITIS-MEDIA; SYSTEMS; STRAIN	Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen that is a common cause of acute and recurrent mucosal infections. One uncharacterized NTHi toxin-antitoxin (TA) module, NTHI1912-1913, is a host inhibition of growth (higBA) homologue. We hypothesized that this locus, which we designated toxAvapA, contributed to NTHi survival during infection. We deleted toxAvapA and determined that growth of the mutant in defined media was not different from the parent strain. We tested the mutant for persistence during long-term in vitro co-culture with primary human respiratory tissues, which revealed that the Delta toxAvapA mutant was attenuated for survival. We then performed challenge studies using the chinchilla model of otitis media and determined that mutant survival was also reduced in vivo. Following purification, the toxin exhibited ribonuclease activity on RNA in vitro, while the antitoxin did not. A microarray comparison of the transcriptome revealed that the tryptophan biosynthetic regulon was significantly repressed in the mutant compared to the parent strain. HPLC studies of conditioned medium confirmed that there was no significant difference in the concentration of tryptophan remaining in the supernatant, indicating that the uptake of tryptophan by the mutant was not affected. We conclude that the role of the NTHi toxAvapA TA module in persistence following stress is multifactorial and includes effects on essential metabolic pathways.	[Ren, Dabin] Rochester Gen Hosp, Res Inst, Dept Res, Rochester, NY 14621 USA; [Kordis, Alexis A.; Sonenshine, Daniel E.; Daines, Dayle A.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	Rochester General Hospital; Old Dominion University	Daines, DA (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	ddaines@odu.edu	Sonenshine, Daniel/AAF-3625-2020; Daines, Dayle A./J-4393-2019		National Institute on Deafness and other Communication Disorders [DC010187]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010187] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by the National Institute on Deafness and other Communication Disorders grant DC010187 to D. A. D. Website: http://www.nidcd.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENKAMP SJ, 1984, J PEDIATR-US, V105, P533, DOI 10.1016/S0022-3476(84)80415-1; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; Coutard B, 2012, PROTEIN EXPRES PURIF, V82, P352, DOI 10.1016/j.pep.2012.01.014; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Fivian-Hughes AS, 2010, J BACTERIOL, V192, P4348, DOI 10.1128/JB.00454-10; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Goulard C, 2010, J BACTERIOL, V192, P3669, DOI 10.1128/JB.00336-10; Grevers G, 2010, INT J PEDIATR OTORHI, V74, P572, DOI 10.1016/j.ijporl.2010.03.049; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jurenaite M, 2013, J BACTERIOL, V195, P3165, DOI 10.1128/JB.00237-13; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Schuessler DL, 2013, MOL MICROBIOL; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tuomanen E., 1986, REV INFECT DIS S, V8, P279; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Williams JJ, 2011, FEMS MICROBIOL LETT, V322, P41, DOI 10.1111/j.1574-6968.2011.02330.x; Xie G, 2003, MICROBIOL MOL BIOL R, V67, P303, DOI 10.1128/MMBR.67.3.303-342.2003; ZIEGLER F, 1992, J AUTOM CHEM, V14, P145, DOI 10.1155/S1463924692000270	24	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91523	10.1371/journal.pone.0091523	http://dx.doi.org/10.1371/journal.pone.0091523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621787	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300099
J	Yamazaki, M; Naganawa, S; Kawai, H; Ikeda, M; Bokura, K; Isoda, H; Nakashima, T				Yamazaki, Masahiro; Naganawa, Shinji; Kawai, Hisashi; Ikeda, Mitsuru; Bokura, Kiminori; Isoda, Haruo; Nakashima, Tsutomu			Visualization of White Matter Tracts Using a Non-Diffusion Weighted Magnetic Resonance Imaging Method: Does Intravenous Gadolinium Injection Four Hours Prior to the Examination Affect the Visualization of White Matter Tracts?	PLOS ONE			English	Article							HEAVILY T-2-WEIGHTED 3D-FLAIR; NEPHROGENIC SYSTEMIC FIBROSIS; ENDOLYMPHATIC HYDROPS; COCHLEAR PERILYMPH; MENIERES-DISEASE; BRAIN-STEM; CONTRAST AGENTS; 3 TESLA; SEQUENCES; FLUID	Objectives: Visualization of white matter (WM)-tracts such as the corticospinal tract (CST), medial lemniscus (ML), and superior cerebellar peduncle (SCP) using delayed enhanced (DE)-heavily T2-weighted three-dimensional fluid-attenuated inversion-recovery (hT2w-3D-FLAIR) imaging has recently been reported. In that report, all patients were clinically suspected of having Meniere's disease, because DE-hT2w-3D-FLAIR imaging of the inner ear has been reported to separately visualize perilymph and endolymph fluid and can identify the presence of endolymphatic hydrops. Therefore, the previous report could not rule out the possible effect of delayed enhancement. From this perspective, the purpose of this study was to elucidate if the use of gadolinium affects the visualization of WM-tracts on hT2w-3D-FLAIR. Materials and Methods: The records of nine patients with suspected Meniere's disease who underwent plain (P) and DE-hT2w-3D-FLAIR by 3-Tesla were retrospectively analyzed. The regions of interest were set on the CST, ML, and SCP, and on contiguous brain parenchyma: The thalamus (Th), pontine parenchyma (PP), and cerebellar parenchyma (CP), respectively. The signal intensity ratio between each WM-tract and the relevant contiguous brain parenchyma was calculated for both Pand DE-hT2w-3D-FLAIR images, and statistically compared using paired t-tests. Results: The CST/Th signal intensity ratio was 3.75 +/- 0.67 on P-hT2w-3D-FLAIR and 3.62 +/- 0.50 on DE-hT2w-3D-FLAIR (p = 0.24). The ML/PP signal intensity ratio was 2.19 +/- 0.59 on P-hT2w-3D-FLAIR and 2.08 +/- 0.53 on DE-hT2w-3D-FLAIR (p = 0.25). The SCP/CP signal intensity ratio was 4.08 +/- 0.91 on P-hT2w-3D-FLAIR and 4.04 +/- 0.96 on DE-hT2w-3D-FLAIR (p = 0.43). There were no significant differences in the signal intensity ratios between P-and DE-hT2w-3D-FLAIR images. Conclusions: The use of gadolinium is not necessary for visualization of WM-tracts using hT2w-3D-FLAIR, and P-hT2w-3D-FLAIR without gadolinium may have future clinical applications as an imaging procedure.	[Yamazaki, Masahiro; Naganawa, Shinji; Kawai, Hisashi; Bokura, Kiminori] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan; [Ikeda, Mitsuru; Isoda, Haruo] Nagoya Univ, Grad Sch Med, Dept Radiol Technol, Nagoya, Aichi 4648601, Japan; [Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Yamazaki, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan.	yamazaki@med.nagoya-u.ac.jp	Ikeda, Mitsuru/B-5163-2010; Naganawa, Shinji/I-1572-2012; Isoda, Haruo/I-7028-2014; Nakashima, Tsutomu/B-8259-2012; YAMAZAKI, Masahiro/I-7436-2014	Ikeda, Mitsuru/0000-0002-5695-3527; Naganawa, Shinji/0000-0002-0214-613X; Isoda, Haruo/0000-0002-3249-7520; Nakashima, Tsutomu/0000-0003-3930-9120; 	Japan Society for the Promotion of Science (JSPS) [24791288, 22390233, 21390460]; Japanese Ministry of Health, Labour and Welfare [H23-Nanchi-Ippan-021]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the grants from the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html) for Masahiro Yamazaki (JSPS KAKENHI Grant Number 24791288), Shinji Naganawa (JSPS KAKENHI Grant Number 22390233) and Tsutomu Nakashima (JSPS KAKENHI Grant Number 21390460), and the grants from Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) for Tsutomu Nakashima (Grant Number H23-Nanchi-Ippan-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DECOENE B, 1993, NEURORADIOLOGY, V35, P327, DOI 10.1007/BF00588360; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; Hirabayashi H, 2002, MOVEMENT DISORD, V17, pS130, DOI 10.1002/mds.10154; Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kitajima M, 2012, AM J NEURORADIOL, V33, P922, DOI 10.3174/ajnr.A2874; KJOS BO, 1985, AM J ROENTGENOL, V144, P1165, DOI 10.2214/ajr.144.6.1165; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Naganawa S, 2008, AM J NEURORADIOL, V29, P724, DOI 10.3174/ajnr.A0894; Naganawa S, 2006, EUR RADIOL, V16, P733, DOI 10.1007/s00330-005-0046-8; Naganawa S, 2004, EUR RADIOL, V14, P1901, DOI 10.1007/s00330-004-2372-7; Naganawa S, 2011, MAGN RESON MED SCI, V10, P269, DOI 10.2463/mrms.10.269; Naganawa S, 2010, MAGN RESON MED SCI, V9, P237, DOI 10.2463/mrms.9.237; Naganawa S, 2010, MAGN RESON MED SCI, V9, P73, DOI 10.2463/mrms.9.73; Nakashima T, 2007, LARYNGOSCOPE, V117, P415, DOI 10.1097/MLG.0b013e31802c300c; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Patel MD, 2010, MAGN RESON MATER PHY, V23, P399, DOI 10.1007/s10334-010-0201-3; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Sieber MA, 2009, J MAGN RESON IMAGING, V30, P1268, DOI 10.1002/jmri.21971; Sone M, 2007, OTOL NEUROTOL, V28, P1029, DOI 10.1097/MAO.0b013e3181587d95; Sugiura M, 2006, LARYNGOSCOPE, V116, P826, DOI 10.1097/01.MLG.0000215206.75542.BF; Tagaya M, 2011, ACTA OTO-LARYNGOL, V131, P474, DOI 10.3109/00016489.2010.534114; Takahara T, 2010, EUR RADIOL, V20, P1221, DOI 10.1007/s00330-009-1665-2; Taoka T, 2009, AM J NEURORADIOL, V30, P1700, DOI 10.3174/ajnr.A1698; Teranishi M, 2009, EUR ARCH OTO-RHINO-L, V266, P1871, DOI 10.1007/s00405-009-0989-5; Weigel M, 2012, MAGN RESON MED, V67, P1528, DOI 10.1002/mrm.24286; YAGISHITA A, 1994, RADIOLOGY, V191, P455, DOI 10.1148/radiology.191.2.8153321; Yamada K, 2003, RADIOLOGY, V227, P295, DOI 10.1148/radiol.2271020313; Yamazaki M, 2012, AM J NEURORADIOL, V33, P773, DOI 10.3174/ajnr.A2821; Yamazaki M, 2013, EUR C RAD 2013 EPOS, DOI [10.1594/ecr2013/C-0108, DOI 10.1594/ECR2013/C-0108.ACCESSED]; Yamazaki M, 2012, NEURORADIOLOGY, V54, P1161, DOI 10.1007/s00234-012-1078-9; Yamazaki M, 2010, MAGN RESON MED SCI, V9, P65, DOI 10.2463/mrms.9.65; Yamazaki M, 2009, NEURORADIOLOGY, V51, P855, DOI 10.1007/s00234-009-0588-6; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075	37	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91860	10.1371/journal.pone.0091860	http://dx.doi.org/10.1371/journal.pone.0091860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622649	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300135
J	Swarnkar, G; Zhang, KH; Mbalaviele, G; Long, FX; Abu-Amer, Y				Swarnkar, Gaurav; Zhang, Kaihua; Mbalaviele, Gabriel; Long, Fanxin; Abu-Amer, Yousef			Constitutive Activation of IKK2/NF-kappa B Impairs Osteogenesis and Skeletal Development	PLOS ONE			English	Article							NF-KAPPA-B; IKK-BETA; BONE-FORMATION; INFLAMMATION; DICKKOPF-1; INHIBITION; SCLEROSTIN; EXPRESSION; CYTOKINES; DIFFERENTIATION	Pathologic conditions impair bone homeostasis. The transcription factor NF-kappa B regulates bone homeostasis and is central to bone pathologies. Whereas contribution of NF-kappa B to heightened osteoclast activity is well-documented, the mechanisms underlying NF-kappa B impact on chondrocytes and osteoblasts are scarce. In this study, we examined the effect of constitutively active IKK2 (IKK2ca) on chondrogenic and osteogenic differentiation. We show that retroviral IKK2ca but not GFP, IKK2WT, or the inactive IKK2 forms IKK2KM and IKK2SSAA, strongly suppressed osteogenesis and chondrogenesis, in vitro. In order to explore the effect of constitutive NF-kappa B activation on bone formation in vivo, we activated this pathway in a conditional fashion. Specifically, we crossed the R26StopIKK2ca mice with mice carrying the Col2-cre in order to express IKK2ca in osteoblasts and chondrocytes. Both chondrocytes and osteoblasts derived from Col2Cre/IKK2ca expressed IKK2ca. Mice were born alive yet died shortly thereafter. Histologically, newborn Col2Cre+/RosaIKK2ca heterozygotes (Cre+IKK2ca_w/f (het)) and homozygotes (Cre+IKK2ca_f/f (KI)) showed smaller skeleton, deformed vertebrate and reduced or missing digit ossification. The width of neural arches, as well as ossification in vertebral bodies of Cre+IKK2ca_w/f and Cre+IKK2ca_f/f, was reduced or diminished. H&E staining of proximal tibia from new born pups revealed that Cre+IKK2ca_f/f displayed disorganized hypertrophic zones within the smaller epiphysis. Micro-CT analysis indicated that 4-wk old Cre+IKK2ca_w/f has abnormal trabecular bone in proximal tibia compared to WT littermates. Mechanistically, ex-vivo experiments showed that expression of differentiation markers in calvarial osteoblasts derived from newborn IKK2ca knock-in mice was diminished compared to WT-derived cells. In situ hybridization studies demonstrated that the hypertrophic chondrocyte marker type-X collagen, the pre-hypertrophic chondrocyte markers Indian hedgehog and alkaline phosphatase, and the early markers Aggrecan and type-II collagen were reduced in Cre+IKK2ca_w/f and Cre+IKK2ca_f/f mice. Altogether, the in-vitro, in vivo and ex-vivo evidence suggest that IKK2ca perturbs osteoblast and chondrocyte maturation and impairs skeletal development.	[Swarnkar, Gaurav; Zhang, Kaihua; Long, Fanxin; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63130 USA; [Mbalaviele, Gabriel] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63130 USA.	abuamery@wustl.edu	SWARNKAR, GAURAV/AAE-3223-2021		NIH Grants [AR049192, AR054326, P30 AR057235]; Shriners Hospital for Children [85100]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR054326, R01AR049192] Funding Source: NIH RePORTER	NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by NIH Grants: AR049192, AR054326 (to Y. A.-A.), #P30 AR057235 and by grant #85100 from the Shriners Hospital for Children (to Y. A.-A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y., 2006, FUTURE MED, V1, P133, DOI DOI 10.2217/17460816.1.1.133; Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Abu-Amer Y, 2009, CURR OPIN PHARMACOL, V9, P427, DOI 10.1016/j.coph.2009.06.007; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Cheung WW, 2010, PEDIAT NEPHROLOGY, P1; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Haynes DR, 2004, INFLAMM RES, V53, P596, DOI 10.1007/s00011-004-1303-z; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Horwood N, 2008, AUTOIMMUNITY, V41, P230, DOI 10.1080/08916930701694766; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XM, 2007, J CELL BIOCHEM, V100, P527, DOI 10.1002/jcb.21017; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Otero JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038694; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Reikeras O, 2005, ACTA ORTHOP, V76, P749, DOI 10.1080/17453670510045327; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Romas E, 2006, RHEUM DIS CLIN N AM, V32, P759, DOI 10.1016/j.rdc.2006.07.004; Ruocco MG, 2005, ANN RHEUM DIS, V64, P81, DOI 10.1136/ard.2005.042721; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Sarahrudi K, 2012, J ORTHOP RES, V30, P1549, DOI 10.1002/jor.22129; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schett G, 2005, CURR PHARM DESIGN, V11, P3039, DOI 10.2174/1381612054865046; Schopf L, 2006, ARTHRITIS RHEUM-US, V54, P3163, DOI 10.1002/art.22081; SIEBENLIST U, 2001, P NATL ACAD SCI USA, V89, P4333; Swarnkar G, 2012, BRIT J PHARMACOL, V165, P1526, DOI 10.1111/j.1476-5381.2011.01637.x; Sweeney SE, 2004, INT J BIOCHEM CELL B, V36, P372, DOI 10.1016/S1357-2725(03)00259-0; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Ting AY, 2002, SCIENCE, V298, P1189, DOI 10.1126/science.1079331; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang SY, 2011, J RHEUMATOL, V38, P821, DOI 10.3899/jrheum.100089; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	57	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91421	10.1371/journal.pone.0091421	http://dx.doi.org/10.1371/journal.pone.0091421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618907	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400090
J	Lau, ST; Hansford, LM; Chan, WK; Chan, GCF; Wan, TSK; Wong, KKY; Kaplan, DR; Tam, PKH; Ngan, ESW				Lau, S-T; Hansford, L. M.; Chan, W-K; Chan, G. C-F; Wan, T. S-K; Wong, K. K-Y; Kaplan, D. R.; Tam, P. K-H; Ngan, E. S-W			Prokineticin signaling is required for the maintenance of a de novo population of c-KIT+ cells to sustain neuroblastoma progression	ONCOGENE			English	Article							GENE-EXPRESSION; STEM-CELLS; IN-VITRO; HIF-2-ALPHA; RECEPTOR; IDENTIFICATION; PROGNOSIS; IMMATURE; HYPOXIA; GROWTH	High cellular heterogeneity within neuroblastomas (NBs) may account for the non-uniform response to treatment. c-KIT+ cells are frequently detected in NB, but how they influence NB behavior still remains elusive. Here, we used NB tumor-initiating cells to reconstitute NB development and demonstrated that c-KIT+ cells are de novo generated and dynamically maintained within the tumors to sustain tumor progression. c-KIT+ NB cells express higher levels of neural crest and stem cell markers (SLUG, SOX2 and NANOG) and are endowed with high clonogenic capacity, differentiation plasticity and are refractory to drugs. With serial transplantation assays, we found that c-KIT expression is not required for tumor formation, but c-KIT+ cells are more aggressive and can induce tumors ninefold more efficiently than c-KIT-/low cells. Intriguingly, c-KIT+ cells exhibited a long-term in vivo self-renewal capacity to sustain the formation of secondary and tertiary tumors in mice. In addition, we showed that Prokineticin signaling and mitogen-activated protein kinase pathways are crucial for the maintenance of c-KIT+ cells in tumor to promote NB progression. Our results highlight the importance of this de novo population of NB cells in sustainable growth of NB and reveal specific signaling pathways that may provide targets leading to more effective NB therapies.	[Lau, S-T; Wong, K. K-Y; Tam, P. K-H; Ngan, E. S-W] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Hansford, L. M.; Kaplan, D. R.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; [Chan, W-K; Chan, G. C-F] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Wan, T. S-K] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tam, P. K-H; Ngan, E. S-W] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Toronto; University of Hong Kong; University of Hong Kong; University of Hong Kong	Ngan, ESW (corresponding author), Univ Hong Kong, Fac Med Bldg, Dept Surg, L9-56,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	engan@hku.hk	Ngan, Elly/N-1543-2019; Wan, Thomas/AAY-7075-2020; Wong, Kenneth K. Y./B-9920-2008; Chan, Godfrey Chi Fung/C-4205-2009	Ngan, Elly/0000-0002-0022-7999; Chan, Godfrey Chi Fung/0000-0001-5032-8985	University of Hong Kong; Hong Kong Research Grants Council [HKU773909]; Hong Kong Children's Cancer Foundation; SK Yee Medical Research Fund	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Children's Cancer Foundation; SK Yee Medical Research Fund	Seed funding grant for basic research from the University of Hong Kong, General Research Grant HKU773909 from the Hong Kong Research Grants Council, research grant from Hong Kong Children's Cancer Foundation and SK Yee Medical Research Fund to ES-WN. Small project grant from the University of Hong Kong to S-TL. We thank Robin Lovell-Badge (MRC National Institute for Medical Research, London, UK) and Chi-Chung Hui (University of Toronto, Canada) for critical reading of the manuscript.	Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Bellone G, 2006, INT J ONCOL, V29, P851; Biagiotti T, 2006, STEM CELLS, V24, P443, DOI 10.1634/stemcells.2004-0264; Chen QR, 2008, GENOMICS, V92, P195, DOI 10.1016/j.ygeno.2008.05.014; COHEN PS, 1994, BLOOD, V84, P3465; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Gomes AL, 2007, CELL ONCOL, V29, P399; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Krams M, 2004, ONCOGENE, V23, P588, DOI 10.1038/sj.onc.1207145; Krystal GW, 1996, CANCER RES, V56, P370; Lacham-Kaplan O, 2004, REPRODUCTION, V128, P147, DOI 10.1530/rep.1.00220; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Liegl-Atzwanger B, 2010, VIRCHOWS ARCH, V456, P111, DOI 10.1007/s00428-010-0891-y; Luo R, 2003, DEVELOPMENT, V130, P321, DOI 10.1242/dev.00213; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marzi F, 2007, CANCER RES, V67, P2402, DOI 10.1158/0008-5472.CAN-06-3208; Ngan ESW, 2007, CLIN CANCER RES, V13, P868, DOI 10.1158/1078-0432.CCR-06-2176; Nilsson MB, 2010, ONCOGENE, V29, P2938, DOI 10.1038/onc.2010.60; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Pittoni P, 2011, ONCOGENE, V30, P757, DOI 10.1038/onc.2010.494; Shimada A, 2008, PEDIATR BLOOD CANCER, V50, P213, DOI 10.1002/pbc.21288; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Uccini S, 2005, CLIN CANCER RES, V11, P380; Vitali R, 2003, INT J CANCER, V106, P147, DOI 10.1002/ijc.11187; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310	33	12	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1019	1034		10.1038/onc.2014.24	http://dx.doi.org/10.1038/onc.2014.24			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632619				2022-12-25	WOS:000350121300008
J	Jing, G; Westwell-Roper, C; Chen, JQ; Xu, GL; Verchere, CB; Shalev, A				Jing, Gu; Westwell-Roper, Clara; Chen, Junqin; Xu, Guanlan; Verchere, C. Bruce; Shalev, Anath			Thioredoxin-interacting Protein Promotes Islet Amyloid Polypeptide Expression through miR-124a and FoxA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Diabetes; MicroRNA; Thioredoxin; Transcription Regulation; Islet Amyloid Polypeptide; Thioredoxin-interacting protein	PANCREATIC BETA-CELLS; CARBOHYDRATE RESPONSE ELEMENT; GENE-TRANSCRIPTION; INSULIN-SECRETION; IAPP GENE; GLUCOSE; TYPE-2; ACTIVATION; APOPTOSIS; INFLAMMASOME	Background: Islet amyloid polypeptide (IAPP) plays an important role in beta-cell biology, but its regulation is not fully understood. Results: Thioredoxin-interacting protein (TXNIP) induces IAPP by inhibiting miR-124a and promoting FoxA2-mediated transcription. Conclusion: The critical beta-cell signaling pathways of TXNIP and IAPP are linked. Significance: Identification of this novel TXNIP/miR-124a/FoxA2/IAPP signaling pathway provides new insight into an important aspect of transcriptional regulation and beta-cell biology. Thioredoxin-interacting protein (TXNIP) is up-regulated by glucose and diabetes and plays a critical role in glucotoxicity, inflammation, and beta-cell apoptosis, whereas we have found that TXNIP deficiency protects against diabetes. Interestingly, human islet amyloid polypeptide (IAPP) is also induced by glucose, aggregates into insoluble amyloid fibrils found in islets of most individuals with type 2 diabetes and promotes inflammation and beta-cell cytotoxicity. However, so far no connection between TXNIP and IAPP signaling had been reported. Using TXNIP gain and loss of function experiments, INS-1 beta-cells and beta-cell-specific Txnip knock-out mice, we now found that TXNIP regulates IAPP expression. Promoter analyses and chromatin-immunoprecipitation assays further demonstrated that TXNIP increases IAPP expression at the transcriptional level, and we discovered that TXNIP-induced FoxA2 (forkhead box A2) transcription factor expression was conferring this effect by promoting FoxA2 enrichment at the proximal FoxA2 site in the IAPP promoter. Moreover, we found that TXNIP down-regulates miR-124a expression, a microRNA known to directly target FoxA2. Indeed, miR-124a overexpression led to decreased FoxA2 expression and IAPP promoter occupancy and to a significant reduction in IAPP mRNA and protein expression and also effectively inhibited TXNIP-induced IAPP expression. Thus, our studies have identified a novel TXNIP/miR-124a/FoxA2/IAPP signaling cascade linking the critical beta-cell signaling pathways of TXNIP and IAPP and thereby provide new mechanistic insight into an important aspect of transcriptional regulation and beta-cell biology.	[Jing, Gu; Chen, Junqin; Xu, Guanlan; Shalev, Anath] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Jing, Gu; Chen, Junqin; Xu, Guanlan; Shalev, Anath] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Westwell-Roper, Clara; Verchere, C. Bruce] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Child & Family Research Institute; University of British Columbia	Shalev, A (corresponding author), Univ Alabama Birmingham, Comprehens Diabet Ctr, 1825 Univ Blvd,SHELBY Bldg 1206, Birmingham, AL 35294 USA.	shalev@uab.edu		Verchere, Cameron Bruce/0000-0002-9262-0586; Westwell-Roper, Clara/0000-0003-4416-3912	National Institutes of Health [R01DK-078752]; American Diabetes Association [7-12-BS-167]; Juvenile Diabetes Research Foundation; JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to A. S. from the National Institutes of Health (R01DK-078752), the American Diabetes Association (7-12-BS-167) and the Juvenile Diabetes Research Foundation and JNJSI (40-2011-1).	Alarcon C, 2012, ENDOCRINOLOGY, V153, P2082, DOI 10.1210/en.2011-2019; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen F, 2011, ENDOCRINOLOGY, V152, P1779, DOI 10.1210/en.2010-1048; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gasa R, 1997, REGUL PEPTIDES, V68, P99, DOI 10.1016/S0167-0115(96)02109-X; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Macfarlane WM, 2000, J BIOL CHEM, V275, P15330, DOI 10.1074/jbc.M908045199; Marzban L, 2008, DIABETES, V57, P3045, DOI 10.2337/db08-0485; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Mulder H, 1996, AM J PHYSIOL-ENDOC M, V271, pE1008, DOI 10.1152/ajpendo.1996.271.6.E1008; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Shepherd LMA, 2004, BBA-GENE STRUCT EXPR, V1681, P28, DOI 10.1016/j.bbaexp.2004.09.009; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Tokuyama T, 1997, METABOLISM, V46, P1044, DOI 10.1016/S0026-0495(97)90276-6; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhu TH, 2011, DIABETES-METAB RES, V27, P28, DOI 10.1002/dmrr.1140	44	45	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11807	11815		10.1074/jbc.M113.525022	http://dx.doi.org/10.1074/jbc.M113.525022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627476	Green Published, hybrid			2022-12-25	WOS:000335010600021
J	Bartholomew, AJ; Cirulli, ET				Bartholomew, Alex J.; Cirulli, Elizabeth T.			Individual Variation in Contagious Yawning Susceptibility Is Highly Stable and Largely Unexplained by Empathy or Other Known Factors	PLOS ONE			English	Article							COGNITIVE TESTS; CHIMPANZEES; SCALE; PERFORMANCE; SLEEPINESS; IMITATION; AGE	The contagious aspect of yawning is a well-known phenomenon that exhibits variation in the human population. Despite the observed variation, few studies have addressed its intra-individual reliability or the factors modulating differences in the susceptibility of healthy volunteers. Due to its obvious biological basis and impairment in diseases like autism and schizophrenia, a better understanding of this trait could lead to novel insights into these conditions and the general biological functioning of humans. We administered 328 participants a 3-minute yawning video stimulus, a cognitive battery, and a comprehensive questionnaire that included measures of empathy, emotional contagion, circadian energy rhythms, and sleepiness. Individual contagious yawning measurements were found to be highly stable across testing sessions, both in a lab setting and if administered remotely online, confirming that certain healthy individuals are less susceptible to contagious yawns than are others. Additionally, most individuals who failed to contagiously yawn in our study were not simply suppressing their reaction, as they reported not even feeling like yawning in response to the stimulus. In contrast to previous studies indicating that empathy, time of day, or intelligence may influence contagious yawning susceptibility, we found no influence of these variables once accounting for the age of the participant. Participants were less likely to show contagious yawning as their age increased, even when restricting to ages of less than 40 years. However, age was only able to explain 8% of the variability in the contagious yawn response. The vast majority of the variability in this extremely stable trait remained unexplained, suggesting that studies of its inheritance are warranted.	[Bartholomew, Alex J.; Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27706 USA	Duke University	Cirulli, ET (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27706 USA.	etc3@duke.edu		Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health of the National Institutes of Health [K01MH098126]; Ellison Medical Foundation [AG-NS-0441-08]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under award number K01MH098126 and the Ellison Medical Foundation New Scholar award AG-NS-0441-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; BAENNINGER R, 1991, PSYCHOL REC, V41, P453; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cirulli ET, 2011, CLIN NEUROPSYCHOL, V25, P778, DOI 10.1080/13854046.2011.578587; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Cooper NR, 2012, COGN AFFECT BEHAV NE, V12, P393, DOI 10.3758/s13415-011-0081-7; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Gallup AC, 2011, FRONTIERS EVOLUTIONA, V3; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Giganti F., 2009, CURRENT PSYCHOL LETT, V25; Giganti F, 2011, J ETHOL, V29, P215, DOI 10.1007/s10164-010-0242-0; Gilet AL, 2013, CAN J BEHAV SCI, V45, P42, DOI 10.1037/a0030425; Greco M, 1989, B PSYCHONOMIC SOC; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Haker H, 2013, BRAIN IMAGING BEHAV, V7, P28, DOI 10.1007/s11682-012-9189-9; Haker H, 2009, EUR ARCH PSY CLIN N, V259, P352, DOI 10.1007/s00406-009-0007-3; HEUSNER AP, 1946, PHYSIOL REV, V26, P156, DOI 10.1152/physrev.1946.26.1.156; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Madsen EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076266; Meno P, 2003, CURR PSYCHOL LETT, V11, P1; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Monk TH, 2007, J BIOL RHYTHM, V22, P278, DOI 10.1177/0748730407301054; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; OCONNELL SM, 1995, PRIMATES, V36, P397, DOI 10.1007/BF02382862; Ottoni GL, 2011, CHRONOBIOL INT, V28, P229, DOI 10.3109/07420528.2011.553696; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Platek SM, 2010, YAWN YAWN YAWN YAWN; Preacher K. J., 2002, CALCULATION TEST DIF; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; PROVINE RR, 1986, ETHOLOGY, V72, P109, DOI 10.1111/j.1439-0310.1986.tb00611.x; Provine RR, 1989, B PSYCHONOMIC SOC; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schoner J, 2013, EMPHATHY MEMORY GENE; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; SHERER DM, 1991, J ULTRAS MED, V10, P68; StataCorp, 2011, STAT STAT SOFTW REL, P173; Zilli I, 2008, J SLEEP RES, V17, P303, DOI 10.1111/j.1365-2869.2008.00666.x; Zilli I, 2007, PHYSIOL BEHAV, V91, P218, DOI 10.1016/j.physbeh.2007.02.015	48	39	39	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91773	10.1371/journal.pone.0091773	http://dx.doi.org/10.1371/journal.pone.0091773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632594	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400088
J	Zhang, JL; Zhang, CY; Chu, TG; Weissing, FJ				Zhang, Jianlei; Zhang, Chunyan; Chu, Tianguang; Weissing, Franz J.			Cooperation in Networks Where the Learning Environment Differs from the Interaction Environment	PLOS ONE			English	Article							PRISONERS-DILEMMA; SNOWDRIFT GAME; EVOLUTION; REPLACEMENT	We study the evolution of cooperation in a structured population, combining insights from evolutionary game theory and the study of interaction networks. In earlier studies it has been shown that cooperation is difficult to achieve in homogeneous networks, but that cooperation can get established relatively easily when individuals differ largely concerning the number of their interaction partners, such as in scale-free networks. Most of these studies do, however, assume that individuals change their behaviour in response to information they receive on the payoffs of their interaction partners. In real-world situations, subjects do not only learn from their interaction partners, but also from other individuals (e.g. teachers, parents, or friends). Here we investigate the implications of such incongruences between the 'interaction network' and the 'learning network' for the evolution of cooperation in two paradigm examples, the Prisoner's Dilemma game (PDG) and the Snowdrift game (SDG). Individual-based simulations and an analysis based on pair approximation both reveal that cooperation will be severely inhibited if the learning network is very different from the interaction network. If the two networks overlap, however, cooperation can get established even in case of considerable incongruence between the networks. The simulations confirm that cooperation gets established much more easily if the interaction network is scale-free rather than random-regular. The structure of the learning network has a similar but much weaker effect. Overall we conclude that the distinction between interaction and learning networks deserves more attention since incongruences between these networks can strongly affect both the course and outcome of the evolution of cooperation.	[Zhang, Jianlei; Chu, Tianguang] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Zhang, Jianlei; Zhang, Chunyan] Univ Groningen, Inst Ind Engn, Network Anal & Control Grp, Groningen, Netherlands; [Zhang, Jianlei; Zhang, Chunyan; Weissing, Franz J.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Theoret Biol Grp, Groningen, Netherlands	Peking University; University of Groningen; University of Groningen	Chu, TG (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.	chutg@pku.edu.cn; f.j.weissing@rug.nl	Chu, Tianguang/C-3521-2012	Zhang, Jianlei/0000-0002-9932-9265; Weissing, Franz J./0000-0003-3281-663X	National Basic Research Program of China (973 Program) [2012CB821200]; National Natural Science Foundation of China (NSFC) [61273111, 60974064]; Erasmus Mundus Action (EMA2 Lotus Grant); Organization for Scientific Research (NWO) [82301006]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Erasmus Mundus Action (EMA2 Lotus Grant); Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by National Basic Research Program of China (973 Program, No. 2012CB821200), and the National Natural Science Foundation of China (NSFC, Nos. 61273111, 60974064). In addition, JZ, CZ, and FJW acknowledge support from the Erasmus Mundus Action (EMA2 Lotus Grant), and Organization for Scientific Research (NWO, No. 82301006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B., 2001, RANDOM GRAPHS, V73; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Heckathorn DD, 1996, AM SOCIOL REV, V61, P250, DOI 10.2307/2096334; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; McNamara JM, 2010, SOCIAL BEHAV GENES E, P109; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Suzuki R, 2011, INT J BIO-INSPIR COM, V3, P151, DOI 10.1504/IJBIC.2011.040313; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Wu ZX, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041114; Zhang CY, 2011, THEOR POPUL BIOL, V80, P226, DOI 10.1016/j.tpb.2011.06.007; Zhang JL, 2011, CHAOS SOLITON FRACT, V44, P131, DOI 10.1016/j.chaos.2011.01.002	29	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90288	10.1371/journal.pone.0090288	http://dx.doi.org/10.1371/journal.pone.0090288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632774	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400012
J	Hill, WD; de Leeuw, C; Davies, G; Liewald, DCM; Payton, A; Craig, LCA; Whalley, LJ; Horan, M; Ollier, W; Starr, JM; Pendleton, N; Posthuma, D; Bates, TC; Deary, IJ				Hill, W. David; de Leeuw, Christiaan; Davies, Gail; Liewald, David Cherry McLachlan; Payton, Anthony; Craig, Leone C. A.; Whalley, Lawrence J.; Horan, Mike; Ollier, William; Starr, John M.; Pendleton, Neil; Posthuma, Danielle; Bates, Timothy C.; Deary, Ian J.			Functional Gene Group Analysis Indicates No Role for Heterotrimeric G Proteins in Cognitive Ability	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; LARGE PROPORTION; NMDA RECEPTORS; MENTAL SURVEYS; HERITABILITY; INTELLIGENCE; METAANALYSIS; ASSOCIATION; COMPONENTS; COMPLEXES	Previous functional gene group analyses implicated common single nucleotide polymorphisms (SNPs) in heterotrimeric G protein coding genes as being associated with differences in human intelligence. Here, we sought to replicate this finding using five independent cohorts of older adults including current IQ and childhood IQ, and using both gene- and SNP-based analytic strategies. No significant associations were found between variation in heterotrimeric G protein genes and intelligence in any cohort at either of the two time points. These results indicate that, whereas G protein systems are important in cognition, common genetic variation in these genes is unlikely to be a substantial influence on human intelligence differences.	[Hill, W. David; Davies, Gail; Liewald, David Cherry McLachlan; Starr, John M.; Bates, Timothy C.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Hill, W. David; Bates, Timothy C.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [de Leeuw, Christiaan; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [de Leeuw, Christiaan] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands; [Payton, Anthony; Ollier, William; Pendleton, Neil] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Craig, Leone C. A.] Univ Aberdeen, Inst Appl Hlth Sci, Publ Hlth Nutr Grp, Aberdeen, Scotland; [Whalley, Lawrence J.] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Horan, Mike] Univ Manchester, Inst Brain Behav & Mental Hlth, Ctr Clin & Cognit Neurosci, Manchester, Lancs, England; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Posthuma, Danielle] Erasmus Univ, Sophia Child Hosp, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	University of Edinburgh; University of Edinburgh; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Manchester; University of Aberdeen; University of Aberdeen; University of Manchester; Vrije Universiteit Amsterdam; Erasmus University Rotterdam	Deary, IJ (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	iand@staffmail.ed.ac.uk	Deary, Ian J/C-6297-2009; whalley, lawrence j/E-9019-2011; Bates, Timothy C/C-9637-2010; Pendleton, Neil/F-2333-2015	Deary, Ian J/0000-0002-1733-263X; Bates, Timothy C/0000-0002-1153-9007; Pendleton, Neil/0000-0003-0794-2386; Posthuma, Danielle/0000-0001-7582-2365; de Leeuw, Christiaan/0000-0003-1076-9828; Payton, Antony/0000-0003-0335-152X	Engineering and Physical research council (EPSRC); Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Wellcome Trust; Economic and Social Research Council (ESRC); Netherlands Organization of Scientific Research NWO [645-000-003]; Biotechnology and Biological Sciences Research Council [BB/F022441/1, BB/F019394/1] Funding Source: researchfish; Medical Research Council [MC_PC_15018, MR/K026992/1, G0700704] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish; BBSRC [BB/F019394/1, BB/F022441/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI	Engineering and Physical research council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Engineering and Physical research council (EPSRC), the Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), the Wellcome Trust, the Economic and Social Research Council (ESRC), and Netherlands Organization of Scientific Research NWO 645-000-003. The work was undertaken in The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1960, INDIVIDUAL GROUP CUL; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Guildford JP, 1978, ALTERNATE USES MANUA; Heim A.W., 1970, AH 4 GROUP TEST GEN; Hill WD, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.114; Horn JL, 1994, ENCY HUMAN INTELLIGE; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lips E, 2012, JAG TOOL EVALUATE RO; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Nelson H., 1991, NATL ADULT READING T; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Raven JC, 1977, MANUAL RAVENS PROGR; Raven JC, 1965, MILL HILL VOCABULARY; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trzaskowski M, 2013, MOL PSYCHIAT; Tucker-Drob EA, 2008, PSYCHOL AGING, V23, P453, DOI 10.1037/0882-7974.23.2.453; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1998, WECHSLER ADULT INTEL; Wechsler D., 1981, WECHSLER ADULT INTEL; Whalley LJ, 2011, MATURITAS, V69, P365, DOI 10.1016/j.maturitas.2011.05.010; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zorumski CF, 2012, NEUROSCI BIOBEHAV R, V36, P989, DOI 10.1016/j.neubiorev.2011.12.011	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91690	10.1371/journal.pone.0091690	http://dx.doi.org/10.1371/journal.pone.0091690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626473	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300122
J	Seifert, G; Calaminus, G; Wiener, A; Cysarz, D				Seifert, Georg; Calaminus, Gabriele; Wiener, Andreas; Cysarz, Dirk			Heart Rate Variability Reflects the Natural History of Physiological Development in Healthy Children and Is Not Associated with Quality of Life	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BLOOD-PRESSURE; AUTONOMIC FUNCTION; CHILDHOOD-CANCER; ADOLESCENTS; SLEEP; SURVIVAL; PERFORMANCE; MODULATION	Background: Quality of life (QoL), being the sum expression of diverse influencing factors, is not easy to determine. A clinically relevant option would be to identify and measure quality of life on the basis of physiological parameters which correlate plausibly and statistically with psychometrically measured QoL. Analysis of heart rate variability (HRV) offers readily measurable physiological parameters which could be of use here. A correlation of HRV with both course of disease and QoL has been reported in patients with chronic illness. Various psychometric instruments have been developed for use in paediatric oncology. The aim of this study was to obtain data on HRV and QoL and their correlations, initially in healthy children. Methods: Holter ECG and quality of life were examined in 160 children and adolescents (72 male) aged between 8 and 18 years. QoL was determined with the established questionnaire PEDQoL. Standard parameters of HRV from the frequency domain were calculated and correlated with QoL domains using Spearman (nonparametric) correlation analysis. Results: Minor but significant associations were revealed only with regard to the PEDQoL domain "autonomy'' on the one hand and heart rate and HRV (e. g. MRR, MRRn, MRRd, HRV_ULF, SDNN) parameters which evidently reflect distinct physiological functions on the other. Conclusions: In healthy children and adolescents we have a first indication that there is a correlation between parameters of HRV and QoL. However, to a greater extent, HRV reflects associated physiological processes of the autonomic nervous system. A higher correlation is more likely to be found in chronically ill children.	[Seifert, Georg] Charite, Dept Paediat Oncol & Haematol, D-13353 Berlin, Germany; [Calaminus, Gabriele; Wiener, Andreas] Univ Hosp Muenster, Childrens Hosp, Dept Paediat Haematol & Oncol, Munster, Germany; [Cysarz, Dirk] Univ Witten Herdecke, Inst Integrat Med, Integrated Curriculum Anthroposoph Med, Witten, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Witten Herdecke University	Seifert, G (corresponding author), Charite, Dept Paediat Oncol & Haematol, D-13353 Berlin, Germany.	georg.seifert@charite.de	Cysarz, Dirk/F-8845-2010	Cysarz, Dirk/0000-0001-8303-0261	SOFTWARE AG Foundation Germany	SOFTWARE AG Foundation Germany	The study was funded by the SOFTWARE AG Foundation Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audette JF, 2006, AGE AGEING, V35, P388, DOI 10.1093/ageing/afl006; Aziz W, 2012, CLIN AUTON RES, V22, P91, DOI 10.1007/s10286-011-0149-z; Bai XP, 2009, AM J PHYSIOL-HEART C, V297, pH765, DOI 10.1152/ajpheart.01283.2008; Berntson GG, 2004, DYNAMIC ELECTROCARDIOGRAPHY, P57, DOI 10.1002/9780470987483.ch7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Boneva RS, 2007, AUTON NEUROSCI-BASIC, V137, P94, DOI 10.1016/j.autneu.2007.08.002; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; Brosschot JF, 2007, INT J PSYCHOPHYSIOL, V63, P39, DOI 10.1016/j.ijpsycho.2006.07.016; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Buchheit M, 2006, INT J SPORTS MED, V27, P697, DOI 10.1055/s-2005-872929; Buchheit M, 2005, MED SCI SPORT EXER, V37, P1530, DOI 10.1249/01.mss.0000177556.05081.77; Burton AR, 2010, EXP BRAIN RES, V204, P71, DOI 10.1007/s00221-010-2296-1; Calaminus G, 2007, KLIN PADIATR, V219, P152, DOI 10.1055/s-2007-973846; Calaminus G, 2000, KLIN PADIATR, V212, P211, DOI 10.1055/s-2000-9679; Charkoudian N, 2009, MAYO CLIN PROC, V84, P822, DOI 10.1016/S0025-6196(11)60492-8; Chessa M, 2002, HERZ, V27, P785, DOI 10.1007/s00059-002-2340-4; Christ M, 1999, LANCET, V354, P1303, DOI 10.1016/S0140-6736(05)76079-7; Coelho L, 2001, Rev Port Cardiol, V20, P25; Cysarz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019400; De Civita M, 2005, PHARMACOECONOMICS, V23, P659, DOI 10.2165/00019053-200523070-00003; DiVall SA, 2008, ANN NY ACAD SCI, V1135, P19, DOI 10.1196/annals.1429.026; Eiser C, 2007, ARCH DIS CHILD, V92, P348, DOI 10.1136/adc.2005.086405; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Faulkner MS, 2001, NURS RES, V50, P95, DOI 10.1097/00006199-200103000-00005; Fayed Nora, 2011, Qual Life Res, V20, P1247, DOI 10.1007/s11136-011-9851-5; Frisen A, 2007, ACTA PAEDIATR, V96, P963, DOI 10.1111/j.1651-2227.2007.00333.x; Gilliam FR, 2007, PACE, V30, P56; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Guizar JM, 2005, INDIAN PEDIATR, V42, P464; Hathaway DK, 2000, WESTERN J NURS RES, V22, P749, DOI 10.1177/01939450022044728; Kardelen F, 2006, PEDIATR DIABETES, V7, P45, DOI 10.1111/j.1399-543X.2006.00141.x; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; KUMMELL HC, 1993, CLIN CARDIOL, V16, P776; Marques AH, 2010, NEUROIMMUNOMODULAT, V17, P205, DOI 10.1159/000258725; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mormont MC, 2000, CLIN CANCER RES, V6, P3038; Nagai N, 2004, INT J OBESITY, V28, P27, DOI 10.1038/sj.ijo.0802470; Nakamura Y, 2009, REV ENDOCR METAB DIS, V10, P19, DOI 10.1007/s11154-008-9092-2; Newton JL, 2011, QJM-INT J MED, V104, P681, DOI 10.1093/qjmed/hcr029; Nordlund B, 2011, ACTA PAEDIATR, V100, P1454, DOI 10.1111/j.1651-2227.2011.02359.x; Okano Y, 2007, J HUM HYPERTENS, V21, P135, DOI 10.1038/sj.jhh.1002117; Okano Y, 2005, CLIN EXP HYPERTENS, V27, P169, DOI 10.1081/CEH-200048749; Okano Y, 2004, CLIN EXP HYPERTENS, V26, P145, DOI 10.1081/CEH-120028553; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Payot A, 2011, CURR PROB PEDIATR AD, V41, P91, DOI 10.1016/j.cppeds.2010.10.008; Pemberger S, 2005, SUPPORT CARE CANCER, V13, P49, DOI 10.1007/s00520-004-0724-0; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Rachow T, 2011, PSYCHOPHYSIOLOGY, V48, P1323, DOI 10.1111/j.1469-8986.2011.01210.x; Riihimaa PH, 2002, DIABETIC MED, V19, P932, DOI 10.1046/j.1464-5491.2002.00816.x; Roach D, 2004, J AM COLL CARDIOL, V43, P2271, DOI 10.1016/j.jacc.2004.01.050; Rodriguez-Colon SM, 2011, INT J PEDIATR OBES, V6, P128, DOI 10.3109/17477166.2010.490265; Schulz S, 2010, PHYSIOL MEAS, V31, P303, DOI 10.1088/0967-3334/31/3/003; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Solans M, 2011, VALUE HEALTH, V11, P742; Spiegelhalder K, 2011, J SLEEP RES, V20, P137, DOI 10.1111/j.1365-2869.2010.00863.x; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 2009, CIRCULATION, V93, P1043; Taylor J, 2011, EPILEPSIA, V2011, P1528; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; van Gestel AJR, 2011, RESPIROLOGY, V16, P939, DOI 10.1111/j.1440-1843.2011.01992.x; van Litsenburg RRL, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-25; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; von Kanel R, 2009, EUR J CARDIOV PREV R, V16, P645, DOI 10.1097/HJR.0b013e3283299542; Wilson IB, 1999, SOC SCI MED, V48, P1577; Yang AC, 2011, J AFFECT DISORDERS, V131, P179, DOI 10.1016/j.jad.2010.11.030; Yang TF, 2001, CHILD NERV SYST, V17, P602, DOI 10.1007/s003810100505	70	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91036	10.1371/journal.pone.0091036	http://dx.doi.org/10.1371/journal.pone.0091036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625571	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300053
J	Sonsteng, KM; Prigge, JR; Talago, EA; June, RK; Schmidt, EE				Sonsteng, Katherine M.; Prigge, Justin R.; Talago, Emily A.; June, Ronald K.; Schmidt, Edward E.			Hydrodynamic Delivery of Cre Protein to Lineage-Mark or Time-Stamp Mouse Hepatocytes In situ	PLOS ONE			English	Article							GENE-THERAPY; LIVER; MICE; EXPRESSION; REPORTER; VECTORS; VIVO; REGENERATION; MUTAGENESIS; RECOMBINASE	Cre-responsive fluorescent marker alleles are powerful tools for cell lineage tracing in mice; however their utility is limited by regulation of Cre activity. When targeting hepatocytes, hydrodynamic delivery of a Cre-expression plasmid can convert Cre-responsive alleles without inducing the intracellular or systemic antiviral responses often associated with viral-derived Cre-expression vectors. In this method, rapid high-volume intravenous inoculation induces hepatocyte-targeted uptake of extracellular molecules. Here we tested whether hydrodynamic delivery of Cre protein or Cre fused to the HIV-TAT cell-penetrating peptide could convert Cre-responsive reporters in hepatocytes of mice. Hydrodynamic delivery of 2 nmol of either Cre or TAT-Cre protein converted the reporter allele in 5 to 20% of hepatocytes. Neither protein gave detectable Cre activity in endothelia, non-liver organs, or non-hepatocyte cells in liver. Using mice homozygous for a Cre-responsive marker that directs red-(Cre-naive) or green-(Cre-converted) fluorescent proteins to the nucleus, we assessed sub-saturation Cre-activity. One month after hydrodynamic inoculation with Cre protein, 58% of hepatocyte nuclei that were green were also red, indicating that less than half of the hepatocytes that had obtained enough Cre to convert one marker allele to green were able to convert all alleles. For comparison, one month after hydrodynamic delivery of a Cre-expression plasmid with a weak promoter, only 26% of the green nuclei were also red. Our results show that hydrodynamic delivery of Cre protein allows rapid allelic conversion in hepatocytes, but Cre-activity is sub-saturating so many cells will not convert multiple Cre-responsive alleles.	[Sonsteng, Katherine M.; Prigge, Justin R.; Talago, Emily A.; Schmidt, Edward E.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [June, Ronald K.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Schmidt, EE (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	eschmidt@montana.edu			NIH/NIA [AG040020]; Montana Agricultural Experiment Station; NIH-CoBRE [GM103394, GM103500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103394, P20GM103500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040020] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Montana Agricultural Experiment Station; NIH-CoBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIA grant (AG040020) and funds from the Montana Agricultural Experiment Station to EES. Infrastructure support was provided by NIH-CoBRE grants (GM103394 and GM103500) to Montana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Benihoud K, 2000, J GENE MED, V2, P194, DOI 10.1002/(SICI)1521-2254(200005/06)2:3<194::AID-JGM102>3.0.CO;2-5; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Christ M, 2000, HUM GENE THER, V11, P415, DOI 10.1089/10430340050015888; Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Huang M, 2013, HEPATOLOGY, V57, P277, DOI 10.1002/hep.25959; Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; JUTILA MA, 1993, J LEUKOCYTE BIOL, V54, P30, DOI 10.1002/jlb.54.1.30; Keng VW, 2011, HEPATOLOGY, V53, P781, DOI 10.1002/hep.24091; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kimura T, 2007, MOL THER, V15, P1390, DOI 10.1038/sj.mt.6300180; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; MACK A, 1992, NUCLEIC ACIDS RES, V20, P4451, DOI 10.1093/nar/20.17.4451; Mahonen AJ, 2004, BIOCHEM BIOPH RES CO, V320, P366, DOI 10.1016/j.bbrc.2004.05.175; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Overturf K, 1997, AM J PATHOL, V151, P1273; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prigge JR, 2013, MAMM GENOME, V24, P389, DOI 10.1007/s00335-013-9469-8; Rollins MF, 2010, J CELL SCI, V123, P2402, DOI 10.1242/jcs.068106; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Shi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046590; Shigekawa M, 2012, AM J PATHOL, V181, P2105, DOI 10.1016/j.ajpath.2012.08.038; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Zhou XJ, 2012, WORLD J GASTROENTERO, V18, P1892, DOI 10.3748/wjg.v18.i16.1892; Zhu HZ, 2006, FEBS LETT, V580, P4346, DOI 10.1016/j.febslet.2006.06.094	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91219	10.1371/journal.pone.0091219	http://dx.doi.org/10.1371/journal.pone.0091219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626158	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300066
J	Ubbink, DT; Tump, E; Koenders, JA; Kleiterp, S; Goslings, JC; Brolmann, FE				Ubbink, Dirk T.; Tump, Evelien; Koenders, Josje A.; Kleiterp, Sieta; Goslings, J. Carel; Brolmann, Fleur E.			Which Reasons Do Doctors, Nurses, and Patients Have for Hospital Discharge? A Mixed-Methods Study	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HEALTH-CARE; CRITERIA; DELAYS	Background: The decision to discharge a patient from a hospital is a complex process governed by many medical and non-medical factors, while the actual reasons for discharge frequently remain ill-defined. Aim: To define relevant discharge criteria as perceived by doctors, nurses and patients for the development of a standard hospital discharge policy, we collected actual reasons and most pivotal medical and organisational criteria for discharge among all stakeholders. Setting: A tertiary referral university teaching hospital. Methods: We conducted a mixed methods analysis, using patient questionnaires, interviews and a focus group with caregivers, and observations during the daily rounds of doctors, nurses and patients during their hospital stay. Fourteen wards of the Surgery, Paediatrics and Neurology departments contributed. Results: We observed 426 patients during their hospital stay. Forty doctors and nurses were interviewed, and 7 senior nurses attended a focus group. The most commonly used discharge criteria were clinical factors, organisational discharge issues and patient-related factors. A total of 269 patients returned their questionnaires. About one third of the adult patients and nearly half of the children (or their parents) felt their personal situation and assistance needed at home was insufficiently taken into account before discharge. Patients were least satisfied with the information given about what they were allowed to do or should avoid after discharge and their involvement in the planning of their discharge. Thus, besides obvious medical reasons for discharge, several non-medical reasons were signalled by all stakeholders as important issues to be improved. Conclusions: A set of discharge criteria could be defined that is useful for a more uniform hospital discharge policy that may help reduce unnecessary length of stay and improve patient satisfaction.	[Ubbink, Dirk T.; Koenders, Josje A.] Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands; [Ubbink, Dirk T.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Tump, Evelien] Univ Amsterdam, Acad Med Ctr, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands; [Kleiterp, Sieta] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Dept Trauma Surg, NL-1105 AZ Amsterdam, Netherlands; [Brolmann, Fleur E.] St Lucas Andreas Hosp, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Sint Lucas Andreas Hospital	Ubbink, DT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.ubbink@amc.nl	Ubbink, Dirk/AAF-1266-2021	Ubbink, Dirk/0000-0001-9398-8879	hospital's internal committee	hospital's internal committee	This study was funded by an unrestricted grant from the hospital's internal committee for quality improvement projects to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], JCI ACC STAND HOSP; de Vries EN, 2009, QUAL SAF HEALTH CARE, V18, P121, DOI 10.1136/qshc.2008.027524; Delnoij DMJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-88; Fiore JF, 2012, COLORECTAL DIS, V14, P270, DOI 10.1111/j.1463-1318.2010.02477.x; Fiore JF, 2012, DIS COLON RECTUM, V55, P416, DOI 10.1097/DCR.0b013e318244a8f2; Fox MT, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-70; Holland DE, 2011, PROF CASE MANAG, V16, P240, DOI 10.1097/NCM.0b013e31822361d8; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kleefstra SM, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030825; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Middleton Sandy, 2004, Aust Health Rev, V28, P255; Moons P, 2005, ONTSLAGMANAGEMENT BE; NSW Health, 2001, SHAR RESP PAT CAR HO; Ou LX, 2011, AUST HEALTH REV, V35, P357, DOI 10.1071/AH09843; Ou LX, 2009, AUST HEALTH REV, V33, P513, DOI 10.1071/AH090513; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Pieper B, 2007, J WOUND OSTOMY CONT, V34, P245, DOI 10.1097/01.WON.0000270817.06942.00; Pieper B, 2006, J WOUND OSTOMY CONT, V33, P281, DOI 10.1097/00152192-200605000-00009; Saklad M, 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; SELKER HP, 1989, MED CARE, V27, P112, DOI 10.1097/00005650-198902000-00003; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Srivastava R, 2009, J HOSP MED, V4, P481, DOI 10.1002/jhm.490; Stikvoort-Lodewijks MJ, 2008, ZORGEN POSTOPERATIEV; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ubbink DT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000891; Weiss ME, 2014, HEALTH SERV RES, V49, P304, DOI 10.1111/1475-6773.12092; Wong ELY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-242; Zander K, 2010, PROF CASE MANAG, V15, P188, DOI 10.1097/NCM.0b013e3181e26a80	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91333	10.1371/journal.pone.0091333	http://dx.doi.org/10.1371/journal.pone.0091333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625666	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300072
J	Wallace, LMK; Theou, O; Kirkland, SA; Rockwood, MRH; Davidson, KW; Shimbo, D; Rockwood, K				Wallace, Lindsay M. K.; Theou, Olga; Kirkland, Susan A.; Rockwood, Michael R. H.; Davidson, Karina W.; Shimbo, Daichi; Rockwood, Kenneth			Accumulation of Non-Traditional Risk Factors for Coronary Heart Disease Is Associated with Incident Coronary Heart Disease Hospitalization and Death	PLOS ONE			English	Article							FRAILTY INDEX; DEFICIT ACCUMULATION; ELDERLY-PEOPLE; OLDER-ADULTS; AGE	Background: Assessing multiple traditional risk factors improves prediction for late-life diseases, including coronary heart disease (CHD). It appears that non-traditional risk factors can also predict risk. The objective was to investigate contributions of non-traditional risk factors to coronary heart disease risk using a deficit accumulation approach. Methods: Community-dwelling adults with no known history of CHD (n = 2195, mean age 46.9 +/- 18.7 years, 51.8% women) participated in the 1995 Nova Scotia Health Survey. Three risk factor indices were constructed to quantify the proportion of deficits present in individuals: 1) a 17-item Non-Traditional Risk Factor Index (e. g. sinusitis, arthritis); 2) a 9-item Traditional Risk Factor Index (e. g. hypertension, diabetes); and 3) a frailty index (25 items combined from the other two index measures). Ten-year risks of CHD events (defined as CHD-related hospitalization and CHD-related mortality) were evaluated. Results: The Non-Traditional Risk Factor Index, made up of health deficits unrelated to CHD, was independently associated with incident CHD events over 10 years after controlling for age, sex, and the Traditional Risk Factor Index [adjusted {adj.} Hazard Ratio {HR} = 1.31; Confidence Interval {CI} 1.14-1.51]. When all health deficits, both those related and unrelated to CHD, were included in a frailty index the corresponding adjusted hazard ratio was 1.61; CI 1.40-1.85. Conclusion: Both traditional and non-traditional risk factor indices are independently associated with incident CHD events. CHD risk assessment may benefit from consideration of general health information as well as from traditional risk factors.	[Wallace, Lindsay M. K.; Theou, Olga; Kirkland, Susan A.; Rockwood, Michael R. H.; Rockwood, Kenneth] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Kirkland, Susan A.] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Rockwood, Kenneth] QEII Hlth Sci Ctr, Ctr Hlth Care Elderly, Halifax, NS, Canada; [Davidson, Karina W.; Shimbo, Daichi] Columbia Univ, Presbyterian Hosp, Dept Med, New York, NY USA	Dalhousie University; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Columbia University; NewYork-Presbyterian Hospital	Rockwood, K (corresponding author), Dalhousie Univ, Dept Med, Halifax, NS, Canada.	Kenneth.Rockwood@dal.ca	Davidson, Karina/GWC-0996-2022; Theou, Olga/AAS-9923-2020; Rockwood, Kenneth/AAD-8951-2019; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Theou, Olga/0000-0001-6460-782X; Davidson, Karina/0000-0002-9162-477X; Kirkland, Susan/0000-0002-8182-2369	Canadian Institutes of Health Research [MOP-209888]; Dalhousie Medical Research Foundation; Banting Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dalhousie Medical Research Foundation; Banting Postdoctoral Fellowship	This work was supported the Canadian Institutes of Health Research [grant MOP-209888] [KR]; Dalhousie Medical Research Foundation [KR]; Banting Postdoctoral Fellowship [OT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afilalo J, 2009, AM J CARDIOL, V103, P1616, DOI 10.1016/j.amjcard.2009.01.375; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001; Drubbel I, 2013, J GERONTOL A-BIOL, V68, P301, DOI 10.1093/gerona/gls161; Ekerstad N, 2011, CIRCULATION, V124, P2397, DOI 10.1161/CIRCULATIONAHA.111.025452; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gharacholou SM, 2012, AM J CARDIOL, V109, P1569, DOI 10.1016/j.amjcard.2012.01.384; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Hanon O, 2009, ARCH CARDIOVASC DIS, V102, P829, DOI 10.1016/j.acvd.2009.09.004; Howlett SE, 2013, AGE AGEING, V42, P416, DOI 10.1093/ageing/aft059; JARRETT PG, 1995, ARCH INTERN MED, V155, P1060, DOI 10.1001/archinte.155.10.1060; Krishnan M, 2014, AGE AGEING, V43, P122, DOI 10.1093/ageing/aft084; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Kulminski AM, 2007, J AM GERIATR SOC, V55, P935, DOI 10.1111/j.1532-5415.2007.01155.x; Lee DH, 2010, CIRCULATION, V121, P973, DOI 10.1161/CIRCULATIONAHA.108.841437; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Parks RJ, 2012, J GERONTOL A-BIOL, V67, P217, DOI 10.1093/gerona/glr193; Rockwood K, 2006, J AM GERIATR SOC, V54, P975, DOI 10.1111/j.1532-5415.2006.00738.x; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Romero-Ortuno R, 2012, AGE AGEING, V41, P684, DOI 10.1093/ageing/afs051; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Schoenenberger AW, 2013, EUR HEART J, V34, P684, DOI 10.1093/eurheartj/ehs304; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2011, NEUROLOGY, V77, P227, DOI 10.1212/WNL.0b013e318225c6bc; Tang Z, 2013, AGE AGEING, V42, P346, DOI 10.1093/ageing/aft004; Weiss CO, 2011, CLIN GERIATR MED, V27, P39, DOI 10.1016/j.cger.2010.08.003; Wou F, 2013, AGE AGEING, V42, P776, DOI 10.1093/ageing/aft055	31	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90475	10.1371/journal.pone.0090475	http://dx.doi.org/10.1371/journal.pone.0090475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625791	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300021
J	Zhu, F; Liu, Q; Fu, YC; Shen, BR				Zhu, Fei; Liu, Quan; Fu, Yuchen; Shen, Bairong			Segmentation of Neuronal Structures Using SARSA (lambda)-Based Boundary Amendment with Reinforced Gradient-Descent Curve Shape Fitting	PLOS ONE			English	Article							SPEECH	The segmentation of structures in electron microscopy (EM) images is very important for neurobiological research. The low resolution neuronal EM images contain noise and generally few features are available for segmentation, therefore application of the conventional approaches to identify the neuron structure from EM images is not successful. We therefore present a multi-scale fused structure boundary detection algorithm in this study. In the algorithm, we generate an EM image Gaussian pyramid first, then at each level of the pyramid, we utilize Laplacian of Gaussian function (LoG) to attain structure boundary, we finally assemble the detected boundaries by using fusion algorithm to attain a combined neuron structure image. Since the obtained neuron structures usually have gaps, we put forward a reinforcement learning-based boundary amendment method to connect the gaps in the detected boundaries. We use a SARSA (lambda)-based curve traveling and amendment approach derived from reinforcement learning to repair the incomplete curves. Using this algorithm, a moving point starts from one end of the incomplete curve and walks through the image where the decisions are supervised by the approximated curve model, with the aim of minimizing the connection cost until the gap is closed. Our approach provided stable and efficient structure segmentation. The test results using 30 EM images from ISBI 2012 indicated that both of our approaches, i.e., with or without boundary amendment, performed better than six conventional boundary detection approaches. In particular, after amendment, the Rand error and warping error, which are the most important performance measurements during structure segmentation, were reduced to very low values. The comparison with the benchmark method of ISBI 2012 and the recent developed methods also indicates that our method performs better for the accurate identification of substructures in EM images and therefore useful for the identification of imaging features related to brain diseases.	[Zhu, Fei; Shen, Bairong] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Zhu, Fei; Liu, Quan; Fu, Yuchen] Soochow Univ, Sch Comp Sci & Technol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shen, BR (corresponding author), Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China.	bairong.shen@suda.edu.cn	Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019	Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531	National Natural Science Foundation of China [61303108, 61272005, 91230117, 61272258]; High Education Natural Foundation of Jiangsu [13KJB520020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Education Natural Foundation of Jiangsu	This paper is supported by National Natural Science Foundation of China (61303108, 61272005, 91230117,61272258), High Education Natural Foundation of Jiangsu (13KJB520020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attique M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033616; Baddeley B, 2008, IEEE T SYST MAN CY B, V38, P950, DOI 10.1109/TSMCB.2008.921000; Baird L, 1999, ADV NEUR IN, V11, P968; BUCKLAND M, 1994, J AM SOC INFORM SCI, V45, P12, DOI 10.1002/(SICI)1097-4571(199401)45:1<12::AID-ASI2>3.0.CO;2-L; Burget R, 2012, IEEE INT S BIOM IM N, P1; Busoniu L, 2010, AUTOM CONTROL ENG SE, P1, DOI 10.1201/9781439821091-f; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Caruyer E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P50, DOI 10.1109/ISBI.2012.6235481; Caskey CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027372; Chalana V, 1997, IEEE T MED IMAGING, V16, P642, DOI 10.1109/42.640755; Cheng J, 2010, NEUROINFORMATICS, V8, P157, DOI 10.1007/s12021-010-9073-y; Cornelius Weber ME, 2008, REINFORCEMENT LEARNI; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Eggert LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045081; Giuly RJ, 2013, BIOINFORMATICS, V29, P1359, DOI 10.1093/bioinformatics/btt154; Gousias IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059990; Goutte Cyril GE, 2005, PROBABILISTIC INTERP, P345; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; Jurrus E, 2013, NEUROINFORMATICS, V11, P5, DOI 10.1007/s12021-012-9149-y; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033096; Li XY, 2013, IEEE T IMAGE PROCESS, V22, P1915, DOI 10.1109/TIP.2013.2237922; Ma WY, 2000, IEEE T IMAGE PROCESS, V9, P1375, DOI 10.1109/83.855433; Ma XL, 2007, IEEE T NEURAL NETWOR, V18, P573, DOI 10.1109/TNN.2006.888376; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Mori Y, 2009, SIGNAL PROCESS-IMAGE, V24, P65, DOI 10.1016/j.image.2008.10.013; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Plaza SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044448; Powers D.M.W, 2007, SIE07001 FLIND U; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ren JC, 2012, KNOWL-BASED SYST, V26, P144, DOI 10.1016/j.knosys.2011.07.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seghier ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017547; Somkantha K, 2011, IEEE T BIO-MED ENG, V58, P567, DOI 10.1109/TBME.2010.2091129; Szepesvari C., 2010, SYNTHESIS LECT ARTIF, V4, P1, DOI DOI 10.2200/S00268ED1V01Y201005AIM009; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang S, 2013, BIOMEDICAL ENG ONLIN, V12, P1; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874; Yu ZY, 2004, J STRUCT BIOL, V145, P168, DOI 10.1016/j.jsb.2003.10.027; Zhang Q, 2012, BIOPOLYMERS, V97, P709, DOI 10.1002/bip.22052; Zhang Y, 2007, BILING-LANG COGN, V10, P147, DOI 10.1017/S1366728907002908; Zhang Y, 2011, DEVELOPMENTAL SCI, V14, P566, DOI 10.1111/j.1467-7687.2010.01004.x; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	48	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90873	10.1371/journal.pone.0090873	http://dx.doi.org/10.1371/journal.pone.0090873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625699	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300038
J	Davel, AP; Brum, PC; Rossoni, LV				Davel, Ana P.; Brum, Patricia C.; Rossoni, Luciana V.			Isoproterenol Induces Vascular Oxidative Stress and Endothelial Dysfunction via a Gi alpha-Coupled beta(2)-Adrenoceptor Signaling Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SPONTANEOUSLY HYPERTENSIVE-RATS; BETA-ADRENOCEPTOR AGONISTS; ENHANCED EXPRESSION; G(I) PROTEINS; BETA-2-ADRENERGIC RECEPTOR; SUPEROXIDE-PRODUCTION; TARGETED DISRUPTION; DOWN-REGULATION; KNOCKOUT MICE	Objective: Sustained beta-adrenergic stimulation is a hallmark of sympathetic hyperactivity in cardiovascular diseases. It is associated with oxidative stress and altered vasoconstrictor tone. This study investigated the beta-adrenoceptor subtype and the signaling pathways implicated in the vascular effects of b-adrenoceptor overactivation. Methods and Results: Mice lacking the beta(1)- or beta(2)-adrenoceptor subtype (beta 1KO, beta 2KO) and wild-type (WT) were treated with isoproterenol (ISO, 15 mu g.g(-1). day(-1), 7 days). ISO significantly enhanced the maximal vasoconstrictor response (Emax) of the aorta to phenylephrine in WT (+34%) and beta 1KO mice (+35%) but not in beta 2KO mice. The nitric oxide synthase (NOS) inhibitor L-NAME abolished the differences in phenylephrine response between the groups, suggesting that ISO impaired basal NO availability in the aorta of WT and beta 1KO mice. Superoxide dismutase (SOD), pertussis toxin (PTx) or PD 98,059 (p-ERK 1/2 inhibitor) incubation reversed the hypercontractility of aortic rings from ISO-treated WT mice; aortic contraction of ISO-treated beta 2KO mice was not altered. Immunoblotting revealed increased aortic expression of Gi alpha-3 protein (+50%) and phosphorylated ERK1/2 (+90%) and decreased eNOS dimer/monomer ratio in ISO-treated WT mice. ISO enhanced the fluorescence response to dihydroethidium (+100%) in aortas from WT mice, indicating oxidative stress that was normalized by SOD, PTx and L-NAME. The ISO effects were abolished in beta 2KO mice. Conclusions: The beta(2)-adrenoceptor/Gi alpha signaling pathway is implicated in the enhanced vasoconstrictor response and eNOS uncoupling-mediated oxidative stress due to ISO treatment. Thus, long-term beta(2)-AR activation might results in endothelial dysfunction.	[Davel, Ana P.] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Davel, Ana P.; Rossoni, Luciana V.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Rossoni, LV (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	lrossoni@icb.usp.br	Davel, Ana P/L-8801-2013; Rossoni, Luciana Venturini/AFR-0021-2022; Rossoni, Luciana Venturini/C-7226-2012; Brum, Patricia C/E-6605-2011	Davel, Ana P/0000-0002-9862-4262; Rossoni, Luciana Venturini/0000-0002-0944-9483; Brum, Patricia C/0000-0002-4750-6506	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1992, BIOCHEM J, V288, P79, DOI 10.1042/bj2880079; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Au DH, 2003, CHEST, V123, P1964, DOI 10.1378/chest.123.6.1964; Baloglu E, 2007, EUR J PHARMACOL, V564, P167, DOI 10.1016/j.ejphar.2007.02.054; Banerjee SK, 2003, COMP BIOCHEM PHYS C, V136, P377, DOI 10.1016/j.cca.2003.10.011; Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Carll AP, 2011, CARDIOVASC TOXICOL, V11, P91, DOI 10.1007/s12012-011-9103-5; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Chruscinski A, 2001, MOL PHARMACOL, V60, P955, DOI 10.1124/mol.60.5.955; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davel AP, 2012, J VASC RES, V49, P342, DOI 10.1159/000337486; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Davel APC, 2008, AM J PHYSIOL-HEART C, V295, pH211, DOI 10.1152/ajpheart.00581.2007; Davel APC, 2006, BRIT J PHARMACOL, V148, P629, DOI 10.1038/sj.bjp.0706749; Ferro A, 2004, BRIT J PHARMACOL, V143, P397, DOI 10.1038/sj.bjp.0705933; Flacco N, 2013, BRIT J PHARMACOL, V169, P413, DOI 10.1111/bph.12121; Fukuda LE, 2008, J CARDIOVASC PHARM, V52, P413, DOI 10.1097/FJC.0b013e31818a8927; Gava AL, 2004, AUTON NEUROSCI-BASIC, V114, P47, DOI 10.1016/j.autneu.2004.07.003; Ge C, 2006, CAN J PHYSIOL PHARM, V84, P739, DOI 10.1139/Y05-123; Hjalmarson A, 1999, LANCET, V353, P2001; Hothersall JD, 2011, BRIT J PHARMACOL, V164, P317, DOI 10.1111/j.1476-5381.2011.01269.x; ITOH H, 1988, J BIOL CHEM, V263, P6656; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043884; Kim N, 2006, BBA-MOL CELL RES, V1763, P1067, DOI 10.1016/j.bbamcr.2006.08.002; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lembo G, 1997, HYPERTENSION, V30, P1128, DOI 10.1161/01.HYP.30.5.1128; Li Y, 2002, CIRC RES, V91, P247, DOI 10.1161/01.RES.0000029969.39875.4B; Lobato NS, 2012, LIFE SCI, V91, P600, DOI 10.1016/j.lfs.2012.04.013; MA XL, 1993, CIRC RES, V72, P403, DOI 10.1161/01.RES.72.2.403; MIAN KB, 1995, BRIT J PHARMACOL, V115, P993, DOI 10.1111/j.1476-5381.1995.tb15909.x; Moens AL, 2011, J MOL CELL CARDIOL, V51, P559, DOI 10.1016/j.yjmcc.2011.03.009; MOLENAAR P, 1990, J PHARMACOL EXP THER, V255, P393; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Murray DR, 2012, J MOL CELL CARDIOL, V52, P206, DOI 10.1016/j.yjmcc.2011.09.022; Murray DR, 2000, CIRCULATION, V101, P2338, DOI 10.1161/01.CIR.101.20.2338; Negrao CE, 2000, AM J PHYSIOL-HEART C, V278, pH168, DOI 10.1152/ajpheart.2000.278.1.H168; Ogut O, 2008, J CELL MOL MED, V12, P2158, DOI 10.1111/j.1582-4934.2008.00536.x; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Patterson AJ, 2004, CRIT CARE MED, V32, P1041, DOI 10.1097/01.CCM.0000120049.43113.90; Pourageaud F, 2005, N-S ARCH PHARMACOL, V372, P14, DOI 10.1007/s00210-005-1082-2; Queen LR, 2006, J PHYSIOL-LONDON, V576, P585, DOI 10.1113/jphysiol.2006.115998; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Ryall JG, 2008, AM J PHYSIOL-HEART C, V294, pH2587, DOI 10.1152/ajpheart.00985.2007; Saha S, 2008, J MOL CELL CARDIOL, V44, P336, DOI 10.1016/j.yjmcc.2007.11.003; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Soltysinska E, 2011, PFLUG ARCH EUR J PHY, V462, P529, DOI 10.1007/s00424-011-1005-7; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; Xiao RP, 1999, CIRC RES, V84, P43; Xu J, 2008, J CARDIOVASC PHARM, V52, P42, DOI 10.1097/FJC.0b013e31817dfc8f; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Zemancikova A, 2008, PHYSIOL RES, V57, P299, DOI 10.33549/physiolres.931447; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	61	38	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91877	10.1371/journal.pone.0091877	http://dx.doi.org/10.1371/journal.pone.0091877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622771	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300137
J	Ely, B; Scott, LE				Ely, Bert; Scott, LaTia Etheredge			Correction of the Caulobacter crescentus NA1000 Genome Annotation	PLOS ONE			English	Article							GENES; TECHNOLOGIES; BACTERIA; SEQUENCE; TOOL; DNA	Bacterial genome annotations are accumulating rapidly in the GenBank database and the use of automated annotation technologies to create these annotations has become the norm. However, these automated methods commonly result in a small, but significant percentage of genome annotation errors. To improve accuracy and reliability, we analyzed the Caulobacter crescentus NA1000 genome utilizing computer programs Artemis and MICheck to manually examine the third codon position GC content, alignment to a third codon position GC frame plot peak, and matches in the GenBank database. We identified 11 new genes, modified the start site of 113 genes, and changed the reading frame of 38 genes that had been incorrectly annotated. Furthermore, our manual method of identifying protein-coding genes allowed us to remove 112 noncoding regions that had been designated as coding regions. The improved NA1000 genome annotation resulted in a reduction in the use of rare codons since noncoding regions with atypical codon usage were removed from the annotation and 49 new coding regions were added to the annotation. Thus, a more accurate codon usage table was generated as well. These results demonstrate that a comparison of the location of peaks third codon position GC content to the location of protein coding regions could be used to verify the annotation of any genome that has a GC content that is greater than 60%.	[Ely, Bert; Scott, LaTia Etheredge] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ely, B (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	ely@sc.edu			National Science Foundation [EF-0826792]	National Science Foundation(National Science Foundation (NSF))	This work was funded in part by National Science Foundation (nsf.gov) grant EF-0826792 to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cruveiller S, 2005, NUCLEIC ACIDS RES, V33, pW471, DOI 10.1093/nar/gki498; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Fang G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-450; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Pareja-Tobes P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049239; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Stothard P, 2006, CURR OPIN MICROBIOL, V9, P505, DOI 10.1016/j.mib.2006.08.002; Ussery DW, 2004, MICROBIOL-SGM, V150, P2015, DOI 10.1099/mic.0.27338-0; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Yu JF, 2011, DNA RES, V18, P435, DOI 10.1093/dnares/dsr030	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91668	10.1371/journal.pone.0091668	http://dx.doi.org/10.1371/journal.pone.0091668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621776	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300117
J	Makkar, N; Chandra, T; Agrawal, P; Bansal, H; Singh, S; Anand, T; Gupta, MK; Kumar, R				Makkar, Nayani; Chandra, Tany; Agrawal, Prachi; Bansal, Harshit; Singh, Simranjeet; Anand, Tanu; Gupta, Mannan Kumar; Kumar, Rajesh			Evaluating Awareness and Practices Pertaining to Radioactive Waste Management among Scrap Dealers in Delhi, India	PLOS ONE			English	Article							RADIATION ACCIDENT	Objectives: With nuclear technology rapidly taking the spotlight in the last 50 years, radiation accidents seem to be a harsh reality of the modern world. The Mayapuri Radiation accident of 2010 was the worst radiation accident India has yet dealt with. Two years thereafter, we designed a study to assess the awareness and practices regarding radioactive waste among scrap dealers aiming to assess deficiencies in radiation disaster preparedness. Methodology: A community based cross-sectional study. The study population consisted of 209 volunteers (from 108 scrap dealerships) including 108 shop-owners and 101 workers segregated as Group A consisting of 54 dealerships in Mayapuri and Group B of 54 dealerships from the rest of the city. Subjects were then interviewed using a semi-structured questionnaire. Results: Awareness about radioactive waste varied significantly with level of education (p = 0.024), Kuppuswamy's socio-economic scale (p = 0.005), age of the scrap dealer (p = 0.049) and his work experience (p = 0.045). The larger dealerships in Mayapuri were more aware about radioactive waste (p = 0.0004), the accident in 2010 (p = 0.0002), the symbol for radiation hazard (p = 0.016), as well as the emergency guidelines and the agencies to contact in the event of a radiation accident. Conclusions: Our findings seem to signify that while governmental and non-governmental agencies were successful in implementing prompt disaster response and awareness programs, the community continues to be inadequately prepared. These go on to suggest that though concerted awareness and training programs do benefit the affected community, economic and social development is the key to disaster prevention and mitigation.	[Makkar, Nayani; Chandra, Tany; Agrawal, Prachi; Bansal, Harshit; Singh, Simranjeet; Anand, Tanu; Gupta, Mannan Kumar; Kumar, Rajesh] Maulana Azad Med Coll, New Delhi, India	Maulana Azad Medical College	Makkar, N (corresponding author), Maulana Azad Med Coll, New Delhi, India.	nayanisingh@gmail.com	AGRAWAL, PRACHI/AAG-5109-2021	AGRAWAL, PRACHI/0000-0001-5486-6510; Anand, Tanu/0000-0003-2911-2332				AERB G.S.R, 1987, 125 AT EN SAF DISP R; [Anonymous], 2010, HINDU; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201006 G; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201002 G; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201007 G; Atomic Energy Regulatory Board (AERB) Government of India, 2011, AERBITSDPRESS201101; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERB NEWSL, V23, P9; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201004 G; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201003 G; Bagla P, 2010, SCIENCE, V328, P679, DOI 10.1126/science.328.5979.679-a; Department of Atomic Energy (DAE) Government of India, 2004, 303 GSR DAE GOV IND; Dey AB, 2012, RADIAT PROT DOSIM, V151, P645, DOI 10.1093/rpd/ncs162; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Greenpeace India, 2010, MELT POT REG RAD EM; Nenot JC, 2009, J RADIOL PROT, V29, P301, DOI 10.1088/0952-4746/29/3/R01; Ortiz P, 2002, SAFETY, V21, P11; Park K, 2011, TXB PREVENTIVE SOCIA, P638; Perappadan BS, 2010, HINDU; Remesh B. P., 2010, Economic and Political Weekly, V45, P16; StataCorp, 2011, STAT STAT SOFTW REL; Turai I., 2001, CENTRAL EURO J OCCUP, V7, P3; Yardley J, 2010, NEW YORK TIMES	23	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91579	10.1371/journal.pone.0091579	http://dx.doi.org/10.1371/journal.pone.0091579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622341	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300107
J	Steingrimsdottir, L; Halldorsson, TI; Siggeirsdottir, K; Cotch, MF; Einarsdottir, BO; Eiriksdottir, G; Sigurdsson, S; Launer, LJ; Harris, TB; Gudnason, V; Sigurdsson, G				Steingrimsdottir, Laufey; Halldorsson, Thorhallur I.; Siggeirsdottir, Kristin; Cotch, Mary Frances; Einarsdottir, Berglind O.; Eiriksdottir, Gudny; Sigurdsson, Sigurdur; Launer, Lenore J.; Harris, Tamara B.; Gudnason, Vilmundur; Sigurdsson, Gunnar			Hip Fractures and Bone Mineral Density in the Elderly-Importance of Serum 25-Hydroxyvitamin D	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; GENE/ENVIRONMENT SUSCEPTIBILITY-REYKJAVIK; OLDER-ADULTS; NONSPINE FRACTURES; MUSCLE STRENGTH; DIETARY-INTAKE; RISK; METAANALYSIS; ASSOCIATION; CALCIUM	Background: The significance of serum 25-hydroxyvitamin D [25(OH) D] concentrations for hip fracture risk of the elderly is still uncertain. Difficulties reaching both frail and healthy elderly people in randomized controlled trials or large cohort studies may in part explain discordant findings. We determined hazard ratios for hip fractures of elderly men and women related to serum 25(OH) D, including both the frail and the healthy segment of the elderly population. Methods: The AGES-Reykjavik Study is a prospective study of 5764 men and women, age 66-96 years, based on a representative sample of the population of Reykjavik, Iceland. Participation was 71.8%. Hazard ratios of incident hip fractures and baseline bone mineral density were determined according to serum concentrations of 25(OH) D at baseline. Results: Mean follow-up was 5.4 years. Compared with referent values (50-75 nmol/L), hazard ratios for hip fractures were 2.24 (95% CI 1.63, 3.09) for serum 25(OH) D <30 nmol/L, adjusting for age, sex, body mass index, height, smoking, alcohol intake and season, and 2.08 (95% CI 1.51, 2.87), adjusting additionally for physical activity. No difference in risk was associated with 30-50 nmol/L or >= 75 nmol/L in either model compared with referent. Analyzing the sexes separately, hazard ratios were 2.61 (95% CI 1.47, 4.64) in men and 1.93 (95% CI 1.31, 2.84) in women. Values <30 nmol/L were associated with significantly lower bone mineral density of femoral neck compared with referent, z-scores -0.14 (95% CI - 0.27, -0.00) in men and -0.11 (95% CI -0.22, -0.01) in women. Conclusions: Our results lend support to the overarching importance of maintaining serum 25(OH) D above 30 nmol/L for bone health of elderly people while potential benefits of having much higher levels could not be detected.	[Steingrimsdottir, Laufey; Halldorsson, Thorhallur I.] Univ Iceland, Unit Nutr Res, Reykjavik, Iceland; [Steingrimsdottir, Laufey; Halldorsson, Thorhallur I.] Landspitali Univ Hosp, Reykjavik, Iceland; [Siggeirsdottir, Kristin; Einarsdottir, Berglind O.; Eiriksdottir, Gudny; Sigurdsson, Sigurdur; Gudnason, Vilmundur; Sigurdsson, Gunnar] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Gudnason, Vilmundur; Sigurdsson, Gunnar] Univ Iceland, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Iceland	Steingrimsdottir, L (corresponding author), Univ Iceland, Unit Nutr Res, Reykjavik, Iceland.	laufey@hi.is	Halldorsson, Tohrhallur/M-1823-2015; Gudnason, Vilmundur/K-6885-2015; Steingrimsdottir, Laufey/L-3150-2015; Gudnason, Vilmundur/AAE-7126-2019	Halldorsson, Tohrhallur/0000-0001-5115-0162; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Halldorsson, Thorhallur/0000-0002-3488-0777; Cotch, Mary Frances/0000-0002-2046-4350; Einarsdottir, Berglind Osk/0000-0002-5227-8149	National Institutes of Health, USA [N01-AG-12100]; National Institute on Aging Intramural Research Program, the National Eye Institute USA [Z01-EY000401]; National Institutes of Health, Hjartavernd (The Icelandic Heart Association); Althingi (Icelandic Parliament); NATIONAL EYE INSTITUTE [Z01EY000401, ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, ZIAAG007380] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Intramural Research Program, the National Eye Institute USA; National Institutes of Health, Hjartavernd (The Icelandic Heart Association); Althingi (Icelandic Parliament); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health, USA contract N01-AG-12100, and the National Institute on Aging Intramural Research Program, the National Eye Institute USA (Z01-EY000401), National Institutes of Health, Hjartavernd (The Icelandic Heart Association), and Althingi (Icelandic Parliament). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Barbour KE, 2012, J BONE MINER RES, V27, P1177, DOI 10.1002/jbmr.1545; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bjornsson G, 1982, 24 ABC IC HEART ASS; Black DM, 2008, J BONE MINER RES, V23, P1326, DOI 10.1359/JBMR.080316; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Cauley JA, 2010, J BONE MINER RES, V25, P545, DOI 10.1359/jbmr.090826; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dawson-Hughes B, 2013, CALCIFIED TISSUE INT, V92, P184, DOI 10.1007/s00223-012-9606-5; Eysteinsdottir T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-12; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Grimnes G, 2012, OSTEOPOROSIS INT, V23, P201, DOI 10.1007/s00198-011-1752-5; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holvik K, 2013, J CLIN ENDOCR METAB, V98, P3341, DOI 10.1210/jc.2013-1468; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Johnell Olof, 2006, Evid Based Med, V11, P13, DOI 10.1136/ebm.11.1.13; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x; Lai JKC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-331; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Looker AC, 2013, J BONE MINER RES, V28, P997, DOI 10.1002/jbmr.1828; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Muir SW, 2011, J AM GERIATR SOC, V59, P2291, DOI 10.1111/j.1532-5415.2011.03733.x; Rabenda V, 2011, OSTEOPOROSIS INT, V22, P893, DOI 10.1007/s00198-010-1469-x; Rianon NJ, 2014, J CLIN DENSITOM, V17, P25, DOI 10.1016/j.jocd.2013.03.005; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Roddam AW, 2007, AM J EPIDEMIOL, V166, P1327, DOI 10.1093/aje/kwm210; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Schwartz AV, 1999, J AM GERIATR SOC, V47, P1371; Siggeirsdottir K, 2007, EUR J EPIDEMIOL, V22, P631, DOI 10.1007/s10654-007-9163-9; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336	42	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91122	10.1371/journal.pone.0091122	http://dx.doi.org/10.1371/journal.pone.0091122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621578	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300054
J	Vincent, SJ; Coutts, BA; Jones, RAC				Vincent, Stuart J.; Coutts, Brenda A.; Jones, Roger A. C.			Effects of Introduced and Indigenous Viruses on Native Plants: Exploring Their Disease Causing Potential at the Agro-Ecological Interface	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; NON-NECROTIC STRAINS; ANNUAL PASTURE LEGUMES; POTATO LEAFROLL VIRUS; HYPERSENSITIVE RESISTANCE; BIOLOGICAL-PROPERTIES; AUSTRALIA INCIDENCES; TERRESTRIAL ORCHIDS; DWARF-VIRUS; SEED STOCKS	The ever increasing movement of viruses around the world poses a major threat to plants growing in cultivated and natural ecosystems. Both generalist and specialist viruses move via trade in plants and plant products. Their potential to damage cultivated plants is well understood, but little attention has been given to the threat such viruses pose to plant biodiversity. To address this, we studied their impact, and that of indigenous viruses, on native plants from a global biodiversity hot spot in an isolated region where agriculture is very recent (<185 years), making it possible to distinguish between introduced and indigenous viruses readily. To establish their potential to cause severe or mild systemic symptoms in different native plant species, we used introduced generalist and specialist viruses, and indigenous viruses, to inoculate plants of 15 native species belonging to eight families. We also measured resulting losses in biomass and reproductive ability for some host-virus combinations. In addition, we sampled native plants growing over a wide area to increase knowledge of natural infection with introduced viruses. The results suggest that generalist introduced viruses and indigenous viruses from other hosts pose a greater potential threat than introduced specialist viruses to populations of native plants encountered for the first time. Some introduced generalist viruses infected plants in more families than others and so pose a greater potential threat to biodiversity. The indigenous viruses tested were often surprisingly virulent when they infected native plant species they were not adapted to. These results are relevant to managing virus disease in new encounter scenarios at the agro-ecological interface between managed and natural vegetation, and within other disturbed natural vegetation situations. They are also relevant for establishing conservation policies for endangered plant species and avoiding spread of damaging viruses to undisturbed natural vegetation beyond the agro-ecological interface.	[Vincent, Stuart J.; Coutts, Brenda A.; Jones, Roger A. C.] Dept Agr & Food, S Perth, WA, Australia; [Vincent, Stuart J.] Murdoch Univ, State Agr Biotechnol Ctr, Sch Biol Sci & Biotechnol, Murdoch, WA 6150, Australia; [Coutts, Brenda A.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; Murdoch University; University of Western Australia	Jones, RAC (corresponding author), Dept Agr & Food, S Perth, WA, Australia.	roger.jones@uwa.edu.au	Jones, Roger A.C./B-1200-2011	Jones, Roger A.C./0000-0003-3593-3102	Floriculture and Plant Pathology Research Groups of the Department of Agriculture and Food for Western Australia (DAFWA)	Floriculture and Plant Pathology Research Groups of the Department of Agriculture and Food for Western Australia (DAFWA)	This work was funded by the Floriculture and Plant Pathology Research Groups of the Department of Agriculture and Food for Western Australia (DAFWA). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2014, EUR J PLANT PATHOL, V138, P529, DOI 10.1007/s10658-013-0317-1; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Bedhomme S, 2012, MOL BIOL EVOL, V29, P1481, DOI 10.1093/molbev/msr314; Bos L., 1981, Plant diseases and vectors: ecology and epidemiology; ed. by K. Maramoresh and K. F. Harris., P1; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Cheng Y, 2000, ANN APPL BIOL, V136, P215, DOI 10.1111/j.1744-7348.2000.tb00028.x; Cheng Y, 1999, AUST J AGR RES, V50, P589, DOI 10.1071/A98116; Cheng Y, 2002, ANN APPL BIOL, V140, P69, DOI 10.1111/j.1744-7348.2002.tb00158.x; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Coutts BA, 2008, AUST J AGR RES, V59, P844, DOI 10.1071/AR07475; Coutts BA, 2008, AUST J AGR RES, V59, P836, DOI 10.1071/AR08034; Coutts BA, 2006, AUST J AGR RES, V57, P975, DOI 10.1071/AR05407; Coutts BA, 2000, AUST J AGR RES, V51, P925, DOI 10.1071/AR00014; Coutts BA, 2002, ANN APPL BIOL, V140, P37, DOI 10.1111/j.1744-7348.2002.tb00155.x; Coutts BA, 2011, ARCH VIROL, V156, P1757, DOI 10.1007/s00705-011-1046-4; Dwyer GI, 2007, PLANT DIS, V91, P164, DOI 10.1094/PDIS-91-2-0164; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; Gibbs AJ, 2008, ARCH VIROL, V153, P1411, DOI 10.1007/s00705-008-0134-6; Gibbs AJ, 1960, ANN APPL BIOL, V48, P75, DOI 10.1111/j.1744-7348.1960.tb03506.x; Gibbs A, 2008, ARCH VIROL, V153, P2177, DOI 10.1007/s00705-008-0256-x; Gibbs A. J., 1983, Physiological plant ecology III. Responses to the chemical and biological environment., P537; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Harper J. L., 1990, Pests, pathogens and plant communities., P3; HARRISON BD, 1981, ANN APPL BIOL, V99, P195, DOI 10.1111/j.1744-7348.1981.tb04787.x; HARVEY H. L., 1956, Journal of the Department of Agriculture for Western Australia, V5, P329; Hawkes JR, 2005, AUST J AGR RES, V56, P257, DOI 10.1071/AR04259; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Humphries AW, 2014, RANGELAND J, V36, P41, DOI 10.1071/RJ13055; Jones R. A. C., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127022; Jones RAC, 2014, VIRUS RES, V186, P3, DOI 10.1016/j.virusres.2013.11.003; Jones R. A. C., 1990, PLANT PATHOL, V19, P90, DOI DOI 10.1071/APP9900090; Jones RAC, 2005, ANN APPL BIOL, V146, P337, DOI 10.1111/j.1744-7348.2005.040096.x; Jones RAC, 2004, AUST J AGR RES, V55, P757, DOI 10.1071/AR04011; Jones RAC, 2003, AUST J AGR RES, V54, P849, DOI 10.1071/AR03087; JONES RAC, 1994, AUST J AGR RES, V45, P1427, DOI 10.1071/AR9941427; Jones RAC, 1996, ANN APPL BIOL, V129, P491, DOI 10.1111/j.1744-7348.1996.tb05771.x; JONES RAC, 1988, ANN APPL BIOL, V113, P507, DOI 10.1111/j.1744-7348.1988.tb03328.x; JONES RAC, 1992, AUST J AGR RES, V43, P1229, DOI 10.1071/AR9921229; JONES RAC, 1989, ANN APPL BIOL, V115, P263, DOI 10.1111/j.1744-7348.1989.tb03385.x; Jones RAC, 1998, J AGR SCI-CAMBRIDGE, V131, P155, DOI 10.1017/S002185969800570X; JONES RAC, 1979, PHYTOPATHOLOGY, V69, P446, DOI 10.1094/Phyto-69-446; Jones RAC, 2006, ADV VIRUS RES, V67, P205, DOI 10.1016/S0065-3527(06)67006-1; Jones RAC, 2013, CROP PASTURE SCI, V64, P216, DOI 10.1071/CP13134; Jones RAC, 2013, CROP PASTURE SCI, V64, P199, DOI 10.1071/CP13108; Jones RAC, 2012, CROP PASTURE SCI, V63, P399, DOI 10.1071/CP12117; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Koenig R, 1989, POTATO VIRUS; Latham LJ, 2003, AUSTRALAS PLANT PATH, V32, P387, DOI 10.1071/AP03031; Latham LJ, 1997, AUST J AGR RES, V48, P359, DOI 10.1071/A96084; Latham LJ, 2001, AUST J AGR RES, V52, P397, DOI 10.1071/AR00079; Lovisolo O, 2003, ADV VIRUS RES, V62, P325, DOI 10.1016/S0065-3527(03)62006-3; MacClement W. D., 1956, AM J BOT, V34, P793; Malmstrom CM, 2011, VIRUS RES, V159, P84, DOI 10.1016/j.virusres.2011.05.010; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Maskell LC, 1999, ANN APPL BIOL, V135, P401, DOI 10.1111/j.1744-7348.1999.tb00867.x; McKirdy SJ, 1997, AUST J AGR RES, V48, P31, DOI 10.1071/A96040; MCKIRDY SJ, 1993, AUST J AGR RES, V44, P1195, DOI 10.1071/AR9931195; MCKIRDY SJ, 1994, AUST J AGR RES, V45, P183, DOI 10.1071/AR9940183; MCKIRDY SJ, 1995, AUST J AGR RES, V46, P763, DOI 10.1071/AR9950763; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Power Alison G., 2008, P15, DOI 10.1007/978-3-540-75763-4_2; Prendeville HR, 2012, AM J BOT, V99, P1033, DOI 10.3732/ajb.1100509; Rodelo-Urrego M, 2013, MOL ECOL, V22, P2325, DOI 10.1111/mec.12232; Roossinck MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003304; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; SHIVAS R G, 1989, Australasian Plant Pathology, V18, P29, DOI 10.1071/APP9890029; Spetz C, 2003, J GEN VIROL, V84, P2565, DOI 10.1099/vir.0.19208-0; Stevens M, 2005, MOL PLANT PATHOL, V6, P1, DOI 10.1111/j.1364-3703.2004.00258.x; Tatineni S, 2011, P NATL ACAD SCI USA, V108, P17366, DOI 10.1073/pnas.1113227108; Thackray DJ, 2002, ANN APPL BIOL, V141, P45, DOI 10.1111/j.1744-7348.2002.tb00194.x; Thresh J. M., 1980, Comparative epidemiology. A tool for better disease management. (Proceedings of the session of comparative epidemiology, 3rd International Congress of Plant Pathology, Munich 16-23 August, 1978.), P57; Thresh J.M., 1980, APPLIED BIOL, V5, P1; Thresh JM, 1981, PESTS PATHOGENS VEGE; TORRANCE L, 1981, PLANT PATHOL, V30, P1, DOI 10.1111/j.1365-3059.1981.tb01218.x; Torrance L, 1986, DEV APPL BIOL, V1, P103; Van Regenmortel MHV, 2000, VIRUS TAXONOMY, P477; Varsani A, 2008, J GEN VIROL, V89, P2063, DOI 10.1099/vir.0.2008/003590-0; Vincent SJ, 2012, EV IMP INF REC INTR; Webster CG, 2007, PLANT PATHOL, V56, P729, DOI 10.1111/j.1365-3059.2007.01653.x; Whattam M, 2014, HDB PLANT BIOSECURIT, P149, DOI [10.1007/978-94-007-7365-3_6, DOI 10.1007/978-94-007-7365-3_6]; WILSON CR, 1990, ANN APPL BIOL, V116, P103, DOI 10.1111/j.1744-7348.1990.tb06589.x; WILSON CR, 1993, AUST J AGR RES, V44, P1891, DOI 10.1071/AR9931891; WILSON CR, 1992, J GEN VIROL, V73, P3219, DOI 10.1099/0022-1317-73-12-3219; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Wylie SJ, 2009, PHYTOPATHOLOGY, V99, P512, DOI 10.1094/PHYTO-99-5-0512; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2012, ARCH VIROL, V157, P2447, DOI 10.1007/s00705-012-1452-2; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x	92	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91224	10.1371/journal.pone.0091224	http://dx.doi.org/10.1371/journal.pone.0091224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621926	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300066
J	Weissbrod, L; Malkinson, D; Cucchi, T; Gadot, Y; Finkelstein, I; Bar-Oz, G				Weissbrod, Lior; Malkinson, Dan; Cucchi, Thomas; Gadot, Yuval; Finkelstein, Israel; Bar-Oz, Guy			Ancient Urban Ecology Reconstructed from Archaeozoological Remains of Small Mammals in the Near East	PLOS ONE			English	Article							POPULATION-DENSITY; MESOPOTAMIA; SPRAWL; CITIES; SITE; MICE; AREA	Modern rapidly expanding cities generate intricate patterns of species diversity owing to immense complexity in urban spatial structure and current growth trajectories. We propose to identify and uncouple the drivers that give rise to these patterns by looking at the effect of urbanism on species diversity over a previously unexplored long temporal frame that covers early developments in urbanism. To provide this historical perspective we analyzed archaeozoological remains of small mammals from ancient urban and rural sites in the Near East from the 2nd to the 1st millennium BCE, and compared them to observations from modern urban areas. Our data show that ancient urban assemblages consistently comprised two main taxa (Mus musculus domesticus and Crocidura sp.), whereas assemblages of contemporaneous rural sites were significantly richer. Low species diversity also characterizes high-density core areas of modern cities, suggesting that similar ecological drivers have continued to operate in urban areas despite the vast growth in their size and population densities, as well as in the complexity of their technologies and social organization. Research in urban ecology has tended to emphasize the relatively high species diversity observed in low-density areas located on the outskirts of cities, where open and vegetated patches are abundant. The fact that over several millennia urban evolution did not significantly alter species diversity suggests that low diversity is an attribute of densely-populated settlements. The possibility that high diversity in peripheral urban areas arose only recently as a short-term phenomenon in urban ecology merits further research based on long-term data.	[Weissbrod, Lior; Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Malkinson, Dan] Univ Haifa, Dept Geog, IL-31999 Haifa, Israel; [Malkinson, Dan] Univ Haifa, Golan Res Inst, Katzrin, Israel; [Cucchi, Thomas] Museum Natl Hist Nat, CNRS, UMR Archeozool Archeobot Soc Prat & Environm 7209, Paris, France; [Cucchi, Thomas] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Gadot, Yuval; Finkelstein, Israel] Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, IL-69978 Tel Aviv, Israel	University of Haifa; University of Haifa; University of Haifa; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of Aberdeen; Tel Aviv University	Weissbrod, L (corresponding author), Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel.	lweissbr@research.haifa.ac.il	BarOz, Guy/ABF-6518-2020; Cucchi, Thomas/Q-4014-2018; Weissbrod, Lior/I-8735-2019	BarOz, Guy/0000-0002-1009-5619; Cucchi, Thomas/0000-0001-6021-5001; Weissbrod, Lior/0000-0003-3401-8180	European Research Council under the European Community's Seventh Framework Program (FP7)/ERC [229418]; Israel Science Foundation [52/10]	European Research Council under the European Community's Seventh Framework Program (FP7)/ERC(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation)	The research was funded by a post-doctoral grant awarded to L.W. from the European Research Council under the European Community's Seventh Framework Program (FP7/2007e2013)/ERC grant agreement number 229418. The laboratory work was also supported by funding by the Israel Science Foundation (Grant 52/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P.L., 1985, T LONDON MIDDLESEX A, V36, P107; ARMITAGE PL, 1985, BIOLOGIST, V32, P65; AUFFRAY JC, 1990, Z SAUGETIERKD, V55, P1; Baylac M, 2005, DEV PRIMATOL-PROG PR, P145, DOI 10.1007/0-387-27614-9_6; BOCEK B, 1986, AM ANTIQUITY, V51, P589, DOI 10.2307/281754; Bookstein F L, 1997, Med Image Anal, V1, P225; BROSHI M, 1992, B AM SCH ORIENTAL RE, P47, DOI 10.2307/1357138; CANOVA L, 1994, REV ECOL-TERRE VIE, V49, P87; Castillo E, 2003, INT BIODETER BIODEGR, V52, P135, DOI 10.1016/S0964-8305(03)00033-7; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Childe V.G., 1950, TOWN PLAN REV, V21, P3; Christensen JT, 1996, AFR J ECOL, V34, P298, DOI 10.1111/j.1365-2028.1996.tb00624.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cowgill GL, 2004, ANNU REV ANTHROPOL, V33, P525, DOI 10.1146/annurev.anthro.32.061002.093248; Cucchi T, 2011, HOLOCENE, V21, P1195, DOI 10.1177/0959683611405233; Cucchi T, 2012, EVOLUTION HOUSE MOUS, P67; Cucchi T, 2013, BIOL J LINN SOC, V108, P917, DOI 10.1111/bij.12004; Czamanski D, 2008, INT REV ENVIRON RESO, V2, P321, DOI 10.1561/101.00000019; De Cupere B, 2009, INT J OSTEOARCHAEOL, V19, P1, DOI 10.1002/oa.965; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; DICKMAN CR, 1987, J APPL ECOL, V24, P337, DOI 10.2307/2403879; Dor M., 1947, Mammalia Paris, V11, P50, DOI 10.1515/mamm.1947.11.1.50; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; FALCONER SE, 1995, AM ANTIQUITY, V60, P37, DOI 10.2307/282075; Finkelstein I, 1995, TEL AVIV, V22, P37; Flannery K.V., 1972, ANNU REV ECOL SYST, V3, P399, DOI 10.1146/annurev.es.03.110172.002151; Fletcher R., 2007, LIMITS SETTLEMENT GR; Gaston K., 2010, URBAN ECOL, P1; Gillham O., 2002, LIMITLESS CITY PRIME; Gippoliti Spartaco, 2006, Aldrovandia, V2, P69; Gonen R., 1984, B AM SCH ORIENT RES, V253, P61; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Greenberg R., 2002, EARLY URBANIZATIONS; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hofmann R., 2012, TELLS SOCIAL ENV SPA, P19; Hofmann R., 2012, TELLS SOCIAL ENV SPA, V3, P15; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Jenkins E, 2012, J SOC ARCHAEOL, V12, P380, DOI 10.1177/1469605312455765; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Luck Gary W., 2010, P88; Lyman R. Lee, 2004, ZOOARCHAEOLOGY CONSE; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; Mahan CG, 2005, NORTHEAST NAT, V12, P307, DOI 10.1656/1092-6194(2005)012[0307:SMUOSA]2.0.CO;2; McKinney M. L., 2010, URBAN ECOL, P287, DOI DOI 10.1017/CBO9780511778483.013; Mendelssohn H., 1999, MAMMALIA ISRAEL; Mendelssohn H, 1987, MAMMALS PLANTS ANIMA; Misonne X, 1963, RONGEURS RUWENZORI R; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Pickett STA, 2008, BIOSCIENCE, V58, P139, DOI 10.1641/B580208; Redman CL, 1978, RISE CIVILIZATION EA; Ripley B. D., 1996, PATTERN RECOGNITION; Rosen AM., 1986, CITIES CLAY GEOARCHE; Rosenstock E., 2012, UNIVERSITATSFORSCHUN, V207, P33; Setzer H. W., 1959, Journal of the Egyptian Public Health Association, V34, P93; Shiloh Y., 1980, B AM SCH ORIENT RES, V239, P25, DOI DOI 10.2307/1356754; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Smith ME, 2010, CAMB ARCHAEOL J, V20, P229, DOI 10.1017/S0959774310000259; Strona G, 2012, NED ONLINE SOFTWARE; Tchernov E., 1984, BAR INT SERIES, P91; Tikhonova GN, 2012, RUSS J ECOL+, V43, P236, DOI 10.1134/S1067413612030162; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Ur JA, 2010, J ARCHAEOL RES, V18, P387, DOI 10.1007/s10814-010-9041-y; Valenzuela-Lamas S, 2011, BIOL J LINN SOC, V102, P483, DOI 10.1111/j.1095-8312.2010.01603.x; Weissbrod L, 2013, J ARCHAEOL SCI, V40, P257, DOI 10.1016/j.jas.2012.07.001; Weissbrod L., 2010, ARCHAEOLOGY ANTHROPO, P295	67	11	11	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91795	10.1371/journal.pone.0091795	http://dx.doi.org/10.1371/journal.pone.0091795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC9HN	24622726	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300129
J	Takahashi, S; Saito, K; Jia, HJ; Kato, H				Takahashi, Shoko; Saito, Kenji; Jia, Huijuan; Kato, Hisanori			An Integrated Multi-Omics Study Revealed Metabolic Alterations Underlying the Effects of Coffee Consumption	PLOS ONE			English	Article							RISK; CYCLE	Many epidemiological studies have indicated that coffee consumption may reduce the risks of developing obesity and diabetes, but the underlying mechanisms of these effects are poorly understood. Our previous study revealed the changes on gene expression profiles in the livers of C57BL/6J mice fed a high-fat diet containing three types of coffee (caffeinated, decaffeinated and green unroasted coffee), using DNA microarrays. The results revealed remarkable alterations in lipid metabolism-related molecules which may be involved in the anti-obesity effects of coffee. We conducted the present study to further elucidate the metabolic alterations underlying the effects of coffee consumption through comprehensive proteomic and metabolomic analyses. Proteomics revealed an up-regulation of isocitrate dehydrogenase (a key enzyme in the TCA cycle) and its related proteins, suggesting increased energy generation. The metabolomics showed an upregulation of metabolites involved in the urea cycle, with which the transcriptome data were highly consistent, indicating accelerated energy expenditure. The TCA cycle and the urea cycle are likely be accelerated in a concerted manner, since they are directly connected by mutually providing each other's intermediates. The up-regulation of these pathways might result in a metabolic shift causing increased ATP turnover, which is related to the alterations of lipid metabolism. This mechanism may play an important part in the suppressive effects of coffee consumption on obesity, inflammation, and hepatosteatosis. This study newly revealed global metabolic alterations induced by coffee intake, providing significant insights into the association between coffee intake and the prevention of type 2 diabetes, utilizing the benefits of multi-omics analyses.	[Takahashi, Shoko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Takahashi, Shoko; Saito, Kenji; Jia, Huijuan; Kato, Hisanori] Univ Tokyo, Org Interdisciplinary Res Projects, Tokyo, Japan	University of Tokyo; University of Tokyo	Kato, H (corresponding author), Univ Tokyo, Org Interdisciplinary Res Projects, Tokyo, Japan.	akatoq@mail.ecc.u-tokyo.ac.jp			All Japan Coffee Association	All Japan Coffee Association(All Japan Coffee Association)	This study was partly supported by a grant from the All Japan Coffee Association. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER T, 1985, BIOCHEM J, V230, P675, DOI 10.1042/bj2300675; Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185; Evans GA, 2000, NAT BIOTECHNOL, V18, P127, DOI 10.1038/72480; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u; Goodman N, 2002, CURR OPIN BIOTECH, V13, P68, DOI 10.1016/S0958-1669(02)00287-2; Jia HJ, 2013, MOL NUTR FOOD RES, V57, P291, DOI 10.1002/mnfr.201200538; Kato H, 2008, ASIA PAC J CLIN NUTR, V17, P12; Kato Hisanori, 2011, J Tradit Complement Med, V1, P25; Monton MRN, 2007, J CHROMATOGR A, V1168, P237, DOI 10.1016/j.chroma.2007.02.065; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; SHAMBAUGH GE, 1977, AM J CLIN NUTR, V30, P2083, DOI 10.1093/ajcn/30.12.2083; Takahashi S, 2013, J FUNCT FOO IN PRESS; Takahashi S, 2011, BIOCHEM BIOPH RES CO, V405, P462, DOI 10.1016/j.bbrc.2011.01.054; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c	18	11	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91134	10.1371/journal.pone.0091134	http://dx.doi.org/10.1371/journal.pone.0091134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618914	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400049
J	Marshall, KE; Offerdahl, DK; Speare, JO; Dorward, DW; Hasenkrug, A; Carmody, AB; Baron, GS				Marshall, Karen E.; Offerdahl, Danielle K.; Speare, Jonathan O.; Dorward, David W.; Hasenkrug, Aaron; Carmody, Aaron B.; Baron, Gerald S.			Glycosylphosphatidylinositol Anchoring Directs the Assembly of Sup35NM Protein into Non-fibrillar, Membrane-bound Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Electron Microscopy (EM); Glycosylphosphatidylinositol Anchors; Prions; Protein Aggregation; Protein Misfolding; Protein Self-assembly	SCRAPIE PRION PROTEIN; STRAUSSLER-SCHEINKER DISEASE; YEAST PRION; IN-VIVO; ALZHEIMERS-DISEASE; AMYLOID DEPOSITS; SACCHAROMYCES-CEREVISIAE; NEUROBLASTOMA-CELLS; ELECTRON-MICROSCOPY; BETA-AMYLOIDOSIS	Background: Sup35NM is a soluble protein that when misfolded forms amyloid fibril aggregates. Results: When tethered to membranes via a lipid anchor, Sup35NM aggregates adopt a non-fibrillar, membrane-bound structure. Conclusion: Lipid anchor-directed membrane association prevents assembly into fibrils. Significance: This may explain differences between prion diseases compared with related protein aggregation diseases because only prion diseases involve aggregation of a lipid-anchored protein. In prion-infected hosts, PrPSc usually accumulates as non-fibrillar, membrane-bound aggregates. Glycosylphosphatidylinositol (GPI) anchor-directed membrane association appears to be an important factor controlling the biophysical properties of PrPSc aggregates. To determine whether GPI anchoring can similarly modulate the assembly of other amyloid-forming proteins, neuronal cell lines were generated that expressed a GPI-anchored form of a model amyloidogenic protein, the NM domain of the yeast prion protein Sup35 (Sup35(GPI)). We recently reported that GPI anchoring facilitated the induction of Sup35(GPI) prions in this system. Here, we report the ultrastructural characterization of self-propagating Sup35(GPI) aggregates of either spontaneous or induced origin. Like membrane-bound PrPSc, Sup35(GPI) aggregates resisted release from cells treated with phosphatidylinositol-specific phospholipase C. Sup35(GPI) aggregates of spontaneous origin were detergent-insoluble, protease-resistant, and self-propagating, in a manner similar to that reported for recombinant Sup35NM amyloid fibrils and induced Sup35(GPI) aggregates. However, GPI-anchored Sup35 aggregates were not stained with amyloid-binding dyes, such as Thioflavin T. This was consistent with ultrastructural analyses, which showed that the aggregates corresponded to dense cell surface accumulations of membrane vesicle-like structures and were not fibrillar. Together, these results showed that GPI anchoring directs the assembly of Sup35NM into non-fibrillar, membrane-bound aggregates that resemble PrPSc, raising the possibility that GPI anchor-dependent modulation of protein aggregation might occur with other amyloidogenic proteins. This may contribute to differences in pathogenesis and pathology between prion diseases, which uniquely involve aggregation of a GPI-anchored protein, versus other protein misfolding diseases.	[Marshall, Karen E.; Offerdahl, Danielle K.; Speare, Jonathan O.; Dorward, David W.; Hasenkrug, Aaron; Carmody, Aaron B.; Baron, Gerald S.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Baron, GS (corresponding author), 903 S 4th St, Hamilton, MT 59840 USA.	gbaron@niaid.nih.gov		Offerdahl, Danielle K/0000-0002-0736-1664	National Institutes of Health, NIAID, Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001112, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program.	Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Belichenko PV, 2000, NEUROPATH APPL NEURO, V26, P143, DOI 10.1046/j.1365-2990.2000.026002143.x; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Caughey B, 2003, BRIT MED BULL, V66, P109, DOI 10.1093/bmb/66.1.109; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; GABIZON R, 1988, J BIOL CHEM, V263, P4950; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; GIACCONE G, 1992, P NATL ACAD SCI USA, V89, P9349, DOI 10.1073/pnas.89.19.9349; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Godsave SF, 2013, NEUROBIOL AGING, V34, P1621, DOI 10.1016/j.neurobiolaging.2012.12.015; Godsave SF, 2008, J NEUROSCI, V28, P12489, DOI 10.1523/JNEUROSCI.4474-08.2008; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; Jeffrey M, 2012, BRAIN PATHOL, V22, P58, DOI 10.1111/j.1750-3639.2011.00508.x; Jeffrey M, 2011, ACTA NEUROPATHOL, V121, P113, DOI 10.1007/s00401-010-0700-3; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Klingeborn M, 2011, J VIROL, V85, P1484, DOI 10.1128/JVI.02167-10; Klunk WE, 2001, LIFE SCI, V69, P1471, DOI 10.1016/S0024-3205(01)01232-2; Kneipp J, 2003, BBA-MOL BASIS DIS, V1639, P152, DOI 10.1016/j.bbadis.2003.08.005; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Krzewska J, 2007, J BIOL CHEM, V282, P1679, DOI 10.1074/jbc.M608110200; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Levine H, 2005, AMYLOID, V12, P5, DOI 10.1080/13506120500032295; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P109; Linke RP, 2000, VIRCHOWS ARCH, V436, P439, DOI 10.1007/s004280050471; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PICCARDO P, 1995, J NEUROPATH EXP NEUR, V54, P790, DOI 10.1097/00005072-199511000-00006; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmued L, 2012, J NEUROSCI METH, V209, P120, DOI 10.1016/j.jneumeth.2012.05.019; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Serpell LC, 2007, AMYLOID, V14, P199, DOI 10.1080/13506120701461111; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Skovronsky DM, 2000, P NATL ACAD SCI USA, V97, P7609, DOI 10.1073/pnas.97.13.7609; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Speransky VV, 2001, J CELL BIOL, V153, P1327, DOI 10.1083/jcb.153.6.1327; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tyedmers J, 2010, P NATL ACAD SCI USA, V107, P8633, DOI 10.1073/pnas.1003895107; Vazquez-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050111; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wolf K, 2005, INFECT IMMUN, V73, P4560, DOI 10.1128/IAI.73.8.4560-4570.2005; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	89	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12245	12263		10.1074/jbc.M114.556639	http://dx.doi.org/10.1074/jbc.M114.556639			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627481	Green Published, hybrid			2022-12-25	WOS:000335581400006
J	Nakano, N; Maeyama, K; Sakata, N; Itoh, F; Akatsu, R; Nakata, M; Katsu, Y; Ikeno, S; Togawa, Y; Nguyen, TTV; Watanabe, Y; Kato, M; Itoh, S				Nakano, Naoko; Maeyama, Kota; Sakata, Nobuo; Itoh, Fumiko; Akatsu, Ryosuke; Nakata, Miki; Katsu, Yuki; Ikeno, Souichi; Togawa, Yoko; Thanh Thao Vo Nguyen; Watanabe, Yukihide; Kato, Mitsuyasu; Itoh, Susumu			C18 ORF1, a Novel Negative Regulator of Transforming Growth Factor- beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Activin; EMT; Receptor Serine; threonine Kinase; SMAD Transcription Factor; Transforming Growth Factor (TGF); C18ORF1; SARA; SIM; TMEPAI	FYVE DOMAIN PROTEIN; TGF-BETA; SMAD PROTEINS; CANCER; GENE; ACTIVATION; FAMILY; SARA; RECEPTOR; DISEASE	Background: The structure of C18ORF1 is similar to that of TMEPAI. Results: C18ORF1 inhibits TGF- signaling, but not BMP signaling, by its competition with SARA for Smad2/3 binding. Conclusion: C18ORF1 is a surveillant during the steady state of TGF- signaling, although it is helped by TMEPAI to inhibit TGF- signaling in a coordinated manner. Significance: C18ORF1 acts as a gatekeeper that abrogates excessive TGF- signaling. Transforming growth factor (TGF)- signaling is deliberately regulated at multiple steps in its pathway from the extracellular microenvironment to the nucleus. However, how TGF- signaling is activated or attenuated is not fully understood. We recently identified transmembrane prostate androgen-induced RNA (TMEPAI), which is involved in a negative feedback loop of TGF- signaling. When we searched for a family molecule(s) for TMEPAI, we found C18ORF1, which, like TMEPAI, possesses two PY motifs and one Smad-interacting motif (SIM) domain. As expected, C18ORF1 could block TGF- signaling but not bone morphogenetic protein signaling. C18ORF1 bound to Smad2/3 via its SIM and competed with the Smad anchor for receptor activation for Smad2/3 binding to attenuate recruitment of Smad2/3 to the TGF- type I receptor (also termed activin receptor-like kinase 5 (ALK5)), in a similar fashion to TMEPAI. Knockdown of C18ORF1 prolonged duration of TGF--induced Smad2 phosphorylation and concomitantly potentiated the expression of JunB, p21, and TMEPAI mRNAs induced by TGF-. Consistently, TGF--induced cell migration was enhanced by the knockdown of C18ORF1. These results indicate that the inhibitory function of C18ORF1 on TGF- signaling is similar to that of TMEPAI. However, in contrast to TMEPAI, C18ORF1 was not induced upon TGF- signaling. Thus, we defined C18ORF1 as a surveillant of steady state TGF- signaling, whereas TMEPAI might help C18ORF1 to inhibit TGF- signaling in a coordinated manner when cells are stimulated with high levels of TGF-.	[Nakano, Naoko; Maeyama, Kota; Itoh, Fumiko; Thanh Thao Vo Nguyen; Watanabe, Yukihide; Kato, Mitsuyasu; Itoh, Susumu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, Tsukuba, Ibaraki 3058575, Japan; [Nakano, Naoko; Sakata, Nobuo; Akatsu, Ryosuke; Nakata, Miki; Katsu, Yuki; Ikeno, Souichi; Togawa, Yoko; Itoh, Susumu] Showa Pharmaceut Univ, Biochem Lab, Machida, Tokyo 1948543, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 1920392, Japan	University of Tsukuba; Showa Pharmaceutical University; Tokyo University of Pharmacy & Life Sciences	Kato, M (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mit-kato@md.tsukuba.ac.jp; sitoh@ac.shoyaku.ac.jp	Sakata, Nobuo/L-9753-2015	Sakata, Nobuo/0000-0001-9967-8409; Itoh, Susumu/0000-0002-7967-0730; Itoh, Fumiko/0000-0002-6134-5331	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; MEXT; Takeda Science Foundation; Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Vehicle Racing Commemorative Foundation; Showa Pharmaceutical University; Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [25118728, 23689023, 25670168] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Vehicle Racing Commemorative Foundation; Showa Pharmaceutical University; Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for young scientists (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to F. I.); a grant-in-aid for exploratory research (A) from Japan Society for the Promotion of Science) (to N. S.); MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (to S. Itoh); the Takeda Science Foundation (to S. Itoh); the Smoking Research Foundation (to S. Itoh); the Daiichi-Sankyo Foundation of Life Science (to S. Itoh); the Naito Foundation (to S. Itoh); the Vehicle Racing Commemorative Foundation (to S. Itoh); a grant-in-aid for young scientists of Showa Pharmaceutical University (to S. Ikeno); the Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University (to S. Itoh); and the Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling" of the Japan Society for the Promotion of Science (to S. Itoh).	Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Brunschwig EB, 2003, CANCER RES, V63, P1568; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hirokawa YS, 2007, CELL MOL BIOL LETT, V12, P370, DOI 10.2478/s11658-007-0009-y; Hofsli E, 2008, BRIT J CANCER, V99, P1330, DOI 10.1038/sj.bjc.6604565; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kikuchi M, 2003, MOL PSYCHIATR, V8, P467, DOI 10.1038/sj.mp.4001280; Kikuchi Mika, 2003, Journal of Medical and Dental Sciences, V50, P225; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meerabux JMA, 2009, J HUM GENET, V54, P386, DOI 10.1038/jhg.2009.47; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakano N, 2010, J BIOL CHEM, V285, P38023, DOI 10.1074/jbc.M110.132209; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Reichling T, 2005, CANCER RES, V65, P166; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	42	34	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12680	12692		10.1074/jbc.M114.558981	http://dx.doi.org/10.1074/jbc.M114.558981			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627487	Green Published, hybrid			2022-12-25	WOS:000335581400040
J	Vishwanatha, K; Back, N; Mains, RE; Eipper, BA				Vishwanatha, Kurutihalli; Baeck, Nils; Mains, Richard E.; Eipper, Betty A.			A Histidine-rich Linker Region in Peptidylglycine alpha- Amidating Monooxygenase Has the Properties of a pH Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Glycoprotein Secretion; Neuropeptide; pH Regulation; Protein Secretion	PEPTIDE-PROCESSING ENZYME; GRANULE MEMBRANE-PROTEIN; REGULATED SECRETORY PROTEINS; CYTOSOLIC DOMAIN; ATT-20 CELLS; CARBOXYPEPTIDASE-E; ACIDIC PH; V-ATPASES; TRAFFICKING; PATHWAY	Background: Secretory granule membrane proteins are retrieved and reused or degraded after exocytosis. Results: A pH-sensitive His cluster in the amidating enzyme is essential for its trafficking. Conclusion: Lacking this conserved His cluster, proteolytic maturation and generation of a soluble cytosolic fragment of amidating enzyme fail to occur, disrupting secretion and nuclear signaling. Significance: The storage and regulated secretion of peptides requires intraluminal signaling. Decreasing luminal pH is thought to play a role in the entry of newly synthesized and endocytosed membrane proteins into secretory granules. The two catalytic domains of peptidylglycine -amidating monooxygenase (PAM), a type I integral membrane protein, catalyze the sequential reactions that convert peptidyl-Gly substrates into amidated products. We explored the hypothesis that a conserved His-rich cluster (His-Gly-His-His) in the linker region connecting its two catalytic domains senses pH and affects PAM trafficking by mutating these His residues to Ala (Ala-Gly-Ala-Ala; H3A). Purified recombinant wild-type and H3A linker peptides were examined using circular dichroism and tryptophan fluorescence; mutation of the His cluster largely eliminated its pH sensitivity. An enzymatically active PAM protein with the same mutations (PAM-1/H3A) was expressed in HEK293 cells and AtT-20 corticotrope tumor cells. Metabolic labeling followed by immunoprecipitation revealed more rapid loss of newly synthesized PAM-1/H3A than PAM-1; although release of newly synthesized monofunctional PHM/H3A was increased, release of soluble bifunctional PAM/H3A, a product of the endocytic pathway, was decreased. Surface biotinylation revealed rapid loss of PAM-1/H3A, with no detectable return of the mutant protein to secretory granules. Consistent with its altered endocytic trafficking, little PAM-1/H3A was subjected to regulated intramembrane proteolysis followed by release of a small nuclear-targeted cytosolic fragment. AtT-20 cells expressing PAM-1/H3A adopted the morphology of wild-type AtT-20 cells; secretory products no longer accumulated in the trans-Golgi network and secretory granule exocytosis was more responsive to secretagogue.	[Vishwanatha, Kurutihalli; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Baeck, Nils] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland	University of Connecticut; University of Connecticut; University of Helsinki	Eipper, BA (corresponding author), 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu		Rao, Vishwanatha/0000-0001-9471-807X; Back, Nils/0000-0001-9992-3726	National Institutes of Health [DK-32949]; Janice and Rodney Reynolds Endowment; Scoville Endowment; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Perklen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032949, R01DK032949, R56DK032949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janice and Rodney Reynolds Endowment; Scoville Endowment; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Perklen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-32949, the Janice and Rodney Reynolds Endowment, Scoville Endowment, Liv och Halsa Foundation, Magnus Ehrnrooth Foundation, and the Perklen Foundation.	Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Attenborough RMF, 2012, MOL BIOL EVOL, V29, P3095, DOI 10.1093/molbev/mss114; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; Da Poian AT, 2009, PROTEIN PEPTIDE LETT, V16, P779, DOI 10.2174/092986609788681823; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; De M, 2006, J BIOL CHEM, V281, P20873, DOI 10.1074/jbc.M513886200; Dickson EJ, 2012, P NATL ACAD SCI USA, V109, pE3539, DOI 10.1073/pnas.1218247109; Drose S, 1997, J EXP BIOL, V200, P1; EIPPER BA, 1992, J BIOL CHEM, V267, P4008; EIPPER BA, 1993, ANN NY ACAD SCI, V680, P147, DOI 10.1111/j.1749-6632.1993.tb19681.x; EIPPER BA, 1993, PROTEIN SCI, V2, P489; El Kadi N, 2006, BIOPHYS J, V91, P3397, DOI 10.1529/biophysj.106.088963; Ferraro F, 2005, J BIOL CHEM, V280, P25424, DOI 10.1074/jbc.M414156200; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; FRICKER LD, 1988, J CELL BIOCHEM, V38, P279, DOI 10.1002/jcb.240380407; GREENE D, 1992, BIOCHEM J, V285, P613, DOI 10.1042/bj2850613; Hanakam F, 1996, EMBO J, V15, P2935, DOI 10.1002/j.1460-2075.1996.tb00656.x; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; HUSTEN EJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P487, DOI 10.1006/abbi.1994.1336; JENKS BG, 1985, J ENDOCRINOL, V107, P365, DOI 10.1677/joe.0.1070365; KULIAWAT R, 1992, J CELL BIOL, V118, P521, DOI 10.1083/jcb.118.3.521; Lauf PK, 1998, CELL PHYSIOL BIOCHEM, V8, P46, DOI 10.1159/000016270; Lee SN, 2007, BIOCHEM BIOPH RES CO, V355, P825, DOI 10.1016/j.bbrc.2007.02.034; Lee SN, 2004, J ENDOCRINOL, V182, P353, DOI 10.1677/joe.0.1820353; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MAINS RE, 1991, MOL ENDOCRINOL, V5, P187, DOI 10.1210/mend-5-2-187; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Perez-Sayans M, 2012, BRAZ J BIOL, V72, P189, DOI 10.1590/S1519-69842012000100023; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; Rajagopal C, 2010, J BIOL CHEM, V285, P34632, DOI 10.1074/jbc.M110.145334; Rajagopal C, 2009, J BIOL CHEM, V284, P25723, DOI 10.1074/jbc.M109.035782; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Steidl JV, 1999, MOL PHARMACOL, V55, P812; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Williamson DM, 2013, J BIOL CHEM, V288, P19154, DOI 10.1074/jbc.M112.442681; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; YUN HY, 1994, J BIOL CHEM, V269, P10946; YUN HY, 1995, J BIOL CHEM, V270, P30075; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x	67	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12404	12420		10.1074/jbc.M113.545947	http://dx.doi.org/10.1074/jbc.M113.545947			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627494	Green Published, hybrid			2022-12-25	WOS:000335581400018
J	Kolesnikoff, N; Attema, JL; Roslan, S; Bert, AG; Schwarz, QP; Gregory, PA; Goodall, GJ				Kolesnikoff, Natasha; Attema, Joanne L.; Roslan, Suraya; Bert, Andrew G.; Schwarz, Quenten P.; Gregory, Philip A.; Goodall, Gregory J.			Specificity Protein 1 ( Sp1) Maintains Basal Epithelial Expression of the miR-200 Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial mesenchymal transition; Metastasis; MicroRNA; Sp1; Transcription; ZEB transcription factor; miR-200	E-CADHERIN GENE; TRANSCRIPTION FACTOR SNAIL; REPRESSES E-CADHERIN; MESENCHYMAL TRANSITION; CANCER-CELLS; BREAST-CANCER; TUMOR PROGRESSION; MIRNA-200 FAMILY; TARGETING ZEB1; METASTASIS	Background: Epithelial-mesenchymal transition (EMT) is a key process in embryonic development and cancer metastasis. Results: Sp1 activates miR-200 transcription in epithelial cells and prevents EMT. Conclusion: miR-200 family members require Sp1 to drive basal expression and maintain an epithelial state. Significance: Defining the mechanisms controlling the epithelial state has implications for understanding early differentiation and for designing interventions to prevent cancer metastasis. Epithelial-mesenchymal transition (EMT) is required for the specification of tissues during embryonic development and is recapitulated during the metastatic progression of tumors. The miR-200 family plays a critical role in enforcing the epithelial state with their expression lost in cells undergoing EMT. EMT can be mediated by activation of the ZEB1 and ZEB2 (ZEB) transcription factors, which repress miR-200 expression via a self-reinforcing double negative feedback loop to promote the mesenchymal state. However, it remains unclear what factors drive and maintain epithelial-specific expression of miR-200 in the absence of EMT-inducing factors. Here, we show that the transcription factor Specificity Protein 1 (Sp1) binds to the miR-200b approximate to 200a approximate to 429 proximal promoter and activates miR-200 expression in epithelial cells. In mesenchymal cells, Sp1 expression is maintained, but its ability to activate the miR-200 promoter is perturbed by ZEB-mediated repression. Reduction of Sp1 expression caused changes in EMT-associated markers in epithelial cells. Furthermore, we observed co-expression of Sp1 and miR-200 during mouse embryonic development wherein miR-200 expression was only lost in regions with high ZEB expression. Together, these findings indicate that miR-200 family members require Sp1 to drive basal expression and to maintain an epithelial state.	[Gregory, Philip A.; Goodall, Gregory J.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Gregory, Philip A.; Goodall, Gregory J.] SA Pathol, Adelaide, SA 5000, Australia; [Attema, Joanne L.; Gregory, Philip A.; Goodall, Gregory J.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; University of Adelaide	Gregory, PA (corresponding author), SA Pathol, Ctr Canc Biol, Frome Rd, Adelaide, SA 5000, Australia.	philip.gregory@health.sa.gov.au; greg.goodall@health.sa.gov.au	Gregory, Philip/F-4089-2013; Schwarz, Quenten/AAC-3726-2019; Schwarz, Quenten/AAE-7513-2021	Gregory, Philip/0000-0002-0999-0632; Schwarz, Quenten/0000-0002-5958-4181; Kolesnikoff Prizzi, Natasha/0000-0003-4314-4779; Bert, Andrew/0000-0003-3876-1537; Goodall, Gregory/0000-0003-1294-0692	National Health and Medical Research Council of Australia [APP1008440]; Cancer Council of South Australia Fellowship; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of South Australia Fellowship(Cancer Council South Australia); National Breast Cancer Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia (APP1008440) and by a Cancer Council of South Australia Fellowship (to P. A. G.).	Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; BUSSEMAKERS MJG, 1994, BIOCHEM BIOPH RES CO, V203, P1284, DOI 10.1006/bbrc.1994.2321; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Frisch SM, 1997, BIOESSAYS, V19, P705, DOI 10.1002/bies.950190811; Gessert S, 2010, DEV BIOL, V341, P222, DOI 10.1016/j.ydbio.2010.02.031; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Sumigama S, 2004, ONCOGENE, V23, P5496, DOI 10.1038/sj.onc.1207723; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; West-Mays JA, 2003, DIFFERENTIATION, V71, P206, DOI 10.1046/j.1432-0436.2003.710302.x; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13	70	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11194	11205		10.1074/jbc.M113.529172	http://dx.doi.org/10.1074/jbc.M113.529172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24627491	Green Published, hybrid			2022-12-25	WOS:000334638500023
J	Chen, J; Li, CH; Wang, SH				Chen, Jing; Li, Chenghai; Wang, Sihong			Periodic Heat Shock Accelerated the Chondrogenic Differentiation of Human Mesenchymal Stem Cells in Pellet Culture	PLOS ONE			English	Article							SELF-ASSEMBLING PEPTIDE; PROTECTS ARTICULAR CHONDROCYTES; MARROW STROMAL CELLS; IN-VITRO CULTURE; BONE-MARROW; CARTILAGE TISSUE; HEAT-SHOCK-PROTEIN-70 HSP70; CLINICAL-APPLICATIONS; KNEE OSTEOARTHRITIS; INDUCED APOPTOSIS	Osteoarthritis (OA) is one of diseases that seriously affect elderly people's quality of life. Human mesenchymal stem cells (hMSCs) offer a potential promise for the joint repair in OA patients. However, chondrogenic differentiation from hMSCs in vitro takes a long time (similar to 6 weeks) and differentiated cells are still not as functionally mature as primary isolated chondrocytes, though chemical stimulations and mechanical loading have been intensively studied to enhance the hMSC differentiation. On the other hand, thermal stimulations of hMSC chondrogenesis have not been well explored. In this study, the direct effects of mild heat shock (HS) on the differentiation of hMSCs into chondrocytes in 3D pellet culture were investigated. Periodic HS at 41 degrees C for 1 hr significantly increased sulfated glycosaminoglycan in 3D pellet culture at Day 10 of chondrogenesis. Immunohistochemical and Western Blot analyses revealed an increased expression of collagen type II and aggrecan in heat-shocked pellets than non heat-shocked pellets on Day 17 of chondrogenesis. In addition, HS also upregulated the expression of collagen type I and X as well as heat shock protein 70 on Day 17 and 24 of differentiation. These results demonstrate that HS accelerated the chondrogenic differentiation of hMSCs and induced an early maturation of chondrocytes differentiated from hMSCs. The results of this study will guide the design of future protocols using thermal treatments to facilitate cartilage regeneration with human mesenchymal stem cells.	[Chen, Jing; Li, Chenghai; Wang, Sihong] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Wang, SH (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	shwang@ccny.cuny.edu			National Institutes of Health/National Institute on Aging (NIH/NIA) [SC2AG036823]; NATIONAL INSTITUTE ON AGING [SC2AG036823] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project is partially funded by National Institutes of Health/National Institute on Aging (NIH/NIA) SC2AG036823 (http://www.nia.nih.gov/research). NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]; Arai Y, 1997, J RHEUMATOL, V24, P1787; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Chen J, 2013, TISSUE ENG PT A, V19, P716, DOI [10.1089/ten.tea.2012.0070, 10.1089/ten.TEA.2012.0070]; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Cucchiarini M, 2012, BIO-MED MATER ENG, V22, P197, DOI 10.3233/BME-2012-0709; Dickhut A, 2008, FRONT BIOSCI-LANDMRK, V13, P4517, DOI 10.2741/3020; DOYLE JR, 1963, J BONE JOINT SURG AM, V45, P15, DOI 10.2106/00004623-196345010-00002; Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099; Etienne S, 2008, BIO-MED MATER ENG, V18, P253, DOI 10.3233/BME-2008-0534; Grossin L, 2006, FASEB J, V20, P65, DOI 10.1096/fj.04-2889com; Grossin L, 2004, BIORHEOLOGY, V41, P521; Guo XD, 2006, BIOMED MATER, V1, P206, DOI 10.1088/1748-6041/1/4/006; Hojo Tatsuya, 2003, J Orthop Sci, V8, P396, DOI 10.1007/s10776-002-0643-2; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]; Kubo T, 2001, J RHEUMATOL, V28, P330; Lim CL, 2008, ANN ACAD MED SINGAP, V37, P347; Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329; Raghunath J, 2005, CURR OPIN BIOTECH, V16, P503, DOI 10.1016/j.copbio.2005.08.004; RICHARDS V, 1959, SURGERY, V46, P84; Shereif WI, 2011, LIFE SCI J, V8, P388; Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515; Steinert AF, 2009, ARTHRITIS RES THER, V11; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Takahashi KA, 2009, INT J HYPERTHER, V25, P661, DOI 10.3109/02656730903107519; Terauchi R, 2003, ARTHRITIS RHEUM-US, V48, P1562, DOI 10.1002/art.11040; Tonomura H, 2006, OSTEOARTHR CARTILAGE, V14, P545, DOI 10.1016/j.joca.2005.12.008; Tonomura H, 2008, J ORTHOP RES, V26, P34, DOI 10.1002/jor.20421; van Osch GJVM, 2009, J CELL MOL MED, V13, P792, DOI 10.1111/j.1582-4934.2009.00789.x; Vinatier C, 2006, BIO-MED MATER ENG, V16, pS107; Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747; Yildirim N, 2010, J CLIN NURS, V19, P1113, DOI 10.1111/j.1365-2702.2009.03070.x; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zhou XZ, 2008, INT J ARTIF ORGANS, V31, P480, DOI 10.1177/039139880803100603; Zou L, 2013, SCI REPORTS	53	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91561	10.1371/journal.pone.0091561	http://dx.doi.org/10.1371/journal.pone.0091561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632670	Green Published, gold			2022-12-25	WOS:000332858400069
J	Jo, A; Park, H; Lee, SH; Ahn, SH; Kim, HJ; Park, EM; Choi, YH				Jo, Ara; Park, Hyunju; Lee, Sung-Hee; Ahn, So-Hee; Kim, Hee Ja; Park, Eun-Mi; Choi, Youn-Hee			SHP-2 Binds to Caveolin-1 and Regulates Src Activity via Competitive Inhibition of CSK in Response to H2O2 in Astrocytes	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FOCAL ADHESION KINASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; EPIDERMAL-GROWTH; C-SRC; ACTIVATION; CELLS; PHOSPHORYLATION; EXPRESSION	Reactive oxygen species (ROS) regulate diverse cellular functions by triggering signal transduction events, such as Src and mitogen-activated protein (MAP) kinases. Here, we report the role of caveolin-1 and Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP-2) in H2O2-induced signaling pathway in brain astrocytes. H2O2-mediated oxidative stress induced phosphorylation of caveolin-1 and association between p-caveolin-1 and SHP-2. SHP-2 specifically bound to wild-type caveolin-1 similarly to c-Src tyrosine kinase (CSK), but not to phosphorylation-deficient mutant of caveolin-1 (Y14A), and interfered with complex formation between caveolin-1 and CSK. In the presence of CSK siRNA, binding between caveolin-1 and SHP-2 was enhanced by H2O2 treatment, which led to reduced Src phosphorylation at tyrosine (Tyr) 530 and enhanced Src phosphorylation at Tyr 419. In contrast, siRNA targeting of SHP-2 facilitated H2O2-mediated interaction between caveolin-1 and CSK and enhanced Src phosphorylation at Tyr 530, leading to subsequent decrease in Src downstream signaling, such as focal adhesion kinase (FAK) and extracellular signal-related kinase (ERK). Our results collectively indicate that SHP-2 alters Src kinase activity by interfering with the complex formation between CSK and phosphotyrosine caveolin-1 in the presence of H2O2, thus functions as a positive regulator in Src signaling under oxidative stress in brain astrocytes.	[Jo, Ara; Park, Hyunju; Lee, Sung-Hee; Ahn, So-Hee; Kim, Hee Ja; Choi, Youn-Hee] Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Dept Physiol, Seoul, South Korea; [Park, Eun-Mi] Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Dept Pharmacol, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Choi, YH (corresponding author), Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Dept Physiol, Seoul, South Korea.	yc@ewha.ac.kr	LEE, Sunghee/HCH-4510-2022	PARK, EUN-MI/0000-0003-2414-3789	National Research Foundation of Korea (NRF); Korea government (MSIP) [2012R1A5A2A32671866]; Korea government (MEST) [2010-0029352]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) [grant 2012R1A5A2A32671866] and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) 2010-0029352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2000, FASEB J, V14, P1965, DOI 10.1096/fj.00-0105com; Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Biagini RE, 2003, CLIN DIAGN LAB IMMUN, V10, P744, DOI 10.1128/CDLI.10.5.744-750.2003; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Cameron PL, 1997, J NEUROSCI, V17, P9520; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Chong ZZ, 2003, CELL MOL NEUROBIOL, V23, P561, DOI 10.1023/A:1025158314016; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Gadoth N, 2011, OXIDATIVE STRESS FRE, Vviii; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Gupta VK, 2012, BBA-MOL BASIS DIS, V1822, P1643, DOI 10.1016/j.bbadis.2012.07.016; Ha CH, 2008, J BIOL CHEM, V283, P7261, DOI 10.1074/jbc.M702881200; Hirrlinger J, 2010, BRAIN RES REV, V63, P177, DOI 10.1016/j.brainresrev.2009.10.003; Ilic D, 1997, J CELL SCI, V110, P401; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kim YN, 2002, EXP CELL RES, V280, P134, DOI 10.1006/excr.2002.5623; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; OKADA M, 1989, J BIOL CHEM, V264, P20886; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Park SJ, 2009, FREE RADICAL BIO MED, V46, P1694, DOI 10.1016/j.freeradbiomed.2009.03.026; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Place AT, 2011, MOL PHARMACOL, V80, P665, DOI 10.1124/mol.111.073957; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Salmond RJ, 2006, TRENDS IMMUNOL, V27, P154, DOI 10.1016/j.it.2006.01.007; Servidei T, 1998, NEUROSCIENCE, V82, P529; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V211, P950, DOI 10.1006/bbrc.1995.1904; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tiffany-Castiglioni E, 2011, INT J DEV NEUROSCI, V29, P811, DOI 10.1016/j.ijdevneu.2011.09.004; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vepa S, 1997, FREE RADICAL BIO MED, V22, P25, DOI 10.1016/S0891-5849(96)00241-9; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yun JH, 2011, EXP MOL MED, V43, P660, DOI 10.3858/emm.2011.43.12.075; Zheng J, 2005, BIOL REPROD, V72, P1421, DOI 10.1095/biolreprod.104.039172	46	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91582	10.1371/journal.pone.0091582	http://dx.doi.org/10.1371/journal.pone.0091582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632723	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400071
J	Lacerda, RB; Sales, NM; da Silva, LL; Tesch, R; Miranda, ALP; Barreiro, EJ; Fernandes, PD; Fraga, CAM				Lacerda, Renata B.; Sales, Natalia M.; da Silva, Leandro L.; Tesch, Roberta; Miranda, Ana Luisa P.; Barreiro, Eliezer J.; Fernandes, Patricia D.; Fraga, Carlos A. M.			Novel Potent Imidazo[1,2-a]pyridine-N-Glycinyl-Hydrazone Inhibitors of TNF-alpha Production: In Vitro and In Vivo Studies	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; MAP KINASE; INFLAMMATION; ASSAY	In this work, we describe the design, synthesis and pharmacological evaluation of novel imidazo[1,2-a]pyridine-N-glycinylhydrazone derivatives (1a-k) intended for use as inhibitors of tumor necrosis factor alpha (TNF-alpha) production. The compounds were designed based on the orally active anti-inflammatory prototype LASSBio-1504 (2), which decreases the levels of the pro-inflammatory cytokine TNF-alpha in vitro and in vivo. The in vitro pharmacological evaluation of the imidazo[1,2-a] pyridine compounds (1) showed that substitution of the N-phenylpyrazole core present in prototype 2 by a bioisosteric imidazo[1,2-a]pyridine scaffold generated anti-TNF-alpha compounds that were more potent than the previously described N-phenylpyrazole derivative 2 and as potent as SB-203580, a p38 MAPK inhibitor. The most active derivative (E)-2-( 2-tert-butylimidazo[1,2-a]pyridin-3-ylamino)-N'-(4-chlorobenzylidene) acetohydrazide, or LASSBio-1749 (1i) was orally active as an anti-inflammatory agent in a subcutaneous air pouch model, reducing expressively the levels in vivo of TNF-alpha and other pro-inflammatory cytokines at all of the tested doses.	[Lacerda, Renata B.; Barreiro, Eliezer J.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Lab Avaliacao & Sintese Substancias Bioat LASSBio, Rio De Janeiro, Brazil; [Lacerda, Renata B.; Barreiro, Eliezer J.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Quim, Rio De Janeiro, Brazil; [Sales, Natalia M.; da Silva, Leandro L.; Tesch, Roberta; Miranda, Ana Luisa P.; Barreiro, Eliezer J.; Fernandes, Patricia D.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Farmacol & Quim Med, Rio De Janeiro, Brazil; [da Silva, Leandro L.; Miranda, Ana Luisa P.] Univ Fed Rio de Janeiro, Fac Farm, Lab Estudos Farmacol Expt, Rio De Janeiro, Brazil; [Sales, Natalia M.; Fernandes, Patricia D.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fraga, CAM (corresponding author), Univ Fed Rio de Janeiro, Lab Avaliacao & Sintese Substancias Bioat LASSBio, Rio De Janeiro, Brazil.	cmfraga@ccsdecania.ufrj.br	Fernandes, Patricia Dias/C-4489-2013; Fernandes, Patricia Dias/W-1565-2019; lacerda, renata/V-4003-2019; Fraga, Carlos/G-3495-2012; da Silva, Leandro Louback/AAQ-7573-2020; Barreiro, Eliezer J/B-1131-2011	Fernandes, Patricia Dias/0000-0001-6870-6745; Fernandes, Patricia Dias/0000-0001-6870-6745; Fraga, Carlos/0000-0001-6733-7079; Barreiro, Eliezer J/0000-0003-1759-0038	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Programa de Apoio a Nucleos de Excelencia (PRONEX, Brazil); Instituto Nacional de Ciencia e Tecnologia de Farmacos e Medicamentos (INCT-INOFAR, Brazil) [573.564/2008-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Apoio a Nucleos de Excelencia (PRONEX, Brazil); Instituto Nacional de Ciencia e Tecnologia de Farmacos e Medicamentos (INCT-INOFAR, Brazil)	The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil), Programa de Apoio a Nucleos de Excelencia (PRONEX, Brazil) and Instituto Nacional de Ciencia e Tecnologia de Farmacos e Medicamentos (INCT-INOFAR, Brazil, Grant #573.564/2008-6) for financial support and fellowships (to RBL, CKFdL, LLdS, ALPM, EJB, CAMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeni F, 2012, AUTOIMMUN REV, V12, P225, DOI 10.1016/j.autrev.2012.06.008; Campbell IK, 2003, IMMUNOL CELL BIOL, V81, P354; DiMauro EF, 2006, J ORG CHEM, V71, P3959, DOI 10.1021/jo060218p; Domling A, 2000, ANGEW CHEM INT EDIT, V39, P3168, DOI 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U; Domling A, 2012, CHEM REV, V112, P3083, DOI 10.1021/cr100233r; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Goettert M, 2010, ANAL BIOCHEM, V406, P233, DOI 10.1016/j.ab.2010.07.007; Groebke K, 1998, SYNLETT, P661, DOI 10.1055/s-1998-1721; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ismail MA, 2004, J MED CHEM, V47, P3658, DOI 10.1021/jm0400092; Lacerda RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046925; Lacerda RB, 2009, BIOORGAN MED CHEM, V17, P74, DOI 10.1016/j.bmc.2008.11.018; Lopes AB, 2013, MOLECULES, V18, P11683, DOI 10.3390/molecules181011683; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PALLA G, 1986, TETRAHEDRON, V42, P3649, DOI 10.1016/S0040-4020(01)87332-4; PALLA G, 1982, GAZZ CHIM ITAL, V112, P339; Patel HS, 2003, TETRAHEDRON LETT, V44, P4077, DOI 10.1016/S0040-4039(03)00875-X; Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; Slobbe P, 2012, MEDCHEMCOMM, V3, P1189, DOI 10.1039/c2md20089a; Toussirot E, 2004, EXPERT OPIN PHARMACO, V5, P581, DOI 10.1517/14656566.5.3.581; Wong SH, 2004, ARCH IMMUNOL THER EX, V52, P379; Wyrzykiewicz E, 2000, J HETEROCYCLIC CHEM, V37, P975, DOI 10.1002/jhet.5570370448; Zhu DJ, 2009, J BRAZIL CHEM SOC, V20, P482, DOI 10.1590/S0103-50532009000300012	28	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91660	10.1371/journal.pone.0091660	http://dx.doi.org/10.1371/journal.pone.0091660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632827	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400076
J	Luan, MD; Xu, MY; Lu, YM; Zhang, QX; Zhang, L; Zhang, CY; Fan, YL; Lang, ZH; Wang, L				Luan, Mingda; Xu, Miaoyun; Lu, Yunming; Zhang, Qiuxue; Zhang, Lan; Zhang, Chunyi; Fan, Yunliu; Lang, Zhihong; Wang, Lei			Family-Wide Survey of miR169s and NF-YAs and Their Expression Profiles Response to Abiotic Stress in Maize Roots	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; SMALL RNAS; MICRORNAS; ARABIDOPSIS; PLANT; GENES; IDENTIFICATION; REGULATOR; ROLES	Previous studies have identified miR169/NF-YA modules are important regulators of plant development and stress responses. Currently, reported genome sequence data offers an opportunity for global characterization of miR169 and NF-YA genes, which may provide insights into the molecular mechanisms of the miR169/NF-YA modules in maize. In our study, fourteen NF-YA transcription factors with conserved domains were identified based on maize genome loci. The miR169 gene family has 18 members that generate 10 mature products, and 8 of these mature miR169 members could target 7 of 14 ZmNF-YA genes in maize. The seven ZmNF-YA proteins were localized to the nucleus while lacked transcriptional activity. We investigated the expression patterns of the zma-miR169 members and their targeted ZmNF-YA genes in maize roots treated by drought stress (polyethylene glycol, PEG), hormone stress (abscisic acid, ABA), and salt stress (NaCl). The zma-miR169 family members were downregulated in short term (0,48 h) and generally upregulated over the long term (15 days) in response to the three abiotic stress conditions. Most of the targeted ZmNF-YA genes exhibited a reverse correlation with zma-miR169 gene expression over both the short term and long term. Maize root elongation was promoted by PEG and ABA but repressed by NaCl over the long term. Apparently, ZmNF-YA14 expression perfectly matched the zma-miR169 expression and corresponded to root growth reversely.	[Luan, Mingda; Lang, Zhihong; Wang, Lei] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China; [Luan, Mingda; Xu, Miaoyun; Zhang, Qiuxue; Zhang, Lan; Zhang, Chunyi; Fan, Yunliu; Lang, Zhihong; Wang, Lei] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Lu, Yunming] Shenzhen Nongke Grp CO LTD, Shenzhen, Peoples R China	Southwest University of Science & Technology - China; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Lang, ZH (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China.	langzhihong@caas.cn; wanglei01@caas.cn	Luan, Mingda/GSD-6582-2022; xu, miaoyun/AAF-3676-2021	Luan, Mingda/0000-0001-8772-6733	National High-Tech RD Program [2012AA10A306]; National Key Basic Research Program [2014CB138200]; National Special Program for Transgenic Research [2010ZX08010-002]	National High-Tech RD Program(National High Technology Research and Development Program of China); National Key Basic Research Program(National Basic Research Program of China); National Special Program for Transgenic Research	This work was supported by the National High-Tech R&D Program (Grant No. 2012AA10A306), the National Key Basic Research Program (Grant No. 2014CB138200), and the National Special Program for Transgenic Research (2010ZX08010-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079; Jin DF, 2013, J GENET GENOMICS, V40, P161, DOI 10.1016/j.jgg.2013.02.003; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Warpeha KM, 2007, PLANT SIGNAL BEHAV, V2, P480, DOI 10.4161/psb.2.6.4497; Xu M. Y., 2013, J EXPT BOT; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	33	51	59	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91369	10.1371/journal.pone.0091369	http://dx.doi.org/10.1371/journal.pone.0091369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633051	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400059
J	Moiane, I; Machado, A; Santos, N; Nhambir, A; Inlamea, O; Hattendorf, J; Kallenius, G; Zinsstag, J; Correia-Neves, M				Moiane, Ivania; Machado, Adelina; Santos, Nuno; Nhambir, Andre; Inlamea, Osvaldo; Hattendorf, Jan; Kallenius, Gunilla; Zinsstag, Jakob; Correia-Neves, Margarida			Prevalence of Bovine Tuberculosis and Risk Factor Assessment in Cattle in Rural Livestock Areas of Govuro District in the Southeast of Mozambique	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; SUSCEPTIBILITY; INFECTION; HUSBANDRY; DIAGNOSIS; PATHOLOGY; TANZANIA; DISEASE; TESTS	Background: Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is an infectious disease of cattle that also affects other domestic animals, free-ranging and farmed wildlife, and also humans. In Mozambique, scattered surveys have reported a wide variation of bTB prevalence rates in cattle from different regions. Due to direct economic repercussions on livestock and indirect consequences for human health and wildlife, knowing the prevalence rates of the disease is essential to define an effective control strategy. Methodology/Principal findings: A cross-sectional study was conducted in Govuro district to determine bTB prevalence in cattle and identify associated risk factors. A representative sample of the cattle population was defined, stratified by livestock areas (n = 14). A total of 1136 cattle from 289 farmers were tested using the single comparative intradermal tuberculin test. The overall apparent prevalence was estimated at 39.6% (95% CI 36.8-42.5) using a diagnostic threshold cutoff according to the World Organization for Animal Health. bTB reactors were found in 13 livestock areas, with prevalence rates ranging from 8.1 to 65.8%. Age was the main risk factor; animals older than 4 years were more likely to be positive reactors (OR = 3.2, 95% CI: 2.2-4.7). Landim local breed showed a lower prevalence than crossbred animals (Landim 6 Brahman) (OR = 0.6, 95% CI: 0.4-0.8). Conclusions/Significance: The findings reveal an urgent need for intervention with effective, area-based, control measures in order to reduce bTB prevalence and prevent its spread to the human population. In addition to the high prevalence, population habits in Govuro, particularly the consumption of raw milk, clearly may potentiate the transmission to humans. Thus, further studies on human tuberculosis and the molecular characterization of the predominant strain lineages that cause bTB in cattle and humans are urgently required to evaluate the impact on human health in the region.	[Moiane, Ivania; Santos, Nuno; Correia-Neves, Margarida] Univ Minho, ICVS, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Moiane, Ivania; Santos, Nuno; Correia-Neves, Margarida] PT Govt Associate Lab, Braga, Portugal; [Machado, Adelina; Nhambir, Andre; Inlamea, Osvaldo] Eduardo Mondlane Univ, Fac Vet, Paraclin Dept, Maputo, Mozambique; [Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hattendorf, Jan; Zinsstag, Jakob] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Universidade do Minho; Eduardo Mondlane University; Karolinska Institutet; University of Basel; Swiss Tropical & Public Health Institute	Correia-Neves, M (corresponding author), Univ Minho, ICVS, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.	mcorreianeves@ecsaude.uminho.pt	Zinsstag, Jakob/A-8317-2008; Santos, Nuno/D-6742-2016; Källenius, Gunilla/AGZ-3956-2022; Correia-Neves, Margarida/C-9122-2009; Correia-Neves, Margarida/AAH-4636-2020; Hattendorf, Jan/F-5371-2010	Zinsstag, Jakob/0000-0002-8899-6097; Santos, Nuno/0000-0002-1676-107X; Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431; Hattendorf, Jan/0000-0002-1176-401X; Kallenius, Gunilla/0000-0002-8921-0551	European Union [221948]	European Union(European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Awah-Ndukum J, 2012, Vet Med Int, V2012, P798502, DOI 10.1155/2012/798502; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Boukary AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024629; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cook AJC, 1996, BRIT VET J, V152, P37, DOI 10.1016/S0007-1935(96)80084-4; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dinka H, 2011, AFR J AGR RES, V6, P3853; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Dvorska L, 2007, VET MICROBIOL, V119, P366, DOI 10.1016/j.vetmic.2006.09.010; Etter E, 2006, ANN NY ACAD SCI, V1081, P61, DOI 10.1196/annals.1373.006; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Humblet MF, 2010, J CLIN MICROBIOL, V48, P2802, DOI 10.1128/JCM.00293-10; Ibrahim S, 2012, Vet Med Int, V2012, P865924, DOI 10.1155/2012/865924; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Kazwala RR, 2001, INT J TUBERC LUNG D, V5, P87; Kennedy HE, 2001, INF IMM, V70, P1488; Macucule B, 2008, THESIS U PRETORIA S; Ministerio da Administracao Estatal, 2005, PERF DISTR GOV PROV; Muller B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008215; Nega M, 2012, INT J MED MED SCI, V2, P188; Nicholson M.J., 1986, GUIDE CONDITION SCOR; OIE, 2009, MANUAL DIAGNOSTIC TE; Okuni JB, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-99; Ozygit MO, 2007, VET REC, V160, P307, DOI 10.1136/vr.160.9.307; Pavlik I, 2005, VET MED-CZECH, V50, P281, DOI 10.17221/5625-VETMED; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Sun LP, 2012, VET IMMUNOL IMMUNOP, V147, P195, DOI 10.1016/j.vetimm.2012.04.016; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; Vordermeier M, 2012, COMP IMMUNOL MICROB, V35, P227, DOI 10.1016/j.cimid.2012.01.003; Zanini MS, 1998, J VET MED B, V45, P473, DOI 10.1111/j.1439-0450.1998.tb00818.x	36	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91527	10.1371/journal.pone.0091527	http://dx.doi.org/10.1371/journal.pone.0091527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632593	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000332858400068
J	Peng, LS; Zhuang, Y; Li, WH; Zhou, YY; Wang, TT; Chen, N; Cheng, P; Li, BS; Guo, H; Yang, SM; Chen, WS; Zou, QM				Peng, Liu-sheng; Zhuang, Yuan; Li, Wen-hua; Zhou, Yuan-yuan; Wang, Ting-ting; Chen, Na; Cheng, Ping; Li, Bo-sheng; Guo, Hong; Yang, Shi-ming; Chen, Wei-san; Zou, Quan-ming			Elevated Interleukin-32 Expression Is Associated with Helicobacter pylori-Related Gastritis	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE; CHRONIC RHINOSINUSITIS; SYDNEY SYSTEM; CELL RESPONSE; IL-32; INFLAMMATION; DISEASE; MUCOSA; LIVER	Background: Interleukin-32 (IL-32) is a recently discovered proinflammatory cytokine involved in inflammatory diseases. We investigated the expression of IL-32 and its regulation mechanism in the inflammatory response of patients with Helicobacter pylori (H. pylori) infection. Design and Methods: IL-32 mRNA and protein expression in gastric tissues was detected by quantitative real-time PCR and immunohistochemistry. The regulation of IL-32 in human gastric epithelia cell line AGS was investigated by different cytokine stimulation and different H. pylori strain infection. Results: Gastric IL-32 mRNA and protein expression were elevated in patients with H. pylori infection and positively correlated with gastritis. In H. pylori-infected patients, the mRNA level of IL-32 was also correlated with that of proinflammatory cytokines IL-1 beta and TNF-alpha. In vitro IL-1 beta and TNF-alpha could upregulate IL-32 mRNA and protein level in AGS cells, which was dependent on NF-kappa B signal pathway. The regulation of IL-32 expression in response to H. pylori-infection could be weakened by using neutralizing antibodies to block IL-1 beta and TNF-alpha. Moreover, H. pylori-infected AGS cells also induced IL-32 mRNA and protein expression, which was dependent on CagA. Conclusions: IL-32 level is elevated in patients with H. pylori infection and its expression is regulated by proinflammatory stimuli, suggesting that IL-32 may play a role in the pathogenesis of H. pylori-related gastritis.	[Peng, Liu-sheng; Zhuang, Yuan; Li, Wen-hua; Wang, Ting-ting; Chen, Na; Cheng, Ping; Li, Bo-sheng; Zou, Quan-ming] Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China; [Zhou, Yuan-yuan; Guo, Hong; Yang, Shi-ming] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Chen, Wei-san] La Trobe Univ, Sch Mol Sci, Bundoora, Vic, Australia	Army Medical University; Army Medical University; La Trobe University	Zhuang, Y (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China.	yuanzhuang1983@yahoo.com; qmzou@tmmu.edu.cn	wang, tingting/AAK-2640-2020; Chen, Weisan/E-7828-2012	Chen, Weisan/0000-0002-5221-9771	Medical Science Youth Training Project of Chinese People's Liberation Army [13QNP108]; National Basic Research Program of China (973 Program) [2009CB522606]	Medical Science Youth Training Project of Chinese People's Liberation Army; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Medical Science Youth Training Project of Chinese People's Liberation Army (13QNP108) and National Basic Research Program of China (973 Program, No. 2009CB522606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Andersen LP, 2007, HELICOBACTER, V12, P12, DOI 10.1111/j.1523-5378.2007.00574.x; ANDREW A, 1994, HISTOPATHOLOGY, V25, P317, DOI 10.1111/j.1365-2559.1994.tb01349.x; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Keswani A, 2012, ALLERGY, V67, P25, DOI 10.1111/j.1398-9995.2011.02706.x; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Meyer N, 2010, J ALLERGY CLIN IMMUN, V125, P858, DOI 10.1016/j.jaci.2010.01.016; Moschen AR, 2011, HEPATOLOGY, V53, P1819, DOI 10.1002/hep.24285; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Sakitani K, 2012, INFECT IMMUN, V80, P3795, DOI 10.1128/IAI.00637-12; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Soyka MB, 2012, ALLERGY, V67, P790, DOI 10.1111/j.1398-9995.2012.02820.x; Tan SM, 2004, J BACTERIOL, V186, P885, DOI 10.1128/JB.186.3.885-888.2004; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011; Xu QH, 2012, J INFECTION, V65, P336, DOI 10.1016/j.jinf.2012.05.009; Zhang JY, 2011, IMMUNOBIOLOGY, V216, P803, DOI 10.1016/j.imbio.2010.12.006	27	21	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88270	10.1371/journal.pone.0088270	http://dx.doi.org/10.1371/journal.pone.0088270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633341	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400002
J	Sun, MY; Wang, S; Song, QW; Wang, ZY; Wang, HQ; Ning, DX; Wei, Q; Liu, AL				Sun, Meiyu; Wang, Sheng; Song, Qingwei; Wang, Zhiyuan; Wang, Heqing; Ning, Dianxiu; Wei, Qiang; Liu, Ailian			Utility of R-2* Obtained from T-2*-Weighted Imaging in Differentiating Hepatocellular Carcinomas from Cavernous Hemangiomas of the Liver	PLOS ONE			English	Article							TUMOR; MRI; DISCRIMINATION; CONTRAST; HYPOXIA; LESIONS; BENIGN; TIMES; CT	Purpose: To evaluate the feasibility of applying R-2* values to differentiate hepatocellular carcinomas (HCC) from cavernous hemangiomas of the liver (CHL). Materials and Methods: This retrospective study was approved by the participating Institutional Review Board and written informed consent for all subjects were obtained. Seventy-three patients with 79 pathologically identified HCCs and 65 patients with 91 clinically or pathologically identified CHLs were enrolled in this study. All subjects underwent a breath-hold multi-echo T-2* weighted MR imaging on a 1.5T clinical MR scanner. R2* values from HCC and CHL groups were compared using the Mann-Whitney non-parametric U test. A cut-off value of R2* was evaluated with receiver operator characteristic (ROC) analysis. Results: The mean R-2* value was 23.32 +/- 12.23 Hz (95% confidence interval [CI]: 20.58 Hz, 26.06 Hz) for the HCC group, and 3.66 +/- 2.37 Hz (95% CI: 3.17 Hz, 4.15 Hz) for the CHL group. The mean R-2* value for HCC was significantly higher than that of CHL (p<0.001). A threshold of 9.48 Hz for the minimum R-2* value in the diagnosis of HCC resulted in a sensitivity of 96.20% (76 out of 79 patients), and a specificity of 97.80% (89 out of 91 patients). The positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy for HCC were 97.44% (76 out of 78 patients), 96.74% (89 out of 92 patients) and 97.06% (165 out of 170 patients), respectively. The AUC for differentiation between these two groups was 0.994 (95% CI: 0.980, 1.000). Conclusions: R-2* is a significant MRI biomarker to differentiate HCC from CHL with satisfying sensitivity and specificity.	[Sun, Meiyu; Wang, Sheng; Wang, Heqing; Ning, Dianxiu; Wei, Qiang; Liu, Ailian] Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Liaoning, Peoples R China; [Wang, Sheng] Fuxin Mineral Hosp, Dept CT & MRI, Fuxing, Liaoning, Peoples R China; [Wang, Zhiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Dept Ultrasound, Changsha, Hunan, Peoples R China; [Wang, Zhiyuan] Cent S Univ, Tumor Hosp, Xiangya Med Sch, Changsha, Hunan, Peoples R China	Dalian Medical University; Central South University; Central South University	Liu, AL (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Liaoning, Peoples R China.	liuailian_dalianmu@126.com						Chan YL, 2002, CLIN RADIOL, V57, P250, DOI 10.1053/crad.2001.0763; Cieszanowski A, 2002, EUR RADIOL, V12, P2273, DOI 10.1007/s00330-002-1366-6; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Farraher SW, 2006, J MAGN RESON IMAGING, V24, P1333, DOI 10.1002/jmri.20758; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo LF, 2013, CLIN NEURORADIOL, V23, P121, DOI 10.1007/s00062-012-0185-7; Hamilton SR, 2000, WHO CLASSIFICATION T; Hardie AD, 2011, EUR J RADIOL, V80, pE249, DOI 10.1016/j.ejrad.2010.10.027; Hardie AD, 2010, MAGN RESON IMAGING, V28, P281, DOI 10.1016/j.mri.2009.12.010; Ito K, 1997, RADIOLOGY, V204, P729, DOI 10.1148/radiology.204.3.9280251; Jhaveri KS, 2013, J MAGN RESON IMAGING, V37, P692, DOI 10.1002/jmri.23858; Lee JH, 2012, BRIT J RADIOL, V85, pE573, DOI 10.1259/bjr/86767895; LESLIE DF, 1995, AM J ROENTGENOL, V164, P625, DOI 10.2214/ajr.164.3.7863883; Li Guo-Wei, 2003, Hepatobiliary Pancreat Dis Int, V2, P367; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; QUINN SF, 1992, RADIOLOGY, V182, P545, DOI 10.1148/radiology.182.2.1732978; Santoro L, 2009, J MAGN RESON IMAGING, V30, P1012, DOI 10.1002/jmri.21937; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; SEMELKA RC, 1994, RADIOLOGY, V192, P401, DOI 10.1148/radiology.192.2.8029404; Song TJ, 2004, GASTROENTEROLOGY, V127, pS248, DOI 10.1053/j.gastro.2004.09.039; Soyer P, 2011, EUR J RADIOL, V80, P316, DOI 10.1016/j.ejrad.2010.08.011; Sun XL, 2006, SHIJIE HUA REN XIAO, V14, P3107; Tao R, 2012, CLIN RADIOL, V67, pE91, DOI 10.1016/j.crad.2012.08.015; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vilgrain V, 2000, RADIOGRAPHICS, V20, P379, DOI 10.1148/radiographics.20.2.g00mc01379; Yu De-xin, 2010, Zhonghua Yi Xue Za Zhi, V90, P1463	27	7	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91751	10.1371/journal.pone.0091751	http://dx.doi.org/10.1371/journal.pone.0091751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632579	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400087
J	Wang, CH; Liu, XJ; Peng, ST; Xu, Q; Yuan, XP; Feng, Y; Yu, HY; Wang, YP; Wei, XH				Wang, Caihong; Liu, Xiaojiao; Peng, Suotang; Xu, Qun; Yuan, Xiaoping; Feng, Yue; Yu, Hanyong; Wang, Yiping; Wei, Xinghua			Development of Novel Microsatellite Markers for the BBCC Oryza Genome (Poaceae) Using High-Throughput Sequencing Technology	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENUS ORYZA; CROSS-AMPLIFICATION; CHLOROPLAST DNA; SSR MARKERS; RICE GENUS; DIVERSITY; IDENTIFICATION; MITOCHONDRIAL; CHROMOSOMES	Wild species of Oryza are extremely valuable sources of genetic material that can be used to broaden the genetic background of cultivated rice, and to increase its resistance to abiotic and biotic stresses. Until recently, there was no sequence information for the BBCC Oryza genome; therefore, no special markers had been developed for this genome type. The lack of suitable markers made it difficult to search for valuable genes in the BBCC genome. The aim of this study was to develop microsatellite markers for the BBCC genome. We obtained 13,991 SSR-containing sequences and designed 14,508 primer pairs. The most abundant was hexanuclelotide (31.39%), followed by trinucleotide (27.67%) and dinucleotide (19.04%). 600 markers were selected for validation in 23 accessions of Oryza species with the BBCC genome. A set of 495 markers produced clear amplified fragments of the expected sizes. The average number of alleles per locus (Na) was 2.5, ranging from 1 to 9. The genetic diversity per locus (He) ranged from 0 to 0.844 with a mean of 0.333. The mean polymorphism information content (PIC) was 0.290, and ranged from 0 to 0.825. Of the 495 markers, 12 were only found in the BB genome, 173 were unique to the CC genome, and 198 were also present in the AA genome. These microsatellite markers could be used to evaluate the phylogenetic relationships among different Oryza genomes, and to construct a genetic linkage map for locating and identifying valuable genes in the BBCC genome, and would also for marker-assisted breeding programs that included accessions with the AA genome, especially Oryza sativa.	[Wang, Caihong; Xu, Qun; Yuan, Xiaoping; Feng, Yue; Yu, Hanyong; Wang, Yiping; Wei, Xinghua] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Xiaojiao; Peng, Suotang] Shanxi Agr Univ, Coll Agr Sci, Taigu, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Shanxi Agricultural University	Wei, XH (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	hzxwei@gmail.com	wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022		National Key Technology R&D Program in China [2013BAD01B02-14]	National Key Technology R&D Program in China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program in China (2013BAD01B02-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1999, GENES GENET SYST, V74, P23, DOI 10.1266/ggs.74.23; Akagi H, 1996, THEOR APPL GENET, V93, P1071, DOI 10.1007/BF00230127; AMANTEBORDEOS A, 1992, THEOR APPL GENET, V84, P345, DOI 10.1007/BF00229493; Bastide M, 2007, CURRENT PROTOCOLS BI; DALLY AM, 1990, THEOR APPL GENET, V80, P209, DOI 10.1007/BF00224389; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fukui K, 1997, THEOR APPL GENET, V95, P1239, DOI 10.1007/s001220050687; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; GUPTA PK, 1985, CAN J GENET CYTOL, V27, P515, DOI 10.1139/g85-077; Harushima Y, 1998, GENETICS, V148, P479; Heinrichs E. A., 1985, GENETIC EVALUATION I; Ho KC, 1961, CYTOGENETICAL STUDIE; Jauhar P, 1996, METHODS GENOME ANAL, P21; Joshi SP, 2000, THEOR APPL GENET, V100, P1311, DOI 10.1007/s001220051440; KANNO A, 1992, THEOR APPL GENET, V83, P791, DOI 10.1007/BF00226699; KATAYAMA T, 1977, JPN J GENET, V52, P301, DOI 10.1266/jjg.52.301; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KRISHNASWAMY N., 1957, SCI AND CULTURE, V23, P308; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li CB, 2001, THEOR APPL GENET, V103, P204, DOI 10.1007/s001220100563; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nishikawa T, 2005, THEOR APPL GENET, V110, P696, DOI 10.1007/s00122-004-1895-2; Page RD, 2001, TREEVIEW; Simon VI, 2010, AM J BOT, V97, pE10, DOI 10.3732/ajb.1000023; SITCH LA, 1989, RICE GENET NEWSL, V6, P58; TATEOKA T., 1962, Shokubutsugaku Zasshi = Bot. Mag., V75, P455; TATEOKA T., 1963, Bot. Mag., V76, P165; TATEOKA T., 1962, Shokubutsugaku Zasshi = Bot. Mag., V75, P418; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang ZY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-139; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhou HF, 2011, AM J BOT, V98, pE195, DOI 10.3732/ajb.1100040; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	39	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91826	10.1371/journal.pone.0091826	http://dx.doi.org/10.1371/journal.pone.0091826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632997	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400101
J	Wormer, DB; Davis, KA; Henderson, JH; Turner, CE				Wormer, Duncan B.; Davis, Kevin A.; Henderson, James H.; Turner, Christopher E.			The Focal Adhesion-Localized CdGAP Regulates Matrix Rigidity Sensing and Durotaxis	PLOS ONE			English	Article							MYOSIN-II; CELL MORPHOLOGY; SIMULTANEOUS QUANTIFICATION; RHO-GTPASES; PAXILLIN; ACTIN; ACTOPAXIN; MEMBRANE; RAC; ACTIVATION	Motile cells are capable of sensing the stiffness of the surrounding extracellular matrix through integrin-mediated focal adhesions and migrate towards regions of higher rigidity in a process known as durotaxis. Durotaxis plays an important role in normal development and disease progression, including tumor invasion and metastasis. However, the signaling mechanisms underlying focal adhesion-mediated rigidity sensing and durotaxis are poorly understood. Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness. CdGAP regulated rigidity-dependent motility by controlling membrane protrusion and adhesion dynamics, as well as by modulating Rac1 activity. CdGAP was also found to be necessary for U2OS cell durotaxis. Taken together, these data identify cdGAP as an important component of an integrin-mediated signaling pathway that senses and responds to mechanical cues in the extracellular matrix in order to coordinate directed cell motility.	[Wormer, Duncan B.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [Davis, Kevin A.; Henderson, James H.] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University	Turner, CE (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	turnerce@upstate.edu		Henderson, James/0000-0003-3355-5953	National Institutes of Health [GM47607, CA163296]; National Science Foundation [1334493]; NATIONAL CANCER INSTITUTE [R01CA163296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) Grants GM47607 and CA163296 to CET, and the National Science Foundation (http://www.nsf.gov/funding/) 1334493 to CET and JHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Bosgraaf L, 2010, CELL ADHES MIGR, V4, P46, DOI 10.4161/cam.4.1.9953; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Breckenridge M, 2013, CELL MOL BIOENGINEER; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Chan KT, 2007, METHOD ENZYMOL, V426, P47, DOI 10.1016/S0076-6879(07)26003-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin B, 2012, P NATL ACAD SCI USA, V109, pE3668, DOI 10.1073/pnas.1210295109; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pignatelli J, 2012, J BIOL CHEM, V287, P37309, DOI 10.1074/jbc.M112.385229; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Plotnikov SV, 2013, CURR OPIN CELL BIOL; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saraiva N, 2013, J CELL BIOL, V202, P699, DOI 10.1083/jcb.201301016; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Tyson RA, 2010, MATH MODEL NAT PHENO, V5, P34, DOI 10.1051/mmnp/20105102; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wormer D, 2012, CYTOSKELETON, V69, P644, DOI 10.1002/cm.21057; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	70	34	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91815	10.1371/journal.pone.0091815	http://dx.doi.org/10.1371/journal.pone.0091815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632816	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400095
J	Gasser, L; Daniel, M; Reinhard, T; Bohringer, D				Gasser, Laura; Daniel, Moritz; Reinhard, Thomas; Boehringer, Daniel			Long-Term Tracking of the Central Corneal Endothelial Mosaic	PLOS ONE			English	Article							TRENDS	Purpose: When comparing follow-up endothelial cell (EC) density measurements it is only possible to demonstrate cell loss in large cohorts or in pronounced cases due to the standard deviation of measurements. However, especially in clinical studies or refractive surgery patients, EC stability is an important factor. Thus we developed a computer program to achieve cell-by-cell alignment of conventional specular non-contact EC photographs. This is a pilot study to evaluate whether this new diagnostic technique is applicable in postoperative patients. Methods: Digitized endothelial cell photos of 30 eyes following implantation of a phakic posterior chamber intraocular lens for correction of high myopia were analyzed. All EC centroids were dotted on each image, and early and late follow-up pictures were automatically aligned on the basis of these centroids. The tracking results were confirmed via alternating image presentation of the corresponding image areas, and were reviewed for loss of individual cells. In addition, conventional EC density measurements were performed. Results: Mean time interval between first and second postoperative EC image was 1.4 years (range 3 months -2.2 years), with early images taken at a median of 5.5 months after IOL implantation (lower/upper quartile 1.2-12.3 months). Extrapolated central EC density was 2812 +/- 500/mm(2) at the first time point, and 2797 +/- 524/mm(2) at the second time point. In 26 out of 30 image pairs, the EC mosaic was successfully retraced; cell loss in this area was excluded via photo flickering. Only in 4 image pairs, the EC mosaic could not be matched. Conclusions: We demonstrate that the corneal EC mosaic of clinical routine non-contact microscope pictures can be superimposed and compared on single cell level over time with our new computer based program. This new method is valuable to judge on EC stability even in small cohorts since it does not require mean values and standard deviations.	[Gasser, Laura; Daniel, Moritz; Reinhard, Thomas; Boehringer, Daniel] Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany	University of Freiburg	Gasser, L (corresponding author), Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany.	laura.gasser@uniklinik-freiburg.de		Daniel, Moritz Claudius/0000-0003-2024-542X				Bohringer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059261; Bredow L, 2011, J REFRACT SURG, V27, P858, DOI 10.3928/1081597X-20111017-01; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Keenan TDL, 2012, ARCH OPHTHALMOL-CHIC, V130, P621, DOI 10.1001/archophthalmol.2011.2585; Kohnen T, 2010, J CATARACT REFR SURG, V36, P2168, DOI 10.1016/j.jcrs.2010.10.007; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; R Core Team, 2022, R LANG ENV STAT COMP; Saxena R, 2008, OPHTHALMOLOGY, V115, P608, DOI 10.1016/j.ophtha.2007.05.036	8	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e88603	10.1371/journal.pone.0088603	http://dx.doi.org/10.1371/journal.pone.0088603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625809	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300003
J	Fiorillo, AR; Tykoski, RS				Fiorillo, Anthony R.; Tykoski, Ronald S.			A Diminutive New Tyrannosaur from the Top of the World	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; TARBOSAURUS-BATAAR; DINOSAURIA; THEROPODA; DIVERSITY; EVOLUTION; ALBERTA; TEETH	Tyrannosaurid theropods were dominant terrestrial predators in Asia and western North America during the last of the Cretaceous. The known diversity of the group has dramatically increased in recent years with new finds, but overall understanding of tyrannosaurid ecology and evolution is based almost entirely on fossils from latitudes at or below southern Canada and central Asia. Remains of a new, relatively small tyrannosaurine were recovered from the earliest Late Maastrichtian (70-69Ma) of the Prince Creek Formation on Alaska's North Slope. Cladistic analyses show the material represents a new tyrannosaurine species closely related to the highly derived Tarbosaurus+Tyrannosaurus clade. The new taxon inhabited a seasonally extreme high-latitude continental environment on the northernmost edge of Cretaceous North America. The discovery of the new form provides new insights into tyrannosaurid adaptability, and evolution in an ancient greenhouse Arctic.	[Fiorillo, Anthony R.; Tykoski, Ronald S.] Perot Museum Nat & Sci, Dept Paleontol, Dallas, TX 75201 USA		Fiorillo, AR (corresponding author), Perot Museum Nat & Sci, Dept Paleontol, Dallas, TX 75201 USA.	anthony.fiorillo@perotmuseum.org		Fiorillo, Anthony/0000-0002-8998-0820	National Science Foundation Office of Polar Programs [OPP 0424594]	National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The National Science Foundation Office of Polar Programs provided funding for this work (OPP 0424594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald J.D., 1996, DINOSAUR EXTINCTION; Badgley C, 2013, PALEOBIOLOGY, V39, P373, DOI 10.1666/12024; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Brusatte SL, 2013, ACTA PALAEONTOL POL, V58, P47, DOI 10.4202/app.2011.0141; Brusatte SL, 2011, AM MUS NOVIT, P1, DOI 10.1206/3717.2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, CAN J EARTH SCI, V47, P1213, DOI 10.1139/E10-035; Conrad J.E., 1990, US GEOL SURV B C, P1; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Eberth DA, 2010, CAN J EARTH SCI, V47, P1119, DOI 10.1139/E10-045; Fiorillo AR, 2008, PALAIOS, V23, P322, DOI 10.2110/palo.2007.p07-036r; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Fiorillo AR, 2011, NEW PERSPECTIVES HOR, P456; FLAIG P. P., 2011, SPECIAL PUBLICATION, P233, DOI DOI 10.2110/SEPMSP.097.233; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Lambe LM., 1917, GEOL SURV, V83, P1, DOI [10.4095/101672, DOI 10.4095/101672]; Larson P., 2013, TYRANNOSAURID PALEOB, P15; Lawver LA, 2002, GEOL S AM S, P333; Lehman Thomas M., 2001, P310; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; MADDISON D, 2005, MACCLADE 4; Maddison WP, 2011, MESQUITE MODULAR SYS; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Padian Kevin, 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P379; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; SPICER RA, 2003, CRETACEOUS WORLD, P86; Spicer RA, 2010, PALAEOGEOGR PALAEOCL, V295, P423, DOI 10.1016/j.palaeo.2010.02.025; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Witmer Lawrence M., 2010, Kirtlandia, V57, P61; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	51	45	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91287	10.1371/journal.pone.0091287	http://dx.doi.org/10.1371/journal.pone.0091287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621577	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300073
J	Gole, VC; Chousalkar, KK; Roberts, JR; Sexton, M; May, D; Tan, J; Kiermeier, A				Gole, Vaibhav C.; Chousalkar, Kapil K.; Roberts, Juliet R.; Sexton, Margaret; May, Damian; Tan, Jessica; Kiermeier, Andreas			Effect of Egg Washing and Correlation between Eggshell Characteristics and Egg Penetration by Various Salmonella Typhimurium Strains	PLOS ONE			English	Article							BACTERIAL PENETRATION; SHELL; ENTERITIDIS; SURVIVAL; DISEASE; CUTICLE	Salmonella is an important foodborne pathogen, causing an estimated 11,992 cases of infection in Australia per year. Egg or egg product related salmonellosis is a major concern for the egg industry. Worldwide, S. Typhimurium is one of the most common serovars identified in Salmonella food poisoning cases. The current study investigated the ability of five S. Typhimurium strains to penetrate washed and unwashed eggs using whole egg and agar egg penetration methods. All S. Typhimurium strains were able to penetrate eggshells and survive in egg albumen (at 20 degrees C) according to whole egg penetration results. Polymerase Chain Reaction results demonstrated that S. Typhimurium strain 2 (10(3) and 10(5) CFU/mL), and strain 5 (10(3) and 10(5) CFU/mL) egg penetration was significantly higher (p<0.05) in washed eggs when compared to unwashed eggs. Statistical analysis of the agar penetration experiment indicated that S. Typhimurium was able to penetrate washed eggs at a significantly higher rate when compared to unwashed eggs (p<0.05). When compared to unwashed eggs, washed eggs also had significantly damaged cuticles. Statistical analysis also indicated that eggshell penetration by S. Typhimurium was related to various eggshell ultrastructural features such as cap quality, alignment, erosion, confluence, Type B bodies and cuticle cover.	[Gole, Vaibhav C.; Chousalkar, Kapil K.] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Roberts, Juliet R.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Sexton, Margaret] Primary Ind & Reg SA, Adelaide, SA, Australia; [May, Damian; Tan, Jessica; Kiermeier, Andreas] South Australian Res & Dev Inst, Adelaide, SA, Australia	University of Adelaide; University of New England; South Australian Research & Development Institute (SARDI)	Chousalkar, KK (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia.	kapil.chousalkar@adelaide.edu.au		chousalkar, Kapil/0000-0002-4134-3996; Kiermeier, Andreas/0000-0001-6240-2919	Australian Government's Cooperative Research Centres Program; International Postgraduate Research Scholarship	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); International Postgraduate Research Scholarship(Australian Government)	This research was conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centres Program. Salmonella isolates were obtained from Ms. Diane Davos, Australian Salmonella Reference Centre, Adelaide, South Australia, Australia. Mr. Vaibhav Gole is an International Postgraduate Research Scholarship recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLS AA, 1964, AVIAN DIS, V8, P245, DOI 10.2307/1588067; Baker R. C., 1990, Dairy, Food and Environmental Sanitation, V10, P273; Bell R, 2010, COMMUN DIS INTELL, V34, P396; Berrang ME, 1999, J APPL POULTRY RES, V8, P499, DOI 10.1093/japr/8.4.499; Board R.G., 1995, EGG SCI TECHNOLOGY, V4th, P81; Botey-Salo P, 2012, FOOD CONTROL, V28, P463, DOI 10.1016/j.foodcont.2012.05.033; Braun P., 1999, WORLD POULTRY SPECIA, P23; Chousalkar KK, 2010, INT J FOOD MICROBIOL, V142, P207, DOI 10.1016/j.ijfoodmicro.2010.06.029; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; De Reu K, 2006, INT J FOOD MICROBIOL, V112, P253, DOI 10.1016/j.ijfoodmicro.2006.04.011; European Food Safety Authority, 2005, EFSA J, V269, P39; Fitzsimmons G, 2012, COMMUN DIS INTELL, V36, pE213; Hall G, 2005, EMERG INFECT DIS, V11, P1257, DOI 10.3201/eid1108.041367; Hardy A, 2004, POSTGRAD MED J, V80, P541, DOI 10.1136/pgmj.2003.016584; Hutchison ML, 2004, J FOOD PROTECT, V67, P4, DOI 10.4315/0362-028X-67.1.4; Leleu S, 2011, J FOOD PROTECT, V74, P1649, DOI 10.4315/0362-028X.JFP-11-013; Luo YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040645; Martelli F, 2012, FOOD RES INT, V45, P745, DOI 10.1016/j.foodres.2011.03.054; May D., 2013, 24th Annual Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 17-20 February 2013, P256; Messens W, 2005, BRIT POULTRY SCI, V46, P694, DOI 10.1080/00071660500395582; Messens W, 2005, WORLD POULTRY SCI J, V61, P71, DOI 10.1079/WPS200443; Messens W, 2011, WOODHEAD PUBL FOOD S, P163; Miyamoto T, 1998, J FOOD PROTECT, V61, P350, DOI 10.4315/0362-028X-61.3.350; R Core Team, 2013, R LANG ENV STAT COMP; Radkowski M, 2002, ARCH GEFLUGELKD, V66, P119; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Ricke S.C., 2001, COMPENDIUM METHODS M, V4th, P473, DOI [10.2105/9780875531755ch46, DOI 10.2105/9780875531755CH46]; Roberts J. R., 1994, Poultry Science Reviews, V5, P245; Samiullah, 2013, INT J FOOD MICROBIOL, V165, P77, DOI 10.1016/j.ijfoodmicro.2013.05.002; SCHOENI JL, 1995, INT J FOOD MICROBIOL, V24, P385, DOI 10.1016/0168-1605(94)00042-5; Sergeant ESG, 2003, SALMONELLA ENTERITID; Solomon S. E., 1992, POULTRY INT, V31, P24; Solomon SE, 1992, POULTRY INT, V31, P20; SPARKS NHC, 1984, BRIT POULTRY SCI, V25, P267, DOI 10.1080/00071668408454866; Wales AD, 2011, AVIAN PATHOL, V40, P429, DOI 10.1080/03079457.2011.606799; Wang H, 1998, J FOOD PROTECT, V61, P276, DOI 10.4315/0362-028X-61.3.276	36	58	61	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90987	10.1371/journal.pone.0090987	http://dx.doi.org/10.1371/journal.pone.0090987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621821	gold, Green Submitted, Green Published			2022-12-25	WOS:000332845300042
J	Khan, A; Khan, I; Ali, F; Ulhaq, S; Shafie, S				Khan, Arshad; Khan, Ilyas; Ali, Farhad; Ulhaq, Sami; Shafie, Sharidan			Effects of Wall Shear Stress on Unsteady MHD Conjugate Flow in a Porous Medium with Ramped Wall Temperature	PLOS ONE			English	Article							FREE-CONVECTION FLOW; VERTICAL PLATE; THERMAL-RADIATION; HEAT-TRANSFER; NATURAL-CONVECTION; GENERAL-SOLUTIONS; MASS DIFFUSION; FLUID	This study investigates the effects of an arbitrary wall shear stress on unsteady magnetohydrodynamic (MHD) flow of a Newtonian fluid with conjugate effects of heat and mass transfer. The fluid is considered in a porous medium over a vertical plate with ramped temperature. The influence of thermal radiation in the energy equations is also considered. The coupled partial differential equations governing the flow are solved by using the Laplace transform technique. Exact solutions for velocity and temperature in case of both ramped and constant wall temperature as well as for concentration are obtained. It is found that velocity solutions are more general and can produce a huge number of exact solutions correlative to various fluid motions. Graphical results are provided for various embedded flow parameters and discussed in details.	[Khan, Arshad; Ali, Farhad; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Ulhaq, Sami] City Univ Sci & Informat Technol, Peshawar, Pakistan	Universiti Teknologi Malaysia; Majmaah University	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia.	ridafie@yahoo.com	SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019; Ali, Farhad/Y-5301-2018	SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371; 				[Anonymous], 2012, AM J COMPUT APPL MAT, DOI DOI 10.5923/j.ajcam.20120203.10; [Anonymous], [No title captured]; Chandrakala P., 2011, INT J DYNAM FLUID, V7, P1; Chandran P, 2005, HEAT MASS TRANSFER, V41, P459, DOI 10.1007/s00231-004-0568-7; Das K., 2010, B SOC MATH BANJA LUK, V17, P15; Das S. S., 2012, International Journal of Energy and Environment, V3, P209; Das S. S., 2012, International Journal of Energy and Environment, V3, P109; Das SS, 2011, J APPL FLUID MECH, V4, P91; Das SS, 2009, INT J HEAT MASS TRAN, V52, P5962, DOI 10.1016/j.ijheatmasstransfer.2009.04.038; Fetecau C, 2013, Z NATURFORSCH A, V68, P659, DOI 10.5560/ZNA.2013-0041; Fetecau C, 2011, Z NATURFORSCH A, V66, P753, DOI 10.5560/ZNA.2011-0044; Fetecau C, 2013, Z NATURFORSCH A, V68, P130, DOI 10.5560/ZNA.2012-0083; Ghara N., 2012, AM J SCI IND RES, V3, P376; Ghosh SK, 2008, NONLINEAR ANAL-MODEL, V13, P419, DOI 10.15388/NA.2008.13.4.14548; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hussanan A, 2013, J APPL MATH, DOI 10.1155/2013/434571; Jha BK, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.104401; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104401; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064401; Magyari E, 2011, INT COMMUN HEAT MASS, V38, P554, DOI 10.1016/j.icheatmasstransfer.2011.03.006; Narahari M, 2012, CHEM ENG COMMUN, V199, P628, DOI 10.1080/00986445.2011.611058; Narahari Marneni, 2011, Turkish Journal of Engineering and Environmental Sciences, V35, P187, DOI 10.3906/muh-1101-15; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Narahari M., 2011, WORLD J MECH, V1, P176; Navier C. L., 1823, MEM ACAD SCI I FR, V6, P389; Patra1 RR, 2012, J APPL FLUID MECH, P59; Rajesh V, 2011, CHEM IND CHEM ENG Q, V17, P189, DOI 10.2298/CICEQ100829003R; Samiulhaq, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.044401; Seethamahalakshmi, 2011, ADV APPL SC RES, V2, P261; Seth G.S., 2013, INT J ENERGY TECH, V5, P1; Shercliff JA., 1965, TXB MAGNETOHYDRODYNA; Toki CJ, 2007, ZAMM-Z ANGEW MATH ME, V87, P4, DOI 10.1002/zamm.200510291	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90280	10.1371/journal.pone.0090280	http://dx.doi.org/10.1371/journal.pone.0090280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621775	Green Submitted, gold, Green Published			2022-12-25	WOS:000332845300019
J	Li, W; Wang, W; Li, Y; Wang, WW; Wang, T; Li, L; Han, ZQ; Wang, SX; Ma, D; Wang, H				Li, Wei; Wang, Wei; Li, Yan; Wang, Wenwen; Wang, Tian; Li, Li; Han, Zhiqiang; Wang, Shixuan; Ma, Ding; Wang, Hui			Proteomics Analysis of Normal and Senescent NG108-15 Cells: GRP78 Plays a Negative Role in Cisplatin-Induced Senescence in the NG108-15 Cell Line	PLOS ONE			English	Article							LUNG-CANCER CELLS; INDUCED APOPTOSIS; DNA-DAMAGE; GROWTH; CHEMOTHERAPY; EXPRESSION; RESISTANCE; INDUCTION; PROTEINS	Accelerated senescence (ACS) leading to proliferative arrest is a physiological mechanism of the DNA damage response that occurs during tumor therapy. Our experiment was designed to detect unknown genes that may play important roles in cisplatin-induced senescence and to illustrate the related senescence mechanism. Using 2-dimension electrophoresis (2-DE), we identified 5 protein spots with different expression levels in the normal and senescent NG108-15 cells. According to MALDI-TOF MS analysis, the 5 proteins were determined to be peptidylprolyl isomerase A (PPIA), peroxiredoxin 1 (PRX1), glutathione S-transferase mu 1 (GSTM1), vimentin (VIM) and glucose-regulated protein 78 (GRP78). Then, we investigated how cisplatin-induced senescence was mediated by GRP78 in the NG108-15 cells. Knockdown of GRP78 significantly increased P53 expression in NG108-15 cells. Additionally, 2-deoxy-D-glucose (2DG)-induced GRP78 overexpression protected the NG108-15 cells from cisplatin-induced senescence, which was accompanied by the obvious suppression of P53 and p-CDC2 expression. Inhibition of Ca2+ release from endoplasmic reticulum (ER) stores was also found to be associated with the anti-senescence effect of 2DG-induced GRP78 overexpression. In conclusion, we found 5 proteins that were differentially expressed in normal NG108-15 cells and senescent NG108-15 cells. GRP78 plays an important role in cisplatin-induced senescence in NG108-15 cells, mainly through its regulation of P53 expression and ER calcium efflux.	[Li, Wei; Li, Yan; Wang, Wenwen; Wang, Tian; Li, Li; Han, Zhiqiang; Wang, Shixuan; Ma, Ding; Wang, Hui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Wang, Wei] Southern Med Univ, Nanfang Hosp, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Southern Medical University - China	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	dma@tjh.tjmu.edu.cn; huit71@sohu.com		Li, Li/0000-0003-2294-9842	National Basic Research Program of China 973 program; National Natural Science Foundation of China [2013CB911304, 81072132, 81001152, 81101963, 81172466, 30872751]	National Basic Research Program of China 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China 973 program and the National Natural Science Foundation of China (No. 2013CB911304; 81072132; 81001152; 81101963; 81172466; 30872751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Asish G, 2008, PLOS ONE, V3, P3384; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Bolesta E, 2012, MOL CELL BIOL, V32, P1879, DOI 10.1128/MCB.06214-11; Bosche B, 2013, BIOCHEM BIOPH RES CO, V434, P268, DOI 10.1016/j.bbrc.2013.03.047; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; DOUGLAS DT, 2009, GYNECOL ONCOL, V115, P112; Elmore LW, 2005, CLIN CANCER RES, V11, P2637, DOI 10.1158/1078-0432.CCR-04-1462; Fang K, 2007, ONCOL RES, V16, P479, DOI 10.3727/096504007783338331; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Gannon HS, 2011, DEV BIOL, V353, P1, DOI 10.1016/j.ydbio.2011.02.007; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Goehe RW, 2012, J PHARMACOL EXP THER, V343, P763, DOI 10.1124/jpet.112.197590; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hawkins LK, 2001, GENE THER, V8, P1123, DOI 10.1038/sj.gt.3301507; IKENOUCHI H, 1991, J CLIN INVEST, V88, P55, DOI 10.1172/JCI115304; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN HJ, 1995, CANCER RES, V55, P1224; Nishio K, 2001, HISTOCHEM CELL BIOL, V116, P321, DOI 10.1007/s004180100325; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roninson IB, 2003, CANCER RES, V63, P2705; te Poele RH, 2002, CANCER RES, V62, P1876; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang QS, 2010, NEUROCHEM RES, V35, P13, DOI 10.1007/s11064-009-0023-8; Wang W, 2007, GYNECOL ONCOL, V105, P571, DOI 10.1016/j.ygyno.2007.01.051; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Zu K, 2006, ONCOGENE, V25, P546, DOI 10.1038/sj.onc.1209071	35	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90114	10.1371/journal.pone.0090114	http://dx.doi.org/10.1371/journal.pone.0090114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621580	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300014
J	Xia, Y; Chang, T; Wang, YM; Liu, YX; Li, WH; Li, M; Fan, HY				Xia, Yan; Chang, Ting; Wang, Yingmei; Liu, Yixiong; Li, Wenhui; Li, Ming; Fan, Heng-Yu			YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CONTACT INHIBITION; PROLIFERATION; APOPTOSIS; DOMAIN; GROWTH; EXPRESSION; INDUCTION; SALVADOR	YAP is a key component of the Hippo signaling pathway and plays a critical role in the development and progression of multiple cancer types, including ovarian cancer. However, the effects of YAP on ovarian cancer development in vivo and its downstream effectors remain uncertain. In this study we found that strong YAP expression was associated with poor ovarian cancer patient survival. Specifically, we showed for the first time that high YAP expression levels were positively correlated with TEAD4 gene expression, and their co-expression was a prognostic marker for poor ovarian cancer survival. Hyperactivation of YAP by mutating its five inhibitory phosphorylation sites (YAP-5SA) increased ovarian cancer cell proliferation, resistance to chemotherapeutic drugs, cell migration, and anchorage-independent growth. In contrast, expression of a dominant negative YAP mutant reversed these phenotypes in ovarian cancer cells both in vitro and in vivo. Our results suggested that YAP caused these effects by promoting an epithelial-to-mesenchymal transition. Thus, YAP promotes ovarian cancer cell growth and tumorigenesis both in vitro and in vivo. Further, high YAP and TEAD4 expression is a prognostic marker for ovarian cancer progression and a potential target for ovarian cancer treatment.	[Xia, Yan; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Yan; Fan, Heng-Yu] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chang, Ting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Peoples R China; [Wang, Yingmei; Liu, Yixiong] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Li, Wenhui] Fourth Mil Med Univ, Xijing Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China; [Li, Ming] Xi An Jiao Tong Univ, Affiliated Guangren Hosp, Xian 710049, Peoples R China	Zhejiang University; Zhejiang University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Fan, HY (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hyfan@zju.edu.cn			National Natural Science Foundation of China [81172473]; National Basic Research Program of China [2011CB944504, 2012CB944403]; Basic Scientific Research Funding of Zhejiang University [2011QN81001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Basic Scientific Research Funding of Zhejiang University	This study was supported by the National Natural Science Foundation of China (81172473), the National Basic Research Program of China (2011CB944504, 2012CB944403), and Basic Scientific Research Funding of Zhejiang University (2011QN81001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Buttitta F, 1997, BRIT J CANCER, V75, P230, DOI 10.1038/bjc.1997.38; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hau JC, 2013, CHEMBIOCHEM, V14, P1218, DOI 10.1002/cbic.201300163; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Qin LF, 2002, CANCER LETT, V175, P27, DOI 10.1016/S0304-3835(01)00720-0; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	37	115	127	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91770	10.1371/journal.pone.0091770	http://dx.doi.org/10.1371/journal.pone.0091770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622501	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300126
J	Yang, J; Kalogerou, M; Samsel, PA; Zhang, Y; Griffiths, DFR; Gallacher, J; Sampson, JR; Shen, MH				Yang, J.; Kalogerou, M.; Samsel, P. A.; Zhang, Y.; Griffiths, D. F. R.; Gallacher, J.; Sampson, J. R.; Shen, M. H.			Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin	ONCOGENE			English	Article							TUBEROUS SCLEROSIS COMPLEX; INSULIN-RESISTANCE; MAMMALIAN TARGET; MTOR; ACTIVATION; REVEALS; KINASE; IDENTIFICATION; LETHALITY; SUBSTRATE	Tuberous sclerosis (TSC) is an inherited syndrome in which tumours in multiple organs are characterised by activation of mammalian target of rapamycin complex 1 (mTORC1). Previous work suggests that mTORC1 activation is associated with feedback inhibition of Akt, a substrate of mTORC2. This could limit TSC-associated tumour growth but lead to paradoxical promotion of tumour cell survival upon treatment with mTOR inhibitors. However, Akt/mTOR signalling has not been fully investigated in TSC-associated tumours and it has been uncertain whether mTOR inhibition can prevent TSC-associated renal tumourigenesis. In this study, we investigated Akt/mTOR signalling in renal tumours using a Tsc2(+/-) mouse model and tested whether mTOR inhibition could prevent renal tumourigenesis. We found that all renal lesions including cysts, adenomas and carcinomas exhibited activation of both Akt and mTORC1 as evidenced by increased protein expression and phosphorylation of Akt and mTOR and their downstream targets. Protein kinase Ca was also highly expressed and phosphorylated in these lesions, consistent with activation of mTORC2. Surprisingly, IRS proteins were highly expressed, in contrast to a striking decrease seen in cultured Tsc2(-/-) mouse embryonic fibroblasts, suggesting one mechanism through which loss of feedback inhibition of Akt may occur in mTORC1 hyperactivated Tsc-associated tumours. Long-term treatment with rapamycin reduced both Akt and mTORC1 activity in normal kidney tissues and blocked the development of all types of renal lesions. In conclusion, in contrast to previous studies, we found that Akt signalling is not inhibited in Tsc-associated renal lesions and that by partially inhibiting the Akt/mTOR pathway, rapamycin is highly effective in preventing Tsc-associated tumours.	[Yang, J.; Kalogerou, M.; Samsel, P. A.; Zhang, Y.; Sampson, J. R.; Shen, M. H.] Cardiff Univ, Sch Med, Inst Canc & Genet, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Griffiths, D. F. R.] Cardiff Univ, Sch Med, Inst Canc & Genet, Sect Pathol, Cardiff CF14 4XN, S Glam, Wales; [Gallacher, J.] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Shen, MH (corresponding author), Cardiff Univ, Sch Med, Inst Canc & Genet, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales.	Sampson@cf.ac.uk; shenmh@cf.ac.uk			Wales Gene Park, UK; Tuberous Sclerosis Association, UK	Wales Gene Park, UK; Tuberous Sclerosis Association, UK	We thank Dr David Kwiatkowski for providing the Tsc2<SUP>+/-</SUP> mouse model. This project was supported by the Wales Gene Park, UK and the Tuberous Sclerosis Association, UK.	Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Kalogerou M, 2012, EUR J RADIOL, V81, P2069, DOI 10.1016/j.ejrad.2011.06.054; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; NELLIST M, 1993, CELL, V75, P1305; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; Proud CG, 2011, BIOCHEM SOC T, V39, P431, DOI 10.1042/BST0390431; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wilson C, 2005, HUM MOL GENET, V14, P1839, DOI 10.1093/hmg/ddi190; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Xu XS, 2012, J BIOL CHEM, V287, P40758, DOI 10.1074/jbc.M112.405209; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	38	13	13	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					922	931		10.1038/onc.2014.17	http://dx.doi.org/10.1038/onc.2014.17			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24632604	Green Accepted			2022-12-25	WOS:000349472000012
J	Stalhberger, T; Simenel, C; Clavaud, C; Eijsink, VGH; Jourdain, R; Delepierre, M; Latge, JP; Breton, L; Fontaine, T				Stalhberger, Thomas; Simenel, Catherine; Clavaud, Cecile; Eijsink, Vincent G. H.; Jourdain, Roland; Delepierre, Muriel; Latge, Jean-Paul; Breton, Lionel; Fontaine, Thierry			Chemical Organization of the Cell Wall Polysaccharide Core of Malassezia restricta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Complex; Carbohydrate Structure; Cell Wall; Chitin; Yeast	SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-FUMIGATUS; FUNGAL CELL; CANDIDA-ALBICANS; GENE-PRODUCT; STRUCTURAL-CHARACTERIZATION; SCHIZOSACCHAROMYCES-POMBE; NMR-SPECTROSCOPY; HUMAN SKIN; IN-VITRO	Background: Cell wall of Malassezia restricta is involved in interactions with human skin. Results: Its core is composed of cross-linked polysaccharides such as chitin, chitosan, -(1,3)-glucan and -(1,6)-glucan. Conclusion: The composition of cell wall polysaccharides of M. restricta is unique in the fungal kingdom. Significance: The cell wall of M. restricta has evolved as a yeast that adapted to the skin microenvironment and host interactions. Malassezia species are ubiquitous residents of human skin and are associated with several diseases such as seborrheic dermatitis, tinea versicolor, folliculitis, atopic dermatitis, and scalp conditions such as dandruff. Host-Malassezia interactions and mechanisms to evade local immune responses remain largely unknown. Malassezia restricta is one of the most predominant yeasts of the healthy human skin, its cell wall has been investigated in this paper. Polysaccharides in the M. restricta cell wall are almost exclusively alkali-insoluble, showing that they play an essential role in the organization and rigidity of the M. restricta cell wall. Fractionation of cell wall polymers and carbohydrate analyses showed that the polysaccharide core of the cell wall of M. restricta contained an average of 5% chitin, 20% chitosan, 5% -(1,3)-glucan, and 70% -(1,6)-glucan. In contrast to other yeasts, chitin and chitosan are relatively abundant, and -(1,3)-glucans constitute a minor cell wall component. The most abundant polymer is -(1,6)-glucans, which are large molecules composed of a linear -(1,6)-glucan chains with -(1,3)-glucosyl side chain with an average of 1 branch point every 3.8 glucose unit. Both -glucans are cross-linked, forming a huge alkali-insoluble complex with chitin and chitosan polymers. Data presented here show that M. restricta has a polysaccharide organization very different of all fungal species analyzed to date.	[Stalhberger, Thomas; Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Unite Aspergillus, F-75724 Paris, France; [Simenel, Catherine; Delepierre, Muriel] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, F-75724 Paris, France; [Clavaud, Cecile; Jourdain, Roland; Breton, Lionel] LOreal Res & Innovat, F-93600 Aulnay Sous Bois, France; [Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Delepierre, Muriel] Inst Pasteur, CNRS, UMR3528, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group; Norwegian University of Life Sciences; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fontaine, T (corresponding author), Inst Pasteur, Unite Aspergillus, 25 Rue Docteur Roux, F-75724 Paris, France.	thierry.fontaine@pasteur.fr	Fontaine, thierry/Q-2201-2018; Fontaine, Thierry/F-8227-2011	Fontaine, thierry/0000-0002-8184-789X; 	L'Oreal, Paris	L'Oreal, Paris	Supported by L'Oreal, Paris.	Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BOCK K, 1974, J ANTIBIOT, V27, P139, DOI 10.7164/antibiotics.27.139; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Cabib E, 2012, EUKARYOT CELL, V11, P388, DOI 10.1128/EC.05328-11; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; David M., 2003, SCRIPTA MED BRNO, V76, P173; de Medina-Redondo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014046; Delay C, 1997, CARBOHYD RES, V302, P67, DOI 10.1016/S0008-6215(97)00101-8; Dimzon IKD, 2013, CARBOHYD POLYM, V92, P564, DOI 10.1016/j.carbpol.2012.09.035; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duenas-Santero E, 2010, EUKARYOT CELL, V9, P1650, DOI 10.1128/EC.00187-10; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fontaine T, 1997, EUR J BIOCHEM, V243, P315, DOI 10.1111/j.1432-1033.1997.0315a.x; FONTAINE T, 1991, ANAL BIOCHEM, V199, P154, DOI 10.1016/0003-2697(91)90083-6; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gastebois A, 2013, J BIOL CHEM, V288, P13387, DOI 10.1074/jbc.M112.440172; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Goldman DL, 2012, MBIO, V3, DOI 10.1128/mBio.00056-12; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; GUILLOT J, 1995, ANTON LEEUW INT J G, V67, P297, DOI 10.1007/BF00873693; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; Heggset EB, 2010, BIOMACROMOLECULES, V11, P2487, DOI 10.1021/bm1006745; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Kim YT, 2000, CARBOHYD RES, V328, P331, DOI 10.1016/S0008-6215(00)00105-1; Kobayashi M, 2009, BRIT J DERMATOL, V160, P297, DOI 10.1111/j.1365-2133.2008.08897.x; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Koller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016594; Kruppa MD, 2009, CARBOHYD RES, V344, P2474, DOI 10.1016/j.carres.2009.09.029; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MITTAG H, 1995, MYCOSES, V38, P13, DOI 10.1111/j.1439-0507.1995.tb00003.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; NEBREDA AR, 1987, FEBS LETT, V220, P27, DOI 10.1016/0014-5793(87)80869-4; Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; Shibata N, 2009, MICROBIOL-SGM, V155, P3420, DOI 10.1099/mic.0.029967-0; Sugawara T, 2004, CARBOHYD RES, V339, P2255, DOI 10.1016/j.carres.2004.05.033; Vorgias C. E., 1993, PURIFICATION CHARACT, P417; WAGNER G, 1983, J MAGN RESON, V55, P151, DOI 10.1016/0022-2364(83)90284-6; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zhou KQ, 2006, LWT-FOOD SCI TECHNOL, V39, P1087, DOI 10.1016/j.lwt.2005.07.009; Zverlov VV, 1997, MICROBIOL-SGM, V143, P1701, DOI 10.1099/00221287-143-5-1701	63	42	46	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12647	12656		10.1074/jbc.M113.547034	http://dx.doi.org/10.1074/jbc.M113.547034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627479	Green Published, hybrid			2022-12-25	WOS:000335581400036
J	Wang, QS; He, YH; Shen, YJ; Zhang, QQ; Chen, D; Zuo, CJ; Qin, J; Wang, H; Wang, JW; Yu, Y				Wang, Qingsong; He, Yuhu; Shen, Yujun; Zhang, Qianqian; Chen, Di; Zuo, Caojian; Qin, Jing; Wang, Hui; Wang, Junwen; Yu, Ying			Vitamin D Inhibits COX-2 Expression and Inflammatory Response by Targeting Thioesterase Superfamily Member 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Lipopolysaccharide (LPS); Macrophages; NF-kappa B (NF-KB); Vitamin D; VDR	NF-KAPPA-B; TERMINAL MODULATOR PROTEIN; GROWTH-PLATE CHONDROCYTES; PROSTATE-CANCER; DNA-BINDING; KINASE-C; CYCLOOXYGENASE-2; RECEPTOR; D-3; HEALTH	Background: Vitamin D insufficiency has been associated with chronic inflammatory diseases. However, the underlying mechanisms remain unclear. Results: Vitamin D inhibits COX-2-mediated inflammatory response by modulating the Akt/NF-B signaling pathway via direct up-regulation of thioesterase superfamily member 4. Conclusion: Vitamin D plays novel roles in anti-inflammation. Significance: Supplemental vitamin D could protect against chronic inflammatory diseases by targeting THEM4/Akt/NF-B signaling. Inadequate vitamin D status has been linked to increased risk of type 2 diabetes and cardiovascular disease. Inducible cyclooxygenase (COX) isoform COX-2 has been involved in the pathogenesis of such chronic inflammatory diseases. We found that the active form of vitamin D, 1,25(OH)(2)D produces dose-dependent inhibition of COX-2 expression in murine macrophages under both basal and LPS-stimulated conditions and suppresses proinflammatory mediators induced by LPS. Administration of 1,25(OH)(2)D significantly alleviated local inflammation in a carrageenan-induced paw edema mouse model. Strikingly, the phosphorylation of both Akt and its downstream target IB in macrophages were markedly suppressed by 1,25(OH)(2)D in the presence and absence of LPS stimulation through up-regulation of THEM4 (thioesterase superfamily member 4), an Akt modulator protein. Knockdown of both vitamin D receptor and THEM4 attenuated the inhibitory effect of 1,25(OH)(2)D on COX-2 expression in macrophages. A functional vitamin D-responsive element in the THEM4 promoter was identified by chromatin immunoprecipitation and luciferase reporter assay. Our results indicate that vitamin D restrains macrophage-mediated inflammatory processes by suppressing the Akt/NF-B/COX-2 pathway, suggesting that vitamin D supplementation might be utilized for adjunctive therapy for inflammatory disease.	[Wang, Qingsong; He, Yuhu; Shen, Yujun; Zhang, Qianqian; Chen, Di; Zuo, Caojian; Wang, Hui; Yu, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China; [Wang, Qingsong] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou 571199, Peoples R China; [Wang, Hui; Yu, Ying] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Qin, Jing; Wang, Junwen] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Wang, Junwen] Univ Hong Kong, LKS Fac Med, Ctr Genom Sci, Hong Kong, Peoples R China; [Qin, Jing; Wang, Junwen] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Hainan Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	yuying@sibs.ac.cn	CHEN, DI/Y-5795-2019; Wang, Junwen/D-3700-2011	Wang, Junwen/0000-0002-4432-4707; Qin, Jing/0000-0002-8327-8846	Ministry of Science and Technology of China [2012CB945100, 2011CB503906, 2011ZX09307-302-01, 2012BAK01B00]; National Natural Science Foundation of China [81030004, 31200860]; Natural Science Foundation of China-Canadian Institutes of Health Research [NSFC81161120538, CIHR-CCI117951]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]; Clinic Research Center at Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences [CRC2010007]; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP514, 2013KIP312, 2010OHTP10]; Pujiang Talents Program of Shanghai Municipality [11PJ1411100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China-Canadian Institutes of Health Research; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Clinic Research Center at Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Pujiang Talents Program of Shanghai Municipality	This work was supported by Grants 2012CB945100, 2011CB503906, 2011ZX09307-302-01, and 2012BAK01B00 from the Ministry of Science and Technology of China and National Natural Science Foundation of China Grants 81030004 and 31200860, Natural Science Foundation of China-Canadian Institutes of Health Research Joint Grants NSFC81161120538 and CIHR-CCI117951, Grant KSCX2-EW-R-09 from the Knowledge Innovation Program of the Chinese Academy of Sciences, funds from the Clinic Research Center at Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences Grant CRC2010007, the Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences, and Chinese Academy of Sciences Grants 2012KIP514 and 2013KIP312.; Supported by Grant 2010OHTP10 from the One Hundred Talents Program of the Chinese Academy of Sciences and Grant 11PJ1411100 from the Pujiang Talents Program of Shanghai Municipality. Fellow at the Jiangsu Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. To whom correspondence should be addressed. Inst. for Nutritional Sciences, Shanghai Inst. for Biological Sciences, Chinese Academy of Sciences, 294 Taiyuan Rd., Shanghai 200031, China. Tel. and Fax: 86-2154920970; E-mail: yuying@sibs.ac.cn.	Adams AE, 1999, J CELL BIOCHEM, V74, P587, DOI 10.1002/(SICI)1097-4644(19990915)74:4<587::AID-JCB8>3.0.CO;2-G; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Aparna R, 2008, J CELL BIOCHEM, V104, P1832, DOI 10.1002/jcb.21749; Boyan BD, 1999, STEROIDS, V64, P129, DOI 10.1016/S0039-128X(98)00099-3; Boyan BD, 2002, CRIT REV ORAL BIOL M, V13, P143, DOI 10.1177/154411130201300205; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Ermert L, 1998, AM J RESP CELL MOL, V18, P479, DOI 10.1165/ajrcmb.18.4.2939; Glade MJ, 2013, NUTRITION, V29, P37, DOI 10.1016/j.nut.2012.05.010; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Harant H, 1998, FEBS LETT, V436, P329, DOI 10.1016/S0014-5793(98)01153-3; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hinz B, 2007, Handb Exp Pharmacol, P65; Holick MF, 2005, SEMIN DIALYSIS, V18, P266, DOI 10.1111/j.1525-139X.2005.18402.x; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Krishnan AV, 2007, J BONE MINER RES, V22, pV74, DOI 10.1359/JBMR.07S213; Krishnan AV, 2010, ENDOCRINOLOGY, V151, P32, DOI 10.1210/en.2009-0855; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Liu XD, 2014, AM J RESP CELL MOL, V50, P40, DOI 10.1165/rcmb.2013-0211OC; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Moreno J, 2005, CANCER RES, V65, P7917, DOI 10.1158/0008-5472.CAN-05-1435; Muszkat P, 2010, ARQ BRAS ENDOCRINOL, V54, P110, DOI 10.1590/S0004-27302010000200005; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schwab M, 2007, MOL IMMUNOL, V44, P3625, DOI 10.1016/j.molimm.2007.04.010; Schwartz Z, 2000, J CELL PHYSIOL, V182, P390, DOI 10.1002/(SICI)1097-4652(200003)182:3<390::AID-JCP10>3.3.CO;2-K; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Sylvia VL, 2001, J CELL BIOCHEM, P32; Thota C, 2013, REPROD SCI, V20, P463, DOI 10.1177/1933719112459225; Tjandrawinata RR, 1997, ADV EXP MED BIOL, V407, P163; Tsugawa N, 1999, BIOL PHARM BULL, V22, P371; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Winyard P. G., 2003, INFLAMMATION PROTOCO; Wu SP, 2011, DISCOV MED, V11, P325; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhao H, 2009, BIOCHEMISTRY-US, V48, P5507, DOI 10.1021/bi900710w	60	82	86	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11681	11694		10.1074/jbc.M113.517581	http://dx.doi.org/10.1074/jbc.M113.517581			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619416	Green Published, hybrid			2022-12-25	WOS:000335010600011
J	Kang, S; Xu, MX; Cooper, EC; Hoshi, N				Kang, Seungwoo; Xu, Mingxuan; Cooper, Edward C.; Hoshi, Naoto			Channel-anchored Protein Kinase CK2 and Protein Phosphatase 1 Reciprocally Regulate KCNQ2-containing M-channels via Phosphorylation of Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calmodulin; Potassium Channels; PP1; Protein Kinases; Protein Phosphorylation; CK2; KCNQ2	CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; ANKYRIN-G; IDENTIFICATION; MODULATION; PIP2; SUBUNITS; DOMAINS; KCNQ; SITE	Background: Calmodulin binding to KCNQ subunit is required for maintaining the M-current. Results: Protein kinase CK2-mediated phosphorylation of CaM enhances KCNQ2 current. KCNQ2 subunit tethers protein kinase CK2 and protein phosphatase 1. Conclusion: Phosphorylation status of CaM regulates the M-current. Significance: Phosphorylation status of calmodulin regulates neuronal excitability via M-current modulation. M-type potassium channels, encoded by the KCNQ family genes (KCNQ2-5), require calmodulin as an essential co-factor. Calmodulin bound to the KCNQ2 subunit regulates channel trafficking and stabilizes channel activity. We demonstrate that phosphorylation of calmodulin by protein kinase CK2 (casein kinase 2) rapidly and reversibly modulated KCNQ2 current. CK2-mediated phosphorylation of calmodulin strengthened its binding to KCNQ2 channel, caused resistance to phosphatidylinositol 4,5-bisphosphate depletion, and increased KCNQ2 current amplitude. Accordingly, application of CK2-selective inhibitors suppressed KCNQ2 current. This suppression was prevented by co-expression of CK2 phosphomimetic calmodulin mutants or pretreatment with a protein phosphatase inhibitor, calyculin A. We also demonstrated that functional CK2 and protein phosphatase 1 (PP1) were selectively tethered to the KCNQ2 subunit. We identified a functional KVXF consensus site for PP1 binding in the N-terminal tail of KCNQ2 subunit: mutation of this site augmented current density. CK2 inhibitor treatment suppressed M-current in rat superior cervical ganglion neurons, an effect negated by overexpression of phosphomimetic calmodulin or pretreatment with calyculin A Furthermore, CK2 inhibition diminished the medium after hyperpolarization by suppressing the M-current. These findings suggest that CK2-mediated phosphorylation of calmodulin regulates the M-current, which is tonically regulated by CK2 and PP1 anchored to the KCNQ2 channel complex.	[Kang, Seungwoo; Hoshi, Naoto] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Hoshi, Naoto] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Xu, Mingxuan; Cooper, Edward C.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Cooper, Edward C.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Baylor College of Medicine; Baylor College of Medicine	Hoshi, N (corresponding author), Univ Calif Irvine, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	nhoshi@uci.edu	Kang, Seungwoo/K-5130-2015; Cooper, Edward/X-6659-2019; Kang, Seungwoo/L-4841-2019	Kang, Seungwoo/0000-0003-1301-8480; Cooper, Edward/0000-0003-3672-8442; Kang, Seungwoo/0000-0003-1301-8480	National Institutes of Health [R01 NS067288, R01 NS49119]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R21NS042100, R01NS049119, R01NS067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS067288 (to N. H.) and R01 NS49119 (to E. C. C.).	Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086711; Arrigoni G, 2004, BIOCHEMISTRY-US, V43, P12788, DOI 10.1021/bi049365c; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Cohen PTW, 2002, J CELL SCI, V115, P241; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Greif DM, 2004, P NATL ACAD SCI USA, V101, P1165, DOI 10.1073/pnas.0306377101; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Kosenko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082290; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; Le AV, 2011, BIOCHEMISTRY-US, V50, P5279, DOI 10.1021/bi200089z; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Maingret F, 2008, NEURON, V59, P439, DOI 10.1016/j.neuron.2008.05.026; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PLANCKE YD, 1983, MOL CELL BIOL, V3, P1412, DOI 10.1128/MCB.3.8.1412; QUADRONI M, 1994, J BIOL CHEM, V269, P16116; Quadroni M, 1998, BIOCHEMISTRY-US, V37, P6523, DOI 10.1021/bi972930+; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	33	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11536	11544		10.1074/jbc.M113.528497	http://dx.doi.org/10.1074/jbc.M113.528497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24627475	Green Published, hybrid			2022-12-25	WOS:000334638500053
J	Feng, QQ; Ma, YX; Mu, SH; Wu, JJ; Chen, S; OuYang, LS; Lei, WL				Feng, Qiqi; Ma, Yuxin; Mu, Shuhua; Wu, Jiajia; Chen, Si; OuYang, Lisi; Lei, Wanlong			Specific Reactions of Different Striatal Neuron Types in Morphology Induced by Quinolinic Acid in Rats	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; CELL-DEATH; INTRASTRIATAL INJECTIONS; 3-NITROPROPIONIC ACID; NADPH-DIAPHORASE; INTERNEURONS; SURVIVAL; MODELS; EXCITOTOXICITY; VULNERABILITY	Huntington's disease (HD) is a neurological degenerative disease and quinolinic acid (QA) has been used to establish HD model in animals through the mechanism of excitotoxicity. Yet the specific pathological changes and the underlying mechanisms are not fully elucidated. We aimed to reveal the specific morphological changes of different striatal neurons in the HD model. Sprague-Dawley (SD) rats were subjected to unilaterally intrastriatal injections of QA to mimic the HD model. Behavioral tests, histochemical and immunhistochemical stainings as well as Western blots were applied in the present study. The results showed that QA-treated rats had obvious motor and cognitive impairments when compared with the control group. Immunohistochemical detection showed a great loss of NeuN+ neurons and Darpp32+ projection neurons in the transition zone in the QA group when compared with the control group. The numbers of parvalbumin (Parv)+ and neuropeptide Y (NPY)+ interneurons were both significantly reduced while those of calretinin (Cr)+ and choline acetyltransferase (ChAT)+ were not changed notably in the transition zone in the QA group when compared to the controls. Parv+, NPY+ and ChAT+ interneurons were not significantly increased in fiber density while Cr+ neurons displayed an obvious increase in fiber density in the transition zone in QA-treated rats. The varicosity densities of Parv+, Cr+ and NPY+ interneurons were all raised in the transition zone after QA treatment. In conclusion, the present study revealed that QA induced obvious behavioral changes as well as a general loss of striatal projection neurons and specific morphological changes in different striatal interneurons, which may help further explain the underlying mechanisms and the specific functions of various striatal neurons in the pathological process of HD.	[Feng, Qiqi; Ma, Yuxin; Mu, Shuhua; Wu, Jiajia; Chen, Si; OuYang, Lisi; Lei, Wanlong] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China; [Feng, Qiqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Yuxin] Guangdong Pharmaceut Univ, Sch Basic Med, Dept Anat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Pharmaceutical University	Lei, WL (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China.	leiwl@mail.sysu.edu.cn	MU, shuhua/CAG-2304-2022	mu, shuhua/0000-0002-4457-6795; Chen, Si/0000-0002-4196-0740	National Science Foundations of China [31070941, 30770679]; Major State Basic Research Development Program of China (973 Program) [2010CB530004]	National Science Foundations of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Science Foundations of China (No. 31070941, No. 30770679) and the Major State Basic Research Development Program of China (973 Program, No. 2010CB530004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bithell A, 2009, BIOCHEM SOC T, V37, P1270, DOI 10.1042/BST0371270; BOEGMAN RJ, 1988, BRAIN RES, V445, P358, DOI 10.1016/0006-8993(88)91199-7; Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; BRUYN RPM, 1990, J NEUROL SCI, V95, P29, DOI 10.1016/0022-510X(90)90114-3; Cicchetti F, 1996, BRAIN RES, V730, P232; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; CLAES S, 1995, ARCH NEUROL-CHICAGO, V52, P749, DOI 10.1001/archneur.1995.00540320021009; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; DAVIES SW, 1988, NEUROSCIENCE, V26, P387, DOI 10.1016/0306-4522(88)90156-X; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; Figueredo-Cardenas G, 1998, EXP NEUROL, V149, P356, DOI 10.1006/exnr.1997.6724; FigueredoCardenas G, 1997, EXP NEUROL, V146, P444, DOI 10.1006/exnr.1997.6549; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2003, ADV EXP MED BIOL, V527, P137; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guyot MC, 1997, NEUROSCIENCE, V79, P45, DOI 10.1016/S0306-4522(96)00602-1; Haik KL, 2000, EXP NEUROL, V163, P430, DOI 10.1006/exnr.2000.7384; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; HUANG Q, 1995, NEUROSCIENCE, V65, P397, DOI 10.1016/0306-4522(94)00494-P; Kalonia H, 2011, BEHAV BRAIN RES, V216, P220, DOI 10.1016/j.bbr.2010.07.040; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kim SH, 2011, ASN NEURO, V3, DOI 10.1042/AN20110009; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACKENZIE GM, 1995, NEUROSCIENCE, V67, P357, DOI 10.1016/0306-4522(94)00621-B; Massouh M, 2008, NEUROSCI RES, V62, P216, DOI 10.1016/j.neures.2008.08.007; Meade CA, 2000, EXP NEUROL, V166, P307, DOI 10.1006/exnr.2000.7530; Mejia ROS, 2001, NEUROSCIENTIST, V7, P480, DOI 10.1177/107385840100700604; Mu SH, 2011, J NEUROSCI RES, V89, P744, DOI 10.1002/jnr.22591; Ngai LY, 2005, J NEUROENDOCRINOL, V17, P424, DOI 10.1111/j.1365-2826.2005.01321.x; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Perez-De La Cruz V, 2012, INT J TRYPTOPHAN RES, V5, P1, DOI 10.4137/IJTR.S8158; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; ROBERTS RC, 1993, EXP NEUROL, V124, P274, DOI 10.1006/exnr.1993.1197; Sawa A, 2003, CYTOGENET GENOME RES, V100, P287, DOI 10.1159/000072864; Schwarcz R, 2010, PROG NEUROBIOL, V90, P230, DOI 10.1016/j.pneurobio.2009.04.005; Shear DA, 1998, PROG NEURO-PSYCHOPH, V22, P1217, DOI 10.1016/S0278-5846(98)00070-0; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tarawneh R, 2010, CLIN GERIATR MED, V26, P125, DOI 10.1016/j.cger.2009.12.003; Tasset I, 2010, NEUROSIGNALS, V18, P24, DOI 10.1159/000243650; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Voogd J, 1981, METHODS NEUROBIOLOGY, V2, P301; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Watson C, 2006, RAT BRAIN STEREOTAXI; WOLFENSBERGER M, 1983, NEUROSCI LETT, V41, P247, DOI 10.1016/0304-3940(83)90458-5	58	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91512	10.1371/journal.pone.0091512	http://dx.doi.org/10.1371/journal.pone.0091512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632560	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400066
J	Gao, XX; Liu, ZM; Cui, WJ; Zhou, L; Tian, YP; Zhou, ZM				Gao, Xinxing; Liu, Zhongmei; Cui, Wenjing; Zhou, Li; Tian, Yaping; Zhou, Zhemin			Enhanced Thermal Stability and Hydrolytic Ability of Bacillus subtilis Aminopeptidase by Removing the Thermal Sensitive Domain in the Non-Catalytic Region	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DOUBLE-ZINC AMINOPEPTIDASE; PROTEASE-ASSOCIATED DOMAIN; STREPTOMYCES-GRISEUS; AEROMONAS-PROTEOLYTICA; PEPTIDE HYDROLYSIS; LEUCINE AMINOPEPTIDASE; MECHANISM; ENZYME; THERMOSTABILITY	Besides the catalytic ability, many enzymes contain conserved domains to perform some other physiological functions. However, sometimes these conserved domains were unnecessary or even detrimental to the catalytic process for industrial application of the enzymes. In this study, based on homology modeling and molecular dynamics simulations, we found that Bacillus subtilis aminopeptidase contained a thermal sensitive domain (protease-associated domain) in the non-catalytic region, and predicted that deletion of this flexible domain can enhance the structure stability. This prediction was then verified by the deletion of protease-associated domain from the wild-type enzyme. The thermal stability analysis showed that deletion of this domain improved the T-50 (the temperature required to reduce initial activity by 50% in 30 min) of the enzyme from 71 degrees C to 77 degrees C. The melting temperature (T-m) of the enzyme also increased, which was measured by thermal denaturation experiments using circular dichroism spectroscopy. Further studies indicated that this deletion did not affect the activity and specificity of the enzyme toward aminoacyl-p-nitroanilines, but improved its hydrolytic ability toward a 12aa-long peptide (LKRLKRFLKRLK) and soybean protein. These findings suggested the possibility of a simple technique for enzyme modification and the artificial enzyme obtained here was more suitable for the protein hydrolysis in food industry than the wild-type enzyme.	[Gao, Xinxing; Liu, Zhongmei; Cui, Wenjing; Zhou, Li; Tian, Yaping; Zhou, Zhemin] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Zhou, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	zhmzhou@jiangnan.edu.cn		Zhou, Li/0000-0001-8448-2040	National High Technology Research and Development Program of China (863 Program) [2011AA100905]; Program for New Century Excellent Talents in University [NCET-10-0461]; Key project of Chinese Ministry of Education [NCET-10-0461]; Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education [KLIB-KF201107, KLIB-KF201203]; Fundamental Research Funds for the Central Universities [JUSRP1001]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key project of Chinese Ministry of Education(Ministry of Education, China); Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National High Technology Research and Development Program of China (863 Program, 2011AA100905), the Program for New Century Excellent Talents in University (NCET-10-0461), the Key project of Chinese Ministry of Education (311023), the Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education (KLIB-KF201107 and KLIB-KF201203) and the Fundamental Research Funds for the Central Universities JUSRP1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2000, J CELL BIOL, V149, P1335, DOI 10.1083/jcb.149.7.1335; Arima J, 2006, APPL MICROBIOL BIOT, V70, P541, DOI 10.1007/s00253-005-0105-8; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Chebaro Y, 2009, J PHYS CHEM B, V113, P7668, DOI 10.1021/jp900425e; Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676; Chen SL, 2008, J PHYS CHEM B, V112, P2494, DOI 10.1021/jp710035j; Du LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062306; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Fundoiano-Hershcovitz Y, 2004, FEBS LETT, V571, P192, DOI 10.1016/j.febslet.2004.07.001; Gao XX, 2013, PRION, V7, P328, DOI 10.4161/pri.25147; Gao XX, 2013, J SCI FOOD AGR, V93, P2810, DOI 10.1002/jsfa.6105; Gilboa R, 2001, PROTEINS, V44, P490, DOI 10.1002/prot.1115; Guo YX, 2009, FOOD CHEM, V114, P328, DOI 10.1016/j.foodchem.2008.09.041; Hershcovitz YF, 2007, FEBS J, V274, P3864, DOI 10.1111/j.1742-4658.2007.05912.x; Holz RC, 2003, CURR OPIN CHEM BIOL, V7, P197, DOI 10.1016/S1367-5931(03)00033-4; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Kato GJ, 1999, HUM MUTAT, V13, P87, DOI 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.0.CO;2-K; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; Liu J, 2008, J MOL GRAPH MODEL, V27, P529, DOI 10.1016/j.jmgm.2008.09.004; Liu XT, 2013, J MOL CATAL B-ENZYM, V93, P44, DOI 10.1016/j.molcatb.2013.04.002; Lu X, 2013, APPL MICROBIOL BIOT, P1; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Mahadevan D, 1999, PROTEIN SCI, V8, P2546; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; MILLER J, 1977, J AGR FOOD CHEM, V25, P653, DOI 10.1021/jf60211a051; Munih P, 2007, J INORG BIOCHEM, V101, P1099, DOI 10.1016/j.jinorgbio.2007.03.010; Nilsang S, 2005, J FOOD ENG, V70, P571, DOI 10.1016/j.jfoodeng.2004.10.011; Pulido-Cejudo G, 1997, ANTIVIR RES, V36, P167, DOI 10.1016/S0166-3542(97)00052-1; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Su GW, 2011, FOOD CHEM, V126, P1306, DOI 10.1016/j.foodchem.2010.11.083; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Wang FH, 2012, J AGR FOOD CHEM, V60, P165, DOI 10.1021/jf204002e; Wang YJ, 2009, BIORESOURCE TECHNOL, V100, P345, DOI 10.1016/j.biortech.2008.06.001; WU XC, 1991, J BACTERIOL, V173, P4952, DOI 10.1128/jb.173.16.4952-4958.1991; Yan MC, 2008, PROTEINS, V70, P731, DOI 10.1002/prot.21539; Zhou C, 2010, J BIOSCI BIOENG, V110, P12, DOI 10.1016/j.jbiosc.2009.12.002	38	20	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92357	10.1371/journal.pone.0092357	http://dx.doi.org/10.1371/journal.pone.0092357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633010	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400158
J	Huang, XY; Du, YH; Hu, XN; Ma, HX; Wang, HF; You, AG; Kang, K; Chen, HM; Zhang, L; Liu, GH; Xu, BL				Huang, Xueyong; Du, Yanhua; Hu, Xiaoning; Ma, Hongxia; Wang, Haifeng; You, Aiguo; Kang, Kai; Chen, Haomin; Zhang, Li; Liu, Guohua; Xu, Bianli			Epidemiological and Etiological Characteristics of Fever, Thrombocytopenia and Leukopenia Syndrome in Henan Province, China, 2011-2012	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; BUNYAVIRUS; INFECTION; VIRUS; DIAGNOSIS	The Fever, Thrombocytopenia and Leukopenia Syndrome (FTLS) is caused by a bunyavirus known as the FTLS virus (FTLSV), which was recently discovered in China. We examined the epidemiological and etiological features of 637 laboratory-confirmed cases of FTLS with onset from January 2011 to December 2012 in Henan Province, China. The highest incidence of FTLS occurred between May and August: 76.5% of all laboratory-confirmed cases occurred during those four months. Of the laboratory-confirmed cases, 60.9% were in the 46-69 years old age groups; 96.1% (612/637) occurred in farmers; 98.1% (625/637) were reported from Xinyang Prefecture. During the same time period, 2047 cases were reported in China. The nucleotide and amino acid sequences of FTLSV strains identified during 2011-2012 in Henan Province were >= 96% identical. This findings provides insight for developing public-health interventions for the control and prevention of FTLS in epidemic area.	[Huang, Xueyong; Du, Yanhua; Hu, Xiaoning; Ma, Hongxia; Wang, Haifeng; You, Aiguo; Kang, Kai; Chen, Haomin; Liu, Guohua; Xu, Bianli] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Hu, Xiaoning] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou 450052, Peoples R China; [Zhang, Li] Xinyang Ctr Dis Control & Prevent, Xinyang, Peoples R China	Zhengzhou University	Xu, BL (corresponding author), Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China.	bianlixu@163.com			Henan Medical Science Project [200702016]; Henan Province Health Department [201101017]; National Health and Fimaly Planning Commission of the People's Republic of China [201101017]; China-Australia Health and HIV/AIDS Facility [EID35]	Henan Medical Science Project; Henan Province Health Department; National Health and Fimaly Planning Commission of the People's Republic of China; China-Australia Health and HIV/AIDS Facility	This research was supported by Henan Medical Science Project (200702016), Henan Province Health Department and National Health and Fimaly Planning Commission of the People's Republic of China Co-build Project (201101017), and China-Australia Health and HIV/AIDS Facility (EID35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman BR, 2013, J WILDLIFE DIS, V49, P132, DOI 10.7589/2012-02-041; [Anonymous], 2010, NAT GUID PREV CONTR; Chang MS, 2013, J KOREAN MED SCI, V28, P795, DOI 10.3346/jkms.2013.28.6.795; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; DU Yan-Hua, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P169; Huang Xue-Yong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P165; Huang XY, 2013, J MED MICROBIOL, V62, P1060, DOI 10.1099/jmm.0.049577-0; Jiang Xiao-lin, 2012, Chinese Journal of Virology, V28, P252; Lam TTY, 2013, EPIDEMICS-NETH, V5, P1, DOI 10.1016/j.epidem.2012.09.002; Lam WY, 2010, J MED VIROL, V82, P675, DOI 10.1002/jmv.21725; Lihoradova OA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002181; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu Yang, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P500; Martin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046752; Neeraja M, 2013, J CLIN DIAGN RES, V7, P457, DOI 10.7860/JCDR/2013/4786.2798; Ojogun N, 2012, INFECT IMMUN, V80, P3748, DOI 10.1128/IAI.00654-12; Pan H, 2013, VIROL J, V10, P1; Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu L, 2011, PLOS ONE, V7; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	26	13	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91166	10.1371/journal.pone.0091166	http://dx.doi.org/10.1371/journal.pone.0091166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633131	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400044
J	Kotani, Y; Kunisawa, J; Suzuki, Y; Sato, I; Saito, T; Toba, M; Kohda, N; Kiyono, H				Kotani, Yoshifumi; Kunisawa, Jun; Suzuki, Yuji; Sato, Ikutaro; Saito, Takao; Toba, Masamichi; Kohda, Noriyuki; Kiyono, Hiroshi			Role of Lactobacillus pentosus Strain b240 and the Toll-Like Receptor 2 Axis in Peyer's Patch Dendritic Cell-Mediated Immunoglobulin A Enhancement	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; B-CELLS; IGA PRODUCTION; IMMUNE-SYSTEM; IN-VIVO; GUT; PROBIOTICS; MECHANISMS; RESPONSES; IMMUNOSTIMULATION	Lactic acid bacteria are well known to possess immune-modulating effects, but the mechanisms underlying their modulation of the gut immune system are not fully understood. Here, we examined the localization of heat-killed Lactobacillus pentosus strain b240 (b240) in intestinal tissues and the effect of b240 on adaptive immune cascades in the gut. Histological analysis showed that b240 co-localized with dendritic cells (DCs) in the subepithelial dome region of Peyer's patches (PPs). In a PP cell culture system, b240 promoted the production of immunoglobulin A (IgA), interleukin (IL)6, IL-10, interferon (IFN)-gamma, and tumor necrosis factor, but not IL-4, IL-5, B-cell activating factors, IFN-alpha, IFN-beta, and transforming growth factor-beta 1. The enhanced IgA production by b240 was attenuated by neutralizing IL-6, a potent IgA-enhancing cytokine. b240 stimulated DCs to produce an elevated amount of IL-6 in a Toll-like receptor (TLR) 2-, but not TLR4- or TLR9-dependent manner. Finally, we demonstrated that TLR2-mediated IL-6 production from PP DCs in response to b240 activated B cells to produce a large amount of IgA in a DC-B cell co-culture system. Our findings open up the possibility that the heat-killed form of Lactobacillus pentosus strain b240 can be used as a TLR2-mediated DC-activating biologic for enhancing IgA production in the intestine.	[Kotani, Yoshifumi; Sato, Ikutaro; Saito, Takao; Toba, Masamichi; Kohda, Noriyuki] Otsuka Pharmaceut Co Ltd, Otsu Nutraceut Res Inst, Shiga, Japan; [Kotani, Yoshifumi; Kunisawa, Jun; Suzuki, Yuji; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kotani, Yoshifumi; Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka, Japan	Otsuka Pharmaceutical; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan	Kunisawa, J (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	kunisawa@nibio.go.jp; Kohda.Noriyuki@otsuka.jp; kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health and Welfare of Japan; Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation; Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation; Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists A [to J.K.], for Scientific Research on Innovative Areas [to J.K.], for Scientific Research S [to H.K.], for Scientific Research on Priority Area [to H.K.], Leading-edge Research Infrastructure Program [J.K. and H.K.]); the Ministry of Health and Welfare of Japan (to J.K. and H.K.); the Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine (to H.K.); the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN; to J.K.); the Yakult Bio-Science Foundation (to J.K.); Kowa Life Science Foundation (to J.K.); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to J.K.); and CREST (to H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; Forsythe P, 2010, IMMUNOL INVEST, V39, P429, DOI 10.3109/08820131003667978; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Jin HK, 2010, BIOL PHARM BULL, V33, P289, DOI 10.1248/bpb.33.289; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kishi K, 2006, JPN J LACTIC ACID BA, V17, P132; Kotani Yoshifumi, 2010, Immun Ageing, V7, P11, DOI 10.1186/1742-4933-7-11; Kotzamanidis C, 2010, INT J FOOD MICROBIOL, V140, P154, DOI 10.1016/j.ijfoodmicro.2010.04.004; Kunisawa J, 2005, CELL MOL LIFE SCI, V62, P1308, DOI 10.1007/s00018-005-5035-1; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Galdeano CM, 2009, J DAIRY RES, V76, P446, DOI 10.1017/S0022029909990021; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; OKADA S, 1986, J GEN APPL MICROBIOL, V32, P57, DOI 10.2323/jgam.32.57; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Perdigon G, 2000, INT J IMMUNOPATH PH, V13, P141; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Tsai YT, 2010, INT IMMUNOPHARMACOL, V10, P791, DOI 10.1016/j.intimp.2010.04.012; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Yamahira S, 2006, JPN J LACTIC ACID BA, V17, P57	42	26	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91857	10.1371/journal.pone.0091857	http://dx.doi.org/10.1371/journal.pone.0091857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632732	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400110
J	Siboni, N; Abrego, D; Motti, CA; Tebben, J; Harder, T				Siboni, Nachshon; Abrego, David; Motti, Cherie A.; Tebben, Jan; Harder, Tilmann			Gene Expression Patterns during the Early Stages of Chemically Induced Larval Metamorphosis and Settlement of the Coral Acropora millepora	PLOS ONE			English	Article							PROTEIN	The morphogenetic transition of motile coral larvae into sessile primary polyps is triggered and genetically programmed upon exposure to environmental biomaterials, such as crustose coralline algae (CCA) and bacterial biofilms. Although the specific chemical cues that trigger coral larval morphogenesis are poorly understood there is much more information available on the genes that play a role in this early life phase. Putative chemical cues from natural biomaterials yielded defined chemical samples that triggered different morphogenetic outcomes: an extract derived from a CCA-associated Pseudoalteromonas bacterium that induced metamorphosis, characterized by non-attached metamorphosed juveniles; and two fractions of the CCA Hydrolithon onkodes (Heydrich) that induced settlement, characterized by attached metamorphosed juveniles. In an effort to distinguish the genes involved in these two morphogenetic transitions, competent larvae of the coral Acropora millepora were exposed to these predictable cues and the expression profiles of 47 coral genes of interest (GOI) were investigated after only 1 hour of exposure using multiplex RT-qPCR. Thirty-two GOI were differentially expressed, indicating a putative role during the early regulation of morphogenesis. The most striking differences were observed for immunity-related genes, hypothesized to be involved in cell recognition and adhesion, and for fluorescent protein genes. Principal component analysis of gene expression profiles resulted in separation between the different morphogenetic cues and exposure times, and not only identified those genes involved in the early response but also those which influenced downstream biological changes leading to larval metamorphosis or settlement.	[Siboni, Nachshon; Abrego, David; Motti, Cherie A.; Harder, Tilmann] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Tebben, Jan; Harder, Tilmann] Univ New S Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Australian Institute of Marine Science; University of New South Wales Sydney	Siboni, N (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	N.Siboni@aims.gov.au	Abrego, David/AAT-8120-2020; Siboni, Nachshon/K-4202-2012; Tebben, Jan/ABD-2247-2020; Motti, Cherie/A-2588-2012; Harder, Tilmann/B-6861-2008	Abrego, David/0000-0003-3311-2730; Siboni, Nachshon/0000-0001-6082-0949; Tebben, Jan/0000-0002-2780-2236; Harder, Tilmann/0000-0003-3173-6806; Motti, Cherie/0000-0002-3292-2785	Australian Institute of Marine Science [2233]; German Research Foundation [HA 3496/5-1]	Australian Institute of Marine Science; German Research Foundation(German Research Foundation (DFG))	Funding was provided by the Australian Institute of Marine Science, Futures Project, Appropriation Fund 2233. TH was partially supported by a Research Fellowship awarded by the German Research Foundation (HA 3496/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball EE, 2002, INT J DEV BIOL, V46, P671; Beltran-Ramirez V, 2010, THESIS J COOK U TOWN; Cheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038650; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; Harrington L, 2004, THESIS J COOK U TOWN; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Li HL, 2008, J EXP ZOOL PART B, V310B, P417, DOI 10.1002/jez.b.21214; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MORSE DE, 1991, BIOL BULL, V181, P104, DOI 10.2307/1542493; Muller WA, 2002, CAN J ZOOL, V80, P1755, DOI 10.1139/Z02-130; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Orhan IE, 2012, REC NAT PROD, V6, P356; Palmer CV, 2012, DEV COMP IMMUNOL, V38, P395, DOI 10.1016/j.dci.2012.07.008; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Siboni N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037774; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Tebben J, 2013, THESIS U NEW S WALES; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152	32	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91082	10.1371/journal.pone.0091082	http://dx.doi.org/10.1371/journal.pone.0091082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632854	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400039
J	Xu, QB; Wu, YM; Liu, HY; Xie, YM; Huang, XB; Liu, JX				Xu, Qingbiao; Wu, Yueming; Liu, Hongyun; Xie, Yingming; Huang, Xinbei; Liu, Jianxin			Establishment and Characterization of an Omasal Epithelial Cell Model Derived from Dairy Calves for the Study of Small Peptide Absorption	PLOS ONE			English	Article							PRIMARY CULTURES; INCUBATION TECHNIQUES; AMINO-ACIDS; SHEEP RUMEN; METABOLISM; FLUX; COWS; FORESTOMACH; EXPRESSION; CARNOSINE	The objective of this study was to establish a primary culture of omasal epithelial cells (OECs) derived from dairy calves and to characterize its function in small peptide absorption. Bovine omasal tissues were obtained from newborn Chinese Holstein calves and digested with a 2.5% trypsin solution to obtain OECs. The isolated cells were later cultured in DMEM containing 10% fetal bovine serum, 5 mg/ml insulin, 10 ng/ml epidermal growth factor, 100 U/ml penicillin, 100 mg/ml streptomycin, 50 mg/ml gentamycin and 2.5 mg/ml amphotericin B. Hematoxylin and eosin staining of omasal tissue after digestion indicated that the cultured cells originated from the epithelial strata. Pure epithelial cells displayed an epithelial cell-like morphology, similar to cobblestone, with few visible fibroblasts and were cytokeratin 18-positive according to immunocytochemical analyses. The OECs were morphologically characterized with desmosomes, tight junctions and microvilli. These cells exhibited normal growth properties, as assessed using a cell growth curve, and were stably cultured for 10 passages. The OECs expressed the peptide transporter 1 (PEPT1) mRNA and absorbed intact glycylsarcosine (Gly-Sar). The uptake of Gly-Sar by OECs was pH-dependent with an optimal pH of 5.5-6.5. Furthermore, the uptake of Gly-Sar was also time-dependent, concentration-dependent and temperature-dependent. Moreover, PEPT1 was saturated with Gly-Sar at a concentration of 2.5 mM. The uptake via PEPT1 was higher compared with that via passive route at low substrate concentrations (<1.5 mM). This result suggested that PEPT1 contributed more to total small peptide absorption at low concentrations. In addition, this uptake could be competitively inhibited by methionine-glycine. Taken together, these data suggested that PEPT1 contributes to small peptide absorption in OECs. Thus, OECs may serve as a useful culture model for the study of the absorption of small peptides in bovine omasum.	[Xu, Qingbiao; Wu, Yueming; Liu, Hongyun; Xie, Yingming; Huang, Xinbei; Liu, Jianxin] Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci,Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, YM (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci,Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	ymwu@zju.edu.cn; liujx@zju.edu.cn	Xu, Qingbiao/AAZ-3477-2021	Xu, Qingbiao/0000-0001-8461-9924	National Key Basic Research Program of China Ministry of Science and Technology [2011CB100801]	National Key Basic Research Program of China Ministry of Science and Technology	This research was supported by the grant from the National Key Basic Research Program of China Ministry of Science and Technology (Grant No. 2011CB100801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2006, J COMP PHYSIOL B, V176, P477, DOI 10.1007/s00360-006-0069-8; Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; BALDWIN RL, 1991, J ANIM SCI, V69, P3603, DOI 10.2527/1991.6993603x; Chen H, 2002, J NUTR, V132, P38, DOI 10.1093/jn/132.1.38; Chen H, 2002, J NUTR, V132, P387, DOI 10.1093/jn/132.3.387; Choi CW, 2002, ANIM FEED SCI TECH, V102, P15, DOI 10.1016/S0377-8401(02)00251-1; CHOPRA DP, 1991, IN VITRO CELL DEV B, V27, P13, DOI 10.1007/BF02630889; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; EVANS GS, 1992, J CELL SCI, V101, P219; Fell B., 1975, DIGESTION METABOLISM, P101; Follmann W, 2000, TOXICOL IN VITRO, V14, P435, DOI 10.1016/S0887-2333(00)00033-3; GALFI P, 1981, VET RES COMMUN, V4, P295; Garcia A, 2013, HISTOL HISTOPATHOL, V28, P737, DOI 10.14670/HH-28.737; Gilbert ER, 2008, J ANIM SCI, V86, P2135, DOI 10.2527/jas.2007-0826; Gillis RC, 2002, SMALL RUMINANT RES, V45, P291, DOI 10.1016/S0921-4488(02)00117-7; Hidalgo I J, 1996, Pharm Biotechnol, V8, P35; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huhtanen P, 1997, J ANIM SCI, V75, P1380; Jayawardena VP, 2000, OBERVATIONS RUMINAL; JESSE BW, 1992, J ANIM SCI, V70, P2235, DOI 10.2527/1992.7072235x; Kaushik RS, 2008, J VIROL METHODS, V148, P182, DOI 10.1016/j.jviromet.2007.11.006; Klotz JL, 2001, J DAIRY SCI, V84, P183, DOI 10.3168/jds.S0022-0302(01)74468-2; Liu ZH, 2011, PEPTIDES, V32, P747, DOI 10.1016/j.peptides.2011.01.019; Loret S, 2009, RES VET SCI, V87, P123, DOI 10.1016/j.rvsc.2008.12.002; MATTHEWS JC, 1995, J ANIM SCI, V73, P3464, DOI 10.2527/1995.73113464x; McCollum MQ, 1998, J ANIM SCI, V76, P2706; Miyazawa K, 2010, HISTOCHEM CELL BIOL, V133, P125, DOI 10.1007/s00418-009-0648-3; PICKETT PB, 1975, J CELL BIOL, V66, P316, DOI 10.1083/jcb.66.2.316; Remond D, 2000, J ANIM SCI, V78, P158; Remond D, 2000, J ANIM SCI, V78, P1960; Ren HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027010; Rusu D, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-42; Scow JS, 2011, J SURG RES, V170, P17, DOI 10.1016/j.jss.2011.02.018; Shimizu R, 2008, INT J PHARMACEUT, V354, P104, DOI 10.1016/j.ijpharm.2007.12.045; Stumpff F, 2011, J EXP BIOL, V214, P2871, DOI 10.1242/jeb.055582; Tagari H, 2008, J DAIRY SCI, V91, P679, DOI 10.3168/jds.2007-0629; Waldron MR, 2002, J ANIM SCI, V80, P270; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zhou MM, 2011, J ANIM PHYSIOL AN N, V95, P781, DOI 10.1111/j.1439-0396.2010.01110.x	39	13	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88993	10.1371/journal.pone.0088993	http://dx.doi.org/10.1371/journal.pone.0088993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633419	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400005
J	Borges, AH; O'Connor, JL; Phillips, AN; Baker, JV; Vjecha, MJ; Losso, MH; Klinker, H; Lopardo, G; Williams, I; Lundgren, JD				Borges, Alvaro H.; O'Connor, Jemma L.; Phillips, Andrew N.; Baker, Jason V.; Vjecha, Michael J.; Losso, Marcelo H.; Klinker, Hartwig; Lopardo, Gustavo; Williams, Ian; Lundgren, Jens D.		INSIGHT SMART Study Grp; ESPRIT Study Grp; SILCAAT Sci Comm	Factors Associated with D-Dimer Levels in HIV-Infected Individuals	PLOS ONE			English	Article							FIBRIN D-DIMER; PLASMA D-DIMER; ANTIRETROVIRAL THERAPY; COAGULATION; BIOMARKERS; DISEASE; INTERLEUKIN-6; INTERRUPTION; INFLAMMATION; DEGRADATION	Background: Higher plasma D-dimer levels are strong predictors of mortality in HIV+ individuals. The factors associated with D-dimer levels during HIV infection, however, remain poorly understood. Methods: In this cross-sectional study, participants in three randomized controlled trials with measured D-dimer levels were included (N = 9,848). Factors associated with D-dimer were identified by linear regression. Covariates investigated were: age, gender, race, body mass index, nadir and baseline CD4(+) count, plasma HIV RNA levels, markers of inflammation (C-reactive protein [CRP], interleukin-6 [IL-6]), antiretroviral therapy (ART) use, ART regimens, co-morbidities (hepatitis B/C, diabetes mellitus, prior cardiovascular disease), smoking, renal function (estimated glomerular filtration rate [eGFR] and cystatin C) and cholesterol. Results: Women from all age groups had higher D-dimer levels than men, though a steeper increase of D-dimer with age occurred in men. Hepatitis B/C co-infection was the only co-morbidity associated with higher D-dimer levels. In this subgroup, the degree of hepatic fibrosis, as demonstrated by higher hyaluronic acid levels, but not viral load of hepatitis viruses, was positively correlated with D-dimer. Other factors independently associated with higher D-dimer levels were black race, higher plasma HIV RNA levels, being off ART at baseline, and increased levels of CRP, IL-6 and cystatin C. In contrast, higher baseline CD4+ counts and higher high-density lipoprotein cholesterol were negatively correlated with D-dimer levels. Conclusions: D-dimer levels increase with age in HIV+ men, but are already elevated in women at an early age due to reasons other than a higher burden of concomitant diseases. In hepatitis B/C co-infected individuals, hepatic fibrosis, but not hepatitis viral load, was associated with higher D-dimer levels.	[Borges, Alvaro H.; Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Ctr Hlth & Infect Dis Res CHIP, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [O'Connor, Jemma L.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [Baker, Jason V.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Baker, Jason V.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Vjecha, Michael J.] Vet Affairs Med Ctr, Washington, DC 20422 USA; [Losso, Marcelo H.] Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Klinker, Hartwig] Univ Wurzburg, Med Ctr, D-97070 Wurzburg, Germany; [Lopardo, Gustavo] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina; [Williams, Ian] UCL, Ctr Sexual Hlth & HIV Res, London, England	Rigshospitalet; University of Copenhagen; University of London; University College London; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Hospital Ramos Mejia; University of Buenos Aires; University of Wurzburg; University of London; University College London	Borges, AH (corresponding author), Univ Copenhagen, Rigshosp, Ctr Hlth & Infect Dis Res CHIP, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	adb@cphiv.dk	Borges, Alvaro/G-3231-2016; Ostergaard, Lars/AAA-3020-2020; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017; Phillips, Andrew N/B-4427-2008; Klinker, Hartwig/AAC-1134-2021; Brites, Carlos/D-1353-2013; Lundgren, Jens/AAE-6876-2019; Pulido, Federico/B-8417-2009	Borges, Alvaro/0000-0003-2020-3828; Ostergaard, Lars/0000-0003-2459-0511; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Phillips, Andrew N/0000-0003-2384-4807; Brites, Carlos/0000-0002-4673-6991; Pulido, Federico/0000-0002-7414-8812; Leen, Clifford/0000-0001-8439-7719; Ristola, Matti/0000-0001-5115-2811; Medland, Nicholas Andrew/0000-0003-0403-8930; Lundgren, Jens/0000-0001-8901-7850; ABEL, Sylvie/0000-0002-3351-0547; Magenta, Lorenzo/0000-0002-7644-3647; Okhuysen, Pablo/0000-0002-1596-3411; Cabie, Andre/0000-0003-0117-3061; Ostergaard, Lars/0000-0002-7619-605X; Kozal, Michael/0000-0002-3100-8254; Easterbrook, Philippa/0000-0002-2603-5418; Gayet-Ageron, Angele/0000-0002-6164-9693; Koirala, Janak/0000-0002-3608-474X	NIH [U01AI46957, U01AI068641, U01AI042170, U01AI46362]; Chiron; Novartis; Gilead Pharmaceuticals; ViiV Health Care; CTS Inc., Durham, NC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046957, U01AI046362, U01AI042170, P30AI094189, U01AI068641, UM1AI068641] Funding Source: NIH RePORTER; Medical Research Council [MR/J01477X/1, MC_U122886352, MC_UU_12023/16] Funding Source: researchfish; MRC [MC_UU_12023/16, MR/J01477X/1, MC_U122886352] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chiron; Novartis(Novartis); Gilead Pharmaceuticals(Gilead Sciences); ViiV Health Care; CTS Inc., Durham, NC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by NIH [grant numbers: U01AI46957 and U01AI068641 (ESPRIT and SMART); U01AI042170 and U01AI46362 (SMART)]. The SILCAAT trial was supported by grants from Chiron and Novartis. In the ESPRIT and SILCAAT trials, laboratory measurements were performed by SAIC-Frederick. In the SMART trial, cholesterol was measured by Quest Diagnostics, Inc. JVB receives research support from Gilead Pharmaceuticals and ViiV Health Care. VC and JE are affiliated with International Drug Distribution (CTS Inc., Durham, NC) and received support from this company in wage form. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker J, 2010, HIV MED, V11, P608, DOI 10.1111/j.1468-1293.2010.00835.x; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Di Castelnuovo A, 2013, HAEMATOLOGICA, V98, P1476, DOI 10.3324/haematol.2012.083410; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fichtenbaum Carl J, 2011, Curr Infect Dis Rep, V13, P94, DOI 10.1007/s11908-010-0153-9; Folsom AR, 2009, AM J HEMATOL, V84, P349, DOI 10.1002/ajh.21429; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; GORDGE MP, 1989, THROMB HAEMOSTASIS, V61, P522; HAGER K, 1995, GERONTOLOGY, V41, P159; Harper PL, 2007, INTERN MED J, V37, P607, DOI 10.1111/j.1445-5994.2007.01388.x; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Kabrhel C, 2010, ACAD EMERG MED, V17, P589, DOI 10.1111/j.1553-2712.2010.00765.x; Khaleghi M, 2009, J THROMB HAEMOST, V7, P34, DOI 10.1111/j.1538-7836.2008.03215.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lange LA, 2008, J THROMB HAEMOST, V6, P654, DOI 10.1111/j.1538-7836.2008.02906.x; LASSILA R, 1993, ARTERIOSCLER THROMB, V13, P1738, DOI 10.1161/01.ATV.13.12.1738; Ledwaba L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024243; LEE AJ, 1995, ARTERIOSCL THROM VAS, V15, P1094, DOI 10.1161/01.ATV.15.8.1094; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Peters L, 2011, ANTIVIR THER, V16, P667, DOI 10.3851/IMP1815; Pieper CF, 2000, J GERONTOL A-BIOL, V55, pM649, DOI 10.1093/gerona/55.11.M649; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Rosendaal FR, 2002, ARTERIOSCL THROM VAS, V22, P201, DOI 10.1161/hq0202.102318; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Spadaro A, 2008, WORLD J GASTROENTERO, V14, P1549, DOI 10.3748/wjg.14.1549; Stouthard JML, 1996, THROMB HAEMOSTASIS, V76, P738; Tedaldi E, 2008, CLIN INFECT DIS, V47, P1468, DOI 10.1086/593102	36	49	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90978	10.1371/journal.pone.0090978	http://dx.doi.org/10.1371/journal.pone.0090978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626096	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300045
J	Etokebe, GE; Bulat-Kardum, L; Munthe, LA; Balen, S; Dembic, Z				Etokebe, Godfrey Essien; Bulat-Kardum, Ljiljana; Munthe, Ludvig Andre; Balen, Sanja; Dembic, Zlatko			Association of Variable Number of Tandem Repeats in the Coding Region of the FAM46A Gene, FAM46A rs11040 SNP and BAG6 rs3117582 SNP with Susceptibility to Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IDENTIFICATION; DETERMINANTS; POPULATION; FAMILIES; AFRICANS; RECEPTOR; C6ORF37; PROTEIN; ALLELE	We analyzed for association between the Family with sequence similarity 46, member A (FAM46A) gene (located on chromosome 6q14.1), BCL2-Associated Athanogene 6 (BAG6) gene (located on chromosome 6p21.3) and tuberculosis in Croatian Caucasian. We genotyped the FAM46A rs11040 SNP, FAM46A VNTR and BAG6 rs3117582 polymorphisms in a case-control study with 257 tuberculosis patients and 493 healthy individuals in a Croatian Caucasian population. We found that genotype FAM46A 3/3 (three VNTR repeats homozygote) was associated with susceptibility to tuberculosis (p<0.0015, P-corr<0.029, Odds ratio = 2.42, 95% Confidence Interval = 1.34-4.3). This association suggests that the protein domain encoded by the VNTR might be important for the function of the FAM46A protein, which, in turn, could be relevant in developing tuberculosis. In addition, we found that FAM46A rs11040 SNP:FAM46A VNTR:BAG6 haplotype 132 (G-3-C) is associated with susceptibility to tuberculosis (p<0.012, p(corr), <0.024, Odds ratio 3.45, 95% Confidence Interval = 1.26-9.74). This may suggests that the interaction between the FAM46A and BAG6 proteins may be involved in tuberculosis etiology. We found also that infection of human macrophages with heat-killed M. tuberculosis (H37Rv) led to over-expression of FAM46A (VNTR 3/4) transcript. This is the first study to show associations between the FAM46A gene VNTR polymorphisms, FAM46A rs11040 SNP: FAM46A VNTR: BAG6 haplotypes and any disease.	[Etokebe, Godfrey Essien; Dembic, Zlatko] Univ Oslo, Dept Oral Biol, Fac Dent, Mol Genet Lab, Oslo, Norway; [Bulat-Kardum, Ljiljana] Univ Rijeka, Sect Pulmol, Dept Internal Med, Clin Hosp Ctr, Rijeka, Croatia; [Munthe, Ludvig Andre] OUS Rikshosp, Dept Immunol, Oslo, Norway; [Balen, Sanja] Univ Rijeka, Clin Inst Transfus Med, Univ Hosp Ctr Rijeka, Sch Med, Rijeka, Croatia	University of Oslo; University of Rijeka; University of Oslo; National Hospital Norway; University of Rijeka	Etokebe, GE (corresponding author), Univ Oslo, Dept Oral Biol, Fac Dent, Mol Genet Lab, Oslo, Norway.	godfrey.etokebe@odont.uio.no	Balen, Sanja/S-5253-2018; Munthe, Ludvig/GRJ-3355-2022; Dembic, Zlatko/A-1833-2008	Balen, Sanja/0000-0003-2408-6868; Dembic, Zlatko/0000-0002-9970-6497; Munthe, Ludvig A/0000-0002-0344-3654				Awofeso N, 2010, PUBLIC HEALTH REP, V125, P25, DOI 10.1177/00333549101250S406; Barragan I, 2008, ANN HUM GENET, V72, P26, DOI 10.1111/j.1469-1809.2007.00393.x; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cui J, 2006, CLIN CHIM ACTA, V368, P155, DOI 10.1016/j.cca.2005.12.043; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Etokebe GE, 2009, ARCH ORAL BIOL, V54, P1002, DOI 10.1016/j.archoralbio.2009.08.005; Goldfeld AE, 1998, JAMA-J AM MED ASSOC, V279, P226, DOI 10.1001/jama.279.3.226; Grant AV, 2013, AM J HUM GENET, V92, P407, DOI 10.1016/j.ajhg.2013.01.013; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040836; Hannan AJ, 2010, DISCOV MED, V10, P314; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lagali PS, 2002, BIOCHEM BIOPH RES CO, V293, P356, DOI 10.1016/S0006-291X(02)00228-0; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Moustafa JSE, 2012, HUM MOL GENET, V21, P3727, DOI 10.1093/hmg/dds187; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; World Health Organization, 2012, 9 WHO; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91385	10.1371/journal.pone.0091385	http://dx.doi.org/10.1371/journal.pone.0091385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625963	Green Published, gold			2022-12-25	WOS:000332851300079
J	Kong, XD; Li, L; Sun, L; Fu, KP; Long, J; Weng, XJ; Ye, XH; Liu, XX; Wang, B; Yan, SH; Ye, HM; Fan, ZQ				Kong, Xiangdong; Li, Lin; Sun, Lei; Fu, Kepeng; Long, Ju; Weng, Xunjin; Ye, Xuehe; Liu, Xinxiong; Wang, Bo; Yan, Shanhuo; Ye, Haiming; Fan, Zuqian			Rapid Diagnosis of Aneuploidy Using Segmental Duplication Quantitative Fluorescent PCR	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; PRENATAL-DIAGNOSIS; DOWN-SYNDROME; HUMAN-GENOME; TRISOMY-21; QUANTIFICATION; CHROMOSOME-21; MLPA	The aim of this study was use a simple and rapid procedure, called segmental duplication quantitative fluorescent polymerase chain reaction (SD-QF-PCR), for the prenatal diagnosis of fetal chromosomal aneuploidies. This method is based on the co-amplification of segmental duplications located on two different chromosomes using a single pair of fluorescent primers. The PCR products of different sizes were subsequently analyzed through capillary electrophoresis, and the aneuploidies were determined based on the relative dosage between the two chromosomes. Each primer set, containing five pairs of primers, was designed to simultaneously detect aneuploidies located on chromosomes 21, 18, 13, X and Y in a single reaction. We applied these two primer sets to DNA samples isolated from individuals with trisomy 21 (n = 36); trisomy 18 (n = 6); trisomy 13 (n = 4); 45, X (n = 5); 47, XXX (n = 3); 48, XXYY (n = 2); and unaffected controls (n = 40). We evaluated the performance of this method using the karyotyping results. A correct and unambiguous diagnosis with 100% sensitivity and 100% specificity, was achieved for clinical samples examined. Thus, the present study demonstrates that SD-QF-PCR is a robust, rapid and sensitive method for the diagnosis of common aneuploidies, and these analyses can be performed in less than 4 hours for a single sample, providing a competitive alternative for routine use.	[Kong, Xiangdong] Zhengzhou Univ, Affiliated Hosp 1, Prenatal Diag Ctr, Zhengzhou, Henan, Peoples R China; [Li, Lin] Lin Yi Peoples Hosp, Dept Genet Lab, Linyi, Shandong, Peoples R China; [Sun, Lei; Fu, Kepeng; Long, Ju; Weng, Xunjin; Ye, Xuehe; Liu, Xinxiong; Yan, Shanhuo; Ye, Haiming; Fan, Zuqian] Qinzhou Maternal & Child Hlth Care Hosp, Med Genet Lab, Guangxi, Peoples R China; [Wang, Bo] Hubei Maternal & Child Hlth Hosp, Genet Lab, Suizhou, Hubei, Peoples R China	Zhengzhou University	Sun, L (corresponding author), Qinzhou Maternal & Child Hlth Care Hosp, Med Genet Lab, Guangxi, Peoples R China.	sunshijie12345@163.com			Scientific Research and Technological Development of Guangxi Province [1140003A-48]; Then Health Project of Guangxi Province [Z2010032]; Scientific Research and Technological Development of Qinzhou City [20100901, 20136104]	Scientific Research and Technological Development of Guangxi Province; Then Health Project of Guangxi Province; Scientific Research and Technological Development of Qinzhou City	The study was supported by Scientific Research and Technological Development of Guangxi Province (1140003A-48), Then Health Project of Guangxi Province (project no. Z2010032) and Scientific Research and Technological Development of Qinzhou City (20100901 and 20136104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atef SH, 2011, PEDIATR RES, V70, P412, DOI 10.1038/pr.2011.637; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Baldus CD, 2004, P NATL ACAD SCI USA, V101, P3915, DOI 10.1073/pnas.0400272101; Boormans EM, 2010, OBSTET GYNECOL, V115, P297, DOI 10.1097/AOG.0b013e3181cbc652; Caine A, 2005, LANCET, V366, P123, DOI 10.1016/S0140-6736(05)66790-6; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; Deutsch S, 2004, J MED GENET, V41, P908, DOI 10.1136/jmg.2004.023184; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Dudarewicz Lech, 2005, Journal of Applied Genetics, V46, P207; Guo QW, 2012, CLIN CHEM, V58, P1019, DOI 10.1373/clinchem.2011.178475; Helmy SMH, 2009, FETAL DIAGN THER, V25, P220, DOI 10.1159/000218031; Ho SSY, 2012, PRENATAL DIAG, V32, P321, DOI 10.1002/pd.2946; Lee HH, 1997, HUM GENET, V99, P364, DOI 10.1007/s004390050373; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Slater HR, 2003, J MED GENET, V40, P907, DOI 10.1136/jmg.40.12.907; VONEGGELING F, 1993, HUM GENET, V91, P567, DOI 10.1007/BF00205081; Willis AS, 2012, PRENATAL DIAG, V32, P315, DOI 10.1002/pd.3860; Zimmermann B, 2002, CLIN CHEM, V48, P362	21	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e88932	10.1371/journal.pone.0088932	http://dx.doi.org/10.1371/journal.pone.0088932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625828	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300004
J	Molina-Pinelo, S; Gutierrez, G; Pastor, MD; Hergueta, M; Moreno-Bueno, G; Garcia-Carbonero, R; Nogal, A; Suarez, R; Salinas, A; Pozo-Rodriguez, F; Lopez-Rios, F; Agullo-Ortuno, MT; Ferrer, I; Perpina, A; Palacios, J; Carnero, A; Paz-Ares, L				Molina-Pinelo, Sonia; Gutierrez, Gabriel; Dolores Pastor, Maria; Hergueta, Marta; Moreno-Bueno, Gema; Garcia-Carbonero, Rocio; Nogal, Ana; Suarez, Rocio; Salinas, Ana; Pozo-Rodriguez, Francisco; Lopez-Rios, Fernando; Teresa Agullo-Ortuno, Maria; Ferrer, Irene; Perpina, Asuncion; Palacios, Jose; Carnero, Amancio; Paz-Ares, Luis			MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; PANCREATIC ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; EXPRESSION PROFILES; PREDICTS SURVIVAL; BREAST-CANCER; CARCINOMA; RESISTANCE; CEACAM6; MUC1	Squamous cell lung cancer (SCC) and adenocarcinoma are the most common histological subtypes of non-small cell lung cancer (NSCLC), and have been traditionally managed in the clinic as a single entity. Increasing evidence, however, illustrates the biological diversity of these two histological subgroups of lung cancer, and supports the need to improve our understanding of the molecular basis beyond the different phenotypes if we aim to develop more specific and individualized targeted therapy. The purpose of this study was to identify microRNA (miRNA)-dependent transcriptional regulation differences between SCC and adenocarcinoma histological lung cancer subtypes. In this work, paired miRNA (667 miRNAs by TaqMan Low Density Arrays (TLDA)) and mRNA profiling (Whole Genome 44 K array G112A, Agilent) was performed in tumor samples of 44 NSCLC patients. Nine miRNAs and 56 mRNAs were found to be differentially expressed in SCC versus adenocarcinoma samples. Eleven of these 56 mRNA were predicted as targets of the miRNAs identified to be differently expressed in these two histological conditions. Of them, 6 miRNAs (miR-149, miR-205, miR-375, miR-378, miR-422a and miR-708) and 9 target genes (CEACAM6, CGN, CLDN3, ABCC3, MLPH, ACSL5, TMEM45B, MUC1) were validated by quantitative PCR in an independent cohort of 41 lung cancer patients. Furthermore, the inverse correlation between mRNAs and microRNAs expression was also validated. These results suggest miRNA-dependent transcriptional regulation differences play an important role in determining key hallmarks of NSCLC, and may provide new biomarkers for personalized treatment strategies.	[Molina-Pinelo, Sonia; Dolores Pastor, Maria; Garcia-Carbonero, Rocio; Nogal, Ana; Suarez, Rocio; Salinas, Ana; Ferrer, Irene; Paz-Ares, Luis] Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Mol Oncol & New Therapies Grp,HUVR, Seville, Spain; [Gutierrez, Gabriel] Univ Seville, Dept Genet, Seville, Spain; [Hergueta, Marta; Moreno-Bueno, Gema] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Biochem, Madrid, Spain; [Garcia-Carbonero, Rocio; Paz-Ares, Luis] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain; [Nogal, Ana] Inst Ciencias Biomed Abel Salazar ICBAS, Oporto, Portugal; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Serv Neumol, E-28041 Madrid, Spain; [Pozo-Rodriguez, Francisco] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Lopez-Rios, Fernando] Ctr Integral Oncol Clara Campal, Dept Pathol, Lab Dianas Terapeut, Madrid, Spain; [Teresa Agullo-Ortuno, Maria] Hosp Doce Octubre, Inst Invest Sanitaria I 12, Madrid, Spain; [Perpina, Asuncion] Hosp Severo Ochoa, Serv Neumol, Madrid, Spain; [Palacios, Jose] Hosp Univ Ramon & Cajal, Inst Invest Sanitaria Ramon & Cajal IRYCIS, Dept Pathol, Madrid, Spain; [Carnero, Amancio] Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Mol Biol Canc Grp,HUVR, Seville, Spain; [Hergueta, Marta; Moreno-Bueno, Gema] IdiPAZ Inst Invest Sanitaria La Paz, Madrid, Spain; [Hergueta, Marta; Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Virgen del Rocio University Hospital; Universidade do Porto; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario 12 de Octubre; Severo Ochoa University Hospital; Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Texas System; UTMD Anderson Cancer Center	Paz-Ares, L (corresponding author), Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Mol Oncol & New Therapies Grp,HUVR, Seville, Spain.	lpazares@hotmail.com	Ferrer, Irene/C-9418-2015; Agulló Ortuño, M. Teresa/T-1494-2017; Molina-Pinelo, Sonia/M-4643-2015; gutierrez, gabriel/S-7646-2017; Pozo, Gabriel Gutiérrez/N-7824-2019; Moreno-Bueno, Gema/K-9354-2016; Agulló-Ortuño, M. Teresa/ABA-3155-2021; IBIS, CANCER/P-3323-2015; Palacios, Jose/AAV-3765-2020; Paz-Ares, Luis/AAH-2750-2019	Ferrer, Irene/0000-0002-2748-2607; Agulló Ortuño, M. Teresa/0000-0002-7617-6681; Molina-Pinelo, Sonia/0000-0002-5726-2453; gutierrez, gabriel/0000-0002-1354-2883; Pozo, Gabriel Gutiérrez/0000-0002-1354-2883; Moreno-Bueno, Gema/0000-0002-5030-6687; Agulló-Ortuño, M. Teresa/0000-0002-7617-6681; Nogal, Ana/0000-0002-7576-0210; Pastor, Maria Dolores/0000-0003-2736-0447; Garcia-Carbonero, Rocio/0000-0002-3342-397X; Carnero, Amancio/0000-0003-4357-3979	Fondo de Investigacion Sanitaria [PI081156, PI1102688, R12/0036/0028, CD1100153, CD0900148, PI10/02164]; Proyecto de Excelencia de la Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [P08-CVI-04090]; Roche Fellowship in 75th Anniversary, Spain; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Consejeria de Salud, Servicio Andaluz de Salud [PI-0224/2009, PI-0046/2012]; Fundacion Mutua Madrilena; Madrid Regional Government [S2010/BMD-2303]; Spanish Ministry of Economy and Competitivity, ISCIII [PI12/00137, RTICC: RD12/0036/0028]; Consejeria de Ciencia e Innovacion [CTS-6844]; Consejeria de Salud of the Junta de Andalucia [PI-0135-2010, PI-0306-2012];  [SAF2010-20175]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Proyecto de Excelencia de la Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia; Roche Fellowship in 75th Anniversary, Spain; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Consejeria de Salud, Servicio Andaluz de Salud; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Madrid Regional Government; Spanish Ministry of Economy and Competitivity, ISCIII; Consejeria de Ciencia e Innovacion; Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); 	LPA is funded by Fondo de Investigacion Sanitaria (PI081156, PI1102688 and R12/0036/0028), Proyecto de Excelencia de la Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (P08-CVI-04090), and the Roche Fellowship in 75th Anniversary, Spain. SMP is funded by Fondo de Investigacion Sanitaria (CD1100153), Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Consejeria de Salud, Servicio Andaluz de Salud (PI-0224/2009 and PI-0046/2012), and Fundacion Mutua Madrilena (2009). MDP is funded by Fondo de Investigacion Sanitaria (CD0900148). RGC is funded by Fondo de Investigacion Sanitaria (PI10/02164). GMB is funded by SAF2010-20175 and Madrid Regional Government (S2010/BMD-2303). AC lab was supported by grants to from the Spanish Ministry of Economy and Competitivity, ISCIII (PI12/00137, RTICC: RD12/0036/0028), Consejeria de Ciencia e Innovacion (CTS-6844) and Consejeria de Salud of the Junta de Andalucia (PI-0135-2010 and PI-0306-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Chang HH, 2011, CANCER-AM CANCER SOC, V117, P353, DOI 10.1002/cncr.25592; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Giatromanolaki A, 2000, CLIN CANCER RES, V6, P1917; Gibbs S, 2000, WOUND REPAIR REGEN, V8, P192, DOI 10.1046/j.1524-475x.2000.00192.x; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guddo F, 1998, J CLIN PATHOL, V51, P667, DOI 10.1136/jcp.51.9.667; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Huang W, 2012, AM J RESP CRIT CARE, V186, P1160, DOI 10.1164/rccm.201203-0534OC; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kayser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056333; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logsdon CD, 2003, CANCER RES, V63, P2649; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Molina-Pinelo S, 2012, DIS MARKERS, V32, P221, DOI [10.1155/2012/873749, 10.3233/DMA-2011-0882]; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Perez-Soler R, 2009, ONCOGENE, V28, pS38, DOI 10.1038/onc.2009.200; Petersen I, 1997, CANCER RES, V57, P2331; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tran QN, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S11; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Yamashita Y, 2000, ONCOGENE, V19, P5919, DOI 10.1038/sj.onc.1203981; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	51	58	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90524	10.1371/journal.pone.0090524	http://dx.doi.org/10.1371/journal.pone.0090524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625834	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300023
J	Shiraishi, N; Suzuki, Y; Matsumoto, D; Jeong, S; Sugiyama, M; Kondo, K; Kuzuya, M				Shiraishi, Nariaki; Suzuki, Yusuke; Matsumoto, Daisuke; Jeong, Seungwon; Sugiyama, Motoya; Kondo, Katsunori; Kuzuya, Masafumi			The Effect of Additional Training on Motor Outcomes at Discharge from Recovery Phase Rehabilitation Wards: A Survey from Multi-Center Stroke Data Bank in Japan	PLOS ONE			English	Article							UNIT	Objectives: The purpose of the present study was to examine the potential benefits of additional training in patients admitted to recovery phase rehabilitation ward using the data bank of post-stroke patient registry. Subjects and Methods: Subjects were 2507 inpatients admitted to recovery phase rehabilitation wards between November 2004 and November 2010. Participants were retrospectively divided into four groups based upon chart review; patients who received no additional rehabilitation, patients who were added with self-initiated off hours training, patients who were added with off hours training by ward staff, patients who received both self-initiated training and training by ward staff. Parameters for assessing outcomes included length of stay, motor/cognitive subscales of functional independent measures (FIM) and motor benefit of FIM calculated by subtracting the score at admission from that at discharge. Results: Participants were stratified into three groups depending on the motor FIM at admission (<= 28, 29 similar to 56, 57 <=) for comparison. Regarding outcome variables, significant inter-group differences were observed in all items examined within the subgroup who scored 28 or less and between 29 and 56. Meanwhile no such trends were observed in the group who scored 57 or more compared with those who scored less. In a decision tree created based upon Exhaustive Chi-squared Automatic Interaction Detection method, variables chosen were the motor FIM at admission (the first node) additional training (the second node), the cognitive FIM at admission(the third node). Conclusions: Overall the results suggest that additional training can compensate for the shortage of regular rehabilitation implemented in recovery phase rehabilitation ward, thus may contribute to improved outcomes assessed by motor FIM at discharge.	[Shiraishi, Nariaki; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Program Hlth & Community Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan; [Shiraishi, Nariaki] Nihon Fukushi Univ, Dept Rehabil, Fac Hlth Sci, Nagoya, Aichi, Japan; [Suzuki, Yusuke] Nagoya Univ, Grad Sch Med, Dept Comprehens Community Care Syst, Nagoya, Aichi 4648601, Japan; [Matsumoto, Daisuke] Kio Univ, Fac Hlth Sci, Dept Phys Therapy, Koryo, Japan; [Jeong, Seungwon] Chubu Rosai Hosp, Dept Social Sci, Ctr Gerontol & Social Sci, Nagoya, Aichi, Japan; [Sugiyama, Motoya] Chubu Rosai Hosp, Dept Rehabil, Nagoya, Aichi, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Shiraishi, N (corresponding author), Nagoya Univ, Grad Sch Med, Program Hlth & Community Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan.	n-shira@n-fukushi.ac.jp	Matsumoto, Daisuke/AFM-3401-2022; SHIRAO, N/H-3280-2019; Kuzuya, Masafumi/I-1583-2012; Matsumoto, Daisuke/ABG-8286-2021; Kondo, Katsunori/AAI-6373-2020	Matsumoto, Daisuke/0000-0002-6615-5318; Matsumoto, Daisuke/0000-0002-6615-5318; Jeong, Seungwon/0000-0003-2919-7508	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Grant-in-Aid for Scientific Research (C) by The Ministry of Education, Culture, Sports, Science and Technology of the Japanese government, issued for the research project entitled "The effect of additional training after stroke: a data base study.'' The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1995, POSTSTROKE REHABILIT; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Duncan P, 1998, STROKE, V29, P6; Galvin R, 2011, STROKE, V42, P681, DOI 10.1161/STROKEAHA.110.594689; Gan XM, 2011, J NEUROL SCI, V306, P108, DOI 10.1016/j.jns.2011.03.032; Indredavik B, 1999, STROKE, V30, P1524, DOI 10.1161/01.STR.30.8.1524; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kawano T, 2011, SOGO RIHABIRITESHON, V39, P1151; Kondo K, 2004, JPN J REHABIL MED, V41, P214; Kondo K, 2005, SOGO RIHABIRITESHON, V33, P1119; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Maeshima S, 2003, AM J PHYS MED REHAB, V82, P456, DOI 10.1097/01.PHM.0000069195.87219.E0; Miyakoshi K, 2008, JPN J STROKE, V30, P69; Rabadi MH, 2011, MED SCI MONITOR, V17, pRA25, DOI 10.12659/MSM.881382; Skidmore ER, 2006, CLIN REHABIL, V20, P523, DOI 10.1191/0269215506cr980oa; Suzuki E, 2004, JPN J REHABIL MED, V41	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91738	10.1371/journal.pone.0091738	http://dx.doi.org/10.1371/journal.pone.0091738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626224	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300130
J	Xiao, Q; Hu, YT; Liu, Y; Wang, ZH; Geng, HT; Hu, LF; Xu, DY; Wang, K; Zheng, L; Zheng, S; Ding, KF				Xiao, Qian; Hu, Yeting; Liu, Yue; Wang, Zhanhuai; Geng, Haitao; Hu, Lifeng; Xu, Dengyong; Wang, Ke; Zheng, Lei; Zheng, Shu; Ding, Kefeng			BEX1 Promotes Imatinib-Induced Apoptosis by Binding to and Antagonizing BCL-2	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BREAST-CANCER; MALIGNANT GLIOMA; GENE FAMILY; CELL-CYCLE; RESISTANCE; THERAPY; INHIBITION; ACTIVATION; PHOSPHORYLATION	An enhanced anti-apoptotic capacity of tumor cells plays an important role in the process of breakpoint cluster region/Abelson tyrosine kinase gene (BCR/ABL)-independent imatinib resistance. We have previously demonstrated that brain expressed X-linked 1 (BEX1) was silenced in secondary imatinib-resistant K562 cells and that re-expression of BEX1 can restore imatinib sensitivity resulting in the induction of apoptosis. However, the mechanism by which BEX1 executes its proapoptotic function remains unknown. We identified B-cell lymphoma 2 (BCL-2) as a BEX1-interacting protein using a yeast two-hybrid screen. The interaction between BEX1 and BCL-2 was subsequently confirmed by co-immunoprecipitation assays. Like BCL-2, BEX1 was localized to the mitochondria. The region between 33K and 64Q on BEX1 is important for its localization to the mitochondria and its ability to interact with BCL-2. Additionally, we found that this region is essential for BEX1-regulated imatinib-induced apoptosis. Furthermore, we demonstrated that the interaction between BCL-2 and BEX1 promotes imatinib-induced apoptosis by suppressing the formation of anti-apoptotic BCL-2/BCL-2-associated X protein (BAX) heterodimers. Our results revealed an interaction between BEX1 and BCL-2 and a novel mechanism of imatinib resistance mediated by the BEX1/BCL-2 pathway.	[Xiao, Qian; Hu, Yeting; Liu, Yue; Wang, Zhanhuai; Geng, Haitao; Hu, Lifeng; Xu, Dengyong; Wang, Ke; Zheng, Shu; Ding, Kefeng] Inst Canc Res, China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xiao, Qian; Hu, Yeting; Liu, Yue; Wang, Zhanhuai; Geng, Haitao; Hu, Lifeng; Xu, Dengyong; Wang, Ke; Zheng, Lei; Zheng, Shu; Ding, Kefeng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Surg, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA	Zhejiang University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Zheng, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	lzheng6@jhmi.edu; zhengshu@zju.edu.cn; Dingkefeng@zju.edu.cn			National Natural Science Foundation of China [30772473, 81071801, 81272455]; Zhejiang Provincial Natural Science Foundation of China [R2100071]; US NIH [K23 CA148964-01]; Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE [P50CA062924, K23CA148964, R01CA169702] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in Cancer Institute of Zhejiang University School of Medicine was supported by grants from the National Natural Science Foundation of China (No. 30772473, 81071801, 81272455) and Zhejiang Provincial Natural Science Foundation of China (No. R2100071). Lei Zheng is supported by a US NIH K23 CA148964-01 and a Johns Hopkins University School of Medicine Clinician Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Giuliani F, 2012, EXPERT OPIN THER TAR, V16, pS35, DOI 10.1517/14728222.2012.657627; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Juan WC, 2012, PROG MOL BIOL TRANSL, V106, P107, DOI 10.1016/B978-0-12-396456-4.00007-9; Karvela M, 2012, EXPERT REV ANTICANC, V12, P381, DOI [10.1586/ERA.12.10, 10.1586/era.12.10]; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Lee F, 2008, INT J BIOCHEM CELL B, V40, P334, DOI 10.1016/j.biocel.2007.10.001; Melarangi T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.102; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pratesi G, 2001, BIOCHEM PHARMACOL, V61, P381, DOI 10.1016/S0006-2952(00)00538-4; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Thomadaki H, 2006, CRIT REV CL LAB SCI, V43, P1, DOI 10.1080/10408360500295626; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; WELLER M, 1995, J CLIN INVEST, V95, P2633, DOI 10.1172/JCI117965; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Yang QS, 2002, BIOCHEM GENET, V40, P1, DOI 10.1023/A:1014565320998	32	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91782	10.1371/journal.pone.0091782	http://dx.doi.org/10.1371/journal.pone.0091782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626299	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300135
J	Blok, CA; Kersbergen, KJ; van der Aa, NE; van Kooij, BJ; Anbeek, P; Isgum, I; de Vries, LS; Krediet, TG; Groenendaal, F; Vreman, HJ; van Bel, F; Benders, MJ				Blok, Cornelie A.; Kersbergen, Karina J.; van der Aa, Niek E.; van Kooij, Britt J.; Anbeek, Petronella; Isgum, Ivana; de Vries, Linda S.; Krediet, Tannette G.; Groenendaal, Floris; Vreman, Hendrik J.; van Bel, Frank; Benders, Manon J.			Unmyelinated White Matter Loss in the Preterm Brain Is Associated with Early Increased Levels of End-Tidal Carbon Monoxide	PLOS ONE			English	Article							HEME OXYGENASE-1; INFANTS; INJURY; HISTORY; LESIONS; STRESS; BIRTH; AGE	Objective: Increased levels of end-tidal carbon monoxide (ETCOc) in preterm infants during the first day of life are associated with oxidative stress, inflammatory processes and adverse neurodevelopmental outcome at 2 years of age. Therefore, we hypothesized that early ETCOc levels may also be associated with impaired growth of unmyelinated cerebral white matter. Methods: From a cohort of 156 extremely and very preterm infants in which ETCOc was determined within 24 h after birth, in 36 infants 3D-MRI was performed at term-equivalent age to assess cerebral tissue volumes of important brain regions. Results: Linear regression analysis between cerebral ventricular volume, unmyelinated white matter/total brain volume-, and cortical grey matter/total brain volume-ratio and ETCOc showed a positive, negative and positive correlation, respectively. Multivariable analyses showed that solely ETCOc was positively related to cerebral ventricular volume and cortical grey matter/total brain volume ratio, and that solely ETCOc was inversely related to the unmyelinated white matter/total brain volume ratio, suggesting that increased levels of ETCOc, associated with oxidative stress and inflammation, were related with impaired growth of unmyelinated white matter. Conclusion: Increased values of ETCOc, measured within the first 24 hours of life may be indicative of oxidative stress and inflammation in the immediate perinatal period, resulting in impaired growth of the vulnerable unmyelinated white matter of the preterm brain.	[Blok, Cornelie A.; Kersbergen, Karina J.; van der Aa, Niek E.; van Kooij, Britt J.; Anbeek, Petronella; de Vries, Linda S.; Krediet, Tannette G.; Groenendaal, Floris; van Bel, Frank; Benders, Manon J.] Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Isgum, Ivana] Univ Med Ctr, Image Sci Inst, Utrecht, Netherlands; [Vreman, Hendrik J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Stanford University	Krediet, TG (corresponding author), Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	f.vanbel@umcutrecht.nl	Groenendaal, Floris/P-6872-2019; de Vries, Linda S/AAB-6454-2021; Isgum, Ivana/H-8659-2014	Groenendaal, Floris/0000-0002-9284-1637; Isgum, Ivana/0000-0003-1869-5034				Anbeek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081895; Avino TA, 2010, BRAIN RES, V1360, P138, DOI 10.1016/j.brainres.2010.08.091; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Blackmon K, 2011, J NEUROSCI, V31, P15257, DOI 10.1523/JNEUROSCI.3039-11.2011; Blok CA, 2011, DEV MED CHILD NEUROL, V53, P1113, DOI 10.1111/j.1469-8749.2011.04110.x; Buntinx M, 2004, J NEUROSCI RES, V76, P834, DOI 10.1002/jnr.20118; Buser JR, 2010, J CEREBR BLOOD F MET, V30, P1053, DOI 10.1038/jcbfm.2009.286; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6; Giedion A, 1973, PEDIATR RADIOL, V1, P45; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Hemels MA, 2012, PEDIATR CRIT CARE ME, V13, P678, DOI 10.1097/PCC.0b013e3182455778; Horvath I, 1998, THORAX, V53, P668, DOI 10.1136/thx.53.8.668; Kersbergen KJ, 2013, J PEDIATR-US, V163, P666, DOI 10.1016/j.jpeds.2013.04.001; Kharitonov SA, 2002, BIOMARKERS, V7, P1, DOI 10.1080/13547500110104233; Krediet TG, 2006, ACTA PAEDIATR, V95, P1075, DOI 10.1080/08035250500537017; Leitch DN, 2005, RESP MED, V99, P32, DOI 10.1016/j.rmed.2004.03.027; Maunu J, 2011, DEV MED CHILD NEUROL, V53, P48, DOI 10.1111/j.1469-8749.2010.03785.x; May C, 2007, PEDIATR RES, V61, P474, DOI 10.1203/pdr.0b013e3180332bfe; PAPILE LA, 1983, J PEDIATR-US, V103, P273, DOI 10.1016/S0022-3476(83)80366-7; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shi Y, 2003, ARCH DIS CHILD, V88, P889, DOI 10.1136/adc.88.10.889; Stevenson DK, 1979, J PEDIAT, V94, P56; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Terheggen-Lagro SW, 2003, AM J RESP CRIT CARE, V168, P1227, DOI 10.1164/rccm.200302-248OC; Torrance HL, 2008, NEONATOLOGY, V94, P138, DOI 10.1159/000119724; van Bel F, 2005, J APPL PHYSIOL, V98, P1044, DOI 10.1152/japplphysiol.00760.2004; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Vreman HJ, 1998, CAN J PHYSIOL PHARM, V76, P1057; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89061	10.1371/journal.pone.0089061	http://dx.doi.org/10.1371/journal.pone.0089061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622422	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300005
J	Hendrix, J; van Heertum, B; Vanstreels, E; Daelemans, D; De Rijck, J				Hendrix, Jelle; van Heertum, Bart; Vanstreels, Els; Daelemans, Dirk; De Rijck, Jan			Dynamics of the Ternary Complex Formed by c-Myc Interactor JPO2, Transcriptional Co- activator LEDGF/p75, and Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Coactivator Transcription; Fluorescence Correlation Spectroscopy; Integrase; Protein Dynamics; Protein-Protein Interactions; Transcription Factors; JPO2; LEDGF; p75; PogZ	FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; PULSED INTERLEAVED EXCITATION; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 INTEGRASE; IN-VIVO; GROWTH-FACTOR; COACTIVATOR P75; LIVE CELLS; MONOAMINE-OXIDASE	Background: The function of transcription factors can be investigated by monitoring their movement inside the nucleus of cells with biophysical techniques. Results: A model for interaction of JPO2 with chromatin in the absence and presence of its interaction partner LEDGF/p75 is proposed. Conclusion: JPO2 adopts the dynamics of LEDGF/p75. Significance: Our approach is generic for the study of transcription factor dynamics. Lens epithelium-derived growth factor (LEDGF/p75) is a transcriptional co-activator involved in targeting human immunodeficiency virus (HIV) integration and the development of MLL fusion-mediated acute leukemia. A previous study revealed that LEDGF/p75 dynamically scans the chromatin, and upon interaction with HIV-1 integrase, their complex is locked on chromatin. At present, it is not known whether LEDGF/p75-mediated chromatin locking is typical for interacting proteins. Here, we employed continuous photobleaching and fluorescence correlation and cross-correlation spectroscopy to investigate in vivo chromatin binding of JPO2, a LEDGF/p75- and c-Myc-interacting protein involved in transcriptional regulation. In the absence of LEDGF/p75, JPO2 performs chromatin scanning inherent to transcription factors. However, whereas the dynamics of JPO2 chromatin binding are decelerated upon interaction with LEDGF/p75, very strong locking of their complex onto chromatin is absent. Similar results were obtained with the domesticated transposase PogZ, another cellular interaction partner of LEDGF/p75. We furthermore show that diffusive JPO2 can oligomerize; that JPO2 and LEDGF/p75 interact directly and specifically in vivo through the specific interaction domain of JPO2 and the C-terminal domain of LEDGF/p75, comprising the integrase-binding domain; and that modulation of JPO2 dynamics requires a functional PWWP domain in LEDGF/p75. Our results suggest that the dynamics of the LEDGF/p75-chromatin interaction depend on the specific partner and that strong chromatin locking is not a property of all LEDGF/p75-binding proteins.	[Hendrix, Jelle] Univ Louvain, Dept Chem, Lab Photochem & Spect, B-3001 Louvain, Belgium; [van Heertum, Bart; De Rijck, Jan] Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium; [Vanstreels, Els; Daelemans, Dirk] Univ Louvain, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst Med Res, B-3000 Louvain, Belgium	KU Leuven	De Rijck, J (corresponding author), Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, Kapucijnenvoer 33, B-3000 Louvain, Belgium.	jan.derijck@med.kuleuven.be	De Rijck, Jan/A-2729-2013; Vanstreels, Els/I-2366-2018; Daelemans, Dirk/P-7923-2017; HENDRIX, Jelle/H-1721-2018	Vanstreels, Els/0000-0002-7814-8035; Daelemans, Dirk/0000-0001-7092-1153; HENDRIX, Jelle/0000-0001-5731-1297	Bijzonder Onderzoeksfonds (BOF) KU Leuven; Fonds voor Wetenschappelijk Onderzoek in Vlaanderen (FWO); European Union (EU) (Framework Programme 7 (FP7) Combined Highly Active Anti-Retroviral Microbicides (CHAARM)); Research Foundation Flanders (FWO Vlaanderen); agency for Innovation by Science and Technology (IWT Flanders)	Bijzonder Onderzoeksfonds (BOF) KU Leuven; Fonds voor Wetenschappelijk Onderzoek in Vlaanderen (FWO)(FWO); European Union (EU) (Framework Programme 7 (FP7) Combined Highly Active Anti-Retroviral Microbicides (CHAARM)); Research Foundation Flanders (FWO Vlaanderen)(FWO); agency for Innovation by Science and Technology (IWT Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Bijzonder Onderzoeksfonds (BOF) KU Leuven, Fonds voor Wetenschappelijk Onderzoek in Vlaanderen (FWO), and European Union (EU) (Framework Programme 7 (FP7) Combined Highly Active Anti-Retroviral Microbicides (CHAARM)).; Supported by a postdoctoral scholarship from the Research Foundation Flanders (FWO Vlaanderen).; Supported by a doctoral fellowship from the agency for Innovation by Science and Technology (IWT Flanders).	Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2011, MOL PHARMACOL, V79, P308, DOI 10.1124/mol.110.067439; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Delon A, 2004, J FLUORESC, V14, P255, DOI 10.1023/B:JOFL.0000024557.73246.f9; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hendrix J, 2008, BIOPHYS J, V94, P4103, DOI 10.1529/biophysj.107.123596; Hendrix J, 2014, METHODS MOL BIOL, V1076, P653, DOI 10.1007/978-1-62703-649-8_30; Hendrix J, 2013, BIOPHYS J, V105, P848, DOI 10.1016/j.bpj.2013.05.059; Hendrix J, 2013, METHOD ENZYMOL, V518, P205, DOI 10.1016/B978-0-12-388422-0.00009-1; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Hwang LC, 2004, CHEMPHYSCHEM, V5, P549, DOI 10.1002/cphc.200301057; Johnson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2139, DOI 10.1038/npp.2011.105; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; Kohl T, 2005, BIOPHYS J, V89, P2770, DOI 10.1529/biophysj.105.061127; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2005, FASEB J, V19, P1039, DOI 10.1096/fj.04-3373fje; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; Mazza D, 2012, METHODS MOL BIOL, V833, P177, DOI 10.1007/978-1-61779-477-3_12; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Mereau H, 2013, LEUKEMIA, V27, P1245, DOI 10.1038/leu.2013.10; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; PETERS R, 1981, P NATL ACAD SCI-BIOL, V78, P962, DOI 10.1073/pnas.78.2.962; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rauer B, 1996, BIOPHYS CHEM, V58, P3, DOI 10.1016/0301-4622(95)00080-1; Ries J, 2006, BIOPHYS J, V91, P1915, DOI 10.1529/biophysj.106.082297; Rivera-Gonzalez GC, 2012, NUCLEIC ACIDS RES, V40, P4825, DOI 10.1093/nar/gks143; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Shi XK, 2009, BIOPHYS J, V97, P678, DOI 10.1016/j.bpj.2009.05.006; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2011, CHROMOSOMA, V120, P533, DOI 10.1007/s00412-011-0340-y; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Thalmeier A, 2008, INT J NEUROPSYCHOPH, V11, P217, DOI 10.1017/S1461145707007894; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107; Wachsmuth M, 2003, BIOPHYS J, V84, P3353, DOI 10.1016/S0006-3495(03)70059-9; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	86	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12494	12506		10.1074/jbc.M113.525964	http://dx.doi.org/10.1074/jbc.M113.525964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634210	Green Published, hybrid			2022-12-25	WOS:000335581400025
J	Eom, S; Kim, Y; Park, D; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Eom, Sangkyung; Kim, Youngmi; Park, Deokbum; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			Histone Deacetylase-3 Mediates Positive Feedback Relationship between Anaphylaxis and Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Cell-Cell Interaction; Histone Deacetylase; MicroRNA; Tumor Metastases; Anaphylaxis; Histone Deacetylase-3; Positive Feedback Regulatory Loop; MicroRNA-384	EPITHELIAL-MESENCHYMAL TRANSITION; ALLERGIC AIRWAY INFLAMMATION; MOUSE ASTHMA MODEL; MAST-CELLS; SYSTEMIC-ANAPHYLAXIS; SKIN INFLAMMATION; ACTIVATION; EXPRESSION; GROWTH; OVEREXPRESSION	Background: The relationship between anaphylaxis and tumor metastasis remains unknown at the molecular level. Results: The miR-384/HDAC3 axis regulates an interaction between tumor cells and mast cells. Conclusion: HDAC3 mediates a positive feedback loop between anaphylaxis and tumor metastasis. Significance: HDAC3 can be a target for the development of allergy and cancer therapeutics. Allergic inflammation has been known to enhance the metastatic potential of tumor cells. The role of histone deacetylase-3 (HDAC3) in allergic skin inflammation was reported. We investigated HDAC3 involvement in the allergic inflammation-promotion of metastatic potential of tumor cells. Passive systemic anaphylaxis (PSA) induced HDAC3 expression and FcERI signaling in BALB/c mice. PSA enhanced the tumorigenic and metastatic potential of mouse melanoma cells in HDAC3- and monocyte chemoattractant protein 1-(MCP1)-dependent manner. The PSA-mediated enhancement of metastatic potential involved the induction of HDAC3, MCP1, and CD11b (a macrophage marker) expression in the lung tumor tissues. We examined an interaction between anaphylaxis and tumor growth and metastasis at the molecular level. Conditioned medium from antigen-stimulated bone marrow-derived mouse mast cell cultures induced the expression of HDAC3, MCP1, and CCR2, a receptor for MCP1, in B16F1 mouse melanoma cells and enhanced migration and invasion potential of B16F1 cells. The conditioned medium from B16F10 cultures induced the activation of FcERI signaling in lung mast cells in an HDAC3-dependent manner. FcERI signaling was observed in lung tumors derived from B16F10 cells. Target scan analysis predicted HDAC3 to be as a target of miR-384, and miR-384 and HDAC3 were found to form a feedback regulatory loop. miR-384, which is decreased by PSA, negatively regulated HDAC3 expression, allergic inflammation, and the positive feedback regulatory loop between anaphylaxis and tumor metastasis. We show the miR-384/HDAC3 feedback loop to be a novel regulator of the positive feedback relationship between anaphylaxis and tumor metastasis.	[Eom, Sangkyung; Kim, Youngmi; Park, Deokbum; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [20100021357, 2011-0010867, 2012H1B8A2025495, C1008749-01-01]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]	National Research Foundation; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by National Research Foundation Grants 20100021357, 2011-0010867, 2012H1B8A2025495, and C1008749-01-01 and by National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea, Grant 1320160.	Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Chang DZ, 2012, ONCOIMMUNOLOGY, V1, P754, DOI 10.4161/onci.19612; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; de Souza DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040790; Falanga YT, 2012, J IMMUNOL, V188, P4360, DOI 10.4049/jimmunol.1003223; Hayashi A, 2010, INT J CANCER, V127, P1332, DOI 10.1002/ijc.25151; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Jeong HJ, 2013, INT J CANCER, V132, P2492, DOI 10.1002/ijc.27937; Khan BQ, 2011, CURR OPIN ALLERGY CL, V11, P319, DOI 10.1097/ACI.0b013e3283481ab6; Kim Y, 2013, MOL IMMUNOL, V53, P1, DOI 10.1016/j.molimm.2012.06.010; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lee SH, 2012, LAB INVEST, V92, P1698, DOI 10.1038/labinvest.2012.132; Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Matoba K, 2010, BIOCHEM BIOPH RES CO, V402, P725, DOI 10.1016/j.bbrc.2010.10.093; Mayoral RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026133; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; Meyts I, 2006, J IMMUNOL, V177, P6460, DOI 10.4049/jimmunol.177.9.6460; Mizuno H, 2012, LEUKEMIA, V26, P2269, DOI 10.1038/leu.2012.81; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Nakayama T, 2004, J CLIN INVEST, V114, P1317, DOI 10.1172/JCI200422089; Olivera A, 2013, IMMUNOL LETT, V150, P89, DOI 10.1016/j.imlet.2013.01.005; Pande K, 2009, MOL THER, V17, P508, DOI 10.1038/mt.2008.280; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Qi D, 2008, EMBO J, V27, P898, DOI 10.1038/emboj.2008.26; Rabenhorst A, 2012, BLOOD, V120, P2042, DOI 10.1182/blood-2012-03-415638; Raica M, 2013, ANTICANCER RES, V33, P957; Rudolph MI, 2008, J PHARMACOL SCI, V106, P208, DOI 10.1254/jphs.FP0070736; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Song C, 2012, SCAND J IMMUNOL, V75, P599, DOI 10.1111/j.1365-3083.2012.02693.x; Song Y, 2010, J ALLERGY CLIN IMMUN, V126, P1208, DOI 10.1016/j.jaci.2010.09.013; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Taranova AG, 2008, CANCER RES, V68, P8582, DOI 10.1158/0008-5472.CAN-08-1673; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274	47	24	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12126	12144		10.1074/jbc.M113.521245	http://dx.doi.org/10.1074/jbc.M113.521245			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619412	Green Published, hybrid			2022-12-25	WOS:000335010600049
J	Briseno-Roa, L; Bessereau, JL				Briseno-Roa, Luis; Bessereau, Jean-Louis			Proteolytic Processing of the Extracellular Scaffolding Protein LEV-9 Is Required for Clustering Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix Proteins; Nicotinic Acetylcholine Receptors; Post-translational Modification; Scaffold Proteins; Synapses; CCP Domain; Limited Proteolysis	CAENORHABDITIS-ELEGANS; ECTODOMAIN CLEAVAGE; PREDICTION; PLASTICITY; SEQUENCE; CALPAIN; SERVER; SITES	Background: LEV-9 is an extracellular scaffolding protein required for synaptic clustering of acetylcholine receptors in C. elegans.Results: C-terminal cleavage of LEV-9 is necessary for its synaptic function. Conclusion: LEV-9 is activated by proteolytic cleavage following the final tandem complement control protein (CCP) modules. Significance: Many LEV-9-related factors are likely cleaved after CCP domains, suggesting that cleavage location can be conserved in distant architecturally related proteins. Correct positioning of neurotransmitter-gated receptors at postsynapses is essential for synaptic transmission. At Caenorhabditis elegans neuromuscular junctions, clustering of levamisole-sensitive acetylcholine receptors (L-AChRs) requires the muscle-secreted scaffolding protein LEV-9, a multidomain factor containing complement control protein (CCP) modules. Here we show that LEV-9 needs to be cleaved at its C terminus to exert its function. LEV-9 cleavage is not required for trafficking nor secretion but directly controls scaffolding activity. The cleavage site is evolutionarily conserved, and post-translational cleavage ensures the structural and functional decoupling between different isoforms encoded by the lev-9 gene. Data mining indicates that most human CCP-containing factors are likely cleaved C-terminally from CCP tandems, suggesting that not only domain architectures but also cleavage location can be conserved in distant architecturally related proteins.	[Briseno-Roa, Luis; Bessereau, Jean-Louis] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Briseno-Roa, Luis; Bessereau, Jean-Louis] INSERM, U1024, F-75005 Paris, France; [Bessereau, Jean-Louis] Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire CGphiMC, CNRS, UMR 5534, F-69622 Villeurbanne, France; [Briseno-Roa, Luis] Inst Jacques Monod, CNRS, UMR 7592, F-75013 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Briseno-Roa, L (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592, Bt Buffon,15 Rue Helene Brion, F-75205 Paris, France.	briseno-roa@ijm.univ-paris-diderot.fr; jean-louis.bessereau@univ-lyon1.fr	Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621	INSERM; Agence Nationale de la Recherche (ANR) [11-BSV4-019]; Association Francaise contre les Myopathies; INSERM Jeunes Chercheurs Confirmes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM Jeunes Chercheurs Confirmes	This work was supported by INSERM, Agence Nationale de la Recherche (ANR) Grant 11-BSV4-019, and the Association Francaise contre les Myopathies.; Supported by INSERM Jeunes Chercheurs Confirmes. To whom correspondence may be addressed: Institut Jacques Monod, UMR CNRS 7592, Universite Paris Diderot, Bt. Buffon, 15 rue Helene Brion, F-75205 Paris, France. Tel.: 33-157278092; Fax 33-157278087; E-mail: briseno-roa@ijm.univ-paris-diderot.fr.	Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hakulinen J, 2004, EUR J IMMUNOL, V34, P2620, DOI 10.1002/eji.200424969; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; Nakagawa H, 2009, BLOOD, V114, P2553, DOI 10.1182/blood-2008-12-190629; Nakayama M, 2011, NEUROSCI RES, V69, P87, DOI 10.1016/j.neures.2010.11.006; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Vinade L, 2001, SYNAPSE, V40, P302, DOI 10.1002/syn.1053; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091	24	5	6	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10967	10974		10.1074/jbc.C113.534677	http://dx.doi.org/10.1074/jbc.C113.534677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619422	Green Published, hybrid			2022-12-25	WOS:000334638500003
J	Dazzi, L; Talani, G; Biggio, F; Utzeri, C; Lallai, V; Licheri, V; Lutzu, S; Mostallino, MC; Secci, PP; Biggio, G; Sanna, E				Dazzi, Laura; Talani, Giuseppe; Biggio, Francesca; Utzeri, Cinzia; Lallai, Valeria; Licheri, Valentina; Lutzu, Stefano; Mostallino, Maria Cristina; Secci, Pietro Paolo; Biggio, Giovanni; Sanna, Enrico			Involvement of the Cannabinoid CB1 Receptor in Modulation of Dopamine Output in the Prefrontal Cortex Associated with Food Restriction in Rats	PLOS ONE			English	Article							GABA RELEASE; EXTRACELLULAR DOPAMINE; BEHAVIOR; ANTAGONIST; INHIBITION; EXPRESSION; NEURONS; ENDOCANNABINOIDS; BRAIN; TRANSMISSION	Increase in dopamine output on corticolimbic structures, such as medial prefrontal cortex (mPFC) and nucleus accumbens, has been related to reward effects associated with palatable food or food presentation after a fasting period. The endocannabinoid system regulates feeding behavior through a modulatory action on different neurotransmitter systems, including the dopaminergic system. To elucidate the involvement of type 1 cannabinoid receptors in the regulation of dopamine output in the mPFC associated with feeding in hungry rats, we restricted the food availability to a 2-h period daily for 3 weeks. In food-restricted rats the extracellular dopamine concentration in the mPFC increased starting 80 min before food presentation and returned to baseline after food removal. These changes were attenuated in animals treated with the CB1 receptor antagonist SR141716. To better understand how food restriction can change the response of mesocortical dopaminergic neurons, we studied several components of the neuronal circuit that regulates dopamine output in the mPFC. Patch-clamp experiments revealed that the inhibitory effect of the CB1 receptor agonist WIN 55,212-2 on GABAergic sIPSC frequency was diminished in mPFC neurons of FR compared to fed ad libitum rats. The basal sIPSC frequency resulted reduced in mPFC neurons of food-restricted rats, suggestive of an altered regulation of presynaptic GABA release; these changes were accompanied by an enhanced excitability of mPFC and ventral tegmental area neurons. Finally, type 1 cannabinoid receptor expression in the mPFC was reduced in food-restricted rats. Together, our data support an involvement of the endocannabinoid system in regulation of dopamine release in the mPFC through changes in GABA inhibitory synapses and suggest that the emphasized feeding-associated increase in dopamine output in the mPFC of food-restricted rats might be correlated with an altered expression and function of type 1 cannabinoid receptor in this brain region.	[Dazzi, Laura; Biggio, Francesca; Utzeri, Cinzia; Lallai, Valeria; Licheri, Valentina; Lutzu, Stefano; Secci, Pietro Paolo; Biggio, Giovanni; Sanna, Enrico] Univ Cagliari, Ctr Excellence Neurobiol Dependence, Sect Neurosci & Anthropol, Dept Life & Environm Sci, Cagliari, Italy; [Talani, Giuseppe; Mostallino, Maria Cristina; Biggio, Giovanni; Sanna, Enrico] CNR, Inst Neurosci, Cagliari, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR)	Dazzi, L (corresponding author), Univ Cagliari, Ctr Excellence Neurobiol Dependence, Sect Neurosci & Anthropol, Dept Life & Environm Sci, Cagliari, Italy.	dazzi@unica.it	lallai, valeria/AHE-2859-2022; sanna, enrico/HHY-8509-2022	Dazzi, Laura/0000-0002-7102-0530	Regione Autonoma della Sardegna (RAS)	Regione Autonoma della Sardegna (RAS)(Russian Academy of SciencesRegione Sardegna)	Funding for this study was provided by grants from Regione Autonoma della Sardegna (RAS). RAS had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the paper for publication.	Abood ME, 2005, HANDB EXP PHARMACOL, V168, P81; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bassareo V, 1997, J NEUROSCI, V17, P851; Beaufour CC, 2001, PHARMACOL BIOCHEM BE, V69, P133, DOI 10.1016/S0091-3057(01)00492-0; Bello NT, 2012, PHYSIOL BEHAV, V105, P720, DOI 10.1016/j.physbeh.2011.09.021; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Carr TP, 2008, NUTR RES, V28, P641, DOI 10.1016/j.nutres.2008.08.003; Chiu CQ, 2010, J NEUROSCI, V30, P7236, DOI 10.1523/JNEUROSCI.0736-10.2010; Dazzi L, 1997, SYNAPSE, V26, P351; De Luca MA, 2012, NEUROPHARMACOLOGY, V63, P161, DOI 10.1016/j.neuropharm.2011.10.018; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Egerton A, 2006, NEUROSCI BIOBEHAV R, V30, P680, DOI 10.1016/j.neubiorev.2005.12.002; EVANS KR, 1987, PHARMACOL BIOCHEM BE, V27, P649, DOI 10.1016/0091-3057(87)90189-4; FIBIGER HC, 1973, BRAIN RES, V55, P135, DOI 10.1016/0006-8993(73)90493-9; FUKUDA A, 1993, J NEUROPHYSIOL, V70, P448, DOI 10.1152/jn.1993.70.1.448; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Ghiani CA, 1998, PHARMACOL BIOCHEM BE, V59, P657, DOI 10.1016/S0091-3057(97)00426-7; GRACE AA, 1989, J NEUROSCI, V9, P3463; Ito R, 2000, J NEUROSCI, V20, P7489; Jentsch JD, 1997, NEUROPSYCHOPHARMACOL, V16, P426, DOI 10.1016/S0893-133X(97)00018-3; Katona I, 1999, J NEUROSCI, V19, P4544; Kiritoshi T, 2013, NEUROPHARMACOLOGY, V66, P170, DOI 10.1016/j.neuropharm.2012.03.024; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kirkham TC, 2001, NUTR RES REV, V14, P65, DOI 10.1079/NRR200118; Kobayashi M, 2012, J NEUROPHYSIOL, V107, P1431, DOI 10.1152/jn.00813.2011; Koch JE, 2001, NUTR NEUROSCI, V4, P179, DOI 10.1080/1028415X.2001.11747361; Lovinger David M., 2008, V184, P435; Maccioni P, 2008, BEHAV PHARMACOL, V19, P197, DOI 10.1097/FBP.0b013e3282fe8888; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Marongiu MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035013; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Melis T, 2007, NEUROSCI LETT, V419, P231, DOI 10.1016/j.neulet.2007.04.012; Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018; Oleson EB, 2012, NEURON, V73, P360, DOI 10.1016/j.neuron.2011.11.018; Paxinos G., 2004, J CHEM INF MODEL, V5th; Pistis M, 2002, BRAIN RES, V948, P155, DOI 10.1016/S0006-8993(02)03055-X; RETAUX S, 1991, NEUROSCIENCE, V43, P323, DOI 10.1016/0306-4522(91)90296-Z; Ross HE, 1999, INT J EAT DISORDER, V26, P245, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;245::AID-EAT2&gt;3.0.CO;2-R; Rubino T, 2000, SYNAPSE, V35, P8, DOI 10.1002/(SICI)1098-2396(200001)35:1<8::AID-SYN2>3.0.CO;2-Y; Sanna E, 2011, FRONT NEUROSCI, V10, P5; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Talani G, 2011, FRONT ENDOCRINOL, V2, P1; Thompson SE, 2006, NEUROSIGNALS, V15, P202, DOI 10.1159/000098515; Timofeeva E, 2009, J NEUROENDOCRINOL, V21, P982, DOI 10.1111/j.1365-2826.2009.01921.x; Trettel J, 2002, J NEUROPHYSIOL, V88, P534, DOI 10.1152/jn.2002.88.1.534; Tzavara ET, 2003, BRIT J PHARMACOL, V138, P544, DOI 10.1038/sj.bjp.0705100; Verrico CD, 2003, SYNAPSE, V48, P178, DOI 10.1002/syn.10202; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3	53	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92224	10.1371/journal.pone.0092224	http://dx.doi.org/10.1371/journal.pone.0092224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632810	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400153
J	Egarter, S; Andenmatten, N; Jackson, AJ; Whitelaw, JA; Pall, G; Black, JA; Ferguson, DJP; Tardieux, I; Mogilner, A; Meissner, M				Egarter, Saskia; Andenmatten, Nicole; Jackson, Allison J.; Whitelaw, Jamie A.; Pall, Gurman; Black, Jennifer Ann; Ferguson, David J. P.; Tardieux, Isabelle; Mogilner, Alex; Meissner, Markus			The Toxoplasma Acto-MyoA Motor Complex Is Important but Not Essential for Gliding Motility and Host Cell Invasion	PLOS ONE			English	Article							GONDII MYOSIN-A; APICOMPLEXAN PARASITES; RHOPTRY ORGANELLES; MOVING JUNCTION; DYNAMICS; GENE; CYTOSKELETON; MECHANISM; MEMBRANE; ADHESION	Apicomplexan parasites are thought to actively invade the host cell by gliding motility. This movement is powered by the parasite's own actomyosin system, and depends on the regulated polymerisation and depolymerisation of actin to generate the force for gliding and host cell penetration. Recent studies demonstrated that Toxoplasma gondii can invade the host cell in the absence of several core components of the invasion machinery, such as the motor protein myosin A (MyoA), the microneme proteins MIC2 and AMA1 and actin, indicating the presence of alternative invasion mechanisms. Here the roles of MyoA, MLC1, GAP45 and Act1, core components of the gliding machinery, are re-dissected in detail. Although important roles of these components for gliding motility and host cell invasion are verified, mutant parasites remain invasive and do not show a block of gliding motility, suggesting that other mechanisms must be in place to enable the parasite to move and invade the host cell. A novel, hypothetical model for parasite gliding motility and invasion is presented based on osmotic forces generated in the cytosol of the parasite that are converted into motility.	[Egarter, Saskia; Andenmatten, Nicole; Jackson, Allison J.; Whitelaw, Jamie A.; Pall, Gurman; Black, Jennifer Ann; Meissner, Markus] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ferguson, David J. P.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Tardieux, Isabelle] Univ Paris 05, Inst Cochin, INSERM U 1016, CNRS UMR 8104, Paris, France; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of Glasgow; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Davis; University of California System; University of California Davis	Meissner, M (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	markus.meissner@glasgow.ac.uk	Whitelaw, Jamie/HHZ-1062-2022; Tardieux, Isabelle/G-4733-2014	Whitelaw, Jamie/0000-0001-6739-1032; Tardieux, Isabelle/0000-0002-5677-7463; Black, Jennifer Ann/0000-0001-5219-3172; Ferguson, David/0000-0001-5045-819X; Egarter, Saskia/0000-0003-2577-9228; Meissner, Markus/0000-0002-5341-5969	Wellcome Trust; Wellcome Trust Senior Fellowship [087582/Z/08/Z]; ERC Starting Grant [ERC-2012-StG 309255]; EviMalaR PhD fellowship [242095]; Wellcome Trust [085349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Senior Fellowship(Wellcome Trust); ERC Starting Grant(European Research Council (ERC)); EviMalaR PhD fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wellcome Trust. M.M. is funded by a Wellcome Trust Senior Fellowship (087582/Z/08/Z) and an ERC Starting Grant (ERC-2012-StG 309255). N.A. is supported by an EviMalaR (European FP7/2007-2013, grant number 242095) PhD fellowship. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Atzberger PJ, 2009, PHYSICA D, V238, P1168, DOI 10.1016/j.physd.2009.03.018; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Delbac F, 2001, J CELL BIOL, V155, P613, DOI 10.1083/jcb.200012116; Delorme-Walker V, 2012, J CELL SCI, V125, P4333, DOI 10.1242/jcs.103648; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Hellmann JK, 2013, ADV HEALTHC MATER, V2, P1162, DOI 10.1002/adhm.201200426; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Meissner M, 2013, CURR OPIN MICROBIOL, V16, P438, DOI 10.1016/j.mib.2013.05.002; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Nardi J, 1999, PHYS REV LETT, V82, P5168, DOI 10.1103/PhysRevLett.82.5168; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; OSTER GF, 1987, J CELL SCI, P35; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Polonais V, 2011, TRAFFIC, V12, P287, DOI 10.1111/j.1600-0854.2010.01148.x; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; Skillman KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3285; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; STEINBERG IZ, 1966, NATURE, V210, P568, DOI 10.1038/210568a0; Venit T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061406; Volkmann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041409; Xian WJ, 1999, BIOCHEMISTRY-US, V38, P7219, DOI 10.1021/bi982301f	56	79	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91819	10.1371/journal.pone.0091819	http://dx.doi.org/10.1371/journal.pone.0091819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632839	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000332858400098
J	Sievert, W; Tapio, S; Breuninger, S; Gaipl, U; Andratschke, N; Trott, KR; Multhoff, G				Sievert, Wolfgang; Tapio, Soile; Breuninger, Stephanie; Gaipl, Udo; Andratschke, Nicolaus; Trott, Klaus-Ruediger; Multhoff, Gabriele			Adhesion Molecule Expression and Function of Primary Endothelial Cells in Benign and Malignant Tissues Correlates with Proliferation	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; VE-CADHERIN; MONOCLONAL-ANTIBODY; ENDOGLIN CD105; MELANOMA CELLS; ANGIOGENESIS; CD34; GENE; VASCULATURE; MODULATION	Background: Comparative analysis of the cellular biology of the microvasculature in different tissues requires the availability of viable primary endothelial cells (ECs). This study describes a novel method to isolate primary ECs from healthy organs, repair blastemas and tumors as examples of non-proliferating and proliferating benign and malignant tissues and their functional characterization. Methodology/Principal Findings: Single cell suspensions from hearts, lungs, repair blastemas and tumors were incubated consecutively with an anti-CD31 antibody and magnetic micro-beads, coupled to a derivative of biotin and streptavidin, respectively. Following magnetic bead separation, CD31-positive ECs were released by biotin-streptavidin competition. In the absence of micro-beads, ECs became adherent to plastic surfaces. ECs from proliferating repair blastemas and tumors were larger and exhibited higher expression densities of CD31, CD105 and CD102 compared to those from non-proliferating normal tissues such as heart and lung. The expression density of CD34 was particularly high in tumor-derived ECs, and that of CD54 and CD144 in ECs of repair blastemas. Functionally, ECs of non-proliferating and proliferating tissues differed in their capacity to form tubes in matrigel and to align under flow conditions. Conclusions/Significance: This method provides a powerful tool to generate high yields of viable, primary ECs of different origins. The results suggest that an altered expression of adhesion molecules on ECs in proliferating tissues contribute to loss of EC function that might cause a chaotic tumor vasculature.	[Sievert, Wolfgang; Breuninger, Stephanie; Andratschke, Nicolaus; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany; [Sievert, Wolfgang; Breuninger, Stephanie; Andratschke, Nicolaus; Multhoff, Gabriele] Helmholtz Zentrum Munchen HMGU, German Res Ctr Environm Hlth Munich, Clin Cooperat Grp CCG Innate Immun Tumor Biol, Neuherberg, Germany; [Tapio, Soile] Helmholtz Zentrum Munchen HMGU, German Res Ctr Environm Hlth Munich, Dept Radiat Biol, Neuherberg, Germany; [Gaipl, Udo] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Trott, Klaus-Ruediger] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Imperial College London	Multhoff, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Multhoff, Gabriele/AAW-9796-2021; Tapio, Soile/CAJ-5871-2022; Gaipl, Udo/AAE-1060-2020; Tapio, Soile/M-7358-2014	Multhoff, Gabriele/0000-0002-2616-3137; Tapio, Soile/0000-0001-9860-3683	Deutsche Forschungsgemeinschaft (DFG) [SFB814, (DFG) INST95/980-1 FUGG]; DFG- Cluster of Excellence: MunichAdvanced Photonics (MAP); BMBF; m4 - Cluster of Excellence [01EX1021C]; Kompetenzverbund Strahlenforschung [03NUK007E]; European Union (EU CARDIORISK) [FP7-2114033]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG- Cluster of Excellence: MunichAdvanced Photonics (MAP)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); m4 - Cluster of Excellence; Kompetenzverbund Strahlenforschung; European Union (EU CARDIORISK)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB814, (DFG) INST95/980-1 FUGG, DFG- Cluster of Excellence: MunichAdvanced Photonics (MAP), BMBF, m4 - Cluster of Excellence (01EX1021C), Kompetenzverbund Strahlenforschung (03NUK007E), and the European Union (EU CARDIORISK, FP7-2114033). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; DENEKAMP J, 1991, RADIOTHER ONCOL, V20, P103, DOI 10.1016/0167-8140(91)90196-N; DUSTIN ML, 1986, J IMMUNOL, V137, P245; FIDLER IJ, 1975, CANCER RES, V35, P218; Fiedler U, 2006, AM J PATHOL, V168, P1045, DOI 10.2353/ajpath.2006.050554; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Haveman J, 2007, J RADIAT RES, V48, P107, DOI 10.1269/jrr.0631; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hendry JH, 2008, RADIAT ENVIRON BIOPH, V47, P189, DOI 10.1007/s00411-007-0155-7; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Ikubo A, 1999, CLIN EXP METASTAS, V17, P849, DOI 10.1023/A:1006730320248; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Liao F, 2002, CANCER RES, V62, P2567; Liao F, 2000, CANCER RES, V60, P6805; LIN GS, 1995, EUR J IMMUNOL, V25, P1508, DOI 10.1002/eji.1830250606; Maltby S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018160; MIELE ME, 1994, EXP CELL RES, V214, P231, DOI 10.1006/excr.1994.1253; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Postiglione L, 2005, INT J ONCOL, V26, P1193; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Scholz D, 1997, CELL TISSUE RES, V290, P623, DOI 10.1007/s004410050968; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Solowiej A, 2003, AM J PATHOL, V162, P953, DOI 10.1016/S0002-9440(10)63890-4; Steri V, 2014, CIRC RES, V114, P79, DOI 10.1161/CIRCRESAHA.114.301591; STOCKINGER H, 1990, J IMMUNOL, V145, P3889; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Wood HB, 1997, BLOOD, V90, P2300; Xu H, 1996, J IMMUNOL, V156, P4909; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382	45	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91808	10.1371/journal.pone.0091808	http://dx.doi.org/10.1371/journal.pone.0091808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632811	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000332858400094
J	Zhang, B; Shen, CY; Bealmear, B; Ragheb, S; Xiong, WC; Lewis, RA; Lisak, RP; Mei, L				Zhang, Bin; Shen, Chengyong; Bealmear, Beverly; Ragheb, Samia; Xiong, Wen-Cheng; Lewis, Richard A.; Lisak, Robert P.; Mei, Lin			Autoantibodies to Agrin in Myasthenia Gravis Patients	PLOS ONE			English	Article							TYROSINE KINASE MUSK; ACETYLCHOLINE-RECEPTOR; PROTEIN 4; DISTINCT ROLES; MUSCLE; ANTIBODY; LRP4; DIFFERENTIATION; LOCALIZATION; AGGREGATION	To determine if patients with myasthenia gravis (MG) have antibodies to agrin, a proteoglycan released by motor neurons and is critical for neuromuscular junction (NMJ) formation, we collected serum samples from 93 patients with MG with known status of antibodies to acetylcholine receptor (AChR), muscle specific kinase (MuSK) and lipoprotein-related 4 (LRP4) and samples from control subjects (healthy individuals and individuals with other diseases). Sera were assayed for antibodies to agrin. We found antibodies to agrin in 7 serum samples of MG patients. None of the 25 healthy controls and none of the 55 control neurological patients had agrin antibodies. Two of the four triple negative MG patients (i.e., no detectable AChR, MuSK or LRP4 antibodies, AChR-/MuSK-/LRP4-) had antibodies against agrin. In addition, agrin antibodies were detected in 5 out of 83 AChR+/MuSK-/LRP4- patients but were not found in the 6 patients with MuSK antibodies (AChR-/MuSK+/LRP4-). Sera from MG patients with agrin antibodies were able to recognize recombinant agrin in conditioned media and in transfected HEK293 cells. These sera also inhibited the agrin-induced MuSK phosphorylation and AChR clustering in muscle cells. Together, these observations indicate that agrin is another autoantigen in patients with MG and agrin autoantibodies may be pathogenic through inhibition of agrin/LRP4/MuSK signaling at the NMJ.	[Zhang, Bin; Shen, Chengyong; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA; [Zhang, Bin] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Zhang, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, Basic Med Sch, Dept Physiol, Wuhan, Hubei Province, Peoples R China; [Bealmear, Beverly; Ragheb, Samia; Lewis, Richard A.; Lisak, Robert P.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Ragheb, Samia] Oakland Univ, William Beaumont Sch Med, Dept Biomed Sci, Rochester, MI 48063 USA; [Lewis, Richard A.] Cedars Sinai Med Ctr, Dept Neurol, West Hollywood, CA USA; [Lisak, Robert P.] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI USA; [Shen, Chengyong; Xiong, Wen-Cheng; Mei, Lin] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Huazhong University of Science & Technology; Wayne State University; Oakland University; Cedars Sinai Medical Center; Wayne State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mei, L (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA.	lmei@gru.edu		Xiong, Wen-Cheng/0000-0001-9071-7598; Zhang, Bin/0000-0003-1323-8678	National Institutes of Health; Parker Webber Chair in Neurology Endowment; Mary Parker Neuroscience Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Webber Chair in Neurology Endowment; Mary Parker Neuroscience Fund	This work was supported in part by grants from National Institutes of Health (WCX, LM), and by Parker Webber Chair in Neurology Endowment and the Mary Parker Neuroscience Fund (SR, RPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONOV A, 1975, P NATL ACAD SCI USA, V72, P1456, DOI 10.1073/pnas.72.4.1456; Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; CHRISTADOSS P, 1981, J IMMUNOL, V126, P1646; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Cossins J, 2012, ANN NY ACAD SCI, V1275, P123, DOI 10.1111/j.1749-6632.2012.06833.x; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; ENGEL AG, 1977, MAYO CLIN PROC, V52, P267; ENGEL AG, 1987, ANN NY ACAD SCI, V505, P326, DOI 10.1111/j.1749-6632.1987.tb51301.x; ENGEL AG, 1976, J NEUROPATH EXP NEUR, V35, P569, DOI 10.1097/00005072-197609000-00008; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GOMEZ CM, 1983, P NATL ACAD SCI-BIOL, V80, P4089, DOI 10.1073/pnas.80.13.4089; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; KAO I, 1977, SCIENCE, V196, P527, DOI 10.1126/science.850793; Kim JY, 2011, J CLIN NEUROL, V7, P173, DOI 10.3988/jcn.2011.7.4.173; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kumar V, 2011, CURR NEUROL NEUROSCI, V11, P89, DOI 10.1007/s11910-010-0151-1; Lavrnic D, 2005, J NEUROL NEUROSUR PS, V76, P1099, DOI 10.1136/jnnp.2004.052415; Leite MI, 2005, ANN NEUROL, V57, P444, DOI 10.1002/ana.20386; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LINDSTROM JM, 1976, ANN NY ACAD SCI, V274, P254, DOI 10.1111/j.1749-6632.1976.tb47691.x; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Phillips LH, 2003, ANN NY ACAD SCI, V998, P407, DOI 10.1196/annals.1254.053; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; Richman DP, 2003, NEUROLOGY, V61, P1652, DOI 10.1212/01.WNL.0000098887.24618.A0; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Saka E, 2005, NEUROLOGY, V65, P782, DOI 10.1212/WNL.65.5.782; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen CY, 2013, J CLIN INVEST, V123, P5190, DOI 10.1172/JCI66039; Shigemoto K, 2008, ANN NY ACAD SCI, V1132, P93, DOI 10.1196/annals.1405.002; Suhail H, 2010, INT J NEUROSCI, V120, P115, DOI 10.3109/00207450903389131; ter Beek WP, 2009, AM J PATHOL, V175, P1536, DOI 10.2353/ajpath.2009.090040; Tsiamalos P, 2009, EUR J NEUROL, V16, P925, DOI 10.1111/j.1468-1331.2009.02624.x; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zhou L, 2004, MUSCLE NERVE, V30, P55, DOI 10.1002/mus.20069; Zisimopoulou P, 2013, J AUTOIMMUNITY	69	97	101	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91816	10.1371/journal.pone.0091816	http://dx.doi.org/10.1371/journal.pone.0091816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632822	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400096
J	Zhang, Y; Liu, B; Yang, S; An, JB; Chen, CH; Zhang, XL; Ren, HZ				Zhang, Yan; Liu, Bin; Yang, Sen; An, Jingbo; Chen, Chunhua; Zhang, Xiaolan; Ren, Huazhong			A Cucumber DELLA Homolog CsGAIP May Inhibit Staminate Development through Transcriptional Repression of B Class Floral Homeotic Genes	PLOS ONE			English	Article							GAMYB-LIKE GENES; GIBBERELLIN RECEPTOR; ARABIDOPSIS-THALIANA; MOLECULAR-MECHANISM; SEX DETERMINATION; SYNTHASE GENE; FEMALE FLOWER; GAI GENE; SATIVUS; EXPRESSION	In hermaphroditic Arabidopsis, the phytohormone gibberellin (GA) stimulates stamen development by opposing the DELLA repression of B and C classes of floral homeotic genes. GA can promote male flower formation in cucumber (Cucumis sativus L.), a typical monoecious vegetable with unisexual flowers, and the molecular mechanism remains unknown. Here we characterized a DELLA homolog CsGAIP in cucumber, and we found that CsGAIP is highly expressed in stem and male flower buds. In situ hybridization showed that CsGAIP is greatly enriched in the stamen primordia, especially during the hermaphrodite stage of flower development. Further, CsGAIP protein is located in nucleus. CsGAIP can partially rescue the plant height, stamen development and fertility phenotypes of Arabidopsis rga-24/gai-t6 mutant, and ectopic expression of CsGAIP in wide-type Arabidopsis results in reduced number of stamens and decreased transcription of B class floral homeotic genes APETALA3 (AP3) and PISTILLATA (PI). Our data suggest that monoecious CsGAIP may inhibit staminate development through transcriptional repression of B class floral homeotic genes in Arabidopsis.	[Zhang, Xiaolan] China Agr Univ, Coll Agron & Biotechnol, Dept Vegetable Sci, Beijing 100094, Peoples R China; China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Zhang, XL (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Dept Vegetable Sci, Beijing 100094, Peoples R China.	zhxiaolan@cau.edu.cn; renhuazhong@cau.edu.cn	Liu, Bin/B-4768-2018	Liu, Bin/0000-0002-0855-0213	National Basic Research Program of China [2009CB119000]; Research Projects for the Areas of Public Interest (Agriculture) [201203003]; National Key Research Program of China [2011BAD12B03, 2013BAD20B01]; Key Project of Scientific & Technological Research of Beijing [D131100000713001]; national basic research of China 973 program [2012CB113900]	National Basic Research Program of China(National Basic Research Program of China); Research Projects for the Areas of Public Interest (Agriculture); National Key Research Program of China; Key Project of Scientific & Technological Research of Beijing; national basic research of China 973 program(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (2009CB119000); Research Projects for the Areas of Public Interest (Agriculture, 201203003); National Key Research Program of China (2011BAD12B03 and 2013BAD20B01); Key Project of Scientific & Technological Research of Beijing (D131100000713001) to HR; and by the national basic research of China 973 program (2012CB113900) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Chen XueHao, 2003, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V24, P68; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Gubler F, 1999, PLANT J, V17, P1, DOI 10.1046/j.1365-313X.1999.00346.x; Hao YJ, 2003, PLANTA, V217, P888, DOI 10.1007/s00425-003-1064-x; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; HARBERD NP, 1989, GENETICS, V121, P827; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Helliwell CA, 1998, P NATL ACAD SCI USA, V95, P9019, DOI 10.1073/pnas.95.15.9019; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Huang HY, 2013, SCI HORTIC-AMSTERDAM, V150, P206, DOI 10.1016/j.scienta.2012.11.011; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; King KE, 2001, GENETICS, V159, P767; King RW, 2003, ANNU REV PLANT BIOL, V54, P307, DOI 10.1146/annurev.arplant.54.031902.135029; Knopf RR, 2006, PLANT CELL PHYSIOL, V47, P1217, DOI 10.1093/pcp/pcj092; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PHARIS RP, 1985, ANNU REV PLANT PHYS, V36, P517, DOI 10.1146/annurev.pp.36.060185.002505; PIKE LM, 1969, EUPHYTICA, V18, P106; ROOD SB, 1980, PLANT PHYSIOL, V66, P793, DOI 10.1104/pp.66.5.793; Saito S, 2007, J EXP BOT, V58, P2897, DOI 10.1093/jxb/erm141; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwechheimer C, 2008, CURR OPIN PLANT BIOL, V11, P9, DOI 10.1016/j.pbi.2007.10.011; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Swain SM, 2004, PLANT PHYSIOL, V134, P694, DOI 10.1104/pp.103.031666; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Wang DH, 2010, PLANT J, V61, P862, DOI 10.1111/j.1365-313X.2009.04114.x; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; WITTWER SH, 1962, NATURWISSENSCHAFTEN, V49, P305, DOI 10.1007/BF00622719; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yamasaki S, 2003, SEX PLANT REPROD, V16, P103, DOI 10.1007/s00497-003-0183-7; Yamasaki S, 2003, PLANT CELL ENVIRON, V26, P537, DOI 10.1046/j.1365-3040.2003.00984.x; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Zhang XL, 2013, PLANT CELL, V25, P83, DOI 10.1105/tpc.112.107854	64	19	22	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91804	10.1371/journal.pone.0091804	http://dx.doi.org/10.1371/journal.pone.0091804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632777	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400092
J	Kotagal, M; Agarwal-Harding, KJ; Mock, C; Quansah, R; Arreola-Risa, C; Meara, JG				Kotagal, Meera; Agarwal-Harding, Kiran J.; Mock, Charles; Quansah, Robert; Arreola-Risa, Carlos; Meara, John G.			Health and Economic Benefits of Improved Injury Prevention and Trauma Care Worldwide	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; COST-EFFECTIVENESS; STATISTICAL LIFE; GLOBAL BURDEN; MORTALITY; SURGERY; LIVES; DISEASES	Objectives: Injury is a significant source of morbidity and mortality worldwide, and often disproportionately affects younger, more productive members of society. While many have made the case for improved injury prevention and trauma care, health system development in low-and middle-income countries is often limited by resources. This study aims to determine the economic benefit of improved injury prevention and trauma care in low-and middle-income countries. Methods: This study uses existing data on injury mortality worldwide from the 2010 Global Burden of Disease Study to estimate the number of lives that could be saved if injury mortality rates in low-and middle-income countries could be reduced to rates in high-income countries. Using economic modeling - through the human capital approach and the value of a statistical life approach - the study then demonstrates the associated economic benefit of these lives saved. Results: 88 percent of injury-related deaths occur in low-and middle-income countries. If injury mortality rates in low-and middle-income countries were reduced to rates in high-income countries, 2,117,500 lives could be saved per year. This would result in between 49 million and 52 million disability adjusted life years averted per year, with discounting and age weighting. Using the human capital approach, the associated economic benefit of reducing mortality rates ranges from $245 to $261 billion with discounting and age weighting. Using the value of a statistical life approach, the benefit is between 758 and 786 billion dollars per year. Conclusions: Reducing injury mortality in low-and middle-income countries could save over 2 million lives per year and provide significant economic benefit globally. Further investments in trauma care and injury prevention are needed.	[Kotagal, Meera] Harvard Univ, Sch Med, Dept Surg, Univ Washington,Program Global Surg & Social Chan, Seattle, WA 98122 USA; [Agarwal-Harding, Kiran J.; Meara, John G.] Harvard Univ, Sch Med, Dept Plast & Oral Surg, Boston Childrens Hosp,Program Global Surg & Socia, Boston, MA USA; [Mock, Charles] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Quansah, Robert] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Surg, Kumasi, Ghana; [Arreola-Risa, Carlos] Tecnol Monterrey, Sch Med, Dept Emergency Med, Monterrey, Mexico	Harvard University; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard Medical School; Harborview Medical Center; University of Washington; University of Washington Seattle; Kwame Nkrumah University Science & Technology; Tecnologico de Monterrey	Kotagal, M (corresponding author), Harvard Univ, Sch Med, Dept Surg, Univ Washington,Program Global Surg & Social Chan, Seattle, WA 98122 USA.	mkotagal@uw.edu		Meara, John G./0000-0003-4369-3209; Mock, Charles/0000-0002-0564-568X	University of Washington Department of Surgery T32 training fellowship grant from the National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK070555-03]; Doris Duke Clinical Research Fellowship; Program in Global Surgery and Social Change (PGSSC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK070555] Funding Source: NIH RePORTER	University of Washington Department of Surgery T32 training fellowship grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Doris Duke Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); Program in Global Surgery and Social Change (PGSSC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Kotagal is supported by a University of Washington Department of Surgery T32 training fellowship grant from the National Institute of Diabetes and Digestive and Kidney Diseases (grant 5T32DK070555-03). Mr. Agarwal-Harding was supported by the Doris Duke Clinical Research Fellowship and The Program in Global Surgery and Social Change (PGSSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldy JE, 2008, REV ECON STAT, V90, P573, DOI 10.1162/rest.90.3.573; Alkire B, 2011, WORLD J SURG, V35, P1194, DOI 10.1007/s00268-011-1055-1; Alkire BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034595; [Anonymous], 2012, GLOBAL BURDEN DIS IN; [Anonymous], 2010, FREQUENTLY ASKED QUE; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Fieno JV, 2008, AIDS CARE, V20, P515, DOI 10.1080/09540120701867149; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Hammitt JK, 2007, REV ENV ECON POLICY, V1, P228, DOI 10.1093/reep/rem015; Jamison D.T., 1993, DIS CONTROL PRIORITI; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marseille E, 1996, B WORLD HEALTH ORGAN, V74, P319; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rivara FP, 2005, INJURY PREV, V11, P321, DOI 10.1136/ip.2005.009928; Sachs J.D., 2001, MACROECONOMICS HLTH; Tiska MA, 2004, EMERG MED J, V21, P237, DOI 10.1136/emj.2002.002097; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; World Bank, 2011, WORLD BANK OP DAT	30	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91862	10.1371/journal.pone.0091862	http://dx.doi.org/10.1371/journal.pone.0091862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626472	Green Published, gold			2022-12-25	WOS:000332851300141
J	Li, D; Zhang, HJ; Fu, LJ; An, XL; Zhang, BZ; Li, Y; Chen, ZR; Zheng, W; Yi, L; Zheng, TL				Li, Dong; Zhang, Huajun; Fu, Lijun; An, Xinli; Zhang, Bangzhou; Li, Yi; Chen, Zhangran; Zheng, Wei; Yi, Lin; Zheng, Tianling			A Novel Algicide: Evidence of the Effect of a Fatty Acid Compound from the Marine Bacterium, Vibrio sp BS02 on the Harmful Dinoflagellate, Alexandrium tamarense	PLOS ONE			English	Article							ALGAL BLOOMS; IDENTIFICATION; ACTINOMYCETE; DYNAMICS; DEATH; LYSIS; SEA	Alexandrium tamarense is a notorious bloom-forming dinoflagellate, which adversely impacts water quality and human health. In this study we present a new algicide against A. tamarense, which was isolated from the marine bacterium Vibrio sp. BS02. MALDI-TOF-MS, NMR and algicidal activity analysis reveal that this compound corresponds to palmitoleic acid, which shows algicidal activity against A. tamarense with an EC50 of 40 mu g/mL. The effects of palmitoleic acid on the growth of other algal species were also studied. The results indicate that palmitoleic acid has potential for selective control of the Harmful algal blooms (HABs). Over extended periods of contact, transmission electron microscopy shows severe ultrastructural damage to the algae at 40 mu g/mL concentrations of palmitoleic acid. All of these results indicate potential for controlling HABs by using the special algicidal bacterium and its active agent.	[Li, Dong; Zhang, Huajun; Fu, Lijun; An, Xinli; Zhang, Bangzhou; Li, Yi; Chen, Zhangran; Zheng, Wei; Zheng, Tianling] Xiamen Univ, State Key Lab Marine Environm Sci, Sch Life Sci, Xiamen, Peoples R China; [Li, Dong; Zhang, Huajun; Fu, Lijun; An, Xinli; Zhang, Bangzhou; Li, Yi; Chen, Zhangran; Zheng, Wei; Zheng, Tianling] Xiamen Univ, Key Lab MOE Coast & Wetland Ecosyst, Sch Life Sci, Xiamen, Peoples R China; [Li, Dong; Yi, Lin] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China	Xiamen University; Xiamen University; Huaqiao University	Yi, L (corresponding author), Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.	lyhxm@hqu.edu.cn; wshwzh@xmu.edu.cn	Zhang, Bangzhou/CAG-9625-2022		National Nature Science Foundation of China [40930847]; Special Fund for Ph.D. Program in University [20120121130001]; Public Science and Technology Research Funds Projects of Ocean [201305016, 201305041, 201305022]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Ph.D. Program in University; Public Science and Technology Research Funds Projects of Ocean	This work was supported by the National Nature Science Foundation of China (40930847) (http://isis.nsfc.gov.cn/portal/Proj_List.asp), Special Fund for Ph.D. Program in University (20120121130001) (http://211.68.23.117/SSO/loginshow?u = null), and Public Science and Technology Research Funds Projects of Ocean (201305016, 201305041, and 201305022) (http://www.soanbu.com/ and MELRI1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamsjah MA, 2005, BIOSCI BIOTECH BIOCH, V69, P2186, DOI 10.1271/bbb.69.2186; Alamsjah MA, 2009, DEV APPL PHYCOLOGY, V2, P263; Alamsjah MA, 2007, BIOSCI BIOTECH BIOCH, V71, P265, DOI 10.1271/bbb.60475; Anderson D, 2001, INTERGUVERNAMENTAL O, V268; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 1996, TOXICON, V34, P579, DOI 10.1016/0041-0101(95)00158-1; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; [Anonymous], MARINE POLLUTION B, V51, P1018; Baek SH, 2003, J MICROBIOL BIOTECHN, V13, P651; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Bernbom N, 2011, APPL ENVIRON MICROB, V77, P8557, DOI 10.1128/AEM.06038-11; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Chen WM, 2011, ENZYME MICROB TECH, V49, P372, DOI 10.1016/j.enzmictec.2011.06.016; Chen WM, 2012, ARCH MICROBIOL, V194, P103, DOI 10.1007/s00203-011-0730-9; Chiang IZ, 2004, J PHYCOL, V40, P474, DOI 10.1111/j.1529-8817.2004.03096.x; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; D'Costa PM, 2012, CURR SCI INDIA, V102, P1552; Darehshouri A, 2008, PLANT BIOLOGY, V10, P732, DOI 10.1111/j.1438-8677.2008.00078.x; Fu LJ, 2011, WORLD J MICROB BIOT, V27, P2949, DOI 10.1007/s11274-011-0778-3; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Gumbo JR, 2011, PHYS CHEM EARTH, V36, P881, DOI 10.1016/j.pce.2011.07.050; Hirao S, 2012, BIOSCI BIOTECH BIOCH, V76, P372, DOI 10.1271/bbb.110645; IKAWA M, 1994, J CHEM ECOL, V20, P2429, DOI 10.1007/BF02033211; Jeong HJ, 2008, HARMFUL ALGAE, V7, P368, DOI 10.1016/j.hal.2007.12.004; Jeong HJ, 2002, PHYCOLOGIA, V41, P643, DOI 10.2216/i0031-8884-41-6-643.1; Kamaya Y, 2003, ENVIRON TOXICOL, V18, P289, DOI 10.1002/tox.10127; Kang YH, 2005, J APPL MICROBIOL, V98, P1030, DOI 10.1111/j.1365-2672.2005.02533.x; Kawano Y, 1997, J MAR BIOTECHNOL, V5, P225; Keawtawee T, 2012, FISHERIES SCI, V78, P641, DOI 10.1007/s12562-012-0497-1; Kim D, 2007, J APPL MICROBIOL, V102, P937, DOI 10.1111/j.1365-2672.2006.03172.x; Kim JD, 2009, MAR BIOTECHNOL, V11, P463, DOI 10.1007/s10126-008-9167-9; Kim YM, 2012, MOL CELLS, P1; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Nakai S, 2005, HYDROBIOLOGIA, V543, P71, DOI 10.1007/s10750-004-6822-7; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Oh MY, 2010, J APPL PHYCOL, V22, P453, DOI 10.1007/s10811-009-9478-x; Ozaki K, 2009, J HEALTH SCI, V55, P578, DOI 10.1248/jhs.55.578; Pan G, 2011, HARMFUL ALGAE, V10, P381, DOI 10.1016/j.hal.2011.01.003; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Pokrzywinski KL, 2012, HARMFUL ALGAE, V19, P23, DOI 10.1016/j.hal.2012.05.002; Sala MM, 2005, FEMS MICROBIOL ECOL, V54, P257, DOI 10.1016/j.femsec.2005.04.005; SECHER S, 2009, PLYMOUTH STUDENT SCI, V2, P212; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Sun XX, 2004, MAR POLLUT BULL, V48, P937, DOI 10.1016/j.marpolbul.2003.11.021; Takamura Y., 2004, MICROBES ENVIRON, V19, P31, DOI DOI 10.1264/JSME2.19.31; Tang Y, 2011, WATER RES, V45, P2855, DOI 10.1016/j.watres.2011.03.003; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang B.X., 2012, HARMFUL ALGAE, V13, P83; Wu JT, 2006, AQUAT TOXICOL, V80, P338, DOI 10.1016/j.aquatox.2006.09.011; Xu D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033648, 10.1371/journal.pone.0042243]; Yang CY, 2012, HARMFUL ALGAE, V20, P132, DOI 10.1016/j.hal.2012.09.002; Yang XL, 2012, PLANT PHYSIOL BIOCH, V51, P153, DOI 10.1016/j.plaphy.2011.10.019; Yoshichika T., 1999, ENV SCI, V12, P329; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8	58	46	50	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91201	10.1371/journal.pone.0091201	http://dx.doi.org/10.1371/journal.pone.0091201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626054	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300064
J	Reid, JE; Wernisch, L				Reid, John E.; Wernisch, Lorenz			STEME: A Robust, Accurate Motif Finder for Large Data Sets	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; DISCOVERY; SITES; IMPROVES; NETWORK; MODELS; TOOLS	Motif finding is a difficult problem that has been studied for over 20 years. Some older popular motif finders are not suitable for analysis of the large data sets generated by next-generation sequencing. We recently published an efficient approximation (STEME) to the EM algorithm that is at the core of many motif finders such as MEME. This approximation allows the EM algorithm to be applied to large data sets. In this work we describe several efficient extensions to STEME that are based on the MEME algorithm. Together with the original STEME EM approximation, these extensions make STEME a fully-fledged motif finder with similar properties to MEME. We discuss the difficulty of objectively comparing motif finders. We show that STEME performs comparably to existing prominent discriminative motif finders, DREME and Trawler, on 13 sets of transcription factor binding data in mouse ES cells. We demonstrate the ability of STEME to find long degenerate motifs which these discriminative motif finders do not find. As part of our method, we extend an earlier method due to Nagarajan et al. for the efficient calculation of motif E-values. STEME's source code is available under an open source license and STEME is available via a web interface.	[Reid, John E.; Wernisch, Lorenz] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England	MRC Biostatistics Unit; University of Cambridge	Reid, JE (corresponding author), Inst Publ Hlth, MRC Biostat Unit, Cambridge, England.	john.reid@mrc-bsu.cam.ac.uk		Reid, John/0000-0002-7762-6760	Medical Research Council Unit Programme [U105260799]; Medical Research Council [MC_U105260799] Funding Source: researchfish; MRC [MC_U105260799] Funding Source: UKRI	Medical Research Council Unit Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Unit Programme number U105260799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Gordan R, 2008, LECT N BIOINFORMAT, V4955, P98; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hirji KF, 1997, COMMUN STAT-SIMUL C, V26, P1197, DOI 10.1080/03610919708813435; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jauch R, 2008, J MOL BIOL, V376, P758, DOI 10.1016/j.jmb.2007.11.091; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Morikawa M, 2011, NUCL ACIDS RES; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Nagarajan N, 2005, BIOINFORMATICS, V21, pI311, DOI 10.1093/bioinformatics/bti1044; Narlikar L, 2007, LECT NOTES COMPUT SC, V4453, P107; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Reid JE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr574; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Siddharthan R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000156; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valen E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000562; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148	42	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90735	10.1371/journal.pone.0090735	http://dx.doi.org/10.1371/journal.pone.0090735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625410	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300030
J	Takx, RAP; de Jong, PA; Leiner, T; Oudkerk, M; de Koning, HJ; Mol, CP; Viergever, MA; Isgum, I				Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim; Oudkerk, Matthijs; de Koning, Harry J.; Mol, Christian P.; Viergever, Max A.; Isgum, Ivana			Automated Coronary Artery Calcification Scoring in Non-Gated Chest CT: Agreement and Reliability	PLOS ONE			English	Article							ELECTRON-BEAM CT; ALL-CAUSE MORTALITY; LUNG-CANCER; CALCIUM SCORE; RISK-FACTORS; DISEASE; PREDICTION; GUIDELINES; MDCT	Objective: To determine the agreement and reliability of fully automated coronary artery calcium (CAC) scoring in a lung cancer screening population. Materials and Methods: 1793 low-dose chest CT scans were analyzed (non-contrast-enhanced, non-gated). To establish the reference standard for CAC, first automated calcium scoring was performed using a preliminary version of a method employing coronary calcium atlas and machine learning approach. Thereafter, each scan was inspected by one of four trained raters. When needed, the raters corrected initially automaticity-identified results. In addition, an independent observer subsequently inspected manually corrected results and discarded scans with gross segmentation errors. Subsequently, fully automatic coronary calcium scoring was performed. Agatston score, CAC volume and number of calcifications were computed. Agreement was determined by calculating proportion of agreement and examining Bland-Altman plots. Reliability was determined by calculating linearly weighted kappa (k) for Agatston strata and intraclass correlation coefficient (ICC) for continuous values. Results: 44 (2.5%) scans were excluded due to metal artifacts or gross segmentation errors. In the remaining 1749 scans, median Agatston score was 39.6 (P25-P75:0-345.9), median volume score was 60.4 mm(3) (P25-P75:0-361.4) and median number of calcifications was 2 (P25-P75:0-4) for the automated scores. The k demonstrated very good reliability (0.85) for Agatston risk categories between the automated and reference scores. The Bland-Altman plots showed underestimation of calcium score values by automated quantification. Median difference was 2.5 (p25-p75:0.0-53.2) for Agatston score, 7.6 (p25-p75:0.0-94.4) for CAC volume and 1 (p25-p75:0-5) for number of calcifications. The ICC was very good for Agatston score (0.90), very good for calcium volume (0.88) and good for number of calcifications (0.64). Discussion: Fully automated coronary calcium scoring in a lung cancer screening setting is feasible with acceptable reliability and agreement despite an underestimation of the amount of calcium when compared to reference scores.	[Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Oudkerk, Matthijs] Ctr Med Imaging North East, Groningen, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Mol, Christian P.; Viergever, Max A.; Isgum, Ivana] Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Isgum, I (corresponding author), Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands.	ivana@isi.uu.nl	Isgum, Ivana/H-8659-2014; Takx, Richard/T-2852-2019; de+Koning, Harry/AAF-9062-2019; Viergever, Max A/J-1215-2014; de Jong, Pim A/G-7220-2014	Isgum, Ivana/0000-0003-1869-5034; Takx, Richard/0000-0003-2252-3040; de+Koning, Harry/0000-0003-4682-3646; de Jong, Pim A/0000-0003-4840-6854; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organisation for Health Research and Development (ZonMw) [22000130]; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital workstations and LungCARE for the performance of 3D measurements; Rotterdam Oncologic Thoracic Steering Committee; G. Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund; project Care4Me (Cooperative Advanced Research for Medical Efficiency [ITEA2 Call3-08004]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital workstations and LungCARE for the performance of 3D measurements; Rotterdam Oncologic Thoracic Steering Committee; G. Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund; project Care4Me (Cooperative Advanced Research for Medical Efficiency	The NELSON-trial was supported by the Netherlands Organisation for Health Research and Development (ZonMw, grant number 22000130, http:// www.zonmw.nl/); Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital workstations and LungCARE for the performance of 3D measurements; Rotterdam Oncologic Thoracic Steering Committee; and the G. Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund. The contribution of I. Isgum was financially partly supported by the project Care4Me (Cooperative Advanced Research for Medical Efficiency, grant number ITEA2 Call3-08004, http://www.compassis.com/care4me/) in the framework of the EU research programme ITEA (Information Technology for European Advancement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Achenbach S, 2000, RADIOLOGY, V216, P457, DOI 10.1148/radiology.216.2.r00au19457; BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926; Bland JM, 2005, HLF NORMAL DIS UNPUB; Buckens CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071204; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327; Isgum I, 2010, SPIE MEDIMAG, V7624; Isgum I, 2012, IEEE T MED IMAGING, V31, P2322, DOI 10.1109/TMI.2012.2216889; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Jacobs PCA, 2010, AM J ROENTGENOL, V194, P1244, DOI 10.2214/AJR.09.3047; Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu YC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/472347; Ma SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012036; McEvoy John W, 2012, Curr Treat Options Cardiovasc Med, V14, P69, DOI 10.1007/s11936-011-0154-5; Mets OM, 2013, JACC CARDIOVASC IMAG; Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008; Mets OM, 2012, JAMA-J AM MED ASSOC, V308, P1433, DOI 10.1001/jama.2012.12656; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Rutten A, 2011, EUR J RADIOL, V80, P83, DOI 10.1016/j.ejrad.2010.06.009; Schmermund A, 2011, LANCET, V378, P641, DOI 10.1016/S0140-6736(11)61129-X; Sevrukov AB, 2005, AM J ROENTGENOL, V185, P1546, DOI 10.2214/AJR.04.1589; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Shemesh J, 2006, CLIN IMAG, V30, P181, DOI 10.1016/j.clinimag.2005.11.002; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Winkelmann BR, 2009, BIOMARK MED, V3, P617, DOI [10.2217/BMM.09.51, 10.2217/bmm.09.51]; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Xie X, 2013, VALIDAITON PROGNOSIS; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	37	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91239	10.1371/journal.pone.0091239	http://dx.doi.org/10.1371/journal.pone.0091239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625525	Green Published, gold			2022-12-25	WOS:000332851300068
J	Emad, A; Milenkovic, O				Emad, Amin; Milenkovic, Olgica			CaSPIAN: A Causal Compressive Sensing Algorithm for Discovering Directed Interactions in Gene Networks	PLOS ONE			English	Article							EXPRESSION REGULATORY NETWORKS; INFERENCE; INFORMATION; PURSUIT; MODELS	We introduce a novel algorithm for inference of causal gene interactions, termed CaSPIAN (Causal Subspace Pursuit for Inference and Analysis of Networks), which is based on coupling compressive sensing and Granger causality techniques. The core of the approach is to discover sparse linear dependencies between shifted time series of gene expressions using a sequential list-version of the subspace pursuit reconstruction algorithm and to estimate the direction of gene interactions via Granger-type elimination. The method is conceptually simple and computationally efficient, and it allows for dealing with noisy measurements. Its performance as a stand-alone platform without biological side-information was tested on simulated networks, on the synthetic IRMA network in Saccharomyces cerevisiae, and on data pertaining to the human HeLa cell network and the SOS network in E. coli. The results produced by CaSPIAN are compared to the results of several related algorithms, demonstrating significant improvements in inference accuracy of documented interactions. These findings highlight the importance of Granger causality techniques for reducing the number of false-positives, as well as the influence of noise and sampling period on the accuracy of the estimates. In addition, the performance of the method was tested in conjunction with biological side information of the form of sparse "scaffold networks'', to which new edges were added using available RNA-seq or microarray data. These biological priors aid in increasing the sensitivity and precision of the algorithm in the small sample regime.	[Emad, Amin; Milenkovic, Olgica] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Emad, A (corresponding author), Univ Illinois, Dept Elect & Comp Engn, 1406 W Green St, Urbana, IL 61801 USA.	emad2@illinois.edu			NSERC; NSF [CCF 0809895, CCF 1218764]; Emerging Frontiers for Science of Information Center [CCF 0939370]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Emerging Frontiers for Science of Information Center	This work was supported in part by an NSERC graduate fellowship, and NSF grants CCF 0809895, CCF 1218764 and the Emerging Frontiers for Science of Information Center, CCF 0939370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Becker S, 2011, SIAM J IMAGING SCI, V4, P1, DOI 10.1137/090756855; Butte A J, 2000, Pac Symp Biocomput, P418; Cai XD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003068; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chen BS, 2011, MATH BIOSCI, V230, P23, DOI 10.1016/j.mbs.2010.12.007; Chen T, 1999, Pac Symp Biocomput, P29; Dai W, 2009, IEEE T INFORM THEORY, V55, P2230, DOI 10.1109/TIT.2009.2016006; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Deng M, 2012, 2012 IEEE STATISTICAL SIGNAL PROCESSING WORKSHOP (SSP), P696, DOI 10.1109/SSP.2012.6319797; Dingel J, 2009, BIOINFORMATICS, V25, P1686, DOI 10.1093/bioinformatics/btp281; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; DOUGHERTY J, 2008, EURASIP J BIOINFORMA, V2008, P1; El Samad H, 2005, INT J ROBUST NONLIN, V15, P691, DOI 10.1002/rnc.1018; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Ewens W., 2004, STAT METHODS BIOINFO; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Geweke JF, 2003, J AM STAT ASSOC, V79, P907; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hang XY, 2009, IEEE INT WORK GENOM, P25; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Liu WB, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/780541; Long PM, 2010, MACH LEARN, V78, P287, DOI 10.1007/s10994-009-5165-z; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Pearl J., 2000, CAUSALITY MODELS REA, V29; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; PENROSE R, 1955, P CAMBRIDGE PHILOS S, V51, DOI [DOI 10.1017/S0305004100030401, 10.1017/S0305004100030401]; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Prat Y, 2011, BIOINFORMATICS, V27, P655, DOI 10.1093/bioinformatics/btr002; Rao Arvind, 2008, Journal of Bioinformatics and Computational Biology, V6, P493, DOI 10.1142/S0219720008003515; Ruklisa Dace, 2005, Genome Inform, V16, P225; Sambo F, 2008, NETTAB2008 VAR IT; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; van den Berg E, 2008, SIAM J SCI COMPUT, V31, P890, DOI 10.1137/080714488; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Xu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S18; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhao WT, 2008, IEEE ACM T COMPUT BI, V5, P262, DOI 10.1109/TCBB.2007.1067; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	62	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90781	10.1371/journal.pone.0090781	http://dx.doi.org/10.1371/journal.pone.0090781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622336	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300028
J	Semsey, S				Semsey, Szabolcs			A Mixed Incoherent Feed-Forward Loop Allows Conditional Regulation of Response Dynamics	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; GENE-EXPRESSION; SMALL RNA; POSTTRANSCRIPTIONAL REGULATION; DEGRADATION; MANGANESE; FUR; AUTOREGULATION; REPRESSION	Expression of the SodA superoxide dismutase (MnSOD) in Escherichia coli is regulated by superoxide concentration through the SoxRS system and also by Fur (Ferric uptake regulator) through a mixed incoherent feed forward loop (FFL) containing the RyhB small regulatory RNA. In this work I theoretically analyze the function of this feed forward loop as part of the network controlling expression of the two cytoplasmic superoxide dismutases, SodA and SodB. I find that feed forward regulation allows faster response to superoxide stress at low intracellular iron levels compared to iron rich conditions. That is, it can conditionally modulate the response time of a superimposed transcriptional control mechanism.	Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Semsey, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	semsey@nbi.dk		Semsey, Szabolcs/0000-0002-4522-5495	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This research was supported by the Danish National Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbel-Goren R, 2013, NUCLEIC ACIDS RES, V41, P4825, DOI 10.1093/nar/gkt184; Argaman L, 2012, P NATL ACAD SCI USA, V109, P4621, DOI 10.1073/pnas.1113113109; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Battistoni A, 1998, BIOCHEM BIOPH RES CO, V243, P804, DOI 10.1006/bbrc.1998.8182; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V319, P508, DOI 10.1006/abbi.1995.1324; BENOV LT, 1994, J BIOL CHEM, V269, P25310; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BROWN OR, 1995, ARCH BIOCHEM BIOPHYS, V319, P10, DOI 10.1006/abbi.1995.1262; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; Diaz JM, 2013, SCIENCE, V340, P1223, DOI 10.1126/science.1237331; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; El Bekay R, 2002, J LEUKOCYTE BIOL, V71, P255; FEE JA, 1991, MOL MICROBIOL, V5, P2599, DOI 10.1111/j.1365-2958.1991.tb01968.x; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mank NN, 2013, RNA BIOL, V10, P347, DOI 10.4161/rna.23769; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pesce A, 1997, J MOL BIOL, V274, P408, DOI 10.1006/jmbi.1997.1400; SCHRUM LW, 1994, ARCH BIOCHEM BIOPHYS, V309, P288, DOI 10.1006/abbi.1994.1115; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; Semsey S, 2013, NUCLEIC ACIDS RES, V41, P6381, DOI 10.1093/nar/gkt351; Semsey S, 2009, J BACTERIOL, V191, P4487, DOI 10.1128/JB.00056-09; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; Takeda K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002413; Vance CK, 1998, BIOCHEMISTRY-US, V37, P5518, DOI 10.1021/bi972580r	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91243	10.1371/journal.pone.0091243	http://dx.doi.org/10.1371/journal.pone.0091243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621982	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300067
J	Szantho, E; Bhattoa, HP; Csoban, M; Antal-Szalmas, P; Ujfalusi, A; Kappelmayer, J; Hevessy, Z				Szantho, Eszter; Bhattoa, Harjit Pal; Csoban, Maria; Antal-Szalmas, Peter; Ujfalusi, Aniko; Kappelmayer, Janos; Hevessy, Zsuzsanna			Serum Thymidine Kinase Activity: Analytical Performance, Age-Related Reference Ranges and Validation in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CD38 EXPRESSION; DEOXYTHYMIDINE KINASE; DEOXYRIBONUCLEIC-ACID; PROGNOSTIC INDICATORS; 1ST TREATMENT; TUMOR-MARKER; ZAP-70; CARCINOMA; ANTIGEN	Background: To date no age-related reference ranges are available for serum thymidine kinase (TK1) activity. Being a proliferation marker, it may be used as a prognostic marker in malignant diseases, including chronic lymphocytic leukemia (CLL). Our aim was to establish age-specific reference ranges for TK1 and examine its utility as a screening marker in CLL, a disease of the elderly. Methods: Serum TK1 activity was measured by a competitive chemiluminescent immunoassay in 369 healthy adults and 115 de novo CLL patients. Results: We observed a statistically significant decline in TK1 activity from young (18-35 years) to middle-aged (36-60 years) and further on to elderly (60-86 years) healthy individuals. Age-related reference range was: <30 U/L for young, <25 U/L for middle-aged and <19 U/L for elderly. There was no difference in TK1 activity between the studied healthy men and women. In CLL patients, TK1 activity was the highest in the advanced Rai stages. The area under the receiver operating characteristic curve (ROC-AUC) for TK1 was 0.840 (95% CI: 0.787-0.892), for differentiating CLL patients from age and sex matched healthy controls, with a cut-off value of 10.5 U/L (sensitivity: 80.9%, specificity: 73.4%). TK1 was significantly elevated in CD38+/Zap70+ CLL patients, and showed significant correlation with WBC and absolute B-cell count. Conclusion: In the healthy, serum TK1 activity does not differ in the two sexes but declines significantly with age. As such, use of age-related reference ranges is warranted, especially when evaluating CLL patients who generally belong to the elderly age group.	[Szantho, Eszter; Bhattoa, Harjit Pal; Csoban, Maria; Antal-Szalmas, Peter; Ujfalusi, Aniko; Kappelmayer, Janos; Hevessy, Zsuzsanna] Univ Debrecen, Med & Hlth Sci Ctr, Dept Lab Med, H-4012 Debrecen, Hungary	University of Debrecen	Hevessy, Z (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Lab Med, H-4012 Debrecen, Hungary.	hevessy@med.unideb.hu	Hevessy, Zsuzsanna/AAA-1186-2019	Bhattoa, Harjit Pal/0000-0002-4909-0065	European Union; European Social Fund; OTKA [105073]; National Development Agency of Hungary (mAB-CHIC) [TECH-09-A1-2009-0113];  [TAMOP-4.2.2.A-11/1/KONV-2012-0025]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency of Hungary (mAB-CHIC); 	The work is supported by the TAMOP-4.2.2.A-11/1/KONV-2012-0025 project. The project is co-financed by the European Union and the European Social Fund. This work is supported by the OTKA 105073 research grant (HPB) and by the National Office for Research and Technology (presently National Development Agency) of Hungary (TECH-09-A1-2009-0113; mAB-CHIC) (PAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo J, 2011, BLOOD S1, V118; BERK AJ, 1973, J BIOL CHEM, V248, P2722; Chen ZH, 2011, SENSORS-BASEL, V11, P11064, DOI 10.3390/s111211064; Chen ZH, 2008, ANTICANCER RES, V28, P3897; Clinical and Laboratory Standards Institute, 2008, C28A3 CLSI; D'Arena G, 2007, AM J HEMATOL, V82, P787, DOI 10.1002/ajh.20936; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Faria M, 2012, J CHROMATOGR B, V907, P13, DOI 10.1016/j.jchromb.2012.08.024; Foekens JA, 2001, CANCER RES, V61, P1421; Fujiwaki R, 2001, ONCOLOGY-BASEL, V61, P47, DOI 10.1159/000055352; Funaro A, 1997, TISSUE ANTIGENS, V49, P7, DOI 10.1111/j.1399-0039.1997.tb02703.x; Furman RR, 2010, HEMATOL-AM SOC HEMAT, P77, DOI 10.1182/asheducation-2010.1.77; GRONOWITZ JS, 1983, BRIT J CANCER, V47, P487, DOI 10.1038/bjc.1983.78; GRONOWITZ JS, 1980, INFECT IMMUN, V29, P425; HAGBERG H, 1984, SCAND J HAEMATOL, V32, P41; Hallek M, 1999, BLOOD, V93, P1732; HALLEK M, 1992, ANN HEMATOL, V65, P1, DOI 10.1007/BF01715117; Henny J, 2013, CLIN CHEM LAB MED, V51, P1335, DOI 10.1515/cclm-2013-0410; HOUSTEK J, 1968, J PEDIATR-US, V72, P186, DOI 10.1016/S0022-3476(68)80307-5; Hus I, 2006, ANN ONCOL, V17, P683, DOI 10.1093/annonc/mdj120; KALLANDER CFR, 1984, CANCER, V54, P2450, DOI 10.1002/1097-0142(19841201)54:11<2450::AID-CNCR2820541123>3.0.CO;2-R; Konoplev SN, 2010, AM J CLIN PATHOL, V134, P472, DOI 10.1309/AJCPHMYT93HUIZKW; Kornberg A, 1989, Biochim Biophys Acta, V1000, P57; Letestu R, 2010, BLOOD, V116, P4588, DOI 10.1182/blood-2010-06-288274; Magnac C, 2003, LEUKEMIA, V17, P133, DOI 10.1038/sj.leu.2402780; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Molica S, 2014, LEUKEMIA LYMPHOMA, V55, P964, DOI 10.3109/10428194.2013.825908; Molica S, 2013, LEUKEMIA RES, V37, P943, DOI 10.1016/j.leukres.2013.02.016; Nisman B, 2013, CLIN CHEM LAB MED, V51, P439, DOI 10.1515/cclm-2012-0162; O'Neill K L, 2001, Expert Rev Mol Diagn, V1, P428, DOI 10.1586/14737159.1.4.428; Ohrvik A, 2004, CLIN CHEM, V50, P1597, DOI 10.1373/clinchem.2003.030379; Panteghini M, 2012, CLIN CHEM LAB MED, V50, P813, DOI [10.1515/cclm.2011.828, 10.1515/CCLM.2011.828]; REICHARD P, 1951, J BIOL CHEM, V188, P839; Rivkina A., 2011, Experimental Oncology, V33, P99; Sagatys EM, 2012, CANCER CONTROL, V19, P18, DOI 10.1177/107327481201900103; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Siest G, 2013, CLIN CHEM LAB MED, V51, P47, DOI 10.1515/cclm-2012-0682; Stenman UH, 1999, SEMIN CANCER BIOL, V9, P83, DOI 10.1006/scbi.1998.0086; Thomas W M, 1995, Eur J Surg Oncol, V21, P632, DOI 10.1016/S0748-7983(95)95434-1; VAITUKAITIS JL, 1974, ANN CLIN LAB SCI, V4, P276; WEISSMAN SM, 1960, BIOCHIM BIOPHYS ACTA, V45, P101, DOI 10.1016/0006-3002(60)91430-X; Wierda WG, 2011, J CLIN ONCOL, V29, P4088, DOI 10.1200/JCO.2010.33.9002; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Wu CJ, 2003, J IMMUNOL METHODS, V277, P157, DOI 10.1016/S0022-1759(03)00062-0; Xu W, 2009, INT J HEMATOL, V90, P205, DOI 10.1007/s12185-009-0380-8; Zhou J, 2013, MOL CLIN ONCOL, V1, P18, DOI 10.3892/mco.2012.19	48	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91647	10.1371/journal.pone.0091647	http://dx.doi.org/10.1371/journal.pone.0091647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621590	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300112
J	Ramos, JBE; Schulz, KG; Brownlee, C; Sett, S; Azevedo, EB				Barcelos e Ramos, Joana; Schulz, Kai Georg; Brownlee, Colin; Sett, Scarlett; Azevedo, Eduardo Brito			Effects of Increasing Seawater Carbon Dioxide Concentrations on Chain Formation of the Diatom Asterionellopsis glacialis	PLOS ONE			English	Article							MARINE DIATOMS; CO2 CONCENTRATION; SKELETONEMA-COSTATUM; INORGANIC CARBON; ORGANIC-MATTER; GROWTH; PHYTOPLANKTON; ACIDIFICATION; FLOTATION; PH	Diatoms can occur as single cells or as chain-forming aggregates. These two strategies affect buoyancy, predator evasion, light absorption and nutrient uptake. Adjacent cells in chains establish connections through various processes that determine strength and flexibility of the bonds, and at distinct cellular locations defining colony structure. Chain length has been found to vary with temperature and nutrient availability as well as being positively correlated with growth rate. However, the potential effect of enhanced carbon dioxide (CO2) concentrations and consequent changes in seawater carbonate chemistry on chain formation is virtually unknown. Here we report on experiments with semi-continuous cultures of the freshly isolated diatom Asterionellopsis glacialis grown under increasing CO2 levels ranging from 320 to 3400 mu atm. We show that the number of cells comprising a chain, and therefore chain length, increases with rising CO2 concentrations. We also demonstrate that while cell division rate changes with CO2 concentrations, carbon, nitrogen and phosphorus cellular quotas vary proportionally, evident by unchanged organic matter ratios. Finally, beyond the optimum CO2 concentration for growth, carbon allocation changes from cellular storage to increased exudation of dissolved organic carbon. The observed structural adjustment in colony size could enable growth at high CO2 levels, since longer, spiral-shaped chains are likely to create microclimates with higher pH during the light period. Moreover increased chain length of Asterionellopsis glacialis may influence buoyancy and, consequently, affect competitive fitness as well as sinking rates. This would potentially impact the delicate balance between the microbial loop and export of organic matter, with consequences for atmospheric carbon dioxide.	[Barcelos e Ramos, Joana; Azevedo, Eduardo Brito] Univ Azores, Ctr Climate Meteorol & Global Change, Angra Do Heroismo, Azores, Portugal; [Barcelos e Ramos, Joana; Azevedo, Eduardo Brito] Res Ctr Agr & Environm Sci & Technol Azores, Angra Do Heroismo, Azores, Portugal; [Schulz, Kai Georg] So Cross Univ, Sch Environm Sci & Management, Ctr Coastal Biogeochem, Lismore, NSW 2480, Australia; [Brownlee, Colin] Marine Biol Assoc UK, Plymouth, Devon, England; [Sett, Scarlett] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany	Universidade dos Acores; Southern Cross University; Marine Biological Association United Kingdom; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Ramos, JBE (corresponding author), Univ Azores, Ctr Climate Meteorol & Global Change, Angra Do Heroismo, Azores, Portugal.	joanabr@uac.pt	Barcelos e Ramos, Joana/ABD-3747-2020; Schulz, Kai/AEZ-9073-2022; Barcelos e Ramos, Joana/HDN-3479-2022; Schulz, Kai G./Q-5608-2017; Azevedo, Eduardo B/M-4266-2013	Schulz, Kai/0000-0002-8481-4639; Schulz, Kai G./0000-0002-8481-4639; Azevedo, Eduardo B/0000-0001-5172-7742; Ramos, Joana/0000-0003-4545-202X; Barcelos e Ramos, Joana/0000-0002-0879-2298	Azores Regional Science Fund; Fundation for Science and Tecnology of Portugal [PTDC/AAC-CLI/112735/2009]; Australian Research Council [FT120100384]; ARC [FT120100384]	Azores Regional Science Fund; Fundation for Science and Tecnology of Portugal; Australian Research Council(Australian Research Council); ARC(Australian Research Council)	The research was supported by Azores Regional Science Fund, the Fundation for Science and Tecnology of Portugal by the project ROPICO2 (PTDC/AAC-CLI/112735/2009), the Australian Research Council by project FT120100384, and by ARC grant FT120100384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Barcelos e Ramos J, 2007, GLOBAL BIOGEOCHEMICA, V21; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Borchard C, 2012, BIOGEOSCIENCES, V9, P3405, DOI 10.5194/bg-9-3405-2012; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; CHEN CY, 1994, MAR ECOL PROG SER, V109, P83, DOI 10.3354/meps109083; Chen XW, 2004, FUNCT PLANT BIOL, V31, P399, DOI 10.1071/FP03240; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FRYXELL GA, 1978, J PHYCOL, V14, P62, DOI 10.1111/j.0022-3646.1978.00062.x; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hoogstraten A, 2012, J PHYCOL, V48, P559, DOI 10.1111/j.1529-8817.2012.01148.x; Hopkinson BM, 2011, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.1018062108.PR0CEED-INGS; IPCC, 2007, CONTRIBUTION WORKING; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kooistra Wiebe H. C. F., 2007, P207; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P1543, DOI 10.4319/lo.1994.39.7.1543; Lewis E., 1998, PROGRAM DEV CO2 SYST; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; McGinn PJ, 2008, PLANT PHYSIOL, V146, P300, DOI 10.1104/pp.107.110569; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Milligan AJ, 2004, LIMNOL OCEANOGR, V49, P322, DOI 10.4319/lo.2004.49.2.0322; Morel FMM, 2002, FUNCT PLANT BIOL, V29, P301, DOI 10.1071/PP01199; Ploug H, 2008, LIMNOL OCEANOGR, V53, P914, DOI 10.4319/lo.2008.53.3.0914; Raven JA, 2003, PHOTOSYNTH RES, V77, P155, DOI 10.1023/A:1025877902752; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Schulz KG, 2008, BIOGEOSCIENCES, V5, P707, DOI 10.5194/bg-5-707-2008; Schulz KG, 2009, BIOGEOSCIENCES, V6, P2145, DOI 10.5194/bg-6-2145-2009; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; SMAYDA THEODORE J., 1965, LIMNOL OCEANOGR, V10, P499; SMAYDA TJ, 1966, LIMNOL OCEANOGR, V11, P35, DOI 10.4319/lo.1966.11.1.0035; SMAYDA TJ, 1966, LIMNOL OCEANOGR, V11, P18, DOI 10.4319/lo.1966.11.1.0018; Takabayashi M, 2006, J PLANKTON RES, V28, P831, DOI 10.1093/plankt/fbl018; Tatters AO, 2012, SHORT VERSUS LONG TE; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Vardi Assaf, 2008, Commun Integr Biol, V1, P134; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010	46	11	11	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90749	10.1371/journal.pone.0090749	http://dx.doi.org/10.1371/journal.pone.0090749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618939	Green Published, gold, Green Accepted			2022-12-25	WOS:000332842400028
J	Makela, JA; Toppari, J; Rivero-Muller, A; Ventela, S				Makela, Juho-Antti; Toppari, Jorma; Rivero-Muller, Adolfo; Ventela, Sami			Reconstruction of Mouse Testicular Cellular Microenvironments in Long-Term Seminiferous Tubule Culture	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; PERITUBULAR MYOID CELLS; UNDIFFERENTIATED SPERMATOGONIA; GENE-EXPRESSION; SERTOLI-CELLS; GERMLINE TRANSMISSION; EPITHELIAL CYCLE; DEFINED STAGES; SELF-RENEWAL; IN-VIVO	Research on spermatogonia is hampered by complex architecture of the seminiferous tubule, poor viability of testicular tissue ex vivo and lack of physiologically relevant long-term culture systems. Therefore there is a need for an in vitro model that would enable long term survival and propagation of spermatogonia. We aimed at the most simplified approach to enable all different cell types within the seminiferous tubules to contribute to the creation of a niche for spermatogonia. In the present study we describe the establishment of a co-culture of mouse testicular cells that is based on proliferative and migratory activity of seminiferous tubule cells and does not involve separation, purification or differential plating of individual cell populations. The co-culture is composed of the constituents of testicular stem cell niche: Sertoli cells [identified by expression of Wilm's tumour antigen 1 (WT1) and secretion of glial cell line-derived neurotrophic factor, GDNF], peritubular myoid cells (expressing alpha smooth muscle actin, alpha SMA) and spermatogonia [expressing MAGE-B4, PLZF (promyelocytic leukaemia zinc finger), LIN28, Gpr125 (G protein-coupled receptor 125), CD9, c-Kit and Nanog], and can be maintained for at least five weeks. GDNF was found in the medium at a sufficient concentration to support proliferating spermatogonial stem cells (SSCs) that were able to start spermatogenic differentiation after transplantation to an experimentally sterile recipient testis. Gdnf mRNA levels were elevated by follicle-stimulating hormone (FSH) which shows that the Sertoli cells in the co-culture respond to physiological stimuli. After approximately 2-4 weeks of culture a spontaneous formation of cord-like structures was monitored. These structures can be more than 10 mm in length and branch. They are formed by peritubular myoid cells, Sertoli cells, fibroblasts and spermatogonia as assessed by gene expression profiling. In conclusion, we have managed to establish in vitro conditions that allow spontaneous reconstruction of testicular cellular microenvironments.	[Makela, Juho-Antti; Toppari, Jorma; Rivero-Muller, Adolfo; Ventela, Sami] Univ Turku, Dept Physiol, Turku, Finland; [Makela, Juho-Antti; Toppari, Jorma] Univ Turku, Dept Paediat, Turku, Finland; [Ventela, Sami] Turku Univ Hosp, Dept Otorhinolaryngol, FIN-20520 Turku, Finland; [Makela, Juho-Antti] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	University of Turku; University of Turku; University of Turku; Australian Regenerative Medicine Institute; Monash University	Makela, JA (corresponding author), Univ Turku, Dept Physiol, Turku, Finland.	juho.makela@monash.edu	Rivero-Muller, Adolfo/A-5120-2008; Ventela, Sami/I-7253-2018	Rivero-Muller, Adolfo/0000-0002-9794-802X; Ventela, Sami/0000-0001-6672-6662	Sigrid Juselius Foundation; Emil Aaltonen's Foundation; Finnish Cultural Foundation; Finnish Medical Foundation; Academy of Finland; Turku University Hospital	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen's Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Academy of Finland(Academy of Finland); Turku University Hospital	This work was supported by grants from Sigrid Juselius Foundation (http://www.sigridjuselius.fi), Emil Aaltonen's Foundation (http://www.emilaaltonen.fi), Finnish Cultural Foundation (www.skr.fi), The Finnish Medical Foundation (http://www.laaketieteensaatio.fi), The Academy of Finland (www.aka.fi) and Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; EDDY EM, 1976, ANAT REC, V185, P333, DOI 10.1002/ar.1091850307; Gassei K, 2006, J ANDROL, V27, P611, DOI 10.2164/jandrol.05207; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; HADLEY MA, 1990, DEV BIOL, V140, P318, DOI 10.1016/0012-1606(90)90082-T; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makela JA, 2011, REPRODUCTION, V142, P711, DOI 10.1530/REP-11-0110; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Meachem SJ, 2005, J ENDOCRINOL, V186, P429, DOI 10.1677/joe.1.06121; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osterlund C, 2000, CANCER RES, V60, P1054; Pan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060054; Rahimi N, 1999, MOL BIOL CELL, V10, P3401, DOI 10.1091/mbc.10.10.3401; Rossi F, 2002, ENDOCRINOLOGY, V143, P3096, DOI 10.1210/en.143.8.3096; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; SKINNER MK, 1989, MOL ENDOCRINOL, V3, P625, DOI 10.1210/mend-3-4-625; Sonne SB, 2006, VIRCHOWS ARCH, V449, P200, DOI 10.1007/s00428-006-0223-4; SORRENTINO V, 1991, ONCOGENE, V6, P149; Steger K, 1996, INT J ANDROL, V19, P122, DOI 10.1111/j.1365-2605.1996.tb00448.x; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; TOPPARI J, 1985, J ANDROL, V6, P334; TOPPARI J, 1986, J ENDOCRINOL, V108, P417, DOI 10.1677/joe.0.1080417; TOPPARI J, 1985, J ANDROL, V6, P325; TUNG PS, 1980, BIOL REPROD, V23, P207, DOI 10.1093/biolreprod/23.1.207; TUNG PS, 1990, BIOL REPROD, V42, P351, DOI 10.1095/biolreprod42.2.351; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Ventela S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033209; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801; Yokonishi T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108613; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; ZENZES MT, 1981, DIFFERENTIATION, V20, P157, DOI 10.1111/j.1432-0436.1981.tb01170.x; Zhang FP, 2003, P NATL ACAD SCI USA, V100, P13692, DOI 10.1073/pnas.2232815100; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795	61	20	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90088	10.1371/journal.pone.0090088	http://dx.doi.org/10.1371/journal.pone.0090088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619130	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400009
J	Dekanty, A; Barrio, L; Milan, M				Dekanty, A.; Barrio, L.; Milan, M.			Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cells	ONCOGENE			English	Article							DEPENDENT KINASE INHIBITOR; APOPTOSIS; PROLIFERATION; MORPHOGENESIS; ANEUPLOIDY; ABSENCE; MELANOGASTER; EXPRESSION; RADIATION; TRIBBLES	When exposed to DNA-damaging agents, components of the DNA damage response (DDR) pathway trigger apoptosis, cell cycle arrest and DNA repair. Although failures in this pathway are associated with cancer development, the tumor suppressor roles of cell cycle arrest and apoptosis have recently been questioned in mouse models. Using Drosophila epithelial cells that are unable to activate the apoptotic program, we provide evidence that ionizing radiation (IR)-induced DNA damage elicits a tumorigenic behavior in terms of E-cadherin delocalization, cell delamination, basement membrane degradation and neoplasic overgrowth. The tumorigenic response of the tissue to IR is enhanced by depletion of Okra/DmRAD54 or spnA/DmRAD51-genes required for homologous recombination (HR) repair of DNA double-strand breaks in G2-and it is independent of the activity of Lig4, a ligase required for nonhomologous end-joining repair in G1. Remarkably, depletion of Grapes/DmChk1 or Mei-41/dATR-genes affecting DNA damage-induced cell cycle arrest in G2-compromised DNA repair and enhanced the tumorigenic response of the tissue to IR. On the contrary, DDR-independent lengthening of G2 had a positive impact on the dynamics of DNA repair and suppressed the tumorigenic response of the tissue to IR. Our results support a tumor suppressor role of apoptosis, DNA repair by HR and cell cycle arrest in G2 in simple epithelia subject to IR-induced DNA damage.	[Dekanty, A.; Barrio, L.; Milan, M.] IRB Barcelona, Barcelona 08028, Spain; [Milan, M.] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Milan, M (corresponding author), IRB Barcelona, Dept Cell & Dev Biol, Baldiri Reixac 10-12, Barcelona 08028, Spain.	marco.milan@irbbarcelona.org	Dekanty, Andres/C-3925-2018; Milan, Marco/H-1450-2015; Barrio Guerrero, Lara/F-4155-2016	Dekanty, Andres/0000-0002-0587-0449; Milan, Marco/0000-0002-7111-6444; Barrio Guerrero, Lara/0000-0001-7347-3114	Juan de la Cierva post-doctoral contract; Ministerio de Economia y Competitividad [BFU2010-21123, CSD2007-00008]; Generalitat de Catalunya [2005 SGR 00118]; EMBO Young Investigator Programme; ICREA Funding Source: Custom	Juan de la Cierva post-doctoral contract; Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); ICREA(ICREA)	We thank B Edgar and I Hariharan for flies and reagents, T Yates for help in editing the manuscript, and M Clemente-Ruiz for comments on the manuscript. AD is funded by a Juan de la Cierva post-doctoral contract and LB by a pre-doctoral fellowship (Ministerio de Economia y Competitividad), MM is an ICREA Research Professor and MM's laboratory was funded by Grants from the Ministerio de Economia y Competitividad (BFU2010-21123 and CSD2007-00008), the Generalitat de Catalunya (2005 SGR 00118), intramural funds and the EMBO Young Investigator Programme.	Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Dekanty A, 2012, P NATL ACAD SCI USA, V109, P20549, DOI 10.1073/pnas.1206675109; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; Foster SS, 2012, P NATL ACAD SCI USA, V109, P9953, DOI 10.1073/pnas.1120476109; Garcia AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r121; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAY BA, 1994, DEVELOPMENT, V120, P2121; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Kooistra R, 1997, MOL CELL BIOL, V17, P6097, DOI 10.1128/MCB.17.10.6097; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Romeijn RJ, 2005, GENETICS, V169, P795, DOI 10.1534/genetics.104.033464; Salomon RN, 2008, FLY, V2, P265, DOI 10.4161/fly.7396; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Song YH, 2005, MOL CELLS, V19, P167; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Srivastava N, 2009, MUTAT RES-REV MUTAT, V681, P180, DOI 10.1016/j.mrrev.2008.08.003; Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025	50	23	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					978	985		10.1038/onc.2014.42	http://dx.doi.org/10.1038/onc.2014.42			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632609				2022-12-25	WOS:000350121300004
J	Ewens, CA; Panico, S; Kloppsteck, P; McKeown, C; Ebong, IO; Robinson, C; Zhang, XD; Freemont, PS				Ewens, Caroline A.; Panico, Silvia; Kloppsteck, Patrik; McKeown, Ciaran; Ebong, Ima-Obong; Robinson, Carol; Zhang, Xiaodong; Freemont, Paul S.			The p97-FAF1 Protein Complex Reveals a Common Mode of p97 Adaptor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Electron Microscopy (EM); Fas; Isothermal Titration Calorimetry; Protein Cross-linking; FAF1; p97	VALOSIN-CONTAINING PROTEIN; FAS-ASSOCIATED FACTOR-1; AAA-ATPASE; KAPPA-B; PROTEASOME; VCP/P97; P97/VCP; DOMAIN; FAF1	Background: p97 function is facilitated by a huge array of varied adaptor proteins, including FAF1. Results: FAF1 binds over the AAA rings of p97 alone and in a trimer-hexamer arrangement. Conclusion: p97 and FAF1 bind with a similar affinity and in a similar conformation to other p97-adaptor complexes. Significance: p97 binds multiple different adaptors by a common mode. p97, also known as valosin-containing protein, is a versatile participant in the ubiquitin-proteasome system. p97 interacts with a large network of adaptor proteins to process ubiquitylated substrates in different cellular pathways, including endoplasmic reticulum-associated degradation and transcription factor activation. p97 and its adaptor Fas-associated factor-1 (FAF1) both have roles in the ubiquitin-proteasome system during NF-B activation, although the mechanisms are unknown. FAF1 itself also has emerging roles in other cell-cycle pathways and displays altered expression levels in various cancer cell lines. We have performed a detailed study the p97-FAF1 interaction. We show that FAF1 binds p97 stably and in a stoichiometry of 3 to 6. Cryo-EM analysis of p97-FAF1 yielded a 17 reconstruction of the complex with FAF1 above the p97 ring. Characteristics of p97-FAF1 uncovered in this study reveal common features in the interactions of p97, providing mechanistic insight into how p97 mediates diverse functionalities.	[Ewens, Caroline A.; Panico, Silvia; Kloppsteck, Patrik; McKeown, Ciaran; Zhang, Xiaodong; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Struct Biol Ctr, London SW7 2AZ, England; [Ebong, Ima-Obong; Robinson, Carol] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	Imperial College London; University of Oxford	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	p.freemont@imperial.ac.uk		Zhang, Xiaodong/0000-0001-9786-7038; Panico, Silvia/0000-0002-2196-0727; Freemont, Paul/0000-0002-5658-8486; robinson, carol/0000-0001-7829-5505	Biotechnology and Biological Sciences Research Council; Wellcome Trust; CRUK; Cancer Research UK [13449] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and CRUK.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Grant T., 2007, THESIS IMPERIAL COLL; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644	31	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12077	12084		10.1074/jbc.M114.559591	http://dx.doi.org/10.1074/jbc.M114.559591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619421	hybrid, Green Published			2022-12-25	WOS:000335010600045
J	Duan, F; Chapeau-Blondeau, F; Abbott, D				Duan, Fabing; Chapeau-Blondeau, Francois; Abbott, Derek			Stochastic Resonance with Colored Noise for Neural Signal Detection	PLOS ONE			English	Article							WEAKLY DEPENDENT NOISE; SYSTEM; TRANSDUCTION; ENHANCEMENT; THRESHOLD	We analyze signal detection with nonlinear test statistics in the presence of colored noise. In the limits of small signal and weak noise correlation, the optimal test statistic and its performance are derived under general conditions, especially concerning the type of noise. We also analyze, for a threshold nonlinearity-a key component of a neural model, the conditions for noise-enhanced performance, establishing that colored noise is superior to white noise for detection. For a parallel array of nonlinear elements, approximating neurons, we demonstrate even broader conditions allowing noise-enhanced detection, via a form of suprathreshold stochastic resonance.	[Duan, Fabing] Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China; [Chapeau-Blondeau, Francois] Univ Angers, Lab Ingn Syst Automatises, Angers, France; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Qingdao University; Universite d'Angers; University of Adelaide; University of Adelaide	Duan, F (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China.	fabing.duan@gmail.com	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674; CHAPEAU-BLONDEAU, Francois/0000-0003-0536-7146	NSF of Shandong Province [ZR2010FM006]	NSF of Shandong Province	This work is sponsored by the NSF of Shandong Province (No. ZR2010FM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Benzi R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01052; Bezrukov SM, 1997, NATURE, V385, P319, DOI 10.1038/385319a0; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Blanchard S, 2007, NEUROCOMPUTING, V71, P333, DOI 10.1016/j.neucom.2006.12.014; BULSARA AR, 1993, PHYS REV E, V47, P3734, DOI 10.1103/PhysRevE.47.3734; Chapeau-Blondeau F, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.060101; Chapeau-Blondeau F, 2009, J STAT MECH-THEORY E, V1; Chapeau-Blondeau F, 2007, PHYS REV E, V81; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5031, DOI 10.1109/TSP.2008.928509; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Collins JJ, 2003, IEEE ENG MED BIOL, V22, P76, DOI 10.1109/MEMB.2003.1195700; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Duan FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034282; Duan FB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051107; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Gosak M, 2011, EUR PHYS J B, V80, P519, DOI 10.1140/epjb/e2011-10573-8; Gosak M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013012; Hanggi P, 2000, PHYS REV E, V62, P6155, DOI 10.1103/PhysRevE.62.6155; HANGGI P, 1993, J STAT PHYS, V70, P25, DOI 10.1007/BF01053952; Inchiosa ME, 1996, PHYS REV E, V53, pR2021, DOI 10.1103/PhysRevE.53.R2021; Kassam S. A., 1988, SIGNAL DETECTION NON; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Kay S. M., 1998, FUNDAMENTALS STAT SI; Kitajo K, 2006, EUROPHYS LETT, V76, P1029, DOI 10.1209/epl/i2006-10377-0; Kosko B, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051110; Kurita Y, 2013, IEEE T HUM-MACH SYST, V43, P333, DOI 10.1109/TSMC.2013.2242886; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LINDNER JF, 1995, PHYS REV LETT, V75, P3, DOI 10.1103/PhysRevLett.75.3; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; Makra P, 2003, PHYS LETT A, V317, P228, DOI 10.1016/j.physleta.2003.08.042; MARTINEZ AB, 1984, IEEE T INFORM THEORY, V30, P815, DOI 10.1109/TIT.1984.1056981; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Neiman A, 1996, PHYS LETT A, V223, P341, DOI 10.1016/S0375-9601(96)00742-6; Nikitin A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021121; Nozaki D, 1999, PHYS REV LETT, V82, P2402, DOI 10.1103/PhysRevLett.82.2402; Patel A, 2011, IEEE T SIGNAL PROCES, V59, P488, DOI 10.1109/TSP.2010.2091409; Patel A, 2009, NEURAL NETWORKS, V22, P697, DOI 10.1016/j.neunet.2009.06.044; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036105; POOR HV, 1982, IEEE T INFORM THEORY, V28, P735, DOI 10.1109/TIT.1982.1056545; POOR HV, 1982, IEEE T INFORM THEORY, V28, P744, DOI 10.1109/TIT.1982.1056546; PORTNOY SL, 1977, ANN STAT, V5, P22, DOI 10.1214/aos/1176343738; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Rousseau D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021102; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stocks NG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041114; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Xu BH, 2003, CHAOS SOLITON FRACT, V16, P93, DOI 10.1016/S0960-0779(02)00201-1; Zeng LZ, 2012, CHAOS SOLITON FRACT, V45, P378, DOI 10.1016/j.chaos.2011.10.012; Zozor S, 2003, IEEE T SIGNAL PROCES, V51, P3177, DOI 10.1109/TSP.2003.818905	63	19	19	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91345	10.1371/journal.pone.0091345	http://dx.doi.org/10.1371/journal.pone.0091345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632853	gold, Green Published			2022-12-25	WOS:000332858400056
J	Goeldner, I; Skare, T; Boldt, ABW; Nass, FR; Messias-Reason, IJ; Utiyama, SR				Goeldner, Isabela; Skare, Thelma; Boldt, Angelica B. W.; Nass, Flavia R.; Messias-Reason, Iara J.; Utiyama, Shirley R.			Association of MASP-2 Levels and MASP2 Gene Polymorphisms with Rheumatoid Arthritis in Patients and Their Relatives	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; SERINE PROTEASE-2 MASP-2; PATHWAY COMPONENTS; COMPLEMENT; SERUM; DEFICIENCY; ACTIVATION; DISEASE; RISK	Background: Mannan-binding lectin-associated serine protease 2 (MASP-2) is a key protein of the lectin pathway of complement. MASP-2 levels have been associated with different polymorphisms within MASP2 gene as well as with the risk for inflammatory disorders and infections. Despite its clinical importance, MASP-2 remains poorly investigated in rheumatoid arthritis (RA). Methods: In this case-control study, we measured MASP-2 serum levels in 156 RA patients, 44 patient relatives, and 100 controls from Southern Brazil, associating the results with nine MASP2 polymorphisms in all patients, 111 relatives, and 230 controls genotyped with multiplex SSP-PCR. Results: MASP-2 levels were lower in patients than in controls and relatives (medians 181 vs. 340 or 285 ng/ml, respectively, P<0.0001). Conversely, high MASP-2 levels were associated with lower susceptibility to RA and to articular symptoms independently of age, gender, ethnicity, smoking habit, anti-CCP and rheumatoid factor positivity (OR = 0.05 [95% CI = 0.019-0.13], P<0.0001 between patients and controls; OR = 0.12, [95% CI = 0.03-0.45], P = 0.002 between patients and relatives; OR = 0.06, [95% CI = 0.004-0.73], P = 0.03 between relatives with and without articular symptoms). MASP2 haplotypes *2A1 and *2B1-i were associated with increased susceptibility to RA (OR = 3.32 [95% CI = 1.48-7.45], P = 0.004). Deficiency-causing p.120G and p.439H substitutions were associated with five times increased susceptibility to articular symptoms in relatives (OR = 5.13 [95% CI = 1.36-20.84], P = 0.02). There was no association of MASP-2 levels or MASP2 polymorphisms with autoantibodies, Sjogren's syndrome, nodules and functional class. Conclusions: In this study, we found the first evidence that MASP-2 deficiency might play an important role in the development of RA and articular symptoms among relatives of RA patients.	[Goeldner, Isabela; Boldt, Angelica B. W.; Nass, Flavia R.; Messias-Reason, Iara J.] Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil; [Skare, Thelma] Evangel Univ Hosp, Rheumatol Unit, Curitiba, Parana, Brazil; [Utiyama, Shirley R.] Univ Fed Parana, Dept Clin Anal, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Goeldner, I (corresponding author), Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil.	igoeldner@gmail.com.br	Boldt, Angelica/G-3630-2012; Eibofner, Isabela/D-1884-2014	Boldt, Angelica/0000-0002-0902-9622; Eibofner, Isabela/0000-0002-9850-6231; Jose de Messias Reason, Iara/0000-0002-5573-260X	Araucaria Foundation [412/2009, 5103]; National Counsel of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was partially supported by grants from the Araucaria Foundation (no. 412/2009, protocol 5103, http://www.fundacaoaraucaria.org.br/), as well as by fellowships from the National Counsel of Technological and Scientific Development (CNPq) and Coordination for the Improvement of Higher Level Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammitzboll CG, 2012, RHEUMATOL INT, V32, P1457, DOI 10.1007/s00296-011-1879-x; Arlestig L, 2012, ANN RHEUM DIS, V71, P825, DOI 10.1136/annrheumdis-2011-200668; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Banda NK, 2010, J IMMUNOL, V185, P5598, DOI 10.4049/jimmunol.1001564; Bergstrom U, 2011, RHEUMATOLOGY, V50, P2005, DOI 10.1093/rheumatology/ker258; Boldt ABW, 2011, HUM IMMUNOL, V72, P753, DOI 10.1016/j.humimm.2011.05.015; Boldt ABW, 2013, PLOS ONE IN PRESS; Boldt ABW, 2012, ADV CLIN CHEM, V56, P105, DOI 10.1016/B978-0-12-394317-0.00012-1; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; Braun-Prado K, 2000, TISSUE ANTIGENS, V56, P417, DOI 10.1034/j.1399-0039.2000.560504.x; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Dolman KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2386; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Endo Y, 2002, INT IMMUNOL, V14, P1193, DOI 10.1093/intimm/dxf085; Gabriel SE, 1999, J RHEUMATOL, V26, P2529; Goeldner I, 2010, RHEUMATOLOGY, V49, P1590, DOI 10.1093/rheumatology/keq134; Guthrie KA, 2009, ANN RHEUM DIS, V68, P107, DOI 10.1136/ard.2008.092312; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Ip WK, 2000, ARTHRITIS RHEUM, V43, P1679, DOI 10.1002/1529-0131(200008)43:8<1679::AID-ANR3>3.3.CO;2-4; Jacobsen S, 2009, J RHEUMATOL, V36, P731, DOI 10.3899/jrheum.080846; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Herraez DL, 2013, ARTHRITIS RHEUM-US, V65, P1457, DOI 10.1002/art.37923; Martiny FL, 2012, J RHEUMATOL, V39, P6, DOI 10.3899/jrheum.110052; Messias-Reason I, 2008, CLIN EXP DERMATOL, V33, P495, DOI 10.1111/j.1365-2230.2008.02743.x; Michou L, 2008, J RHEUMATOL, V35, P790; Myouzen K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002949; Nebert DW, 2002, HUM MUTAT, V20, P463, DOI 10.1002/humu.10143; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Probst CM, 2000, HUM BIOL, V72, P597; Rojas-Villarraga A, 2009, J AUTOIMMUN, V32, P64, DOI 10.1016/j.jaut.2008.11.004; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schafranski MD, 2008, HUM IMMUNOL, V69, P41, DOI 10.1016/j.humimm.2007.11.003; Schlapbach LJ, 2009, PEDIATR INFECT DIS J, V26, P989; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Sorensen CM, 2006, CLIN EXP IMMUNOL, V145, P173, DOI 10.1111/j.1365-2249.2006.03101.x; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stover C, 2001, GENES IMMUN, V2, P119, DOI 10.1038/sj.gene.6363745; Thiel S, 2007, GENES IMMUN, V8, P154, DOI 10.1038/sj.gene.6364373; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Troelsen LN, 2010, MOL IMMUNOL, V47, P713, DOI 10.1016/j.molimm.2009.10.021; Unterberger C, 2007, BIOCHEM BIOPH RES CO, V364, P1022, DOI 10.1016/j.bbrc.2007.10.114; Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Zhang M, 2013, INT J CARDIOL, V166, P499, DOI 10.1016/j.ijcard.2011.11.032	48	11	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90979	10.1371/journal.pone.0090979	http://dx.doi.org/10.1371/journal.pone.0090979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632598	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400028
J	Manea, A; Leishman, MR				Manea, Anthony; Leishman, Michelle R.			Leaf Area Index Drives Soil Water Availability and Extreme Drought-Related Mortality under Elevated CO2 in a Temperate Grassland Model System	PLOS ONE			English	Article							CLIMATE-CHANGE; C-4 GRASSES; SPECIES COMPOSITION; SEMIARID GRASSLAND; ATMOSPHERIC CO2; GLOBAL CHANGE; GAS-EXCHANGE; RESPONSES; ECOSYSTEM; PLANTS	The magnitude and frequency of climatic extremes, such as drought, are predicted to increase under future climate change conditions. However, little is known about how other factors such as CO2 concentration will modify plant community responses to these extreme climatic events, even though such modifications are highly likely. We asked whether the response of grasslands to repeat extreme drought events is modified by elevated CO2, and if so, what are the underlying mechanisms? We grew grassland mesocosms consisting of 10 co-occurring grass species common to the Cumberland Plain Woodland of western Sydney under ambient and elevated CO2 and subjected them to repeated extreme drought treatments. The 10 species included a mix of C-3, C-4, native and exotic species. We hypothesized that a reduction in the stomatal conductance of the grasses under elevated CO2 would be offset by increases in the leaf area index thus the retention of soil water and the consequent vulnerability of the grasses to extreme drought would not differ between the CO2 treatments. Our results did not support this hypothesis: soil water content was significantly lower in the mesocosms grown under elevated CO2 and extreme drought-related mortality of the grasses was greater. The C-4 and native grasses had significantly higher leaf area index under elevated CO2 levels. This offset the reduction in the stomatal conductance of the exotic grasses as well as increased rainfall interception, resulting in reduced soil water content in the elevated CO2 mesocosms. Our results suggest that projected increases in net primary productivity globally of grasslands in a high CO2 world may be limited by reduced soil water availability in the future.	[Manea, Anthony; Leishman, Michelle R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Manea, A (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	anthony.manea@students.mq.edu.au	Leishman, Michelle M/G-9726-2012; Leishman, Michelle/AAU-4102-2020	Leishman, Michelle M/0000-0003-4830-5797; Leishman, Michelle/0000-0003-4830-5797; Manea, Anthony/0000-0002-0956-4529	Macquarie University Research Excellence; National Climate Change Adaptation Research Flagship scholarship	Macquarie University Research Excellence; National Climate Change Adaptation Research Flagship scholarship	This research was funded by a Macquarie University Research Excellence and National Climate Change Adaptation Research Flagship scholarship to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson LJ, 2001, GLOBAL CHANGE BIOL, V7, P693, DOI 10.1046/j.1354-1013.2001.00438.x; [Anonymous], 2004, ANNU REV ENV RESOUR; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Cavaleri MA, 2010, ECOLOGY, V91, P2705, DOI 10.1890/09-0582.1; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dijkstra FA, 2010, FUNCT ECOL, V24, P1152, DOI 10.1111/j.1365-2435.2010.01717.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; ETCCDI/CRD, 2012, CC1 CLIVAR JCOMM EXP; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Field C. B, 2011, MANAGING RISKS EXTRE; Funk JL, 2010, BIOL INVASIONS, V12, P1685, DOI 10.1007/s10530-009-9581-6; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Joussaume S, 2013, WORKING GROUP 1 CONT; Lecain DR, 2003, ANN BOT-LONDON, V92, P41, DOI 10.1093/aob/mcg109; Little D, 2003, BRINGING BUSH BACK W, P47; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2001, GLOBAL CHANGE BIOL, V7, P451, DOI 10.1046/j.1365-2486.2001.00415.x; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Newingham BA, 2013, GLOBAL CHANGE BIOL, V19, P2168, DOI 10.1111/gcb.12177; Niklaus PA, 2001, ECOL MONOGR, V71, P341, DOI 10.1890/0012-9615(2001)071[0341:ALTFSO]2.0.CO;2; PARTON WJ, 1995, GLOBAL CHANGE BIOL, V1, P13, DOI 10.1111/j.1365-2486.1995.tb00002.x; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Polley HW, 2012, GLOBAL CHANGE BIOL, V18, P700, DOI 10.1111/j.1365-2486.2011.02529.x; Polley HW, 2003, NEW PHYTOL, V160, P319, DOI 10.1046/j.1469-8137.2003.00897.x; Schiermeier Q, 2008, NATURE, V452, P270, DOI 10.1038/452270a; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WOODWARD FI, 1990, TRENDS ECOL EVOL, V5, P308, DOI 10.1016/0169-5347(90)90087-T	30	20	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91046	10.1371/journal.pone.0091046	http://dx.doi.org/10.1371/journal.pone.0091046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632832	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400038
J	Manso, R; Rodriguez-Pinilla, SM; Lombardia, L; de Garibay, GR; Lopez, MD; Requena, L; Sanchez, L; Sanchez-Beato, M; Piris, MA				Manso, Rebeca; Maria Rodriguez-Pinilla, Socorro; Lombardia, Luis; Ruiz de Garibay, Gorka; del Mar Lopez, Maria; Requena, Luis; Sanchez, Lydia; Sanchez-Beato, Margarita; Angel Piris, Miguel			An A91V SNP in the Perforin Gene Is Frequently Found in NK/T-Cell Lymphomas	PLOS ONE			English	Article							NATURAL-KILLER-CELL; BARR-VIRUS INFECTION; NASAL-TYPE; T-CELL; CLINICAL-FEATURES; K-RAS; PROGNOSTIC-FACTORS; C-KIT; MUTATIONS; P53	NK/T-cell lymphoma (NKTCL) is the most frequent EBV-related NK/T-cell disease. Its clinical manifestations overlap with those of familial haemophagocytic lymphohistiocytosis (FHLH). Since PERFORIN (PRF1) mutations are present in FHLH, we analysed its role in a series of 12 nasal and 12 extranasal-NKTCLs. 12.5% of the tumours and 25% of the nasal-origin cases had the well-known g.272C>T(p.Ala91Val) pathogenic SNP, which confers a poor prognosis. Two of these cases had a double-CD4/CD8-positive immunophenotype, although no correlation was found with perforin protein expression. p53 was overexpressed in 20% of the tumoral samples, 80% of which were of extranasal origin, while none showed PRF1 SNVs. These results suggest that nasal and extranasal NKTCLs have different biological backgrounds, although this requires validation.	[Manso, Rebeca; Maria Rodriguez-Pinilla, Socorro] Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Maria Rodriguez-Pinilla, Socorro; Ruiz de Garibay, Gorka; del Mar Lopez, Maria; Sanchez-Beato, Margarita; Angel Piris, Miguel] CNIO, Lymphoma Grp, Mol Pathol Programme, Madrid, Spain; [Lombardia, Luis] CNIO, Diagnost Clin Res Unit, Clin Res Programme, Madrid, Spain; [Ruiz de Garibay, Gorka] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [del Mar Lopez, Maria] CNIO, Monoclonal Antibodies Unit, Biotechnol Programme, Madrid, Spain; [Requena, Luis] Fdn Jimenez Diaz, Dept Dermatol, Madrid, Spain; [Sanchez, Lydia] CNIO, Immunohistochem Unit, Biotechnol Programme, Madrid, Spain; [Sanchez-Beato, Margarita] Hosp Univ Puerta Hierro Majadahonda, Inst Invest Sanitaria, Oncol Haematol Area, Madrid, Spain; [Angel Piris, Miguel] Univ Cantabria, Hosp Univ Marques Valdecilla, IFIMAV, Dept Pathol, E-39005 Santander, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Clinico San Carlos; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Rodriguez-Pinilla, SM (corresponding author), Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain.	smrodriguez@fjd.es	de Garibay, Gorka Ruiz/AAB-6579-2020; Piris, Miguel A/B-7067-2008; Piris, Miguel A/AAP-1445-2020; Sanchez-Beato, Margarita/G-8753-2012	de Garibay, Gorka Ruiz/0000-0001-9936-8419; Piris, Miguel A/0000-0001-5839-3634; Piris, Miguel A/0000-0001-5839-3634; Sanchez-Beato, Margarita/0000-0002-0058-7599	Ministerio de Ciencia e Innovacion, Spain (RETICC) [SAF2008-03871, FIS 08/0856]; Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias [CP11/00018]; Conchita Rabago Foundation	Ministerio de Ciencia e Innovacion, Spain (RETICC); Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Conchita Rabago Foundation	This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (RETICC, SAF2008-03871, FIS 08/0856) and the Spanish Association Against Cancer (AECC). MSB is supported by a Miguel Servet Contract (CP11/00018) from the Fondo de Investigaciones Sanitarias. RM is supported by the Conchita Rabago Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aozasa K, 2008, INT J HEMATOL, V87, P110, DOI 10.1007/s12185-008-0021-7; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Berti E, 2010, BLOOD, V116, P165, DOI 10.1182/blood-2009-11-252957; Brennan AJ, 2010, CELL DEATH DIFFER, V17, P607, DOI 10.1038/cdd.2009.212; Cannella S, 2007, CANCER-AM CANCER SOC, V109, P2566, DOI 10.1002/cncr.22718; Chan KC Q-ML, 2008, WHO CLASSIFICATION T; Chen RL, 2007, J CLIN PATHOL, V60, P1168, DOI 10.1136/jcp.2007.049551; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Clementi R, 2005, BLOOD, V105, P4424, DOI 10.1182/blood-2004-04-1477; Elenitoba-Johnson KSJ, 1998, MODERN PATHOL, V11, P905; Gaal K, 2000, AM J SURG PATHOL, V24, P1511, DOI 10.1097/00000478-200011000-00006; Garcia JF, 2003, BLOOD, V101, P681, DOI 10.1182/blood-2002-04-1128; Hongyo T, 2005, ONCOL REP, V13, P265; Hoshida Y, 2003, CANCER SCI, V94, P297, DOI 10.1111/j.1349-7006.2003.tb01436.x; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Isobe Y, 2012, J CLIN PATHOL, V65, P278, DOI 10.1136/jclinpath-2011-200523; Jo JC, 2012, EUR J HAEMATOL, V89, P103, DOI 10.1111/j.1600-0609.2012.01796.x; KANAVAROS P, 1993, BLOOD, V81, P2688; Katano H, 2004, BLOOD, V103, P1244, DOI 10.1182/blood-2003-06-2171; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kurniawan AN, 2006, ONCOL REP, V15, P1257; Lee J, 2005, BRIT J CANCER, V92, P1226, DOI 10.1038/sj.bjc.6602502; Lee SM, 2004, J MED GENET, V41, P137, DOI 10.1136/jmg.2003.011528; Li SY, 2013, AM J SURG PATHOL, V37, P14, DOI 10.1097/PAS.0b013e31826731b5; Li T, 2000, LAB INVEST, V80, P493, DOI 10.1038/labinvest.3780055; Li YX, 2008, BLOOD, V112, P3057, DOI 10.1182/blood-2008-05-160176; Li YX, 2011, CANCER-AM CANCER SOC, V117, P5203, DOI 10.1002/cncr.26167; Li YX, 2009, CLIN CANCER RES, V15, P2905, DOI 10.1158/1078-0432.CCR-08-2914; Lu G, 2009, CHINESE MED J-PEKING, V122, P262, DOI 10.3760/cma.j.issn.0366-6999.2009.03.005; Ng SB, 2004, MODERN PATHOL, V17, P1097, DOI 10.1038/modpathol.3800157; Petit B, 2001, HUM PATHOL, V32, P196, DOI 10.1053/hupa.2001.21569; Pipkin ME, 2010, IMMUNOL REV, V235, P55, DOI 10.1111/j.0105-2896.2010.00905.x; Pongpruttipan T, 2012, AM J SURG PATHOL, V36, P481, DOI 10.1097/PAS.0b013e31824433d8; Pongpruttipan T, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-79; Quintanilla-Martinez L, 1999, HUM PATHOL, V30, P849, DOI 10.1016/S0046-8177(99)90147-8; Quintanilla-Martinez L, 2001, AM J PATHOL, V159, P2095, DOI 10.1016/S0002-9440(10)63061-1; Risma KA, 2006, J CLIN INVEST, V116, P182, DOI 10.1172/JCI26217; Santoro A, 2005, HAEMATOLOGICA, V90, P697; Schwartz EJ, 2008, AM J CLIN PATHOL, V130, P343, DOI 10.1309/V561QTM6854W4WAV; Stadt UZ, 2004, BLOOD, V104, P1909, DOI 10.1182/blood-2004-02-0733; Suzuki R, 2009, BLOOD, V113, P6260, DOI 10.1182/blood-2009-03-211011; Swerdlow E., 2008, WHO CLASSIFICATION T; Takahara M, 2004, HUM PATHOL, V35, P86, DOI 10.1016/j.humpath.2003.08.025; Trambas C, 2005, BLOOD, V106, P932, DOI 10.1182/blood-2004-09-3713; Voskoboinik I, 2006, IMMUNOL CELL BIOL, V84, P66, DOI 10.1111/j.1440-1711.2005.01409.x; Voskoboinik I, 2005, BLOOD, V105, P4700, DOI 10.1182/blood-2004-12-4935; Willemze R, 2008, BLOOD, V111, P838, DOI 10.1182/blood-2007-04-087288; Yang LY, 2011, LEUKEMIA RES, V35, P196, DOI 10.1016/j.leukres.2010.06.016; Ye ZY, 2013, J CLIN PATHOL, V66, P676, DOI 10.1136/jclinpath-2013-201454	49	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91521	10.1371/journal.pone.0091521	http://dx.doi.org/10.1371/journal.pone.0091521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632576	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400067
J	Ruser, A; Dahne, M; Sundermeyer, J; Lucke, K; Houser, DS; Finneran, JJ; Driver, J; Pawliczka, I; Rosenberger, T; Siebert, U				Ruser, Andreas; Daehne, Michael; Sundermeyer, Janne; Lucke, Klaus; Houser, Dorian S.; Finneran, James J.; Driver, Joerg; Pawliczka, Iwona; Rosenberger, Tanja; Siebert, Ursula			In-Air Evoked Potential Audiometry of Grey Seals (Halichoerus grypus) from the North and Baltic Seas	PLOS ONE			English	Article							TEMPORARY THRESHOLD SHIFT; HEARING SENSITIVITY; AMPHIBIOUS HEARING; HARBOR SEALS; NOISE; VOCALIZATIONS; PINNIPEDS; EXPOSURE; SINGLE	In-air anthropogenic sound has the potential to affect grey seal (Halichoerus grypus) behaviour and interfere with acoustic communication. In this study, a new method was used to deliver acoustic signals to grey seals as part of an in-air hearing assessment. Using in-ear headphones with adapted ear inserts allowed for the measurement of auditory brainstem responses (ABR) on sedated grey seals exposed to 5-cycle (2-1-2) tone pips. Thresholds were measured at 10 frequencies between 1-20 kHz. Measurements were made using subcutaneous electrodes on wild seals from the Baltic and North Seas. Thresholds were determined by both visual and statistical approaches (single point F-test) and good agreement was obtained between the results using both methods. The mean auditory thresholds were <= 40 dB re 20 mu Pa peak equivalent sound pressure level (peSPL) between 4-20 kHz and showed similar patterns to in-air behavioural hearing tests of other phocid seals between 3 and 20 kHz. Below 3 kHz, a steep reduction in hearing sensitivity was observed, which differed from the rate of decline in sensitivity obtained in behavioural studies on other phocids. Differences in the rate of decline may reflect influence of the ear inserts on the ability to reliably transmit lower frequencies or interference from the structure of the distal end of the ear canal.	[Ruser, Andreas; Daehne, Michael; Sundermeyer, Janne; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Fdn, Busum, Schleswig Holst, Germany; [Lucke, Klaus] Wageningen UR, Imares, Inst Marine Resources & Ecosyst Studies, Den Burg, North Holland, Netherlands; [Houser, Dorian S.] Natl Marine Mammal Fdn, San Diego, CA USA; [Finneran, James J.] US Navy Marine Mammal Program, Space & Naval Warfare Syst Ctr Pacific, San Diego, CA USA; [Driver, Joerg] Vet Clin, Reinsbuttel, Schleswig Holst, Germany; [Pawliczka, Iwona] Univ Gdansk, Hel Marine Stn, Hel, Pomerania, Poland; [Rosenberger, Tanja] Seal Ctr Friedrichskoog, Schleswig Holstein, Germany	University of Veterinary Medicine Hannover, Foundation; Wageningen University & Research; Naval Information Warfare Center Pacific; United States Department of Defense; United States Navy; Fahrenheit Universities; University of Gdansk	Ruser, A (corresponding author), Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Fdn, Busum, Schleswig Holst, Germany.	andreas.ruser@tiho-hannover.de	Lucke, Klaus/B-9349-2015; Houser, Dorian/AAG-6359-2020	Lucke, Klaus/0000-0002-5414-3715; Houser, Dorian/0000-0002-0960-8528; Pawliczka, Iwona/0000-0001-9235-9456	Federal Agency for Nature Conservation, Germany [Z1.2-5330/2010/14]; Wehrtechnische Dienststelle of the German Bundeswehr [71]	Federal Agency for Nature Conservation, Germany; Wehrtechnische Dienststelle of the German Bundeswehr	This study was funded by the Federal Agency for Nature Conservation, Germany (http://www.bfn.de/index+M52087573ab0.html) under the contract Z1.2-5330/2010/14. The data acquisition hardware was purchased by means of funding by the Wehrtechnische Dienststelle 71 of the German Bundeswehr (http://www.baain.de/portal/a/baain/!ut/p/c4/04_SB8K8xLLM9MSSzPy8xBz9CP3I5EyrpHK9pMTEzDy9lMzUvOKSYr3ykhRzQ_1wkPKcdP3I1Dz9gtxcRwConM6j/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSELIN S, 1993, CAN J ZOOL, V71, P2211, DOI 10.1139/z93-310; BfN - Bundesamt fur Naturschutz, 2007, NAT BER 2007 BEW FFH; BMWI - Bundesministerium fur Wirtschaft und Technologie, 2011, RES ENV SOUND REL AF; Breton SP, 2009, RENEW ENERG, V34, P646, DOI 10.1016/j.renene.2008.05.040; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; Dudzinski KM, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P260; ELBERLING C, 1984, SCAND AUDIOL, V13, P187, DOI 10.3109/01050398409043059; Finneran JJ, 2006, J ACOUST SOC AM, V119, P3181, DOI 10.1121/1.2180208; Finneran JJ, 2009, J ACOUST SOC AM, V126, P491, DOI 10.1121/1.3148214; Finneran JJ, 2002, J ACOUST SOC AM, V111, P2929, DOI 10.1121/1.1479150; Finneran JJ, 2008, 3226 SSC SAN DIEG; Harkonen Tero, 2007, NAMMCO Scientific Publications, V6, P57; Herrmann C, 2007, NATURSCHUTZARBEIT MV, V50, P56; Houser Dorian S., 2007, Aquatic Mammals, V33, P110, DOI 10.1578/AM.33.1.2007.110; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; Kastak D, 2005, J ACOUST SOC AM, V118, P3154, DOI 10.1121/1.2047128; Kastak D, 1999, CAN J ZOOL, V77, P1751, DOI 10.1139/cjz-77-11-1751; Kastak D, 1998, J ACOUST SOC AM, V103, P2216, DOI 10.1121/1.421367; Kastak D, 2007, J ACOUST SOC AM, V122, P2916, DOI 10.1121/1.2783111; King J. E., 1991, SEALS WORLD; Lucke K., 2008, AUDITORY STUDIES MAR; MOHL B, 1968, Journal of Auditory Research, V8, P27; Mulsow J, 2011, J ACOUST SOC AM, V129, P2298, DOI 10.1121/1.3552882; Nachtigall PE, 2004, MAR MAMMAL SCI, V20, P673, DOI 10.1111/j.1748-7692.2004.tb01187.x; National Research Council, 2005, MAR MAMM POP OC NOIS; OLIVER GW, 1978, BEHAVIOUR, V67, P97, DOI 10.1163/156853978X00279; OSPAR Commission, 2000, QUAL STAT REP 2000; RALLS K, 1985, CAN J ZOOL, V63, P1050, DOI 10.1139/z85-157; Reichmuth C, 2013, J COMP PHYSIOL A, V199, P491, DOI 10.1007/s00359-013-0813-y; Reijnders Peter J.H., 2009, Wadden Sea Ecosystem, V25, P1; RIDGWAY S H, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P81; SCHEVILL WE, 1963, SCIENCE, V141, P50, DOI 10.1126/science.141.3575.50; Siebert U., 2012, THREATENED BIODIVERS, P488; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Sundermeyer J, 2006, UNTERSUCHUNGEN OPTIM; TERHUNE JM, 1971, CAN J ZOOLOG, V49, P385, DOI 10.1139/z71-057; Thomas J. A., 1983, ANTARCT J, V17, P186; Thomson D.H., 1995, MARINE MAMMALS NOISE, P159, DOI [10.1016/B978-0-08-057303-8.50010-0., DOI 10.1016/B978-0-08-057303-8.50010-0]; TURNBULL SD, 1990, CAN J ZOOL, V68, P2090, DOI 10.1139/z90-291; Wolski LF, 2003, J ACOUST SOC AM, V113, P629, DOI 10.1121/1.1527961	41	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90824	10.1371/journal.pone.0090824	http://dx.doi.org/10.1371/journal.pone.0090824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632891	Green Published, gold			2022-12-25	WOS:000332858400019
J	Tan, T; Chen, Z; Lei, Y; Zhu, Y; Liang, QJ				Tan, Tan; Chen, Zhe; Lei, Yan; Zhu, Yan; Liang, Qianjin			A Regulatory Effect of INMAP on Centromere Proteins: Antisense INMAP Induces CENP-B Variation and Centromeric Halo	PLOS ONE			English	Article							KINETOCHORE PROTEINS; CELL-DIVISION; DNA-BINDING; HELA-CELLS; NULL MICE; SATELLITE; COMPLEX; LOCALIZATION; MICROTUBULES; CHECKPOINT	CENP-B is a highly conserved protein that facilitates the assembly of specific centromere structures both in interphase nuclei and on mitotic chromosomes. INMAP is a conserved protein that localizes at nucleus in interphase cells and at mitotic apparatus in mitotic cells. Our previous results showed that INMAP over-expression leads to spindle defects, mitotic arrest and formation of polycentrosomal and multinuclear cells, indicating that INMAP may modulate the function of (a) key protein(s) in mitotic apparatus. In this study, we demonstrate that INMAP interacts with CENP-B and promotes cleavage of the N-terminal DNA binding domain from CENP-B. The cleaved CENP-B cannot associate with centromeres and thus lose its centromere-related functions. Consistent with these results, CENP-B in INMAP knockdown cells becomes more diffused around kinetochores. Although INMAP knockdown cells do not exhibit gross defects in mitotic spindle formation, these cells go through mitosis, especially prophase and metaphase, with different relative timing, indicating subtle abnormality. These results identify INMAP as a model regulator of CENP-B and support the notion that INMAP regulates mitosis through modulating CENP-B-mediated centromere organization.	[Tan, Tan; Lei, Yan; Zhu, Yan; Liang, Qianjin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Chen, Zhe; Liang, Qianjin] Beijing Normal Univ, Beijing Key Lab Gene Engn Drugs & Biol Technol, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Liang, QJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China.	lqj@bnu.edu.cn			National Natural Science Foundation of China [30971470]; Beijing Natural Science Foundation [5122017]; Key Laboratory of Cell Proliferation and Regulation Biology, the Ministry of Education [201001]; Beijing Key Laboratory of Gene Resource and Molecular Development [201102, 201204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Key Laboratory of Cell Proliferation and Regulation Biology, the Ministry of Education; Beijing Key Laboratory of Gene Resource and Molecular Development	This study was supported by the National Natural Science Foundation of China (no. 30971470 to QL), the Beijing Natural Science Foundation (no. 5122017 to QL), the open fund of Key Laboratory of Cell Proliferation and Regulation Biology, the Ministry of Education (no. 201001 to YZ) and the open fund of Beijing Key Laboratory of Gene Resource and Molecular Development (no. 201102 to YZ and no. 201204 YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; Burrack LS, 2011, CURR BIOL, V21, P889, DOI 10.1016/j.cub.2011.04.002; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Fowler KJ, 2000, GENOME RES, V10, P30; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; He DC, 1997, P 14 INT S MORPH SCI, V3; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; Hudson M, 2012, J RHEUMATOL, V39, P787, DOI 10.3899/rheum.111133; KIPLING D, 1995, MOL CELL BIOL, V15, P4009; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Orthaus S, 2008, CHEMBIOCHEM, V9, P77, DOI 10.1002/cbic.200700358; Orthaus S, 2006, BIOCHEM BIOPH RES CO, V348, P36, DOI 10.1016/j.bbrc.2006.06.187; Ortiz-Lombardia M, 1998, J MOL BIOL, V277, P757, DOI 10.1006/jmbi.1998.1646; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shen EZ, 2009, EXP CELL RES, V315, P1100, DOI 10.1016/j.yexcr.2009.01.022; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Yang CH, 1996, MOL CELL BIOL, V16, P3576; Yang ZY, 2003, CELL RES, V13, P275, DOI 10.1038/sj.cr.7290172; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yoda K, 1998, GENES CELLS, V3, P533, DOI 10.1046/j.1365-2443.1998.00210.x; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413; Zhou YL, 2013, MOL CELL BIOCHEM, V374, P81, DOI 10.1007/s11010-012-1507-4; ZHU XL, 1995, J BIOL CHEM, V270, P19545, DOI 10.1074/jbc.270.33.19545; Zhu XL, 1999, MOL CELL BIOL, V19, P1016; Zhu XL, 1997, J CELL BIOCHEM, V66, P441, DOI 10.1002/(SICI)1097-4644(19970915)66:4<441::AID-JCB3>3.0.CO;2-L	52	6	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91937	10.1371/journal.pone.0091937	http://dx.doi.org/10.1371/journal.pone.0091937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633075	Green Published, gold			2022-12-25	WOS:000332858400123
J	Zhou, C; Dobrinsky, J; Tsoi, S; Foxcroft, GR; Dixon, WT; Stothard, P; Verstegen, J; Dyck, MK				Zhou, Chi; Dobrinsky, John; Tsoi, Stephen; Foxcroft, George R.; Dixon, Walter T.; Stothard, Paul; Verstegen, John; Dyck, Michael K.			Characterization of the Altered Gene Expression Profile in Early Porcine Embryos Generated from Parthenogenesis and Somatic Cell Chromatin Transfer	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MICE LACKING; TIME; RNA; DIFFERENTIATION; TROPHECTODERM; DEGRADATION; EFFECTORS; SOFTWARE; PROTEINS	The in vitro production of early porcine embryos is of particular scientific and economic interest. In general, embryos produced from in vitro Assisted Reproductive Technologies (ART) manipulations, such as somatic cell chromatin transfer (CT) and parthenogenetic activation (PA), are less developmentally competent than in vivo-derived embryos. The mechanisms underlying the deficiencies of embryos generated from PA and CT have not been completely understood. To characterize the altered genes and gene networks in embryos generated from CT and PA, comparative transcriptomic analyses of in vivo (IVV) expanded blastocysts (XB), IVV hatched blastocyst (HB), PA XB, PA HB, and CT HB were performed using a custom microarray platform enriched for genes expressed during early embryonic development. Differential expressions of 1492 and 103 genes were identified in PA and CT HB, respectively, in comparison with IVV HB. The "eIF2 signalling", "mitochondrial dysfunction", "regulation of eIF4 and p70S6K signalling", "protein ubiquitination", and "mTOR signalling" pathways were down-regulated in PA HB. Dysregulation of notch signalling-associated genes were observed in both PA and CT HB. TP53 was predicted to be activated in both PA and CT HB, as 136 and 23 regulation targets of TP53 showed significant differential expression in PA and CT HB, respectively, in comparison with IVV HB. In addition, dysregulations of several critical pluripotency, trophoblast development, and implantation-associated genes (NANOG, GATA2, KRT8, LGMN, and DPP4) were observed in PA HB during the blastocyst hatching process. The critical genes that were observed to be dysregulated in CT and PA embryos could be indicative of underlying developmental deficiencies of embryos produced from these technologies.	[Zhou, Chi; Tsoi, Stephen; Foxcroft, George R.; Dixon, Walter T.; Stothard, Paul; Dyck, Michael K.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Dobrinsky, John; Verstegen, John] Minitube Amer, Int Ctr Biotechnol, Mt Horeb, WI USA	University of Alberta	Dyck, MK (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	michael.dyck@ualberta.ca	Zhou, Chi/R-4277-2019	Zhou, Chi/0000-0002-3349-9069	Natural Science and Engineering Research Council of Canada (NSERC) [NETPG 340825-06]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funding from the Natural Science and Engineering Research Council of Canada (NSERC, Grant number: NETPG 340825-06). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027767; Assou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039306; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Carlson DF, 2011, TRANSGENIC RES, V20, P1125, DOI 10.1007/s11248-010-9481-7; Castro FO, 2010, THERIOGENOLOGY, V73, P71, DOI 10.1016/j.theriogenology.2009.08.003; Collas P, 2007, Methods for cloning nonhuman mammals using reprogrammed donor chromatin or donor cells US Patent, Patent No. [7,253,334, 7253334]; Degenstein KL, 2008, THERIOGENOLOGY, V70, P1075, DOI 10.1016/j.theriogenology.2008.06.027; Degrelle SA, 2009, PROTEOMICS, V9, P2678, DOI 10.1002/pmic.200800776; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dudek EJ, 2010, INVEST OPHTH VIS SCI, V51, P4164, DOI 10.1167/iovs.09-4087; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Foltz M, 2004, FASEB J, V18, P1758, DOI 10.1096/fj.03-1387fje; Fujiwara H, 2005, BBA-PROTEINS PROTEOM, V1751, P26, DOI 10.1016/j.bbapap.2005.04.007; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert I, 2009, MOL REPROD DEV, V76, P762, DOI 10.1002/mrd.21030; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Hao YH, 2004, BIOL REPROD, V70, P1644, DOI 10.1095/biolreprod.103.026005; Hata H, 2014, MOL CARCINOGEN, V53, P181, DOI 10.1002/mc.21961; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Isom SC, 2013, PHYSIOL GENOMICS, V45, P577, DOI 10.1152/physiolgenomics.00094.2012; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Klein C, 2010, BIOL REPROD, V83, P102, DOI 10.1095/biolreprod.109.081612; Konig R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh027; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ledgard AM, 2009, MOL REPROD DEV, V76, P65, DOI 10.1002/mrd.20931; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Lonergan P, 2007, Soc Reprod Fertil Suppl, V64, P315; Ma GT, 1997, DEVELOPMENT, V124, P907; Mesquita FS, 2013, ANIM REPROD SCI, V136, P231, DOI 10.1016/j.anireprosci.2012.10.030; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Nanassy L, 2008, ANIM REPROD SCI, V104, P264, DOI 10.1016/j.anireprosci.2007.01.019; Naturil-Alfonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051271; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; Rodriguez-Osorio N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-190; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Seshagiri PB, 2009, J REPROD IMMUNOL, V83, P79, DOI 10.1016/j.jri.2009.06.264; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Tsoi S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-370; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; Whitworth KM, 2005, BIOL REPROD, V72, P1437, DOI 10.1095/biolreprod.104.037952; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yoshioka K, 2012, ANIM REPROD SCI, V131, P23, DOI 10.1016/j.anireprosci.2012.01.018; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	70	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91728	10.1371/journal.pone.0091728	http://dx.doi.org/10.1371/journal.pone.0091728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633136	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400083
J	Chang, CY; Chen, WL; Liou, YF; Ke, CC; Lee, HC; Huang, HL; Ciou, LP; Chou, CC; Yang, MC; Ho, SY; Lin, YR				Chang, Chih-Yu; Chen, Wen-Liang; Liou, Yi-Fan; Ke, Chih-Chi; Lee, Hua-Chin; Huang, Hui-Ling; Ciou, Li-Ping; Chou, Chu-Chung; Yang, Mei-Chueh; Ho, Shinn-Ying; Lin, Yan-Ren			Increased Risk of Major Depression in the Three Years following a Femoral Neck Fracture-A National Population-Based Follow-Up Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HIP FRACTURE; ELDERLY-PATIENTS; MORTALITY; SHAFT; OUTCOMES; SURGERY; FEMUR	Femoral neck fracture is common in the elderly, and its impact has increased in aging societies. Comorbidities, poor levels of activity and pain may contribute to the development of depression, but these factors have not been well addressed. This study aims to investigate the frequency and risk of major depression after a femoral neck fracture using a nationwide population-based study. The Taiwan Longitudinal Health Insurance Database was used in this study. A total of 4,547 patients who were hospitalized for femoral neck fracture within 2003 to 2007 were recruited as a study group; 13,641 matched non-fracture participants were enrolled as a comparison group. Each patient was prospectively followed for 3 years to monitor the occurrence of major depression. Cox proportional-hazards models were used to compute the risk of major depression between members of the study and comparison group after adjusting for residence and sociodemographic characteristics. The most common physical comorbidities that were present after the fracture were also analyzed. The incidences of major depression were 1.2% (n = 55) and 0.7% (n = 95) in the study and comparison groups, respectively. The stratified Cox proportional analysis showed a covariate-adjusted hazard ratio of major depression among patients with femoral neck fracture that was 1.82 times greater (95% CI, 1.30-2.53) than that of the comparison group. Most major depressive episodes (34.5%) presented within the first 200 days following the fracture. In conclusion, patients with a femoral neck fracture are at an increased risk of subsequent major depression. Most importantly, major depressive episodes mainly occurred within the first 200 days following the fracture.	[Chang, Chih-Yu; Chou, Chu-Chung; Yang, Mei-Chueh; Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Chang, Chih-Yu; Chen, Wen-Liang; Lee, Hua-Chin; Huang, Hui-Ling; Ho, Shinn-Ying; Lin, Yan-Ren] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chang, Chih-Yu; Liou, Yi-Fan; Huang, Hui-Ling; Ciou, Li-Ping; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Ke, Chih-Chi] Natl Chiao Tung Univ, Inst Multimedia Engn, Hsinchu, Taiwan; [Chou, Chu-Chung; Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chou, Chu-Chung] Taipei Med Univ, Sch Med, Taipei, Taiwan	Changhua Christian Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taipei Medical University	Ho, SY (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	syho@mail.nctu.edu; h6213.lac@gmail.com	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022; Lin, Yan-Ren/AAU-4136-2020	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; Lin, Yan-Ren/0000-0002-9015-2678	National Chiao Tung University; Changhua Christian Hospital; National Science Council [NSC 102-2314-B-371-010]	National Chiao Tung University; Changhua Christian Hospital; National Science Council(Ministry of Science and Technology, Taiwan)	The authors thank the National Chiao Tung University, Changhua Christian Hospital and National Science Council (NSC 102-2314-B-371-010) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho A, 1997, ANN CHIR GYNAECOL FE, V86, P326; Ancelin ML, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.95; Browne JA, 2009, J TRAUMA, V66, P809, DOI 10.1097/TA.0b013e31816166bb; Cannada LK, 2009, J ORTHOP TRAUMA, V23, P254, DOI 10.1097/BOT.0b013e31819a6651; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Duggal NA, 2013, BRAIN BEHAV IMMUN, V33, P173, DOI 10.1016/j.bbi.2013.07.004; Enocson A, 2009, QUAL LIFE RES, V18, P1177, DOI 10.1007/s11136-009-9531-x; Fenn AM, 2013, BIOL PSYCHIAT; Gambatesa M, 2013, J MULTIDISCIP HEALTH, V6, P335, DOI 10.2147/JMDH.S48240; Gonzalez-Rozas M, 2012, AGING CLIN EXP RES, V24, P181; Gordon Jason, 2012, Arch Osteoporos, V7, P267; Hartholt KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022227; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; Holvik K, 2010, J AGING HEALTH, V22, P1114, DOI 10.1177/0898264310378040; Hsu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070458; Kim SM, 2012, BONE, V50, P1343, DOI 10.1016/j.bone.2012.02.633; Lai SC, 2013, J NEUROSCI NEUROENG, V2, P465; Miyanishi Keita, 2010, J Orthop Surg (Hong Kong), V18, P265; Phillips AC, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-60; Piscitelli P, 2012, CLIN CASES MINER BON, V9, P40; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Sendtner E, 2010, DTSCH ARZTEBL INT, V107, P401, DOI 10.3238/arztebl.2010.0401; Shen HP, 2012, J NEUROSCI NEUROENG, V1, P90; Shyu YIL, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-225; Shyu YIL, 2004, OSTEOPOROSIS INT, V15, P95, DOI 10.1007/s00198-003-1533-x; Valaviciene R, 2012, INT ORTHOP, V36, P1681, DOI 10.1007/s00264-012-1531-8; WOLINSKY PR, 1995, CLIN ORTHOP RELAT R, P81	28	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89867	10.1371/journal.pone.0089867	http://dx.doi.org/10.1371/journal.pone.0089867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626193	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300010
J	Chen, WC; Chen, MF; Lin, PY				Chen, Wen-Cheng; Chen, Miao-Fen; Lin, Paul-Yang			Significance of DNMT3b in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA METHYLTRANSFERASE 1; PROMOTER HYPERMETHYLATION; NECK-CANCER; PRECANCEROUS LESIONS; GASTRIC-CARCINOMA; LUNG-CANCER; METHYLATION; GENE; EXPRESSION	The aim of this study was to explore specific molecular markers that could lead to new insights into the identification of innovative treatments. The role of DNMT3b and its predictive power in the prognosis of oral cancer were identified. Human oral cancer cell lines including SCC4 and SCC25 were selected for cellular experiments. Changes in tumor growth, aggressiveness and the responsible signaling pathway were investigated in vitro and in vivo. Furthermore, 125 oral cancer tissue specimens were analyzed using immunohistochemical staining on tissue microarray slides, and correlations calculated between the level of DNMT3b and the clinical outcome of patients. Our data revealed that inhibition of DNMT3b resulted in slower tumor growth, attenuated tumor invasion ability and epithelial mesenchymal transition, as determined by in vitro and in vivo experiments. Activated IL-6 signaling might be responsible to the induction of DNMT3b overexpression on oral cancer. Regarding clinical data, the incidence of DNMT3b immunoreactivity in oral cancer specimens was significantly higher than in non-malignant epithelium, and positively linked to expression of IL-6. Furthermore, expression of DNMT3b was significantly linked with the risk of lymph node involvement, disease recurrence and shorter survival in patients with pathological stage III-IV oral cancer. In conclusion, IL-6 -DNMT3b axis could be used to predict the prognosis of oral cancer in clinics, and targeting DNMT3b could represent a promising treatment strategy.	[Chen, Wen-Cheng; Chen, Miao-Fen] Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Chen, Wen-Cheng; Chen, Miao-Fen; Lin, Paul-Yang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lin, Paul-Yang] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, WC (corresponding author), Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan.	rto_chen@yahoo.com.tw			Chang Gung Memorial Hospital, Taiwan [CMRPG6A0222-3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The work was support by Chang Gung Memorial Hospital, Taiwan, grant CMRPG6A0222-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen CC, 2011, HEAD NECK-J SCI SPEC, V33, P1132, DOI 10.1002/hed.21586; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Chen MF, 2012, CLIN SCI, V122, P459, DOI 10.1042/CS20110434; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Culig Z, 2013, EXPERT OPIN THER TAR, V17, P53, DOI 10.1517/14728222.2013.733368; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Diez-Perez R, 2011, ONCOL REP, V25, P1203, DOI 10.3892/or.2011.1205; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kato K, 2006, J CANCER RES CLIN, V132, P735, DOI 10.1007/s00432-006-0122-8; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Quan JJ, 2012, CANCER METAST REV, V31, P209, DOI 10.1007/s10555-011-9335-7; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Roth MJ, 2006, ONCOL REP, V15, P1591; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Shaw R, 2006, INT J ORAL MAX SURG, V35, P101, DOI 10.1016/j.ijom.2005.06.014; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Su XW, 2010, ONCOL REP, V23, P819, DOI 10.3892/or_00000703; Takeshima M, 2008, J ORAL PATHOL MED, V37, P475, DOI 10.1111/j.1600-0714.2008.00644.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Viet C T, 2007, J Calif Dent Assoc, V35, P844	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89956	10.1371/journal.pone.0089956	http://dx.doi.org/10.1371/journal.pone.0089956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625449	Green Submitted, gold, Green Published			2022-12-25	WOS:000332851300012
J	Pisapia, C; Anderson, K; Pratchett, MS				Pisapia, Chiara; Anderson, Kristen; Pratchett, Morgan S.			Intraspecific Variation in Physiological Condition of Reef-Building Corals Associated with Differential Levels of Chronic Disturbance	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; ARTIFICIAL INJURIES; ACROPORA-HYACINTHUS; POPULATION-DYNAMICS; PARTIAL MORTALITY; TISSUE BIOMASS; LONG-TERM	Even in the absence of major disturbances (e.g., cyclones, bleaching), corals are subject to high levels of partial or whole-colony mortality, often caused by chronic and small-scale disturbances. Depending on levels of background mortality, these chronic disturbances may undermine individual fitness and have significant consequences on the ability of colonies to withstand subsequent acute disturbances or environmental change. This study quantified intraspecific variations in physiological condition (measured based on total lipid content and zooxanthellae density) through time in adult colonies of two common and widespread coral species (Acropora spathulata and Pocillopora damicornis), subject to different levels of biological and physical disturbances along the most disturbed reef habitat, the crest. Marked intraspecific variation in the physiological condition of A. spathulata was clearly linked to differences in local disturbance regimes and habitat. Specifically, zooxanthellae density decreased (r(2) = 26, df = 5,42, p<0.02, B = -2121255, p = 0.03) and total lipid content increased (r(2) = 14, df = 5,42, p = 0.01, B = 0.9, p = 0.01) with increasing distance from exposed crests. Moreover, zooxanthellae density was strongly and negatively correlated with the individual level of partial mortality (r(2) = 26, df = 5,42, p<0.02, B = -7386077, p = 0.01). Conversely, P. damicornis exhibited very limited intraspecific variation in physiological condition, despite marked differences in levels of partial mortality. This is the first study to relate intraspecific variation in the condition of corals to localized differences in chronic disturbance regimes. The next step is to ascertain whether these differences have further ramifications for susceptibility to periodic acute disturbances, such as climate-induced coral bleaching.	[Pisapia, Chiara; Anderson, Kristen; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Pisapia, Chiara] James Cook Univ, AIMS JCU Australian Inst Marine Sci, Sch Marine Biol, Townsville, Qld 4811, Australia	James Cook University; Australian Institute of Marine Science; James Cook University	Pisapia, C (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	chiara.pisapia@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Pratchett, Morgan S/0000-0002-1862-8459; Anderson, Kristen/0000-0002-1576-6979	ARC Centre of Excellence for Coral Reef Studies, Townsville; AIMS@JCU, Townsville	ARC Centre of Excellence for Coral Reef Studies, Townsville(Australian Research Council); AIMS@JCU, Townsville	This project was supported by the ARC Centre of Excellence for Coral Reef Studies, Townsville, and AIMS@JCU, Townsville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Bachok Z, 2006, CORAL REEFS, V25, P545, DOI 10.1007/s00338-006-0130-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bak R. P. M, 1977, Proceedings int Coral Reef Symp, V3, P143; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; BAK RPM, 1980, OECOLOGIA, V47, P145, DOI 10.1007/BF00346812; Baker Andrew C., 1997, P1301; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BARNES H, 1973, Journal of Experimental Marine Biology and Ecology, V12, P103, DOI 10.1016/0022-0981(73)90040-3; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bonaldo RM, 2012, CORAL REEFS, V31, P263, DOI 10.1007/s00338-011-0846-z; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Cole AJ, 2011, CORAL REEFS, V30, P85, DOI 10.1007/s00338-010-0674-6; Cole AJ, 2009, J EXP MAR BIOL ECOL, V373, P11, DOI 10.1016/j.jembe.2009.02.016; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020434; Cooper TF, 2009, ESTUAR COAST SHELF S, V83, P186, DOI 10.1016/j.ecss.2009.03.015; COX EF, 1986, J EXP MAR BIOL ECOL, V101, P161, DOI 10.1016/0022-0981(86)90047-X; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; Cumming RL, 2002, MAR ECOL PROG SER, V242, P131, DOI 10.3354/meps242131; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DONE TJ, 1988, MAR BIOL, V100, P51, DOI 10.1007/BF00392954; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; Ferrier-Pages C, 2001, J EXP MAR BIOL ECOL, V259, P249, DOI 10.1016/S0022-0981(01)00241-6; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Graham JE, 2013, MAR BIOL, V160, P2561, DOI 10.1007/s00227-013-2248-y; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Gurney WSC, 1996, THEOR POPUL BIOL, V49, P344, DOI 10.1006/tpbi.1996.0017; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hall VR, 1997, J EXP MAR BIOL ECOL, V212, P9, DOI 10.1016/S0022-0981(96)02760-8; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Hourigan T.F., 1988, P107; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Knowlton N, 1990, CASE STUDY NATURAL P; Kojis B.L., 1985, P 5 INT COR REEF C, V4, P289; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Madin JS, 2013, CORAL REEFS, V32, P173, DOI 10.1007/s00338-012-0958-0; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mass T, 2011, LIMNOL OCEANOGR, V56, P2176, DOI 10.4319/lo.2011.56.6.2176; McCowan D.M., 2011, GALAXEA J CORAL REEF, V13, P29, DOI [10.3755/galaxea.13.29, DOI 10.3755/GALAXEA.13.29]; Meesters E.H., 1992, P 7 INT COR REEF S, V2, P681; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; MOTTA PJ, 1988, ENVIRON BIOL FISH, V22, P39, DOI 10.1007/BF00000543; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; Pernet V, 2002, J COMP PHYSIOL B, V172, P455, DOI 10.1007/s00360-002-0268-x; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; Pisapia C, 2012, P 12 INT COR REEF S, V13, P1; Pratchett MS, 2013, MAR ENVIRON RES, V86, P29, DOI 10.1016/j.marenvres.2013.02.007; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rotjan RD, 2006, CORAL REEFS, V25, P361, DOI 10.1007/s00338-006-0120-y; Rotjan RD, 2009, MAR BIOL, V156, P569, DOI 10.1007/s00227-008-1108-7; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; STIMSON JS, 1987, B MAR SCI, V41, P889; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strickland D, 2010, THESIS U W AUSTR; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; Titlyanov EA, 2005, J EXP MAR BIOL ECOL, V323, P27, DOI 10.1016/j.jembe.2005.02.015; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1	92	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91529	10.1371/journal.pone.0091529	http://dx.doi.org/10.1371/journal.pone.0091529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626395	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300099
J	Boerleider, AW; Francke, AL; van de Reep, M; Mannien, J; Wiegers, TA; Deville, WLJM				Boerleider, Agatha W.; Francke, Anneke L.; van de Reep, Merle; Mannien, Judith; Wiegers, Therese A.; Deville, Walter L. J. M.			"Being Flexible and Creative'': A Qualitative Study on Maternity Care Assistants' Experiences with Non-Western Immigrant Women	PLOS ONE			English	Article							HEALTH-CARE; PROFESSIONALS; MORTALITY	Background: Several studies conducted in developed countries have explored postnatal care professionals' experiences with non-western women. These studies reported different cultural practices, lack of knowledge of the maternity care system, communication difficulties, and the important role of the baby's grandmother as care-giver in the postnatal period. However, not much attention has been paid in existing literature to postnatal care professionals' approaches to these issues. Our main objective was to gain insight into how Dutch postnatal care providers - 'maternity care assistants' (MCA) - address issues encountered when providing care for non-western women. Methods: A generic qualitative research approach was used. Two researchers interviewed fifteen MCAs individually, analysing the interview material separately and then comparing and discussing their results. Analytical codes were organised into main themes and subthemes. Results: MCAs perceive caring for non-western women as interesting and challenging, but sometimes difficult too. To guarantee the health and safety of mother and baby, they have adopted flexible and creative approaches to address issues concerning traditional practices, socioeconomic status and communication. Furthermore, they employ several other strategies to establish relationships with non-western clients and their families, improve women's knowledge of the maternity care system and give health education. Conclusion: Provision of postnatal care to non-western clients may require special skills and measures. The quality of care for non-western clients might be improved by including these skills in education and retraining programmes for postnatal care providers on top of factual knowledge about traditional practices.	[Boerleider, Agatha W.; Francke, Anneke L.; van de Reep, Merle; Wiegers, Therese A.; Deville, Walter L. J. M.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Francke, Anneke L.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, Dept Midwifery Sci, AVAG, Amsterdam, Netherlands; [Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Deville, Walter L. J. M.] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands; [Deville, Walter L. J. M.] Natl Knowledge & Advisory Ctr Migrants Refugees &, Utrecht, Netherlands	Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Boerleider, AW (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	agathawb75@yahoo.com		Mannien, Judith/0000-0003-1698-9979	Academy of Midwifery Amsterdam-Groningen (AVAG); Dutch Ministry of Education, Culture and Science	Academy of Midwifery Amsterdam-Groningen (AVAG); Dutch Ministry of Education, Culture and Science	This study was funded by the Academy of Midwifery Amsterdam-Groningen (AVAG) and the Dutch Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cioffi J, 2004, J MIDWIFERY WOM HEAL, V49, P437, DOI 10.1016/j.jmwh.2004.01.019; El Fakiri F, 1999, KRAAMZORG ALLOCHTONE; Foets M, 2008, GEZONDHEIDS ZORG OND, P29; Fort A.L., 2006, POSTPARTUM CARE LEVE; Green J, 2009, QUALITATIVE METHODS, P198; Jirwe M, 2010, SCAND J CARING SCI, V24, P436, DOI 10.1111/j.1471-6712.2009.00733.x; Lyons SM, 2008, ETHNIC HEALTH, V13, P261, DOI 10.1080/13557850801903020; Mathai M, 2010, WHO TECHNICAL CONSUL; McAree T., 2010, EVIDENCE BASED MIDWI, V8, P91; Mill J., 2003, INT J QUAL METH, V2, P1, DOI [10.1177/160940690300200201, DOI 10.1177/160940690300200201]; Ockleford E. M., 2004, BRIT J MIDWIFERY, V12, P166, DOI DOI 10.12968/BJOM.2004.12.3.15363; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Puthussery S, 2008, J HEALTH SERV RES PO, V13, P195, DOI 10.1258/jhsrp.2008.007153; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Rice PL, 1999, MIDWIFERY, V15, P47, DOI 10.1016/S0266-6138(99)90037-2; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Statistics Netherlands StatLine, 2012, GEB HERK LEEFT MOED; Tran M, 2001, J Qual Clin Pract, V21, P135, DOI 10.1046/j.1440-1762.2001.00431.x; Tucker CM, 2011, HEALTH PSYCHOL, V30, P342, DOI 10.1037/a0022967; Wiegers TA, 2006, J NEONATAL NURS, V12, P163, DOI [10.1016/j.jnn.2006.07.003, DOI 10.1016/J.JNN.2006.07.003]; Wiklund H, 2000, MIDWIFERY, V16, P105, DOI 10.1054/midw.1999.0197; Yelland J, 1998, MIDWIFERY, V14, P144, DOI 10.1016/S0266-6138(98)90029-8	22	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91843	10.1371/journal.pone.0091843	http://dx.doi.org/10.1371/journal.pone.0091843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622576	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300134
J	Montgomery, RA; Vucetich, JA; Roloff, GJ; Bump, JK; Peterson, RO				Montgomery, Robert A.; Vucetich, John A.; Roloff, Gary J.; Bump, Joseph K.; Peterson, Rolf O.			Where Wolves Kill Moose: The Influence of Prey Life History Dynamics on the Landscape Ecology of Predation	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; RATIO-DEPENDENT PREDATION; ISLE ROYALE WOLVES; WOLF PREDATION; POPULATION-DYNAMICS; PATCHY ENVIRONMENTS; HABITAT SELECTION; WINTER SEVERITY; NATIONAL-PARK; LAND-COVER	The landscape ecology of predation is well studied and known to be influenced by habitat heterogeneity. Little attention has been given to how the influence of habitat heterogeneity on the landscape ecology of predation might be modulated by life history dynamics of prey in mammalian systems. We demonstrate how life history dynamics of moose (Alces alces) contribute to landscape patterns in predation by wolves (Canis lupus) in Isle Royale National Park, Lake Superior, USA. We use pattern analysis and kernel density estimates of moose kill sites to demonstrate that moose in senescent condition and moose in prime condition tend to be wolf-killed in different regions of Isle Royale in winter. Predation on senescent moose was clustered in one kill zone in the northeast portion of the island, whereas predation on prime moose was clustered in 13 separate kill zones distributed throughout the full extent of the island. Moreover, the probability of kill occurrence for senescent moose, in comparison to prime moose, increased in high elevation habitat with patches of dense coniferous trees. These differences can be attributed, at least in part, to senescent moose being more vulnerable to predation and making different risk-sensitive habitat decisions than prime moose. Landscape patterns emerging from prey life history dynamics and habitat heterogeneity have been observed in the predation ecology of fish and insects, but this is the first mammalian system for which such observations have been made.	[Montgomery, Robert A.; Roloff, Gary J.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Vucetich, John A.; Bump, Joseph K.; Peterson, Rolf O.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan State University; Michigan Technological University	Montgomery, RA (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	montg164@msu.edu	Montgomery, Robert A./C-5541-2019	Montgomery, Robert A./0000-0001-5894-0589	National Science Foundation Graduate Research Fellowship program; National Science Foundation [DEB-0918247]; CESU from Isle Royale National Park, National Park Service [J6310110025]; Michigan Technological University	National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); CESU from Isle Royale National Park, National Park Service; Michigan Technological University	This work was supported by the National Science Foundation Graduate Research Fellowship program and the National Science Foundation DEB-0918247 and CESU Task Agreement No. J6310110025 from Isle Royale National Park, National Park Service. R.O. Peterson was also supported by the Robbins Chair, Michigan Technological University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, P ROY SOC B-BIOL SCI, V278, P3336, DOI 10.1098/rspb.2011.0261; Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; ARDITI R, 1992, ECOLOGY, V73, P1544, DOI 10.2307/1940007; Arditi R., 2012, SPECIES INTERACT; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; BERGERUD AT, 1983, J WILDLIFE MANAGE, V47, P977, DOI 10.2307/3808156; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Birkhofer K, 2011, OIKOS, V120, P1705, DOI 10.1111/j.1600-0706.2011.19546.x; Birkhofer K, 2010, BASIC APPL ECOL, V11, P486, DOI 10.1016/j.baae.2010.06.010; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Bubenik AB., 1997, ECOLOGY MANAGEMENT N, P77; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CARBYN LN, 1983, J WILDLIFE MANAGE, V47, P963, DOI 10.2307/3808155; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; De Roos AM, 2009, ECOLOGY, V90, P945, DOI 10.1890/07-1153.1; DELGIUDICE GD, 1991, J WILDLIFE DIS, V27, P407, DOI 10.7589/0090-3558-27.3.407; Floater GJ, 2001, ECOL MONOGR, V71, P447, DOI 10.1890/0012-9615(2001)071[0447:HCSIAM]2.0.CO;2; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; Gervasi V, 2013, ECOLOGICAL APPL; GINZBURG LR, 1992, ECOLOGY, V73, P1536, DOI 10.2307/1940006; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; HASSELL MP, 1982, ECOL ENTOMOL, V7, P365, DOI 10.1111/j.1365-2311.1982.tb00678.x; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hoef JMV, 2001, SPATIAL UNCERTAINTY IN ECOLOGY, P214; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; HUBER NK, 1973, 754A US GEOL SURV; Huber NK, 1975, GEOLOGICAL SURVEY B, V1309; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Jordan Peter A., 2000, Alces, V36, P233; Jost C, 2005, J ANIM ECOL, V74, P809, DOI 10.1111/j.1365-2656.2005.00977.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Krefting LW, 1974, U MINNESOTA AGR EXPT, V15; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; McCann K. S., 2012, FOOD WEBS; McCoy MW, 2009, OIKOS, V118, P87, DOI 10.1111/j.1600-0706.2008.16878.x; McLaren BE, 1996, CAN J FOREST RES, V26, P782, DOI 10.1139/x26-088; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; Mech LD, 2001, J WILDLIFE MANAGE, V65, P998, DOI 10.2307/3803048; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Mitchell R.J., 2001, DESIGN ANAL ECOLOGIC, P217; Montgomery RA, 2013, J ANIM ECOL, V82, P301, DOI 10.1111/1365-2656.12000; MURDOCH WW, 1989, AM NAT, V134, P288, DOI 10.1086/284981; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Ogada DL, 2008, OECOLOGIA, V156, P387, DOI 10.1007/s00442-008-0994-1; Perfecto I, 2008, ECOLOGY, V89, P915, DOI 10.1890/06-2121.1; Peterson R. O., 1977, US DEP INTERIOR NATL, V11; Peterson RO, 1998, J MAMMAL, V79, P828, DOI 10.2307/1383091; PETERSON RO, 1988, J MAMMAL, V69, P89, DOI 10.2307/1381751; Peterson RO, 2010, ECOL LETT, V13, P1124, DOI 10.1111/j.1461-0248.2010.01504.x; PHILLIPS RL, 1973, J WILDLIFE MANAGE, V37, P266, DOI 10.2307/3800117; Puttock GD, 1996, FOREST ECOL MANAG, V81, P169, DOI 10.1016/0378-1127(95)03644-X; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rodewald AD, 2002, J WILDLIFE MANAGE, V66, P634, DOI 10.2307/3803130; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; SIH A, 1984, AM NAT, V123, P143, DOI 10.1086/284193; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stenseth NC, 1998, P NATL ACAD SCI USA, V95, P15430, DOI 10.1073/pnas.95.26.15430; Steury TD, 2010, J WILDLIFE MANAGE, V74, P539, DOI 10.2193/2008-327; Sundell J, 2004, J ANIM ECOL, V73, P167, DOI 10.1111/j.1365-2656.2004.00795.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vucetich J. A., 2011, ECOLOGICAL STUDIES W; Vucetich JA, 2004, OIKOS, V107, P309, DOI 10.1111/j.0030-1299.2004.13483.x; Vucetich JA, 2002, ECOLOGY, V83, P3003; Vucetich JA, 2011, J ANIM ECOL, V80, P1236, DOI 10.1111/j.1365-2656.2011.01855.x; Wickham JD, 2010, REMOTE SENS ENVIRON, V114, P1286, DOI 10.1016/j.rse.2010.01.018; Wikenros C, 2009, ACTA THERIOL, V54, P207, DOI 10.4098/j.at.0001-7051.082.2008; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x; Wilmers CC, 2004, ECOL MODEL, V177, P193, DOI 10.1016/j.ecolmodel.2004.02.007; Wilson RR, 2010, J WILDLIFE MANAGE, V74, P1343, DOI 10.2193/2009-438; Wright GJ, 2006, J WILDLIFE MANAGE, V70, P1070, DOI 10.2193/0022-541X(2006)70[1070:SONYEB]2.0.CO;2	84	20	20	1	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91414	10.1371/journal.pone.0091414	http://dx.doi.org/10.1371/journal.pone.0091414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622241	Green Published, gold			2022-12-25	WOS:000332845300086
J	Senna, I; Maravita, A; Bolognini, N; Parise, CV				Senna, Irene; Maravita, Angelo; Bolognini, Nadia; Parise, Cesare V.			The Marble-Hand Illusion	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; ADAPTATION; EMBODIMENT; SOUNDS	Our body is made of flesh and bones. We know it, and in our daily lives all the senses constantly provide converging information about this simple, factual truth. But is this always the case? Here we report a surprising bodily illusion demonstrating that humans rapidly update their assumptions about the material qualities of their body, based on their recent multisensory perceptual experience. To induce a misperception of the material properties of the hand, we repeatedly gently hit participants' hand with a small hammer, while progressively replacing the natural sound of the hammer against the skin with the sound of a hammer hitting a piece of marble. After five minutes, the hand started feeling stiffer, heavier, harder, less sensitive, unnatural, and showed enhanced Galvanic skin response (GSR) to threatening stimuli. Notably, such a change in skin conductivity positively correlated with changes in perceived hand stiffness. Conversely, when hammer hits and impact sounds were temporally uncorrelated, participants did not spontaneously report any changes in the perceived properties of the hand, nor did they show any modulation in GSR. In two further experiments, we ruled out that mere audio-tactile synchrony is the causal factor triggering the illusion, further demonstrating the key role of material information conveyed by impact sounds in modulating the perceived material properties of the hand. This novel bodily illusion, the 'Marble-Hand Illusion', demonstrates that the perceived material of our body, surely the most stable attribute of our bodily self, can be quickly updated through multisensory integration.	[Senna, Irene; Maravita, Angelo; Bolognini, Nadia] Milano Bicocca Univ, Fac Psychol, Milan, Italy; [Bolognini, Nadia] IRCCS Ist Auxol Italiano, Milan, Italy; [Parise, Cesare V.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Parise, Cesare V.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Senna, Irene; Parise, Cesare V.] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Senna, Irene; Parise, Cesare V.] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany	University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano; Max Planck Society; University of Bielefeld; University of Bielefeld	Senna, I (corresponding author), Milano Bicocca Univ, Fac Psychol, Milan, Italy.	irene.senna@uni-bielefeld.de; cesare.parise@uni-bielefeld.de	Parise, Cesare/AAY-2913-2020; BOLOGNINI, NADIA/J-5746-2016	BOLOGNINI, NADIA/0000-0002-2921-8658; Senna, Irene/0000-0002-3237-8193	Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]; EU [248587]; FAR grants (University of Milano-Bicocca)	Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); FAR grants (University of Milano-Bicocca)	C.P. was supported by the Bernstein Center for Computational Neuroscience, Tubingen, funded by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002), and by the EU grant 248587 "THE''; N.B. and A. M. were supported by FAR grants (University of Milano-Bicocca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Forgiarini M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00108; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Guterstam A, 2013, J COGNITIVE NEUROSCI, V25, P1078, DOI 10.1162/jocn_a_00393; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kleiner M, 2007, PERCEPTION, V36, P14; Knoblich G, 2005, PERCEPTION HUMAN BOD; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; Newport R, 2011, CURR BIOL, V21, pR804, DOI 10.1016/j.cub.2011.08.044; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Ploghaus A, 2001, J NEUROSCIENCE; Rhudy JL, 2010, PAIN, V148, P320, DOI 10.1016/j.pain.2009.11.018; Tajadura-Jimenez A, 2012, CURR BIOL, V22, pR516, DOI 10.1016/j.cub.2012.04.028; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017	23	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91688	10.1371/journal.pone.0091688	http://dx.doi.org/10.1371/journal.pone.0091688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621793	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300118
J	Zhang, Y; Schiff, D; Park, D; Abounader, R				Zhang, Ying; Schiff, David; Park, Deric; Abounader, Roger			MicroRNA-608 and MicroRNA-34a Regulate Chordoma Malignancy by Targeting EGFR, Bcl-xL and MET	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; C-MET; DIFFERENTIAL EXPRESSION; P53; PROLIFERATION; HYBRIDIZATION; GLIOBLASTOMA; CHROMOSOME-7; ACTIVATION; BCL-X(L)	Chordomas are rare malignant tumors that originate from the notochord remnants and occur in the skull base, spine and sacrum. Due to a very limited understanding of the molecular pathogenesis of chordoma, there are no adjuvant and molecular therapies besides surgical resection and radiation therapy. microRNAs (miRNAs) are small noncoding regulatory RNA molecules with critical roles in cancer. The role of miRNAs in chordomas is mostly unknown. We uncover microRNA-608 (miR-608) and microRNA-34a (miR-34a) as novel tumor suppressive microRNAs that regulate malignancy in chordoma. We find that miR-608 and miR-34a expressions are downregulated in human chordoma cell lines and primary cells at least partially via alteration of their genes' copy numbers. We identify the commonly deregulated oncogenes EGFR and Bcl-xL as direct targets of miR-608 and the receptor tyrosine kinase MET as direct target of miR-34a. We show that EGFR and MET activations promote chordoma cell proliferation and invasion and that pharmacological inhibition of EGFR and MET inhibits chordoma cell proliferation and survival. We demonstrate that restoration of miR-608 and miR-34a inhibits cell proliferation and invasion and induces apoptosis in chordoma cells. We find that miR-34a inversely correlates with MET expression and miR-608 inversely correlates with EGFR expression in chordoma cells. These findings demonstrate for the first time that miR-608 and miR-34a regulate chordoma malignancy by regulating EGFR, MET and Bcl-xL.	[Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Immunol, Charlottesville, VA USA; [Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Canc Biol, Charlottesville, VA USA; [Schiff, David; Abounader, Roger] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Park, Deric] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA; [Abounader, Roger] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Zhang, Y (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	yz5h@virginia.edu; ra6u@virginia.edu			National Institutes of Health [RO1 NS045209]; NIH [R01 CA134843]; NATIONAL CANCER INSTITUTE [P30CA044579, R01CA134843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health RO1 NS045209 and NIH R01 CA134843 to R. Abounader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 1999, J NATL CANCER I, V91, P1548, DOI 10.1093/jnci/91.18.1548; Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Bayrak OF, 2013, J NEURO-ONCOL, V115, P143, DOI 10.1007/s11060-013-1211-6; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bruederlein Silke, 2010, Sarcoma, V2010, P630129, DOI 10.1155/2010/630129; Bydon M, 2012, EXPERT OPIN THER TAR, V16, P1139, DOI 10.1517/14728222.2012.714772; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Coskun E, 2011, LEUKEMIA RES, V35, P208, DOI 10.1016/j.leukres.2010.05.007; De Martino I, 2009, ONCOGENE, V28, P1432, DOI 10.1038/onc.2008.495; Dewaele B, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-4; Duan ZF, 2010, J ORTHOP RES, V28, P746, DOI 10.1002/jor.21055; Fasig JH, 2008, NEUROPATH APPL NEURO, V34, P95, DOI 10.1111/j.1365-2990.2007.00873.x; Grabellus F, 2010, TUMOR BIOL, V31, P157, DOI 10.1007/s13277-010-0021-0; Guan XX, 2013, FASEB J, V27, P1404, DOI 10.1096/fj.12-223420; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li J, 2011, MOL CELL BIOCHEM, V357, P31, DOI 10.1007/s11010-011-0872-8; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Long C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066676; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Naka T, 1997, MODERN PATHOL, V10, P832; Naka T, 2008, CANCER-AM CANCER SOC, V112, P104, DOI 10.1002/cncr.23141; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Nguyen-Huynh A, 2006, OTOLARYNG CLIN N AM, V39, P783, DOI 10.1016/j.otc.2006.04.006; Ostroumov E, 2008, SPINE, V33, P2774, DOI 10.1097/BRS.0b013e31817e2d1e; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Ptaszynski K, 2009, POL J PATHOL, V60, P81; Ruddel J, 2010, ANTICANCER RES, V30, P4579; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Sciubba DM, 2008, NEUROSURG CLIN N AM, V19, P5, DOI 10.1016/j.nec.2007.09.006; Shalaby A, 2011, J PATHOL, V223, P336, DOI 10.1002/path.2818; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Walter BA, 2011, J NEURO-ONCOL, V101, P199, DOI 10.1007/s11060-010-0250-5; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhang Y, 2012, FRONT BIOSCI-LANDMRK, V17, P700, DOI 10.2741/3952	49	66	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91546	10.1371/journal.pone.0091546	http://dx.doi.org/10.1371/journal.pone.0091546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621885	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300102
J	Huang, HY; Wang, H; Li, LM; Wu, ZJ; Chen, JP				Huang, Huayuan; Wang, Hui; Li, Linmiao; Wu, Zhengjun; Chen, Jinping			Genetic Diversity and Population Demography of the Chinese Crocodile Lizard (Shinisaurus crocodilurus) in China	PLOS ONE			English	Article							CONSERVATION; INFERENCE; EVOLUTION; PROGRAM	The Chinese crocodile lizard Shinisaurus crocodilurus is a critically endangered species, listed in Appendix II of CITES. Its populations and habitat in China have undergone significant changes in recent years. Understanding the genetic variability and phylogeography of this species is very important for successful conservation. In this study, samples were taken from 11 wild ponds and two captive populations in China. We sequenced mitochondrial CYTB, partial ND6, and partial tRNA-Glu and genotyped 10 microsatellite loci. Our analyses of these data showed low genetic variability, no strong isolation caused by distance, and a lack of a phylogeographic structure in this species. Based on our results, the basal divergence between two clades of S. crocodilurus in China may have been caused by the formation of the Pearl River system. We found a population expansion in one of these clades. Microsatellite analysis indicated the presence of three clusters, separated by significant genetic differences. We found that most individuals in the two captive populations were from the Luokeng (Guangdong) and Guangxi wild source populations, respectively.	[Huang, Huayuan; Wu, Zhengjun] Guangxi Normal Univ, Coll Life Sci, Key Lab Rare & Endangered Anim Ecol, Guilin, Guangxi Provinc, Peoples R China; [Huang, Huayuan; Wang, Hui; Li, Linmiao; Chen, Jinping] South China Inst Endangered Anim, Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China	Guangxi Normal University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Wu, ZJ (corresponding author), Guangxi Normal Univ, Coll Life Sci, Key Lab Rare & Endangered Anim Ecol, Guilin, Guangxi Provinc, Peoples R China.	2581572507@qq.com; chenjp@gdei.gd.cn			Program for Innovative Research Team of Crossdiscipline; National Natural Science Foundation of China [31060288, 31360522]; Funding project for excellent talents in Guangxi higher schools; Chinese Academy of Sciences	Program for Innovative Research Team of Crossdiscipline; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding project for excellent talents in Guangxi higher schools; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Program for Innovative Research Team of Crossdiscipline and cooperation from Chinese Academy of Sciences, the National Natural Science Foundation of China (No. 31060288, 31360522), Funding project for excellent talents in Guangxi higher schools. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl E, 1930, SITZUNGSBERICHTE GES, V1, P329; Allendorf F., 2007, CONSERVATION GENETIC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bei RB, 2012, CONSERV GENET RESOUR, V4, P743, DOI 10.1007/s12686-012-9635-4; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Chen Z, 2006, J GUANGXI NORMAL U N, V24, P83; Cunningham M, 1998, BIOL CONSERV, V83, P19, DOI 10.1016/S0006-3207(97)00046-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gong MH, 2006, STUDY POPULATION HAB; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gullberg A, 1998, BIOL J LINN SOC, V65, P257, DOI 10.1006/bijl.1998.0221; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Huang C. M., 2008, Animal Biodiversity and Conservation, V31, P63; Huang W., 2009, CHINESE J WILDLIFE, V30, P287; Levy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046351; Li Zheng-Chang, 2002, Chinese Journal of Zoology, V37, P76; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Peng SM, 1988, 30 INT GEOL C; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Quyet L. K., 2003, HAMADRYAD, V27, P193; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; TAJIMA F, 1989, GENETICS, V123, P585; Wan J. J, 2009, THESIS SICHUAN U; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yu Hai, 2005, Sichuan Journal of Zoology, V24, P395; Zeng ZF, 2003, THESIS GUANGXI NORMA; Zhang Y. X, 2002, BIOL SHINISAURUS CRO; Zhang YX, 1991, CROCODILE LIZARD CHI	32	11	11	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91570	10.1371/journal.pone.0091570	http://dx.doi.org/10.1371/journal.pone.0091570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618917	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400106
J	Wood, S; Jayaraman, V; Huelsmann, EJ; Bonish, B; Burgad, D; Sivaramakrishnan, G; Qin, SS; DiPietro, LA; Zloza, A; Zhang, CX; Shafikhani, SH				Wood, Stephen; Jayaraman, Vijayakumar; Huelsmann, Erica J.; Bonish, Brian; Burgad, Derick; Sivaramakrishnan, Gayathri; Qin, Shanshan; DiPietro, Luisa A.; Zloza, Andrew; Zhang, Chunxiang; Shafikhani, Sasha H.			Pro-Inflammatory Chemokine CCL2 (MCP-1) Promotes Healing in Diabetic Wounds by Restoring the Macrophage Response	PLOS ONE			English	Article							CELL-LINEAGE; MOUSE; REPAIR; MICE; EXPRESSION; RECRUITMENT; NEUTROPHILS; DISEASE; DB/DB; PDGF	Prior studies suggest that the impaired healing seen in diabetic wounds derives from a state of persistent hyper-inflammation characterized by harmful increases in inflammatory leukocytes including macrophages. However, such studies have focused on wounds at later time points (day 10 or older), and very little attention has been given to the dynamics of macrophage responses in diabetic wounds early after injury. Given the importance of macrophages for the process of healing, we studied the dynamics of macrophage response during early and late phases of healing in diabetic wounds. Here, we report that early after injury, the diabetic wound exhibits a significant delay in macrophage infiltration. The delay in the macrophage response in diabetic wounds results from reduced Chemokine (C-C motif) ligand 2 (CCL2) expression. Importantly, one-time treatment with chemoattractant CCL2 significantly stimulated healing in diabetic wounds by restoring the macrophage response. Our data demonstrate that, rather than a hyper-inflammatory state; the early diabetic wound exhibits a paradoxical and damaging decrease in essential macrophage response. Our studies suggest that the restoration of the proper kinetics of macrophage response may be able to jumpstart subsequent healing stages. CCL2 chemokine-based therapy may be an attractive strategy to promote healing in diabetic wounds.	[Wood, Stephen; Jayaraman, Vijayakumar; Huelsmann, Erica J.; Bonish, Brian; Burgad, Derick; Sivaramakrishnan, Gayathri; Zloza, Andrew; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Huelsmann, Erica J.; Zloza, Andrew; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA; [Bonish, Brian] Rush Univ, Med Ctr, Dept Dermatol, Chicago, IL 60612 USA; [Huelsmann, Erica J.; Zloza, Andrew] Rush Univ, Med Ctr, Dev Ctr AIDS Res, Chicago, IL 60612 USA; [Qin, Shanshan; Zhang, Chunxiang] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [DiPietro, Luisa A.] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA	Rush University; Rush University; Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shafikhani, SH (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	Shafikhani, Sasha/AAM-3460-2021; zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495; Shafikhani, Sasha/0000-0003-1755-9997; Zloza, Andrew/0000-0001-8844-6493	Rush University Committee on Research, Young Investigator Award Fund [31184]; National Institute of Health [R21NR013876-0]; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR013876] Funding Source: NIH RePORTER	Rush University Committee on Research, Young Investigator Award Fund; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by The Rush University Committee on Research, Young Investigator Award Fund #: 31184 to (SHS) and the National Institute of Health grant R21NR013876-0 to (CZ & SHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Avwioro G., 2011, JPCS, V1, P24; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bellavance EC, 2011, J IMMUNOL, V186, P3309, DOI 10.4049/jimmunol.1002549; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Davies John Q, 2005, Methods Mol Biol, V290, P91; DiPietro LA, 2001, WOUND REPAIR REGEN, V9, P28, DOI 10.1046/j.1524-475x.2001.00028.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DONG YL, 1993, J TRAUMA, V35, P340, DOI 10.1097/00005373-199309000-00002; Dvivedi Sanjay, 1997, Indian Journal of Experimental Biology, V35, P1243; Fang Y, 2010, BRIT J DERMATOL, V162, P478, DOI 10.1111/j.1365-2133.2009.09528.x; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Frevert CW, 1998, J IMMUNOL METHODS, V213, P41, DOI 10.1016/S0022-1759(98)00016-7; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hackstein H, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-94; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kohlhapp FJ, 2012, J IMMUNOL, V188, P3639, DOI 10.4049/jimmunol.1101580; KREIPE H, 1987, J HISTOCHEM CYTOCHEM, V35, P1117, DOI 10.1177/35.10.3476670; Krischak G D, 2007, J Wound Care, V16, P76; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STROBL H, 1995, BRIT J HAEMATOL, V90, P774, DOI 10.1111/j.1365-2141.1995.tb05195.x; Wang JF, 2007, J LEUKOCYTE BIOL, V82, P1554, DOI 10.1189/0507306; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Zloza A, 2012, NAT MED, V18, P422, DOI 10.1038/nm.2683	41	160	167	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91574	10.1371/journal.pone.0091574	http://dx.doi.org/10.1371/journal.pone.0091574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618995	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400107
J	Kumagai, Y; Naoki, H; Nakasyo, E; Kamioka, Y; Kiyokawa, E; Matsuda, M				Kumagai, Y.; Naoki, H.; Nakasyo, E.; Kamioka, Y.; Kiyokawa, E.; Matsuda, M.			Heterogeneity in ERK activity as visualized by in vivo FRET imaging of mammary tumor cells developed in MMTV-Neu mice	ONCOGENE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; INITIATING CELLS; SELF-RENEWAL; KINASE-ACTIVITY; MOUSE MODELS; MORPHOGENESIS; TUMORIGENESIS; EXPRESSION; TAMOXIFEN	Human epidermal growth factor receptor2/Neu, which is overexpressed in about 30% of human breast cancers, transduces growth signals in large part via the Ras-Raf-MEK-ERK pathway. Nevertheless, it is a matter of controversy whether high ERK activity in breast cancer tissues correlates with better or worse prognosis, leaving the role of ERK activity in the progression of breast cancers unresolved. To address this issue, we live-imaged ERK activity in mammary tumors developed in mouse mammary tumor virus-Neu transgenic mice, which had been crossed with transgenic mice expressing a Forster resonance energy transfer biosensor for ERK. Observation of the tumor by two-photon microscopy revealed significant heterogeneity in ERK activity among the mammary tumor cells. The level of ERK activity in each cell was stable up to several hours, implying a robust mechanism that maintained the ERK activity within a limited range. By sorting the mammary tumor cells on the basis of their ERK activity, we found that ERKhigh cells less efficiently generated tumorspheres in vitro and tumors in vivo than did ERKlow cells. In agreement with this finding, the expressions of the cancer stem cell markers CD49f, CD24 and CD61 were decreased in ERKhigh cells. These observations suggest that high ERK activity may suppress the self-renewal of mammary cancer stem cells.	[Kumagai, Y.; Matsuda, M.] Kyoto Univ, Grad Sch Biostudies, Dept Bioimaging & Cell Signaling, Kyoto 6068501, Japan; [Naoki, H.] Kyoto Univ, Kyoto 6068501, Japan; [Nakasyo, E.] Olympus Corp, R&D Div, Life & Ind Prod Dev Dept 1, Hachioji, Tokyo, Japan; [Kamioka, Y.; Matsuda, M.] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan; [Kamioka, Y.] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Kiyokawa, E.] Kanazawa Med Univ, Dept Oncol Pathol, Uchinada, Ishikawa 92002, Japan	Kyoto University; Kyoto University; Olympus Corporation; Kyoto University; Kyoto University; Kanazawa Medical University	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	matsuda.michiyuki.2c@kyoto-u.ac.jp	Naoki, Honda/AAW-6284-2020; Naoki, Honda/N-5674-2017	Naoki, Honda/0000-0001-6816-9126; Naoki, Honda/0000-0001-6816-9126; Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22113002]; Innovative Techno-Hub for the Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology by MEXT, Japan; MEXT, Japan; Animal Care and Use Committee of Kyoto University Graduate School of Medicine [10584]; Grants-in-Aid for Scientific Research [15H05949, 22113001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Innovative Techno-Hub for the Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology by MEXT, Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Animal Care and Use Committee of Kyoto University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	J3B1 cells were kindly provided by Roberto Montesano. We thank Y Inaoka, K Hirano, K Takakura, R Tabata, Y Kitagawa and A Kawagishi for their technical assistance. We are grateful to the members of the Matsuda Laboratory for their helpful discussions. MM was supported by a Grant-in-Aid for Scientific Research on the Innovative Area of 'Fluorescence Live imaging' (No. 22113002) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and by an Innovative Techno-Hub for the Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology by MEXT, Japan. YK was supported by a Grant-in-Aid for JSPS Fellows from MEXT, Japan. The animal protocols were reviewed and approved by the Animal Care and Use Committee of Kyoto University Graduate School of Medicine (No. 10584).	Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bergqvist J, 2006, EUR J CANCER, V42, P1104, DOI 10.1016/j.ejca.2006.01.028; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Goto A, 2013, J NEUROSCI, V33, P4901, DOI 10.1523/JNEUROSCI.4828-12.2013; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kamioka Y, 2012, CELL STRUCT FUNCT, V37, P65, DOI 10.1247/csf.11045; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; McGlynn LM, 2009, CLIN CANCER RES, V15, P1487, DOI 10.1158/1078-0432.CCR-07-4967; Milde-Langosch K, 2005, BRIT J CANCER, V92, P2206, DOI 10.1038/sj.bjc.6602655; Montesano R, 2002, J CELL SCI, V115, P4419, DOI 10.1242/jcs.00164; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Nobis M, 2013, CANCER RES, V73, P4674, DOI 10.1158/0008-5472.CAN-12-4545; Parashurama N, 2012, STEM CELLS, V30, P2114, DOI 10.1002/stem.1205; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	36	17	17	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1051	1057		10.1038/onc.2014.28	http://dx.doi.org/10.1038/onc.2014.28			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632612	Green Published			2022-12-25	WOS:000350121300011
J	Marion, S; Urs, NM; Peterson, SM; Sotnikova, TD; Beaulieu, JM; Gainetdinov, RR; Caron, MG				Marion, Sebastien; Urs, Nikhil M.; Peterson, Sean M.; Sotnikova, Tatyana D.; Beaulieu, Jean-Martin; Gainetdinov, Raul R.; Caron, Marc G.			Dopamine D2 Receptor Relies upon PPM/PP2C Protein Phosphatases to Dephosphorylate Huntingtin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Arrestin; Dopamine Receptors; G Protein-coupled Receptors (GPCR); G Proteins; Phosphatase; PP2C; Dopamine D2 Receptor; Huntingtin	MUTANT HUNTINGTIN; STRIATAL NEURONS; IN-VIVO; PHOSPHORYLATION; DISEASE; DEGENERATION; TOXICITY; BINDING; TETRABENAZINE; CALCINEURIN	Background: Motor function and emotions are regulated by dopamine and dopaminergic receptors. Results: Pharmacological inhibition of PPM/PP2C phosphatases prevents dopamine D2 receptor-mediated dephosphorylation of the huntingtin protein. Conclusion: A previously unappreciated signaling pathway exists downstream of dopamine D2 receptor activation. Significance: This pathway may have therapeutic potential in dopamine-related disorders. Striatal dopamine D2 receptor (D2R) relies upon G protein- and -arrestin-dependent signaling pathways to convey its action on motor control and behavior. Considering that D2R activation inhibits Akt in the striatum and that huntingtin physiological functions are affected by Akt phosphorylation, we sought to investigate whether D2R-mediated signaling could regulate huntingtin phosphorylation. We demonstrate that D2R activation decreases huntingtin phosphorylation on its Akt site. This dephosphorylation event depends upon the G(i)-dependent engagement of specific members of the protein phosphatase metallo-dependent (PPM/PP2C) family and is independent of -arrestin 2. These observations identify the PPM/PP2C family as a mediator of G protein-coupled receptor signaling and thereby suggest a novel mechanism of dopaminergic signaling.	[Marion, Sebastien; Urs, Nikhil M.; Peterson, Sean M.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Sotnikova, Tatyana D.; Gainetdinov, Raul R.] Univ Laval IUSMQ, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1J 2G3, Canada; [Beaulieu, Jean-Martin] Italian Inst Technol, Dept Neurosci, I-16163 Genoa, Italy	Duke University; Duke University; Duke University; Laval University; Istituto Italiano di Tecnologia - IIT; University of Genoa	Caron, MG (corresponding author), 487 CARL Bldg,Res Dr, Durham, NC 27710 USA.	marc.caron@dm.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Peterson, Sean/0000-0003-4873-0283; Marion, Sebastien/0000-0002-3302-3845	National Institutes of Health [NS-19576, MH073853]; Natural Sciences and Engineering Research Council of Canada (NSERC); Hereditary Disease Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH073853, R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hereditary Disease Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-19576 and MH073853 (to M. G. C.) and a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (to J. M. B.).; Recipient of a fellowship award from the Hereditary Disease Foundation.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Charvin D, 2008, NEUROBIOL DIS, V29, P22, DOI 10.1016/j.nbd.2007.07.028; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; COHEN P, 1989, J BIOL CHEM, V264, P21435; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Cyr M, 2006, FASEB J, V20, P2541, DOI 10.1096/fj.06-6533fje; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jan G, 2007, BIOCHEM J, V401, P711, DOI 10.1042/BJ20061324; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Marshall FJ, 2006, NEUROLOGY, V66, P366, DOI 10.1212/01.wnl.0000198586.85250.13; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Pan C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02333; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Rosenstock TR, 2011, NEUROCHEM INT, V59, P600, DOI 10.1016/j.neuint.2011.04.009; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Weiser D. C., 2003, CURR PROTOC PROTEIN; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zheng GR, 2006, AAPS J, V8, pE682, DOI 10.1208/aapsj080478	41	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11715	11724		10.1074/jbc.M113.544312	http://dx.doi.org/10.1074/jbc.M113.544312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619418	hybrid, Green Published			2022-12-25	WOS:000335010600014
J	Mi, YL; Lin, A; Fiete, D; Steirer, L; Baenziger, JU				Mi, Yiling; Lin, Angela; Fiete, Dorothy; Steirer, Lindsay; Baenziger, Jacques U.			Modulation of Mannose and Asialoglycoprotein Receptor Expression Determines Glycoprotein Hormone Half-life at Critical Points in the Reproductive Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Carbohydrate Function; Carbohydrate Glycoprotein; Endocrinology; Endocytosis; Hormones; Circulatory Half-life	ASPARAGINE-LINKED OLIGOSACCHARIDES; TRANSFERASE 3 BETA-4GALNAC-T3; CYSTEINE-RICH DOMAIN; BETA 1,4GLCNAC BETA; MICE LACKING; RAT-LIVER; SIALYLATED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE; BOVINE LUTROPIN; STRUCTURAL ELUCIDATION	Background: Unique glycan structures on glycoprotein hormones are recognized by glycan-specific receptors that control hormone half-life in the blood. Results: Clearance rates for recognized glycoproteins are determined by the level of receptor expression in the liver. Conclusion: Expression of glycan-specific receptors is modulated at critical points in the reproductive cycle. Significance: Glycans and glycan-specific receptors play critical roles in reproduction. The rate at which glycoproteins are cleared from the circulation has a critical impact on their biologic activity in vivo. We have shown that clearance rates for glycoproteins such as luteinizing hormone (LH) that undergo regulated release into the circulation determine their potency. Two highly abundant, carbohydrate-specific, endocytic receptors, the asialoglycoprotein receptor (ASGR) and the mannose receptor (ManR) are expressed in the liver by parenchymal and sinusoidal endothelial cells, respectively. We demonstrate that the ManR mediates the clearance of glycoproteins such as LH that bear N-linked glycans terminating with 1,4-linked GalNAc-4-SO4, as well as glycoproteins bearing glycans that terminate with Man. Steady state levels of mRNA encoding the ASGR and the ManR are regulated by progesterone in pregnant mice, reaching maximal levels on day 12.5 of pregnancy. Protein expression and glycan-specific binding activity also increase in the livers of pregnant mice. In contrast, ManR mRNA, but not ASGR mRNA, decreases in male mice at the time of sexual maturation. We show that levels of ManR and ASGR expression control the clearance rate for glycoproteins bearing recognized glycans. Thus, reduced expression of the ManR at the time of sexual maturation will increase the potency of LH in vivo, whereas increased expression during pregnancy will reduce LH potency until progesterone and receptor levels fall prior to parturition.	[Mi, Yiling; Lin, Angela; Fiete, Dorothy; Steirer, Lindsay; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 South Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health Grants [R01-CA21923, R01-HD058474]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA21923 and R01-HD058474 (to J. U. B.).	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; COLLINS JC, 1984, HEPATOLOGY, V4, P80, DOI 10.1002/hep.1840040114; Dai GL, 2011, EXP BIOL MED, V236, P1322, DOI 10.1258/ebm.2011.011076; DRICKAMER K, 1984, J BIOL CHEM, V259, P770; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fiete D, 2012, J BIOL CHEM, V287, P29194, DOI 10.1074/jbc.M112.371567; Fiete D, 2012, J BIOL CHEM, V287, P29204, DOI 10.1074/jbc.M112.371880; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Milona A, 2010, AM J PHYSIOL-GASTR L, V298, pG151, DOI 10.1152/ajpgi.00336.2009; PAIETTA E, 1992, J BIOL CHEM, V267, P11078; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; SMITH PL, 1990, J BIOL CHEM, V265, P874; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200	36	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12157	12167		10.1074/jbc.M113.544973	http://dx.doi.org/10.1074/jbc.M113.544973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619407	Green Published, hybrid			2022-12-25	WOS:000335010600051
J	Jiao, F; Bai, SY; Ma, Y; Yan, ZH; Yue, Z; Yu, Y; Wang, X; Wang, J				Jiao, Fei; Bai, Shi-yu; Ma, Ying; Yan, Zhong-hai; Yue, Zhen; Yu, Yuan; Wang, Xin; Wang, Juan			DNA Methylation of Heparanase Promoter Influences Its Expression and Associated with the Progression of Human Breast Cancer	PLOS ONE			English	Article							CELLS IN-VITRO; GENE-EXPRESSION; DOWN-REGULATION; MAMMALIAN HEPARANASE; MDA-MB-435 CELLS; PROSTATE-CANCER; M14 MELANOMA; METASTASIS; INVASION; LINES	Heparanase promotes tumor invasion and metastasis in several malignancies including breast cancer. However, the roles and regulation mechanisms of heparanase during breast cancer progression are still not fully understood. The aim of this study is to determine the differential regulation of heparanase gene expression in specific stages of breast cancer by DNA methylation. We detected levels of heparanase expression and DNA methylation patterns of its promoter in breast cancer cell lines (MCF-7 and MDA-MB-435) and clinical tissues, respectively. It has been observed that heparanase is highly expressed in the invasive MDA-MB-435 cells with low methylation modification in the heparanase promoter. In contrast, lower expression of heparanase in MCF-7 cells is accompanied by higher methylation in the promoter. Treatment of MCF-7 cells with 5-aza-2'-deoxycytidine (5-aza-dC), a potent demethylating agent, results in induction of heparanase expression and higher invasion potential in vitro and leads to an advantage of tumor formation in vivo. In 54 tissue samples, cancer samples at late stages (stage IV) showed the highest heparanase expression accomplished by little DNA methylation. On the contrary, methylation prevalence is highest in normal tissue and inversely correlated with heparanase expression. A significant correlation between DNA methylation and clinical stage was demonstrated (p = 0.012). Collectively, these results demonstrate that DNA methylation play the regulation role in heparanase gene in different stages of breast cancer and present a direct effect on tumor progression.	[Jiao, Fei; Ma, Ying; Yue, Zhen; Yu, Yuan] Binzhou Med Coll, Dept Biochem & Mol Biol, Yantai, Shandong, Peoples R China; [Bai, Shi-yu] Taian City Cent Hosp, Dept Clin Lab, Tai An, Shandong, Peoples R China; [Yan, Zhong-hai] Columbia Univ, Dept Med, New York, NY USA; [Wang, Xin] Jinan Mil Area Command, Binzhou Med Coll Yantai, PLA 107th Hosp, Dept Clin Lab, Jinan, Peoples R China; [Wang, Juan] Binzhou Med Coll, Dept Biotechnol, Yantai, Shandong, Peoples R China	Binzhou Medical University; Columbia University; Binzhou Medical University; Binzhou Medical University	Wang, X (corresponding author), Jinan Mil Area Command, Binzhou Med Coll Yantai, PLA 107th Hosp, Dept Clin Lab, Jinan, Peoples R China.	wang3j@gmail.com; lamei050109@126.com	Yan, Zhonghai/B-9228-2017	Yan, Zhonghai/0000-0003-2456-4284	National Natural Science Foundation of China [31000564]; Natural Science Foundation of Shandong Province [ZR2012BM006]; Foundation of Shandong Educational Committee [J10LF12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Educational Committee	This work was partly supported by grants from the National Natural Science Foundation of China (No. 31000564), the Natural Science Foundation of Shandong Province (No. ZR2012BM006) and the Foundation of Shandong Educational Committee (No. J10LF12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2006, CANCER-AM CANCER SOC, V106, P2514, DOI 10.1002/cncr.21905; Arvatz G, 2010, FASEB J, V24, P4969, DOI 10.1096/fj.10-156372; BAO L, 1994, BRIT J CANCER, V70, P228, DOI 10.1038/bjc.1994.284; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Baraz L, 2006, ONCOGENE, V25, P3939, DOI 10.1038/sj.onc.1209425; Bertolesi GE, 2011, DEV DYNAM, V240, P2657, DOI 10.1002/dvdy.22770; Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057697; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chen ZT, 2013, ACTA BIOCH BIOPH SIN, V45, P188, DOI 10.1093/abbs/gms109; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Elkin M, 2003, CANCER RES, V63, P8821; Guo YJ, 2002, J BIOL CHEM, V277, P41571, DOI 10.1074/jbc.M201864200; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Hong X, 2012, INT J ONCOL, V40, P494, DOI 10.3892/ijo.2011.1229; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; Klajic J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-456; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li Y, 2013, INT J MOL MED, V31, P1234, DOI 10.3892/ijmm.2013.1292; Lu WC, 2003, ONCOGENE, V22, P919, DOI 10.1038/sj.onc.1206201; Meirovitz A, 2011, CANCER RES, V71, P2772, DOI 10.1158/0008-5472.CAN-10-3402; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; Nerlich AG, 2013, ONCOL LETT, V5, P1370, DOI 10.3892/ol.2013.1157; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Pakneshan P, 2003, FASEB J, V17, P1081, DOI 10.1096/fj.02-0973com; Peerless Y, 2013, EXP MOL PATHOL, V94, P309, DOI 10.1016/j.yexmp.2013.01.001; PRICE JE, 1990, CANCER RES, V50, P717; Rabbani SA, 2008, NEOPLASIA, V10, P266, DOI 10.1593/neo.07947; Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027355; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Ridgway LD, 2011, EXP THER MED, V2, P229, DOI 10.3892/etm.2010.189; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Szyf M, 2008, CURR ONCOL, V15, P72; Szyf M, 2012, GENOME MED, V4, DOI 10.1186/gm325; Tost J, 2011, EPIGENETICS-US, V6, P1035, DOI 10.4161/epi.6.8.16077; Veronesi U, 2006, BREAST, V15, P3, DOI 10.1016/j.breast.2005.11.011; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 2001, BIOCHIMIE, V83, P831, DOI 10.1016/S0300-9084(01)01318-9; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Xiong Z, 2012, INT J ONCOL, V40, P1601, DOI 10.3892/ijo.2012.1338; Zeng C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0403-9; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712; Zhang ZH, 2007, CANCER BIOL THER, V6, P587, DOI 10.4161/cbt.6.4.3888; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92190	10.1371/journal.pone.0092190	http://dx.doi.org/10.1371/journal.pone.0092190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632672	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400148
J	Koyio, LN; van der Sanden, WJM; Dimba, E; Mulder, J; Creugers, NHJ; Merkx, MAW; van der Ven, A; Frencken, JE				Koyio, Lucina N.; van der Sanden, Wil J. M.; Dimba, Elizabeth; Mulder, Jan; Creugers, Nico H. J.; Merkx, Matthias A. W.; van der Ven, Andre; Frencken, Jo E.			Oral Health Training Programs for Community and Professional Health Care Workers in Nairobi East District Increases Identification of HIV-Infected Patients	PLOS ONE			English	Article							LESIONS	Background: Better knowledge and skills for diagnosis and management of human immunodeficiency virus (HIV) related oral lesions by primary healthcare workers (PHWs) may increase recognition of HIV-related oral lesions (HROLs) and may improve implementation of HIV testing in Kenya. For this purpose training programs at health facility and community level were evaluated. Design and Methods: A pre-post control-test group design in two administrative divisions of Nairobi East District was used. Clinical competencies of PHWs (n = 32 intervention, and n = 27 control) at health facility level were assessed 9 months after training, and after 6 months for community health workers, (CHWs) (n = 411 intervention and n = 404 control) using written questionnaires, clinical data and patient interviews. Effects on referral for HIV testing and actual HIV testing were assessed by comparing laboratory registries pre- and post training. Results: PHWs in intervention (n = 27; 84%) and control (n = 15; 60%) divisions, and CHWs in intervention (n = 330; 80%) and control (189; 47%) divisions, completed all questionnaires. Trained PHWs significantly increased their knowledge of HROLs (p<0.02), frequency of oral examinations, diagnosis of HROLs and referral of patients with HROLs for HIV testing. Trained CHWs significantly gained knowledge about HROLs (p<0.02) and referred more patients with HROLs to health facilities. Overall percentage of HIV-positive test results was three-fold for HROLs compared to non-HROLs. Specifically, 70% of patients with oro pharyngeal candidiasis (OPC), the most commonly diagnosed HROL, were confirmed as being HIV-positive. Increase in overall HIV testing rates (1.6% pre-, 1.2% post training) and overall percentage of HIV-positive results (13% pre-, 16% post-intervention) was not significant. Conclusion: Training programs significantly increased PHW and CHW knowledge, recognition and management of HROLs but increased neither overall HIV testing rates nor overall percentage of positive tests. Speculation is that the health system and patient-related barriers seriously limit HIV testing.	[Koyio, Lucina N.] Minist Publ Hlth & Sanitat, Dept Primary Hlth Care Serv, Nairobi, Kenya; [van der Sanden, Wil J. M.; Mulder, Jan; Frencken, Jo E.] Radboud Univ Nijmegen, Coll Oral Sci, Med Ctr, Dept Global Oral Hlth, NL-6525 ED Nijmegen, Netherlands; [Dimba, Elizabeth] Univ Nairobi, Dent Teaching Hosp, Dept Oral & Maxillofacial Surg, Nairobi, Kenya; [Creugers, Nico H. J.] Radboud Univ Nijmegen, Coll Oral Sci, Med Ctr, Dept Oral Rehabil, NL-6525 ED Nijmegen, Netherlands; [Merkx, Matthias A. W.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [van der Ven, Andre] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Dept Gen Internal Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Nairobi; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van der Sanden, WJM (corresponding author), Radboud Univ Nijmegen, Coll Oral Sci, Med Ctr, Dept Global Oral Hlth, NL-6525 ED Nijmegen, Netherlands.	wil.vanderSanden@radboudumc.nl	Creugers, N.H.J./H-8022-2014; x, x/M-4834-2017; Merkx, Matthias AW/H-8074-2014; van der Ven, A.J.A.M./H-8102-2014; Sanden, W.J.M. van der/L-4621-2015	x, x/0000-0002-7739-6723; Merkx, Matthias AW/0000-0002-0687-9760; van der Ven, A.J.A.M./0000-0003-1833-3391; Sanden, W.J.M. van der/0000-0003-0720-1983	Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Hague, The Netherlands [C&B-NFP-PHD.10/110]	Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Hague, The Netherlands	This study is funded by a research grant from The Netherlands Organization for International Cooperation in Higher Education (NUFFIC, Grant nr: C&B-NFP-PHD.10/110, The Hague, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbelusi GA, 2005, ORAL DIS, V11, P370, DOI 10.1111/j.1601-0825.2005.01132.x; Anver M., 2010, J KENYA DENT ASS, V1, P93; Bhayat A, 2010, ORAL SURG ORAL MED O, V109, P720, DOI 10.1016/j.tripleo.2009.11.019; Ferrinho P, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-34; Hamza Omar J M, 2006, BMC Oral Health, V6, P12; KDHS, 2008, KEN DEM HLTH SURV 20; Kenya, 2011, KEN SIN SLUM FIR TRA; Koyio LN, 2014, OROPHARYNGEAL CANDID, P59; Koyio LN, 2014, OROPHARYNGEAL CANDID, P135; Koyio Lucina N, 2013, J Public Health Res, V2, P22, DOI 10.4081/jphr.2013.e5; Koyio LN, 2012, J PUBLIC HEALTH RES, V1, P137, DOI 10.4081/jphr.2012.e20; Koyio LN, 2013, J PUBLIC HEALTH DENT, V73, P127, DOI 10.1111/j.1752-7325.2012.00353.x; Ministry of Health (MOH) [Kenya], 2006, TAK KEN ESS PACK HLT; Miziara ID, 2008, J ORAL PATHOL MED, V37, P99, DOI 10.1111/j.1600-0714.2007.00598.x; MoH, 2007, KEN AIDS IND SURV 20; Ranganathan K, 2006, Adv Dent Res, V19, P63; Robinson PG, 1998, SEX TRANSM INFECT, V74, P345, DOI 10.1136/sti.74.5.345; WILLIAMS DM, 1993, J ORAL PATHOL MED, V22, P289, DOI 10.1111/j.1600-0714.1993.tb01074.x; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	20	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90927	10.1371/journal.pone.0090927	http://dx.doi.org/10.1371/journal.pone.0090927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633223	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400025
J	Westrate, LM; Sayfie, AD; Burgenske, DM; MacKeigan, JP				Westrate, Laura M.; Sayfie, Aaron D.; Burgenske, Danielle M.; MacKeigan, Jeffrey P.			Persistent Mitochondrial Hyperfusion Promotes G2/M Accumulation and Caspase-Dependent Cell Death	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; MAMMALIAN-CELLS; FISSION; APOPTOSIS; FUSION; DRP1; MITOSIS; STRESS; GTPASE; ARREST	Cancer cells have several hallmarks that define their neoplastic behavior. One is their unabated replicative potential that allows cells to continually proliferate, and thereby contribute to increasing tumor burden. The progression of a cell through the cell cycle is regulated by a series of checkpoints that ensures successful transmission of genetic information, as well as various cellular components, including organelles and protein complexes to the two resulting daughter cells. The mitochondrial reticulum undergoes coordinated changes in shape to correspond with specific stages of the cell cycle, the most dramatic being complete mitochondrial fragmentation prior to cytokinesis. To determine whether mitochondrial fission is a required step to ensure proper mitochondrial segregation into two daughter cells, we investigated the importance of mitochondrial dynamics to cell cycle progression. We found that mitochondrial hyperfusion promotes a defect in cell cycle progression characterized by an inability for cells to exit G2/M. Additionally, extended periods of persistent mitochondrial fusion led to robust caspase-dependent cell death. The cell death signals were coordinated through activation and cleavage of caspase-8, promoting a potent death response. These results demonstrate the importance of mitochondrial dynamics in cell cycle progression, and that inhibiting mitochondrial fission regulators may provide a therapeutic strategy to target the replicative potential of cancer cells.	[Westrate, Laura M.; Sayfie, Aaron D.; Burgenske, Danielle M.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; Grad Sch, Van Andel Inst, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	MacKeigan, JP (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA.	jeff.mackeigan@vai.org		MacKeigan, Jeffrey/0000-0002-0198-5679	National Cancer Institute [RO1CA138651]; Van Andel Institute Graduate School; NATIONAL CANCER INSTITUTE [R01CA138651] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Institute Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by award number RO1CA138651 from the National Cancer Institute to J.P. MacKeigan and a fellowship from the Van Andel Institute Graduate School to L.M. Westrate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Harper Jane V., 2004, V296, P157; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Niemi NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053803; Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2001, J CELL SCI, V114, P867; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	30	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91911	10.1371/journal.pone.0091911	http://dx.doi.org/10.1371/journal.pone.0091911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632851	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400119
J	Qiao, Y; Zhao, YL; Wu, QL; Sun, LM; Ruan, QL; Chen, YY; Wang, M; Duan, JN; Wang, DY				Qiao, Yan; Zhao, Yunli; Wu, Qiuli; Sun, Lingmei; Ruan, Qinli; Chen, Yanyan; Wang, Meng; Duan, Jinao; Wang, Dayong			Full Toxicity Assessment of Genkwa Flos and the Underlying Mechanism in Nematode Caenorhabditis elegans	PLOS ONE			English	Article							ENVIRONMENTAL RELEVANT CONCENTRATIONS; POTENT INHIBITORY-ACTIVITY; MICROCYSTIN-LR EXPOSURE; WALLED CARBON NANOTUBES; LUNG-CANCER CELLS; DAPHNE-GENKWA; OXIDATIVE STRESS; DITERPENE ESTERS; FLOWER BUDS; REPRODUCTIVE TOXICITY	Genkwa Flos (GF), the dried flower bud from Daphne genkwa Sieb. et Zucc. (Thymelaeaceae), is a well-known and widely used traditional Chinese medicine. However, we know little about the in vivo mechanism of GF toxicity. Nematode Caenorhabditis elegans has been considered as a useful toxicity assay system by offering a system best suited for asking the in vivo questions. In the present study, we employed the prolonged exposure assay system of C. elegans to perform the full in vivo toxicity assessment of raw-processed GF. Our data show that GF exposure could induce the toxicity on lifespan, development, reproduction, and locomotion behavior. GF exposure not only decreased body length but also induced the formation of abnormal vulva. The decrease in brood size in GF exposed nematodes appeared mainly at day-1 during the development of adult nematodes. The decrease of locomotion behavior in GF exposed nematodes might be due to the damage on development of D-type GABAergic motor neurons. Moreover, we observed the induction of intestinal reactive oxygen species (ROS) production and alteration of expression patterns of genes required for development of apical domain, microvilli, and apical junction of intestine in GF exposed nematodes, implying the possible dysfunction of the primary targeted organ. In addition, GF exposure induced increase in defecation cycle length and deficits in development of AVL and DVB neurons controlling the defecation behavior. Therefore, our study implies the usefulness of C. elegans assay system for toxicity assessment from a certain Chinese medicine or plant extract. The observed toxicity of GF might be the combinational effects of oxidative stress, dysfunction of intestine, and altered defecation behavior in nematodes.	[Qiao, Yan; Ruan, Qinli; Chen, Yanyan; Wang, Meng; Duan, Jinao] Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China; [Qiao, Yan; Zhao, Yunli; Wu, Qiuli; Sun, Lingmei; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Southeast University - China	Wang, M (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China.	mengwang.drug@hotmail.com; dja@njutcm.edu.cn; dayongw@seu.edu.cn	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Basic Research Program of China (973 Program) [2011CB505303]; National Natural Science Foundation of China [81172698, 81202233, 81302814]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (973 Program) (No. 2011CB505303), and National Natural Science Foundation of China (No. 81172698, 81202233, 81302814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Bang KK, 2013, BIOORG MED CHEM LETT, V23, P3334, DOI 10.1016/j.bmcl.2013.03.096; Boyd WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007024; BRENNER S, 1974, GENETICS, V77, P71; Chang CW, 2012, VIRUSES-BASEL, V4, P539, DOI 10.3390/v4040539; Chen YY, 2013, PHYTOMEDICINE, V21, P82, DOI 10.1016/j.phymed.2013.06.012; Dharmalingam K, 2012, J ETHNOPHARMACOL, V139, P657, DOI 10.1016/j.jep.2011.12.016; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Fan D, 2011, FOOD CHEM, V124, P195, DOI 10.1016/j.foodchem.2010.06.008; Geng LL, 2013, PHYTOTHER RES, V27, P521, DOI 10.1002/ptr.4748; Goh GY, 2013, AGING CELL, DOI [10.1111/acel.12, DOI 10.1111/ACEL.12]; Helmcke KJ, 2009, TOXICOL APPL PHARM, V240, P265, DOI 10.1016/j.taap.2009.03.013; Hong JY, 2011, J NAT PROD, V74, P2102, DOI 10.1021/np2003512; Hong JY, 2010, CHEM PHARM BULL, V58, P234, DOI 10.1248/cpb.58.234; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Jiangsu New Medical College, 1985, ENC TRAD CHIN MED; Ju JJ, 2013, ENVIRON SCI POLLUT R, V20, P1823, DOI 10.1007/s11356-012-1151-2; Kandasamy S, 2012, MAR DRUGS, V10, P84, DOI 10.3390/md10010084; Kumar S, 2010, REPROD TOXICOL, V29, P415, DOI 10.1016/j.reprotox.2010.02.006; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Lee MY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/728196; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li FF, 2013, BIOORG MED CHEM LETT, V23, P2500, DOI 10.1016/j.bmcl.2013.03.025; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044688; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071180; Li YH, 2009, J ENVIRON SCI, V21, P971, DOI 10.1016/S1001-0742(08)62370-0; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067451; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Lublin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027762; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1324, DOI 10.1897/08-262.1; MCGHEE JD, 2007, C ELEGANS INTESTINE, DOI DOI 10.1895/W0RMB00K.1.133.1; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909; Mukai D, 2008, J NAT MED, V62, P155, DOI 10.1007/s11418-007-0201-4; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park BY, 2008, INT IMMUNOPHARMACOL, V8, P967, DOI 10.1016/j.intimp.2008.02.012; Park BY, 2006, PHYTOTHER RES, V20, P610, DOI 10.1002/ptr.1915; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Ruan QL, 2012, J APPL TOXICOL, V32, P527, DOI 10.1002/jat.1783; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Rui Q, 2009, FRONT MED-PRC, V3, P76; Rui Q, 2013, CHEMOSPHERE, V93, P2289, DOI 10.1016/j.chemosphere.2013.08.007; Sangha JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043990; Tullet JM, 2008, CELL, V132; Wang DY, 2008, ARCH ENVIRON CON TOX, V54, P447, DOI 10.1007/s00244-007-9050-0; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P1221, DOI 10.1016/j.ecoenv.2010.05.002; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P423, DOI 10.1016/j.ecoenv.2009.12.014; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang R, 2013, J ASIAN NAT PROD RES, V15, P502, DOI 10.1080/10286020.2013.786703; Wang SC, 2009, CHEM-BIOL INTERACT, V180, P151, DOI 10.1016/j.cbi.2009.03.012; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Wu QL, 2013, NANOSCALE, V5, P11166, DOI 10.1039/c3nr03917j; Wu QL, 2013, NANOSCALE, V5, P9934, DOI 10.1039/c3nr02084c; Wu QL, 2012, J HAZARD MATER, V243, P161, DOI 10.1016/j.jhazmat.2012.10.013; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Wu S, 2011, ENVIRON TOXICOL PHAR, V31, P179, DOI 10.1016/j.etap.2010.10.005; Xie HC, 2011, J LIQ CHROMATOGR R T, V34, P2360, DOI 10.1080/10826076.2011.589094; Xing X, 2009, B ENVIRON CONTAM TOX, V83, P530, DOI 10.1007/s00128-009-9816-3; Xing XJ, 2009, J ENVIRON SCI, V21, P1684, DOI 10.1016/S1001-0742(08)62474-2; Yang CL, 1993, TOXIC HERBAL MED; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Zeitoun-Ghandour S, 2010, FEBS J, V277, P2531, DOI 10.1111/j.1742-4658.2010.07667.x; Zhan ZJ, 2005, BIOORGAN MED CHEM, V13, P645, DOI 10.1016/j.bmc.2004.10.054; Zhang HF, 2010, METALLOMICS, V2, P806, DOI 10.1039/c0mt00059k; Zhang SX, 2006, BIOORGAN MED CHEM, V14, P3888, DOI 10.1016/j.bmc.2006.01.055; Zhang WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074553; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093; Zhao YL, 2014, NANOMED-NANOTECHNOL, V10, P89, DOI 10.1016/j.nano.2013.07.004; Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c; Zheng WF, 2007, INT IMMUNOPHARMACOL, V7, P117, DOI 10.1016/j.intimp.2006.07.010; Zheng WF, 2007, INT IMMUNOPHARMACOL, V7, P128, DOI 10.1016/j.intimp.2006.07.011	82	33	36	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91825	10.1371/journal.pone.0091825	http://dx.doi.org/10.1371/journal.pone.0091825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626436	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300139
J	Theriault, BL; Basavarajappa, HD; Lim, H; Pajovic, S; Gallie, BL; Corson, TW				Theriault, Brigitte L.; Basavarajappa, Halesha D.; Lim, Harvey; Pajovic, Sanja; Gallie, Brenda L.; Corson, Timothy W.			Transcriptional and Epigenetic Regulation of KIF14 Overexpression in Ovarian Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FAMILY-MEMBER 14; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC MARKER; SIGNALING PATHWAY; GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; FACTORS SP1; PROGRESSION	KIF14 (kinesin family member 14) is a mitotic kinesin and an important oncogene in several cancers. Tumor KIF14 expression levels are independently predictive of poor outcome, and in cancer cells KIF14 can modulate metastatic behavior by maintaining appropriate levels of cell adhesion and migration proteins at the cell membrane. Thus KIF14 is an exciting potential therapeutic target. Understanding KIF14's regulation in cancer cells is crucial to the development of effective and selective therapies to block its tumorigenic function(s). We previously determined that close to 30% of serous ovarian cancers (OvCa tumors) exhibit low-level genomic gain, indicating one mechanism of KIF14 overexpression in tumors. We now report on transcriptional and epigenetic regulation of KIF14. Through promoter deletion analyses, we identified one cis-regulatory region containing binding sites for Sp1, HSF1 and YY1. siRNA-mediated knockdown of these transcription factors demonstrated endogenous regulation of KIF14 overexpression by Sp1 and YY1, but not HSF1. ChIP experiments confirmed an enrichment of both Sp1 and YY1 binding to the endogenous KIF14 promoter in OvCa cell lines with high KIF14 expression. A strong correlation was seen in primary serous OvCa tumors between Sp1, YY1 and KIF14 expression, further evidence that these transcription factors are important players in KIF14 overexpression. Hypomethylation patterns were observed in primary serous OvCa tumors, suggesting a minor role for promoter methylation in the control of KIF14 gene expression. miRNA expression analysis determined that miR-93, miR-144 and miR-382 had significantly lower levels of expression in primary serous OvCa tumors than normal tissues; treatment of an OvCa cell line with miRNA mimics and inhibitors specifically modulated KIF14 mRNA levels, pointing to potential novel mechanisms of KIF14 overexpression in primary tumors. Our findings reveal multiple mechanisms of KIF14 upregulation in cancer cells, offering new targets for therapeutic interventions to reduce KIF14 in tumors, aiming at improved prognosis.	[Theriault, Brigitte L.; Lim, Harvey; Pajovic, Sanja; Gallie, Brenda L.] Princess Margaret Canc Ctr, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Basavarajappa, Halesha D.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Basavarajappa, Halesha D.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lim, Harvey; Gallie, Brenda L.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Gallie, Brenda L.] Toronto Western Hosp, Res Inst, Div Visual Sci, Toronto, ON M5T 2S8, Canada; [Gallie, Brenda L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Gallie, Brenda L.] Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; [Corson, Timothy W.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis	Gallie, BL (corresponding author), Princess Margaret Canc Ctr, Campbell Family Canc Res Inst, Toronto, ON, Canada.	brenda@gallie.ca; tcorson@iupui.edu	Corson, Timothy W./B-6851-2009; Basavarajappa, Halesha Dhurvigere/V-2038-2019	Corson, Timothy W./0000-0002-1402-7875; Basavarajappa, Halesha Dhurvigere/0000-0002-2840-5937; Gallie, Brenda/0000-0002-9697-9211	U.S. Department of Defence [OC080083]; Marsha Rivkin Ovarian Cancer Center Scientific Scholar Award; Indiana Clinical and Translational Sciences Institute; United States National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000163]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	U.S. Department of Defence(United States Department of Defense); Marsha Rivkin Ovarian Cancer Center Scientific Scholar Award; Indiana Clinical and Translational Sciences Institute; United States National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the U.S. Department of Defence Career Development Award; grant #OC080083, and the Marsha Rivkin Ovarian Cancer Center Scientific Scholar Award. This work was also supported in part by the Indiana Clinical and Translational Sciences Institute funded, in part by the United States National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (TR000163; TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bijron Jonathan G, 2012, Expert Opin Med Diagn, V6, P421, DOI 10.1517/17530059.2012.702105; Bowles E, 2007, GENE CHROMOSOME CANC, V46, P118, DOI 10.1002/gcc.20383; Campbell MJ, 2013, ADV EXP MED BIOL, V754, P81, DOI 10.1007/978-1-4419-9967-2_4; Carleton M, 2006, MOL CELL BIOL, V26, P3853, DOI 10.1128/MCB.26.10.3853-3863.2006; Chiang YC, 2013, ENDOCR-RELAT CANCER, V20, P213, DOI 10.1530/ERC-12-0117; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Ehrlichova M, 2013, GENOMICS, V102, P96, DOI 10.1016/j.ygeno.2013.03.005; Filges I, 2013, CLIN GENET; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Heichman KA, 2012, CLIN CHEM LAB MED, V50, P1707, DOI 10.1515/cclm-2011-0935; Ho CM, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-53; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Joung JG, 2013, J AM MED INFORM ASS; Jun DY, 2008, BBA-GENE REGUL MECH, V1779, P356, DOI 10.1016/j.bbagrm.2008.03.013; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kong LM, 2010, CANCER SCI, V101, P1463, DOI 10.1111/j.1349-7006.2010.01554.x; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Madhavan J, 2009, MOL VIS, V15, P235; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Markowski J, 2009, EUR ARCH OTO-RHINO-L, V266, P1501, DOI 10.1007/s00405-009-1019-3; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Renna M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703778200; Sarver AL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-7; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sriraksa R, 2010, CLIN BIOCHEM, V43, P528, DOI 10.1016/j.clinbiochem.2009.11.005; Stefansson OA, 2012, EPIGENETICS-US, V7, P1225, DOI 10.4161/epi.22561; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Szponar A, 2009, INT J CANCER, V124, P2071, DOI 10.1002/ijc.24180; Theriault BL, 2012, ATLAS GENETICS CYTOG; Theriault BL, 2012, INT J CANCER, V130, P1844, DOI 10.1002/ijc.26189; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; Wang Q, 2013, CANCER EPIDEMIOL, V37, P79, DOI 10.1016/j.canep.2012.08.011; Wang YQ, 2013, J OBSTET GYNAECOL RE, V39, P549, DOI 10.1111/j.1447-0756.2012.01979.x; Yang T, 2013, CANCER SCI, V104, P552, DOI 10.1111/cas.12128; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Zaman MS, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-44; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995	54	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91540	10.1371/journal.pone.0091540	http://dx.doi.org/10.1371/journal.pone.0091540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626475	gold, Green Published			2022-12-25	WOS:000332851300102
J	Chu, DK; Zhao, ZW; Li, YM; Li, JP; Zheng, JY; Wang, WZ; Zhao, QC; Ji, G				Chu, Dake; Zhao, Zhengwei; Li, Yunming; Li, Jipeng; Zheng, Jianyong; Wang, Weizhong; Zhao, Qingchuan; Ji, Gang			Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival	PLOS ONE			English	Article							MORTALITY; EPIDEMIOLOGY; STATISTICS; TRENDS; ROLES; RNAS	MicroRNAs are noncoding RNAs that regulate multiple cellular processes during cancer progression. Among various microRNAs, MiR-630 has recently been identified to be implicated in many critical processes in human malignancies. We aimed to investigate the significance and prognostic value of miR-630 in human gastric cancer. Gastric cancer and adjacent normal specimens from 236 patients from who had not received neoadjuvant chemotherapy were collected. The expression of miR-630 was investigated by quantitative real-time PCR assay and its association with overall survival of patients was analyzed by statistical analysis. MiR-630 expression level was significantly elevated in gastric cancer in comparison to adjacent normal specimens. It is also proved that miR-630 expression was to be associated with gastric cancer invasion, lymph node metastasis, distant metastasis and TNM stage. In addition, survival analysis proved that elevated miR-630 expression was associated with poor overall survival of patients. Multivariate survival analysis also proved that miR-630 was an independent prognostic marker after adjusted for known prognostic factors. The present study proved the overexpression of miR-630 and its association with tumor progression in human gastric cancer. It also provided the first evidence that miR-630 expression was an independent prognostic factor for patients with gastric cancer, which might be a potential valuable biomarker for gastric cancer.	[Chu, Dake; Li, Jipeng; Zheng, Jianyong; Wang, Weizhong; Zhao, Qingchuan; Ji, Gang] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake; Li, Jipeng; Zheng, Jianyong; Wang, Weizhong; Zhao, Qingchuan; Ji, Gang] Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Zhengwei] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Shaanxi, Peoples R China; [Li, Yunming] Gen Hosp Chengdu Mil Reg, Dept Med Affair, Chengdu, Sichuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Ji, G (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	jigang@fmmu.edu.cn	JI, Gang/AAG-9877-2020	JI, Gang/0000-0002-2415-6275; Li, Yunming/0000-0001-6363-4869	National Natural Science Foundation of China [81201927, 81272204, 31270812]; China Postdoctoral Science Foundation [2012M521862]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from National Natural Science Foundation of China (No. 81201927, 81272204 and 31270812) and China Postdoctoral Science Foundation (No. 2012M521862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chan SH, 2008, ANTICANCER RES, V28, P907; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Dassen AE, 2010, EUR J CANCER, V46, P1101, DOI 10.1016/j.ejca.2010.02.013; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Guo LH, 2013, INT J MOL SCI, V14, P14171, DOI 10.3390/ijms140714171; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Huang YP, 2012, CELL CYCLE, V11, P1247, DOI 10.4161/cc.11.6.19670; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jing JJ, 2012, WORLD J GASTROENTERO, V18, P1262, DOI 10.3748/wjg.v18.i11.1262; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krol Jacek, 2006, V342, P19, DOI 10.1385/1-59745-123-1:19; Lavy R, 2013, GASTRIC CANCER, V16, P121, DOI 10.1007/s10120-012-0155-4; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Shah AA, 2010, J APPL GENET, V51, P501, DOI 10.1007/BF03208880; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Srivastava K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050966; Wang SH, 2013, TUMOUR BIOL; Wang WB, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-102; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yanokura M, 2010, ONCOL LETT, V1, P935, DOI 10.3892/ol.2010.173; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069756	34	49	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90526	10.1371/journal.pone.0090526	http://dx.doi.org/10.1371/journal.pone.0090526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621930	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300023
J	Sasaki, K; Yamashita, T; Yoshida, K; Inoue, K; Shichida, Y; Kandori, H				Sasaki, Kengo; Yamashita, Takahiro; Yoshida, Kazuho; Inoue, Keiichi; Shichida, Yoshinori; Kandori, Hideki			Chimeric Proton-Pumping Rhodopsins Containing the Cytoplasmic Loop of Bovine Rhodopsin	PLOS ONE			English	Article							STRUCTURAL-CHANGES; SENSORY RHODOPSIN; PHARAONIS PHOBORHODOPSIN; TRANSMEMBRANE HELICES; RETINAL CHROMOPHORE; M-INTERMEDIATE; BACTERIORHODOPSIN; LIGHT; PROTEIN; PHOTOCYCLE	G-protein-coupled receptors (GPCRs) transmit stimuli to intracellular signaling systems. Rhodopsin (Rh), which is a prototypical GPCR, possesses an 11-cis retinal. Photoisomerization of 11-cis to all-trans leads to structural changes in the protein of cytoplasmic loops, activating G-protein. Microbial rhodopsins are similar heptahelical membrane proteins that function as bacterial sensors, light-driven ion-pumps, or light-gated channels. They possess an all-trans retinal, and photoisomerization to 13-cis triggers structural changes in protein. Despite these similarities, there is no sequence homology between visual and microbial rhodopsins, and microbial rhodopsins do not activate G-proteins. In this study, new chimeric proton-pumping rhodopsins, proteorhodopsin (PR) and Gloeobacter rhodopsin (GR) were designed by replacing cytoplasmic loops with bovine Rh loops. Although G-protein was not activated by the PR chimeras, all 12 GR chimeras activated G-protein. The GR chimera containing the second cytoplasmic loop of bovine Rh did not activate G-protein. However, the chimera with a second and third double-loop further enhanced G-protein activation. Introduction of an E132Q mutation slowed the photocycle 30-fold and enhanced activation. The highest catalytic activity of the GR chimera was still 3,200 times lower than bovine Rh but only 64 times lower than amphioxus Go-rhodopsin. This GR chimera showed a strong absorption change of the amide-I band on a light-minus-dark difference FTIR spectrum which could represent a larger helical opening, important for G-protein activation. The light-dependent catalytic activity of this GR chimera makes it a potential optogenetic tool for enzymatic activation by light.	[Sasaki, Kengo; Yoshida, Kazuho; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi, Japan; [Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Honcho Kawaguchi, Saitama, Japan	Nagoya Institute of Technology; Kyoto University; Japan Science & Technology Agency (JST)	Kandori, H (corresponding author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi, Japan.	kandori@nitech.ac.jp	Inoue, Keiichi/AEO-3337-2022	Inoue, Keiichi/0000-0002-6898-4347	Japanese Ministry of Education, Culture, Sports, Science and Technology [24115509, 24115508, 24655009, 25251036, 22247024, 25620011]; Grants-in-Aid for Scientific Research [25440167, 24655009] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology to TY (24115509), KI (24115508, 24655009), YS (25251036), and HK (22247024, 25620011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Devine EL, 2013, P NATL ACAD SCI USA, V110, P13351, DOI 10.1073/pnas.1306826110; Dioumaev AK, 2013, J PHYS CHEM B, V117, P7235, DOI 10.1021/jp402430w; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P2909, DOI 10.1021/bi047893i; Geiser AH, 2006, PROTEIN SCI, V15, P1679, DOI 10.1110/ps.062192306; Han M, 1997, J BIOL CHEM, V272, P23081, DOI 10.1074/jbc.272.37.23081; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; HAUSS T, 1994, P NATL ACAD SCI USA, V91, P11854, DOI 10.1073/pnas.91.25.11854; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kandori H, 2001, BIOCHEMISTRY-US, V40, P9238, DOI 10.1021/bi0103819; Kandori H, 2001, P NATL ACAD SCI USA, V98, P1571, DOI 10.1073/pnas.98.4.1571; Kandori H, 2006, CIS TRANS ISOMERIZAT, P53; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kawanabe A, 2011, J MICROBIOL, V49, P1, DOI 10.1007/s12275-011-0547-x; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Nagata T, 1997, BIOCHEMISTRY-US, V36, P6164, DOI 10.1021/bi962920t; Nakatsuma A, 2011, BIOPHYS J, V100, P1874, DOI 10.1016/j.bpj.2011.02.054; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Oka T, 2000, P NATL ACAD SCI USA, V97, P14278, DOI 10.1073/pnas.260504897; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Rink T, 2000, BIOPHYS J, V78, P1519, DOI 10.1016/S0006-3495(00)76704-X; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Sato H, 1999, ACTA CRYSTALLOGR D, V55, P1251, DOI 10.1107/S090744499900503X; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Sineshchekov OA, 2010, BIOCHEMISTRY-US, V49, P6696, DOI 10.1021/bi100798w; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Watanabe Hiroshi C, 2010, Biophysics (Oxf), V6, P67, DOI 10.2142/biophysics.6.67; Yamada K, 2010, BIOCHEMISTRY-US, V49, P2416, DOI 10.1021/bi9020204; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989	62	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91323	10.1371/journal.pone.0091323	http://dx.doi.org/10.1371/journal.pone.0091323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621599	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300075
J	Yamato, M; Tamura, Y; Eguchi, A; Kume, S; Miyashige, Y; Nakano, M; Watanabe, Y; Kataoka, Y				Yamato, Masanori; Tamura, Yasuhisa; Eguchi, Asami; Kume, Satoshi; Miyashige, Yukiharu; Nakano, Masayuki; Watanabe, Yasuyoshi; Kataoka, Yosky			Brain Interleukin-1 beta and the Intrinsic Receptor Antagonist Control Peripheral Toll-Like Receptor 3-Mediated Suppression of Spontaneous Activity in Rats	PLOS ONE			English	Article							INTERFERON-ALPHA; SYSTEMIC INFLAMMATION; POLYCYTIDYLIC ACID; DEPRESSION; CYTOKINES; ACTIVATION; IL-1-BETA; ADENOSINE; CINGULATE; SYMPTOMS	During acute viral infections such as influenza, humans often experience not only transient fever, but also prolonged fatigue or depressive feelings with a decrease in social activity for days or weeks. These feelings are thought to be due to neuroinflammation in the brain. Recent studies have suggested that chronic neuroinflammation is a precipitating event of various neurological disorders, but the mechanism determining the duration of neuroinflammation has not been elucidated. In this study, neuroinflammation was induced by intraperitoneal injection of polyriboinosinic: polyribocytidylic acid (poly I: C), a Toll-like receptor-3 agonist that mimics viral infection in male Sprague-Dawley rats, and then investigated how the neuroinflammation shift from acute to the chronic state. The rats showed transient fever and prolonged suppression of spontaneous activity for several days following poly I: C injection. NS-398, a cyclooxygenase-2 inhibitor, completely prevented fever, but did not improve spontaneous activity, indicating that suppression of spontaneous activity was not induced by the arachidonate cascade that generated the fever. The animals overexpressed interleukin (IL)-1 beta and IL-1 receptor antagonist (IL-1ra) in the brain including the cerebral cortex. Blocking the IL-1 receptor in the brain by intracerebroventricular (i.c.v.) infusion of recombinant IL-1ra completely blocked the poly I: C-induced suppression of spontaneous activity and attenuated amplification of brain interferon (IFN)-alpha expression, which has been reported to produce fatigue-like behavior by suppressing the serotonergic system. Furthermore, i.c.v. infusion of neutralizing antibody for IL-1ra prolonged recovery from suppression of spontaneous activity. Our findings indicated that IL-1 beta is the key trigger of neuroinflammation and that IL-1ra prevents the neuroinflammation entering the chronic state.	[Yamato, Masanori; Tamura, Yasuhisa; Eguchi, Asami; Kume, Satoshi; Miyashige, Yukiharu; Nakano, Masayuki; Kataoka, Yosky] RIKEN Ctr Life Sci Technol, Cellular Funct Imaging Team, Kobe, Hyogo, Japan; [Watanabe, Yasuyoshi] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Kobe, Hyogo, Japan; [Nakano, Masayuki; Watanabe, Yasuyoshi; Kataoka, Yosky] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka 558, Japan	RIKEN; RIKEN; Osaka Metropolitan University	Kataoka, Y (corresponding author), RIKEN Ctr Life Sci Technol, Cellular Funct Imaging Team, Kobe, Hyogo, Japan.	kataokay@riken.jp			Core Research for Evolution Science and Technology (CREST) of Japan Science and Technology (JST) [25460399, 25750169, 25108515]	Core Research for Evolution Science and Technology (CREST) of Japan Science and Technology (JST)	This study was supported in part by the Core Research for Evolution Science and Technology (CREST) of Japan Science and Technology (JST), Grant-in-Aid for Scientific Research C (MEXT KAKENHI Grant Number 25460399 to Y.K), and Grant-in-Aid for Young Scientists B (MEXT KAKENHI Grant Number 25750169 to M.Y.), Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Number 25108515 to Y. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe Chikara, 2009, Journal of Pharmacological and Toxicological Methods, V59, P7, DOI 10.1016/j.vascn.2008.09.002; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Burak KW, 2002, GASTROENTEROLOGY, V122, P681, DOI 10.1053/gast.2002.31878; Cao CY, 2001, EUR J NEUROSCI, V13, P1781, DOI 10.1046/j.0953-816x.2001.01551.x; Chen GJ, 1999, ENDOCRINOLOGY, V140, P5549, DOI 10.1210/en.140.12.5549; CONN CA, 1995, AM J PHYSIOL-REG I, V268, pR78, DOI 10.1152/ajpregu.1995.268.1.R78; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Di Santo E, 1999, NEUROIMMUNOMODULAT, V6, P300, DOI 10.1159/000026388; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Flagmeyer I, 1997, BRAIN RES, V778, P178, DOI 10.1016/S0006-8993(97)01060-3; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Hannestad J, 2012, J NUCL MED, V53, P601, DOI 10.2967/jnumed.111.097014; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Hu XM, 2005, J NEUROCHEM, V93, P26, DOI 10.1111/j.1471-4159.2004.02968.x; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; Katafuchi T, 2005, EUR J NEUROSCI, V22, P2817, DOI 10.1111/j.1460-9568.2005.04478.x; Katafuchi T, 2003, NEUROSCIENCE, V120, P837, DOI 10.1016/S0306-4522(03)00365-8; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111/j.1460-9568.2008.06549.x; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, CURR OPIN INVEST DR, V10, P664; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; Loddick SA, 1997, BIOCHEM BIOPH RES CO, V234, P211, DOI 10.1006/bbrc.1997.6436; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; MAGEE WE, 1972, LIFE SCI 2-BIOCH GEN, V11, P1081, DOI 10.1016/0024-3205(72)90216-0; Magrone T, 2012, CURR PHARM DESIGN, V18, P34, DOI 10.2174/138161212798919057; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; Masino SA, 1999, J NEUROSCI, V19, P1932; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Morikawa O, 1998, EUR J PHARMACOL, V349, P317, DOI 10.1016/S0014-2999(98)00187-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinteaux E, 2006, GLIA, V53, P551, DOI 10.1002/glia.20308; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Song C, 2011, PROG NEURO-PSYCHOPH, V35, P760, DOI 10.1016/j.pnpbp.2010.06.020; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Traynor TR, 2007, BRAIN BEHAV IMMUN, V21, P311, DOI 10.1016/j.bbi.2006.09.007	40	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90950	10.1371/journal.pone.0090950	http://dx.doi.org/10.1371/journal.pone.0090950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621600	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300036
J	Rossi, A; Riccio, A; Coccia, M; Trotta, E; La Frazia, S; Santoro, MG				Rossi, Antonio; Riccio, Anna; Coccia, Marta; Trotta, Edoardo; La Frazia, Simone; Santoro, M. Gabriella			The Proteasome Inhibitor Bortezomib Is a Potent Inducer of Zinc Finger AN1-type Domain 2a Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Heat Shock Protein; Proteasome; Stress Response; Transcription Regulation	HEAT-SHOCK FACTOR-1; DNA-BINDING ACTIVITY; FACTOR-KAPPA-B; TRANSCRIPTION-FACTOR; ENDOTHELIAL-CELLS; FACTOR-I; POSTTRANSLATIONAL MODIFICATION; PROSTAGLANDIN A(1); MULTIPLE-MYELOMA; FACTOR FAMILY	Background: AIRAP is a recently identified heat shock protein whose function and regulation are still not well defined. Results: Proteasome inhibition causes abundant AIRAP expression in human primary cells. Conclusion: The anticancer drug bortezomib regulates AIRAP expression through HSF1-HSF2 interplay. Significance: This study reveals how persistent proteasomal inhibition by clinically relevant concentrations of bortezomib affects heat shock response regulation and HSF-mediated AIRAP induction. The zinc finger AN1-type domain 2a gene, also known as arsenite-inducible RNA-associated protein (AIRAP), was recently identified as a novel human canonical heat shock gene strictly controlled by heat shock factor (HSF) 1. Little is known about AIRAP gene regulation in human cells. Here we report that bortezomib, a proteasome inhibitor with anticancer and antiangiogenic properties used in the clinic for treatment of multiple myeloma, is a potent inducer of AIRAP expression in human cells. Using endothelial cells as a model, we unraveled the molecular mechanism regulating AIRAP expression during proteasome inhibition. Bortezomib induces AIRAP expression at the transcriptional level early after treatment, concomitantly with polyubiquitinated protein accumulation and HSF activation. AIRAP protein is detected at high levels for at least 48 h after bortezomib exposure, together with the accumulation of HSF2, a factor implicated in differentiation and development regulation. Different from heat-mediated induction, in bortezomib-treated cells, HSF1 and HSF2 interact directly, forming HSF1-HSF2 heterotrimeric complexes recruited to a specific heat shock element in the AIRAP promoter. Interestingly, whereas HSF1 has been confirmed to be critical for AIRAP gene transcription, HSF2 was found to negatively regulate AIRAP expression after bortezomib treatment, further emphasizing an important modulatory role of this transcription factor under stress conditions. AIRAP function is still not defined. However, the fact that AIRAP is expressed abundantly in primary human cells at bortezomib concentrations comparable with plasma levels in treated patients suggests that AIRAP may participate in the regulatory network controlling proteotoxic stress during bortezomib treatment.	[Rossi, Antonio; Riccio, Anna; Coccia, Marta; Trotta, Edoardo; Santoro, M. Gabriella] CNR, Inst Translat Pharmacol, I-00133 Rome, Italy; [Riccio, Anna; Coccia, Marta; La Frazia, Simone; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata	Santoro, MG (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	santoro@bio.uniroma2.it	Trotta, Edoardo/AAW-4697-2020; Riccio, Anna/HHC-2105-2022	Trotta, Edoardo/0000-0002-1417-9238; Riccio, Anna/0000-0002-1140-1366; La Frazia, Simone/0000-0002-6987-5409; ROSSI, ANTONIO/0000-0003-0383-3828; Santoro, Maria Gabriella/0000-0003-1432-4949	Italian Ministry of University and Scientific Research PRIN project [N 2010PHT9NF-006]	Italian Ministry of University and Scientific Research PRIN project	This work was supported by Italian Ministry of University and Scientific Research PRIN project Grant N 2010PHT9NF-006.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Ahlskog JK, 2010, MOL CELL BIOL, V30, P5608, DOI 10.1128/MCB.01506-09; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Dy GK, 2005, CLIN CANCER RES, V11, P3410, DOI 10.1158/1078-0432.CCR-04-2068; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; Eriksson M, 2000, INT J DEV BIOL, V44, P471; Ferrarini M, 2011, CURR MED CHEM, V18, P5185, DOI 10.2174/092986711798184316; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Lecomte S, 2010, ONCOGENE, V29, P4216, DOI 10.1038/onc.2010.171; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Manuel M, 2002, EUR J BIOCHEM, V269, P2527, DOI 10.1046/j.1432-1033.2002.02917.x; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Moran-Crusio K, 2012, TRENDS IMMUNOL, V33, P357, DOI 10.1016/j.it.2012.01.009; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; MURPHY SP, 1994, MOL CELL BIOL, V14, P5309, DOI 10.1128/MCB.14.8.5309; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pirkkala L, 1999, FASEB J, V13, P1089, DOI 10.1096/fasebj.13.9.1089; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Rossi A, 1998, J BIOL CHEM, V273, P16446, DOI 10.1074/jbc.273.26.16446; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rossi A, 2006, CANCER RES, V66, P7678, DOI 10.1158/0008-5472.CAN-05-4282; Rossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031304; Rossi A, 2010, J BIOL CHEM, V285, P13607, DOI 10.1074/jbc.M109.082693; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schwartz Rowena, 2004, Oncology (Williston Park), V18, P14; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Turturici G, 2009, BIOCHEM J, V421, P193, DOI 10.1042/BJ20082309; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Xu YM, 2012, J PROTEOME RES, V11, P2625, DOI 10.1021/pr201151a; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	58	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12705	12715		10.1074/jbc.M113.513242	http://dx.doi.org/10.1074/jbc.M113.513242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24619424	hybrid, Green Published			2022-12-25	WOS:000335581400042
J	Gould, FDH				Gould, Francois D. H.			To 3D or Not to 3D, That Is the Question: Do 3D Surface Analyses Improve the Ecomorphological Power of the Distal Femur in Placental Mammals?	PLOS ONE			English	Article							DISCRIMINANT FUNCTION-ANALYSIS; FUNCTIONAL-MORPHOLOGY; LOCOMOTOR BEHAVIOR; HINDLIMB; CARNIVORANS; EVOLUTION; ANATOMY; RATIOS; CORPUS; SIZE	Improvements in three-dimensional imaging technologies have renewed interest in the study of functional and ecological morphology. Quantitative approaches to shape analysis are used increasingly to study form-function relationships. These methods are computationally intensive, technically demanding, and time-consuming, which may limit sampling potential. There have been few side-by-side comparisons of the effectiveness of such approaches relative to more traditional analyses using linear measurements and ratios. Morphological variation in the distal femur of mammals has been shown to reflect differences in locomotor modes across clades. Thus I tested whether a geometric morphometric analysis of surface shape was superior to a multivariate analysis of ratios for describing ecomorphological patterns in distal femoral variation. A sample of 164 mammalian specimens from 44 genera was assembled. Each genus was assigned to one of six locomotor categories. The same hypotheses were tested using two methods. Six linear measurements of the distal femur were taken with calipers, from which four ratios were calculated. A 3D model was generated with a laser scanner, and analyzed using three dimensional geometric morphometrics. Locomotor category significantly predicted variation in distal femoral morphology in both analyses. Effect size was larger in the geometric morphometric analysis than in the analysis of ratios. Ordination reveals a similar pattern with arboreal and cursorial taxa as extremes on a continuum of morphologies in both analyses. Discriminant functions calculated from the geometric morphometric analysis were more accurate than those calculated from ratios. Both analysis of ratios and geometric morphometric surface analysis reveal similar, biologically meaningful relationships between distal femoral shape and locomotor mode. The functional signal from the morphology is slightly higher in the geometric morphometric analysis. The practical costs of conducting these sorts of analyses should be weighed against potentially slight increases in power when designing protocols for ecomorphological studies.	[Gould, Francois D. H.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD USA	Johns Hopkins University	Gould, FDH (corresponding author), Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA.	fgould@neomed.edu			Center for Functional Anatomy and Evolution at Johns Hopkins University	Center for Functional Anatomy and Evolution at Johns Hopkins University	Funding for this work was provided by the Center for Functional Anatomy and Evolution at Johns Hopkins University while the author was a graduate student there. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1984, ORDERS FAMILIES RECE; Andersson K, 2004, ZOOL J LINN SOC-LOND, V142, P91, DOI 10.1111/j.1096-3642.2004.00129.x; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; ATCHLEY WR, 1976, SYST ZOOL, V25, P137, DOI 10.2307/2412740; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; BANFIELD A W F, 1974, P438; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; BIKNEVICIUS AR, 1993, J MAMMAL, V74, P95, DOI 10.2307/1381908; Bonnan MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075216; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Curran SC, 2012, J ARCHAEOL SCI, V39, P1172, DOI 10.1016/j.jas.2011.12.028; De Groote I, 2011, AM J PHYS ANTHROPOL, V144, P498, DOI 10.1002/ajpa.21467; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dunn RH, 2007, J VERTEBR PALEONTOL, V27, P987, DOI 10.1671/0272-4634(2007)27[987:SMALBO]2.0.CO;2; Eisenberg J., 1989, MAMMALS NEOTROPICS; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Fabre AC, 2013, J EVOLUTION BIOL, V26, P1521, DOI 10.1111/jeb.12161; FLETCHER JM, 1978, CORTEX, V14, P564, DOI 10.1016/S0010-9452(78)80031-8; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; Gittleman JL., 1989, SPRINGER, DOI [10.1007/978-1-4757-4716-4, DOI 10.1007/978-1-4757-4716-4]; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Harcourt-Smith William E. H., 2008, P373, DOI 10.1007/978-1-4020-6997-0_17; Janis CM, 2012, J VERTEBR PALEONTOL, V32, P433, DOI 10.1080/02724634.2012.635737; KAPPELMAN J, 1988, J MORPHOL, V198, P119, DOI 10.1002/jmor.1051980111; Kingdon J, 1971, E AFRICAN MAMMALS AT; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kovarovic K, 2011, J ARCHAEOL SCI, V38, P3006, DOI 10.1016/j.jas.2011.06.028; Lariviere Serge, 2002, Mammalian Species, P1; Leopold AS., 1959, WILDLIFE MEXICO GAME, DOI 10.1525/9780520326422; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; MacLeod N, 2009, NEW SYSTEMATICS; Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683; POGLAYEN-NEUWALL I, 1988, Mammalian Species, P1, DOI 10.2307/3504321; Polly PD, 2011, J VERTEBR PALEONTOL, V31, P175; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Prater S.H., 1965, BOOK INDIAN ANIMALS; Presley S.J., 2000, MAMM SPECIES, V636, P1, DOI [DOI 10.1644/1545-1410(2000)6362.0.CO;2, 10.2307/0.636.1, DOI 10.1644/1545-1410(2000)636<0001:EB>2.0.CO;2]; R Core Team, 2021, R LANG ENV STAT COMP; Ricklefs R. E., 1994, ECOLOGICAL MORPHOLOG; Roberts MS, 1984, MAMMALIAN SPECIES; Salton Justine A., 2008, P51, DOI 10.1007/978-1-4020-6997-0_4; Sargis EJ, 2002, J MORPHOL, V254, P149, DOI 10.1002/jmor.10025; Smith RJ, 2005, CURR ANTHROPOL, V46, P249, DOI 10.1086/427117; SMYTHE N, 1970, AM NAT, V104, P491, DOI 10.1086/282684; Stein BR, 1997, J ZOOL, V242, P185, DOI 10.1111/j.1469-7998.1997.tb02939.x; Stroganov S.U., 1969, CARNIVOROUS MAMMALS; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; Tocheri MW, 2005, J HUM EVOL, V49, P570, DOI 10.1016/j.jhevol.2005.06.005; Tocheri MW, 2009, ADV IMAGING BIOL MED, P85, DOI DOI 10.1007/978-3-540-68993-5_4; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Walker E. P., 1991, MAMMALS OF THE WORLD; Weber Gerhard W., 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P69, DOI 10.2114/jpa.20.69; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; White JW, 2007, MAR ECOL PROG SER, V329, P301, DOI 10.3354/meps329301; White Jennifer L., 1993, Journal of Vertebrate Paleontology, V13, P230; Wood AR, 2011, J MAMM EVOL, V18, P1, DOI 10.1007/s10914-010-9145-7	62	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91719	10.1371/journal.pone.0091719	http://dx.doi.org/10.1371/journal.pone.0091719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633081	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400082
J	Jones, DL; Simfukwe, P; Hill, PW; Mills, RTE; Emmett, BA				Jones, David L.; Simfukwe, Paul; Hill, Paul W.; Mills, Robert T. E.; Emmett, Bridget A.			Evaluation of Dissolved Organic Carbon as a Soil Quality Indicator in National Monitoring Schemes	PLOS ONE			English	Article							ULTRAVIOLET ABSORBENCY; UV-ABSORBENCY; MATTER; WATER; DOC; COUNTRYSIDE; ABSORPTION; FOLIN	Background: Monitoring the properties of dissolved organic carbon (DOC) in soil water is frequently used to evaluate changes in soil quality and to explain shifts in freshwater ecosystem functioning. Methods: Using >700 individual soils (0-15 cm) collected from a 209,331 km(2) area we evaluated the relationship between soil classification (7 major soil types) or vegetation cover (8 dominant classes, e. g. cropland, grassland, forest) and the absorbance properties (254 and 400 nm), DOC quantity and quality (SUVA, total soluble phenolics) of soil water. Results: Overall, a good correlation (r(2) = 0.58) was apparent between soil water absorbance and DOC concentration across the diverse range of soil types tested. In contrast, both DOC and the absorbance properties of soil water provided a poor predictor of SUVA or soluble phenolics which we used as a measure of humic substance concentration. Significant overlap in the measured ranges for UV absorbance, DOC, phenolic content and especially SUVA of soil water were apparent between the 8 vegetation and 7 soil classes. A number of significant differences, however, were apparent within these populations with total soluble phenolics giving the greatest statistical separation between both soil and vegetation groups. Conclusions: We conclude that the quality of DOC rather than its quantity provides a more useful measure of soil quality in large scale surveys.	[Jones, David L.; Simfukwe, Paul; Hill, Paul W.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Mills, Robert T. E.] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, Lab Ecol Syst ECOS, Lausanne, Switzerland; [Emmett, Bridget A.] Environm Ctr Wales, Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales	Bangor University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institute for Forest, Snow & Landscape Research; UK Centre for Ecology & Hydrology (UKCEH)	Jones, DL (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	d.jones@bangor.ac.uk	Jones, Davey/AAD-6037-2020; Jones, Davey L/C-7411-2011; jones, davey/AAN-5606-2020; Emmett, Bridget A/D-6199-2011	Jones, Davey/0000-0002-1482-4209; Jones, Davey L/0000-0002-1482-4209; Emmett, Bridget A/0000-0002-2713-4389	United Kingdom Department for Environment, Food and Rural Affairs; Natural Environment Research Council [ceh010010] Funding Source: researchfish	United Kingdom Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the United Kingdom Department for Environment, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amery F, 2008, EUR J SOIL SCI, V59, P1087, DOI 10.1111/j.1365-2389.2008.01078.x; [Anonymous], 2006, GUID SOIL DESCR; Avery B.W., 1990, SOILS BRIT ISLES; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Brandstetter A, 1996, Z PFLANZ BODENKUNDE, V159, P605, DOI 10.1002/jpln.1996.3581590612; Bunce R. G. H., 1999, VEGETATION BRIT COUN; Camarero L, 2009, FRESHWATER BIOL, V54, P2452, DOI 10.1111/j.1365-2427.2009.02296.x; Clutterbuck B, 2010, SCI TOTAL ENVIRON, V408, P6179, DOI 10.1016/j.scitotenv.2010.08.038; Dilling J, 2002, WATER RES, V36, P5037, DOI 10.1016/S0043-1354(02)00365-2; Dittman JA, 2009, ENVIRON POLLUT, V157, P1953, DOI 10.1016/j.envpol.2009.01.031; DOUGAN WK, 1974, ANALYST, V99, P413, DOI 10.1039/an9749900413; EDWARDS AC, 1987, WATER RES, V21, P49, DOI 10.1016/0043-1354(87)90098-4; Emmett B.A., 2010, 907 CS CTR EC HYDR; Emmett BA, 2008, 307 NERC CS CTR EC H; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Filep T, 2008, CEREAL RES COMMUN, V36, P667; Hansson K, 2010, SOIL BIOL BIOCHEM, V42, P178, DOI 10.1016/j.soilbio.2009.10.013; Izbicki JA, 2007, ENVIRON CHEM, V4, P35, DOI 10.1071/EN06046; Jaffrain J, 2007, SOIL SCI SOC AM J, V71, P1851, DOI 10.2136/sssaj2006.0202; Lawrence GB, 2013, J ENVIRON QUAL, V42, P623, DOI 10.2134/jeq2012.0378; Matilainen A, 2011, CHEMOSPHERE, V83, P1431, DOI 10.1016/j.chemosphere.2011.01.018; MATTSON JS, 1974, LIMNOL OCEANOGR, V19, P530, DOI 10.4319/lo.1974.19.3.0530; Norton LR, 2012, J ENVIRON MANAGE, V113, P117, DOI 10.1016/j.jenvman.2012.07.030; O'Neill KP, 2005, ENVIRON MONIT ASSESS, V107, P59, DOI 10.1007/s10661-005-2144-0; Ohno T, 1998, J ENVIRON QUAL, V27, P776, DOI 10.2134/jeq1998.00472425002700040008x; Osborne DM, 2013, RAPID COMMUN MASS SP, V27, P851, DOI 10.1002/rcm.6521; Reynolds B, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0114; Rowe EC, 2012, SCI TOTAL ENVIRON, V434, P62, DOI 10.1016/j.scitotenv.2011.12.027; SHARMA OK, 1966, ANAL BIOCHEM, V14, P11, DOI 10.1016/0003-2697(66)90050-9; Smart SM, 2003, J ENVIRON MANAGE, V67, P239, DOI 10.1016/S0301-4797(02)00177-9; Steinberg CEW, 2004, ENVIRON TOXICOL, V19, P409, DOI 10.1002/tox.20019; THORN KA, 1989, 894196 US GEOL SURV; Tipping E, 2009, ENVIRON CHEM, V6, P472, DOI 10.1071/EN09090; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; WHEELER JR, 1977, LIMNOL OCEANOGR, V22, P573, DOI 10.4319/lo.1977.22.3.0573; Zhang Q, 2009, J HAZARD MATER, V172, P880, DOI 10.1016/j.jhazmat.2009.07.068	37	27	32	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90882	10.1371/journal.pone.0090882	http://dx.doi.org/10.1371/journal.pone.0090882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633085	Green Published, Green Accepted, gold			2022-12-25	WOS:000332858400023
J	Ketabchi, A; Komm, K; Miles-Rossouw, M; Cassani, DAD; Variola, F				Ketabchi, Amirhossein; Komm, Kristopher; Miles-Rossouw, Malaika; Cassani, Davide A. D.; Variola, Fabio			Nanoporous Titanium Surfaces for Sustained Elution of Proteins and Antibiotics	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; CONTROLLED DRUG-DELIVERY; DELAYED RELEASE; TIO2 NANOTUBES; ADSORPTION; TOPOGRAPHY; VANCOMYCIN; ATTACHMENT; VIBRATIONS; DIFFUSION	Current medically relevant metals for prosthetic reconstructions enjoy a relatively good success rate, but their performance drops significantly in patients with compromised health status, and post-surgical infections still remain an important challenge. To address these problems, different nanotechnology-based strategies have been exploited to create implantable metals with an enhanced bioactivity and antibacterial capacities. Among these, oxidative nanopatterning has emerged as a very effective approach to engender nanoporous surfaces that stimulate and guide the activity of adhering cells. The resulting nanoporosity is also attractive because it offers nanoconfined volumes that can be exploited to load bioactive compounds and modulate their release over time. Such extended elution is needed since a single exposure to growth factors and/or antibiotics, for instance, may not be adequate to further sustain bone regeneration and/or to counteract bacterial colonization. In this article, we assessed the capacities of nanoporous titanium surfaces generated by oxidative nanopatterning to provide controlled and sustained elution of proteins and antibiotic molecules. To this end, we have selected bovine serum albumin (BSA) and vancomycin to reflect commonly used compounds, and investigated their adsorption and elution by Fourier-transform infrared (FT-IR) and ultraviolet-visible (UV-VIS) spectroscopy. Our results demonstrate that while the elution of albumin is not significantly affected by the nanoporosity, in the case of vancomycin, nanoporous surfaces provided an extended release. These findings were successively correlated to the establishment of interactions with the surface and physical-entrapment effects exerted by the nanopores, ultimately highlighting their synergistic contribution to the release profiles and thus their importance in the design of nanostructured eluting platforms for applications in medicine.	[Ketabchi, Amirhossein; Komm, Kristopher; Miles-Rossouw, Malaika; Cassani, Davide A. D.; Variola, Fabio] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada; [Komm, Kristopher; Miles-Rossouw, Malaika] Univ Ottawa, Dept Chem & Biol Engn, Ottawa, ON K1N 6N5, Canada; [Cassani, Davide A. D.] Politecn Milan, Dept Chem Mat & Chem Engn, I-20133 Milan, Italy; [Variola, Fabio] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa; Polytechnic University of Milan; University of Ottawa	Variola, F (corresponding author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.	fabio.variola@uottawa.ca		Variola, Fabio/0000-0002-5519-6915	uOttawa Faculty of Engineering start up funds; Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); Ontario Ministry of Research and Innovation (MRI)	uOttawa Faculty of Engineering start up funds; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario)	uOttawa Faculty of Engineering start up funds; Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC); Leaders Opportunity Fund from the Canada Foundation for Innovation (CFI); and the Ontario Ministry of Research and Innovation (MRI). The funding agencies did not participate in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided money used to pay for materials, students, and equipment.	Aucoin HR, 2013, POLYMERS-BASEL, V5, P1241, DOI 10.3390/polym5041241; Aw MS, 2012, CHEM COMMUN, V48, P3348, DOI 10.1039/c2cc17690d; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Ben Jazia D, 2011, COLLOID SURFACE A, V384, P643, DOI 10.1016/j.colsurfa.2011.05.033; Bouhekka A, 2012, ACTA CHIM SLOV, V59, P841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Cauda V, 2008, J MATER CHEM, V18, P5888, DOI 10.1039/b805395b; Dash S, 2010, ACTA POL PHARM, V67, P217; de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955; Ferrer ML, 2001, BIOPHYS J, V80, P2422, DOI 10.1016/S0006-3495(01)76211-X; Frutos P, 2002, BIOMATERIALS, V23, P3787, DOI 10.1016/S0142-9612(02)00028-5; Gonzalez B, 2008, CHEM MATER, V20, P4826, DOI 10.1021/cm703568k; Grdadolink J, 2001, BIOPOLYMERS, V62, P40, DOI 10.1002/1097-0282(2001)62:1<40::AID-BIP60>3.0.CO;2-C; Gulati K, 2012, ACTA BIOMATER, V8, P449, DOI 10.1016/j.actbio.2011.09.004; Gultepe E, 2010, SMALL, V6, P213, DOI 10.1002/smll.200901736; Gurzawska K, 2012, J BIOMED NANOTECHNOL, V8, P1012, DOI 10.1166/jbn.2012.1457; Haris PI, 2010, BIOCHEM SOC T, V38, P940, DOI 10.1042/BST0380940; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Ketonis C, 2009, CLIN ORTHOP RELAT R, V467, P1678, DOI 10.1007/s11999-009-0828-4; Kim MH, 2011, J NANOSCI NANOTECHNO, V11, P1656, DOI 10.1166/jnn.2011.3303; Kupser P, 2010, J AM CHEM SOC, V132, P2085, DOI 10.1021/ja909842j; LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603; Lin Y, 2013, LUMINESCENC IN PRESS; Mavropoulos E, 2011, COLLOID SURFACE B, V83, P1, DOI 10.1016/j.colsurfb.2010.10.025; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052; Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412; Poully JC, 2010, PHYS CHEM CHEM PHYS, V12, P3606, DOI 10.1039/b923787a; Richert L, 2008, ADV MATER, V15, P1; Richert L, 2010, SURF SCI, V604, P1445, DOI 10.1016/j.susc.2010.05.007; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601; Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; Sahoo S., 2012, J CHEM PHARM RES, V4, P2268; SALTER CJ, 1995, J CHEM SOC PERK T 2, P2203, DOI 10.1039/p29950002203; Swanson TE, 2011, J BIOMED MATER RES A, V97A, P167, DOI 10.1002/jbm.a.33043; Tao CH, 2011, J NANOSCI NANOTECHNO, V11, P5068, DOI 10.1166/jnn.2011.4144; Temenoff J. S., 2008, BIOMATERIALS INTERSE, V1st; Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040; Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e; Variola F, 2009, APPL SPECTROSC, V63, P1187, DOI 10.1366/000370209789553129; Variola F, 2009, ADV ENG MATER, V11, pB227, DOI 10.1002/adem.200900122; Vetrone F, 2008, NANO LETT; Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002; Yang L, 2009, EXPERT OPIN DRUG DEL, V6, P851, DOI 10.1517/17425240903044935; Yi JH, 2006, SURF SCI, V600, P4613, DOI 10.1016/j.susc.2006.07.053; Yoshikawa H, 2012, INT J BIOL MACROMOL, V50, P1286, DOI 10.1016/j.ijbiomac.2012.03.014; Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7; Zhou J, 2012, J BIOMED MATER RES A, V100A, P2295, DOI 10.1002/jbm.a.34170; Zhou JA, 2011, J MICROENCAPSUL, V28, P99, DOI 10.3109/02652048.2010.534824	53	21	22	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92080	10.1371/journal.pone.0092080	http://dx.doi.org/10.1371/journal.pone.0092080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633020	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400140
J	Sagulenko, E; Morgan, GP; Webb, RI; Yee, B; Lee, KC; Fuerst, JA				Sagulenko, Evgeny; Morgan, Garry P.; Webb, Richard I.; Yee, Benjamin; Lee, Kuo-Chang; Fuerst, John A.			Structural Studies of Planctomycete Gemmata obscuriglobus Support Cell Compartmentalisation in a Bacterium	PLOS ONE			English	Article							ESCHERICHIA-COLI; IGNICOCCUS-HOSPITALIS; BACILLUS-SUBTILIS; OUTER-MEMBRANE; RIBOSOMAL-RNA; SURFACE-LAYER; PROTEIN; DIVISION; EVOLUTION; FTSK	Members of phylum Planctomycetes have been proposed to possess atypical cell organisation for the Bacteria, having a structure of sectioned cells consistent with internal compartments surrounded by membranes. Here via electron tomography we confirm the presence of compartments in the planctomycete Gemmata obscuriglobus cells. Resulting 3-D models for the most prominent structures, nuclear body and riboplasm, demonstrate their entirely membrane - enclosed nature. Immunogold localization of the FtsK protein also supports the internal organisation of G. obscuriglobus cells and their unique mechanism of cell division. We discuss how these new data expand our knowledge on bacterial cell biology and suggest evolutionary consequences of the findings.	[Sagulenko, Evgeny; Yee, Benjamin; Lee, Kuo-Chang; Fuerst, John A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Morgan, Garry P.; Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Sagulenko, E (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	e.sagulenko@uq.edu.au; j.fuerst@uq.edu.au	Fuerst, John/I-8649-2012	Fuerst, John/0000-0002-6451-8533	Australian Research Council (ARC) [DP0881485]; Dow Agrosciences; University of Queensland	Australian Research Council (ARC)(Australian Research Council); Dow Agrosciences; University of Queensland(University of Queensland)	The work was supported by the Australian Research Council (ARC) discovery grant number DP0881485. A PhD scholarship of B.Y. was supported by Dow Agrosciences, and that of K-C.L. by the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2013, J CELL SCI; Acehan D, 2014, J CELL SCI, V127, P277, DOI 10.1242/jcs.137596; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Amat F, 2010, J BACTERIOL, V192, P5855, DOI 10.1128/JB.00747-10; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bisicchia P, 2013, MBIO, V4; Dacks JB, 2008, P NATL ACAD SCI USA, V105, P588, DOI 10.1073/pnas.0707318105; Devos DP, 2014, ANTON LEEUW INT J G, V105, P271, DOI 10.1007/s10482-013-0087-y; Devos DP, 2014, TRENDS MICROBIOL, V22, P14, DOI 10.1016/j.tim.2013.10.008; Devos DP, 2013, TRENDS MICROBIOL; Devos DP, 2013, A VANLEEUWENHOEK; Dubarry N, 2010, EMBO J, V29, P597, DOI 10.1038/emboj.2009.381; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; Fuerst JA, 2014, BBA-MOL CELL RES, V1843, P1732, DOI 10.1016/j.bbamcr.2013.10.002; Fuerst JA, 2013, ANTON LEEUW INT J G, V104, P451, DOI 10.1007/s10482-013-9986-1; Fuerst JA, 2013, J MOL MICROB BIOTECH, V23, P95, DOI 10.1159/000346544; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Fuerst John A, 2010, Commun Integr Biol, V3, P572, DOI 10.4161/cib.3.6.13061; GIOVANNONI SJ, 1987, J BACTERIOL, V169, P2702, DOI 10.1128/jb.169.6.2702-2707.1987; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; HOBOT JA, 1984, J BACTERIOL, V160, P143, DOI 10.1128/JB.160.1.143-152.1984; Huber H, 2012, ANTON LEEUW INT J G, V102, P203, DOI 10.1007/s10482-012-9748-5; Jogler C, 2011, APPL ENVIRON MICROB, V77, P5826, DOI 10.1128/AEM.05132-11; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Kuznetsov YG, 2013, J VIROL, V87, P11200, DOI 10.1128/JVI.01372-13; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; LIESACK W, 1986, ARCH MICROBIOL, V145, P361, DOI 10.1007/BF00470872; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lindsay MR, 1997, MICROBIOL-UK, V143, P739, DOI 10.1099/00221287-143-3-739; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Pilhofer M, 2008, J BACTERIOL, V190, P3192, DOI 10.1128/JB.01797-07; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; SCHLESNER H, 1994, SYST APPL MICROBIOL, V17, P135, DOI 10.1016/S0723-2020(11)80042-1; Sherratt D, 2013, EMBO J, V32, P1208, DOI 10.1038/emboj.2013.84; Speth DR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00304; STACKEBRANDT E, 1986, FEMS MICROBIOL LETT, V37, P289, DOI 10.1016/0378-1097(86)90421-0; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; van Teeseling MCF, 2014, J BACTERIOL, V196, P80, DOI 10.1128/JB.00988-13; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Wang SCE, 2006, J BACTERIOL, V188, P1497, DOI 10.1128/JB.188.4.1497-1508.2006; Yee B, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00326	53	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91344	10.1371/journal.pone.0091344	http://dx.doi.org/10.1371/journal.pone.0091344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632833	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400055
J	Sun, L; Jin, YQ; Shen, C; Qi, H; Chu, P; Yin, QQ; Li, JQ; Tian, JL; Jiao, WW; Xiao, J; Shen, AD				Sun, Lin; Jin, Ya-qiong; Shen, Chen; Qi, Hui; Chu, Ping; Yin, Qing-qin; Li, Jie-qiong; Tian, Jian-ling; Jiao, Wei-wei; Xiao, Jing; Shen, A-dong			Genetic Contribution of CISH Promoter Polymorphisms to Susceptibility to Tuberculosis in Chinese Children	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; T-CELLS; SH2-CONTAINING PROTEIN; SOUTHEAST IRAN; SOCS PROTEINS; CYTOKINE; INTERLEUKIN-10; ASSOCIATION; INFLAMMATION; EXPRESSION	Tuberculosis (TB) is the leading cause of death due to an infectious disease worldwide, particularly in developing countries. A series of candidate genes have been suggested to be associated with development of TB disease. Among them, the human Cytokine-inducible Src homology 2(SH2) domain protein (CISH) gene has been very recently reported to be involved in T cell activation and differentiation in response to Mycobacterium tuberculosis infection. Here, we studied the association between CISH promoter polymorphisms and pediatric TB. A case-control study enrolled 352 TB patients and 527 healthy controls, who were of Han Chinese ethnicity and aged from 0.2 to 18 years. CISH gene promoter SNPs rs414171, rs622502 and rs809451 were genotyped in all subjects and transcriptional activity, mRNA level, and plasma cytokine level of subjects with different genotypes were further examined. Carriers with rs414171TT homozygotes and rs809451GC heterozygotes had a 1.78-fold (95% CI, 1.16-2.74) and 1.86-fold (95% CI, 1.26-2.74) excess risk of developing TB compared to those with wild-type genotypes. A greater risk of TB disease was observed in population carrying C-809451-T-414171-C-622502 haplotype (OR 3.66, 95% CI: 2.12-6.32). The G(-809451)-A(-414171)-C-622502-containing CISH promoter drove a 5.43-fold increased reporter expression compared to the C-809451-T-(414171)-C-622502-containing counterpart in Hela cell lines (P = 0.0009). PBMCs carrying rs414171TT homozygotes and rs809451GC heterozygotes showed a reduced CISH mRNA level compared to cells carrying wild type genotypes. Individuals with the rs414171TT genotype had significantly increased IL-12p40 and IL-10 production. In conclusion, CISH promoter rs414171 and rs809451 polymorphisms may play a vital role in mediating individual susceptibility to tuberculosis.	[Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China; Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China.	shenad16@hotmail.com	shen, chen/AAC-2458-2020; 孙, 琳/HGE-6966-2022	Jin, Yaqiong/0000-0002-9318-6531	National Natural Science Foundation of China [81201263]; Beijing Natural Science Foundation [7121007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (No. 81201263) and Beijing Natural Science Foundation (No. 7121007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Bahari G, 2013, GENET MOL RES, V12, P160, DOI 10.4238/2013.January.24.8; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Endo TA, 1997, NATURE, V387, P924; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gunsten S, 2009, IMMUNOLOGY, V126, P500, DOI 10.1111/j.1365-2567.2008.02923.x; Hanta I, 2012, BRATISL MED J, V113, P657, DOI 10.4149/BLL_2012_148; Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026; Hu YM, 2002, TXB PEDIAT, P970; Ikeda T, 2002, J LEUKOCYTE BIOL, V72, P1198; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Kouhpayeh HR, 2012, GENET MOL RES, V11, P1075, DOI 10.4238/2012.April.27.6; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; MarfaingKoka A, 1996, INT IMMUNOL, V8, P1587, DOI 10.1093/intimm/8.10.1587; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Meenakshi P, 2013, SCAND J IMMUNOL, V78, P92, DOI 10.1111/sji.12055; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nolan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059461; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067816; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tong HV, 2012, IMMUNOGENETICS, V64, P261, DOI 10.1007/s00251-011-0584-y; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uchida K, 1997, CYTOGENET CELL GENET, V78, P209, DOI 10.1159/000134658; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao L, 2013, CELL BIOCH BIOPHYS	38	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92020	10.1371/journal.pone.0092020	http://dx.doi.org/10.1371/journal.pone.0092020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632804	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400132
J	Vera, NPM; Schmidt, R; Langer, K; Zlatev, I; Wronski, R; Auer, E; Havas, D; Windisch, M; von Briesen, H; Wagner, S; Stab, J; Deutsch, M; Pietrzik, C; Fazekas, F; Ropele, S				Vera, Naira P. Martinez; Schmidt, Reinhold; Langer, Klaus; Zlatev, Iavor; Wronski, Robert; Auer, Ewald; Havas, Daniel; Windisch, Manfred; von Briesen, Hagen; Wagner, Sylvia; Stab, Julia; Deutsch, Motti; Pietrzik, Claus; Fazekas, Franz; Ropele, Stefan			Tracking of Magnetite Labeled Nanoparticles in the Rat Brain Using MRI	PLOS ONE			English	Article							SATURATION-TRANSFER CEST; IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; ENGINEERED NANOPARTICLES; ALBUMIN NANOPARTICLES; HSA-NANOPARTICLES; NERVOUS-SYSTEM; AGENTS; FLUORESCENCE; CONTRAST	This study was performed to explore the feasibility of tracing nanoparticles for drug transport in the healthy rat brain with a clinical MRI scanner. Phantom studies were performed to assess the R-1 (= 1/T-1) relaxivity of different magnetically labeled nanoparticle (MLNP) formulations that were based on biodegradable human serum albumin and that were labeled with magnetite of different size. In vivo MRI measurements in 26 rats were done at 3T to study the effect and dynamics of MLNP uptake in the rat brain and body. In the brain, MLNPs induced T-1 changes were quantitatively assessed by T-1 relaxation time mapping in vivo and compared to post-mortem results from fluorescence imaging. Following intravenous injection of MLNPs, a visible MLNP uptake was seen in the liver and spleen while no visual effect was seen in the brain. However a histogram analysis of T-1 changes in the brain demonstrated global and diffuse presence of MLNPs. The magnitude of these T-1 changes scaled with post-mortem fluorescence intensity. This study demonstrates the feasibility of tracking even small amounts of magnetite labeled NPs with a sensitive histogram technique in the brain of a living rodent.	[Vera, Naira P. Martinez; Schmidt, Reinhold; Fazekas, Franz; Ropele, Stefan] Med Univ Graz, Dept Neurol, Graz, Austria; [Langer, Klaus; Zlatev, Iavor] Univ Munster, Inst Pharmaceut Technol & Biopharm, D-48149 Munster, Germany; [Wronski, Robert; Auer, Ewald; Havas, Daniel; Windisch, Manfred] JSW Live Sci GmbH, Grambach, Austria; [von Briesen, Hagen; Wagner, Sylvia; Stab, Julia] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Germany; [Deutsch, Motti] Bar Ilan Univ, Schottenstein Ctr Res & Technol Cellome, Dept Phys, Ramat Gan, Israel; [Pietrzik, Claus] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55122 Mainz, Germany	Medical University of Graz; University of Munster; Fraunhofer Gesellschaft; Bar Ilan University; Johannes Gutenberg University of Mainz	Ropele, S (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	stefan.ropele@medunigraz.at	Schmidt, Reinhold/E-1137-2014	Langer, Klaus/0000-0002-0203-7478; Wagner, Sylvia/0000-0001-7922-977X	ERA-NET Neuron Call "Development and advancement in methods and technologies towards understanding of brain diseases"; Austrian Science Fund (FWF) [I453-B09, I454-B09]; Deutsches Bundesministerium fur Bildung und Forschung [01EW1009, 01EW1010]; Israel Ministry of Health [6694]; Austrian Science Fund (FWF) [I 453] Funding Source: researchfish	ERA-NET Neuron Call "Development and advancement in methods and technologies towards understanding of brain diseases"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsches Bundesministerium fur Bildung und Forschung; Israel Ministry of Health; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This collaborative work resulted from the NanoBrain project which was funded by the ERA-NET Neuron Call "Development and advancement in methods and technologies towards understanding of brain diseases". Grant sponsors: Austrian Science Fund (FWF): I453-B09 and I454-B09, Deutsches Bundesministerium fur Bildung und Forschung: 01EW1009 and 01EW1010, and Israel Ministry of Health: 6694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqudami A, 2007, PLASMONICS, V2, P5, DOI 10.1007/s11468-006-9019-2; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Birkl C, 2014, MAGN RESON MED, V71, P1575, DOI 10.1002/mrm.24799; Brisset JC, 2011, MOL IMAGING BIOL, V13, P672, DOI 10.1007/s11307-010-0402-1; Castelli DD, 2013, NMR BIOMED, V26, P839, DOI 10.1002/nbm.2974; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; GhoshMitra S, 2012, ADV DRUG DELIVER REV, V64, P110, DOI 10.1016/j.addr.2011.12.013; Gossuin Y, 2009, WIRES NANOMED NANOBI, V1, P299, DOI 10.1002/wnan.36; Herrmann KH, 2012, MAGN RESON MATER PHY, V25, P233, DOI 10.1007/s10334-011-0284-5; Huang J, 2012, THERANOSTICS, V2, P86, DOI 10.7150/thno.4006; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Low K, 2011, NANOMED-NANOTECHNOL, V7, P454, DOI 10.1016/j.nano.2010.12.003; Marrache S, 2013, CURR MED CHEM, V20, P3500, DOI 10.2174/0929867311320280007; McMahon MT, 2006, MAGN RESON MED, V55, P836, DOI 10.1002/mrm.20818; Naahidi S, 2013, J CONTROL RELEASE, V166, P182, DOI 10.1016/j.jconrel.2012.12.013; Pelaz B, 2013, SMALL, V9, P1573, DOI 10.1002/smll.201201229; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Re F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/7/073001; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Roohi F, 2012, INT J NANOMED, V7, P4447, DOI 10.2147/IJN.S33120; Rumenapp C, 2012, PHARM RES-DORDR, V29, P1165, DOI 10.1007/s11095-012-0711-y; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Silva GA, 2010, ANN NY ACAD SCI, V1199, P221, DOI 10.1111/j.1749-6632.2009.05361.x; Siwach OP, 2008, MATER SCI ENG B-ADV, V149, P99, DOI 10.1016/j.mseb.2007.12.007; Soesbe TC, 2013, NMR BIOMED, V26, P829, DOI 10.1002/nbm.2874; Stephen ZR, 2011, MATER TODAY, V14, P330, DOI 10.1016/S1369-7021(11)70163-8; Tu CQ, 2012, WIRES NANOMED NANOBI, V4, P448, DOI 10.1002/wnan.1170; von Storp B, 2012, J MICROENCAPSUL, V29, P138, DOI 10.3109/02652048.2011.635218; Wagner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032568; Wagner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014213; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Weber C, 2000, INT J PHARM, V211, P67, DOI 10.1016/S0378-5173(00)00590-1; Weber C, 2000, INT J PHARM, V196, P197, DOI 10.1016/S0378-5173(99)00420-2; Xu S, 2013, ADV DRUG DELIVER REV, V65, P121, DOI 10.1016/j.addr.2012.09.041; Yokel R, 2013, WIRES NANOMED NANOBI, V5, P346, DOI 10.1002/wnan.1202; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002; Zhang LJ, 2011, J MAGN RESON IMAGING, V33, P194, DOI 10.1002/jmri.22412; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	41	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92068	10.1371/journal.pone.0092068	http://dx.doi.org/10.1371/journal.pone.0092068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633006	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400139
J	Perez-Mendoza, D; Aragon, IM; Prada-Ramirez, HA; Romero-Jimenez, L; Ramos, C; Gallegos, MT; Sanjuan, J				Perez-Mendoza, Daniel; Aragon, Isabel M.; Prada-Ramirez, Harold A.; Romero-Jimenez, Lorena; Ramos, Cayo; Gallegos, Maria-Trinidad; Sanjuan, Juan			Responses to Elevated c-di-GMP Levels in Mutualistic and Pathogenic Plant-Interacting Bacteria	PLOS ONE			English	Article							SAVASTANOI PV. SAVASTANOI; GRAM-NEGATIVE BACTERIA; RHIZOBIUM-LEGUMINOSARUM; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; DIGUANYLATE CYCLASE; CELLULOSE SYNTHESIS; CYCLIC DIGUANYLATE; ESCHERICHIA-COLI; PILZ DOMAIN	Despite a recent burst of research, knowledge on c-di-GMP signaling pathways remains largely fragmentary and molecular mechanisms of regulation and even c-di-GMP targets are yet unknown for most bacteria. Besides genomics or bioinformatics, accompanying alternative approaches are necessary to reveal c-di-GMP regulation in bacteria with complex lifestyles. We have approached this study by artificially altering the c-di-GMP economy of diverse pathogenic and mutualistic plant-interacting bacteria and examining the effects on the interaction with their respective host plants. Phytopathogenic Pseudomonas and symbiotic Rhizobium strains with enhanced levels of intracellular c-di-GMP displayed common free-living responses: reduction of motility, increased production of extracellular polysaccharides and enhanced biofilm formation. Regarding the interaction with the host plants, P. savastanoi pv. savastanoi cells containing high c-di-GMP levels formed larger knots on olive plants which, however, displayed reduced necrosis. In contrast, development of disease symptoms in P. syringae-tomato or P. syringae-bean interactions did not seem significantly affected by high c-di-GMP. On the other hand, increasing c-di-GMP levels in symbiotic R. etli and R. leguminosarum strains favoured the early stages of the interaction since enhanced adhesion to plant roots, but decreased symbiotic efficiency as plant growth and nitrogen contents were reduced. Our results remark the importance of c-di-GMP economy for plant-interacting bacteria and show the usefulness of our approach to reveal particular stages during plant-bacteria associations which are sensitive to changes in c-di-GMP levels.	[Perez-Mendoza, Daniel; Prada-Ramirez, Harold A.; Romero-Jimenez, Lorena; Gallegos, Maria-Trinidad; Sanjuan, Juan] CSIC, Dpto Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain; [Aragon, Isabel M.; Ramos, Cayo] Univ Malaga, Inst Hortofruticultura Subtrop & La Mayora, IHSM, Area Genet,CSIC,UMA, E-29071 Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Sanjuan, J (corresponding author), CSIC, Dpto Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain.	juan.sanjuan@eez.csic.es	RAMOS, CAYO/G-3818-2011; MENDOZA, DANIEL PEREZ/L-9353-2014; Gallegos, María-Trinidad M.T./K-6501-2014	RAMOS, CAYO/0000-0002-2362-5041; MENDOZA, DANIEL PEREZ/0000-0001-9918-5671; Gallegos, María-Trinidad M.T./0000-0001-7633-8807; Sanjuan, Juan/0000-0002-6404-8754	Andalusian Government (Junta de Andalucia); Spanish Plan Nacional I+D+i (Ministerio de Economia y Competitividad) [BIO2011-23032, AGL2011-30343-C02-01]; Fondo Europeo de Desarrollo Regional (FEDER); FPU; FPI fellowship (Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad, Spain); JAE-Pre fellowship; JAE-doc postdoctoral contract from Consejo Superior de Investigaciones Cientificas (CSIC); Junta de Andalucia	Andalusian Government (Junta de Andalucia)(Junta de Andalucia); Spanish Plan Nacional I+D+i (Ministerio de Economia y Competitividad); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); FPU(Spanish Government); FPI fellowship (Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad, Spain); JAE-Pre fellowship; JAE-doc postdoctoral contract from Consejo Superior de Investigaciones Cientificas (CSIC); Junta de Andalucia(Junta de Andalucia)	This work was supported by grant P10-CVI-5800 from the Andalusian Government (Junta de Andalucia) and by the Spanish Plan Nacional I+D+i grants BIO2011-23032 and AGL2011-30343-C02-01 (Ministerio de Economia y Competitividad), all co-financed by Fondo Europeo de Desarrollo Regional (FEDER). IMA was supported by FPU and HPR by an FPI fellowship (Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad, Spain). LRJ was supported by JAE-Pre fellowship and DPM by a JAE-doc postdoctoral contract from Consejo Superior de Investigaciones Cientificas (CSIC, 2009-2011) and by a postdoctoral contract from Junta de Andalucia (2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; AMIKAM D, 1995, BIOCHEM J, V311, P921, DOI 10.1042/bj3110921; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Ausmees N, 1999, MICROBIOL-UK, V145, P1253, DOI 10.1099/13500872-145-5-1253; Barnhart DM, 2013, APPL ENVIRON MICROB, V79, P7188, DOI 10.1128/AEM.02148-13; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatterjee S, 2010, MOL PLANT MICROBE IN, V23, P1356, DOI 10.1094/MPMI-03-10-0057; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Edmunds AC, 2013, J BACTERIOL, V195, P2155, DOI 10.1128/JB.02068-12; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; FETT WF, 1989, PLANT PHYSIOL, V89, P5, DOI 10.1104/pp.89.1.5; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hosni T, 2011, ISME J, V5, P1857, DOI 10.1038/ismej.2011.65; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Laus MC, 2005, MOL PLANT MICROBE IN, V18, P533, DOI 10.1094/MPMI-18-0533; LEYVA A, 1987, J BACTERIOL, V169, P4929, DOI 10.1128/jb.169.11.4929-4934.1987; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matas IM, 2012, NEW PHYTOL, V196, P1182, DOI 10.1111/j.1469-8137.2012.04357.x; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; MAY TB, 1994, METHOD ENZYMOL, V235, P295; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Moretti C, 2008, PSEUDOMONAS SYRINGAE, P321; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Penyalver R, 2006, PHYTOPATHOLOGY, V96, P313, DOI 10.1094/PHYTO-96-0313; Perez-Martinez I, 2007, RES MICROBIOL, V158, P60, DOI 10.1016/j.resmic.2006.09.008; Perez-Mendoza D, 2005, J BACTERIOL, V187, P7341, DOI 10.1128/JB.187.21.7341-7350.2005; Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0; Perez-Mendoza D, 2011, MOL MICROBIOL, V82, P719, DOI 10.1111/j.1365-2958.2011.07849.x; QUINTO C, 1985, P NATL ACAD SCI USA, V82, P1170, DOI 10.1073/pnas.82.4.1170; RIGAUD J, 1975, J GEN MICROBIOL, V88, P223, DOI 10.1099/00221287-88-2-223; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Robertson M, 2013, ANTON LEEUW INT J G, V103, P251, DOI 10.1007/s10482-012-9796-x; Rodriguez-Moreno L, 2008, PHYTOPATHOLOGY, V98, P815, DOI 10.1094/PHYTO-98-7-0815; Rodriguez-Moreno L, 2009, MICROB BIOTECHNOL, V2, P476, DOI 10.1111/j.1751-7915.2009.00101.x; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMIT G, 1987, J BACTERIOL, V169, P4294, DOI 10.1128/jb.169.9.4294-4301.1987; Soto MJ, 2002, MOL MICROBIOL, V43, P371, DOI 10.1046/j.1365-2958.2002.02749.x; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Taylor JD, 1996, PLANT PATHOL, V45, P469, DOI 10.1046/j.1365-3059.1996.d01-147.x; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; Vargas P, 2011, MOL PLANT MICROBE IN, V24, P1207, DOI 10.1094/MPMI-03-11-0077; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Williams A, 2008, J BACTERIOL, V190, P4706, DOI 10.1128/JB.01694-07; Xu J, 2013, MOL MICROBIOL, V89, P929, DOI 10.1111/mmi.12321; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yu J, 1999, MOL MICROBIOL, V33, P712, DOI 10.1046/j.1365-2958.1999.01516.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	82	46	48	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91645	10.1371/journal.pone.0091645	http://dx.doi.org/10.1371/journal.pone.0091645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626229	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300112
J	Puron-Sierra, L; Miranda, MI				Puron-Sierra, Liliana; Isabel Miranda, Maria			Histaminergic Modulation of Cholinergic Release from the Nucleus Basalis Magnocellularis into Insular Cortex during Taste Aversive Memory Formation	PLOS ONE			English	Article							CORTICAL ACETYLCHOLINE-RELEASE; DUAL-PROBE MICRODIALYSIS; H-3 RECEPTOR INHIBITION; K+-EVOKED RELEASE; ENHANCES ACETYLCHOLINE; AUDITORY-CORTEX; FRONTAL-CORTEX; SPATIAL MEMORY; DIAGONAL BAND; MEDIAL SEPTUM	The ability of acetylcholine (ACh) to alter specific functional properties of the cortex endows the cholinergic system with an important modulatory role in memory formation. For example, an increase in ACh release occurs during novel stimulus processing, indicating that ACh activity is critical during early stages of memory processing. During novel taste presentation, there is an increase in ACh release in the insular cortex (IC), a major structure for taste memory recognition. There is extensive evidence implicating the cholinergic efferents of the nucleus basalis magnocellularis (NBM) in cortical activity changes during learning processes, and new evidence suggests that the histaminergic system may interact with the cholinergic system in important ways. However, there is little information as to whether changes in cholinergic activity in the IC are modulated during taste memory formation. Therefore, in the present study, we evaluated the influence of two histamine receptor subtypes, H-1 in the NBM and H-3 in the IC, on ACh release in the IC during conditioned taste aversion (CTA). Injection of the H-3 receptor agonist R-alpha-methylhistamine (RAMH) into the IC or of the H-1 receptor antagonist pyrilamine into the NBM during CTA training impaired subsequent CTA memory, and simultaneously resulted in a reduction of ACh release in the IC. This study demonstrated that basal and cortical cholinergic pathways are finely tuned by histaminergic activity during CTA, since dual actions of histamine receptor subtypes on ACh modulation release each have a significant impact during taste memory formation.	[Puron-Sierra, Liliana; Isabel Miranda, Maria] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Qro, Mexico	Universidad Nacional Autonoma de Mexico	Miranda, MI (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Qro, Mexico.	mirandami@unam.mx	Miranda, María-Isabel I/G-8210-2014	Miranda, María-Isabel I/0000-0003-1823-2152	CONACYT [152208, 208245]; PAPPIT [IN220991]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPPIT	Funding provided by grants: CONACYT 152208, PAPPIT IN220991. This work was carried out in partial fulfillment of requirements to obtain the Doctoral Degree (Doctorado en Ciencias Biomedicas, UNAM) at the Instituto de Neurobiologia, UNAM), by Liliana Puron Sierra, who received a Graduate Scholarship 208245 from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; ARRANG JM, 1995, ANN NY ACAD SCI, V757, P314, DOI 10.1111/j.1749-6632.1995.tb17489.x; ARRANG JM, 1995, BRIT J PHARMACOL, V114, P1518, DOI 10.1111/j.1476-5381.1995.tb13379.x; Bacciottini L, 2002, EUR J NEUROSCI, V15, P1669, DOI 10.1046/j.1460-9568.2002.02005.x; Bacciottini L, 2001, BEHAV BRAIN RES, V124, P183, DOI 10.1016/S0166-4328(01)00230-3; Baldi E, 2008, NEUROBIOL LEARN MEM; BARTUS RT, 1985, ANN NY ACAD SCI, V444, P332, DOI 10.1111/j.1749-6632.1985.tb37600.x; Benetti F., 2013, INT J NEUROPSYCHOPH, P1; Benetti F, 2012, INT J NEUROPSYCHOPH, P1; Benetti F, 2013, INT J NEUROPSYCHOPH, V16, P575, DOI 10.1017/S1461145712000181; Benetti F, 2012, NEUROBIOL LEARN MEM, V97, P54, DOI 10.1016/j.nlm.2011.09.004; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Blandina P, 1996, INFLAMM RES, V45, pS54, DOI 10.1007/BF03354086; Blandina P, 1996, BRIT J PHARMACOL, V119, P1656, DOI 10.1111/j.1476-5381.1996.tb16086.x; Blandina P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00033; Brabant C, 2013, BEHAV BRAIN RES, V243, P199, DOI 10.1016/j.bbr.2012.12.063; Bures J, 1998, CONDITIONED TASTE AV; Cangioli I, 2002, EUR J NEUROSCI, V16, P521, DOI 10.1046/j.1460-9568.2002.02092.x; Cecchi M, 1998, INFLAMM RES, V47, pS32; Cecchi M, 2001, EUR J NEUROSCI, V13, P68, DOI 10.1046/j.1460-9568.2001.01361.x; Clark EW, 2009, BEHAV NEUROSCI, V123, P764, DOI 10.1037/a0016398; DEALMEIDA MAMR, 1986, ARCH INT PHARMACOD T, V283, P193; DEALMEIDA MAMR, 1988, ARCH INT PHARMACOD T, V291, P202; Dere E, 2010, BEHAV BRAIN RES, V215, P209, DOI 10.1016/j.bbr.2009.12.045; Douchamps V, 2013, J NEUROSCI, V33, P8689, DOI 10.1523/JNEUROSCI.4483-12.2013; Esbenshade TA, 2012, J PHARMACOL EXP THER, V343, P233, DOI 10.1124/jpet.112.194126; FIBIGER HC, 1991, ADV EXP MED BIOL, V295, P399; FLICKER C, 1983, PHARMACOL BIOCHEM BE, V18, P973, DOI 10.1016/S0091-3057(83)80023-9; Gianlorenco ACL, 2011, BRAIN RES BULL, V86, P134, DOI 10.1016/j.brainresbull.2011.05.014; Giannoni P, 2012, J PHARMACOL EXP THER, V332, P164; Giannoni P, 2009, EUR J NEUROSCI, V29, P2363, DOI 10.1111/j.1460-9568.2009.06765.x; Giorgetti M, 1997, INFLAMM RES, V46, pS33, DOI 10.1007/s000110050044; Giovannini MG, 1998, J PHARMACOL EXP THER, V285, P1219; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Gutierrez R, 2003, NEUROBIOL LEARN MEM, V80, P323, DOI 10.1016/S1074-7427(03)00066-2; HAGAN JJ, 1988, BEHAV BRAIN RES, V27, P9, DOI 10.1016/0166-4328(88)90105-2; Hasselmo M E, 1999, Prog Brain Res, V121, P3; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; HASSELMO ME, 1995, J NEUROSCI, V15, P6592; Hasselmo ME, 2002, NEURAL NETWORKS, V15, P689, DOI 10.1016/S0893-6080(02)00057-6; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Heys JG, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00032; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; KHATEB A, 1995, NEUROSCIENCE, V69, P495, DOI 10.1016/0306-4522(95)00264-J; Kohler CA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/328602; Kruk M, 2012, PHARMACOL REP, V64, P1316, DOI 10.1016/S1734-1140(12)70929-5; Lin JS, 2011, J PHARMACOL EXP THER, V336, P17, DOI 10.1124/jpet.110.170134; LOPEZGARCIA JC, 1993, PHARMACOL BIOCHEM BE, V45, P147; McGaugh JL, 1997, BEHAV BRAIN RES, V83, P31, DOI 10.1016/S0166-4328(97)86042-1; Miranda MI, 1999, P NATL ACAD SCI USA, V96, P6478, DOI 10.1073/pnas.96.11.6478; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; Miranda MI, 2002, P NATL ACAD SCI USA, V99, P11417, DOI 10.1073/pnas.182200499; Miranda MI, 1998, BRAIN RES PROTOC, V2, P215, DOI 10.1016/S1385-299X(97)00046-9; Miranda MI, 2000, BRAIN RES, V882, P230, DOI 10.1016/S0926-6410(00)00050-1; Montero-Pastor A, 2001, BRAIN RES, V900, P337, DOI 10.1016/S0006-8993(01)02325-3; Moron I, 2002, BEHAV BRAIN RES, V134, P425, DOI 10.1016/S0166-4328(02)00056-6; Munari L, 2013, NEUROPHARMACOLOGY, V70, P131, DOI 10.1016/j.neuropharm.2013.01.021; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; ONODERA K, 1994, PROG NEUROBIOL, V42, P685, DOI 10.1016/0301-0082(94)90017-5; Orsetti M, 1996, BRAIN RES, V724, P89, DOI 10.1016/0006-8993(96)00292-2; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Passani MB, 2007, BIOCHEM PHARMACOL, V73, P1113, DOI 10.1016/j.bcp.2006.12.002; Passani MB, 2011, J PHARMACOL EXP THER, V336, P24, DOI 10.1124/jpet.110.171306; Passani MB, 2000, NEUROSCI BIOBEHAV R, V24, P107, DOI 10.1016/S0149-7634(99)00053-6; Paxinos G., 2004, J CHEM INF MODEL, V5th; Power AE, 2004, CURR MED CHEM, V11, P987, DOI 10.2174/0929867043455558; Privou C, 1998, NEUROPHARMACOLOGY, V37, P1019, DOI 10.1016/S0028-3908(98)00087-2; Privou C, 1999, NEUROBIOL LEARN MEM, V71, P308, DOI 10.1006/nlme.1998.3885; Puron-Sierra L, 2010, NEUROBIOL LEARN MEM, V93, P216, DOI 10.1016/j.nlm.2009.10.001; Raddatz R, 2010, CURR TOP MED CHEM, V10, P153, DOI 10.2174/156802610790411027; Rasmusson AM, 2000, BIOL PSYCHIAT, V47, P526, DOI 10.1016/S0006-3223(99)00185-7; Robinson L, 2011, BEHAV BRAIN RES, V221, P443, DOI 10.1016/j.bbr.2011.01.055; Rokem A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00066; Savage LM, 2012, BEHAV NEUROSCI, V126, P226, DOI 10.1037/a0027257; Silva MAD, 2013, P NATL ACAD SCI USA, V110, P15097, DOI 10.1073/pnas.1306884110; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787; Weinberger NM, 1998, SCIENCE, V280, P1174; Zlomuzica A, 2009, BRIT J PHARMACOL, V157, P86, DOI 10.1111/j.1476-5381.2009.00225.x	83	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91120	10.1371/journal.pone.0091120	http://dx.doi.org/10.1371/journal.pone.0091120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625748	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300057
J	Smithson, C; Purdy, A; Verster, AJ; Upton, C				Smithson, Chad; Purdy, Alex; Verster, Adrian J.; Upton, Chris			Prediction of Steps in the Evolution of Variola Virus Host Range	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; ECTROMELIA-VIRUS; CAUSATIVE AGENT; DNA-SEQUENCES; MYXOMA VIRUS; PROTEIN; LOCALIZATION; RESISTANT; ALIGNMENT; SMALLPOX	Variola virus, the agent of smallpox, has a severely restricted host range (humans) but a devastatingly high mortality rate. Although smallpox has been eradicated by a World Health Organization vaccination program, knowledge of the evolutionary processes by which human super-pathogens such as variola virus arise is important. By analyzing the evolution of variola and other closely related poxviruses at the level of single nucleotide polymorphisms we detected a hotspot of genome variation within the smallpox ortholog of the vaccinia virus O1L gene, which is known to be necessary for efficient replication of vaccinia virus in human cells. These mutations in the variola virus ortholog and the subsequent loss of the functional gene from camelpox virus and taterapox virus, the two closest relatives of variola virus, strongly suggest that changes within this region of the genome may have played a key role in the switch to humans as a host for the ancestral virus and the subsequent host-range restriction that must have occurred to create the phenotype exhibited by smallpox.	[Smithson, Chad; Purdy, Alex; Upton, Chris] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Verster, Adrian J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Victoria; University of Toronto	Upton, C (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	cupton@uvic.ca		Upton, Chris/0000-0002-9019-8967	Natural Sciences and Engineering Research Council [155125]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council Discovery Grant to CU (#155125; www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2006, J VIROL, V80, P4978, DOI 10.1128/JVI.80.10.4978-4991.2006; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Babkin IV, 2012, INFECT GENET EVOL, V12, P1597, DOI 10.1016/j.meegid.2012.07.011; Best SM, 2000, VIROLOGY, V277, P76, DOI 10.1006/viro.2000.0505; Brodie R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-96; Brunetti CR, 2003, J VIROL, V77, P13335, DOI 10.1128/JVI.77.24.13335-13347.2003; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Camus-Bouclainville C, 2011, EMERG INFECT DIS, V17, P633, DOI 10.3201/eid1704.101146; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cottingham MG, 2013, VACCINE, V31, P4247, DOI 10.1016/j.vaccine.2013.03.021; Coulson D, 2011, VIRUS GENES, V42, P171, DOI 10.1007/s11262-010-0560-x; Cresawn SG, 2007, VIROLOGY, V363, P319, DOI 10.1016/j.virol.2007.02.005; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Esteban DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-261; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Hendrickson RC, 2010, VIRUSES-BASEL, V2, P1933, DOI 10.3390/v2091933; Hillary William, 2011, Microb Inform Exp, V1, P2, DOI 10.1186/2042-5783-1-2; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Johnston SC, 2009, J VIROL, V83, P1708, DOI 10.1128/JVI.01364-08; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kerr PJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002950; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Kerr PJ, 1998, REV SCI TECH OIE, V17, P256, DOI 10.20506/rst.17.1.1081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HJ, 2001, VIROLOGY, V281, P170, DOI 10.1006/viro.2000.0761; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McFadden G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000727; Morales M, 2009, J VIROL, V83, P2397, DOI 10.1128/JVI.02189-08; Morgan GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000785; Nazarian SH, 2007, VIRUS RES, V129, P11, DOI 10.1016/j.virusres.2007.05.001; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Postigo A, 2009, CELL MICROBIOL, V11, P1208, DOI 10.1111/j.1462-5822.2009.01327.x; Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11; ROSEL J, 1985, J VIROL, V56, P830, DOI 10.1128/JVI.56.3.830-838.1985; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Schweneker M, 2012, J VIROL, V86, P2323, DOI 10.1128/JVI.06166-11; Shchelkunov SN, 2011, VACCINE, V29, pD49, DOI 10.1016/j.vaccine.2011.05.037; Sleator RD, 2011, ARCH MICROBIOL, V193, P235, DOI 10.1007/s00203-011-0677-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yadav VN, 2012, J IMMUNOL, V189, P1431, DOI 10.4049/jimmunol.1200946; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	48	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91520	10.1371/journal.pone.0091520	http://dx.doi.org/10.1371/journal.pone.0091520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626337	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300097
J	van Loon, JE; Sonneveld, MAH; Praet, SFE; de Maat, MPM; Leebeek, FWG				van Loon, Janine E.; Sonneveld, Michelle A. H.; Praet, Stephan F. E.; de Maat, Moniek P. M.; Leebeek, Frank W. G.			Performance Related Factors Are the Main Determinants of the von Willebrand Factor Response to Exhaustive Physical Exercise	PLOS ONE			English	Article							ABO BLOOD-GROUP; SINGLE-NUCLEOTIDE POLYMORPHISM; VONWILLEBRAND-FACTOR; FACTOR-VIII; CARDIOVASCULAR-DISEASE; PLATELET ACTIVATION; MAXIMAL EXERCISE; GENE PROMOTER; PLASMA-LEVELS; RISK	Background: Physical stress triggers the endothelium to release von Willebrand Factor (VWF) from the Weibel Palade bodies. Since VWF is a risk factor for arterial thrombosis, it is of great interest to discover determinants of VWF response to physical stress. We aimed to determine the main mediators of the VWF increase by exhaustive physical exercise. Methods: 105 healthy individuals (18-35 years) were included in this study. Each participant performed an incremental exhaustive exercise test on a cycle ergometer. Respiratory gas exchange measurements were obtained while cardiac function was continuously monitored. Blood was collected at baseline and directly after exhaustion. VWF antigen (VWF:Ag) levels, VWF collagen binding (VWF:CB) levels, ADAMTS13 activity and common variations in Syntaxin Binding Protein-5 (STXBP5, rs1039084 and rs9399599), Syntaxin-2 (STX2, rs7978987) and VWF (promoter, rs7965413) were determined. Results: The median VWF:Ag level at baseline was 0.94 IU/mL [IQR 0.8-1.1] and increased with 47% [IQR 25-73] after exhaustive exercise to a median maximum VWF:Ag of 1.38 IU/mL [IQR 1.1-1.8] (p<0.0001). VWF:CB levels and ADAMTS13 activity both also increased after exhaustive exercise (median increase 43% and 12%, both p<0.0001). The strongest determinants of the VWF:Ag level increase are performance related (p<0.0001). We observed a gender difference in VWF:Ag response to exercise (females 1.2 IU/mL; males 1.7 IU/mL, p = 0.001), which was associated by a difference in performance. Genetic variations in STXBP5, STX2 and the VWF promoter were not associated with VWF:Ag levels at baseline nor with the VWF:Ag increase. Conclusions:VWF:Ag levels strongly increase upon exhaustive exercise and this increase is strongly determined by physical fitness level and the intensity of the exercise, while there is no clear effect of genetic variation in STXBP5, STX2 and the VWF promoter.	[van Loon, Janine E.; Sonneveld, Michelle A. H.; de Maat, Moniek P. M.; Leebeek, Frank W. G.] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands; [Sonneveld, Michelle A. H.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Praet, Stephan F. E.] Erasmus Univ, Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Leebeek, FWG (corresponding author), Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands.	leebeek@erasmusmc.nl			Dutch Thrombosis Foundation	Dutch Thrombosis Foundation	This work was supported by a grant of the Dutch Thrombosis Foundation (2010-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bladbjerg EM, 2006, J THROMB HAEMOST, V4, P599, DOI 10.1111/j.1538-7836.2005.01778.x; Casonato A, 2008, BRIT J HAEMATOL, V140, P230, DOI 10.1111/j.1365-2141.2007.06907.x; Claus RA, 2006, J THROMB HAEMOST, V4, P902, DOI 10.1111/j.1538-7836.2006.01837.x; Creighton BC, 2013, EUR J APPL PHYSIOL, V113, P2203, DOI 10.1007/s00421-013-2645-4; Daidone V, 2009, THROMB HAEMOSTASIS, V101, P298, DOI 10.1160/TH08-08-0501; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Delp MD, 2004, J APPL PHYSIOL, V97, P1112, DOI 10.1152/japplphysiol.00147.2003; El-Sayed MS, 2000, MED SCI SPORT EXER, V32, P918; ElSayed MS, 1995, BLOOD COAGUL FIBRIN, V6, P747, DOI 10.1097/00001721-199512000-00009; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; HANSEN JB, 1990, THROMB HAEMOSTASIS, V64, P385; Harvey PJ, 2000, BRIT J HAEMATOL, V109, P349, DOI 10.1046/j.1365-2141.2000.02000.x; Hickson N, 2011, J THROMB HAEMOST, V9, P603, DOI 10.1111/j.1538-7836.2010.04161.x; Hollestelle MJ, 2001, THROMB HAEMOSTASIS, V86, P855, DOI 10.1055/s-0037-1616143; Kanaji S, 2012, J THROMB HAEMOST, V10, P1646, DOI 10.1111/j.1538-7836.2012.04797.x; Keightley AM, 1999, BLOOD, V93, P4277, DOI 10.1182/blood.V93.12.4277.412k03_4277_4283; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Lethagen S, 2008, THROMB HAEMOSTASIS, V99, P1013, DOI 10.1160/TH07-06-0419; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Lippi G, 2005, BLOOD COAGUL FIBRIN, V16, P533, DOI 10.1097/01.mbc.0000183117.66605.a3; Lippi G, 2009, SEMIN THROMB HEMOST, V35, P269, DOI 10.1055/s-0029-1222605; Martinelli I, 2005, SEMIN HEMATOL, V42, P49, DOI 10.1053/j.seminhematol.2004.09.009; MAYADAS T, 1989, BLOOD, V73, P706; Middeldorp Saskia, 2005, Gend Med, V2 Suppl A, pS3, DOI 10.1016/S1550-8579(05)80059-2; MYERS J, 1990, J APPL PHYSIOL, V68, P404, DOI 10.1152/jappl.1990.68.1.404; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Reiter RA, 2003, BLOOD, V101, P946, DOI 10.1182/blood-2002-03-0814; Ribeiro J, 2007, J SCI MED SPORT, V10, P164, DOI 10.1016/j.jsams.2006.06.001; Ribeiro JL, 2008, CLIN APPL THROMB-HEM, V14, P454, DOI 10.1177/1076029607305530; Rock G, 1997, CLIN J SPORT MED, V7, P94, DOI 10.1097/00042752-199704000-00004; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SMALL M, 1984, HAEMOSTASIS, V14, P262; Smith NL, 2011, BLOOD, V117, P6007, DOI 10.1182/blood-2010-10-315473; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2003, THROMB HAEMOSTASIS, V89, P468; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Stakiw J, 2008, J THROMB HAEMOST, V6, P90; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; van Loon JE, 2010, CIRC-CARDIOVASC GENE, V3, P507, DOI 10.1161/CIRCGENETICS.110.957407; van Schie MC, 2011, J THROMB HAEMOST, V9, P899, DOI 10.1111/j.1538-7836.2011.04243.x; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Weber CT, 1986, CARDIOPULMONARY EXER; WHINCUP PH, 1990, BMJ-BRIT MED J, V300, P1679, DOI 10.1136/bmj.300.6741.1679; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Wieberdink RG, 2010, STROKE, V41, P2151, DOI 10.1161/STROKEAHA.110.586289; Wu O, 2008, J THROMB HAEMOST, V6, P62; ZHANG YY, 1991, MED SCI SPORT EXER, V23, P625	51	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91687	10.1371/journal.pone.0091687	http://dx.doi.org/10.1371/journal.pone.0091687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626470	Green Published, gold			2022-12-25	WOS:000332851300121
J	Waters, PS; Dwyer, RM; Brougham, C; Glynn, CL; Wall, D; Hyland, P; Duignan, M; McLoughlin, M; Newell, J; Kerin, MJ				Waters, Peadar S.; Dwyer, Roisin M.; Brougham, Cathy; Glynn, Claire L.; Wall, Deirdre; Hyland, Peter; Duignan, Maria; McLoughlin, Mark; Newell, John; Kerin, Michael J.			Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients	PLOS ONE			English	Article							DOWN-REGULATION; EXPRESSION; MARKERS; SERUM; RECOMMENDATIONS; BIOMARKERS; DIAGNOSIS; TISSUES	While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breast cancer, little is known about the relationship between circulating levels and tumour characteristics. The aim of this study was to analyse alterations in circulating miRNA expression during tumour progression in a murine model of breast cancer, and to detemine the clinical relevance of identified miRNAs at both tissue and circulating level in patient samples. Athymic nude mice received a subcutaneous or mammary fat pad injection of MDA-MB-231 cells. Blood sampling was performed at weeks 1, 3 and 6 following tumour induction, and microRNA extracted. MicroRNA microArray analysis was performed comparing samples harvested at week 1 to those collected at week 6 from the same animals. Significantly altered miRNAs were validated across all murine samples by RQ-PCR (n = 45). Three miRNAs of interest were then quantified in the circulation(n = 166) and tissue (n = 100) of breast cancer patients and healthy control individuals. MicroArray-based analysis of murine blood samples revealed levels of 77 circulating microRNAs to be changed during disease progression, with 44 demonstrating changes >2-fold. Validation across all samples revealed miR-138 to be significantly elevated in the circulation of animals during disease development, with miR-191 and miR-106a levels significantly decreased. Analysis of patient tissue and blood samples revealed miR-138 to be significantly up-regulated in the circulation of patients with breast cancer, with no change observed in the tissue setting. While not significantly changed overall in breast cancer patients compared to controls, circulating miR-106a and miR-191 were significantly decreased in patients with basal breast cancer. In tissue, both miRNAs were significantly elevated in breast cancer compared to normal breast tissue. The data demonstrates an impact of tumour epithelial subtype on circulating levels of miRNAs, and highlights divergent miRNA profiles between tissue and blood samples from breast cancer patients.	[Waters, Peadar S.; Dwyer, Roisin M.; Brougham, Cathy; Glynn, Claire L.; Hyland, Peter; Duignan, Maria; McLoughlin, Mark; Kerin, Michael J.] Natl Univ Ireland Galway, Sch Med, Discipline Surg, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Galway, HRB Clin Res Facil, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Galway, Sch Math Stat & Appl Math, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Dwyer, RM (corresponding author), Natl Univ Ireland Galway, Sch Med, Discipline Surg, Galway, Ireland.	roisin.dwyer@nuigalway.ie	Dwyer, Roisin M/C-6654-2013	Dwyer, Roisin M/0000-0002-5854-0339; Wall, Deirdre/0000-0001-6510-6082; GLYNN, CLAIRE/0000-0002-1846-2858; Kerin, Michael/0000-0003-4164-5561; Newell, John/0000-0001-7685-6655	National Breast Cancer Research Institute	National Breast Cancer Research Institute	This study was funded by the National Breast Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Feldman ED, 2012, CLIN OBSTET GYNECOL, V55, P662, DOI 10.1097/GRF.0b013e31825ca884; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Lee YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052979; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Mar-Aguilar F, 2013, ASIA-PAC J CLIN ONCO, V9, P53, DOI 10.1111/j.1743-7563.2012.01548.x; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Nagpal N, 2013, CARCINOGENESIS; Ravert PK, 2010, J AM ACAD NURSE PRAC, V22, P668, DOI 10.1111/j.1745-7599.2010.00564.x; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sturgeon CM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3527; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang Y, 2013, FEBS LETT, V587, P3069, DOI 10.1016/j.febslet.2013.06.058	30	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90605	10.1371/journal.pone.0090605	http://dx.doi.org/10.1371/journal.pone.0090605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626163	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300027
J	Zhang, XY; Li, CX; Gong, ZY				Zhang, Xiaoyan; Li, Caixia; Gong, Zhiyuan			Development of a Convenient In Vivo Hepatotoxin Assay Using a Transgenic Zebrafish Line with Liver-Specific DsRed Expression	PLOS ONE			English	Article							OXIDATIVE STRESS; N-NITROSODIMETHYLAMINE; LINDANE TOXICITY; RAT HEPATOCYTES; DRINKING-WATER; DANIO-RERIO; INJURY; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; MODELS; CELLS	Previously we have developed a transgenic zebrafish line (LiPan) with liver-specific red fluorescent protein (DsRed) expression under the fabp10a promoter. Since red fluorescence in the liver greatly facilitates the observation of liver in live LiPan fry, we envision that the LiPan zebrafish may provide a useful tool in analyses of hepatotoxicity based on changes of liver red fluorescence intensity and size. In this study, we first tested four well-established hepatotoxins (acetaminophen, aspirin, isoniazid and phenylbutazone) in LiPan fry and demonstrated that these hepatotoxins could significantly reduce both liver red fluorescence and liver size in a dosage-dependent manner, thus the two measurable parameters could be used as indicators of hepatotoxicity. We then tested the LiPan fry with nine other chemicals including environmental toxicants and human drugs. Three (mefenamic acid, lindane, and arsenate) behave like hepatotoxins in reduction of liver red fluorescence, while three others (17 beta-estradiol, TCDD [2,3,7,8-tetrachlorodibenzo-p-dioxin] and NDMA [N-nitrosodimethylamine]) caused increase of liver red fluorescence and the liver size. Ethanol and two other chemicals, amoxicillin (antibiotics) and chlorphenamine (pain killer) did not resulted in significant changes of liver red fluorescence and liver size. By quantitative RT-PCR analysis, we found that the changes of red fluorescence intensity caused by different chemicals correlated to the changes of endogenous fabp10a RNA expression, indicating that the measured hepatotoxicity was related to fatty acid transportation and metabolism. Finally we tested a mixture of four hepatotoxins and observed a significant reduction of red fluorescence in the liver at concentrations below the lowest effective concentrations of individual hepatotoxins, suggesting that the transgenic zebrafish assay is capable of reporting compound hepatotoxicity effect from chemical mixtures. Thus, the LiPan transgenic fry provide a rapid and convenient in vivo hepatotoxicity assay that should be applicable to high-throughput hepatotoxicity test in drug screening as well as in biomonitoring environmental toxicants.	[Zhang, Xiaoyan; Li, Caixia; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Li, Caixia/0000-0003-2190-655X	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JA, 2011, EXPERT OPIN DRUG MET, V7, P817, DOI 10.1517/17425255.2011.574613; Aithal GP, 2011, NAT REV RHEUMATOL, V7, P139, DOI 10.1038/nrrheum.2010.214; Aronson JK., 2008, MEYLERS SIDE EFFECTS; Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001; Bhadauria S, 2007, CELL MOL BIOL, V53, P102, DOI 10.1170/T781; Bhadauria S, 2010, TOXICOL MECH METHOD, V20, P242, DOI 10.3109/15376511003793325; Bioulac-Sage P, 2008, HEPATOL INT, V2, P316, DOI 10.1007/s12072-008-9075-0; BOLL M, 1995, Z NATURFORSCH C, V50, P135; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlson P, 2013, AQUAT TOXICOL; Carlson P, 2013, TOXICOL SCI, V134, P83, DOI 10.1093/toxsci/kft086; Cheng TJ, 2011, TOXICOL APPL PHARM, V256, P146, DOI 10.1016/j.taap.2011.08.001; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; Greenhough S., 2012, Pharmaceutical Medicine, V26, P85; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Hill A, 2012, DRUG METAB REV, V44, P127, DOI 10.3109/03602532.2011.645578; Huang XQ, 2012, FUTURE ONCOL, V8, P21, DOI [10.2217/FON.11.137, 10.2217/fon.11.137]; Hussaini SH, 2007, EXPERT OPIN DRUG SAF, V6, P673, DOI 10.1517/14740338.6.6.673; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Kanungo J, 2011, NEUROTOXICOL TERATOL, V33, P618, DOI 10.1016/j.ntt.2011.08.013; Kasap E, 2012, EXP THER MED, V4, P33, DOI 10.3892/etm.2012.561; Katz J., 2005, ESSENTIALS PAIN MED, P141; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lewis JH, 2007, DRUG INDUCED LIVER D, P440; Liteplo RG, 2001, J ENVIRON SCI HEAL C, V19, P281, DOI 10.1081/GNC-100103588; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Matsumura F, 1997, BIOCHEM PHARMACOL, V53, P1397, DOI 10.1016/S0006-2952(97)00036-1; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Minigh J., 2008, XPHARM COMPREHENSIVE, P1; Mizgireuv IV, 2004, TOXICOL PATHOL, V32, P514, DOI 10.1080/01926230490496311; Mrema EJ, 2013, TOXICOLOGY, V307, P74, DOI 10.1016/j.tox.2012.11.015; Nadanaciva S, 2013, TOXICOL APPL PHARM, V272, P272, DOI 10.1016/j.taap.2013.06.019; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; Niemela O, 2010, SCAND J CLIN LAB INV, V70, P305, DOI 10.3109/00365513.2010.486442; Nolan K, 2012, PEDIATR DERMATOL, V29, P141, DOI 10.1111/j.1525-1470.2011.01519.x; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; Okada M, 2010, INT J MOL SCI, V11, P4114, DOI 10.3390/ijms11104114; Padma VV, 2011, FOOD CHEM TOXICOL, V49, P991, DOI 10.1016/j.fct.2011.01.005; Patlolla AK, 2012, MICROCHEM J, V105, P101, DOI 10.1016/j.microc.2012.08.013; Radosavljevic T, 2009, HUM EXP TOXICOL, V28, P747, DOI 10.1177/0960327109353055; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Roth RA, 2011, CRIT REV TOXICOL, V41, P723, DOI 10.3109/10408444.2011.575765; Singh Amrit Pal, 2011, Toxicol Int, V18, P87, DOI 10.4103/0971-6580.84258; Soma LR, 2012, J VET PHARMACOL THER, V35, P1, DOI 10.1111/j.1365-2885.2011.01299.x; Somchit N., 2004, SMJ Singapore Medical Journal, V45, P530; Storch J, 2002, MOL CELL BIOCHEM, V239, P25, DOI 10.1023/A:1020546321508; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Tafazoli S, 2005, DRUG METAB REV, V37, P311, DOI 10.1081/DMR-200055227; Tolman Keith G., 1998, American Journal of Medicine, V105, p13S, DOI 10.1016/S0002-9343(98)00070-9; Tolosa L, 2013, ARCH TOXICOL, V87, P1115, DOI 10.1007/s00204-013-1012-x; TOMATIS L, 1964, J NATL CANCER I, V33, P341; Ung CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027819; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Wauson EM, 2002, TOXICOL SCI, V65, P211, DOI 10.1093/toxsci/65.2.211; WEBER LWD, 1995, TOXICOL APPL PHARM, V131, P155, DOI 10.1006/taap.1995.1057; Weger BD, 2013, CHEM SCREENING PROCE; Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969; Zhang M, 2003, DIGEST DIS SCI, V48, P926, DOI 10.1023/A:1023003730138; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055474; Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0; ZIMMERMAN HJ, 1993, DM-DIS MON, V39, P678; Zimmerman HJ, 1999, HEPATOTOXICITY ADVER, P126; Zucchini-Pascal N, 2011, FOOD CHEM TOXICOL, V49, P3128, DOI 10.1016/j.fct.2011.09.033	71	35	39	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91874	10.1371/journal.pone.0091874	http://dx.doi.org/10.1371/journal.pone.0091874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626481	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300143
J	Breton, A; Jerbi, K; Henaff, MA; Cheylus, A; Baudouin, JY; Schmitz, C; Krolak-Salmon, P; Van der Henst, JB				Breton, Audrey; Jerbi, Karim; Henaff, Marie-Anne; Cheylus, Anne; Baudouin, Jean-Yves; Schmitz, Christina; Krolak-Salmon, Pierre; Van der Henst, Jean-Baptiste			Face the Hierarchy: ERP and Oscillatory Brain Responses in Social Rank Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; TIME-COURSE; EARLY-STAGE; PERCEPTION; RACE; FAMILIARITY; GENDER; DOMINANCE	Recognition of social hierarchy is a key feature that helps us navigate through our complex social environment. Neuroimaging studies have identified brain structures involved in the processing of hierarchical stimuli but the precise temporal dynamics of brain activity associated with such processing remains largely unknown. Here, we used electroencephalography to examine the effect of social hierarchy on neural responses elicited by faces. In contrast to previous studies, the key manipulation was that a hierarchical context was constructed, not by varying facial expressions, but by presenting neutral-expression faces in a game setting. Once the performance-based hierarchy was established, participants were presented with high-rank, middle-rank and low-rank player faces and had to evaluate the rank of each face with respect to their own position. Both event-related potentials and task-related oscillatory activity were investigated. Three main findings emerge from the study. First, the experimental manipulation had no effect on the early N170 component, which may suggest that hierarchy did not modulate the structural encoding of neutral-expression faces. Second, hierarchy significantly modulated the amplitude of the late positive potential (LPP) within a 400-700 ms time-window, with more a prominent LPP occurring when the participants processed the face of the highest-rank player. Third, high-rank faces were associated with the highest reduction of alpha power. Taken together these findings provide novel electrophysiological evidence for enhanced allocation of attentional resource in the presence of high-rank faces. At a broader level, this study brings new insights into the neural processing underlying social categorization.	[Breton, Audrey; Cheylus, Anne; Baudouin, Jean-Yves; Van der Henst, Jean-Baptiste] Univ Lyon 1, CNRS, UMR 5304, L2C2, Bron, France; [Jerbi, Karim; Henaff, Marie-Anne; Schmitz, Christina; Krolak-Salmon, Pierre] CNRL, CNRS, UMR5292, INSERM,U1028, Bron, France; [Baudouin, Jean-Yves] Univ Bourgogne, Pole AAFE, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Breton, A (corresponding author), Univ Lyon 1, CNRS, UMR 5304, L2C2, Bron, France.	abreton@isc.cnrs.fr; vanderhenst@isc.cnrs.fr	Cheylus, Anne/GSD-3809-2022; krolak-salmon, pierre/AAV-2152-2020; Schmitz, Christina/G-9195-2011	Cheylus, Anne/0000-0002-4243-3686; Schmitz, Christina/0000-0002-8377-9608; Baudouin, Jean-Yves/0000-0002-4405-7987	CNRS; INSERM; DGA	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); DGA	This study was supported by CNRS, INSERM and DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Baudouin JY, 2006, J EXP PSYCHOL HUMAN, V32, P789, DOI 10.1037/0096-1523.32.4.789; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boyce WT, 2004, ANN NY ACAD SCI, V1036, P47, DOI 10.1196/annals.1330.003; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Brown D. E., 1991, HUMAN UNIVERSALS; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; Caldara R, 2003, CLIN NEUROPHYSIOL, V114, P515, DOI 10.1016/S1388-2457(02)00407-8; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Chiao JY, 2008, GROUP PROCESS INTERG, V11, P201, DOI 10.1177/1368430207088038; Chiao JY, 2009, NEUROPSYCHOLOGIA, V47, P354, DOI 10.1016/j.neuropsychologia.2008.09.023; Conty L, 2007, NEUROPSYCHOLOGIA, V45, P3024, DOI 10.1016/j.neuropsychologia.2007.05.017; Crites SL, 1996, PSYCHOL SCI, V7, P318, DOI 10.1111/j.1467-9280.1996.tb00381.x; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2011, OXF HDB FACE PERCEPT; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farrow TFD, 2011, NEUROIMAGE, V57, P1552, DOI 10.1016/j.neuroimage.2011.05.069; Fieder M, 2005, ETHOLOGY, V111, P940, DOI 10.1111/j.1439-0310.2005.01129.x; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Freeman JB, 2010, NEUROREPORT, V21, P24, DOI 10.1097/WNR.0b013e3283320d54; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Goffaux V, 2003, COGNITIVE SCI, V27, P313, DOI 10.1016/S0364-0213(03)00002-8; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Harris AM, 2008, J VISION, V8, DOI 10.1167/8.10.4; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Itier RJ, 2007, BRAIN RES, V1177, P79, DOI 10.1016/j.brainres.2007.07.094; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Jemel B, 2003, NEUROREPORT, V14, P525, DOI 10.1097/01.wnr.0000057864.05120.ba; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; Lachaux J-P, 2007, INT C SERIES, V1300, P421; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Marsh AA, 2009, J COGNITIVE NEUROSCI, V21, P713, DOI 10.1162/jocn.2009.21052; Marzi T, 2007, INT J PSYCHOPHYSIOL, V65, P182, DOI 10.1016/j.ijpsycho.2007.04.003; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Mouchetant-Rostaing Y, 2003, J COGNITIVE NEUROSCI, V15, P900, DOI 10.1162/089892903322370816; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Paller KA, 2000, NEUROIMAGE, V11, P98, DOI 10.1006/nimg.1999.0521; Pastor MC, 2008, BRAIN RES, V1189, P145, DOI 10.1016/j.brainres.2007.10.072; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Rilling JK, 2004, BIOL PSYCHIAT, V56, P364, DOI 10.1016/j.biopsych.2004.06.027; RITTER W, 1992, ANN NY ACAD SCI, V658, P1, DOI 10.1111/j.1749-6632.1992.tb22837.x; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Sabatinelli D, 2013, BIOL PSYCHOL, V92, P513, DOI 10.1016/j.biopsycho.2012.04.005; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Senholzi KB, 2013, SOC COGN AFFECT NEUR, V8, P937, DOI 10.1093/scan/nss091; Smith ML, 2007, NEUROIMAGE, V37, P974, DOI 10.1016/j.neuroimage.2007.05.030; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tanaka J, 1999, NEUROREPORT, V10, P829, DOI 10.1097/00001756-199903170-00030; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Walker PM, 2008, SOC COGN AFFECT NEUR, V3, P16, DOI 10.1093/scan/nsm035; WHEELER L, 1966, J EXP SOC PSYCHOL, V2, P27, DOI 10.1016/0022-1031(66)90062-x; Wiese H, 2014, CEREB CORTEX, V24, P826, DOI 10.1093/cercor/bhs369; Wild-Wall N, 2008, BIOL PSYCHOL, V77, P138, DOI 10.1016/j.biopsycho.2007.10.001; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251; Zitek EM, 2012, J PERS SOC PSYCHOL, V102, P98, DOI 10.1037/a0025345	92	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91451	10.1371/journal.pone.0091451	http://dx.doi.org/10.1371/journal.pone.0091451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622288	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300087
J	Ge, XL; Pan, SM; Zeng, FF; Tang, ZH; Wang, YW				Ge, Xiaoli; Pan, Shu-Ming; Zeng, Fangfang; Tang, Zi-Hui; Wang, Ying-Wei			A Simple Chinese Risk Score Model for Screening Cardiovascular Autonomic Neuropathy	PLOS ONE			English	Article							METABOLIC-SYNDROME; DYSFUNCTION; HYPERTENSION; SYSTEM	Background: The purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population. Methods and Materials: A population-based sample of 2,092 individuals aged 30-80 years, without previously diagnosed CAN, was surveyed between 2011 and 2012. All participants underwent short-term HRV test. The risk score was derived from an exploratory set. The risk score was developed by stepwise backward multiple logistic regression. The coefficients from this model were transformed into components of a CAN score. This score was tested in a validation and entire sample. Results: The final risk score included age, body mass index, hypertension, resting hear rate, items independently and significantly (P<0.05) associated with the presence of previously undiagnosed CAN. The area under the receiver operating curve was 0.726 (95% CI 0.686-0.766) for exploratory set, 0.784 (95% CI 0.749-0.818) for validation set, and 0.756 (95% CI 0.729-0.782) for entire sample. In validation set, at optimal cutoff score of 5 of 10, the risk score system has the sensitivity, specificity, and percentage that needed subsequent testing were 69, 78, and 30%, respectively. Conclusion: We developed a CAN risk score system based on a set of variables not requiring laboratory tests. The score system is simple fast, inexpensive, noninvasive, and reliable tool that can be applied to early intervention to delay or prevent the disease in China.	[Ge, Xiaoli; Wang, Ying-Wei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Ge, Xiaoli; Pan, Shu-Ming] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Emergence Dept, Shanghai 200030, Peoples R China; [Zeng, Fangfang; Tang, Zi-Hui] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Tang, ZH (corresponding author), Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	albert.tang@163.com; wangyingwei@yahoo.com	Tang, Zihui/P-2222-2016		China National Grant on Science and Technology	China National Grant on Science and Technology	The authors thank the grant from China National Grant on Science and Technology to support the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayad F, 2010, DIABETIC MED, V27, P804, DOI 10.1111/j.1464-5491.2010.03027.x; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bian RW, 2011, ACTA GASTRO-ENT BELG, V74, P28; Camm AJ, 1996, EUR HEART J, V17, P354; Ding W, 2011, ACTA CARDIOL, V66, P465, DOI 10.1080/AC.66.4.2126595; Erdem A, 2012, J INTERV CARD ELECTR, V35, P253, DOI 10.1007/s10840-012-9741-y; Garruti G, 2012, EXP DIABETES RES, DOI 10.1155/2012/615835; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hazari MA, 2012, NEUROSCIENCES, V17, P173; Iodice V, 2011, J NEUROL SCI, V310, P133, DOI 10.1016/j.jns.2011.07.014; Jarczok MN, 2013, INT J CARDIOL, V167, P855, DOI 10.1016/j.ijcard.2012.02.002; Kamphuis MH, 2007, EUR J CARDIOV PREV R, V14, P796, DOI 10.1097/HJR.0b013e32829c7d0c; Laitinen T, 2011, DIABETIC MED, V28, P699, DOI 10.1111/j.1464-5491.2011.03278.x; Lambrecht R, 2007, AUTON NEUROSCI-BASIC, V131, P102, DOI 10.1016/j.autneu.2006.07.001; Li Y, 2008, STAT MED, V27, P937, DOI 10.1002/sim.3027; Liu JM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-80; Meinhold JA, 2001, DIABETIC MED, V18, P607, DOI 10.1046/j.1464-5491.2001.00480.x; Min KB, 2008, INT HEART J, V49, P175, DOI 10.1536/ihj.49.175; Nanaiah Amrit, 2012, Indian J Endocrinol Metab, V16, P749, DOI 10.4103/2230-8210.100668; Spallone V, 2011, DIABETES-METAB RES, V27, P639, DOI 10.1002/dmrr.1239; Swartz MD, 2008, STAT MED, V27, P6158, DOI 10.1002/sim.3434; Tang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070571; Vespasiani G, 1996, COMPUT METH PROG BIO, V51, P211, DOI 10.1016/S0169-2607(96)01774-9; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Ziegler D, 2006, EXP CLIN ENDOCR DIAB, V114, P153, DOI 10.1055/s-2006-924083	25	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89623	10.1371/journal.pone.0089623	http://dx.doi.org/10.1371/journal.pone.0089623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621478	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300010
J	Gutierrez-Ibanez, C; Iwaniuk, AN; Moore, BA; Fernandez-Juricic, E; Corfield, JR; Krilow, JM; Kolominsky, J; Wylie, DR				Gutierrez-Ibanez, Cristian; Iwaniuk, Andrew N.; Moore, Bret A.; Fernandez-Juricic, Esteban; Corfield, Jeremy R.; Krilow, Justin M.; Kolominsky, Jeffrey; Wylie, Douglas R.			Mosaic and Concerted Evolution in the Visual System of Birds	PLOS ONE			English	Article							ACCESSORY OPTIC-SYSTEM; LATERAL GENICULATE-NUCLEUS; PIGEONS COLUMBA-LIVIA; PHYLOGENETIC COMPARATIVE-ANALYSIS; ISTHMI PARS MAGNOCELLULARIS; AVIAN TELENCEPHALON; MOLECULAR PHYLOGENY; CHOLINE-ACETYLTRANSFERASE; LENTIFORMIS MESENCEPHALI; OPTOKINETIC NYSTAGMUS	Two main models have been proposed to explain how the relative size of neural structures varies through evolution. In the mosaic evolution model, individual brain structures vary in size independently of each other, whereas in the concerted evolution model developmental constraints result in different parts of the brain varying in size in a coordinated manner. Several studies have shown variation of the relative size of individual nuclei in the vertebrate brain, but it is currently not known if nuclei belonging to the same functional pathway vary independently of each other or in a concerted manner. The visual system of birds offers an ideal opportunity to specifically test which of the two models apply to an entire sensory pathway. Here, we examine the relative size of 9 different visual nuclei across 98 species of birds. This includes data on interspecific variation in the cytoarchitecture and relative size of the isthmal nuclei, which has not been previously reported. We also use a combination of statistical analyses, phylogenetically corrected principal component analysis and evolutionary rates of change on the absolute and relative size of the nine nuclei, to test if visual nuclei evolved in a concerted or mosaic manner. Our results strongly indicate a combination of mosaic and concerted evolution (in the relative size of nine nuclei) within the avian visual system. Specifically, the relative size of the isthmal nuclei and parts of the tectofugal pathway covary across species in a concerted fashion, whereas the relative volume of the other visual nuclei measured vary independently of one another, such as that predicted by the mosaic model. Our results suggest the covariation of different neural structures depends not only on the functional connectivity of each nucleus, but also on the diversity of afferents and efferents of each nucleus.	[Gutierrez-Ibanez, Cristian; Kolominsky, Jeffrey; Wylie, Douglas R.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Iwaniuk, Andrew N.; Corfield, Jeremy R.; Krilow, Justin M.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Moore, Bret A.; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Corfield, Jeremy R.; Wylie, Douglas R.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	University of Alberta; University of Lethbridge; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alberta	Gutierrez-Ibanez, C (corresponding author), Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada.	cagutier@ualberta.ca	Iwaniuk, Andrew/H-7255-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Gutierrez-Ibanez, Cristian/0000-0002-0468-8223	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to ANI and DRW (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J COMP NEUROL, V500, P211; Asadollahi A, 2011, J NEUROSCI, V31, P6088, DOI 10.1523/JNEUROSCI.0023-11.2011; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bischof HJ, 1997, EUR J MORPHOL, V35, P246, DOI 10.1076/ejom.35.4.246.13080; BODNARENKO SR, 1988, J COMP NEUROL, V269, P431, DOI 10.1002/cne.902690310; BRECHA N, 1980, J COMP NEUROL, V189, P615, DOI 10.1002/cne.901890404; Brecha NC, 1978, SOME OBSERVATIONS OR; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; BURNS S, 1981, EXP BRAIN RES, V42, P171; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; Crowder NA, 2003, J NEUROPHYSIOL, V90, P1140, DOI 10.1152/jn.00653.2002; DEACON TW, 1990, INT J PRIMATOL, V11, P193, DOI 10.1007/BF02192869; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dobson SD, 2011, ANAT RES INT, V2011; Dobson SD, 2011, BIOL LETTERS, V7, P86, DOI 10.1098/rsbl.2010.0427; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; EHRLICH D, 1989, NEUROSCI LETT, V104, P1, DOI 10.1016/0304-3940(89)90319-4; Faunes M, 2013, J COMP NEUROL, V521, P1727, DOI 10.1002/cne.23253; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; FITE KV, 1981, J COMP NEUROL, V195, P279, DOI 10.1002/cne.901950208; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Frost B.J., 1994, P248; GAMLIN PDR, 1988, J COMP NEUROL, V269, P1, DOI 10.1002/cne.902690102; GAMLIN PDR, 1988, J COMP NEUROL, V269, P18, DOI 10.1002/cne.902690103; GAMLIN PDR, 1984, J COMP NEUROL, V226, P523, DOI 10.1002/cne.902260407; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GIOANNI H, 1991, EXP BRAIN RES, V86, P601; GIOANNI H, 1983, EXP BRAIN RES, V50, P237; GIOANNI H, 1983, EXP BRAIN RES, V50, P248; Gonzalez-Voyer A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-238; GRANDA RH, 1989, J COMP NEUROL, V287, P455, DOI 10.1002/cne.902870405; Gruberg E, 2006, J NEUROSCI, V26, P10368, DOI 10.1523/JNEUROSCI.3288-06.2006; GUNTURKUN O, 1990, NEUROSCI LETT, V111, P18, DOI 10.1016/0304-3940(90)90337-9; Gutierrez-Ibanez C, 2013, BRAIN BEHAV EVOLUT, V81, P27, DOI 10.1159/000343810; Gutierrez-Ibanez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037816; Gutierrez-Ibanez C, 2011, BRAIN BEHAV EVOLUT, V78, P286, DOI 10.1159/000330359; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harmon AL, 2013, PACKAGE GEIGER; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hellmann B, 2004, J COMP NEUROL, V472, P395, DOI 10.1002/cne.20056; Hellmann B, 2001, J COMP NEUROL, V436, P153; Hunt S.P., 1984, P619; HUNT SP, 1975, J COMP NEUROL, V162, P433, DOI 10.1002/cne.901620403; HUNT SP, 1976, J COMP NEUROL, V170, P153, DOI 10.1002/cne.901700203; Husband S., 2001, AVIAN VISUAL COGNITI; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Iwaniuk A., 2004, INT J COMP PSYCHOL, V17, P17; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2010, BRAIN BEHAV EVOLUT, V75, P122, DOI 10.1159/000311729; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Karten H.J., 1967, STEREOTAXIC ATLAS BR; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; KARTEN HJ, 1977, P NATL ACAD SCI USA, V74, P1753, DOI 10.1073/pnas.74.4.1753; Karten HJ, 1997, J COMP NEUROL, V387, P449; KARTEN HJ, 1970, J COMP NEUROL, V140, P35, DOI 10.1002/cne.901400103; Kimball RT, 2008, J AVIAN BIOL, V39, P438, DOI 10.1111/j.2008.0908-8857.04270.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; KNUDSEN EI, 1983, J COMP NEUROL, V218, P187, DOI 10.1002/cne.902180206; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Krutzfeldt NOE, 2005, J COMP NEUROL, V490, P40, DOI 10.1002/cne.20627; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lisney TJ, 2013, J COMP PHYSIOL A, V199, P385, DOI 10.1007/s00359-013-0802-1; Lisney TJ, 2012, J COMP PHYSIOL A, V198, P717, DOI 10.1007/s00359-012-0742-1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison WP, 2017, MESQUITE MODULAR SYS; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; Marin GJ, 2012, J NEUROSCI, V32, P1110, DOI 10.1523/JNEUROSCI.4151-11.2012; MATURANA HR, 1982, BRAIN RES, V247, P227, DOI 10.1016/0006-8993(82)91248-3; MCKENNA OC, 1985, BRAIN BEHAV EVOLUT, V26, P91, DOI 10.1159/000118770; MEDINA L, 1994, J COMP NEUROL, V342, P497, DOI 10.1002/cne.903420403; MICELI D, 1987, J HIRNFORSCH, V28, P45; MICELI D, 1979, NEURAL MECHANISMS BE, P223; Midford PE, 2008, PDAP MESQUITE TRANSL; MORGAN B, 1981, EXP BRAIN RES, V42, P181; Mpodozis J, 1995, Int J Neurosci, V81, P123, DOI 10.3109/00207459509015304; Mpodozis J, 1996, J COMP NEUROL, V374, P204, DOI 10.1002/(SICI)1096-9861(19961014)374:2<204::AID-CNE4>3.0.CO;2-6; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Nguyen AP, 2004, J NEUROSCI, V24, P4962, DOI 10.1523/JNEUROSCI.0146-04.2004; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pakan JMP, 2006, J COMP NEUROL, V495, P84, DOI 10.1002/cne.20855; Pereira SL, 2007, SYST BIOL, V56, P656, DOI 10.1080/10635150701549672; PUBOLS BH, 1965, J NEUROPHYSIOL, V28, P312, DOI 10.1152/jn.1965.28.2.312; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; R Core Team, 2021, R LANG ENV STAT COMP; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; REINER A, 1982, J COMP NEUROL, V204, P165, DOI 10.1002/cne.902040206; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; Reperant J, 1973, J Hirnforsch, V14, P151; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; RIO JP, 1983, BRAIN RES, V271, P145, DOI 10.1016/0006-8993(83)91375-6; Schoenemann PT, 2004, BRAIN BEHAV EVOLUT, V63, P47, DOI 10.1159/000073759; SERENO MI, 1987, J COMP NEUROL, V261, P319, DOI 10.1002/cne.902610302; Smaers JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0269; SORENSON EM, 1989, J COMP NEUROL, V281, P641, DOI 10.1002/cne.902810412; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Striedter GF, 2008, J COMP NEUROL, V507, P1663, DOI 10.1002/cne.21640; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; Tombol T, 1998, CELL TISSUE RES, V291, P255, DOI 10.1007/s004410050995; Vega-Zuniga T, 2011, 2011 NEUR M PLANN; WAKITA M, 1992, BEHAV BRAIN RES, V51, P211, DOI 10.1016/S0166-4328(05)80215-3; WALLS G L, 1953, Univ Calif Publ Physiol, V9, P1; Wang Y, 2006, J COMP NEUROL, V494, P7, DOI 10.1002/cne.20821; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; WANG YC, 1993, VISUAL NEUROSCI, V10, P21, DOI 10.1017/S0952523800003199; Whiting BA, 2003, J HUM EVOL, V44, P3, DOI 10.1016/S0047-2484(02)00162-8; WILD JM, 1989, J COMP NEUROL, V287, P1, DOI 10.1002/cne.902870102; Wilson M, 2011, VISUAL NEUROSCI, V28, P337, DOI 10.1017/S0952523811000022; Wink Michael, 2004, P517; Wink M, 2009, ARDEA, V97, P581, DOI 10.5253/078.097.0425; WINTERSON BJ, 1985, EXP BRAIN RES, V60, P215; WOODSON W, 1995, J COMP NEUROL, V362, P489, DOI 10.1002/cne.903620405; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Wylie DR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00004; Wylie DRW, 2007, VISUAL NEUROSCI, V24, P691, DOI 10.1017/S0952523807070599; Wylie DRW, 2009, CAN J EXP PSYCHOL, V63, P328, DOI 10.1037/a0016826; Wylie DRW, 1998, J COMP NEUROL, V391, P456; Wylie DRW, 1997, J COMP NEUROL, V384, P517, DOI 10.1002/(SICI)1096-9861(19970811)384:4<517::AID-CNE3>3.0.CO;2-5; Yopak KE, 2010, P NATL ACAD SCI USA, V107, P12946, DOI 10.1073/pnas.1002195107	136	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90102	10.1371/journal.pone.0090102	http://dx.doi.org/10.1371/journal.pone.0090102			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621573	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300013
J	Li, L; Tan, JJ; Zhang, Y; Han, NJ; Di, XB; Xiao, T; Cheng, SJ; Gao, YN; Liu, Y				Li, Lin; Tan, Jinjing; Zhang, Ying; Han, Naijun; Di, Xuebing; Xiao, Ting; Cheng, Shujun; Gao, Yanning; Liu, Yu			DLK1 Promotes Lung Cancer Cell Invasion through Upregulation of MMP9 Expression Depending on Notch Signaling	PLOS ONE			English	Article							INHIBIT ADIPOCYTE DIFFERENTIATION; HEPATOCELLULAR-CARCINOMA; HUMAN PROSTATE; STEM-CELLS; PATHWAY; PROTEIN; GENE; ADIPOGENESIS; ACTIVATION; DROSOPHILA	The transmembrane and secreted protein delta-like 1 homolog (DLK1) belongs to the EGF-like family. It is widely accepted that DLK1 plays important roles in regulating cell differentiation, such as adipogenesis and osteogenesis. Aberrant expression of DLK1 has been found in various types of human cancers, including lung cancer. A previous study in this lab has revealed that DLK1 is associated with tumor invasion, although the mechanism is still unknown. To explore the potential effects that DLK1 might have on invasion, DLK1 was overexpressed or knocked down in the human lung cancer cell lines. The protein's influences on cell invasion were subsequently evaluated. A transwell assay showed that DLK1 overexpression significantly promoted cancer cell invasion. Western blotting and gelatin zymography analysis indicated that DLK1 could affect both matrix metalloproteinase-9 (MMP9) expression and its extracellular activity. An analysis of NOTCH1 and HES1 gene expression and Notch intracellular domain (NICD) nuclear translocation during DLK1 stimulation or depletion demonstrated that DLK1 could activate Notch signaling in lung cancer cells. Additionally, the elevated expression of MMP9 induced by DLK1 stimulation could be significantly decreased by inhibiting Notch signaling using c-secretase inhibitor (GSI). The data presented in this study suggest that DLK1 can promote the invasion of lung cancer cells by upregulating MMP9 expression, which depends on Notch signaling.	[Li, Lin; Tan, Jinjing; Zhang, Ying; Han, Naijun; Di, Xuebing; Xiao, Ting; Cheng, Shujun; Gao, Yanning; Liu, Yu] Peking Union Med Coll, Canc Inst Hosp, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Li, Lin; Tan, Jinjing; Zhang, Ying; Han, Naijun; Di, Xuebing; Xiao, Ting; Cheng, Shujun; Gao, Yanning; Liu, Yu] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Gao, YN (corresponding author), Peking Union Med Coll, Canc Inst Hosp, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	yngao@cicams.ac.cn; liuyu@cicams.ac.cn	Tan, Jinjing/I-1042-2016		Natural Science Foundation of China [30930042, 81301852]; Specialized Research Fund for the Doctoral Program of Higher Education [20111106110017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the Natural Science Foundation of China (30930042 and 81301852) and the Specialized Research Fund for the Doctoral Program of Higher Education (20111106110017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Begum A, 2012, CANCER LETT, V318, P26, DOI 10.1016/j.canlet.2011.11.032; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Ceder JA, 2008, EUR UROL, V54, P1344, DOI 10.1016/j.eururo.2008.03.006; Chu D, 2011, ANN ONCOL; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Glittenberg M, 2006, EMBO J, V25, P4697, DOI 10.1038/sj.emboj.7601337; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Liu Yu, 2010, Zhongguo Fei Ai Za Zhi, V13, P923, DOI 10.3779/j.issn.1009-3419.2010.10.12; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Xu X, 2012, MOL CANCER THER, V11, P629, DOI 10.1158/1535-7163.MCT-11-0531; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219; Yu F, 2010, LIVER INT, V30, P703, DOI 10.1111/j.1478-3231.2010.02214.x	29	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91509	10.1371/journal.pone.0091509	http://dx.doi.org/10.1371/journal.pone.0091509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621612	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300097
J	Winhofer, Y; Krssak, M; Wolf, P; Tura, A; Anderwald, CH; Kosi, L; Reiter, G; Pacini, G; Trattnig, S; Luger, A; Krebs, M; Kautzky-Willer, A				Winhofer, Yvonne; Krssak, Martin; Wolf, Peter; Tura, Andrea; Anderwald, Christian-Heinz; Kosi, Lana; Reiter, Gert; Pacini, Giovanni; Trattnig, Siegfried; Luger, Anton; Krebs, Michael; Kautzky-Willer, Alexandra			Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes	PLOS ONE			English	Article							RESONANCE-SPECTROSCOPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL STEATOSIS; INSULIN SENSITIVITY; MELLITUS; PREDICTOR; HEART; REPRODUCIBILITY; HYPERGLYCEMIA; TRIGLYCERIDE	Background: Increased myocardial lipid accumulation has been described in patients with pre- and overt type 2 diabetes and could underlie the development of left-ventricular dysfunction in metabolic diseases (diabetic cardiomyopathy). Since women with prior gestational diabetes (pGDM) display a generally young population at high risk of developing diabetes and associated cardiovascular complications, we aimed to assess whether myocardial lipid accumulation can be detected at early stages of glucose intolerance and relates to markers of hepatic steatosis (Fatty Liver Index), cardiac function, insulin sensitivity and secretion. Methods: Myocardial lipid content (MYCL), left-ventricular function (1 H-magnetic-resonance-spectroscopy and -imaging), insulin sensitivity/secretion (oral glucose tolerance test) and the fatty liver index (FLI) were assessed in 35 pGDM (45.6 +/- 7.0 years, 28.3 +/- 4.8 kg/m(2)) and 14 healthy control females (CON; 44.7 +/- 9.8 years, 26.1 +/- 2.5 kg/m(2)), matching for age and body-mass-index (each p>0.1). Results: Of 35 pGDM, 9 displayed normal glucose tolerance (NGT), 6 impaired glucose regulation (IGR) and 20 had been already diagnosed with type 2 diabetes (T2DM). MYCL and cardiac function were comparable between pGDM and CON; in addition, no evidence of left-ventricular dysfunction was observed. MYCL was inversely correlated with the ejection fraction in T2DM (R = -20.45, p<0.05), while the FLI was tightly correlated with metabolic parameters (such as HbA1C, fasting plasma glucose and HDL-cholesterol) and rose along GT-groups. Conclusions: There is no evidence of cardiac steatosis in middle-aged women with prior gestational diabetes, suggesting that cardiac complications might develop later in the time-course of diabetes and may be accelerated by the co-existence of further risk factors, whereas hepatic steatosis remains a valid biomarker for metabolic diseases even in this rather young female cohort.	[Winhofer, Yvonne; Krssak, Martin; Wolf, Peter; Anderwald, Christian-Heinz; Kosi, Lana; Luger, Anton; Krebs, Michael; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria; [Tura, Andrea; Anderwald, Christian-Heinz; Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Anderwald, Christian-Heinz] Mariahilf Community Pharm, Arnoldstein, Austria; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, Micheldorf, Austria; [Reiter, Gert] Siemens AG Healthcare, Vienna, Austria; [Trattnig, Siegfried] Med Univ Vienna, Dept Radiodiagnost, High Field MR, Ctr Excellence, Vienna, Austria	Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Siemens AG; Medical University of Vienna	Winhofer, Y (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria.	yvonne.winhofer@meduniwien.ac.at	Krssak, Martin/AAU-8183-2020; Anderwald, Christian Heinz/AAG-2271-2021	Krssak, Martin/0000-0001-9717-803X; Anderwald, Christian Heinz/0000-0001-7485-0815; Winhofer, Yvonne/0000-0002-0555-9044; Wolf, Peter/0000-0001-6779-734X; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Trattnig, Siegfried/0000-0003-1623-3303; Krebs, Michael/0000-0002-9265-7274	"Jubilaumsfonds" of the Austrian National Bank [11198, 13249, 15363]; Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna [12023]	"Jubilaumsfonds" of the Austrian National Bank; Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna	The study was supported by the "Jubilaumsfonds" of the Austrian National Bank (Grant Nr. 11198 to AKW, Grant Nr. 13249 and 15363 to M. Krssak.), the Austrian Heart Foundation and the Medical Scientific Fund of the Mayor of the City of Vienna (Grant 12023, both to M. Krebs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bo S, 2004, J ENDOCRINOL INVEST, V27, P629, DOI 10.1007/BF03347494; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Glenn DJ, 2011, HYPERTENSION, V57, P216, DOI 10.1161/HYPERTENSIONAHA.110.160655; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Iozzo P, 2009, J CLIN ENDOCR METAB, V94, P4472, DOI 10.1210/jc.2009-0436; Krssak M, 2011, DIABETOLOGIA, V54, P1871, DOI 10.1007/s00125-011-2146-0; Krssak M, 2010, EUR J RADIOL, V74, pE61, DOI 10.1016/j.ejrad.2009.03.062; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Ng ACT, 2010, CIRCULATION, V122, P2538, DOI 10.1161/CIRCULATIONAHA.110.955542; Prikoszovich T, 2011, DIABETES CARE, V34, P430, DOI 10.2337/dc10-1002; Reingold JS, 2005, AM J PHYSIOL-ENDOC M, V289, pE935, DOI 10.1152/ajpendo.00095.2005; Retnakaran R, 2009, CAN MED ASSOC J, V181, P371, DOI 10.1503/cmaj.090569; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Sullivan SD, 2012, CURR DIABETES REP, V12, P43, DOI 10.1007/s11892-011-0238-3; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Szendroedi J, 2009, DIABETES CARE, V32, P209, DOI 10.2337/dc08-1123; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Utz W, 2011, HEART, V97, P1585, DOI 10.1136/hrt.2011.224451; van de Weijer T, 2011, CARDIOVASC RES, V92, P10, DOI 10.1093/cvr/cvr212; van der Meer RW, 2007, RADIOLOGY, V245, P251, DOI 10.1148/radiol.2451061904; van der Meer RW, 2007, J CARDIOVASC MAGN R, V9, P645, DOI 10.1080/10976640601093703; Velagaleti RS, 2010, CIRC-CARDIOVASC IMAG, V3, P257, DOI 10.1161/CIRCIMAGING.109.911438; Waiter GD, 1999, MAGN RESON IMAGING, V17, P99, DOI 10.1016/S0730-725X(98)00158-1; Winhofer Y, 2013, EUR J CLIN INVEST, V43, P190, DOI 10.1111/eci.12031; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275; Winzer C, 2004, DIABETES CARE, V27, P1721, DOI 10.2337/diacare.27.7.1721	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91607	10.1371/journal.pone.0091607	http://dx.doi.org/10.1371/journal.pone.0091607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621572	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300110
J	Witz, S; Panwar, P; Schober, M; Deppe, J; Pasha, FA; Lemieux, MJ; Mohlmann, T				Witz, Sandra; Panwar, Pankaj; Schober, Markus; Deppe, Johannes; Pasha, Farhan Ahmad; Lemieux, M. Joanne; Moehlmann, Torsten			Structure-Function Relationship of a Plant NCS1 Member - Homology Modeling and Mutagenesis Identified Residues Critical for Substrate Specificity of PLUTO, a Nucleobase Transporter from Arabidopsis	PLOS ONE			English	Article							CATION SYMPORTER 1; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; ALLANTOIN TRANSPORT; SALVAGE PATHWAY; MECHANISM; PROTEINS; PERMEASE; TRANSLOCATOR; SEQUENCE	Plastidic uracil salvage is essential for plant growth and development. So far, PLUTO, the plastidic nucleobase transporter from Arabidopsis thaliana is the only known uracil importer at the inner plastidic membrane which represents the permeability barrier of this organelle. We present the first homology model of PLUTO, the sole plant NCS1 member from Arabidopsis based on the crystal structure of the benzyl hydantoin transporter MHP1 from Microbacterium liquefaciens and validated by molecular dynamics simulations. Polar side chains of residues Glu-227 and backbones of Val-145, Gly-147 and Thr-425 are proposed to form the binding site for the three PLUTO substrates uracil, adenine and guanine. Mutational analysis and competition studies identified Glu-227 as an important residue for uracil and to a lesser extent for guanine transport. A differential response in substrate transport was apparent with PLUTO double mutants E227Q G147Q and E227Q T425A, both of which most strongly affected adenine transport, and in V145A G147Q, which markedly affected guanine transport. These differences could be explained by docking studies, showing that uracil and guanine exhibit a similar binding mode whereas adenine binds deep into the catalytic pocket of PLUTO. Furthermore, competition studies confirmed these results. The present study defines the molecular determinants for PLUTO substrate binding and demonstrates key differences in structure-function relations between PLUTO and other NCS1 family members.	[Witz, Sandra; Schober, Markus; Deppe, Johannes; Moehlmann, Torsten] Univ Kaiserslautern, Dept Plant Physiol, D-67663 Kaiserslautern, Germany; [Panwar, Pankaj; Lemieux, M. Joanne] Univ Alberta, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [Pasha, Farhan Ahmad] King Abdullah Univ Sci & Technol, Catalysis Res Ctr, Thuwal, Saudi Arabia	University of Kaiserslautern; University of Alberta; King Abdullah University of Science & Technology	Mohlmann, T (corresponding author), Univ Kaiserslautern, Dept Plant Physiol, D-67663 Kaiserslautern, Germany.	moehlmann@biologie.uni-kl.de	Pasha, F. A./AAB-9581-2019; Pasha, Farhan Ahmad/A-7429-2008	Pasha, F. A./0000-0002-7132-6361; Lemieux, Joanne/0000-0003-4745-9153	DFG [MO 1032/3-2];  [IRTG1830]	DFG(German Research Foundation (DFG)); 	This work was supported by a DFG Grant (MO 1032/3-2) to SW and IRTG1830 "Complex membrane proteins in cellular development and disease". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JL, 2011, BIOPHYS J, V101, P2399, DOI 10.1016/j.bpj.2011.09.061; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Chen MJ, 2011, PLANT CELL, V23, P2991, DOI 10.1105/tpc.111.085829; CHEVALLIER MR, 1982, EMBO J, V1, P375, DOI 10.1002/j.1460-2075.1982.tb01177.x; COOPER TG, 1987, J BACTERIOL, V169, P4660, DOI 10.1128/jb.169.10.4660-4667.1987; Geigenberger P, 2005, PLANT CELL, V17, P2077, DOI 10.1105/tpc.105.033548; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; KAMPFENKEL K, 1995, FEBS LETT, V374, P351, DOI 10.1016/0014-5793(95)01143-3; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Krypotou E, 2012, J BIOL CHEM, V287, P36792, DOI 10.1074/jbc.M112.400382; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Liu XY, 2007, NEW PHYTOL, V175, P448, DOI 10.1111/j.1469-8137.2007.02117.x; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Ludwig A, 2000, PLANT J, V24, P503, DOI 10.1046/j.1365-313x.2000.00900.x; Mainguet SE, 2009, PLANT J, V60, P280, DOI 10.1111/j.1365-313X.2009.03963.x; Mourad GS, 2012, FEBS LETT, V586, P1370, DOI 10.1016/j.febslet.2012.03.058; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schein JR, 2013, PLANT PHYSIOL BIOCH, V70, P52, DOI 10.1016/j.plaphy.2013.05.015; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sukrong S, 2012, MOL PLANT, V5, P1310, DOI 10.1093/mp/sss065; SUMRADA R, 1977, J BACTERIOL, V131, P839, DOI 10.1128/JB.131.3.839-847.1977; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaziri H, 2013, MOL MEMBR BIOL, V30, P114, DOI 10.3109/09687688.2012.748939; Vazquez-Ibar JL, 2004, J BIOL CHEM, V279, P49214, DOI 10.1074/jbc.M407408200; Vlanti A, 2008, MOL MICROBIOL, V68, P959, DOI 10.1111/j.1365-2958.2008.06198.x; Werner AK, 2011, TRENDS PLANT SCI, V16, P381, DOI 10.1016/j.tplants.2011.03.012; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Witz S, 2012, PLANT CELL, V24, P1549, DOI 10.1105/tpc.112.096743; Zhang J, 2006, J BIOL CHEM, V281, P28210, DOI 10.1074/jbc.M605129200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91343	10.1371/journal.pone.0091343	http://dx.doi.org/10.1371/journal.pone.0091343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621654	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300078
J	Zhang, SF; Liu, YX; Liu, ZX; Zhang, C; Cao, H; Ye, YQ; Wang, SL; Zhang, YA; Xiao, SF; Yang, P; Li, JD; Bai, ZM				Zhang, Shufang; Liu, Yanxuan; Liu, Zhenxiang; Zhang, Chong; Cao, Hui; Ye, Yongqing; Wang, Shunlan; Zhang, Ying'ai; Xiao, Sifang; Yang, Peng; Li, Jindong; Bai, Zhiming			Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; UPPER URINARY-TRACT; FACTOR A-CHAIN; MESSENGER-RNA; CANCER; EXPRESSION; GENE; PROSTATE; ISOFORM; MECHANISMS	Urothelial carcinoma of the bladder (UCB) is one of the commonly diagnosed cancers in the world. The UCB has the highest rate of recurrence of any malignancy. A genome-wide screening of transcriptome dysregulation between cancer and normal tissue would provide insight into the molecular basis of UCB recurrence and is a key step to discovering biomarkers for diagnosis and therapeutic targets. Compared with microarray technology, which is commonly used to identify expression level changes, the recently developed RNA-seq technique has the ability to detect other abnormal regulations in the cancer transcriptome, such as alternative splicing. In this study, we performed high-throughput transcriptome sequencing at similar to 50x coverage on a recurrent muscle-invasive cisplatin-resistance UCB tissue and the adjacent non-tumor tissue. The results revealed cancer-specific differentially expressed genes between the tumor and non-tumor tissue enriched in the cell adhesion molecules, focal adhesion and ECM-receptor interaction pathway. Five dysregulated genes, including CDH1, VEGFA, PTPRF, CLDN7, and MMP2 were confirmed by Real time qPCR in the sequencing samples and the additional eleven samples. Our data revealed that more than three hundred genes showed differential splicing patterns between tumor tissue and non-tumor tissue. Among these genes, we filtered 24 cancer-associated alternative splicing genes with differential exon usage. The findings from RNA-Seq were validated by Real time qPCR for CD44, PDGFA, NUMB, and LPHN2. This study provides a comprehensive survey of the UCB transcriptome, which provides better insight into the complexity of regulatory changes during recurrence and metastasis.	[Zhang, Shufang; Liu, Zhenxiang; Zhang, Chong; Cao, Hui; Wang, Shunlan; Zhang, Ying'ai; Xiao, Sifang; Yang, Peng; Li, Jindong; Bai, Zhiming] Cent South Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou Municipal Peoples Hosp, Haikou, Peoples R China; [Liu, Yanxuan] Xinxiang Med Univ, Dept Genet Dis, Affiliated Hosp 1, Xinxiang, Peoples R China; [Ye, Yongqing] Dept Shanghai Claison Biotechnol, Shanghai, Peoples R China	Xinxiang Medical University	Bai, ZM (corresponding author), Cent South Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou Municipal Peoples Hosp, Haikou, Peoples R China.	hkbaizhiming@163.com			Hainan Provincial Natural Science Foundation [813256]; Key Municipal Scientific Project of Haikou [2012-073]; Key Scientific Project of Hainan Province	Hainan Provincial Natural Science Foundation; Key Municipal Scientific Project of Haikou; Key Scientific Project of Hainan Province	This work was supported by 2013 Hainan Provincial Natural Science Foundation (Grant number: 813256), Key Municipal Scientific Project of Haikou (Grant number: 2012-073), and Key Scientific Project of Hainan Province (Title: Preliminary screening of molecular markers in bladder cancer by high-throughput transcriptome sequencing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang SS, 2003, J UROLOGY, V170, P1085, DOI 10.1097/01.ju.0000086828.26001.ca; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; Cook JL, 2002, J MOL CELL CARDIOL, V34, P1525, DOI 10.1006/jmcc.2002.2106; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crews L, 2004, BRAIN PATHOL, V14, P312; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; DAVIES B, 1993, CANCER RES, V53, P5365; Dong L, 2009, ADV APPL BIOINFORMAT, V17; Drayton RM, 2012, EXPERT REV ANTICANC, V12, P271, DOI [10.1586/era.11.201, 10.1586/ERA.11.201]; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; El-Rifai W, 2000, AM J PATHOL, V156, P871, DOI 10.1016/S0002-9440(10)64956-5; Elsamman E, 2006, BJU INT, V97, P1202, DOI 10.1111/j.1464-410X.2006.06153.x; Emerich DF, 2004, EXPERT OPIN BIOL TH, V4, P1191, DOI 10.1517/14712598.4.8.1191; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gerhards S, 2001, UROLOGY, V57, P675, DOI 10.1016/S0090-4295(00)01087-6; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hayne D, 2004, J UROLOGY, V172, P1051, DOI 10.1097/01.ju.0000136376.11896.62; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2011, CSHL BIOL GEN C; Knowles MA, 2001, J CLIN PATHOL-MOL PA, V54, P215, DOI 10.1136/mp.54.4.215; Koberle B, 2012, MOL BASIS CISPLATIN; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Korkolopoulou P, 2001, EUR UROL, V39, P167, DOI 10.1159/000052432; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; LIPPONEN PK, 1995, J CANCER RES CLIN, V121, P303, DOI 10.1007/BF01209598; Marin-Aguilera M, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.006; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Mitra AP, 2006, CLIN GENITOURIN CANC, V5, P67, DOI 10.3816/CGC.2006.n.020; Miyake H, 2002, J UROLOGY, V167, P1282, DOI 10.1016/S0022-5347(05)65282-2; Miyake H, 1999, MOL UROL, V3, P365; Miyake H, 2004, J UROLOGY, V172, P1127, DOI 10.1097/01.ju.0000129541.23460.48; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nazarenko I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018303; Norskov MS, 2011, PHARMACOGENOMICS J, V11, P292, DOI 10.1038/tpj.2010.38; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasala K, 2003, UROLOGY, V62, P952, DOI 10.1016/S0090-4295(03)00660-5; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Herr HW, 2007, J UROLOGY, V177, P437, DOI 10.1016/j.juro.2006.09.027; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams SG, 2004, UROL RES, V32, P373, DOI 10.1007/s00240-003-0345-y; Wolff EM, 2005, NAT CLIN PRACT UROL, V2, P502, DOI 10.1038/ncpuro0318; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018255	75	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91466	10.1371/journal.pone.0091466	http://dx.doi.org/10.1371/journal.pone.0091466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622401	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300089
J	Zhou, F; Toivonen, H; King, RD				Zhou, Fang; Toivonen, Hannu; King, Ross D.			The Use of Weighted Graphs for Large-Scale Genome Analysis	PLOS ONE			English	Article							METABOLIC NETWORKS; EVOLUTION; MODEL; SETS	There is an acute need for better tools to extract knowledge from the growing flood of sequence data. For example, thousands of complete genomes have been sequenced, and their metabolic networks inferred. Such data should enable a better understanding of evolution. However, most existing network analysis methods are based on pair-wise comparisons, and these do not scale to thousands of genomes. Here we propose the use of weighted graphs as a data structure to enable large-scale phylogenetic analysis of networks. We have developed three types of weighted graph for enzymes: taxonomic (these summarize phylogenetic importance), isoenzymatic (these summarize enzymatic variety/redundancy), and sequence-similarity (these summarize sequence conservation); and we applied these types of weighted graph to survey prokaryotic metabolism. To demonstrate the utility of this approach we have compared and contrasted the large-scale evolution of metabolism in Archaea and Eubacteria. Our results provide evidence for limits to the contingency of evolution.	[Zhou, Fang] Univ Nottingham, Div Comp Sci, Ningbo, Zhejiang, Peoples R China; [Toivonen, Hannu] Univ Helsinki, Dept Comp Sci, FIN-00014 Helsinki, Finland; [King, Ross D.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Nottingham Ningbo China; University of Helsinki; University of Manchester	King, RD (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	ross.king@manchester.ac.uk	Toivonen, Hannu TT/A-3657-2012	Toivonen, Hannu TT/0000-0003-1339-8022; King, Ross/0000-0001-7208-4387	Algorithmic Data Analysis (Algodan) Centre of Excellence of the Academy of Finland [118653]; European Commission; BBSRC [BB/J006955/1]; Bureau of Education; Bureau of Science and Technology, Ningbo Municipality; Biotechnology and Biological Sciences Research Council [BB/F008228/1, BB/J006955/1] Funding Source: researchfish; BBSRC [BB/F008228/1] Funding Source: UKRI	Algorithmic Data Analysis (Algodan) Centre of Excellence of the Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bureau of Education; Bureau of Science and Technology, Ningbo Municipality; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Algorithmic Data Analysis (Algodan) Centre of Excellence of the Academy of Finland (Grant 118653), by the European Commission under the FP7 Collaborative Programme UNICELLSYS, by the BBSRC (BB/J006955/1), and by the Bureau of Education and Bureau of Science and Technology, Ningbo Municipality, under the IDIC Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, KDD 11 P 17 ACM SIGK; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Freilich S, 2005, J MOL BIOL, V349, P745, DOI 10.1016/j.jmb.2005.04.027; Gould S. J., 1990, WONDERFUL LIFE BURGE; Holme P, 2009, J R SOC INTERFACE, V6, P1027, DOI 10.1098/rsif.2008.0489; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lacroix V, 2008, IEEE ACM T COMPUT BI, V5, P594, DOI 10.1109/TCBB.2008.79; Morris S. C., 2000, CRUCIBLE CREATION BU; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Ridley M., 1993, EVOLUTION; Whelan KE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-97; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	19	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e89618	10.1371/journal.pone.0089618	http://dx.doi.org/10.1371/journal.pone.0089618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619061	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400007
J	Schredelseker, J; Paz, A; Lopez, CJ; Altenbach, C; Leung, CS; Drexler, MK; Chen, JN; Hubbell, WL; Abramson, J				Schredelseker, Johann; Paz, Aviv; Lopez, Carlos J.; Altenbach, Christian; Leung, Calvin S.; Drexler, Maria K.; Chen, Jau-Nian; Hubbell, Wayne L.; Abramson, Jeff			High Resolution Structure and Double Electron-Electron Resonance of the Zebrafish Voltage-dependent Anion Channel 2 Reveal an Oligomeric Population	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Ion Channels; Mitochondria; X-ray Crystallography; Zebrafish; DEER; VDAC2	OUTER MITOCHONDRIAL-MEMBRANE; PEPTIDE-SPECIFIC ANTIBODIES; VDAC; PROTEIN; BAK; INSIGHTS; SYSTEM; PROBES; MODEL	Background: Biochemical characterization of voltage-dependent anion channel 2 (VDAC2) is limited due to an inability to obtain functional protein. Results: The crystal structure of VDAC2 suggests a dimer interface that is confirmed by double electron-electron resonance and cross-linking. Conclusion: zfVDAC2 has a fractional dimeric population. Significance: VDAC isoforms are structurally similar, but this study has identified a number of hot spots that require further exploration. In recent years, there has been a vast increase in structural and functional understanding of VDAC1, but VDAC2 and -3 have been understudied despite having many unique phenotypes. One reason for the paucity of structural and biochemical characterization of the VDAC2 and -3 isoforms stems from the inability of obtaining purified, functional protein. Here we demonstrate the expression, isolation, and basic characterization of zebrafish VDAC2 (zfVDAC2). Further, we resolved the structure of zfVDAC2 at 2.8 resolution, revealing a crystallographic dimer. The dimer orientation was confirmed in solution by double electron-electron resonance spectroscopy and by cross-linking experiments disclosing a dimer population of approximate to 20% in lauryldimethine amine oxide detergent micelles, whereas in lipidic bicelles a higher population of dimeric and higher order oligomers species were observed. The present study allows for a more accurate structural comparison between VDAC2 and its better-studied counterpart VDAC1.	[Schredelseker, Johann; Chen, Jau-Nian] Univ Munich, Dept Mol Cell & Dev Biol, D-80336 Munich, Germany; [Schredelseker, Johann; Paz, Aviv; Leung, Calvin S.; Abramson, Jeff] Univ Munich, Dept Physiol, D-80336 Munich, Germany; [Schredelseker, Johann; Drexler, Maria K.] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Lopez, Carlos J.; Altenbach, Christian; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Lopez, Carlos J.; Altenbach, Christian; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Abramson, Jeff] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med inStem, Bangalore 560065, Karnataka, India	University of Munich; University of Munich; University of Munich; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Chen, JN (corresponding author), Univ Munich, Dept Mol Cell & Dev Biol, D-80336 Munich, Germany.	chenjn@mcdb.ucla.edu; hubbellw@jsei.ucla.edu; jabramson@mednet.ucla.edu	Paz, Aviv/AAN-3966-2021; Chen, Jau-Nian/AAM-7808-2020	Paz, Aviv/0000-0003-0792-492X; Schredelseker, Johann/0000-0002-6657-0466; Chen, Jau-Nian/0000-0001-8807-3607; Schweitzer, Maria Katharina/0000-0002-9977-019X	National Institutes of Health [RO1 GM078844, 5R01 EY005216]; Austrian Science Fund FWF Erwin-Schrodinger Fellowship [J3065-B11]; Jules Stein Eye Institute Training Grant [2T32EY007026-36A1]; Jules Stein Professor Endowment; NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216, T32EY007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF Erwin-Schrodinger Fellowship(Austrian Science Fund (FWF)); Jules Stein Eye Institute Training Grant; Jules Stein Professor Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM078844 (to J. A.) and 5R01 EY005216 (to C. J. L.). This work was also supported by Austrian Science Fund FWF Erwin-Schrodinger Fellowship J3065-B11 (to J. S.), Jules Stein Eye Institute Training Grant 2T32EY007026-36A1 (to C. J. L.), and the Jules Stein Professor Endowment (to W. L. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvira CM, 2012, AM J RESP CELL MOL, V47, P669, DOI 10.1165/rcmb.2011-0436OC; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt H, 2007, J MEMBRANE BIOL, V216, P93, DOI 10.1007/s00232-007-9038-8; Fleissner MR, 2011, P NATL ACAD SCI USA, V108, P16241, DOI 10.1073/pnas.1111420108; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Min CK, 2012, BIOCHEM J, V447, P371, DOI 10.1042/BJ20120705; Naghdi S, 2012, BIOPHYS J, V102, p437A, DOI 10.1016/j.bpj.2011.11.2391; Naghdi S, 2013, BIOPHYS J, V104, p656A, DOI 10.1016/j.bpj.2012.11.3621; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palaniappan KK, 2013, CELL REP, V5, P546, DOI 10.1016/j.celrep.2013.08.048; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Ujwal R., 2012, JOVE-J VIS EXP, V59, pe3383; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859	45	104	107	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12566	12577		10.1074/jbc.M113.497438	http://dx.doi.org/10.1074/jbc.M113.497438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627492	Green Published, hybrid			2022-12-25	WOS:000335581400030
J	Sun, YF; Kasiappan, R; Tang, JF; Webb, PL; Quarni, W; Zhang, XH; Bai, WL				Sun, Yuefeng; Kasiappan, Ravi; Tang, Jinfu; Webb, Panida L.; Quarni, Waise; Zhang, Xiaohong; Bai, Wenlong			A Novel Function of the Fe65 Neuronal Adaptor in Estrogen Receptor Action in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Growth; DNA Transcription; Endocrinology; Gene Transcription; Hormone Receptors; Hormones; Nuclear Receptors; Breast Cancer; Estrogens; Estrogen Receptor; Fe65; Tamoxifen	AMYLOID PRECURSOR PROTEIN; TISSUE-SPECIFICITY; ANDROGEN RECEPTOR; BINDING PROTEIN; NUCLEAR-MATRIX; GROWTH; TRANSCRIPTION; TIP60; APP; STABILIZATION	Background: Fe65 is a neuronal adaptor with essential roles in neuronal cells. Results: Fe65 regulates promoter recruitments of the estrogen receptor and growth response of breast cancers to estrogens and tamoxifen. Conclusion: Fe65 is a positive regulator of estrogen actions in breast cancer cells. Significance: The studies define a novel role for a neuronal adaptor in estrogen actions in breast cancer cells. Fe65 is a multidomain adaptor with established functions in neuronal cells and neurodegeneration diseases. It binds to the C terminus of the A amyloid precursor protein and is involved in regulating gene transcription. The present studies show that Fe65 is expressed in breast cancer (BCa) cells and acts as an ER transcriptional coregulator that is recruited by 17-estradiol to the promoters of estrogen target genes. Deletion analyses mapped the ER binding domain to the phosphotyrosine binding domain 2 (PTB2). Ectopic Fe65 increased the transcriptional activity of the ER in a PTB2-dependent manner in reporter assays. Fe65 knockdown decreased, whereas its stable expression increased the transcriptional activity of endogenous ER in BCa cells and the ability of estrogens to stimulate target gene expression, ER, and coactivator recruitment to target gene promoters and cell growth. Furthermore, Fe65 expression decreased the antagonistic activity of tamoxifen (TAM), suggesting a role for Fe65 in TAM resistance. Overall, the studies define a novel role for the neuronal adaptor in estrogen actions in BCa cells.	[Sun, Yuefeng; Kasiappan, Ravi; Tang, Jinfu; Webb, Panida L.; Quarni, Waise; Zhang, Xiaohong; Bai, Wenlong] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Canc Biol, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Evolut, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC 64, Tampa, FL 33612 USA.	wbai@health.usf.edu	Quarni, Waise/J-1095-2019; Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Kasiappan, Ravi/0000-0002-5351-9098; Sun, Yuefeng/0000-0003-4578-856X	National Institutes of Health Public Health Service [R01 CA111334]; Breast Cancer Research Program of United States Department of Defense [W81XWH-09-1-0574]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA111334] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Breast Cancer Research Program of United States Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant R01 CA111334. This work was also supported by an Idea Award from the Breast Cancer Research Program of United States Department of Defense Grant W81XWH-09-1-0574.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bao JY, 2007, MOL CELL BIOL, V27, P1321, DOI 10.1128/MCB.01280-06; Borquez Daniel A, 2012, Int J Alzheimers Dis, V2012, P353145, DOI 10.1155/2012/353145; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gradishar WJ, 2005, BREAST CANCER RES TR, V89, pS17, DOI 10.1007/s10549-005-0144-y; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hu QB, 1999, J NEUROSCI RES, V58, P632, DOI 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Kasiappan R, 2012, J BIOL CHEM, V287, P41297, DOI 10.1074/jbc.M112.407189; Kawai T, 2010, FEBS LETT, V584, P765, DOI 10.1016/j.febslet.2009.12.040; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lee EJ, 2008, BMB REP, V41, P41, DOI 10.5483/BMBRep.2008.41.1.041; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Nakaya T, 2009, FEBS J, V276, P6364, DOI 10.1111/j.1742-4658.2009.07349.x; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; SAVOURET JF, 1994, J BIOL CHEM, V269, P28955; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stante M, 2009, P NATL ACAD SCI USA, V106, P5093, DOI 10.1073/pnas.0810869106; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	47	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12217	12231		10.1074/jbc.M113.526194	http://dx.doi.org/10.1074/jbc.M113.526194			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24619425	Green Published, hybrid			2022-12-25	WOS:000335581400004
J	Lee, H; Yoon, Y				Lee, Hakjoo; Yoon, Yisang			Transient Contraction of Mitochondria Induces Depolarization through the Inner Membrane Dynamin OPA1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer; Membrane; Membrane Fusion; Mitochondria; Drp1; OPA1; Dynamin; Mitochondrial Fission; Proton Leak	PERMEABILITY TRANSITION PORE; TRANSMITTING CABLES; CARDIAC MYOCYTES; OXIDATIVE STRESS; FUSION; RELEASE; ORGANIZATION; MORPHOLOGY; FISSION; CARDIOMYOCYTES	Background: Simultaneous fluctuation of the inner membrane potential in filamentous mitochondria suggests electrical and functional connection. Results: Transient contraction of mitochondrial matrix induces depolarization through the inner membrane fusion dynamin OPA1. Conclusion: Transient mitochondrial contraction is a previously unrecognized cellular mechanism that induces depolarization. Significance: Transient morphological contraction of mitochondria represents a new mechanism regulating mitochondrial activity. Dynamin-related membrane remodeling proteins regulate mitochondrial morphology by mediating fission and fusion. Although mitochondrial morphology is considered an important factor in maintaining mitochondrial function, a direct mechanistic link between mitochondrial morphology and function has not been defined. We report here a previously unrecognized cellular process of transient contraction of the mitochondrial matrix. Importantly, we found that this transient morphological contraction of mitochondria is accompanied by a reversible loss or decrease of inner membrane potential. Fission deficiency greatly amplified this phenomenon, which functionally exhibited an increase of inner membrane proton leak. We found that electron transport activity is necessary for the morphological contraction of mitochondria. Furthermore, we discovered that silencing the inner membrane-associated dynamin optic atrophy 1 (OPA1) in fission deficiency prevented mitochondrial depolarization and decreased proton leak without blocking mitochondrial contraction, indicating that OPA1 is a factor in coupling matrix contraction to mitochondrial depolarization. Our findings show that transient matrix contraction is a novel cellular mechanism regulating mitochondrial activity through the function of the inner membrane dynamin OPA1.	[Lee, Hakjoo; Yoon, Yisang] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Yoon, Y (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	yyoon@gru.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [DK078618, DK061991]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078618, R01DK061991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078618 and DK061991 (to Y.Y.).	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; Diaz G, 2000, FEBS LETT, V475, P218, DOI 10.1016/S0014-5793(00)01683-5; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Galloway CA, 2012, DIABETES, V61, P2093, DOI 10.2337/db11-1640; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hattori T, 2005, BIOPHYS J, V88, P2340, DOI 10.1529/biophysj.104.041483; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jacobson J, 2002, J CELL SCI, V115, P1175; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Santo-Domingo J, 2013, EMBO J, V32, P1927, DOI 10.1038/emboj.2013.124; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	39	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11862	11872		10.1074/jbc.M113.533299	http://dx.doi.org/10.1074/jbc.M113.533299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627489	Green Published, hybrid			2022-12-25	WOS:000335010600028
J	De Jesus, M; Ostroff, GR; Levitz, SM; Bartling, TR; Mantis, NJ				De Jesus, Magdia; Ostroff, Gary R.; Levitz, Stuart M.; Bartling, Toni R.; Mantis, Nicholas J.			A Population of Langerin-Positive Dendritic Cells in Murine Peyer's Patches Involved in Sampling beta-Glucan Microparticles	PLOS ONE			English	Article							C-TYPE LECTIN; SUBEPITHELIAL DOME; IMMUNE-RESPONSES; INNATE IMMUNITY; T-CELL; RECOGNITION; PATHOGEN; LOCALIZATION; IMMUNIZATION; CD11B(+)	Glucan particles (GPs) are 2-4 mu m hollow, porous shells composed of 1,3-beta-D-glucan that have been effectively used for oral targeted-delivery of a wide range of payloads, including small molecules, siRNA, DNA, and protein antigens. While it has been demonstrated that the transepithelial transport of GPs is mediated by Peyer's patch M cells, the fate of the GPs once within gut-associated lymphoid tissue (GALT) is not known. Here we report that fluorescently labeled GPs administered to mice by gavage accumulate in CD11c(+) DCs situated in Peyer's patch sub-epithelial dome (SED) regions. GPs appeared in DCs within minutes after gavage and remained within the SED for days afterwards. The co-administration or sequential administration of GPs with differentially labeled GPs or poly(lactic-co-glycolic acid) nanoparticles demonstrated that the SED DC subpopulation in question was capable of internalizing particles of different sizes and material compositions. Phenotypic analysis identified the GP-containing DCs as being CD8(alpha-) and CD11b(lo/-), suggesting they are the so-called myeloid and/or double negative (DN) subset(s) of PP DCs. A survey of C-type lectin receptors (CLRs) known to be expressed by leukocytes within the intestinal mucosa revealed that GP-containing SED DCs were positive for Langerin (CD207), a CLR with specificity for beta-D-glucan and that has been shown to mediate the internalization of a wide range of microbial pathogens, including bacteria, viruses and fungi. The presence of Langerin(+) DCs in the SED as determined by immunofluorescence was confirmed using Langerin E-GFP transgenic mice. In summary, our results demonstrate that following M cell-mediated transepithelial transport, GPs (and other micro/nanoparticles) are sampled by a population of SED DCs distinguished from other Peyer's patch DC subsets by their expression of Langerin. Future studies will be aimed at defining the role of Langerin in antigen sampling and antigen presentation within the context of the GALT.	[De Jesus, Magdia; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12237 USA; [Ostroff, Gary R.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Bartling, Toni R.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA; [Mantis, Nicholas J.] Univ Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12237 USA.	nmantis@wadsworth.org		Mantis, Nicholas/0000-0002-5083-8640	Life Sciences Research Foundation, Howard Hughes Medical Institute (HHMI); American Society for Microbiology; National Institutes of Health [HD061916, GM082978, AI025780, AI102618, HL112671];  [R01DK085753];  [1R21AI094074]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102618, R01AI025780, R21AI094074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082978] Funding Source: NIH RePORTER	Life Sciences Research Foundation, Howard Hughes Medical Institute (HHMI); American Society for Microbiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MDJ was supported by the Life Sciences Research Foundation, Howard Hughes Medical Institute (HHMI) sponsored fellowship. MDJ also acknowledges the generous support of a 2012 Career Development award for Postdoctoral Women from the American Society for Microbiology. This work was supported in part by National Institutes of Health grants HD061916 and GM082978 to NJM. GRO was supported in part by R01DK085753 and 1R21AI094074. SML was supported in part by National Institutes of Health grants AI025780, AI102618, and HL112671. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; BENACH JL, 1982, INFECT IMMUN, V35, P947, DOI 10.1128/IAI.35.3.947-951.1982; Chang SY, 2010, IMMUNOL REV, V234, P233, DOI 10.1111/j.0105-2896.2009.00878.x; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; De Smet R, 2013, J CONTROL RELEASE, V172, P671, DOI 10.1016/j.jconrel.2013.09.007; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Hopkins SA, 1997, ADV EXP MED BIOL, V417, P105; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Huang H, 2013, CLIN VACCINE IMMUNOL; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Igyarto BZ, 2013, CURR OPIN IMMUNOL, V25, P115, DOI 10.1016/j.coi.2012.11.007; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Lopatin U, 2013, J VIROL, V87, P524, DOI 10.1128/JVI.01801-12; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Preza GC, 2013, AIDS RES HUM RETROVI; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rochereau N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001658; Rochereau N, 2011, VACCINE, V29, P3655, DOI 10.1016/j.vaccine.2011.03.012; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Shin MK, 2013, MICROBIOL IMMUNOL, V57, P417, DOI 10.1111/1348-0421.12053; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Soto ER, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/143524; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; van den Berg LM, 2013, ADV EXP MED BIOL, V762, P45, DOI 10.1007/978-1-4614-4433-6_2	42	44	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91002	10.1371/journal.pone.0091002	http://dx.doi.org/10.1371/journal.pone.0091002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632738	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400031
J	Sugiura, T; Kawaguchi, Y; Goto, K; Hayashi, Y; Gono, T; Furuya, T; Nishino, I; Yamanaka, H				Sugiura, Tomoko; Kawaguchi, Yasushi; Goto, Kanako; Hayashi, Yukiko; Gono, Takahisa; Furuya, Takefumi; Nishino, Ichizo; Yamanaka, Hisashi			Association between a C8orf13-BLK Polymorphism and Polymyositis/Dermatomyositis in the Japanese Population: An Additive Effect with STAT4 on Disease Susceptibility	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IDIOPATHIC INFLAMMATORY MYOPATHY; RHEUMATOID-ARTHRITIS; EXPRESSION; HAPLOTYPE; MYOSITIS; REGION; RISK; GENE	Background: Accumulating evidence has shown that several non-HLA genes are involved in the susceptibility to polymyositis/dermatomyositis. This study aimed to investigate the involvement of C8orf13-BLK, one of the strongest candidate genes for autoimmune diseases, in susceptibility to polymyositis/dermatomyositis in the Japanese population. A possible gene-gene interaction between C8orf13-BLK and STAT4, which we recently showed to be associated with Japanese polymyositis/dermatomyositis, was also analyzed. Methods: A single-nucleotide polymorphism in C8orf13-BLK (dbSNP ID: rs13277113) was investigated in the Japanese population using a TaqMan assay in 283 polymyositis patients, 194 dermatomyositis patients, and 656 control subjects. Results: The C8orf13-BLK rs13277113A allele was associated with overall polymyositis/dermatomyositis (P<0.001, odds ratio [OR] 1.44, 95% confidence interval [CI] 1.19-1.73), as well as polymyositis (P = 0.011, OR 1.32, 95% CI 1.06-1.64) and dermatomyositis (P<0.001, OR 1.64, 95% CI 1.26-2.12). No association was observed between the C8orf13-BLK rs13277113A allele and either interstitial lung disease or anti-Jo-1 antibody positivity. The C8orf13-BLK rs13277113 A and STAT4 rs7574865 T alleles had an additive effect on polymyositis/ dermatomyositis susceptibility. The strongest association was observed in dermatomyositis, with an OR of 3.07 (95% CI; 1.57-6.02) for the carriers of four risk alleles at the two SNP sites, namely, rs1327713 and rs7574865. Conclusions: This study established C8orf13-BLK as a new genetic susceptibility factor for polymyositis/ dermatomyositis. Both C8orf13-BLK and STAT4 exert additive effects on disease susceptibility. These observations suggested that C8orf13-BLK, in combination with STAT4, plays a pivotal role in creating genetic susceptibility to polymyositis/ dermatomyositis in Japanese individuals.	[Sugiura, Tomoko; Kawaguchi, Yasushi; Gono, Takahisa; Furuya, Takefumi; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Goto, Kanako; Hayashi, Yukiko; Nishino, Ichizo] Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Goto, Kanako; Hayashi, Yukiko; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Dev, Tokyo, Japan	Tokyo Women's Medical University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Kawaguchi, Y (corresponding author), Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan.	y-kawa@ior.twmu.ac.jp	Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X	Ministry of Health, Labor, and Welfare, Japan; National Center of Neurology and Psychiatry [23-4, 23-5]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)	This study was supported by autoimmune disease research grants from the Ministry of Health, Labor, and Welfare, Japan and was partly supported by an Intramural Research Grant (23-4, 23-5) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chinoy H, 2008, ARTHRITIS RHEUM-US, V58, P3247, DOI 10.1002/art.23900; Chinoy H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3327; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Fan Y, 2011, MOL BIOL REP, V38, P4445, DOI 10.1007/s11033-010-0573-5; Furuya T, 2004, J RHEUMATOL, V31, P1768; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ito I, 2010, ARTHRITIS RHEUM-US, V62, P890, DOI 10.1002/art.27303; Ito I, 2009, ARTHRITIS RHEUM-US, V60, P553, DOI 10.1002/art.24246; Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216; Kawasaki A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2516; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Koga M, 2011, J HUM GENET, V56, P503, DOI 10.1038/jhg.2011.49; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Miller FW, 2013, ARTHRITIS RHEUM-US, V65, P3239, DOI 10.1002/art.38137; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Ramesha KN, 2010, ANN INDIAN ACAD NEUR, V13, P250, DOI 10.4103/0972-2327.74190; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rider LG, 1999, ARTHRITIS RHEUM, V42, P1285, DOI 10.1002/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1; Samuelson EM, 2012, IMMUNOL CELL BIOL, V90, P620, DOI 10.1038/icb.2011.76; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Sugiura T, 2012, ANN RHEUM DIS, V71, P1646, DOI 10.1136/annrheumdis-2011-200839; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x	28	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90019	10.1371/journal.pone.0090019	http://dx.doi.org/10.1371/journal.pone.0090019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632671	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400009
J	Evans, MF; Peng, ZH; Clark, KM; Adamson, CSC; Ma, XJ; Wu, XY; Wang, HW; Luo, YL; Cooper, K				Evans, Mark F.; Peng, Zhihua; Clark, Kelli M.; Adamson, Christine S. -C.; Ma, Xiao-Jun; Wu, Xingyong; Wang, Hongwei; Luo, Yuling; Cooper, Kumarasen			HPV E6/E7 RNA In Situ Hybridization Signal Patterns as Biomarkers of Three-Tier Cervical Intraepithelial Neoplasia Grade	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; GENE-EXPRESSION; LIFE-CYCLE; RISK; TRANSCRIPTS; MANAGEMENT; REGRESSION; BIOLOGY; CANCER; SENSE	Cervical lesion grading is critical for effective patient management. A three-tier classification (cervical intraepithelial neoplasia [CIN] grade 1, 2 or 3) based on H&E slide review is widely used. However, for reasons of considerable inter-observer variation in CIN grade assignment and for want of a biomarker validating a three-fold stratification, CAP-ASCCP LAST consensus guidelines recommend a two-tier system: low-or high-grade squamous intraepithelial lesions (LSIL or HSIL). In this study, high-risk HPV E6/E7 and p16 mRNA expression patterns in eighty-six CIN lesions were investigated by RNAscope chromogenic in situ hybridization (CISH). Specimens were also screened by immunohistochemistry for p16(INK4a) (clone E6H4), and by tyramide-based CISH for HPV DNA. HPV genotyping was performed by GP5+/6+ PCR combined with cycle-sequencing. Abundant high-risk HPV RNA CISH signals were detected in 26/32 (81.3%) CIN 1, 22/22 (100%) CIN 2 and in 32/32 (100%) CIN 3 lesions. CIN 1 staining patterns were typified (67.7% specimens) by abundant diffusely staining nuclei in the upper epithelial layers; CIN 2 lesions mostly (66.7%) showed a combination of superficial diffuse-stained nuclei and multiple dot-like nuclear and cytoplasmic signals throughout the epithelium; CIN 3 lesions were characterized (87.5%) by multiple dot-like nuclear and cytoplasmic signals throughout the epithelial thickness and absence/scarcity of diffusely staining nuclei (trend across CIN grades: P<0.0001). These data are consistent with productive phase HPV infections exemplifying CIN 1, transformative phase infections CIN 3, whereas CIN 2 shows both productive and transformative phase elements. Three-tier data correlation was not found for the other assays examined. The dual discernment of diffuse and/or dot-like signals together with the assay's high sensitivity for HPV support the use of HPV E6/E7 RNA CISH as an adjunct test for deciding lesion grade when CIN 2 grading may be beneficial (e.g. among young women) or when 'LSIL vs. HSIL' assignment is equivocal.	[Evans, Mark F.; Peng, Zhihua; Clark, Kelli M.; Adamson, Christine S. -C.; Cooper, Kumarasen] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Clark, Kelli M.; Cooper, Kumarasen] Fletcher Allen Hlth Care, Dept Pathol & Lab Med, Burlington, VT USA; [Ma, Xiao-Jun; Wu, Xingyong; Wang, Hongwei; Luo, Yuling] Adv Cell Diagnost Inc, Hayward, CA USA	University of Vermont; University of Vermont Medical Center	Evans, MF (corresponding author), Univ Vermont, Dept Pathol, Burlington, VT 05405 USA.	mark.evans@med.uvm.edu	Evans, Mark/GYU-3450-2022		University of Vermont Department of Pathology	University of Vermont Department of Pathology	This study was supported by the University of Vermont Department of Pathology. RNAscope in situ hybridization was performed by Advanced Cell Diagnostics (ACD), Hayward, CA at no charge. Authors Xiao-Jun Ma, Xingyong Wu, Hongwei Wang and Yuling Luo are employees and shareholders of ACD. XJM and YL contributed reagents, materials and technical consultancy on the performance of RNAscope assays, which were performed by XW and HW at ACDs facility in Hayward, CA. XJM contributed text for the technical sections of the manuscript. ACD employees had no role in study design, data interpretation, control over manuscript contents or decision to publish.	Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; COOPER K, 1991, J CLIN PATHOL, V44, P400, DOI 10.1136/jcp.44.5.400; Crum C, US CAN AC PATH USCAP; Crum CP, 2008, AM J CLIN PATHOL, V130, P162, DOI 10.1309/GCVB5C4KFV7TFC7F; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; Doeberitz MV, 2012, EXPERT REV PROTEOMIC, V9, P149, DOI [10.1586/epr.12.13, 10.1586/EPR.12.13]; Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; DURST M, 1992, VIROLOGY, V189, P132, DOI 10.1016/0042-6822(92)90688-L; Evans MF, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-10; Evans MF, 2003, EUR J GYNAECOL ONCOL, V24, P373; Evans MF, 2002, MODERN PATHOL, V15, P1339, DOI 10.1038/modpathol.3880698; Fukuchi E, 2013, J LOW GENIT TRACT DI, V17, P255, DOI 10.1097/LGT.0b013e31826ca4d9; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; HIGGINS GD, 1992, CANCER-AM CANCER SOC, V70, P136, DOI 10.1002/1097-0142(19920701)70:1<136::AID-CNCR2820700123>3.0.CO;2-2; HIGGINS GD, 1991, J GEN VIROL, V72, P885, DOI 10.1099/0022-1317-72-4-885; HIGGINS GD, 1992, J GEN VIROL, V73, P2047, DOI 10.1099/0022-1317-73-8-2047; HIGGINS GD, 1991, CANCER-AM CANCER SOC, V68, P561, DOI 10.1002/1097-0142(19910801)68:3<561::AID-CNCR2820680320>3.0.CO;2-R; HUSMAN AMD, 1995, BRIT J CANCER, V72, P412, DOI 10.1038/bjc.1995.347; McAllum B, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.069; Moscicki AB, 2010, OBSTET GYNECOL, V116, P1373, DOI 10.1097/AOG.0b013e3181fe777f; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; STOLER MH, 1986, HUM PATHOL, V17, P1250, DOI 10.1016/S0046-8177(86)80569-X; Stoler MH, US CAN AC PATH USCAP; Syrjanen K, 2012, EUR J GYNAECOL ONCOL, V33, P5; Syrjanen K, 2009, CME J GYNECOL ONCOL, V14, P4; Triglia RD, 2009, GYNECOL ONCOL, V112, P114, DOI 10.1016/j.ygyno.2008.09.047; VORMWALDDOGAN V, 1992, J GEN VIROL, V73, P1833, DOI 10.1099/0022-1317-73-7-1833; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Waxman AG, 2012, OBSTET GYNECOL, V120, P1465, DOI [10.1097/AOG.0b013e31827001d5, http://10.1097/AOG.0b013e31827001d5]; Zeng SY, 2012, EUR J GYNAECOL ONCOL, V33, P257	37	35	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91142	10.1371/journal.pone.0091142	http://dx.doi.org/10.1371/journal.pone.0091142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625757	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300058
J	Rao, XG; Huang, DF; Sui, XX; Liu, GF; Song, XH; Xie, JL; Huang, DY				Rao, Xuguang; Huang, Daofu; Sui, Xuxia; Liu, Gefei; Song, Xuhong; Xie, Jinglian; Huang, Dongyang			Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; EXPRESSION; GENE; P53; REGULATOR; ANTIGEN; TARGET; ROLES; RISK	Background: Esophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer whose underlying molecular mechanisms are poorly understood. The natural antisense transcript (NAT) WRAP53 regulates p53 expression and WRAP53 protein is a component of telomerase. NATs play key roles in carcinogenesis, and although WRAP53 is known to increase cancer cell survival, its role in ESCC clinicopathology is unknown. The aim of this study was to investigate WRAP53 expression in ESCC and to correlate it with clinicopathological characteristics. Methods: WRAP53 mRNA and protein expression was measured by quantitative PCR (qRT-PCR) and western blotting, respectively, in 4 ESSC cells lines and in 45 paired ESCC and non-neoplastic esophageal mucosa tissues. To correlate WRAP53 protein expression with clinicopathological characteristics, immunohistochemistry (IHC) was performed on 134 ESCC and 85 non-neoplastic esophageal mucosa tissues. Results: Expression of WRAP53 was detected in all ESCC cell lines and was upregulated in the ESCC tissues compared with the corresponding non-neoplastic tissues (P<0.01). More cells expressed WRAP53 protein in the ESCC tissues than in the non-neoplastic tissues (P<0.01). Overexpression of WRAP53 was significantly correlated with tumor infiltration depth (P = 0.000), clinical stage (P = 0.001), and lymph node metastasis (P = 0.025). Wrap53 expression was not correlated with age, gender, or tumor differentiation. Conclusion: This report indicates increased expression of WRAP53 in ESCC and that WRAP53 overexpression is correlated with tumor progression. WRAP53 may play a significant role in ESCC; accordingly, WRAP53 could be a useful biomarker for ESCC.	[Rao, Xuguang; Huang, Daofu; Xie, Jinglian] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, Shantou, Guangdong, Peoples R China; [Rao, Xuguang] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China; [Sui, Xuxia; Liu, Gefei; Song, Xuhong; Huang, Dongyang] Shantou Univ, Coll Med, Dept Cell Biol, Key Lab High Canc Incidence Coastal Chaoshan Area, Shantou, Guangdong, Peoples R China	Shantou University; Guangzhou Medical University; Shantou University	Huang, DY (corresponding author), Shantou Univ, Coll Med, Dept Cell Biol, Key Lab High Canc Incidence Coastal Chaoshan Area, Shantou, Guangdong, Peoples R China.	huangdy@stu.edu.cn			Guangdong Natural Science Foundation [10151503102000049, S2012030006289]; Natural Scientific Foundation of China [31371333]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Guangdong Natural Science Foundation (No. 10151503102000049 and No. S2012030006289) and Natural Scientific Foundation of China (31371333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Cancer Institute of the Chinese Academy of Medical Sciences (CICAMS), 1976, CHIN MED J, V2, P357; Dolnick BJ, 2003, CANCER BIOL THER, V2, P364, DOI 10.4161/cbt.2.4.424; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Farnebo M, 2009, CELL CYCLE, V8, P2343, DOI 10.4161/cc.8.15.9223; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; Lam AKY, 2000, CRIT REV ONCOL HEMAT, V33, P71, DOI 10.1016/S1040-8428(99)00054-2; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Lin M, 2012, CHINESE SCI BULL, V57, P959, DOI 10.1007/s11434-011-4917-x; Lu XF, 2010, CELL MOL LIFE SCI, V67, P3313, DOI 10.1007/s00018-010-0382-y; Mahmoudi S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.90; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Metindir J, 2008, EUR J GYNAECOL ONCOL, V29, P489; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Oto OA, 2007, LEUKEMIA RES, V31, P1495, DOI 10.1016/j.leukres.2007.01.005; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rossignol F, 2002, GENE, V299, P135, DOI 10.1016/S0378-1119(02)01049-1; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, CELL CYCLE, V8, P1329, DOI 10.4161/cc.8.9.8288; Wang LD, 2002, DIS ESOPHAGUS, V15, P80, DOI 10.1046/j.1442-2050.2002.00228.x; Wang N, 2009, MOL BIOL REP, V36, P357, DOI 10.1007/s11033-007-9187-y; Xu Xiao-chun, 2009, V471, P335, DOI 10.1007/978-1-59745-416-2_17; Yao XQ, 2004, WORLD J GASTROENTERO, V10, P1262; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang SC, 2007, J MOL MED, V85, P1215, DOI 10.1007/s00109-007-0219-9; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	31	21	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91670	10.1371/journal.pone.0091670	http://dx.doi.org/10.1371/journal.pone.0091670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626331	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300117
J	Sun, SJ; Han, YY; Liu, J; Fang, Y; Tian, Y; Zhou, JF; Ma, D; Wu, P				Sun, Shujuan; Han, Yingyan; Liu, Jia; Fang, Yong; Tian, Yuan; Zhou, Jianfeng; Ma, Ding; Wu, Peng			Trichostatin A Targets the Mitochondrial Respiratory Chain, Increasing Mitochondrial Reactive Oxygen Species Production to Trigger Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; THIOREDOXIN; THERAPY; DRUGS; TRANSCRIPTION; METABOLISM; INDUCTION; PATHWAY; GROWTH	Aim: Histone deacetylase inhibitors (HDACIs)-based therapies have stimulated interest via their anti-tumor activities, including apoptosis induction, cell cycle arrest, cell differentiation, and autophagy. However, the mechanisms of HDACI-associated anti-tumor activity are not yet clearly defined. The aim of this study was to explore the key events of Trichostatin A (TSA), a classic HDACI agent, against breast cancer cells. Methods: The MCF-7, MDA-MB-231 and MCF-10A cell lines were evaluated with colony-forming and cell viability assays. Apoptosis and cell cycle distribution were detected by flow cytometry. Mitochondrial function was measured with biochemical assays, flow cytometry and transmission electron microscopy. Results: TSA inhibited breast cancer cell viability and proliferation, without affecting MCF-10A cell. TSA-induced breast cancer cell apoptosis was initiated by G2-M arrest and depended on mitochondrial reactive oxygen species (ROS) produced subsequent to reduced mitochondrial respiratory chain activity. The enhanced mitochondrial ROS production and apoptosis in cancer cells were markedly attenuated by antioxidants, such as N-acetyl cysteine (NAC), reduced glutathione (GSH) and Vitamin C. Conclusion: The present study demonstrated that TSA-induced cell death by arresting cell cycle in G2-M phase and was dependent on production of mitochondria-derived ROS, which was derived from impaired mitochondrial respiratory chain.	[Sun, Shujuan; Han, Yingyan; Liu, Jia; Fang, Yong; Tian, Yuan; Zhou, Jianfeng; Ma, Ding; Wu, Peng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Peoples R China.	dma@tjh.tjmu.edu.cn; pengwu8626@126.com	wu, peng/M-1812-2019	wu, peng/0000-0002-4016-6641	National Science Foundation of China [81372806, 81101962, 81101965, 81202060, 20120142120049]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by Grant Supports: National Science Foundation of China (81372806; 81101962; 81101965; 81202060; 20120142120049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Bernhard D, 1999, FASEB J, V13, P1991, DOI 10.1096/fasebj.13.14.1991; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; de la Vega L, 2012, MOL CELL, V46, P472, DOI 10.1016/j.molcel.2012.03.003; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Lustberg MB, 2011, CURR BREAST CANCER R, V3, P34, DOI 10.1007/s12609-010-0034-0; Ma XL, 2010, CLIN CANCER RES, V16, P5165, DOI 10.1158/1078-0432.CCR-09-3174; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Mo QQ, 2013, ACTA PHARMACOL SIN, V34, P541, DOI 10.1038/aps.2012.197; Pandolfi PP, 2001, ONCOGENE, V20, P3116, DOI 10.1038/sj.onc.1204299; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Rajendran P, 2011, CRIT REV BIOCHEM MOL, V46, P181, DOI 10.3109/10409238.2011.557713; Rosato RR, 2003, CANCER RES, V63, P3637; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Schmidt K, 1999, ARCH PHARM, V332, P353, DOI 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stearman RS, 2007, MOL CANCER RES, V5, P295, DOI 10.1158/1541-7786.MCR-06-0221; TSUJI N, 1976, J ANTIBIOT, V29, P1, DOI 10.7164/antibiotics.29.1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu P, 2010, CELL DEATH DIFFER, V17, P109, DOI 10.1038/cdd.2009.142; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhu Y, 2013, ONCOGENE IN PRESS	31	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91610	10.1371/journal.pone.0091610	http://dx.doi.org/10.1371/journal.pone.0091610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626188	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300108
J	Hoffmeister, MC; Briceno, JDC; Nielsen, SN				Chavez Hoffmeister, Martin; Carrillo Briceno, Jorge D.; Nielsen, Sven N.			The Evolution of Seabirds in the Humboldt Current: New Clues from the Pliocene of Central Chile	PLOS ONE			English	Article							FOSSIL PENGUINS; SOUTHERN; MIOCENE; SPHENISCIFORMES; PERU; AVES; BIOGEOGRAPHY; SPHENISCUS; PATTERNS; NORTHERN	Background: During the last decade, new Neogene fossil assemblages from South America have revealed important clues about the evolution of seabird faunas in one of the major upwelling systems of the world: the Humboldt Current. However, most of this record comes from arid Northern Chile and Southern Peru and, in consequence, our knowledge of the evolutionary history of seabirds in the temperate transitional zone is negligible. A new Late Pliocene assemblage of fossil birds from the coastal locality of Horcon in Central Chile offers a unique opportunity to fill this gap. Principal Findings: Isolated bones of a medium-sized penguin are the most abundant bird remains. Morphological and cladistic analyses reveal that these specimens represent a new species of crested penguin, Eudyptes calauina sp. nov. Eudyptes is a penguin genus that inhabit temperate and subantarctic regions and currently absent in central Chile. Additionally, a partial skeleton of a small species of cormorant and a partial tarsometatarsus of a sooty shearwater have been identified. Conclusion/Significance: The Horcon fossils suggest the existence of a mixed avifauna in central Chile during the Pliocene in concordance with the latitudinal thermal gradient. This resembles the current assemblages from the transitional zone, with the presence of species shared with Northern Chile and Southern Peru and a previously unrecorded penguin currently absent from the Humboldt System but present in the Magellanic region. Comparison of Pliocene seabird diversity across the Pacific coast of South America shows that the Horcon avifauna represents a distinctive assemblage linking the living faunas with the Late Miocene ones. A comparison with the fossil record near the Benguela Current (west coast of southern Africa) suggests that the thermic gradient could play an important role in the preservation of a higher diversity of cold/temperate seabirds in the Humboldt Current.	[Chavez Hoffmeister, Martin] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Carrillo Briceno, Jorge D.] Univ Zurich, Palaeontol Inst & Museum, Zurich, Switzerland; [Chavez Hoffmeister, Martin; Nielsen, Sven N.] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Valdivia, Chile	University of Bristol; University of Zurich; Universidad Austral de Chile	Hoffmeister, MC (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	glmfch@bristol.ac.uk	Nielsen, Sven N/A-2187-2009	Nielsen, Sven N/0000-0003-2064-8050; Chavez Hoffmeister, Martin/0000-0001-5940-5983; Carrillo Briceno, Jorge Domingo/0000-0002-8652-7692	Direccion de Investigacion y Desarrollo (DID) of the Universidad Austral de Chile	Direccion de Investigacion y Desarrollo (DID) of the Universidad Austral de Chile	The Direccion de Investigacion y Desarrollo (DID) of the Universidad Austral de Chile provided funding to cover part of the Publication Fees of the present paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Acosta Hospitaleche C, 2006, REV ESPANOLA PALEONT, V21, P115; Acosta Hospitaleche Carolina, 2005, Revista Espanola de Paleontologia, V20, P1; Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Avery Graham, 2011, Transactions of the Royal Society of South Africa, V66, P14, DOI 10.1080/0035919X.2011.564490; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Carrillo-Briceno JD, 2013, REV CHIL HIST NAT, V86, P191, DOI 10.4067/S0716-078X2013000200008; Chandler RM, 1990, ORNITHOL MONOGR, V44, P73; Chavez M., 2007, B I FRANCAIS ETUDES, V36, P175; Chavez Martin, 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P551; Chavez MF, 2007, REV CHIL HIST NAT, V80, P255; Cheneval Jacques, 1993, Documents des Laboratoires de Geologie Lyon, V125, P85; Crawford RJM, 2006, AFR J MAR SCI, V28, P553, DOI 10.2989/18142320609504205; Davis LS., 2003, PENGUINS; De Muizon C, 2004, J VERTEBR PALEONTOL, V24, P398, DOI 10.1671/2429b; DeFrance SD, 2005, J ARCHAEOL SCI, V32, P1131, DOI 10.1016/j.jas.2005.03.001; DeVries Thomas J., 1997, Tulane Studies in Geology and Paleontology, V30, P125; DeVries TJ, 2005, VELIGER, V47, P277; DeVries TJ, 1997, J PALEONTOL, V71, P610, DOI 10.1017/S0022336000040099; Dowsett HJ, 2009, CLIM PAST, V5, P769, DOI 10.5194/cp-5-769-2009; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; DUFFY DC, 1983, BIOL CONSERV, V26, P227, DOI 10.1016/0006-3207(83)90075-7; Ehret DJ, 2012, PALAEONTOLOGY, V55, P1139, DOI 10.1111/j.1475-4983.2012.01201.x; Emslie SD, 2003, P BIOL SOC WASH, V116, P308; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Forsythe R.D., 1985, Revista Geologica de Chile, V25-26, P3; Frassinetti C. Daniel, 2000, Boletin del Museo Nacional de Historia Natural Chile, V49, P131; Garcia P, 2013, PENGUINS NATURAL HIS; Gohlich UB, 2007, ACTA PALAEONTOL POL, V52, P285; Griffin M, 2008, J SYST PALAEONTOL, V6, P251, DOI 10.1017/S1477201907002374; HARRISON P, 1985, SEABIRDS IDENTIFICAT; Hartmann-Schroder VG, 1962, MITTEILUNGEN HAMBU S, V60, P270; Herm D., 1969, Zitteliana, V2, P1; Hospitaleche CA, 2007, ACTA PALAEONTOL POL, V52, P299; Hospitaleche CA, 2006, REV GEOL CHILE, V33, P327; Howard H., 1971, Contr Sci, VNo. 217, P1; Howard H, 1949, CARNEGIE I WASHINGTO, V584, P179; KNOX GA, 1960, PROC R SOC SER B-BIO, V152, P577, DOI 10.1098/rspb.1960.0068; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Ksepka DT, 2012, J VERTEBR PALEONTOL, V32, P235, DOI 10.1080/02724634.2012.652051; Ksepka DT, 2012, P ROY SOC B-BIOL SCI, V279, P1027, DOI 10.1098/rspb.2011.1592; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Ksepka DT., 2011, LIVING DINOSAURS EVO, P155, DOI DOI 10.1002/9781119990475.CH6; Le Roux JP, 2012, SEDIMENT GEOL, V247, P1, DOI 10.1016/j.sedgeo.2011.12.014; LIVEZEY BC, 1989, J ZOOL, V219, P269, DOI 10.1111/j.1469-7998.1989.tb02582.x; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; Nielsen SN, 2013, PALAEONTOL Z, V87, P33, DOI 10.1007/s12542-012-0146-0; Oehler DA, 2008, WILSON J ORNITHOL, V120, P575, DOI 10.1676/07-108.1; OLSON S L, 1985, Annals of the South African Museum, V95, P123; OLSON SL, 1983, S AFR J SCI, V79, P399; Sallaberry M, 2006, BIOL RES SB, V39, pR; Schlatter Roberto P., 1999, Estudios Oceanologicos, V18, P25; SIMPSON G G, 1972, Records of the Canterbury Museum, V9, P159; STUCCHI M, 2005, B SOC GEOLOGICA PERU, V100, P67; Stucchi M, 2003, B SOC GEOLOGICA PERU, V96, P117; STUCCHI M, 2003, B SOC GEOLOGICA PERU, V95, P75; Stucchi M, 2007, 4 EUR M PAL STRAT LA; Stucchi M., 2002, B SOC GEOL PERU, V94, P19; Subramanian S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0748; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tavera J, 1960, FACULTAD CIENCIAS FI, V17, P346; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; THOMAS H, 1958, I INVESTIGACIONES GE, V2, P1; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Urbina M, 2005, B SOC GEOLOGICA PERU, V99, P41; Valenzuela-Toro AM, 2013, J VERTEBR PALEONTOL, V33, P216, DOI 10.1080/02724634.2012.710282; Walsh S.A., 2006, HIST BIOL, V18, P119, DOI [DOI 10.1080/08912960600640796, 10.1080/08912960600640796]; Walsh SA, 2001, J VERTEBR PALEONTOL, V21, P484, DOI 10.1671/0272-4634(2001)021[0484:ANNMAA]2.0.CO;2; Warheit Kenneth I., 2002, P17; WARHEIT KI, 1992, SYST BIOL, V41, P345, DOI 10.2307/2992571; WARHEIT KI, 1992, PALEOBIOLOGY, V18, P401, DOI 10.1017/S0094837300010976; Weimerskirch H, 2012, MAR ECOL PROG SER, V458, P231, DOI 10.3354/meps09752; Worthy Trevor H., 1997, New Zealand Natural Sciences, V23, P71	74	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90043	10.1371/journal.pone.0090043	http://dx.doi.org/10.1371/journal.pone.0090043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621560	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000332845300012
J	Gao, T; Han, Y; Yu, L; Ao, S; Li, ZY; Ji, JF				Gao, Tian; Han, Yong; Yu, Ling; Ao, Sheng; Li, Ziyu; Ji, Jiafu			CCNA2 Is a Prognostic Biomarker for ER plus Breast Cancer and Tamoxifen Resistance	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; MICROARRAY DATA; CYCLIN A2; SURVIVAL; GENE; OVEREXPRESSION; RECURRENCE	Identification of effective prognostic biomarkers and targets are of crucial importance to the management of estrogen receptor positive (ER+) breast cancer. CCNA2 (also known as CyclinA2) belongs to the highly conserved cyclin family and is significantly overexpressed in various cancer types. In this study, we demonstrated that CCNA2 had significant predictive power in distant metastasis free survival, disease free survival, recurrence free survival and overall survival of ER+ breast cancer patients. We also found that CCNA2 was closely associated with tamoxifen resistance. In addition, gene set enrichment analysis (GSEA) revealed that its expression was positively associated with genes overexpressed in endocrine therapy resistant samples. Finally, though CCNA2-Drug interaction network, we demonstrated the interactions between CCNA2 and several available cancer drugs. Overall, we suggest that CCNA2 is a biomarker for the prognosis of ER+ breast cancer and monitoring of tamoxifen efficacy. It's also a promising target for developing new strategies to prevent or even reverse tamoxifen resistance. Moreover, CCNA2 expression may help monitoring tamoxifen efficacy and directing personalized therapies. Nevertheless, in vivo and in vitro experiments and multi-center randomized controlled clinical trials are still needed before its application in clinical settings.	[Gao, Tian; Ao, Sheng; Li, Ziyu; Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Gastrointestinal Surg, Beijing 100871, Peoples R China; [Han, Yong] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Yu, Ling] Wuhan Univ, Dept Orthoped, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China	Peking University; Peking University; Wuhan University	Ji, JF (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Gastrointestinal Surg, Beijing 100871, Peoples R China.	JiafJi2002@gmail.com		Han, Yong/0000-0001-9935-2978				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Bendris Nawal, 2012, Small GTPases, V3, P225, DOI 10.4161/sgtp.20791; Bergh J, 2000, LANCET, V355, P944, DOI 10.1016/S0140-6736(00)90007-2; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Castellano I, 2013, ANN ONCOL, V24, P2292, DOI 10.1093/annonc/mdt183; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Davis AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058201; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Guo SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052380; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hiscox S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-458; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Johansson HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3175; Ko E, 2013, ANN SURG ONCOL, V20, P1005, DOI 10.1245/s10434-012-2727-2; Loh YN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-174; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Osborne CK, 2003, BREAST, V12, P362, DOI 10.1016/S0960-9776(03)00137-1; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Palmieri C, 2013, MOL CELL ENDOCRINOL, V7; Piva M, 2013, EMBO MOL MED, V31; Ruckhaberle E, 2009, CLIMACTERIC, V12, P502, DOI 10.3109/13697130902939913; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taminau J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-335; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ur-Rehman S, 2013, BREAST CANCER RES TR, V139, P907, DOI 10.1007/s10549-013-2593-z; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Xu XL, 2013, BREAST CANCER RES TR, V139, P329, DOI 10.1007/s10549-013-2563-5; Yamamoto M, 2013, CANCER SCI, V10, P12302	39	75	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91771	10.1371/journal.pone.0091771	http://dx.doi.org/10.1371/journal.pone.0091771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622579	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300127
J	Moreno-Palomo, J; Creus, A; Marcos, R; Hernandez, A				Moreno-Palomo, Jennifer; Creus, Amadeu; Marcos, Ricard; Hernandez, Alba			Genomic Instability in Newborn with Short Telomeres	PLOS ONE			English	Article							PRENATAL STRESS; LENGTH; RISK; DYSFUNCTION; CANCER; BLOOD; INDUCTION; DIET; END	Telomere length is considered to be a risk factor in adults due to its proved association with cancer incidence and mortality. Since newborn present a wide interindividual variation in mean telomere length, it is relevant to demonstrate if these differences in length can act also as an early risk indicator. To answer this question, we have measured the mean telomere length of 74 samples of cord blood from newborns and studied its association with the basal genetic damage, measured as the frequency of binucleated cells carrying micronuclei. In addition, we have challenged the cells of a subgroup of individuals (N = 35) against mitomycin-C (MMC) to establish their sensitivity to induced genomic instability. Results indicate that newborn with shorter telomeres present significantly higher levels of genetic damage when compared to those with longer telomeres. In addition, the cellular response to MMC was also significantly higher among those samples from subjects with shorter telomeres. Independently of the causal mechanisms involved, our results show for the first time that telomere length at delivery influence both the basal and induced genetic damage of the individual. Impact: Individuals born with shorter telomeres may be at increased risk, especially for those biological processes triggered by genomic instability as is the case of cancer and other age-related diseases.	[Moreno-Palomo, Jennifer; Creus, Amadeu; Marcos, Ricard; Hernandez, Alba] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Mutagenesi, Cerdanyola Del Valles, Spain; [Creus, Amadeu; Marcos, Ricard; Hernandez, Alba] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ, Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Marcos, R (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Mutagenesi, Campus Bellaterra, Cerdanyola Del Valles, Spain.	ricard.marcos@uab.es; alba.hernandez@uab.es	Creus, Amadeu/A-7778-2013; Marcos, Ricard/G-9671-2015; Hernandez, Alba/H-5251-2015	Creus, Amadeu/0000-0003-0848-9448; Marcos, Ricard/0000-0001-7891-357X; Hernandez, Alba/0000-0001-6938-1233	Generalitat de Catalunya (CIRIT) [2009SGR-725]	Generalitat de Catalunya (CIRIT)(Generalitat de Catalunya)	This work was supported by Generalitat de Catalunya (CIRIT, 2009SGR-725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Ban S, 2004, J RADIAT RES, V45, P535, DOI 10.1269/jrr.45.535; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Callen E, 2004, MUTAT RES-REV MUTAT, V567, P85, DOI 10.1016/j.mrrev.2004.06.003; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Castella A, 2007, TOXICOL LETT, V172, P29, DOI 10.1016/j.toxlet.2007.05.012; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Duensing A, 2010, ADV EXP MED BIOL, V676, P93; Entringer S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/632548; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Gilley D, 2005, INT J BIOCHEM CELL B, V37, P1000, DOI 10.1016/j.biocel.2004.09.003; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lin SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060815; Marcon F, 2012, MUTAGENESIS, V27, P49, DOI 10.1093/mutage/ger056; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Orjuela MA, 2010, MUTAT RES-GEN TOX EN, V703, P108, DOI 10.1016/j.mrgentox.2010.08.004; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Prescott J, 2012, MUTAT RES, V730, P73; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Samassekou O, 2010, ANN ANAT, V192, P284, DOI 10.1016/j.aanat.2010.07.005; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Slyskova J, 2011, ENVIRON MOL MUTAGEN, V52, P511, DOI 10.1002/em.20650; SURRALLES J, 1995, MUTAT RES-GENET TOX, V341, P169, DOI 10.1016/0165-1218(95)90007-1; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wright WE, 2005, NAT GENET, V37, P116, DOI 10.1038/ng0205-116; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	38	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91753	10.1371/journal.pone.0091753	http://dx.doi.org/10.1371/journal.pone.0091753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622247	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300123
J	Uzochukwu, BSC; Onwujekwe, OE; Okwuosa, C; Ibe, OP				Uzochukwu, Benjamin S. C.; Onwujekwe, Obinna E.; Okwuosa, Chinenye; Ibe, Ogochukwu P.			Patent Medicine Dealers and Irrational Use of Medicines in Children: The Economic Cost and Implications for Reducing Childhood Mortality in Southeast Nigeria	PLOS ONE			English	Article							MALARIA; SELLERS; VENDORS; URBAN	This study assessed the economic costs of irrational medicine use by Patent Medicine Dealers (PMDs) for malaria, acute respiratory infection (ARI) and diarrhea diseases (DD) in Nigeria. Exit interviews were conducted with 395 respondents who sought care for their children from 15 PMDs in Abakpa district of Enugu state Nigeria. Of the total respondents, 80.0% received treatment for malaria while 12.0% and 8.0% received treatment for DD and ARI respectively. The average number of drugs dispensed per patient was 6.8, average percentage of patients given injections was 72.5%, average percentage of patients given one or more antibiotics was 59.7%, while the percentage of patients given non essential drugs was 45.9%. The additional costs to the standard treatment in Naira was 255, 350 and 175 for malaria, ARI and DD respectively. The losses attributable to irrational dispensing was 4,500 Naira. However, more than half of the drugs were on essential drug list, implying some cost savings for the consumers, but the high number of drugs (6.8) on average/patient is likely to increase the total cost of drugs cancelling out the cost savings to consumers arising from dispensing essential drugs.	[Uzochukwu, Benjamin S. C.] Univ Nigeria Enugu Campus, Dept Community Med, Coll Med, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Obinna E.] Univ Nigeria Enugu Campus, Coll Med, Dept Hlth Adm & Management, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Obinna E.; Okwuosa, Chinenye; Ibe, Ogochukwu P.] Univ Nigeria Enugu Campus, Coll Med, Hlth Policy Res Grp, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria	Uzochukwu, BSC (corresponding author), Univ Nigeria Enugu Campus, Dept Community Med, Coll Med, Enugu, Nigeria.	bscuzochukwu@gmail.com	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285				Abiola AB, 1993, QUALITATIVE ASSESSME; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Aina BA, 2008, J INFECT DEV COUNTR, V2, P68, DOI 10.3855/jidc.325; AKINDE J, 1982, SURVEY PATENT MED ST; Ansari K. U., 1998, Indian Journal of Pharmacology, V30, P43; Biswas Nihar R., 2000, Indian Journal of Physiology and Pharmacology, V44, P109; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brugha R, 2002, HLTH POLICY PLAN, V13, P103; de Jong J, 2008, EUR J CLIN PHARMACOL, V64, P913, DOI 10.1007/s00228-008-0479-5; Erhun WO., 2001, J HLTH POPULATION DE, V4, P23; Federal Government of Nigeria, 2007, OFFICIAL GAZETTE LAG, V24, P94; Federal Ministry of Health, 1999, NIG IMCI POL; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Holloway KA, 2001, HEALTH POLICY PLANN, V16, P421, DOI 10.1093/heapol/16.4.421; IWEZE EA, 1987, URBAN POOR NIGERIA, P317; MASSELE AY, 1993, E AFR MED J, V70, P639; Mirza NY, 2009, BANGL J PHARMACOL, V4, P39, DOI 10.3329/bjp.v4i1.1062; Mohanty BK, 2010, J CLIN DIAGN RES, V4, P2047; National Bureau of Statistics, 2005, POV PROF NIG; Nsimba Stephen Elias Damson, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P206; Nurgozhin T, 2004, DRUG PRESCRIPTION PR; Ojuawo A, 1993, Niger J Paediatr, V20, P41; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Oladepo O, 2008, POLICY BRIEF, V2008, P01; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Osamor PE, 2001, THESIS U IBADAN NIGE; OSHINAME FO, 1992, SOC SCI MED, V35, P1477, DOI 10.1016/0277-9536(92)90050-Z; Qidwai Waris, 2006, J Coll Physicians Surg Pak, V16, P743; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; Souleymane M, 1994, PUBLIC HLTH MEASURE; TAWFIK Y, 2002, UTILIZING POTENTIAL; Ukwaja KN, 2010, AFR J RESPIR MED, V6, P18; USAID, 2008, MAN SCI HLTH RAT DRU; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Uzochukwu Benjamin Sc, 2004, Int J Equity Health, V3, P6, DOI 10.1186/1475-9276-3-6; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; VANDERGEEST S, 1991, CULT MED PSYCHIAT, V15, P69, DOI 10.1007/BF00050828; World Bank, 1992, 4 WORLD BANK AFR TEC; World Bank Development Data Group, 2004, DAT COUNTR; World Health Organization, 2006, SEARO TECH PUBL SER	40	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91667	10.1371/journal.pone.0091667	http://dx.doi.org/10.1371/journal.pone.0091667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621618	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300116
J	Unmack, PJ; Dowling, TE; Laitinen, NJ; Secor, CL; Mayden, RL; Shiozawa, DK; Smith, GR				Unmack, Peter J.; Dowling, Thomas E.; Laitinen, Nina J.; Secor, Carol L.; Mayden, Richard L.; Shiozawa, Dennis K.; Smith, Gerald R.			Influence of Introgression and Geological Processes on Phylogenetic Relationships of Western North American Mountain Suckers (Pantosteus, Catostomidae)	PLOS ONE			English	Article							LOWER COLORADO RIVER; GREAT-BASIN; LAKE BONNEVILLE; BOUSE FORMATION; EVOLUTION; HYBRIDIZATION; TELEOSTEI; MIOCENE; HISTORY; BIOGEOGRAPHY	Intense geological activity caused major topographic changes in Western North America over the past 15 million years. Major rivers here are composites of different ancient rivers, resulting in isolation and mixing episodes between river basins over time. This history influenced the diversification of most of the aquatic fauna. The genus Pantosteus is one of several clades centered in this tectonically active region. The eight recognized Pantosteus species are widespread and common across southwestern Canada, western USA and into northern Mexico. They are typically found in medium gradient, middle-elevation reaches of rivers over rocky substrates. This study (1) compares molecular data with morphological and paleontological data for proposed species of Pantosteus, (2) tests hypotheses of their monophyly, (3) uses these data for phylogenetic inferences of sister-group relationships, and (4) estimates timing of divergence events of identified lineages. Using 8055 base pairs from mitochondrial DNA protein coding genes, Pantosteus and Catostomus are reciprocally monophyletic, in contrast with morphological data. The only exception to a monophyletic Pantosteus is P. columbianus whose mtDNA is closely aligned with C. tahoensis because of introgression. Within Pantosteus, several species have deep genetic divergences among allopatric sister lineages, several of which are diagnosed and elevated to species, bringing the total diversity in the group to 11 species. Conflicting molecular and morphological data may be resolved when patterns of divergence are shown to be correlated with sympatry and evidence of introgression.	[Unmack, Peter J.; Laitinen, Nina J.; Shiozawa, Dennis K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Unmack, Peter J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Dowling, Thomas E.; Secor, Carol L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Dowling, Thomas E.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Mayden, Richard L.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Smith, Gerald R.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	Brigham Young University; The National Evolutionary Synthesis Center; Arizona State University; Arizona State University-Tempe; Wayne State University; Saint Louis University; University of Michigan System; University of Michigan	Unmack, PJ (corresponding author), Brigham Young Univ, Dept Biol, WIDB 401, Provo, UT 84602 USA.	peter.pub@unmack.net	Unmack, Peter J./AAU-3023-2020	Unmack, Peter J./0000-0003-1175-1152	US Bureau of Reclamation; National Evolutionary Synthesis Center (NESCent); NSF [EF-0905606, DEB 0240184, EF 0431326, DEB-0817027, DBI-0956370, DEB-1021840]	US Bureau of Reclamation; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF))	This work was supported in part by funds from the US Bureau of Reclamation to TED and CLS, by the National Evolutionary Synthesis Center (NESCent) and NSF EF-0905606 to PJU and NSF DEB 0240184, EF 0431326, DEB-0817027, DBI-0956370 and DEB-1021840 to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Bart HL, 2010, INT J MOL SCI, V11, P1090, DOI 10.3390/ijms11031090; BENCRABTREE C, 1987, COPEIA, P843; Benson L, 2004, DEV QUA SCI, V1, P185; Beranek LP, 2006, GEOL SOC AM BULL, V118, P1027, DOI 10.1130/B25896.1; Billman EJ, 2010, WEST N AM NATURALIST, V70, P39, DOI 10.3398/064.070.0105; Blackwelder E, 1948, B U UTAH, V38, P1; BLAKEY R., 2008, ANCIENT LANDSCAPES C; Bouchard DP, 1998, PALAEOGEOGR PALAEOCL, V141, P95, DOI 10.1016/S0031-0182(98)00005-4; Bufalino AP, 2010, MOL PHYLOGENET EVOL, V55, P274, DOI 10.1016/j.ympev.2009.12.017; Cavender T.M., 1986, P699; Chamberlain CP, 2012, AM J SCI, V312, P213, DOI 10.2475/02.2012.05; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cope ED, 1872, US GEOLOGICAL SURV 4, P432; Cummings ML, 2000, GEOL SOC AM BULL, V112, P668, DOI 10.1130/0016-7606(2000)112<0668:SASEOT>2.3.CO;2; CURREY DR, 1990, PALAEOGEOGR PALAEOCL, V76, P189, DOI 10.1016/0031-0182(90)90113-L; Dallegge T.A., 2001, GRAND CANYON ASS MON, V12, P47; Davies OK, 1999, REV PALAEOBOT PALYNO, V107, P249, DOI 10.1016/S0034-6667(99)00020-2; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; Doosey MH, 2010, MOL PHYLOGENET EVOL, V54, P1028, DOI 10.1016/j.ympev.2009.06.006; DOWLING TE, 1989, EVOLUTION, V43, P620, DOI 10.1111/j.1558-5646.1989.tb04257.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Dowling TE, 2002, COPEIA, P665, DOI 10.1643/0045-8511(2002)002[0665:EROTPT]2.0.CO;2; DOWLING TE, 1984, COPEIA, P617; DOWLING TE, 1992, CONSERV BIOL, V6, P600, DOI 10.1046/j.1523-1739.1992.06040600.x; DOWLING TE, 1992, CONSERV BIOL, V6, P7, DOI 10.1046/j.1523-1739.1992.6100064.x; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Echelle AA, 2005, COPEIA, P320, DOI 10.1643/CG-03-093R3; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; Faulds J.E., 1998, GEOLOGICAL SOC AM SP, V323, P1, DOI DOI 10.1130/0-8137-2323-X.1; FERRIS SD, 1982, COPEIA, P444, DOI 10.2307/1444627; Gerber AS, 2001, EVOLUTION, V55, P2028; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hansen W.R., 1985, Mountain Geologist, V22, P192; Harper KT, 1978, GREAT BASIN NAT MEM, V2; Hershler R, 2002, SMITHSON CONTRIB EAR, P255; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Howard KA, 2008, GEOL SOC AM SPEC PAP, V439, P391, DOI 10.1130/2008.2439(18); Hubbs C. L., 1943, CONTRIB LAB VERT BIO, V22, P1; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Hubbs CL, 1948, B U UTAH, V38, P18; Hunt CB, 1960, US GEOL SURV PROF PA, V279, P1; Johnson JB, 2004, SYST BIOL, V53, P841, DOI 10.1080/10635150490522557; KIMMEL P.G., 1975, U MICHIGAN MUSEUM PA, V14, P69; Kinziger AP, 2005, COPEIA, P303, DOI 10.1643/CI-03-290R1; Kohn MJ, 2008, GEOLOGY, V36, P783, DOI 10.1130/G24928A.1; LUCCHITTA I, 1972, GEOL SOC AM BULL, V83, P1933, DOI 10.1130/0016-7606(1972)83[1933:EHOTCR]2.0.CO;2; Lucchitta I., 2011, GSA TODAY, V21, P4, DOI [10.1130/G119A.1, DOI 10.1130/G119A.1]; MARSHALL CR, 1990, PALEOBIOLOGY, V16, P1, DOI 10.1017/S0094837300009672; NEFF NA, 1979, SYST ZOOL, V28, P176, DOI 10.2307/2412521; Negrini RM, 2002, SMITHSON CONTRIB EAR, P11; NORRIS S. M., 2005, FRESHWATER FISHES ME; Oviatt CG, 2002, SMITHSON CONTRIB EAR, P121; Oviatt CG, 1994, UTAH GEOL ASS PUBL, V23, P97; PARENTI L.R., 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reheis MC, 2002, SMITHSON CONTRIB EAR, P53; Reheis MC, 2008, 439 GEOL SOC AM; Retallack GJ, 2004, PALAEOGEOGR PALAEOCL, V214, P97, DOI 10.1016/j.palaeo.2004.07.024; Roskowski JA, 2010, GEOL SOC AM BULL, V122, P1625, DOI 10.1130/B30186.1; Sack D, 2002, SMITHSON CONTRIB EAR, P129; Smith G.R., 1993, P778; SMITH G.R., 1982, CENOZOIC GEOLOGY IDA, V26, P519; Smith G.R., 2000, U MICHIGAN MUSEUM PA, V32, P1; Smith Gerald R., 2013, Occasional Papers of the Museum of Zoology University of Michigan, V743, P1; Smith GR, 2010, EVOL ECOL RES, V12, P693; SMITH GERALD RAY, 1966, MISC PUBLICATIONS MUS ZOOL UNIV MICH, V129, P1; SMITH GR, 1992, SYST BIOL, V41, P41, DOI 10.2307/2992505; Smith GR, 2002, SMITHSON CONTRIB EAR, P175; SMITH GR, 1983, COPEIA, P37, DOI 10.2307/1444696; SMITH GR, 1971, SYST ZOOL, V20, P282, DOI 10.2307/2412341; Snyder JO, 1924, P US NATL MUS, V64, P1; Spencer JE, 2013, GEOSPHERE, V9, P444, DOI 10.1130/GES00896.1; Spencer JE, 2008, GEOL SOC AM SPEC PAP, V439, P279, DOI 10.1130/2008.2439(12); Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor D.W., 1985, P265; Tibbets CA, 1996, EVOLUTION, V50, P1280, DOI 10.1111/j.1558-5646.1996.tb02368.x; Tolan T. L., 2009, FIELD GUIDES, V15, P645; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; Wernicke B, 2011, GEOL SOC AM BULL, V123, P1288, DOI 10.1130/B30274.1; WHEELER HE, 1954, J GEOL, V62, P525, DOI 10.1086/626205; [No title captured]	88	28	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90061	10.1371/journal.pone.0090061	http://dx.doi.org/10.1371/journal.pone.0090061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619087	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400008
J	Bendrioua, L; Smedh, M; Almquist, J; Cvijovic, M; Jirstrand, M; Goksor, M; Adiels, CB; Hohmann, S				Bendrioua, Loubna; Smedh, Maria; Almquist, Joachim; Cvijovic, Marija; Jirstrand, Mats; Goksor, Mattias; Adiels, Caroline B.; Hohmann, Stefan			Yeast AMP-activated Protein Kinase Monitors Glucose Concentration Changes and Absolute Glucose Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Glucose Metabolism; Nuclear Translocation; Signal Transduction; Yeast Physiology; Dynamic Control	SACCHAROMYCES-CEREVISIAE; MIG1 REPRESSOR; SNF1 KINASE; NUCLEAR-LOCALIZATION; ENERGY SENSOR; SUC2 GENE; PHOSPHORYLATION; BINDING; SIGNAL; ADP	Background: Little is known about the signaling dynamics of AMP-activated protein kinase. Results: We define the dynamics of yeast AMPK signaling under different glucose concentrations. Conclusion: The Snf1-Mig1 signaling system monitors glucose concentration changes and absolute glucose levels to adjust the metabolism to a wide range of conditions. Significance: This description of AMPK signaling dynamics will stimulate studies defining the integration of signaling and metabolism. Analysis of the time-dependent behavior of a signaling system can provide insight into its dynamic properties. We employed the nucleocytoplasmic shuttling of the transcriptional repressor Mig1 as readout to characterize Snf1-Mig1 dynamics in single yeast cells. Mig1 binds to promoters of target genes and mediates glucose repression. Mig1 is predominantly located in the nucleus when glucose is abundant. Upon glucose depletion, Mig1 is phosphorylated by the yeast AMP-activated kinase Snf1 and exported into the cytoplasm. We used a three-channel microfluidic device to establish a high degree of control over the glucose concentration exposed to cells. Following regimes of glucose up- and downshifts, we observed a very rapid response reaching a new steady state within less than 1 min, different glucose threshold concentrations depending on glucose up- or downshifts, a graded profile with increased cell-to-cell variation at threshold glucose concentrations, and biphasic behavior with a transient translocation of Mig1 upon the shift from high to intermediate glucose concentrations. Fluorescence loss in photobleaching and fluorescence recovery after photobleaching data demonstrate that Mig1 shuttles constantly between the nucleus and cytoplasm, although with different rates, depending on the presence of glucose. Taken together, our data suggest that the Snf1-Mig1 system has the ability to monitor glucose concentration changes as well as absolute glucose levels. The sensitivity over a wide range of glucose levels and different glucose concentration-dependent response profiles are likely determined by the close integration of signaling with the metabolism and may provide for a highly flexible and fast adaptation to an altered nutritional status.	[Bendrioua, Loubna; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden; [Smedh, Maria] Univ Gothenburg, Ctr Cellular Imaging, Sahlgrenska Core Facil, S-40530 Gothenburg, Sweden; [Almquist, Joachim; Jirstrand, Mats] Fraunhofer Chalmers Res Ctr Ind Math, S-41288 Gothenburg, Sweden; [Almquist, Joachim] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Cvijovic, Marija] Chalmers, Dept Math Sci, S-41296 Gothenburg, Sweden; [Cvijovic, Marija] Univ Gothenburg, S-41296 Gothenburg, Sweden; [Goksor, Mattias; Adiels, Caroline B.] Univ Gothenburg, Dept Phys, S-41296 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Chalmers University of Technology; Fraunhofer-Chalmers Research Centre for Industrial Mathematics; Chalmers University of Technology; Chalmers University of Technology; University of Gothenburg; University of Gothenburg	Hohmann, S (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, S-40530 Gothenburg, Sweden.	stefan.hohmann@gu.se	Almquist, Joachim/U-8894-2019; Hohmann, Stefan/K-9895-2013	Almquist, Joachim/0000-0002-4745-9332; Hohmann, Stefan/0000-0002-0809-1985; Beck Adiels, Caroline/0000-0002-2403-2213; Jirstrand, Mats/0000-0002-6612-8037	European Commission [201142]; ISOLATE project [289995]	European Commission(European CommissionEuropean Commission Joint Research Centre); ISOLATE project	This work was supported by European Commission UNICELLSYS project contract 201142 (to S. H., M. G., and M.J.) and by ISOLATE project contract 289995 (to S.H. and M.G).	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Babazadeh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080901; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chandrashekarappa DG, 2013, J BIOL CHEM, V288, P89, DOI 10.1074/jbc.M112.422659; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Eriksson E, 2010, LAB CHIP, V10, P617, DOI 10.1039/b913587a; Frey S, 2011, MOL BIOSYST, V7, P215, DOI 10.1039/c005305h; Frolova E, 1999, NUCLEIC ACIDS RES, V27, P1350, DOI 10.1093/nar/27.5.1350; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Garcia-Salcedo R, 2014, FEBS J, V281, P1901, DOI 10.1111/febs.12753; Geijer C, 2013, FEBS J, V280, P3854, DOI 10.1111/febs.12382; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; Gustavsson AK, 2012, FEBS J, V279, P2837, DOI 10.1111/j.1742-4658.2012.08639.x; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2011, NATURE, V472, P176, DOI 10.1038/472176a; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Meijer MMC, 1998, J BIOL CHEM, V273, P24102, DOI 10.1074/jbc.273.37.24102; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Ostling J, 1996, MOL CELL BIOL, V16, P753; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Ozcan S, 1997, YEAST, V13, P127; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; ROSE M, 1991, EUR J BIOCHEM, V199, P511, DOI 10.1111/j.1432-1033.1991.tb16149.x; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Scrimgeour J, 2007, METHOD CELL BIOL, V82, P629, DOI 10.1016/S0091-679X(06)82022-4; Smedh M, 2010, PROC SPIE, V7762, DOI 10.1117/12.860403; Sunnaker M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003621; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; VANAELST L, 1993, MOL MICROBIOL, V8, P927; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x	53	21	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12863	12875		10.1074/jbc.M114.547976	http://dx.doi.org/10.1074/jbc.M114.547976			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627493	Green Published, hybrid			2022-12-25	WOS:000335581400055
J	Plaganyi, EE; van Putten, I; Thebaud, O; Hobday, AJ; Innes, J; Lim-Camacho, L; Norman-Lopez, A; Bustamante, RH; Farmery, A; Fleming, A; Frusher, S; Green, B; Hoshino, E; Jennings, S; Pecl, G; Pascoe, S; Schrobback, P; Thomas, L				Plaganyi, Eva E.; van Putten, Ingrid; Thebaud, Olivier; Hobday, Alistair J.; Innes, James; Lim-Camacho, Lilly; Norman-Lopez, Ana; Bustamante, Rodrigo H.; Farmery, Anna; Fleming, Aysha; Frusher, Stewart; Green, Bridget; Hoshino, Eriko; Jennings, Sarah; Pecl, Gretta; Pascoe, Sean; Schrobback, Peggy; Thomas, Linda			A Quantitative Metric to Identify Critical Elements within Seafood Supply Networks	PLOS ONE			English	Article							ASYMMETRIC PRICE TRANSMISSION; CHAIN MANAGEMENT; CLIMATE-CHANGE; EQUILIBRIUM; ECOSYSTEM; COST	A theoretical basis is required for comparing key features and critical elements in wild fisheries and aquaculture supply chains under a changing climate. Here we develop a new quantitative metric that is analogous to indices used to analyse food-webs and identify key species. The Supply Chain Index (SCI) identifies critical elements as those elements with large throughput rates, as well as greater connectivity. The sum of the scores for a supply chain provides a single metric that roughly captures both the resilience and connectedness of a supply chain. Standardised scores can facilitate cross-comparisons both under current conditions as well as under a changing climate. Identification of key elements along the supply chain may assist in informing adaptation strategies to reduce anticipated future risks posed by climate change. The SCI also provides information on the relative stability of different supply chains based on whether there is a fairly even spread in the individual scores of the top few key elements, compared with a more critical dependence on a few key individual supply chain elements. We use as a case study the Australian southern rock lobster Jasus edwardsii fishery, which is challenged by a number of climate change drivers such as impacts on recruitment and growth due to changes in large-scale and local oceanographic features. The SCI identifies airports, processors and Chinese consumers as the key elements in the lobster supply chain that merit attention to enhance stability and potentially enable growth. We also apply the index to an additional four real-world Australian commercial fishery and two aquaculture industry supply chains to highlight the utility of a systematic method for describing supply chains. Overall, our simple methodological approach to empirically-based supply chain research provides an objective method for comparing the resilience of supply chains and highlighting components that may be critical.	[Plaganyi, Eva E.; Thebaud, Olivier; Innes, James; Lim-Camacho, Lilly; Norman-Lopez, Ana; Bustamante, Rodrigo H.; Pascoe, Sean] Climate Adaptat Flagship, Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia; [van Putten, Ingrid; Hobday, Alistair J.; Fleming, Aysha] Climate Adaptat Flagship, Commonwealth Sci & Ind Res Org, Hobart, Tas, Australia; [Farmery, Anna; Frusher, Stewart; Green, Bridget; Hoshino, Eriko; Jennings, Sarah; Pecl, Gretta] Univ Tasmania, Hobart, Tas, Australia; [Schrobback, Peggy] Queensland Univ Technol, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Queensland University of Technology (QUT)	Plaganyi, EE (corresponding author), Climate Adaptat Flagship, Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia.	Eva.Plaganyi-lloyd@csiro.au	Fleming, Aysha/E-8753-2011; Innes, James/D-9424-2011; Hoshino, Eriko/N-7557-2013; Schrobback, Peggy/X-4697-2019; van putten, ingrid/AAV-1301-2021; Thomas, Linda/Q-2521-2018; Pecl, Gretta/D-7267-2011; Jennings, Sarah/J-7888-2014; Hobday, Alistair/A-1460-2012; Frusher, Stewart/G-5117-2014; Green, Bridget/G-3368-2014; Farmery, Anna/H-9696-2014; Plaganyi, Eva E/C-5130-2011; Lim-Camacho, Lilly/A-7502-2015; Thebaud, Olivier/D-9792-2011; Pascoe, Sean/D-9710-2011	Fleming, Aysha/0000-0001-9895-1928; Innes, James/0000-0003-1975-6062; Hoshino, Eriko/0000-0001-7110-4251; Schrobback, Peggy/0000-0003-0526-1659; van putten, ingrid/0000-0001-8397-9768; Thomas, Linda/0000-0001-8989-8109; Pecl, Gretta/0000-0003-0192-4339; Jennings, Sarah/0000-0002-5760-4193; Hobday, Alistair/0000-0002-3194-8326; Frusher, Stewart/0000-0003-2493-3676; Green, Bridget/0000-0001-8214-6430; Farmery, Anna/0000-0002-8938-0040; Plaganyi, Eva E/0000-0002-4740-4200; Lim-Camacho, Lilly/0000-0002-4897-1186; Thebaud, Olivier/0000-0001-8665-3827; Pascoe, Sean/0000-0001-6581-2649	Australia's CSIRO Climate Adaptation Flagship; Fisheries Research and Development Corporation - Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program) [2011/233]	Australia's CSIRO Climate Adaptation Flagship; Fisheries Research and Development Corporation - Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program)	This work was supported by funding from Australia's CSIRO Climate Adaptation Flagship (www.csiro.au) and the Fisheries Research and Development Corporation - Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program 2011/233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 1992, MARINE RESOURCE EC; Asche F, 2007, APPL ECON, V39, P2535, DOI 10.1080/00036840500486524; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.1890/0012-9658(2002)083[2394:QDOFWM]2.0.CO;2; Carter CR, 2008, INT J PHYS DISTR LOG, V38, P360, DOI 10.1108/09600030810882816; Chen IJ, 2004, J OPER MANAG, V22, P119, DOI 10.1016/j.jom.2003.12.007; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2011, ECOL MODEL, V222, P857, DOI 10.1016/j.ecolmodel.2010.09.030; Christopher M., 1992, LOGISTICS SUPPLY CHA; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; DPIPWE, 2013, TOX ALG BLOOM UPD FI; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Essington T. E., 2012, MODEL DATA ADEQUACY; Essington TE, 2013, ICES J MAR SCI, DOI [10.1093/icesjms/fst047., DOI 10.1093/ICESJMS/FST047.E]; Fackler PL, 2001, HANDB ECON, V18, P971; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Harland C.M., 1996, BRIT J MANAGE, V7, pS63, DOI [10.1111/j.1467-8551.1996.tb00148.x, DOI 10.1111/J.1467-8551.1996.TB00148.X]; Hobday A. J., 2008, IMPLICATIONS CLIMATE; Hobday A.J., 2013, GROWTH OPPORTUNITIES; Jaffry SA, 1999, APPL ECON, V31, P473, DOI 10.1080/000368499324183; James SJ, 2010, FOOD RES INT, V43, P1944, DOI 10.1016/j.foodres.2010.02.001; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Linnane A, 2010, FISH RES, V105, P163, DOI 10.1016/j.fishres.2010.04.001; Meyer J, 2004, J AGR ECON, V55, P581, DOI 10.1111/j.1477-9552.2004.tb00116.x; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Mullon C, 2009, NAT RESOUR MODEL, V22, P564, DOI 10.1111/j.1939-7445.2009.00053.x; Nagurney A, 2010, INT J PROD ECON, V128, P200, DOI 10.1016/j.ijpe.2010.07.020; Nielsen M., 2005, MAR RESOUR ECON, V20, P185, DOI [DOI 10.1086/MRE.20.2.42629468, https://doi.org/10.1086/mre.20.2.42629468]; Nielsen M, 2012, MAR RESOUR ECON, V27, P165, DOI 10.5950/0738-1360-27.2.165; Norman-Lopez A, 2013, AUSTR J AGR RESOURCE, V57, P1; Oshita Y, 2012, ENERG ECON, V34, P1041, DOI 10.1016/j.eneco.2011.08.013; Pecl G, 2009, E COAST TASMANIAN RO; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Plaganyi EE, 2013, P NATL ACAD SCI USA, V110, P3639, DOI 10.1073/pnas.1217822110; Samuelson PA, 1952, AM ECON REV, V42, P283; Simioni M, 2013, CAN J AGR ECON, V61, P37, DOI 10.1111/j.1744-7976.2012.01257.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith ADM, 2011, SCIENCE, V334, P39; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TAKAYAMA T, 1964, J FARM ECON, V46, P67, DOI 10.2307/1236473; van Putten IE, 2013, REG ENVIRON CHANGE, V13, P1313, DOI 10.1007/s10113-013-0456-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wohlgenant MK, 2001, HANDB ECON, V18, P933	46	26	28	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91833	10.1371/journal.pone.0091833	http://dx.doi.org/10.1371/journal.pone.0091833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633147	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000332858400104
J	Tran, MV; O'Grady, M; Colborn, J; Van Ness, K; Hill, RW				Tran, Mark V.; O'Grady, Matthew; Colborn, Jeremiah; Van Ness, Kimberly; Hill, Richard W.			Aggression and Food Resource Competition between Sympatric Hermit Crab Species	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; INTERSPECIFIC COMPETITION; VERTICAL ZONATION; COEXISTENCE; INTERFERENCE; EXPLOITATION; DISPLACEMENT; POPULATIONS; COMPONENTS; PHYSIOLOGY	The vertical zonation patterns of intertidal organisms have been topics of interest to marine ecologists for many years, with interspecific food competition being implicated as a contributing factor to intertidal community organization. In this study, we used behavioral bioassays to examine the potential roles that interspecific aggression and food competition have on the structuring of intertidal hermit crab assemblages. We studied two ecologically similar, sympatric hermit crab species, Clibanarius digueti [1] and Paguristes perrieri [2], which occupy adjacent zones within the intertidal region of the Gulf of California. During the search phase of foraging, C. digueti showed higher frequencies of aggressive behaviors than P. perrieri. In competition assays, C. digueti gained increased access to food resources compared to P. perrieri. The results suggest that food competition may play an important role in structuring intertidal hermit crab assemblages, and that the zonation patterns of Gulf of California hermit crab species may be the result of geographical displacement by the dominant food competitor (C. digueti).	[Tran, Mark V.; O'Grady, Matthew; Colborn, Jeremiah; Van Ness, Kimberly; Hill, Richard W.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Tran, Mark V.; Hill, Richard W.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Tran, MV (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	mvtran27@gmail.com			Dr. Marvin Hensley Endowed Scholarship in Zoology; Zoology Department at Michigan State University	Dr. Marvin Hensley Endowed Scholarship in Zoology; Zoology Department at Michigan State University	This research was funded by the Dr. Marvin Hensley Endowed Scholarship in Zoology awarded to Mark V. Tran by the Zoology Department at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayon-Parente Manuel, 2010, Nauplius, V18, P1; BERTNESS MD, 1981, J EXP MAR BIOL ECOL, V49, P189, DOI 10.1016/0022-0981(81)90070-8; BERTNESS MD, 1981, AM NAT, V118, P432, DOI 10.1086/283835; BERTNESS MD, 1981, ECOLOGY, V62, P411, DOI 10.2307/1936715; Bouvier E. L., 1895, B MUS NATL HIST NAT, V1, P6; Bouvier E.L, 1898, B MUSEUM HIST NATURE, V4, P371; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; DEBACH P, 1966, ANNU REV ENTOMOL, V11, P183, DOI 10.1146/annurev.en.11.010166.001151; Gherardi F, 1997, CRUSTACEANA, V70, P608, DOI 10.1163/156854097X00717; Gherardi F, 2005, ETHOLOGY, V111, P271, DOI 10.1111/j.1439-0310.2004.01060.x; GHERARDI F, 1990, J EXP MAR BIOL ECOL, V143, P221, DOI 10.1016/0022-0981(90)90072-K; Harvey AW, 1988, THESIS U ARIZONA; HAZLETT BA, 1981, ANNU REV ECOL SYST, V12, P1, DOI 10.1146/annurev.es.12.110181.000245; HELLER HC, 1971, ECOLOGY, V52, P312, DOI 10.2307/1934590; Kaiser MJ, 1998, J NAT HIST, V32, P521, DOI 10.1080/00222939800770281; Kellog CW, 1996, J EXP MAR BIOL ECOL, V22, P101; Laidre ME, 2012, J ZOOL, V288, P33, DOI 10.1111/j.1469-7998.2012.00921.x; Laidre ME, 2013, MAR ECOL-EVOL PERSP, V34, P80, DOI 10.1111/j.1439-0485.2012.00527.x; Laidre ME, 2011, J EXP MAR BIOL ECOL, V397, P65, DOI 10.1016/j.jembe.2010.10.024; Lee PG, 1996, AQUACULT NUTR, V2, P157, DOI 10.1111/j.1365-2095.1996.tb00055.x; Lohrer AM, 2000, J EXP MAR BIOL ECOL, V244, P203, DOI 10.1016/S0022-0981(99)00139-2; McKillup SC, 1997, MAR ECOL PROG SER, V148, P109, DOI 10.3354/meps148109; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Morton B, 2000, J EXP MAR BIOL ECOL, V246, P1, DOI 10.1016/S0022-0981(99)00170-7; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Peiman KS, 2010, Q REV BIOL, V85, P133, DOI 10.1086/652374; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Ramsay K, 1997, ESTUAR COAST SHELF S, V44, P213, DOI 10.1006/ecss.1996.0213; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; SCULLY EP, 1983, J EXP MAR BIOL ECOL, V71, P221, DOI 10.1016/0022-0981(83)90116-8; SNYDERCONN E, 1980, MAR BEHAV PHYSIOL, V7, P135, DOI 10.1080/10236248009386977; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Stillman JH, 1996, J EXP BIOL, V199, P1845; Tran MV, 2013, J CRUSTACEAN BIOL, V33, P512, DOI 10.1163/1937240X-00002154; Tricarico E, 2008, J EXP MAR BIOL ECOL, V354, P150, DOI 10.1016/j.jembe.2007.11.001; Turra A, 2004, MAR BIOL, V145, P251, DOI 10.1007/s00227-004-1323-9; Turra A, 2004, J EXP MAR BIOL ECOL, V310, P183, DOI 10.1016/j.jembe.2004.04.008; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	41	22	23	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91823	10.1371/journal.pone.0091823	http://dx.doi.org/10.1371/journal.pone.0091823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632897	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400100
J	Wang, QW; Ren, J; Morgan, S; Liu, ZJ; Dou, CL; Liu, B				Wang, Qiwei; Ren, Jun; Morgan, Stephanie; Liu, Zhenjie; Dou, Changlin; Liu, Bo			Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BOUND FAS LIGAND; INDUCED APOPTOSIS; INDUCE APOPTOSIS; MICE; EXPRESSION; WALL; INFLAMMATION; POLARIZATION; PATHOGENESIS	Aims: In abdominal aortic aneurysm (AAA), macrophages are detected in the proximity of aortic smooth muscle cells (SMCs). We have previously demonstrated in a murine model of AAA that apoptotic SMCs attract monocytes and other leukocytes by producing MCP-1. Here we tested whether infiltrating macrophages also directly contribute to SMC apoptosis. Methods and Results: Using a SMC/RAW264.7 macrophage co-culture system, we demonstrated that MCP-1-primed RAWs caused a significantly higher level of apoptosis in SMCs as compared to control macrophages. Next, we detected an enhanced Fas ligand (FasL) mRNA level and membrane FasL protein expression in MCP-1-primed RAWs. Neutralizing FasL blocked SMC apoptosis in the co-culture. In situ proximity ligation assay showed that SMCs exposed to primed macrophages contained higher levels of receptor interacting protein-1 (RIP1)/Caspase 8 containing cell death complexes. Silencing RIP1 conferred apoptosis resistance to SMCs. In the mouse elastase injury model of aneurysm, aneurysm induction increased the level of RIP1/Caspase 8 containing complexes in medial SMCs. Moreover, TUNEL-positive SMCs in aneurysmal tissues were frequently surrounded by CD68(+)/FasL(+) macrophages. Conversely, elastase-treated arteries from MCP-1 knockout mice display a reduction of both macrophage infiltration and FasL expression, which was accompanied by diminished apoptosis of SMCs. Conclusion: Our data suggest that MCP-1-primed macrophages are more cytotoxic. MCP-1 appears to modulate macrophage cytotoxicity by increasing the level of membrane bound FasL. Thus, we showed that MCP-1-primed macrophages kill SMCs through a FasL/Fas-Caspase8-RIP1 mediated mechanism.	[Wang, Qiwei; Ren, Jun; Morgan, Stephanie; Liu, Zhenjie; Liu, Bo] Univ Wisconsin, Dept Surg, Div Vasc Surg, Madison, WI 53706 USA; [Dou, Changlin] Luye Pharma Grp, Yantai, Peoples R China	University of Wisconsin System; University of Wisconsin Madison	Liu, B (corresponding author), Univ Wisconsin, Dept Surg, Div Vasc Surg, Madison, WI 53706 USA.	liub@surgery.wisc.edu		Wang, Qiwei/0000-0003-3897-2529; REN, Jun/0000-0002-6358-0765	National Institute of Health [R01HL088447]; Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute [T32 HL 07936, T32 HL110853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088447, T32HL007936, T32HL110853] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health R01HL088447 (BL) and the Ruth L. Kirschstein National Research Service Award T32 HL 07936 and T32 HL110853 from the National Heart Lung and Blood Institute to the University of Wisconsin-Madison Cardiovascular Research Center and Department of Surgery (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhari BA, 2013, ONCOGENE, V32, P3263, DOI 10.1038/onc.2012.337; Boyle JJ, 2003, ARTERIOSCL THROM VAS, V23, P1553, DOI 10.1161/01.ATV.0000086961.44581.B7; Boyle JJ, 2002, ARTERIOSCL THROM VAS, V22, P1624, DOI 10.1161/01.ATV.0000033517.48444.1A; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; CLOWES AW, 1989, LAB INVEST, V60, P360; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; de Waard V, 2010, ATHEROSCLEROSIS, V211, P84, DOI 10.1016/j.atherosclerosis.2010.01.042; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Iida Y, 2013, ARTERIOSCL THROM VAS, V33, P718, DOI 10.1161/ATVBAHA.112.300329; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; KOCH AE, 1993, AM J PATHOL, V142, P1423; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Morgan MJ, 2009, J IMMUNOL, V183, P3278, DOI 10.4049/jimmunol.0803428; Morgan S, 2012, ARTERIOSCL THROM VAS, V32, P2493, DOI 10.1161/ATVBAHA.112.255661; Nahrendorf M, 2011, ARTERIOSCL THROM VAS, V31, P750, DOI 10.1161/ATVBAHA.110.221499; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Niu JL, 2006, J MOL CELL CARDIOL, V40, P810, DOI 10.1016/j.yjmcc.2006.03.010; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Nordon IM, 2009, VASCULAR, V17, P253, DOI 10.2310/6670.2009.00046; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Yamanouchi D, 2010, ARTERIOSCL THROM VAS, V30, P702, DOI 10.1161/ATVBAHA.109.200527; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P6026, DOI 10.1167/iovs.10-7023; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	44	17	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92053	10.1371/journal.pone.0092053	http://dx.doi.org/10.1371/journal.pone.0092053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632850	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400136
J	Zheng, WL; Li, Z; Nguyen, AT; Li, CX; Emelyanov, A; Gong, ZY				Zheng, Weiling; Li, Zhen; Anh Tuan Nguyen; Li, Caixia; Emelyanov, Alexander; Gong, Zhiyuan			Xmrk, Kras and Myc Transgenic Zebrafish Liver Cancer Models Share Molecular Signatures with Subsets of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							COMPARATIVE FUNCTIONAL GENOMICS; GENE-EXPRESSION; EARLY RECURRENCE; CANDIDATE GENES; POOR-PROGNOSIS; MOUSE MODELS; PRAVASTATIN; ACTIVATION; STATHMIN; HEPATOCARCINOGENESIS	Previously three oncogene transgenic zebrafish lines with inducible expression of xmrk, kras or Myc in the liver have been generated and these transgenic lines develop oncogene-addicted liver tumors upon chemical induction. In the current study, comparative transcriptomic approaches were used to examine the correlation of the three induced transgenic liver cancers with human liver cancers. RNA profiles from the three zebrafish tumors indicated relatively small overlaps of significantly deregulated genes and biological pathways. Nevertheless, the three transgenic tumor signatures all showed significant correlation with advanced or very advanced human hepatocellular carcinoma (HCC). Interestingly, molecular signature from each oncogene-induced zebrafish liver tumor correlated with only a small subset of human HCC samples (24-29%) and there were conserved up-regulated pathways between the zebrafish and correlated human HCC subgroup. The three zebrafish liver cancer models together represented nearly half (47.2%) of human HCCs while some human HCCs showed significant correlation with more than one signature defined from the three oncogene-addicted zebrafish tumors. In contrast, commonly deregulated genes (21 up and 16 down) in the three zebrafish tumor models generally showed accordant deregulation in the majority of human HCCs, suggesting that these genes might be more consistently deregulated in a broad range of human HCCs with different molecular mechanisms and thus serve as common diagnosis markers and therapeutic targets. Thus, these transgenic zebrafish models with well-defined oncogene-induced tumors are valuable tools for molecular classification of human HCCs and for understanding of molecular drivers in hepatocarcinogenesis in each human HCC subgroup.	[Zheng, Weiling; Li, Zhen; Anh Tuan Nguyen; Li, Caixia; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Emelyanov, Alexander] Inst Cell & Mol Biol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Li, Caixia/0000-0003-2190-655X; Emelyanov, Alexander/0000-0002-8693-794X	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, BJU INT, V107, P126, DOI 10.1111/j.1464-410X.2010.09344.x; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Foster J, 2007, ANN SURG ONCOL, V14, P752, DOI 10.1245/s10434-006-9123-8; GAN FY, 1993, J HISTOCHEM CYTOCHEM, V41, P1185, DOI 10.1177/41.8.7687263; Gan L, 2010, ONCOL REP, V23, P1037, DOI 10.3892/or_00000730; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Gomez A, 2001, J BIOL CHEM, V276, P3333, DOI 10.1074/jbc.M006574200; Graf H, 2008, DIGESTION, V78, P34, DOI 10.1159/000156702; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2000.1716; Kudo T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-32; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Lee JS, 2005, CARCINOGENESIS, V26, P1013, DOI 10.1093/carcin/bgi030; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Leenders MWH, 2008, WORLD J GASTROENTERO, V14, P6915, DOI 10.3748/wjg.14.6915; Lersch C, 2004, HEPATO-GASTROENTEROL, V51, P1099; Li Y, 2008, HEPATOL RES, V38, P85, DOI 10.1111/j.1872-034X.2007.00207.x; Li Z, 2012, DIS MODEL MECH; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu S, 2011, ANNU REV PATHOL-MECH, V6, P71, DOI 10.1146/annurev-pathol-011110-130330; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Lu JW, 2011, BIRTH DEFECTS RES C, V93, P157, DOI 10.1002/bdrc.20205; Mavaddat N, 2009, CANCER EPIDEM BIOMAR, V18, P255, DOI 10.1158/1055-9965.EPI-08-0704; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Mirbahai L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-3; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Wang X, 2009, PROTEOMICS, V9, P242, DOI 10.1002/pmic.200800155; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019	50	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91179	10.1371/journal.pone.0091179	http://dx.doi.org/10.1371/journal.pone.0091179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633177	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400045
J	Bhat, S; Amundsen, PA; Knudsen, R; Gjelland, KO; Fevolden, SE; Bernatchez, L; Praebel, K				Bhat, Shripathi; Amundsen, Per-Arne; Knudsen, Rune; Gjelland, Karl Oystein; Fevolden, Svein-Erik; Bernatchez, Louis; Praebel, Kim			Speciation Reversal in European Whitefish (Coregonus lavaretus (L.)) Caused by Competitor Invasion	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; POPULATION-STRUCTURE; SPECIES COMPLEX; GENETIC ARCHITECTURE; DIVERGENT SELECTION; SEXUAL SELECTION; DNA MARKERS; ALBULA L.; HYBRIDIZATION	Invasion of exotic species has caused the loss of biodiversity and imparts evolutionary and ecological changes in the introduced systems. In northern Fennoscandia, European whitefish (Coregonus lavaretus (L.)) is a highly polymorphic species displaying adaptive radiations into partially reproductively isolated and thus genetically differentiated sympatric morphs utilizing the planktivorous and benthivorous food niche in many lakes. In 1993, Lake Skrukkebukta was invaded by vendace (Coregonus albula (L.)) which is a zooplanktivorous specialist. The vendace displaced the densely rakered whitefish from its preferred pelagic niche to the benthic habitat harbouring the large sparsely rakered whitefish. In this study, we investigate the potential influence of the vendace invasion on the breakdown of reproductive isolation between the two whitefish morphs. We inferred the genotypic and phenotypic differentiation between the two morphs collected at the arrival (1993) and 15 years after (2008) the vendace invasion using 16 microsatellite loci and gill raker numbers, the most distinctive adaptive phenotypic trait between them. The comparison of gill raker number distributions revealed two modes growing closer over 15 years following the invasion. Bayesian analyses of genotypes revealed that the two genetically distinct whitefish morphs that existed in 1993 had collapsed into a single population in 2008. The decline in association between the gill raker numbers and admixture values over 15 years corroborates the findings from the Bayesian analysis. Our study thus suggests an apparent decrease of reproductive isolation in a morph-pair of European whitefish within 15 years (. 3 generations) following the invasion of a superior trophic competitor (vendace) in a subarctic lake, reflecting a situation of "speciation in reverse''.	[Bhat, Shripathi; Amundsen, Per-Arne; Knudsen, Rune; Fevolden, Svein-Erik; Praebel, Kim] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Bernatchez, Louis] Univ Laval, IBIS, Quebec City, PQ, Canada; [Gjelland, Karl Oystein] Norwegian Inst Nat Res, Tromso, Norway	UiT The Arctic University of Tromso; Laval University; Norwegian Institute Nature Research	Bhat, S (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	shripathi.bhat@uit.no	Gjelland, Karl/I-7023-2012; Præbel, Kim/A-2844-2014	Gjelland, Karl/0000-0003-4036-4207; Præbel, Kim/0000-0002-0681-1854; Amundsen, Per-Arne/0000-0002-2203-8216; Bernatchez, Louis/0000-0002-8085-9709	Norwegian Research Council [186320/V40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was financially supported by the Norwegian Research Council (grant no. 186320/V40), www.forskningsradet.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Amundsen PA, 2004, ANN ZOOL FENN, V41, P291; Amundsen PA, 1999, BIOL CONSERV, V88, P405, DOI 10.1016/S0006-3207(98)00110-4; Amundsen PA, 2009, FRESHWATER BIOL, V54, P24, DOI 10.1111/j.1365-2427.2008.02088.x; Behm JE, 2010, AM NAT, V175, P11, DOI 10.1086/648559; Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bernatchez L, 1996, EVOLUTION, V50, P624, DOI [10.2307/2410836, 10.1111/j.1558-5646.1996.tb03873.x]; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bohn T, 1998, J PLANKTON RES, V20, P243, DOI 10.1093/plankt/20.2.243; Bohn T, 2008, BIOL INVASIONS, V10, P359, DOI 10.1007/s10530-007-9135-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Chouinard A, 1996, CAN J ZOOL, V74, P1989, DOI 10.1139/z96-226; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Coyne JA, 2004, SPECIATION, V37; CROWDER LB, 1984, COPEIA, P878, DOI 10.2307/1445332; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; FOOTE CJ, 1988, BEHAVIOUR, V106, P63, DOI 10.1163/156853988X00098; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; Gilman RT, 2011, EVOLUTION, V65, P2592, DOI 10.1111/j.1558-5646.2011.01320.x; Gjelland KO, 2007, J FISH BIOL, V71, P196, DOI 10.1111/j.1095-8649.2007.01678.x; Grant PR, 1996, PHILOS T ROY SOC B, V351, P765, DOI 10.1098/rstb.1996.0071; GRANT PR, 1993, PHILOS T R SOC B, V340, P127, DOI 10.1098/rstb.1993.0052; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; IBM Corp, 2010, IBM SPSS STAT WIND V; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Klemetsen Anders, 2010, Freshwater Reviews, V3, P49, DOI 10.1608/FRJ-3.1.3; Lu GQ, 1998, P ROY SOC B-BIOL SCI, V265, P1025, DOI 10.1098/rspb.1998.0394; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Mutenia Ahti, 1992, Polskie Archiwum Hydrobiologii, V39, P797; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Ostbye K, 2005, J EVOLUTION BIOL, V18, P683, DOI 10.1111/j.1420-9101.2004.00844.x; Patton JC, 1997, CAN J FISH AQUAT SCI, V54, P1548, DOI 10.1139/cjfas-54-7-1548; Praebel K, 2013, ADV LIMNOL, V64, P247, DOI 10.1127/1612-166X/2013/0064-0026; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; Praebel K, 2013, ECOL EVOL, V3, P1400, DOI 10.1002/ece3.552; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Rogers SM, 2004, MOL ECOL NOTES, V4, P89, DOI 10.1046/j.1471-8286.2003.00578.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Senn HV, 2010, MOL ECOL, V19, P910, DOI 10.1111/j.1365-294X.2009.04497.x; Siwertsson A, 2012, ADV LIMNOL, V63, P229; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Susnik S, 1999, MOL ECOL, V8, P1756, DOI 10.1046/j.1365-294x.1999.00723-2.x; Svardson G., 1979, REP I FRESHWATER RES, V57, P3; SVARDSON G., 1970, BIOL COREGONID FISHE, P33; SVARDSON GUNNAR, 1965, REP INST FRESHWATER RES DROTTNINGHOLM, V46, P95; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; TODD TN, 1989, CAN J ZOOL, V67, P1679, DOI 10.1139/z89-241; Turgeon J, 1999, EVOLUTION, V53, P1857, DOI 10.1111/j.1558-5646.1999.tb04568.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VARNAVSKAYA NV, 1994, CAN J FISH AQUAT SCI, V51, P147, DOI 10.1139/f94-301; Velema GJ, 2012, CAN J ZOOL, V90, P1328, DOI 10.1139/z2012-102; Vines TH, 2006, P ROY SOC B-BIOL SCI, V273, P911, DOI 10.1098/rspb.2005.3387; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; WIMBERGER PH, 1994, BEL BAR LIB, P19; Winkler KA, 2008, MOL ECOL RESOUR, V8, P1055, DOI 10.1111/j.1755-0998.2008.02153.x; Woods PJ, 2009, J EVOLUTION BIOL, V22, P2305, DOI 10.1111/j.1420-9101.2009.01846.x; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152	84	40	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91208	10.1371/journal.pone.0091208	http://dx.doi.org/10.1371/journal.pone.0091208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626131	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300065
J	Cheng, CY; Lin, JG; Tang, NY; Kao, ST; Hsieh, CL				Cheng, Chin-Yi; Lin, Jaung-Geng; Tang, Nou-Ying; Kao, Shung-Te; Hsieh, Ching-Liang			Electroacupuncture-Like Stimulation at the Baihui (GV20) and Dazhui (GV14) Acupoints Protects Rats against Subacute-Phase Cerebral Ischemia-Reperfusion Injuries by Reducing S100B-Mediated Neurotoxicity	PLOS ONE			English	Article							PERMANENT FOCAL ISCHEMIA; APOPTOTIC CELL-DEATH; BRAIN-DAMAGE; ASTROCYTIC ACTIVATION; ARTERY OCCLUSION; NEONATAL-RAT; EXPRESSION; STROKE; S100B; INFARCTION	Objectives: The purpose of this study was to evaluate the effects of electroacupuncture-like stimulation at the Baihui (GV20) and Dazhui (GV14) acupoints (EA at acupoints) during the subacute phase of cerebral ischemia-reperfusion (I/R) injury and to establish the neuroprotective mechanisms involved in the modulation of the S100B-mediated signaling pathway. Methods: The experimental rats were subjected to middle cerebral artery occlusion (MCAo) for 15 min followed by 1 d or 7 d of reperfusion. EA at acupoints was applied 1 d postreperfusion then once daily for 6 consecutive days. Results: We observed that 15 min of MCAo caused delayed infarct expansion 7 d after reperfusion. EA at acupoints significantly reduced the cerebral infarct and neurological deficit scores. EA at acupoints also downregulated the expression of the glial fibrillary acidic protein (GFAP), S100B, nuclear factor-kappa B (NF-kappa B; p50), and tumor necrosis factor-alpha (TNF-alpha), and reduced the level of inducible nitric oxide synthase (iNOS) and apoptosis in the ischemic cortical penumbra 7 d after reperfusion. Western blot analysis showed that EA at acupoints significantly downregulated the cytosolic expression of phospho-p38 MAP kinase (p-p38 MAP kinase), tumor necrosis factor receptor type 1-associated death domain (TRADD), Fas-associated death domain (FADD), cleaved caspase-8, and cleaved caspase-3 in the ischemic cortical penumbra 7 d after reperfusion. EA at acupoints significantly reduced the numbers of GFAP/S100B and S100B/nitrotyrosine double-labeled cells. Conclusion: Our study results indicate that EA at acupoints initiated 1 d postreperfusion effectively downregulates astrocytic S100B expression to provide neuroprotection against delayed infarct expansion by modulating p38 MAP kinase-mediated NF-kappa B expression. These effects subsequently reduce oxidative/nitrative stress and inhibit the TNF-alpha/TRADD/ FADD/cleaved caspase-8/cleaved caspase-3 apoptotic pathway in the ischemic cortical penumbra 7 d after reperfusion.	[Cheng, Chin-Yi; Lin, Jaung-Geng; Tang, Nou-Ying; Kao, Shung-Te] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Cheng, Chin-Yi] Hui Sheng Hosp, Dept Chinese Med, Taichung, Taiwan; [Hsieh, Ching-Liang] China Med Univ, Acupuncture Res Ctr, Taichung, Taiwan; [Hsieh, Ching-Liang] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Hsieh, Ching-Liang] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hsieh, CL (corresponding author), China Med Univ, Acupuncture Res Ctr, Taichung, Taiwan.	clhsieh@mail.cmuh.org.tw			China Medical University [CMU101-S-07]; Taiwanese Department of Health, Clinical Trials and Research Center of Excellence [DOH102-TD-B-111-004]	China Medical University(China Medical University); Taiwanese Department of Health, Clinical Trials and Research Center of Excellence	This study was supported by grants from China Medical University (CMU101-S-07), and the Taiwanese Department of Health, Clinical Trials and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Buyukuysal RL, 2005, NEUROCHEM INT, V47, P580, DOI 10.1016/j.neuint.2005.06.009; Chao XD, EXP NEUROL, V239, P163; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Coeroli L, 1998, J NEUROCHEM, V70, P2516; Collino M, 2008, SHOCK, V30, P299, DOI 10.1097/SHK.0b013e318164e762; Collino M, 2006, FREE RADICAL BIO MED, V41, P1619, DOI 10.1016/j.freeradbiomed.2006.09.013; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hu JR, 1996, BBA-MOL CELL RES, V1313, P239, DOI 10.1016/0167-4889(96)00095-X; Iadecola C, 1997, J NEUROSCI, V17, P9157; Johansson BB, 2001, STROKE, V32, P707, DOI 10.1161/01.STR.32.3.707; Jung DH, 2009, J ETHNOPHARMACOL, V125, P374, DOI 10.1016/j.jep.2009.08.002; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Lee SH, 2002, BRAIN RES, V956, P14, DOI 10.1016/S0006-8993(02)03197-9; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo Y, 2011, CHIN J INTEGR MED, V17, P750, DOI 10.1007/s11655-011-0754-7; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mori T, 2005, J CEREBR BLOOD F MET, V25, P748, DOI 10.1038/sj.jcbfm.9600063; Mori T., 2010, CARDIOVASC PSYCHIAT; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Park J, 2001, J NEUROL, V248, P558, DOI 10.1007/s004150170132; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sallstrom S, 1995, Tidsskr Nor Laegeforen, V115, P2884; Tanaka Y, 2007, BRAIN RES, V1137, P140, DOI 10.1016/j.brainres.2006.12.025; Tateishi N, 1998, Nihon Yakurigaku Zasshi, V112 Suppl 1, p103P; Wang Q, 2005, NEUROSCI LETT, V381, P158, DOI 10.1016/j.neulet.2005.02.019; Wang YH, 2006, J BIOMED SCI, V13, P127, DOI 10.1007/s11373-005-9031-0; Xiong L, 2003, CHINESE MED J-PEKING, V116, P108; Yang J, 2011, BRAIN RES, V1398, P94, DOI 10.1016/j.brainres.2011.05.007; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Ye YL, 2007, EUR J PHARMACOL, V557, P23, DOI 10.1016/j.ejphar.2006.11.003; Yu LY, 2006, NEUROCHEM RES, V31, P21, DOI 10.1007/s11064-005-9004-8; Zhai DX, 2008, NEUROSCI LETT, V445, P117, DOI 10.1016/j.neulet.2008.08.077; Zhang F, 2011, BRAIN INJURY, V25, P895, DOI 10.3109/02699052.2011.581639; Zhou Hai-peng, 2011, Zhonghua Yi Xue Za Zhi, V91, P1203; Zhu CL, 2004, J NEUROCHEM, V90, P462, DOI 10.1111/j.1471-4159.2004.02500.x; Zong H, J BIOL CHEM, V285, P23137	44	37	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91426	10.1371/journal.pone.0091426	http://dx.doi.org/10.1371/journal.pone.0091426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626220	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300084
J	Hoeppner, MP; Lundquist, A; Pirun, M; Meadows, JRS; Zamani, N; Johnson, J; Sundstrom, G; Cook, A; FitzGerald, MG; Swofford, R; Mauceli, E; Moghadam, BT; Greka, A; Alfoldi, J; Abouelleil, A; Aftuck, L; Bessette, D; Berlin, A; Brown, A; Gearin, G; Lui, A; Macdonald, JP; Priest, M; Shea, T; Turner-Maier, J; Zimmer, A; Lander, ES; di Palma, F; Lindblad-Toh, K; Grabherr, MG				Hoeppner, Marc P.; Lundquist, Andrew; Pirun, Mono; Meadows, Jennifer R. S.; Zamani, Neda; Johnson, Jeremy; Sundstrom, Gorel; Cook, April; FitzGerald, Michael G.; Swofford, Ross; Mauceli, Evan; Moghadam, Behrooz Torabi; Greka, Anna; Alfoeldi, Jessica; Abouelleil, Amr; Aftuck, Lynne; Bessette, Daniel; Berlin, Aaron; Brown, Adam; Gearin, Gary; Lui, Annie; Macdonald, J. Pendexter; Priest, Margaret; Shea, Terrance; Turner-Maier, Jason; Zimmer, Andrew; Lander, Eric S.; di Palma, Federica; Lindblad-Toh, Kerstin; Grabherr, Manfred G.			An Improved Canine Genome and a Comprehensive Catalogue of Coding Genes and Non-Coding Transcripts	PLOS ONE			English	Article							RNA; SEQUENCE; IDENTIFICATION; DOMESTICATION; LANDSCAPE; LINCRNAS; MUTATION; CIS	The domestic dog, Canis familiaris, is a well-established model system for mapping trait and disease loci. While the original draft sequence was of good quality, gaps were abundant particularly in promoter regions of the genome, negatively impacting the annotation and study of candidate genes. Here, we present an improved genome build, canFam3.1, which includes 85 MB of novel sequence and now covers 99.8% of the euchromatic portion of the genome. We also present multiple RNA-Sequencing data sets from 10 different canine tissues to catalog similar to 175,000 expressed loci. While about 90% of the coding genes previously annotated by EnsEMBL have measurable expression in at least one sample, the number of transcript isoforms detected by our data expands the EnsEMBL annotations by a factor of four. Syntenic comparison with the human genome revealed an additional similar to 3,000 loci that are characterized as protein coding in human and were also expressed in the dog, suggesting that those were previously not annotated in the EnsEMBL canine gene set. In addition to,20,700 high-confidence protein coding loci, we found,4,600 antisense transcripts overlapping exons of protein coding genes, similar to 7,200 intergenic multi-exon transcripts without coding potential, likely candidates for long intergenic non-coding RNAs (lincRNAs) and,11,000 transcripts were reported by two different library construction methods but did not fit any of the above categories. Of the lincRNAs, about 6,000 have no annotated orthologs in human or mouse. Functional analysis of two novel transcripts with shRNA in a mouse kidney cell line altered cell morphology and motility. All in all, we provide a much-improved annotation of the canine genome and suggest regulatory functions for several of the novel non-coding transcripts.	[Hoeppner, Marc P.; Meadows, Jennifer R. S.; Zamani, Neda; Sundstrom, Gorel; Lindblad-Toh, Kerstin; Grabherr, Manfred G.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Labs, Uppsala, Sweden; [Lundquist, Andrew; Johnson, Jeremy; Cook, April; FitzGerald, Michael G.; Swofford, Ross; Greka, Anna; Alfoeldi, Jessica; Abouelleil, Amr; Aftuck, Lynne; Bessette, Daniel; Berlin, Aaron; Brown, Adam; Gearin, Gary; Lui, Annie; Macdonald, J. Pendexter; Priest, Margaret; Shea, Terrance; Turner-Maier, Jason; Zimmer, Andrew; Lander, Eric S.; di Palma, Federica; Lindblad-Toh, Kerstin; Grabherr, Manfred G.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lundquist, Andrew] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Lundquist, Andrew] Harvard Univ, Sch Med, Charlestown, MA USA; [Pirun, Mono] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Mauceli, Evan] Boston Childrens Hosp, Boston, MA USA; [Moghadam, Behrooz Torabi] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [di Palma, Federica] Genome Anal Ctr, Norwich, Norfolk, England	Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Uppsala University; The Genome Analysis Centre (TGAC)	Lindblad-Toh, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Labs, Uppsala, Sweden.	kersli@broadinstitute.org; manfred.grabherr@imbim.uu.se	Berlin, Aaron M/AFY-6549-2022	Berlin, Aaron M/0000-0002-0714-2808; Meadows, Jennifer/0000-0002-0850-230X; Swofford, Ross/0000-0003-3676-8479; Grabherr, Manfred/0000-0001-8792-6508; Di-Palma, Federica/0000-0002-4394-0102	NHGRI [U54 HG003067]; Uppsala University; Swedish Medical Research Council; Research Council FORMAS; European Commission [FP7-LUPA, GA-201370]; Science for Life Laboratory; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Uppsala University; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Research Council FORMAS(Swedish Research Council Formas); European Commission(European CommissionEuropean Commission Joint Research Centre); Science for Life Laboratory; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by NHGRI (U54 HG003067), Uppsala University, Swedish Medical Research Council, Research Council FORMAS, and the European Commission (FP7-LUPA, GA-201370), and a start-up grant from the Science for Life Laboratory to MGG. KLT is a recipient of a EURYI from the ESF and received a Consolidator Award from ERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bogdanov EA, 2010, CURR PROTOC MOL BIOL, V5, P11, DOI DOI 10.1002/0471142727.MB3001S90; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Dreger DL, 2013, J HERED, V104, P399, DOI 10.1093/jhered/est012; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Grabherr MG, 2010, BIOINFORMATICS, V26, P1145, DOI 10.1093/bioinformatics/btq102; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Owczarek-Lipska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039176; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Schmidt EE, 1996, CURR BIOL, V6, P768, DOI 10.1016/S0960-9822(02)00589-4; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weiss B, 1999, CELL MOL LIFE SCI, V55, P334, DOI 10.1007/s000180050296; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	50	131	132	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91172	10.1371/journal.pone.0091172	http://dx.doi.org/10.1371/journal.pone.0091172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625832	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300061
J	Mandal, M; Mukhopadhyay, A				Mandal, Monalisa; Mukhopadhyay, Anirban			A Graph-Theoretic Approach for Identifying Non-Redundant and Relevant Gene Markers from Microarray Data Using Multiobjective Binary PSO	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; FEATURE-SELECTION; CANCER; CLASSIFICATION	The purpose of feature selection is to identify the relevant and non-redundant features from a dataset. In this article, the feature selection problem is organized as a graph-theoretic problem where a feature-dissimilarity graph is shaped from the data matrix. The nodes represent features and the edges represent their dissimilarity. Both nodes and edges are given weight according to the feature's relevance and dissimilarity among the features, respectively. The problem of finding relevant and non-redundant features is then mapped into densest subgraph finding problem. We have proposed a multiobjective particle swarm optimization (PSO)-based algorithm that optimizes average node-weight and average edge-weight of the candidate subgraph simultaneously. The proposed algorithm is applied for identifying relevant and non-redundant disease-related genes from microarray gene expression data. The performance of the proposed method is compared with that of several other existing feature selection techniques on different real-life microarray gene expression datasets.	[Mandal, Monalisa; Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India	Kalyani University	Mandal, M (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	monalisa@klyuniv.ac.in; anirban@klyuniv.ac.in	Mukhopadhyay, Anirban/H-3220-2012; Mukhopadhyay, Anirban/ABB-5739-2021	Mukhopadhyay, Anirban/0000-0001-8128-3521				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bahmani B, 2012, PROC VLDB ENDOW, V5, P454, DOI 10.14778/2140436.2140442; Baya A, 2007, GENE SET ENRICHMENT; Cai D, 2010, KDD10 WASH DC US; Chen LF, 2012, INTELL DATA ANAL, V16, P167, DOI 10.3233/IDA-2012-0517; Cheok M, 2003, OPERATIONS RES LETT, V31; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Chuang L, 2011, INT C MACH LEARN COM; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Cover T.M., 2006, ELEM INF THEORY, V2nd, P16; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dy JG, 2003, IEEE T PATTERN ANAL, V25, P373, DOI 10.1109/TPAMI.2003.1182100; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fukuta K, 2012, P INT CONTR INN COMP; Gordon GJ, 2002, CANCER RES, V62, P4963; Hall M. A., 1999, P 12 INT FLAIRS C; Hanczar B, 2003, SIGKDD EXPLOR NEWSLE; Iashkargir M, 2009, INT J COMPUTER SCI I, V4; Jaeger J, 2003, PAC S BIOCOMPUT; Jiang S, 2012, NEW FRONTIERS APPL D; Kamandar M, 2009, INT C HYBR ART INT S; Kamandar M, 2011, INT WORKSH GRAPH BAS; Kamandar M., 2011, 19 IR C EL ENG ICEE; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Krause E, ADDISON WESLEY INNOV; Lee I, 2011, J CLIN BIOINFORMATIC, V1; Li Y, 2006, HYBRID METHOD UNSUPE; Liu YN, 2011, J BIONIC ENG, V8, P191, DOI 10.1016/S1672-6529(11)60020-6; M-Cedeno A, 2010, P IEEE IND EL SOC; Mankiewicz R., 2000, STORY MATH; Mao KZ, 2004, IEEE T SYST MAN CY B, V34, P629, DOI 10.1109/TSMCB.2002.804363; Maulik U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-27; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P301, DOI 10.1109/34.990133; Mohamad MS, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-15; Morita M., 2004, FRONTIERS HANDWRITIN; Parsopoulos KE, 2010, PARTICLE SWARM OPTIMIZATION AND INTELLIGENCE: ADVANCES AND APPLICATIONS, P1, DOI 10.4018/978-1-61520-666-7; Reyes-Sierra M., 2006, INT J COMPUTATIONAL, V2, P287, DOI DOI 10.5019/J.IJCIR.2006.68; Ruiz R, 2006, PATTERN RECOGN, V39, P2383, DOI 10.1016/j.patcog.2005.11.001; Shipp M, 2002, NATURE MED, V8; Tang E, 2005, IEEE S COMP INT BIOI; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Unler A, 2010, EUR J OPER RES, V206, P528, DOI 10.1016/j.ejor.2010.02.032; Wang X, 2009, INT C GEN INF; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Xue B, 2012, CONNECT SCI, V24, P91, DOI 10.1080/09540091.2012.737765; Yoon YR, 2008, INFORM SCIENCES, V178, P88, DOI 10.1016/j.ins.2007.08.013; Zhang Z, 2011, GRAPH BASED APPROACH	49	30	30	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90949	10.1371/journal.pone.0090949	http://dx.doi.org/10.1371/journal.pone.0090949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625895	Green Published, gold			2022-12-25	WOS:000332851300043
J	Vato, A; Szymanski, FD; Semprini, M; Mussa-Ivaldi, FA; Panzeri, S				Vato, Alessandro; Szymanski, Francois D.; Semprini, Marianna; Mussa-Ivaldi, Ferdinando A.; Panzeri, Stefano			A Bidirectional Brain-Machine Interface Algorithm That Approximates Arbitrary Force-Fields	PLOS ONE			English	Article							CORTICAL-NEURONS; STIMULUS LOCATION; PARIETAL CORTEX; MOTOR CORTEX; MOVEMENT; MUSCLE; RAT; INFORMATION; PRIMITIVES; RESPONSES	We examine bidirectional brain-machine interfaces that control external devices in a closed loop by decoding motor cortical activity to command the device and by encoding the state of the device by delivering electrical stimuli to sensory areas. Although it is possible to design this artificial sensory-motor interaction while maintaining two independent channels of communication, here we propose a rule that closes the loop between flows of sensory and motor information in a way that approximates a desired dynamical policy expressed as a field of forces acting upon the controlled external device. We previously developed a first implementation of this approach based on linear decoding of neural activity recorded from the motor cortex into a set of forces (a force field) applied to a point mass, and on encoding of position of the point mass into patterns of electrical stimuli delivered to somatosensory areas. However, this previous algorithm had the limitation that it only worked in situations when the position-to-force map to be implemented is invertible. Here we overcome this limitation by developing a new non-linear form of the bidirectional interface that can approximate a virtually unlimited family of continuous fields. The new algorithm bases both the encoding of position information and the decoding of motor cortical activity on an explicit map between spike trains and the state space of the device computed with Multi-Dimensional-Scaling. We present a detailed computational analysis of the performance of the interface and a validation of its robustness by using synthetic neural responses in a simulated sensory-motor loop.	[Vato, Alessandro; Szymanski, Francois D.; Semprini, Marianna] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Mussa-Ivaldi, Ferdinando A.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Mussa-Ivaldi, Ferdinando A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Mussa-Ivaldi, Ferdinando A.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Panzeri, Stefano] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy; [Panzeri, Stefano] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Istituto Italiano di Tecnologia - IIT; Northwestern University; Northwestern University; Shirley Ryan AbilityLab; Istituto Italiano di Tecnologia - IIT; University of Glasgow	Vato, A (corresponding author), Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	alessandro.vato@iit.it	Semprini, Marianna/AAC-3059-2019; Vato, Alessandro/B-2651-2013; Panzeri, Stefano/L-5977-2013	Semprini, Marianna/0000-0001-5504-0251; Vato, Alessandro/0000-0002-7217-999X; Panzeri, Stefano/0000-0003-1700-8909	BMI project of the Robotics, Brain and Cognitive Sciences Department, Italian Institute of Technology Italy; NICHHD [1R01HD072080-01]; SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission [FP7-284553]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072080] Funding Source: NIH RePORTER	BMI project of the Robotics, Brain and Cognitive Sciences Department, Italian Institute of Technology Italy; NICHHD; SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the BMI project of the Robotics, Brain and Cognitive Sciences Department, Italian Institute of Technology Italy and NICHHD grant 1R01HD072080-01 to FAM-I. The authors acknowledge the financial support of the SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: FP7-284553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienenstock E., 1995, HDB BRAIN THEORY NEU, P223; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Black A.H., 1972, PSYCHOL LEARNING MOT, V6, P47; Chakrabarti S, 2008, J NEUROPHYSIOL, V100, P50, DOI 10.1152/jn.90327.2008; Chao ZC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; EVARTS EV, 1981, CAN J PHYSIOL PHARM, V59, P757, DOI 10.1139/y81-112; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GISZTER SF, 1993, J NEUROSCI, V13, P467; Golledge HDR, 2003, NEUROREPORT, V14, P1045, DOI 10.1097/00001756-200305230-00028; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P143, DOI 10.1113/jphysiol.1966.sp007908; Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927; GRILLNER S, 1991, NEURON, V7, P1, DOI 10.1016/0896-6273(91)90069-C; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; HOGAN N, 1985, J DYN SYST-T ASME, V107, P1, DOI 10.1115/1.3140702; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; Houghton C, 2008, NEURAL COMPUT, V20, P1495, DOI 10.1162/neco.2007.10-06-350; Jackson A, 2011, IEEE T NEUR SYS REH, V19, P534, DOI 10.1109/TNSRE.2011.2158586; Karnopp D., 1990, SYSTEM DYNAMICS UNIF; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; Kim HK, 2007, IEEE T BIO-MED ENG, V54, P1520, DOI 10.1109/TBME.2007.900818; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Mussa-Ivaldi FA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.008.2010; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; MUSSAIVALDI FA, 1992, BIOL CYBERN, V67, P479, DOI 10.1007/BF00198755; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Panzeri S, 2003, CEREB CORTEX, V13, P45, DOI 10.1093/cercor/13.1.45; Patil PG, 2008, NEUROTHERAPEUTICS, V5, P137, DOI 10.1016/j.nurt.2007.11.002; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; RACK PMH, 1969, J PHYSIOL-LONDON, V204, P443, DOI 10.1113/jphysiol.1969.sp008923; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Scaglione A, 2011, P NATL ACAD SCI USA, V108, P14956, DOI 10.1073/pnas.1103168108; Schwartz AB, 2007, J PHYSIOL-LONDON, V579, P581, DOI 10.1113/jphysiol.2006.126698; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Szymanski FD, 2011, IEEE ENG MED BIO, P4592, DOI 10.1109/IEMBS.2011.6091137; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Vato A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002578; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Von Neumann J., 2012, COMPUTER BRAIN; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Zimmermann JB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/054001	56	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91677	10.1371/journal.pone.0091677	http://dx.doi.org/10.1371/journal.pone.0091677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626393	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000332851300119
J	Wojtalewicz, N; Sadeqzadeh, E; Weiss, JV; Tehrani, MM; Klein-Scory, S; Hahn, S; Schmiegel, W; Warnken, U; Schnolzer, M; de Bock, CE; Thorne, RF; Schwarte-Waldhoff, I				Wojtalewicz, Nathalie; Sadeqzadeh, Elham; Weiss, Jakob V.; Tehrani, Mahnaz Moradian; Klein-Scory, Susanne; Hahn, Stephan; Schmiegel, Wolff; Warnken, Uwe; Schnoelzer, Martina; de Bock, Charles E.; Thorne, Rick F.; Schwarte-Waldhoff, Irmgard			A Soluble Form of the Giant Cadherin Fat1 Is Released from Pancreatic Cancer Cells by ADAM10 Mediated Ectodomain Shedding	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROTOCADHERIN FAT1; BETA-CATENIN; DROSOPHILA; EXPRESSION; SERUM; PROTEINS; ADHESION; HOMOLOG; BIOMARKERS	In pancreatic cancer, there is a clear unmet need to identify new serum markers for either early diagnosis, therapeutic stratification or patient monitoring. Proteomic analysis of tumor cell secretomes is a promising approach to indicate proteins released from tumor cells in vitro. Ectodomain shedding of transmembrane proteins has previously been shown to contribute significant fractions the tumor cell secretomes and to generate valuable serum biomarkers. Here we introduce a soluble form of the giant cadherin Fat1 as a novel biomarker candidate. Fat1 expression and proteolytic processing was analyzed by mass spectrometry and Western blotting using pancreatic cancer cell lines as compared to human pancreatic ductal epithelial cells. RNA expression in cancer tissues was assessed by in silico analysis of publically available microarray data. Involvement of ADAM10 (A Disintegrin and metalloproteinase domain-containing protein 10) in Fat1 ectodomain shedding was analyzed by chemical inhibition and knockdown experiments. A sandwich ELISA was developed to determine levels of soluble Fat1 in serum samples. In the present report we describe the release of high levels of the ectodomain of Fat1 cadherin into the secretomes of human pancreatic cancer cells in vitro, a process that is mediated by ADAM10. We confirm the full-length and processed heterodimeric form of Fat1 expressed on the plasma membrane and also show the p60 C-terminal transmembrane remnant fragment corresponding to the shed ectodomain. Fat1 and its sheddase ADAM10 are overexpressed in pancreatic adenocarcinomas and ectodomain shedding is also recapitulated in vivo leading to increased Fat1 serum levels in some pancreatic cancer patients. We suggest that soluble Fat1 may find an application as a marker for patient monitoring complementing carbohydrate antigen 19-9 (CA19-9). In addition, detailed analysis of the diverse processed protein isoforms of the candidate tumor suppressor Fat1 can also contribute to our understanding of cell biology and tumor behavior.	[Wojtalewicz, Nathalie; Weiss, Jakob V.; Klein-Scory, Susanne; Schwarte-Waldhoff, Irmgard] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Internal Med, IMBL, Bochum, Germany; [Sadeqzadeh, Elham; Thorne, Rick F.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Tehrani, Mahnaz Moradian; Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, Heidelberg, Germany; [Hahn, Stephan] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, Bochum, Germany; [Schmiegel, Wolff] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Internal Med, Bochum, Germany; [de Bock, Charles E.] Vlaams Inst Biotechnol, Ctr Biol Dis, Louvain, Belgium	Ruhr University Bochum; University of Newcastle; Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Ruhr University Bochum; Flanders Institute for Biotechnology (VIB)	Schwarte-Waldhoff, I (corresponding author), Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Internal Med, IMBL, Univ Str 150, Bochum, Germany.	Irmgard.Schwarte-Waldhoff@rub.de	de Bock, Charles/H-7699-2019; Hahn, Stephan/E-3880-2010; Hahn, Stephan A./AAV-6062-2021	de Bock, Charles/0000-0001-5182-8535; Hahn, Stephan/0000-0003-0855-9741; Hahn, Stephan A./0000-0003-0855-9741; Thorne, Rick/0000-0001-7882-7081; Wojtalewicz, Nathalie/0000-0002-1977-7931; Klein-Scory, Susanne/0000-0003-1930-3354	Bundesministerium fur Bildung und Forschung, NGFN Plus program [01GS08117, 01GS08118]; Hunter Translational Cancer Research Unit	Bundesministerium fur Bildung und Forschung, NGFN Plus program(Federal Ministry of Education & Research (BMBF)); Hunter Translational Cancer Research Unit	This work was supported by the Bundesministerium fur Bildung und Forschung, NGFN Plus program, 01GS08117 (to MS) and 01GS08118 (to IS-W) and by a grant from the Hunter Translational Cancer Research Unit (to RFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk KA, 2011, LIFE SCI, V89, P304, DOI 10.1016/j.lfs.2011.06.020; Ballehaninna UK, 2011, INDIA J SURG ONCOL, V2, P88, DOI 10.1007/s13193-011-0042-1; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Chosdol K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-5; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Cox B, 2000, DEV DYNAM, V217, P233, DOI 10.1002/(SICI)1097-0177(200003)217:3<233::AID-DVDY1>3.0.CO;2-O; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Diehl HC, 2007, PROTEOM CLIN APPL, V1, P47, DOI 10.1002/prca.200600491; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Fong ZV, 2012, CANCER J, V18, P530, DOI 10.1097/PPO.0b013e31827654ea; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Gunawardana CG, 2009, J PROTEOME RES, V8, P4705, DOI 10.1021/pr900411g; Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561; Hundhausen Christian, 2003, Blood, V102, P1186; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katoh Y, 2006, INT J MOL MED, V18, P523; Kwaepila N, 2006, PATHOLOGY, V38, P125, DOI 10.1080/00313020600559975; LOHR M, 1994, BRIT J CANCER, V69, P144, DOI 10.1038/bjc.1994.24; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marrelli D, 2009, AM J SURG, V198, P333, DOI 10.1016/j.amjsurg.2008.12.031; May M, 2009, NAT MED, V15, P828, DOI 10.1038/nm0809-828; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Moradian Tehrani M, 2012, THESIS U HEIDELBERG; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; O'Reilly EM, 2012, CANCER J, V18, P609, DOI 10.1097/PPO.0b013e3182758e27; Ponassi M, 1999, MECH DEVELOP, V80, P207, DOI 10.1016/S0925-4773(98)00217-2; Sadeqzadeh E, 2013, MED RES REV IN PRESS; Sadeqzadeh E, 2011, J BIOL CHEM, V286, P28181, DOI 10.1074/jbc.M111.234419; Settakorn J, 2005, J CLIN PATHOL, V58, P1249, DOI 10.1136/jcp.2005.026575; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Singh S, 2011, DIGEST DIS SCI, V56, P2491, DOI 10.1007/s10620-011-1709-8; Sopko R, 2009, CURR OPIN CELL BIOL, V21, P717, DOI 10.1016/j.ceb.2009.07.001; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; TEMPERO MA, 1987, CANCER RES, V47, P5501; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; van Kilsdonk JWJ, 2010, EUR J CELL BIOL, V89, P415, DOI 10.1016/j.ejcb.2009.11.026; Vestergaard EM, 1999, CLIN CHEM, V45, P54; Volmer MW, 2005, PROTEOMICS, V5, P2587, DOI 10.1002/pmic.200401188; Weiss JV, 2011, INT J CANCER, V128, P1384, DOI 10.1002/ijc.25438; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52	51	20	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90461	10.1371/journal.pone.0090461	http://dx.doi.org/10.1371/journal.pone.0090461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625754	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300020
J	Forbes, KM; Stuart, P; Mappes, T; Hoset, KS; Henttonen, H; Huitu, O				Forbes, Kristian M.; Stuart, Peter; Mappes, Tapio; Hoset, Katrine S.; Henttonen, Heikki; Huitu, Otso			Diet Quality Limits Summer Growth of Field Vole Populations	PLOS ONE			English	Article							FOOD SUPPLEMENTATION EXPERIMENTS; RODENT DYNAMICS; CYCLES; PREDATION; CLIMATE; AVAILABILITY; REPRODUCTION; TERRESTRIAL; TEMPERATURE; MECHANISMS	Marked variation occurs in both seasonal and multiannual population density peaks of northern European small mammal species, including voles. The availability of dietary proteins is a key factor limiting the population growth of herbivore species. The objective of this study is to investigate the degree to which protein availability influences the growth of increasing vole populations. We hypothesise that the summer growth of folivorous vole populations is positively associated with dietary protein availability. A field experiment was conducted over a summer reproductive period in 18 vegetated enclosures. Populations of field voles (Microtus agrestis) were randomised amongst three treatment groups: 1) food supplementation with ad libitum high protein (30% dry weight) pellets, 2) food supplementation with ad libitum low protein (1% dry weight; both supplemented foods had equivalent energy content) pellets, and 3) control (no food supplementation), n = 6 per treatment. Vole density, survival, demographic attributes and condition indicators were monitored with live-trapping and blood sampling. Highest final vole densities were attained in populations that received high protein supplementation and lowest in low protein populations. Control populations displayed intermediate densities. The survival rate of voles was similar in all treatment groups. The proportion of females, and of those that were pregnant or lactating, was highest in the high protein supplemented populations. This suggests that variation in reproductive, rather than survival rates of voles, accounted for density differences between the treatment groups. We found no clear association between population demography and individual physiological condition. Our results demonstrate that dietary protein availability limits vole population growth during the summer growing season. This suggests that the nutritional quality of forage may be an underestimated source of interannual variation in the density and growth rates of widely fluctuating populations of herbivorous small mammals.	[Forbes, Kristian M.; Stuart, Peter; Huitu, Otso] Finnish Forest Res Inst, Suonenjoki Res Unit, Suonenjoki, Finland; [Forbes, Kristian M.; Mappes, Tapio] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Stuart, Peter] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Hoset, Katrine S.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Henttonen, Heikki] Finnish Forest Res Inst, Vantaa Res Unit, Vantaa, Finland	Natural Resources Institute Finland (Luke); University of Jyvaskyla; Masaryk University Brno; University of Turku; Natural Resources Institute Finland (Luke)	Huitu, O (corresponding author), Finnish Forest Res Inst, Suonenjoki Res Unit, Suonenjoki, Finland.	otso.huitu@metla.fi	Hoset, Katrine S./A-5090-2010; Stuart, Peter/N-1830-2016; Mappes, Tapio/B-9780-2013	Hoset, Katrine S./0000-0002-1371-012X; Mappes, Tapio/0000-0002-5936-7355	Academy of Finland [133495, 132190]	Academy of Finland(Academy of Finland)	The experiment was funded by the Academy of Finland (www.aka.fi/eng: grant 133495 to OH, grant 132190 to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen HP, 2013, OIKOS, V122, P507, DOI 10.1111/j.1600-0706.2012.00238.x; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; BOONSTRA R, 1994, EVOL ECOL, V8, P196, DOI 10.1007/BF01238250; BOONSTRA R, 1979, ECOLOGY, V60, P567, DOI 10.2307/1936077; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Burnham K. P., 2002, MODEL SELECTION INTE; Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6; Cameron GN, 1996, J MAMMAL, V77, P220, DOI 10.2307/1382723; CHAPIN FS, 1980, J ECOL, V68, P189; CHITTY D, 1952, PHILOS T ROY SOC B, V236, P505, DOI 10.1098/rstb.1952.0009; COLE FR, 1979, J ANIM ECOL, V48, P455, DOI 10.2307/4172; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Dalkvist T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022834; DESY EA, 1989, ECOLOGY, V70, P411, DOI 10.2307/1937546; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Ergon T, 2001, NATURE, V411, P1043, DOI 10.1038/35082553; FROMMEL TO, 1988, J PARASITOL, V74, P957, DOI 10.2307/3282215; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; HANSSON L, 1979, OECOLOGIA, V37, P297, DOI 10.1007/BF00347907; HANSSON L, 1985, ANN ZOOL FENN, V22, P277; Helle H, 2012, J ANIM ECOL, V81, P573, DOI 10.1111/j.1365-2656.2011.01937.x; HENTTONEN H, 1987, OIKOS, V50, P366, DOI 10.2307/3565497; Hornfeldt B, 2005, P ROY SOC B-BIOL SCI, V272, P2045, DOI 10.1098/rspb.2005.3141; Huitu O, 2003, ECOLOGY, V84, P2108, DOI 10.1890/02-0040; Huitu O, 2007, OIKOS, V116, P565, DOI 10.1111/j.2007.0030-1299.15488.x; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Inchausti P, 1998, J ANIM ECOL, V67, P180, DOI 10.1046/j.1365-2656.1998.00189.x; Jonsdottir IS, 2005, CAN J BOT, V83, P1608, DOI 10.1139/b05-129; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Klemola T, 2000, P ROY SOC B-BIOL SCI, V267, P351, DOI 10.1098/rspb.2000.1008; Korpela K, 2013, GLOBAL CHANGE BIOL, V19, P697, DOI 10.1111/gcb.12099; Korpimaki E, 2005, J ANIM ECOL, V74, P1150, DOI 10.1111/j.1365-2656.2005.01015.x; Koskela E, 1998, P ROY SOC B-BIOL SCI, V265, P1129, DOI 10.1098/rspb.1998.0408; Krebs C.J., 2013, POPULATION FLUCTUATI; KUMMEROW J, 1980, ARCTIC ALPINE RES, V12, P335, DOI 10.2307/1550719; Lack D., 1954, P343; LAINE KM, 1987, OIKOS, V50, P389, DOI 10.2307/3565500; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mira A, 1994, HYSTRIX, V5, P63; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; MYLLYMAKI A, 1977, OIKOS, V29, P468, DOI 10.2307/3543588; Norrdahl K, 2002, OECOLOGIA, V130, P239, DOI 10.1007/s004420100795; NORRDAHL K, 1995, BIOL REV, V70, P621, DOI 10.1111/j.1469-185X.1995.tb01654.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; POLLOCK KH, 1983, BIOMETRICS, V39, P1035, DOI 10.2307/2531337; Rikalainen K, 2012, ECOL EVOL, V2, P1491, DOI 10.1002/ece3.277; Schetter TA, 1998, J ANIM ECOL, V67, P705, DOI 10.1046/j.1365-2656.1998.00240.x; Schoech SJ, 2009, INTEGR COMP BIOL, V49, P480, DOI 10.1093/icb/icp005; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sinclair ARE, 2002, PHILOS T ROY SOC B, V357, P1221, DOI 10.1098/rstb.2002.1123; Speakman JR, 2003, P NATL ACAD SCI USA, V100, P14057, DOI 10.1073/pnas.2235671100; Suleiman A, 1999, J RANGE MANAGE, V52, P75, DOI 10.2307/4003495; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White TCR, 2005, WHY DOES THE WORLD STAY GREEN: NUTRITION AND SURVIVAL OF PLANT-EATERS, P1; WHITE TCR, 1978, OECOLOGIA, V33, P71, DOI 10.1007/BF00376997	65	22	25	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91113	10.1371/journal.pone.0091113	http://dx.doi.org/10.1371/journal.pone.0091113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621513	Green Published, gold			2022-12-25	WOS:000332845300051
J	Glauzy, S; Andre-Schmutz, I; Larghero, J; Ezine, S; de Latour, RP; Moins-Teisserenc, H; Servais, S; Robin, M; Socie, G; Clave, E; Toubert, A				Glauzy, Salome; Andre-Schmutz, Isabelle; Larghero, Jerome; Ezine, Sophie; de Latour, Regis Peffault; Moins-Teisserenc, Helene; Servais, Sophie; Robin, Marie; Socie, Gerard; Clave, Emmanuel; Toubert, Antoine			CXCR4-Related Increase of Circulating Human Lymphoid Progenitors after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ADULT THYMUS; GRAFT; MOBILIZATION; RECONSTITUTION; REGENERATION; CHEMOTHERAPY; MAINTENANCE; MACROPHAGES	Immune recovery after profound lymphopenia is a major challenge in many clinical situations, such as allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recovery depends, in a first step, on hematopoietic lymphoid progenitors production in the bone marrow (BM). In this study, we characterized CD34(+) Lin(-)CD10(+) lymphoid progenitors in the peripheral blood of allo-HSCT patients. Our data demonstrate a strong recovery of this population 3 months after transplantation. This rebound was abolished in patients who developed acute graft-versus-host disease (aGVHD). A similar recovery profile was found for both CD24(+) and CD24(-) progenitor subpopulations. CD34(+)lin(-)CD10(+)CD24(-) lymphoid progenitors sorted from allo-HSCT patients preserved their T cell potentiel according to in vitro T-cell differentiation assay and the expression profile of 22 genes involved in T-cell differentiation and homing. CD34(+)lin(-)CD10(+)CD24(-) cells from patients without aGVHD had reduced CXCR4 gene expression, consistent with an enhanced egress from the BM. CCR7 gene expression was reduced in patients after allo-HSCT, as were its ligands CCL21 and CCL19. This reduction was particularly marked in patients with aGVHD, suggesting a possible impact on thymic homing. Thus, the data presented here identify this population as an important early step in T cell reconstitution in humans and so, an important target when seeking to enhance immune reconstitution.	[Glauzy, Salome; Larghero, Jerome; de Latour, Regis Peffault; Moins-Teisserenc, Helene; Robin, Marie; Socie, Gerard; Clave, Emmanuel; Toubert, Antoine] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France; [Glauzy, Salome; Larghero, Jerome; Moins-Teisserenc, Helene; Socie, Gerard; Clave, Emmanuel; Toubert, Antoine] INSERM, UMR1160, Paris, France; [Glauzy, Salome; Moins-Teisserenc, Helene; Clave, Emmanuel; Toubert, Antoine] Hop St Louis, AP HP, Lab Immunol & Histocompatibil, Paris, France; [Andre-Schmutz, Isabelle] Univ Paris 05, Sorbonne Paris Cite, INSERM, U768,Inst Imagine, Paris, France; [Larghero, Jerome] Hop St Louis, AP HP, Unite Therapie Cellulaire & CIC Biotherapies, Paris, France; [Ezine, Sophie] INSERM, U1020, Paris, France; [de Latour, Regis Peffault; Servais, Sophie; Robin, Marie; Socie, Gerard] Hop St Louis, AP HP, Serv Hematol Greffe Moelle, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Clave, E (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France.	emmanuel.clave@univ-paris-diderot.fr	Andre, Isabelle/F-6263-2013; Moins-Teisserenc, helene/AAL-1566-2021; Clave, Emmanuel/ABD-8112-2020; Toubert, Antoine/Q-3404-2017; Andre-Schmutz, Isabelle/M-1279-2016	Andre, Isabelle/0000-0002-3905-9910; Moins-Teisserenc, helene/0000-0003-1602-7534; Clave, Emmanuel/0000-0001-8217-5039; Toubert, Antoine/0000-0002-7308-7317; Robin, Marie/0000-0003-1388-9876	Assistance Publique-Hopitaux de Paris [RTB10002]; LABEX Milieu Interieur; LABEX Transplantex; ERA-NET program [TRANSCAN 12-072 HAPLO-IMMUNE]	Assistance Publique-Hopitaux de Paris; LABEX Milieu Interieur; LABEX Transplantex; ERA-NET program	This work was supported by research grants from Assistance Publique-Hopitaux de Paris (#RTB10002), LABEX Milieu Interieur, LABEX Transplantex, ERA-NET program TRANSCAN 12-072 HAPLO-IMMUNE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clave E, 2005, BLOOD, V105, P2608, DOI 10.1182/blood-2004-04-1667; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Dean RM, 2008, J CLIN ONCOL, V26, P5735, DOI 10.1200/JCO.2008.17.1314; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI200522492; Hauri-Hohl MM, 2007, BLOOD, V109, P4080, DOI 10.1182/blood-2006-07-034157; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Krenger W, 2000, BLOOD, V96, P347, DOI 10.1182/blood.V96.1.347.013k26_347_354; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; Mavroudis D, 1996, BLOOD, V88, P3223, DOI 10.1182/blood.V88.8.3223.bloodjournal8883223; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Peaudecerf L, 2012, J EXP MED, V209, P1401, DOI 10.1084/jem.20120845; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Reimann C, 2012, STEM CELLS, V30, P1771, DOI 10.1002/stem.1145; Rettig MP, 2012, LEUKEMIA, V26, P34, DOI 10.1038/leu.2011.197; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Roux E, 2000, BLOOD, V96, P2299; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SEEMAYER TA, 1977, AM J PATHOL, V88, P119; Shono Y, 2010, BLOOD, V115, P5401, DOI 10.1182/blood-2009-11-253559; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Talvensarri K, 2002, BLOOD, V99, P1458, DOI 10.1182/blood.V99.4.1458; Thiant S, 2011, BONE MARROW TRANSPL, V46, P1374, DOI 10.1038/bmt.2010.300; Tichelli A, 2008, BEST PRACT RES CL HA, V21, P139, DOI 10.1016/j.beha.2008.02.002; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; WEAVER CH, 1995, BLOOD, V86, P3961, DOI 10.1182/blood.V86.10.3961.bloodjournal86103961; Zlotoff DA, 2011, BLOOD, V118, P1962, DOI 10.1182/blood-2010-12-324954; Zlotoff DA, 2011, ANN NY ACAD SCI, V1217, P122, DOI 10.1111/j.1749-6632.2010.05881.x; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	44	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91492	10.1371/journal.pone.0091492	http://dx.doi.org/10.1371/journal.pone.0091492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621606	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300096
J	Henriksen, JR; Etzerodt, T; Gjetting, T; Andresen, TL				Henriksen, Jonas R.; Etzerodt, Thomas; Gjetting, Torben; Andresen, Thomas L.			Side Chain Hydrophobicity Modulates Therapeutic Activity and Membrane Selectivity of Antimicrobial Peptide Mastoparan-X	PLOS ONE			English	Article							MAGAININ 2 AMIDE; TITRATION CALORIMETRY; LIPID-MEMBRANES; ANTIBACTERIAL; BINDING; MODEL; THERMODYNAMICS; ACYLATION	The discovery of new anti-infective compounds is stagnating and multi-resistant bacteria continue to emerge, threatening to end the "antibiotic era''. Antimicrobial peptides (AMPs) and lipo-peptides such as daptomycin offer themselves as a new potential class of antibiotics; however, further optimization is needed if AMPs are to find broad use as antibiotics. In the present work, eight analogues of mastoparan-X (MPX) were investigated, having side chain modifications in position 1, 8 and 14 to modulate peptide hydrophobicity. The self-association properties of the peptides were characterized, and the peptide-membrane interactions in model membranes were compared with the bactericidal and haemolytic properties. Alanine substitution at position 1 and 14 resulted in higher target selectivity (red blood cells versus bacteria), but also decreased bactericidal potency. For these analogues, the gain in target selectivity correlated to biophysical parameters showing an increased effective charge and reduction in the partitioning coefficient for membrane insertion. Introduction of an unnatural amino acid, with an octyl side chain by amino acid substitution, at positions 1, 8 and 14 resulted in increased bactericidal potency at the expense of radically reduced membrane target selectivity. Overall, optimized membrane selectivity or bactericidal potency was achieved by changes in side chain hydrophobicity of MPX. However, enhanced potency was achieved at the expense of selectivity and vice versa in all cases.	[Henriksen, Jonas R.] Tech Univ Denmark, Dept Chem, Ctr Nanomed & Theranost, DTU Chem, DK-2800 Lyngby, Denmark; [Etzerodt, Thomas; Gjetting, Torben; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Henriksen, JR (corresponding author), Tech Univ Denmark, Dept Chem, Ctr Nanomed & Theranost, DTU Chem, DK-2800 Lyngby, Denmark.	jonas.henriksen@kemi.dtu.dk	Andresen, Thomas L/B-5324-2012	Andresen, Thomas Lars/0000-0002-1048-127X; Henriksen, Jonas Rosager/0000-0001-9154-6639	Danish Research Council (FSS); Strategic Research Council; Danish Research Council for Technology and Innovation; Technical University of Denmark	Danish Research Council (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Strategic Research Council; Danish Research Council for Technology and Innovation; Technical University of Denmark	The Danish Research Council (FSS), the Strategic Research Council, the Danish Research Council for Technology and Innovation, and the Technical University of Denmark have funded the current project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P10995, DOI 10.1021/bi00501a018; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chu-Kung AF, 2010, J COLLOID INTERF SCI, V345, P160, DOI 10.1016/j.jcis.2009.11.057; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m; Etzerodt T, 2011, BIOPHYS J, V100, P399, DOI 10.1016/j.bpj.2010.11.040; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5; Hellmann N, 1998, BBA-BIOMEMBRANES, V1369, P267, DOI 10.1016/S0005-2736(97)00230-7; Henriksen JR, 2011, BIOPHYS J, V101, P100, DOI 10.1016/j.bpj.2011.05.047; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hristova K, 2005, BIOCHEMISTRY-US, V44, P12614, DOI 10.1021/bi051193b; Japelj B, 2007, J AM CHEM SOC, V129, P1022, DOI 10.1021/ja067419v; Jiang Z, 2007, PEPTIDE SCI, V90, P369; Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Lockwood NA, 2004, BIOCHEM J, V378, P93, DOI 10.1042/BJ20031393; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; NAKAJIMA T, 1986, BIOPOLYMERS, V25, pS115; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Song YM, 2004, BIOCHEM BIOPH RES CO, V314, P615, DOI 10.1016/j.bbrc.2003.12.142; Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91007	10.1371/journal.pone.0091007	http://dx.doi.org/10.1371/journal.pone.0091007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621994	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300045
J	Legland, D; Devaux, MF; Guillon, F				Legland, David; Devaux, Marie-Francoise; Guillon, Fabienne			Statistical Mapping of Maize Bundle Intensity at the Stem Scale Using Spatial Normalisation of Replicated Images	PLOS ONE			English	Article							CELL-WALL; TOMATO PERICARP; SHAPE; MORPHOLOGY; LIGNIN; MUTANT; TISSUE; SIZE; QUANTIFICATION; DEHYDROGENASES	The cellular structure of plant tissues is a key parameter for determining their properties. While the morphology of cells can easily be described, few studies focus on the spatial distribution of different types of tissues within an organ. As plants have various shapes and sizes, the integration of several individuals for statistical analysis of tissues distribution is a difficult problem. The aim of this study is to propose a method that quantifies the average spatial organisation of vascular bundles within maize stems, by integrating information from replicated images. In order to compare observations made on stems of different sizes and shapes, a spatial normalisation strategy was used. A model of average stem contour was computed from the digitisation of several stem slab images. Point patterns obtained from individual stem slices were projected onto the average stem to normalise them. Group-wise analysis of the spatial distribution of vascular bundles was applied on normalised data through the construction of average intensity maps. A quantitative description of average bundle organisation was obtained, via a 3D model of bundle distribution within a typical maize internode. The proposed method is generic and could easily be extended to other plant organs or organisms.	[Legland, David] INRA, Food Proc Engn & Microbiol UMR782, F-78850 Thiverval Grignon, France; [Legland, David] AgroParisTech, Food Proc Engn & Microbiol UMR782, Thiverval Grignon, France; [Legland, David] INRA, UMR Inst Jean Pierre Bourgin 1318, F-78026 Versailles, France; [Legland, David] AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France; [Devaux, Marie-Francoise; Guillon, Fabienne] INRA, Biopolymers Interact & Assemblies UR1268, F-44026 Nantes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Legland, D (corresponding author), INRA, Food Proc Engn & Microbiol UMR782, F-78850 Thiverval Grignon, France.	david.legland@grignon.inra.fr	Legland, David/AAI-2455-2020; /U-1825-2018	Legland, David/0000-0001-7456-4632; /0000-0001-7925-3104	Agence Nationale de la Recherche Genoplante programm [ANR-07-GPLA-0018 GrassBioFuel]	Agence Nationale de la Recherche Genoplante programm(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche Genoplante 2007 programm, project ANR-07-GPLA-0018 GrassBioFuel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey P, 2008, I S BIOMED IMAGING, P1183, DOI 10.1109/ISBI.2008.4541213; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Barriere Y, 2009, EUPHYTICA, V170, P183, DOI 10.1007/s10681-009-9923-6; Barros-Rios J, 2012, ANIM FEED SCI TECH, V172, P226, DOI 10.1016/j.anifeedsci.2012.01.005; Bookstein F L, 1997, Med Image Anal, V1, P225; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bruce DM, 2003, PHILOS T R SOC B, V358, P1437, DOI 10.1098/rstb.2003.1337; Burguet J, 2011, PATTERN RECOGN LETT, V32, P1894, DOI 10.1016/j.patrec.2011.07.008; Burguet J, 2009, J COMP NEUROL, V513, P483, DOI 10.1002/cne.21954; Casler MD, 2006, ANIM FEED SCI TECH, V125, P151, DOI 10.1016/j.anifeedsci.2005.05.015; Chassagne-Berces S, 2009, FOOD RES INT, V42, P788, DOI 10.1016/j.foodres.2009.03.001; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Cressie N, 2011, STAT SPATIO TEMPORAL; Devaux MF, 2008, POSTHARVEST BIOL TEC, V47, P199, DOI 10.1016/j.postharvbio.2007.06.017; Devaux MF, 2009, MACROVISION ANAL GRA, P93; DIGGLE P, 1985, J R STAT SOC C-APPL, V34, P138; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Dryden I., 1998, STAT ANAL SHAPE; Fromont L, 2005, 9 EUR C STER IM AN 1, V2, P71; Genard M, 2007, J EXP BOT, V58, P917, DOI 10.1093/jxb/erl287; Grenander U, 1998, Q APPL MATH, V56, P617, DOI 10.1090/qam/1668732; Guillemin F., 2004, Image Analysis & Stereology, V23, P13, DOI 10.5566/ias.v23.p13-22; Guillon F, 2008, J EXP BOT, V59, P273, DOI 10.1093/jxb/erm323; Hahn U, 2003, ADV APPL PROBAB, V35, P319, DOI 10.1239/aap/1051201648; Higashi K, 1999, J EXP BOT, V50, P1593, DOI 10.1093/jexbot/50.339.1593; Iwata H, 1998, EUPHYTICA, V102, P143, DOI 10.1023/A:1018392531226; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; Jung HJG, 2012, PLANT SCI, V185, P65, DOI 10.1016/j.plantsci.2011.10.014; Kaack K, 2003, IND CROP PROD, V17, P131, DOI 10.1016/S0926-6690(02)00093-6; Karkonen A, 2006, PLANTA, V223, P858, DOI 10.1007/s00425-005-0207-7; Karkonen A, 2005, BIOCHEM J, V391, P409, DOI 10.1042/BJ20050800; Legland D, 2012, J MICROSC-OXFORD, V247, P78, DOI 10.1111/j.1365-2818.2012.03623.x; Legland D, 2010, ANN BOT-LONDON, V105, P265, DOI 10.1093/aob/mcp283; Lootens P, 2007, COMPUT ELECTRON AGR, V58, P164, DOI 10.1016/j.compag.2007.03.014; Malladi A, 2010, J EXP BOT, V61, P3003, DOI 10.1093/jxb/erq134; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Mebatsion HK, 2006, COMPUT ELECTRON AGR, V52, P36, DOI 10.1016/j.compag.2006.01.002; Mebatsion HK, 2012, COMPUT ELECTRON AGR, V80, P63, DOI 10.1016/j.compag.2011.10.016; Mechin V, 2005, J AGR FOOD CHEM, V53, P5872, DOI 10.1021/jf050722f; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Moller J, 2004, STAT MONOGRAPHS STAT, V100; Ntenga R, 2011, COMP MATER SCI, V50, P1442, DOI 10.1016/j.commatsci.2010.11.032; Pieczywek PM, 2012, COMPUT ELECTRON AGR, V81, P72, DOI 10.1016/j.compag.2011.11.006; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Ripley BD, 1981, SPATIAL STAT PROBABI; Sarath G, 2011, BIORESOURCE TECHNOL, V102, P9579, DOI 10.1016/j.biortech.2011.07.086; Schauer K, 2010, NAT METHODS, V7, P560, DOI [10.1038/NMETH.1462, 10.1038/nmeth.1462]; Soille P., 2013, MORPHOLOGICAL IMAGE; WILSON JR, 1993, J SCI FOOD AGR, V63, P407, DOI 10.1002/jsfa.2740630406; Zdunek A, 2005, J TEXTURE STUD, V36, P25, DOI 10.1111/j.1745-4603.2005.00002.x; Zhang Y, 2013, J AGR FOOD CHEM, V61, P3186, DOI 10.1021/jf400912s	53	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90673	10.1371/journal.pone.0090673	http://dx.doi.org/10.1371/journal.pone.0090673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622152	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300025
J	Polo, P; Hernandez-Lloreda, V; Colmenares, F				Polo, Pablo; Hernandez-Lloreda, Victoria; Colmenares, Fernando			Male Takeovers Are Reproductively Costly to Females in Hamadryas Baboons: A Test of the Sexual Coercion Hypothesis	PLOS ONE			English	Article							MULTILEVEL SOCIETY; HYBRID BABOONS; CONFLICT; COLONY; CLANS; PRIMATES; CHOICE; UNITS	During male takeovers, in addition to fighting off the female's current mating partner, males may exhibit intense aggressive mate guarding of the newly acquired females. Recent studies indicate that coercive sexual aggression by males is an important strategy through which sexual conflict is expressed. Previous tests of the sexual coercion hypothesis in primates have focused on assessing if female mate choice is effectively reduced by male aggression, however, only one recent study has tested a critical prediction of this hypothesis, namely, that male coercion is reproductively costly to victim females. The present study uses 15 years of data on inter-birth intervals from a large multilevel colony of baboons, mostly Papio h. hamadryas, with a mating system based on harem-defence polygyny to examine if male takeovers impact the length of the abducted females' inter-birth intervals. Our analysis of 121 inter-birth intervals from 45 adult females indicates that male takeovers are reproductively costly to abducted females as they are associated with an increase in the time they take to conceive and a lengthening of the inter-birth intervals. We discuss how several factors may contribute to this reproductive cost, including male-female sexual conflict, male-male competition, and female-female competition. Our findings suggest that the male's aggressive herding is the main contributor to the abducted females' immediate reproductive cost. We argue that although some of the male's aggressive herding may be driven by male-male competition, nonetheless, it serves a coercive function as it both constrains the female's mate choice options and hampers her immediate breeding performance. This conclusion is backed up by results obtained in the only other study that has tested the same prediction and which has been carried out in a wild population of hamadryas baboons.	[Polo, Pablo; Hernandez-Lloreda, Victoria; Colmenares, Fernando] Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain; [Polo, Pablo; Colmenares, Fernando] Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Madrid, Spain; [Hernandez-Lloreda, Victoria] Univ Complutense Madrid, Dept Metodol Ciencias Comportamiento, Fac Psicol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Colmenares, F (corresponding author), Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain.	colmenares@psi.ucm.es	Polo, Pablo/E-6878-2016	Polo, Pablo/0000-0002-6366-933X; Hernandez-Lloreda, Maria Victoria/0000-0003-0966-7453	Ministerio de Educacion (Spain); Ministerio de Ciencia e Innovacion (Spain) [PSI2008-00526, PSI2011-29016-C02-01]; Universidad Complutense de Madrid [GR35/10-A-940813]	Ministerio de Educacion (Spain)(Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad Complutense de Madrid	Partly supported by a studentship from the Ministerio de Educacion (Spain) to Pablo Polo and by project grants PSI2008-00526, PSI2011-29016-C02-01 from the Ministerio de Ciencia e Innovacion (Spain) and GR35/10-A-940813 from the Universidad Complutense de Madrid to Fernando Colmenares. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegglen JJ., 1984, SOCIALIZATION HAMADR; ALTMANN J, 1978, SCIENCE, V201, P1028, DOI 10.1126/science.98844; Anaya-Huertas C, 2002, FOLIA PRIMATOL, V73, P291; Arnqvist Goran, 2005, pUnpaginated; BACHMANN C, 1980, BEHAV ECOL SOCIOBIOL, V6, P315, DOI 10.1007/BF00292774; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Clarke Parry, 2009, P42; Clutton-Brock Tim H., 2004, P24, DOI 10.1017/CBO9780511542459.004; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Colmenares F, 2006, AM J PRIMATOL, V68, P21, DOI 10.1002/ajp.20204; Colmenares F, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P242; COLMENARES F, 1992, BEHAVIOUR, V121, P61, DOI 10.1163/156853992X00444; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; Colmenares F, 1992, BEHAV MECH EVOLUTION, P74; Connor R. C., 2009, SEXUAL COERCION PRIM; Darwin G., 1871, P423; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; Dunbar R., 1984, REPROD DECISIONS EC; Harcourt AH, 2007, GORILLA SOC COMPROMI; Hernandez-Lloreda MV, 2003, ANIM BEHAV, V66, P607, DOI 10.1006/anbe.2003.2241; Kappeler Peter M., 2003, P1; Kitchen DM, 2009, SEXUAL COERCION PRIM, P129; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Kummer Hans, 1995, QUEST SACRED BABOON; Mulder MB, 2009, EVOL ANTHROPOL, V18, P201, DOI 10.1002/evan.20226; Muller MN, 2011, BEHAV ECOL SOCIOBIOL, V65, P921, DOI 10.1007/s00265-010-1093-y; Muller MN, 2009, SEXUAL COERCION PRIM, P3, DOI DOI 10.4159/9780674054349-001; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Polo P, 2012, BEHAV PROCESS, V90, P238, DOI 10.1016/j.beproc.2012.02.004; Robbins Martha M., 2009, P112; Robbins MM, 2011, PRIMATES PERSPECTIVE, P326; Schreier AL, 2009, AM J PRIMATOL, V71, P948, DOI 10.1002/ajp.20736; Setchell JM, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P373, DOI 10.1017/CBO9780511542602.016; SHAIKH A A, 1982, Primates, V23, P444, DOI 10.1007/BF02381326; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Smuts BB, 1989, AM J PRIMATOL, V119, P229; Snijders T. A. B., 2003, MULTILEVEL ANAL INTR; Stumpf R, 2011, PRIMATES PERSPECTIVE, P340; Stumpf RM, 2010, ANIM BEHAV, V79, P333, DOI 10.1016/j.anbehav.2009.11.008; Stumpf RM, 2011, EVOL ANTHROPOL, V20, P62, DOI 10.1002/evan.20297; SWEDELL L, 2006, STRATEGIES SEX SURVI; Swedell L, 2011, PRIMATES PERSPECTIVE, P241; Swedell L, 2014, BEHAV ECOL SOCIOBIOL, V68, P263, DOI 10.1007/s00265-013-1641-3; Swedell L, 2011, AM J PHYS ANTHROPOL, V145, P360, DOI 10.1002/ajpa.21504; Swedell Larissa, 2009, P244; Tregenza T, 2006, PHILOS T R SOC B, V361, P229, DOI 10.1098/rstb.2005.1796; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Schaik Carel P., 2000, P27, DOI 10.1017/CBO9780511542312.004; West B. T., 2007, LINEAR MIXED MODELS; Zar JH, 1999, BIOSTATISTICAL ANAL; Zinner D, 2000, AM J PRIMATOL, V52, P157, DOI 10.1002/1098-2345(200012)52:4<157::AID-AJP1>3.0.CO;2-L; Zuckerman S., 1932, SOCIAL LIFE MONKEYS	53	9	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90996	10.1371/journal.pone.0090996	http://dx.doi.org/10.1371/journal.pone.0090996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621865	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300043
J	Niu, XB; Hong, J; Zheng, XF; Melville, DB; Knapik, EW; Meng, AM; Peng, JR				Niu, Xubo; Hong, Jian; Zheng, Xiaofeng; Melville, David B.; Knapik, Ela W.; Meng, Anming; Peng, Jinrong			The Nuclear Pore Complex Function of Sec13 Protein Is Required for Cell Survival during Retinal Development*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Endoplasmic Reticulum (ER); Molecular Genetics; p53; Zebrafish; Sec13; Sec31; Nuclear Pore Complexes; Retina Development	ZEBRAFISH DEVELOPMENT; VESICLE COATS; EXPRESSION; P53; DIFFERENTIATION; SECRETION; APOPTOSIS; GENE; ORGANOGENESIS; ORGANIZATION	Background: Sec13 is a core component in both the protein trafficking complex and the nuclear pore complex (NPC). Results: The role of Sec13 in retina development has been investigated. Conclusion: The NPC function of Sec13 is essential for retina development. Significance: This is the first genetic evidence to differentiate the contributions of the two functions of Sec13 during organogenesis. Sec13 is a dual function protein, being a core component of both the COPII coat, which mediates protein trafficking from the endoplasmic reticulum to the Golgi apparatus, and the nuclear pore complex (NPC), which facilitates nucleo-cytoplasmic traffic. Here, we present a genetic model to differentiate the roles of these two functions of Sec13 in vivo. We report that sec13(sq198) mutant embryos develop small eyes that exhibit disrupted retinal lamination and that the mutant retina contains an excessive number of apoptotic cells. Surprisingly, we found that loss of COPII function by oligonucleotide-mediated gene knockdown of sec31a and sec31b or brefeldin A treatment did not disrupt retinal lamination, although it did result in digestive organ defects similar to those seen in sec13(sq198), suggesting that the digestive organ defects observed in sec13(sq198) are due to loss of COPII function, whereas the retinal lamination defects are due to loss of the NPC function. We showed that the retinal cells of sec13(sq198) failed to form proper nuclear pores, leading to a nuclear accumulation of total mRNA and abnormal activation of the p53-dependent apoptosis pathway, causing the retinal defect in sec13(sq198). Furthermore, we found that a mutant lacking Nup107, a key NPC-specific component, phenocopied the retinal lamination phenotype as observed in sec13(sq198). Our results demonstrate a requirement for the nuclear pore function of Sec13 in development of the retina and provide the first genetic evidence to differentiate the contributions of the NPC and the COPII functions of Sec13 during organogenesis.	[Niu, Xubo; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Hong, Jian] Zhejiang Univ, Inst Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China; [Zheng, Xiaofeng; Meng, Anming] Tsinghua Univ, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Melville, David B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Melville, David B.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA	Zhejiang University; Zhejiang University; Tsinghua University; University of California System; University of California Berkeley; Vanderbilt University	Peng, JR (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	pengjr@zju.edu.cn	Niu, Xubo/AAH-7166-2021; Meng, Anming/A-4785-2012; Knapik, Ela W./J-6172-2014	Knapik, Ela W./0000-0002-2977-3619; Peng, Jinrong/0000-0002-0793-4848	"973 Program" Grant [2012CB944550]; National Natural Science Foundation of China [31330050]; National Institutes of Health Grant from NIDCR [R01 DE018477]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	"973 Program" Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health Grant from NIDCR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by "973 Program" Grant 2012CB944550 and National Natural Science Foundation of China Grant 31330050 (to J. R. P.). This work was also supported in part by National Institutes of Health Grant R01 DE018477 from NIDCR (to E. W. K.).	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cerveny KL, 2010, DEVELOPMENT, V137, P2107, DOI 10.1242/dev.047753; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012; DeAngelis RA, 2012, J IMMUNOL, V188, P641, DOI 10.4049/jimmunol.1101925; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Melville DB, 2011, CELL ADHES MIGR, V5, P114, DOI 10.4161/cam.5.2.14377; Meyers JR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-30; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nelson SM, 2009, DEV BIOL, V328, P24, DOI 10.1016/j.ydbio.2008.12.040; Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Pujic Z, 2004, SEMIN CELL DEV BIOL, V15, P105, DOI 10.1016/j.semcdb.2003.09.008; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schmidt K, 2013, BIOL OPEN, V2, P256, DOI 10.1242/bio.20133251; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Senger S, 2011, DEVELOPMENT, V138, P2133, DOI 10.1242/dev.057372; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Townley AK, 2012, J CELL SCI, V125, P673, DOI 10.1242/jcs.091355; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Zheng XF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408997	51	26	26	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11971	11985		10.1074/jbc.M114.547190	http://dx.doi.org/10.1074/jbc.M114.547190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627485	Green Published, hybrid			2022-12-25	WOS:000335010600036
J	Chung, YG; Tu, D; Franck, D; Gil, ES; Algarrahi, K; Adam, RM; Kaplan, DL; Estrada, CR; Mauney, JR				Chung, Yeun Goo; Tu, Duong; Franck, Debra; Gil, Eun Seok; Algarrahi, Khalid; Adam, Rosalyn M.; Kaplan, David L.; Estrada, Carlos R., Jr.; Mauney, Joshua R.			Acellular Bi-Layer Silk Fibroin Scaffolds Support Tissue Regeneration in a Rabbit Model of Onlay Urethroplasty	PLOS ONE			English	Article							URETHRAL STRICTURE REPAIR; BUCCAL MUCOSA GRAFT; COLLAGEN MATRIX; MURINE MODEL; BLADDER; SUBMUCOSA; MANAGEMENT; RECONSTRUCTION; BIOMATERIAL; PERFORMANCE	Acellular scaffolds derived from Bombyx mori silk fibroin were investigated for their ability to support functional tissue regeneration in a rabbit model of urethra repair. A bi-layer silk fibroin matrix was fabricated by a solvent-casting/salt leaching process in combination with silk fibroin film casting to generate porous foams buttressed by homogeneous silk fibroin films. Ventral onlay urethroplasty was performed with silk fibroin grafts (Group 1, N = 4) (WidthxLength, 1x2 cm(2)) in adult male rabbits for 3 m of implantation. Parallel control groups consisted of animals receiving small intestinal submucosa (SIS) implants (Group 2, N = 4) or urethrotomy alone (Group 3, N = 3). Animals in all groups exhibited 100% survival prior to scheduled euthanasia and achieved voluntary voiding following 7 d of initial catheterization. Retrograde urethrography of each implant group at 3 m post-op revealed wide urethral calibers and preservation of organ continuity similar to pre-operative and urethrotomy controls with no evidence of contrast extravasation, strictures, fistulas, or stone formation. Histological (hematoxylin and eosin and Masson's trichrome), immunohistochemical, and histomorphometric analyses demonstrated that both silk fibroin and SIS scaffolds promoted similar extents of smooth muscle and epithelial tissue regeneration throughout the original defect sites with prominent contractile protein (a-smooth muscle actin and SM22 alpha) and cytokeratin expression, respectively. De novo innervation and vascularization were also evident in all regenerated tissues indicated by synaptophysin-positive neuronal cells and vessels lined with CD31 expressing endothelial cells. Following 3 m post-op, minimal acute inflammatory reactions were elicited by silk fibroin scaffolds characterized by the presence of eosinophil granulocytes while SIS matrices promoted chronic inflammatory responses indicated by mobilization of mononuclear cell infiltrates. The results of this study demonstrate that bi-layer silk fibroin scaffolds represent promising biomaterials for onlay urethroplasty, capable of promoting similar degrees of tissue regeneration in comparison to conventional SIS scaffolds, but with reduced immunogenicity.	[Chung, Yeun Goo; Tu, Duong; Franck, Debra; Algarrahi, Khalid; Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA; [Tu, Duong; Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tufts University	Estrada, CR (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA.	carlos.estrada@childrens.harvard.edu; joshua.mauney@childrens.harvard.edu	Estrada, Carlos R/H-2199-2015	Estrada, Carlos R/0000-0003-0586-9832	NIH/NIDDK [R00 DK083616-01A2, T32-DK60442]; Tissue Engineering Resource Center, NIH/NIBIB [P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060442] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Tissue Engineering Resource Center, NIH/NIBIB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the following sources: NIH/NIDDK R00 DK083616-01A2 (MAUNEY); Tissue Engineering Resource Center, NIH/NIBIB P41 EB002520 (KAPLAN); NIH/NIDDK T32-DK60442 (FREEMAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9; Bhatnagar A, 2012, INDIAN J PLAST SURG, V45, P563, DOI 10.4103/0970-0358.105979; Brandes S, 2006, UROL CLIN N AM, V33, P87, DOI 10.1016/j.ucl.2005.10.001; Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301; Chandrasekharam V V S, 2013, Indian J Urol, V29, P173, DOI [10.4103/0970-1591.109984, 10.4103/0970-1591.117269]; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; Cilento BG, 1995, J UROLOGY, V153, P371; Cimador M, 2013, NAT REV UROL, DOI [10.1038/nrurol.2013.164, DOI 10.1038/NRUR0L.2013.164]; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Elgammal MAA, 2009, INT BRAZ J UROL, V35, P450, DOI 10.1590/S1677-55382009000400009; FINKELSTEIN LH, 1991, J UROLOGY, V146, P840, DOI 10.1016/S0022-5347(17)37937-5; Fu Q, 2011, UROLOGY, V79, P246, DOI [10.1016/j.urology.2011.08.043, DOI 10.1016/J.UR0L0GY.2011.08.043]; Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067; Hauser S, 2006, UROLOGY, V68, P263, DOI 10.1016/j.urology.2006.02.044; Kadian Yogender Singh, 2011, Afr J Paediatr Surg, V8, P164, DOI 10.4103/0189-6725.86054; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kozinn SI, 2013, UROLOGY, V82, P718, DOI 10.1016/j.urology.2013.03.081; Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9; Lee YJ, 2013, KOREAN J UROL, V54, P561, DOI 10.4111/kju.2013.54.9.561; Macedo A, 2012, CURR OPIN UROL, V22, P447, DOI 10.1097/MOU.0b013e328357bc62; Villoldo GM, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.023; Marzorati G, 2008, UROLOG J, V75, P177, DOI 10.1177/039156030807500306; Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051; Mawhinney M, 2013, PERIODONTOL 2000, V61, P232, DOI 10.1111/j.1600-0757.2011.00408.x; Meeks JJ, 2009, J UROLOGY, V182, P1266, DOI 10.1016/j.juro.2009.06.027; Mellon MJ, 2014, INT J UROL, V21, P190, DOI 10.1111/iju.12236; MONFORT G, 1992, J UROLOGY, V148, P1504, DOI 10.1016/S0022-5347(17)36950-1; OLESEN K P, 1975, International Urology and Nephrology, V7, P303, DOI 10.1007/BF02082120; OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220; Palmer BW, 2013, CURR UROL REP, V14, P327, DOI 10.1007/s11934-013-0329-6; Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016; Palminteri E, 2012, UROLOGY, V79, P695, DOI 10.1016/j.urology.2011.09.055; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038; Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0; Siosaki MD, 2013, CUAJ-CAN UROL ASSOC, V7, pE499, DOI 10.5489/cuaj.399; Sugita Y, 2001, J UROLOGY, V166, P1051, DOI 10.1016/S0022-5347(05)65918-6; Tu DD, 2013, BIOMATERIALS, V34, P8681, DOI 10.1016/j.biomaterials.2013.08.001; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Xie LH, 2013, UROL INT, V91, P256, DOI 10.1159/000353101; Zinman L, 1997, UROL CLIN N AM, V24, P683, DOI 10.1016/S0094-0143(05)70408-0	42	39	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91592	10.1371/journal.pone.0091592	http://dx.doi.org/10.1371/journal.pone.0091592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632740	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400072
J	Hunter, PR; Risebro, H; Yen, M; Lefebvre, H; Lo, C; Hartemann, P; Longuet, C; Jaquenoud, F				Hunter, Paul R.; Risebro, Helen; Yen, Marie; Lefebvre, Helene; Lo, Chay; Hartemann, Philippe; Longuet, Christophe; Jaquenoud, Francois			Impact of the Provision of Safe Drinking Water on School Absence Rates in Cambodia: A Quasi-Experimental Study	PLOS ONE			English	Article							MORTALITY; CHILDREN; SANITATION; COUNTRIES; RISK	Background: Education is one of the most important drivers behind helping people in developing countries lift themselves out of poverty. However, even when schooling is available absenteeism rates can be high. Recently interest has focussed on whether or not WASH interventions can help reduce absenteeism in developing countries. However, none has focused exclusively on the role of drinking water provision. We report a study of the association between absenteeism and provision of treated water in containers into schools. Methods and Findings: We undertook a quasi-experimental longitudinal study of absenteeism rates in 8 schools, 4 of which received one 20 L container of treated drinking water per day. The water had been treated by filtration and ultraviolet disinfection. Weekly absenteeism rates were compared across all schools using negative binomial model in generalized estimating equations. There was a strong association with provision of free water and reduced absenteeism (Incidence rate ratio = 0.39 (95% Confidence Intervals 0.27-0.56)). However there was also a strong association with season (wet versus dry) and a significant interaction between receiving free water and season. In one of the intervention schools it was discovered that the water supplier was not fulfilling his contract and was not delivering sufficient water each week. In this school we showed a significant association between the number of water containers delivered each week and absenteeism (IRR = 0.98 95% CI 0.96-1.00). Conclusion: There appears to be a strong association between providing free safe drinking water and reduced absenteeism, though only in the dry season. The mechanism for this association is not clear but may in part be due to improved hydration leading to improved school experience for the children.	[Hunter, Paul R.; Risebro, Helen] Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England; [Yen, Marie; Lefebvre, Helene; Jaquenoud, Francois] 1001 Fontaines Demain, Caluire Et Cuire, France; [Lefebvre, Helene] Teuk Saat 1001, Phnom Penh, Cambodia; [Hartemann, Philippe] Univ Lorraine, Fac Med Nancy, Dept Environm & Sante Publ, Nancy, France; [Longuet, Christophe] Fdn Merieux, Lyon, France	University of East Anglia; Universite de Lorraine	Hunter, PR (corresponding author), Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England.	Paul.Hunter@uea.ac.uk	Hunter, Paul/N-9021-2019; Hunter, Paul/A-7172-2008; Risebro, Helen/S-5693-2016	Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; Risebro, Helen/0000-0003-4389-748X	Fondation Ensemble; Danone Group; Agence Francaise de Developpement; Fondation Merieux; Fondation Avenir Finance	Fondation Ensemble; Danone Group(Danone Nutricia); Agence Francaise de Developpement; Fondation Merieux; Fondation Avenir Finance	The study received financial support as charitable donations from Fondation Ensemble, Danone Group, Agence Francaise de Developpement, Fondation Merieux, and Fondation Avenir Finance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadzi H, 2009, WORLD BANK RES OBSER, V24, P267, DOI 10.1093/wbro/lkp008; Bar-David Y, 2005, ACTA PAEDIATR, V94, P1667, DOI 10.1080/08035250500254670; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Doria MD, 2009, SCI TOTAL ENVIRON, V407, P5455, DOI 10.1016/j.scitotenv.2009.06.031; Fadda R, 2012, APPETITE, V59, P730, DOI 10.1016/j.appet.2012.07.005; Freeman MC, 2012, TROP MED INT HEALTH, V17, P380, DOI 10.1111/j.1365-3156.2011.02927.x; FULLER B, 1987, REV EDUC RES, V57, P255, DOI 10.3102/00346543057003255; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Heiner JD, 2011, WILD ENVIRON MED, V22, P329, DOI 10.1016/j.wem.2011.08.003; Huber AC, 2013, INT J ENVIRON HEAL R, V23, P96, DOI 10.1080/09603123.2012.699032; Hunter PR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1145; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Jasper C, 2012, INT J ENV RES PUB HE, V9, P2772, DOI 10.3390/ijerph9082772; Maughan RJ, 2012, NUTR REV, V70, pS152, DOI 10.1111/j.1753-4887.2012.00531.x; Ngai TKK, 2007, J ENVIRON SCI HEAL A, V42, P1879, DOI 10.1080/10934520701567148; Risebro HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042762; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Tamas A, 2011, HEALTH EDUC BEHAV, V38, P357, DOI 10.1177/1090198110374702; United Nations, 2011, MILL DEV GOALS REP 2	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91847	10.1371/journal.pone.0091847	http://dx.doi.org/10.1371/journal.pone.0091847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632573	Green Accepted, gold, Green Published			2022-12-25	WOS:000332858400107
J	Perez-Rivas, LG; Jerez, JM; Carmona, R; de Luque, V; Vicioso, L; Claros, MG; Viguera, E; Pajares, B; Sanchez, A; Ribelles, N; Alba, E; Lozano, J				Perez-Rivas, Luis G.; Jerez, Jose M.; Carmona, Rosario; de Luque, Vanessa; Vicioso, Luis; Gonzalo Claros, M.; Viguera, Enrique; Pajares, Bella; Sanchez, Alfonso; Ribelles, Nuria; Alba, Emilio; Lozano, Jose			A microRNA Signature Associated with Early Recurrence in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; TARGET RECOGNITION; PROGNOSTIC-FACTORS; TUMOR DORMANCY; HAZARD RATES; EXPRESSION; SURGERY; CYTOSCAPE; PATTERNS; REVEALS	Recurrent breast cancer occurring after the initial treatment is associated with poor outcome. A bimodal relapse pattern after surgery for primary tumor has been described with peaks of early and late recurrence occurring at about 2 and 5 years, respectively. Although several clinical and pathological features have been used to discriminate between low-and high-risk patients, the identification of molecular biomarkers with prognostic value remains an unmet need in the current management of breast cancer. Using microarray-based technology, we have performed a microRNA expression analysis in 71 primary breast tumors from patients that either remained disease-free at 5 years post-surgery (group A) or developed early (group B) or late (group C) recurrence. Unsupervised hierarchical clustering of microRNA expression data segregated tumors in two groups, mainly corresponding to patients with early recurrence and those with no recurrence. Microarray data analysis and RT-qPCR validation led to the identification of a set of 5 microRNAs (the 5-miRNA signature) differentially expressed between these two groups: miR-149, miR-10a, miR-20b, miR-30a-3p and miR-342-5p. All five microRNAs were down-regulated in tumors from patients with early recurrence. We show here that the 5-miRNA signature defines a high-risk group of patients with shorter relapse-free survival and has predictive value to discriminate non-relapsing versus early-relapsing patients (AUC = 0.993, p-value<0.05). Network analysis based on miRNA-target interactions curated by public databases suggests that down-regulation of the 5-miRNA signature in the subset of early-relapsing tumors would result in an overall increased proliferative and angiogenic capacity. In summary, we have identified a set of recurrence-related microRNAs with potential prognostic value to identify patients who will likely develop metastasis early after primary breast surgery.	[Perez-Rivas, Luis G.; de Luque, Vanessa; Pajares, Bella; Sanchez, Alfonso; Ribelles, Nuria; Alba, Emilio; Lozano, Jose] Hosp Univ Virgen Victoria, Inst Biomed Malaga IBIMA, Serv Oncol Med, Lab Oncol Mol, Malaga, Spain; [Jerez, Jose M.] Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain; [Carmona, Rosario; Gonzalo Claros, M.] Univ Malaga, Plataforma Andaluza Bioinformat, E-29071 Malaga, Spain; [Vicioso, Luis] Hosp Univ Virgen Victoria, Inst Biomed Malaga IBIMA, Serv Anat Patol, Malaga, Spain; [Gonzalo Claros, M.; Lozano, Jose] Univ Malaga, Dept Bioquim & Biol Mol, E-29071 Malaga, Spain; [Viguera, Enrique] Univ Malaga, Dept Biol Celular Genet & Fisiol Anim, E-29071 Malaga, Spain	Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Lozano, J (corresponding author), Hosp Univ Virgen Victoria, Inst Biomed Malaga IBIMA, Serv Oncol Med, Lab Oncol Mol, Malaga, Spain.	jlozano@uma.es	Lozano, José/C-2760-2014; Jerez, José Manuel M/L-1801-2014; Mínguez, Enrique Viguera/H-4416-2015; Jerez, José/GYV-4500-2022; Ribelles, Nuria/ABH-2617-2020; Aragonés, José Manuel Jerez/ABF-7743-2020; Alba, Emilio/S-1435-2019; Claros, Manuel Gonzalo/K-2274-2014; Carmona, Rosario/K-9092-2014	Lozano, José/0000-0002-8187-2833; Jerez, José Manuel M/0000-0002-7858-2966; Mínguez, Enrique Viguera/0000-0001-5475-3807; Ribelles, Nuria/0000-0003-3194-7398; Aragonés, José Manuel Jerez/0000-0002-7858-2966; Alba, Emilio/0000-0002-3364-2603; Claros, Manuel Gonzalo/0000-0002-0112-3550; Carmona, Rosario/0000-0002-4235-2886	Spanish Society of Medical Oncology (SEOM); Spanish Ministerio de Economia [SAF2010-20203, TIN2010-16556]; Junta de Andalucia [TIN-4026]	Spanish Society of Medical Oncology (SEOM); Spanish Ministerio de Economia(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by a grant from the Spanish Society of Medical Oncology (SEOM, to NR) and by grants from the Spanish Ministerio de Economia, (SAF2010-20203 to J.L and TIN2010-16556 to J.J) and from the Junta de Andalucia (TIN-4026, to JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caruso S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.33; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cox D. R., 1984, ANAL SURVIVAL DATA; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Demicheli R, 2007, ANN SURG ONCOL, V13, P776; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Demicheli R, 2007, ANN SURG ONCOL, V14, P1519, DOI 10.1245/s10434-006-9279-2; Demicheli R, 2010, CANCER SCI, V101, P826, DOI 10.1111/j.1349-7006.2009.01472.x; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Dylla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063032; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; FISHER ER, 1978, HUM PATHOL, V9, P523, DOI 10.1016/S0046-8177(78)80133-6; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grammatikakis I, 2013, INT J MOL SCI, V14, P1822, DOI 10.3390/ijms14011822; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess KR, 2003, BREAST CANCER RES TR, V78, P105, DOI 10.1023/A:1022166517963; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iqbal J, 2012, BLOOD, V119, P4939, DOI 10.1182/blood-2011-07-370122; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Jatoi I, 2005, BREAST CANCER RES TR, V89, P173, DOI 10.1007/s10549-004-1722-0; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lumley T, 2007, SURVIVAL PACKAGE R H; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; McCarthy N, 2013, NAT REV CANCER, V13, P441; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perez-Rivas LG, 2012, INT J ONCOL, V41, P2200, DOI 10.3892/ijo.2012.1667; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietrowska M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-66; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Romero-Cordoba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031904; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spitale A, 2009, ANN ONCOL, V20, P628, DOI 10.1093/annonc/mdn675; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takeshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059057; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Tu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051606; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167	108	68	73	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91884	10.1371/journal.pone.0091884	http://dx.doi.org/10.1371/journal.pone.0091884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632820	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400115
J	Sala, M; Kroft, LJM; Roell, B; van der Grond, J; Slagboom, PE; Mooijaart, SP; de Roos, A; van Heemst, D				Sala, Michiel; Kroft, Lucia J. M.; Roell, Boudewijn; van der Grond, Jeroen; Slagboom, P. Eline; Mooijaart, Simon P.; de Roos, Albert; van Heemst, Diana			Association of Liver Enzymes and Computed Tomography Markers of Liver Steatosis with Familial Longevity	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; FATTY LIVER; HEPATIC STEATOSIS; ALANINE AMINOTRANSFERASE; NONAGENARIAN SIBLINGS; DIABETES-MELLITUS; DISEASE; PREVALENCE; RISK; POPULATION	Objective: Familial longevity is marked by enhanced peripheral but not hepatic insulin sensitivity. The liver has a critical role in the pathogenesis of hepatic insulin resistance. Therefore we hypothesized that the extent of liver steatosis would be similar between offspring of long-lived siblings and control subjects. To test our hypothesis, we investigated the extent of liver steatosis in non-diabetic offspring of long-lived siblings and age-matched controls by measuring liver enzymes in plasma and liver fat by computed tomography (CT). Research Design and Methods:: We measured nonfasting alanine transaminase (ALT), aspartate aminotransferase (AST), and U-glutamyl transferase (GGT) in 1625 subjects (736 men, mean age 59.1 years) from the Leiden Longevity Study, comprising offspring of long-lived siblings and partners thereof. In a random subgroup, fasting serum samples (n = 230) were evaluated and CT was performed (n = 268) for assessment of liver-spleen (L/S) ratio and the prevalence of moderate-to-severe non-alcoholic fatty liver disease (NAFLD). Linear mixed model analysis was performed adjusting for age, gender, body mass index, smoking, use of alcohol and hepatotoxic medication, and correlation of sibling relationship. Results: Offspring of long-lived siblings had higher nonfasting ALT levels as compared to control subjects (24.3 mmol/L versus 23.2 mmol/L, p = 0.03), while AST and GGT levels were similar between the two groups. All fasting liver enzyme levels were similar between the two groups. CT L/S ratio and prevalence of moderate-to-severe NAFLD was similar between groups (1.12 vs 1.14, p = 0.25 and 8% versus 8%, p = 0.91, respectively). Conclusions: Except for nonfasting levels of ALT, which were slightly higher in the offspring of long-lived siblings compared to controls, no differences were found between groups in the extent of liver steatosis, as assessed with liver biochemical tests and CT. Thus, our data indicate that the extent of liver steatosis is similar between offspring of long-lived siblings and control subjects.	[Sala, Michiel; Kroft, Lucia J. M.; Roell, Boudewijn; van der Grond, Jeroen; de Roos, Albert] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Mooijaart, Simon P.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [van der Grond, Jeroen; Mooijaart, Simon P.; van Heemst, Diana] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sala, M (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	M.L.Sala@lumc.nl	Mooijaart, Simon P./A-5306-2008; Slagboom, P. Eline/R-4790-2016	Mooijaart, Simon P./0000-0003-3106-3568; Slagboom, P. Eline/0000-0002-2875-4723	Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (Netherlands Consortium for Healthy Aging) [05040202]; European Community [Health-2013-INNOVATION-1-602757]	Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (Netherlands Consortium for Healthy Aging); European Community(European Commission)	Funding was provided by Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (05040202 Netherlands Consortium for Healthy Aging) and by the European Community within the Seventh Framework Program under grant agreement no. Health-2013-INNOVATION-1-602757 (HUMAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; [Anonymous], 2013, GUID ATC CLASS DDD A; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Dick TJM, 2013, ATHEROSCLEROSIS, V226, P208, DOI 10.1016/j.atherosclerosis.2012.10.040; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Ford I, 2011, INT J EPIDEMIOL, V40, P1530, DOI 10.1093/ije/dyr172; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; JESSURUN N, 2013, PHARM WEEKBLAD, V148, P28; Kim LJ, 2011, OBESITY, V19, P1265, DOI 10.1038/oby.2010.291; Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Passtoors WM, 2013, AGING CELL, V12, P24, DOI 10.1111/acel.12015; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Reaven GM, 2005, ENDOCRIN METAB CLIN, V34, P49, DOI 10.1016/j.ecl.2004.12.001; Redgrave TG, 2004, BIOCHEM SOC T, V32, P79, DOI 10.1042/BST0320079; Rozing MP, 2011, AGE, V33, P623, DOI 10.1007/s11357-011-9206-8; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Speliotes EK, 2008, J GASTROEN HEPATOL, V23, P894, DOI 10.1111/j.1440-1746.2008.05420.x; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Targher G, 2006, J HEPATOL, V45, P879, DOI 10.1016/j.jhep.2006.09.005; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; Vliegenthart R, 2002, AM J EPIDEMIOL, V155, P332, DOI 10.1093/aje/155.4.332; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2012, AM J PHYSIOL-ENDOC M, V302, pE344, DOI 10.1152/ajpendo.00455.2011; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91085	10.1371/journal.pone.0091085	http://dx.doi.org/10.1371/journal.pone.0091085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632889	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400040
J	Xiao, L; Zhang, CK; Li, XH; Gong, SC; Hu, RM; Balasubramanian, R; Crowley Jr, WF; Hastings, MH; Zhou, QY				Xiao, Ling; Zhang, Chengkang; Li, Xiaohan; Gong, Shiaoching; Hu, Renming; Balasubramanian, Ravikumar; Crowley, William F. W., Jr.; Hastings, Michael H.; Zhou, Qun-Yong			Signaling Role of Prokineticin 2 on the Estrous Cycle of Female Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE SURGE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; EFFERENT PROJECTIONS; OLFACTORY-BULB; PREOPTIC AREA; NEURONS; KISSPEPTIN; RATS	The possible signaling role of prokineticin 2 (PK2) and its receptor, prokineticin receptor 2 (PKR2), on female reproduction was investigated. First, the expression of PKR2 and its co-localization with estrogen receptor (ER alpha) in the hypothalamus was examined. Sexually dimorphic expression of PKR2 in the preoptic area of the hypothalamus was observed. Compared to the male mice, there was more widespread PKR2 expression in the preoptic area of the hypothalamus in the female mice. The likely co-expression of PKR2 and ERa in the preoptic area of the hypothalamus was observed. The estrous cycles in female PK2-null, and PKR2-null heterozygous mice, as well as in PK2-null and PKR2-null compound heterozygous mice were examined. Loss of one copy of PK2 or PKR2 gene caused elongated and irregular estrous cycle in the female mice. The alterations in the estrous cycle were more pronounced in PK2-null and PKR2-null compound heterozygous mice. Consistent with these observations, administration of a small molecule PK2 receptor antagonist led to temporary blocking of estrous cycle at the proestrous phase in female mice. The administration of PKR2 antagonist was found to blunt the circulating LH levels. Taken together, these studies indicate PK2 signaling is required for the maintenance of normal female estrous cycles.	[Xiao, Ling; Zhang, Chengkang; Li, Xiaohan; Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Xiao, Ling] Fudan Univ, Jinshan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China; [Gong, Shiaoching] Rockefeller Univ, GENSAT Project, New York, NY 10021 USA; [Hu, Renming] Fudan Univ, Huashan Hosp, Inst Endocrinol & Diabetol, Shanghai 200433, Peoples R China; [Balasubramanian, Ravikumar; Crowley, William F. W., Jr.] Massachusetts Gen Hosp, Harvard Reprod Endocrine Sci Ctr, Boston, MA 02114 USA; [Balasubramanian, Ravikumar; Crowley, William F. W., Jr.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Hastings, Michael H.] Med Res Council Lab Mol Biol, Div Neurobiol, Cambridge, England	University of California System; University of California Irvine; Fudan University; Rockefeller University; Fudan University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Zhou, QY (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	qzhou@uci.edu		Zhang, Chengkang/0000-0002-3746-2095; Hastings, Michael Harvey/0000-0001-8576-6651	NIH [HD15788]; Medical Research Council [MC_U105170643] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015788] Funding Source: NIH RePORTER; MRC [MC_U105170643] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH grant HD15788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Boden MJ, 2010, REPRODUCTION, V139, P1077, DOI 10.1530/REP-09-0523; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cheng MY, 2006, J COMP NEUROL, V498, P796, DOI 10.1002/cne.21087; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chu A, 2013, ENDOCRINOLOGY, V154, P2924, DOI 10.1210/en.2013-1080; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Colledge W. H., 2008, V46, P117, DOI 10.1007/400_2007_050; Curtis VF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054916; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; KALRA SP, 1993, ENDOCR REV, V14, P507, DOI 10.1210/er.14.5.507; Kim GL, 2010, ENDOCRINOLOGY, V151, P5038, DOI 10.1210/en.2010-0521; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Levine JE, 1997, BIOL REPROD, V56, P293, DOI 10.1095/biolreprod56.2.293; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Miller BH, 2006, BIOL REPROD, V75, P778, DOI 10.1095/biolreprod.106.052845; Mitsushima D, 2003, NEUROSCI RES, V46, P399, DOI 10.1016/S0168-0102(03)00099-3; Mitsushima D, 2002, NEUROSCIENCE, V113, P109, DOI 10.1016/S0306-4522(02)00160-4; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Palm IF, 1999, NEUROSCIENCE, V93, P659, DOI 10.1016/S0306-4522(99)00106-2; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2010, FRONT HORM RES, V39, P142, DOI 10.1159/000312700; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020263; SCHWARTZ WJ, 1985, J NEUROSCI, V5, P2771; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; vanderBeek EM, 1996, PROG BRAIN RES, V111, P295, DOI 10.1016/S0079-6123(08)60415-X; vanderBeek EM, 1997, BRAIN RES, V755, P101, DOI 10.1016/S0006-8993(97)00086-3; WATTS AG, 1989, J ENDOCRINOL, V122, P593, DOI 10.1677/joe.0.1220593; Xu Z, 2011, MOL CELL ENDOCRINOL, V339, P90, DOI 10.1016/j.mce.2011.03.020; Zhang CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007151	45	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90860	10.1371/journal.pone.0090860	http://dx.doi.org/10.1371/journal.pone.0090860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633064	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400022
J	Zhou, Y; Tao, SY; Chen, H; Huang, LL; Zhu, X; Li, YP; Wang, ZL; Lin, H; Hao, F; Yang, ZL; Wang, LY; Zhu, XJ				Zhou, Yu; Tao, Siyu; Chen, Hui; Huang, Lulin; Zhu, Xiong; Li, Youping; Wang, Zhili; Lin, He; Hao, Fang; Yang, Zhenglin; Wang, Liya; Zhu, Xianjun			Exome Sequencing Analysis Identifies Compound Heterozygous Mutation in ABCA4 in a Chinese Family with Stargardt Disease	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; MACULAR DYSTROPHY; GENE ABCR; FUNDUS-FLAVIMACULATUS; RETINITIS-PIGMENTOSA; TRANSPORTER GENE; RIM PROTEIN; DEGENERATION; LIPOFUSCIN; MICE	Stargardt disease is the most common cause of juvenile macular dystrophy. Five subjects from a two-generation Chinese family with Stargardt disease are reported in this study. All family members underwent complete ophthalmologic examinations. Patients of the family initiated the disease during childhood, developing progressively impaired central vision and bilateral atrophic macular lesions in the retinal pigmental epithelium (RPE) that resembled a "beaten-bronze'' appearance. Peripheral venous blood was obtained from all patients and their family members for genetic analysis. Exome sequencing was used to analyze the exome of two patients II1, II2. A total of 50709 variations shared by the two patients were subjected to several filtering steps against existing variation databases. Identified variations were verified in all family members by PCR and Sanger sequencing. Compound heterozygous variants p.Y808X and p.G607R of the ATP-binding cassette, sub-family A (ABC1), member 4 (ABCA4) gene, which encodes the ABCA4 protein, a member of the ATP-binding cassette (ABC) transport superfamily, were identified as causative mutations for Stargardt disease of this family. Our findings provide one novel ABCA4 mutation in Chinese patients with Stargardt disease.	[Zhou, Yu; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Sichuan Acad Med Sci, Inst Lab Med, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Chen, Hui; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Tao, Siyu; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan, Peoples R China; [Tao, Siyu; Wang, Zhili; Wang, Liya] Zhengzhou Univ, Peoples Hosp, Henan Eye Hosp, Zhengzhou, Henan, Peoples R China; [Tao, Siyu; Wang, Zhili; Wang, Liya] Zhengzhou Univ, Peoples Hosp, Henan Eye Inst, Zhengzhou, Henan, Peoples R China; [Chen, Hui] Sichuan Acad Med Sci, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Chen, Hui] Sichuan Acad Med Sci, Inst Lab Anim, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Huang, Lulin; Zhu, Xiong; Yang, Zhenglin; Zhu, Xianjun] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Huang, Lulin; Zhu, Xiong; Yang, Zhenglin; Zhu, Xianjun] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Zhenglin; Zhu, Xianjun] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China; [Zhu, Xianjun] Xinan Jiaotong Univ, Coll Life Sci & Engn, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Zhengzhou University; Zhengzhou University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Electronic Science & Technology of China	Wang, LY (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Eye Hosp, Zhengzhou, Henan, Peoples R China.	wangliya55@126.com; xjzhu2@gmail.com		Zhu, Xianjun/0000-0002-2531-7552	National Natural Science Foundation of China [81025006, 81170883, 81271007]; Department of Science and Technology of Sichuan Province, China [SZ20120209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province, China	This research was supported by the National Natural Science Foundation of China [81025006, 81170883 (Z.Y.), 81271007 (X.Z.)], and Department of Science and Technology of Sichuan Province, China (SZ20120209, Z.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Birch DG, 2001, EXP EYE RES, V73, P877, DOI 10.1006/exer.2001.1093; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Casals F, 2012, J NEUROIMMUNOL, V248, P10, DOI 10.1016/j.jneuroim.2011.12.017; Coco RM, 2010, EUR J OPHTHALMOL, V20, P724, DOI 10.1177/112067211002000413; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Edwards AO, 2001, INVEST OPHTH VIS SCI, V42, P2652; Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Franceschetti A, 1965, Arch Ophtalmol Rev Gen Ophtalmol, V25, P505; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Klevering BJ, 1999, BRIT J OPHTHALMOL, V83, P914, DOI 10.1136/bjo.83.8.914; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Michaelides M, 2007, BRIT J OPHTHALMOL, V91, P1650, DOI 10.1136/bjo.2007.118356; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rozet JM, 1996, GENOMICS, V36, P554, DOI 10.1006/geno.1996.0508; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STEINMETZ RL, 1991, OPHTHALMOLOGY, V98, P953; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Strom SP, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-67; Vasireddy V, 2010, PROG RETIN EYE RES, V29, P191, DOI 10.1016/j.preteyeres.2010.01.001; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; WELEBER RG, 1994, ARCH OPHTHALMOL-CHIC, V112, P752, DOI 10.1001/archopht.1994.01090180050033; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91962	10.1371/journal.pone.0091962	http://dx.doi.org/10.1371/journal.pone.0091962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632595	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400127
J	Zurek, G; Rybka, K; Pogrzeba, M; Krzyzak, J; Prokopiuk, K				Zurek, Grzegorz; Rybka, Krystyna; Pogrzeba, Marta; Krzyzak, Jacek; Prokopiuk, Kamil			Chlorophyll a Fluorescence in Evaluation of the Effect of Heavy Metal Soil Contamination on Perennial Grasses	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; PHOTOSYSTEM-II; HIGHER-PLANTS; CADMIUM; METABOLISM; TOXICITY; ZINC; PHYTOREMEDIATION; PHYTOEXTRACTION; INDUCTION	Chlorophyll a fluorescence gives information about the plant physiological status due to its coupling to the photosynthetic electron transfer chain and to the further biochemical processes. Environmental stresses, which acts synergistically, disturbs the photosynthesis. The OJIP test, elaborated by Strasser and co-workers, enables comparison of the physiological status of plants grown on polluted vs. control areas. The paper shows that the Chl a measurements are very useful tool in evaluating of heavy metal ions influence on perennial grasses, tested as potential phytoremediators. Among 5 cultivars tested, the highest concentration of Cd and Zn ions, not associated with the yield reduction, was detected in the biomass of tall fescue cv. Rahela. Chl a fluorescence interpreted as double normalized curves pointed out Rahela as the outstanding cultivar under the HM ions stress.	[Zurek, Grzegorz; Prokopiuk, Kamil] Plant Breeding & Acclimatizat Inst IHAR PIB, Dept Grasses Legumes & Energy Plants, Blonie, Poland; [Rybka, Krystyna] Plant Breeding & Acclimatizat Inst IHAR PIB, Dept Plant Physiol & Biochem, Blonie, Poland; [Pogrzeba, Marta; Krzyzak, Jacek] Inst Ecol Ind Areas, Dept Environm Biotechnol, Phytoremediat Team, Katowice, Poland	Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization; Institute for Ecology of Industrial Areas	Rybka, K (corresponding author), Plant Breeding & Acclimatizat Inst IHAR PIB, Dept Plant Physiol & Biochem, Blonie, Poland.	k.rybka@ihar.edu.pl	Zurek, Grzegorz/F-3493-2013; Krzyżak, Jacek/AAT-6515-2020	Krzyżak, Jacek/0000-0003-1606-8416; Pogrzeba, Marta/0000-0002-9934-094X; Rybka, Krystyna/0000-0002-4707-8492; Zurek, Grzegorz/0000-0003-2359-2232; Prokopiuk, Kamil/0000-0003-0308-3078	Ministry of Agriculture and Rural Development, Poland [PW3-3-00-0-03]	Ministry of Agriculture and Rural Development, Poland	The work was financed by the Ministry of Agriculture and Rural Development, Poland, as grant PW3-3-00-0-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak B., 2002, J WATER LAND DEV, V6, P29; Baker NR, 2004, ADV PHOTO RESPIRAT, V19, P65; Borjesson P, 1999, BIOMASS BIOENERG, V16, P137, DOI 10.1016/S0961-9534(98)00080-4; Bryson GM, 2007, COMMUN SOIL SCI PLAN, V38, P315, DOI 10.1080/00103620601172316; Buonasera K, 2011, ANAL BIOANAL CHEM, V401, P1139, DOI 10.1007/s00216-011-5166-1; Caldelas C, 2012, ACTA PHYSIOL PLANT, V34, P1217, DOI 10.1007/s11738-012-0956-4; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Gibson D. J., 2009, GRASSES GRASSLAND EC; Goltsev V, 2012, BBA-BIOENERGETICS, V1817, P1490, DOI 10.1016/j.bbabio.2012.04.018; Guha A, 2013, J PHOTOCH PHOTOBIO B, V119, P71, DOI 10.1016/j.jphotobiol.2012.12.006; Gururani MA, 2012, PLANT PHYSIOL BIOCH, V58, P182, DOI 10.1016/j.plaphy.2012.07.003; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Janik E, 2010, PLANT CELL PHYSIOL, V51, P1330, DOI 10.1093/pcp/pcq093; Joshi MK, 2004, ADV PHOTO RESPIRAT, V19, P637; Kalaji HM, 2007, PLANT SOIL ENVIRON, V53, P511, DOI 10.17221/2191-PSE; Kalaji HM, 2012, PHOTOSYNTH RES, V114, P69, DOI 10.1007/s11120-012-9780-3; Krupa Z, 1998, PLANT SCI, V138, P149, DOI 10.1016/S0168-9452(98)00159-9; Kucharski R, 2005, PLANT SOIL, V273, P291, DOI 10.1007/s11104-004-8068-6; Lin YF, 2012, CELL MOL LIFE SCI, V69, P3187, DOI 10.1007/s00018-012-1089-z; Molins H, 2013, PLANT CELL ENVIRON, V36, P804, DOI 10.1111/pce.12016; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Mysliwa-Kurdziel B., 2004, P146; Nedunuri KV, 2010, INT J PHYTOREMEDIAT, V12, P200, DOI 10.1080/15226510903213928; Oukarroum A, 2007, ENVIRON EXP BOT, V60, P438, DOI 10.1016/j.envexpbot.2007.01.002; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Sas-Nowosielska A, 2004, ENVIRON POLLUT, V128, P373, DOI 10.1016/j.envpol.2003.09.012; Schansker G, 2013, PHOTOSYNTH RES, V1, P1, DOI [10.1007/s11120-01309806-01309805, DOI 10.1007/S11120-01309806-01309805]; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Siedlecka A, 1999, PHOTOSYNTHETICA, V36, P321, DOI 10.1023/A:1007097518297; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Stirbet A, 1998, J THEOR BIOL, V193, P131, DOI 10.1006/jtbi.1998.0692; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Tlustos P, 2006, PLANT SOIL ENVIRON, V52, P413, DOI 10.17221/3460-PSE; Toth SZ, 2007, BBA-BIOENERGETICS, V1767, P295, DOI 10.1016/j.bbabio.2007.02.019; Toth SZ, 2013, PHYSIOL PLANTARUM, V148, P161, DOI 10.1111/ppl.12006; Tsimilli-Michael M, 2008, MYCORRHIZA STATE ART, P679, DOI DOI 10.1007/978-3-540-78826-3_32; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wierzbicka MH, 2007, PROTOPLASMA, V231, P99, DOI 10.1007/s00709-006-0227-6; ZAGDANSKA B, 1995, ACTA BIOCHIM POL, V42, P281	42	68	68	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91475	10.1371/journal.pone.0091475	http://dx.doi.org/10.1371/journal.pone.0091475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633293	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400063
J	Li, S; Kang, JD; Jin, JX; Hong, Y; Zhu, HY; Jin, L; Gao, QS; Yan, CG; Cui, CD; Li, WX; Yin, XJ				Li, Suo; Kang, Jin-Dan; Jin, Jun-Xue; Hong, Yu; Zhu, Hai-Ying; Jin, Long; Gao, Qing-Shan; Yan, Chang-Guo; Cui, Cheng-Du; Li, Wen-Xue; Yin, Xi-Jun			Effect of Demecolcine-Assisted Enucleation on the MPF Level and Cyclin B1 Distribution in Porcine Oocytes	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; METAPHASE-II ARREST; MOUSE OOCYTES; IN-VITRO; FIBROBLAST CELLS; RAT OOCYTES; CLONED PIGS; MEIOSIS-I; ACTIVATION; EMBRYOS	Demecolcine (DEM) treatment of oocytes induces formation of a membrane protrusion containing a mass of condensed maternal chromosomes, which can be removed with minimal damage prior to somatic cell nuclear transfer (SCNT). However, the effect of this method on the distribution of maturation- promoting factor (MPF) in porcine oocytes has not been reported. Here, the level of MPF and the distribution of cyclin B1 were assessed in porcine oocytes following DEM treatment. In addition, the efficiencies of DEM- assisted and mechanical enucleation were compared, as were the development (in vitro and in vivo) of these oocytes following SCNT. MPF was uniformly distributed in oocytes that had been treated with 0.4 mu g/ml DEM for 1 h. Immunofluorescence microscopy showed that in untreated oocytes, cyclin B1, the regulatory subunit of MPF, accumulated around the spindle, and was lowly detected in the cytoplasm. DEM treatment disrupted spindle microtubules, induced chromosome condensation, and reduced the level of cyclin B1 in the nuclear region. Cyclin B1 was uniformly distributed in DEM- treated oocytes and the level of MPF was increased. The potential of embryos generated from DEM-treated oocytes to develop in vivo was significantly greater than that of embryos generated from mechanically enucleated oocytes. This is the first study to report the effects of DEM- assisted enucleation of porcine oocytes on the distribution of cyclin B1. MPF in mature oocytes is important for the development of reconstructed embryos and for efficient SCNT.	[Li, Suo; Kang, Jin-Dan; Jin, Jun-Xue; Hong, Yu; Zhu, Hai-Ying; Jin, Long; Gao, Qing-Shan; Yan, Chang-Guo; Yin, Xi-Jun] Yanbian Univ, Coll Agr, Dept Anim Sci, Yanji, Peoples R China; [Cui, Cheng-Du; Li, Wen-Xue] Yanbian Univ, Dept Vet Med, Coll Agr, Yanji, Peoples R China	Yanbian University; Yanbian University	Yin, XJ (corresponding author), Yanbian Univ, Coll Agr, Dept Anim Sci, Yanji, Peoples R China.	yinxj33@msn.com			National Natural Science Foundation of China [30960175]; State Key Development Program for Basic Research of China [2012CB526710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported by the National Natural Science Foundation of China (grant number 30960175), and the State Key Development Program for Basic Research of China (grant number 2012CB526710). The authors thank XJ Yin and all members of the laboratory for their technical assistance and advice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Costa-Borges N, 2011, THERIOGENOLOGY, V75, P527, DOI 10.1016/j.theriogenology.2010.09.022; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Fulka J, 1995, REPROD FERT DEVELOP, V7, P1123, DOI 10.1071/RD9951123; Galat V, 2007, CLONING STEM CELLS, V9, P303, DOI 10.1089/clo.2006.0059; Gasparrini B, 2003, BIOL REPROD, V68, P1259, DOI 10.1095/biolreprod.102.008730; Goto S, 2002, MOL REPROD DEV, V63, P388, DOI 10.1002/mrd.90022; Goudet G, 1998, MOL HUM REPROD, V4, P563, DOI 10.1093/molehr/4.6.563; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Kang JD, 2013, THERIOGENOLOGY, V79, P306, DOI 10.1016/j.theriogenology.2012.08.021; KATO Y, 1992, J REPROD FERTIL, V95, P39, DOI 10.1530/jrf.0.0950039; Kato Y, 2000, J REPROD FERTIL, V120, P231, DOI 10.1530/reprod/120.2.231; Kawakami M, 2003, CLONING STEM CELLS, V5, P379, DOI 10.1089/153623003772032871; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Miyara F, 2006, DEV BIOL, V289, P206, DOI 10.1016/j.ydbio.2005.10.030; Miyoshi K, 2008, J REPROD DEVELOP, V54, P117, DOI 10.1262/jrd.19142; Miyoshi K, 2007, MOL REPROD DEV, V74, P1568, DOI 10.1002/mrd.20730; Nixon VL, 2002, CURR BIOL, V12, P746, DOI 10.1016/S0960-9822(02)00811-4; Peura TT, 1998, MOL REPROD DEV, V50, P185, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;185::AID-MRD9&gt;3.0.CO;2-G; Russell DF, 2005, MOL REPROD DEV, V72, P161, DOI 10.1002/mrd.20356; Sakamoto I, 1998, DEV BIOL, V195, P60, DOI 10.1006/dbio.1997.8835; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Tani T, 2006, CLONING STEM CELLS, V8, P61, DOI 10.1089/clo.2006.8.61; Van Thuan N, 2006, BIOL REPROD, V74, P777, DOI 10.1095/biolreprod.105.044677; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1998, ZYGOTE, V6, P341, DOI 10.1017/S096719949800029X; Wang HL, 2011, CELL REPROGRAM, V13, P225, DOI 10.1089/cell.2010.0101; Wu YG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012706; Yin XJ, 2008, THERIOGENOLOGY, V69, P1001, DOI 10.1016/j.theriogenology.2008.01.017; Yin XJ, 2008, BIOL REPROD, V78, P425, DOI 10.1095/biolreprod.107.065185; Yin XJ, 2002, ZYGOTE, V10, P217, DOI 10.1017/S0967199402002289; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yin XJ, 2002, REPRODUCTION, V124, P41, DOI 10.1530/rep.0.1240041; ZERNICKAGOETZ M, 1993, MOL REPROD DEV, V35, P165, DOI 10.1002/mrd.1080350210	41	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91483	10.1371/journal.pone.0091483	http://dx.doi.org/10.1371/journal.pone.0091483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626152	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300088
J	Maganti, N; Moody, TD; Truax, AD; Thakkar, M; Spring, AM; Germann, MW; Greer, SF				Maganti, Nagini; Moody, Tomika D.; Truax, Agnieszka D.; Thakkar, Meghna; Spring, Alexander M.; Germann, Markus W.; Greer, Susanna F.			Nonproteolytic Roles of 19S ATPases in Transcription of CIITApIV Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; MAJOR HISTOCOMPATIBILITY COMPLEX; 26S PROTEASOME; P-TEFB; HIV-1 TRANSCRIPTION; REGULATORY PARTICLE; INITIATION-FACTORS; TERMINAL DOMAIN; EXPRESSION; PROMOTER	Accumulating evidence shows the 26S proteasome is involved in the regulation of gene expression. We and others have demonstrated that proteasome components bind to sites of gene transcription, regulate covalent modifications to histones, and are involved in the assembly of activator complexes in mammalian cells. The mechanisms by which the proteasome influences transcription remain unclear, although prior observations suggest both proteolytic and non-proteolytic activities. Here, we define novel, non-proteolytic, roles for each of the three 19S heterodimers, represented by the 19S ATPases Sug1, S7, and S6a, in mammalian gene expression using the inflammatory gene CIITApIV. These 19S ATPases are recruited to induced CIITApIV promoters and also associate with CIITA coding regions. Additionally, these ATPases interact with elongation factor PTEFb complex members CDK9 and Hexim-1 and with Ser5 phosphorylated RNA Pol II. Both the generation of transcripts from CIITApIV and efficient recruitment of RNA Pol II to CIITApIV are negatively impacted by siRNA mediated knockdown of these 19S ATPases. Together, these results define novel roles for 19S ATPases in mammalian gene expression and indicate roles for these ATPases in promoting transcription processes.	[Maganti, Nagini; Moody, Tomika D.; Truax, Agnieszka D.; Thakkar, Meghna; Greer, Susanna F.] Georgia State Univ, Dept Biol, Grad Program Cell Biol & Immunol, Atlanta, GA 30302 USA; [Spring, Alexander M.; Germann, Markus W.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Greer, SF (corresponding author), Georgia State Univ, Dept Biol, Grad Program Cell Biol & Immunol, Atlanta, GA 30302 USA.	sgreer@gsu.edu		Germann, Markus/0000-0002-1674-8166	American Cancer Society [RSG-09-067-01-LB]	American Cancer Society(American Cancer Society)	Research was supported by grant # RSG-09-067-01-LB from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Garrido F, 1991, Semin Cancer Biol, V2, P3; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gorbea C, 1999, MOL BIOL REP, V26, P15, DOI 10.1023/A:1006957802028; GUY K, 1986, BRIT J CANCER, V53, P161, DOI 10.1038/bjc.1986.31; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Ishizuka T, 2001, MOL ENDOCRINOL, V15, P1329, DOI 10.1210/me.15.8.1329; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Koues OI, 2009, BIOCH BIOPHYS ACTA; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Koues OI, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-5; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Truax AD, 2010, J MOL BIOL, V395, P254, DOI 10.1016/j.jmb.2009.10.035; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91200	10.1371/journal.pone.0091200	http://dx.doi.org/10.1371/journal.pone.0091200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625964	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300063
J	Pentzold, S; Zagrobelny, M; Roelsgaard, PS; Moller, BL; Bak, S				Pentzold, Stefan; Zagrobelny, Mika; Roelsgaard, Pernille Solvhoj; Moller, Birger Lindberg; Bak, Soren			The Multiple Strategies of an Insect Herbivore to Overcome Plant Cyanogenic Glucoside Defence	PLOS ONE			English	Article							GLUCOSINOLATE-MYROSINASE SYSTEM; IRIDOID GLYCOSIDES; LEPIDOPTERAN MIDGUT; LARVAL LEPIDOPTERA; BETA-GLYCOSIDASES; SEQUESTRATION; PURIFICATION; CATERPILLAR; CYANIDE; BIOSYNTHESIS	Cyanogenic glucosides (CNglcs) are widespread plant defence compounds that release toxic hydrogen cyanide by plant beta-glucosidase activity after tissue damage. Specialised insect herbivores have evolved counter strategies and some sequester CNglcs, but the underlying mechanisms to keep CNglcs intact during feeding and digestion are unknown. We show that CNglc-sequestering Zygaena filipendulae larvae combine behavioural, morphological, physiological and biochemical strategies at different time points during feeding and digestion to avoid toxic hydrolysis of the CNglcs present in their Lotus food plant, i.e. cyanogenesis. We found that a high feeding rate limits the time for plant beta-glucosidases to hydrolyse CNglcs. Larvae performed leaf-snipping, a minimal disruptive feeding mode that prevents mixing of plant beta-glucosidases and CNglcs. Saliva extracts did not inhibit plant cyanogenesis. However, a highly alkaline midgut lumen inhibited the activity of ingested plant beta-glucosidases significantly. Moreover, insect b-glucosidases from the saliva and gut tissue did not hydrolyse the CNglcs present in Lotus. The strategies disclosed may also be used by other insect species to overcome CNglc-based plant defence and to sequester these compounds intact.	[Bak, Soren] Univ Copenhagen, Plant Biochem Lab, Copenhagen, Denmark; Univ Copenhagen, Villum Res Ctr Plant Plast, Dept Plant & Environm Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Bak, S (corresponding author), Univ Copenhagen, Plant Biochem Lab, Copenhagen, Denmark.	bak@plen.ku.dk	Bak, Soren/H-4404-2014; Pentzold, Stefan/I-3083-2019; Zagrobelny, Mika/L-8679-2015; Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Bak, Soren/0000-0003-4100-115X; Zagrobelny, Mika/0000-0001-5574-2894; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; Pentzold, Stefan/0000-0003-3101-7465	Villum Foundation; Villum Fonden [00007523] Funding Source: researchfish	Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation (www.villumfoundation.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 1998, BIORESOURCE TECHNOL, V64, P175, DOI 10.1016/S0960-8524(97)00182-X; Azevedo TR, 2003, INSECT BIOCHEM MOLEC, V33, P81, DOI 10.1016/S0965-1748(02)00179-0; Baden CU, 2012, CHEMOECOLOGY, V22, P113, DOI 10.1007/s00049-012-0103-0; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Ballhorn DJ, 2010, J ECOL, V98, P226, DOI 10.1111/j.1365-2745.2009.01591.x; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; BARBEHENN RV, 1992, OECOLOGIA, V89, P229, DOI 10.1007/BF00317222; BEREBAUM M, 1980, AM NAT, V115, P138, DOI 10.1086/283551; BERNAYS EA, 1988, ECOLOGY, V69, P1153, DOI 10.2307/1941269; Bjarnholt N, 2008, PHYTOCHEMISTRY, V69, P1507, DOI 10.1016/j.phytochem.2008.01.022; BLAKE JD, 1971, CARBOHYD RES, V16, P49, DOI 10.1016/S0008-6215(00)86097-8; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Bridges M, 2002, P ROY SOC B-BIOL SCI, V269, P187, DOI 10.1098/rspb.2001.1861; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; CHRISTELLER JT, 1992, INSECT BIOCHEM MOLEC, V22, P735, DOI 10.1016/0965-1748(92)90052-G; DAVIS RH, 1987, INSECT BIOCHEM, V17, P689, DOI 10.1016/0020-1790(87)90037-0; Dobler S, 2001, BASIC APPL ECOL, V2, P15, DOI 10.1078/1439-1791-00032; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Dow J. A. T., 1987, ADV INSECT PHYSIOL, V19, P187, DOI [DOI 10.1016/S0065-2806(08)60102-2, 10.1016/S0065-2806(08)60102-2]; DOW JAT, 1992, J EXP BIOL, V172, P355; DOW JAT, 1990, J EXP BIOL, V150, P247; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Fanger H, 2001, EUR J ENTOMOL, V98, P201, DOI 10.14411/eje.2001.038; FEIGL F, 1966, ANALYST, V91, P282, DOI 10.1039/an9669100282; FELTON GW, 1991, J CHEM ECOL, V17, P1821, DOI 10.1007/BF00993731; Ferreira C, 1998, COMP BIOCHEM PHYS B, V119, P219, DOI 10.1016/S0305-0491(97)00310-6; Fitzgerald TD, 2008, J CHEM ECOL, V34, P1283, DOI 10.1007/s10886-008-9545-9; Fitzgerald TD, 2008, J EXP BIOL, V211, P671, DOI 10.1242/jeb.013664; Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3; FRANZL S, 1989, EXPERIENTIA, V45, P712, DOI 10.1007/BF01974565; GRINGORTEN JL, 1993, J EXP BIOL, V183, P353; HALKIER BA, 1989, PLANT PHYSIOL, V90, P1552, DOI 10.1104/pp.90.4.1552; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; LAMBERT JL, 1975, ANAL CHEM, V47, P916, DOI 10.1021/ac60356a036; Marana SR, 2000, INSECT BIOCHEM MOLEC, V30, P1139, DOI 10.1016/S0965-1748(00)00090-4; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Opitz SEW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033649; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Pankoke H, 2012, INSECT BIOCHEM MOLEC, V42, P426, DOI 10.1016/j.ibmb.2012.02.004; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Pentzold S, 2014, BIOL REV, V89, P531, DOI 10.1111/brv.12066; Pytelkova J, 2009, FEBS J, V276, P3531, DOI 10.1111/j.1742-4658.2009.07074.x; Ruuhola T, 2003, J CHEM ECOL, V29, P1083, DOI 10.1023/A:1023821304656; Ruuhola T, 2001, J CHEM ECOL, V27, P1595, DOI 10.1023/A:1010458208335; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Takos A, 2010, PLANT CELL, V22, P1605, DOI 10.1105/tpc.109.073502; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Vegliante F, 2005, ACTA ZOOL-STOCKHOLM, V86, P167, DOI 10.1111/j.1463-6395.2005.00198.x; Vegliante F, 2004, EUR J ENTOMOL, V101, P165, DOI 10.14411/eje.2004.021; Vegliante F, 2012, ANNU REV ENTOMOL, V57, P187, DOI 10.1146/annurev-ento-120710-100646; WATERHOUSE DF, 1949, AUST J SCI RES SER B, V2, P428, DOI 10.1071/BI9490428; Winde I, 2011, PHYTOCHEMISTRY, V72, P1566, DOI 10.1016/j.phytochem.2011.01.016; WITTHOHN K, 1987, J CHEM ECOL, V13, P1789, DOI 10.1007/BF01013229; Zagrobelny M, 2008, PHYTOCHEMISTRY, V69, P1457, DOI 10.1016/j.phytochem.2008.02.019; Zagrobelny M, 2007, INSECT BIOCHEM MOLEC, V37, P10, DOI 10.1016/j.ibmb.2006.09.008; Zagrobelny M, 2014, INSECT BIOCHEM MOLEC, V44, P44, DOI 10.1016/j.ibmb.2013.11.003; Zagrobelny M, 2011, PHYTOCHEMISTRY, V72, P1585, DOI 10.1016/j.phytochem.2011.02.023	66	52	52	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91337	10.1371/journal.pone.0091337	http://dx.doi.org/10.1371/journal.pone.0091337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625698	Green Submitted, gold, Green Published			2022-12-25	WOS:000332851300073
J	Suzuki, K; Nakamura, S; Morimoto, M; Fujii, K; Noda, NN; Inagaki, F; Ohsumi, Y				Suzuki, Kuninori; Nakamura, Shingo; Morimoto, Mayumi; Fujii, Kiyonaga; Noda, Nobuo N.; Inagaki, Fuyuhiko; Ohsumi, Yoshinori			Proteomic Profiling of Autophagosome Cargo in Saccharomyces cerevisiae	PLOS ONE			English	Article							UBIQUITIN PROTEASE; YEAST; PROTEINS; PATHWAYS; MUTANTS; VACUOLE; STARVATION; CYTOPLASM; RIBOSOMES; DELIVERY	Macroautophagy (autophagy) is a bulk protein-degradation system ubiquitously conserved in eukaryotic cells. During autophagy, cytoplasmic components are enclosed in a membrane compartment, called an autophagosome. The autophagosome fuses with the vacuole/lysosome and is degraded together with its cargo. Because autophagy is important for the maintenance of cellular homeostasis by degrading unwanted proteins and organelles, identification of autophagosome cargo proteins (i.e., the targets of autophagy) will aid in understanding the physiological roles of autophagy. In this study, we developed a method for monitoring intact autophagosomes ex vivo by detecting the fluorescence of GFP-fused aminopeptidase I, the best-characterized selective cargo of autophagosomes in Saccharomyces cerevisiae. This method facilitated optimization of a biochemical procedure to fractionate autophagosomes. A combination of LC-MS/MS with subsequent statistical analyses revealed a list of autophagosome cargo proteins; some of these are selectively enclosed in autophagosomes and delivered to the vacuole in an Atg11-independent manner. The methods we describe will be useful for analyzing the mechanisms and physiological significance of Atg11-independent selective autophagy.	[Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan; [Nakamura, Shingo; Fujii, Kiyonaga; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido, Japan; [Noda, Nobuo N.] Inst Microbial Chem BIKAKEN, Mol Struct Lab, Tokyo, Japan; [Morimoto, Mayumi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan	University of Tokyo; Hokkaido University; Tokyo Institute of Technology	Suzuki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan.	kuninori@k.u-tokyo.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Noda, Nobuo/0000-0002-6940-8069	Hamaguchi Foundation for the Advancement of Biochemistry [H23-3]; Mishima Kaiun Memorial Foundation [H25-130]; NOVARTIS Foundation (Japan) [11-128]; Takeda Science Foundation; Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24121707, 24657083, 25291040, 23000015]	Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); NOVARTIS Foundation (Japan)(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Hamaguchi Foundation for the Advancement of Biochemistry (H23-3 to KS; http://www.hamaguchi-foundation.or.jp/); the Mishima Kaiun Memorial Foundation (H25-130 to KS; http://www.mishima-kaiun.or.jp/); the NOVARTIS Foundation (Japan) for the Promotion of Science (11-128 to KS; http://novartisfound.or.jp/); the Takeda Science Foundation (to KS; http://www.takeda-sci.or.jp/); the Yamada Science Foundation (to KS; http://www.yamadazaidan.jp/); and by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24121707, 24657083, and 25291040 to KS; 23000015 to YO; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; EGNER R, 1993, J BIOL CHEM, V268, P27269; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirchberger J, 1999, BIOCHEM J, V341, P15, DOI 10.1042/0264-6021:3410015; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5	26	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91651	10.1371/journal.pone.0091651	http://dx.doi.org/10.1371/journal.pone.0091651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626240	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300114
J	Wang, XY; Fan, SL; Song, MZ; Pang, CY; Wei, HL; Yu, JW; Ma, QF; Yu, SX				Wang, Xiaoyan; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Yu, Jiwen; Ma, Qifeng; Yu, Shuxun			Upland Cotton Gene GhFPF1 Confers Promotion of Flowering Time and Shade-Avoidance Responses in Arabidopsis thaliana	PLOS ONE			English	Article							FLORAL INDUCTION; SALICYLIC-ACID; LOCUS-T; PHYTOCHROME; HOMOLOG; PROTEIN; VERNALIZATION; COMPETENCE; POLYPLOIDY; EXPRESSION	Extensive studies on floral transition in model species have revealed a network of regulatory interactions between proteins that transduce and integrate developmental and environmental signals to promote or inhibit the transition to flowering. Previous studies indicated FLOWERING PROMOTING FACTOR 1 (FPF1) gene was involved in the promotion of flowering, but the molecular mechanism was still unclear. Here, FPF1 homologous sequences were screened from diploid Gossypium raimondii L. (D-genome, n = 13) and Gossypium arboreum L. genome (A-genome, n = 13) databases. Orthologous genes from the two species were compared, suggesting that distinctions at nucleic acid and amino acid levels were not equivalent because of codon degeneracy. Six FPF1 homologous genes were identified from the cultivated allotetraploid Gossypium hirsutum L. (AD-genome, n = 26). Analysis of relative transcripts of the six genes in different tissues revealed that this gene family displayed strong tissue-specific expression. GhFPF1, encoding a 12.0-kDa protein (Accession No: KC832319) exerted more transcripts in floral apices of short-season cotton, hinting that it could be involved in floral regulation. Significantly activated APETALA 1 and suppressed FLOWERING LOCUS C expression were induced by over-expression of GhFPF1 in the Arabidopsis Columbia-0 ecotype. In addition, transgenic Arabidopsis displayed a constitutive shade-avoiding phenotype that is characterized by long hypocotyls and petioles, reduced chlorophyll content, and early flowering. We propose that GhFPF1 may be involved in flowering time control and shade-avoidance responses.	[Wang, Xiaoyan; Ma, Qifeng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Wang, Xiaoyan; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Yu, Jiwen; Ma, Qifeng; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn		Wang, Xiaoyan/0000-0003-3222-2567	Earmarked Fund for China Agriculture Research System [CARS-18]; National High-tech Research and Development Projects of China [2011AA10A102]	Earmarked Fund for China Agriculture Research System; National High-tech Research and Development Projects of China(National High Technology Research and Development Program of China)	This research was supported by the Earmarked Fund for China Agriculture Research System (CARS-18) and funded by the National High-tech Research and Development Projects of China (2011AA10A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Attitalla Idress Hamad, 2011, Pak J Biol Sci, V14, P998, DOI 10.3923/pjbs.2011.998.999; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; BALLARE CL, 1987, PLANT CELL ENVIRON, V10, P551, DOI 10.1111/1365-3040.ep11604091; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bernier G, 2002, RUSS J PLANT PHYSL+, V49, P445, DOI 10.1023/A:1016343421814; Borner Roland, 2000, 11 INT C AR RES JUN; Chen LG, 2010, MOL PLANT MICROBE IN, V23, P558, DOI 10.1094/MPMI-23-5-0558; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Ge L, 2004, PLANT PHYSIOL, V135, P1502, DOI 10.1104/pp.104.041996; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Havelange A, 2000, PHYSIOL PLANTARUM, V109, P343, DOI 10.1034/j.1399-3054.2000.100316.x; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Lai DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028676; Li J, 2013, PLANT CELL REP, V32, P1675, DOI 10.1007/s00299-013-1479-1; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Melzer S, 1999, PLANT J, V18, P395, DOI 10.1046/j.1365-313X.1999.00461.x; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Pajerowska-Mukhtar KM, 2013, TRENDS PLANT SCI, V18, P402, DOI 10.1016/j.tplants.2013.04.004; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Ren GJ, 2000, ACTA BOT BOREALI-OCC, V20, P847; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smykal P, 2004, PLANT MOL BIOL, V55, P253, DOI 10.1007/s11103-004-0557-8; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wang GF, 2011, PLANT PHYSIOL, V156, P1508, DOI 10.1104/pp.111.176776; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Yang MW, 2002, CHINESE J SPECTROSCO, V19, P479; Zhang Y, 2008, BIOSCIENCE REP, V28, P7, DOI 10.1042/BSR20070028	48	12	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91869	10.1371/journal.pone.0091869	http://dx.doi.org/10.1371/journal.pone.0091869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626476	gold, Green Published, Green Submitted			2022-12-25	WOS:000332851300142
J	Woo, JI; Oh, S; Webster, P; Lee, YJ; Lim, DJ; Moon, SK				Woo, Jeong-Im; Oh, Sejo; Webster, Paul; Lee, Yoo Jin; Lim, David J.; Moon, Sung K.			NOD2/RICK-Dependent beta-Defensin 2 Regulation Is Protective for Nontypeable Haemophilus influenzae-Induced Middle Ear Infection	PLOS ONE			English	Article							NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; NEGATIVE CROSS-TALK; ACUTE OTITIS-MEDIA; UP-REGULATION; SIGNALING PATHWAY; STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; HUMAN BETA-DEFENSIN-2; GENE-EXPRESSION	Middle ear infection, otitis media (OM), is clinically important due to the high incidence in children and its impact on the development of language and motor coordination. Previously, we have demonstrated that the human middle ear epithelial cells up-regulate beta-defensin 2, a model innate immune molecule, in response to nontypeable Haemophilus influenzae (NTHi), the most common OM pathogen, via TLR2 signaling. NTHi does internalize into the epithelial cells, but its intracellular trafficking and host responses to the internalized NTHi are poorly understood. Here we aimed to determine a role of cytoplasmic pathogen recognition receptors in NTHi-induced beta-defensin 2 regulation and NTHi clearance from the middle ear. Notably, we observed that the internalized NTHi is able to exist freely in the cytoplasm of the human epithelial cells after rupturing the surrounding membrane. The human middle ear epithelial cells inhibited NTHi-induced beta-defensin 2 production by NOD2 silencing but augmented it by NOD2 over-expression. NTHi-induced beta-defensin 2 up-regulation was attenuated by cytochalasin D, an inhibitor of actin polymerization and was enhanced by alpha-hemolysin, a pore-forming toxin. NOD2 silencing was found to block alpha-hemolysin-mediated enhancement of NTHi-induced beta-defensin 2 up-regulation. NOD2 deficiency appeared to reduce inflammatory reactions in response to intratympanic inoculation of NTHi and inhibit NTHi clearance from the middle ear. Taken together, our findings suggest that a cytoplasmic release of internalized NTHi is involved in the pathogenesis of NTHi infections, and NOD2-mediated beta-defensin 2 regulation contributes to the protection against NTHi-induced otitis media.	[Woo, Jeong-Im; Lee, Yoo Jin; Lim, David J.; Moon, Sung K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Oh, Sejo] House Ear Res Inst, Div Clin & Translat Res, Los Angeles, CA 90034 USA; [Webster, Paul] Univ So Calif, Ctr Electron Microscopy & Microanal, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; House Research Institute; University of Southern California	Lim, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	djlim@mednet.ucla.edu; skmoon@mednet.ucla.edu		Webster, Paul/0000-0002-1980-6931	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) [RO1 DC005025, R21 DC011862]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011862, R01DC005025] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) grants RO1 DC005025 and R21 DC011862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren IL, 2001, J INFECT DIS, V184, P150, DOI 10.1086/322016; Akkerman AE, 2005, J ANTIMICROB CHEMOTH, V56, P569, DOI 10.1093/jac/dki257; ANDREWS NW, 1991, PARASITOL TODAY, V7, P335, DOI 10.1016/0169-4758(91)90212-7; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559; BLUESTONE CD, 1995, ARCH OTOLARYNGOL, V121, P505; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chattoraj P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058514; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; COSSART P, 1989, MOL BIOL MED, V6, P463; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; Darrow David H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P416, DOI 10.1097/00020840-200312000-00002; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; Gilsdorf JR, 1996, PEDIATR RES, V39, P343, DOI 10.1203/00006450-199602000-00025; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Granath A, 2011, J INFECTION, V63, P174, DOI 10.1016/j.jinf.2011.06.006; GROENEVELD K, 1990, J INFECT DIS, V161, P512, DOI 10.1093/infdis/161.3.512; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hernandez M, 2008, J INFECT DIS, V198, P1862, DOI 10.1086/593213; Holmes KA, 1997, MICROB PATHOGENESIS, V23, P157, DOI 10.1006/mpat.1997.0145; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; HORWITZ MA, 1988, CURR OPIN IMMUNOL, V1, P41, DOI 10.1016/0952-7915(88)90049-0; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P137, DOI 10.1016/j.anl.2009.03.012; Hruz P, 2008, CURR OPIN GASTROEN, V24, P108, DOI 10.1097/MOG.0b013e3282f50fdf; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jeong YJ, 2012, J MICROBIOL, V50, P489, DOI 10.1007/s12275-012-1534-6; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Ketterer MR, 1999, INFECT IMMUN, V67, P4161, DOI 10.1128/IAI.67.8.4161-4170.1999; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Leibovitz E, 2003, PEDIATR INFECT DIS J, V22, P509, DOI 10.1097/00006454-200306000-00006; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Maxson S, 1996, Pediatr Rev, V17, P191, DOI 10.1542/pir.17-6-191; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Mikami F, 2006, J BIOL CHEM, V281, P22397, DOI 10.1074/jbc.M602124200; Moon SK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-12; Moon SK, 2002, BBA-MOL CELL RES, V1590, P41, DOI 10.1016/S0167-4889(02)00196-9; Moon SK, 2007, INFECT IMMUN, V75, P3361, DOI 10.1128/IAI.01886-06; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Morrison GM, 1999, FEBS LETT, V442, P112, DOI 10.1016/S0014-5793(98)01630-5; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2000, PEDIATR INFECT DIS J, V19, pS9, DOI 10.1097/00006454-200005001-00003; Nabatov AA, 2013, BBA-GEN SUBJECTS, V1830, P5277, DOI 10.1016/j.bbagen.2013.07.017; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh S, 2012, J IMMUNOL, V188, P3496, DOI 10.4049/jimmunol.1103182; Ratner AJ, 2007, CELL MICROBIOL, V9, P1343, DOI 10.1111/j.1462-5822.2006.00878.x; Ren DB, 2012, EXP BIOL MED, V237, P540, DOI 10.1258/ebm.2012.011377; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Schroder JM, 1999, BIODRUGS, V11, P293, DOI 10.2165/00063030-199911050-00001; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sinai AP, 1997, J CELL SCI, V110, P2117; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Theivanthiran B, 2012, INFECT IMMUN, V80, P2558, DOI 10.1128/IAI.06230-11; Tong HH, 2001, INFECT IMMUN, V69, P3678, DOI 10.1128/IAI.69.6.3678-3684.2001; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Webster P, 2002, J HISTOCHEM CYTOCHEM, V50, P503, DOI 10.1177/002215540205000407; Wilson E, 2008, J INFECT DIS, V197, pS178, DOI 10.1086/522136; Woo JI, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-314; Xu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028216; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yao QP, 2013, SEMIN ARTHRITIS RHEU, V43, P125, DOI 10.1016/j.semarthrit.2012.12.005	87	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90933	10.1371/journal.pone.0090933	http://dx.doi.org/10.1371/journal.pone.0090933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625812	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300041
J	Connelly, JJ; Golding, J; Gregory, SP; Ring, SM; Davis, JM; Smith, GD; Harris, JC; Carter, CS; Pembrey, M				Connelly, Jessica J.; Golding, Jean; Gregory, Steven P.; Ring, Susan M.; Davis, John M.; Smith, George Davey; Harris, James C.; Carter, C. Sue; Pembrey, Marcus			Personality, Behavior and Environmental Features Associated with OXTR Genetic Variants in British Mothers	PLOS ONE			English	Article							OXYTOCIN RECEPTOR OXTR; EXPOSOME; CHILDREN; PSYCHOPATHOLOGY; VULNERABILITY; VASOPRESSIN; METABOLISM; PARENTS; SCALE	Background: It is assumed that the oxytocin receptor gene (OXTR) is associated with factors that are related to features of reproduction as well as the currently emerging fields of mood and emotional response. Methods: We analysed data from over 8000 mothers who participated in the Avon Longitudinal Study of Parents and Children (ALSPAC). We determined reproductive, emotional and personality differences related to the two SNPs rs53576 and rs2254298 of the oxytocin receptor gene to determine whether there was evidence in this population for: (i) associations with emotional and personality differences, and (ii) behavioural or environmental links with these SNPs using a hypothesis free approach with over 1000 types of exposure. Results: Our analyses of 7723 women showed that there were no differences in 11 mood, social or relationship characteristics associated with the rs2254298, and just one with rs53576 (with emotional loneliness) - one statistically significant out of 22 tests is no more than would be expected by chance. There were no interactions with childhood abuse. Using a hypothesis-free approach we found few indicators of environmental or behavioural differences associated with rs2254298, but there was an excess of associations with eating habits with rs53576. The findings included an association with dieting to lose weight, and habits typical of bulimia for the women with GG. The nutrition of the women also showed negative associations of the GG genotype with 13 nutrients, including vitamins D, B-12 and retinol, and intake of calcium, potassium and iodine. Conclusions: We conclude that this large database of pregnant women was unable to provide confirmation of the types of personality associated with these two OXTR SNPs, but we have shown some evidence of eating differences in those with GG on rs53576. Confirmation of our hypothesis free associations using other data sets is important.	[Connelly, Jessica J.] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA; [Connelly, Jessica J.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Golding, Jean; Gregory, Steven P.; Pembrey, Marcus] Univ Bristol, Ctr Child & Adolescent Hlth, Sch Social & Community Med, Bristol, Avon, England; [Ring, Susan M.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; [Davis, John M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Carter, C. Sue] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Carter, C. Sue] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Pembrey, Marcus] UCL, Inst Child Hlth, London, England	University of Virginia; University of Virginia; University of Bristol; University of Bristol; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Northeastern University; University of London; University College London	Connelly, JJ (corresponding author), Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA.	jessica.connelly@virginia.edu	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Gregory, Steve/0000-0002-1529-9338; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Golding, Jean/0000-0003-2826-3307	Medical Research Council [G1100226]; Fetzer Institute [3091.00]; Medical Research Council [MC_PC_15018, MC_UU_12013/1] Funding Source: researchfish; MRC [G1100226, MC_UU_12013/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fetzer Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. The statistical analyses for this project were undertaken with funding from the Medical Research Council [grant no. G1100226]. Genotyping to confirm imputation of rs2254298 was funded through the Fetzer Institute (Project #3091.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Armitage P., 2002, STAT METHODS MED RES; BACHMAN JG, 1977, J PERS SOC PSYCHOL, V35, P365, DOI 10.1037/0022-3514.35.6.365; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; BOYCE P, 1989, AUST NZ J PSYCHIAT, V23, P341; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bradley B, 2011, DEV PSYCHOPATHOL, V23, P439, DOI 10.1017/S0954579411000162; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Chen FS, 2012, SOC PSYCHOL PERS SCI, V3, P93, DOI 10.1177/1948550611410325; Cornelis MC, 2012, MOL PSYCHIATR, V17, P1157, DOI 10.1038/mp.2011.178; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gillath O, 2008, PERS SOC PSYCHOL B, V34, P1396, DOI 10.1177/0146167208321484; Golding J, 2004, EUR J ENDOCRINOL, V151, pU119, DOI 10.1530/eje.0.151U119; Graustella AJ, 2012, HORM BEHAV, V61, P410, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jones R, 2005, PAEDIATR PERINAT EP, V19, P264, DOI 10.1111/j.1365-3016.2005.00664.x; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Lawson EA, 2012, J CLIN ENDOCR METAB, V97, pE1898, DOI 10.1210/jc.2012-1702; Louis GMB, 2012, STAT MED, V31, P2569, DOI 10.1002/sim.5496; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MacDonald K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00035; Malik AI, 2012, GENES BRAIN BEHAV, V11, P545, DOI 10.1111/j.1601-183X.2012.00776.x; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; Mwenifumbo Jill C, 2009, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-540-69248-5_9; NOWICKI S, 1974, J PERS ASSESS, V38, P136, DOI 10.1080/00223891.1974.10119950; O'Connor TG, 1999, J CHILD PSYCHOL PSYC, V40, P777, DOI 10.1111/1469-7610.00493; Peters A, 2012, J EPIDEMIOL COMMUN H, V66, P103, DOI 10.1136/jech-2011-200643; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rodriguez S, 2013, J INVEST DERMATOL, V133, P1760, DOI 10.1038/jid.2012.480; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013	42	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90465	10.1371/journal.pone.0090465	http://dx.doi.org/10.1371/journal.pone.0090465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621820	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300021
J	Ma, Q; Zou, Y; Lv, YJ; Song, H; Yuan, YJ				Ma, Qian; Zou, Yang; Lv, Yajin; Song, Hao; Yuan, Ying-Jin			Comparative Proteomic Analysis of Experimental Evolution of the Bacillus cereus-Ketogulonicigenium vulgare Co-Culture	PLOS ONE			English	Article							TERM EXPERIMENTAL EVOLUTION; SYSTEMS BIOLOGY; OLIGOPEPTIDE TRANSPORT; COMMUNITY PROTEOMICS; ESCHERICHIA-COLI; EXOSPORIUM; SPORULATION; EXPRESSION; SPECIFICITY; MEGATERIUM	The microbial co-culture system composing of Ketogulonicigenium vulgare and Bacillus cereus was widely adopted in industry for the production of 2-keto-gulonic acid (2-KGA), the precursor of vitamin C. We found serial subcultivation of the co-culture could enhance the yield of 2-KGA by 16% in comparison to that of the ancestral co-culture. To elucidate the evolutionary dynamics and interaction mechanisms of the two microbes, we performed iTRAQ-based quantitative proteomic analyses of the pure cultures of K. vulgare, B. cereus and their co-culture during serial subcultivation. Hierarchy cluster analyses of the proteomic data showed that the expression level of a number of crucial proteins associated with sorbose conversion and oligopeptide transport was significantly enhanced by the experimental evolution. In particular, the expression level of sorbose/sorbosone dehydrogenase was enhanced in the evolved K. vulgare, while the expression level of InhA and the transport efficiency of oligopeptides were increased in the evolved B. cereus. The decreased sporulating protein expression and increased peptide transporter expression observed in evolved B. cereus, together with the increased amino acids synthesis in evolved K. vulgare suggested that serial subcultivation result in enhanced synergistic cooperation between K. vulgare and B. cereus, enabling an increased production of 2-KGA.	[Yuan, Ying-Jin] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; Tianjin Univ, Sch Chem Engn & Technol, Collaborat Innovat Ctr Chem Sci & Engn, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Song, Hao/G-6207-2010	Song, Hao/0000-0001-5553-2539	National Basic Research Program of China ("973'' Program) [2013CB733600]; National Natural Science Foundation of China; National High Technology Research and Development Program ("863'' Program) [2012AA02A701]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863'' Program)(National High Technology Research and Development Program of China)	This work was funded by the National Basic Research Program of China ("973'' Program: 2013CB733600), the National Natural Science Foundation of China, the National High Technology Research and Development Program ("863'' Program: 2012AA02A701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 1999, BIOSCI BIOTECH BIOCH, V63, P46, DOI 10.1271/bbb.63.46; Ball DA, 2008, MOL MICROBIOL, V68, P947, DOI 10.1111/j.1365-2958.2008.06206.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang WT, 2007, BIORESOURCE TECHNOL, V98, P1224, DOI 10.1016/j.biortech.2006.05.005; Charlton S, 1999, J APPL MICROBIOL, V87, P241, DOI 10.1046/j.1365-2672.1999.00878.x; de Lorenzo V, 2008, CURR OPIN BIOTECH, V19, P579, DOI 10.1016/j.copbio.2008.10.004; de Vries YP, 2004, APPL ENVIRON MICROB, V70, P2514, DOI 10.1128/AEM.70.4.2514-2519.2004; dos Santos VM, 2010, CURR OPIN BIOTECH, V21, P539, DOI 10.1016/j.copbio.2010.08.003; Fazzini MM, 2010, J BACTERIOL, V192, P4012, DOI 10.1128/JB.00197-10; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Hillesland KL, 2009, P ROY SOC B-BIOL SCI, V276, P459, DOI 10.1098/rspb.2008.1098; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032156; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; MATZ LL, 1970, J BACTERIOL, V101, P196, DOI 10.1128/JB.101.1.196-201.1970; Monnet V, 2003, CELL MOL LIFE SCI, V60, P2100, DOI 10.1007/s00018-003-3054-3; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Saito Y, 1997, APPL ENVIRON MICROB, V63, P454, DOI 10.1128/AEM.63.2.454-460.1997; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; Tauveron G, 2006, INT J FOOD MICROBIOL, V110, P254, DOI 10.1016/j.ijfoodmicro.2006.04.027; Travisano M, 1996, GENETICS, V143, P15; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; VerBerkmoes NC, 2009, NAT REV MICROBIOL, V7, P196, DOI 10.1038/nrmicro2080; Wang W, 2006, J BIOTECHNOL, V126, P313, DOI 10.1016/j.jbiotec.2006.05.005; Wilmes P, 2009, CURR OPIN MICROBIOL, V12, P310, DOI 10.1016/j.mib.2009.03.004; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11; Zhu Y, 2012, PROCESS BIOCH; Zou Y, 2012, BIORESOURCE TECHNOLO	34	15	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91789	10.1371/journal.pone.0091789	http://dx.doi.org/10.1371/journal.pone.0091789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619085	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400130
J	Wang, XQ; Frank, JW; Little, DR; Dunlap, KA; Satterfield, MC; Burghardt, RC; Hansen, TR; Wu, GY; Bazer, FW				Wang, Xiaoqiu; Frank, James W.; Little, Danielle R.; Dunlap, Kathrin A.; Satterfield, M. Carey; Burghardt, Robert C.; Hansen, Thomas R.; Wu, Guoyao; Bazer, Fuller W.			Functional role of arginine during the peri-implantation period of pregnancy. I. Consequences of loss of function of arginine transporter SLC7A1 mRNA in ovine conceptus trophectoderm	FASEB JOURNAL			English	Article						development; sheep; morpholino	NITRIC-OXIDE SYNTHASE; SELECT NUTRIENTS; EMBRYONIC-DEVELOPMENT; FETAL-DEVELOPMENT; PLACENTAL GROWTH; UTERINE GLANDS; POLYAMINES; PROLIFERATION; METABOLISM; SECRETIONS	Arginine, the common substrate for production of nitric oxide (NO) and polyamines in mammals, increases in the uterine lumen during the peri-implantation period of pregnancy. However, functional roles of arginine within the uterine lumen for conceptus (embryo and extraembryonic membranes) development have not been elucidated in vivo. To assess roles of arginine in reproductive tissue for survival and development of the conceptus, we conducted an in vivo morpholino antisense oligonucleotide (MAO)-mediated knockdown of SLC7A1 mRNA, the arginine transporter in ovine conceptus trophectoderm (Tr). Translational knockdown of SLC7A1 mRNA resulted in retarded conceptus development and abnormal function compared to MAO control. Use of MAO-SLC7A1 knockdown in conceptuses decreased arginine transport (73%, P<0.01), the abundance of ornithine decarboxylase, and nitric oxide synthase (NOS3) proteins, arginine-related amino acids [citrulline (76%, P<0.05) and ornithine (40%, P<0.05)], and polyamines, which likely accounts for their retarded development. Also, no alternative arginine precursors (glutamine and glutamate), isoforms of nitric oxide synthase (NOS1 and NOS2), or alternative pathways for polyamine biosynthesis via arginine decarboxylase and agmatinase were activated to rescue conceptus development. Collectively, SLC7A1 is the key transporter of arginine by conceptus Tr, and arginine is essential for conceptus survival and development.	[Wang, Xiaoqiu; Wu, Guoyao; Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX 77843 USA; [Wang, Xiaoqiu; Dunlap, Kathrin A.; Satterfield, M. Carey; Wu, Guoyao; Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Frank, James W.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Little, Danielle R.; Burghardt, Robert C.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Hansen, Thomas R.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Colorado State University	Bazer, FW (corresponding author), Texas A&M Univ, TAMU 2471, College Stn, TX 77843 USA.	fbazer@cvm.tamu.edu	Bazer, Fuller/AAF-4317-2021; Hansen, Thomas/GWZ-2858-2022; Wang, Xiaoqiu/AAT-4148-2021; Burghardt, Robert C./AAF-4847-2021; Wang, Xiaoqiu/AAT-3368-2021	Bazer, Fuller/0000-0002-5823-5086; Burghardt, Robert C./0000-0003-1021-8444; Wang, Xiaoqiu/0000-0001-9660-528X; Little, Danielle/0000-0001-7262-1496	Agriculture and Food Research Initiative from the U.S. Department of Agriculture National Institute of Food and Agriculture [2011-6705-20028, 2011-67015-20067]	Agriculture and Food Research Initiative from the U.S. Department of Agriculture National Institute of Food and Agriculture	This research was supported by Agriculture and Food Research Initiative competitive grants 2011-6705-20028 and 2011-67015-20067 from the U.S. Department of Agriculture National Institute of Food and Agriculture. The contributions of graduate students and postdoctoral fellows from the Laboratory of Uterine Biology and Pregnancy (Texas A&M University) are gratefully acknowledged, as is the assistance of Kendrick Leblanc, Colt Sharpton, and Caleb Wendt for management of experimental animals.	Antoniazzi AQ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105684; Arques O., 2012, PROTOCOL EXCHANGE, DOI [10.1038/protex.2012.008, DOI 10.1038/PROTEX.2012.008]; Bazer FW, 2012, ANN NY ACAD SCI, V1271, P88, DOI 10.1111/j.1749-6632.2012.06741.x; Bazer FW, 2012, J REPROD DEVELOP, V58, P180, DOI 10.1262/jrd.2011-019; Bazer FW, 2008, REPROD BIOL, V8, P179, DOI 10.1016/S1642-431X(12)60012-6; Bazer FW, 2009, SEMIN REPROD MED, V27, P90, DOI 10.1055/s-0028-1108013; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Bird IM, 2003, AM J PHYSIOL-REG I, V284, pR245, DOI 10.1152/ajpregu.00108.2002; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; CONRAD KP, 1993, FASEB J, V7, P1269, DOI 10.1096/fasebj.7.13.7691671; Dorniak P, 2013, J ANIM SCI, V91, P1627, DOI 10.2527/jas.2012-5845; Dorniak P, 2013, ENDOCRINOLOGY, V154, P931, DOI 10.1210/en.2012-1909; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Dye JF, 2004, FASEB J, V18, P125, DOI 10.1096/fj.02-0916fje; Gao HJ, 2009, BIOL REPROD, V81, P67, DOI 10.1095/biolreprod.108.075473; Gao HJ, 2009, BIOL REPROD, V80, P602, DOI 10.1095/biolreprod.108.073890; Gao HJ, 2009, BIOL REPROD, V80, P86, DOI 10.1095/biolreprod.108.071597; Gouge RC, 1998, BIOL REPROD, V58, P875, DOI 10.1095/biolreprod58.4.875; Gray C. A., 2001, ARBS Annual Review of Biomedical Sciences, V3, P85; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; GUILLOMOT M, 1995, J REPROD FERTIL, P39; Guillomot M, 1993, REPROD MAMMALS MAN, P387; Heby O, 1995, INT J DEV BIOL, V39, P737; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Kim JY, 2011, BIOL REPROD, V84, P70, DOI 10.1095/biolreprod.110.085753; Kim JY, 2011, BIOL REPROD, V84, P62, DOI 10.1095/biolreprod.110.085738; Kim J, 2011, BIOL REPROD, V84, P1139, DOI 10.1095/biolreprod.110.088153; Maeda T, 2006, BIOL PHARM BULL, V29, P234, DOI 10.1248/bpb.29.234; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875, DOI 10.1530/jrf.0.0820875; Self JT, 2004, BIOL REPROD, V70, P1444, DOI 10.1095/biolreprod.103.025486; Sengoku K, 2001, MOL REPROD DEV, V58, P262, DOI 10.1002/1098-2795(200103)58:3&lt;262::AID-MRD3&gt;3.0.CO;2-8; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wen HY, 2005, PLACENTA, V26, pS63, DOI 10.1016/j.placenta.2005.02.004; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu G, 2011, J ANIM SCI, V89, P2017, DOI 10.2527/jas.2010-3614; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Wu GY, 2000, AM J PHYSIOL-ENDOC M, V279, pE395, DOI 10.1152/ajpendo.2000.279.2.E395; WU GY, 1995, AM J PHYSIOL-REG I, V268, pR334; Wu GY, 1997, J NUTR, V127, P2342, DOI 10.1093/jn/127.12.2342; Wu GY, 2005, BIOL REPROD, V72, P842, DOI 10.1095/biolreprod.104.036293; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Wu GY, 1998, J NUTR, V128, P2395, DOI 10.1093/jn/128.12.2395	49	50	54	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2852	2863		10.1096/fj.13-248757	http://dx.doi.org/10.1096/fj.13-248757			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24627544				2022-12-25	WOS:000337949400011
J	Ni, DC; Wang, Y; Yang, X; Zhou, HZ; Hou, XM; Cao, BH; Lu, ZX; Zhao, XS; Yang, K; Huang, YH				Ni, Dongchun; Wang, Yan; Yang, Xu; Zhou, Haizhen; Hou, Xiaomin; Cao, Baohua; Lu, Zhixin; Zhao, Xinsheng; Yang, Kun; Huang, Yihua			Structural and functional analysis of the beta-barrel domain of BamA from Escherichia coli	FASEB JOURNAL			English	Article						outer membrane protein; Omp85 protein family; outer membrane protein biogenesis	OUTER-MEMBRANE PROTEINS; CRYSTAL-STRUCTURE; ESSENTIAL COMPONENT; ASSEMBLY MACHINERY; OMP85 FAMILY; BIOGENESIS; FHAC; TRANSLOCATION; CONFORMATION; FLEXIBILITY	In gram-negative bacteria, the assembly of outer membrane proteins (OMPs) requires a beta-barrel assembly machinery (BAM) complex, of which BamA is an essential and evolutionarily conserved component. To elucidate the mechanism of BamA-mediated OMP biogenesis, we determined the crystal structure of the C-terminal transmembrane domain of BamA from Escherichia coli (EcBamA) at 2.6 angstrom resolution. The structure reveals 2 distinct features. First, a portion of the extracellular side of the beta barrel is composed of 5 markedly short beta strands, and the loops stemming from these beta strands form a potential surface cavity, filled by a portion of the L6 loop that includes the conserved VRGF/Y motif found in the Omp85 family. Second, the 4 extracellular loops L3, L4, L6, and L7 of EcBamA form a dome over the barrel, stabilized by a salt-bridge interaction network. Functional data show that hydrophilic-to-hydrophobic mutations of the potential hydrophilic surface cavity and a single Arg547Ala point mutation that may destabilize the dome severely affect the function of EcBamA. Our structure of the EcBamA beta barrel and structure-based mutagenesis studies suggest that the transmembrane beta strands of OMP substrates may integrate into the outer membrane at the interface of the first and last beta strands of the EcBamA barrel, whereas the soluble loops or domains may be transported out of the cell via the hydrophilic surface cavity on dislocation of the VRGF/Y motif of L6. In addition, the dome over the barrel may play an important role in maintaining the efficiency of OMP biogenesis.	[Ni, Dongchun; Wang, Yan; Yang, Xu; Zhou, Haizhen; Hou, Xiaomin; Cao, Baohua; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Ni, Dongchun; Yang, Kun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Wang, Yan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Zhixin; Zhao, Xinsheng] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Lu, Zhixin; Zhao, Xinsheng] Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Beijing 100871, Peoples R China; [Lu, Zhixin; Zhao, Xinsheng] Peking Univ, Coll Chem & Mol Engn, Dept Biol Chem, Beijing 100871, Peoples R China; [Lu, Zhixin; Zhao, Xinsheng] Peking Univ, Biodynam Optic Imaging Ctr, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Tianjin Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Peking University; Peking University; Peking University	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	yihuahuang@sun5.ibp.ac.cn			Ministry of Science and Technology [2012CB917302, 2013CB910603]; National Natural Science Foundation of China [31170698]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to Dr. Thomas Silhavy (Princeton University, Princeton, NJ, USA) for generously providing E. coli strain JCM320 for functional analysis and Dr. Susan Buchanan (National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA) for providing the PDB coordinates of HdBamA and NgBamA. The authors also thank Nian Huang, Kai Zhang, Yan Zhao, Shuai Zhang, Changlin Tian, Peng Chen, Xiou Cao, Li Deng, Chuanqi Sun, and Maoshui Wang for technical assistance and the Shanghai Synchrotron Radiation Facility (Shanghai, China) beamline scientists for technical support during data collection. The coordinates and diffraction data have been deposited into PDB (http://www.rscb.org/pdb/) with accession code 4N75 for EcBamA(426-810). This work was supported by grants from the Ministry of Science and Technology (2012CB917302 and 2013CB910603 to Y.H.) and the National Natural Science Foundation of China (31170698 to Y.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DeLano WL, 2009, ABSTR PAP AM CHEM S, V238; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jiang JH, 2012, INT J MOL SCI, V13, P8038, DOI 10.3390/ijms13078038; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Leonard-Rivera M, 2012, J BACTERIOL, V194, P4662, DOI 10.1128/JB.00825-12; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004; Tellez R, 2012, J BACTERIOL, V194, P317, DOI 10.1128/JB.06192-11; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254	48	73	74	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2677	2685		10.1096/fj.13-248450	http://dx.doi.org/10.1096/fj.13-248450			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24619089				2022-12-25	WOS:000339883600025
J	Munch, D; Muller, A; Schneider, T; Kohl, B; Wenzel, M; Bandow, JE; Maffioli, S; Sosio, M; Donadio, S; Wimmer, R; Sahl, HG				Muench, Daniela; Mueller, Anna; Schneider, Tanja; Kohl, Bastian; Wenzel, Michaela; Bandow, Julia Elisabeth; Maffioli, Sonia; Sosio, Margherita; Donadio, Stefano; Wimmer, Reinhard; Sahl, Hans-Georg			The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Cell Wall; Membrane; Nuclear Magnetic Resonance; Peptidoglycan; Staphylococcus aureus; Teichoic Acid; Lantibiotics; Lipid II; Nisin	PEPTIDE ANTIBIOTIC NISIN; LIPID-II; PEPTIDOGLYCAN BIOSYNTHESIS; PORE FORMATION; TEICHOIC-ACID; MODE; MICROBISPORICIN; EPIDERMIN; INHIBITION; STRATEGIES	Background: NAI-107 is a potent lantibiotic with an unknown mode of action. Results: NAI-107 targets bactoprenol-bound cell envelope precursors, e.g. lipid II, and in addition affects the bacterial membrane. Conclusion: Cell wall biosynthesis is blocked by sequestration of lipid II and functional disorganization of the cell wall machinery. Significance: The dual mechanism of action may explain the potency of NAI-107 and related lantibiotics. The lantibiotic NAI-107 is active against Gram-positive bacteria including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. To identify the molecular basis of its potency, we studied the mode of action in a series of whole cell and in vitro assays and analyzed structural features by nuclear magnetic resonance (NMR). The lantibiotic efficiently interfered with late stages of cell wall biosynthesis and induced accumulation of the soluble peptidoglycan precursor UDP-N-acetylmuramic acid-pentapeptide (UDP-MurNAc-pentapeptide) in the cytoplasm. Using membrane preparations and a complete cascade of purified, recombinant late stage peptidoglycan biosynthetic enzymes (MraY, MurG, FemX, PBP2) and their respective purified substrates, we showed that NAI-107 forms complexes with bactoprenol-pyrophosphate-coupled precursors of the bacterial cell wall. Titration experiments indicate that first a 1:1 stoichiometric complex occurs, which then transforms into a 2:1 (peptide: lipid II) complex, when excess peptide is added. Furthermore, lipid II and related molecules obviously could not serve as anchor molecules for the formation of defined and stable nisin-like pores, however, slow membrane depolarization was observed after NAI-107 treatment, which could contribute to killing of the bacterial cell.	[Muench, Daniela; Mueller, Anna; Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Sect, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany; [Kohl, Bastian; Wenzel, Michaela; Bandow, Julia Elisabeth] Ruhr Univ Bochum, Dept Biol Microorganisms, D-44780 Bochum, Germany; [Maffioli, Sonia; Sosio, Margherita; Donadio, Stefano] NAICONS Srl, I-20139 Milan, Italy; [Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark	University of Bonn; Ruhr University Bochum; Aalborg University	Munch, D (corresponding author), Meckenheimer Allee 168, D-53115 Bonn, Germany.	dmuench@uni-bonn.de; hgsahl@uni-bonn.de	Wenzel, Michaela/D-5643-2015; Mueller, Anna/L-9779-2017; Wenzel, Michaela/M-5445-2019; Wimmer, Reinhard/M-2346-2019; Bandow, Julia/K-8854-2012; maffioli, sonia/K-7575-2019; Schneider, Tanja/L-8049-2013; Wimmer, Reinhard/A-7901-2012	Wenzel, Michaela/0000-0001-9969-6113; Mueller, Anna/0000-0001-6420-3868; Wenzel, Michaela/0000-0001-9969-6113; Bandow, Julia/0000-0003-4100-8829; Wimmer, Reinhard/0000-0001-6942-5056; Schneider, Tanja/0000-0001-7269-4716; Rausch, Daniela/0000-0003-3211-5745; Sosio, Margherita/0000-0003-4297-6936	Obel Foundation; SparNord Foundation; Carlsberg Foundation; Danish Center for Antibiotic Research and Development (DanCARD) - Danish Council for Strategic Research Grant [09-067075]; state of North Rhine Westphalia (Forschungsgrossgerate der Lander)	Obel Foundation; SparNord Foundation; Carlsberg Foundation(Carlsberg Foundation); Danish Center for Antibiotic Research and Development (DanCARD) - Danish Council for Strategic Research Grant; state of North Rhine Westphalia (Forschungsgrossgerate der Lander)	We thank Dirk Albrecht (University of Greifswald, Germany) for MALDI-TOF analysis. We thank the Centre for Biomolecular Magnetic Resonance, Frankfurt, Germany, for access to NMR equipment and Dr. Frank Lohr for expert assistance. Michaele Josten provided excellent technical help. The NMR laboratory at Aalborg University is supported by the Obel, SparNord, and Carlsberg Foundations as well as part of the Danish Center for Antibiotic Research and Development (DanCARD) financed by Danish Council for Strategic Research Grant 09-067075. The Synapt G2S mass spectrometer was supported by the state of North Rhine Westphalia (Forschungsgrossgerate der Lander).	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; Bandow JE, 2008, PROTEOMICS, V8, P3030, DOI 10.1002/pmic.200701184; Barrett John F, 2005, Curr Opin Investig Drugs, V6, P781; Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006; Breukink E, 2000, BIOCHEMISTRY-US, V39, P10247, DOI 10.1021/bi000915q; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x; Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Castiglione F, 2008, CHEM BIOL, V15, P22, DOI 10.1016/j.chembiol.2007.11.009; Castiglione F, 2007, BIOCHEMISTRY-US, V46, P5884, DOI 10.1021/bi700131x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Christ K, 2008, J MEMBRANE BIOL, V226, P9, DOI 10.1007/s00232-008-9134-4; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Foulston L, 2011, J BACTERIOL, V193, P3064, DOI 10.1128/JB.00250-11; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; Franzmann M, 2009, CHEMBIOCHEM, V10, P2339, DOI 10.1002/cbic.200900347; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; Jabes D, 2010, METHODS MOL BIOL, V618, P31, DOI 10.1007/978-1-60761-594-1_3; Kim SJ, 2008, J MOL BIOL, V377, P281, DOI 10.1016/j.jmb.2008.01.031; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lazzarini A, 2008, US Patent, Patent No. 07351687; Muller A, 2012, MICROB DRUG RESIST, V18, P261, DOI 10.1089/mdr.2011.0242; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Orlov DS, 2002, J MICROBIOL METH, V49, P325, DOI 10.1016/S0167-7012(01)00383-9; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rogers LA, 1928, J BACTERIOL, V16, P321, DOI 10.1128/JB.16.5.321-325.1928; Rohrer S, 2003, ANTIMICROB AGENTS CH, V47, P837, DOI 10.1128/AAC.47.3.837-846.2003; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; SAHL HG, 1982, ZBL BAKT-INT J MED M, V252, P166, DOI 10.1016/S0174-3031(82)80114-5; SAHL HG, 1987, ARCH MICROBIOL, V149, P120, DOI 10.1007/BF00425076; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Scherer K, 2013, BBA-BIOMEMBRANES, V1828, P2628, DOI 10.1016/j.bbamem.2013.07.014; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; UMBREIT JN, 1972, J BACTERIOL, V112, P1306, DOI 10.1128/JB.112.3.1306-1309.1972; VANHEIJENOORT Y, 1978, FEBS LETT, V89, P141, DOI 10.1016/0014-5793(78)80540-7; Vasile F, 2012, J PEPT SCI, V18, P129, DOI 10.1002/psc.1425; Wenzel M., 2014, P NATL ACAD IN PRESS, DOI [10.1073/pnas.131199001, DOI 10.1073/PNAS.131199001]; Wenzel M, 2013, ACS CHEM BIOL, V8, P1442, DOI 10.1021/cb4000844; Wenzel M, 2012, ANTIMICROB AGENTS CH, V56, P5749, DOI 10.1128/AAC.01380-12; Wenzel M, 2011, PROTEOMICS, V11, P3256, DOI 10.1002/pmic.201100046; Wenzel M, 2011, ANTIMICROB AGENTS CH, V55, P2590, DOI 10.1128/AAC.00078-11; Wiedemann I, 2004, J BACTERIOL, V186, P3259, DOI 10.1128/JB.186.10.3259-3261.2004; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	58	57	58	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12063	12076		10.1074/jbc.M113.537449	http://dx.doi.org/10.1074/jbc.M113.537449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627484	Green Published, hybrid			2022-12-25	WOS:000335010600044
J	Belhassen-Garcia, M; Romero-Alegria, A; Velasco-Tirado, V; Alonso-Sardon, M; Lopez-Bernus, A; Alvela-Suarez, L; del Villar, LP; Carpio-Perez, A; Galindo-Perez, I; Cordero-Sanchez, M; Pardo-Lledias, J				Belhassen-Garcia, Moncef; Romero-Alegria, Angela; Velasco-Tirado, Virginia; Alonso-Sardon, Montserrat; Lopez-Bernus, Amparo; Alvela-Suarez, Lucia; Perez del Villar, Luis; Carpio-Perez, Adela; Galindo-Perez, Inmaculada; Cordero-Sanchez, Miguel; Pardo-Lledias, Javier			Study of Hydatidosis-Attributed Mortality in Endemic Area	PLOS ONE			English	Article							ECHINOCOCCUS-GRANULOSUS; CYST; INFECTION; SURGERY; SPAIN	Background: Cystic hydatid disease is still an important health problem in European Mediterranean areas. In spite of being traditionally considered as a "benign" pathology, cystic echinococcosis is an important cause of morbidity in these areas. Nevertheless, there are few analyses of mortality attributed to human hydatidosis. Objective: To describe the epidemiology, the mortality rate and the causes of mortality due to E. granulosus infection in an endemic area. Methodology: A retrospective study followed up over a period of 14 years (1998-2011). Principal Findings: Of the 567 patients diagnosed with hydatid disease over the period 1998-2011, eleven deaths directly related to hydatid disease complications were recorded. Ten patients (90.9%) died due to infectious complications and the remaining one (9.1%) died due to mechanical complications after a massive hemoptysis. We registered a case fatality rate of 1.94% and a mortality rate of 3.1 per 100.000 inhabitants. Conclusions: Hydatidosis is still a frequent parasitic disease that causes a considerable mortality. The main causes of mortality in patients with hydatidosis are complications related to the rupture of CE cysts with supurative collangitis. Therefore, an expectant management can be dangerous and it must be only employed in well-selected patients.	[Belhassen-Garcia, Moncef; Cordero-Sanchez, Miguel] Complejo Asistencial Univ Salamanca, CIETUS, IBSAL, Secc Enfermedades Infecciosas,Serv Med Interna, Salamanca, Spain; [Romero-Alegria, Angela; Lopez-Bernus, Amparo; Carpio-Perez, Adela] Complejo Asistencial Univ Salamanca, IBSAL, Serv Med Interna, Salamanca, Spain; [Velasco-Tirado, Virginia; Alvela-Suarez, Lucia] Complejo Asistencial Univ Salamanca, CIETUS, IBSAL, Serv Med Interna, Salamanca, Spain; [Alonso-Sardon, Montserrat] Univ Salamanca, Dept Med Prevent Salud Publ & Microbiol Med, E-37008 Salamanca, Spain; [Perez del Villar, Luis] Univ Salamanca, IBSAL, CIETUS, E-37008 Salamanca, Spain; [Galindo-Perez, Inmaculada] CAP Camargo, Jose Barros, Cantabria, Spain; [Pardo-Lledias, Javier] Hosp Gen Palencia Ri Carrion, Serv Med Interna, Palencia, Spain	University of Salamanca; University of Salamanca	Belhassen-Garcia, M (corresponding author), Complejo Asistencial Univ Salamanca, CIETUS, IBSAL, Secc Enfermedades Infecciosas,Serv Med Interna, Salamanca, Spain.	mbelhassen@hotmail.com	Alonso-Sardon, Montserrat/E-2185-2018	Velasco Tirado, Virginia/0000-0001-7175-1758; Alonso-Sardon, Montserrat/0000-0003-1829-5858; Belhassen-Garcia, Moncef/0000-0002-2230-1256				Garcia MB, 2010, AM J TROP MED HYG, V82, P376, DOI 10.4269/ajtmh.2010.09-0375; Bristow BN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001524; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Daali M, 2001, ANN CHIR, V126, P242, DOI 10.1016/S0003-3944(01)00507-7; DIAZ A, 1995, EXP PARASITOL, V80, P473, DOI 10.1006/expr.1995.1059; Ferreira AM, 2000, PARASITOL TODAY, V16, P168, DOI 10.1016/S0169-4758(99)01625-7; Ghoshal A G, 2012, J Assoc Physicians India, V60, P12; Gruttadauria S, 2003, DIGEST DIS SCI, V48, P358, DOI 10.1023/A:1021995914494; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; Kocer NE, 2008, INT J INFECT DIS, V12, P248, DOI 10.1016/j.ijid.2007.08.005; Li YM, 2011, AM J TROP MED HYG, V85, P452, DOI 10.4269/ajtmh.2011.10-0448; Loinaz C, 2001, WORLD J SURG, V25, P1260, DOI 10.1007/s00268-001-0106-4; Martinez P, 2011, REV CHIL INFECTOL, V28, P585, DOI /S0716-10182011000700013; Pardo J, 2005, ENFERM INFEC MICR CL, V23, P266, DOI 10.1157/13074966; Rojo-Vazquez FA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000893; Tagliacozzo S, 2011, AM J SURG, V201, P797, DOI 10.1016/j.amjsurg.2010.02.011; Yilmaz M, 2012, INT SURG, V97, P239, DOI 10.9738/CC116.1; Zubiaurre Lizarralde Leire, 2006, Gastroenterol Hepatol, V29, P405, DOI 10.1157/13091454	18	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91342	10.1371/journal.pone.0091342	http://dx.doi.org/10.1371/journal.pone.0091342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632824	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400054
J	Nieland, TJF; Logan, DJ; Saulnier, J; Lam, D; Johnson, C; Root, DE; Carpenter, AE; Sabatini, BL				Nieland, Thomas J. F.; Logan, David J.; Saulnier, Jessica; Lam, Daniel; Johnson, Caroline; Root, David E.; Carpenter, Anne E.; Sabatini, Bernardo L.			High Content Image Analysis Identifies Novel Regulators of Synaptogenesis in a High-Throughput RNAi Screen of Primary Neurons	PLOS ONE			English	Article							BETA-CATENIN; SCHIZOPHRENIA; EXPRESSION; PROTEINS; AUTISM; FAMILY; SCALE; AXIN	The formation of synapses, the specialized points of chemical communication between neurons, is a highly regulated developmental process fundamental to establishing normal brain circuitry. Perturbations of synapse formation and function causally contribute to human developmental and degenerative neuropsychiatric disorders, such as Alzheimer's disease, intellectual disability, and autism spectrum disorders. Many genes controlling synaptogenesis have been identified, but lack of facile experimental systems has made systematic discovery of regulators of synaptogenesis challenging. Thus, we created a high-throughput platform to study excitatory and inhibitory synapse development in primary neuronal cultures and used a lentiviral RNA interference library to identify novel regulators of synapse formation. This methodology is broadly applicable for high-throughput screening of genes and drugs that may rescue or improve synaptic dysfunction associated with cognitive function and neurological disorders.	[Nieland, Thomas J. F.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Lam, Daniel; Root, David E.] Broad Inst Harvard & MIT, RNAi Platform, Cambridge, MA USA; [Logan, David J.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Saulnier, Jessica; Johnson, Caroline; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Nieland, TJF (corresponding author), Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA.	tnieland@broadinstitute.org; bernardo_sabatini@hms.harvard.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; Johnson, Caroline/0000-0001-5770-6176	National Institutes of Health [MH095096, R01 GM089652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grants supported by National Institutes of Health (MH095096 to BLS and R01 GM089652 to AEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Boda B, 2010, CURR OPIN NEUROBIOL, V20, P519, DOI 10.1016/j.conb.2010.03.012; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen Y, 2013, IUBMB LIFE, V65, P685, DOI 10.1002/iub.1184; Fang WQ, 2011, J NEUROSCI, V31, P13613, DOI 10.1523/JNEUROSCI.3120-11.2011; Gejman PV, 2011, ANNU REV GENOM HUM G, V12, P121, DOI 10.1146/annurev-genom-082410-101459; Hempel CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025999; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Noh HJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003523; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wenzel A, 1997, J NEUROCHEM, V68, P469	30	30	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91744	10.1371/journal.pone.0091744	http://dx.doi.org/10.1371/journal.pone.0091744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633176	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400084
J	Zhang, XH; Yu, ZY; Zhang, SP; He, KW				Zhang, Xuehan; Yu, Zhengyu; Zhang, Shuping; He, Kongwang			Immunization with H7-HCP-Tir-Intimin Significantly Reduces Colonization and Shedding of Escherichia coli O157:H7 in Goats	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VITRO; O157-H7; O157/H7; CATTLE; INFECTION; ADHERENCE; FLAGELLIN; VACCINATION; PROTEINS	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is the causative agent of hemorrhagic colitis and hemolytic uremic syndrome in humans. However, the bacterium can colonize the intestines of ruminants without causing clinical signs. EHEC O157:H7 needs flagella (H7) and hemorrhagic coli pili (HCP) to adhere to epithelial cells. Then the bacterium uses the translocated intimin receptor (Tir) and an outer membrane adhesion (Intimin) protein to colonize hosts. This leads to the attachment and effacement of (A/E) lesions. A tetravalent recombinant vaccine (H7-HCP-Tir-Intimin) composed of immunologically important portions of H7, HCP, Tir and Intimin proteins was constructed and its efficacy was evaluated using a caprine model. The results showed that the recombinant vaccine induced strong humoral and mucosal immune responses and protected the subjects from live challenges with EHEC O157:H7 86-24 stain. After a second immunization, the average IgG titer peaked at 7.2x10(5). Five days after challenge, E. coli O157:H7 was no longer detectable in the feces of vaccinated goats, but naive goats shed the bacterium throughout the course of the challenge. Cultures of intestinal tissues showed that vaccination of goats with H7-HCP-Tir-Intimin reduced the amount of intestinal colonization by EHEC O157:H7 effectively. Recombinant H7-HCP-Tir-Intimin protein is an excellent vaccine candidate. Data from the present study warrant further efficacy studies aimed at reducing EHEC O157:H7 load on farms and the contamination of carcasses by this zoonotic pathogen.	[Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Minist Agr, Key Lab Engn Res Vet Bioprod, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Natl Ctr Engn Res Vet Bioprod, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Jiangsu Coinnovat Ctr Prevent & Control Importan, Yangzhou, Peoples R China; [Zhang, Shuping] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; University of Missouri System; University of Missouri Columbia	Zhang, XH (corresponding author), Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing, Jiangsu, Peoples R China.	liuxuehan1996@hotmail.com; kwh2003@263.net			National Science Fund for Young Scholars [31201919]	National Science Fund for Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Science Fund for Young Scholars (31201919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Amani J, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-28; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Ando H, 2007, MICROBIOL-SGM, V153, P464, DOI 10.1099/mic.0.2006/000893-0; Atef YM, 2011, VET IMMUN IMMUNO, V140, P42; Best A, 2006, VET MICROBIOL, V113, P63, DOI 10.1016/j.vetmic.2005.10.033; Daniel UT, 2009, FOODBORNE PATHOG DIS, V6, P871; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Keskinen LA, 2011, INT J FOOD MICROBIOL, V147, P157, DOI 10.1016/j.ijfoodmicro.2011.04.002; La Ragione RM, 2006, J MED MICROBIOL, V55, P819, DOI 10.1099/jmm.0.46469-0; La Ragione RM, 2005, J MED MICROBIOL, V54, P485, DOI 10.1099/jmm.0.45897-0; Maria AL, 2011, PLOS ONE, V29, P3923; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; McNeilly TN, 2010, VACCINE, V28, P1422, DOI 10.1016/j.vaccine.2009.10.076; McNeilly TN, 2010, VACCINE, V28, P1412, DOI 10.1016/j.vaccine.2009.10.148; Moxley RA, 2009, FOODBORNE PATHOG DIS, V6, P879, DOI 10.1089/fpd.2009.0297; Muehlherr JE, 2003, J DAIRY SCI, V86, P3849, DOI 10.3168/jds.S0022-0302(03)73992-7; Neville LF, 2005, INT J MOL MED, V16, P165; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; Rich AR, 2010, VACCINATION REDUCE P, P94; Solomakos N, 2009, FOOD MICROBIOL, V26, P865, DOI 10.1016/j.fm.2009.06.002; Sukumar S, 2007, J IMMUNOL, V17, P1147; Vilte DA, 2012, VET IMMUNOL IMMUNOP, V146, P169, DOI 10.1016/j.vetimm.2012.03.002; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Yin XH, 2011, CAN J VET RES, V75, P81; Zhang XH, 2012, VET REC, V170, P178, DOI 10.1136/vr.100325; Zhang XH, 2010, SCI AGR SINICA, V43, P2070; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007; Zhang XueHan, 2012, Chinese Journal of Zoonoses, V28, P1065; Zhang XueHan, 2011, Jiangsu Journal of Agricultural Sciences, V27, P1021; Zhao PanDeng, 2011, Jiangsu Journal of Agricultural Sciences, V27, P1300	34	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91632	10.1371/journal.pone.0091632	http://dx.doi.org/10.1371/journal.pone.0091632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632795	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400074
J	Chipman, PH; Zhang, Y; Rafuse, VF				Chipman, Peter H.; Zhang, Ying; Rafuse, Victor F.			A Stem-Cell Based Bioassay to Critically Assess the Pathology of Dysfunctional Neuromuscular Junctions	PLOS ONE			English	Article							ADHESION MOLECULE; MOTOR-NEURONS; SYNAPSE FORMATION; N-CAM; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; MOUSE MODEL; NERVE; NCAM; MOTONEURONS	Pluripotent stem cells can be directed to differentiate into motor neurons and assessed for functionality in vitro. An emerging application of this technique is to model genetically inherited diseases in differentiated motor neurons and to screen for new therapeutic targets. The neuromuscular junction (NMJ) is essential to the functionality of motor neurons and its dysfunction is a primary hallmark of motor neuron disease. However, mature NMJs that possess the functional and morphological characteristics of those formed in vivo have so far not been obtained in vitro. Here we describe the generation and analysis of mature NMJs formed between embryonic stem cell-derived motor neurons (ESCMNs) and primary myotubes. We compared the formation and maturation of NMJs generated by wild-type (NCAM(+/+)) ESCMNs to those generated by neural cell adhesion molecule null (NCAM(-/-)) ESCMNs in order to definitively test the sensitivity of this assay to identify synaptic pathology. We find that co-cultures using NCAM(-/-) ESCMNs replicate key in vivo NCAM(-/-) phenotypes and reveal that NCAM influences neuromuscular synaptogenesis by controlling the mode of synaptic vesicle endocytosis. Further, we could improve synapse formation and function in NCAM(-/-) co-cultures by chronic treatment with nifedipine, which blocks an immature synaptic vesicle recycling pathway. Together, our results demonstrate that this ESCMN/myofiber co-culture system is a highly sensitive bioassay for examining molecules postulated to regulate synaptic function and for screening therapeutics that will improve the function of compromised NMJs.	[Chipman, Peter H.; Zhang, Ying; Rafuse, Victor F.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada; [Rafuse, Victor F.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Zhang, Ying; Rafuse, Victor F.] Life Sci Res Ctr, Brain Repair Ctr, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Rafuse, VF (corresponding author), Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada.	vrafuse@dal.ca		Zhang, Ying/0000-0003-4363-5666	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Canadian Institutes for Health Research (V.F.R.). P.H.C. was funded by Natural Sciences and Engineering Research Council of Canada graduate student scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Chipman PH, 2012, PROG BRAIN RES, V201, P313, DOI 10.1016/B978-0-444-59544-7.00015-9; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; CHOW I, 1985, J NEUROSCI, V5, P1076; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; DUTTON EK, 1995, J NEUROSCI, V15, P7401; FISCHBACH GD, 1970, SCIENCE, V169, P1331, DOI 10.1126/science.169.3952.1331; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guo XF, 2011, BIOMATERIALS, V32, P9602, DOI 10.1016/j.biomaterials.2011.09.014; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Proszynski TJ, 2009, P NATL ACAD SCI USA, V106, P18373, DOI 10.1073/pnas.0910391106; Rafuse VF, 2000, J NEUROSCI, V20, P1056, DOI 10.1523/JNEUROSCI.20-03-01056.2000; Rafuse VF, 1996, J CELL BIOL, V132, P969, DOI 10.1083/jcb.132.5.969; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Shetty A, 2013, J NEUROSCI, V33, P16828, DOI 10.1523/JNEUROSCI.2192-13.2013; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Sugiura Y, 1997, J NEUROSCI, V17, P1101; TAKAHASHI T, 1987, J NEUROSCI, V7, P473; Thomson SR, 2012, J ANAT, V220, P122, DOI 10.1111/j.1469-7580.2011.01459.x; Umbach JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036049; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1	52	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91643	10.1371/journal.pone.0091643	http://dx.doi.org/10.1371/journal.pone.0091643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626225	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300111
J	Stapleton, DI; Lau, XZ; Flores, M; Trieu, J; Gehrig, SM; Chee, A; Naim, T; Lynch, GS; Koopman, R				Stapleton, David I.; Lau, Xianzhong; Flores, Marcelo; Trieu, Jennifer; Gehrig, Stefan M.; Chee, Annabel; Naim, Timur; Lynch, Gordon S.; Koopman, Rene			Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; BRANCHING ENZYME; HEPATIC GLYCOGEN; SKELETAL-MUSCLE; STORAGE-DISEASE; EXERCISE; MOUSE; RESISTANCE; HEALTHY; BINDING	Background: Duchenne muscular dystrophy (DMD) is a severe, genetic muscle wasting disorder characterised by progressive muscle weakness. DMD is caused by mutations in the dystrophin (dmd) gene resulting in very low levels or a complete absence of the dystrophin protein, a key structural element of muscle fibres which is responsible for the proper transmission of force. In the absence of dystrophin, muscle fibres become damaged easily during contraction resulting in their degeneration. DMD patients and mdx mice (an animal model of DMD) exhibit altered metabolic disturbances that cannot be attributed to the loss of dystrophin directly. We tested the hypothesis that glycogen metabolism is defective in mdx dystrophic mice. Results: Dystrophic mdx mice had increased skeletal muscle glycogen (79%, (P<0.01)). Skeletal muscle glycogen synthesis is initiated by glycogenin, the expression of which was increased by 50% in mdx mice (P<0.0001). Glycogen synthase activity was 12% higher (P<0.05) but glycogen branching enzyme activity was 70% lower (P<0.01) in mdx compared with wild-type mice. The rate-limiting enzyme for glycogen breakdown, glycogen phosphorylase, had 62% lower activity (P<0.01) in mdx mice resulting from a 24% reduction in PKA activity (P<0.01). In mdx mice glycogen debranching enzyme expression was 50% higher (P<0.001) together with starch-binding domain protein 1 (219% higher; P<0.01). In addition, mdx mice were glucose intolerant (P<0.01) and had 30% less liver glycogen (P<0.05) compared with control mice. Subsequent analysis of the enzymes dysregulated in skeletal muscle glycogen metabolism in mdx mice identified reduced glycogenin protein expression (46% less; P<0.05) as a possible cause of this phenotype. Conclusion: We identified that mdx mice were glucose intolerant, and had increased skeletal muscle glycogen but reduced amounts of liver glycogen.	[Stapleton, David I.; Lau, Xianzhong; Flores, Marcelo; Trieu, Jennifer; Gehrig, Stefan M.; Chee, Annabel; Naim, Timur; Lynch, Gordon S.; Koopman, Rene] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia	University of Melbourne	Koopman, R (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	rkoopman@unimelb.edu.au	Lynch, Gordon/G-9553-2015	Lynch, Gordon/0000-0001-9220-9810; Koopman, Rene/0000-0001-5359-0284; Lau, Xianzhong/0000-0001-7845-8933	Muscular Dystrophy Association [175821]	Muscular Dystrophy Association(Muscular Dystrophy Association)	Supported by the Muscular Dystrophy Association (project grant 175821 to Gordon S. Lynch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 1996, J CLIN INVEST, V97, P941, DOI 10.1172/JCI118517; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; CAUDWELL FB, 1980, EUR J BIOCHEM, V109, P391, DOI 10.1111/j.1432-1033.1980.tb04806.x; ELLIS DA, 1980, BRIT MED BULL, V36, P165, DOI 10.1093/oxfordjournals.bmb.a071633; FREIDENBERG GR, 1985, J CLIN ENDOCR METAB, V60, P320, DOI 10.1210/jcem-60-2-320; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; GIBSON WB, 1971, BIOCHEMISTRY-US, V10, P4253, DOI 10.1021/bi00799a016; Ham DJ, 2013, CLIN NUTR; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; KOUBI H, 1991, CAN J PHYSIOL PHARM, V69, P841, DOI 10.1139/y91-127; Lau X, 2013, DIABETOLOGIA, V56, P675, DOI 10.1007/s00125-012-2805-9; Lienenlueke B, 2007, HISTOCHEM CELL BIOL, V128, P371, DOI 10.1007/s00418-007-0327-1; MACLENNAN PA, 1991, BIOCHEM J, V275, P477, DOI 10.1042/bj2750477; Matsumura T, 2009, J NEUROL SCI, V276, P60, DOI 10.1016/j.jns.2008.08.037; MCARDLE A, 1995, NEUROMUSCULAR DISORD, V5, P445, DOI 10.1016/0960-8966(95)00001-4; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roder IV, 2009, CELL SIGNAL, V21, P819, DOI 10.1016/j.cellsig.2009.01.029; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Rufo A, 2011, J BONE MINER RES, V26, P1891, DOI 10.1002/jbmr.410; Ryu JH, 2009, INT J BIOL MACROMOL, V45, P478, DOI 10.1016/j.ijbiomac.2009.08.006; Sharma U, 2003, MAGN RESON IMAGING, V21, P145, DOI 10.1016/S0730-725X(02)00646-X; Shearer J, 2011, AM J PHYSIOL-ENDOC M, V301, pE31, DOI 10.1152/ajpendo.00525.2010; SRIVASTAVA U, 1981, CAN J PHYSIOL PHARM, V59, P329, DOI 10.1139/y81-051; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Sullivan MA, 2011, BIOMACROMOLECULES, V12, P1983, DOI 10.1021/bm2006054; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; van Maanen MH, 1999, BBA-GENE STRUCT EXPR, V1447, P284, DOI 10.1016/S0167-4781(99)00159-1; WATKINS SC, 1987, J NEUROL SCI, V82, P181, DOI 10.1016/0022-510X(87)90017-7; Wineinger MA, 1998, AM J PHYS MED REHAB, V77, P20, DOI 10.1097/00002060-199801000-00004; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	35	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91514	10.1371/journal.pone.0091514	http://dx.doi.org/10.1371/journal.pone.0091514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626262	gold, Green Submitted, Green Published			2022-12-25	WOS:000332851300095
J	Zhang, Y; Sheng, XJ; Meng, XF; Li, Y				Zhang, Yu; Sheng, Xiaojing; Meng, Xiangfei; Li, Yan			The Circular F-Actin Bundles Provide a Track for Turnaround and Bidirectional Movement of Mitochondria in Arabidopsis Root Hair	PLOS ONE			English	Article							FLUORESCENT PROTEIN FUSION; MYOSIN-XI; TIP GROWTH; PLANT; CYTOSKELETON; MORPHOGENESIS; TRAFFICKING; ORGANIZATION; PROFILIN; FAMILY	Background: The movement of organelles in root hairs primarily occurs along the actin cytoskeleton. Circulation and "reverse fountain'' cytoplasmic streaming constitute the typical forms by which most organelles (such as mitochondria and the Golgi apparatus) in plant root hair cells engage in bidirectional movement. However, there remains a lack of in-depth research regarding the relationship between the distribution of the actin cytoskeleton and turnaround organelle movement in plant root hair cells. Results: In this paper, Arabidopsis seedlings that had been stably transformed with a GFP-ABD2-GFP (green fluorescent protein-actin-binding domain 2-green fluorescent protein) construct were utilized to study the distribution of bundles of filamentous (F)-actin and the directed motion of mitochondria along these bundles in root hairs. Observations with a confocal laser scanning microscope revealed that there were widespread circular F-actin bundles in the epidermal cells and root hairs of Arabidopsis roots. In root hairs, these circular bundles primarily start at the sub-apical region, which is the location where the turnaround movement of organelles occurs. MitoTracker probes were used to label mitochondria, and the dynamic observation of root hair cells with a confocal laser scanning microscope indicated that turnaround mitochondrial movement occurred along circular F-actin bundles. Conclusions: Relevant experimental results demonstrated that the circular F-actin bundles provide a track for the turnaround and bidirectional movement of mitochondria.	[Zhang, Yu; Sheng, Xiaojing; Meng, Xiangfei; Li, Yan] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Li, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	liyan@cau.edu.cn			National Natural Science Foundation of China [31270230, 30971435]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant nos. 31270230 and 30971435 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Baluska F, 2000, DEV BIOL, V227, P618, DOI 10.1006/dbio.2000.9908; Baluska F, 2002, TRENDS CELL BIOL, V12, P14, DOI 10.1016/S0962-8924(01)02208-5; Baluska F, 2001, DEV BIOL, V231, P113, DOI 10.1006/dbio.2000.0115; Bezanilla M, 2003, J MOL EVOL, V57, P229, DOI 10.1007/s00239-003-2469-7; Braun M, 1999, PLANTA, V209, P435, DOI 10.1007/s004250050746; Ditengou FA, 2003, PLANTA, V218, P217, DOI 10.1007/s00425-003-1095-3; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Geitmann A, 2000, J MICROSC-OXFORD, V198, P218, DOI 10.1046/j.1365-2818.2000.00702.x; He X, 2006, ANN BOT-LONDON, V98, P49, DOI 10.1093/aob/mcl084; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hodge T, 2000, J CELL SCI, V113, P3353; Ketelaar T, 2004, CURR BIOL, V14, P145, DOI 10.1016/j.cub.2004.01.004; KINKEMA M, 1994, PLANT MOL BIOL, V26, P1139, DOI 10.1007/BF00040695; Li Y, 2001, PLANTA, V213, P722, DOI 10.1007/s004250100543; Mathur J, 2002, CURR BIOL, V12, pR669, DOI 10.1016/S0960-9822(02)01164-8; Miller DD, 1999, PLANT J, V17, P141, DOI 10.1046/j.1365-313X.1999.00358.x; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; Ovecka M, 2005, PROTOPLASMA, V226, P39, DOI 10.1007/s00709-005-0103-9; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; RIDGE RW, 1988, BOT MAG TOKYO, V101, P427, DOI 10.1007/BF02488086; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sheahan MB, 2004, PLANT PHYSIOL, V136, P3968, DOI 10.1104/pp.104.049411; Sieberer B, 2000, PROTOPLASMA, V214, P118, DOI 10.1007/BF02524268; Tominaga M, 2000, PLANTA, V210, P836, DOI 10.1007/s004250050687; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Walter N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-74; Wang YS, 2004, CELL MOTIL CYTOSKEL, V59, P79, DOI 10.1002/cm.20024; Wang YS, 2008, NEW PHYTOL, V177, P525, DOI 10.1111/j.1469-8137.2007.02261.x; Yokota E, 1999, PLANT PHYSIOL, V121, P525, DOI 10.1104/pp.121.2.525	32	3	3	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91501	10.1371/journal.pone.0091501	http://dx.doi.org/10.1371/journal.pone.0091501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626218	Green Published, gold			2022-12-25	WOS:000332851300091
J	Birngruber, T; Ghosh, A; Hochmeister, S; Asslaber, M; Kroath, T; Pieber, TR; Sinner, F				Birngruber, Thomas; Ghosh, Arijit; Hochmeister, Sonja; Asslaber, Martin; Kroath, Thomas; Pieber, Thomas R.; Sinner, Frank			Long-Term Implanted cOFM Probe Causes Minimal Tissue Reaction in the Brain	PLOS ONE			English	Article							IN-VIVO; MICRODIALYSIS PROBES; RAT; TRANSPORT; DOPAMINE; ADIPOSE; INJURY; MODEL; FLUID	This study investigated the histological tissue reaction to long-term implanted cerebral open flow microperfusion (cOFM) probes in the frontal lobe of the rat brain. Most probe-based cerebral fluid sampling techniques are limited in application time due to the formation of a glial scar that hinders substance exchange between brain tissue and the probe. A glial scar not only functions as a diffusion barrier but also alters metabolism and signaling in extracellular brain fluid. cOFM is a recently developed probe-based technique to continuously sample extracellular brain fluid with an intact blood-brain barrier. After probe implantation, a 2 week healing period is needed for blood-brain barrier reestablishment. Therefore, cOFM probes need to stay in place and functional for at least 15 days after implantation to ensure functionality. Probe design and probe materials are optimized to evoke minimal tissue reaction even after a long implantation period. Qualitative and quantitative histological tissue analysis revealed no continuous glial scar formation around the cOFM probe 30 days after implantation and only a minor tissue reaction regardless of perfusion of the probe.	[Birngruber, Thomas; Kroath, Thomas; Pieber, Thomas R.; Sinner, Frank] JOANNEUM RES, HLTH Inst Biomed & Hlth Sci, Graz, Austria; [Ghosh, Arijit; Pieber, Thomas R.; Sinner, Frank] Med Univ Graz, Div Endocrinol & Metab, Graz, Austria; [Hochmeister, Sonja] Med Univ Graz, Div Gen Neurol, Graz, Austria; [Asslaber, Martin] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Sinner, F (corresponding author), JOANNEUM RES, HLTH Inst Biomed & Hlth Sci, Graz, Austria.	ca.health@joanneum.at		Pieber, Thomas/0000-0003-3554-0405	FFG - Austrian Research Promotion Agency [IDT4Brain]	FFG - Austrian Research Promotion Agency	This project was funded by FFG - Austrian Research Promotion Agency: Programm line: COIN (Cooperation and Inovation) Project: IDT4Brain (Improved Diagnosis and Treatment for neurodegenerative Diseases through direct Tissue Access in Brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5; Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Birngruber T, 2013, CLIN EXP PHARMACOL P, V40, P864, DOI 10.1111/1440-1681.12174; Bodenlenz M, 2005, AM J PHYSIOL-ENDOC M, V289, pE296, DOI 10.1152/ajpendo.00431.2004; Bodenlenz M, 2012, EUR J PHARM BIOPHARM, V81, P635, DOI 10.1016/j.ejpb.2012.04.009; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Bungay PM, 2003, J NEUROCHEM, V86, P932, DOI 10.1046/j.1471-4159.2003.01904.x; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; deLange ECM, 1997, BRAIN RES REV, V25, P27, DOI 10.1016/S0165-0173(97)00014-3; DELANGE ECM, 1995, BRAIN RES, V702, P261, DOI 10.1016/0006-8993(95)01184-X; Fitch MT, 1999, J NEUROSCI, V19, P8182; Grabb MC, 1998, J NEUROSCI METH, V82, P25, DOI 10.1016/S0165-0270(98)00025-9; Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066011; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Holmgaard R, 2012, PHARM RES-DORDR, V29, P1808, DOI 10.1007/s11095-012-0705-9; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kottegoda S, 2002, J NEUROSCI METH, V121, P93, DOI 10.1016/S0165-0270(02)00245-5; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; MYERS RD, 1986, ANN NY ACAD SCI, V473, P21, DOI 10.1111/j.1749-6632.1986.tb23601.x; Myers RD, 1998, NEUROSCI BIOBEHAV R, V22, P371, DOI 10.1016/S0149-7634(97)00025-0; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Schaupp L, 1999, AM J PHYSIOL-ENDOC M, V276, pE401, DOI 10.1152/ajpendo.1999.276.2.E401; Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; von Grote EC, 2011, MOL BIOSYST, V7, P150, DOI 10.1039/c0mb00059k; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90221	10.1371/journal.pone.0090221	http://dx.doi.org/10.1371/journal.pone.0090221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621608	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300016
J	Kusza, S; Podgorski, T; Scandura, M; Borowik, T; Javor, A; Sidorovich, VE; Bunevich, AN; Kolesnikov, M; Jedrzejewska, B				Kusza, Szilvia; Podgorski, Tomasz; Scandura, Massimo; Borowik, Tomasz; Javor, Andras; Sidorovich, Vadim E.; Bunevich, Aleksei N.; Kolesnikov, Mikhail; Jedrzejewska, Bogumila			Contemporary Genetic Structure, Phylogeography and Past Demographic Processes of Wild Boar Sus scrofa Population in Central and Eastern Europe	PLOS ONE			English	Article							DOMESTIC PIG; MITOCHONDRIAL-DNA; ANCIENT DNA; DIVERSITY; COLONIZATION; EXPANSION; SOFTWARE; GROWTH; BREEDS	The wild boar (Sus scrofa) is one of the most widely distributed mammals in Europe. Its demography was affected by various events in the past and today populations are increasing throughout Europe. We examined genetic diversity, structure and population dynamics of wild boar in Central and Eastern Europe. MtDNA control region (664 bp) was sequenced in 254 wild boar from six countries (Poland, Hungary, Belarus, Ukraine, Moldova and the European part of Russia). We detected 16 haplotypes, all known from previous studies in Europe; 14 of them belonged to European 1 (E1) clade, including 13 haplotypes from E1-C and one from E1-A lineages. Two haplotypes belonged respectively to the East Asian and the Near Eastern clade. Both haplotypes were found in Russia and most probably originated from the documented translocations of wild boar. The studied populations showed moderate haplotype (0.714 +/- 0.023) and low nucleotide diversity (0.003 +/- 0.002). SAMOVA grouped the genetic structuring of Central and Eastern European wild boar into three subpopulations, comprising of: (1) north-eastern Belarus and the European part of Russia, (2) Poland, Ukraine, Moldova and most of Belarus, and (3) Hungary. The multimodal mismatch distribution, Fu's Fs index, Bayesian skyline plot and the high occurrence of shared haplotypes among populations did not suggest strong demographic fluctuations in wild boar numbers in the Holocene and pre-Holocene times. This study showed relatively weak genetic diversity and structure in Central and Eastern European wild boar populations and underlined gaps in our knowledge on the role of southern refugia and demographic processes shaping genetic diversity of wild boar in this part of Europe.	[Kusza, Szilvia; Javor, Andras] Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, H-4012 Debrecen, Hungary; [Podgorski, Tomasz; Borowik, Tomasz; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Scandura, Massimo] Dept Sci Nat & Environm Resources, Sassari, Italy; [Sidorovich, Vadim E.] Natl Acad Sci Belarus, Inst Zool, Minsk, BELARUS; [Bunevich, Aleksei N.] State Natl Pk Belovezhskaya Pushcha, Kamenec Raion, Kamenyuki, BELARUS; [Kolesnikov, Mikhail] Luhansk Taras Shevchenko Natl Univ, Lugansk, Ukraine	University of Debrecen; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; National Park "Belovezhskaya Pushcha"; Ministry of Education & Science of Ukraine; Luhansk Taras Shevchenko National University	Kusza, S (corresponding author), Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, H-4012 Debrecen, Hungary.	kusza@agr.unideb.hu	Podgórski, Tomasz/B-4869-2015; Borowik, Tomasz/W-4008-2018	Podgórski, Tomasz/0000-0001-6858-7838; Borowik, Tomasz/0000-0003-0321-8200; Scandura, Massimo/0000-0003-2754-6866	Polish Ministry of Science and Higher Education [NN304-253935]; BIOCONSUS [245737]; BIOGEAST [247652]; Hungarian State Eotvos fellowship	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); BIOCONSUS; BIOGEAST; Hungarian State Eotvos fellowship	This study was funded by the Polish Ministry of Science and Higher Education (grant no. NN304-253935), BIOCONSUS (Research Potential in Conservation and Sustainable Management of Biodiversity, 7th Framework Programme contract no. 245737), BIOGEAST (Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme contract no. 247652), and supported by Hungarian State Eotvos fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Alves E, 2003, ANIM GENET, V34, P319, DOI 10.1046/j.1365-2052.2003.01010.x; Alves PC, 2010, BIOL J LINN SOC, V101, P797, DOI 10.1111/j.1095-8312.2010.01530.x; Apollonio M., 2010, EUROPEAN UNGULATES T; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Corbet G.B, 1978, MAMMALS PALAEARCTIC; Danilkin A A, 2001, Dokl Biol Sci, V380, P457, DOI 10.1023/A:1012323421633; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fadeev E. V., 1969, Byulleten Moskovskogo Obshchestva Ispytatelei Prirody, V74, P37; Fang M, 2006, ANIM GENET, V37, P459, DOI 10.1111/j.1365-2052.2006.01498.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Farago S, 1997, VADALLOMANY SZABALYO; Fauvelot C, 2003, EVOLUTION, V57, P1571; Feichtner B, 1998, Z JAGDWISS, V44, P140, DOI 10.1007/BF02250741; Frantz AC, 2013, BIOL J LINN SOC, V110, P104, DOI 10.1111/bij.12111; Fu YX, 1997, GENETICS, V147, P915; Giuffra E, 2000, GENETICS, V154, P1785; Gongora J, 2004, MOL PHYLOGENET EVOL, V33, P339, DOI 10.1016/j.ympev.2004.06.004; Gongora J, 2003, ACTA AGR SCAND A-AN, V53, P161, DOI 10.1080/09064710310010602; Gongora J, 2011, ZOOL SCR, V40, P327, DOI 10.1111/j.1463-6409.2011.00480.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hajji GE, 2011, EUR J WILDLIFE RES, V57, P449, DOI 10.1007/s10344-010-0452-3; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Kim BW, 2011, GENES GENOM, V33, P111, DOI 10.1007/s13258-010-0129-z; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucchini V, 2005, J ZOOL, V266, P25, DOI 10.1017/S0952836905006588; Markova AK, 2009, QUATERN INT, V201, P53, DOI 10.1016/j.quaint.2008.05.020; Martel C, 2004, MAR ECOL PROG SER, V273, P163, DOI 10.3354/meps273163; McDevitt AD, 2013, EUR J WILDLIFE RES, V59, P761, DOI 10.1007/s10344-013-0721-z; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Montiel-Sosa JF, 2000, J AGR FOOD CHEM, V48, P2829, DOI 10.1021/jf9907438; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2012, FIGTREE V 1 4 0; Rambaut A, 2014, TRACER V1 6; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russakov OS, 1984, KABAN EKOLOGIYA RESU, P1; SAEZROYUELA C, 1986, MAMMAL REV, V16, P97; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; TAJIMA F, 1989, GENETICS, V123, P585; van Asch B, 2012, ANIM GENET, V43, P35, DOI 10.1111/j.1365-2052.2011.02222.x; Vilaca ST, 2014, J BIOGEOGR IN PRESS; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	55	29	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91401	10.1371/journal.pone.0091401	http://dx.doi.org/10.1371/journal.pone.0091401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622149	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300085
J	Saevereid, HA; Schnohr, P; Prescott, E				Saevereid, Hans Askelund; Schnohr, Peter; Prescott, Eva			Speed and Duration of Walking and Other Leisure Time Physical Activity and the Risk of Heart Failure: A Prospective Cohort Study from the Copenhagen City Heart Study	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; WOMEN; MEN; EXERCISE; EPIDEMIOLOGY; ASSOCIATION; PREVENTION; INTENSITY; DISEASE	Aim: Physical activity (PA) confers some protection against development of heart failure (HF) but little is known of the role of intensity and duration of exercise. Methods and Results: In a prospective cohort study of men and women free of previous MI, stroke or HF with one or more examinations in 1976-2003, we studied the association between updated self-assessed leisure-time PA, speed and duration of walking and subsequent hospitalization or death from HF. Light and moderate/high level of leisure-time PA and brisk walking were associated with reduced risk of HF in both genders whereas no consistent association with duration of walking was seen. In 18,209 subjects age 20-80 with 1580 cases of HF, using the lowest activity level as reference, the confounder-adjusted hazard ratios (HR) for light and moderate/high leisure-time physical activity were 0.75 (0.66-0.86) and 0.80 (0.69-0.93), respectively. In 9,937 subjects with information on walking available and 542 cases of HF, moderate and high walking speed were associated with adjusted HRs of 0.53 (0.43-0.66) and 0.30 (0.21-0.44), respectively, and daily walking of 1/2-1 hrs, 1-2 and >2 hrs with HR of 0.80 (0.61-1.06), 0.82 (0.62-1.06), and 0.96 (0.73-1.27), respectively. Results were similar for both genders and remained robust after exclusion of HF related to coronary heart disease and after a series of sensitivity analyses. Conclusions: Speed rather than duration of walking was associated with reduced risk of HF. Walking is the most widespread PA and public health measures to curb the increase in HF may benefit from this information.	[Saevereid, Hans Askelund; Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Schnohr, Peter; Prescott, Eva] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Saevereid, HA (corresponding author), Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.	hans.saevereid@gmail.com	Prescott, Eva/AAJ-7441-2020; Saevereid, Hans/Q-7747-2019	Prescott, Eva/0000-0002-4134-0349	Danish Council for Independent Research \ Medical Sciences [11-115808]	Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	This work was supported by The Danish Council for Independent Research vertical bar Medical Sciences [grant number 11-115808]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard M., 1989, SCAND J SOC MED, V41, P1; Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Australian Bureau of Statistics, 2011, PHYS ACT AUSTR SNAPS; Boone-Heinonen J, 2009, OBES REV, V10, P204, DOI 10.1111/j.1467-789X.2008.00533.x; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Eyler AA, 2003, MED SCI SPORT EXER, V35, P1529, DOI 10.1249/01.MSS.0000084622.39122.0C; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GORE CJ, 1995, EUR RESPIR J, V8, P773; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hoevenaar-Blom MP, 2011, EUR J CARDIOV PREV R, V18, P41, DOI 10.1097/HJR.0b013e32833bfc87; Holtermann A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000556; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu G, 2010, CIRCULATION, V121, P237, DOI 10.1161/CIRCULATIONAHA.109.887893; Kenchaiah S, 2009, CIRCULATION, V119, P44, DOI 10.1161/CIRCULATIONAHA.108.807289; KOKKINOS PF, 1995, NEW ENGL J MED, V333, P1462, DOI 10.1056/NEJM199511303332204; Kraigher-Krainer E, 2013, EUR J HEART FAIL, V15, P742, DOI 10.1093/eurjhf/hft025; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Laursen AH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001711; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Molmen HE, 2012, SCAND CARDIOVASC J, V46, P163, DOI 10.3109/14017431.2012.660192; Molmen-Hansen HE, 2012, EUR J PREV CARDIOL, V19, P151, DOI 10.1177/1741826711400512; Patel K, 2013, INT J CARDIOL; Reis JP, 2008, J PHYS ACT HEALTH, V5, P337, DOI 10.1123/jpah.5.3.337; Schnohr P, 2007, EUR J CARDIOV PREV R, V14, P72, DOI 10.1097/HJR.0b013e3280144470; Schnohr P, 2009, DAN MED BULL, V56, P40; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; SIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706, DOI 10.2105/AJPH.85.5.706; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Wang YJ, 2010, J AM COLL CARDIOL, V56, P1140, DOI 10.1016/j.jacc.2010.05.035; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Zheng H, 2009, EUR J EPIDEMIOL, V24, P181, DOI 10.1007/s10654-009-9328-9	35	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89909	10.1371/journal.pone.0089909	http://dx.doi.org/10.1371/journal.pone.0089909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621514	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300011
J	Nakhnikian, A; Rebec, GV; Grasse, LM; Dwiel, LL; Shimono, M; Beggs, JM				Nakhnikian, Alexander; Rebec, George V.; Grasse, Leslie M.; Dwiel, Lucas L.; Shimono, Masanori; Beggs, John M.			Behavior Modulates Effective Connectivity between Cortex and Striatum	PLOS ONE			English	Article							FIELD POTENTIAL OSCILLATIONS; BASAL GANGLIA; INFORMATION-FLOW; CEREBRAL-CORTEX; LARGE-SCALE; HIPPOCAMPUS; TOOLBOX; NEURONS; MODELS; SYNCHRONIZATION	It has been notoriously difficult to understand interactions in the basal ganglia because of multiple recurrent loops. Another complication is that activity there is strongly dependent on behavior, suggesting that directional interactions, or effective connections, can dynamically change. A simplifying approach would be to examine just the direct, monosynaptic projections from cortex to striatum and contrast this with the polysynaptic feedback connections from striatum to cortex. Previous work by others on effective connectivity in this pathway indicated that activity in cortex could be used to predict activity in striatum, but that striatal activity could not predict cortical activity. However, this work was conducted in anesthetized or seizing animals, making it impossible to know how free behavior might influence effective connectivity. To address this issue, we applied Granger causality to local field potential signals from cortex and striatum in freely behaving rats. Consistent with previous results, we found that effective connectivity was largely unidirectional, from cortex to striatum, during anesthetized and resting states. Interestingly, we found that effective connectivity became bidirectional during free behaviors. These results are the first to our knowledge to show that striatal influence on cortex can be as strong as cortical influence on striatum. In addition, these findings highlight how behavioral states can affect basal ganglia interactions. Finally, we suggest that this approach may be useful for studies of Parkinson's or Huntington's diseases, in which effective connectivity may change during movement.	[Nakhnikian, Alexander; Rebec, George V.; Beggs, John M.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Rebec, George V.; Grasse, Leslie M.; Dwiel, Lucas L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Nakhnikian, Alexander] Indiana Univ, Cognit Sci Program, Bloomington, IN USA; [Shimono, Masanori; Beggs, John M.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Shimono, Masanori] Univ Tokyo, Grad Sch Educ, Dept Phys & Hlth Educ, Tokyo, Japan	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Tokyo	Beggs, JM (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA.	jmbeggs@indiana.edu		shimono, masanori/0000-0003-3549-7697	NIH [R01 DA 12964, P50 DA 05312, R01 NS 35663]; NSF, NSF GRFP [0343636]; Japan Society for the Promotion of Science [8652]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005312, R01DA012964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF, NSF GRFP; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH R01 DA 12964, P50 DA 05312, R01 NS 35663 (http://www.nih.gov/); and NSF 0343636, the NSF GRFP (http://www.nsf.gov). Masanori Shimono: Japan Society for the Promotion of Science Research Fellowships for Young Scientists #8652 and Research Fellowship for Young Scientists Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brillinger D.R., 1981, TIME SERIES DATA ANA; Brittain JS, 2007, IEEE T BIO-MED ENG, V54, P854, DOI 10.1109/TBME.2006.889185; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009; CARELLI RM, 1993, BRAIN RES, V626, P14, DOI 10.1016/0006-8993(93)90557-4; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Courtemanche R, 2003, J NEUROSCIENCE, V23; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Dorner JL, 2009, BRAIN RES, V1290, P111, DOI 10.1016/j.brainres.2009.07.019; Estrada-Sanchez AM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00019; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Gatev P, 2009, CEREB CORTEX, V19, P1330, DOI 10.1093/cercor/bhn171; Gerhard F, SUCCESSFUL RECONSTRU; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hermer-Vazquez L, 2008, J COMB OPTIM, V15, P242, DOI 10.1007/s10878-007-9101-5; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047026; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kispersky T, 2011, NEURAL SYSTEMS CIRCU; Kopell N, 2010, SPR SER COMPUT NEURO, V5, P423, DOI 10.1007/978-1-4419-0996-1_15; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montgomery EB, 2007, PARKINSONISM RELAT D, V13, P455, DOI 10.1016/j.parkreldis.2007.07.020; Montgomery Jr EB, 2004, NONLINEAR STUDIES, V11, P385; Murphy-Nakhnikian A, 2012, NEUROSCI LETT, V512, P1, DOI 10.1016/j.neulet.2011.12.040; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Olhede SC, 2002, IEEE T SIGNAL PROCES, V50, P2661, DOI 10.1109/TSP.2002.804066; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sanger TD, 2003, J NEUROL NEUROSUR PS, V74, P1509, DOI 10.1136/jnnp.74.11.1509; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sharott A, 2005, J PHYSIOL-LONDON, V562, P951, DOI 10.1113/jphysiol.2004.073189; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Walker A, 2008, J NEUROSCIENCE, V28; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Wilson GT, 1972, SIAM J APPL MATH, DOI [10.1016/S0167-6911(01)00109-8, DOI 10.1016/S0167-6911(01)00109-8]	63	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e89443	10.1371/journal.pone.0089443	http://dx.doi.org/10.1371/journal.pone.0089443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618981	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400005
J	Camacho, CV; Todorova, PK; Hardebeck, MC; Tomimatsu, N; del Alcazar, CRG; Ilcheva, M; Mukherjee, B; McEllin, B; Vemireddy, V; Hatanpaa, K; Story, MD; Habib, AA; Murty, VV; Bachoo, R; Burma, S				Camacho, C. V.; Todorova, P. K.; Hardebeck, M. C.; Tomimatsu, N.; del Alcazar, C. R. Gil; Ilcheva, M.; Mukherjee, B.; McEllin, B.; Vemireddy, V.; Hatanpaa, K.; Story, M. D.; Habib, A. A.; Murty, V. V.; Bachoo, R.; Burma, S.			DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification	ONCOGENE			English	Article							CENTRAL-NERVOUS-SYSTEM; IONIZING-RADIATION; GROWTH-FACTOR; LET RADIATION; BRAIN-TUMORS; STEM-CELLS; CANCER; GLIOMAS; REPAIR; EXPRESSION	Glioblastomas (GBM) are highly radioresistant and lethal brain tumors. Ionizing radiation (IR)-induced DNA double-strand breaks (DSBs) are a risk factor for the development of GBM. In this study, we systematically examined the contribution of IR-induced DSBs to GBM development using transgenic mouse models harboring brain-targeted deletions of key tumor suppressors frequently lost in GBM, namely Ink4a, Ink4b, Arf and/or PTEN. Using low linear energy transfer (LET) X-rays to generate simple breaks or high LET HZE particles (Fe ions) to generate complex breaks, we found that DSBs induce high-grade gliomas in these mice which, otherwise, do not develop gliomas spontaneously. Loss of Ink4a and Arf was sufficient to trigger IR-induced glioma development but additional loss of Ink4b significantly increased tumor incidence. We analyzed IR-induced tumors for copy number alterations to identify oncogenic changes that were generated and selected for as a consequence of stochastic DSB events. We found Met amplification to be the most significant oncogenic event in these radiation-induced gliomas. Importantly, Met activation resulted in the expression of Sox2, a GBM cancer stem cell marker, and was obligatory for tumor formation. In sum, these results indicate that radiation-induced DSBs cooperate with loss of Ink4 and Arf tumor suppressors to generate high-grade gliomas that are commonly driven by Met amplification and activation.	[Camacho, C. V.; Todorova, P. K.; Hardebeck, M. C.; Tomimatsu, N.; del Alcazar, C. R. Gil; Ilcheva, M.; Mukherjee, B.; Story, M. D.; Burma, S.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [McEllin, B.; Vemireddy, V.; Habib, A. A.; Bachoo, R.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Hatanpaa, K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Habib, A. A.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Murty, V. V.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Columbia University	Burma, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, 2201 Inwood Rd,NC7-214E, Dallas, TX 75390 USA.	sandeep.burma@utsouthwestern.edu	Story, Michael/AAX-2864-2021; Camacho, Cristel/Q-6197-2017	Story, Michael/0000-0001-6522-4169; Camacho, Cristel/0000-0003-1723-579X; vemireddy, vamsidhara/0000-0001-7068-6640	National Aeronautics and Space Administration [NNX13AI13G]; National Institutes of Health [RO1 CA149461, R01 NS062080]; Cancer Prevention and Research Institute of Texas [RP100644]; National Institute of General Medical Sciences [5T32GM008203]; NCI training [T32CA124334]; NATIONAL CANCER INSTITUTE [R01CA149461, T32CA124334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062080] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SB is supported by grants from the National Aeronautics and Space Administration (NNX13AI13G), National Institutes of Health (RO1 CA149461) and the Cancer Prevention and Research Institute of Texas(RP100644). AAH is supported by a National Institutes of Health grant (R01 NS062080). MCH is supported by a National Institute of General Medical Sciences training grant 5T32GM008203 in cellular and molecular biology. CVC was supported by a NCI training grant (T32CA124334). CVC completed this work in partial fulfillment of the requirements for her PhD degree. We thank Dr Chaitanya Nirodi for valuable advice on cloning and lentivirus production strategies. We also thank the support staff at the NASA Space Radiation Research Laboratory, Brookhaven National Laboratory, Upton, NY, USA, for facilitating particle radiation experiments.	Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BIGNER SH, 1990, CANCER RES, V50, P8017; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Camacho CV, 2010, CARCINOGENESIS, V31, P1889, DOI 10.1093/carcin/bgq153; Chef T, 2008, RADIAT RES, V170, P553, DOI 10.1667/RR1393.1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; De Bacco F, 2012, CANCER RES, V72, P4537, DOI 10.1158/0008-5472.CAN-11-3490; De Bacco F, 2011, J NATL CANCER I, V103, P645, DOI 10.1093/jnci/djr093; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; FISCHER U, 1995, GENE CHROMOSOME CANC, V12, P63, DOI 10.1002/gcc.2870120111; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hambardzumyan D, 2011, GLIA, V59, P1155, DOI 10.1002/glia.21142; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Joo KM, 2012, CANCER RES, V72, P3828, DOI 10.1158/0008-5472.CAN-11-3760; Jun HJ, 2012, ONCOGENE, V31, P3039, DOI 10.1038/onc.2011.474; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Laterra J, 1997, BIOCHEM BIOPH RES CO, V235, P743, DOI 10.1006/bbrc.1997.6853; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Liu W, 2011, J CLIN NEUROSCI, V18, P119, DOI 10.1016/j.jocn.2010.05.010; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mukherjee B, 2008, DNA REPAIR, V7, P1717, DOI 10.1016/j.dnarep.2008.06.016; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Okayasu R, 2012, INT J CANCER, V130, P991, DOI 10.1002/ijc.26445; Paulino AC, 2008, INT J RADIAT ONCOL, V71, P1381, DOI 10.1016/j.ijrobp.2007.12.018; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Ron E, 2002, PEDIATR RADIOL, V32, P232, DOI 10.1007/s00247-002-0672-0; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Saha J, 2013, DNA REPAIR, V12, P1143, DOI 10.1016/j.dnarep.2013.10.004; Salvati M, 2003, SURG NEUROL, V60, P60, DOI 10.1016/S0090-3019(03)00137-X; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Smolen GA, 2006, CANCER RES, V66, P3452, DOI 10.1158/0008-5472.CAN-05-4181; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sutter R, 2007, BBA-REV CANCER, V1776, P125, DOI 10.1016/j.bbcan.2007.07.006; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009	50	17	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1064	1072		10.1038/onc.2014.29	http://dx.doi.org/10.1038/onc.2014.29			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632607	Green Accepted, Green Submitted			2022-12-25	WOS:000350121300013
J	Zhou, X; Zhang, CZ; Lu, SX; Chen, GG; Li, LZ; Liu, LL; Yi, C; Fu, J; Hu, W; Wen, JM; Yun, JP				Zhou, X.; Zhang, C. Z.; Lu, S-X; Chen, G. G.; Li, L-Z; Liu, L-L; Yi, C.; Fu, J.; Hu, W.; Wen, J-M; Yun, J-P			miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma	ONCOGENE			English	Article							CELL-MIGRATION; VICKZ PROTEINS; C-MYC; EXPRESSION; MICRORNA; TRANSLATION; METASTASIS; FAMILY; INVOLVEMENT; ADHESION	Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies and the third leading cause of cancer-related deaths worldwide. Tumour metastasis is one of the major causes of high mortality. microRNAshave been implicated in HCC metastasis. In this study, we found that miR-625 was frequently downregulated in HCC samples. A decrease in miR-625 was significantly correlated with lymph node anddistance metastasis (P = 0.013), the presence of portal venous invasion (P = 0.036), tumor-nodemetastasis (TNM) stage (P = 0.027) and unfavourable overall survival (P = 0.003). Compared with primary tumours, miR-625 expression was markedly reduced in portal venous metastatic tumours. Re-expression of miR-625 in HCC cells was remarkably effective in suppressing cell migration andinvasiveness in vitro and in vivo. Mechanistically, miR-625 was confirmed to downregulate IGF2 mRNA-binding protein 1(IGF2BP1) directly, the expression of which was inversely correlated with the level of miR-625 in HCC cell lines and tissues. High expression of IGF2BP1 was frequently found in HCC samples, and associated with poor prognosis. Knockdown of endogenous IGF2BP1 by siRNA exhibited similar effects as the overexpression of miR-625, whereas overexpression of IGF2BP1 (without the 3'-UTR) abrogated miR-625-mediated metastasis inhibition. Interference of the PTEN/HSP27 pathway contributed to miR-625-mediated metastasis inhibition. Taken together, our data suggest that miR-625 might function as an antimetastatic miRNA to have an important role in HCC progression by modulating the IGF2BP1/PTEN pathway. The newly identified miR-625/IGF2BP1 axis represents a new potential therapeutic target for HCC treatment.	[Zhou, X.; Zhang, C. Z.; Lu, S-X; Li, L-Z; Liu, L-L; Yi, C.; Fu, J.; Hu, W.; Yun, J-P] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Zhou, X.; Zhang, C. Z.; Lu, S-X; Li, L-Z; Liu, L-L; Yi, C.; Fu, J.; Hu, W.; Yun, J-P] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China; [Zhou, X.; Wen, J-M] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China; [Chen, G. G.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital	Yun, JP (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Pathol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.	yunjp@sysucc.org.cn	Zhang, Chris Zhiyi/F-9862-2013; Chen, George Gong/I-2757-2016		National Natural Science Foundation of China [81372572, 81201717]; State Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncology in South China	This study was supported by grants from the National Natural Science Foundation of China (No. 81372572, 81201717), and the Project of State Key Laboratory of Oncology in South China.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Forner A, 2006, CRIT REV ONCOL HEMAT, V60, P89, DOI 10.1016/j.critrevonc.2006.06.001; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lapidus K, 2007, J CELL SCI, V120, P3173, DOI 10.1242/jcs.000638; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Read DE, 2009, BIOCHEM BIOPH RES CO, V382, P6, DOI 10.1016/j.bbrc.2009.02.114; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Tan S, 2011, FEBS LETT, V585, P2229, DOI 10.1016/j.febslet.2011.05.042; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vainer G, 2008, J PATHOL, V215, P445, DOI 10.1002/path.2376; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	35	77	80	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					965	977		10.1038/onc.2014.35	http://dx.doi.org/10.1038/onc.2014.35			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632613				2022-12-25	WOS:000350121300003
J	Chen, X; Khambu, B; Zhang, H; Gao, WT; Li, M; Chen, XY; Yoshimori, T; Yin, XM				Chen, Xi; Khambu, Bilon; Zhang, Hao; Gao, Wentao; Li, Min; Chen, Xiaoyun; Yoshimori, Tamotsu; Yin, Xiao-Ming			Autophagy Induced by Calcium Phosphate Precipitates Targets Damaged Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cell Signaling; Endosomes; Lysosomes; Signaling; Autophagosome; Calcium Phosphate Precipitate; Endosomal Damage	MEDIATED GENE-TRANSFER; MAMMALIAN-CELLS; DNA; MEMBRANE; CHOLESTEROL; UBIQUITIN; RECRUITMENT; MECHANISMS; MATURATION; INHIBITORS	Background: Relationship of autophagosomes with endosomal vesicles varies in different conditions. Results: Calcium phosphate precipitates required endocytosis to induce autophagy, caused endosome damage, and recruited autophagosomes to the damaged vesicles. Conclusion: Damaged endosomes can be targeted by autophagosomes. Significance: Autophagy may play a role in endosomal homeostasis. Calcium phosphate precipitates (CPPs) form complexes with DNA, which enter cells via endocytosis. Under this condition CPPs induce autophagy via the canonic autophagy machinery. Here we showed that CPP-induced autophagy was also dependent on endocytosis as the process was significantly inhibited by methyl--cyclodextrin and dynasore, which suppress clathrin-dependent endocytosis. Consistently, CPP treatment triggered the formation of filipin-positive intracellular vesicles whose membranes are rich in cholesterol. Unexpectedly, these vesicles were also positive for galectin 3, suggesting that they were damaged and the membrane glycans became accessible to galectins to bind. Endosome damage was caused by endocytosis of CPPs and was reversed by calcium chelators or by endocytosis inhibitors. Notably, CPP-induced LC3-positive autophagosomes were colocalized with galectin 3, ubiquitin, and p62/SQSTM1. Inhibition of galectin 3 reduced p62 puncta and autophagosome formation. Knockdown of p62 additionally inhibited the colocalization of autophagosomes with galectins. Furthermore, most of the galectin 3-positive vesicles were colocalized with Rab7 or LAMP1. Agents that affect endosome/lysosome maturation and function, such as bafilomycin A(1), also significantly affected CPP-induced tubulovesicular autophagosome formation. These findings thus indicate that endocytosed CPPs caused endosome damage and recruitment of galectins, particularly at the later endosome stage, which led to the interaction of the autophagosomal membranes with the damaged endosome in the presence of p62.	[Chen, Xi] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China; [Chen, Xi; Khambu, Bilon; Zhang, Hao; Li, Min; Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Gao, Wentao] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15261 USA; [Li, Min] Sun Yat Sen Univ, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Suita, Osaka 5650871, Japan	Zhejiang University; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sun Yat Sen University; Osaka University	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, W 350 11th St, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Li, Min/B-1281-2011; Khambu, Bilon/P-6148-2019	Khambu, Bilon/0000-0002-9432-2064	National Institutes of Health from the NCI [R01CA111456, R01CA 83817]; National Institute of Mental Health; NATIONAL CANCER INSTITUTE [R01CA111456, R01CA083817] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26251020] Funding Source: KAKEN	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA111456 and R01CA 83817 from the NCI and the National Institute of Mental Health (to X.-M. Y).	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052347; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; EGE T, 1984, EXP CELL RES, V155, P9, DOI 10.1016/0014-4827(84)90762-6; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; GINSBACH C, 1987, HISTOCHEMISTRY, V86, P241, DOI 10.1007/BF00490254; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Lechardeur Delphine, 2002, Current Gene Therapy, V2, P183, DOI 10.2174/1566523024605609; LOYTER A, 1982, EXP CELL RES, V139, P223, DOI 10.1016/0014-4827(82)90336-6; LOYTER A, 1982, P NATL ACAD SCI-BIOL, V79, P422, DOI 10.1073/pnas.79.2.422; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Man N, 2010, AUTOPHAGY, V6, P449, DOI 10.4161/auto.6.4.11612; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; ORRANTIA E, 1990, EXP CELL RES, V190, P170, DOI 10.1016/0014-4827(90)90181-9; ORRANTIA E, 1990, SOMAT CELL MOLEC GEN, V16, P305, DOI 10.1007/BF01232458; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Roberts R, 2013, AUTOPHAGY, V9, P667, DOI 10.4161/auto.23877; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831	40	59	60	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11162	11174		10.1074/jbc.M113.531855	http://dx.doi.org/10.1074/jbc.M113.531855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619419	Green Published, hybrid			2022-12-25	WOS:000334638500020
J	Kizuka, Y; Kitazume, S; Okahara, K; Villagra, A; Sotomayor, EM; Taniguchi, N				Kizuka, Yasuhiko; Kitazume, Shinobu; Okahara, Kyohei; Villagra, Alejandro; Sotomayor, Eduardo M.; Taniguchi, Naoyuki			Epigenetic Regulation of a Brain-specific Glycosyltransferase N-Acetylglucosaminyltransferase-IX ( GnT-IX) by Specific Chromatin Modifiers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epigenetics; Glycobiology; Glycosyltransferases; Histone Deacetylase; O-GlcNAc; Transcription; GnT-IX; NeuroD1; TET3	O-GLCNAC TRANSFERASE; HISTONE DEACETYLASE; GENE-EXPRESSION; TET PROTEINS; IN-VIVO; GLCNACYLATION; OGT; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; GLYCOSYLATION	Background: Epigenetic mechanisms of regulating expression of glycosyltransferase genes are largely unknown. Results: Novel epigenetic factors were identified that specifically regulate a brain-specific glycosyltransferase gene, GnT-IX (Mgat5b). Conclusion:GnT-IX is epigenetically regulated by a combination of specific chromatin modifiers (HDAC11, OGT, and TET3) and a transcriptional factor NeuroD1. Significance: This is the first study showing that a glycosyltransferase gene is regulated by another glycosyltransferase, OGT, in combination with histone modifications. Expression of glycosyltransferase genes is essential for glycosylation. However, the detailed mechanisms of how glycosyltransferase gene expression is regulated in a specific tissue or during disease progression are poorly understood. In particular, epigenetic studies of glycosyltransferase genes are limited, although epigenetic mechanisms, such as histone and DNA modifications, are central to establish tissue-specific gene expression. We previously found that epigenetic histone activation is essential for brain-specific expression of N-acetylglucosaminyltransferase-IX (GnT-IX, also designated GnT-Vb), but the mechanism of brain-specific chromatin activation around GnT-IX gene (Mgat5b) has not been clarified. To reveal the mechanisms regulating the chromatin surrounding GnT-IX, we have investigated the epigenetic factors that are specifically involved with the mouse GnT-IX locus by comparing their involvement with other glycosyltransferase loci. We first found that a histone deacetylase (HDAC) inhibitor enhanced the expression of GnT-IX but not of other glycosyltransferases tested. By overexpression and knockdown of a series of HDACs, we found that HDAC11 silenced GnT-IX. We also identified the O-GlcNAc transferase (OGT) and ten-eleven translocation-3 (TET3) complex as a specific chromatin activator of GnT-IX gene. Moreover, chromatin immunoprecipitation (ChIP) analysis in combination with OGT or TET3 knockdown showed that this OGT-TET3 complex facilitates the binding of a potent transactivator, NeuroD1, to the GnT-IX promoter, suggesting that epigenetic chromatin activation by the OGT-TET3 complex is a prerequisite for the efficient binding of NeuroD1. These results reveal a new epigenetic mechanism of brain-specific GnT-IX expression regulated by defined chromatin modifiers, providing new insights into the tissue-specific expression of glycosyltransferases.	[Kizuka, Yasuhiko; Kitazume, Shinobu; Okahara, Kyohei; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Global Res Cluster, Dis Glyc Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Villagra, Alejandro; Sotomayor, Eduardo M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33613 USA	RIKEN; H Lee Moffitt Cancer Center & Research Institute	Taniguchi, N (corresponding author), RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Ctr Syst Chem Biol, Dis Glyc Team,Syst Glycobiol Res Grp,Global Res C, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Kizuka, Yasuhiko/0000-0002-3181-9743; Villagra, Alejandro/0000-0001-9346-8355	RIKEN (Systems Glycobiology Research Project); Japan Society for the Promotion of Science (JSPS) (KAKENHI) [23770163]; Grants-in-Aid for Scientific Research [23770163] Funding Source: KAKEN	RIKEN (Systems Glycobiology Research Project); Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by RIKEN (Systems Glycobiology Research Project) (to N. T.) and Japan Society for the Promotion of Science (JSPS) (KAKENHI Grant 23770163).	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Horvat T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054672; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Inamori KI, 2006, BBA-GEN SUBJECTS, V1760, P678, DOI 10.1016/j.bbagen.2005.11.019; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lauc G, 2014, BBA-GEN SUBJECTS, V1840, P65, DOI 10.1016/j.bbagen.2013.08.017; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Lopez-Atalaya JP, 2013, NUCLEIC ACIDS RES, V41, P8072, DOI 10.1093/nar/gkt590; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Miyoshi E, 1997, INT J CANCER, V72, P1117; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Taniguchi N, 2009, J BIOL CHEM, V284, P34469, DOI 10.1074/jbc.X109.023150; Tsai YT, 2014, J NEUROCHEM, V128, P101, DOI 10.1111/jnc.12456; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	49	37	37	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11253	11261		10.1074/jbc.M114.554311	http://dx.doi.org/10.1074/jbc.M114.554311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619417	hybrid, Green Published			2022-12-25	WOS:000334638500028
J	Bu, Y; Jia, QA; Ren, ZG; Zhang, JB; Jiang, XM; Liang, L; Xue, TC; Zhang, QB; Wang, YH; Zhang, L; Xie, XY; Tang, ZY				Bu, Yang; Jia, Qing-An; Ren, Zheng-Gang; Zhang, Ju-Bo; Jiang, Xue-Mei; Liang, Lei; Xue, Tong-Chun; Zhang, Quan-Bao; Wang, Yan-Hong; Zhang, Lan; Xie, Xiao-Ying; Tang, Zhao-You			Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-INITIATING CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; I RECEPTOR; CANCER; INSULIN; CHEMORESISTANCE; METASTASIS	Background: Evidence suggests that many types of cancers are composed of different cell types, including cancer stem cells (CSCs). We have previously shown that the chemotherapeutic agent oxaliplatin induced epithelial-mesenchymal transition, which is thought to be an important mechanism for generating CSCs. In the present study, we investigate whether oxaliplatin-treated cancer tissues possess characteristics of CSCs, and explore oxaliplatin resistance in these tissues. Methods: Hepatocellular carcinoma cells (MHCC97H cells) were subcutaneously injected into mice to form tumors, and the mice were intravenously treated with either oxaliplatin or glucose. Five weeks later, the tumors were orthotopically xenografted into livers of other mice, and these mice were treated with either oxaliplatin or glucose. Metastatic potential, sensitivity to oxaliplatin, and expression of CSC-related markers in the xenografted tumor tissues were evaluated. DNA microarrays were used to measure changes in gene expression as a result of oxaliplatin treatment. Additionally, an oxaliplatin-resistant cell line (MHCC97H-OXA) was established to assess insulin-like growth factor 1 secretion, cell invasion, cell colony formation, oxaliplatin sensitivity, and expression of CSC-related markers. The effects of an insulin-like growth factor 1 receptor inhibitor were also assessed. Results: Oxaliplatin treatment inhibited subcutaneous tumor growth. Tumors from oxaliplatin-treated mice that were subsequently xenografted into livers of other mice exhibited that decreasing sensitivity to oxaliplatin and increasing pulmonary metastatic potential. Among the expression of CSC-related proteins, the gene for insulin-like growth factor 1, was up-regulated expecially in these tumor tissues. Additionally, MHCC97H-OXA cells demonstrated that increasing cell invasion, colony formation, and expression of insulin-like growth factor 1 and CSC-related markers, whereas treatment with an inhibitor of the insulin-like growth factor 1 receptor suppressed these effects. Conclusion: Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma cells is associated with increased autocrine of IGF1.	[Bu, Yang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Bu, Yang; Jia, Qing-An; Ren, Zheng-Gang; Zhang, Ju-Bo; Liang, Lei; Xue, Tong-Chun; Zhang, Quan-Bao; Wang, Yan-Hong; Zhang, Lan; Xie, Xiao-Ying; Tang, Zhao-You] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Liver Canc Inst,Zhongshan Hosp, Shanghai 200433, Peoples R China; [Jia, Qing-An] Shanxi Prov Peoples Hosp, Xian, Peoples R China; [Jiang, Xue-Mei] Haikou Peoples Hosp, Dept Gastroenterol, Haikou, Peoples R China	Fudan University; Fudan University; Shanxi People's Hospital	Tang, ZY (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Liver Canc Inst,Zhongshan Hosp, Shanghai 200433, Peoples R China.	zytang88@163.com	wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022		Foundation of China National '211' Project for Higher Education [2007-353]; National Key Science, Technology Specific Project [2008ZX10002-019]; National Natural Science Foundation of China [81172275, 21272565]; National Basic Research Program of China (973 Program) [2009CB521700]	Foundation of China National '211' Project for Higher Education; National Key Science, Technology Specific Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research project was supported in part by grants from The Foundation of China National '211' Project for Higher Education (No. 2007-353); The National Key Science, Technology Specific Project (2008ZX10002-019); The National Natural Science Foundation of China (81172275 and 21272565); and The National Basic Research Program of China (973 Program, 2009CB521700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2006, CLIN CANCER RES, V12, P5611, DOI 10.1158/1078-0432.CCR-06-1564; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Bitelman C, 2013, CANC LETT; Bodzin AS, 2012, J CELL PHYSIOL, V227, P2947, DOI 10.1002/jcp.23041; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Costello RT, 2000, CANCER RES, V60, P4403; De Larco JE, 2001, CANCER RES, V61, P2857; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ford NA, 2013, ENDOCR-RELAT CANCER, V20, P39, DOI 10.1530/ERC-12-0329; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia QA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/908601; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Kajiyama H, 2007, INT J ONCOL, V31, P277; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu LL, 2011, STEM CELLS DEV, V20, P2023, DOI 10.1089/scd.2011.0012; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Plymate SR, 2007, CLIN CANCER RES, V13, P6429, DOI 10.1158/1078-0432.CCR-07-0648; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sivakumar R, 2009, INT J ONCOL, V34, P329, DOI 10.3892/ijo_00000155; Sun YG, 2012, INT J RADIAT ONCOL, V82, pE563, DOI 10.1016/j.ijrobp.2011.06.1999; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Tong CM, 2011, J GASTROEN HEPATOL, V26, P1229, DOI 10.1111/j.1440-1746.2011.06762.x; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Xiao YH, 2012, J IMMUNOL METHODS, V384, P148, DOI 10.1016/j.jim.2012.06.009; Xiong W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-219; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Ye SL, 2010, ONCOLOGIST, V15, P34, DOI 10.1634/theoncologist.2010-S4-34; Yen Y, 2008, AM J CLIN ONCOL-CANC, V31, P317, DOI 10.1097/COC.0b013e318162f57d; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Zhang T, 2005, CLIN CANCER RES, V11, P8557, DOI 10.1158/1078-0432.CCR-05-0944	52	25	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e89686	10.1371/journal.pone.0089686	http://dx.doi.org/10.1371/journal.pone.0089686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632571	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400007
J	Hammamieh, R; Chakraborty, N; Gautam, A; Miller, SA; Muhie, S; Meyerhoff, J; Jett, M				Hammamieh, Rasha; Chakraborty, Nabarun; Gautam, Aarti; Miller, Stacy-Ann; Muhie, Seid; Meyerhoff, James; Jett, Marti			Transcriptomic Analysis of the Effects of a Fish Oil Enriched Diet on Murine Brains	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SUPPLEMENTATION LOWERS INFLAMMATION; DEFICIENT MALE RATS; GENE-EXPRESSION; DOCOSAHEXAENOIC ACID; BIPOLAR DISORDER; OMEGA-3-FATTY-ACID SUPPLEMENTATION; OMEGA-3 SUPPLEMENTATION; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE	The health benefits of fish oil enriched with high omega-3 polyunsaturated fatty acids (n-3 PUFA) are widely documented. Fish oil as dietary supplements, however, show moderate clinical efficacy, highlighting an immediate scope of systematic in vitro feedback. Our transcriptomic study was designed to investigate the genomic shift of murine brains fed on fish oil enriched diets. A customized fish oil enriched diet (FD) and standard lab diet (SD) were separately administered to two randomly chosen populations of C57BL/6J mice from their weaning age until late adolescence. Statistical analysis mined 1,142 genes of interest (GOI) differentially altered in the hemibrains collected from the FD- and SD-fed mice at the age of five months. The majority of identified GOI (similar to 40%) encodes proteins located in the plasma membrane, suggesting that fish oil primarily facilitated the membrane-oriented biofunctions. FD potentially augmented the nervous system's development and functions by selectively stimulating the Src-mediated calcium-induced growth cascade and the downstream PI3K-AKT-PKC pathways. FD reduced the amyloidal burden, attenuated oxidative stress, and assisted in somatostatin activation-the signatures of attenuation of Alzheimer's disease, Parkinson's disease, and affective disorder. FD induced elevation of FKBP5 and suppression of BDNF, which are often linked with the improvement of anxiety disorder, depression, and post-traumatic stress disorder. Hence we anticipate efficacy of FD in treating illnesses such as depression that are typically triggered by the hypoactivities of dopaminergic, adrenergic, cholinergic, and GABAergic networks. Contrastingly, FD's efficacy could be compromised in treating illnesses such as bipolar disorder and schizophrenia, which are triggered by hyperactivities of the same set of neuromodulators. A more comprehensive investigation is recommended to elucidate the implications of fish oil on disease pathomechanisms, and the result-driven repositioning of fish oil utilization may revitalize its therapeutic efficacy.	[Hammamieh, Rasha; Chakraborty, Nabarun; Gautam, Aarti; Miller, Stacy-Ann; Muhie, Seid; Meyerhoff, James; Jett, Marti] United States Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA		Hammamieh, R (corresponding author), United States Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	Rasha.Hammamieh1@us.army.mil		Hammamieh, Rasha/0000-0001-8643-6232	Military and Operational Medicine Research Area Directorate III	Military and Operational Medicine Research Area Directorate III	Funding was provided by the Military and Operational Medicine Research Area Directorate III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Adams PB, 1996, LIPIDS, V31, pS157, DOI 10.1007/BF02637069; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Alkhalil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-173; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Begg DP, 2012, HYPERTENS RES, V35, P381, DOI 10.1038/hr.2011.194; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bivens CLM, 2004, BIOL REPROD, V70, P1458, DOI 10.1095/biolreprod.103.026351; Blandini F, 2006, NEUROLOGY, V66, P529, DOI 10.1212/01.wnl.0000198511.09968.b3; Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; BOURRE JM, 1990, BIOCHIM BIOPHYS ACTA, V1043, P149, DOI 10.1016/0005-2760(90)90288-9; BOURRE JM, 1988, BIOCHIM BIOPHYS ACTA, V960, P458, DOI 10.1016/0005-2760(88)90055-0; BOURRE JM, 1990, LIPIDS, V25, P465, DOI 10.1007/BF02538090; Bousquet M, 2009, PROG NEURO-PSYCHOPH, V33, P1401, DOI 10.1016/j.pnpbp.2009.07.018; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Carlsen H, 2009, GENES NUTR, V4, P215, DOI 10.1007/s12263-009-0133-6; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Caughey GE, 1996, AM J CLIN NUTR, V63, P116, DOI 10.1093/ajcn/63.1.116; CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; CLARK WF, 1994, AM J KIDNEY DIS, V23, P644, DOI 10.1016/S0272-6386(12)70273-1; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; Conklin SM, 2007, PSYCHOSOM MED, V69, P932, DOI 10.1097/PSY.0b013e31815aaa42; Conner JM, 2010, CEREB CORTEX, V20, P2739, DOI 10.1093/cercor/bhq022; Cui HX, 2010, SCHIZOPHR RES, V121, P172, DOI 10.1016/j.schres.2010.05.003; CUNNANE SC, 1984, BRIT J NUTR, V51, P209, DOI 10.1079/BJN19840025; Curcic-Blake B, 2012, NEUROIMAGE, V59, P1540, DOI 10.1016/j.neuroimage.2011.08.036; Cysneiros RM, 2010, EPILEPSY BEHAV, V17, P33, DOI 10.1016/j.yebeh.2009.11.006; da Silva TM, 2008, J AFFECT DISORDERS, V111, P351, DOI 10.1016/j.jad.2008.03.008; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; Deckelbaum RJ, 2012, J NUTR, V142, p587S, DOI 10.3945/jn.111.148080; Duffy EM, 2004, J RHEUMATOL, V31, P1551; ENDRES S, 1993, J LEUKOCYTE BIOL, V54, P599, DOI 10.1002/jlb.54.6.599; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Freeman MP, 2006, PROSTAG LEUKOTR ESS, V75, P291, DOI 10.1016/j.plefa.2006.07.007; Freeman MP, 2006, ACTA PSYCHIAT SCAND, V113, P31, DOI 10.1111/j.1600-0447.2005.00660.x; Gao SF, 2012, CEREB CORTEX; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Gorjao R, 2009, PHARMACOL THERAPEUT, V122, P56, DOI 10.1016/j.pharmthera.2009.01.004; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Grassi-Oliveira R, 2008, BIOL PSYCHIAT, V64, P281, DOI 10.1016/j.biopsych.2008.02.023; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gulesserian T, 2001, J INVEST MED, V49, P41, DOI 10.2310/6650.2001.34089; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hammamieh R, 2007, OMICS, V11, P143, DOI 10.1089/omi.2007.4322; Hammamieh R, 2007, BREAST CANCER RES TR, V101, P7, DOI 10.1007/s10549-006-9269-x; Hammamieh R, 2012, BEHAV BRAIN RES, V235, P55, DOI 10.1016/j.bbr.2012.07.022; Harbeby E, 2012, PROSTAG LEUKOTR ESS, V86, P211, DOI 10.1016/j.plefa.2012.04.008; Hauck S, 2010, PROG NEURO-PSYCHOPH, V34, P459, DOI 10.1016/j.pnpbp.2010.01.010; Heck A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029337; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; Hennebelle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042142; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Hooijmans CR, 2012, J ALZHEIMERS DIS, V28, P191, DOI 10.3233/JAD-2011-111217; Im DS, 2012, PROG LIPID RES, V51, P232, DOI 10.1016/j.plipres.2012.02.003; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kang JI, 2012, PSYCHONEUROENDOCRINO, V37, P1569, DOI 10.1016/j.psyneuen.2012.02.017; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Kil TH, 2010, EUR J PAEDIATR NEURO, V14, P278, DOI 10.1016/j.ejpn.2009.08.004; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Le-Niculescu H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.1; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee Y, 2013, PSYCHIAT INVEST, V10, P56, DOI 10.4306/pi.2013.10.1.56; Lei X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070645; Lesperance F, 2011, J CLIN PSYCHIAT, V72, P1054, DOI 10.4088/JCP.10m05966blu; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lin CH, 2011, PARKINSONISM RELAT D, V17, P84, DOI 10.1016/j.parkreldis.2010.11.011; Liuzzi GM, 2007, NEUROCHEM RES, V32, P2184, DOI 10.1007/s11064-007-9415-9; Logan Alan C, 2004, Lipids Health Dis, V3, P25; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lucas M, 2011, AM J CLIN NUTR, V93, P1337, DOI 10.3945/ajcn.111.011817; Maes M, 2000, BIOL PSYCHIAT, V47, P910, DOI 10.1016/S0006-3223(99)00268-1; Mann J. J., 2012, NEUROBIOLOGICAL BASI; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Matsuda Y, 1996, CYTOGENET CELL GENET, V74, P107, DOI 10.1159/000134393; Matsuoka Y, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-3; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Menke A, 2013, GENES BRAIN BEHAV; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Muhie S, 2013, GENES IMMUN, V14, P19, DOI 10.1038/gene.2012.49; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Post RM, 2010, NEUROTOX RES, V18, P256, DOI 10.1007/s12640-010-9182-2; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Puskas LG, 2004, BIOCHIMIE, V86, P817, DOI 10.1016/j.biochi.2004.10.004; Reif A, 2011, J ALZHEIMERS DIS, V23, P327, DOI 10.3233/JAD-2010-101491; Rizzo AM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-82; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Ross BM, 2007, MED HYPOTHESES, V68, P515, DOI 10.1016/j.mehy.2006.07.054; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019; Rybakowski JK, 2009, SCHIZOPHR RES, V109, P90, DOI 10.1016/j.schres.2009.02.005; Sanchez-Resendis O, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00033; Sarris J, 2012, J CLIN PSYCHIAT, V73, P81, DOI 10.4088/JCP.10r06710; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Silberberg G, 2010, AM J MED GENET B, V153B, P1318, DOI 10.1002/ajmg.b.31112; Simopoulos AP, 2011, WORLD REV NUTR DIET, V102, P10, DOI 10.1159/000327785; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; SOMERVILLE MJ, 1991, MOL BRAIN RES, V9, P1, DOI 10.1016/0169-328X(91)90123-F; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Stomrud E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt44; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; Takei S, 2011, J PSYCHIATR RES, V45, P460, DOI 10.1016/j.jpsychires.2010.08.009; Takuma K, 2012, NEUROSCIENCE, V207, P261, DOI 10.1016/j.neuroscience.2012.01.034; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tuo JS, 2009, AM J PATHOL, V175, P799, DOI 10.2353/ajpath.2009.090089; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; VONAU D, 1988, EUR J APPL PHYSIOL O, V58, P97, DOI 10.1007/BF00636610; Wakefield SL, 2008, AM J PHYSIOL-ENDOC M, V294, pE425, DOI 10.1152/ajpendo.00409.2007; Wang D, 2013, J BIOL CHEM; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Woodworth HL, 2010, CANCER RES, V70, P7960, DOI 10.1158/0008-5472.CAN-10-1396; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yon MA, 2013, BRIT J NUTR, V109, P1573, DOI 10.1017/S000711451200579X; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006	139	27	27	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90425	10.1371/journal.pone.0090425	http://dx.doi.org/10.1371/journal.pone.0090425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632812	Green Published, gold			2022-12-25	WOS:000332858400014
J	Ishikawa, M; Maekawa, K; Saito, K; Senoo, Y; Urata, M; Murayama, M; Tajima, Y; Kumagai, Y; Saito, Y				Ishikawa, Masaki; Maekawa, Keiko; Saito, Kosuke; Senoo, Yuya; Urata, Masayo; Murayama, Mayumi; Tajima, Yoko; Kumagai, Yuji; Saito, Yoshiro			Plasma and Serum Lipidomics of Healthy White Adults Shows Characteristic Profiles by Subjects' Gender and Age	PLOS ONE			English	Article							MASS-SPECTROMETRY; METABOLOMICS; ACID; BIOMARKERS; BLOOD; SPHINGOMYELIN; INFLAMMATION; RESOLUTION; MEDIATORS; REVEALS	Blood is a commonly used biofluid for biomarker discovery. Although blood lipid metabolites are considered to be potential biomarker candidates, their fundamental properties are not well characterized. We aimed to (1) investigate the matrix type (serum vs. plasma) that may be preferable for lipid biomarker exploration, (2) elucidate age-and gender-associated differences in lipid metabolite levels, and (3) examine the stability of lipid metabolites in matrix samples subjected to repeated freeze-thaw cycles. Using liquid chromatography-mass spectrometry, we performed lipidomic analyses for fasting plasma and serum samples for four groups (15 subjects/group) of young and elderly (25-34 and 55-64 years old, respectively) males and females and for an additional aliquot of samples from young males, which were subjected to repeated freeze-thaw cycles. Lysophosphatidylcholine and diacylglycerol levels were higher in serum than in plasma samples, suggesting that the clotting process influences serum lipid metabolite levels. Gender-associated differences highlighted that the levels of many sphingomyelin species were significantly higher in females than in males, irrespective of age and matrix (plasma and serum). Age-associated differences were more prominent in females than in males, and in both matrices, levels of many triacylglycerols were significantly higher in elderly females than in young females. Plasma and serum levels of most lipid metabolites were reduced by freeze-thawing. Our results indicate that plasma is an optimal matrix for exploring lipid biomarkers because it represents the original properties of an individual's blood sample. In addition, the levels of some blood lipid species of healthy adults showed gender-and age-associated differences; thus, this should be considered during biomarker exploration and its application in diagnostics. Our fundamental findings on sample selection and handling procedures for measuring blood lipid metabolites is important for ensuring the quality of biomarkers identified and its qualification process.	[Ishikawa, Masaki; Maekawa, Keiko; Saito, Kosuke; Senoo, Yuya; Urata, Masayo; Murayama, Mayumi; Tajima, Yoko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Tokyo, Japan; [Ishikawa, Masaki; Maekawa, Keiko; Saito, Kosuke; Senoo, Yuya; Urata, Masayo; Murayama, Mayumi; Tajima, Yoko; Saito, Yoshiro] Natl Inst Hlth Sci, Dis Metabolome Project, Tokyo, Tokyo, Japan; [Kumagai, Yuji] Kitasato Univ, East Hosp, Clin Trial Ctr, Sagamihara, Kanagawa 228, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kitasato University	Maekawa, K (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Tokyo, Japan.	maekawa@nihs.go.jp	Saito, Kosuke/AAI-2878-2020		Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare [028]; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan [10-45]	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan	This work was supported by the Health Labour Sciences Research Grants (Grant number 028) from the Ministry of Health, Labour and Welfare, and by the Advanced Research for Products Mining Program (Grant number 10-45) from the National Institute of Biomedical Innovation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri JM, 2012, EUR J NUTR, V51, P199, DOI 10.1007/s00394-011-0208-1; Arana L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-15; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; Ben-Amor N, 2006, J PHYSIOL-LONDON, V570, P309, DOI 10.1113/jphysiol.2005.100800; Bjornerem A, 2004, J CLIN ENDOCR METAB, V89, P6039, DOI 10.1210/jc.2004-0735; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Demirkan A, 2013, J PSYCHIATR RES, V47, P357, DOI 10.1016/j.jpsychires.2012.11.001; Denery JR, 2011, ANAL CHEM, V83, P1040, DOI 10.1021/ac102806p; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Jiang H, 2013, ANAL BIOANAL CHEM, V405, P7357, DOI 10.1007/s00216-013-7166-9; KNOPP RH, 1994, ATHEROSCLEROSIS, V110, pS83, DOI 10.1016/0021-9150(94)05379-W; Kogure R, 2011, BIOCHEM BIOPH RES CO, V416, P58, DOI 10.1016/j.bbrc.2011.10.141; Lagarde M, 2010, PROSTAG LEUKOTR ESS, V82, P227, DOI 10.1016/j.plefa.2010.02.017; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; McClay JL, 2013, METABOLOMICS, V9, P392, DOI 10.1007/s11306-012-0456-y; MERRILL AH, 1985, LIPIDS, V20, P252, DOI 10.1007/BF02534197; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Parman T, 2011, TOXICOL SCI, V124, P487, DOI 10.1093/toxsci/kfr238; Rees D, 2006, AM J CLIN NUTR, V83, P331; Sangkuhl K, 2011, PHARMACOGENET GENOM, V21, P516, DOI 10.1097/FPC.0b013e3283406323; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Seijo S, 2013, AM J GASTROENTEROL, V108, P926, DOI 10.1038/ajg.2013.11; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Subbaiah PV, 2012, BBA-MOL CELL BIOL L, V1821, P908, DOI 10.1016/j.bbalip.2012.02.007; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; Vouk K, 2012, HUM REPROD, V27, P2955, DOI 10.1093/humrep/des152; Walker CG, 2013, BR J NUTR, P1; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230	42	117	118	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91806	10.1371/journal.pone.0091806	http://dx.doi.org/10.1371/journal.pone.0091806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632803	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400093
J	Kuhn, S; Lorenz, R; Banaschewski, T; Barker, GJ; Buechel, C; Conrod, PJ; Flor, H; Garavan, H; Ittermann, B; Loth, E; Mann, K; Nees, F; Artiges, E; Paus, T; Rietschel, M; Smolka, MN; Strohle, A; Walaszek, B; Schumann, G; Heinz, A; Gallinat, JR				Kuehn, Simone; Lorenz, Robert; Banaschewski, Tobias; Barker, Gareth J.; Buechel, Christian; Conrod, Patricia J.; Flor, Herta; Garavan, Hugh; Ittermann, Bernd; Loth, Eva; Mann, Karl; Nees, Frauke; Artiges, Eric; Paus, Tomas; Rietschel, Marcella; Smolka, Michael N.; Stroehle, Andreas; Walaszek, Bernadetta; Schumann, Gunter; Heinz, Andreas; Galliant, Juergen		Imagen Consortium	Positive Association of Video Game Playing with Left Frontal Cortical Thickness in Adolescents	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; PERCEPTUAL DECISION-MAKING; HUMAN CEREBRAL-CORTEX; NEURAL BASIS; SEGREGATION; EXPERIENCE; EFFICIENCY; MECHANISM; INFERENCE; DYNAMICS	Playing video games is a common recreational activity of adolescents. Recent research associated frequent video game playing with improvements in cognitive functions. Improvements in cognition have been related to grey matter changes in prefrontal cortex. However, a fine-grained analysis of human brain structure in relation to video gaming is lacking. In magnetic resonance imaging scans of 152 14-year old adolescents, FreeSurfer was used to estimate cortical thickness. Cortical thickness across the whole cortical surface was correlated with self-reported duration of video gaming (hours per week). A robust positive association between cortical thickness and video gaming duration was observed in left dorsolateral prefrontal cortex (DLPFC) and left frontal eye fields (FEFs). No regions showed cortical thinning in association with video gaming frequency. DLPFC is the core correlate of executive control and strategic planning which in turn are essential cognitive domains for successful video gaming. The FEFs are a key region involved in visuo-motor integration important for programming and execution of eye movements and allocation of visuo-spatial attention, processes engaged extensively in video games. The results may represent the biological basis of previously reported cognitive improvements due to video game play. Whether or not these results represent a-priori characteristics or consequences of video gaming should be studied in future longitudinal investigations.	[Kuehn, Simone; Stroehle, Andreas] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, B-9000 Ghent, Belgium; [Kuehn, Simone; Lorenz, Robert; Heinz, Andreas; Galliant, Juergen] Ghent Inst Funct & Metab Imaging, Ghent, Belgium; [Kuehn, Simone] Charite, Clin Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Banaschewski, Tobias] PTB, Berlin, Germany; [Barker, Gareth J.; Conrod, Patricia J.; Loth, Eva] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat, Mannheim, Germany; [Buechel, Christian; Schumann, Gunter] Kings Coll London, Inst Psychiat, London, England; [Flor, Herta; Nees, Frauke] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Garavan, Hugh] Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Mann, Karl] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Artiges, Eric] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, Mannheim, Germany; [Artiges, Eric] Univ Paris Sud, INSERM Unit Imaging & Psychiat, Inst Natl Sante Rech Med, Orsay, France; [Paus, Tomas] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, Paris, France; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rietschel, Marcella] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Smolka, Michael N.] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany; [Galliant, Juergen] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, D-01062 Dresden, Germany; [Galliant, Juergen] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany	Ghent University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB); Central Institute of Mental Health; University of London; King's College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Trinity College Dublin; Central Institute of Mental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Baycrest; McGill University; University of Nottingham; Central Institute of Mental Health; Technische Universitat Dresden; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kuhn, S (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, B-9000 Ghent, Belgium.	kuehn@mpib-berlin.mpg.de	Vollstädt-Klein, Sabine/C-6744-2012; Rapp, Michael/ABB-7573-2020; Banaschewski, Tobias/ABE-5985-2020; Conrod, Patricia J/P-4187-2018; Artiges, Eric/AAT-7219-2021; Artiges, Eric/C-2815-2019; Nees, Frauke/AAZ-2150-2020; Kuehn, Simone/P-6145-2014; Ströhle, Andreas/E-4286-2012; Barker, Gareth J/C-9616-2009; Smolka, Michael/B-4865-2011; Heinz, Andreas/ABB-7736-2020	Vollstädt-Klein, Sabine/0000-0002-6210-672X; Rapp, Michael/0000-0003-0106-966X; Banaschewski, Tobias/0000-0003-4595-1144; Artiges, Eric/0000-0003-4461-7646; Artiges, Eric/0000-0003-4461-7646; Barker, Gareth J/0000-0002-5214-7421; Smolka, Michael/0000-0001-5398-5569; Heinz, Andreas/0000-0001-5405-9065; Nees, Frauke/0000-0002-7796-8234; Flor, Herta/0000-0003-4809-5398; Kuhn, Simone/0000-0001-6823-7969; Loth, Eva/0000-0001-9458-9167	European Community [LSHM-CT-2007-037286]; UK Department of Health NIHR-Biomedical Research Centre 'Mental Health'; MRC program grant "Developmental pathways into adolescents' substance abuse"; Berliner Senatsverwaltung "Implikationen biopsychosozialer Grundlagen der Spielsucht fur Pravention und Therapie" Vergabe [002-2008/ I B 35]; BMBF [01 GQ 0914]; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G0901858, G9817803B] Funding Source: researchfish	European Community(European Commission); UK Department of Health NIHR-Biomedical Research Centre 'Mental Health'; MRC program grant "Developmental pathways into adolescents' substance abuse"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Berliner Senatsverwaltung "Implikationen biopsychosozialer Grundlagen der Spielsucht fur Pravention und Therapie" Vergabe; BMBF(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IMAGEN study receives research funding from the European Community's Sixth Framework Program (LSHM-CT-2007-037286) and is supported by the UK Department of Health NIHR-Biomedical Research Centre 'Mental Health' and the MRC program grant "Developmental pathways into adolescents' substance abuse." Project coordination: Gunter Schumann (Gunter.Schumann@iop.kcl.ac.uk), website: http://www.imagen-europe.com. Additional funding was provided by the Berliner Senatsverwaltung "Implikationen biopsychosozialer Grundlagen der Spielsucht fur Pravention und Therapie" Vergabe-Nr. 002-2008/ I B 35 and BMBF 01 GQ 0914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Cannonieri GC, 2007, NEUROREPORT, V18, P1063, DOI 10.1097/WNR.0b013e3281a030e5; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Goel V, 2000, J COGNITIVE NEUROSCI, V12, P110, DOI 10.1162/08989290051137639; GOLDBERG E, 1994, J COGNITIVE NEUROSCI, V6, P276, DOI 10.1162/jocn.1994.6.3.276; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2010, CURR BIOL, V20, P1573, DOI 10.1016/j.cub.2010.07.040; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Groussard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013225; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kirsh SJ, 2007, AGGRESSIVE BEHAV, V33, P353, DOI 10.1002/ab.20191; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Kuhn S., 2013, MOL PSYCHIAT; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Lobel E, 2001, J NEUROSURG, V95, P804, DOI 10.3171/jns.2001.95.5.0804; Lovden M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.013; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Lynch J, 2010, J SURG EDUC, V67, P184, DOI 10.1016/j.jsurg.2010.02.010; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; Schmidt-Wilcke T, 2010, NEUROIMAGE, V51, P1234, DOI 10.1016/j.neuroimage.2010.03.042; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Spence I, 2009, J EXP PSYCHOL LEARN, V35, P1097, DOI 10.1037/a0015641; Talairach J., 1988, COPLANAR STEREOTAXIC; Wolfling K, 2011, PSYCHOTHER PSYCH MED, V61, P216, DOI 10.1055/s-0030-1263145; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055	57	57	57	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91506	10.1371/journal.pone.0091506	http://dx.doi.org/10.1371/journal.pone.0091506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633348	Green Published, gold			2022-12-25	WOS:000332858400065
J	Lee, FY; Wang, SS; Tsai, MH; Huang, HC; Lin, HC; Lee, SD				Lee, Fa-Yauh; Wang, Sun-Sang; Tsai, Ming-Hung; Huang, Hui-Chun; Lin, Han-Chieh; Lee, Shou-Dong			Adrenal Dysfunction in Portal Hypertensive Rats with Acute Hemorrhage	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; SEPTIC SHOCK; SPLANCHNIC HYPOSENSITIVITY; HYPERDYNAMIC CIRCULATION; VASCULAR HYPOREACTIVITY; ADRENALECTOMIZED RATS; ARTERIAL-PRESSURE; CIRRHOTIC RATS; INSUFFICIENCY	Nitric oxide (NO) participates in shock and poorer portal hypotensive effect to vasoconstrictors in portal hypertension with hemorrhage, the so-called splanchnic hyposensitivity. Relative adrenal insufficiency accompanies hemorrhagic shock and is found in liver disease, the 'hepatoadrenal syndrome', but the relevant interactions remain unsettled. Portal hypertensive rats were induced by partial portal vein ligation (PVL). Experiments were performed on the 14th day post PVL: (I) ACTH stimulation test for rats without or with hemorrhage; (II) Glypressin response (mean arterial pressure, MAP; portal pressure, PP) in rats (a) without hemorrhage or with hemorrhage, injected with (b) distilled water (DW), (c) dexamethasone 3 mg/kg; (III) To survey the dose-dependent effects of glucocorticoid without being confounded by endogenous adrenal hormone, glypressin response was surveyed in PVL rats with adrenalectomy: (a) without hemorrhage or with hemorrhage, injected with (b) DW; (c) dexamethasone 3 mg/kg; (d) dexamethasone 5 mg/kg. Plasma tumor necrosis factor-alpha (TNF-alpha) concentrations and abdominal aorta (AA), superior mesenteric artery (SMA) NO synthases (NOS) mRNA expressions were determined. The results showed that ACTH induced corticosterone release similarly in PVL rats with or without hemorrhage. In bleeding PVL rats, dexamethasone (1) down-regulated AA NOS and enhanced glypressin-induced MAP elevation; (2) did not influence glypressin-induced PP reduction; (3) reduced TNF-alpha. In bleeding PVL and adrenalectomized rats, high-dose dexamethasone (1) down-regulated AA/SMA NOS; (2) enhanced glypressin-induced MAP elevation and PP reduction; (3) reduced TNF-alpha. In conclusion, bleeding portal hypertensive rats failed to enhance corticosterone release, suggesting a relative adrenal insufficiency. High-dose dexamethasone reversed systemic hypotension and splanchnic hyporesponsiveness to glypressin in adrenalectomized PVL rats accompanied by TNF-alpha and NOS down-regulation, suggesting the importance of adequate adrenocorticoid supplement in portal hypertension with hemorrhage and adrenal dysfunction.	[Lee, Fa-Yauh; Wang, Sun-Sang; Huang, Hui-Chun; Lin, Han-Chieh; Lee, Shou-Dong] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Lee, Fa-Yauh; Huang, Hui-Chun; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wang, Sun-Sang] Taipei Vet Gen Hosp, Dept Med Affair & Planning, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Tsai, Ming-Hung] Chang Gung Mem Hosp, Div Digest Therapeut Endoscopy, Taipei 10591, Taiwan; [Tsai, Ming-Hung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Tsai, MH (corresponding author), Chang Gung Mem Hosp, Div Digest Therapeut Endoscopy, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	mhtsai@adm.cgmh.org.tw; hchuang2@vghtpe.gov.tw			National Science Council, Taiwan [NSC 99-2314-B-182A-072-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 99-2314-B-182A-072-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; AYALA A, 1990, Cytokine, V2, P170, DOI 10.1016/1043-4666(90)90012-I; Bellissant E, 2000, CLIN PHARMACOL THER, V68, P293, DOI 10.1067/mcp.2000.109354; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; BUTLER DG, 1985, COMP BIOCHEM PHYS A, V81, P353; CATALANO RD, 1984, ARCH SURG-CHICAGO, V119, P145; Chan CC, 1999, HEPATOLOGY, V30, P630, DOI 10.1002/hep.510300317; Chen YC, 2005, J AM SOC NEPHROL, V16, P2864, DOI 10.1681/ASN.2004110944; Chu C J, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P145; Chu CJ, 1998, CLIN SCI, V95, P629, DOI 10.1042/cs0950629; Chu CJ, 2000, CLIN SCI, V99, P475, DOI 10.1042/CS20000067; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145; DARLINGTON DN, 1989, AM J PHYSIOL, V256, pH1274, DOI 10.1152/ajpheart.1989.256.5.H1274; DORIN RI, 1988, CRIT CARE MED, V16, P296, DOI 10.1097/00003246-198803000-00019; Fernandez J, 2006, HEPATOLOGY, V44, P1288, DOI 10.1002/hep.21352; GRUNFELD JP, 1987, HYPERTENSION, V10, P608, DOI 10.1161/01.HYP.10.6.608; HADDY FJ, 1965, AM J PHYSIOL, V208, P169, DOI 10.1152/ajplegacy.1965.208.1.169; Hamet P, 1983, HYPERTENSION, P964; Huang HC, 2003, EUR J CLIN INVEST, V33, P505, DOI 10.1046/j.1365-2362.2003.01162.x; Huang Hui-Chun, 2004, J Chin Med Assoc, V67, P268; IMMS FJ, 1974, ARCH INT PHARMACOD T, V207, P9; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; KRAVETZ D, 1987, GASTROENTEROLOGY, V93, P170, DOI 10.1016/0016-5085(87)90330-1; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Liu LM, 2005, J SURG RES, V125, P128, DOI 10.1016/j.jss.2004.12.008; Marik PE, 2005, CRIT CARE MED, V33, P1254, DOI 10.1097/01.CCM.0000164541.12106.57; MONCADA S, 1991, PHARMACOL REV, V43, P109; PALLER MS, 1984, AM J PHYSIOL, V246, pH25, DOI 10.1152/ajpheart.1984.246.1.H25; PIZCUETA P, 1992, GASTROENTEROLOGY, V103, P1909, DOI 10.1016/0016-5085(92)91451-9; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P151, DOI 10.1210/jc.77.1.151; RUBANYI GM, 1990, BLOOD VESSELS, V27, P246; Rushing GD, 2006, AM SURGEON, V72, P552; Skimming JW, 2003, AM J PHYSIOL-LUNG C, V285, pL484, DOI 10.1152/ajplung.00433.2002; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; Tsai MH, 2006, HEPATOLOGY, V43, P673, DOI 10.1002/hep.21101; Tsai MH, 2005, UPDATE TREATMENT LIV, P3; WAAGE A, 1987, CLIN IMMUNOL IMMUNOP, V45, P348, DOI 10.1016/0090-1229(87)90087-0; Wagner C, 2007, AM J PHYSIOL-REG I, V293, pR1781, DOI 10.1152/ajpregu.00439.2007; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; Wang P, 1999, ARCH SURG-CHICAGO, V134, P394, DOI 10.1001/archsurg.134.4.394; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; YAGIL Y, 1988, HYPERTENSION, V11, P174, DOI 10.1161/01.HYP.11.2.174; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483; ZINGARELLI B, 1994, AM J PHYSIOL, V266, pH1512, DOI 10.1152/ajpheart.1994.266.4.H1512; ZINGARELLI B, 1994, SHOCK, V2, P210, DOI 10.1097/00024382-199409000-00009	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92093	10.1371/journal.pone.0092093	http://dx.doi.org/10.1371/journal.pone.0092093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633079	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400141
J	Mockett, RJ; Matsumoto, Y				Mockett, Robin J.; Matsumoto, Yuri			Effect of Prolonged Coldness on Survival and Fertility of Drosophila melanogaster	PLOS ONE			English	Article							TEMPERATURE; LIFE; CRYOPRESERVATION; DIAPAUSE; HISTORY; EMBRYOS; FLIES; RATES; SHOCK	The laboratory fruit fly, Drosophila melanogaster, is used widely in biological research, but the requirement to maintain stocks with a roughly biweekly generation time imposes substantial burdens of labor, potential cross-contamination and mutation accumulation. The purpose of this study was to assess the impact of prolonged cold stress or milder cooling on survivorship and fertility. The hypothesis was that cold storage would result in postponement of reproduction and a longer generation time. Flies of several genotypes were maintained continuously at 4-11 degrees C; recovery rates and subsequent yields of adult progeny were recorded. Adults and pupae of a relatively long-lived y w lineage were more resistant to severe cold stress than embryos and larvae. Adults exhibited minimal mortality up to at least 5 d at 4 degrees C, 20 d at 8 degrees C and 12 weeks at 11 degrees C. Reproduction did not occur at these temperatures, but progeny were obtained after recovery at 25 degrees C. At all temperatures, chilling caused a rapid, severe and progressive decrease in fertility during the first 2 d of recovery. The impact on fertility during the subsequent 2-4 d was much milder and it occurred only after prolonged incubation at low temperatures. The total reproductive output during the first 6 d of recovery was sufficient to replace the parental population after 12 weeks at 11 degrees C. Food spoilage had an unexpectedly low impact on survivorship and fertility, and the reproductive output of F1 progeny was not affected by storing parental flies at 11 degrees C for 8-10 weeks. In the case of w(1118) flies, replacement of the parents within 6 d of recovery was possible for up to 60 d at 11 degrees C. Among less fertile genotypes, replacement of the parents was possible within 18 d after 4-10 weeks at 11 degrees C. These results show that the 2-week maintenance interval of stocks of D. melanogaster can be extended 3-7 fold, at least for 1 generation, by storing adult flies at 11 degrees C.	[Mockett, Robin J.; Matsumoto, Yuri] Univ S Alabama, Dept Biomed Sci, Mobile, AL 36688 USA	University of South Alabama	Mockett, RJ (corresponding author), Univ S Alabama, Dept Biomed Sci, Mobile, AL 36688 USA.	mockett@southalabama.edu			College of Allied Health Professions, University of South Alabama	College of Allied Health Professions, University of South Alabama	This project was supported by the College of Allied Health Professions, University of South Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anxolabehere D, 1970, Bull. Soc. zool. Fr., V95, P61; Anxolabehere D, 1970, DROS INF SERV, V45, P78; ASHBURNER M, 1992, SCIENCE, V258, P1896, DOI 10.1126/science.1470912; Ashburner M., 2005, DROSOPHILA LAB HDB, P122; Ashburner M., 1978, GENETICS BIOL DROS A, P1; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; DAVID J, 1969, ANN SOC ENTOMOL FR, V5, P161; Dillon ME, 2007, J EXP BIOL, V210, P2897, DOI 10.1242/jeb.007591; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Houle D, 1997, GENET RES, V69, P209, DOI 10.1017/S0016672397002760; Kelty JD, 1999, J INSECT PHYSIOL, V45, P719, DOI 10.1016/S0022-1910(99)00040-2; Kim K, 2010, EXP GERONTOL, V45, P984, DOI 10.1016/j.exger.2010.08.033; KIMURA MT, 1988, EVOLUTION, V42, P1288, DOI 10.1111/j.1558-5646.1988.tb04188.x; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Lerman DN, 2001, J EXP BIOL, V204, P315; Lindsley DL, 1992, GENOME DROSOPHILA ME, P138; Loeb J, 1917, J BIOL CHEM, V32, P103; MacAlpine JLP, 2011, J INSECT PHYSIOL, V57, P35, DOI 10.1016/j.jinsphys.2010.09.003; MAZUR P, 1992, SCIENCE, V258, P1932, DOI 10.1126/science.1470915; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Mitchell KA, 2013, NATURWISSENSCHAFTEN, V100, P281, DOI 10.1007/s00114-013-1023-8; Mockett RJ, 2012, MECH AGEING DEV, V133, P359, DOI 10.1016/j.mad.2012.04.002; Nilson TL, 2006, J INSECT PHYSIOL, V52, P1027, DOI 10.1016/j.jinsphys.2006.07.001; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Rako L, 2009, J EVOLUTION BIOL, V22, P2438, DOI 10.1111/j.1420-9101.2009.01852.x; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; STEPONKUS PL, 1990, NATURE, V345, P170, DOI 10.1038/345170a0; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Zajitschek F, 2013, AGE, V35, P1193, DOI 10.1007/s11357-012-9445-3	37	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92228	10.1371/journal.pone.0092228	http://dx.doi.org/10.1371/journal.pone.0092228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632815	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400154
J	Montiel, EE; Cabrero, J; Ruiz-Estevez, M; Burke, WD; Eickbush, TH; Camacho, JPM; Lopez-Leon, MD				Montiel, Eugenia E.; Cabrero, Josefa; Ruiz-Estevez, Mercedes; Burke, William D.; Eickbush, Thomas H.; Camacho, Juan Pedro M.; Lopez-Leon, Maria Dolores			Preferential Occupancy of R2 Retroelements on the B Chromosomes of the Grasshopper Eyprepocnemis plorans	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; NON-LTR RETROTRANSPOSONS; RDNA LOCUS; REVERSE TRANSCRIPTION; NUCLEOLAR ORGANIZER; CHROMATIN-STRUCTURE; NORTH-AFRICA; ELEMENTS; DNA; GENOME	R2 non-LTR retrotransposons exclusively insert into the 28S rRNA genes of their host, and are expressed by co-transcription with the rDNA unit. The grasshopper Eyprepocnemis plorans contains transcribed rDNA clusters on most of its A chromosomes, as well as non-transcribed rDNA clusters on the parasitic B chromosomes found in many populations. Here the structure of the E. plorans R2 element, its abundance relative to the number of rDNA units and its retrotransposition activity were determined. Animals screened from five populations contained on average over 12,000 rDNA units on their A chromosomes, but surprisingly only about 100 R2 elements. Monitoring the patterns of R2 insertions in individuals from these populations revealed only low levels of retrotransposition. The low rates of R2 insertion observed in E. plorans differ from the high levels of R2 insertion previously observed in insect species that have many fewer rDNA units. It is proposed that high levels of R2 are strongly selected against in E. plorans, because the rDNA transcription machinery in this species is unable to differentiate between R2-inserted and uninserted units. The B chromosomes of E. plorans contain an additional 7,000 to 15,000 rDNA units, but in contrast to the A chromosomes, from 150 to over 1,500 R2 elements. The higher concentration of R2 in the inactive B chromosomes rDNA clusters suggests these chromosomes can act as a sink for R2 insertions thus further reducing the level of insertions on the A chromosomes. These studies suggest an interesting evolutionary relationship between the parasitic B chromosomes and R2 elements.	[Montiel, Eugenia E.; Cabrero, Josefa; Ruiz-Estevez, Mercedes; Camacho, Juan Pedro M.; Lopez-Leon, Maria Dolores] Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain; [Burke, William D.; Eickbush, Thomas H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Granada; University of Rochester	Lopez-Leon, MD (corresponding author), Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain.	mdlopez@ugr.es	Jimenez, Eugenia E Montiel/I-2936-2015; Burke, William/C-1203-2012; Camacho, Juan Pedro M/L-6869-2014; Cabrero, Josefa/L-8899-2014; López-León, María Dolores/L-9026-2014	Jimenez, Eugenia E Montiel/0000-0002-2461-9268; Camacho, Juan Pedro M/0000-0002-2507-9814; Cabrero, Josefa/0000-0002-5848-6985; López-León, María Dolores/0000-0003-2337-7313	Spanish Ministerio de Ciencia y Tecnologia [CGL2009-11917]; Plan Andaluz de Investigacion [CVI-6649]; FEDER funds; National Institutes of Health [GM42790]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Andaluz de Investigacion; FEDER funds(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (CGL2009-11917) and Plan Andaluz de Investigacion (CVI-6649), and was partially performed by FEDER funds and a grant from the National Institutes of Health (GM42790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachtrog D, 2003, MOL BIOL EVOL, V20, P173, DOI 10.1093/molbev/msg035; Bakkali M, 2004, HEREDITY, V92, P428, DOI 10.1038/sj.hdy.6800437; Bakkali M, 2002, HEREDITY, V88, P14, DOI 10.1038/sj.hdy.6800002; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; CABRERO J, 1987, GENOME, V29, P116, DOI 10.1139/g87-020; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; CAMACHO JPM, 1991, GENOME, V34, P638, DOI 10.1139/g91-097; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Christensen SM, 2005, MOL CELL BIOL, V25, P6617, DOI 10.1128/MCB.25.15.6617-6628.2005; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; Darlington CD., 1958, EVOLUTION GENETIC SY; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066441; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Eickbush MT, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-11; EICKBUSH TH, 1985, EMBO J, V4, P2281, DOI 10.1002/j.1460-2075.1985.tb03927.x; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feng JL, 2008, BIOTECHNIQUES, V44, P901, DOI 10.2144/000112750; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; George JA, 1996, GENETICS, V142, P853; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HENRIQUESGIL N, 1990, EVOLUTION, V44, P747, DOI [10.1111/j.1558-5646.1990.tb05952.x, 10.2307/2409449]; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; JAKUBCZAK JL, 1992, GENETICS, V131, P129; JAKUBCZAK JL, 1991, P NATL ACAD SCI USA, V88, P3295, DOI 10.1073/pnas.88.8.3295; Jamburuthugoda VK, 2011, J MOL BIOL, V407, P661, DOI 10.1016/j.jmb.2011.02.015; Jones RN, 1985, EVOLUTION GENOME SIZ, P397; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2005, GENOME RES, V15, P1106, DOI 10.1101/gr.3271405; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Lamb JC, 2007, CHROMOSOME RES, V15, P383, DOI 10.1007/s10577-007-1135-0; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; LOPEZLEON MD, 1993, HEREDITY, V71, P352, DOI 10.1038/hdy.1993.149; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; McAllister BF, 1997, MOL BIOL EVOL, V14, P69, DOI 10.1093/oxfordjournals.molbev.a025704; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Montiel EE, 2012, GENETICA, V140, P365, DOI 10.1007/s10709-012-9686-1; NUR U, 1977, GENETICS, V87, P499; NUR U, 1966, GENETICS, V54, P1239; OSTERGREN G., 1945, Botaniska Notiser, P157; Parkin EJ, 2004, MOL BIOL EVOL, V21, P1595, DOI 10.1093/molbev/msh163; Perez-Gonzalez CE, 2002, GENETICS, V162, P799; Perez-Gonzalez CE, 2001, GENETICS, V158, P1557; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P338, DOI 10.1159/000079309; PLOWMAN AB, 1994, HEREDITY, V72, P587, DOI 10.1038/hdy.1994.81; Randolph L, 1928, ANAT REC, V41, P102; Rezende-Teixeira P, 2009, CHROMOSOME RES, V17, P455, DOI 10.1007/s10577-009-9038-x; ROIHA H, 1981, NATURE, V290, P749, DOI 10.1038/290749a0; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; RUFAS JS, 1982, ARCH BIOL, V93, P267; Ruiz-Estevez M, 2013, GENETICA, V141, P337, DOI 10.1007/s10709-013-9733-6; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; Ruiz-Ruano FJ, 2011, CYTOGENET GENOME RES, V134, P120, DOI 10.1159/000324690; SCHAFER M, 1987, DEV BIOL, V120, P418, DOI 10.1016/0012-1606(87)90245-4; Shaw M.W., 1990, Oxford Surveys in Evolutionary Biology, V7, P197; Teruel M, 2007, CHROMOSOME RES, V15, P755, DOI 10.1007/s10577-007-1159-5; Teruel M, 2009, CHROMOSOMA, V118, P291, DOI 10.1007/s00412-008-0197-x; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; Theuri J, 2005, CYTOGENET GENOME RES, V110, P203, DOI 10.1159/000084953; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; White W, 1973, ANIMAL CYTOLOGY EVOL; Wilson E, 1907, SCIENCE, V26, P870, DOI [10.1126/science.26.677.870-a, DOI 10.1126/SCIENCE.26.660.258]; Yang J, 1999, P NATL ACAD SCI USA, V96, P7847, DOI 10.1073/pnas.96.14.7847; Ye JQ, 2006, MOL CELL BIOL, V26, P8781, DOI 10.1128/MCB.01409-06; Zhang X, 2005, GENETICS, V170, P195, DOI 10.1534/genetics.104.038703; Zhang X, 2008, MOL BIOL EVOL, V25, P229, DOI 10.1093/molbev/msm250; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179; Zhou J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000386; Ziegler CG, 2003, CHROMOSOME RES, V11, P23, DOI 10.1023/A:1022053931308; Zurita S, 1998, EVOLUTION, V52, P274, DOI 10.1111/j.1558-5646.1998.tb05163.x	81	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91820	10.1371/journal.pone.0091820	http://dx.doi.org/10.1371/journal.pone.0091820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632855	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400099
J	Peters, I; Dubrowinskaja, N; Abbas, M; Seidel, C; Kogosov, M; Scherer, R; Gebauer, K; Merseburger, AS; Kuczyk, MA; Grunwald, V; Serth, J				Peters, Inga; Dubrowinskaja, Natalia; Abbas, Mahmoud; Seidel, Christoph; Kogosov, Michael; Scherer, Ralph; Gebauer, Kai; Merseburger, Axel S.; Kuczyk, Markus A.; Gruenwald, Viktor; Serth, Juergen			DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies	PLOS ONE			English	Article							FACTOR-TARGETED THERAPY; PROGNOSTIC-FACTORS; CARCINOMA; RECURRENCE; SUNITINIB; MODELS	VEGF-targeted therapy increases both the progression-free (PFS) and overall survival (OS) of patients with metastasized renal cell cancer (mRCC). Identification of molecular phenotypes of RCC could improve risk-stratification and the prediction of the clinical disease course. We investigated whether gene-specific DNA hypermethylation can predict PFS and OS among patients undergoing anti-VEGF-based therapy. Primary tumor tissues from 18 patients receiving targeted therapy were examined retrospectively using quantitative methylation-specific PCR analysis of CST6, LAD1, hsa-miR-124-3, and hsa-miR-91 CpG islands. PFS and OS were analyzed for first-line and sequential antiangiogenic therapies using the log rank statistics. Sensitivity and specificity were determined for predicting first-line therapy failure. Hypermethylation of CST6 and LAD1 was associated with both a shortened PFS (log rank p = 0.009 and p = 0.004) and OS (p = 0.011 and p = 0.043). The median PFS observed for the high and low methylation groups of CST6 and LAD1 was 2.0 vs. 11.4 months. LAD1 methylation had a specificity of 1.0 (95% CI 0.65-1.0) and a sensitivity of 0.73 (95% CI 0.43-0.90) for the prediction of first-line therapy. CST6 and LAD1 methylation are candidate epigenetic biomarkers showing unprecedented association with PFS and OS as well as specificity for the prediction of the response to therapy. DNA methylation markers should be considered for the prospective evaluation of larger patient cohorts in future studies.	[Peters, Inga; Dubrowinskaja, Natalia; Kogosov, Michael; Gebauer, Kai; Merseburger, Axel S.; Kuczyk, Markus A.; Serth, Juergen] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Abbas, Mahmoud] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Seidel, Christoph] Univ Med Ctr Eppendorf, Dept Oncol Hematol Bone MarrowTransplantat Pneumo, Hamburg, Germany; [Scherer, Ralph] Hannover Med Sch, Dept Biometry, Hannover, Germany; [Gruenwald, Viktor] Hannover Med Sch, Clin Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	Hannover Medical School; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School	Serth, J (corresponding author), Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany.	serth.juergen@mh-hannover.de						Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Galsky MD, 2013, LANCET ONCOL, V14, P102, DOI 10.1016/S1470-2045(12)70581-8; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gebauer K, 2013, BRIT J CANCER, V108, P131, DOI 10.1038/bjc.2012.537; Gigante M, 2012, ANTICANCER RES, V32, P5447; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Jemal A, 2011, CA CANC J CLIN; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Knox JJ, 2008, LANCET, V372, P427, DOI 10.1016/S0140-6736(08)61040-5; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Morris MR, 2003, ONCOGENE, V22, P6794, DOI 10.1038/sj.onc.1206914; Morris MR, 2010, ONCOGENE, V30, P1390; Motoki K, 1997, GENOMICS, V39, P323, DOI 10.1006/geno.1996.4507; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nickerson P, 2008, CLIN LAB MED, V28, P455, DOI 10.1016/j.cll.2008.09.003; Seidel C, 2012, EUR J CANCER, V48, P1023, DOI 10.1016/j.ejca.2012.02.048; Skolarikos AA, 2006, AM J NEPHROL, V26, P218, DOI 10.1159/000093631; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Team R. D. C, 2011, R LANG ENV STAT COMP; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987	30	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91440	10.1371/journal.pone.0091440	http://dx.doi.org/10.1371/journal.pone.0091440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633192	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400062
J	Phan, JA; Kicic, A; Berry, LJ; Fernandes, LB; Zosky, GR; Sly, PD; Larcombe, AN				Phan, Jennifer A.; Kicic, Anthony; Berry, Luke J.; Fernandes, Lynette B.; Zosky, Graeme R.; Sly, Peter D.; Larcombe, Alexander N.			Rhinovirus Exacerbates House-Dust-Mite Induced Lung Disease in Adult Mice	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; SUBJECTS IN-VIVO; ASTHMATIC SUBJECTS; CHRONIC BRONCHITIS; EPITHELIAL-CELLS; INDUCED SPUTUM; MOUSE MODELS; MURINE MODEL; INFECTION; CHILDREN	Human rhinovirus is a key viral trigger for asthma exacerbations. To date, murine studies investigating rhinovirus-induced exacerbation of allergic airways disease have employed systemic sensitisation/intranasal challenge with ovalbumin. In this study, we combined human-rhinovirus infection with a clinically relevant mouse model of aero-allergen exposure using house-dust-mite in an attempt to more accurately understand the links between human-rhinovirus infection and exacerbations of asthma. Adult BALB/c mice were intranasally exposed to low-dose house-dust-mite (or vehicle) daily for 10 days. On day 9, mice were inoculated with human-rhinovirus-1B (or UV-inactivated human-rhinovirus-1B). Forty-eight hours after inoculation, we assessed bronchoalveolar cellular inflammation, levels of relevant cytokines/serum antibodies, lung function and responsiveness/sensitivity to methacholine. House-dust-mite exposure did not result in a classical TH2-driven response, but was more representative of noneosinophilic asthma. However, there were significant effects of house-dust-mite exposure on most of the parameters measured including increased cellular inflammation (primarily macrophages and neutrophils), increased total IgE and house-dust-mite-specific IgG(1) and increased responsiveness/sensitivity to methacholine. There were limited effects of human-rhinovirus-1B infection alone, and the combination of the two insults resulted in additive increases in neutrophil levels and lung parenchymal responses to methacholine (tissue elastance). We conclude that acute rhinovirus infection exacerbates house-dust-mite-induced lung disease in adult mice. The similarity of our results using the naturally occurring allergen house-dust-mite, to previous studies using ovalbumin, suggests that the exacerbation of allergic airways disease by rhinovirus infection could act via multiple or conserved mechanisms.	[Phan, Jennifer A.; Kicic, Anthony; Berry, Luke J.; Zosky, Graeme R.; Larcombe, Alexander N.] Univ Western Australia, Telethon Inst Child Hlth Res, Div Clin Sci, Subiaco, WA, Australia; [Phan, Jennifer A.; Fernandes, Lynette B.] Univ Western Australia, Sch Med & Pharmacol, Pharmacol Pharm & Anaesthesiol Unit, Crawley, WA, Australia; [Kicic, Anthony; Berry, Luke J.; Zosky, Graeme R.; Larcombe, Alexander N.] Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia; [Kicic, Anthony] Princess Margaret Hosp, Dept Resp Med, Perth, WA, Australia; [Kicic, Anthony] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Crawley, WA, Australia; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Queensland	Larcombe, AN (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Div Clin Sci, Subiaco, WA, Australia.	alexanderl@ichr.uwa.edu.au	Larcombe, Alexander/AAG-8533-2019; Sly, Peter D/F-1486-2010; Kicic, Anthony/ABA-1252-2021; Fernandes, Lynette/H-9175-2014	Larcombe, Alexander/0000-0003-4196-4482; Sly, Peter D/0000-0001-6305-2201; Kicic, Anthony/0000-0002-0008-9733; Fernandes, Lynette/0000-0003-3768-1340; Zosky, Graeme/0000-0001-9039-0302	Australian Research Council [DP110101706]	Australian Research Council(Australian Research Council)	This project was supported by an Australian Research Council (www.arc.gov.au) Discovery Project Grant (DP110101706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bates JHT, 2003, J APPL PHYSIOL, V94, P1297, DOI 10.1152/japplphysiol.00706.2002; Bates JHT, 2002, J APPL PHYSIOL, V93, P705, DOI 10.1152/japplphysiol.01274.2001; Birrell MA, 2010, EUR RESPIR J, V36, P1220, DOI 10.1183/09031936.00069110; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busse WW, 1997, J ALLERGY CLIN IMMUN, V100, P147, DOI 10.1016/S0091-6749(97)70216-1; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; CHEUNG D, 1995, AM J RESP CRIT CARE, V152, P1490, DOI 10.1164/ajrccm.152.5.7582282; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; EADIE MB, 1966, BMJ-BRIT MED J, V2, P671, DOI 10.1136/bmj.2.5515.671; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408, DOI 10.1152/jappl.1989.67.6.2408; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hershenson MB, 2013, SCIENTIFICA, V2013, P12; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1997, J INFECT DIS, V175, P323, DOI 10.1093/infdis/175.2.323; Kimb KW, 1995, J ALLERGY CLIN IMMUN, V95, P843; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Kuypers J, 2010, EXPERT REV MOL DIAGN, V10, P395, DOI [10.1586/erm.10.38, 10.1586/ERM.10.38]; LAMBERT HP, 1972, BMJ-BRIT MED J, V3, P323, DOI 10.1136/bmj.3.5822.323; Larcombe AN, 2011, INFLUENZA OTHER RESP, V5, P334, DOI 10.1111/j.1750-2659.2011.00236.x; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Lloyd CM, 2007, CURR ALLERGY ASTHM R, V7, P231, DOI 10.1007/s11882-007-0077-0; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Norzila MZ, 2000, AM J RESP CRIT CARE, V161, P769, DOI 10.1164/ajrccm.161.3.9809071; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Pizzichini MMM, 1998, AM J RESP CRIT CARE, V158, P1178, DOI 10.1164/ajrccm.158.4.9712082; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; RUECKERT RR, 1996, FIELDS VIROLOGY, V1, P609; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; SHERRY B, 1985, J VIROL, V53, P137, DOI 10.1128/JVI.53.1.137-143.1985; STENHOUSE AC, 1967, BMJ-BRIT MED J, V3, P461, DOI 10.1136/bmj.3.5563.461; Tuthill TJ, 2003, J GEN VIROL, V84, P2829, DOI 10.1099/vir.0.19109-0; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wilder JA, 1999, AM J RESP CELL MOL, V20, P1326, DOI 10.1165/ajrcmb.20.6.3561; Zosky GR, 2009, AM J PHYSIOL-LUNG C, V297, pL373, DOI 10.1152/ajplung.00053.2009	63	25	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92163	10.1371/journal.pone.0092163	http://dx.doi.org/10.1371/journal.pone.0092163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632596	Green Submitted, gold, Green Published			2022-12-25	WOS:000332858400147
J	Fernandez, JA; Bankhead, P; Zhou, HY; McGeown, JG; Curtis, TM				Fernandez, Jose A.; Bankhead, Peter; Zhou, Huiyu; McGeown, J. Graham; Curtis, Tim M.			Automated Detection and Measurement of Isolated Retinal Arterioles by a Combination of Edge Enhancement and Cost Analysis	PLOS ONE			English	Article							COMPUTER-BASED METHOD; CEREBRAL-ARTERIES; PHOSPHORYLATION; PHYSIOLOGY; AGREEMENT; CHANNELS; KINASE; BRAIN; CELL	Pressure myography studies have played a crucial role in our understanding of vascular physiology and pathophysiology. Such studies depend upon the reliable measurement of changes in the diameter of isolated vessel segments over time. Although several software packages are available to carry out such measurements on small arteries and veins, no such software exists to study smaller vessels (<50 mu m in diameter). We provide here a new, freely available open-source algorithm, MyoTracker, to measure and track changes in the diameter of small isolated retinal arterioles. The program has been developed as an ImageJ plug-in and uses a combination of cost analysis and edge enhancement to detect the vessel walls. In tests performed on a dataset of 102 images, automatic measurements were found to be comparable to those of manual ones. The program was also able to track both fast and slow constrictions and dilations during intraluminal pressure changes and following application of several drugs. Variability in automated measurements during analysis of videos and processing times were also investigated and are reported. MyoTracker is a new software to assist during pressure myography experiments on small isolated retinal arterioles. It provides fast and accurate measurements with low levels of noise and works with both individual images and videos. Although the program was developed to work with small arterioles, it is also capable of tracking the walls of other types of microvessels, including venules and capillaries. It also works well with larger arteries, and therefore may provide an alternative to other packages developed for larger vessels when its features are considered advantageous.	[Fernandez, Jose A.; McGeown, J. Graham; Curtis, Tim M.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Bankhead, Peter] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Zhou, Huiyu] Queens Univ Belfast, Sch Elect Elect Engn & Comp Sci, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast	Fernandez, JA (corresponding author), Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland.	jfernandezgonzalez01@qub.ac.uk	Curtis, Tim/AEU-9750-2022; Zhou, Huiyu/O-2692-2014; Bankhead, Peter/AAA-7915-2020	Zhou, Huiyu/0000-0003-1634-9840; Bankhead, Peter/0000-0003-4851-8813; Curtis, Tim/0000-0003-1543-2781	British Heart Foundation [PG/11/94/29169]; Biotechnology and Biological Sciences Research Council [BB/I026359/1]; BBSRC [BB/I026359/1] Funding Source: UKRI; EPSRC [EP/H049606/1, EP/J006238/1, EP/G034303/1, EP/K004379/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G034303/1, EP/K004379/1, EP/H049606/1, EP/J006238/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the British Heart Foundation (Grant number: PG/11/94/29169) and the Biotechnology and Biological Sciences Research Council (Grant number: BB/I026359/1) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burke M, 2013, CURR VASC P IN PRESS; Chan SL, 2013, FASEB J IN PRESS; Chan YC, 2010, ARTERIOSCL THROM VAS, V30, P992, DOI 10.1161/ATVBAHA.110.203935; Chan YC, 2012, PHARMACOL RES, V65, P182, DOI 10.1016/j.phrs.2011.09.010; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; Dabertrand F, 2012, CIRC RES, V110, P285, DOI 10.1161/CIRCRESAHA.111.258145; Davis Michael J., 2006, Lymphatic Research and Biology, V4, P3, DOI 10.1089/lrb.2006.4.3; Davis MJ, 2012, MICROCIRCULATION, V19, P99, DOI 10.1111/j.1549-8719.2011.00131.x; Davis MJ, 2005, MICROCIRCULATION, V12, P361, DOI 10.1080/10739680590934772; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Fike CD, 2012, NEONATOLOGY, V101, P28, DOI 10.1159/000326270; Gokina NI, 2002, AM J PHYSIOL-HEART C, V282, pH1410, DOI 10.1152/ajpheart.00441.2001; Grande G, 2013, CEPHALALGIA, V33, P152, DOI 10.1177/0333102412468340; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hein TW, 2012, INVEST OPHTH VIS SCI, V53, P7943, DOI 10.1167/iovs.12-11005; Hinds K, 2013, INVEST OPHT IN PRESS; Howitt L, 2011, AM J PHYSIOL-HEART C, V301, pH29, DOI 10.1152/ajpheart.00134.2011; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Izzard AS, 2013, CURR VASC P IN PRESS; Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173; Kim S, 2006, MICROCIRCULATION, V13, P199, DOI 10.1080/10739680600556878; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; McGahon MK, 2007, AM J PHYSIOL-HEART C, V292, pH1001, DOI 10.1152/ajpheart.01003.2006; Nepiyushchikh ZV, 2011, J PHYSIOL-LONDON, V589, P5415, DOI 10.1113/jphysiol.2011.218446; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palomares SM, 2013, CURR VASC P IN PRESS; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Puro DG, 2012, PROG RETIN EYE RES, V31, P258, DOI 10.1016/j.preteyeres.2012.01.001; Scholfield CN, 2007, MICROCIRCULATION, V14, P11, DOI 10.1080/10739680601072115; SIMONS MA, 1987, INVEST RADIOL, V22, P562, DOI 10.1097/00004424-198707000-00006; Tanano I, 2013, INVEST OPHTH VIS SCI, V54, P1443, DOI 10.1167/iovs.12-10115; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P3277, DOI 10.1113/jphysiol.2010.192823	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91791	10.1371/journal.pone.0091791	http://dx.doi.org/10.1371/journal.pone.0091791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626349	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300137
J	Jalah, R; Kulkarni, V; Patel, V; Rosati, M; Alicea, C; Bear, J; Yu, L; Guan, YJ; Shen, XY; Tomaras, GD; LaBranche, C; Montefiori, DC; Prattipati, R; Pinter, A; Bess, J; Lifson, JD; Reed, SG; Sardesai, NY; Venzon, DJ; Valentin, A; Pavlakis, GN; Felber, BK				Jalah, Rashmi; Kulkarni, Viraj; Patel, Vainav; Rosati, Margherita; Alicea, Candido; Bear, Jenifer; Yu, Lei; Guan, Yongjun; Shen, Xiaoying; Tomaras, Georgia D.; LaBranche, Celia; Montefiori, David C.; Prattipati, Rajasekhar; Pinter, Abraham; Bess, Julian, Jr.; Lifson, Jeffrey D.; Reed, Steven G.; Sardesai, Niranjan Y.; Venzon, David J.; Valentin, Antonio; Pavlakis, George N.; Felber, Barbara K.			DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques	PLOS ONE			English	Article							T-CELL RESPONSES; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 VACCINE EFFICACY; RHESUS MACAQUES; GENE-TRANSFER; B-CELL; ELECTROPORATION; PLASMID; SIV; IL-12	We tested the concept of combining DNA with protein to improve anti-HIV Env systemic and mucosal humoral immune responses. Rhesus macaques were vaccinated with DNA, DNA&protein co-immunization or DNA prime followed by protein boost, and the magnitude and mucosal dissemination of the antibody responses were monitored in both plasma and mucosal secretions. We achieved induction of robust humoral responses by optimized DNA vaccination delivered by in vivo electroporation. These responses were greatly increased upon administration of a protein boost. Importantly, a co-immunization regimen of DNA&protein injected in the same muscle at the same time induced the highest systemic binding and neutralizing antibodies to homologous or heterologous Env as well as the highest Env-specific IgG in saliva. Inclusion of protein in the vaccine resulted in more immunized animals with Env-specific IgG in rectal fluids. Inclusion of DNA in the vaccine significantly increased the longevity of systemic humoral immune responses, whereas protein immunization, either as the only vaccine component or as boost after DNA prime, was followed by a great decline of humoral immune responses overtime. We conclude that DNA&protein co-delivery in a simple vaccine regimen combines the strength of each vaccine component, resulting in improved magnitude, extended longevity and increased mucosal dissemination of the induced antibodies in immunized rhesus macaques.	[Jalah, Rashmi; Kulkarni, Viraj; Alicea, Candido; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Frederick, MD 21701 USA; [Patel, Vainav; Rosati, Margherita; Bear, Jenifer; Valentin, Antonio; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Yu, Lei; Guan, Yongjun] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Human Virol, Baltimore, MD 21201 USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Dept Surg, Durham, NC USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Dept Immunol Mol Genet & Microbiol, Durham, NC USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Prattipati, Rajasekhar; Pinter, Abraham] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Bess, Julian, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA USA; [Venzon, David J.] NCI, Biostat & Data Management Sect, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; Duke University; Duke University; Duke University; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pavlakis, GN (corresponding author), NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA.	george.pavlakis@nih.gov; barbara.felber@nih.gov	Guan, Yongjun/V-8117-2019; Tomaras, Georgia/J-5041-2016	Guan, Yongjun/0000-0001-6546-2095; Sardesai, Niranjan/0000-0001-6920-1167	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); NCI/NIH [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases-NIH [HHSN27201100016C, R01AI102718]; Institute of Human Virology Faculty Development Fund; Bill and Melinda Gates Foundation [42387]; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102718] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute of Human Virology Faculty Development Fund; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH) (BKF and GNP); Federal funds from the NCI/NIH under Contract HHSN261200800001E (to JDL); National Institute of Allergy and Infectious Diseases-NIH Contract HHSN27201100016C (to GDT, XS, CL, and DCM), National Institute of Allergy and Infectious Diseases-NIH grant R01AI102718 (to AP), Institute of Human Virology Faculty Development Fund (to YG) and Bill and Melinda Gates Foundation Grant #42387 (to SGR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Bolton DL, 2012, MUCOSAL IMMUNOL, V5, P41, DOI 10.1038/mi.2011.45; Boyer JD, 2005, J MED PRIMATOL, V34, P262, DOI 10.1111/j.1600-0684.2005.00124.x; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cristillo AD, 2008, BIOCHEM BIOPH RES CO, V366, P29, DOI 10.1016/j.bbrc.2007.11.052; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; Halwani R, 2008, J IMMUNOL, V180, P7969, DOI 10.4049/jimmunol.180.12.7969; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Hutnick NA, 2011, CURR OPIN VIROL, V1, P233, DOI 10.1016/j.coviro.2011.08.003; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Jaworski JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031464; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kennedy JS, 2008, VACCINE, V26, P4420, DOI 10.1016/j.vaccine.2008.05.090; Kulkarni V, 2013, HUM VACC IMMUNOTHER, V9, P2081, DOI 10.4161/hv.25473; Kulkarni V, 2013, HUM VACC IMMUNOTHER, V9, P2069, DOI 10.4161/hv.25442; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MOORE JP, 1989, AIDS, V3, P155, DOI 10.1097/00002030-198903000-00006; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Otten GR, 2006, VACCINE, V24, P4503, DOI 10.1016/j.vaccine.2005.08.017; Pal R, 2005, J MED PRIMATOL, V34, P226, DOI 10.1111/j.1600-0684.2005.00120.x; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Robinson TM, 2007, J MED PRIMATOL, V36, P276, DOI 10.1111/j.1600-0684.2007.00245.x; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11	47	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91550	10.1371/journal.pone.0091550	http://dx.doi.org/10.1371/journal.pone.0091550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626482	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300103
J	Shao, F; Wang, XG; Yu, JF; Jiang, HL; Zhu, B; Gu, ZL				Shao, Fang; Wang, Xingguo; Yu, Jianfeng; Jiang, Honglin; Zhu, Bin; Gu, Zhiliang			Expression of miR-33 from an SREBF2 Intron Targets the FTO Gene in the Chicken	PLOS ONE			English	Article							MESSENGER-RNAS; HOST GENES; FAT MASS; CHOLESTEROL; METABOLISM; MICRORNAS; SUBSTRATE	The sterol regulatory element binding transcription factor 2 (SREBF2) gene encodes a transcription factor that activates the expression of many genes involved in the synthesis and uptake of cholesterol, fatty acids, triglycerides, and phospholipids. Through bioinformatics, we found that intron 16 of the chicken SREBF2 gene might encode the chicken miR-33. Using quantitative RT-PCR, we detected the expression of miR-33 in a variety of chicken tissues including skeletal muscle, adipose tissue, and liver. Three hundred and seventy eight genes were predicted to be potential targets of miR-33 in chickens via miRNA target prediction programs "miRanda'' and "TargetScan''. Among these targets, the gene FTO (fat mass and obesity associated) encodes a Fe(II)- and 2-oxoglutarate-dependent nucleic acid demethylase that regulates lipid metabolism, and the possibility that its expression is negatively regulated by miR-33 in the chicken liver was therefore further studied. Co-transfection and dual-luciferase reporter assays showed that the expression of luciferase reporter gene linked to the 3'-untranslated region (3'UTR) of the chicken FTO mRNA was down-regulated by overexpression of the chicken miR-33 in the C2C12 cells (P<0.05). Furthermore, this down-regulation was completely abolished when the predicted miR-33 target site in the FTO 3'UTR was mutated. In contrast, the expression of FTO mRNA in the primary chicken hepatocytes was up-regulated after transfection with the miR-33 inhibitor LNA-anti-miR-33. Using quantitative RT-PCR, we also found that the expression of miR-33 was increased in the chicken liver from day 0 to day 49 of age, whereas that of the FTO mRNA was decreased during the same age period. These data together suggest that miR-33 might play an important role in lipid metabolism in the chicken liver by negatively regulating the expression of the FTO gene.	[Shao, Fang; Wang, Xingguo; Yu, Jianfeng; Gu, Zhiliang] Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Jiangsu, Peoples R China; [Shao, Fang; Zhu, Bin] Soochow Univ, Coll Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China; [Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Changshu Institute of Technology; Soochow University - China; Virginia Polytechnic Institute & State University	Gu, ZL (corresponding author), Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Jiangsu, Peoples R China.	zhilianggu88@hotmail.com	wang, xingguo/AAF-3020-2020	, Honglin/0000-0001-9540-5788	Natural Science Foundation of China [30871789, 31272438]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Natural Science Foundation of China (30871789, 31272438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; DOUAIRE M, 1993, J CELL SCI, V104, P713; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hermier D, 1997, J NUTR, V127, pS805, DOI 10.1093/jn/127.5.805S; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jia X, 2012, INT J OBESITY, V36, P1054, DOI 10.1038/ijo.2011.221; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Poritsanos NJ, 2010, BIOCHEM BIOPH RES CO, V400, P713, DOI 10.1016/j.bbrc.2010.08.133; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Tiwari A, 2012, DOMEST ANIM ENDOCRIN, V42, P1, DOI 10.1016/j.domaniend.2011.08.001; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang XG, 2013, POULTRY SCI, V92, P1888, DOI 10.3382/ps.2012-02919; Wang YF, 2012, COMP BIOCHEM PHYS A, V163, P246, DOI 10.1016/j.cbpa.2012.08.009	37	21	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91236	10.1371/journal.pone.0091236	http://dx.doi.org/10.1371/journal.pone.0091236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626192	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300067
J	Weiterer, S; Schulte, D; Muller, S; Kohlen, T; Uhle, F; Weigand, MA; Henrich, M				Weiterer, Sebastian; Schulte, Dagmar; Mueller, Sabrina; Kohlen, Thomas; Uhle, Florian; Weigand, Markus A.; Henrich, Michael			Tumor Necrosis Factor Alpha Induces a Serotonin Dependent Early Increase in Ciliary Beat Frequency and Epithelial Transport Velocity in Murine Tracheae	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; FACTOR RECEPTOR; TNF-ALPHA; PULMONARY-HYPERTENSION; PATHWAY; CELLS; 5-HYDROXYTRYPTAMINE; ACETYLCHOLINE; STIMULATION; CONTRIBUTES	The tracheal epithelium prevents via its highly effective clearance mechanism the contamination of the lower airways by pathogens. This mechanism is driven by ciliary bearing cells which are not only in contact with the gas phase; in addition they are also influenced by inflammatory mediators. These mediators can alter the protective function of the epithelium. Since the pro-inflammatoric cytokine tumor necrosis factor-alpha (TNF-alpha) plays a pivotal role within the inflammatory cascade, we investigated its effect onto the tracheal epithelium measured by its ciliary beat frequency and the particle transport velocity. In organ explant experiments the ciliary beat frequency and the particle transport velocity were measured under the application of TNF-alpha using tracheae from male C57BL6J mice. We observed a dose dependent TNF-alpha induced increase of both particle transport velocity and ciliary beat frequency. Knock out mice experiments made evident that the increase was depended on the expression of tumor necrosis factor receptor 1 (TNF-R1). The increases in ciliary beat frequency as well as the accelerated particle transport velocity were either inhibited by the unspecific serotonin antagonist methysergide or by cyproheptadine a specific 5-HT2 receptor antagonist. Thus, acetylcholine antagonists or nitric oxide synthase (NOS) inhibitors failed to inhibit the TNF-alpha induced activation. In conclusion, TNF-alpha may play a pivotal role in the protection of lower airways by inducing ciliary activity and increase in particle transport velocity via TNF-R1 and 5-HT2 receptor.	[Weiterer, Sebastian; Schulte, Dagmar; Mueller, Sabrina; Kohlen, Thomas; Uhle, Florian; Weigand, Markus A.; Henrich, Michael] Univ Giessen, Dept Anaesthesiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Henrich, M (corresponding author), Univ Giessen, Dept Anaesthesiol, D-35390 Giessen, Germany.	michael.henrich@anatomie.med.uni-giessen.de	Uhle, Florian/Q-6191-2019		Fachbereich Medizin der Justus-Liebig-UniversitAt Giessen	Fachbereich Medizin der Justus-Liebig-UniversitAt Giessen	This work was supported from the Fachbereich Medizin der Justus-Liebig-UniversitAt Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani Y, 1996, REV MAL RESPIR, V13, P539; Amrani Y, 2000, MOL PHARMACOL, V58, P237, DOI 10.1124/mol.58.1.237; Aparicio CL, 1996, MOL IMMUNOL, V33, P671, DOI 10.1016/0161-5890(96)00013-2; Arisoy O, 2013, RHEUMATOL INT; BENYO DF, 1992, ENDOCRINOLOGY, V130, P854, DOI 10.1210/en.130.2.854; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Brzezinska-Blaszczyk E, 2007, J INTERF CYTOK RES, V27, P911, DOI 10.1089/jir.2006.0158; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; Eddahibi S, 1999, CIRC RES, V84, P329, DOI 10.1161/01.RES.84.3.329; Esteve JM, 2007, CELL BIOCHEM BIOPHYS, V47, P33, DOI 10.1385/CBB:47:1:33; Fry DE, 2012, AM SURGEON, V78, P1; Gertsberg I, 2004, J GEN PHYSIOL, V124, P527, DOI 10.1085/jgp.200409153; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; JAIN B, 1995, AM J PHYSIOL-LUNG C, V268, pL911, DOI 10.1152/ajplung.1995.268.6.L911; Kereveur A, 2000, ARTERIOSCL THROM VAS, V20, P2233, DOI 10.1161/01.ATV.20.10.2233; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Konig P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004938; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Lee TW, 2012, COCHRANE DB SYST REV, V10; MacLean MR, 2010, ADV EXP MED BIOL, V661, P309, DOI 10.1007/978-1-60761-500-2_20; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; McFarlane SM, 2001, BIOCHEM PHARMACOL, V61, P749, DOI 10.1016/S0006-2952(01)00530-5; Moffatt JD, 2004, BRIT J PHARMACOL, V141, P1159, DOI 10.1038/sj.bjp.0705720; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sangaletti S, 2010, CANCER RES, V70, P7764, DOI 10.1158/0008-5472.CAN-10-0471; Schliemann M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-204; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Schmid A, 2010, J BIOL CHEM, V285, P29998, DOI 10.1074/jbc.M110.113621; Schulman CI, 2002, SHOCK, V18, P75, DOI 10.1097/00024382-200207000-00014; Shimoda LA, 2013, J MOL MED, V91, P297, DOI 10.1007/s00109-013-0998-0; Sisson JH, 1999, ALCOHOL CLIN EXP RES, V23, P1528, DOI 10.1111/j.1530-0277.1999.tb04677.x; SUTER PM, 1992, AM REV RESPIR DIS, V145, P1016, DOI 10.1164/ajrccm/145.5.1016; Uzlaner N, 1999, J PHYSIOL-LONDON, V516, P179, DOI 10.1111/j.1469-7793.1999.179aa.x; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Weigand LA, 2009, J PHYSIOL-LONDON, V587, P3355, DOI 10.1113/jphysiol.2009.173054; Wyatt TA, 2008, EUR RESPIR J, V31, P1249, DOI 10.1183/09031936.00015007; Wyatt TA, 1998, AM J PHYSIOL-LUNG C, V275, pL827, DOI 10.1152/ajplung.1998.275.4.L827; Zhang Q, 2013, J MOL CELL BIOL	43	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91705	10.1371/journal.pone.0091705	http://dx.doi.org/10.1371/journal.pone.0091705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626175	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300126
J	Gallace, A; Soravia, G; Cattaneo, Z; Moseley, GL; Vallar, G				Gallace, Alberto; Soravia, Giovanna; Cattaneo, Zaira; Moseley, G. Lorimer; Vallar, Giuseppe			Temporary Interference over the Posterior Parietal Cortices Disrupts Thermoregulatory Control in Humans	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; SOMATOSENSORY CORTEX; SKIN TEMPERATURE; BODY-OWNERSHIP; INTRAPARIETAL SULCUS; RUBBER HAND; STROKE; BRAIN	The suggestion has recently been made that certain higher-order cortical areas involved in supporting multisensory representations of the body, and of the space around it, might also play a role in controlling thermoregulatory functions. Here we demonstrate that temporary interference with the function of one of these areas, the posterior parietal cortex, by repetitive transcranial magnetic stimulation, results in a decrease in limb temperature. By contrast, interference with the activity of a sensory-specific area (the primary somatosensory cortex) had no effect on temperature. The results of this experiment suggest that associative multisensory brain areas might exert a top-down modulation over basic physiological control. Such a function might be part of a larger neural circuit responsible for maintaining the integrity of the body at both a homeostatic and a psychological level.	[Gallace, Alberto; Soravia, Giovanna; Cattaneo, Zaira; Vallar, Giuseppe] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia; [Vallar, Giuseppe] IRCCS Ist Auxol Italiano, Milan, Italy	University of Milano-Bicocca; University of South Australia; Neuroscience Research Australia; IRCCS Istituto Auxologico Italiano	Gallace, A (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	alberto.gallace1@unimib.it	Gallace, Alberto/L-7276-2015; Moseley, Lorimer/A-7095-2009	Moseley, Lorimer/0000-0002-3750-4945; GALLACE, ALBERTO/0000-0002-4561-8926	National Health & Medical Research Council of Australia [571090]; Ricerca Corrente Grant from the IRCCS Istituto Auxologico Italiano; Futuro in Ricerca grant [RBFR12F0BD_003]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ricerca Corrente Grant from the IRCCS Istituto Auxologico Italiano; Futuro in Ricerca grant	GLM was supported by the National Health & Medical Research Council of Australia ID 571090. G. V. was supported by a Ricerca Corrente Grant from the IRCCS Istituto Auxologico Italiano. A. G. and Z. C. were supported by a Futuro in Ricerca 2012 grant (RBFR12F0BD_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerra NE, 2007, J REHABIL MED, V39, P109, DOI 10.2340/16501977-0027; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; BASSETTI C, 1993, NEUROLOGY, V43, P1942, DOI 10.1212/WNL.43.10.1942; Blankenburg F, 2010, CEREB CORTEX, V20, P2702, DOI 10.1093/cercor/bhq015; Blatow M, 2007, NEUROIMAGE, V37, P927, DOI 10.1016/j.neuroimage.2007.05.038; Bottini G, 2005, NEUROLOGY, V65, P1278, DOI 10.1212/01.wnl.0000182398.14088.e8; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; DELUCA B, 1989, BRAIN RES BULL, V22, P1003, DOI 10.1016/0361-9230(89)90012-9; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Egan GF, 2005, P NATL ACAD SCI USA, V102, P5262, DOI 10.1073/pnas.0409753102; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ellis LB, 1936, ARCH NEURO PSYCHIATR, V36, P362, DOI 10.1001/archneurpsyc.1936.02260080134008; Ferretti A, 2003, NEUROIMAGE, V20, P1625, DOI 10.1016/j.neuroimage.2003.07.004; Fiorio M, 2005, EUR J NEUROSCI, V22, P773, DOI 10.1111/j.1460-9568.2005.04267.x; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Freund Hans-Joachim, 2003, Adv Neurol, V93, P179; Gallace A., 2010, PSYCHE INTERDISCIPLI, V16, P30; Gallace A, 2008, CONSCIOUS COGN, V17, P370, DOI 10.1016/j.concog.2007.01.005; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hasselberg MJ, SLEEP MED IN PRESS; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Ishii K, 1996, CLIN NEUROLOGY, V36, P951; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Kim JS, 2007, NEUROLOGY, V68, P174, DOI 10.1212/01.wnl.0000251298.12763.9b; Kitazawa S, 2002, CONSCIOUS COGN, V11, P475, DOI 10.1016/S1053-8100(02)00031-4; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Marinus J, 2011, LANCET NEUROL, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Miniussi C, 2010, CORTEX, V46, P128, DOI 10.1016/j.cortex.2009.03.004; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2013, PAIN, V154, P2463, DOI 10.1016/j.pain.2013.07.026; Moseley GL, 2012, BRAIN, V135, P3676, DOI 10.1093/brain/aws297; Moseley GL, 2012, NEUROLOGY, V79, P327, DOI 10.1212/WNL.0b013e318260cba2; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; NAVER H, 1995, STROKE, V26, P1379, DOI 10.1161/01.STR.26.8.1379; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira FTP, 2010, P NATL ACAD SCI USA, V107, P17751, DOI 10.1073/pnas.1006223107; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Petchkrua W, 2000, NEUROREHAB NEURAL RE, V14, P59, DOI 10.1177/154596830001400107; Reed CL, 1996, BRAIN, V119, P875, DOI 10.1093/brain/119.3.875; Riedl B, 2001, ACTA NEUROL SCAND, V103, P27, DOI 10.1034/j.1600-0404.2001.00139.x; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Satoh M, 2002, J NEUROL, V249, P1404, DOI 10.1007/S00415-002-0853-7; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; STERZI R, 1993, J NEUROL NEUROSUR PS, V56, P308, DOI 10.1136/jnnp.56.3.308; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 1997, HIPPOCAMPAL PARIETAL, P33; Vallar G, 2007, BEHAV BRAIN SCI, V30, P223, DOI 10.1017/S0140525X0700163X; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WANKLYN P, 1994, STROKE, V25, P1765, DOI 10.1161/01.STR.25.9.1765; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	67	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e88209	10.1371/journal.pone.0088209	http://dx.doi.org/10.1371/journal.pone.0088209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622382	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000332845300004
J	Konno, K; Inoue, TA; Nakamura, M				Konno, Kotaro; Inoue, Takashi A.; Nakamura, Masatoshi			Synergistic Defensive Function of Raphides and Protease through the Needle Effect	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALS; LATEX; PLANTS; CARCINOGENESIS; INHIBITION; ACTIVATION; EXPRESSION; CHITINASE; INSECTS; ARACEAE	Raphides, needle-shaped calcium oxalate crystals in tissues of many plants, have been thought to play defensive roles against herbivores without detailed bioassays for their defensive roles and modes of function using purified raphides. In order to examine the defensive roles and modes of function of raphides in a clear experimental system, we performed bioassays giving the larvae of the Eri silkmoth, Samia ricini (Saturniidae), leaves of their host plant, the castor oil plant, Ricinus communis (Euphorbiaceae), painted with the raphides purified from kiwifruits, Actinidia deliciosa (Actinidiaceae), in presence or absence of cysteine protease, which often coincide with raphides in plant tissues. Raphides alone or cysteine protease alone showed only weak defensive activities around experimental concentrations. However, when raphides and cysteine protease coexisted, they synergistically showed very strong growth-reducing activities, and the mortality of caterpillars was very high. In contrast, amorphous calcium oxalate did not show synergism with cysteine protease on defensive activities, indicating that the needle-shape of raphides is essential for the synergism. The present study provides the first clear experimental evidence for the synergism between raphides and other defensive factors. Further, the study suggests that "the needle effect", which intensify the bioactivities of other bioactive factors by making holes to the barriers (cell membrane, cuticle, epithelium, the nuclear membrane, etc.) and facilitate the bioactive factors to go through them and reach the targets, is important in the defensive activities of raphides, and possibly in the allergy caused by raphides, and in the carcinogenic activities of other needle-shaped components including asbestos and plant derived silica needles.	[Konno, Kotaro; Inoue, Takashi A.] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Masatoshi] Natl Inst Agrobiol Sci, Hokuto, Yamanashi, Japan	National Institute of Agrobiological Sciences - Japan	Konno, K (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	konno@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF)	Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was supported by a Research Grant Project from the Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; ARAKI T, 1992, J BIOL CHEM, V267, P19944; Arnott HJ, 2000, INT J PLANT SCI, V161, P133, DOI 10.1086/314230; BHATT T, 1984, INT J CANCER, V34, P519, DOI 10.1002/ijc.2910340415; Bradbury JH, 1998, J SCI FOOD AGR, V76, P608, DOI [10.1002/(SICI)1097-0010(199804)76:4&lt;608::AID-JSFA996&gt;3.0.CO;2-2, 10.1002/(SICI)1097-0010(199804)76:4<608::AID-JSFA996>3.3.CO;2-U]; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Cote GG, 2012, AM J BOT, V99, P1231, DOI 10.3732/ajb.1100499; DENOUTER RW, 1988, J HORTIC SCI, V63, P645, DOI 10.1080/14620316.1988.11515906; Dussourd David E., 1993, P92; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; Fukui Akiko, 2002, Entomological Science, V5, P263; GARDNER DG, 1994, ORAL SURG ORAL MED O, V78, P631, DOI 10.1016/0030-4220(94)90177-5; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hartmann T, 2008, P NATL ACAD SCI USA, V105, P4541, DOI 10.1073/pnas.0709231105; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Konno K, 2004, PLANT J, V37, P370, DOI 10.1046/j.1365-313X.2003.01968.x; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Konno K, 2011, PHYTOCHEMISTRY, V72, P1510, DOI 10.1016/j.phytochem.2011.02.016; Lawrence SD, 2006, BIOTECHNOL LETT, V28, P593, DOI 10.1007/s10529-006-0022-7; Lucas JSA, 2003, PEDIAT ALLERG IMM-UK, V14, P420, DOI 10.1046/j.0905-6157.2003.00095.x; Ota E, 2013, PHYTOCHEMISTRY, V89, P15, DOI 10.1016/j.phytochem.2013.01.013; PERERA CO, 1990, J FOOD SCI, V55, P1066, DOI 10.1111/j.1365-2621.1990.tb01599.x; PRAEKELT UM, 1988, PLANT MOL BIOL, V10, P193, DOI 10.1007/BF00027396; Prychid CJ, 1999, ANN BOT-LONDON, V84, P725, DOI 10.1006/anbo.1999.0975; Rinallo C, 2002, BIOL PLANTARUM, V45, P137, DOI 10.1023/A:1015189616477; SAKAI WS, 1972, SCIENCE, V178, P314, DOI 10.1126/science.178.4058.314; Salinas ML, 2001, CONTACT DERMATITIS, V44, P94, DOI 10.1034/j.1600-0536.2001.440208.x; Seigler D. S., 1991, HERBIVORES THEIR INT, VI, P35; Stahl E, 1919, FLORA, V111, P1; Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1; Ward D, 1997, J CHEM ECOL, V23, P333, DOI 10.1023/B:JOEC.0000006363.34360.9d; Wasano N, 2009, PHYTOCHEMISTRY, V70, P880, DOI 10.1016/j.phytochem.2009.04.014; Wen ZM, 2006, J CHEM ECOL, V32, P507, DOI 10.1007/s10886-005-9014-7	36	23	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91341	10.1371/journal.pone.0091341	http://dx.doi.org/10.1371/journal.pone.0091341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621613	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300077
J	Kuo, HC; Hsu, YW; Lo, MH; Huang, YH; Chien, SC; Chang, WC				Kuo, Ho-Chang; Hsu, Yu-Wen; Lo, Mao-Hung; Huang, Ying-Hsien; Chien, Shu-Chen; Chang, Wei-Chiao			Single-Nucleotide Polymorphism rs7251246 in ITPKC Is Associated with Susceptibility and Coronary Artery Lesions in Kawasaki Disease	PLOS ONE			English	Article							IMMUNITY; MODEL	Kawasaki disease (KD) is a multi-systemic vasculitis that preferentially affects children. A single nucleotide polymorphism (SNP) in inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) has been identified to be an important polymorphism in the risk of KD. This study was conducted to comprehensively investigate the associations between all tagging SNPs of ITPKC in the risk of KD in a Taiwanese population. A total of 950 subjects (381 KD patients and 569 controls) were recruited. Seven tagging SNPs (rs11673492, rs7257602, rs7251246, rs890934, rs10420685, rs2607420, rs2290692) were selected for TaqMan allelic discrimination assay. Clinical data of coronary artery lesions (CAL) and aneurysms were collected for analysis. A significant association was found between rs7251246 in ITPKC and CAL formation. Haplotype analysis for ITPKC polymorphisms also confirmed this association in the patients with CAL and aneurysm formation. This is the first study to identify that SNP rs7251246 in ITPKC is associated with the severity of KD.	[Kuo, Ho-Chang; Lo, Mao-Hung; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Huang, Ying-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hsu, Yu-Wen; Chien, Shu-Chen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan [NSC 102-2314-B-182-053-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPG8B0211, CMRPG8B0151]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182-053-MY3), and grants from Chang Gung Memorial Hospital, Taiwan (CMRPG8B0211 and CMRPG8B0151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Franco A, 2010, AUTOIMMUNITY, V43, P317, DOI 10.3109/08916930903405891; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kuo HC, 2011, J HUM GENET, V56, P840, DOI 10.1038/jhg.2011.113; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Lee E., 2012, PSYCHOL MED, V1, P1, DOI [10.1007/978-3-642-35289-8_25, DOI 10.1007/978-3-642-35289-8_25]; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Lin MT, 2011, PEDIATR INFECT DIS J, V30, P148, DOI 10.1097/INF.0b013e3181f43a4e; Lou J, 2012, MOL BIOL REP, V39, P11137, DOI 10.1007/s11033-012-2022-0; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Peng Q, 2012, PEDIATR CARDIOL, V33, P1046, DOI 10.1007/s00246-012-0223-x; Schulte DJ, 2009, J IMMUNOL, V183, P5311, DOI 10.4049/jimmunol.0901395; Takahashi K, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-30; Tremoulet AH, 2012, J PEDIATR-US, V161, P506, DOI 10.1016/j.jpeds.2012.02.048; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Yeter D, 2012, AUTOIMMUN REV, V11, P903, DOI 10.1016/j.autrev.2012.03.006	22	26	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91118	10.1371/journal.pone.0091118	http://dx.doi.org/10.1371/journal.pone.0091118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621571	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300053
J	Milder, DA; Sutherland, EJ; Gandevia, SC; McNulty, PA				Milder, David A.; Sutherland, Emily J.; Gandevia, Simon C.; McNulty, Penelope A.			Sustained Maximal Voluntary Contraction Produces Independent Changes in Human Motor Axons and the Muscle They Innervate	PLOS ONE			English	Article							DEPENDENT EXCITABILITY CHANGES; HUMAN PERIPHERAL-NERVE; MYELINATED AXONS; VOLTAGE-DEPENDENCE; NATURAL ACTIVITY; HYPERPOLARIZATION; NEUROPATHY; PUMP; RAT; FATIGUE	The repetitive discharges required to produce a sustained muscle contraction results in activity-dependent hyperpolarization of the motor axons and a reduction in the force-generating capacity of the muscle. We investigated the relationship between these changes in the adductor pollicis muscle and the motor axons of its ulnar nerve supply, and the reproducibility of these changes. Ten subjects performed a 1-min maximal voluntary contraction. Activity-dependent changes in axonal excitability were measured using threshold tracking with electrical stimulation at the wrist; changes in the muscle were assessed as evoked and voluntary electromyography (EMG) and isometric force. Separate components of axonal excitability and muscle properties were tested at 5 min intervals after the sustained contraction in 5 separate sessions. The current threshold required to produce the target muscle action potential increased immediately after the contraction by 14.8% (p<0.05), reflecting decreased axonal excitability secondary to hyperpolarization. This was not correlated with the decline in amplitude of muscle force or evoked EMG. A late reversal in threshold current after the initial recovery from hyperpolarization peaked at -5.9% at similar to 35 min (p<0.05). This pattern was mirrored by other indices of axonal excitability revealing a previously unreported depolarization of motor axons in the late recovery period. Measures of axonal excitability were relatively stable at rest but less so after sustained activity. The coefficient of variation (CoV) for threshold current increase was higher after activity (CoV 0.54, p<0.05) whereas changes in voluntary (CoV 0.12) and evoked twitch (CoV 0.15) force were relatively stable. These results demonstrate that activity-dependent changes in motor axon excitability are unlikely to contribute to concomitant changes in the muscle after sustained activity in healthy people. The variability in axonal excitability after sustained activity suggests that care is needed when using these measures if the integrity of either the muscle or nerve may be compromised.	[McNulty, Penelope A.] Neurosci Res Australia, Sydney, NSW, Australia; Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	McNulty, PA (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	p.mcnulty@neura.edu.au	Gandevia, Simon/D-5009-2011	Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council of Australia; New South Wales Office of Science and Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Office of Science and Medical Research	This work was supported by the National Health and Medical Research Council of Australia and the New South Wales Office of Science and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; BIGLANDRITCHIE B, 1983, J NEUROPHYSIOL, V50, P313, DOI 10.1152/jn.1983.50.1.313; BOSTOCK H, 1985, J PHYSIOL-LONDON, V365, P239, DOI 10.1113/jphysiol.1985.sp015769; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Burke R.E., 1981, HDB PHYSL SECTION 1, VII, P345, DOI 10.1002/cphy.cp010210; Cappelen Smith C, 2000, ANN NEUROL, V48, P826; DAVID G, 1995, J PHYSIOL-LONDON, V489, P141, DOI 10.1113/jphysiol.1995.sp021037; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; DESCHENES M, 1980, BRAIN RES, V191, P538, DOI 10.1016/0006-8993(80)91302-5; EDSTROM L, 1986, MUSCLE NERVE, V9, P104, DOI 10.1002/mus.880090203; ENOKA RM, 1995, J CLIN NEUROPHYSIOL, V12, P538, DOI 10.1097/00004691-199511000-00002; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P581, DOI 10.1152/jn.1965.28.3.581; Howells J, 2013, J PHYSIOL-LONDON, V591, P3063, DOI 10.1113/jphysiol.2012.249060; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Ishihara A, 2003, EXERC SPORT SCI REV, V31, P51, DOI 10.1097/00003677-200301000-00010; ITO M, 1965, J PHYSIOL-LONDON, V180, P607, DOI 10.1113/jphysiol.1965.sp007720; Kaji R, 2000, BRAIN, V123, P1602, DOI 10.1093/brain/123.8.1602; KAJI R, 1989, NEUROLOGY, V39, P1364, DOI 10.1212/WNL.39.10.1364; KERNELL D, 1992, ARCH ITAL BIOL, V130, P19; Kiernan MC, 2004, J PHYSIOL-LONDON, V558, P341, DOI 10.1113/jphysiol.2004.063966; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2006, CLIN NEUROPHYSIOL, V117, P992, DOI 10.1016/j.clinph.2006.02.002; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kuwabara S, 2002, MUSCLE NERVE, V25, P176, DOI 10.1002/mus.10030.abs; Kuwabara S, 2001, J PHYSIOL-LONDON, V531, P265, DOI 10.1111/j.1469-7793.2001.0265j.x; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCPHEDRA.AM, 1965, J NEUROPHYSIOL, V28, P71, DOI 10.1152/jn.1965.28.1.71; MORITA K, 1993, J NEUROPHYSIOL, V70, P1874, DOI 10.1152/jn.1993.70.5.1874; Murray JE, 2011, CLIN NEUROPHYSIOL, V122, P2290, DOI 10.1016/j.clinph.2011.04.007; Nodera H, 2006, CLIN NEUROPHYSIOL, V117, P1902, DOI 10.1016/j.clinph.2006.01.018; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Park SB, 2011, EXP NEUROL, V227, P120, DOI 10.1016/j.expneurol.2010.10.002; RAKOWSKI RF, 1989, J GEN PHYSIOL, V93, P903, DOI 10.1085/jgp.93.5.903; RITCHIE JM, 1957, J PHYSIOL-LONDON, V136, P80, DOI 10.1113/jphysiol.1957.sp005744; SIMPSON JA, 1969, ELECTROEN CLIN NEURO, V26, P224; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; STAMPFLI R, 1954, PHYSIOL REV, V34, P101, DOI 10.1152/physrev.1954.34.1.101; Sutherland E, 2010, DIFFERENT TIME COURS; Tasaki I, 1939, AM J PHYSIOL, V127, P211, DOI 10.1152/ajplegacy.1939.127.2.211; Tomlinson SE, 2010, MUSCLE NERVE, V41, P247, DOI 10.1002/mus.21482; Trevillion L, 2004, MUSCLE NERVE, V30, P437, DOI 10.1002/mus.20134; Vagg R, 1998, J PHYSIOL-LONDON, V507, P919, DOI 10.1111/j.1469-7793.1998.919bs.x; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Vucic S, 2007, J NEUROL NEUROSUR PS, V78, P1202, DOI 10.1136/jnnp.2006.112078; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85; Z'Graggen WJ, 2006, BRAIN, V129, P2461, DOI 10.1093/brain/awl191	56	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91754	10.1371/journal.pone.0091754	http://dx.doi.org/10.1371/journal.pone.0091754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622330	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300124
J	Singh, M; Sareen, D				Singh, Mangal; Sareen, Dipti			Novel LanT Associated Lantibiotic Clusters Identified by Genome Database Mining	PLOS ONE			English	Article							LEADER SEQUENCE; PEPTIDE; BIOSYNTHESIS; NISIN; BACTERIOCIN; STREPTOCOCCUS; STRAIN; IMMUNITY; LICHENICIDIN; HALODURACIN	Background: Frequent use of antibiotics has led to the emergence of antibiotic resistance in bacteria. Lantibiotic compounds are ribosomally synthesized antimicrobial peptides against which bacteria are not able to produce resistance, hence making them a good alternative to antibiotics. Nisin is the oldest and the most widely used lantibiotic, in food preservation, without having developed any significant resistance against it. Having their antimicrobial potential and a limited number, there is a need to identify novel lantibiotics. Methodology/Findings: Identification of novel lantibiotic biosynthetic clusters from an ever increasing database of bacterial genomes, can provide a major lead in this direction. In order to achieve this, a strategy was adopted to identify novel lantibiotic biosynthetic clusters by screening the sequenced genomes for LanT homolog, which is a conserved lantibiotic transporter specific to type IB clusters. This strategy resulted in identification of 54 bacterial strains containing the LanT homologs, which are not the known lantibiotic producers. Of these, 24 strains were subjected to a detailed bioinformatic analysis to identify genes encoding for precursor peptides, modification enzyme, immunity and quorum sensing proteins. Eight clusters having two LanM determinants, similar to haloduracin and lichenicidin were identified, along with 13 clusters having a single LanM determinant as in mersacidin biosynthetic cluster. Besides these, orphan LanT homologs were also identified which might be associated with novel bacteriocins, encoded somewhere else in the genome. Three identified gene clusters had a C39 domain containing LanT transporter, associated with the LanBC proteins and double glycine type precursor peptides, the only known example of such a cluster is that of salivaricin. Conclusion: This study led to the identification of 8 novel putative two-component lantibiotic clusters along with 13 having a single LanM and 3 with LanBC genes. Putative lantibiotic clusters identified here hold the potential for the discovery of novel lantibiotic(s).	[Singh, Mangal; Sareen, Dipti] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Panjab University	Sareen, D (corresponding author), Panjab Univ, Dept Biochem, Chandigarh 160014, India.	diptsare@pu.ac.in	Panwar, Mangal Singh/ABD-4791-2020; Singh, Mangal/Y-9283-2018	Panwar, Mangal Singh/0000-0002-2381-2250; Singh, Mangal/0000-0002-2381-2250; Sareen, Dipti/0000-0001-9432-0870	Junior Research Fellowship (JRF) by the Indian Council of Medical Research (ICMR), Government of India (New Delhi) [3/1/3/JRF-2011/HRD-99(11005)]	Junior Research Fellowship (JRF) by the Indian Council of Medical Research (ICMR), Government of India (New Delhi)	M.S. acknowledges the independent Junior Research Fellowship (JRF) No. 3/1/3/JRF-2011/HRD-99(11005), awarded by the Indian Council of Medical Research (ICMR; http://icmr.nic.in/), Government of India (New Delhi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09; BROTZ H, 1995, ANTIMICROB AGENTS CH, V39, P714, DOI 10.1128/AAC.39.3.714; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chang YJ, 2011, STAND GENOMIC SCI, V5, P97, DOI 10.4056/sigs.2114901; Corvey C, 2003, BIOCHEM BIOPH RES CO, V304, P48, DOI 10.1016/S0006-291X(03)00529-1; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Cox CR, 2005, CURR PROTEIN PEPT SC, V6, P77, DOI 10.2174/1389203053027557; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; FREDENHAGEN A, 1990, J ANTIBIOT, V43, P1403, DOI 10.7164/antibiotics.43.1403; Goto Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000339; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; He ZG, 2008, FEBS LETT, V582, P2787, DOI 10.1016/j.febslet.2008.07.008; Hyink O, 2005, FEMS MICROBIOL LETT, V252, P235, DOI 10.1016/j.femsle.2005.09.003; Izaguirre G, 1997, APPL ENVIRON MICROB, V63, P3965, DOI 10.1128/AEM.63.10.3965-3971.1997; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Li XL, 2012, BIOTECHNOL LETT, V34, P2133, DOI 10.1007/s10529-012-1024-2; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Marsh AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-679; Mattick ATR, 1944, NATURE, V154, P551, DOI 10.1038/154551a0; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Navaratna MADB, 1998, APPL ENVIRON MICROB, V64, P4803; Nes IF, 2007, J BACTERIOL, V189, P1189, DOI 10.1128/JB.01254-06; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Patton GC, 2008, BIOCHEMISTRY-US, V47, P7342, DOI 10.1021/bi800277d; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Ryan MP, 1996, APPL ENVIRON MICROB, V62, P612, DOI 10.1128/AEM.62.2.612-619.1996; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Stepper J, 2011, FEBS LETT, V585, P645, DOI 10.1016/j.febslet.2011.01.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; WAKAMIYA T, 1985, TETRAHEDRON LETT, V26, P665, DOI 10.1016/S0040-4039(00)89174-1; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022384; Wang XJ, 2010, J BACTERIOL, V192, P4526, DOI 10.1128/JB.00596-10; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Xiong ZH, 2009, J BACTERIOL, V191, P1120, DOI 10.1128/JB.01629-08; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	54	37	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91352	10.1371/journal.pone.0091352	http://dx.doi.org/10.1371/journal.pone.0091352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621781	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300079
J	Ma, B; Wells, A				Ma, Bo; Wells, Alan			The Mitogen-activated Protein ( MAP) Kinases p38 and Extracellular Signal-regulated Kinase ( ERK) Are Involved in Hepatocyte-mediated Phenotypic Switching in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E-cadherin; EMT; Epidermal Growth Factor Receptor (EGFR); Epithelial to Mesenchymal Transition; Metastasis; Mesenchymal to Epithelial Reverting Transition	EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; CARCINOMA-CELLS; BREAST-CANCER; GROWTH; PATHWAY; AMPLIFICATION; METASTASIS; INHIBITION; P38-ALPHA	Background: Epithelial mesenchymal phenotypic switching enables cancers to seed and survive in metastatic sites. Results: Both p38 and ERK1/2 MAP kinases need to be inhibited to allow for an epithelial reversion but activated to provide survival advantage in the face of chemotherapy. Conclusion: Distinct p38/ERK signaling outcomes are involved in hepatocytes-mediated MErT and tumor cells survival. Significance: Provides insights in understanding approaches to p38 or ERK1/2 activity regulation for cancer therapy. The greatest challenge for the seeding of cancer in metastatic sites is integration into the ectopic microenvironment despite the lack of an orthotopic supportive environment and presence of pro-death signals concomitant with a localized foreign-body inflammatory response. In this metastatic location, many carcinoma cells display a reversion of the epithelial-to-mesenchymal transition that marks dissemination in the primary tumor mass. This mesenchymal to epithelial reverting transition (MErT) is thought to help seeding and colonization by protecting against cell death. We have previously shown that hepatocyte coculture induces the re-expression of E-cadherin via abrogation of autocrine EGFR signaling pathway in prostate cancer (PCa) cells and that this confers a survival advantage. Herein, we show that hepatocytes educate PCa to undergo MErT by modulating the activity of p38 and ERK1/2. Hepatocytes inhibited p38 and ERK1/2 activity in prostate cancer cells, which allowed E-cadherin re-expression. Introduction of constitutively active MEK6 and MEK1 to DU145 cells cocultured with hepatocytes abrogated E-cadherin re-expression. At least a partial phenotypic reversion can be achieved by suppression of p38 and ERK1/2 activation in DU145 cells even in the absence of hepatocytes. Interestingly, these mitogen-activated protein kinase activities were also triggered by re-expressed E-cadherin leading to p38 and ERK1/2 activity in PCa cells; these signals provide protection to PCa cells upon challenge with chemotherapy and cell death-inducing cytokines. We propose that distinct p38/ERK pathways are related to E-cadherin levels and function downstream of E-cadherin allowing, respectively, for hepatocyte-mediated MErT and tumor cell survival in the face of death signals.	[Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Wells, Alan] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, 3550 Terrace St,Scaife Hall S713, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu	; ma, bo/B-1163-2019	Wells, Alan/0000-0002-1637-8150; ma, bo/0000-0003-0816-6630	National Institutes of Health National Center for Advancing Translational Sciences Microphysiological Systems (MPS) program; Veterans Affairs Merit Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000496] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001017] Funding Source: NIH RePORTER	National Institutes of Health National Center for Advancing Translational Sciences Microphysiological Systems (MPS) program; Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the National Institutes of Health National Center for Advancing Translational Sciences Microphysiological Systems (MPS) program. This work was also supported by a Veterans Affairs Merit Award.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Chao Y, 2012, CLIN EXP METASTAS, V29, P39, DOI 10.1007/s10585-011-9427-3; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Elenitoba-Johnson KSJ, 2003, P NATL ACAD SCI USA, V100, P7259, DOI 10.1073/pnas.1137463100; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Horn G, 2009, EXP CELL RES, V315, P1490, DOI 10.1016/j.yexcr.2009.02.011; JACKSON RC, 1989, ADV ENZYME REGUL, V29, P27, DOI 10.1016/0065-2571(89)90092-7; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Krysan K, 2008, J THORAC ONCOL, V3, P107, DOI 10.1097/JTO.0b013e3181630ece; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lim Minyoung, 2011, Hormones & Cancer, V2, P298, DOI 10.1007/s12672-011-0084-4; Liu Y, 2008, DEV BIOL, V314, P224, DOI 10.1016/j.ydbio.2007.12.003; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Munshi A, 2002, CANCER CHEMOTH PHARM, V50, P46, DOI 10.1007/s00280-002-0465-z; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Saha B, 2007, ANTICANCER RES, V27, P3903; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Yates C, 2005, BRIT J CANCER, V92, P366, DOI 10.1038/sj.bjc.6602350; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	39	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11153	11161		10.1074/jbc.M113.540237	http://dx.doi.org/10.1074/jbc.M113.540237			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619413	hybrid, Green Published			2022-12-25	WOS:000334638500019
J	Guicciardi, ME; Werneburg, NW; Bronk, SF; Franke, A; Yagita, H; Thomas, G; Gores, GJ				Guicciardi, Maria Eugenia; Werneburg, Nathan W.; Bronk, Steven F.; Franke, Adrian; Yagita, Hideo; Thomas, Gary; Gores, Gregory J.			Cellular Inhibitor of Apoptosis (cIAP)-Mediated Ubiquitination of Phosphofurin Acidic Cluster Sorting Protein 2 (PACS-2) Negatively Regulates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Cytotoxicity	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; LYSOSOMAL PATHWAY; DOWN-REGULATION; IAP PROTEINS; CIAP1; ACTIVATION; XIAP; DEGRADATION; BINDING	Lysosomal membrane permeabilization is an essential step in TRAIL-induced apoptosis of liver cancer cell lines. TRAIL-induced lysosomal membrane permeabilization is mediated by the multifunctional sorting protein PACS-2 and repressed by the E3 ligases cIAP-1 and cIAP-2. Despite the opposing roles for PACS-2 and cIAPs in TRAIL-induced apoptosis, an interaction between these proteins has yet to be examined. Herein, we report that cIAP-1 and cIAP-2 confer TRAIL resistance to hepatobiliary cancer cell lines by reducing PACS-2 levels. Under basal conditions, PACS-2 underwent K48-linked poly-ubiquitination, resulting in PACS-2 proteasomal degradation. Biochemical assays showed cIAP-1 and cIAP-2 interacted with PACS-2 in vitro and co-immunoprecipitation studies demonstrated that the two cIAPs bound PACS-2 in vivo. More importantly, both cIAP-1 and cIAP-2 directly mediated PACS-2 ubiquitination in a cell-free assay. Single c-Iap-1 or c-Iap-2 gene knock-outs in mouse hepatocytes did not lead to PACS-2 accumulation. However, deletion of both cIAP-1 and cIAP-2 reduced PACS-2 ubiquitination, which increased PACS-2 levels and sensitized HuH-7 cells to TRAIL-induced lysosomal membrane permeabilization and apoptosis. Correspondingly, deletion of cIAPs sensitized wild-type, but not PACS-2-deficient hepatocarcinoma cells or Pacs-2(-/-) mouse hepatocytes to TRAIL-induced apoptosis. Together, these data suggest cIAPs constitutively downregulate PACS-2 by polyubiquitination and proteasomal degradation, thereby restraining TRAIL-induced killing of liver cancer cells.	[Guicciardi, Maria Eugenia; Werneburg, Nathan W.; Bronk, Steven F.; Franke, Adrian; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Thomas, Gary] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Mayo Clinic; Juntendo University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	gores.gregory@mayo.edu			NIH [R01 DK63947, CA151564]; Mayo Foundation;  [DK84567]; NATIONAL CANCER INSTITUTE [R01CA151564, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK063947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NIH R01 DK63947 (to GJG), CA151564 (GT), Optical Microscopy Core DK84567 and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dynek JN, 2013, CANCER LETT, V332, P206, DOI 10.1016/j.canlet.2010.06.013; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Gao Z, 2007, J BIOL CHEM, V282, P30718, DOI 10.1074/jbc.M705258200; Garrison SP, 2012, CELL DEATH DIFFER, V19, P642, DOI 10.1038/cdd.2011.136; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gores GJ, 2001, HEPATOLOGY, V34, P3, DOI 10.1053/jhep.2001.25173; Guicciardi ME, 2007, AM J PHYSIOL-GASTR L, V292, pG1337, DOI 10.1152/ajpgi.00497.2006; Guicciardi ME, 2011, EXP CELL RES, V317, P107, DOI 10.1016/j.yexcr.2010.10.005; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Takeda K, 2008, P NATL ACAD SCI USA, V105, P10895, DOI 10.1073/pnas.0802702105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Werneburg NW, 2012, J BIOL CHEM, V287, P24427, DOI 10.1074/jbc.M112.342238; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	44	20	20	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92124	10.1371/journal.pone.0092124	http://dx.doi.org/10.1371/journal.pone.0092124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633224	Green Accepted, Green Published, gold			2022-12-25	WOS:000332858400144
J	Zhang, XX; Cao, RS; Liu, RP; Zhao, RP; Huang, Y; Gurley, EC; Hylemon, PB; Pandak, WM; Wang, GJ; Zhang, LY; Li, XK; Zhou, HP				Zhang, Xiaoxuan; Cao, Risheng; Liu, Runping; Zhao, Renping; Huang, Yi; Gurley, Emily C.; Hylemon, Phillip B.; Pandak, William M.; Wang, Guangji; Zhang, Luyong; Li, Xiaokun; Zhou, Huiping			Reduction of the HIV Protease Inhibitor-Induced ER Stress and Inflammatory Response by Raltegravir in Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID; OXIDATIVE STRESS; LIPID-METABOLISM; LIVER; HYPERLIPIDEMIA; EXPRESSION; PREVENTION; ACTIVATE; THERAPY	Background: HIV protease inhibitor (PI), the core component of highly active antiretroviral treatment (HAART) for HIV infection, has been implicated in HAART-associated cardiovascular complications. Our previous studies have demonstrated that activation of endoplasmic reticulum (ER) stress is linked to HIV PI-induced inflammation and foam cell formation in macrophages. Raltegravir is a first-in-its-class HIV integrase inhibitor, the newest class of anti-HIV agents. We have recently reported that raltegravir has less hepatic toxicity and could prevent HIV PI-induced dysregulation of hepatic lipid metabolism by inhibiting ER stress. However, little information is available as to whether raltegravir would also prevent HIV PI-induced inflammatory response and foam cell formation in macrophages. Methodology and Principal Findings: In this study, we examined the effect of raltegravir on ER stress activation and lipid accumulation in cultured mouse macrophages (J774A.1), primary mouse macrophages, and human THP-1-derived macrophages, and further determined whether the combination of raltegravir with existing HIV PIs would potentially exacerbate or prevent the previously observed activation of inflammatory response and foam cell formation. The results indicated that raltegravir did not induce ER stress and inflammatory response in macrophages. Even more interestingly, HIV PI-induced ER stress, oxidative stress, inflammatory response and foam cell formation were significantly reduced by raltegravir. High performance liquid chromatography (HPLC) analysis further demonstrated that raltegravir did not affect the uptake of HIV PIs in macrophages. Conclusion and Significance: Raltegravir could prevent HIV PI-induced inflammatory response and foam cell formation by inhibiting ER stress. These results suggest that incorporation of this HIV integrase inhibitor may reduce the cardiovascular complications associated with current HAART.	[Zhang, Xiaoxuan; Liu, Runping; Zhao, Renping; Huang, Yi; Wang, Guangji; Zhang, Luyong] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaoxuan; Cao, Risheng; Liu, Runping; Gurley, Emily C.; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Huang, Yi; Li, Xiaokun; Zhou, Huiping] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China; [Hylemon, Phillip B.; Pandak, William M.; Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Hylemon, Phillip B.; Pandak, William M.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA	China Pharmaceutical University; Virginia Commonwealth University; Wenzhou Medical University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Wang, GJ (corresponding author), China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhao, Renping/C-8175-2014; Stefanadis, Christodoulos/ABH-2232-2020; Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015	Stefanadis, Christodoulos/0000-0001-5974-6454; Zhou, Huiping/0000-0002-0050-372X; 	Merck Research Fund; National Institute of Allergy and Infectious Diseases [AI06843, AI057189]; National Institute of Complementary and Alternative Medicine [AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057189] Funding Source: NIH RePORTER	Merck Research Fund; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Complementary and Alternative Medicine; VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is supported by Merck Research Fund; the National Institute of Allergy and Infectious Diseases [Grants AI06843 and AI057189]; the National Institute of Complementary and Alternative Medicine [Grant AT004148]; VA Merit Award (1I01BX001390) and National Science Foundation of China (Grants 81070245 and 81270489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg K, 2005, FREE RADICAL RES, V39, P629, DOI 10.1080/10715760400028027; Cao RS, 2010, J PHARMACOL EXP THER, V334, P530, DOI 10.1124/jpet.110.168484; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Cocohoba J, 2008, CLIN THER, V30, P1747, DOI 10.1016/j.clinthera.2008.10.012; Deng W, 2010, J MOL CELL CARDIOL, V49, P746, DOI 10.1016/j.yjmcc.2010.08.013; Fan Jianglin, 2003, J Atheroscler Thromb, V10, P63; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Hughes CA, 2009, EXPERT OPIN PHARMACO, V10, P2445, DOI 10.1517/14656560903176446; Imaz A, 2009, JAIDS-J ACQ IMM DEF, V52, P382, DOI 10.1097/QAI.0b013e3181b17f53; Jacob A, 2007, BBA-MOL BASIS DIS, V1772, P766, DOI 10.1016/j.bbadis.2007.03.010; Jager R, 2012, BIOL CELL; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kaplowitz N, 2006, J GASTROEN HEPATOL, V21, pS7, DOI 10.1111/j.1440-1746.2006.04581.x; Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c; Koster JC, 2003, DIABETES, V52, P1695, DOI 10.2337/diabetes.52.7.1695; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mooser V, 2001, CURR OPIN LIPIDOL, V12, P313, DOI 10.1097/00041433-200106000-00011; Moyle Graeme, 2002, HIV Clin Trials, V3, P89; Nair V, 2007, REV MED VIROL, V17, P277, DOI 10.1002/rmv.539; Poirier JM, 2008, J CHROMATOGR B, V867, P277, DOI 10.1016/j.jchromb.2008.03.026; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Spector AA, 2006, ARTERIOSCL THROM VAS, V26, P7, DOI 10.1161/01.ATV.0000198749.28422.29; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tousoulis D, 2009, INT J CARDIOL, V136, P258, DOI 10.1016/j.ijcard.2008.04.087; Vlahakis SR, 2007, APOPTOSIS, V12, P969, DOI 10.1007/s10495-007-0755-3; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou H, 2007, ATHEROSCLEROSIS; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006	34	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90856	10.1371/journal.pone.0090856	http://dx.doi.org/10.1371/journal.pone.0090856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625618	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300036
J	Hao, WR; Friedman, A				Hao, Wenrui; Friedman, Avner			The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LYMPHOCYTES-T; MYCOBACTERIUM-TUBERCULOSIS; ANTIOXIDANT VITAMINS; TISSUE INHIBITOR; PARTICLE-SIZE; GROWTH; CELL; MACROPHAGES; EXPRESSION	Atherosclerosis, the leading death in the United State, is a disease in which a plaque builds up inside the arteries. As the plaque continues to grow, the shear force of the blood flow through the decreasing cross section of the lumen increases. This force may eventually cause rupture of the plaque, resulting in the formation of thrombus, and possibly heart attack. It has long been recognized that the formation of a plaque relates to the cholesterol concentration in the blood. For example, individuals with LDL above 190 mg/dL and HDL below 40 mg/dL are at high risk, while individuals with LDL below 100 mg/dL and HDL above 50 mg/dL are at no risk. In this paper, we developed a mathematical model of the formation of a plaque, which includes the following key variables: LDL and HDL, free radicals and oxidized LDL, MMP and TIMP, cytockines: MCP-1, IFN-gamma, IL-12 and PDGF, and cells: macrophages, foam cells, T cells and smooth muscle cells. The model is given by a system of partial differential equations with in evolving plaque. Simulations of the model show how the combination of the concentrations of LDL and HDL in the blood determine whether a plaque will grow or disappear. More precisely, we create a map, showing the risk of plaque development for any pair of values (LDL, HDL).	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 0931642 (http://nsf.gov/awardsearch/showAward?AWD_ID = 0931642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty J, 1999, NUMER ALGORITHMS, V20, P117, DOI 10.1023/A:1019155918070; ANTONIADES HN, 1981, P NATL ACAD SCI-BIOL, V78, P7314, DOI 10.1073/pnas.78.12.7314; Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057; BARRETT TB, 1988, P NATL ACAD SCI USA, V85, P2810, DOI 10.1073/pnas.85.8.2810; Barter P, 2005, EUR HEART J SUPPL, V7, pF4, DOI 10.1093/eurheartj/sui036; Barter PJ, 2010, J LIPID RES, V51, P1546, DOI 10.1194/jlr.P002816; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; BOWENPOPE DF, 1984, BLOOD, V64, P458; Byrne HM, 1999, J MATH BIOL, V39, P59, DOI 10.1007/s002850050163; Byrne HM, 1997, IMA J MATH APPL MED, V14, P305; Byrne HM, 1996, MATH COMPUT MODEL, V24, P1, DOI 10.1016/S0895-7177(96)00174-4; Calvez V, 2009, CEMRACS 2008 MODELLI, V28, P1; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cobbold CA, 2002, B MATH BIOL, V64, P65, DOI 10.1006/bulm.2001.0267; Cohen A, 2012, PREPRINT; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Fabunmi RP, 1998, CIRC RES, V83, P270, DOI 10.1161/01.RES.83.3.270; Friedman A, 2008, EXP GERONTOL, V43, P275, DOI 10.1016/j.exger.2007.12.004; Frink R., 2002, INFLAMMATORY ATHEROS; Garcia-Tunon I, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-158; Gattorno M, 1998, ANN RHEUM DIS, V57, P425, DOI 10.1136/ard.57.7.425; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; HANSSON GK, 1989, AM J PATHOL, V135, P169; Harrington JR, 2000, STEM CELLS, V18, P65, DOI 10.1634/stemcells.18-1-65; HOKLAND B, 1992, J LIPID RES, V33, P1335; Hoyert D. L., 2012, NATL VITAL STAT REPO, V61; INGOLD KU, 1993, P NATL ACAD SCI USA, V90, P45, DOI 10.1073/pnas.90.1.45; Ishigaki Y, 2009, CURR OPIN LIPIDOL, V20, P363, DOI 10.1097/MOL.0b013e32832fa58d; JANIN J, 1978, BIOCHEMISTRY-US, V17, P2943, DOI 10.1021/bi00608a001; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; KOSAKA C, 1992, ATHEROSCLEROSIS, V97, P75, DOI 10.1016/0021-9150(92)90053-J; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Li Z, FINITE ELEMENT METHO; Liao KL, 2013, J THEOR BIOL, V328, P65, DOI 10.1016/j.jtbi.2013.03.017; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mayo Clinic Staff, IMP IS CHOL RAT; Mckay C., 2005, MODEL ATHEROSCLEROSI; Mercapide J, 2003, INT J CANCER, V106, P676, DOI 10.1002/ijc.11286; Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X; Mitsuhashi T, 2013, FISHERIES SCI, V79, P495, DOI 10.1007/s12562-013-0616-7; Moreno Pedro R, 2010, Cardiol Clin, V28, P1, DOI 10.1016/j.ccl.2009.09.008; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Orbe J, 2003, ATHEROSCLEROSIS, V167, P45, DOI 10.1016/S0021-9150(02)00392-1; ORME IM, 1987, J IMMUNOL, V138, P4414; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Otani H, 2013, OXID MED CELL LONGEV; Ozkanlar S, 2012, ADV CLIN EXP MED, V21, P115; Palosaari H, 2003, MATRIX METALLOPROTEI; Persson PO, 2004, SIAM REV, V46, P329, DOI 10.1137/S0036144503429121; Rahdert D A, 1999, Cardiovasc Radiat Med, V1, P358; RAINES EW, 1993, BRIT HEART J, V69, pS30; Rajman I, 1999, BRIT J CLIN PHARMACO, V48, P125, DOI 10.1046/j.1365-2125.1999.00991.x; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rhodes J, 2009, J TRAUMA, V66, P1591, DOI 10.1097/TA.0b013e31819a0344; Rodriguez JA, 2007, REV ESP CARDIOL, V60, P959, DOI 10.1157/13109649; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; Ryu B.H., 2000, BIOTECHNOL BIOPROC E, V5, P313, DOI [10.1007/BF02942205, DOI 10.1007/BF02942205]; Tardif Jean-Claude, 2005, Curr Atheroscler Rep, V7, P71, DOI 10.1007/s11883-005-0078-1; Tietz NW, 1999, CLIN GUIDE LAB TESTS; Tsimikas S, 2001, CIRCULATION, V103, P1930; TSUKAGUCHI K, 1995, J IMMUNOL, V154, P1786; Xue C, 2009, P NATL ACAD SCI USA, V106, P16782, DOI 10.1073/pnas.0909115106; Yamamoto S, 2006, J SURG RES, V134, P307, DOI 10.1016/j.jss.2005.11.588; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862	74	48	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90497	10.1371/journal.pone.0090497	http://dx.doi.org/10.1371/journal.pone.0090497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621857	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300022
J	Liu, JH; Zhang, ZK; Chen, LJ; Liu, C; Yang, CC; Wang, XQ				Liu, Jin-Hu; Zhang, Zi-Ke; Chen, Lingjiao; Liu, Chuang; Yang, Chengcheng; Wang, Xueqi			Gravity Effects on Information Filtering and Network Evolving	PLOS ONE			English	Article							COMPLEX NETWORKS; MODEL; EVOLUTION	In this paper, based on the gravity principle of classical physics, we propose a tunable gravity-based model, which considers tag usage pattern to weigh both the mass and distance of network nodes. We then apply this model in solving the problems of information filtering and network evolving. Experimental results on two real-world data sets, Del.icio.us and MovieLens, show that it can not only enhance the algorithmic performance, but can also better characterize the properties of real networks. This work may shed some light on the in-depth understanding of the effect of gravity model.	[Liu, Jin-Hu; Chen, Lingjiao; Yang, Chengcheng] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Liu, Jin-Hu; Zhang, Zi-Ke; Chen, Lingjiao; Liu, Chuang] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Liu, Jin-Hu; Zhang, Zi-Ke; Chen, Lingjiao; Liu, Chuang] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Peoples R China; [Wang, Xueqi] Second Mil Med Univ, Shanghai Changzheng Hosp, Div Translat Med, Shanghai, Peoples R China	University of Electronic Science & Technology of China; Hangzhou Normal University; Hangzhou Normal University; Naval Medical University	Zhang, ZK (corresponding author), Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China.	zhangzike@gmail.com; xueqiniu.wang@gmail.com	chuang, liu/AAH-1377-2021		Zhejiang Provincial Natural Science Foundation of China [LY12A05003, LQ13F030015];  [NSFC: 11105024];  [11205040];  [11301490];  [11305043]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); ; ; ; 	NSFC: 11105024, 11205040, 11301490 and 11305043. Zhejiang Provincial Natural Science Foundation of China: Grant Nos. LY12A05003 and LQ13F030015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERGSTRAND JH, 1985, REV ECON STAT, V67, P474, DOI 10.2307/1925976; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bouttier J, 2002, NUCL PHYS B, V645, P477, DOI 10.1016/S0550-3213(02)00813-1; Casey HJ, 1955, TRAFFIC Q, V9, P313; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cui AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050702; Dorogovtsev SN, 2000, EUROPHYS LETT, V52, P33, DOI 10.1209/epl/i2000-00400-0; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Galileo G., 1914, DIALOGUES 2 NEW SCI; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hu F, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.198901; Jin EM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046132; Jung WS, 2008, EUR PHYS J B, V62, P113, DOI 10.1140/epjb/e2008-00123-0; Karemera D, 2000, APPL ECON, V32, P1745, DOI 10.1080/000368400421093; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Newton I., 1999, MATH PRINCIPLES NATU; Qiu T, 2014, COMPUT PHYS COMMUN, V185, P489, DOI 10.1016/j.cpc.2013.10.003; Qiu T, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/48007; Qiu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063531; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Reilly W.J, 1929, METHODS STUDY RETAIL; Reilly WJ, 1931, LAWS RETAIL GRAVITAT; RIETVELD P, 1989, ANN REGIONAL SCI, V23, P255, DOI 10.1007/BF01579778; Rodrigue J.-P., 2013, GEOGRAPHY TRANSPORT; Rose AK, 2004, AM ECON REV, V94, P98, DOI 10.1257/000282804322970724; Salton G, 1983, INTRO MODEL INFORM R; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI DOI 10.1145/371920.372071; STEWART JQ, 1950, AM J PHYS, V18, P239, DOI 10.1119/1.1932559; Tinbergen J, 1962, SHAPING WORLD EC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westerlund J, 2011, APPL ECON, V43, P641, DOI 10.1080/00036840802599784; Willumsen LG, 2011, MOD TRANSP 4 ED; Zhang CX, 2013, PHYSICA A, V392, P6100, DOI 10.1016/j.physa.2013.07.027; Zhang ZK, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501660; Zhang ZK, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10005; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhang ZK, 2010, PHYSICA A, V389, P179, DOI 10.1016/j.physa.2009.08.036; Zhou S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/173; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2010, P NATL ACAD SCI USA, V107, P4511, DOI 10.1073/pnas.1000488107; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	55	8	10	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91070	10.1371/journal.pone.0091070	http://dx.doi.org/10.1371/journal.pone.0091070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622162	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300047
J	McAleer, P; Todorov, A; Belin, P				McAleer, Phil; Todorov, Alexander; Belin, Pascal			How Do You Say 'Hello'? Personality Impressions from Brief Novel Voices	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; VOCAL ATTRACTIVENESS; 1ST IMPRESSIONS; SPEAKER HEIGHT; FACIAL ATTRACTIVENESS; WEIGHT IDENTIFICATION; JUDGING PERSONALITY; MENS VOICES; BODY-SIZE; FACES	On hearing a novel voice, listeners readily form personality impressions of that speaker. Accurate or not, these impressions are known to affect subsequent interactions; yet the underlying psychological and acoustical bases remain poorly understood. Furthermore, hitherto studies have focussed on extended speech as opposed to analysing the instantaneous impressions we obtain from first experience. In this paper, through a mass online rating experiment, 320 participants rated 64 sub-second vocal utterances of the word 'hello' on one of 10 personality traits. We show that: (1) personality judgements of brief utterances from unfamiliar speakers are consistent across listeners; (2) a two-dimensional 'social voice space' with axes mapping Valence (Trust, Likeability) and Dominance, each driven by differing combinations of vocal acoustics, adequately summarises ratings in both male and female voices; and (3) a positive combination of Valence and Dominance results in increased perceived male vocal Attractiveness, whereas perceived female vocal Attractiveness is largely controlled by increasing Valence. Results are discussed in relation to the rapid evaluation of personality and, in turn, the intent of others, as being driven by survival mechanisms via approach or avoidance behaviours. These findings provide empirical bases for predicting personality impressions from acoustical analyses of short utterances and for generating desired personality impressions in artificial voices.	[McAleer, Phil; Belin, Pascal] Univ Glasgow, Sch Psychol, Coll Sci & Engn, Glasgow, Lanark, Scotland; [Todorov, Alexander] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Belin, Pascal] Univ Glasgow, Coll Med Vet & Life Sci, Voice Neurocognit Lab, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Belin, Pascal] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Belin, Pascal] Univ Aix Marseille, Inst Neurosci La Timone, Marseille, France	University of Glasgow; Princeton University; University of Glasgow; Universite de Montreal; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	McAleer, P (corresponding author), Univ Glasgow, Sch Psychol, Coll Sci & Engn, Glasgow, Lanark, Scotland.	Philip.McAleer@glasgow.ac.uk	Belin, Pascal/C-6247-2009; McAleer, Phil/A-8178-2011	Belin, Pascal/0000-0002-7578-6365; McAleer, Phil/0000-0002-4523-2097	ESRC/MRC [RES-060-25-0010]; ESRC [ES/E020933/1] Funding Source: UKRI; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish	ESRC/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This project was funded by an ESRC/MRC large grant RES-060-25-0010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport GW, 1934, J SOC PSYCHOL, V5, P37, DOI 10.1080/00224545.1934.9921582; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Baumann O, 2010, PSYCHOL RES-PSYCH FO, V74, P110, DOI 10.1007/s00426-008-0185-z; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BERRY DS, 1989, PERS SOC PSYCHOL B, V15, P266, DOI 10.1177/0146167289152013; BERRY DS, 1991, J PERS SOC PSYCHOL, V61, P298, DOI 10.1037/0022-3514.61.2.298; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Berry DS, 1992, J NONVERBAL BEHAV, V14, P141; Bestelmeyer PEG, 2012, CEREB CORTEX, V22, P1263, DOI 10.1093/cercor/bhr204; Bestelmeyer PEG, 2010, COGNITION, V117, P217, DOI 10.1016/j.cognition.2010.08.008; Boersma P, 2001, GLOT INT, V5, P341; BORKENAU P, 1993, J PERS, V61, P477, DOI 10.1111/j.1467-6494.1993.tb00779.x; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Feinberg DR, 2012, BEHAV ECOL SOCIOBIOL, V66, P413, DOI 10.1007/s00265-011-1287-y; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Ferdenzi C, 2013, BEHAV RES METHODS, V45, P405, DOI 10.3758/s13428-012-0275-0; Ferrand CT, 2002, J VOICE, V16, P480, DOI 10.1016/S0892-1997(02)00123-6; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Funder DC, 2012, CURR DIR PSYCHOL SCI, V21, P177, DOI 10.1177/0963721412445309; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Hughes S. M., 2009, J SOCIAL EVOLUTIONAR, V3, P343, DOI DOI 10.1037/H0099311); Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Hughes SM, 2010, J SOC EVOL CULT PSYC, V4, P290, DOI DOI 10.1037/H0099282; Jones BC, 2007, PERCEPT PSYCHOPHYS, V69, P1273, DOI 10.3758/BF03192944; Kawahara H, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL I, PROCEEDINGS, P256; KENNY DA, 1992, J PERS SOC PSYCHOL, V62, P88, DOI 10.1037/0022-3514.62.1.88; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Ko SJ, 2006, PERS SOC PSYCHOL B, V32, P806, DOI 10.1177/0146167206286627; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Krauss RM, 2002, J EXP SOC PSYCHOL, V38, P618, DOI 10.1016/S0022-1031(02)00510-3; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; LASS NJ, 1980, J PHONETICS, V8, P277, DOI 10.1016/S0095-4470(19)31477-9; Latinus M, 2013, CURR BIOL, V23, P1075, DOI 10.1016/j.cub.2013.04.055; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Latinus M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00175; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lewis JW, 2009, J NEUROSCI, V29, P2283, DOI 10.1523/JNEUROSCI.4145-08.2009; Little AC, 2013, ARCH SEX BEHAV; Little AC, 2007, BRIT J PSYCHOL, V98, P111, DOI 10.1348/000712606X109648; Little AC, 2012, Q J EXP PSYCHOL, V65, P2018, DOI 10.1080/17470218.2012.677048; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Luevano V.X., 2007, EVOL PSYCHOL-US, V5, P15, DOI [10.1177/147470490700500102, DOI 10.1177/147470490700500102]; MCARTHUR LZ, 1983, PSYCHOL REV, V90, P215, DOI 10.1037/0033-295X.90.3.215; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MIYAKE K, 1993, J PERS, V61, P411, DOI 10.1111/j.1467-6494.1993.tb00287.x; MONTEPARE JM, 1987, J EXP SOC PSYCHOL, V23, P331, DOI 10.1016/0022-1031(87)90045-X; Nass C, 2001, J EXP PSYCHOL-APPL, V7, P171, DOI 10.1037//1076-898X.7.3.171; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; PAGE RA, 1978, J SOC PSYCHOL, V105, P65, DOI 10.1080/00224545.1978.9924091; PASSINI FT, 1966, J PERS SOC PSYCHOL, V4, P44, DOI 10.1037/h0023519; Patel S, 2011, BIOL PSYCHOL, V87, P93, DOI 10.1016/j.biopsycho.2011.02.010; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Pivonkova V, 2011, ARCH SEX BEHAV, V40, P1137, DOI 10.1007/s10508-011-9821-6; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Rendall D, 2007, J EXP PSYCHOL HUMAN, V33, P1208, DOI 10.1037/0096-1523.33.5.1208; Rhodes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026653; ROSENBER.S, 1968, J PERS SOC PSYCHOL, V9, P283, DOI 10.1037/h0026086; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Scherer K.R., 1979, LANGUAGE SOCIAL PSYC, P88; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Schotz Susanne, 2007, Speaker Classification I. Fundamentals, Features, and Methods. (Lecture Notes in Artificial Intelligence vol. 4343), P88, DOI 10.1007/978-3-540-74200-5_5; Secord PF., 1958, PERSON PERCEPTION IN, P300; Shevlin M, 2003, PERS INDIV DIFFER, V35, P1373, DOI 10.1016/S0191-8869(02)00356-2; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; vanDommelen WA, 1995, LANG SPEECH, V38, P267, DOI 10.1177/002383099503800304; VANDOMMELEN WA, 1993, J PHONETICS, V21, P337, DOI 10.1016/S0095-4470(19)31343-9; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Verosky SC, 2010, PSYCHOL SCI, V21, P779, DOI 10.1177/0956797610371965; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Yao B, 2012, NEUROIMAGE, V60, P1832, DOI 10.1016/j.neuroimage.2012.01.111; Yao B, 2011, COGNITION, V121, P447, DOI 10.1016/j.cognition.2011.08.007; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 1996, FDN STEREOTYPES STER; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zebrowitz LA, 2012, J CROSS CULT PSYCHOL, V43, P119, DOI 10.1177/0022022111411386; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990; ZEBROWITZMCARTHUR L, 1989, J NONVERBAL BEHAV, V13, P189, DOI 10.1007/BF00987049; ZUCKERMAN M, 1995, J RES PERS, V29, P253, DOI 10.1006/jrpe.1995.1015; ZUCKERMAN M, 1990, J NONVERBAL BEHAV, V14, P97, DOI 10.1007/BF01670437; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	105	133	137	6	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90779	10.1371/journal.pone.0090779	http://dx.doi.org/10.1371/journal.pone.0090779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622283	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000332845300027
J	Weinandy, S; Babczyk, P; Dreier, A; Unger, RE; Flanagan, TC; Kirkpatrick, CJ; Zenke, M; Klee, D; Jockenhoevel, S				Weinandy, Stefan; Babczyk, Patrick; Dreier, Agnieszka; Unger, Ronald E.; Flanagan, Thomas C.; Kirkpatrick, C. James; Zenke, Martin; Klee, Doris; Jockenhoevel, Stefan			Ovine Carotid Artery-Derived Cells as an Optimized Supportive Cell Layer in 2-D Capillary Network Assays	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ANGIOGENESIS; VEGF; INHIBITION; DELIVERY; ANTIBODY; SCAFFOLD; SYSTEM	Background: Endothelial cell co-culture assays are differentiation assays which simulate the formation of capillary-like tubules with the aid of a supportive cell layer. Different cell types have been employed as a supportive cell layer, including human pulmonary artery smooth muscle cells (PASMCs) and human mammary fibroblasts. However, these sources of human tissue-derived cells are limited, and more readily accessible human or animal tissue-derived cell sources would simplify the endothelial cell co-culture assay. In the present study, we investigated the potential use of alternative, accessible supportive cells for endothelial cell co-culture assay, including human umbilical cord and ovine carotid artery. Methods and Results: Human umbilical artery SMCs (HUASMCs) and ovine carotid artery-derived cells were seeded into 96-well plates, followed by addition of human umbilical vein endothelial cells (HUVECs). Nine days after co-culture, cells were fixed, immunostained and analysed using an in vitro angiogenesis quantification tool. Capillary-like structures were detected on ovine carotid artery-derived supportive cell layers. The initial cell number, as well as pro-and anti-angiogenic factors (VEGF, PDGF-BB and Bevacizumab), had a positive or negative influence on the number of capillary-like structures. Furthermore, HUVECs from different donors showed distinct levels of VEGF receptor-2, which correlated with the amount of capillary-like structures. In the case of HUASMC supportive cell layers, HUVECs detached almost completely from the surface. Conclusions: Cells of different origin have a varying applicability regarding the endothelial cell co-culture assay: under the conditions described here, ovine carotid artery-derived cells seem to be more suitable than HUASMCs for an endothelial co-culture assay. Furthermore, the ovine carotid artery-derived cells are easier to obtain and are in more abundant supply than the currently used dermal or breast tissue cells. The use of ovine carotid artery-derived cells simplifies the endothelial co-culture assay with respect to testing large amounts of pro-and anti-angiogenic factors.	[Weinandy, Stefan; Babczyk, Patrick; Jockenhoevel, Stefan] Rhein Westfal TH Aachen, AME Helmholtz Inst Biomed Engn, Dept Tissue Engn & Text Implants, Aachen, Germany; [Dreier, Agnieszka] Rhein Westfal TH Aachen, Fac Med, Dept Neurosurg, Aachen, Germany; [Unger, Ronald E.; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-55122 Mainz, Germany; [Flanagan, Thomas C.] Univ Coll Dublin, Hlth Sci Ctr, Sch Med & Med Sci, Dublin 2, Ireland; [Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Aachen, Germany; [Klee, Doris] Rhein Westfal TH Aachen, ITMC, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; Johannes Gutenberg University of Mainz; University College Dublin; RWTH Aachen University; RWTH Aachen University	Jockenhoevel, S (corresponding author), Rhein Westfal TH Aachen, AME Helmholtz Inst Biomed Engn, Dept Tissue Engn & Text Implants, Aachen, Germany.	jockenhoevel@hia.rwth-aachen.de		Kirkpatrick, Charles James/0000-0002-0088-418X; Jockenhoevel, Stefan/0000-0003-0584-9444	DFG graduate school Biointerface [1035]	DFG graduate school Biointerface	The published work is funded by DFG graduate school Biointerface 1035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Davies NH, 2012, TISSUE ENG PT A, V18, P26, DOI 10.1089/ten.tea.2011.0192; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Dreier A, 2012, TUMOR BIOL, V33, P85, DOI 10.1007/s13277-011-0248-4; Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022; Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FINKENZELLER G, 1992, CANCER RES, V52, P4821; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Mabry R, 2010, MABS-AUSTIN, V2, P20, DOI 10.4161/mabs.2.1.10498; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; NICOSIA RF, 1990, LAB INVEST, V63, P115; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; OREILLY MS, 1994, COLD SPRING HARB SYM, V59, P471, DOI 10.1101/SQB.1994.059.01.052; Presta LG, 1997, CANCER RES, V57, P4593; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; SATO N, 1993, AM J PATHOL, V142, P1119; Semela D, 2008, GASTROENTEROLOGY, V135, P671, DOI 10.1053/j.gastro.2008.04.010; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; STAVRI GT, 1995, FEBS LETT, V358, P311, DOI 10.1016/0014-5793(94)01458-D	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91664	10.1371/journal.pone.0091664	http://dx.doi.org/10.1371/journal.pone.0091664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621607	Green Submitted, gold, Green Published			2022-12-25	WOS:000332845300115
J	Cesari, P; Camponogara, I; Papetti, S; Rocchesso, D; Fontana, F				Cesari, Paola; Camponogara, Ivan; Papetti, Stefano; Rocchesso, Davide; Fontana, Federico			Might as Well Jump: Sound Affects Muscle Activation in Skateboarding	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; AUDITORY MIRROR SYSTEM; ACTION REPRESENTATION; FUNCTIONAL-ANATOMY; SPEECH PRODUCTION; MUSIC PERCEPTION; GAIT INITIATION; VENTRAL STREAMS; ARM MOVEMENTS; OLDER-ADULTS	The aim of the study is to reveal the role of sound in action anticipation and performance, and to test whether the level of precision in action planning and execution is related to the level of sensorimotor skills and experience that listeners possess about a specific action. Individuals ranging from 18 to 75 years of age - some of them without any skills in skateboarding and others experts in this sport - were compared in their ability to anticipate and simulate a skateboarding jump by listening to the sound it produces. Only skaters were able to modulate the forces underfoot and to apply muscle synergies that closely resembled the ones that a skater would use if actually jumping on a skateboard. More importantly we showed that only skaters were able to plan the action by activating anticipatory postural adjustments about 200 ms after the jump event. We conclude that expert patterns are guided by auditory events that trigger proper anticipations of the corresponding patterns of movements.	[Cesari, Paola; Camponogara, Ivan] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Fontana, Federico] Univ Udine, Dept Math & Comp Sci, I-33100 Udine, Italy; [Rocchesso, Davide] Iuav Univ Venice, Dept Architecture & Arts, Venice, Italy; [Papetti, Stefano] Zurich Univ Arts, Inst Comp Mus & Sound Technol, Zurich, Switzerland	University of Verona; University of Udine; IUAV University Venice	Cesari, P (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	paola.cesari@univr.it	Camponogara, Ivan/AAW-6596-2020; Rocchesso, Davide/H-4711-2019; Papetti, Stefano/ABC-9182-2020	Camponogara, Ivan/0000-0001-5140-3449; Rocchesso, Davide/0000-0002-0849-7766; Papetti, Stefano/0000-0002-7490-3574; Cesari, Paola/0000-0002-1705-6065	European Community [222107]; European Commission [618067]	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding for the experimental activities leading to this research was received from the European Community's Seventh Framework Programme under FET-Open grant agreement 222107 NIW - Natural Interactive Walking. Author DR acknowledges the financial support of the Future and EmergingTechnologies (FET) program within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number 618067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Aglioti SM, 2011, TRENDS COGN SCI, V15, P47, DOI 10.1016/j.tics.2010.12.003; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Belinkiy VE, 1967, BIOFIZIKA, V12, P135; Benvenuti F, 1997, BRAIN RES, V761, P59, DOI 10.1016/S0006-8993(97)00260-6; Bertucco M, 2010, NEUROSCIENCE, V171, P205, DOI 10.1016/j.neuroscience.2010.08.023; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012240; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; De Wolf S, 1998, EXP BRAIN RES, V121, P7, DOI 10.1007/s002210050431; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Frederick EC, 2006, J APPL BIOMECH, V22, P33, DOI 10.1123/jab.22.1.33; Freriks B, 1999, EUROPEAN RECOMMENDAT, P1; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Goodale MA, 2005, PROG BRAIN RES, V149, P269, DOI 10.1016/S0079-6123(05)49019-6; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hesse S, 1997, ARCH PHYS MED REHAB, V78, P719, DOI 10.1016/S0003-9993(97)90079-4; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2001, J PSYCHOLINGUIST RES, V30, P225, DOI 10.1023/A:1010486816667; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hyodo M, 2012, GAIT POSTURE, V36, P625, DOI 10.1016/j.gaitpost.2012.06.018; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Pezzulo G, 2011, MIND LANG, V26, P78, DOI 10.1111/j.1468-0017.2010.01411.x; Pizzamiglio L, 2005, NEUROIMAGE, V24, P852, DOI 10.1016/j.neuroimage.2004.09.025; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Rath M, 2005, IEEE MULTIMEDIA, V12, P60, DOI 10.1109/MMUL.2005.24; Rogers MW, 2001, ARCH PHYS MED REHAB, V82, P619, DOI 10.1053/apmr.2001.20833; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Sedda A, 2011, EXP BRAIN RES, V209, P365, DOI 10.1007/s00221-011-2559-5; Shiratori T, 2001, CLIN NEUROPHYSIOL, V112, P1250, DOI 10.1016/S1388-2457(01)00553-3; Shiratori T, 2000, CLIN NEUROPHYSIOL, V111, P613, DOI 10.1016/S1388-2457(99)00300-4; Slijper H, 2002, BRAIN RES, V924, P184, DOI 10.1016/S0006-8993(01)03233-4; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Turchet L, 2013, T APPL PRCE IN PRESS; Uemura K, 2012, GAIT POSTURE, V35, P282, DOI 10.1016/j.gaitpost.2011.09.100; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Young W, 2013, J EXP PSYCHOL HUMAN, V39, P464, DOI 10.1037/a0029402; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	53	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90156	10.1371/journal.pone.0090156	http://dx.doi.org/10.1371/journal.pone.0090156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24619134	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400010
J	Gyore, J; Parameswar, AR; Hebbard, CFF; Oh, Y; Bi, EF; Demchenko, AV; Price, NP; Orlean, P				Gyore, Jacob; Parameswar, Archana R.; Hebbard, Carleigh F. F.; Oh, Younghoon; Bi, Erfei; Demchenko, Alexei V.; Price, Neil P.; Orlean, Peter			2-Acylamido Analogues of N-Acetylglucosamine Prime Formation of Chitin Oligosaccharides by Yeast Chitin Synthase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Chitin; Glycosyltransferases; Polysaccharide; Yeast Physiology	SACCHAROMYCES-CEREVISIAE; CELLULOSE SYNTHESIS; CELL-WALL; PURIFICATION; BIOSYNTHESIS; SYNTHETASE; EXTRACTION; BINDING; SITES; FUNGI	Background: Chitin synthases are stimulated by N-acetylglucosamine (GlcNAc). Results: GlcNAc and 2-acylamido analogues of GlcNAc stimulate formation of chitin oligosaccharides by yeast chitin synthase, and GlcNAc is transferred to the 2-acylamido analogues. Conclusion: Chitin synthases use GlcNAc analogues as primers and transfer one GlcNAc at a time. Significance: Results are new insights into polysaccharide synthase mechanism and suggest ways of synthesizing novel modified polysaccharides. Chitin, a homopolymer of 1,4-linked N-acetylglucosamine (GlcNAc) residues, is a key component of the cell walls of fungi and the exoskeletons of arthropods. Chitin synthases transfer GlcNAc from UDP-GlcNAc to preexisting chitin chains in reactions that are typically stimulated by free GlcNAc. The effect of GlcNAc was probed by using a yeast strain expressing a single chitin synthase, Chs2, by examining formation of chitin oligosaccharides (COs) and insoluble chitin, and by replacing GlcNAc with 2-acylamido analogues of GlcNAc. Synthesis of COs was strongly dependent on inclusion of GlcNAc in chitin synthase incubations, and N,N-diacetylchitobiose (GlcNAc(2)) was the major reaction product. Formation of both COs and insoluble chitin was also stimulated by GlcNAc(2) and by N-propanoyl-, N-butanoyl-, and N-glycolylglucosamine. MALDI analyses of the COs made in the presence of 2-acylamido analogues of GlcNAc showed they that contained a single GlcNAc analogue and one or more additional GlcNAc residues. These results indicate that Chs2 can use certain 2-acylamido analogues of GlcNAc, and likely free GlcNAc and GlcNAc(2) as well, as GlcNAc acceptors in a UDP-GlcNAc-dependent glycosyltransfer reaction. Further, formation of modified disaccharides indicates that CSs can transfer single GlcNAc residues.	[Gyore, Jacob; Hebbard, Carleigh F. F.; Orlean, Peter] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Parameswar, Archana R.; Demchenko, Alexei V.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA; [Oh, Younghoon; Bi, Erfei] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Price, Neil P.] ARS, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Saint Louis; University of Pennsylvania; Pennsylvania Medicine; United States Department of Agriculture (USDA)	Orlean, P (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	p-orlean@illinois.edu		Demchenko, Alexei/0000-0003-3515-212X	National Institutes of Health [GM077170, GM87365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM077170, R01GM087365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077170 (to A.V.D.) and GM87365 (to E.B.).	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Becker Hubert F, 2011, BMC Res Notes, V4, P454, DOI 10.1186/1756-0500-4-454; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CABIB E, 1987, METHOD ENZYMOL, V138, P643; CABIB E, 1987, ADV ENZYMOL RAMB, V59, P59; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrano L, 1997, J ANTIBIOT, V50, P177, DOI 10.7164/antibiotics.50.177; FAHNRICH M, 1981, EUR J BIOCHEM, V121, P113, DOI 10.1111/j.1432-1033.1981.tb06438.x; Horsch M, 1996, EUR J BIOCHEM, V237, P476, DOI 10.1111/j.1432-1033.1996.0476k.x; JOURDIAN GW, 1962, J BIOL CHEM, V237, P2442; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; KANG MS, 1984, J BIOL CHEM, V259, P4966; KELLER FA, 1971, J BIOL CHEM, V246, P160; Kristova V, 2005, J BIOTECHNOL, V115, P157, DOI 10.1016/j.jbiotec.2004.08.007; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Lubineau A, 1994, Bioorg Med Chem, V2, P669, DOI 10.1016/0968-0896(94)85016-X; Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Oh Y, 2012, MOL BIOL CELL, V23, P2445, DOI 10.1091/mbc.E12-01-0033; ORLEAN P, 1987, J BIOL CHEM, V262, P5732; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Redmond JW, 1999, CARBOHYD RES, V319, P74, DOI 10.1016/S0008-6215(99)00130-5; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Ruiz-Herrera Jose, 2002, FEMS Yeast Research, V1, P247, DOI 10.1016/S1567-1356(01)00049-6; SBURLATI A, 1986, J BIOL CHEM, V261, P5147; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Tanaka T, 1999, APPL ENVIRON MICROB, V65, P5338; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yabe T, 1998, EUR J BIOCHEM, V258, P941, DOI 10.1046/j.1432-1327.1998.2580941.x	33	8	8	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12835	12841		10.1074/jbc.M114.550749	http://dx.doi.org/10.1074/jbc.M114.550749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24619411	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000335581400052
J	Iannotti, MJ; Figard, L; Sokac, AM; Sifers, RN				Iannotti, Michael J.; Figard, Lauren; Sokac, Anna M.; Sifers, Richard N.			A Golgi-localized Mannosidase ( MAN1B1) Plays a Nonenzymatic Gatekeeper Role in Protein Biosynthetic Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Glycoprotein; ER Quality Control; ER-associated Degradation; ERAD; Glycoprotein Secretion; Glycosidases; Protein Degradation; Protein Evolution; Protein Misfolding; Protein Sorting	RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; FAMILY-47 ALPHA-MANNOSIDASES; N-GLYCAN BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; STRUCTURAL BASIS; EDEM1 PROTEIN; ALPHA-1,2-MANNOSIDASE	Background: The capacity of Golgi-localized MAN1B1 to promote ERAD was investigated. Results: The MAN1B1 catalytic domain is dispensable for ERAD, which helped identify an important conserved, non-enzymatic decapeptide sequence within the luminal stem. Conclusion: The tempo-spatial expansion of quality control in the secretory pathway includes evolutionary gain-of-function for MAN1B1. Significance: Evolutionary distinctions can exist in how quality control systems operate. Conformation-based disorders are manifested at the level of protein structure, necessitating an accurate understanding of how misfolded proteins are processed by the cellular proteostasis network. Asparagine-linked glycosylation plays important roles for protein quality control within the secretory pathway. The suspected role for the MAN1B1 gene product MAN1B1, also known as ER mannosidase I, is to function within the ER similar to the yeast ortholog Mns1p, which removes a terminal mannose unit to initiate a glycan-based ER-associated degradation (ERAD) signal. However, we recently discovered that MAN1B1 localizes to the Golgi complex in human cells and uncovered its participation in ERAD substrate retention, retrieval to the ER, and subsequent degradation from this organelle. The objective of the current study was to further characterize the contribution of MAN1B1 as part of a Golgi-based quality control network. Multiple lines of experimental evidence support a model in which neither the mannosidase activity nor catalytic domain is essential for the retention or degradation of the misfolded ERAD substrate Null Hong Kong. Instead, a highly conserved, vertebrate-specific non-enzymatic decapeptide sequence in the luminal stem domain plays a significant role in controlling the fate of overexpressed Null Hong Kong. Together, these findings define a new functional paradigm in which Golgi-localized MAN1B1 can play a mannosidase-independent gatekeeper role in the proteostasis network of higher eukaryotes.	[Iannotti, Michael J.; Figard, Lauren; Sokac, Anna M.; Sifers, Richard N.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Figard, Lauren; Sokac, Anna M.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Iannotti, Michael J.; Sifers, Richard N.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Sifers, RN (corresponding author), Dept Pathol & Immunol, 1 Baylor Plaza,Rm T228, Houston, TX 77030 USA.	rsifers@bcm.edu	Sifers, Richard Norman/AGQ-7262-2022		National Institutes of Health [RO1 DK064232]; Alpha1-Foundation; Huffington Center on Aging Biology of Aging Training Grant [T32AG000183-19]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha1-Foundation; Huffington Center on Aging Biology of Aging Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK064232. This work has also been supported by a grant from the Alpha1-Foundation (to R. N. S.) and Huffington Center on Aging Biology of Aging Training Grant T32AG000183-19 (to M. J. I.).	Anelli T, 2010, SEMIN CELL DEV BIOL, V21, P520, DOI 10.1016/j.semcdb.2010.02.006; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Burke J, 1996, EUR J CELL BIOL, V70, P298; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Dole K, 1997, J STRUCT BIOL, V120, P69, DOI 10.1006/jsbi.1997.3903; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; Groisman B, 2011, J BIOL CHEM, V286, P1292, DOI 10.1074/jbc.M110.154849; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; JELINEKKELLY S, 1985, J BIOL CHEM, V260, P2253; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; KLUG WS, 2006, CONCEPTS GENETICS; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Nyfeler B., 2008, GOLGI APPARATUS; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Pan SJ, 2013, MOL BIOL CELL, V24, P1111, DOI 10.1091/mbc.E12-12-0886; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200	58	29	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11844	11858		10.1074/jbc.M114.552091	http://dx.doi.org/10.1074/jbc.M114.552091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627495	Green Published, hybrid			2022-12-25	WOS:000335010600024
J	Kopach, P; Lockatell, V; Pickering, EM; Haskell, RE; Anderson, RD; Hasday, JD; Todd, NW; Luzina, IG; Atamas, SP				Kopach, Pavel; Lockatell, Virginia; Pickering, Edward M.; Haskell, Ronald E.; Anderson, Richard D.; Hasday, Jeffrey D.; Todd, Nevins W.; Luzina, Irina G.; Atamas, Sergei P.			IFN-gamma Directly Controls IL-33 Protein Level through a STAT1and LMP2-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caspase; Cytokines; Interferon; Immunology; Inflammation; Interleukin; LMP2; STAT1; Interferon-; Interleukin-33; Interleukin-4	RECEPTOR FAMILY-MEMBER; INNATE LYMPHOID-CELLS; INTERFERON-GAMMA; CYTOKINE IL-33; UP-REGULATION; INTRATRACHEAL INSTILLATION; TRANSCRIPTIONAL RESPONSE; PULMONARY INFLAMMATION; COLLAGEN PRODUCTION; PROGENITOR CELLS	Background: IL-33 levels are regulated through poorly understood cytokine-dependent mechanisms. Results: IFN- but not IL-4 down-regulates IL-33 protein by activating STAT1 and LMP2 proteasome, without engaging caspase-1, -3, or -8. Conclusion: Down-regulation of IL-33 protein by IFN- requires STAT1 and non-canonical involvement of LMP2 proteasome. Significance: Understanding the mechanisms of IL-33 regulation is important for the development of IL-33-targeting therapies. IL-33 contributes to disease processes in association with Th1 and Th2 phenotypes. IL-33 mRNA is rapidly regulated, but the fate of synthesized IL-33 protein is unknown. To understand the interplay among IL-33, IFN-, and IL-4 proteins, recombinant replication-deficient adenoviruses were produced and used for dual expression of IL-33 and IFN- or IL-33 and IL-4. The effects of such dual gene delivery were compared with the effects of similar expression of each of these cytokines alone. In lung fibroblast culture, co-expression of IL-33 and IFN- resulted in suppression of the levels of both proteins, whereas co-expression of IL-33 and IL-4 led to mutual elevation. In vivo, co-expression of IL-33 and IFN- in the lungs led to attenuation of IL-33 protein levels. Purified IFN- also attenuated IL-33 protein in fibroblast culture, suggesting that IFN- controls IL-33 protein degradation. Specific inhibition of caspase-1, -3, and -8 had minimal effect on IFN--driven IL-33 protein down-regulation. Pharmacological inhibition, siRNA-mediated silencing, or gene deficiency of STAT1 potently up-regulated IL-33 protein expression levels and attenuated the down-regulating effect of IFN- on IL-33. Stimulation with IFN- strongly elevated the levels of the LMP2 proteasome subunit, known for its role in IFN--regulated antigen processing. siRNA-mediated silencing of LMP2 expression abrogated the effect of IFN- on IL-33. Thus, IFN-, IL-4, and IL-33 are engaged in a complex interplay. The down-regulation of IL-33 protein levels by IFN- in pulmonary fibroblasts and in the lungs in vivo occurs through STAT1 and non-canonical use of the LMP2 proteasome subunit in a caspase-independent fashion.	[Kopach, Pavel; Lockatell, Virginia; Pickering, Edward M.; Hasday, Jeffrey D.; Todd, Nevins W.; Luzina, Irina G.; Atamas, Sergei P.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pickering, Edward M.; Hasday, Jeffrey D.; Todd, Nevins W.; Luzina, Irina G.; Atamas, Sergei P.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Haskell, Ronald E.; Anderson, Richard D.] ViraQuest Inc, North Liberty, IA 52317 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Atamas, SP (corresponding author), Univ Maryland, Sch Med, Dept Med, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA.	satamas@umaryland.edu			National Institutes of Health from NHLBI [R21HL106196]; Veterans Affairs Merit Awards [I01CX000101, I01CX000107]; Mark Flapan Award from the Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106196] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000101, I01CX000107] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs Merit Awards(US Department of Veterans Affairs); Mark Flapan Award from the Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported, in whole or in part, by National Institutes of Health Grant R21HL106196 from NHLBI (to S. P. A.). This study was also supported by Veterans Affairs Merit Awards I01CX000101 (to I. G. L.) and I01CX000107 (to S. P. A.) and a Mark Flapan Award from the Scleroderma Foundation (to I. G. L.).	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Ando M, 2012, J GENE MED, V14, P288, DOI 10.1002/jgm.2616; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Atamas SP, 2002, J IMMUNOL, V168, P1139, DOI 10.4049/jimmunol.168.3.1139; Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L; Badea I, 2012, GENE THER, V19, P978, DOI 10.1038/gt.2011.159; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chapuis J, 2009, MOL PSYCHIATR, V14, P1004, DOI 10.1038/mp.2009.10; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Demyanets S, 2013, J MOL CELL CARDIOL, V60, P16, DOI 10.1016/j.yjmcc.2013.03.020; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Hoey T, 1997, SCIENCE, V278, P1578, DOI 10.1126/science.278.5343.1578; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liang YJ, 2013, J IMMUNOL, V190, P5666, DOI 10.4049/jimmunol.1300117; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luzina IG, 2006, AM J RESP CELL MOL, V35, P298, DOI 10.1165/rcmb.2006-0033OC; Luzina IG, 2006, ARTHRITIS RHEUM-US, V54, P2643, DOI 10.1002/art.21950; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; Luzina IG, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-2; Luzina IG, 2011, IMMUNOLOGY, V132, P385, DOI 10.1111/j.1365-2567.2010.03393.x; Luzina IG, 2011, J LEUKOCYTE BIOL, V89, P763, DOI 10.1189/jlb.0510271; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; Martin S, 2004, NEUROSCI LETT, V357, P76, DOI 10.1016/j.neulet.2003.10.085; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; MONACO JJ, 1986, HUM IMMUNOL, V15, P416, DOI 10.1016/0198-8859(86)90019-4; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pochetuhen K, 2007, AM J PATHOL, V171, P428, DOI 10.2353/ajpath.2007.061167; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Rathbun RK, 2000, BLOOD, V96, P4204; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rock RB, 2005, GENES IMMUN, V6, P712, DOI 10.1038/sj.gene.6364246; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SINGAL DP, 1995, J BIOL CHEM, V270, P1966, DOI 10.1074/jbc.270.4.1966; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sponheim J, 2010, AM J PATHOL, V177, P2804, DOI 10.2353/ajpath.2010.100378; STARCHER B, 1989, LAB ANIM, V23, P234, DOI 10.1258/002367789780810536; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tanaka K, 1998, IMMUNOL REV, V163, P161; TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; van Erp K, 2006, PHYSIOL GENOMICS, V25, P75, DOI 10.1152/physiolgenomics.00188.2005; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yanaba K, 2011, CLIN RHEUMATOL, V30, P825, DOI 10.1007/s10067-011-1686-5; Yang XZ, 2003, CANCER RES, V63, P1122; Yin H, 2010, TRANSPLANTATION, V89, P1189, DOI 10.1097/TP.0b013e3181d720af; Zhao WH, 2012, CYTOKINE, V58, P267, DOI 10.1016/j.cyto.2012.01.019; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	97	30	32	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11829	11843		10.1074/jbc.M113.534396	http://dx.doi.org/10.1074/jbc.M113.534396			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619410	hybrid, Green Published			2022-12-25	WOS:000335010600023
J	Buja, A; Damiani, G; Gini, R; Visca, M; Federico, B; Donato, D; Francesconi, P; Marini, A; Donatini, A; Brugaletta, S; Baldo, V; Bellentani, MD				Buja, Alessandra; Damiani, Gianfranco; Gini, Rosa; Visca, Modesta; Federico, Bruno; Donato, Daniele; Francesconi, Paolo; Marini, Alessandro; Donatini, Andrea; Brugaletta, Salvatore; Baldo, Vincenzo; Bellentani, Maria Donata		Valore Project	Systematic Age-Related Differences in Chronic Disease Management in a Population-Based Cohort Study: A New Paradigm of Primary Care Is Required	PLOS ONE			English	Article							HEALTH-CARE; QUALITY; INDICATORS; PROGRAMS; PROJECT	Background: Our interest in chronic conditions is due to the fact that, worldwide, chronic diseases have overtaken infectious diseases as the leading cause of death and disability, so their management represents an important challenge for health systems. The aim of this study was to compare the performance of primary health care services in managing diabetes, congestive heart failure (CHF) and coronary heart disease (CHD), by age group. Methods: This population-based retrospective cohort study was conducted in Italy, enrolling 1,948,622 residents >= 16 years old. A multilevel regression model was applied to analyze compliance to care processes with explanatory variables at both patient and district level, using age group as an independent variable, and adjusting for sex, citizenship, disease duration, and Charlson index on the first level, and for District Health Unit on the second level. Results: The quality of chronic disease management showed an inverted U-shaped relationship with age. In particular, our findings indicate lower levels for young adults (16-44 year-olds), adults (45-64), and oldest old (+85) than for patients aged 65-74 in almost all quality indicators of CHD, CHF and diabetes management. Young adults (16-44 y), adults (45-64 y), the very old (75-84 y) and the oldest old (+85 y) patients with CHD, CHF and diabetes are less likely than 65-74 year-old patients to be monitored and treated using evidence-based therapies, with the exceptions of echocardiographic monitoring for CHF in young adult patients, and renal monitoring for CHF and diabetes in the very old. Conclusion: Our study shows that more effort is needed to ensure that primary health care systems are sensitive to chronic conditions in the young and in the very elderly.	[Buja, Alessandra; Baldo, Vincenzo] Univ Padua, Dipartimento Med Mol, Sect Publ Hlth, Lab Publ Hlth & Populat Studies, Padua, Italy; [Damiani, Gianfranco] Univ Cattolica Sacro Cuore, Fac Med, Ist Sanita Pubbl, Rome, Italy; [Gini, Rosa; Francesconi, Paolo] Agenzia Reg Sanita Toscana, Osservatorio Epidemiol, Florence, Italy; [Visca, Modesta] Agenzia Nazl & Serv Sanit, Agenas, Sez OSS, Rome, Italy; [Federico, Bruno] Univ Cassino & Lazio Meridionale, Dipartimento Sci Umane Sociali & Salute, Cassino, Italy; [Donato, Daniele] ULSS 16 Padova, Padua, Italy; [Marini, Alessandro] Zona Terr Senigallia, Ancona, Italy; [Donatini, Andrea] Reg Emilia Romagna, Bologna, Italy; [Brugaletta, Salvatore] ASP 7 Ragusa, Ragusa, Italy	University of Padua; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Cassino	Buja, A (corresponding author), Univ Padua, Dipartimento Med Mol, Sect Publ Hlth, Lab Publ Hlth & Populat Studies, Padua, Italy.	alessandra.buja@unipd.it	Vincenzo, Baldo/D-7822-2018; Buja, Alessandra/AAN-8141-2020; Baldo, Vincenzo/V-4005-2019; Damiani, Gianfranco/K-2782-2016; Brugaletta, Salvatore/AAJ-2090-2020	Vincenzo, Baldo/0000-0001-6012-9453; Buja, Alessandra/0000-0003-2216-3807; Baldo, Vincenzo/0000-0001-6012-9453; Damiani, Gianfranco/0000-0003-3028-6188; Gini, Rosa/0000-0002-6250-877X	"La Valutazione dei nuovi modelli organizzativi della Medicina Generale," acronym VALORE; Italian Ministry of Health [art.12-bis, d. lgs. 502/1992]	"La Valutazione dei nuovi modelli organizzativi della Medicina Generale," acronym VALORE; Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the project named "La Valutazione dei nuovi modelli organizzativi della Medicina Generale," acronym VALORE, funded by the Italian Ministry of Health in the context of regular health research (art.12-bis, d. lgs. 502/1992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology American Heart Association and American Medical Association, HEART FAIL WORK HEAR; American College of Cardiology American Heart Association and American Medical Association. Chronic Stable Coronary Artery Disease Work Group, CHRON STABL COR ART; [Anonymous], 2012, GU; [Anonymous], PIAN PREV 2010 2012; [Anonymous], 2008, B UFFICIALE REGIONE; Buja A, 2014, EUR J PREV CARDIOL, V21, P222, DOI 10.1177/2047487312462148; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Dahrouge S, 2011, CAN FAM PHYSICIAN, V57, P1300; Dall TM, 2010, AM J MANAG CARE, V16, P438; Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI 10.2337/diaclin.24.2.71.; Direzione Generale Prevenzione Sanitaria Ufficio I n, 2009, DGPREV13488PF; Eduardo Sabate, 2008, ADHERENCE LONG TERM; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Funnell M.M., 2004, CLIN DIABETES, V22, P123, DOI [10.2337/diaclin.22.3.123, DOI 10.2337/DIACLIN.22.3.123]; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Hill PL, 2011, HEALTH PSYCHOL, V30, P797, DOI 10.1037/a0023860; Institut National d'Excellence en Sante et en Services Sociaux, 2012, SUMM SUPP CONT QUAL; Krieger Nancy, 2003, American Journal of Public Health, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Kuzuya M, 2006, J AM GERIATR SOC, V54, P598, DOI 10.1111/j.1532-5415.2006.00659.x; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Linden A, 2007, J EVAL CLIN PRACT, V13, P400, DOI 10.1111/j.1365-2753.2006.00721.x; Lukas CV, 2007, HEALTH CARE MANAGE R, V32, P309, DOI 10.1097/01.HMR.0000296785.29718.5d; Maciocco G, 2007, Ann Ig, V19, P551; Magnezi R, 2013, AM J MANAG CARE, V19, pE140; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Ministero dell'Istruzione dell'Universita e della Ricerca, 2011, BUSS RIF ISTR TREND; Morandi I, 2010, ASSISTENZA GLI ANZIA; Nicolucci A, 2006, INT J QUAL HEALTH C, V18, P26, DOI 10.1093/intqhc/mzl023; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner Edward H, 1996, MILBANK Q, V74, P511; WHO Library Cataloguing-in-Publication Data, WHO LIB CAT PUBL DAT; World Development Indicators, 2009, WORLD DEV IND	36	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91340	10.1371/journal.pone.0091340	http://dx.doi.org/10.1371/journal.pone.0091340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632818	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400053
J	Buturovic, L; Wong, M; Tang, GW; Altman, RB; Petkovic, D				Buturovic, Ljubomir; Wong, Mike; Tang, Grace W.; Altman, Russ B.; Petkovic, Dragutin			High Precision Prediction of Functional Sites in Protein Structures	PLOS ONE			English	Article							EXPRESSION PROFILE; CLASSIFICATION; IDENTIFICATION; VALIDATION; DISCOVERY	We address the problem of assigning biological function to solved protein structures. Computational tools play a critical role in identifying potential active sites and informing screening decisions for further lab analysis. A critical parameter in the practical application of computational methods is the precision, or positive predictive value. Precision measures the level of confidence the user should have in a particular computed functional assignment. Low precision annotations lead to futile laboratory investigations and waste scarce research resources. In this paper we describe an advanced version of the protein function annotation system FEATURE, which achieved 99% precision and average recall of 95% across 20 representative functional sites. The system uses a Support Vector Machine classifier operating on the microenvironment of physicochemical features around an amino acid. We also compared performance of our method with state-of-the-art sequence-level annotator Pfam in terms of precision, recall and localization. To our knowledge, no other functional site annotator has been rigorously evaluated against these key criteria. The software and predictive models are incorporated into the WebFEATURE service at http://feature.stanford.edu/wf4.0-beta.	[Buturovic, Ljubomir; Petkovic, Dragutin] San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA; [Wong, Mike; Petkovic, Dragutin] San Francisco State Univ, Ctr Comp Life Sci, San Francisco, CA 94132 USA; [Tang, Grace W.; Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; Stanford University	Buturovic, L (corresponding author), San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA.	ljubomir@sfsu.edu		Altman, Russ/0000-0003-3859-2905	Amazon Web Services in Education Research Grant; NIH [LM05652, GM072970, GM102365]; NSFBIOX2 award [CNS-0619926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970, R01GM102365] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005652, R29LM005652] Funding Source: NIH RePORTER	Amazon Web Services in Education Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFBIOX2 award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The computational resources of this research were supported through an Amazon Web Services in Education Research Grant to Center for Computing for Life Sciences at San Francisco State University, awarded June 18, 2012. RBA is supported by NIH grants LM05652, GM072970, GM102365 and the NSFBIOX2 award CNS-0619926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fetrow JS, 1998, J MOL BIOL, V281, P949, DOI 10.1006/jmbi.1998.1993; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Glazer DS, 2009, STRUCTURE, V17, P919, DOI 10.1016/j.str.2009.05.010; Halperin I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S2; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Lal A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-44; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Petrey D, 2009, CURR OPIN STRUC BIOL, V19, P363, DOI 10.1016/j.sbi.2009.02.001; Pillai R, 2011, J MOL DIAGN, V13, P48, DOI 10.1016/j.jmoldx.2010.11.001; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Tang GW, 2011, STRUCTURE, V19, P461, DOI 10.1016/j.str.2011.02.007; Thornton Janet, 2001, Trends in Biochemical Sciences, V26, P88, DOI 10.1016/S0968-0004(00)01765-5; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Wang L, 2008, BIOINFORMATICS, V24, P412, DOI 10.1093/bioinformatics/btm579; Wei L, 1998, Pac Symp Biocomput, P497; Wei Liping, 2003, J Bioinform Comput Biol, V1, P119, DOI 10.1142/S0219720003000150; Wu TF, 2004, J MACH LEARN RES, V5, P975	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91240	10.1371/journal.pone.0091240	http://dx.doi.org/10.1371/journal.pone.0091240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632601	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400048
J	Chen, WS; Dong, N; Huang, CH; Zhang, ZH; Hu, JY; Xie, H; Pan, JX; Liu, ZG				Chen, Wensheng; Dong, Nuo; Huang, Caihong; Zhang, Zhenhao; Hu, Jiaoyue; Xie, Hui; Pan, Juxin; Liu, Zuguo			Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit	PLOS ONE			English	Article							BENZALKONIUM CHLORIDE; IN-VITRO; PROSTAGLANDIN ANALOGS; EPITHELIAL-CELLS; VIVO; CONJUNCTIVA; PERMEABILITY; RESISTANCE; PRESSURE; GLAUCOMA	Prostaglandin (PG) analogs, including latanoprost, travoprost, and bimatoprost, are currently the most commonly used topical ocular hypotensive medications. The purpose of this study was to investigate the corneal alterations in rabbits following exposure to commercial solution of latanoprost, travoprost and bimatoprost. A total of 64 New Zealand albino rabbits were used and four groups of treatments were constituted. Commercial latanoprost, travoprost, bimatoprost or 0.02% benzalkonium chloride (BAK) was applied once daily to one eye each of rabbits for 30 days. The contralateral untreated eyes used as controls. Schirmer test, tear break-up time (BUT), rose Bengal and fluorescein staining were performed on days 5, 10, 20, and 30. Central corneal changes were analyzed by in vivo confocal microscopy, and the corneal barrier function was evaluated by measurement of corneal transepithelial electrical resistance on day 5. Whole mount corneas were analyzed by using fluorescence confocal microscopy for the presence of tight-junction (ZO-1, occludin) and adherens-junction (E-cadherin, beta-catenin) proteins, actin cytoskeleton, proliferative marker Ki67 and cell apoptosis in the epithelium. Topical application of commercial PG analogs resulted in significant corneal epithelial and stromal defects while no significant changes in aqueous tear production, BUT, rose bengal and fluorescein staining scores on day 5. Commercial PG analogs induced dislocation of ZO-1 and occludin from their normal locus, disorganization of cortical actin cytoskeleton at the superficial layer, and disruption of epithelial barrier function. The eyes treated with 0.02% BAK and latanoprost exhibited significantly reduced Schirmer scores, BUT, and increased fluorescein staining scores on days 10 and 30, respectively. Topical application of commercial PG analogs can quickly impair the corneal epithelium and stroma without tear deficiency. Commercial PG analogs break down the barrier integrity of corneal epithelium, concomitant with the disruption of cell junction and actin cytoskeleton between superficial cells in the corneal epithelium in vivo.	[Chen, Wensheng] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Inst Eye, Fujian, Peoples R China; Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Affiliated Xiamen Eye Ctr, Fujian, Peoples R China	Xiamen University; Xiamen University	Chen, WS (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Inst Eye, Fujian, Peoples R China.	cwensheng@hotmail.com; zuguoliu@xmu.edu.cn			National Natural Science Foundation of China, Beijing, China [81270978, U1205025, 81330022, 30973249, 81100638]; Medical Innovative Program of Fujian Province, China [2012-CXB-31]; Science and Technology Planning Projects of Xiamen [3502Z20094027, 3502Z20131017]; Health Department Project of Fujian [2013-2-112]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Medical Innovative Program of Fujian Province, China; Science and Technology Planning Projects of Xiamen; Health Department Project of Fujian	This work was supported by the National Natural Science Foundation of China, Beijing, China (grant no 81270978, U1205025, 81330022, 30973249, 81100638); Medical Innovative Program of Fujian Province, China (grnat no 2012-CXB-31); Science and Technology Planning Projects of Xiamen (No. 3502Z20094027, No. 3502Z20131017); and Health Department Project of Fujian (No. 2013-2-112). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Chen WS, 2013, CORNEA, V32, P1599, DOI 10.1097/ICO.0b013e3182a8196f; Chen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040893; Chen WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026103; Cracknell KPB, 2009, EXP EYE RES, V88, P786, DOI 10.1016/j.exer.2008.08.022; Crichton ACS, 2013, ADV THER, V30, P260, DOI 10.1007/s12325-013-0014-7; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Georgiev GA, 2011, INVEST OPHTH VIS SCI, V52, P4645, DOI 10.1167/iovs.10-6271; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P4594, DOI 10.1167/iovs.05-0776; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P2444, DOI 10.1167/iovs.04-1331; Guo Y, 2007, INVEST OPHTH VIS SCI, V48, P2001, DOI 10.1167/iovs.06-0613; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kimura K, 2013, INVEST OPHTH VIS SCI, V17, P2572; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Kusano M, 2010, CORNEA, V29, P80, DOI 10.1097/ICO.0b013e3181a3c3e6; Liang H, 2011, BRIT J OPHTHALMOL, V95, P869, DOI 10.1136/bjo.2010.189449; McKee HDR, 2005, EYE, V19, P923, DOI 10.1038/sj.eye.6701674; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Nakagawa S, 2012, INVEST OPHTH VIS SCI, V53, P5154, DOI 10.1167/iovs.12-9685; Parrish RK, 2003, AM J OPHTHALMOL, V135, P688, DOI 10.1016/S0002-9394(03)00098-9; Pauly A, 2012, INVEST OPHTH VIS SCI, V53, P8172, DOI 10.1167/iovs.12-10766; Pisella PJ, 2004, INVEST OPHTH VIS SCI, V45, P1360, DOI 10.1167/iovs.03-1067; Prausnitz MR, 1998, J PHARM SCI, V87, P1479, DOI 10.1021/js9802594; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Yanai R, 2009, INVEST OPHTH VIS SCI, V50, P4605, DOI 10.1167/iovs.09-3407; Yu FF, 2013, INVEST OPHTH VIS SCI, V54, P3385, DOI 10.1167/iovs.12-11181	26	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e89205	10.1371/journal.pone.0089205	http://dx.doi.org/10.1371/journal.pone.0089205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632558	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400006
J	Kerkhof, E; Lakhanpaul, M; Ray, S; Verbakel, JY; Van den Bruel, A; Thompson, M; Berger, MY; Moll, HA; Oostenbrink, R				Kerkhof, Evelien; Lakhanpaul, Monica; Ray, Samiran; Verbakel, Jan Y.; Van den Bruel, Ann; Thompson, Matthew; Berger, Marjolein Y.; Moll, Henriette A.; Oostenbrink, Rianne		European Res Network Recognising S	The Predictive Value of the NICE "Red Traffic Lights" in Acutely Ill Children	PLOS ONE			English	Article							SERIOUS BACTERIAL-INFECTION; FEBRILE CHILDREN; EMERGENCY-DEPARTMENT; OBSERVATION SCALES; DECISION RULE; MANAGEMENT; FEVER; SYMPTOMS; SIGNS; CARE	Objective: Early recognition and treatment of febrile children with serious infections (SI) improves prognosis, however, early detection can be difficult. We aimed to validate the predictive rule-in value of the National Institute for Health and Clinical Excellence (NICE) most severe alarming signs or symptoms to identify SI in children. Design, Setting and Participants: The 16 most severe ("red") features of the NICE traffic light system were validated in seven different primary care and emergency department settings, including 6,260 children presenting with acute illness. Main Outcome Measures: We focussed on the individual predictive value of single red features for SI and their combinations. Results were presented as positive likelihood ratios, sensitivities and specificities. We categorised "general" and "disease-specific" red features. Changes in pre-test probability versus post-test probability for SI were visualised in Fagan nomograms. Results: Almost all red features had rule-in value for SI, but only four individual red features substantially raised the probability of SI in more than one dataset: "does not wake/stay awake", "reduced skin turgor", "non-blanching rash", and "focal neurological signs". The presence of >= 3 red features improved prediction of SI but still lacked strong rule-in value as likelihood ratios were below 5. Conclusions: The rule-in value of the most severe alarming signs or symptoms of the NICE traffic light system for identifying children with SI was limited, even when multiple red features were present. Our study highlights the importance of assessing the predictive value of alarming signs in clinical guidelines prior to widespread implementation in routine practice.	[Kerkhof, Evelien; Moll, Henriette A.; Oostenbrink, Rianne] Erasmus MC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands; [Lakhanpaul, Monica] UCL, Inst Child Hlth, Dept Gen & Adolescent Pediat, London, England; [Ray, Samiran] Great Ormond St Hosp Sick Children, Pediat Intens Care Unit, London, England; [Verbakel, Jan Y.] Katholieke Univ Leuven, Dept Gen Practice, Louvain, Belgium; [Van den Bruel, Ann; Thompson, Matthew] Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford, England; [Berger, Marjolein Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; KU Leuven; University of Oxford; University of Groningen	Oostenbrink, R (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands.	r.oostenbrink@erasmusmc.nl	Ray, Samiran/AAZ-4916-2020; Van den Bruel, Ann/AAC-2442-2020; Verbakel, Jan/E-6758-2015	Ray, Samiran/0000-0002-3738-4672; Van den Bruel, Ann/0000-0001-9012-2009; Verbakel, Jan/0000-0002-7166-7211; Lakhanpaul, Monica/0000-0002-9855-2043	ZonMW, a Dutch organisation for health research and development; Europe Container Terminals B.V; European Society of Pediatric Infectious Diseases	ZonMW, a Dutch organisation for health research and development(Netherlands Organization for Health Research and Development); Europe Container Terminals B.V; European Society of Pediatric Infectious Diseases	EK is supported by ZonMW, a Dutch organisation for health research and development; RO is supported by an unrestricted grant of the Europe Container Terminals B.V and by a fellowship award of European Society of Pediatric Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon K, 2004, ARCH DIS CHILD, V89, P159, DOI 10.1136/adc.2002.024406; BAKER MD, 1990, PEDIATRICS, V85, P1040; Berger MY, 2008, GUIDELINE CHILDREN F; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; Brent AJ, 2011, ARCH DIS CHILD, V96, P361, DOI 10.1136/adc.2010.183111; Bruijnzeels MA, 1998, BRIT J GEN PRACT, V48, P880; Chen SM, 2013, EMERG MED J, V30, P406, DOI 10.1136/emermed-2011-200808; Chiappini E, 2009, CLIN THER, V31, P1826, DOI 10.1016/j.clinthera.2009.08.006; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; De S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f866; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; MCCARTHY PL, 1985, PEDIATRICS, V76, P167; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; Monteny M, 2008, BRIT J GEN PRACT, V58, P242, DOI 10.3399/bjgp08X279643; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Oostenbrink R, 2004, EUR J EPIDEMIOL, V19, P109, DOI 10.1023/B:EJEP.0000017828.13995.76; Oostenbrink R, 2012, ARCH DIS CHILD, V97, P667, DOI 10.1136/archdischild-2011-300667; Roukema J, 2008, J AM MED INFORM ASSN, V15, P107, DOI 10.1197/jamia.M2164; TEACH SJ, 1995, J PEDIATR-US, V126, P877, DOI 10.1016/S0022-3476(95)70200-8; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; van Charante EPM, 2007, BMC FAM PRACT, V8, P1, DOI 10.1186/1471-2296-8-46; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Verbakel JY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-10	26	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90847	10.1371/journal.pone.0090847	http://dx.doi.org/10.1371/journal.pone.0090847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633015	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400021
J	Yuan, FR; Yosef, N; Reddy, CL; Huang, AL; Chiang, SC; Tithi, HR; Ubogu, EE				Yuan, Furong; Yosef, Nejla; Reddy, Chetan Lakshmana; Huang, Ailing; Chiang, Sharon C.; Tithi, Hafiza Rahman; Ubogu, Eroboghene E.			CCR2 Gene Deletion and Pharmacologic Blockade Ameliorate a Severe Murine Experimental Autoimmune Neuritis Model of Guillain-Barre Syndrome	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIPHERAL NERVOUS-SYSTEM; CHEMOKINE RECEPTOR CCR2; SCHWANN-CELLS; IN-VITRO; DISEASE; EXPRESSION; NERVES; MICE; INFLAMMATION	The molecular determinants and signaling pathways responsible for hematogenous leukocyte trafficking during peripheral neuroinflammation are incompletely elucidated. Chemokine ligand/receptor pair CCL2/CCR2 has been pathogenically implicated in the acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome (GBS). We evaluated the role of CCR2 in peripheral neuroinflammation utilizing a severe murine experimental autoimmune neuritis (sm-EAN) model. Sm-EAN was induced in 8-12 week old female SJL CCR2 knockout (CCR2KO), heterozygote (CCR2HT) and wild type (CCR2WT) mice, and daily neuromuscular severity scores and weights recorded. In vitro and in vivo splenocyte proliferation and cytokine expression assays, and sciatic nerve Toll-like receptor (TLR) 2, TLR4 and CCL2 expression assays were performed to evaluate systemic and local innate immune activation at disease onset. Motor nerve electrophysiology and sciatic nerve histology were also performed to characterize the inflammatory neuropathy at expected peak severity. To further determine the functional relevance of CCR2 in sm-EAN, 20 mg/kg CCR2 antagonist, RS 102895 was administered daily for 5 days to a cohort of CCR2WT mice following sm-EAN disease onset, with efficacy compared to 400 mg/kg human intravenous immunoglobulin (IVIg). CCR2KO mice were relatively resistant to sm-EAN compared to CCR2WT and CCR2HT mice, associated with attenuated peripheral nerve demyelinating neuritis. Partial CCR2 gene deletion did not confer any protection against sm-EAN. CCR2KO mice demonstrated similar splenocyte activation or proliferation profiles, as well as TLR2, TLR4 and CCL2 expression to CCR2WT or CCR2HT mice, implying a direct role for CCR2 in sm-EAN pathogenesis. CCR2 signaling blockade resulted in rapid, near complete recovery from sm-EAN following disease onset. RS 102895 was significantly more efficacious than IVIg. CCR2 mediates pathogenic hematogenous monocyte trafficking into peripheral nerves, with consequential demyelination in sm-EAN. CCR2 is amenable to pharmacologic blockade, making it a plausible drug target for GBS.	[Yuan, Furong; Yosef, Nejla; Reddy, Chetan Lakshmana; Huang, Ailing; Tithi, Hafiza Rahman; Ubogu, Eroboghene E.] Baylor Coll Med, Dept Neurol, Neuromuscular Immunopathol Res Lab, Houston, TX 77030 USA; [Yosef, Nejla] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chiang, Sharon C.] Rice Univ, Dept Stat, Houston, TX 77251 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Ubogu, EE (corresponding author), Baylor Coll Med, Dept Neurol, Neuromuscular Immunopathol Res Lab, Houston, TX 77030 USA.	ubogu@uab.edu	Ubogu, Eroboghene/R-3894-2019	Ubogu, Eroboghene/0000-0002-8307-9994	Baylor College of Medicine New Investigator Start-Up program; Guillain-Barre syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International; National Institutes of Health (NIH) [R21 NS073702, R21 NS078226, R01 NS075212, P30 AI27767]; NATIONAL CANCER INSTITUTE [T32CA096520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS078226, R01NS075212, R21NS073702] Funding Source: NIH RePORTER	Baylor College of Medicine New Investigator Start-Up program; Guillain-Barre syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Baylor College of Medicine New Investigator Start-Up program from 2007-2011 and a research grant from the Guillain-Barre syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International from 2010-2012. Work in the Neuromuscular Immunopathology Research Laboratory at Baylor College of Medicine was supported by National Institutes of Health (NIH) grants R21 NS073702, R21 NS078226 and R01 NS075212, and a subaward P30 AI27767 to E.E.U. from 2011-2013. The funding sources had no involvement in the conduct of the research, manuscript preparation, data collection/analyses or decision to submit this work for publication.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bennett JL, 2007, VIRAL IMMUNOL, V20, P19, DOI 10.1089/vim.2006.0068; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Calida DM, 2000, J NEUROIMMUNOL, V107, P1, DOI 10.1016/S0165-5728(00)00249-6; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chiang S, 2013, MUSCLE NERVE, V48, P320, DOI 10.1002/mus.23829; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Duan RS, 2004, NEUROBIOL DIS, V16, P630, DOI 10.1016/j.nbd.2004.04.007; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; Hartung HP, 2002, CURR OPIN NEUROL, V15, P571, DOI 10.1097/00019052-200210000-00008; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; JESSEN KR, 1987, J NEUROSCI, V7, P3362; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2002, BRAIN, V125, P823, DOI 10.1093/brain/awf070; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mitchell LA, 2013, INT IMMUNOPHARMACOL, V15, P357, DOI 10.1016/j.intimp.2012.11.016; Orlikowski D, 2003, J NEUROIMMUNOL, V134, P118, DOI 10.1016/S0165-5728(02)00393-4; Press R, 2003, J CLIN IMMUNOL, V23, P259, DOI 10.1023/A:1024532715775; Reddy CL, 2013, CELL MOL NEUROBIOL, V33, P789, DOI 10.1007/s10571-013-9946-3; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Ubogu Eroboghene E, 2013, Methods Mol Biol, V1013, P17, DOI 10.1007/978-1-62703-426-5_2; Ubogu EE, 2012, J PERIPHER NERV SYST, V17, P53, DOI 10.1111/j.1529-8027.2012.00375.x; Ubogu Eroboghene E., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P141; Viquez OM, 2007, CHEM RES TOXICOL, V20, P370, DOI 10.1021/tx6003453; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Xia RH, 2010, NEUROPATH APPL NEURO, V36, P388, DOI 10.1111/j.1365-2990.2010.01092.x; Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588; Xia RH, 2010, J NEUROIMMUNOL, V219, P54, DOI 10.1016/j.jneuroim.2009.11.019; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005; Yosef N, 2013, CELL MOL NEUROBIOL, V33, P175, DOI 10.1007/s10571-012-9882-7; Yosef N, 2012, J CELL PHYSIOL, V227, P3857, DOI 10.1002/jcp.24100; Yosef N, 2012, MICROVASC RES, V83, P298, DOI 10.1016/j.mvr.2012.01.005; Yosef N, 2010, J NEUROPATH EXP NEUR, V69, P82, DOI 10.1097/NEN.0b013e3181c84a9a; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	41	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90463	10.1371/journal.pone.0090463	http://dx.doi.org/10.1371/journal.pone.0090463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632828	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400015
J	Atwoli, L; Ayuku, D; Hogan, J; Koech, J; Vreeman, RC; Ayaya, S; Braitstein, P				Atwoli, Lukoye; Ayuku, David; Hogan, Joseph; Koech, Julius; Vreeman, Rachel Christine; Ayaya, Samuel; Braitstein, Paula			Impact of Domestic Care Environment on Trauma and Posttraumatic Stress Disorder among Orphans in Western Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; VIOLENCE; CHILDREN; VICTIMIZATION; ADOLESCENTS; AGGRESSION; HOMELESS; FOSTER; HEALTH	Objective: The aim of this study was to determine the impact of the domestic care environment on the prevalence of potentially traumatic events (PTEs) and posttraumatic stress disorder (PTSD) among orphaned and separated children in Uasin Gishu County, western Kenya. Methods: A total of 1565 (55.5% male) orphaned and separated adolescents aged 10-18 years (mean 13.8 years, sd 2.2), were assessed for PTSD and PTEs including bullying, physical abuse and sexual abuse. In this sample, 746 lived in extended family households, 746 in Charitable Children's Institutions (CCIs), and 73 on the street. Posttraumatic stress symptom (PTSS) scores and PTSD were assessed using the Child PTSD Checklist. Results: Bullying was the commonest PTE in all domestic care environments, followed by physical and sexual abuse. All PTEs were commonest among the street youth followed by CCIs. However, sexual abuse was more prevalent in households than in CCIs. Prevalence of PTSD was highest among street youth (28.8%), then households (15.0%) and CCIs (11.5%). PTSS scores were also highest among street youth, followed by CCIs and households. Bullying was associated with higher PTSS scores and PTSD odds than either sexual or physical abuse. Conclusion: This study demonstrated differences in distribution of trauma and PTSD among orphaned and separated children in different domestic care environments, with street youth suffering more than those in CCIs or households. Interventions are needed to address bullying and sexual abuse, especially in extended family households. Street youth, a heretofore neglected population, are urgently in need of dedicated mental health services and support.	[Atwoli, Lukoye] Moi Univ, Coll Hlth Sci, Sch Med, Dept Mental Hlth, Eldoret, Kenya; [Ayuku, David] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Hogan, Joseph] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Hogan, Joseph; Koech, Julius; Vreeman, Rachel Christine; Braitstein, Paula] USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Vreeman, Rachel Christine] Indiana Univ Sch Med, Dept Childrens Hlth Serv Res, Indianapolis, IN 46202 USA; [Ayaya, Samuel] Moi Univ, Coll Hlth Sci, Sch Med, Dept Child Hlth & Pediat, Eldoret, Kenya; [Braitstein, Paula] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Braitstein, Paula] Moi Univ, Coll Hlth Sci, Sch Med, Dept Med, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Moi University; Brown University; United States Agency for International Development (USAID); Indiana University System; Indiana University Bloomington; Moi University; Indiana University System; Indiana University Bloomington; Moi University; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Atwoli, L (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Dept Mental Hlth, Eldoret, Kenya.	Lukoye@gmail.com	Ayuku, David/AAB-8485-2019; Hogan, Joseph/J-4579-2014	Atwoli, Lukoye/0000-0001-7710-9723; Hogan, Joseph/0000-0001-7959-7361	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD060478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020, R01HD060478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Award Number R01HD060478 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1996, CHILD ABUSE NEGLECT, V20, P1161, DOI 10.1016/S0145-2134(96)00067-1; Atwoli L, 2010, East Afr Med J, V87, P465; Boyes ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046905; Cluver Lucie, 2006, Ann Gen Psychiatry, V5, P8, DOI 10.1186/1744-859X-5-8; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2011, JAIDS-J ACQ IMM DEF, V58, P336, DOI 10.1097/QAI.0b013e31822f0d82; Cluver L, 2010, CHILD ABUSE NEGLECT, V34, P793, DOI 10.1016/j.chiabu.2010.04.002; Harder VS, 2012, J TRAUMA STRESS, V25, P64, DOI 10.1002/jts.21660; Hasanovic M, 2006, CROAT MED J, V47, P85; Kamanda A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-91; Karsberg Sidsel H, 2012, Clin Pract Epidemiol Ment Health, V8, P91, DOI 10.2174/1745017901208010091; Kettrey HH, 2006, J FAM VIOLENCE, V21, P407, DOI 10.1007/s10896-006-9036-0; Lombe M, 2008, INT SOC WORK, V51, P682, DOI 10.1177/0020872808093345; Morantz G, 2013, CHILD ABUSE NEGL, DOI 00210.01016/j.chiabu.02012.00210.00007; NORTH CS, 1994, J TRAUMA STRESS, V7, P95, DOI 10.1007/BF02111915; NORTH CS, 1992, HOSP COMMUNITY PSYCH, V43, P1010; Schaal S, 2006, J TRAUMA STRESS, V19, P95, DOI 10.1002/jts.20104; Seedat S, 2004, BRIT J PSYCHIAT, V184, P169, DOI 10.1192/bjp.184.2.169; Tucker CJ, 2013, PEDIATRICS, V132, P79, DOI 10.1542/peds.2012-3801; Uasin Gishu County Government, 2013, WELC COUNT CHAMP ELD; UNICEF, 2013, AFR ORPH VULN GEN CH; Zolotor AJ, 2009, CHILD ABUSE NEGLECT, V33, P833, DOI 10.1016/j.chiabu.2009.09.004	22	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89937	10.1371/journal.pone.0089937	http://dx.doi.org/10.1371/journal.pone.0089937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625395	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300011
J	Ge, C; Song, JT; Chen, L; Wang, L; Chen, YF; Liu, XX; Zhang, Y; Zhang, LN; Zhang, M				Ge, Cheng; Song, Jiantao; Chen, Liang; Wang, Lin; Chen, Yifei; Liu, Xinxin; Zhang, Yu; Zhang, Lining; Zhang, Mei			Atheroprotective Pulsatile Flow Induces Ubiquitin-Proteasome-Mediated Degradation of Programmed Cell Death 4 in Endothelial Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; ACTIVATED PROTEIN-KINASE; SHEAR-STRESS; DISTURBED FLOW; MESSENGER-RNA; TRANSLATION; EXPRESSION; PROLIFERATION; APOPTOSIS; MUSCLE	Objectives: We recently found low level of tumor suppressor programmed cell death 4 (PDCD4) associated with reduced atherosclerotic plaque area (unpublished). We investigated whether atheroprotective unidirectional pulsatile shear stress affects the expression of PDCD4 in endothelial cells. Methods and Results: En face co-immunostaining of the mouse aortic arch revealed a low level of PDCD4 in endothelial cells undergoing pulsatile shear stress. Application of unidirectional pulsatile shear stress to human umbilical vein endothelial cells (HUVECs) decreased PDCD4 protein but not mRNA level. Immunoprecipitation revealed that pulsatile shear stress induced the coupling of ubiquitin with PDCD4 expression. The phosphatidyl inositol 3-kinase (PI3K)/Akt pathway was involved in this ubiquitin-proteasome-mediated degradation of PDCD4. Gain of function and loss of function experiments showed that PDCD4 induced turnover (proliferation and apoptosis) of HUVECs. Low PDCD4 level was associated with reduced proliferation but not apoptosis or phosphorylation of endothelial nitric oxide synthase caused by pulsatile shear stress to help maintain the homeostasis of endothelial cells. Conclusions: Pulsatile shear stress induces ubiquitin-proteasome-mediated degradation of PDCD4 via a PI3K/Akt pathway in HUVECs. PDCD4 induces turnover (proliferation and apoptosis) of HUVECs. Low PDCD4 level is associated with reduced proliferation for maintenance of HUVEC homeostasis under pulsatile shear stress.	[Ge, Cheng; Song, Jiantao; Wang, Lin; Chen, Yifei; Liu, Xinxin; Zhang, Yu; Zhang, Mei] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Ge, Cheng; Song, Jiantao; Wang, Lin; Chen, Yifei; Liu, Xinxin; Zhang, Yu; Zhang, Mei] Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Chen, Liang] Shandong Univ, Dept Emergency, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhang, Lining] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	daixh@vip.sina.com			National Basic Research Program of China (973 Program) [2010CB732605, 2011CB503906]; National Natural Science Foundation of China [30970709, 81270404, 81172863]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Basic Research Program of China (973 Program, 2010CB732605, 2011CB503906) and the National Natural Science Foundation of China (No. 30970709, 81270404, 81172863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; ASAKURA T, 1990, CIRC RES, V66, P1045, DOI 10.1161/01.RES.66.4.1045; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eto K, 2012, CELL DEATH DIFFER, V19, P573, DOI 10.1038/cdd.2011.126; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Guo DL, 2007, CIRC RES, V100, P564, DOI 10.1161/01.RES.0000259561.23876.c5; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Hayashi A, 2010, HUM PATHOL, V41, P1507, DOI 10.1016/j.humpath.2010.02.019; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Kadohama T, 2007, J CELL PHYSIOL, V212, P244, DOI 10.1002/jcp.21024; Kolpa HJ, 2013, DEVELOPMENT, V140, P2172, DOI 10.1242/dev.084475; Kraiss LW, 2001, J SURG RES, V97, P20, DOI 10.1006/jsre.2001.6091; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee DY, 2012, P NATL ACAD SCI USA, V109, P1967, DOI 10.1073/pnas.1121214109; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu XJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1481, DOI 10.1152/ajpcell.00413.2009; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Singh P, 2011, ONCOGENE, V30, P4864, DOI 10.1038/onc.2011.202; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Song XG, 2013, AUTOPHAGY, V9, P743, DOI 10.4161/auto.24069; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Wang F, 2012, J CELL BIOCHEM, V113, P2989, DOI 10.1002/jcb.24176; Wang XL, 2007, PROTEOMICS, V7, P588, DOI 10.1002/pmic.200600568; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	42	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91564	10.1371/journal.pone.0091564	http://dx.doi.org/10.1371/journal.pone.0091564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626527	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300104
J	Hesse, C; Ball, K; Schenk, T				Hesse, Constanze; Ball, Keira; Schenk, Thomas			Pointing in Visual Periphery: Is DF's Dorsal Stream Intact?	PLOS ONE			English	Article							UNILATERAL OPTIC ATAXIA; FORM AGNOSIA; PSYCHOPHYSICS TOOLBOX; PATIENT DF; VISUOMOTOR; PERCEPTION; DEFICIT; EYE; DISSOCIATION; HANDEDNESS	Observations of the visual form agnosic patient DF have been highly influential in establishing the hypothesis that separate processing streams deal with vision for perception (ventral stream) and vision for action (dorsal stream). In this context, DF's preserved ability to perform visually-guided actions has been contrasted with the selective impairment of visuomotor performance in optic ataxia patients suffering from damage to dorsal stream areas. However, the recent finding that DF shows a thinning of the grey matter in the dorsal stream regions of both hemispheres in combination with the observation that her right-handed movements are impaired when they are performed in visual periphery has opened up the possibility that patient DF may potentially also be suffering from optic ataxia. If lesions to the posterior parietal cortex (dorsal stream) are bilateral, pointing and reaching deficits should be observed in both visual hemifields and for both hands when targets are viewed in visual periphery. Here, we tested DF's visuomotor performance when pointing with her left and her right hand toward targets presented in the left and the right visual field at three different visual eccentricities. Our results indicate that DF shows large and consistent impairments in all conditions. These findings imply that DF's dorsal stream atrophies are functionally relevant and hence challenge the idea that patient DF's seemingly normal visuomotor behaviour can be attributed to her intact dorsal stream. Instead, DF seems to be a patient who suffers from combined ventral and dorsal stream damage meaning that a new account is needed to explain why she shows such remarkably normal visuomotor behaviour in a number of tasks and conditions.	[Hesse, Constanze] Univ Aberdeen, Sch Psychol, Aberdeen AB24 3FX, Scotland; [Ball, Keira] Univ Durham, Dept Psychol, Stockton On Tees, England; [Schenk, Thomas] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Aberdeen; Durham University; University of Erlangen Nuremberg	Hesse, C (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen AB24 3FX, Scotland.	c.hesse@abdn.ac.uk	Hesse, Constanze/H-2941-2016; S, T/GRY-0013-2022; S, T/GXF-0648-2022	Hesse, Constanze/0000-0002-4395-0781; 				Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Blangero A, 2008, CORTEX, V44, P560, DOI 10.1016/j.cortex.2007.09.004; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridge H, 2013, J NEUROSCI, V33, P12779, DOI 10.1523/JNEUROSCI.4853-12.2013; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Desmurget M, 1997, J NEUROPHYSIOL, V77, P1644, DOI 10.1152/jn.1997.77.3.1644; Fiehler K, 2011, VISION RES, V51, P890, DOI 10.1016/j.visres.2010.12.015; GAUTHIER GM, 1994, VISION RES, V34, P2613, DOI 10.1016/0042-6989(94)90247-X; Glover S, 2003, NEUROSCI BIOBEHAV R, V27, P447, DOI 10.1016/S0149-7634(03)00072-1; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Goodale M, 2013, SIGHT UNSEEN EXPLORA; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; Goodale MA, 2005, PROG BRAIN RES, V149, P269, DOI 10.1016/S0079-6123(05)49019-6; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; Henriques DYP, 2002, J NEUROPHYSIOL, V87, P1677, DOI 10.1152/jn.00509.2001; Hesse C, 2012, NEUROPSYCHOLOGIA, V50, P90, DOI 10.1016/j.neuropsychologia.2011.11.002; Himmelbach M, 2012, NEUROPSYCHOLOGIA, V50, P139, DOI 10.1016/j.neuropsychologia.2011.11.011; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Kleiner M, 2010, PERCEPTION, V39, P189; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 1999, P ROY SOC B-BIOL SCI, V266, P2225, DOI 10.1098/rspb.1999.0912; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Mon-Williams M, 2001, EXP BRAIN RES, V139, P137, DOI 10.1007/s002210000658; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Perenin M.-T., 1997, PARIETAL LOBE CONTRI, P289; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Rice NJ, 2008, NEUROPSYCHOLOGIA, V46, P1549, DOI 10.1016/j.neuropsychologia.2008.01.012; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; RONDOT P, 1977, BRAIN, V100, P355, DOI 10.1093/brain/100.2.355; Rossetti Y, 2005, NEUROPSYCHOLOGIA, V43, P162, DOI 10.1016/j.neuropsychologia.2004.11.004; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Schenk T, 2012, J NEUROSCI, V32, P2013, DOI 10.1523/JNEUROSCI.3413-11.2012; Schenk T, 2010, VISION RES, V50, P2627, DOI 10.1016/j.visres.2010.08.013	39	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91420	10.1371/journal.pone.0091420	http://dx.doi.org/10.1371/journal.pone.0091420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626162	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000332851300082
J	Kojima, T; Van Deusen, M; Jerome, WG; Garrett, CG; Sivasankar, MP; Novaleski, CK; Rousseau, B				Kojima, Tsuyoshi; Van Deusen, Mark; Jerome, W. Gray; Garrett, C. Gaelyn; Sivasankar, M. Preeti; Novaleski, Carolyn K.; Rousseau, Bernard			Quantification of Acute Vocal Fold Epithelial Surface Damage with Increasing Time and Magnitude Doses of Vibration Exposure	PLOS ONE			English	Article							EVOKED RABBIT PHONATION; VOICE DISORDERS; DESQUAMATION; IMPACT; MICROPROJECTIONS; VERTEBRATES; POPULATION; CELLS; MODEL; IMAGE	Because the vocal folds undergo repeated trauma during continuous cycles of vibration, the epithelium is routinely susceptible to damage during phonation. Excessive and prolonged vibration exposure is considered a significant predisposing factor in the development of vocal fold pathology. The purpose of the present study was to quantify the extent of epithelial surface damage following increased time and magnitude doses of vibration exposure using an in vivo rabbit phonation model. Forty-five New Zealand white breeder rabbits were randomized to nine groups and received varying phonation time-doses (30, 60, or 120 minutes) and magnitude-doses (control, modal intensity phonation, or raised intensity phonation) of vibration exposure. Scanning electron microscopy and transmission electron microscopy was used to quantify the degree of epithelial surface damage. Results revealed a significant reduction in microprojection density, microprojection height, and depth of the epithelial surface with increasing time and phonation magnitudes doses, signifying increased epithelial surface damage risk with excessive and prolonged vibration exposure. Destruction to the epithelial cell surface may provide significant insight into the disruption of cell function following prolonged vibration exposure. One important goal achieved in the present study was the quantification of epithelial surface damage using objective imaging criteria. These data provide an important foundation for future studies of long-term tissue recovery from excessive and prolonged vibration exposure.	[Kojima, Tsuyoshi; Van Deusen, Mark; Garrett, C. Gaelyn; Rousseau, Bernard] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Novaleski, Carolyn K.; Rousseau, Bernard] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37212 USA; [Jerome, W. Gray] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Sivasankar, M. Preeti] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rousseau, B (corresponding author), Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA.	bernard.rousseau@vanderbilt.edu		Garrett, Catherine Gaelyn/0000-0002-3434-8844	NIH from the National Institute on Deafness and Other Communication Disorders [R01 DC 011338]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, U2CDK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011338] Funding Source: NIH RePORTER	NIH from the National Institute on Deafness and Other Communication Disorders; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01 DC 011338 from the National Institute on Deafness and Other Communication Disorders. Electron microscopy was performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P M, 1981, Prog Clin Biol Res, V59B, P21; Bouwers F, 2009, J VOICE, V23, P218, DOI 10.1016/j.jvoice.2007.08.007; Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947; Cohen SM, 2012, LARYNGOSCOPE, V122, P1582, DOI 10.1002/lary.23189; Cohen SM, 2010, LARYNGOSCOPE, V120, P2022, DOI 10.1002/lary.21058; Collin HB, 2000, PHILOS T ROY SOC B, V355, P1171, DOI 10.1098/rstb.2000.0661; Collin SP, 2006, J MORPHOL, V267, P273, DOI 10.1002/jmor.10400; Egelrud T, 2000, ACTA DERM-VENEREOL, P44; Fisher KV, 2001, J APPL PHYSIOL, V91, P1401, DOI 10.1152/jappl.2001.91.3.1401; Fisher KV, 2001, J SPEECH LANG HEAR R, V44, P354, DOI 10.1044/1092-4388(2001/029); Ge PJ, 2009, ANN OTO RHINOL LARYN, V118, P51, DOI 10.1177/000348940911800109; GRAY S, 1988, ANN OTO RHINOL LARYN, V97, P381, DOI 10.1177/000348948809700410; Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HAZLETT LD, 1980, OPHTHALMIC RES, V12, P315, DOI 10.1159/000265095; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; JEROME WG, 1983, SCAN ELECTRON MICROS, P1453; Julio G, 2008, J ANAT, V212, P879, DOI 10.1111/j.1469-7580.2008.00898.x; Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Ling CY, 2011, CELLS TISSUES ORGANS, V193, P158, DOI 10.1159/000318605; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rousseau B, 2011, LARYNGOSCOPE, V121, P346, DOI 10.1002/lary.21364; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivasankar M, 2010, OTOLARYNG HEAD NECK, V142, P79, DOI 10.1016/j.otohns.2009.09.011; SOKOL JL, 1990, INVEST OPHTH VIS SCI, V31, P294; Swanson ER, 2010, OTOLARYNG HEAD NECK, V143, P567, DOI 10.1016/j.otohns.2010.04.264; Swanson ER, 2009, LARYNGOSCOPE, V119, P1439, DOI 10.1002/lary.20532; Talbot C, 2012, J COMP PHYSIOL A, V198, P849, DOI 10.1007/s00359-012-0755-9; TILLMANN B, 1977, CELL TISSUE RES, V185, P279; TITZE IR, 1994, J VOICE, V8, P99, DOI 10.1016/S0892-1997(05)80302-9	33	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91615	10.1371/journal.pone.0091615	http://dx.doi.org/10.1371/journal.pone.0091615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626217	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300109
J	Buttigieg, KR; Dowall, SD; Findlay-Wilson, S; Miloszewska, A; Rayner, E; Hewson, R; Carroll, MW				Buttigieg, Karen R.; Dowall, Stuart D.; Findlay-Wilson, Stephen; Miloszewska, Aleksandra; Rayner, Emma; Hewson, Roger; Carroll, Miles W.			A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model	PLOS ONE			English	Article							VIRUS GLYCOPROTEIN; IMMUNE-RESPONSE; DNA VACCINES; VIRAL LOAD; MVA; INFECTION; IMMUNOGENICITY; LOCALIZATION; ANTIBODY; IDENTIFICATION	Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15-70% of reported cases are fatal. There is no approved vaccine available, and preclinical protection in vivo by an experimental vaccine has not been demonstrated previously. In the present study, the attenuated poxvirus vector, Modified Vaccinia virus Ankara, was used to develop a recombinant candidate vaccine expressing the CCHF virus glycoproteins. Cellular and humoral immunogenicity was confirmed in two mouse strains, including type I interferon receptor knockout mice, which are susceptible to CCHF disease. This vaccine protected all recipient animals from lethal disease in a challenge model adapted to represent infection via a tick bite. Histopathology and viral load analysis of protected animals confirmed that they had been exposed to challenge virus, even though they did not exhibit clinical signs. This is the first demonstration of efficacy of a CCHF vaccine.	[Buttigieg, Karen R.; Dowall, Stuart D.; Findlay-Wilson, Stephen; Miloszewska, Aleksandra; Rayner, Emma; Hewson, Roger; Carroll, Miles W.] Publ Hlth England, Microbiol Serv Res, Porton Down, Wilts, England	Public Health England	Hewson, R (corresponding author), Publ Hlth England, Microbiol Serv Res, Porton Down, Wilts, England.	Roger.Hewson@phe.gov.uk			Health Protection Agency (subsequently part of Public Health England) of the United Kingdom	Health Protection Agency (subsequently part of Public Health England) of the United Kingdom	This work was funded by the Health Protection Agency (subsequently part of Public Health England) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2005, J GEN VIROL, V86, P3327, DOI 10.1099/vir.0.81175-0; Akinci E, 2009, INT J INFECT DIS, V13, P560, DOI 10.1016/j.ijid.2008.08.027; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Amato RJ, 2010, CLIN CANCER RES, V16, P5539, DOI 10.1158/1078-0432.CCR-10-2082; Atkinson B, 2012, EUROSURVEILLANCE, P17; Atkinson B, 2012, VECTOR-BORNE ZOONOT, V12, P786, DOI 10.1089/vbz.2011.0770; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Bergeron E, 2007, J VIROL, V81, P13271, DOI 10.1128/JVI.01647-07; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; CASALS J, 1969, P SOC EXP BIOL MED, V131, P233; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; Chumakov M., 1945, NEW TICK BORNE VIRUS, P13; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Cottingham MG, 2013, VACCINE, V31, P4247, DOI 10.1016/j.vaccine.2013.03.021; Dowall SD, 2012, J VIROL METHODS, V179, P335, DOI 10.1016/j.jviromet.2011.11.020; Draper SJ, 2013, VACCINE, V31, P4223, DOI 10.1016/j.vaccine.2013.05.091; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Duh D, 2007, EMERG INFECT DIS, V13, P1769, DOI 10.3201/eid1311.070222; Earl PL, 1998, CURR PROTOC PROTEI S, V13; Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Erickson BR, 2007, VIROLOGY, V361, P348, DOI 10.1016/j.virol.2006.11.023; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia S, 2006, J CLIN VIROL, V35, P154, DOI 10.1016/j.jcv.2005.02.016; Ghiasi SM, 2011, CLIN VACCINE IMMUNOL, V18, P2031, DOI 10.1128/CVI.05352-11; Haferkamp S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-42; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011; Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Mousavi-Jazi M, 2012, VACCINE, V30, P6225, DOI 10.1016/j.vaccine.2012.08.003; Nabeth P, 2004, EMERG INFECT DIS, V10, P2143, DOI 10.3201/eid1012.040535; Ozturk B, 2012, INT J INFECT DIS, V16, pE89, DOI 10.1016/j.ijid.2011.06.005; Powell TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062778; Saksida A, 2010, CLIN VACCINE IMMUNOL, V17, P1086, DOI 10.1128/CVI.00530-09; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Shih CM, 1996, J CLIN MICROBIOL, V34, P2297, DOI 10.1128/JCM.34.9.2297-2299.1996; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; SWANEPOEL R, 1989, REV INFECT DIS, V11, pS794; Tezer H, 2009, J INFECTION, V59, P291, DOI 10.1016/j.jinf.2009.07.011; Thomas S, 2012, VECTOR-BORNE ZOONOT, V12, P800, DOI 10.1089/vbz.2011.0776; TIGNOR GH, 1993, ANTIVIR RES, V22, P309, DOI 10.1016/0166-3542(93)90040-P; Tobery TW, 2001, J IMMUNOL METHODS, V254, P59, DOI 10.1016/S0022-1759(01)00397-0; Varela AS, 2003, J WILDLIFE DIS, V39, P881, DOI 10.7589/0090-3558-39.4.881; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Vipond J, 2006, VACCINE, V24, P6340, DOI 10.1016/j.vaccine.2006.05.025; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Xiao XD, 2011, BIOCHEM BIOPH RES CO, V411, P253, DOI 10.1016/j.bbrc.2011.06.109; Zivcec M, 2013, J INFECT DIS, V207, P1909, DOI 10.1093/infdis/jit061	66	79	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91516	10.1371/journal.pone.0091516	http://dx.doi.org/10.1371/journal.pone.0091516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621656	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300098
J	Hu, WC; Liu, YT; Yan, J				Hu, Wenchao; Liu, Yuting; Yan, Jun			Microarray Meta-Analysis of RNA-Binding Protein Functions in Alternative Polyadenylation	PLOS ONE			English	Article							PRE-MESSENGER-RNA; 3' UNTRANSLATED REGIONS; COMPUTATIONAL ANALYSIS; WIDE ANALYSIS; CLEAVAGE; DATABASE; SITES; EXPRESSION; IDENTIFY; NETWORKS	Alternative polyadenylation (APA) is a post-transcriptional mechanism to generate diverse mRNA transcripts with different 3'UTRs from the same gene. In this study, we systematically searched for the APA events with differential expression in public mouse microarray data. Hundreds of genes with over-represented differential APA events and the corresponding experiments were identified. We further revealed that global APA differential expression occurred prevalently in tissues such as brain comparing to peripheral tissues, and biological processes such as development, differentiation and immune responses. Interestingly, we also observed widespread differential APA events in RNA-binding protein (RBP) genes such as Rbm3, Eif4e2 and Elavl1. Given the fact that RBPs are considered as the main regulators of differential APA expression, we constructed a co-expression network between APAs and RBPs using the microarray data. Further incorporation of CLIP-seq data of selected RBPs showed that Nova2 represses and Mbnl1 promotes the polyadenylation of closest poly(A) sites respectively. Altogether, our study is the first microarray meta-analysis in a mammal on the regulation of APA by RBPs that integrated massive mRNA expression data under a wide-range of biological conditions. Finally, we present our results as a comprehensive resource in an online website for the research community.	[Hu, Wenchao; Liu, Yuting; Yan, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Yan, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	junyan@picb.ac.cn	Hu, Wencheng/K-2380-2014		Chinese Academy of Sciences; German Max-Planck Society	Chinese Academy of Sciences(Chinese Academy of Sciences); German Max-Planck Society(Max Planck Society)	This research was supported by Chinese Academy of Sciences and German Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cowley M, 2012, NUCLEIC ACIDS RES, V40, P8917, DOI 10.1093/nar/gks654; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; Hilgers V, 2012, GENE DEV, V26, P2259, DOI 10.1101/gad.199653.112; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Martins R, 2012, PLOS ONE, V7; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miura P, 2013, GENOME RES; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Naipauer J, 2013, BIOCHEM J, V454, P345, DOI 10.1042/BJ20130062; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; van Dam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-535; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang HF, 2010, PHYSIOL GENOMICS, V42, P427, DOI 10.1152/physiolgenomics.00205.2009; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	48	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90774	10.1371/journal.pone.0090774	http://dx.doi.org/10.1371/journal.pone.0090774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622240	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300026
J	Huang, JC; Tang, XJ; Liang, XM; Wen, QW; Zhang, SJ; Xuan, FF; Jian, J; Lin, X; Huang, RB				Huang, Jianchun; Tang, XiaoJun; Liang, Xingmei; Wen, Qingwei; Zhang, Shijun; Xuan, Feifei; Jian, Jie; Lin, Xing; Huang, Renbin			The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LEFT-VENTRICULAR HYPERTROPHY; ANGIOTENSIN RECEPTOR ANTAGONIST; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; ESSENTIAL-HYPERTENSION; HEART; DISEASE; RATS; PERFORMANCE	We investigated the effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone (MHBFC), which was isolated from the roots of Millettia pulchra (Benth.) Kurz var. Laxior (Dunn) Z. Wei (Papilionaceae) (MKL), on the progression of cardiac hypertrophy to failure in a rat model of abdominal aortic banding (AAB)-induced pressure overloading. Endothelial dysfunction is central to pressure overload-induced cardiac hypertrophy and failure. It would be useful to clarify whether MHBFC could prevent this dysfunction. The effects of pressure overload were assessed in male Sprague-Dawley rats 6 weeks after AAB using the progression of cardiac hypertrophy to heart failure as the endpoint. The AAB-treated rats exhibited a greater progression to heart failure and had significantly elevated blood pressure, systolic and diastolic cardiac dysfunction, and evidence of left ventricular hypertrophy (LVH). LVH was characterized by increases in the ratios of heart and left ventricular weights to body weight, increased myocyte cross-sectional areas, myocardial and perivascular fibrosis, and elevated cardiac hydroxyproline. These symptoms could be prevented by treatment with MHBFC at daily oral doses of 6 and 12 mg/kg for 6 weeks. The progression to cardiac failure, which was demonstrated by increases in relative lung and right ventricular weights, cardiac function disorders and overexpression of atrial natriuretic peptide (ANP) mRNA, could also be prevented. Furthermore, MHBFC partialy rescued the downregulated nitric oxide signaling system, whereas inhibited the upregulated endothelin signaling system, normalizing the balance between these two systems. MHBFC protected the endothelium and prevented the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.	[Huang, Jianchun; Liang, Xingmei; Wen, Qingwei; Zhang, Shijun; Xuan, Feifei; Jian, Jie; Lin, Xing; Huang, Renbin] Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China; [Tang, XiaoJun] Guangxi Med Coll, Dept Lab Med, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Huang, RB (corresponding author), Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China.	huangrenbin518@163.com			Guangxi Scientific Research and Technology Development Research Projects [0630002-2A]; Guangxi Natural Science Foundation [2013GXNSFAA019175]; Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization [FPRU2013-3]; Outstanding Doctoral Dissertation Breeding Program in the Guangxi Zhuang Autonomous Region [YCBZ2012013]	Guangxi Scientific Research and Technology Development Research Projects; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization; Outstanding Doctoral Dissertation Breeding Program in the Guangxi Zhuang Autonomous Region	This work was supported by the Guangxi Scientific Research and Technology Development Research Projects (No. 0630002-2A); the Guangxi Natural Science Foundation (No. 2013GXNSFAA019175); the Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization (No. FPRU2013-3); and the Outstanding Doctoral Dissertation Breeding Program in the Guangxi Zhuang Autonomous Region (No. YCBZ2012013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Chen X, 2001, HYPERTENSION, V38, P606, DOI 10.1161/hy09t1.094005; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Dhalla NS, 1999, ANN NY ACAD SCI, V874, P100, DOI 10.1111/j.1749-6632.1999.tb09228.x; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Fraccarollo D, 1997, CIRCULATION, V96, P3963; Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702; FRIBERG P, 1990, J HYPERTENS, V8, P879, DOI 10.1097/00004872-199010000-00001; Frohlich ED, 2001, HYPERTENSION, V38, P1388, DOI 10.1161/hy1201.098768; Gao S, 2009, CARDIOVASC RES, V83, P444, DOI 10.1093/cvr/cvp099; Grantham JA, 1997, CIRCULATION, V96, P388; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Huang RB, 2003, CHINESE J HOSP PHARM, V6, P726; [黄仁彬 Huang Renbin], 2010, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V25, P287; [黄媛恒 HUANG Yuan-heng], 2008, [中国新药杂志, Chinese Journal New Drugs], V17, P1764; Janssens S, 2004, CIRC RES, V94, P1256, DOI 10.1161/01.RES.0000126497.38281.23; Jian J, 2009, CHIN J GERONTOL, V29, P73; Jian J, 2012, PLANTA MED, V78, P1324, DOI 10.1055/s-0032-1314964; Jian Jie, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1313; Jian Jie, 2009, Zhongguo Yaolixue Tongbao, V25, P942; Jiao Y., 2004, ACTA ACADEMIAE MEDIC, V21, P22; Kobayashi N, 2001, J HYPERTENS, V19, P795, DOI 10.1097/00004872-200104000-00017; Mc Murray A, 2008, REV ARGENT CARDIOL, V76, P295; OWENS GK, 1985, CIRC RES, V57, P695, DOI 10.1161/01.RES.57.5.695; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; SAVAGE DD, 1987, CIRCULATION, V75, P26; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Schiffrin EL, 2002, J HYPERTENS, V20, P71, DOI 10.1097/00004872-200201000-00011; Schiffrin EL, 1996, J CARDIOVASC PHAR S2, V27, P13; STEPHENSON TJ, 1990, ARCH DIS CHILD, V65, P1293, DOI 10.1136/adc.65.12.1293; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; van Zwieten PA, 2000, CARDIOVASC RES, V45, P82, DOI 10.1016/S0008-6363(99)00291-6; Woodard GE, 2008, INT REV CEL MOL BIO, V268, P59, DOI 10.1016/S1937-6448(08)00803-4; Zhang YX, 2011, AM J PHYSIOL-HEART C, V301, pH634, DOI 10.1152/ajpheart.01315.2010	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91834	10.1371/journal.pone.0091834	http://dx.doi.org/10.1371/journal.pone.0091834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622486	Green Submitted, gold, Green Published			2022-12-25	WOS:000332845300133
J	Rodrigues, APD; Farias, LHS; Carvalho, ASC; Santos, AS; do Nascimento, JLM; Silva, EO				Rodrigues, Ana Paula D.; Farias, Luis Henrique S.; Carvalho, Antonio Sergio C.; Santos, Alberdan S.; do Nascimento, Jose Luiz M.; Silva, Edilene O.			A Novel Function for Kojic Acid, a Secondary Metabolite from Aspergillus Fungi, as Antileishmanial Agent	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; DRUG-RESISTANCE; ABSENCE	Kojic acid (KA) is a fungal metabolite used as a topical treatment skin-whitening cosmetic agent for melasma in humans; however its potential as an anti-leishmanial agent is unknown. Chemotherapy is one of the most effective treatments for Leishmaniasis. However, the drugs available are expensive, invasive, require long-term treatment and have severe side effects. Thus, the development of new effective leishmanicidal agents is a necessity. In this study we investigated the anti-leishmanial effect of KA on L. amazonensis, following in vitro and in vivo infections. KA (50 mu g/mL) was found to decrease the growth by 62% (IC50 34 mu g/mL) and 79% (IC50 27.84 mu g/mL) of promastigotes and amastigotes in vitro, respectively. Ultrastructural analysis of KA-treated amastigotes showed the presence of vesicles bodies into the flagellar pocket, and an intense intracellular vacuolization and swelling of the mitochondrion. During the in vitro interaction of parasites and the host cell, KA reverses the superoxide anions (O-2(-)) inhibitory mechanism promoted by parasite. In addition, 4 weeks after KA-topical formulation treatment of infected animals, a healing process was observed with a high production of collagen fibers and a decrease in parasite burden. Thus, these results demonstrated the great potential of KA as an anti-leishmanial compound.	[Rodrigues, Ana Paula D.; Farias, Luis Henrique S.; Silva, Edilene O.] Fed Univ Para, Inst Ciencias Biol, Lab Biol Estrutural, BR-66059 Belem, Para, Brazil; [Carvalho, Antonio Sergio C.; Santos, Alberdan S.] Fed Univ Para, Inst Ciencias Exactas & Nat, Lab Invest Sistemat Biotecnol & Biodiversidade Mo, BR-66059 Belem, Para, Brazil; [do Nascimento, Jose Luiz M.] Fed Univ Para, Inst Ciencias Biol, Lab Neuroquim Mol & Celular, BR-66059 Belem, Para, Brazil; [Rodrigues, Ana Paula D.; Farias, Luis Henrique S.; Silva, Edilene O.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Rodrigues, Ana Paula D.] Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Lab Microscopia Eletron, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio de Janeiro; Instituto Evandro Chagas	Silva, EO (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Biol Estrutural, BR-66059 Belem, Para, Brazil.	edilene@ufpa.br	Santos, Alberdan Silva/AAY-7861-2020; Silva, Edilene O/B-8239-2015; Farias, Ana Paula Paula/AAW-7164-2021	Farias, Ana Paula Paula/0000-0002-5016-392X; do Nascimento, jose/0000-0003-3647-9124; Silva, Edilene/0000-0001-6555-6868	Programa Nacional de Cooperacao Academica (PROCAD) [620179/2008-2]; Programa Nacional de Cooperacao Academica (Novas Fronteiras) [630/2010]; Instituto Nacional de Biologia Estrutural e Bioimagem (CNPq) [573767/2008-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal) [482922/2010-9]; Fundacao de Amparo a Pesquisa do Estado do Para; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo e Desenvolvimento da Pesquisa; Universidade Federal do Para/PROPESP	Programa Nacional de Cooperacao Academica (PROCAD); Programa Nacional de Cooperacao Academica (Novas Fronteiras); Instituto Nacional de Biologia Estrutural e Bioimagem (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal); Fundacao de Amparo a Pesquisa do Estado do Para(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo e Desenvolvimento da Pesquisa; Universidade Federal do Para/PROPESP	The work was supported by Programa Nacional de Cooperacao Academica (PROCAD - grant number 620179/2008-2 and Novas Fronteiras - grant number 630/2010), Instituto Nacional de Biologia Estrutural e Bioimagem (CNPq - grant number 573767/2008-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal - grant number 482922/2010-9), Fundacao de Amparo a Pesquisa do Estado do Para, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo e Desenvolvimento da Pesquisa and Universidade Federal do Para/PROPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Silva AL, 2004, PARASITOLOGY, V128, P385, DOI 10.1017/S0031182003004621; Adade C.M., 2010, OPEN PARASITOL J, V4, P178, DOI [https://doi.org/10.2174/1874421401004010178, DOI 10.2174/1874421401004010178, 10.2174/1874421401004010178]; Alavi-Naini R, 2012, Prague Med Rep, V113, P105; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Bentley R, 2006, NAT PROD REP, V23, P1046, DOI 10.1039/b603758p; Blumenthal CZ, 2004, REGUL TOXICOL PHARM, V39, P214, DOI 10.1016/j.yrtph.2003.09.002; Burdock FA, 2001, REGUL TOXICOL PHARM, V33, P80, DOI 10.1006/rtph.2000.1442; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2006, INDIAN J MED RES, V123, P399; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Emami S, 2007, BIOORG MED CHEM LETT, V17, P45, DOI 10.1016/j.bmcl.2006.09.097; Ferreira NR, 2010, AN ACAD BRAS CIENC, V82, P569, DOI 10.1590/S0001-37652010000300004; Fitzpatrick JM, 2007, FASEB J, V21, P823, DOI 10.1096/fj.06-7314com; Gomes AJ, 2001, BRAZ J MED BIOL RES, V34, P1487, DOI 10.1590/S0100-879X2001001100018; Guimaraes LRC, 2010, PARASITOL RES, V107, P1075, DOI 10.1007/s00436-010-1973-0; Ha YM, 2007, BIOL PHARM BULL, V30, P1711, DOI 10.1248/bpb.30.1711; HAGGIS GH, 1977, J MICROSC-OXFORD, V111, P193, DOI 10.1111/j.1365-2818.1977.tb00059.x; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lainson Ralph, 2010, Revista Pan-Amazonica de Saude, V1, P13; Lecoeur H, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000034; Lim JTE, 1999, DERMATOL SURG, V25, P282, DOI 10.1046/j.1524-4725.1999.08236.x; Lin CH, 2007, ANAL CHIM ACTA, V581, P102, DOI 10.1016/j.aca.2006.08.002; Miller MC, 2005, BIODRUGS, V19, P363, DOI 10.2165/00063030-200519060-00004; Mohammadpour M, 2013, INT WOUND J, V10, P260, DOI 10.1111/j.1742-481X.2012.00971.x; Moto M, 2006, ARCH TOXICOL, V80, P299, DOI 10.1007/s00204-005-0034-4; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; Nohynek GJ, 2004, FOOD CHEM TOXICOL, V42, P93, DOI 10.1016/j.fct.2003.08.008; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Polonio T, 2008, INT J MOL MED, V22, P277, DOI 10.3892/ijmm_00000020; Rocha-Vieira E, 2003, IMMUNOLOGY, V108, P401, DOI 10.1046/j.1365-2567.2003.01582.x; Rodrigues APD, 2011, CELL BIOL INT, V35, P335, DOI 10.1042/CBI20100083; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Sakthianandeswaren A, 2005, P NATL ACAD SCI USA, V102, P15551, DOI 10.1073/pnas.0505630102; Santos AS, 2011, U.S. Patent, Patent No. [2011/0178169 A1, 20110178169]; Santos AS, 2011, Brazilian patent PI, Patent No. [0817954-9, 08179549]; Santos AS, 2010, European patent WO, Patent No. 2010017613; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Silveira FT, 2009, GAZ MED BAHIA, V79, P25; Tamura T, 2006, TOXICOLOGY, V222, P213, DOI 10.1016/j.tox.2006.02.023; Valadares DG, 2011, PARASITOL INT, V60, P357, DOI 10.1016/j.parint.2011.06.001; Vendrametto MC, 2010, PARASITOL INT, V59, P154, DOI 10.1016/j.parint.2009.12.009	43	58	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91259	10.1371/journal.pone.0091259	http://dx.doi.org/10.1371/journal.pone.0091259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621481	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300070
J	Sicoli, MA; Holton, G				Sicoli, Mark A.; Holton, Gary			Linguistic Phylogenies Support Back-Migration from Beringia to Asia	PLOS ONE			English	Article							LANGUAGE EVOLUTION; NETWORKS; HISTORY; EXPANSION; ORIGINS; TREES; SHAPE	Recent arguments connecting Na-Dene languages of North America with Yeniseian languages of Siberia have been used to assert proof for the origin of Native Americans in central or western Asia. We apply phylogenetic methods to test support for this hypothesis against an alternative hypothesis that Yeniseian represents a back-migration to Asia from a Beringian ancestral population. We coded a linguistic dataset of typological features and used neighbor-joining network algorithms and Bayesian model comparison based on Bayes factors to test the fit between the data and the linguistic phylogenies modeling two dispersal hypotheses. Our results support that a Dene-Yeniseian connection more likely represents radiation out of Beringia with back-migration into central Asia than a migration from central or western Asia to North America.	[Sicoli, Mark A.] Georgetown Univ, Dept Linguist, Washington, DC 20057 USA; [Holton, Gary] Univ Alaska Fairbanks, Alaska Native Language Ctr, Fairbanks, AK USA	Georgetown University; University of Alaska System; University of Alaska Fairbanks	Sicoli, MA (corresponding author), Georgetown Univ, Dept Linguist, Washington, DC 20057 USA.	mas498@georgetown.edu			Alaska EPSCoR; Direct For Social, Behav & Economic Scie [0936887] Funding Source: National Science Foundation; Directorate For Geosciences [1642783, 1003160] Funding Source: National Science Foundation	Alaska EPSCoR; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by Alaska EPSCoR for an RA in Mark Sicoli's lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bowern C, 2012, LANGUAGE, V88, P817, DOI 10.1353/lan.2012.0081; Campbell L, 2011, INT J AM LINGUIST, V77, P445, DOI 10.1086/660977; Castren M. Alexander, 1858, VERSUCH JENISSEI OST; Diamond J, 2011, NATURE, V476, P291, DOI 10.1038/476291a; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunn M, 2005, SCIENCE, V309, P2072, DOI 10.1126/science.1114615; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Dunn M, 2009, LINGUA, V119, P1664, DOI 10.1016/j.lingua.2007.10.026; Georg S, 2007, LANG ASIA, V1, P1; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; GREENHILL SJ, 2005, EVOLUTION CULTURAL D, P31; Holland BR, 2005, SYST BIOL, V54, P66, DOI 10.1080/10635150590906055; Holman EW, 2011, CURR ANTHROPOL, V52, P841, DOI 10.1086/662127; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krauss ME, 1973, LINGUISTICS N AM, P903; Krauss Michael E., 1981, HDB N AM INDIANS, V6, P67; Levinson SC, 2012, TRENDS COGN SCI, V16, P167, DOI 10.1016/j.tics.2012.01.007; Nelson-Sathi S, 2011, P ROY SOC B-BIOL SCI, V278, P1794, DOI 10.1098/rspb.2010.1917; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Potter Ben, 2010, ANTHR PAPERS U ALASK, V5, P138; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Robinson LC, 2012, LANG DYN CHANG, V2, P123, DOI 10.1163/22105832-20120201; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruhlen M, 1998, P NATL ACAD SCI USA, V95, P13994, DOI 10.1073/pnas.95.23.13994; Sapir E, 1916, CANADA DEP MINES MEM, V13; Sherzer J, 1976, N HOLLAND LINGUISTIC, V20; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Trombetti Alfredo, 1923, ELEMENTI GLOTTOLOGIA; VAJDA EJ, 2010, ANTHR PAPERS U ALASK, V5, P100; Wichmann S, 2011, LANG DYN CHANG, V1, P205, DOI 10.1163/221058212X648072; Wichmann Soren, 2007, DIACHRONICA, V24, P373, DOI DOI 10.1075/DIA.24.2.06WIC; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102	39	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91722	10.1371/journal.pone.0091722	http://dx.doi.org/10.1371/journal.pone.0091722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC9HN	24621925	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300120
J	Jung, HR; Song, KH; Chang, JT; Doh, J				Jung, Hong-Ryul; Song, Kwang Hoon; Chang, John T.; Doh, Junsang			Geometrically Controlled Asymmetric Division of CD4+T Cells Studied by Immunological Synapse Arrays	PLOS ONE			English	Article							T-LYMPHOCYTE DIVISION; DENDRITIC CELLS; EFFECTOR; DIFFERENTIATION; MEMORY; ACTIVATION; RESPONSES; SURFACES; FATE; RECOGNITION	Similar to stem cells, naive T cells undergo asymmetric division following activation. While asymmetric division of T cells has been shown to be an important mechanism for the generation of lymphocyte fate diversity during immune responses, key factors that influence whether T cells will undergo symmetric or asymmetric divisions are not completely understood. Here, we utilized immunological synapse arrays (ISAs) to begin to dissect mechanisms of asymmetric T lymphocyte division. ISAs are protein micropatterned surfaces composed of two segregated regions, activation sites and adhesion fields. Activation sites are small spots presenting activation signals such as anti-CD3 and anti-CD28, and adhesion fields are the remaining regions surrounding activation sites immobilized with interintercel adhesion molecule 1 (ICAM-1). By varying the size and the distance between the activation sites and measuring the incidence of asymmetric cell divisions, we found that the distance between activation sites is an important regulator of asymmetric division. Further analysis revealed that more symmetric divisions occurred when two nascent daughter cells stably interacted with two distinct activation sites throughout and following cytokinesis. In contrast, more asymmetric divisions occurred when only one daughter cell remained anchored on an activation site while the other daughter became motile and moved away following cytokinesis. Together, these results indicate that TCR signaling events during cytokinesis may repolarize key molecules for asymmetric partitioning, suggesting the possibility that the density of antigen presenting cells that interact with T cells as they undergo cytokinesis may be a critical factor regulating asymmetric division in T cells.	[Jung, Hong-Ryul; Doh, Junsang] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea; [Song, Kwang Hoon; Doh, Junsang] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea; [Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of California System; University of California San Diego	Chang, JT (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	changj@ucsd.edu; jsdoh@postech.ac.kr	Song, Kwanghoon/Q-6934-2016	Song, Kwanghoon/0000-0001-8143-7148; jung, hong ryul/0000-0001-7969-5885	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A121177/HI12C1079]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095277] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (JD, Grant No. A121177/HI12C1079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2012, CURR OPIN CELL BIOL, V24, P526, DOI 10.1016/j.ceb.2012.05.002; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Doh J, 2010, BIOMATERIALS, V31, P3422, DOI 10.1016/j.biomaterials.2010.01.018; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Irvine DJ, 2007, CURR OPIN IMMUNOL, V19, P463, DOI 10.1016/j.coi.2007.05.003; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.smim.2007.02.011; Jung HR, 2012, WILEY INTERDISCIPLIN; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	31	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91926	10.1371/journal.pone.0091926	http://dx.doi.org/10.1371/journal.pone.0091926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632942	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400121
J	Kornmeier, J; Worner, R; Riedel, A; Bach, M; van Elst, LT				Kornmeier, Juergen; Woerner, Rike; Riedel, Andreas; Bach, Michael; van Elst, Ludger Tebartz			A Different View on the Checkerboard? Alterations in Early and Late Visually Evoked EEG Potentials in Asperger Observers	PLOS ONE			English	Article							FUNCTIONING AUTISM; ATTENTION; QUOTIENT; P300; RECOGNITION; DISORDERS; CHILDREN; BRAIN	Background: Asperger Autism is a lifelong psychiatric condition with highly circumscribed interests and routines, problems in social cognition, verbal and nonverbal communication, and also perceptual abnormalities with sensory hypersensitivity. To objectify both lower-level visual and cognitive alterations we looked for differences in visual event-related potentials (EEG) between Asperger observers and matched controls while they observed simple checkerboard stimuli. Methods: In a balanced oddball paradigm checkerboards of two checksizes (0.6 degrees and 1.2 degrees) were presented with different frequencies. Participants counted the occurrence times of the rare fine or rare coarse checkerboards in different experimental conditions. We focused on early visual ERP differences as a function of checkerboard size and the classical P3b ERP component as an indicator of cognitive processing. Results: We found an early (100-200 ms after stimulus onset) occipital ERP effect of checkerboard size (dominant spatial frequency). This effect was weaker in the Asperger than in the control observers. Further a typical parietal/central oddball-P3b occurred at 500 ms with the rare checkerboards. The P3b showed a right-hemispheric lateralization, which was more prominent in Asperger than in control observers. Discussion: The difference in the early occipital ERP effect between the two groups may be a physiological marker of differences in the processing of small visual details in Asperger observers compared to normal controls. The stronger lateralization of the P3b in Asperger observers may indicate a stronger involvement of the right-hemispheric network of bottom-up attention. The lateralization of the P3b signal might be a compensatory consequence of the compromised early checksize effect. Higher-level analytical information processing units may need to compensate for difficulties in low-level signal analysis.	[Kornmeier, Juergen] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany; [Kornmeier, Juergen; Bach, Michael] Univ Freiburg, Ctr Eye, D-79106 Freiburg, Germany; [Woerner, Rike] PPD Germany GmbH & Co Kg, Karlsruhe, Germany; [Riedel, Andreas; van Elst, Ludger Tebartz] Univ Freiburg, Sect Expt Neuropsychiat, Clin Psychiat & Psychotherapy, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Kornmeier, J (corresponding author), Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany.	juergen.kornmeier@uni-freiburg.de	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X	Deutsche Forschungsgemeinschaft [KO 4764/1-1, TE 280/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (KO 4764/1-1 & TE 280/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1995, PSYCHOPHYSIOLOGY, V32, P467, DOI 10.1111/j.1469-8986.1995.tb02098.x; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; Bach M, 1998, FUNCTIONAL IMAGING, P391; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Edgington E.S., 2007, RANDOMIZATION TESTS; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066797; Jarbrink K, 2007, AUTISM, V11, P453, DOI 10.1177/1362361307079602; Jemel B, 2010, J VISION, V10, DOI 10.1167/10.6.13; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; Kornmeier J, 2009, J VISION, V9, DOI 10.1167/9.1.7; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; McCleery JP, 2007, BIOL PSYCHIAT, V62, P1007, DOI 10.1016/j.biopsych.2007.02.009; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; PARKER DM, 1977, PERCEPTION, V6, P85, DOI 10.1068/p060085; PLANT GT, 1983, ELECTROEN CLIN NEURO, V56, P147, DOI 10.1016/0013-4694(83)90069-X; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Preiser D, 2013, INVEST OPHTH VIS SCI, V54, P1182, DOI 10.1167/iovs.12-11201; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shalom DB, 2009, NEUROSCIENTIST, V15, P589, DOI 10.1177/1073858409336371; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Tebartz van Elst L, 2013, ASPERGER SYNDROM ERW, P412; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; van Elst LT, 2013, EUR ARCH PSY CLIN N, V263, pS189, DOI 10.1007/s00406-013-0459-3; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	42	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90993	10.1371/journal.pone.0090993	http://dx.doi.org/10.1371/journal.pone.0090993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632708	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400030
J	Limpens, J; Holmgren, M; Jacobs, CMJ; Van der Zee, SEATM; Karofeld, E; Berendse, F				Limpens, Juul; Holmgren, Milena; Jacobs, Cor M. J.; Van der Zee, Sjoerd E. A. T. M.; Karofeld, Edgar; Berendse, Frank			How Does Tree Density Affect Water Loss of Peatlands? A Mesocosm Experiment	PLOS ONE			English	Article							CARBON-DIOXIDE; SPHAGNUM MOSSES; VASCULAR PLANTS; CLIMATE-CHANGE; SCOTS PINE; BOREAL; EVAPOTRANSPIRATION; EVAPORATION; VEGETATION; TABLE	Raised bogs have accumulated more atmospheric carbon than any other terrestrial ecosystem on Earth. Climate-induced expansion of trees and shrubs may turn these ecosystems from net carbon sinks into sources when associated with reduced water tables. Increasing water loss through tree evapotranspiration could potentially deepen water tables, thus stimulating peat decomposition and carbon release. Bridging the gap between modelling and field studies, we conducted a three-year mesocosm experiment subjecting natural bog vegetation to three birch tree densities, and studied the changes in subsurface temperature, water balance components, leaf area index and vegetation composition. We found the deepest water table in mesocosms with low tree density. Mesocosms with high tree density remained wettest (i.e. highest water tables) whereas the control treatment without trees had intermediate water tables. These differences are attributed mostly to differences in evapotranspiration. Although our mesocosm results cannot be directly scaled up to ecosystem level, the systematic effect of tree density suggests that as bogs become colonized by trees, the effect of trees on ecosystem water loss changes with time, with tree transpiration effects of drying becoming increasingly offset by shading effects during the later phases of tree encroachment. These density-dependent effects of trees on water loss have important implications for the structure and functioning of peatbogs.	[Limpens, Juul; Berendse, Frank] Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Holmgren, Milena] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; Alterra, Climate Change & Adapt Land & Water Management, Wageningen, Netherlands; [Van der Zee, Sjoerd E. A. T. M.] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Karofeld, Edgar] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Limpens, J (corresponding author), Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6700 AP Wageningen, Netherlands.	Juul.Limpens@wur.nl	Karofeld, Edgar/H-3628-2018	Karofeld, Edgar/0000-0001-6533-8473; Jacobs, Cor/0000-0003-4079-9067	Dutch Forest Service; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Foundation for Conservation of Irish Bogs; European development Fund (Centre of Excellence FIBIR);  [SF0180025s12]	Dutch Forest Service; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Foundation for Conservation of Irish Bogs; European development Fund (Centre of Excellence FIBIR); 	Grants from the Dutch Forest Service, the Dutch Ministry of Economic Affairs, Agriculture and Innovation and the Foundation for Conservation of Irish Bogs made the research possible. From the Estonian side, the study was supported by the target-financed research project SF0180025s12 and by the European development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Berg EE, 2009, CAN J FOREST RES, V39, P2033, DOI 10.1139/X09-121; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bragg OM, 2002, SCI TOTAL ENVIRON, V294, P111, DOI 10.1016/S0048-9697(02)00059-1; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Breeuwer A, 2009, BASIC APPL ECOL, V10, P330, DOI 10.1016/j.baae.2008.05.005; de Bruin HAR, 1998, HYDROL PROCESS, V12, P1053, DOI 10.1002/(SICI)1099-1085(19980615)12:7&lt;1053::AID-HYP639&gt;3.0.CO;2-E; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Elbers, 2009, GEMETEN ACTUELE VERD; Eppinga MB, 2009, PLANT ECOL, V200, P53, DOI 10.1007/s11258-007-9309-6; Fay E, 2009, CANADA MIRES PEAT, V5, P1; Frankl R, 2000, FLORA, V195, P267; GOUDRIAAN J, 1977, P249; Gunnarsson U, 1998, WETLANDS, V18, P133, DOI 10.1007/BF03161450; Hamaker P, 2000, WATERVERBRUIK BOSSEN; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Heijmans MMPD, 2004, AGR FOREST METEOROL, V123, P135, DOI 10.1016/j.agrformet.2003.12.006; Heijmans MMPD, 2013, GLOBAL CHANGE BIOL, V19, P2240, DOI 10.1111/gcb.12202; Holmgren M, 2012, OECOLOGIA, V169, P293, DOI 10.1007/s00442-011-2196-5; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Humphreys ER, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000111; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; Juutinen S, 2010, ECOSYSTEMS, V13, P874, DOI 10.1007/s10021-010-9361-2; Kapfer J, 2011, J ECOL, V99, P1179, DOI 10.1111/j.1365-2745.2011.01847.x; Kellner E, 2001, AGR FOREST METEOROL, V110, P101, DOI 10.1016/S0168-1923(01)00283-0; Kettridge N, 2013, J GEOPHYS RES-BIOGEO, V118, P422, DOI 10.1002/jgrg.20043; Kramer P.J., 1983, WATER RELATIONS PLAN; LAFLEUR P, 1990, CAN GEOGR-GEOGR CAN, V34, P79, DOI 10.1111/j.1541-0064.1990.tb01072.x; Lafleur PM, 2005, HYDROL PROCESS, V19, P3533, DOI 10.1002/hyp.5842; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Limpens J, 2009, ROL BERK BIJ HERSTEL; Limpens J, 2014, FUNCT ECOL, V28, P283, DOI 10.1111/1365-2435.12148; Linderholm HW, 2004, WETLANDS, V24, P357, DOI 10.1672/0277-5212(2004)024[0357:AAOTCT]2.0.CO;2; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Ohlson M, 2001, OIKOS, V94, P425, DOI 10.1034/j.1600-0706.2001.940305.x; Pellerin S, 2000, CAN J BOT, V78, P255, DOI 10.1139/cjb-78-2-255; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pouliot R, 2011, ACTA OECOL, V37, P346, DOI 10.1016/j.actao.2011.04.001; Price JS, 2009, J HYDROL, V369, P175, DOI 10.1016/j.jhydrol.2009.02.044; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Proctor MCF, 2000, NEW PHYTOL, V148, P1, DOI 10.1111/j.1469-8137.2000.00751.x; Robroek BJM, 2009, GLOBAL CHANGE BIOL, V15, P680, DOI 10.1111/j.1365-2486.2008.01724.x; Sarkkola S, 2010, CAN J FOREST RES, V40, P1485, DOI 10.1139/X10-084; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2005, GLOBAL CHANGE BIOL, V11, P1003, DOI 10.1111/j.1365-2486.2005.00962.x; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Stewart RIA, 2013, ADV ECOL RES, V48, P71, DOI 10.1016/B978-0-12-417199-2.00002-1; Strakova P, 2012, GLOBAL CHANGE BIOL, V18, P322, DOI 10.1111/j.1365-2486.2011.02503.x; Strilesky SL, 2012, AGR FOREST METEOROL, V153, P45, DOI 10.1016/j.agrformet.2011.06.006; Thompson DK, 2012, THESIS MCMASTER U HA; Turunen J, 2002, HOLOCENE, V12, P69, DOI 10.1191/0959683602hl522rp; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Weltzin JF, 2001, OECOLOGIA, V128, P557, DOI 10.1007/s004420100691; Wiedermann MM, 2007, ECOLOGY, V88, P454, DOI 10.1890/05-1823	57	25	26	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91748	10.1371/journal.pone.0091748	http://dx.doi.org/10.1371/journal.pone.0091748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632565	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400086
J	Lodh, N; Naples, JM; Bosompem, KM; Quartey, J; Shiff, CJ				Lodh, Nilanjan; Naples, Jean M.; Bosompem, Kwabena M.; Quartey, Joseph; Shiff, Clive J.			Detection of Parasite-Specific DNA in Urine Sediment Obtained by Filtration Differentiates between Single and Mixed Infections of Schistosoma mansoni and S. haematobium from Endemic Areas in Ghana	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIAGNOSTIC-TESTS; FILTERED URINE; FRAGMENTS; CHILDREN; ADULTS	Differential diagnosis of Schistosoma mansoni and S. haematobium, which often occur sympatrically in Africa, requires both urine and stool and the procedures are low in sensitivity. The standard diagnostic tests, such as Kato-Katz (KK) for S. mansoni eggs and presence of haematuria for S. haematobium both lack sensitivity, produce false-negative results and show reduced accuracy with decreasing intensity of infection. The need for a single diagnostic test with high sensitivity and specificity for both parasites is important as many African countries are implementing Mass Drug Administration (MDA) following recommendations of the World Health Organization (WHO). Eighty-six samples of urine sediment obtained by filtration were collected from a group of 5-23 years old people from an endemic area of southern Ghana. DNA was extracted from the urine sediment on filter paper from which a species-specific repeat fragment was amplified by polymerase chain reaction (PCR) with specific primers for S. mansoni and for S. haematobium. Additionally, all participants were tested by KK (stool) and dipstick for haematuria. Diagnostic parameters for all three tests were analyzed statistically. Amplification of species-specific DNA by PCR showed much higher sensitivity (99%-100%) and specificity (100%) compared to KK and haematuria (sensitivity: 76% and 30% respectively) for both schistosome species. The same pattern was observed when the data were stratified for age group and sex specific analysis. In addition PCR amplification detected DNA from 11 individuals infected with both parasites who were negative by KK and haematuria. This approach of detecting parasite specific DNA from either or both species in a single urine specimen is a practical advantage that avoids the need for two specimens and is more effective than standard tests including those based on serology. This promises to improve the effectiveness of surveillance of MDA control programs of schistosomiasis.	[Lodh, Nilanjan; Naples, Jean M.; Shiff, Clive J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Bosompem, Kwabena M.; Quartey, Joseph] NMIMR, Dept Parasitol, Legon, Accra, Ghana	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lodh, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	nlodh@jhsph.edu			Department of Molecular Microbiology and Immunology of Johns Hopkins School of Public Health allocation; Open Access Promotion Fund of the Johns Hopkins University Libraries	Department of Molecular Microbiology and Immunology of Johns Hopkins School of Public Health allocation; Open Access Promotion Fund of the Johns Hopkins University Libraries	Financial support for the molecular work was from the Department of Molecular Microbiology and Immunology of Johns Hopkins School of Public Health allocation. Specimen collection and parasitological examination, Kato-Katz and haematuria kits were provided by Noguchi Memorial Institute for Medical Research. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GLOBAL BURDEN DIS CO; Chen M, 1989, TROP DIS B, V84, P1; DEVLAS SJ, 1992, PARASITOL TODAY, V8, P274, DOI 10.1016/0169-4758(92)90144-Q; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Gelfand M, 1967, CLIN STUDY INTESTINA; Hamburger J, 2001, AM J TROP MED HYG, V65, P907, DOI 10.4269/ajtmh.2001.65.907; HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R; Hamilton JV, 1998, PARASITOLOGY, V117, pS41; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Ibironke O, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001464; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; KNIGHT WB, 1976, AM J TROP MED HYG, V25, P818, DOI 10.4269/ajtmh.1976.25.818; Koukounari A, 2009, AM J TROP MED HYG, V80, P435, DOI 10.4269/ajtmh.2009.80.435; Krampe A, 2007, COMPUT STAT DATA AN, V51, P4124, DOI 10.1016/j.csda.2007.01.021; Lodh N, 2013, AM J TROP MED HYG, V89, P46, DOI 10.4269/ajtmh.13-0104; Mharakurwa S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-103; Navaratnam AMD, 2012, T ROY SOC TROP MED H, V106, P400, DOI 10.1016/j.trstmh.2012.03.013; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; SHIFF CJ, 1968, J PARASITOL, V54, P1133, DOI 10.2307/3276977; Shiff C, 2006, T ROY SOC TROP MED H, V100, P847, DOI 10.1016/j.trstmh.2005.10.010; Shiff C, 2010, T ROY SOC TROP MED H, V104, P3, DOI 10.1016/j.trstmh.2009.05.013; Terer CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002106; Zhong XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059089	25	35	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91144	10.1371/journal.pone.0091144	http://dx.doi.org/10.1371/journal.pone.0091144			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632992	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400041
J	Su, Q; Xie, W; Wang, SL; Wu, QJ; Ghanim, M; Zhang, YJ				Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Ghanim, Murad; Zhang, Youjun			Location of Symbionts in the Whitefly Bemisia tabaci Affects Their Densities during Host Development and Environmental Stress	PLOS ONE			English	Article							LEAF CURL VIRUS; SECONDARY SYMBIONTS; INFECTION DENSITY; CYTOPLASMIC INCOMPATIBILITY; EVOLUTIONARY RELATIONSHIPS; TRANSOVARIAL TRANSMISSION; BACTERIAL SYMBIONTS; WOLBACHIA; RICKETTSIA; VECTOR	Bacterial symbionts often enhance the physiological capabilities of their arthropod hosts and enable their hosts to expand into formerly unavailable niches, thus leading to biological diversification. Many arthropods, including the worldwide invasive whitefly Bemisia tabaci, have individuals simultaneously infected with symbionts of multiple genera that occur in different locations in the host. This study examined the population dynamics of symbionts that are located in different areas within B. tabaci. While densities of Portiera and Hamiltonella (which are located in bacteriocytes) appeared to be well-regulated during host development, densities of Rickettsia (which are not located in bacteriocytes) were highly variable among individual hosts during host development. Host mating did not significantly affect symbiont densities. Infection by Tomato yellow leaf curl virus did not affect Portiera and Hamiltonella densities in either sex, but increased Rickettsia densities in females. High and low temperatures did not affect Portiera and Hamiltonella densities, but low temperature (15 degrees C) significantly suppressed Rickettsia densities whereas high temperature (35 degrees C) had little effect on Rickettsia densities. The results are consistent with the view that the population dynamics of bacterial symbionts in B. tabaci are regulated by symbiont location within the host and that the regulation reflects adaptation between the bacteria and insect.	[Su, Qi] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China; [Ghanim, Murad] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [31171857]; Beijing Natural Science Foundation [6131002]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), the National Natural Science Foundation of China (31171857), the Beijing Natural Science Foundation (6131002), and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Darby AC, 2001, FEMS MICROBIOL ECOL, V36, P43, DOI 10.1111/j.1574-6941.2001.tb00824.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2007, ARTHROPOD-PLANT INTE, V1, P195, DOI 10.1007/s11829-007-9018-z; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Ikeda T, 2003, J INVERTEBR PATHOL, V84, P1, DOI 10.1016/S0022-2011(03)00106-X; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pan HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02230; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Su Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089002; Su Q, 2013, ENVIRON ENTOMOL, V42, P1265, DOI 10.1603/EN13182; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Zhang H, 2009, VIRUS GENES, V39, P249, DOI 10.1007/s11262-009-0384-8	61	16	16	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91802	10.1371/journal.pone.0091802	http://dx.doi.org/10.1371/journal.pone.0091802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632746	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400091
J	Caceres-Gorriti, KY; Carmona, E; Barres, V; Rahimi, K; Letourneau, IJ; Tonin, PN; Provencher, D; Mes-Masson, AM				Caceres-Gorriti, Katia Y.; Carmona, Euridice; Barres, Veronique; Rahimi, Kurosh; Letourneau, Isabelle J.; Tonin, Patricia N.; Provencher, Diane; Mes-Masson, Anne-Marie			RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer	PLOS ONE			English	Article							BINDING PROTEIN; IMPORTIN-ALPHA; IDENTIFICATION; GTPASE; EXPRESSION; MITOSIS; CHROMOSOME; PACLITAXEL; APOPTOSIS; BIOLOGY	Purpose: Epithelial ovarian cancer has the highest mortality rate of all gynecological malignancies. We have shown that high RAN expression strongly correlates with high-grade and poor patient survival in epithelial ovarian cancer. However, as RAN is a small GTPase involved in two main biological functions, nucleo-cytoplasmic transport and mitosis, it is still unknown which of these functions associate with poor prognosis. Methods: To examine the biomarker value of RAN network components in serous epithelial ovarian cancer, protein expression of six specific RAN partners was analyzed by immunohistochemistry using a tissue microarray representing 143 patients associated with clinical parameters. The RAN GDP/GTP cycle was evaluated by the expression of RANBP1 and RCC1, the mitotic function by TPX2 and IMP beta, and the nucleo-cytoplasmic trafficking function by XPO7, XPOT and IMP beta. Results: Based on Kaplan-Meier analyses, RAN, cytoplasmic XPO7 and TPX2 were significantly associated with poor overall patient survival, and RAN and TPX2 were associated with lower disease free survival in patients with high-grade serous carcinoma. Cox regression analysis revealed that RAN and TPX2 expression were independent prognostic factors for both overall and disease free survival, and that cytoplasmic XPO7 expression was a prognostic factor for overall patient survival. Conclusions: In this systematic study, we show that RAN and two protein partners involved in its nucleo-cytoplasmic and mitotic functions (XPO7 and TPX2, respectively) can be used as biomarkers to stratify patients based on prognosis. In particular, we reported for the first time the clinical relevance of the exportin XPO7 and showed that TPX2 expression had the strongest prognostic value. These findings suggest that protein partners in each of RAN's functions can discriminate between different outcomes in high-grade serous epithelial ovarian cancer patients. Furthermore, these proteins point to cellular processes that may ultimately be targeted to improve the survival in serous epithelial ovarian cancer.	[Caceres-Gorriti, Katia Y.; Carmona, Euridice; Barres, Veronique; Letourneau, Isabelle J.; Provencher, Diane; Mes-Masson, Anne-Marie] CRCHUM, Montreal, PQ, Canada; [Caceres-Gorriti, Katia Y.; Carmona, Euridice; Barres, Veronique; Letourneau, Isabelle J.; Provencher, Diane; Mes-Masson, Anne-Marie] Inst Canc Montreal, Montreal, PQ, Canada; [Rahimi, Kurosh] CHUM, Dept Pathol, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Provencher, Diane] Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal	Mes-Masson, AM (corresponding author), CRCHUM, Montreal, PQ, Canada.	anne-marie.mes-masson@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X	Canadian Institutes of Health Research (CIHR) (MOP) [36056]; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec - Sante (FRQS); Carole Epstein Foundation; Canderel fund of the Institut du cancer de Montreal; FRQS postdoctoral training award; FRQS	Canadian Institutes of Health Research (CIHR) (MOP)(Canadian Institutes of Health Research (CIHR)); Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec - Sante (FRQS); Carole Epstein Foundation; Canderel fund of the Institut du cancer de Montreal; FRQS postdoctoral training award; FRQS	This work was supported by a grant (MOP #36056) from the Canadian Institutes of Health Research (CIHR) to A-MM-M, PNT and DP. Tumor banking was supported by the Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec - Sante (FRQS), associated with the Canadian Tumor Repository Network (CTRNet). KYC-G was supported in part by studentships from the Carole Epstein Foundation and the Canderel fund of the Institut du cancer de Montreal. IJL was supported by a FRQS postdoctoral training award. A-MM-M and DMP are researchers of the Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM) and PNT is a researcher at the Research Institute of the McGill University Health Centre (MUHC), both of which receive support from the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DESOUZA PL, 1992, HEMATOL ONCOL CLIN N, V6, P761; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Etemadmoghadam D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015498; Fan H, 2012, INT J CLIN ONCOL; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Koch P, 2000, BIOCHEM BIOPH RES CO, V278, P241, DOI 10.1006/bbrc.2000.3788; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 2000, J BIOL CHEM, V275, P40163, DOI 10.1074/jbc.M006242200; Li H, 2006, ACTA BIOCH BIOPH SIN, V38, P900, DOI 10.1111/j.1745-7270.2006.00235.x; Ly TK, 2010, J BIOL CHEM, V285, P5815, DOI 10.1074/jbc.M109.071886; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malpica A, 2008, INT J GYNECOL PATHOL, V27, P175, DOI 10.1097/PGP.0b013e31816085e0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McGuire WP, 2009, J CLIN ONCOL, V27, P4633, DOI 10.1200/JCO.2009.23.6653; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; Roscioli E, 2010, BIOCHEM SOC T, V38, P1709, DOI 10.1042/BST0381709; Scharer CD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-79; Seidman JD, 2000, HUM PATHOL, V31, P539, DOI 10.1053/hp.2000.8048; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singer G, 2002, AM J PATHOL, V160, P1223, DOI 10.1016/S0002-9440(10)62549-7; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strom AC, 2001, GENOME BIOL, V2; Vainio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039801; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; Woo IS, 2008, APOPTOSIS, V13, P1223, DOI 10.1007/s10495-008-0247-0; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279	50	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91000	10.1371/journal.pone.0091000	http://dx.doi.org/10.1371/journal.pone.0091000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625450	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300049
J	Goychuk, I; Kharchenko, VO; Metzler, R				Goychuk, Igor; Kharchenko, Vasyl O.; Metzler, Ralf			How Molecular Motors Work in the Crowded Environment of Living Cells: Coexistence and Efficiency of Normal and Anomalous Transport	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; DYNAMICS; MOTION; VISCOELASTICITY; SUBDIFFUSION; DIFFUSION; KINETICS	Recent experiments reveal both passive subdiffusion of various nanoparticles and anomalous active transport of such particles by molecular motors in the molecularly crowded environment of living biological cells. Passive and active microrheology reveals that the origin of this anomalous dynamics is due to the viscoelasticity of the intracellular fluid. How do molecular motors perform in such a highly viscous, dissipative environment? Can we explain the observed co-existence of the anomalous transport of relatively large particles of 100 to 500 nm in size by kinesin motors with the normal transport of smaller particles by the same molecular motors? What is the efficiency of molecular motors in the anomalous transport regime? Here we answer these seemingly conflicting questions and consistently explain experimental findings in a generalization of the well-known continuous diffusion model for molecular motors with two conformational states in which viscoelastic effects are included.	[Goychuk, Igor; Kharchenko, Vasyl O.; Metzler, Ralf] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Kharchenko, Vasyl O.] Natl Acad Sci Ukraine, Inst Appl Phys, Sumy, Ukraine; [Metzler, Ralf] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	University of Potsdam; National Academy of Sciences Ukraine; Institute of Applied Physics, National Academy of Sciences of Ukraine; Tampere University	Goychuk, I (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	igoychuk@uni-potsdam.de	Kharchenko, Vasyl/X-5475-2019; Kharchenko, Vasyl O./E-9432-2014; Metzler, Ralf/J-9088-2013; Goychuk, Igor/A-7103-2008	Kharchenko, Vasyl/0000-0002-0148-6001; Kharchenko, Vasyl O./0000-0002-0148-6001; Metzler, Ralf/0000-0002-6013-7020; Goychuk, Igor/0000-0002-6818-9159	Deutsche Forschungsgemeinschaft(DFG) [GO 2052/1-1, GO 2052/1-2]; Finland Distinguished Professor program, Academy of Finland	Deutsche Forschungsgemeinschaft(DFG)(German Research Foundation (DFG)); Finland Distinguished Professor program, Academy of Finland	Grants GO 2052/1-1, GO 2052/1-2 (IG), Deutsche Forschungsgemeinschaft(DFG); Finland Distinguished Professor program (RM), Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard F, 1996, PHYS REV LETT, V77, P4470, DOI 10.1103/PhysRevLett.77.4470; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Astumian RD, 1996, BIOPHYS J, V70, P637, DOI 10.1016/S0006-3495(96)79605-4; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Bruno L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018332; Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Franosch T, 2011, NATURE, V478, P85, DOI 10.1038/nature10498; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Goychuk I, 2013, MATH MODEL NAT PHENO, V8, P144, DOI 10.1051/mmnp/20138210; Goychuk I, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051131; Goychuk I, 2012, ADV CHEM PHYS, V150, P187; Goychuk I, 2010, CHEM PHYS, V375, P450, DOI 10.1016/j.chemphys.2010.04.009; Goychuk I, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046125; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Holyst R, 2009, PHYS CHEM CHEM PHYS, V11, P9025, DOI 10.1039/b908386c; Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/NPHYS1953, 10.1038/nphys1953]; Jeon JH, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/045011; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jones AT, 2003, ADV DRUG DELIVER REV, V55, P1353, DOI 10.1016/j.addr.2003.07.002; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; JULICHER F, 1999, LECT NOTES PHYS, V532, P46; Kharchenko V, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043042; Kharchenko VO, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052119; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Makhnovskii YA, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021102; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mattsson J, 2009, NATURE, V462, P83, DOI 10.1038/nature08457; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Nelson P, 2004, BIOLOGICAL PHYSICS E; Odijk T, 2000, BIOPHYS J, V79, P2314, DOI 10.1016/S0006-3495(00)76477-0; PALMER RG, 1984, PHYS REV LETT, V53, P958, DOI 10.1103/PhysRevLett.53.958; Perez-Carrasco R, 2010, BIOPHYS J, V98, P2591, DOI 10.1016/j.bpj.2010.02.027; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Qian H, 2000, BIOPHYS J, V79, P137, DOI 10.1016/S0006-3495(00)76278-3; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; Robert D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010046; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sekimoto K, 1997, J PHYS SOC JPN, V66, P1234, DOI 10.1143/JPSJ.66.1234; Szymanski J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038102; Tabei SMA, 2013, P NATL ACAD SCI USA, V110, P4911, DOI 10.1073/pnas.1221962110; Taylor MA, 2013, NAT PHOTONICS, V7, P229, DOI [10.1038/NPHOTON.2012.346, 10.1038/nphoton.2012.346]; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; WYMAN J, 1975, P NATL ACAD SCI USA, V72, P3983, DOI 10.1073/pnas.72.10.3983; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	54	67	68	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91700	10.1371/journal.pone.0091700	http://dx.doi.org/10.1371/journal.pone.0091700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626511	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300124
J	Rogers, SM; Turner, CF; Hobbs, M; Miller, WC; Tan, S; Roman, AM; Eggleston, E; Villarroel, MA; Ganapathi, L; Chromy, JR; Erbelding, E				Rogers, Susan M.; Turner, Charles F.; Hobbs, Marcia; Miller, William C.; Tan, Sylvia; Roman, Anthony M.; Eggleston, Elizabeth; Villarroel, Maria A.; Ganapathi, Laxminarayana; Chromy, James R.; Erbelding, Emily			Epidemiology of Undiagnosed Trichomoniasis in a Probability Sample of Urban Young Adults	PLOS ONE			English	Article							VAGINALIS INFECTION; T-ACASI; CHLAMYDIAL INFECTION; UNITED-STATES; DRUG-USE; PREVALENCE; RISK; HEALTH; IMPACT; WOMEN	T. vaginalis infection (trichomoniasis) is the most common curable sexually transmitted infection (STI) in the U. S. It is associated with increased HIV risk and adverse pregnancy outcomes. Trichomoniasis surveillance data do not exist for either national or local populations. The Monitoring STIs Survey Program (MSSP) collected survey data and specimens which were tested using nucleic acid amplification tests to monitor trichomoniasis and other STIs in 2006-09 among a probability sample of young adults (N = 2,936) in Baltimore, Maryland - an urban area with high rates of reported STIs. The estimated prevalence of trichomoniasis was 7.5% (95% CI 6.3, 9.1) in the overall population and 16.1% (95% CI 13.0, 19.8) among Black women. The overwhelming majority of infected men (98.5%) and women (73.3%) were asymptomatic. Infections were more common in both women (OR = 3.6, 95% CI 1.6, 8.2) and men (OR = 9.0, 95% CI 1.8, 44.3) with concurrent chlamydial infection. Trichomoniasis did not vary significantly by age for either men or women. Women with two or more partners in the past year and women with a history of personal or partner incarceration were more likely to have an infection. Overall, these results suggest that routine T vaginalis screening in populations at elevated risk of infection should be considered.	[Rogers, Susan M.; Turner, Charles F.; Tan, Sylvia; Eggleston, Elizabeth; Villarroel, Maria A.] Res Triangle Inst, Washington, DC 20037 USA; [Turner, Charles F.] CUNY Queens Coll, Program Data Analyt & Appl Social Res, Flushing, NY 11367 USA; [Turner, Charles F.] Grad Ctr, Flushing, NY USA; [Hobbs, Marcia; Miller, William C.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Hobbs, Marcia; Miller, William C.] Univ N Carolina, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Roman, Anthony M.] Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; [Villarroel, Maria A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ganapathi, Laxminarayana] Res Triangle Inst, Res Comp Div, Res Triangle Pk, NC 27709 USA; [Chromy, James R.] Res Triangle Inst, Stat & Epidemiol Div, Res Triangle Pk, NC 27709 USA; [Erbelding, Emily] Johns Hopkins Bayview Med Ctr, Div Infect Dis, Baltimore, MD USA	Research Triangle Institute; City University of New York (CUNY) System; Queens College NY (CUNY); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Boston; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Research Triangle Institute; Research Triangle Institute; Johns Hopkins University; Johns Hopkins Medicine	Rogers, SM (corresponding author), Res Triangle Inst, Washington, DC 20037 USA.	smr@rti.org	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Tan, Sylvia Margaret/0000-0002-2987-0072; Ganapathi, Laxminarayana/0000-0001-8751-3797	National Institute of Child Health and Human Development [HD047163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047163] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development [HD047163]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2009, SEX TRANSM DIS, V36, P738, DOI 10.1097/OLQ.0b013e3181b38a4b; [Anonymous], ASS REPR PUBL OP SUR; Bachmann LH, 2011, CLIN INFECT DIS, V53, pS160, DOI 10.1093/cid/cir705; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; *CDCP, 2007, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Cooley PC, 1998, COMPUT HUM BEHAV, V14, P195, DOI 10.1016/S0747-5632(98)00001-6; Cooley PC, 2000, COMPUT HUM BEHAV, V16, P1, DOI 10.1016/S0747-5632(99)00048-5; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Field N, 2012, J MED ETHICS, V38, P380, DOI 10.1136/medethics-2011-100068; Genesys, 1996, METH NOT LIST HOUS S; Gribble JN, 2000, SUBST USE MISUSE, V35, P869, DOI 10.3109/10826080009148425; Helms DJ, 2008, SEX TRANSM DIS, V35, P484, DOI 10.1097/OLQ.0b013e3181644b9c; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Miller WC, 2005, SEX TRANSM DIS, V32, P593, DOI 10.1097/01.olq.0000179874.76360.ad; Roman AM, 2008, P 2008 JOINT STAT M; Roth AM, 2011, SEX TRANSM DIS, V38, P398, DOI 10.1097/OLQ.0b013e318203e3ce; Schwebke JR, 2002, SEX TRANSM INFECT, V78, P378, DOI 10.1136/sti.78.5.378; StataCorp, 2011, STAT STAT SOFTW REL; Stekler J, 2005, CLIN INFECT DIS, V40, P787, DOI 10.1086/428043; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; Turner CF, 2005, ADDICTION, V100, P1432, DOI 10.1111/j.1360-0443.2005.01196.x; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; U.S. Bureau of the Census, 2006, AM COMM SURV; Van Der Pol B, 2005, J INFECT DIS, V192, P2039, DOI 10.1086/498217; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Van der Pol B, 2007, CLIN INFECT DIS, V44, P23, DOI 10.1086/509934; Villarroel MA, 2008, SEX TRANSM DIS, V35, P499, DOI 10.1097/OLQ.0b013e318165925a; Villarroel MA, 2006, PUBLIC OPIN QUART, V70, P166, DOI 10.1093/poq/nfj023; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Zenilman JM, 2003, SEX TRANSM INFECT, V79, P94, DOI 10.1136/sti.79.2.94	34	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90548	10.1371/journal.pone.0090548	http://dx.doi.org/10.1371/journal.pone.0090548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626058	Green Published, gold			2022-12-25	WOS:000332851300025
J	Carvalho, R; Buzna, L; Bono, F; Masera, M; Arrowsmith, DK; Helbing, D				Carvalho, Rui; Buzna, Lubos; Bono, Flavio; Masera, Marcelo; Arrowsmith, David K.; Helbing, Dirk			Resilience of Natural Gas Networks during Conflicts, Crises and Disruptions	PLOS ONE			English	Article							INTERDEPENDENT NETWORKS; SYSTEMS; SCIENCE	Human conflict, geopolitical crises, terrorist attacks, and natural disasters can turn large parts of energy distribution networks offline. Europe's current gas supply network is largely dependent on deliveries from Russia and North Africa, creating vulnerabilities to social and political instabilities. During crises, less delivery may mean greater congestion, as the pipeline network is used in ways it has not been designed for. Given the importance of the security of natural gas supply, we develop a model to handle network congestion on various geographical scales. We offer a resilient response strategy to energy shortages and quantify its effectiveness for a variety of relevant scenarios. In essence, Europe's gas supply can be made robust even to major supply disruptions, if a fair distribution strategy is applied.	[Carvalho, Rui; Arrowsmith, David K.] Queen Mary Univ London, Sch Math Sci, London, England; [Buzna, Lubos] Univ Zilina, Zilina, Slovakia; [Bono, Flavio] Commiss European Communities, Joint Res Ctr, IPSC, European Lab Struct Assessment, I-21020 Ispra, VA, Italy; [Masera, Marcelo] Joint Res Ctr, Inst Energy & Transport, Energy Secur Unit, Petten, Netherlands; [Helbing, Dirk] ETH, Zurich, Switzerland; [Helbing, Dirk] ETH, Swiss Fed Inst Technol, Risk Ctr, Zurich, Switzerland	University of London; Queen Mary University London; University of Zilina; European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC Institute for Energy & Transport (IET); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Carvalho, R (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	r.carvalho@qmul.ac.uk	Carvalho, Rui/C-4095-2009; Buzna, Lubos/A-1147-2010	Buzna, Lubos/0000-0002-5410-6762; Carvalho, Rui/0000-0002-3279-4218	Engineering and Physical Sciences Research Council [EP/H04812X/1]; APVV [APVV-0760-11]; VEGA [1/0339/13]; EPSRC [EP/H04812X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); APVV(Slovak Research and Development Agency); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council under grant number EP/H04812X/1, by APVV (project APVV-0760-11) and by VEGA (project 1/0339/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan M, 2012, EUR PHYS J-SPEC TOP, V214, P547, DOI 10.1140/epjst/e2012-01705-1; [Anonymous], 2009, ECONOMIST; Bertsimas D, 2011, OPER RES, V59, P17, DOI 10.1287/opre.1100.0865; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Carvalho R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046101; Chiang M, 2007, P IEEE, V95, P255, DOI 10.1109/JPROC.2006.887322; Chrisafis Angelique, 2013, GUARDIAN; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Energy and Environmental Analysis, 2005, TECHNICAL REPORT; Frischmann Brett, 2012, INFRASTRUCTURE SOCIA; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Hunt S., 2002, MAKING COMPETITION W; International Energy Agency, 2012, NAT GAS INF; Kelly F, 1997, EUR T TELECOMMUN, V8, P33, DOI 10.1002/ett.4460080106; Kelly F, 2011, NEXT GENERATION INTE; Kelly FP, 1998, J OPER RES SOC, V49, P237, DOI 10.1057/palgrave.jors.2600523; Kirschen D., 2018, FUNDAMENTALS POWER S, V2nd ed.; Lempert RJ, 2002, P NATL ACAD SCI USA, V99, P7309, DOI 10.1073/pnas.082081699; Levi M., 2013, POWER SURGE ENERGY O; Levin S., 2013, NOT AM MATH SOC, V60, P392; Lochner S, 2011, ENERGY, V36, P2483, DOI 10.1016/j.energy.2011.01.040; Moniz E., 2011, TECHNICAL REPORT; Mouawad J., 2005, NY TIMES; Plimmer G, 2013, FINANCIAL TIMES; Quattrociocchi W, 2013, ARXIV13053450; Schiermeier Q, 2013, NATURE, V496, P156, DOI 10.1038/496156a; Voropai NI, 2012, ENERGY, V42, P3, DOI 10.1016/j.energy.2011.07.038; Wright S, 2012, ECONOMIST; Yergin D., 2012, FOREIGN POLICY	36	38	40	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90265	10.1371/journal.pone.0090265	http://dx.doi.org/10.1371/journal.pone.0090265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621655	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000332845300018
J	Shen, TC; Lin, CL; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Chang, YJ				Shen, Te-Chun; Lin, Cheng-Li; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Chang, Yen-Jung			Increased Risk of Chronic Obstructive Pulmonary Disease in Patients with Systemic Lupus Erythematosus: A Population-Based Cohort Study	PLOS ONE			English	Article							CIGARETTE-SMOKE; RHEUMATOID-ARTHRITIS; INDUCED EMPHYSEMA; COPD PATIENTS; AUTOIMMUNITY; AUTOANTIBODIES; INFLAMMATION; ASSOCIATION; NONSMOKERS; EXPRESSION	Background: There is increasing evidence that autoimmune disease is associated with development of chronic obstructive pulmonary disease (COPD). We aim to assess the relationship between systemic lupus erythematosus (SLE) and COPD risk in a nationwide population. Methods: We conducted a retrospective cohort study using the catastrophic illness registry of the Taiwan National Health Insurance Research Database (NHIRD). We identified 10,623 patients with SLE newly diagnosed between 2000 and 2010. Each patient was randomly frequency-matched with four people without SLE on age, sex, and index year from the general population. Both cohorts were followed up until the end of 2010 to measure the incidence of COPD. The risk of COPD was analyzed using Cox proportional hazards regression models including age, sex, index year and comorbidities. Results: The overall incidence rate of COPD was 1.73-fold higher in the SLE cohort than in the control cohort (17.4 vs. 10.1 per 10,000 person-years, 95% CI = 1.62-1.84). Age related analysis showed increased incidence of COPD with age in both SLE and control cohorts. However, adjusted HR maximum was observed in the youngest age group (adjusted HR: 4.33, 95% CI, 2.39-7.85) while adjusted HR minimum was witnessed in the oldest age group (adjusted HR: 1.19, 95% CI, 0.85-1.22). Conclusion: Patients with SLE have a significant risk of developing COPD than the control population. Based on the findings from this study, it can be hypothesized that in addition to cigarette smoke SLE may be a determining factor for COPD incidence. However, further investigation is needed to corroborate this hypothesis.	[Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ, Taichung, Taiwan; [Shen, Te-Chun] Chu Shang Show Chwan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Nantou, Taiwan; [Lin, Cheng-Li] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Yen-Jung] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan Normal University	Hsia, TC (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.	derrick.hsia@msa.hinet.net; yjchang2012@gmail.com		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH102-TD-C-111-005]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence	This work was supported by Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004) and Taiwan Department of Health Cancer Research Center for Excellence (DOH102-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bengtsson AA, 2002, RHEUMATOLOGY, V41, P563, DOI 10.1093/rheumatology/41.5.563; Bieber V, 2013, IMMUNOL RES, V56, P261, DOI 10.1007/s12026-013-8395-x; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Carmi G, 2011, ISR MED ASSOC J, V13, P121; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; Cooper GS, 2001, J RHEUMATOL, V28, P2653; Drenkard C, 2013, SEMIN ARTHRITIS RHEU, V43, P209, DOI 10.1016/j.semarthrit.2013.04.003; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; FESSEL WJ, 1988, RHEUM DIS CLIN N AM, V14, P15; Freemer MM, 2006, ANN RHEUM DIS, V65, P581, DOI 10.1136/ard.2005.039438; Hagstad S, 2012, RESP MED, V106, P980, DOI 10.1016/j.rmed.2012.03.010; Karayama M, 2010, CHEST, V138, P1303, DOI 10.1378/chest.10-0863; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kuo YB, 2010, IMMUNOL LETT, V128, P131, DOI 10.1016/j.imlet.2009.12.017; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Leidinger P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-20; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Majka DS, 2006, ANN RHEUM DIS, V65, P561, DOI 10.1136/ard.2005.046052; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Nunez B, 2011, AM J RESP CRIT CARE, V183, P1025, DOI 10.1164/rccm.201001-0029OC; Packard TA, 2013, IMMUNOL RES, V55, P48, DOI 10.1007/s12026-012-8347-x; Petri M, 2001, ARTHRITIS RHEUM, V44, pS331; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; REIDENBERG MM, 1993, ARTHRITIS RHEUM, V36, P971, DOI 10.1002/art.1780360714; Shen TC, 2014, QJM; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VERMEULEN A, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431381; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Yeh KW, 2013, RHEUMATOL INT, V33, P1805, DOI 10.1007/s00296-012-2643-6; Zifman E, 2008, AUTOIMMUN REV, V8, P165, DOI 10.1016/j.autrev.2008.06.011	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91821	10.1371/journal.pone.0091821	http://dx.doi.org/10.1371/journal.pone.0091821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622340	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300131
J	Dadi, PK; Vierra, NC; Ustione, A; Piston, DW; Colbran, RJ; Jacobson, DA				Dadi, Prasanna K.; Vierra, Nicholas C.; Ustione, Alessandro; Piston, David W.; Colbran, Roger J.; Jacobson, David A.			Inhibition of Pancreatic beta-Cell Ca2+/Calmodulin-dependent Protein Kinase II Reduces Glucose-stimulated Calcium Influx and Insulin Secretion, Impairing Glucose Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Calcium Imaging; CaMKII; Diabetes; Insulin; Insulin Secretion; Islet; Pancreatic Islets	CARDIAC SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; SYNAPSIN-I; B-CELLS; PHOSPHORYLATION; CHANNELS; FACILITATION; ACTIVATION; EXOCYTOSIS; CAMKII	Background: Glucose activates CaMKII in -cells, how this influences glucose homeostasis has not been determined. Results: Inhibiting CaMKII in mouse -cells causes glucose intolerance by reducing Ca2+ entry and insulin secretion. Conclusion: CaMKII is a -cell Ca2+ sensor that amplifies secretagogue-induced Ca2+ entry and insulin secretion to maintain glucose homeostasis. Significance: This provides the first evidence that -cell CaMKII modulates glucose homeostasis under physiological and insulin resistant states. Glucose-stimulated insulin secretion (GSIS) from pancreatic -cells is caused by Ca2+ entry via voltage-dependent Ca2+ channels. CaMKII is a key mediator and feedback regulator of Ca2+ signaling in many tissues, but its role in -cells is poorly understood, especially in vivo. Here, we report that mice with conditional inhibition of CaMKII in -cells show significantly impaired glucose tolerance due to decreased GSIS. Moreover, -cell CaMKII inhibition dramatically exacerbates glucose intolerance following exposure to a high fat diet. The impairment of islet GSIS by -cell CaMKII inhibition is not accompanied by changes in either glucose metabolism or the activities of K-ATP and voltage-gated potassium channels. However, glucose-stimulated Ca2+ entry via voltage-dependent Ca2+ channels is reduced in islet -cells with CaMKII inhibition, as well as in primary wild-type -cells treated with a peptide inhibitor of CaMKII. The levels of basal -cell cytoplasmic Ca2+ and of endoplasmic reticulum Ca2+ stores are also decreased by CaMKII inhibition. In addition, CaMKII inhibition suppresses glucose-stimulated action potential firing frequency. These results reveal that CaMKII is a Ca2+ sensor with a key role as a feed-forward stimulator of -cell Ca2+ signals that enhance GSIS under physiological and pathological conditions.	[Dadi, Prasanna K.; Vierra, Nicholas C.; Ustione, Alessandro; Piston, David W.; Colbran, Roger J.; Jacobson, David A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Jacobson, DA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 7425B MRB 4,2213 Garland Ave, Nashville, TN 37232 USA.	david.a.jacobson@vanderbilt.edu	Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244; Jacobson, David A./0000-0003-1816-5375	National Institutes of Health [DK096122, DK081666, DK20593]; Pilot and Feasibility Grant through the Vanderbilt University Diabetes Research Training Center [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098659, P60DK020593, R01DK097392, K01DK081666, P30DK020593, R03DK096122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot and Feasibility Grant through the Vanderbilt University Diabetes Research Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant DK096122 (to D. A. J.), DK081666 (to D. A. J.) as well as Pilot and Feasibility Grant P60 DK20593 through the Vanderbilt University Diabetes Research Training Center. The Vanderbilt Islet Procurement and Analysis Core was also supported by National Institutes of Health Grant DK20593.	Abiria SA, 2010, J NEUROCHEM, V112, P150, DOI 10.1111/j.1471-4159.2009.06436.x; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Anthony DF, 2007, J MOL CELL CARDIOL, V43, P492, DOI 10.1016/j.yjmcc.2007.07.003; ASHCROFT SJH, 1994, DIABETOLOGIA, V37, pS21, DOI 10.1007/BF00400822; Babb EL, 1996, BIOCHEM J, V317, P167, DOI 10.1042/bj3170167; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Currie S, 2004, BIOCHEM J, V377, P357, DOI 10.1042/BJ20031043; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Gonzalez A, 2013, ENDOCRINOLOGY, V154, P3515, DOI 10.1210/en.2013-1424; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Gromada J, 1999, J PHYSIOL-LONDON, V518, P745, DOI 10.1111/j.1469-7793.1999.0745p.x; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Kline CF, 2013, P NATL ACAD SCI USA, V110, P17576, DOI 10.1073/pnas.1314195110; Klug JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045323; KRANIAS EG, 1988, MOL CELL BIOCHEM, V82, P37; Krueger KA, 1999, DIABETES, V48, P499, DOI 10.2337/diabetes.48.3.499; Krueger KA, 1997, J BIOL CHEM, V272, P27464, DOI 10.1074/jbc.272.43.27464; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATSUMOTO K, 1995, ENDOCRINOLOGY, V136, P3784, DOI 10.1210/en.136.9.3784; MATTHEWS EK, 1975, J PHYSIOL-LONDON, V246, P421, DOI 10.1113/jphysiol.1975.sp010897; McCord MC, 2013, P NATL ACAD SCI USA, V110, P13988, DOI 10.1073/pnas.1306238110; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; NORLING LL, 1994, CELL CALCIUM, V16, P137, DOI 10.1016/0143-4160(94)90008-6; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; PRENTKI M, 1984, EXPERIENTIA, V40, P1052, DOI 10.1007/BF01971451; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Watson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025975; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; WENHAM RM, 1994, J BIOL CHEM, V269, P4947; WOLLHEIM CB, 1981, UPSALA J MED SCI, V86, P149, DOI 10.3109/03009738109179223; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Wu YJ, 2004, J PHYSIOL-LONDON, V554, P145, DOI 10.1113/jphysiol.2003.053314; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; XU A, 1993, J BIOL CHEM, V268, P8394; Yamamoto H, 2003, J PHARMACOL SCI, V93, P30, DOI 10.1254/jphs.93.30; Zhang DM, 2014, J PHYSIOL-LONDON, V592, P971, DOI 10.1113/jphysiol.2013.264697; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	53	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12435	12445		10.1074/jbc.M114.562587	http://dx.doi.org/10.1074/jbc.M114.562587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627477	Green Published, hybrid			2022-12-25	WOS:000335581400020
J	Zacchi, LF; Wu, HC; Bell, SL; Millen, L; Paton, AW; Paton, JC; Thomas, PJ; Zolkiewski, M; Brodsky, JL				Zacchi, Lucia F.; Wu, Hui-Chuan; Bell, Samantha L.; Millen, Linda; Paton, Adrienne W.; Paton, James C.; Thomas, Philip J.; Zolkiewski, Michal; Brodsky, Jeffrey L.			The BiP Molecular Chaperone Plays Multiple Roles during the Biogenesis of TorsinA, an AAA(+) ATPase Associated with the Neurological Disease Early-onset Torsion Dystonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Molecular Chaperone; Neurological Diseases; Protein Degradation; Protein Folding; Yeast; BiP; DYT1; GRP78; torsinA	RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; ER-ASSOCIATED DEGRADATION; GLUCOSE-REGULATED PROTEIN-78; YEAST ENDOPLASMIC-RETICULUM; NUCLEOTIDE EXCHANGE FACTOR; DNAJ-LIKE PROTEIN; DELTA-E-TORSINA; NUCLEAR-ENVELOPE; SACCHAROMYCES-CEREVISIAE	Background: The E mutation in the AAA(+) ATPase torsinA is associated with the neurological disease torsion dystonia. Results: BiP and its co-factors maintain torsinA and torsinAE stability, glycosylation, and solubility. Conclusion: torsinA/E, a chaperone-like protein, requires the assistance of other chaperones to fold. Significance: Therapeutics that modulate BiP may counteract torsinAE-associated physiological defects. Early-onset torsion dystonia (EOTD) is a neurological disorder characterized by involuntary and sustained muscle contractions that can lead to paralysis and abnormal posture. EOTD is associated with the deletion of a glutamate (E) in torsinA, an endoplasmic reticulum (ER) resident AAA(+) ATPase. To date, the effect of E on torsinA and the reason that this mutation results in EOTD are unclear. Moreover, there are no specific therapeutic options to treat EOTD. To define the underlying biochemical defects associated with torsinAE and to uncover factors that might be targeted to offset defects associated with torsinAE, we developed a yeast torsinA expression system and tested the roles of ER chaperones in mediating the folding and stability of torsinA and torsinAE. We discovered that the ER lumenal Hsp70, BiP, an associated Hsp40, Scj1, and a nucleotide exchange factor, Lhs1, stabilize torsinA and torsinAE. BiP also maintained torsinA and torsinAE solubility. Mutations predicted to compromise specific torsinA functional motifs showed a synthetic interaction with the E mutation and destabilized torsinAE, suggesting that the E mutation predisposes torsinA to defects in the presence of secondary insults. In this case, BiP was required for torsinAE degradation, consistent with data that specific chaperones exhibit either pro-degradative or pro-folding activities. Finally, using two independent approaches, we established that BiP stabilizes torsinA and torsinAE in mammalian cells. Together, these data define BiP as the first identified torsinA chaperone, and treatments that modulate BiP might improve symptoms associated with EOTD.	[Zacchi, Lucia F.; Bell, Samantha L.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Wu, Hui-Chuan; Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Millen, Linda; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kansas State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Adelaide	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Zacchi, Lucia/F-7494-2016; Zacchi, Lucia/N-6484-2019; Bell, Samantha L./AAZ-3080-2021	Zacchi, Lucia/0000-0001-6217-1380; Zacchi, Lucia/0000-0001-6217-1380; Bell, Samantha L./0000-0002-5453-3203	National Institutes of Health [GM75061]; Dystonia Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystonia Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM75061 (to J. L. B.).; Supported by a postdoctoral fellowship from the Dystonia Medical Research Foundation.; Supported by a research grant from the Dystonia Medical Research Foundation.	Adams A, 1997, METHODS YEAST GENETI; Amberg D. C., 2005, METHODS YEAST GENETI, P149; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Becker D. M., 2008, CURR PROTOC MOL BIOL; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Benitez EM, 2011, FEBS LETT, V585, P3015, DOI 10.1016/j.febslet.2011.08.021; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Bharadwaj P, 2010, FEMS YEAST RES, V10, P961, DOI 10.1111/j.1567-1364.2010.00658.x; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Blandy MA, 1920, J NEUROL PSYCHOPATHO, V1, P148, DOI 10.1136/jnnp.s1-1.2.148; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Bragg DC, 2004, MOL CELL NEUROSCI, V27, P417, DOI 10.1016/j.mcn.2004.07.009; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bruggemann N, 2010, CURR NEUROL NEUROSCI, V10, P199, DOI 10.1007/s11910-010-0107-5; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Eletto D, 2012, J CELL SCI, V125, P4865, DOI 10.1242/jcs.108928; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Gelling Cristy L, 2010, Proc Am Thorac Soc, V7, P363, DOI 10.1513/pats.201001-007AW; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Giles LM, 2009, J BIOL CHEM, V284, P21765, DOI 10.1074/jbc.M109.004838; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Gorbatyuk M.S., 2013, J GENET SYNDR GENE T, V4, DOI [10.4172/2157-7412.1000128, DOI 10.4172/2157-7412.1000128]; Gordon KL, 2012, NEUROSCIENCE, V224, P160, DOI 10.1016/j.neuroscience.2012.08.023; Gordon KL, 2008, NEUROSCIENCE, V157, P588, DOI 10.1016/j.neuroscience.2008.09.028; Gordon KL, 2011, NEUROCHEM RES, V36, P452, DOI 10.1007/s11064-010-0363-4; Granata A, 2010, EUR J NEUROL, V17, P81, DOI 10.1111/j.1468-1331.2010.03057.x; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HEMMINGS BA, 1981, P NATL ACAD SCI-BIOL, V78, P435, DOI 10.1073/pnas.78.1.435; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Hoffman C. S., 2008, CURR PROTOC MOL BIOL; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Jakob CA, 2001, EMBO REP, V2, P423; Janska H, 2013, BBA-MOL CELL RES, V1833, P381, DOI 10.1016/j.bbamcr.2012.03.016; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kamm C, 2008, NEUROLOGY, V70, P2261, DOI 10.1212/01.wnl.0000313838.05734.8a; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Kister AE, 2013, BIOCHEM SOC T, V41, P616, DOI 10.1042/BST20120308; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Konakova M, 2005, J MOL NEUROSCI, V25, P105, DOI 10.1385/JMN:25:1:105; Kornfeld S, 1998, J CLIN INVEST, V101, P1293, DOI 10.1172/JCI3140; KRAMER PL, 1994, AM J HUM GENET, V55, P468; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Kustedjo K, 2003, BIOCHEMISTRY-US, V42, P15333, DOI 10.1021/bi0349569; LEPPERT G, 1990, GENETICS, V125, P13; Lim HA, 2006, J MED FOOD, V9, P28, DOI 10.1089/jmf.2006.9.28; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Morawe T, 2012, MOL NEUROBIOL, V46, P41, DOI 10.1007/s12035-012-8246-0; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Panayi Gabriel S, 2008, Novartis Found Symp, V291, P212; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pham P, 2006, NEUROREPORT, V17, P1725, DOI 10.1097/WNR.0b013e3280101220; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; POLAINA J, 1982, MOL GEN GENET, V186, P253, DOI 10.1007/BF00331858; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Priya S, 2013, FEBS LETT, V587, P1981, DOI 10.1016/j.febslet.2013.05.014; Qiu W, 2005, ARTERIOSCL THROM VAS, V25, P571, DOI 10.1161/01.ATV.0000154142.61859.94; Risch NJ, 2007, AM J HUM GENET, V80, P1188, DOI 10.1086/518427; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; SCHMITZ A, 1995, EMBO J, V14, P1091, DOI 10.1002/j.1460-2075.1995.tb07092.x; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; SEGUIREAL B, 1995, EMBO J, V14, P5476, DOI 10.1002/j.1460-2075.1995.tb00234.x; Shashidharan P, 2000, BRAIN RES, V877, P379, DOI 10.1016/S0006-8993(00)02702-5; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; SIMON K, 1988, J CELL BIOL, V107, P2163, DOI 10.1083/jcb.107.6.2163; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Takeuchi M, 2006, J BIOCHEM, V139, P597, DOI 10.1093/jb/mvj063; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tenreiro S, 2010, FEMS YEAST RES, V10, P970, DOI 10.1111/j.1567-1364.2010.00649.x; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Tiffany-Castiglioni E, 2012, NEUROTOXICOLOGY, V33, P545, DOI 10.1016/j.neuro.2012.02.007; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Urano F, 2000, J CELL SCI, V113, P3697; Valastyan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022744; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vendruscolo M, 2012, CURR OPIN STRUC BIOL, V22, P138, DOI 10.1016/j.sbi.2012.01.005; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Weibezahn J, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-1; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471; Zolkiewski M., 2011, PROTEIN CHAPERONES P	166	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12727	12747		10.1074/jbc.M113.529123	http://dx.doi.org/10.1074/jbc.M113.529123			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627482	Green Published, hybrid			2022-12-25	WOS:000335581400044
J	Alizadeh, H; Tripathi, T; Abdi, M; Smith, AD				Alizadeh, Hassan; Tripathi, Trivendra; Abdi, Mahshid; Smith, Ashley Dawn			Pathogenic Strains of Acanthamoeba Are Recognized by TLR4 and Initiated Inflammatory Responses in the Cornea	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; EPITHELIAL-CELLS; KERATITIS; MANNOSE; PROTEIN; EXPRESSION; FLAGELLIN; INNATE; CD14; DIFFERENTIATION	Free-living amoebae of the Acanthamoeba species are the causative agent of Acanthamoeba keratitis (AK), a sight-threatening corneal infection that causes severe pain and a characteristic ring-shaped corneal infiltrate. Innate immune responses play an important role in resistance against AK. The aim of this study is to determine if Toll-like receptors (TLRs) on corneal epithelial cells are activated by Acanthamoeba, leading to initiation of inflammatory responses in the cornea. Human corneal epithelial (HCE) cells constitutively expressed TLR1, TLR2, TLR3, TLR4, and TLR9 mRNA, and A. castellanii upregulated TLR4 transcription. Expression of TLR1, TLR2, TLR3, and TLR9 was unchanged when HCE cells were exposed to A. castellanii. IL-8 mRNA expression was upregulated in HCE cells exposed to A. castellanii. A. castellanii and lipopolysaccharide (LPS) induced significant IL-8 production by HCE cells as measured by ELISA. The percentage of total cells positive for TLR4 was higher in A. castellanii stimulated HCE cells compared to unstimulated HCE cells. A. castellanii induced upregulation of IL-8 in TLR4 expressing human embryonic kidney (HEK)-293 cells, but not TLR3 expressing HEK-293 cells. TLR4 neutralizing antibody inhibited A. castellanii-induced IL-8 by HCE and HEK-293 cells. Clinical strains but not soil strains of Acanthamoeba activated TLR4 expression in Chinese hamster corneas in vivo and in vitro. Clinical isolates but not soil isolates of Acanthamoeba induced significant (P< 0.05) CXCL2 production in Chinese hamster corneas 3 and 7 days after infection, which coincided with increased inflammatory cells in the corneas. Results suggest that pathogenic species of Acanthamoeba activate TLR4 and induce production of CXCL2 in the Chinese hamster model of AK. TLR4 may be a potential target in the development of novel treatment strategies in Acanthamoeba and other microbial infections that activate TLR4 in corneal cells.	[Alizadeh, Hassan] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; North Texas Eye Res Inst, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Alizadeh, H (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	hassan.alizadeh@unthsc.edu	Tripathi, Trivendra/I-9595-2019; Smith, Ashley/GZB-0298-2022; TRIPATHI, TRIVENDRA/H-2759-2014	Tripathi, Trivendra/0000-0002-6006-1273; TRIPATHI, TRIVENDRA/0000-0002-6006-1273	Public Health Service [EY09756]; NATIONAL EYE INSTITUTE [R01EY009756] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Public Health Service Grant EY09756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh H., 1996, OCULAR INFECT IMMUNI, P1062; Alizadeh H, 2007, INVEST OPHTH VIS SCI, V48, P5597, DOI 10.1167/iovs.07-0407; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Blais DR, 2005, INVEST OPHTH VIS SCI, V46, P4235, DOI 10.1167/iovs.05-0543; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Clarke DW, 2006, MICROBES INFECT, V8, P1400, DOI 10.1016/j.micinf.2005.12.009; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Garate M, 2004, J BIOL CHEM, V279, P29849, DOI 10.1074/jbc.M402334200; GARNER A, 1993, BRIT J OPHTHALMOL, V77, P366, DOI 10.1136/bjo.77.6.366; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; HE YG, 1992, INVEST OPHTH VIS SCI, V33, P126; Heine H, 1999, J IMMUNOL, V162, P6971; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Hurt M, 2003, INFECT IMMUN, V71, P6243, DOI 10.1128/IAI.71.11.6243-6255.2003; Hurt M, 2003, INVEST OPHTH VIS SCI, V44, P3424, DOI 10.1167/iovs.03-0019; Hurt M, 2003, J PARASITOL, V89, P565, DOI 10.1645/0022-3395(2003)089[0565:TIOACC]2.0.CO;2; Hurt M, 2001, INFECT IMMUN, V69, P2988, DOI 10.1128/IAI.69.5.2988-2995.2001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson A, 2005, OCUL SURF, V3, pS187; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Lang LL, 2011, INFLAMMATION, V34, P371, DOI 10.1007/s10753-010-9244-x; LARKIN DFP, 1991, EYE, V5, P70, DOI 10.1038/eye.1991.14; LARKIN DFP, 1991, BRIT J OPHTHALMOL, V75, P421, DOI 10.1136/bjo.75.7.421; Leher H, 1999, EXP EYE RES, V69, P75, DOI 10.1006/exer.1999.0678; MATHERS W, 1987, AM J OPHTHALMOL, V103, P626, DOI 10.1016/S0002-9394(14)74321-1; McDermott AM, 2005, OCUL SURF, V3, pS131; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Niederkorn JY, 2002, ARCH IMMUNOL THER EX, V50, P53; Niederkorn JY, 1999, SPRINGER SEMIN IMMUN, V21, P147, DOI 10.1007/BF00810247; Redfern RL, 2010, EXP EYE RES, V90, P679, DOI 10.1016/j.exer.2010.03.012; Ren MY, 2010, IMMUNOL CELL BIOL, V88, P529, DOI 10.1038/icb.2010.6; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; STEWART GL, 1994, INT J PARASITOL, V24, P739, DOI 10.1016/0020-7519(94)90129-5; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tripathi T, 2013, EXP EYE RES, V113, P182, DOI 10.1016/j.exer.2013.05.021; Tripathi T, 2012, INVEST OPHTH VIS SCI, V53, P7973, DOI 10.1167/iovs.12-10436; Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337; WILSON SE, 1995, INVEST OPHTH VIS SCI, V36, P32; Wu MH, 2009, J IMMUNOL, V182, P1609, DOI 10.4049/jimmunol.182.3.1609; WU XA, 1995, CURR EYE RES, V14, P969, DOI 10.3109/02713689508995137; Yang ZT, 1997, INFECT IMMUN, V65, P439, DOI 10.1128/IAI.65.2.439-445.1997; Yu FSX, 2006, INVEST OPHTH VIS SCI, V47, P1255, DOI 10.1167/iovs.05-0956	52	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92375	10.1371/journal.pone.0092375	http://dx.doi.org/10.1371/journal.pone.0092375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633052	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400159
J	Barcelos, QL; Pinto, JMA; Vaillancourt, LJ; Souza, EA				Barcelos, Quelen L.; Pinto, Joyce M. A.; Vaillancourt, Lisa J.; Souza, Elaine A.			Characterization of Glomerella Strains Recovered from Anthracnose Lesions on Common Bean Plants in Brazil	PLOS ONE			English	Article							MATING-TYPE LOCI; COLLETOTRICHUM-LINDEMUTHIANUM; VEGETATIVE COMPATIBILITY; FUNGAL EPIPHYTES; ASCOMYCETE; ENDOPHYTES; GENETICS; GRAMINICOLA; VARIABILITY; PATHOGENS	Anthracnose caused by Colletotrichum lindemuthianum is an important disease of common bean, resulting in major economic losses worldwide. Genetic diversity of the C. lindemuthianum population contributes to its ability to adapt rapidly to new sources of host resistance. The origin of this diversity is unknown, but sexual recombination, via the Glomerella teleomorph, is one possibility. This study tested the hypothesis that Glomerella strains that are frequently recovered from bean anthracnose lesions represent the teleomorph of C. lindemuthianum. A large collection of Glomerella isolates could be separated into two groups based on phylogenetic analysis, morphology, and pathogenicity to beans. Both groups were unrelated to C. lindemuthianum. One group clustered with the C. gloeosporioides species complex and produced mild symptoms on bean tissues. The other group, which belonged to a clade that included the cucurbit anthracnose pathogen C. magna, caused no symptoms. Individual ascospores recovered from Glomerella perithecia gave rise to either fertile (perithecial) or infertile (conidial) colonies. Some pairings of perithecial and conidial strains resulted in induced homothallism in the conidial partner, while others led to apparent heterothallic matings. Pairings involving two perithecial, or two conidial, colonies produced neither outcome. Conidia efficiently formed conidial anastomosis tubes (CATs), but ascospores never formed CATs. The Glomerella strains formed appressoria and hyphae on the plant surface, but did not penetrate or form infection structures within the tissues. Their behavior was similar whether the beans were susceptible or resistant to anthracnose. These same Glomerella strains produced thick intracellular hyphae, and eventually acervuli, if host cell death was induced. When Glomerella was co-inoculated with C. lindemuthianum, it readily invaded anthracnose lesions. Thus, the hypothesis was not supported: Glomerella strains from anthracnose lesions do not represent the teleomorphic phase of C. lindemuthianum, and instead appear to be bean epiphytes that opportunistically invade and sporulate in the lesions.	[Barcelos, Quelen L.; Souza, Elaine A.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Pinto, Joyce M. A.] Empresa Brasileira Pesquisa Agropecuaria Embrapa, Sinop, Mato Grosso, Brazil; [Vaillancourt, Lisa J.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA	Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Kentucky	Vaillancourt, LJ (corresponding author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.	vaillan@uky.edu; easouza@dbi.ufla.br			Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais -FAPEMIG [CAG-APQ00635-12]; Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais -FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants and scholarships from the following Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais -FAPEMIG (CAG-APQ00635-12), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Marcelo C., 2006, Fitopatologia Brasileira, V31, P557, DOI 10.1590/S0100-41582006000600004; Alvindia DG, 2008, CROP PROT, V27, P1200, DOI 10.1016/j.cropro.2008.02.007; Alzate-Marin A.L., 2004, ANN REPORT BEAN IMPR, V47, P241; Arie T, 1997, FUNGAL GENET BIOL, V21, P118, DOI 10.1006/fgbi.1997.0961; BAILEY JA, 1995, DISEASE ANALYSIS THROUGH GENETICS AND BIOTECHNOLOGY, P197; Bailey JA, 1996, PHYTOPATHOLOGY, V86, P1076, DOI 10.1094/Phyto-86-1076; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Batista UG, 1982, SCRIB FITOPATOLOGIA, V7, P285; Bryson RJ, 1990, SEXUAL HYBRIDIZATION; Camargo OA, 2007, GENET MOL RES, V6, P607; Davide LMC, 2009, CROP BREED APPL BIOT, V9, P23, DOI 10.12702/1984-7033.v09n01a04; CHILTON SJP, 1945, AM J BOT, V32, P549, DOI 10.2307/2437685; CHILTON SJP, 1949, AM J BOT, V36, P717, DOI 10.2307/2438224; CHILTON SJP, 1949, AM J BOT, V36, P270, DOI 10.2307/2437882; Cisar CR, 1999, CURR GENET, V35, P127, DOI 10.1007/s002940050441; de Souza BO, 2007, CIENC AGROTEC, V31, P1000, DOI 10.1590/S1413-70542007000400009; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DRIVER CH, 1955, MYCOLOGIA, V47, P311, DOI 10.2307/3755453; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; EDGERTON CW, 1945, AM J BOT, V32, P115, DOI 10.2307/2437529; Ferreira DF, 2011, CIENC AGROTEC, V35, P1039, DOI 10.1590/S1413-70542011000600001; Flowers JL, 2005, CURR GENET, V48, P380, DOI 10.1007/s00294-005-0034-1; Freeman S, 2001, PHYTOPATHOLOGY, V91, P986, DOI 10.1094/PHYTO.2001.91.10.986; Garcia-Serrano M, 2008, MYCOSCIENCE, V49, P312, DOI 10.1007/s10267-008-0424-6; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; HABGOOD RM, 1970, NATURE, V227, P1268, DOI 10.1038/2271268a0; Henry G, 1990, TRENDS CIAT COMM, P89; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Ishikawa F.H., 2012, ANN REP BEAN IMPROV, V55, P141; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Ishikawa FH, 2010, J PHYTOPATHOL, V158, P270, DOI 10.1111/j.1439-0434.2009.01608.x; Junqueira NTV, 1984, CERES, V31, P322; KIMATI H., 1970, Anais da Escola Superior de Agricultura ''Luiz de Queiroz'' (Brazil)., V27, P411; Latunde-Dada AO, 1999, PLANT PATHOL, V48, P777, DOI 10.1046/j.1365-3059.1999.00405.x; Leite TD, 2013, J MICROBIOL, V51, P56, DOI 10.1007/s12275-013-2356-x; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Liu B, 2007, PHYTOPATHOLOGY, V97, P1305, DOI 10.1094/PHYTO-97-10-1305; Liu F, 2013, MYCOLOGIA, V105, P844, DOI 10.3852/12-315; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; LUCAS GB, 1946, AM J BOT, V33, P802, DOI 10.2307/2437277; Lucas GB, 1944, AM J BOT, V31, P233, DOI 10.2307/2437611; MCGAHEN JW, 1951, AM J BOT, V38, P610, DOI 10.2307/2437771; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Mendes Costa M.C., 1996, REV BRASIL GENETICS, V19, P350; MENEZES JR, 1988, PHYTOPATHOLOGY, V78, P650, DOI 10.1094/Phyto-78-650; O'Connell R. J., 1992, Colletotrichum: biology, pathology and control., P67; Oliveira, 1991, THESIS U FEDERAL LAV; Osono T, 2008, MYCOLOGIA, V100, P387, DOI 10.3852/07-110R1; Peloso MJ, 1992, ANTRACNOSIS FRIJOL C, P86; Photita W, 2004, FUNGAL DIVERS, V16, P131; Pinto JMA, 2012, PHYTOPATHOLOGY, V102, P490, DOI 10.1094/PHYTO-06-11-0179; Poggeler S, 2011, FUNGAL BIOL-UK, V115, P615, DOI 10.1016/j.funbio.2011.03.003; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Rava AC, 1994, PRINCIPAIS DOENCAS F, P17; Rava C. A., 1993, Fitopatologia Brasileira, V18, P388; Redman RS, 1999, PLANT PHYSIOL, V119, P795, DOI 10.1104/pp.119.2.795; Roca MG, 2004, MYCOL RES, V108, P1320, DOI 10.1017/S0953756204000838; Rodriguez-Guerra R, 2005, MYCOLOGIA, V97, P793, DOI 10.3852/mycologia.97.4.793; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Saccardo PA, 1878, MICHELIA, V1, P117; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Shear CL, 1913, STUDIES FUNGUS PARAS; SHERRIFF C, 1994, EXP MYCOL, V18, P121, DOI 10.1006/emyc.1994.1014; Silva KJDE, 2007, J PHYTOPATHOL, V155, P241; Souza EA, 2010, GENET MOL RES, V9, P1759, DOI 10.4238/vol9-3gmr863; Sreenivasaprasad S, 1996, GENOME, V39, P499, DOI 10.1139/g96-064; Starnes JH, 2012, GENETICS, V191, P389, DOI 10.1534/genetics.111.137950; SUTTON B, 1992, CL LIB APPL, P1; Talamini Viviane, 2006, Fitopatologia Brasileira, V31, P545, DOI 10.1590/S0100-41582006000600002; Thon MR, 2000, MOL PLANT MICROBE IN, V13, P1356, DOI 10.1094/MPMI.2000.13.12.1356; Vaillancourt L, 2000, COLLETOTRICHUM, P29; VAILLANCOURT LJ, 1994, EXP MYCOL, V18, P311, DOI 10.1016/S0147-5975(06)80004-6; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Von Arx, 1957, PHYTOPATHOL Z, V29, P413; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; WHEELER HE, 1959, AM J BOT, V46, P361, DOI 10.2307/2439196; WHEELER HE, 1948, AM J BOT, V35, P722, DOI 10.2307/2438153; WHEELER HE, 1956, AM J BOT, V43, P1, DOI 10.2307/2438406; WHEELER HE, 1950, AM J BOT, V37, P304, DOI 10.2307/2437851; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zaffarano PL, 2010, FUNGAL GENET BIOL, V47, P761, DOI 10.1016/j.fgb.2010.06.001	82	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90910	10.1371/journal.pone.0090910	http://dx.doi.org/10.1371/journal.pone.0090910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633173	Green Published, gold			2022-12-25	WOS:000332858400024
J	Covington, JD; Galgani, JE; Moro, C; LaGrange, JM; Zhang, ZY; Rustan, AC; Ravussin, E; Bajpeyi, S				Covington, Jeffrey D.; Galgani, Jose E.; Moro, Cedric; LaGrange, Jamie M.; Zhang, Zhengyu; Rustan, Arild C.; Ravussin, Eric; Bajpeyi, Sudip			Skeletal Muscle Perilipin 3 and Coatomer Proteins Are Increased following Exercise and Are Associated with Fat Oxidation	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPID-CONTENT; INSULIN SENSITIVITY; TRIGLYCERIDE CONTENT; PLIN PROTEINS; DROPLETS; CONTRACTION; EXPRESSION; RESISTANCE; SPECTROSCOPY; INTENSITY	Lipid droplet-associated proteins such as perilipin 3 (PLIN3) and coatomer GTPase proteins (GBF1, ARF1, Sec23a, and ARFRP1) are expressed in skeletal muscle but little is known so far as to their regulation of lipolysis. We aimed here to explore the effects of lipolytic stimulation in vitro in primary human myotubes as well as in vivo following an acute exercise bout. In vitro lipolytic stimulation by epinephrine (100 mu M) or by a lipolytic cocktail (30 mu M palmitate, 4 mu M forskolin, and 0.5 mu M ionomycin, PFI) resulted in increases in PLIN3 protein content. Coatomer GTPases such as GBF1, ARF1, Sec23a, and ARFRP1 also increased in response to lipolytic stimuli. Furthermore, a long duration endurance exercise bout (20 males; age 24.0 +/- 4.5 y; BMI 23.6 +/- 1.8 kg/m(2)) increased PLIN3 protein in human skeletal muscle (p = 0.03) in proportion to ex vivo palmitate oxidation (r = 0.45, p = 0.04) and whole body in vivo fat oxidation (r = 0.52, p = 0.03). Protein content of ARF1 was increased (p = 0.04) while mRNA expression was increased for several other coatomers (GBF1, ARF1, and Sec23a, all p<0.05). These data provide novel observational insight into the possible relationships between lipolysis and PLIN3 along with these coatomoer GTPase proteins in human skeletal muscle.	[Covington, Jeffrey D.; LaGrange, Jamie M.; Zhang, Zhengyu; Ravussin, Eric; Bajpeyi, Sudip] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Galgani, Jose E.] Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile; [Moro, Cedric] INSERM, UMR 1048, Inst Metab & Cardiovasc Dis, Toulouse, France; [Moro, Cedric] Univ Toulouse 3, F-31062 Toulouse, France; [Rustan, Arild C.] Univ Oslo, Dept Pharmaceut Biosci, Oslo, Norway; [Bajpeyi, Sudip] Univ Texas El Paso, Dept Kinesiol, El Paso, TX 79968 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Pontificia Universidad Catolica de Chile; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oslo; University of Texas System; University of Texas El Paso	Bajpeyi, S (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	sbajpeyi@utep.edu	Moro, Cedric/N-5754-2017; Ravussin, Eric/N-1985-2017	Ravussin, Eric/0000-0003-2129-547X; Bajpeyi, Sudip/0000-0002-5336-8330; Moro, Cedric/0000-0003-4294-0597	Obesity Society; Nutrition Obesity Research Center (NORC) [NIH 1P30 DK072476]; COBRE [NIH P20 RR021945]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	Obesity Society; Nutrition Obesity Research Center (NORC); COBRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This investigation was supported in part by a young investigator award from The Obesity Society (J.E.G.) and a Nutrition Obesity Research Center (NORC) grant NIH 1P30 DK072476 (E.R.). This work utilized the Genomics Core Facility and the Cell Biology and Bioimaging Core at Pennington Biomedical Research Center, which is supported in part by COBRE (NIH P20 RR021945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpeyi S, 2009, J APPL PHYSIOL, V106, P1079, DOI 10.1152/japplphysiol.91262.2008; Bosma M, 2013, BBA-MOL CELL BIOL L, V1831, P844, DOI 10.1016/j.bbalip.2013.01.007; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; de Wilde J, 2010, FEBS J, V277, P761, DOI 10.1111/j.1742-4658.2009.07525.x; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Galgani JE, 2012, OBESITY, V20, P1387, DOI 10.1038/oby.2011.166; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hommel A, 2010, MOL CELL BIOL, V30, P1231, DOI 10.1128/MCB.01269-09; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kovalik JP, 2011, DIABETES, V60, P1882, DOI 10.2337/db10-0427; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Louche K, 2013, J CLIN ENDOCR METAB, V98, P4863, DOI 10.1210/jc.2013-2058; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; MacPherson REK, 2012, AM J PHYSIOL-REG I, V302, pR29, DOI 10.1152/ajpregu.00163.2011; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Peters SJ, 2012, APPL PHYSIOL NUTR ME, V37, P724, DOI [10.1139/h2012-059, 10.1139/H2012-059]; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Sparks LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021068; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; Watt MJ, 2004, FASEB J, V18, P1445, DOI 10.1096/fj.03-1067fje; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	32	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91675	10.1371/journal.pone.0091675	http://dx.doi.org/10.1371/journal.pone.0091675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632837	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400077
J	Nilsson, EM; Fainberg, HP; Choong, SS; Giles, TC; Sells, J; May, S; Stansfield, FJ; Allen, WR; Emes, RD; Mostyn, A; Mongan, NP; Yon, L				Nilsson, Emeli M.; Fainberg, Hernan P.; Choong, Siew S.; Giles, Thomas C.; Sells, James; May, Sean; Stansfield, Fiona J.; Allen, William R.; Emes, Richard D.; Mostyn, Alison; Mongan, Nigel P.; Yon, Lisa			Molecular Characterization of Adipose Tissue in the African Elephant (Loxodonta africana)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; C-FOS EXPRESSION; INSULIN-RESISTANCE; MISSENSE MUTATION; NORTH-AMERICA; OBESE GENE; MILK-FAT; LEPTIN; PROTEIN; RATS	Adipose tissue (AT) is a dynamic and flexible organ with regulatory roles in physiological functions including metabolism, reproduction and inflammation; secreted adipokines, including leptin, and fatty acids facilitate many of these roles. The African elephant (Loxodonta africana) is experiencing serious challenges to optimal reproduction in captivity. The physiological and molecular basis of this impaired fertility remains unknown. AT production of leptin is a crucial molecular link between nutritional status, adiposity and fertility in many species. We propose that leptin has a similar function in the African elephant. African elephant visceral and subcutaneous adipose tissue (AT) was obtained from both sexes and a range of ages including females with known pregnancy status. RNA was extracted and histological sections created and analyzed by microarray, PCR and immunohistochemistry respectively. Gas-chromatography was used to determine the fatty acid composition of AT. Microarray expression profiling was used to compare gene expression profiles of AT from pre-pubertal versus reproductively competent adult African elephants. This study demonstrates, for the first time, leptin mRNA and protein expression in African elephant AT. The derived protein sequence of the elephant leptin protein was exploited to determine its relationship within the class I helical cytokine superfamily, which indicates that elephant leptin is most closely related to the leptin orthologs of Oryctolagus cuniculus (European rabbit), Lepus oiostolus (woolly hare), and members of the Ochotonidae (Pika). Immunohistological analysis identified considerable leptin staining within the cytoplasm of adipocytes. Significant differences in fatty acid profiles between pregnant and non-pregnant animals were revealed, most notably a reduction in both linoleic and a linoleic acid in pregnant animals. This report forms the basis for future studies to address the effect of nutrient composition and body condition on reproduction in captive and wild elephants.	[Nilsson, Emeli M.; Fainberg, Hernan P.; Choong, Siew S.; Sells, James; Emes, Richard D.; Mostyn, Alison; Mongan, Nigel P.; Yon, Lisa] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough, England; [Giles, Thomas C.; Emes, Richard D.] Univ Nottingham, Adv Data Anal Ctr, Loughborough, England; [May, Sean] Univ Nottingham, Div Plant Sci, Nottingham Arabidopsis Stock Ctr, Loughborough, England; [Stansfield, Fiona J.] Save Valley Conservancy, Elephant Res & Conservat Unit, Harare, Zimbabwe; [Allen, William R.] Paul Mellon Lab, Newmarket, Suffolk, England	University of Nottingham; University of Nottingham; University of Nottingham	Emes, RD (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough, England.	richard.emes@nottingham.ac.uk; alison.mostyn@nottingham.ac.uk; nigel.mongan@nottingham.ac.uk; lisa.yon@nottingham.ac.uk	may, sean t/B-6838-2012; Emes, Richard D/C-5341-2008; Choong, Sandie/Q-2370-2019; Yon, Lisa K/G-4453-2011; Fainberg, Hernan/GQZ-6651-2022	may, sean t/0000-0001-5282-3250; Emes, Richard D/0000-0001-6855-5481; Yon, Lisa K/0000-0002-9765-3192; Choong, Siew Shean/0000-0003-2081-8099; Fainberg, Hernan Pablo/0000-0001-9330-9047; Mongan, Nigel/0000-0001-5438-1126	Society for Reproduction and Fertility Academic Scholarship Fund; University of Nottingham; BBSRC [BB/I001271/1, BB/E022758/1, BB/L010100/1, BB/J018961/1, BB/E01772X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J018961/1, G17764, BBS/B/1356X, G18881, BB/L010100/1, BB/I001271/1, BB/E01772X/1, BB/E022758/1] Funding Source: researchfish	Society for Reproduction and Fertility Academic Scholarship Fund; University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Part of this work was supported by the Society for Reproduction and Fertility Academic Scholarship Fund, and part from internal funding from the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Akiyama S, 2010, BLOOD CELL MOL DIS, V44, P209, DOI 10.1016/j.bcmd.2010.02.013; AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Andres S, 2013, HORMONES CANC, P1; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Budak E, 2006, FERTIL STERIL, V85, P1563, DOI 10.1016/j.fertnstert.2005.09.065; Campfield LA, 1996, HORM METAB RES, V28, P619, DOI 10.1055/s-2007-979867; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chouinard PY, 1999, J DAIRY SCI, V82, P2737, DOI 10.3168/jds.S0022-0302(99)75530-X; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; DEMAN JM, 1963, J DAIRY RES, V30, P339, DOI 10.1017/S0022029900011523; DUNCAN WRH, 1968, COMP BIOCHEM PHYSIOL, V25, P319, DOI 10.1016/0010-406X(68)90939-0; Evans G.H, 1910, ELEPHANTS THEIR DIS; Fainberg HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049101; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Geary N, 2007, SEX DIFFERENCES ENER, P254; Graham NS, 2010, VET J, V186, P323, DOI 10.1016/j.tvjl.2009.08.030; Gulliver CE, 2012, ANIM REPROD SCI, V131, P9, DOI 10.1016/j.anireprosci.2012.02.002; Hamilton BS, 1998, CANADIAN J DIABETES, V22, pS13; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hausman GJ, 2012, BIOCHIMIE, V94, P2075, DOI 10.1016/j.biochi.2012.02.022; Hermes R, 2008, THERIOGENOLOGY, V70, P131, DOI 10.1016/j.theriogenology.2008.04.003; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Huan JN, 2003, J BIOL CHEM, V278, P45638, DOI 10.1074/jbc.M304165200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUERTALEIDENZ NO, 1993, J ANIM SCI, V71, P625, DOI 10.2527/1993.713625x; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; KNITTEL T, 1992, GASTROENTEROLOGY, V102, P1724, DOI 10.1016/0016-5085(92)91736-N; Lacasa D, 1997, ENDOCRINOLOGY, V138, P2729, DOI 10.1210/en.138.7.2729; Lavoie J-M, 2012, J NUTR METABOLISM, V2012; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Licinio J, 1998, J CLIN ENDOCR METAB, V83, P4140, DOI 10.1210/jc.83.11.4140; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; Marjeta Furman SM, 2010, ARCH ANIMAL BREEDING, V53, P73; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; MCCULLAGH KG, 1969, NATURE, V222, P493, DOI 10.1038/222493a0; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151; OLSON AL, 1994, ENDOCRINOLOGY, V134, P271, DOI 10.1210/en.134.1.271; Olson D, 2000, ZOO BIOL, V19, P311, DOI 10.1002/1098-2361(2000)19:5<311::AID-ZOO3>3.3.CO;2-F; PERRY JS, 1953, PHILOS T R SOC B, V237, P93, DOI 10.1098/rstb.1953.0001; Pietrzak-Fiecko R, 2009, CZECH J ANIM SCI, V54, P403, DOI 10.17221/1683-CJAS; Pinilla L, 1999, EUR J ENDOCRINOL, V140, P468, DOI 10.1530/eje.0.1400468; Poitout V., 2002, CURR OPIN ENDOCRINOL, V9, P152; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; ROSENKRANZWEISS P, 1994, J MOL CELL CARDIOL, V26, P261, DOI 10.1006/jmcc.1994.1029; Sasaki Y, 2006, ANIM GENET, V37, P40, DOI 10.1111/j.1365-2052.2005.01380.x; Scantlebury M, 2006, P ROY SOC B-BIOL SCI, V273, P57, DOI 10.1098/rspb.2005.3280; SCHMIDT M, 1986, ZOO WILD ANIMAL MED, P884; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Suzuki R, 2005, J BIOL CHEM, V280, P3331, DOI 10.1074/jbc.M410955200; SWERDLOFF RS, 1976, ENDOCRINOLOGY, V98, P1359, DOI 10.1210/endo-98-6-1359; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; WU Z, 1991, J DAIRY SCI, V74, P3035, DOI 10.3168/jds.S0022-0302(91)78489-0; Wu-Peng S, 1999, OBES RES, V7, P586, DOI 10.1002/j.1550-8528.1999.tb00718.x; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zonta E, 2013, NUCLEIC ACIDS RES, V41, P554, DOI 10.1093/nar/gks1046	73	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91717	10.1371/journal.pone.0091717	http://dx.doi.org/10.1371/journal.pone.0091717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633017	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400081
J	Bao, L; Chen, D; Ding, L; Ling, WH; Xu, F				Bao, Long; Chen, Du; Ding, Li; Ling, Weihua; Xu, Feng			Fever Burden Is an Independent Predictor for Prognosis of Traumatic Brain Injury	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BODY-TEMPERATURE; CLINICAL-TRIAL; IMPACT; MORTALITY; OUTCOMES; DESIGN; STROKE; COMA; AGE	Objective: To evaluate fever burden as an independent predictor for prognosis of traumatic brain injury (TBI). Methods: This retrospective study involved 355 TBI patients with Glasgow Coma Scale (GCS) <= 14, who presented at the emergency department of our hospital between November 2010 and October 2012. At 6 months follow-up, patients were divided into 5 groups based on Glasgow Outcome Scale (GOS) and dichotomized to GOS score (high (4 to 5) vs. low (1 to 3)). The relationship between fever burden and GOS was assessed. Results: Fever burden increased as GOS scores decreased from 5 to 2, except for score 1 of GOS, which corresponded to a significant lower fever burden. Following dichotomization, patients in the high GOS group were younger, and showed less abnormal pupil reactivity (P < 0.001), a higher median GCS score (P < 0.001), and a lower median fever burden (P < 0.001), compared with patients in the low GOS group. Univariate logistic regression analysis revealed that poor TBI prognosis was related to age, GCS, pupil reactivity, and fever burden (OR: 1.166 [95% CI: 1.117-1.217] P < 0.0001). Multivariate logistic regression analysis identified fever burden as an independent predictor of poor prognosis after TBI (OR 1.098; 95% CI: 1.031-1.169; P = 0.003). These observations were confirmed by evaluation of the receiver operating characteristic (ROC) curve for fever burden (area under the curve [AUC] 0.73 [95% CI: 0.663-0.760]). Conclusion: Fever burden might be an independent predictor for prognosis of TBI. High fever burden in the early stage of the disease course associated with TBI could increase the risk of poor prognosis.	[Bao, Long; Chen, Du; Ding, Li; Ling, Weihua; Xu, Feng] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China	Soochow University - China	Xu, F (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China.	xufengmedsci@163.com	Chen, Du/AAM-8789-2021	Chen, Du/0000-0001-6990-3310				Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Naidech AM, 2008, NEUROSURGERY, V63, P212, DOI 10.1227/01.NEU.0000320453.61270.0F; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Phipps MS, 2011, STROKE, V42, P3357, DOI 10.1161/STROKEAHA.111.621425; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577	21	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90956	10.1371/journal.pone.0090956	http://dx.doi.org/10.1371/journal.pone.0090956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626046	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300044
J	Watanabe, H				Watanabe, Hayafumi			Mean Field Approximation for Biased Diffusion on Japanese Inter-Firm Trading Network	PLOS ONE			English	Article							COMPLEX NETWORKS	By analysing the financial data of firms across Japan, a nonlinear power law with an exponent of 1.3 was observed between the number of business partners (i.e. the degree of the inter-firm trading network) and sales. In a previous study using numerical simulations, we found that this scaling can be explained by both the money-transport model, where a firm (i.e. customer) distributes money to its out-edges (suppliers) in proportion to the in-degree of destinations, and by the correlations among the Japanese inter-firm trading network. However, in this previous study, we could not specifically identify what types of structure properties (or correlations) of the network determine the 1.3 exponent. In the present study, we more clearly elucidate the relationship between this nonlinear scaling and the network structure by applying mean-field approximation of the diffusion in a complex network to this money-transport model. Using theoretical analysis, we obtained the mean-field solution of the model and found that, in the case of the Japanese firms, the scaling exponent of 1.3 can be determined from the power law of the average degree of the nearest neighbours of the network with an exponent of -0.7.	Hottolink Inc, Chiyoda Ku, Tokyo, Japan		Watanabe, H (corresponding author), Hottolink Inc, Chiyoda Ku, Tokyo, Japan.	h.watanabe@hottolink.co.jp						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Baronchelli A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011111; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chmiel A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066122; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Fronczak A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016107; Glattfelder JB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036104; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Iino T., 2010, Journal of Physics: Conference Series, V221, DOI 10.1088/1742-6596/221/1/012012; Litvak N, 2009, LECT NOTES COMPUT SC, V5427, P90, DOI 10.1007/978-3-540-95995-3_8; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2003, CONDMAT0312028 ARXIV; Miura W, 2012, EUR PHYS J-SPEC TOP, V212, P65, DOI 10.1140/epjst/e2012-01654-7; Miura W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168701; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Ohnishi T, 2009, PROG THEOR PHYS SUPP, P157, DOI 10.1143/PTPS.179.157; Sen P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036106; Tamura Koutarou, 2012, International Journal of Modern Physics: Conference Series, V16, P93, DOI 10.1142/S2010194512007805; Tamura K, 2012, P AS PAC S INT EV SY; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Vitali S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063021; Watanabe H, 2013, PHYSICA A, V392, P741, DOI 10.1016/j.physa.2012.10.020; Watanabe H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043034	25	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91704	10.1371/journal.pone.0091704	http://dx.doi.org/10.1371/journal.pone.0091704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626149	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300125
J	Tsuda, T; Mochizuki, E; Kishida, S; Iwasaki, K; Tsunashima, K; Kuwabata, S				Tsuda, Tetsuya; Mochizuki, Eiko; Kishida, Shoko; Iwasaki, Kazuki; Tsunashima, Katsuhiko; Kuwabata, Susumu			SEM Observation of Hydrous Superabsorbent Polymer Pretreated with Room-Temperature Ionic Liquids	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; PHYSICOCHEMICAL PROPERTIES; CELLS; ELECTROCHEMISTRY; VACUUM	Room-temperature ionic liquid (RTIL), which is a liquid salt at or below room temperature, shows peculiar physicochemical properties such as negligible vapor pressure and relatively-high ionic conductivity. In this investigation, we used six types of RTILs as a liquid material in the pretreatment process for scanning electron microscope (SEM) observation of hydrous superabsorbent polymer (SAP) particles. Very clear SEM images of the hydrous SAP particles were obtained if the neat RTILs were used for the pretreatment process. Of them, tri-n-butylmethylphosphonium dimethylphosphate ([P-4,P- 4,P- 4,P- 1][DMP]) provided the best result. On the other hand, the surface morphology of the hydrous SAP particles pretreated with 1-ethyl-3-methylimidazolium tetrafluoroborate ([C(2)mim][BF4]) and 1-butyl-3-methylimidazolium tetrafluoroborate ([C(4)mim][BF4]) was damaged. The results of SEM observation and thermogravimetry analysis of the hydrous SAP pretreated with the RTILs strongly suggested that most water in the SAP particles are replaced with RTIL during the pretreatment process.	[Tsuda, Tetsuya; Mochizuki, Eiko; Kishida, Shoko; Iwasaki, Kazuki; Kuwabata, Susumu] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka, Japan; [Tsunashima, Katsuhiko] Wakayama Natl Coll Technol, Dept Mat Sci, Gobo, Wakayama, Japan	Osaka University	Tsuda, T (corresponding author), Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka, Japan.	ttsuda@chem.eng.osaka-u.ac.jp; kuwabata@chem.eng.osaka-u.ac.jp	Kuwabata, Susumu/N-3492-2018; Tsuda, Tetsuya/F-7234-2014	Kuwabata, Susumu/0000-0002-4606-964X; Tsuda, Tetsuya/0000-0001-9462-8066	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24350071]; Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency (JST); Japanese Ministry of Economy, Trade and Industry (METI)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japanese Ministry of Economy, Trade and Industry (METI)	Part of this research was supported by Grant-in-Aid for Scientific Research B, Grant No. 24350071, from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), from Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency (JST), and from Japanese Ministry of Economy, Trade and Industry (METI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001; Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f; Dwiranti A, 2012, MICROSC RES TECHNIQ, V75, P1113, DOI 10.1002/jemt.22038; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; Freire MG, 2011, J CHEM ENG DATA, V56, P4813, DOI 10.1021/je200790q; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P1024, DOI 10.1002/jemt.20989; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Johnston M, 2005, J PHYS CHEM B, V109, P11296, DOI 10.1021/jp051243m; Kawai K, 2011, LANGMUIR, V27, P9671, DOI 10.1021/la201914h; Kuwabata S, 2006, CHEM LETT, V35, P600, DOI 10.1246/cl.2006.600; Kuwabata S, 2010, J PHYS CHEM LETT, V1, P3177, DOI 10.1021/jz100876m; Lovelock KRJ, 2010, CHEM REV, V110, P5158, DOI 10.1021/cr100114t; RADOSAVLJEVIC S, 1979, J FLUORINE CHEM, V13, P465, DOI 10.1016/S0022-1139(00)83094-8; Rilo E, 2010, J CHEM ENG DATA, V55, P639, DOI 10.1021/je900600c; Shima F, 2013, B CHEM SOC JPN, V86, P153, DOI 10.1246/bcsj.20120227; Takahashi C, 2013, MATER CHEM PHYS, V141, P657, DOI 10.1016/j.matchemphys.2013.05.051; Tokuda H, 2006, J PHYS CHEM B, V110, P19593, DOI 10.1021/jp064159v; Torimoto T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404975; Torimoto T, 2010, ADV MATER, V22, P1196, DOI 10.1002/adma.200902184; Tsuda T, 2013, ELECTROCHIM ACTA, V100, P285, DOI 10.1016/j.electacta.2012.05.156; Tsuda T, 2012, ELECTROCHEMISTRY, V80, P308, DOI 10.5796/electrochemistry.80.308; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; Tsuda T, 2011, ANGEW CHEM INT EDIT, V50, P1310, DOI 10.1002/anie.201005208; Tsuda T, 2009, MOD ASP ELECTROCHEM, P63, DOI 10.1007/978-1-4419-0655-7_2; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE, V1; Yanaga K, 2012, MYCOL PROG, V11, P343, DOI 10.1007/s11557-011-0794-6; Yoshii K, 2013, J PHYS CHEM B, V117, P15051, DOI 10.1021/jp406791a	28	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91193	10.1371/journal.pone.0091193	http://dx.doi.org/10.1371/journal.pone.0091193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621609	gold, Green Submitted, Green Published			2022-12-25	WOS:000332845300060
J	Davenport, ER; Mizrahi-Man, O; Michelini, K; Barreiro, LB; Ober, C; Gilad, Y				Davenport, Emily R.; Mizrahi-Man, Orna; Michelini, Katelyn; Barreiro, Luis B.; Ober, Carole; Gilad, Yoav			Seasonal Variation in Human Gut Microbiome Composition	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; DIET; OBESITY; ASSOCIATIONS; COMMUNITIES; METABOLISM; PATTERNS; NUTRIENT; DELIVERY	The composition of the human gut microbiome is influenced by many environmental factors. Diet is thought to be one of the most important determinants, though we have limited understanding of the extent to which dietary fluctuations alter variation in the gut microbiome between individuals. In this study, we examined variation in gut microbiome composition between winter and summer over the course of one year in 60 members of a founder population, the Hutterites. Because of their communal lifestyle, Hutterite diets are similar across individuals and remarkably stable throughout the year, with the exception that fresh produce is primarily served during the summer and autumn months. Our data indicate that despite overall gut microbiome stability within individuals over time, there are consistent and significant population-wide shifts in microbiome composition across seasons. We found seasonal differences in both (i) the abundance of particular taxa (false discovery rate <0.05), including highly abundant phyla Bacteroidetes and Firmicutes, and (ii) overall gut microbiome diversity (by Shannon diversity; P = 0.001). It is likely that the dietary fluctuations between seasons with respect to produce availability explain, at least in part, these differences in microbiome composition. For example, high levels of produce containing complex carbohydrates consumed during the summer months might explain increased abundance of Bacteroidetes, which contain complex carbohydrate digesters, and decreased levels of Actinobacteria, which have been negatively correlated to fiber content in food questionnaires. Our observations demonstrate the plastic nature of the human gut microbiome in response to variation in diet.	[Davenport, Emily R.; Mizrahi-Man, Orna; Michelini, Katelyn; Barreiro, Luis B.; Ober, Carole; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	carole@genetics.uchicago.edu; gilad@uchicago.edu	Barreiro, Luis/I-7772-2015	Davenport, Emily R./0000-0002-6938-4933; Barreiro, Luis/0000-0001-9456-367X; Ober, Carole/0000-0003-4626-9809	NIH [HG006123, HL085197]; Digestive Disease Research Core Center [P30-DK42086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH grants HG006123 to YG and HL085197 to CO, and the Digestive Disease Research Core Center grant P30-DK42086 (through a P&F grant to YG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fava F., 2012, INT J OBESITY; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; MULLEN BJ, 1984, AM J CLIN NUTR, V39, P136, DOI 10.1093/ajcn/39.1.136; Oksanen J., 2008, COMMUNITY ECOLOGY PA, V190, P254, DOI 10.4135/9781412971874.n145; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; R Development Core Team, 2011, R LANG ENV STAT COMP; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Van den Abbeele P, 2011, ENVIRON MICROBIOL, V13, P2667, DOI 10.1111/j.1462-2920.2011.02533.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	55	181	185	6	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90731	10.1371/journal.pone.0090731	http://dx.doi.org/10.1371/journal.pone.0090731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618913	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400027
J	Anamika; Markin, CJ; Rout, MK; Spyracopoulos, L				Anamika; Markin, Craig J.; Rout, Manoj K.; Spyracopoulos, Leo			Molecular Basis for Impaired DNA Damage Response Function Associated with the RAP80 Delta E81 Defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; DNA Damage Response; NMR; Protein-Protein Interactions; Ubiquitination	CHEMICAL-SHIFT TITRATIONS; N-15 NMR RELAXATION; POLYUBIQUITIN CHAINS; IMPROVED SENSITIVITY; BACKBONE DYNAMICS; GENERALIZED BORN; PROTEINS; BINDING; BREAST; DOMAIN	Background: RAP80 recruits repair protein complexes to DNA damage sites through multivalent polyubiquitin binding. Results: A single point deletion (E81) in RAP80 abrogates multivalent interactions with polyubiquitin. Conclusion: Disruption of multivalent binding arises from loss of electrostatic interactions between Glu-81 and ubiquitin. Significance: A single residue deletion mutation in RAP80 impairs DNA damage repair and is implicated in the pathogenesis of cancer. Signal transduction within the DNA damage response is driven by the flux of protein-protein interaction cascades that ultimately recruit repair complexes to sites of damage. The protein RAP80 plays a central role in the damage response by targeting BRCA1/BRCA2 tumor suppressors to DNA damage foci through multivalent binding of Lys-63-linked polyubiquitin chains. Mutations within the high penetrance BRCA1/BRCA2 genes account for approximate to 20% of familial breast cancers. The genetic basis for the remaining cancers remains unknown, but may involve defects in binding partners for BRCA1 and BRCA2 that lead to impaired targeting to foci and a concomitant role in the pathogenesis of cancer. Recently, an in-frame deletion mutation (E81) in a conserved region from the first ubiquitin interaction motif of RAP80 has been linked to an increase in chromosomal abnormalities. Using NMR spectroscopy, we demonstrate that the N-cap motif within the -helix of the first ubiquitin interaction motif from E81 undergoes a structural frameshift that leads to abolishment of multivalent binding of polyubiquitin chains. Loss of this single glutamate residue disrupts favorable electrostatic interactions between RAP80 and ubiquitin, establishing a plausible molecular basis for a potential predisposition to cancer unrelated to mutations within BRCA1/BRCA2 genes.	[Anamika; Markin, Craig J.; Rout, Manoj K.; Spyracopoulos, Leo] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Spyracopoulos, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	leo.spyracopoulos@ualberta.ca		Markin, Craig/0000-0002-2147-0744	University of Alberta	University of Alberta(University of Alberta)	We thank the Canadian National High Field NMR Centre (NANUC) for assistance and for use of the facilities. Operation of NANUC is funded by the University of Alberta. Computational studies were enabled by the use of computing resources provided by WestGrid and Compute/Calcul Canada.	Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Case D.A., 2022, AMBER 2020; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Goddard T. D., 2008, SPARKY 3; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller R., 2004, COMPUTER AIDED RESON, V1; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Markin CJ, 2012, J BIOMOL NMR, V54, P355, DOI 10.1007/s10858-012-9678-6; Markin CJ, 2012, J BIOMOL NMR, V53, P125, DOI 10.1007/s10858-012-9630-9; Markin CJ, 2010, J AM CHEM SOC, V132, P11247, DOI 10.1021/ja103869x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nesmelova I, 2001, BIOCHEMISTRY-US, V40, P2844, DOI 10.1021/bi001293b; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Rebbeck TR, 2011, CANCER RES, V71, P5792, DOI 10.1158/0008-5472.CAN-11-0773; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEALE JW, 1994, PROTEIN SCI, V3, P1741, DOI 10.1002/pro.5560031014; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wolfram S., 2003, MATH BOOK; Yin ZY, 2012, CANCER RES, V72, P5080, DOI 10.1158/0008-5472.CAN-12-1484; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	41	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12852	12862		10.1074/jbc.M113.538280	http://dx.doi.org/10.1074/jbc.M113.538280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627472	Green Published, hybrid			2022-12-25	WOS:000335581400054
J	Pohane, AA; Joshi, H; Jain, V				Pohane, Amol Arunrao; Joshi, Himanshu; Jain, Vikas			Molecular Dissection of Phage Endolysin AN INTERDOMAIN INTERACTION CONFERS HOST SPECIFICITY IN LYSIN A OF MYCOBACTERIUM PHAGE D29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Mycobacteria; Peptidoglycan; Protein-Protein Interactions; Surface Plasmon Resonance (SPR); Periplasmic Expression; Zymography	FUNCTIONAL-ANALYSIS; LYTIC ACTIVITY; DOMAIN; FLUORESCENT; EXPRESSION; HYDROLASE; BINDING; PROTEIN; GENES; IDENTIFICATION	Background: Bacteriophages produce endolysins to hydrolyze host cell wall for their progeny release. Results:Mycobacterium phage endolysin is inactive in E. coli but is active in mycobacteria. Conclusion: An interdomain interaction makes Lysin A inactive in E. coli. Significance: A hydrolase with built-in mechanism attains host specificity. An in-depth study can help in developing strong anti-tuberculosis agents. Mycobacterium tuberculosis has always been recognized as one of the most successful pathogens. Bacteriophages that attack and kill mycobacteria offer an alternate mechanism for the curtailment of this bacterium. Upon infection, mycobacteriophages produce lysins that catalyze cell wall peptidoglycan hydrolysis and mycolic acid layer breakdown of the host resulting in bacterial cell rupture and virus release. The ability to lyse bacterial cells make lysins extremely significant. We report here a detailed molecular dissection of the function and regulation of mycobacteriophage D29 Lysin A. Several truncated versions of Lysin A were constructed, and their activities were analyzed by zymography and by expressing them in both Escherichia coli and Mycobacterium smegmatis. Our experiments establish that Lysin A harbors two catalytically active domains, both of which show E. coli cell lysis upon their expression exclusively in the periplasmic space. However, the expression of only one of these domains and the full-length Lysin A caused M. smegmatis cell lysis. Interestingly, full-length protein remained inactive in E. coli periplasm. Our data suggest that the inactivity is ensued by a C-terminal domain that interacts with the N-terminal domain. This interaction was affirmed by surface plasmon resonance. Our experiments also demonstrate that the C-terminal domain of Lysin A selectively binds to M. tuberculosis and M. smegmatis peptidoglycans. Our methodology of studying E. coli cell lysis by Lysin A and its truncations after expressing these proteins in the bacterial periplasm with the help of signal peptide paves the way for a large scale identification and analysis of such proteins obtained from other bacteriophages.	[Pohane, Amol Arunrao; Joshi, Himanshu; Jain, Vikas] Indian Inst Sci Educ & Res IISER, Dept Biol Sci, Microbiol & Mol Biol Lab, Bhopal 462023, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Jain, V (corresponding author), Indian Inst Sci Educ & Res IISER, Microbiol & Mol Biol Lab, Transit Campus ITI Gas Rahat Bldg, Bhopal 462023, Madhya Pradesh, India.	vikas@iiserb.ac.in	JAIN, VIKAS/B-3142-2008	JAIN, VIKAS/0000-0003-0238-8144	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a rapid grant from the Department of Biotechnology, Government of India.; Recipients of Council of Scientific and Industrial Research, Government of India senior research fellowships.	Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Catalao MJ, 2013, FEMS MICROBIOL REV, V37, P554, DOI 10.1111/1574-6976.12006; Catalao MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020515; Catalao MJ, 2011, J BACTERIOL, V193, P2793, DOI 10.1128/JB.01519-10; Dinh T, 2011, J BACTERIOL, V193, P4984, DOI 10.1128/JB.00315-11; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.72.4.2988-2996.2006; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Garcia M, 2002, J BACTERIOL, V184, P3034, DOI 10.1128/JB.184.11.3034-3043.2002; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Hassan S., 2010, OPEN SYS BIOL J, V3, DOI [10.2174/1876392801003010021, DOI 10.2174/18763]; HENRICH B, 1995, J BACTERIOL, V177, P723, DOI 10.1128/jb.177.3.723-732.1995; Henry M, 2010, FEMS MICROBIOL LETT, V311, P126, DOI 10.1111/j.1574-6968.2010.02080.x; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hernandez VEB, 2008, PROTEIN EXPRES PURIF, V59, P169, DOI 10.1016/j.pep.2008.01.019; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Kana BD, 2010, J BACTERIOL, V192, P2220, DOI 10.1128/JB.01135-09; Kanamaru S, 2005, J MOL BIOL, V346, P1013, DOI 10.1016/j.jmb.2004.12.042; Lella M, 2013, CHEM COMMUN, V49, P9594, DOI 10.1039/c3cc45058a; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Mahapatra S, 2013, APPL ENVIRON MICROB, V79, P768, DOI 10.1128/AEM.02263-12; McNerney R, 1998, RES MICROBIOL, V149, P487, DOI 10.1016/S0923-2508(98)80003-X; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Raghunand TR, 2006, MICROBIOL-SGM, V152, P2735, DOI 10.1099/mic.0.28911-0; Sambrook J, 2001, MOL CLONING LAB MANU; Schmelcher M, 2011, MICROB BIOTECHNOL, V4, P651, DOI 10.1111/j.1751-7915.2011.00263.x; Schofield David A, 2012, Bacteriophage, V2, P105; Schuch Raymond, 2009, V502, P307, DOI 10.1007/978-1-60327-565-1_18; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Simboli N, 2005, ANTIMICROB AGENTS CH, V49, P425, DOI 10.1128/AAC.49.1.425-427.2005; Singh MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063922; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Sudiarta IP, 2010, J BIOL CHEM, V285, P41232, DOI 10.1074/jbc.M110.156273; Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991; Wang S, 2008, J APPL MICROBIOL, V105, P1939, DOI 10.1111/j.1365-2672.2008.03953.x; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	56	32	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12085	12095		10.1074/jbc.M113.529594	http://dx.doi.org/10.1074/jbc.M113.529594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627486	Green Published, hybrid			2022-12-25	WOS:000335010600046
J	Hang, J; Forshey, BM; Yang, Y; Solorzano, VF; Kuschner, RA; Halsey, ES; Jarman, RG; Kochel, TJ				Hang, Jun; Forshey, Brett M.; Yang, Yu; Solorzano, Victor Fiestas; Kuschner, Robert A.; Halsey, Eric S.; Jarman, Richard G.; Kochel, Tadeusz J.			Genomic Characterization of Group C Orthobunyavirus Reference Strains and Recent South American Clinical Isolates	PLOS ONE			English	Article							ARTHROPOD-BORNE VIRUSES; MOLECULAR EPIDEMIOLOGY; FAMILY BUNYAVIRIDAE; S SEGMENT; RNA; IDENTIFICATION; SEQUENCE; POLYMERASE; PROMALS; BIOLOGY	Group C orthobunyaviruses (family Bunyaviridae, genus Orthobunyavirus), discovered in the 1950s, are vector-borne human pathogens in the Americas. Currently there is a gap in genomic information for group C viruses. In this study, we obtained complete coding region sequences of reference strains of Caraparu (CARV), Oriboca (ORIV), Marituba (MTBV) and Madrid (MADV) viruses, and five clinical isolates from Peru and Bolivia, using an unbiased de novo approach consisting of random reverse transcription, random anchored PCR amplification, and high throughput pyrosequencing. The small, medium, and large segments encode for a 235 amino acid nucleocapsid protein, an approximately 1430 amino acid surface glycoprotein polyprotein precursor, and a 2248 amino acid RNA-dependent RNA polymerase, respectively. Additionally, the S segment encodes for an 83 amino acid non-structural protein, although this protein is truncated or silenced in some isolates. Phylogenetically, three clinical isolates clustered with CARV, one clustered with MTBV, and one isolate appeared to be a reassortant or a genetic drift resulted from the high variability of the medium segment which was also seen in a few other orthobunyaviruses. These data represent the first complete coding region sequences for this serocomplex of pathogenic orthobunyaviruses. The genome-wide phylogeny of reference strains is consistent with the antigenic properties of the viruses reported in the original serological studies conducted in the 1960s. Comparative analysis of conserved protein regions across group C virus strains and the other orthobunyavirus groups revealed that these group C viruses contain characteristic domains of potential structural and functional significance. Our results provide the basis for the developments of diagnostics, further genetic analyses, and future epidemiologic studies of group C viruses.	[Hang, Jun; Yang, Yu; Kuschner, Robert A.; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA; [Forshey, Brett M.; Jarman, Richard G.] US Naval Med Res Unit, Lima, Peru; [Solorzano, Victor Fiestas] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Kochel, Tadeusz J.] US Naval Med Res Ctr, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Instituto Nacional de Salud - Peru; Naval Medical Research Center (NMRC)	Hang, J (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.	jun.hang.ctr@mail.mil	Fiestas, Victor/J-6894-2019; Halsey, Eric/AAC-8110-2022	Fiestas, Victor/0000-0002-5554-3542; Halsey, Eric/0000-0001-6291-8923	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center	This work was supported by the Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2010, AM J TROP MED HYG, V83, P714, DOI 10.4269/ajtmh.2010.10-0116; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Briese T, 2007, ARCH VIROL, V152, P2237, DOI 10.1007/s00705-007-1069-z; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250; Chowdhary R, 2012, J GEN VIROL, V93, P1023, DOI 10.1099/vir.0.039479-0; Coupeau D, 2013, J GEN VIROL, V94, P1168, DOI 10.1099/vir.0.051821-0; Magalhaes CLD, 2011, ARCH VIROL, V156, P1173, DOI 10.1007/s00705-011-0976-1; DERODANICHE E, 1964, AM J TROP MED HYG, V13, P839, DOI 10.4269/ajtmh.1964.13.839; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eifan S, 2013, VIRUSES-BASEL, V5, P2447, DOI 10.3390/v5102447; Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Fischer M, 2013, J GEN VIROL, V94, P1161, DOI 10.1099/vir.0.049908-0; Forshey BM, 2014, J VIROL, V88, P3052, DOI 10.1128/JVI.03295-13; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Hang Jun, 2012, J Biomol Tech, V23, P4, DOI 10.7171/jbt.12-2301-001; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Lambert AJ, 2009, J CLIN MICROBIOL, V47, P2398, DOI 10.1128/JCM.00182-09; Lanciotti RS, 2013, VIROLOGY, V444, P55, DOI 10.1016/j.virol.2013.05.031; Magalhaes CLD, 2007, VIRUS GENES, V35, P681, DOI 10.1007/s11262-007-0138-4; Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08; Mores CN, 2009, VECTOR-BORNE ZOONOT, V9, P25, DOI 10.1089/vbz.2008.0030; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pinheiro F, 1994, HDB ZOONOSES F, P212; Plyusnin A, 2012, VIRUS TAXONOMY, P725; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283; SRIHONGS.S, 1966, AM J TROP MED HYG, V15, P379, DOI 10.4269/ajtmh.1966.15.379; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Yanase T, 2012, ARCH VIROL, V157, P1611, DOI 10.1007/s00705-012-1341-8	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92114	10.1371/journal.pone.0092114	http://dx.doi.org/10.1371/journal.pone.0092114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633174	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400143
J	Lago, BV; Mello, FC; Ribas, FS; Valente, F; Soares, CC; Niel, C; Gomes, SA				Lago, Barbara V.; Mello, Francisco C.; Ribas, Flavia S.; Valente, Fatima; Soares, Caroline C.; Niel, Christian; Gomes, Selma A.			Analysis of Complete Nucleotide Sequences of Angolan Hepatitis B Virus Isolates Reveals the Existence of a Separate Lineage within Genotype E	PLOS ONE			English	Article							ANTI-HBS ANTIBODIES; SURFACE-ANTIGEN; PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; BELGIAN PATIENTS; HIGH PREVALENCE; AFRICAN; EPIDEMIOLOGY; CARRIERS	Hepatitis B virus genotype E (HBV/E) is highly prevalent in Western Africa. In this work, 30 HBV/E isolates from HBsAg positive Angolans (staff and visitors of a private hospital in Luanda) were genetically characterized: 16 of them were completely sequenced and the pre-S/S sequences of the remaining 14 were determined. A high proportion (12/30, 40%) of subjects tested positive for both HBsAg and anti-HBs markers. Deduced amino acid sequences revealed the existence of specific substitutions and deletions in the B-and T-cell epitopes of the surface antigen (pre-S1- and pre-S2 regions) of the virus isolates derived from 8/12 individuals with concurrent HBsAg/anti-HBs. Phylogenetic analysis performed with 231 HBV/E full-length sequences, including 16 from this study, showed that all isolates from Angola, Namibia and the Democratic Republic of Congo (n = 28) clustered in a separate lineage, divergent from the HBV/E isolates from nine other African countries, namely Cameroon, Central African Republic, Cote d'Ivoire, Ghana, Guinea, Madagascar, Niger, Nigeria and Sudan, with a Bayesian posterior probability of 1. Five specific mutations, namely small S protein T57I, polymerase Q177H, G245W and M612L, and X protein V30L, were observed in 79-96% of the isolates of the separate lineage, compared to a frequency of 0-12% among the other HBV/E African isolates.	[Lago, Barbara V.; Mello, Francisco C.; Ribas, Flavia S.; Soares, Caroline C.; Niel, Christian; Gomes, Selma A.] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil; [Valente, Fatima] Minist Hlth, Eduardo dos Santos Fdn, Luanda, Angola	Fundacao Oswaldo Cruz	Gomes, SA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	Soares, Caroline Cordeiro/ABM-8961-2022; gomes, selma A/D-2762-2015; Niel, Christian/G-3712-2013	Gomes, Selma/0000-0003-0233-3370	Fiocruz; CNPq	Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sources of funding that have supported the work: Fiocruz, CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Bottecchia M, 2008, J GASTROEN HEPATOL, V23, P67, DOI 10.1111/j.1440-1746.2007.05238.x; Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupinay T, 2010, J MED VIROL, V82, P1515, DOI 10.1002/jmv.21865; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P6410, DOI 10.3748/wjg.v11.i41.6410; Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545; GUNTHER S, 1995, J VIROL, V69, P5437; HEIJTINK RA, 1982, J MED VIROL, V10, P83, DOI 10.1002/jmv.1890100202; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Jang JS, 2009, J MED VIROL, V81, P1531, DOI 10.1002/jmv.21577; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lee BS, 2013, J MED VIROL, V85, P1327, DOI 10.1002/jmv.23594; Margeridon S, 2005, J GEN VIROL, V86, P1687, DOI 10.1099/vir.0.80810-0; Martel N, 2013, J VIROL METHODS, V193, P653, DOI 10.1016/j.jviromet.2013.07.045; Mathet VL, 2006, J CLIN MICROBIOL, V44, P3435, DOI 10.1128/JCM.00866-06; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Odemuyiwa SO, 2001, J MED VIROL, V65, P463, DOI 10.1002/jmv.2058; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourkarim MR, 2011, J MED VIROL, V83, P1876, DOI 10.1002/jmv.22174; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Pourkarim MR, 2010, J MED VIROL, V82, P379, DOI 10.1002/jmv.21726; Rambaut A., 2009, FIGTREE V1 3 1 TREE; SHIELS MT, 1987, GASTROENTEROLOGY, V93, P675, DOI 10.1016/0016-5085(87)90427-6; Sitnik R, 2007, BRAZ J MED BIOL RES, V40, P1689, DOI 10.1590/S0100-879X2007001200013; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSANG TK, 1986, DIGEST DIS SCI, V31, P620, DOI 10.1007/BF01318693; Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004; Wang Y. M., 1996, Singapore Medical Journal, V37, P150; Wang YM, 1999, J GASTROENTEROL, V34, P600, DOI 10.1007/s005350050379; Zhang DK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-307	47	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92223	10.1371/journal.pone.0092223	http://dx.doi.org/10.1371/journal.pone.0092223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632784	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400152
J	Nataraj, R; Evans, PJ; Seitz, WH; Li, ZM				Nataraj, Raviraj; Evans, Peter J.; Seitz, William H., Jr.; Li, Zong-Ming			Effects of Carpal Tunnel Syndrome on Reach-to-Pinch Performance	PLOS ONE			English	Article							PROPRIOCEPTIVE FEEDBACK; PREHENSION MOVEMENTS; INDEX FINGER; HAND; COORDINATION; DIAGNOSIS; SYMPTOMS; POSITION; GRASP; THUMB	Background: Carpal tunnel syndrome (CTS) compromises fine sensorimotor function during activities of daily living. Reach-to-pinch for a small object requires not only dexterity of the grasping digits, but also coordinated transport of the hand to the target. This study examined the effects of CTS on the kinematic performance of reach-to-pinch maneuver. Methods: Eleven CTS subjects and 11 able-bodied (ABL) controls donned markers for motion capture of the hand, thumb and index finger during reach-to-pinch. Subjects were presented with a virtual target they could see without seeing their reaching upper-extremity. Subjects were instructed to reach to and grasp a virtual object as accurately and precisely as possible. Performance was assessed by variability of the movement trajectories of the digits and hand, the accuracy relative to the target, and precision of pinch contact over repetitive trials. Findings: The CTS group demonstrated significantly increased movement variability in inter-pad distance, joint angles, and transport of the hand compared to ABL controls (p<0.01). CTS subjects also exhibited reductions in accuracy (41%) and precision (33%) of their pinch contact location (p<0.05). Interpretation: CTS adversely affects the ability to execute the reach-to-pinch maneuver. Reduced performance was shown in terms of increased variability for both grasp and transport and the ability to locate the grasping digits relative to a target-object. These performance indices could be used for diagnostic and evaluative purposes of CTS.	[Nataraj, Raviraj; Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Evans, Peter J.; Seitz, William H., Jr.; Li, Zong-Ming] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	liz4@ccf.org	Nataraj, Raviraj/G-4535-2010	Nataraj, Raviraj/0000-0002-5261-3031	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR056964]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056964] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR056964. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castiello U, 1998, EXP BRAIN RES, V120, P31, DOI 10.1007/s002210050375; Connolly JD, 1999, EXP BRAIN RES, V125, P281, DOI 10.1007/s002210050684; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Domalain M, 2008, ERGONOMICS, V51, P1441, DOI 10.1080/00140130802130225; Dubrowski A, 2002, EXP BRAIN RES, V145, P365, DOI 10.1007/s00221-002-1120-y; Gay A, 2007, JOINT BONE SPINE, V74, P461, DOI 10.1016/j.jbspin.2006.10.010; Gehrmann S, 2008, J HAND SURG-AM, V33A, P1069, DOI 10.1016/j.jhsa.2008.02.030; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Hibbard PB, 2003, EXP BRAIN RES, V148, P196, DOI 10.1007/s00221-002-1295-2; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; JEANNEROD M, 1981, J PHYSIOLOGY PARIS, V77, pA54; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P397, DOI 10.5435/00124635-200906000-00008; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P389, DOI 10.5435/00124635-200906000-00007; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Napadow V, 2006, NEUROIMAGE, V31, P520, DOI 10.1016/j.neuroimage.2005.12.017; Nataraj R, 2013, COMPUTER METHODS BIO; Nataraj R, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024753; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PHALEN GS, 1966, J BONE JOINT SURG AM, VA 48, P211, DOI 10.2106/00004623-196648020-00001; Radwin RG, 2004, J BONE JOINT SURG AM, V86A, P2614, DOI 10.2106/00004623-200412000-00005; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Shen ZLL, 2012, GAIT POSTURE, V36, P643, DOI 10.1016/j.gaitpost.2012.04.012; SILVERSTEIN BA, 1987, AM J IND MED, V11, P343, DOI 10.1002/ajim.4700110310; Stevens JC, 1999, MUSCLE NERVE, V22, P1448, DOI 10.1002/(SICI)1097-4598(199910)22:10<1448::AID-MUS17>3.3.CO;2-P	24	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92063	10.1371/journal.pone.0092063	http://dx.doi.org/10.1371/journal.pone.0092063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632925	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400138
J	Ng, KP; Stringer, SJ; Jesky, MD; Yadav, P; Athwal, R; Dutton, M; Ferro, CJ; Cockwell, P				Ng, Khai P.; Stringer, Stephanie J.; Jesky, Mark D.; Yadav, Punit; Athwal, Rajbir; Dutton, Mary; Ferro, Charles J.; Cockwell, Paul			Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study	PLOS ONE			English	Article							SERUM URIC-ACID; GLYCATION END-PRODUCTS; VASCULAR OXIDATIVE STRESS; ALL-CAUSE MORTALITY; MIDDLE-AGED MEN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; OXIDANT STRESS	Background: Arterial stiffness is increased in patients with CKD and is a powerful predictor of cardiovascular morbidity and mortality. Use of the xanthine oxidase inhibitor allopurinol has been shown to improve endothelial function, reduce left ventricular hypertrophy and possibly improve cardiovascular outcome. We explored the relationship between use of allopurinol and arterial stiffness in patients with chronic kidney disease (CKD). Methods: Cross-sectional observational study of 422 patients with CKD with evidence of, or at high risk of, renal disease progression. Arterial stiffness was determined by carotid-femoral pulse wave velocity (PWV). Results: The mean age was 63 +/- 16 years, median estimated glomerular filtration rate was 25 (interquartile range: 19-31) ml/min/1.73 m(2) and mean PWV was 10.2 +/- 2.4 m/s. Seventy-seven patients (18%) were receiving regular allopurinol, 61% at a dose of 100 mg/day (range: 50-400 mg/day). Patients receiving allopurinol had significantly lower peripheral pulse pressure, central pulse pressure, central systolic blood pressure, serum uric acid level tissue advanced glycation end product levels but comparable high-sensitivity C-reactive protein levels. Use of allopurinol was associated with lower PWV. After adjusting for age, gender, ethnicity, tissue advanced glycation end product level, peripheral pulse pressure, smoking pack years, presence of diabetes mellitus and use of angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, the use of allopurinol remained a significant independent determinant of PWV (mean difference: -0.63 m/s; 95% CI, -0.09 to -1.17 m/s, p = 0.02). Conclusion: In patients with CKD, use of allopurinol is independently associated with lower arterial stiffness. This study provides further justification for a large definitive randomised controlled trial examining the therapeutic potential of allopurinol to reduce cardiovascular risk in people with CKD.	[Ng, Khai P.; Stringer, Stephanie J.; Jesky, Mark D.; Yadav, Punit; Athwal, Rajbir; Dutton, Mary; Ferro, Charles J.; Cockwell, Paul] Queen Elizabeth Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England; [Stringer, Stephanie J.; Jesky, Mark D.; Yadav, Punit; Ferro, Charles J.; Cockwell, Paul] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Cockwell, P (corresponding author), Queen Elizabeth Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England.	paul.cockwell@uhb.nhs.uk	Ferro, Charles J./O-8912-2016; Stefanadis, Christodoulos/ABH-2232-2020; ferro, charles/L-7250-2019	Ferro, Charles J./0000-0003-0577-7081; Stefanadis, Christodoulos/0000-0001-5974-6454; ferro, charles/0000-0003-0577-7081; Cockwell, Paul/0000-0003-1975-266X	JABBS foundation (Birmingham, United Kingdom); University Hospital Birmingham Charities; British Renal Society; National Institute for Health; National Institute for Health Research [PDF-2012-05-205] Funding Source: researchfish	JABBS foundation (Birmingham, United Kingdom); University Hospital Birmingham Charities; British Renal Society; National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	The study is supported by JABBS foundation (Birmingham, United Kingdom) (URL: http://opencharities.org/charities/1128402), University Hospital Birmingham Charities (URL: http://qehb.org/) and the British Renal Society (URL: http://www.britishrenal.org/). CJF is supported through a National Institute for Health Research Fellowship (URL: http://www.nihrtcc.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2012, J CLIN HYPERTENSION; Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Altman DG., 1999, PRACTICAL STAT MED R; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Edwards N Lawrence, 2008, Cleve Clin J Med, V75 Suppl 5, pS13; ERCAN ZS, 1992, GEN PHARMACOL-VASC S, V23, P1149, DOI 10.1016/0306-3623(92)90303-2; Erdogan D, 2005, INT J CLIN PRACT, V59, P1276, DOI 10.1111/j.1742-1241.2005.00621.x; Eskurza I, 2004, AM J PHYSIOL-HEART C, V286, pH1528, DOI 10.1152/ajpheart.00879.2003; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Galley HF, 1997, CLIN SCI, V92, P361, DOI 10.1042/cs0920361; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Jia N, 2012, CARDIOVASC THER, V30, P117, DOI 10.1111/j.1755-5922.2010.00243.x; Kals J, 2006, AM J HYPERTENS, V19, P902, DOI 10.1016/j.amjhyper.2006.02.003; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Kasal DAB, 2008, HISTOL HISTOPATHOL, V23, P1241, DOI 10.14670/HH-23.1241; Kostka-Jeziorny K, 2011, BLOOD PRESSURE, V20, P104, DOI 10.3109/08037051.2010.532323; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li Yu-lin, 2011, Zhonghua Nei Ke Za Zhi, V50, P555; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Miller E R 3rd, 1997, J Cardiovasc Risk, V4, P19; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Mottram P, 1999, ATHEROSCLEROSIS, V145, P399, DOI 10.1016/S0021-9150(99)00073-8; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Mulder DJ, 2011, ATHEROSCLEROSIS, V218, P102, DOI 10.1016/j.atherosclerosis.2011.05.011; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Pucci G, 2013, J HYPERTENS, V31, P77, DOI 10.1097/HJH.0b013e32835a8eb1; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Schutte AE, 2004, INT J VITAM NUTR RES, V74, P285, DOI 10.1024/0300-9831.74.4.285; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x; Wray DW, 2009, CLIN SCI, V116, P433, DOI 10.1042/CS20080337; Wright JM, 2001, BLOOD PRESS MONIT, V6, P161, DOI 10.1097/00126097-200106000-00008; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yelken B, 2012, CLIN NEPHROL, V77, P275, DOI 10.5414/CN107352; Zureik M, 2004, ARTERIOSCL THROM VAS, V24, P1485, DOI 10.1161/01.ATV.0000136648.62973.c8	60	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91961	10.1371/journal.pone.0091961	http://dx.doi.org/10.1371/journal.pone.0091961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632580	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400126
J	Sato, M; Hiraoka, M; Suzuki, H; Sakima, M; Al Mamun, A; Yamane, Y; Fujita, T; Yokoyama, U; Okumura, S; Ishikawa, Y				Sato, Motohiko; Hiraoka, Masahiro; Suzuki, Hiroko; Sakima, Miho; Al Mamun, Abdullah; Yamane, Yukiko; Fujita, Takayuki; Yokoyama, Utako; Okumura, Satoshi; Ishikawa, Yoshihiro			Protection of Cardiomyocytes from the Hypoxia-Mediated Injury by a Peptide Targeting the Activator of G-Protein Signaling 8	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; RECEPTOR-INDEPENDENT ACTIVATOR; REPERFUSION INJURY; COUPLED RECEPTORS; DRUG DISCOVERY; ISCHEMIC-HEART; RGS PROTEINS; ALPHA; REGULATORS; PHOSPHORYLATION	Signaling via heterotrimeric G-protein is involved in the development of human diseases including ischemia-reperfusion injury of the heart. We previously identified an ischemia-inducible G-protein activator, activator of G-protein signaling 8 (AGS8), which regulates G beta gamma signaling and plays a key role in the hypoxia-induced apoptosis of cardiomyocytes. Here, we attempted to intervene in the AGS8-G beta gamma signaling process and protect cardiomyocytes from hypoxia-induced apoptosis with a peptide that disrupted the AGS8-G beta gamma interaction. Synthesized AGS8-peptides, with amino acid sequences based on those of the G beta gamma-binding domain of AGS8, successfully inhibited the association of AGS8 with G beta gamma. The AGS8-peptide effectively blocked hypoxia-induced apoptosis of cardiomyocytes, as determined by DNA end-labeling and an increase in cleaved caspase-3. AGS8-peptide also inhibited the change in localization/permeability of channel protein connexin 43, which was mediated by AGS8-G beta gamma under hypoxia. Small compounds that inhibit a wide range of G beta gamma signals caused deleterious effects in cardiomyocytes. In contrast, AGS8-peptide did not cause cell damage under normoxia, suggesting an advantage inherent in targeted disruption of the AGS8-G beta gamma signaling pathway. These data indicate a pivotal role for the interaction of AGS8 with G beta gamma in hypoxia-induced apoptosis of cardiomyocytes, and suggest that targeted disruption of the AGS8-G beta gamma signal provides a novel approach for protecting the myocardium against ischemic injury.	[Sato, Motohiko; Suzuki, Hiroko; Sakima, Miho; Al Mamun, Abdullah] Aichi Med Univ, Dept Physiol, Nagakute, Aichi 48011, Japan; [Hiraoka, Masahiro; Yamane, Yukiko; Fujita, Takayuki; Yokoyama, Utako; Ishikawa, Yoshihiro] Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa, Japan; [Okumura, Satoshi] Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa, Japan	Aichi Medical University; Yokohama City University; Tsurumi University	Sato, M (corresponding author), Aichi Med Univ, Dept Physiol, Nagakute, Aichi 48011, Japan.	motosato@aichi-med-u.ac.jp	Yokoyama, Utako/AAD-1404-2022; Mamun, Abdullah/HHM-9898-2022	Yokoyama, Utako/0000-0003-1803-0155; Al Mamun, Md. Abdullah/0000-0003-3839-9603	Toyoaki Scholarship Foundation; Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1101027]; Grants-in-Aid for Scientific Research [25293236] Funding Source: KAKEN	Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grant-in-Aid for Scientific Research on Innovative Areas of Japan (MS), Grant-in-Aid for Scientific Research of Japan (MS), the Toyoaki Scholarship Foundation (MS), The Naito Foundation (MS) and Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2011-2015 (S1101027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Clemons TD, 2013, ACS NANO, V7, P2212, DOI 10.1021/nn305211f; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Flores-Munoz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045564; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Jneid Hani, 2012, Methodist Debakey Cardiovasc J, V8, P26; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McGrath MF, 2012, AM J PHYSIOL-HEART C, V302, pH1826, DOI 10.1152/ajpheart.01085.2011; New DC, 2007, FEBS J, V274, P6025, DOI 10.1111/j.1742-4658.2007.06116.x; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Roof RA, 2006, CHEM BIOL DRUG DES, V67, P266, DOI 10.1111/j.1747-0285.2006.00373.x; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; SATO M, 1995, AM J HYPERTENS, V8, P160, DOI 10.1016/0895-7061(94)00191-D; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sato M, 2013, CIRC J; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Sjogren B, 2011, ADV PHARMACOL, V62, P315, DOI 10.1016/B978-0-12-385952-5.00002-6; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Thuc LC, 2010, APOPTOSIS, V15, P669, DOI 10.1007/s10495-010-0473-0; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Windecker S, 2013, LANCET, V382, P644, DOI 10.1016/S0140-6736(13)61452-X; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zhang P, 2011, CIRC RES, V109, P320, DOI 10.1161/CIRCRESAHA.110.231423; Zhang SS, 2013, BBA-MOL CELL RES, V1833, P876, DOI 10.1016/j.bbamcr.2012.10.020	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91980	10.1371/journal.pone.0091980	http://dx.doi.org/10.1371/journal.pone.0091980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632710	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400129
J	Shi, YW; Zhang, L; Yang, T				Shi, Yawei; Zhang, Lei; Yang, Ting			Nuclear Export of L-Periaxin, Mediated by Its Nuclear Export Signal in the PDZ Domain	PLOS ONE			English	Article							MYELINATING SCHWANN-CELLS; MARIE-TOOTH-DISEASE; HUMAN CYCLIN-A; LIM-KINASE 1; CYTOPLASMIC LOCALIZATION; PROTEIN; NEUROPATHY; RETENTION; SEQUENCE; MUTATION	Myelinating Schwann cells specifically express L-periaxin (L-PRX) in the mammalian peripheral nervous system. Several loss-of-function mutations in periaxin have been described and linked to autosomal recessive Dejerine Sottas neuropathy and to demyelinating Charcot-Marie-Tooth disease. The localization of L-periaxin is developmentally regulated in the nucleus and the plasma membrane of Schwann cells. In this study, L-periaxin, which contains a PDZ domain, a nuclear localization signal (NLS) domain, a repeat domain, and an acidic domain, was localized in the cytoplasm of RSC96 cells. By contrast, a mutant L-periaxin with a deleted PDZ domain was localized mainly in the nucleus of RSC96 cells. After a nuclear cyclin A1, which is localized exclusively in the nucleus, was fused with the PDZ domain, cyclinA1 was found in the cytoplasm of RSC96 cells. Treatment with leptomycin B (LMB), a specific inhibitor of nuclear export mediated by leucine-rich nuclear export signal (NES), also causes nuclear accumulation of wild-type L-periaxin. Double leucine mutation (L83, 85Q) in the putative NES in the PDZ domain prevented L-periaxin nuclear export and induced nuclear accumulation. These results suggested that the localization of L-periaxin in the cytoplasm is supported by NES in the PDZ domain.	[Shi, Yawei; Zhang, Lei; Yang, Ting] Shanxi Univ, Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Shanxi, Peoples R China; [Zhang, Lei] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan, Hubei, Peoples R China; [Zhang, Lei] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China	Shanxi University; Hubei University of Medicine; Hubei University of Medicine	Shi, YW (corresponding author), Shanxi Univ, Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Shanxi, Peoples R China.	yaweishi@sxu.edu.cn	石, 亚伟/AAQ-4263-2020	石, 亚伟/0000-0001-5887-4366	National Sciences Foundation of China [31170748]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported National Sciences Foundation of China (Grant No. 31170748). http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Gonzalez-Mariscal L, 2006, EXP CELL RES, V312, P3323, DOI 10.1016/j.yexcr.2006.07.006; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Kijima K, 2004, J HUM GENET, V49, P376, DOI 10.1007/s10038-004-0162-3; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Masaki T, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740403; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sherman DL, 2012, J NEUROSCI, V32, P9419, DOI 10.1523/JNEUROSCI.1220-12.2012; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tovar C, 2011, VET PATHOL, V48, P1195, DOI 10.1177/0300985811400447; Wu LMN, 2012, CURR BIOL, V22, P1957, DOI 10.1016/j.cub.2012.08.025; Yang N, 1999, BIOCHEM J, V338, P793, DOI 10.1042/0264-6021:3380793; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053	31	10	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91953	10.1371/journal.pone.0091953	http://dx.doi.org/10.1371/journal.pone.0091953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633211	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400125
J	Shimizu, Y; Boehm, H; Yamaguchi, K; Spatz, JP; Nakanishi, J				Shimizu, Yoshihisa; Boehm, Heike; Yamaguchi, Kazuo; Spatz, Joachim P.; Nakanishi, Jun			A Photoactivatable Nanopatterned Substrate for Analyzing Collective Cell Migration with Precisely Tuned Cell-Extracellular Matrix Ligand Interactions	PLOS ONE			English	Article							E-CADHERIN; SPATIOTEMPORAL CONTROL; N-CADHERIN; ADHESION; PROTEIN; MONOLAYER; FORCES; ROLES; BETA; FAK	Collective cell migration is involved in many biological and pathological processes. Various factors have been shown to regulate the decision to migrate collectively or individually, but the impact of cell-extracellular matrix (ECM) interactions is still debated. Here, we developed a method for analyzing collective cell migration by precisely tuning the interactions between cells and ECM ligands. Gold nanoparticles are arrayed on a glass substrate with a defined nanometer spacing by block copolymer micellar nanolithography (BCML), and photocleavable poly(ethylene glycol) (Mw = 12 kDa, PEG12K) and a cyclic RGD peptide, as an ECM ligand, are immobilized on this substrate. The remaining glass regions are passivated with PEG2K-silane to make cells interact with the surface via the nanoperiodically presented cyclic RGD ligands upon the photocleavage of PEG12K. On this nanostructured substrate, HeLa cells are first patterned in photo-illuminated regions, and cell migration is induced by a second photocleavage of the surrounding PEG12K. The HeLa cells gradually lose their cell-cell contacts and become disconnected on the nanopatterned substrate with 10-nm particles and 57-nm spacing, in contrast to their behavior on the homogenous substrate. Interestingly, the relationship between the observed migration collectivity and the cell-ECM ligand interactions is the opposite of that expected based on conventional soft matter models. It is likely that the reduced phosphorylation at tyrosine-861 of focal adhesion kinase (FAK) on the nanopatterned surface is responsible for this unique migration behavior. These results demonstrate the usefulness of the presented method in understanding the process of determining collective and non-collective migration features in defined micro-and nano-environments and resolving the crosstalk between cell-cell and cell-ECM adhesions.	[Shimizu, Yoshihisa; Nakanishi, Jun] Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki, Japan; [Boehm, Heike; Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Boehm, Heike] Max Planck Inst Intelligent Syst, CSF Biomat & Cellular Biophys, Stuttgart, Germany; [Yamaguchi, Kazuo] Kanagawa Univ, Fac Sci, Res Inst Photofunctionalized Mat, Dept Chem, Hiratsuka, Kanagawa, Japan; [Boehm, Heike; Spatz, Joachim P.] Heidelberg Univ, Inst Phys Chem, Dept Biophys Chem, Heidelberg, Germany	National Institute for Materials Science; Max Planck Society; Max Planck Society; Kanagawa University; Ruprecht Karls University Heidelberg	Nakanishi, J (corresponding author), Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki, Japan.	NAKANISHI.Jun@nims.go.jp	Boehm, Heike/I-8473-2016; Spatz, Joachim P/A-1107-2017; NAKANISHI, Jun/H-2616-2011	Boehm, Heike/0000-0002-7124-4913; Spatz, Joachim P/0000-0003-3419-9807; NAKANISHI, Jun/0000-0003-4457-6581	World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics; Max Planck Society	World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck Society)	This work was supported in part by the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics. The financial support of the Max Planck Society is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Bai CY, 2007, J CELL SCI, V120, P2828, DOI 10.1242/jcs.03477; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Doran MR, 2009, LAB CHIP, V9, P2364, DOI 10.1039/b900791a; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839; Luo W, 2011, J AM CHEM SOC, V133, P10780, DOI 10.1021/ja204893w; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Nakanishi J, 2004, J AM CHEM SOC, V126, P16314, DOI 10.1021/ja044684c; Nakanishi J, 2007, J AM CHEM SOC, V129, P6694, DOI 10.1021/ja070294p; Nakanishi J, 2006, ANAL CHIM ACTA, V578, P100, DOI 10.1016/j.aca.2006.04.059; Nakanishi J, 2014, CHEM-ASIAN J, V9, P406, DOI 10.1002/asia.201301325; Nakanishi J, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/044608; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Raghavan S, 2010, LANGMUIR, V26, P17733, DOI 10.1021/la102955m; Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550; Rolli CG, 2012, BIOMATERIALS, V33, P2409, DOI 10.1016/j.biomaterials.2011.12.012; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schaller MD, 2004, J CELL BIOL, V166, P157, DOI 10.1083/jcb.200406151; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shih WT, 2012, CELL ADHES MIGR, V6, P513, DOI 10.4161/cam.21766; Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyoshima M, 2007, CANCER RES, V67, P5162, DOI 10.1158/0008-5472.CAN-06-2756; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zheng YH, 2009, CELL CYCLE, V8, P3474, DOI 10.4161/cc.8.21.9846	39	30	30	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91875	10.1371/journal.pone.0091875	http://dx.doi.org/10.1371/journal.pone.0091875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632806	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400113
J	Gao, ZB; Wang, W; Wang, ZF; Zhao, XL; Shang, YC; Guo, Y; Gong, M; Yang, LJ; Shi, XB; Xu, X; An, NY; Wu, WP				Gao, Zhongbao; Wang, Wei; Wang, Zhenfu; Zhao, Xingli; Shang, Yanchang; Guo, Yaner; Gong, Mei; Yang, Lijuan; Shi, Xiaobing; Xu, Xian; An, Ningyu; Wu, Weiping			Cerebral Microbleeds Are Associated with Deep White Matter Hyperintensities, but Only in Hypertensive Patients	PLOS ONE			English	Article							RISK-FACTORS; ISCHEMIC-STROKE; ARTERIAL STIFFNESS; HEALTHY-SUBJECTS; ROTTERDAM SCAN; PREVALENCE; LESIONS; LEUKOARAIOSIS; BRAIN; AGE	Cerebral microbleeds (CMBs) and white matter hyperintensities (WMH) are the most common manifestations of small vessel disease, and often co-occur in patients with cerebral vascular disease. Hypertension is widely accepted as a risk factor for both CMBs and WMH. However, the effect of hypertension on the association between CMBs and WMH remains unclear. We hypothesized that the relationship between CMBs and WMH is determined by hypertension. One hundred forty-eight patients with acute cerebrovascular disease who were admitted to PLA general hospital in Beijing, China from February 2010 to May 2011 were recruited in this study. CMBs on T2*-weighted angiography (SWAN) were assessed using the Brain Observer Microbleed Rating Scale criteria. The severity of the WMH was separately assessed as either peri-ventricular hyperintensities (PVH) or deep white matter hyperintensities (DWMH). The association among CMBs and the severity of WMH, and hypertension were determined. CMBs were found in 65 (43.9%) patients. The frequency of CMBs was related to the severity of DWMH and PVH. CMBs were more frequently observed in patients with hypertension compared to patients without hypertension (51.3% vs. 20.0%, p = 0.001). Hypertension was an independent risk factor for CMBs (odds ratio 5.239, p = 0.001) and DWMH (odds ratio 2.373, p = 0.040). Furthermore, the relationship between the presence of CMBs and the severity of DWMH was only found in patients with hypertension (r = 0.298, p<0.01). However, CMBs were associated with PVH independently of hypertension. This study demonstrated that hypertension determined the association between CMBs and DWMH.	[Gao, Zhongbao; Wang, Wei; Wang, Zhenfu; Zhao, Xingli; Shang, Yanchang; Guo, Yaner; Gong, Mei; Yang, Lijuan; Shi, Xiaobing; Wu, Weiping] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Neurol, Beijing, Peoples R China; [Xu, Xian; An, Ningyu] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Wang, ZF (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Neurol, Beijing, Peoples R China.	zhenfuw@sina.com; wuwp@vip.sina.com		Gao, Zhongbao/0000-0001-6376-9659	Chinese Central Healthcare Committee Foundation [B2009B104]; PLA general hospital [2013FC-TSYS-2008]	Chinese Central Healthcare Committee Foundation; PLA general hospital	This work was supported by Chinese Central Healthcare Committee Foundation (#B2009B104) and supportive grant for clinical research of PLA general hospital (#2013FC-TSYS-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Boeckh-Behrens T, 2012, EUR J RADIOL, V81, P1238, DOI 10.1016/j.ejrad.2011.02.057; Chowdhury MH, 2011, J STROKE CEREBROVASC, V20, P302, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.010; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Fan YH, 2004, J NEUROL, V251, P537, DOI 10.1007/s00415-004-0359-6; Fazekas F, 1998, DEMENT GERIATR COGN, V9, P2, DOI 10.1159/000051182; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gao TL, 2008, NEUROL RES, V30, P272, DOI 10.1179/016164107X251556; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Hatanaka R, 2011, CEREBROVASC DIS, V31, P329, DOI 10.1159/000322599; Igase M, 2009, CIRC J, V73, P530, DOI 10.1253/circj.CJ-08-0764; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Lee HK, 2013, INT J GERIATR PSYCHI; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Liu PF, 2010, CHINESE MED J-PEKING, V123, P286, DOI 10.3760/cma.j.issn.0366-6999.2010.03.006; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Naganuma T, 2011, CLIN NEPHROL, V75, P346, DOI 10.5414/CNP75346; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Seo WK, 2008, CEREBROVASC DIS, V26, P618, DOI 10.1159/000166837; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; van Es ACGM, 2008, CEREBROVASC DIS, V26, P397, DOI 10.1159/000151680; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Vernooij MW, 2008, RADIOLOGY, V248, P272, DOI 10.1148/radiol.2481071158; Wardlaw JM, 2006, STROKE, V37, P2633, DOI 10.1161/01.STR.0000240513.00579.bf; Werring DJ, 2005, NEUROLOGY, V65, P1914, DOI 10.1212/01.wnl.0000188874.48592.f7; Yamada S, 2012, EUR J NEUROL, V19, P98, DOI 10.1111/j.1468-1331.2011.03451.x	31	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91637	10.1371/journal.pone.0091637	http://dx.doi.org/10.1371/journal.pone.0091637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626222	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300110
J	Koslicki, D; Foucart, S; Rosen, G				Koslicki, David; Foucart, Simon; Rosen, Gail			WGSQuikr: Fast Whole-Genome Shotgun Metagenomic Classification	PLOS ONE			English	Article							IDENTIFICATION	With the decrease in cost and increase in output of whole-genome shotgun technologies, many metagenomic studies are utilizing this approach in lieu of the more traditional 16S rRNA amplicon technique. Due to the large number of relatively short reads output from whole-genome shotgun technologies, there is a need for fast and accurate short-read OTU classifiers. While there are relatively fast and accurate algorithms available, such as MetaPhlAn, MetaPhyler, PhyloPythiaS, and PhymmBL, these algorithms still classify samples in a read-by-read fashion and so execution times can range from hours to days on large datasets. We introduce WGSQuikr, a reconstruction method which can compute a vector of taxonomic assignments and their proportions in the sample with remarkable speed and accuracy. We demonstrate on simulated data that WGSQuikr is typically more accurate and up to an order of magnitude faster than the aforementioned classification algorithms. We also verify the utility of WGSQuikr on real biological data in the form of a mock community. WGSQuikr is a Whole-Genome Shotgun QUadratic, Iterative, K-mer based Reconstruction method which extends the previously introduced 16S rRNA-based algorithm Quikr. A MATLAB implementation of WGSQuikr is available at: http://sourceforge.net/projects/wgsquikr.	[Koslicki, David] Oregon State Univ, Dept Math, Corvallis, OR 97331 USA; [Foucart, Simon] Univ Georgia, Dept Math, Athens, GA 30602 USA; [Rosen, Gail] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA	Oregon State University; University System of Georgia; University of Georgia; Drexel University	Koslicki, D (corresponding author), Oregon State Univ, Dept Math, Corvallis, OR 97331 USA.	david.koslicki@math.oregonstate.edu		Rosen, Gail/0000-0003-1763-5750	NSF [DMS-1120622]	NSF(National Science Foundation (NSF))	Funding was provided by NSF grant DMS-1120622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly F. E., 2012, NUCLEIC ACIDS RES, V40, P1; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Carlos N, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.41; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Davenport CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041224; Foucart S, 2013, IEEE SIGNAL IN PRESS; Jumpstart Consortium HMP Data Generation Working Group, 2012, PLOS ONE, V7; Koslicki D, 2013, BIOINFORMATICS, V29, P2096, DOI 10.1093/bioinformatics/btt336; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; MacDonald NJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks335; MATLAB, 2012, MATLAB; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Srinivasan SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	19	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91784	10.1371/journal.pone.0091784	http://dx.doi.org/10.1371/journal.pone.0091784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626336	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300136
J	Varela, S; Gonzalez-Hernandez, J; Casabella, E; Barrientos, R				Varela, Sara; Gonzalez-Hernandez, Javier; Casabella, Eduardo; Barrientos, Rafael			rAvis: An R-Package for Downloading Information Stored in Proyecto AVIS, a Citizen Science Bird Project	PLOS ONE			English	Article							SUBURBAN NEW-YORK	Citizen science projects store an enormous amount of information about species distribution, diversity and characteristics. Researchers are now beginning to make use of this rich collection of data. However, access to these databases is not always straightforward. Apart from the largest and international projects, citizen science repositories often lack specific Application Programming Interfaces (APIs) to connect them to the scientific environments. Thus, it is necessary to develop simple routines to allow researchers to take advantage of the information collected by smaller citizen science projects, for instance, programming specific packages to connect them to popular scientific environments (like R). Here, we present rAvis, an R-package to connect R-users with Proyecto AVIS (http://proyectoavis.com), a Spanish citizen science project with more than 82,000 bird observation records. We develop several functions to explore the database, to plot the geographic distribution of the species occurrences, and to generate personal queries to the database about species occurrences (number of individuals, distribution, etc.) and birdwatcher observations (number of species recorded by each collaborator, UTMs visited, etc.). This new R-package will allow scientists to access this database and to exploit the information generated by Spanish birdwatchers over the last 40 years.	[Varela, Sara] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Varela, Sara] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Casabella, Eduardo] Actividades Consultoria & Telecomunicac, ACCONTE Grp, Tres Cantos, Spain; [Barrientos, Rafael] Univ Castilla La Mancha, Fac Medio Ambiente, Dept Ciencias Ambientales, Toledo, Spain	Charles University Prague; Universidade Federal de Goias; Universidad de Castilla-La Mancha	Varela, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	svarela@paleobiogeography.org	Barrientos, Rafael/I-2102-2015; Varela, Sara/J-7725-2016	Barrientos, Rafael/0000-0002-1677-3214; Varela, Sara/0000-0002-5756-5737	European Science Foundation and Czech Republic; Education for Competitiveness Operational Programme (ECOP) project "Support of establishment, development and mobility of quality research teams at the Charles University'' [CZ.1.07/2.3.00/30.0022]; Juan de la Cierva program from the Spanish Ministry of Competitiveness	European Science Foundation and Czech Republic; Education for Competitiveness Operational Programme (ECOP) project "Support of establishment, development and mobility of quality research teams at the Charles University''; Juan de la Cierva program from the Spanish Ministry of Competitiveness	Sara Varela and Rafael Barrientos have postdoctoral grants. SV is funded by the European Science Foundation and Czech Republic, from the Education for Competitiveness Operational Programme (ECOP) project "Support of establishment, development and mobility of quality research teams at the Charles University'' (CZ.1.07/2.3.00/30.0022)(http://www.cuni.cz/UKEN-88.html). RB received financial assistance from Juan de la Cierva program from the Spanish Ministry of Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid=fdf669dad3f88310VgnVCM1000001d04140aRCRD). Javier Gonzalez-Hernandez and Eduardo Casabella-Cabana are freelance web-developers that worked on the project during their free time. They were involved in the design, programming and optimization of the R-package ravis and on the web interface of Proyectoavis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton RM, 2010, SCRAPER TOOLS SCRAPI; [Anonymous], 2013, MAPTOOLS TOOLS READI; Bivand R, 2013, RGDAL BINDINGS GEOSP; Boettiger C, 2013, RFISHBASE R INTERFAC; Chamberlain S., 2012, RVERTNET SEARCH VERT; Chamberlain S, 2013, RGBIF INTERFACE GLOB; Chambers JM, 2008, STAT COMPUT SER, P1; Cooper CB, 2012, ENVIRON MANAGE, V50, P11, DOI 10.1007/s00267-012-9866-x; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Duck G, 2013, BMC BIOINFORMATICS, V14; Fellows I, 2013, OPENSTREETMAP ACCESS; Gutierrez R., 2012, LISTA AVES ESPANA ED; Herrando S., 2012, SEO BIRDLIFE ATLAS A; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Joppa LN, 2013, SCIENCE, V340, P814, DOI 10.1126/science.1231535; Lang D. T., 2013, XML TOOLS PARSING GE; Lang DT, 2013, RCURL GEN NETWORK HT; Lepczyk CA, 2005, J APPL ECOL, V42, P672, DOI 10.1111/j.1365-2664.2005.01059.x; Maia R, 2012, REBIRD INTERFACE EBI; Moral JCd, 2002, ATLAS AVES REPROD ES; Moyer-Horner L, 2012, J WILDLIFE MANAGE, V76, P1472, DOI 10.1002/jwmg.373; Mulder RA, 2010, WILDLIFE RES, V37, P440, DOI 10.1071/WR10007; Nagy C, 2012, NORTHEAST NAT, V19, P143, DOI 10.1656/045.019.s611; Oberhauser K, 2012, FRONT ECOL ENVIRON, V10, P318, DOI 10.1890/110274; R Core Team, 2021, R LANG ENV STAT COMP; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sizling AL, 2011, AM NAT, V178, P602, DOI 10.1086/662176; Tjorve E, 2008, J ECOL, V96, P1141, DOI 10.1111/j.1365-2745.2008.01433.x; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Voulgaropoulou S, 2012, IEEE ANNU SOFTW ENG, P1, DOI 10.1109/SEW.2012.7; Warnes G., 2013, GDATA VARIOUS R PROG; Weckel ME, 2010, J WILDLIFE MANAGE, V74, P1163, DOI 10.2193/2008-512; White EP, 2013, IDEAS ECOL EVOL, V6, P1, DOI 10.4033/iee.2013.6b.6.f; Wickham H., 2012, STRINGR MAKE IT EASI; Wickham H., 2012, SCALES SCALE FUNCTIO; Wiersma YF, 2010, AVIAN CONSERV ECOL, V5; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x	38	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91650	10.1371/journal.pone.0091650	http://dx.doi.org/10.1371/journal.pone.0091650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626233	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300113
J	You, JC; Li, Y; Fang, NZ; Liu, B; Zu, LL; Chang, R; Li, XB; Zhou, QH				You, Jiacong; Li, Yang; Fang, Nianzhen; Liu, Bin; Zu, Lingling; Chang, Rui; Li, Xuebing; Zhou, Qinghua			MiR-132 Suppresses the Migration and Invasion of Lung Cancer Cells via Targeting the EMT Regulator ZEB2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; DOWN-REGULATION; BREAST-CANCER; EXPRESSION; METHYLATION; METASTASIS; BIOGENESIS; ZEB1/ZEB2; MICRORNAS	MicroRNAs (miRNAs) are small, non-coding RNAs which can function as oncogenes or tumor suppressor genes in human cancers. Emerging evidence reveals that deregulation of miRNAs contributes to the human non-small cell lung cancer (NSCLC). In the present study, we demonstrated that the expression levels of miR-132 were dramatically decreased in examined NSCLC cell lines and clinical NSCLC tissue samples. Then, we found that introduction of miR-132 significantly suppressed the migration and invasion of lung cancer cells in vitro, suggesting that miR-132 may be a novel tumor suppressor. Further studies indicated that the EMT-related transcription factor ZEB2 was one direct target genes of miR-132, evidenced by the direct binding of miR-132 with the 3' untranslated region (3' UTR) of ZEB2. Further, miR-132 could decrease the expression of ZEB2 at the levels of mRNA and protein. Notably, the EMT marker E-cadherin or vimentin, a downstream of ZEB2, was also down-regulated or up-regulated upon miR-132 treatment. Additionally, over-expressing or silencing ZEB2 was able to elevate or inhibit the migration and invasion of lung cancer cells, parallel to the effect of miR-132 on the lung cancer cells. Meanwhile, knockdown of ZEB2 reversed the enhanced migration and invasion mediated by anti-miR-132. These results indicate that miR-132 suppresses the migration and invasion of NSCLC cells through targeting ZEB2 involving the EMT process. Thus, our finding provides new insight into the mechanism of NSCLC progression. Therapeutically, miR-132 may serve as a potential target in the treatment of human lung cancer.	[You, Jiacong; Li, Yang; Fang, Nianzhen; Liu, Bin; Zu, Lingling; Chang, Rui; Li, Xuebing; Zhou, Qinghua] Tianjin Med Univ, Tianjin Lung Canc Inst, Gen Hosp, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China	Tianjin Medical University	You, JC (corresponding author), Tianjin Med Univ, Tianjin Lung Canc Inst, Gen Hosp, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	yyjjcc_nk@163.com; zhouqh1016@yahoo.com.cn	Zhou, Qinghua/A-4184-2008		Key Project from National Natural Science Foundation of China [81000950]; National 863 Program [2012AA02A201, 2012AA02A502]; National 973 Program [2010CB529405]; Tianjin Scientific Innovation System Program [07SYSYSF05000, 07SYSYJC27900]; China-Sweden Cooperative Foundation [09ZCZDSF04100]; Major Project of Tianjin Sci-Tech Support Program [06YFSZSF05300]	Key Project from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); National 973 Program(National Basic Research Program of China); Tianjin Scientific Innovation System Program; China-Sweden Cooperative Foundation; Major Project of Tianjin Sci-Tech Support Program	This study was partly supported by the grants from the Key Project from National Natural Science Foundation of China (No. 81000950), National 863 Program (No. 2012AA02A201, No. 2012AA02A502), National 973 Program (No. 2010CB529405), Tianjin Scientific Innovation System Program (No. 07SYSYSF05000, No. 07SYSYJC27900), China-Sweden Cooperative Foundation (No. 09ZCZDSF04100), and Major Project of Tianjin Sci-Tech Support Program (No. 06YFSZSF05300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Cai Mu-Yan, 2012, PLoS One, V7, pe32838, DOI 10.1371/journal.pone.0032838; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chu PY, 2013, ORAL ONCOL, V49, P34, DOI 10.1016/j.oraloncology.2012.07.012; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cong NN, 2013, ONCOL REP, V29, P1579, DOI 10.3892/or.2013.2267; Dai YH, 2012, DIGEST DIS SCI, V57, P1253, DOI 10.1007/s10620-012-2042-6; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Henrion M, 2013, HUM MOL GENET, V22, P825, DOI 10.1093/hmg/dds489; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053663; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koopmansch B, 2013, BIOCHEM BIOPH RES CO, V431, P652, DOI 10.1016/j.bbrc.2013.01.070; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Lee JY, 2013, ONCOGENE IN PRESS; Li CY, 2004, ACTA BIOCH BIOPH SIN, V36, P405, DOI 10.1093/abbs/36.6.405; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034832; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miao LJ, 2013, FEBS LETT, V587, P1359, DOI 10.1016/j.febslet.2013.03.006; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Suzuki H, 2008, PHARMACOGENOMICS, V9, P1917, DOI 10.2217/14622416.9.12.1917; Usova E V, 2013, Dokl Biol Sci, V448, P61, DOI 10.1134/S001249661301016X; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Wang Qiu-Yu, 2012, Shengli Xuebao, V64, P403; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wu QH, 2011, GYNECOL ONCOL, V122, P149, DOI 10.1016/j.ygyno.2011.03.026; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhou Qinghua, 2003, Zhongguo Fei Ai Za Zhi, V6, P464, DOI 10.3779/j.issn.1009-3419.2003.06.13	43	95	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91827	10.1371/journal.pone.0091827	http://dx.doi.org/10.1371/journal.pone.0091827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626466	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300140
J	Halley, YA; Dowd, SE; Decker, JE; Seabury, PM; Bhattarai, E; Johnson, CD; Rollins, D; Tizard, IR; Brightsmith, DJ; Peterson, MJ; Taylor, JF; Seabury, CM				Halley, Yvette A.; Dowd, Scot E.; Decker, Jared E.; Seabury, Paul M.; Bhattarai, Eric; Johnson, Charles D.; Rollins, Dale; Tizard, Ian R.; Brightsmith, Donald J.; Peterson, Markus J.; Taylor, Jeremy F.; Seabury, Christopher M.			A Draft De Novo Genome Assembly for the Northern Bobwhite (Colinus virginianus) Reveals Evidence for a Rapid Decline in Effective Population Size Beginning in the Late Pleistocene	PLOS ONE			English	Article							QT INTERVAL DURATION; ZEBRA FINCH; WIDE ASSOCIATION; QUAIL ABUNDANCE; COMMON VARIANTS; ARA-MACAO; MICROSATELLITE LOCI; SPECIES DIVERGENCE; GENETIC-VARIATION; BLOOD-PRESSURE	Wild populations of northern bobwhites (Colinus virginianus; hereafter bobwhite) have declined across nearly all of their U. S. range, and despite their importance as an experimental wildlife model for ecotoxicology studies, no bobwhite draft genome assembly currently exists. Herein, we present a bobwhite draft de novo genome assembly with annotation, comparative analyses including genome-wide analyses of divergence with the chicken (Gallus gallus) and zebra finch (Taeniopygia guttata) genomes, and coalescent modeling to reconstruct the demographic history of the bobwhite for comparison to other birds currently in decline (i.e., scarlet macaw; Ara macao). More than 90% of the assembled bobwhite genome was captured within <40,000 final scaffolds (N50 = 45.4 Kb) despite evidence for approximately 3.22 heterozygous polymorphisms per Kb, and three annotation analyses produced evidence for >14,000 unique genes and proteins. Bobwhite analyses of divergence with the chicken and zebra finch genomes revealed many extremely conserved gene sequences, and evidence for lineage-specific divergence of noncoding regions. Coalescent models for reconstructing the demographic history of the bobwhite and the scarlet macaw provided evidence for population bottlenecks which were temporally coincident with human colonization of the New World, the late Pleistocene collapse of the megafauna, and the last glacial maximum. Demographic trends predicted for the bobwhite and the scarlet macaw also were concordant with how opposing natural selection strategies (i.e., skewness in the r-/K-selection continuum) would be expected to shape genome diversity and the effective population sizes in these species, which is directly relevant to future conservation efforts.	[Halley, Yvette A.; Bhattarai, Eric; Tizard, Ian R.; Brightsmith, Donald J.; Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Decker, Jared E.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Seabury, Paul M.] ElanTech Inc, Greenbelt, MD USA; [Johnson, Charles D.] Texas A&M AgriLife Res, Genom & Bioinformat Core, College Stn, TX USA; [Rollins, Dale] Rolling Plains Quail Res Ranch, Rotan, TX USA; [Peterson, Markus J.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station	Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Dowd, Scot E/M-5386-2017; Decker, Jared E./H-2730-2019; Peterson, Markus J/C-3303-2008	Dowd, Scot E/0000-0002-6296-1427; Decker, Jared E./0000-0001-5685-7343; Peterson, Markus J/0000-0001-6145-0134; Halley-Schultz, Yvette/0000-0002-5159-6137; Johnson, Charles/0000-0003-3892-7082; Brightsmith, Donald/0000-0002-3306-6490	Park Cities Quail; Rolling Plains Quail Research Ranch	Park Cities Quail; Rolling Plains Quail Research Ranch	The funders had no role in study design, data collection, data analysis, interpretation of the data or analyses, decision to publish, or drafting of the manuscript. This study was funded by private donations to CMS from Mr. Joe Crafton, members of Park Cities Quail, and the Rolling Plains Quail Research Ranch. DR directs the Rolling Plains Quail Research Ranch, which funded this study in part, but DR had no role in the primary analysis or interpretation of the data or analyses. DR provided reagents/materials/analysis tools and did make editorial comments and suggestions related to the final manuscript.	Allen CR, 2000, J AGR URBAN ENTOMOL, V17, P43; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; [Anonymous], 1995, SE ARCHAEOLOGY; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Baumgartner F. M., 1944, JOUR WILDLIFE MANAGEMENT, V8, P112, DOI 10.2307/3796443; BECAK ML, 1971, CHROMOSOME ATLAS FIS, V1; Blom J, 2005, ZOOLOGY, V108, P81, DOI 10.1016/j.zool.2005.02.001; Brady S.J., 1998, Gibier Faune Sauvage, V15, P413; Brausch JM, 2010, J TOXICOL ENV HEAL A, V73, P540, DOI 10.1080/15287390903566559; BRENNAN L. A., 2007, TEXAS QUAILS ECOLOGY; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; Brightsmith D, 2005, BIOL CONSERV, V121, P465, DOI 10.1016/j.biocon.2004.05.016; BUECHNER HK, 1950, J WILDLIFE MANAGE, V14, P363, DOI 10.2307/3797265; Caparroz R, 2001, BIOL CONSERV, V99, P307, DOI 10.1016/S0006-3207(00)00196-8; Casinos A, 2001, COMP BIOCHEM PHYS A, V131, P159, DOI 10.1016/S1095-6433(01)00463-9; Church K. E., 1993, P NATL QUAIL S, V3, P44; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Companioni O, 2011, REV ESP CARDIOL, V64, P509, DOI [10.1016/j.recesp.2011.01.010, 10.1016/j.rec.2011.01.011]; DACKE CG, 1993, J EXP BIOL, V184, P63; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; del Hoyo J., 2010, HDB BIRDS WORLD, V15; Del Hoyo J., 1997, HDB BIRDS WORLD, Vthe World, Vol. 2; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deng FY, 2010, OSTEOPOROSIS INT, V21, P579, DOI 10.1007/s00198-009-0998-7; DEVOS T, 1995, WILDLIFE SOC B, V23, P267; Dobzhansky T., 1950, American Scientist, V38, P209; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Droege S, 1990, PERDIX, P2; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Ekblom R, 2011, IMMUNOGENETICS, V63, P523, DOI [10.1007/s00251-011-0525-9, 10.1007/s00251-011-0528-6]; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Errington PL, 1936, IOWA STATE COLL AGR, V201, P305; Ersland KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031687; Eshleman JA, 2003, EVOL ANTHROPOL, V12, P7, DOI 10.1002/evan.10048; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans KO, 2006, GAMEBIRD, P121; Faircloth BC, 2009, CONSERV GENET, V10, P535, DOI 10.1007/s10592-008-9559-4; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Folk TH, 2007, POPUL ECOL, V49, P211, DOI 10.1007/s10144-007-0037-5; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Guthery FS, 2004, WILDLIFE SOC B, V32, P194, DOI 10.2193/0091-7648(2004)32[194:RSAWRN]2.0.CO;2; Guthery FS, 2006, BOBWHITES NO 27, P213; Guthery FS, 2000, NATL QUAIL S P, P198; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; HALE DW, 1988, AUK, V105, P776; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hemmings N, 2012, BIOL LETTERS, V8, P964, DOI 10.1098/rsbl.2012.0655; Hernandez F, 2005, WILDLIFE SOC B, V33, P1071, DOI 10.2193/0091-7648(2005)33[1071:IOPODO]2.0.CO;2; Hernandez F, 2007, TEXAS QUAILS BOOK, P40; Hernandez F, 2013, WILDLIFE SOC B, V37, P177, DOI 10.1002/wsb.223; Higgins PJ, 2006, HDB AUSTR NZ ANTARTI, V6; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Johnson MS, 2005, INT J TOXICOL, V24, P265, DOI 10.1080/10915810591007247; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Kabat C, 1963, TECH B WIS CONSERV D, V30; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kitulagodage M, 2011, CHEMOSPHERE, V83, P524, DOI 10.1016/j.chemosphere.2010.12.057; Kramer PL, 2011, NEUROBIOL AGING, V32, P2113, DOI 10.1016/j.neurobiolaging.2010.01.010; Kricher J.C., 1999, NEOTROPICAL COMPANIO; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lande R., 2003, OXFORD SERIES ECOLOG; Lebeau G, 2011, LEARN MEMORY, V18, P314, DOI 10.1101/lm.2100611; Lehmann VW, 1937, INCREASE QUAIL IMPRO; Leopold A, 1931, REPORT GAME SURVEY N; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; MAC ARTHUR ROBERT H., 1967; Madge S, 2002, PLATE 59 BOBWHITE PH; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; MARSDEN HALSEY M., 1958, JOUR WILDLIFE MANAGEMENT, V22, P414, DOI 10.2307/3796828; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; McClay JL, 2011, NEUROPSYCHOPHARMACOL, V36, P616, DOI 10.1038/npp.2010.193; Meisler MH, 2001, GENOME RES, V11, P1617, DOI 10.1101/gr.211401; Menzaghi C, 2008, J INTERN MED, V263, P653, DOI 10.1111/j.1365-2796.2008.01924.x; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Mitchell GF, 2012, CIRC-CARDIOVASC GENE, V5, P81, DOI 10.1161/CIRCGENETICS.111.959817; Mitgutsch C, 2011, ZOOL SCI, V28, P491, DOI 10.2108/zsj.28.491; Monson MS, 2013, POULTRY SCI, V92, P1523, DOI 10.3382/ps.2012-02951; Mueller JM, 1999, J WILDLIFE MANAGE, V63, P1291, DOI 10.2307/3802847; Murray JR, 2013, J MORPHOL, V274, P1090, DOI 10.1002/jmor.20165; Nachman MW, 2000, GENETICS, V156, P297; Nager R. G., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P674, DOI 10.1002/9781444318777.ch43; Nei M., 2000, MOL EVOLUTION PHYLOG; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nolan DP, 2012, SAFETY AND SECURITY REVIEW FOR THE PROCESS INDUSTRIES: APPLICATION OF HAZOP, PHA, WHAT-IF AND SVA REVIEWS, 3RD EDITION, P5, DOI 10.1016/B978-1-4377-3518-5.00002-5; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14; Ottinger MA, 2005, DOMEST ANIM ENDOCRIN, V29, P411, DOI 10.1016/j.domaniend.2005.02.038; Peterson MJ, 2001, J WILDLIFE MANAGE, V65, P828, DOI 10.2307/3803032; Peterson MJ, 2002, P NATL QUAIL S, V5, P35; Peterson MJ, 2000, P NATL QUAIL S, V4, P85, DOI DOI 10.2307/3803032; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Polasek O, 2010, CROAT MED J, V50, P7; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P1, DOI 10.2307/3801295; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Pushkina D, 2008, J HUM EVOL, V54, P769, DOI 10.1016/j.jhevol.2007.09.024; Quinn MJ, 2007, ENVIRON TOXICOL CHEM, V26, P2202, DOI 10.1897/07-123R.1; Quinn MJ, 2009, J IMMUNOTOXICOL, V6, P171, DOI 10.1080/15476910903023060; Quinn MJ, 2012, ECOTOXICOLOGY, V22, P231; Rawat A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S13; Rawat A, 2010, PHYSIOL GENOMICS, V42, P219, DOI 10.1152/physiolgenomics.00022.2010; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Reynolds SJ, 1997, AUK, V114, P562, DOI 10.2307/4089275; RINGOEN AR, 1945, J MORPHOL, V77, P265, DOI 10.1002/jmor.1050770208; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roseberry J.L., 1984, POPULATION ECOLOGY B; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-102; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Sauer JR, 2005, J WILDLIFE MANAGE, V69, P1321, DOI 10.2193/0022-541X(2005)69[1321:UTNABB]2.0.CO;2; Sauer JR, 2012, N AM BREEDING BIRD S; Schable NA, 2004, MOL ECOL NOTES, V4, P415, DOI 10.1111/j.1471-8286.2004.00670.x; Scott JL, 2013, WILDLIFE SOC B, V37, P168, DOI 10.1002/wsb.239; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Seabury CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pbio.1000475, DOI 10.1371/J0URNAL.PBI0.1000475]; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Shetty PB, 2012, J HYPERTENS, V30, P1970, DOI 10.1097/HJH.0b013e3283578c80; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Speake DW, 1967, THESIS AUBURN U ALAB; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P3; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Strem Rosa I., 2012, Open Conservation Biology Journal, V6, P12, DOI 10.2174/1874839201206010012; Terhune TM, 2010, ECOL APPL, V20, P1040, DOI 10.1890/09-1106.1; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Vaughan C, 2005, BIRD CONSERV INT, V15, P119; Vigo G, 2011, ORNITOL NEOTROP, V22, P143; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waters MR, 2011, SCIENCE, V334, P351, DOI 10.1126/science.1207663; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Williams CK, 2004, WILDLIFE SOC B, V32, P861, DOI 10.2193/0091-7648(2004)032<0861:TNBDSO>2.0.CO;2; Williams CK, 2004, J WILDLIFE MANAGE, V68, P94, DOI 10.2193/0022-541X(2004)068[0094:WSAAHI]2.0.CO;2; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang J, 2011, TISSUE ENG PT A, V17, P1767, DOI 10.1089/ten.tea.2010.0503	155	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90240	10.1371/journal.pone.0090240	http://dx.doi.org/10.1371/journal.pone.0090240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621616	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300017
J	Mejean, C; Macouillard, P; Peneau, S; Lassale, C; Hercberg, S; Castetbon, K				Mejean, Caroline; Macouillard, Pauline; Peneau, Sandrine; Lassale, Camille; Hercberg, Serge; Castetbon, Katia			Association of Perception of Front-of-Pack Labels with Dietary, Lifestyle and Health Characteristics	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; NUTRITION INFORMATION; NATIONAL NUTRITION; FRENCH NUTRITION; FOOD LABELS; CONSUMERS; PROGRAM; IMPACT; RECOMMENDATIONS; ACCEPTABILITY	Objective: To identify patterns of perception of front-of-pack (FOP) nutrition labels and determine dietary, lifestyle and health profiles related to such patterns. Design: Cross-sectional. Participants/Setting: 28,952 French adults participating in the web-based Nutrinet-Sante cohort. Outcome measures: Perception was measured using indicators of understanding and acceptability for three simple FOP labels ("green tick'', the logo of the French Nutrition and Health Program and "simple traffic lights'' (STL)), and two detailed FOP formats ("multiple traffic lights'' (MTL) and "color range'' logo (CR)), placed on ready-to-eat soup packages. Dietary intake data were collected using three web-based 24 h records. Statistical analyses: Associations of perception patterns with individual characteristics, including diet, lifestyle and health status, were examined using analysis of covariance and logistic regression, adjusted for socio-demographic and economic factors. Results: No clear trend emerged concerning differences in dietary intake between perception groups. Low physical activity and obesity were more frequent in the 'favorable to STL' group (respectively, 20.7% and 10.7%). The 'favorable to MTL' group included the highest percentage of individuals who declared type 2 diabetes (2.2%). Persons with hypertension were proportionally more numerous in the 'favorable to MTL' and the 'favorable to CR logo' groups (respectively, 9.5% and 9.3%). Conclusions: After adjustment for socio-demographic and economic factors, no FOP label stood out as being more suitable than another for reaching populations with poor diet. However, both STL and MTL may be most appropriate for increasing awareness of healthy eating among groups at higher risk of nutrition-related chronic diseases.	[Mejean, Caroline; Macouillard, Pauline; Peneau, Sandrine; Lassale, Camille; Hercberg, Serge] Univ Paris 07, Univ Paris 05, Ctr Rech Epidemiol & Biostat, Inserm U1153,Inra U1125,Cnam,Univ Paris 13,Sorbon, Bobigny, France; [Hercberg, Serge; Castetbon, Katia] Univ Paris 13, Unite Surveillance & Epidemiol Nutr USEN, Sorbonne Paris Cite, Ctr Rech Epidemiol & Biostat, Bobigny, France; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93009 Bobigny, France; [Castetbon, Katia] Inst Veille Sanit InVS, Dept Maladies Chron & Traumatisme, Unite Surveillance & Epidemiol Nutr USEN, St Maurice, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Institute of Public Health Surveillance	Mejean, C (corresponding author), Univ Paris 07, Univ Paris 05, Ctr Rech Epidemiol & Biostat, Inserm U1153,Inra U1125,Cnam,Univ Paris 13,Sorbon, Bobigny, France.	c.mejean@uren.smbh.univ-paris13.fr	HERCBERG, Serge/B-4429-2008; Lassale, Camille/ABE-7813-2020; Serge, Hercberg/F-3038-2017; Peneau, Sandrine/F-2701-2017; Mejean, Caroline/F-2792-2017; Castetbon, Katia/F-2686-2017	HERCBERG, Serge/0000-0002-3168-1350; Lassale, Camille/0000-0002-9340-2708; Serge, Hercberg/0000-0002-3168-1350; Peneau, Sandrine/0000-0002-3463-0989; Mejean, Caroline/0000-0001-6467-5056; CASTETBON, Katia/0000-0002-1207-6729; Macouillard, Pauline/0000-0003-0110-2415	French National Research Agency (Agence Nationale de la Recherche) [ANR-07-PNRA-018]; Ministere de la Sante (DGS); Ministere de la Sante (French Ministry of Health); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Ministere de la Sante (DGS); Ministere de la Sante (French Ministry of Health); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	This work was supported by the French National Research Agency (Agence Nationale de la Recherche; http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/) within the PNRA 2007 program (ANR-07-PNRA-018). The Nutrinet-Sante study is supported by the following institutions: Ministere de la Sante (DGS; French Ministry of Health), Institut de Veille Sanitaire (InVS; http://www.invs.sante.fr/en), Institut National de la Prevention et de l'Education pour la Sante (INPES; http://www.inpes.sante.fr), Fondation pour la Recherche Medicale (FRM; http://www.frm.org/), Institut de Recherche en Sante Publique (IRESP; http://www.iresp.net/organisation/presentation-in-english/), Institut National de la Sante et de la Recherche Medicale (INSERM; http://english.inserm.fr/), Institut National de la Recherche Agronomique (INRA; http://www.inra.fr/en/), Conservatoire National des Arts et Metiers (CNAM; http://the.cnam.eu/) and Universite Paris 13 (http://www.univ-paris13.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anses/ CIQUAL (Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail/ Centre d'information sur la qualite des aliments), 2012, FRENCH FOOD COMP TAB; Bittmann RM, 2007, EXPERT SYST, V24, P171, DOI 10.1111/j.1468-0394.2007.00428.x; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bonsmann SSG, 2010, EUR J CLIN NUTR, V64, P1379, DOI 10.1038/ejcn.2010.179; Bonsmann SSG, 2010, EUR J CLIN NUTR, V64, pS14, DOI 10.1038/ejcn.2010.204; Bonsmann SSG, 2012, CURR OBES REP, V1, P134, DOI 10.1007/s13679-012-0020-0; Borgmeier I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-184; Brussaard JH, 2002, EUR J CLIN NUTR, V56, pS89, DOI 10.1038/sj.ejcn.1601432; Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Everitt B. S., 2001, CLUSTER ANAL; Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009; Food Standards Agency, 2005, QUANT EV ALT FOOD SI; Gorton D, 2009, PUBLIC HEALTH NUTR, V12, P1359, DOI 10.1017/S1368980008004059; Grunert K. G., 2009, PAN EUROPEAN CONSUME; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Grunert KG, 2010, APPETITE, V55, P177, DOI 10.1016/j.appet.2010.05.045; Hawley K.L., 2012, PUBLIC HEALTH NUTR, V1, P1; Hercberg S, 2005, TABLE COMPOSITION SU; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Hodgkins C, 2012, APPETITE, V59, P806, DOI 10.1016/j.appet.2012.08.014; INSEE, 2011, FRENCH NAT CENS DAT; Kelly B, 2009, HEALTH PROMOT INT, V24, P120, DOI 10.1093/heapro/dap012; Keppel G., 2004, DESIGN ANAL RES HDB; Kessler H, 1999, DIABETES EDUCATOR, V25, P549, DOI 10.1177/014572179902500407; Kim WK, 2009, NUTR RES PRACT, V3, P300, DOI 10.4162/nrp.2009.3.4.300; Kreuter MW, 1997, AM J PREV MED, V13, P277, DOI 10.1016/S0749-3797(18)30175-2; Lang JE, 2000, J AM DIET ASSOC, V100, P804, DOI 10.1016/S0002-8223(00)00234-0; Larsson I, 1999, EUR J CLIN NUTR, V53, P776, DOI 10.1038/sj.ejcn.1600839; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lewis JE, 2009, AM J CLIN NUTR, V90, P1351, DOI 10.3945/ajcn.2009.27684; Malon A, 2010, J AM DIET ASSOC, V110, P848, DOI 10.1016/j.jada.2010.03.027; Mejean C, 2013, J HUM NUTR DIET, V26, P494, DOI 10.1111/jhn.12039; Mejean C, 2013, PUBLIC HEALTH NUTR, V16, P392, DOI 10.1017/S1368980012003515; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Moser A, 2010, J VERBRAUCH LEBENSM, V5, P169, DOI 10.1007/s00003-009-0531-0; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nielsen J., 1993, USABILITY ENG; Rayner M, 2001, J NUTR EDUC, V33, P24, DOI 10.1016/S1499-4046(06)60006-7; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Visschers VHM, 2010, PUBLIC HEALTH NUTR, V13, P1099, DOI 10.1017/S1368980009993235; Vyth EL, 2010, PUBLIC HEALTH NUTR, V13, P1882, DOI 10.1017/S1368980010000637; Vyth EL, 2009, J HEALTH COMMUN, V14, P631, DOI 10.1080/10810730903204247; Which?, 2006, HLTH SIGNS; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organization, 1995, PHYS STAT US INT ANT; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	54	19	20	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90971	10.1371/journal.pone.0090971	http://dx.doi.org/10.1371/journal.pone.0090971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621617	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300039
J	Shukrun, R; Vivante, A; Pleniceanu, O; Vax, E; Anikster, Y; Dekel, B; Lotan, D				Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Anikster, Yair; Dekel, Benjamin; Lotan, Danny			A Human Integrin-alpha 3 Mutation Confers Major Renal Developmental Defects	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; EXTRACELLULAR-MATRIX; KIDNEY DEVELOPMENT; DISEASE; RECEPTORS; LUNG; EXPRESSION; UPDATE	The development of the mammalian kidney is a highly complex process dependent upon the interplay of various cell types, secreted morphogens, and the extra-cellular matrix (ECM). Although integrins are the most important receptors for ECM proteins and are ubiquitously expressed during kidney development, mice lacking expression of integrin alpha 3 (Itga3) do not demonstrate a reduced number of nephrons, but mostly a disorganized GBM (glomerular basement membrane) leading to proteinuria. Thus, ITGA3 is considered mostly a passive GBM stabilizer and not an active player in nephrogenesis. Recently, mutations in the human ITGA3 were shown to cause congenital nephrotic syndrome, epidermolysis bullosa and interstitial lung disease, otherwise termed NEP syndrome (Nephrotic syndrome, Epidermolysis bullosa and Pulmonary disease). Herein, we performed histological and molecular analysis on the kidneys of a single patient from the initial cohort harboring an ITGA3 mutation, to illuminate the role of ITGA3 in human renal development. We show the patient to harbor a unique phenotype at birth, including severe unilateral renal hypodysplasia. Interrogation of global gene expression in the hypodysplastic kidney versus three controls (fetal, child and adult kidneys) revealed perturbed expression in several renal developmental pathways implicated in hypodysplasia, including the Wnt, BMP (bone morphogenetic protein) and TGF (transforming growth factor) pathways. Moreover, the affected kidney showed upregulation of early embryonic genes (e. g. OCT4 and PAX8) concomitant with downregulated kidney differentiation markers, implying a defect in proper renal differentiation. In conclusion, we show for the first time that ITGA3 is not merely a passive anchor for renal ECM proteins, as predicted by mouse models. Instead, our results may suggest it plays a central role in the interplay of cells, morphogens and ECM, required for proper nephrogenesis, thus adding ITGA3 to the list of CAKUT (congenital anomalies of the kidney and urinary tract)-causing genes.	[Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Dekel, Benjamin; Lotan, Danny] Edmond & Lili Safra Childrens Hosp, Sheba Med Ctr, Pediat Stem Cell Res Inst, Ramat Gan, Israel; [Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Anikster, Yair; Dekel, Benjamin; Lotan, Danny] Sheba Med Ctr, Sheba Ctr Regenerat Med & Canc Res, Ramat Gan, Israel; [Anikster, Yair; Dekel, Benjamin; Lotan, Danny] Safra Childrens Hosp, Sheba Med Ctr, Dept Pediat & Pediat Nephrol, Ramat Gan, Israel; [Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Dekel, Benjamin; Lotan, Danny] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Dekel, B (corresponding author), Edmond & Lili Safra Childrens Hosp, Sheba Med Ctr, Pediat Stem Cell Res Inst, Ramat Gan, Israel.	benjamin.dekel@gmail.com		/0000-0003-0537-4469	Israeli Society of Clinical Pediatrics; Bretler Foundation; Sackler School of Medicine, Tel-Aviv University; Israeli Ministry of Health	Israeli Society of Clinical Pediatrics; Bretler Foundation; Sackler School of Medicine, Tel-Aviv University; Israeli Ministry of Health	This work was supported in part by the Israeli Society of Clinical Pediatrics, The Bretler Foundation, Sackler School of Medicine, Tel-Aviv University and the Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1992, AM J PATHOL, V141, P571; Avni EF, 2011, PEDIATR RADIOL, V41, P76, DOI 10.1007/s00247-010-1793-5; Benoit G, 2010, PEDIATR NEPHROL, V25, P1621, DOI 10.1007/s00467-010-1495-0; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; EKBLOM P, 1991, AM J KIDNEY DIS, V17, P603, DOI 10.1016/S0272-6386(12)80329-5; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Jain S, 2007, PEDIATR NEPHROL, V22, P962, DOI 10.1007/s00467-007-0466-6; Kanwar YS, 2004, AM J PHYSIOL-RENAL, V286, pF202, DOI 10.1152/ajprenal.00157.2003; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreidberg JA, 2000, AM J PHYSIOL-RENAL, V279, pF233, DOI 10.1152/ajprenal.2000.279.2.F233; Lelongt B, 2003, PEDIATR NEPHROL, V18, P731, DOI 10.1007/s00467-003-1153-x; Little MH, 2012, COLD SPRING HARB PER, V4; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; Mathew S, 2012, PEDIATR NEPHROL, V27, P891, DOI 10.1007/s00467-011-1890-1; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Nicolaou N, 2012, J CLIN INVEST, V122, P4375, DOI 10.1172/JCI64100; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; RAHILLY MA, 1992, J PATHOL, V167, P327, DOI 10.1002/path.1711670311; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Vivante A, 2013, J AM SOC NEPHROL, V24, P550, DOI 10.1681/ASN.2012010097	21	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90879	10.1371/journal.pone.0090879	http://dx.doi.org/10.1371/journal.pone.0090879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621570	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300033
J	Hartman, KG; Vitolo, MI; Pierce, AD; Fox, JM; Shapiro, P; Martin, SS; Wilder, PT; Weber, DJ				Hartman, Kira G.; Vitolo, Michele I.; Pierce, Adam D.; Fox, Jennifer M.; Shapiro, Paul; Martin, Stuart S.; Wilder, Paul T.; Weber, David J.			Complex Formation between S100B Protein and the p90 Ribosomal S6 Kinase ( RSK) in Malignant Melanoma Is Calcium-dependent and Inhibits Extracellular Signalregulated Kinase ( ERK)-mediated Phosphorylation of RSK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Binding Proteins; Cancer; ERK; MAP Kinases (MAPKs); Melanoma; RSK; S100 Proteins	MAGNETIC-RESONANCE-SPECTROSCOPY; GLYCATION END-PRODUCTS; BINDING PROTEIN; WILD-TYPE; P53; S100B(BETA-BETA); ACTIVATION; RECEPTOR; CANCER; FAMILY	Background: S100B is overexpressed in malignant melanoma and contributes to cancer progression. Results: The S100B-RSK complex was found to be Ca2+-dependent, block phosphorylation of RSK at Thr-573, and sequester RSK to the cytosol. Conclusion: The Ca2+-dependent S100B-RSK complex provides a new link between the MAPK and Ca2+ signaling pathways. Significance: S100B inhibitors may restore normal MAPK and Ca2+ signaling in malignant melanoma. S100B is a prognostic marker for malignant melanoma. Increasing S100B levels are predictive of advancing disease stage, increased recurrence, and low overall survival in malignant melanoma patients. Using S100B overexpression and shRNA(S100B) knockdown studies in melanoma cell lines, elevated S100B was found to enhance cell viability and modulate MAPK signaling by binding directly to the p90 ribosomal S6 kinase (RSK). S100B-RSK complex formation was shown to be Ca2+-dependent and to block ERK-dependent phosphorylation of RSK, at Thr-573, in its C-terminal kinase domain. Additionally, the overexpression of S100B sequesters RSK into the cytosol and prevents it from acting on nuclear targets. Thus, elevated S100B contributes to abnormal ERK/RSK signaling and increased cell survival in malignant melanoma.	[Pierce, Adam D.; Wilder, Paul T.; Weber, David J.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Hartman, Kira G.; Fox, Jennifer M.; Martin, Stuart S.; Weber, David J.] Univ Maryland, Program Mol Med, Grad Program Life Sci, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Martin, Stuart S.; Wilder, Paul T.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Pierce, Adam D.; Weber, David J.] Univ Maryland, Ctr Biomol Therapeut, Sch Med, Baltimore, MD 21201 USA; [Shapiro, Paul] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Shapiro, Paul; Martin, Stuart S.; Wilder, Paul T.; Weber, David J.] Univ Maryland, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Shapiro, Paul; Martin, Stuart S.; Wilder, Paul T.; Weber, David J.] Stewart Greenebaum NCI Canc Ctr, Baltimore, MD 21201 USA; [Fox, Jennifer M.] Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Dept Pediat, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Wilder, PT (corresponding author), Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	pwild001@umaryland.edu; dweber@som.umaryland.edu	Weber, David J/B-5349-2011	Weber, David J/0000-0002-8824-1110; Vitolo, Michele/0000-0001-8055-9645	National Institutes of Health [GM58888, CA107331, CA166576]; NATIONAL CANCER INSTITUTE [K01CA166576, R01CA107331, P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This works was supported, in whole or in part, by National Institutes of Health grants GM58888 and CA107331 (to D.J.W.) and CA166576 (to M.I.V.).	AMBURGEY JC, 1995, J BIOMOL NMR, V6, P171, DOI 10.1007/BF00211781; Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Boni R, 1997, J CUTAN PATHOL, V24, P76, DOI 10.1111/j.1600-0560.1997.tb01100.x; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; Chaudhuri D, 1997, BIOCHEMISTRY-US, V36, P9674, DOI 10.1021/bi9704358; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; GAYNOR R, 1981, LANCET, V1, P869; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Goncalves DS, 2000, NEUROREPORT, V11, P807, DOI 10.1097/00001756-200003200-00030; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Hauschild A, 1999, ONCOLOGY-BASEL, V56, P338, DOI 10.1159/000011989; Heizmann Claus W, 2002, Methods Mol Biol, V172, P69; HEIZMANN CW, 1986, J CARDIOVASC PHARM, V8, pS7, DOI 10.1097/00005344-198600088-00003; Jung DH, 2010, EUR J PHARMACOL, V641, P7, DOI 10.1016/j.ejphar.2010.04.061; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Lin J, 2010, J BIOL CHEM, V285, P27487, DOI 10.1074/jbc.M110.155382; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liriano MA, 2012, J MOL BIOL, V423, P365, DOI 10.1016/j.jmb.2012.07.011; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; NAGASAKA A, 1987, METABOLISM, V36, P388, DOI 10.1016/0026-0495(87)90213-7; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Romeo Y, 2013, ONCOGENE, V32, P2917, DOI 10.1038/onc.2012.312; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tsoporis JN, 2012, J MOL CELL CARDIOL, V52, P464, DOI 10.1016/j.yjmcc.2011.08.015; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; van Dieck J, 2010, FEBS LETT, V584, P3269, DOI 10.1016/j.febslet.2010.06.024; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; Wilder PT, 2005, BIOCHEMISTRY-US, V44, P5690, DOI 10.1021/bi0475830; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xu SQ, 2006, AM J PHYSIOL-CELL PH, V291, pC1336, DOI 10.1152/ajpcell.00552.2005; Yang Jian-Fu, 2004, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V29, P301; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zimmer Danna B, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/728052; Zimmer Danna B, 2013, Methods Mol Biol, V963, P303, DOI 10.1007/978-1-62703-230-8_18; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	64	23	23	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12886	12895		10.1074/jbc.M114.561613	http://dx.doi.org/10.1074/jbc.M114.561613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627490	hybrid, Green Published			2022-12-25	WOS:000335581400057
J	Azhar, GS; Mavalankar, D; Nori-Sarma, A; Rajiva, A; Dutta, P; Jaiswal, A; Sheffield, P; Knowlton, K; Hess, JJ				Azhar, Gulrez Shah; Mavalankar, Dileep; Nori-Sarma, Amruta; Rajiva, Ajit; Dutta, Priya; Jaiswal, Anjali; Sheffield, Perry; Knowlton, Kim; Hess, Jeremy J.		Ahmedabad HeatClimate Study Group	Heat-Related Mortality in India: Excess All-Cause Mortality Associated with the 2010 Ahmedabad Heat Wave	PLOS ONE			English	Article							CLIMATE-CHANGE; UNITED-STATES; PUBLIC-HEALTH; CITIES; TEMPERATURE; EXTREMES; IMPACTS; WEATHER; INTENSE; STRESS	Introduction: In the recent past, spells of extreme heat associated with appreciable mortality have been documented in developed countries, including North America and Europe. However, far fewer research reports are available from developing countries or specific cities in South Asia. In May 2010, Ahmedabad, India, faced a heat wave where the temperatures reached a high of 46.8 degrees C with an apparent increase in mortality. The purpose of this study is to characterize the heat wave impact and assess the associated excess mortality. Methods: We conducted an analysis of all-cause mortality associated with a May 2010 heat wave in Ahmedabad, Gujarat, India, to determine whether extreme heat leads to excess mortality. Counts of all-cause deaths from May 1-31, 2010 were compared with the mean of counts from temporally matched periods in May 2009 and 2011 to calculate excess mortality. Other analyses included a 7-day moving average, mortality rate ratio analysis, and relationship between daily maximum temperature and daily all-cause death counts over the entire year of 2010, using month-wise correlations. Results: The May 2010 heat wave was associated with significant excess all-cause mortality. 4,462 all-cause deaths occurred, comprising an excess of 1,344 all-cause deaths, an estimated 43.1% increase when compared to the reference period (3,118 deaths). In monthly pair-wise comparisons for 2010, we found high correlations between mortality and daily maximum temperature during the locally hottest "summer'' months of April (r = 0.69, p<0.001), May (r = 0.77, p<0.001), and June (r = 0.39, p<0.05). During a period of more intense heat (May 19-25, 2010), mortality rate ratios were 1.76 [95% CI 1.67-1.83, p<0.001] and 2.12 [95% CI 2.03-2.21] applying reference periods (May 12-18, 2010) from various years. Conclusion: The May 2010 heat wave in Ahmedabad, Gujarat, India had a substantial effect on all-cause excess mortality, even in this city where hot temperatures prevail through much of April-June.	[Azhar, Gulrez Shah; Mavalankar, Dileep; Nori-Sarma, Amruta; Rajiva, Ajit; Dutta, Priya] Indian Inst Publ Hlth, Ahmadabad, Gujarat, India; [Azhar, Gulrez Shah; Mavalankar, Dileep] Publ Hlth Fdn India, New Delhi, India; [Nori-Sarma, Amruta; Knowlton, Kim] Columbia Mailman Sch Publ Hlth, New York, NY USA; [Jaiswal, Anjali; Knowlton, Kim] Nat Resources Def Council, New York, NY USA; [Sheffield, Perry] Icahn Sch Med,Mt Sinai, New York, NY USA; [Hess, Jeremy J.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Hess, Jeremy J.] Emory Univ, Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA USA	Public Health Foundation of India; Icahn School of Medicine at Mount Sinai; Emory University; Emory University	Azhar, GS (corresponding author), Indian Inst Publ Hlth, Ahmadabad, Gujarat, India.	gsazhar@iiphg.org	Mavalankar, Dileep/AAX-6931-2020; Rajiva, Ajit/P-9869-2019	Mavalankar, Dileep/0000-0003-0498-3799; Knowlton, Kim/0000-0002-8075-7817; Dutta, DrPriya/0000-0003-1594-9529	Climate Knowledge Development Network; FOGARTY INTERNATIONAL CENTER [R21TW009535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023515] Funding Source: NIH RePORTER	Climate Knowledge Development Network; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is funded by a grant from the Climate Knowledge Development Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhyaru-Majithia P, 2010, 8 DIE WORST HEAT WAV; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2012, EPIDEMIOLOGY, V23, P189, DOI 10.1097/EDE.0b013e318245c61c; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bush KF, 2011, ENVIRON HEALTH PERSP, V119, P765, DOI 10.1289/ehp.1003000; Centers for Disease Control and Prevention, 2004, EXTR HEAT PREV GUID; Dave J, 2010, DYING HEAT WAVE KILL; De US, 2005, J INDIAN GEOPHYS UNI, V9, P173; Dole R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046582; ELLIS FP, 1976, T ROY SOC TROP MED H, V70, P412, DOI 10.1016/0035-9203(76)90121-8; Fowler DR, 2013, MMWR-MORBID MORTAL W, V62, P433; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Ghosh P., 2009, NAT ACT PLAN CLIM CH; Government of India, 2011, CENS IND; Guttikunda SK, 2012, ATMOS ENVIRON, V62, P551, DOI 10.1016/j.atmosenv.2012.08.074; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; IPCC, 2012, MAN RISKS EXTR EV DI; IPCC Working Group II, 2011, SPEC REP MAN RISKS E; Joubert D, 2011, AM J PUBLIC HEALTH, V101, P395, DOI 10.2105/AJPH.2009.189563; Kalsi SR, 2001, CURR SCI INDIA, V80, P867; Kamaljit Ray AT, 2012, CLIMATE AHMEDABAD; Khosla R., 2010, RELEVANCE ROOFTOPS A; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Lan L, 2012, ECOHEALTH, P1; Lan L, 2012, ECOHEALTH, V9, P310, DOI 10.1007/s10393-012-0790-6; Matthies FB., 2008, HEAT HLTH ACTION PLA; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Ministry of Environment & Forests Government of India, 2010, CLIM CHANG IND 4 4 A; National Oceanic and Atmospheric Administration, 2013, NAT WEATH SERV GLOSS; Parry ML, 2007, 8 2 1 1 HEATWAVES; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sidhu RK, 1998, CURRENT SCI, V75; Takahashi K, 2007, J RISK RES, V10, P339, DOI 10.1080/13669870701217375; Vandentorren S, 2004, AM J PUBLIC HEALTH, V94, P1518, DOI 10.2105/AJPH.94.9.1518; Wong KV, 2013, J ENERG RESOUR-ASME, V135, DOI 10.1115/1.4023176	47	135	136	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91831	10.1371/journal.pone.0091831	http://dx.doi.org/10.1371/journal.pone.0091831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633076	gold, Green Published			2022-12-25	WOS:000332858400103
J	Fu, YC; Lin, CC; Chang, JK; Chen, CH; Tai, IC; Wang, GJ; Ho, ML				Fu, Yin-Chih; Lin, Chih-Chun; Chang, Je-Ken; Chen, Chung-Hwan; Tai, I-Chun; Wang, Gwo-Jaw; Ho, Mei-Ling			A Novel Single Pulsed Electromagnetic Field Stimulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells and Bone Repair	PLOS ONE			English	Article							LOCAL FACTOR PRODUCTION; OSTEOBLAST-LIKE CELLS; MAGNETIC-FIELDS; FEMORAL-HEAD; EXPOSURE; DIFFERENTIATION; OSTEONECROSIS; SAFETY; MODEL; RATS	Pulsed electromagnetic field (PEMF) has been successfully applied to accelerate fracture repair since 1979. Recent studies suggest that PEMF might be used as a nonoperative treatment for the early stages of osteonecrosis. However, PEMF treatment requires a minimum of ten hours per day for the duration of the treatment. In this study, we modified the protocol of the single-pulsed electromagnetic field (SPEMF) that only requires a 3-minute daily treatment. In the in vitro study, cell proliferation and osteogenic differentiation was evaluated in the hBMSCs. In the in vivo study, new bone formation and revascularization were evaluated in the necrotic bone graft. Results from the in vitro study showed no significant cytotoxic effects on the hBMSCs after 5 days of SPEMF treatment (1 Tesla, 30 pulses per day). hBMSC proliferation was enhanced in the SPEMF-treated groups after 2 and 4 days of treatment. The osteogenic differentiation of hBMSCs was significantly increased in the SPEMF-treated groups after 3-7 days of treatment. Mineralization also increased after 10, 15, 20, and 25 days of treatment in SPEMF-treated groups compared to the control group. The 7-day short-course treatment achieved similar effects on proliferation and osteogenesis as the 25-day treatment. Results from the in vivo study also demonstrated that both the 7-day and 25-day treatments of SPEMF increased callus formation around the necrotic bone and also increased new vessel formation and osteocyte numbers in the grafted necrotic bone at the 2nd and 4th weeks after surgery. In conclusion, the newly developed SPEMF accelerates osteogenic differentiation of cultured hBMSCs and enhances bone repair, neo-vascularization, and cell growth in necrotic bone in mice. The potential clinical advantage of the SPEMF is the short daily application and the shorter treatment course. We suggest that SPEMF may be used to treat fractures and the early stages of osteonecrosis.	[Fu, Yin-Chih; Lin, Chih-Chun; Chang, Je-Ken; Chen, Chung-Hwan; Tai, I-Chun; Wang, Gwo-Jaw; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Fu, Yin-Chih; Chen, Chung-Hwan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Fu, Yin-Chih; Chang, Je-Ken; Chen, Chung-Hwan; Wang, Gwo-Jaw; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Orthopaed, Kaohsiung, Taiwan; [Fu, Yin-Chih; Chang, Je-Ken; Chen, Chung-Hwan; Wang, Gwo-Jaw] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Fu, Yin-Chih] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Lin, Chih-Chun; Tai, I-Chun; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Physiol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ho, ML (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.	homelin@cc.kmu.edu.tw	Chen, Chung-Hwan/D-4036-2009	Chen, Chung-Hwan/0000-0001-8941-4792; Ho, Mei-Ling/0000-0001-8064-8488				AARON RK, 1989, J BONE MINER RES, V4, P227, DOI 10.1002/jbmr.5650040215; BASSETT CAL, 1989, CLIN ORTHOP RELAT R, P172; Chang K, 2004, BIOELECTROMAGNETICS, V25, P134, DOI 10.1002/bem.10168; Chang K, 2003, BIOELECTROMAGNETICS, V24, P189, DOI 10.1002/bem.10078; Eyres KS, 1996, BONE, V18, P505, DOI 10.1016/8756-3282(96)00070-1; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; GOSSLING HR, 1992, ORTHOPEDICS, V15, P711; Gowland PA, 2005, PROG BIOPHYS MOL BIO, V87, P175, DOI 10.1016/j.pbiomolbio.2004.08.006; GUIZZARDI S, 1994, J SPINAL DISORD, V7, P36, DOI 10.1097/00002517-199407010-00005; Hannay G, 2005, BIOELECTROMAGNETICS, V26, P670, DOI 10.1002/bem.20166; HECKMAN JD, 1981, CLIN ORTHOP RELAT R, P58; Lin TM, 2005, STEM CELLS DEV, V14, P92, DOI 10.1089/scd.2005.14.92; Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417; Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7; Massari L, 2006, J BONE JOINT SURG AM, V88A, P56, DOI 10.2106/JBJS.F.00536; MCLEOD KJ, 1992, J BONE JOINT SURG AM, V74A, P920, DOI 10.2106/00004623-199274060-00014; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Nakahara T, 2002, RADIOLOGY, V224, P817, DOI 10.1148/radiol.2243011300; Sakurai T, 2008, BIOELECTROMAGNETICS, V29, P118, DOI 10.1002/bem.20370; Schenck J F, 1998, Magn Reson Imaging Clin N Am, V6, P715; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Schiffer IB, 2003, BIOELECTROMAGNETICS, V24, P241, DOI 10.1002/bem.10097; Silva AKA, 2006, RADIAT ENVIRON BIOPH, V45, P245, DOI 10.1007/s00411-006-0065-0; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Taylor KF, 2006, J ORTHOP RES, V24, P2, DOI 10.1002/jor.20014; TROCK DH, 1994, J RHEUMATOL, V21, P1903; Tsai MT, 2009, J ORTHOP RES; Wang CK, 2009, BIOMATERIALS, V30, P4178, DOI 10.1016/j.biomaterials.2009.04.029; Yeh CH, 2009, CLIN ORTHOP RELAT R, V467, P2159, DOI 10.1007/s11999-009-0803-0; Zmyslony Marek, 2006, Medycyna Pracy, V57, P29	30	51	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91581	10.1371/journal.pone.0091581	http://dx.doi.org/10.1371/journal.pone.0091581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632682	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400070
J	Lee, KJ; Suh, GY; Chung, MP; Kim, H; Kwon, OJ; Han, J; Um, SW				Lee, Kyung Jong; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Han, Joungho; Um, Sang-Won			Combined Endobronchial and Transesophageal Approach of an Ultrasound Bronchoscope for Mediastinal Staging of Lung Cancer	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; 7TH EDITION; NODE; ULTRASONOGRAPHY; CLASSIFICATION; PROJECT	Background: We evaluated the utility of a combined approach using endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and transesophageal bronchoscopic ultrasound-guided fine-needle aspiration (EUS-FNA-B/E) for mediastinal staging of lung cancer. Methods: An EBUS-TBNA database was analyzed retrospectively. EUS-FNA-B/E was performed after EBUS-TBNA when mediastinal lymph nodes were not accessible using EBUS-TBNA or when tissue sampling using EBUS-TBNA alone was inadequate. Results: During the study period, 44 patients were enrolled. EBUS-TBNA and EUS-FNA-B/E were performed on 79 and 52 lymph nodes, respectively. The sensitivity, specificity, and accuracy of mediastinal N-staging using EBUS-TBNA alone were 79%, 100%, and 84%, respectively. The sensitivity, specificity, and accuracy of mediastinal N-staging using a combination of EBUS-TBNA and EUS-FNA-B/E were 100%, 100%, and 100%, respectively. Significant differences in sensitivity (P = 0.008) and accuracy (P = 0.004) of mediastinal N-staging were evident when EBUS-TBNA alone and the combined procedure were compared. The nodal stage shifted higher after use of the EUS-FNA-B/E procedure in six cases (13%). No serious complication associated with the procedures was noted. Conclusions: Use of a combination of EBUS-TBNA and EUS-FNA-B/E can afford better sensitivity and accuracy of mediastinal N-staging compared with use of EBUS-TBNA alone. Such combined procedures should be considered for examination of lesions that are inaccessible or difficult to access by EBUS-TBNA.	[Lee, Kyung Jong; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Um, Sang-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Um, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	sangwonum@skku.edu	Suh, Gee Young/O-3676-2019; Um, Sang Won/F-4610-2014	Suh, Gee Young/0000-0001-5473-1712; 				BENNETT BM, 1972, BIOMETRICS, V28, P793, DOI 10.2307/2528763; De Leyn P, 2007, J THORAC ONCOL, V2, P357, DOI 10.1097/01.JTO.0000263722.22686.1c; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Herth FJF, 2010, CHEST, V138, P790, DOI 10.1378/chest.09-2149; Hwangbo B, 2010, CHEST, V138, P795, DOI 10.1378/chest.09-2100; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jhun BW, 2012, J KOREAN MED SCI, V27, P46, DOI 10.3346/jkms.2012.27.1.46; Konge L, 2012, ENDOSCOPY, V44, P928, DOI 10.1055/s-0032-1309892; Lv YL, 2011, J THORAC ONCOL, V6, P1350, DOI 10.1097/JTO.0b013e31821d4384; Ohnishi R, 2011, ENDOSCOPY, V43, P1082, DOI 10.1055/s-0030-1256766; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Szlubowski A, 2010, EUR J CARDIO-THORAC, V37, P1175, DOI 10.1016/j.ejcts.2009.11.015; Tournoy KG, 2012, LANCET ONCOL, V13, pE221, DOI 10.1016/S1470-2045(11)70407-7; Tournoy KG, 2009, J THORAC ONCOL, V4, P1576, DOI 10.1097/JTO.0b013e3181c1274f; Verma A, 2012, THORAC CANCER, V3, P280, DOI 10.1111/j.1759-7714.2011.00090.x; Vilmann P, 2005, ENDOSCOPY, V37, P833, DOI 10.1055/s-2005-870276; Wallace MB, 2008, JAMA-J AM MED ASSOC, V299, P540, DOI 10.1001/jama.299.5.540; Yasufuku K, 2011, J THORAC CARDIOV SUR, V142, P1393, DOI 10.1016/j.jtcvs.2011.08.037	21	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91893	10.1371/journal.pone.0091893	http://dx.doi.org/10.1371/journal.pone.0091893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632834	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400117
J	Lei, YP; Zhu, HP; Yang, W; Ross, ME; Shaw, GM; Finnell, RH				Lei, Yunping; Zhu, Huiping; Yang, Wei; Ross, M. Elizabeth; Shaw, Gary M.; Finnell, Richard H.			Identification of Novel CELSR1 Mutations in Spina Bifida	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; PLANAR-CELL-POLARITY; PHI-29 DNA-POLYMERASE; LOOP-TAIL; MOUSE; GENE; INITIATION; EXTENSION; RISK	Spina bifida is one of the most common neural tube defects (NTDs) with a complex etiology. Variants in planar cell polarity (PCP) genes have been associated with NTDs including spina bifida in both animal models and human cohorts. In this study, we sequenced all exons of CELSR1 in 192 spina bifida patients from a California population to determine the contribution of CELSR1 mutations in the studied population. Novel and rare variants identified in these patients were subsequently genotyped in 190 ethnically matched control individuals. Six missense mutations not found in controls were predicted to be deleterious by both SIFT and PolyPhen. Two TG dinucleotide repeat variants were individually detected in 2 spina bifida patients but not detected in controls. In vitro functional analysis showed that the two TG dinucleotide repeat variants not only changed subcellular localization of the CELSR1 protein, but also impaired the physical association between CELSR1 and VANGL2, and thus diminished the ability to recruit VANGL2 for cell-cell contact. In total, 3% of our spina bifida patients carry deleterious or predicted to be deleterious CELSR1 mutations. Our findings suggest that CELSR1 mutations contribute to the risk of spina bifida in a cohort of spina bifida patients from California.	[Lei, Yunping; Zhu, Huiping; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Dept Nutrit Sci, Austin, TX 78712 USA; [Finnell, Richard H.] Univ Texas Austin, Dept Chem, Coll Nat Sci, Austin, TX 78712 USA; [Yang, Wei; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatol, Stanford, CA 94305 USA; [Ross, M. Elizabeth] Weill Cornell Med Coll, Ctr Neurogenet, Brain & Mind Res Inst, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University; Cornell University	Finnell, RH (corresponding author), Univ Texas Austin, Dell Pediat Res Inst, Dept Nutrit Sci, Austin, TX 78712 USA.	rfinnell@austin.utexas.edu	Lei, Yunping/B-6322-2009; Finnell, Richard/D-8174-2018	Lei, Yunping/0000-0003-1504-0884; Shaw, Gary/0000-0001-7438-4914; Finnell, Richard/0000-0002-5962-8754	NIH [HD067244, NS076465, ES021006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH grants HD067244, NS076465, and ES021006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allache R, 2012, BIRTH DEFECTS RES A, V94, P176, DOI 10.1002/bdra.23002; Bosoi CM, 2011, HUM MUTAT, V32, P1371, DOI 10.1002/humu.21589; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; De Marco P, 2013, J MOL NEUROSCI, V49, P582, DOI 10.1007/s12031-012-9871-9; De Marco P, 2012, HUM MUTAT, V33, P384, DOI 10.1002/humu.21643; Deak KL, 2008, BIRTH DEFECTS RES A, V82, P662, DOI 10.1002/bdra.20511; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Devenport D, 2011, NAT CELL BIOL, V13, P893, DOI 10.1038/ncb2284; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Formstone CJ, 2005, DEV BIOL, V282, P320, DOI 10.1016/j.ydbio.2005.03.026; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Group M. V. S. R., 1991, LANCET, V338, P131, DOI DOI 10.1016/0140-6736(91)90133-A; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Lei YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069262; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Nelson JR, 2002, BIOTECHNIQUES, P44; Olshan AF, 2005, AM J MED GENET A, V135A, P268, DOI 10.1002/ajmg.a.30713; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Tran PX, 2011, BIRTH DEFECTS RES A, V91, P39, DOI 10.1002/bdra.20744; Yang XY, 2013, HUM MUTAT; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	29	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92207	10.1371/journal.pone.0092207	http://dx.doi.org/10.1371/journal.pone.0092207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632739	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400150
J	Goh, LK; Liem, N; Vijayaraghavan, A; Chen, GB; Lim, PL; Tay, KJ; Chang, M; Low, JSW; Joshi, A; Huang, HH; Kalaw, E; Tan, PH; Hsieh, WS; Yong, WP; Alumkal, J; Sim, HG				Goh, Liang Kee; Liem, Natalia; Vijayaraghavan, Aadhitthya; Chen, Gengbo; Lim, Pei Li; Tay, Kae-Jack; Chang, Michelle; Low, John Soon Wah; Joshi, Adita; Huang, Hong Hong; Kalaw, Emarene; Tan, Puay Hoon; Hsieh, Wen-Son; Yong, Wei Peng; Alumkal, Joshi; Sim, Hong Gee			Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer	PLOS ONE			English	Article							TERTIARY GLEASON PATTERN-5; ACUTE MYELOID-LEUKEMIA; METHYLATION; EXPRESSION; REVEALS; KIT; BIOMARKERS; MANAGEMENT; CELLS; STAGE	We aimed to identify a prostate cancer DNA hypermethylation microarray signature (denoted as PHYMA) that differentiates prostate cancer from benign prostate hyperplasia (BPH), high from low-grade and lethal from non-lethal cancers. This is a non-randomized retrospective study in 111 local Asian men (87 prostate cancers and 24 BPH) treated from 1995 to 2009 in our institution. Archival prostate epithelia were laser-capture microdissected and genomic DNA extracted and bisulfite-converted. Samples were profiled using Illumina GoldenGate Methylation microarray, with raw data processed by GenomeStudio. A classification model was generated using support vector machine, consisting of a 55-probe DNA methylation signature of 46 genes. The model was independently validated on an internal testing dataset which yielded cancer detection sensitivity and specificity of 95.3% and 100% respectively, with overall accuracy of 96.4%. Second validation on another independent western cohort yielded 89.8% sensitivity and 66.7% specificity, with overall accuracy of 88.7%. A PHYMA score was developed for each sample based on the state of methylation in the PHYMA signature. Increasing PHYMA score was significantly associated with higher Gleason score and Gleason primary grade. Men with higher PHYMA scores have poorer survival on univariate (p = 0.0038, HR = 3.89) and multivariate analyses when controlled for (i) clinical stage (p = 0.055, HR = 2.57), and (ii) clinical stage and Gleason score (p = 0.043, HR = 2.61). We further performed bisulfite genomic sequencing on 2 relatively unknown genes to demonstrate robustness of the assay results. PHYMA is thus a signature with high sensitivity and specificity for discriminating tumors from BPH, and has a potential role in early detection and in predicting survival.	[Goh, Liang Kee; Vijayaraghavan, Aadhitthya] Duke Natl Univ Singapore, Grad Sch Med, Ctr Quantitat Med, Singapore, Singapore; [Goh, Liang Kee; Chen, Gengbo] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Liem, Natalia; Lim, Pei Li; Low, John Soon Wah; Hsieh, Wen-Son; Yong, Wei Peng] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Tay, Kae-Jack; Chang, Michelle; Joshi, Adita; Huang, Hong Hong; Sim, Hong Gee] Singapore Gen Hosp, Dept Urol, Singapore, Singapore; [Kalaw, Emarene; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Alumkal, Joshi] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; Oregon Health & Science University	Goh, LK (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Ctr Quantitat Med, Singapore, Singapore.	liang.goh@duke-nus.edu.sg; sim.hong.gee@sgh.com.sg	Yong, Wei-Peng/Y-7260-2018; Tay, Kae Jack/N-6526-2016	Yong, Wei-Peng/0000-0003-4404-3777; Tay, Kae Jack/0000-0003-0365-1899	Singapore National Medical Research Council [NMRC NIG/0033/2008]; Khoo Discovery Awards [KDP/2008/0002, KDP/2009/0006]; Duke-NUS Signature Research Program Phase 1; Agency for Science, Technology and Research (A*STAR); Ministry of Health, Singapore; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER	Singapore National Medical Research Council(National Medical Research Council, Singapore); Khoo Discovery Awards; Duke-NUS Signature Research Program Phase 1; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the Singapore National Medical Research Council (NMRC NIG/0033/2008) to HGS, Khoo Discovery Awards (KDP/2008/0002 and KDP/2009/0006) and Duke-NUS Signature Research Program Phase 1 funded by the Agency for Science, Technology and Research (A*STAR), and the Ministry of Health, Singapore, to LKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albany C, 2012, PROSTATE CANC, V2011; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Baden J, 2011, J UROLOGY, V186, P2101, DOI 10.1016/j.juro.2011.06.052; Bailar J C 3rd, 1966, Cancer Chemother Rep, V50, P129; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bratt O, 2006, EUR UROL, V50, P410, DOI 10.1016/j.eururo.2006.03.066; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074775; Chiam K, 2014, CANCER LETT, V342, P248, DOI 10.1016/j.canlet.2012.02.011; Di Lorenzo G, 2004, EJSO-EUR J SURG ONC, V30, P987, DOI 10.1016/j.ejso.2004.07.017; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Gallick GE, 2012, FUTURE MED CHEM, V4, P107, DOI [10.4155/FMC.11.161, 10.4155/fmc.11.161]; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Goh Liang, 2005, Journal of Bioinformatics and Computational Biology, V3, P1107, DOI 10.1142/S0219720005001533; Goh L, 2007, BIOINFORMATICS, V23, P281, DOI 10.1093/bioinformatics/btl620; Gupta Aditi, 2013, Cancers (Basel), V5, P617, DOI 10.3390/cancers5020617; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harkin DP, 2006, ONCOLOGIST, V11, P988, DOI 10.1634/theoncologist.11-9-988; Hewitt KJ, 2012, J CELL SCI, V125, P2276, DOI 10.1242/jcs.099192; Howlader N, 2013, SEER CANC STAT REV 1; Irsoy O, 2012, IEEE ACM T COMPUT BI, V9, P1663, DOI 10.1109/TCBB.2012.117; Jeronimo C, 2014, CANCER LETT, V342, P264, DOI 10.1016/j.canlet.2011.12.026; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Krishnamoorthy S, 2010, EXP CELL RES, V316, P1706, DOI 10.1016/j.yexcr.2010.03.005; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Lowrance William T, 2009, Rev Urol, V11, P117; Mazaris Evangelos, 2013, Nephrourol Mon, V5, P792, DOI 10.5812/numonthly.9430; McLean M, 1997, Clin Oncol (R Coll Radiol), V9, P222, DOI 10.1016/S0936-6555(97)80005-2; Mosse CA, 2004, AM J SURG PATHOL, V28, P394, DOI 10.1097/00000478-200403000-00014; Napieralski R, 2007, CLIN CANCER RES, V13, P5095, DOI 10.1158/1078-0432.CCR-07-0241; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Ohgami RS, 2012, BRIT J HAEMATOL, V159, P182, DOI 10.1111/bjh.12029; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Pavlidis P, 2004, BIOINFORMATICS, V20, P586, DOI 10.1093/bioinformatics/btg461; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Raffoux E, 2010, ONCOTARGET, V1, P34, DOI 10.18632/oncotarget.106; Risk MC, 2010, CLIN CANCER RES, V16, P5414, DOI 10.1158/1078-0432.CCR-10-0272; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Schwartzman J, 2011, EPIGENETICS-US, V6, P1248, DOI 10.4161/epi.6.10.17727; Sim HG, 2008, J UROLOGY, V179, P1775, DOI 10.1016/j.juro.2008.01.016; Sirma H, 2013, ONCOL LETT, V6, P1245, DOI 10.3892/ol.2013.1563; Tawadros T, 2012, BRIT J CANCER, V107, P1737, DOI 10.1038/bjc.2012.457; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Vener T, 2008, CLIN CHEM, V54, P874, DOI 10.1373/clinchem.2007.094912; Verma Mukesh, 2011, Cancers (Basel), V3, P3773, DOI 10.3390/cancers3043773; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yang B, 2007, J INVEST DERMATOL, V127, P2123, DOI 10.1038/sj.jid.5700836; Yu YP, 2005, CARCINOGENESIS, V26, P471, DOI 10.1093/carcin/bgh310; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zam NABM, 2008, PATHOLOGY, V40, P586, DOI 10.1080/00313020802320671; Zawada AM, 2012, CIRC-CARDIOVASC GENE, V5, P611, DOI 10.1161/CIRCGENETICS.112.963207	65	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91666	10.1371/journal.pone.0091666	http://dx.doi.org/10.1371/journal.pone.0091666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626295	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300116
J	Skorvaga, M; Nikitina, E; Kubes, M; Kosik, P; Gajdosechova, B; Leitnerova, M; Copakova, L; Belyaev, I				Skorvaga, Milan; Nikitina, Ekaterina; Kubes, Miroslav; Kosik, Pavol; Gajdosechova, Beata; Leitnerova, Michaela; Copakova, Lucia; Belyaev, Igor			Incidence of Common Preleukemic Gene Fusions in Umbilical Cord Blood in Slovak Population	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL-RESIDUAL-DISEASE; CHILDHOOD LEUKEMIA; RT-PCR; CHROMOSOME TRANSLOCATIONS; TRANSCRIPTS; CELLS; INDIVIDUALS; ABERRATIONS; EXPRESSION	The first event in origination of many childhood leukemias is likely the presence of preleukemic clone (transformed hematopoietic stem/progenitor cells with preleukemic gene fusions (PGF)) in newborn. Thus, the screening of umbilical cord blood (UCB) for PGF may be of high importance for developing strategies for childhood leukemia prevention and treatment. However, the data on incidence of PGF in UCB are contradictive. We have compared multiplex polymerase chain reaction (PCR) and real-time quantitative PCR (RT qPCR) in neonates from Slovak National Birth Cohort. According to multiplex PCR, all 135 screened samples were negative for the most frequent PGF of B-lineage acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). To explore the prevalence of prognostically important TEL-AML1, MLL-AF4 and BCR-ABL (p190), 200 UCB were screened using RT qPCR. The initial screening showed an unexpectedly high incidence of studied PGF. The validation of selected samples in two laboratories confirmed approximately 1/4 of UCB positive, resulting in similar to 4% incidence of TEL-AML1, similar to 6.25% incidence of BCR-ABL1 p190, and similar to 0.75% frequency of MLL-AF4. In most cases, the PGF presented at very low level, about 1-5 copies per 10(5) cells. We hypothesize that low PGF numbers reflect their relatively late origin and are likely to be eliminated in further development while higher number of PGF reflects earlier origination and may represent higher risk for leukemia.	[Skorvaga, Milan; Nikitina, Ekaterina; Kosik, Pavol; Gajdosechova, Beata; Belyaev, Igor] Slovak Acad Sci, Canc Res Inst, Dept Mol Genet, Bratislava, Slovakia; [Nikitina, Ekaterina] Russian Acad Med Sci, Lab Oncovirol, Canc Res Inst, Siberian Branch, Tomsk, Russia; [Kubes, Miroslav] Eurocord Slovakia, Lab R&D, Bratislava, Slovakia; [Leitnerova, Michaela; Copakova, Lucia] Natl Canc Inst, Dept Clin Oncol, Bratislava, Slovakia	Slovak Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cancer Research Institute of the RAS; National Institute of Oncology (NOU)	Belyaev, I (corresponding author), Slovak Acad Sci, Canc Res Inst, Dept Mol Genet, Bratislava, Slovakia.	Igor.Beliaev@savba.sk	Skorvaga, Milan/AAO-2360-2021; Belyaev, Igor Y/I-4029-2018	Belyaev, Igor/0000-0002-7963-2240	Slovak Research and Development Agency [APVV 0669-10]; National Scholarship Program of the Slovak Republic (SAIA); Slovak Academy of Sciences (SAS); Russian Academy of Medical Sciences (RAMS); VEGA Grant Agency of the Slovak Republic [2/0150/11]	Slovak Research and Development Agency(Slovak Research and Development Agency); National Scholarship Program of the Slovak Republic (SAIA); Slovak Academy of Sciences (SAS); Russian Academy of Medical Sciences (RAMS); VEGA Grant Agency of the Slovak Republic(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This study was supported by the Slovak Research and Development Agency (APVV 0669-10); the National Scholarship Program of the Slovak Republic (SAIA); the Joint Research Project "Cancer diagnostics and assesment of cancer risks" between Slovak Academy of Sciences (SAS) and Russian Academy of Medical Sciences (RAMS), and the VEGA Grant Agency (2/0150/11) of the Slovak Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Brown P, 2011, BLOOD, V117, P2, DOI 10.1182/blood-2010-09-304337; Bueno C, 2011, LEUKEMIA, V25, P400, DOI 10.1038/leu.2010.284; Bueno C, 2012, CELL RES, V22, P986, DOI 10.1038/cr.2012.4; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Dickinson HO, 2005, BRIT MED J, V330, P1279, DOI 10.1136/bmj.330.7503.1279; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Fischer S, 2007, BLOOD, V110, P3036, DOI 10.1182/blood-2007-03-077339; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Greaves M, 2011, BLOOD, V117, P369, DOI 10.1182/blood-2010-09-309351; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Kaatsch P, 2008, RADIAT PROT DOSIM, V132, P107, DOI 10.1093/rpd/ncn259; Kim-Rouille MH, 1999, BLOOD, V93, P1107, DOI 10.1182/blood.V93.3.1107; Kowarz E, 2011, AM J BLOOD RES, V1, P1; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; McHale CM, 2004, AM J HEMATOL, V75, P254, DOI 10.1002/ajh.20030; Menendez P, 2009, J EXP MED, V206, P3131, DOI 10.1084/jem.20091050; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Olsen M, 2012, J PEDIAT HEMATOL ONC, V34, P301, DOI 10.1097/MPH.0b013e3182332268; Pakakasama S, 2008, INT J LAB HEMATOL, V30, P286, DOI 10.1111/j.1751-553X.2007.00954.x; Portier C, 2008, RADIAT PROT DOSIM, V132, P273, DOI 10.1093/rpd/ncn282; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rossig C, 2008, RADIAT PROT DOSIM, V132, P114, DOI 10.1093/rpd/ncn269; Shiozaki H, 2014, BONE MARROW TRANSPL, V49, P102, DOI 10.1038/bmt.2013.127; Song JB, 2011, J MOL DIAGN, V13, P213, DOI 10.1016/j.jmoldx.2010.10.009; Trka J, 1999, BLOOD, V93, P1106, DOI 10.1182/blood.V93.3.1106.403a38a_1106_1107; Uckun FM, 1998, BLOOD, V92, P810; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wiemels Joseph, 2008, J Natl Cancer Inst Monogr, P87, DOI 10.1093/jncimonographs/lgn006; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Yang GY, 2009, J VIROL METHODS, V162, P288, DOI 10.1016/j.jviromet.2009.08.004; Zuna J, 2011, BLOOD, V117, P368, DOI 10.1182/blood-2010-09-309070	42	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91116	10.1371/journal.pone.0091116	http://dx.doi.org/10.1371/journal.pone.0091116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621554	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300052
J	Yao, Y; Wang, C; Wei, W; Shen, C; Deng, XH; Chen, LJ; Ma, LY; Hao, SG				Yao, Ye; Wang, Chun; Wei, Wei; Shen, Chang; Deng, Xiaohui; Chen, Linjun; Ma, Liyuan; Hao, Siguo			Dendritic Cells Pulsed with Leukemia Cell-Derived Exosomes More Efficiently Induce Antileukemic Immunities	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; CD8(+) CTL RESPONSES; WT1 PEPTIDE; CLASS-I; IMMUNOTHERAPY; VACCINATION; EPITOPES; ANTIGENS	Dendritic cells (DCs) and tumor cell-derived exosomes have been used to develop antitumor vaccines. However, the biological properties and antileukemic effects of leukemia cell-derived exosomes (LEXs) are not well described. In this study, the biological properties and induction of antileukemic immunity of LEXs were investigated using transmission electron microscopy, western blot analysis, cytotoxicity assays, and animal studies. Similar to other tumor cells, leukemia cells release exosomes. Exosomes derived from K562 leukemia cells (LEXK562) are membrane-bound vesicles with diameters of approximately 50-100 mu m and harbor adhesion molecules (e.g., intercellular adhesion molecule-1) and immunologically associated molecules (e.g., heat shock protein 70). In cytotoxicity assays and animal studies, LEXs-pulsed DCs induced an antileukemic cytotoxic T-lymphocyte immune response and antileukemic immunity more effectively than did LEXs and non-pulsed DCs (P<0.05). Therefore, LEXs may harbor antigens and immunological molecules associated with leukemia cells. As such, LEX-based vaccines may be a promising strategy for prolonging disease-free survival in patients with leukemia after chemotherapy or hematopoietic stem cell transplantation.	[Yao, Ye; Wei, Wei; Deng, Xiaohui; Chen, Linjun; Hao, Siguo] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Wang, Chun; Shen, Chang] Shanghai Jiao Tong Univ, Dept Hematol, Peoples Hosp Shanghai 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hao, SG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	haosghj88@hotmail.com	Wei, Weijun/AAZ-3551-2021	Multhoff, Gabriele/0000-0002-2616-3137	National Natural Science Foundation of China [81070432]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant No. 81070432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Altieri SL, 2004, J IMMUNOTHER, V27, P282, DOI 10.1097/00002371-200407000-00004; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andre F, 2002, VACCINE, V20, pA28, DOI 10.1016/S0264-410X(02)00384-5; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett AJ, 2010, CLIN EXP IMMUNOL, V161, P223, DOI 10.1111/j.1365-2249.2010.04197.x; Chaput N, 2003, ADV EXP MED BIOL, V532, P215; Chaput N, 2004, J IMMUNOL, V172, P2137, DOI 10.4049/jimmunol.172.4.2137; Delluc S, 2005, HAEMATOLOGICA, V90, P1050; Denzer K, 2000, J CELL SCI, V113, P3365; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Fukui M, 2004, TUMOR BIOL, V25, P252, DOI 10.1159/000081388; Hao SG, 2006, CELL MOL IMMUNOL, V3, P205; Hao SG, 2007, IMMUNOLOGY, V120, P90, DOI 10.1111/j.1365-2567.2006.02483.x; Kim JV, 2004, NAT BIOTECHNOL, V22, P403, DOI 10.1038/nbt955; Knight SC, 1998, EUR J IMMUNOL, V28, P1636; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mailander V, 2004, LEUKEMIA, V18, P165, DOI 10.1038/sj.leu.2403186; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Ostankovitch M, 1998, BLOOD, V92, P19, DOI 10.1182/blood.V92.1.19.413a40_19_24; Parkhurst MR, 2003, J IMMUNOL, V170, P5317, DOI 10.4049/jimmunol.170.10.5317; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; SanMiguel JF, 1997, BLOOD, V90, P2465, DOI 10.1182/blood.V90.6.2465.2465_2465_2470; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shen C, 2011, J INT MED RES, V39, P740, DOI 10.1177/147323001103900305; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yao Y, 2013, BIOCHEM BIOPH RES CO, V436, P60, DOI 10.1016/j.bbrc.2013.05.058	34	57	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91463	10.1371/journal.pone.0091463	http://dx.doi.org/10.1371/journal.pone.0091463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622345	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300088
J	Lover, AA; Hartman, M; Chia, KS; Heymann, DL				Lover, Andrew A.; Hartman, Mikael; Chia, Kee Seng; Heymann, David L.			Demographic and Spatial Predictors of Anemia in Women of Reproductive Age in Timor-Leste: Implications for Health Program Prioritization	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; HEMOGLOBIN CONCENTRATION; INFANT-MORTALITY; PREGNANT-WOMEN; RISK-FACTORS; MALARIA; INTERVENTIONS; INFECTIONS; PREVALENCE; CHILDREN	Anemia is a significant risk factor for poor health outcomes for both the mother and neonate; however, the determinants of anemia in many epidemiological settings are poorly understood. Using a subset of a nationally representative cluster survey (2010 Demographic and Health Survey) in combination with other non-contemporaneous survey data, the epidemiology of anemia among women of reproductive age in Timor-Leste has been explored. Logistic regression was used to identify risk factors, population-level impacts were estimated as population attributable fractions and spatial analytics were used to identify regions of highest risk. The DHS survey found that similar to 21% of adult women in Timor-Leste are anemic (49,053; 95% CI: 37,095 to 61,035), with hemoglobin <12.0 g/dL. In this population, the main risk factors (adjusted odds ratio; 95% CI) are: currently abstaining from sex for any reason (2.25; 1.50 to 3.38); illiteracy (2.04; 1.49 to 2.80); giving birth within the previous year (1.80; 1.29 to 2.51); consumption of fruits/vegetables low in vitamin A (1.57; 1.13 to 2.20); and the district-level confirmed malaria incidence (1.31; 1.15 to 1.49). A review of prior soil-transmitted helminth surveys in Timor-Leste indicates low-to-moderate prevalence with generally low egg counts, suggesting a limited impact on anemia in this setting, although comprehensive survey data are lacking. Examination of the population-level effects highlights the impacts of both recent births and malaria on anemia, with more limited impacts from diet; the evidence does not suggest a large contribution from geohelminths within Timor-Leste. These patterns are divergent from some other settings in the Asia-Pacific region and highlight the need for further focused research. Targeting high-burden districts and by increasing access to pre/postnatal care, raising literacy levels, increasing access to family planning, and improving malaria control should be prioritized to maximize inherently limited health budgets in reaching these populations.	[Lover, Andrew A.; Hartman, Mikael; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Heymann, David L.] Publ Hlth England, Dept Hlth, London, England; [Heymann, David L.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England	National University of Singapore; National University of Singapore; Karolinska Institutet; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Lover, AA (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	andrew.a.lover@gmail.com	; Hartman, Mikael/B-4324-2011	Lover, Andrew/0000-0002-2181-3559; Hartman, Mikael/0000-0001-5726-9965				Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2008, WORLDW PREV AN 1993; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Boel M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000887; Deen J, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-8; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Ezzati M, 2004, COMP QUANTIFICATION; Friedman JF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000295; Haider BA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S19; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hotez PJ, 2010, ADV PARASIT, V72, P31, DOI 10.1016/S0065-308X(10)72002-9; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Klemm R, 2011, ARE WE MAKING PROR R; Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Magalhaes RJS, 2013, GEOSPATIAL HEALTH, V7, P341; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McClure EM, 2013, INT J GYNECOL OBSTET, V121, P103, DOI 10.1016/j.ijgo.2012.12.014; Melrose W, 2002, SURVEY GLUCOSE 6 PHO; Ministry of Health and National Statistics Office Timor-Leste University of Newcastle The Australian National University and ACIL Australia, 2004, TIM LEST 2003 DEM HL; Ministry of Health Timor-Leste, 2010, GLOB AIDS PROGR REP; Ministry of Health Timor-Leste World Health Organization AusAID, 2012, TIM LEST NAT PAR SUR; Morrow M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-85; Muhangi L, 2007, T ROY SOC TROP MED H, V101, P899, DOI 10.1016/j.trstmh.2007.03.017; National Statistics Directorate [Timor-Leste] Ministry of Finance [Timor-Leste] and ICF Macro, 2010, TIM LEST DEM HLTH SU; National Statistics Directorate Timor-Leste United National Development Program, 2011, POP HOUS CENS TIM LE; National Statistics Directorate Timor-Leste United National Development Program, TIM LEST GIS MAPS PO; Newson R., 2012, PUNAF STATA MODULE C; Nguyen Phuong H., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1213; Noronha JA, 2010, J OBSTET GYNAECOL, V30, P132, DOI 10.3109/01443610903267457; Nurdiati Detty Siti, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P14; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; PRITCHARD DI, 1990, PARASITOLOGY, V100, P317, DOI 10.1017/S0031182000061333; Pulford J, 2012, SOC SCI MED, V75, P2283, DOI 10.1016/j.socscimed.2012.08.030; Reeve DM, 2010, THESIS J COOK U AUST; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Senn N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009375; Shamah-Levy T, 2003, SALUD PUBLICA MEXICO, V45, pS499; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Tatala S, 1998, AM J CLIN NUTR, V68, P171, DOI 10.1093/ajcn/68.1.171; Timor-Leste Ministry of Health, 2007, ANN HLTH STAT RE JAN; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; United National Development Program, 2009, MILL DEV GOALS TIM L; van den Broek N, 1998, BRIT J OBSTET GYNAEC, V105, P385; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2011, SER FERR CONC ASS IR	49	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91252	10.1371/journal.pone.0091252	http://dx.doi.org/10.1371/journal.pone.0091252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632676	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000332858400049
J	Yeh, JR; Hsu, LC; Lin, C; Chang, FL; Lo, MT				Yeh, Jia-Rong; Hsu, Li-Chi; Lin, Chen; Chang, Fu-Ling; Lo, Men-Tzung			Nonlinear Analysis of Sensory Organization Test for Subjects with Unilateral Vestibular Dysfunction	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; EVALUATING POSTURAL CONTROL; APPROXIMATE ENTROPY; COMPENSATION	Vestibular disorder is the cause of approximately 50% of dizziness in older people. The vestibular system is a critical postural control mechanism, and posturography analysis is helpful for diagnosing vestibular disorder. In clinical practice, the sensory organization test (SOT) is used to quantify postural control in an upright stance under different test conditions. However, both aging and vestibular disorder cause declines of postural control mechanisms. The aim of this study was to enhance the performance of the SOT using a nonlinear algorithm of empirical mode decomposition (EMD) and to verify the differences of effects caused by aging and/or illnesses benefits to clinical diagnosis. A total of 51 subjects belonging to 3 groups-healthy-young, healthy-elderly and dizzy-were recruited for this study. New dynamic parameters of the SOT were derived from the center of pressure (COP) signals. EMD served as an adaptive filter bank to derive the low-and high-frequency components of the COP. The effects on four ratios of sensory analysis caused by aging and vestibular disorder can be investigated for the specific frequency bands. According to our findings, new SOT parameters derived from the component with the specific frequency band more sensitively reflect the functional condition of vestibular dysfunction. Furthermore, both aging and vestibular dysfunction caused an increase in magnitude for the low-frequency component of the AP-direction COP time series. In summary, the low-frequency fluctuation reflects the stability of postural control, while the high-frequency fluctuation is sensitive to the functional condition of the sensory system. EMD successfully improved the accuracy of SOT measurements in this investigation.	[Yeh, Jia-Rong; Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Yeh, Jia-Rong; Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Tao Yuan, Taiwan; [Hsu, Li-Chi] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsu, Li-Chi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chang, Fu-Ling] Taiwan Text Res Inst, New Taipei City, Taiwan; [Chang, Fu-Ling] Natl Yunlin Univ Sci & Technol, Grad Sch Design, Yunlin, Taiwan	National Central University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yunlin University Science & Technology	Lo, MT (corresponding author), Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan.	mzlo@ncu.edu.tw	huang, yuting/T-4341-2019	Lin, Chen/0000-0001-6261-8509	NSC Taiwan, ROC [99-2627-B-008-003, 97-2314-B-038-002-MY3]; NCU [CNJRF-101CGH-NCU-A4, VGHUST103-G1-3-3]; NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 102-2911-I-008-001]; Taipei Veterans General Hospital [V99C1-194, V100C-205, V101C-200]	NSC Taiwan, ROC(Ministry of Science and Technology, Taiwan); NCU; NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The authors wish to thank the support from NSC (http://web1.nsc.gov.tw/mp.aspx?mp=7 Taiwan, ROC), Grant No. 99-2627-B-008-003, and 97-2314-B-038-002-MY3, joint foundation of NCU (http://www.ncu.edu.tw), Grant No. CNJRF-101CGH-NCU-A4, VGHUST103-G1-3-3, NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001) and grants from Taipei Veterans General Hospital (http://www.vghtpe.gov.tw/doce/ V99C1-194, V100C-205 and V101C-200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoud H, 2007, IEEE SIGNAL PROC LET, V14, P297, DOI 10.1109/LSP.2006.888089; Amoud H, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/657391; Ator GA, 2010, VERTIGO EVALUATION T; Brown P, 1997, MOVEMENT DISORD, V12, P977, DOI 10.1002/mds.870120622; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Colnat-Coulbois S, 2005, J NEUROL NEUROSUR PS, V76, P780, DOI 10.1136/jnnp.2004.047829; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; DIENER HC, 1984, J NEUROL NEUROSUR PS, V47, P679, DOI 10.1136/jnnp.47.7.679; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Fife TD, 2008, NEUROLOGY, V168, P2118; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; HASAN SS, 1992, IEEE ENG MED BIOL, V11, P35, DOI 10.1109/51.256956; Horak FB, 2010, RESTOR NEUROL NEUROS, V28, P57, DOI 10.3233/RNN-2010-0515; Horak FB, 2009, ANN NY ACAD SCI, V1164, P76, DOI 10.1111/j.1749-6632.2008.03708.x; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Li L-P, 2011, RES J APPL SCI ENG T, V3, P1014; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Marigold DS, 2004, NEUROREHAB NEURAL RE, V18, P222, DOI 10.1177/1545968304271171; Mease KD, 2003, J GUID CONTROL DYNAM, V26, P318, DOI 10.2514/2.5049; Monsell EM, 1997, OTOLARYNG HEAD NECK, V117, P394, DOI 10.1016/S0194-5998(97)70132-3; Nashner LM, 2008, PRACTICAL MANAGEMENT; NEIMAN J, 1990, NEUROLOGY, V40, P741, DOI 10.1212/WNL.40.5.741; Oie KS, 2001, NEUROSCI LETT, V315, P113, DOI 10.1016/S0304-3940(01)02348-5; Pachori RB, 2009, INT CONF ACOUST SPEE, P537, DOI 10.1109/ICASSP.2009.4959639; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pilkar R, 2011, MATH BIOSCI ENG, V8, P1085, DOI 10.3934/mbe.2011.8.1085; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Reid V A, 2002, Neurol Clin Neurophysiol, V2002, P2, DOI 10.1162/153840902760213658; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Sasaki O, 2001, NEUROSCI RES, V41, P185, DOI 10.1016/S0168-0102(01)00276-0; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sullivan EV, 2010, BIOL PSYCHIAT, V67, P44, DOI 10.1016/j.biopsych.2009.08.008; Turnock MJE, 2010, J MOTOR BEHAV, V42, P61, DOI 10.1080/00222890903397103; Yeh JR, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/943431	38	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91230	10.1371/journal.pone.0091230	http://dx.doi.org/10.1371/journal.pone.0091230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632582	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400047
J	Zhang, XA; Chen, X; Zhai, Y; Cui, Y; Cao, PB; Zhang, HX; Wu, ZH; Li, PY; Yu, LX; Xia, X; He, FC; Zhou, GQ				Zhang, Xiaoai; Chen, Xi; Zhai, Yun; Cui, Ying; Cao, Pengbo; Zhang, Hongxing; Wu, Zhihao; Li, Peiyao; Yu, Lixa; Xia, Xia; He, Fuchu; Zhou, Gangqiao			Combined Effects of Genetic Variants of the PTEN, AKT1, MDM2 and p53 Genes on the Risk of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PI3K/PTEN/AKT/MTOR PATHWAY; ASSOCIATION; CANCER; OVEREXPRESSION; METASTASIS; PROGNOSIS; REGION	Phosphatase and tensin homolog (PTEN), v-akt murine thymoma viral oncogene homolog 1 (AKT1), mouse double minute 2 (MDM2) and p53 play important roles in the development of cancer. We examined whether the single nucleotide polymorphisms (SNPs) in the PTEN, AKT1, MDM2 and p53 genes were related to the risk and severity of nasopharyngeal carcinoma (NPC) in the Chinese population. Seven SNPs [p53 rs1042522, PTEN rs11202592, AKT1 SNP1-5 (rs3803300, rs1130214, rs3730358, rs1130233 and rs2494732)] were genotyped in 593 NPC cases and 480 controls by PCR direct sequencing or PCR-RFLP analysis. Multivariate logistic regression analysis was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). None of the polymorphisms alone was associated with the risk or severity of NPC. However, haplotype analyses indicated that a two-SNP core haplotype (SNP4-5, AA) in AKT1 was associated with a significantly increased susceptibility to NPC risk (adjusted OR = 3.87, 95% CI = 1.96-7.65; P<0.001). Furthermore, there was a significantly increased risk of NPC associated with the combined risk genotypes (i.e., p53 rs1042522 Arg/Pro + Pro/Pro, MDM2 rs2279244 G/T + G/G, PTEN rs11202592 C/C, AKT1 rs1130233 A/A). Compared with the low-risk group (0-2 combined risk genotypes), the high-risk group (3-4 combined risk genotypes) was associated with a significantly increased susceptibility to NPC risk (adjusted OR = 1.67, 95% CI = 1.12-2.50; P = 0.012). Our results suggest that genetic variants in the PTEN, AKT1, MDM2 and p53 tumor suppressor-oncoprotein network may play roles in mediating the susceptibility to NPC in Chinese populations.	[Zhang, Xiaoai; Chen, Xi; Zhai, Yun; Cao, Pengbo; Zhang, Hongxing; Wu, Zhihao; Li, Peiyao; Yu, Lixa; Xia, Xia; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Cui, Ying] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Peoples R China; [Zhang, Xiaoai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Guangxi Medical University; Beijing Institute of Microbiology & Epidemiology	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	hefc@nic.bmi.ac.cn; zhougq114@gmail.com		Liu, Wei/0000-0002-9302-8170; Cao, Pengbo/0000-0002-7820-114X	China National Funds for Distinguished Young Scientists [81125017]; National Natural Science Foundation of China [81222027, 30901707, 30901231]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by China National Funds for Distinguished Young Scientists (No. 81125017) and National Natural Science Foundation of China (No. 81222027, 30901707 and 30901231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2004, IN VIVO, V18, P555; Ashton KA, 2009, GYNECOL ONCOL, V113, P109, DOI 10.1016/j.ygyno.2008.12.036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Faratian D, 2009, CANC RES; Guo SL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3544; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hildesheim A, 2012, SEMIN CANCER BIOL, V22, P107, DOI 10.1016/j.semcancer.2012.01.007; Ishihara H, 2003, FEBS LETT, V554, P450, DOI 10.1016/S0014-5793(03)01225-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Ma J, 2012, J HUM GENET, V57, P261, DOI 10.1038/jhg.2012.15; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Pegtel DM, 2005, J VIROL, V79, P15430, DOI 10.1128/JVI.79.24.15430-15442.2005; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Singh V, 2008, ANN EPIDEMIOL, V18, P48, DOI 10.1016/j.annepidem.2007.06.006; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Taweevisit Mana, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P136; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Xu JL, 2012, ASIAN PAC J CANCER P, V13, P2157, DOI 10.7314/APJCP.2012.13.5.2157; Xu Xijin, 2004, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V18, P658; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yang Y, 2013, PROTEIN CELL, V4, P71, DOI 10.1007/s13238-012-2067-9; Yip WK, 2008, ONCOL REP, V19, P319; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang L, 2013, DRUG DES DEV THER, V7, P37, DOI 10.2147/DDDT.S30753; Zhou GQ, 2007, CLIN CANCER RES, V13, P2627, DOI 10.1158/1078-0432.CCR-06-2281	38	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92135	10.1371/journal.pone.0092135	http://dx.doi.org/10.1371/journal.pone.0092135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632578	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400146
J	Zhang, YF; Zheng, YF; Hu, JW; Du, N; Chen, F				Zhang, Yifei; Zheng, Yunfei; Hu, Jianwei; Du, Ning; Chen, Feng			Functional Diversity of the Microbial Community in Healthy Subjects and Periodontitis Patients Based on Sole Carbon Source Utilization	PLOS ONE			English	Article							BACTERIAL DIVERSITY; PROFILES; PATTERNS; BIOMASS; SHIFTS; PLAQUE; SOILS	Chronic periodontitis is one of the most common forms of biofilm-induced diseases. Most of the recent studies were focus on the dental plaque microbial diversity and microbiomes. However, analyzing bacterial diversity at the taxonomic level alone limits deeper comprehension of the ecological relevance of the community. In this study, we compared the metabolic functional diversity of the microbial community in healthy subjects and periodontitis patients in a creative way-to assess the sole carbon source utilization using Biolog assay, which was first applied on oral micro-ecology assessment. Pattern analyses of 95-sole carbon sources catabolism provide a community-level phenotypic profile of the microbial community from different habitats. We found that the microbial community in the periodontitis group had greater metabolic activity compared to the microbial community in the healthy group. Differences in the metabolism of specific carbohydrates (e. g. beta-methyl-D-glucoside, stachyose, maltose, D-mannose, beta-methyl-D-glucoside and pyruvic acid) were observed between the healthy and periodontitis groups. Subjects from the healthy and periodontitis groups could be well distinguished by cluster and principle component analyses according to the utilization of discriminate carbon sources. Our results indicate significant difference in microbial functional diversity between healthy subjects and periodontitis patients. We also found Biolog technology is effective to further our understanding of community structure as a composite of functional abilities, and it enables the identification of ecologically relevant functional differences among oral microbial communities.	[Zhang, Yifei; Hu, Jianwei; Du, Ning; Chen, Feng] Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China; [Zheng, Yunfei] Peking Univ, Sch Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, F (corresponding author), Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China.	moleculecf@gmail.com	zheng, yunfei/M-4172-2018		National Natural Science Foundation of China [81300880, 81200762]; Peking University School of Stomatology [PKUSS20110301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University School of Stomatology	This work was supported by grants 81300880 and 81200762 from National Natural Science Foundation of China, and by funding from Peking University School of Stomatology (PKUSS20110301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Anderson SA, 2002, APPL ENVIRON MICROB, V68, P5779, DOI 10.1128/AEM.68.11.5779-5783.2002; [Anonymous], 2009, ORAL MICROBIOLOGY; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Derry AM, 1998, WORLD J MICROB BIOT, V14, P571, DOI 10.1023/A:1008812821516; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fisk MC, 2003, SOIL BIOL BIOCHEM, V35, P591, DOI 10.1016/S0038-0717(03)00053-1; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Glimm E, 1997, J MICROBIOL METH, V30, P71, DOI 10.1016/S0167-7012(97)00046-8; GRENIER D, 1986, INFECT IMMUN, V53, P616, DOI 10.1128/IAI.53.3.616-620.1986; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; Kuhn I, 1996, SYST APPL MICROBIOL, V19, P442, DOI 10.1016/S0723-2020(96)80075-0; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Marsh P D, 1994, Adv Dent Res, V8, P263; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; MINAH GE, 1985, ARCH ORAL BIOL, V30, P397, DOI 10.1016/0003-9969(85)90066-4; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Rusznyak A, 2008, AQUAT BOT, V88, P211, DOI 10.1016/j.aquabot.2007.10.007; Schutter M, 2001, SOIL BIOL BIOCHEM, V33, P1481, DOI 10.1016/S0038-0717(01)00057-8; SHAH HN, 1989, ORAL MICROBIOL IMMUN, V4, P19, DOI 10.1111/j.1399-302X.1989.tb00401.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Staddon WJ, 1997, MICROB ECOL, V34, P125, DOI 10.1007/s002489900042; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; THEILADE ELSE, 1966, J PERIODONTAL RES, V1, P1, DOI 10.1111/j.1600-0765.1966.tb01842.x; WHITE DC, 1988, HYDROBIOLOGIA, V159, P119, DOI 10.1007/BF00007373; Zhang SM, 2011, EXP THER MED, V2, P1023, DOI 10.3892/etm.2011.311	31	11	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91977	10.1371/journal.pone.0091977	http://dx.doi.org/10.1371/journal.pone.0091977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632674	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400128
J	Zhu, S; Oremo, JA; Li, SQ; Zhen, MH; Tang, Y; Du, Y				Zhu, Sha; Oremo, Judith Apondi; Li, Sanqiang; Zhen, Minghui; Tang, Yue; Du, Ying			Synergistic Antitumor Activities of Docetaxel and Octreotide Associated with Apoptotic-Upregulation in Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOMATOSTATIN ANALOGS; RECEPTOR; CELLS; VEGF; OVEREXPRESSION; CHEMOTHERAPY; ACTIVATION; EXPRESSION; MECHANISM	Androgen deprivation therapy has become the fist-line treatment of metastatic prostate cancer; however, progression to castrate resistance disease occurs in the majority of patients. Thus, there is an urgent need for improvements in therapy for castration-resistant prostate cancer. The aims of the present study were to determine the efficacy somatostatin analogue octreotide (OCT) combined with a low dose of docetaxel (DTX) using castration resistant prostate cancer cells and to investigate the involved molecular mechanisms in vitro. The anti-proliferative and synergism potential effects were determined by MTT assay. Induction of apoptosis was analyzed employing annexing V and propidium iodide staining and flow cytometry. VEGFA, CASP9, CASP3 and ABCB1 gene expression was evaluated by RT-PCR and Q-RT-PCR analysis. OCT in combination with DTX treatments on DU145 cell migration was also evaluated. Investigation revealed that combined administration of DTX and OCT had significant, synergistically greater cytotoxicity than DTX or OCT treatment alone. The combination of the two drugs caused a more marked increase in apoptosis and resulted in greater suppression of invasive potential than either individual agent. There was obvious increase in caspase 3 expression in the OCT alone and two-drug combined treatment groups, however, VEGFA expression was markedly suppressed in them. These results support the conclusion that somatostatin analogues combined with docetaxel may enhance the chemotherapy efficacies through multiple mechanisms in castration-resistant PCa cell line. This work provides a preclinical rationale for the therapeutic strategies to improve the treatment in castrate resistance disease.	[Zhu, Sha; Oremo, Judith Apondi; Zhen, Minghui; Tang, Yue; Du, Ying] Zhengzhou Univ, Coll Basic Med Sci, Dept Microbiol & Immunol, Zhengzhou 450052, Peoples R China; [Li, Sanqiang] Henan Univ Sci & Technol, Coll Med, Dept Biochem & Mol Biol, Luoyang, Peoples R China	Zhengzhou University; Henan University of Science & Technology	Zhu, S (corresponding author), Zhengzhou Univ, Coll Basic Med Sci, Dept Microbiol & Immunol, Zhengzhou 450052, Peoples R China.	zsha@zzu.edu.cn			National Natural Science Foundation of China [81041102]; Scientific Research Preferred Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Preferred Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	This study was supported in parts by a grant from the National Natural Science Foundation of China (81041102) and Scientific Research Preferred Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appetecchia M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-19; Atmaca A, 2013, BRIT J CANCER, V108, P265, DOI 10.1038/bjc.2012.555; Avramis IA, 2001, ANTICANCER RES, V21, P2281; Bousquet C, 2006, EMBO J, V25, P3943, DOI 10.1038/sj.emboj.7601279; Bousquet C, 2012, J CLIN ENDOCR METAB, V97, P727, DOI 10.1210/jc.2011-2088; Caraglia M, 2005, FRONT BIOSCI, V10, P2566, DOI 10.2741/1720; Casar-Borota O, 2013, J CLIN ENDOCR METAB, V98, pE1730, DOI 10.1210/jc.2013-2145; Choi JH, 2002, BRIT J CANCER, V86, P1578, DOI 10.1038/sj.bjc.6600305; Engels FK, 2005, BRIT J CANCER, V93, P173, DOI 10.1038/sj.bjc.6602698; Goldberg AA, 2011, ONCOTARGET, V2, P761; Huang SM, 2013, ENDOCR RELAT CANC; Januchowski R, 2013, BIOMED PHARMACOTHER, V8; Jiang CC, 2009, NEOPLASIA, V11, P436, DOI 10.1593/neo.09208; Kaliszczak M, 2013, BRIT J CANCER, V109, P2356, DOI 10.1038/bjc.2013.584; Lattanzio L, 2013, ANTI-CANCER DRUG, V24, P120, DOI 10.1097/CAD.0b013e328358d1dc; Lu RC, 2013, ONCOL LETT, V5, P845, DOI 10.3892/ol.2013.1113; Maggioni D, 2010, J NEUROSCI RES, V88, P3171, DOI 10.1002/jnr.22465; Mentlein R, 2001, INT J CANCER, V92, P545, DOI 10.1002/ijc.1223; Nakabayashi M, 2010, BJU INT, V105, P1392, DOI 10.1111/j.1464-410X.2009.08971.x; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Ruscica M, 2013, MOL CELL ENDOCRINOL, V5, P860; Schmid H A, 2005, J Endocrinol Invest, V28, P28; Shen HC, 2009, CANCER CELL, V15, P461, DOI 10.1016/j.ccr.2009.05.005; Shen L, 2013, EUR UROL; Stattin P, 2003, BRIT J CANCER, V89, P1814, DOI 10.1038/sj.bjc.6601351; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Suarez C, 2014, BJU INT, V113, P367, DOI 10.1111/bju.12110; Tsagarakis NJ, 2011, WORLD J GASTROENTERO, V17, P313, DOI 10.3748/wjg.v17.i3.313; Vainas O, 2012, BRIT J CANCER, V107, P814, DOI 10.1038/bjc.2012.316; Wang XL, 2013, INT J CLIN EXP PATHO, V6, P586; Wilson C, 2008, BRIT J CANCER, V99, P2054, DOI 10.1038/sj.bjc.6604804; Yang J, 2013, TRANSPL P, V45, P2433, DOI 10.1016/j.transproceed.2013.02.112	34	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91817	10.1371/journal.pone.0091817	http://dx.doi.org/10.1371/journal.pone.0091817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632829	gold, Green Published, Green Submitted			2022-12-25	WOS:000332858400097
J	Han, L; Gao, Y; Li, DY				Han, Lei; Gao, Yang; Li, Deying			Ion Uptake in Tall Fescue as Affected by Carbonate, Chloride, and Sulfate Salinity	PLOS ONE			English	Article							MG; IRRIGATION; TOLERANCE; ALFALFA; GROWTH; WATER; CA	Turfgrass nutrient uptake may be differentially affected by different salts. The objective of this study was to compare nutrient uptake in tall fescue (Festuca arundinacea Schreb.) as affected by carbonate, chloride, and sulfate under isoosmotic, iso-Na+ strength conditions. 'Tar Heel II' and 'Wolfpack' cultivars were subjected to NaCl, Na2CO3, Na2SO4, CaCl2, NaCl+ CaCl2, Na2CO3+ CaCl2, and Na2SO4+ CaCl2, in the range of 0 to 225 mM. There was no cultivar difference regarding K, Na, Mg, and Mn content in shoots. 'Tar Heel II' had higher shoot Ca content than 'Wolfpack', which were 6.9 and 5.7 g kg 21, respectively. In general, K+/Na+ ratio decreased with increasing salt concentrations, which reached <1 at about 87.5 mM in Na2CO3 treatment. All salt treatments decreased Mg content in shoot tissues, especially in Na2CO3 and treatments containing CaCl2. Both Ca and Mg content in shoot were higher in the NaCl treatment than the Na2SO4 and Na2CO3 treatments. All salt treatments except Na2CO3 had higher Mn content in shoots compared to the control. In conclusion, nutrient uptake was differently affected by carbonate, chloride, and sulfate which are different in pH, electrical conductivity (EC), and osmotic potential at the same concentration. Adding Ca to the sodium salts increased Ca content and balanced K+/Na+ in shoots, but did not increase Mg content, which was below sufficient level. Maintaining Mg content in shoots under salinity stress was recommended. The physiological impact of elevated Mn content in shoot under salinity stress requires further study.	[Han, Lei] State Forestry Adm, Res Inst Forestry, Key Lab Forest Cultivat, Beijing, Peoples R China; [Gao, Yang; Li, Deying] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	North Dakota State University Fargo	Li, DY (corresponding author), N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA.	deying.li@ndsu.edu			National Natural Science Foundation of China [30500396]; National High Technology Research and Development Program of China [2009AA10Z109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The project was funded by the National Natural Science Foundation of China (Project No. 30500396), and the National High Technology Research and Development Program of China (Project No. 2009AA10Z109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshammary SF, 2004, AGR WATER MANAGE, V66, P97, DOI 10.1016/j.agwat.2003.11.002; Baldwin CM, 2006, HORTSCIENCE, V41, P808, DOI 10.21273/HORTSCI.41.3.808; Barnes R. F., 1990, Biotechnology in tall fescue improvement., P1; Bowman DC, 2006, J PLANT NUTR, V29, P1481, DOI 10.1080/01904160600837584; Carrow R.N., 2001, TURFGRASS SOIL FERTI; Carrow RN, 2003, CROP SCI, V43, P978, DOI 10.2135/cropsci2003.0978; Chen LM, 2010, J PLANT NUTR, V33, P1040, DOI 10.1080/01904161003728701; Clark RB, 2003, COMMUN SOIL SCI PLAN, V34, P1681, DOI 10.1081/CSS-120021306; Dudeck A. E., 1993, INT TURF SOC RES, V7, P680; ElSamad HMA, 1996, J PLANT NUTR, V19, P717, DOI 10.1080/01904169609365155; Gao Y, 2012, SCI HORTIC-AMSTERDAM, V139, P1, DOI 10.1016/j.scienta.2012.02.035; Greweling T, 1976, SEARCH, V6, P1; Hameed M, 2008, FLORA, V203, P683, DOI 10.1016/j.flora.2007.11.005; Hothem SD, 2003, J PLANT NUTR; Jones J.B., 1991, PLANT ANAL HDB PRACT; Jones R. G. W., 1979, Laidman, D. L.; Jones, R. G. W. [Editors]: Recent advances in the biochemistry of cereals., P63; Lee GJ, 2007, CROP SCI, V47, P2504, DOI 10.2135/cropsci2006.10.0639; Leskys AM, 1999, AGRON J, V91, P409, DOI 10.2134/agronj1999.00021962009100030009x; MacAdam JW, 1997, J PLANT NUTR, V20, P1137, DOI 10.1080/01904169709365323; Marcum KB, 2006, AGR WATER MANAGE, V80, P132, DOI 10.1016/j.agwat.2005.07.009; Page A.L, 1982, METHODS SOIL ANAL PA, Vsecond, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Qian YL, 2005, HORTSCIENCE, V40, P2170, DOI 10.21273/HORTSCI.40.7.2170; Rhoades JD, 1982, AGRONOMY, V9, P167, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C10; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; SAS Institute Inc, 2008, SAS 9 1 3 SAS US GUI; SHANNON MC, 1978, AGRON J, V70, P719, DOI 10.2134/agronj1978.00021962007000050006x; Shewmaker GE, 2008, PLANT SOIL, V302, P283, DOI 10.1007/s11104-007-9482-3; SIMSON CR, 1979, COMMUN SOIL SCI PLAN, V10, P153, DOI 10.1080/00103627909366885; SLEPER DA, 1977, CROP SCI, V17, P433, DOI 10.2135/cropsci1977.0011183X001700030023x; USDA-NRCS, 2006, NAT RANG PAST HDB; Wilkinson S. R., 1979, Tall Fescue (Buckner, R.C.; Bush, L.P., Editors)., P41; Wipff JK, 2003, 2003 ANN M ASA CSSSA	32	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91908	10.1371/journal.pone.0091908	http://dx.doi.org/10.1371/journal.pone.0091908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626173	gold, Green Submitted, Green Published			2022-12-25	WOS:000332851300145
J	Jung, S; Bang, M; Kim, BS; Lee, S; Kotov, NA; Kim, B; Jeon, D				Jung, Seungmoon; Bang, Minji; Kim, Byung Sun; Lee, Sungmun; Kotov, Nicholas A.; Kim, Bongsoo; Jeon, Daejong			Intracellular Gold Nanoparticles Increase Neuronal Excitability and Aggravate Seizure Activity in the Mouse Brain	PLOS ONE			English	Article							TUNGSTEN CARBIDE NANOPARTICLES; CA2+-ACTIVATED K+ CHANNELS; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; CA1 PYRAMIDAL NEURONS; POTASSIUM CHANNEL; RAT HIPPOCAMPUS; ZINC-OXIDE; DELIVERY; MEMBRANE	Due to their inert property, gold nanoparticles (AuNPs) have drawn considerable attention; their biological application has recently expanded to include nanomedicine and neuroscience. However, the effect of AuNPs on the bioelectrical properties of a single neuron remains unknown. Here we present the effect of AuNPs on a single neuron under physiological and pathological conditions in vitro. AuNPs were intracellularly applied to hippocampal CA1 neurons from the mouse brain. The electrophysiological property of CA1 neurons treated with 5- or 40-nm AuNPs was assessed using the whole-cell patch-clamp technique. Intracellular application of AuNPs increased both the number of action potentials (APs) and input resistance. The threshold and duration of APs and the after hyperpolarization (AHP) were decreased by the intracellular AuNPs. In addition, intracellular AuNPs elicited paroxysmal depolarizing shift-like firing patterns during sustained repetitive firings (SRF) induced by prolonged depolarization (10 sec). Furthermore, low Mg2+-induced epileptiform activity was aggravated by the intracellular AuNPs. In this study, we demonstrated that intracellular AuNPs alter the intrinsic properties of neurons toward increasing their excitability, and may have deleterious effects on neurons under pathological conditions, such as seizure. These results provide some considerable direction on application of AuNPs into central nervous system (CNS).	[Jung, Seungmoon; Bang, Minji; Kim, Byung Sun; Jeon, Daejong] Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, Taejon, South Korea; [Lee, Sungmun] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Kim, Bongsoo] Korea Adv Inst Sci & Technol KAIST, Dept Chem, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Khalifa University of Science & Technology; University of Michigan System; University of Michigan; Korea Advanced Institute of Science & Technology (KAIST)	Jeon, D (corresponding author), Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, Taejon, South Korea.	clark@kaist.ac.kr	Jeon, Daejong/C-1814-2011; Kotov, Nicholas/AAZ-4204-2021; Kim, Bongsoo/C-1545-2011	Kotov, Nicholas/0000-0002-6864-5804; Jeon, Daejong/0000-0002-6998-7603; Lee, Sungmun/0000-0002-1699-8376	Korea Health 21 RD grant [A120051]; Ministry of Health and Welfare; KUSTAR-KAIST Institute, Korea	Korea Health 21 RD grant; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); KUSTAR-KAIST Institute, Korea	This work was supported by the Korea Health 21 R&D grant (A120051) funded by Ministry of Health and Welfare, and also supported by the KUSTAR-KAIST Institute, Korea, under the R&D program supervised by the KAIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Chen YS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485102; Chin C, 2010, INT J NANOMED, V5, P315; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Crosera M, 2009, INT ARCH OCC ENV HEA, V82, P1043, DOI 10.1007/s00420-009-0458-x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Etame AB, 2012, NANOMED-NANOTECHNOL, V8, P1133, DOI 10.1016/j.nano.2012.02.003; Garcia-Garcia E, 2005, INT J PHARMACEUT, V298, P274, DOI 10.1016/j.ijpharm.2005.03.031; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Igelstrom KM, 2011, J NEUROPHYSIOL, V106, P2593, DOI 10.1152/jn.00601.2011; Jeon D, 2008, J BIOL CHEM, V283, P12093, DOI 10.1074/jbc.M800816200; JOHNSTON D, 1984, ANN NEUROL, V16, pS65, DOI 10.1002/ana.410160711; Jung S, 2012, NEUROSCI LETT, V529, P133, DOI 10.1016/j.neulet.2012.08.087; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Koziara JM, 2003, PHARM RES-DORDR, V20, P1772, DOI 10.1023/B:PHAM.0000003374.58641.62; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Leifert A, 2013, P NATL ACAD SCI USA, V110, P8004, DOI 10.1073/pnas.1220143110; Liu ZW, 2012, NANOTOXICOLOGY, V6, P414, DOI 10.3109/17435390.2011.583996; Liu ZW, 2009, TOXICOLOGY, V264, P179, DOI 10.1016/j.tox.2009.08.005; Marquis BJ, 2009, ANALYST, V134, P425, DOI 10.1039/b818082b; Martina M, 1998, J NEUROSCI, V18, P8111; Morin F, 1996, J NEUROPHYSIOL, V76, P1; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Paulo CSO, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494002; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prades R, 2012, BIOMATERIALS, V33, P7194, DOI 10.1016/j.biomaterials.2012.06.063; Sachdev PS, 2007, SCHIZOPHRENIA BULL, V33, P1029, DOI 10.1093/schbul/sbm012; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schulz DJ, 2006, J NEUROSCI, V26, P10362, DOI 10.1523/JNEUROSCI.3194-06.2006; Selvan ST, 2010, LANGMUIR, V26, P11631, DOI 10.1021/la903512m; Shan DH, 2013, TOXICOL IN VITRO, V27, P299, DOI 10.1016/j.tiv.2012.08.025; Shan DH, 2012, TOXICOL LETT, V209, P129, DOI 10.1016/j.toxlet.2011.12.001; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Wang TT, 2012, ACS NANO, V6, P1251, DOI 10.1021/nn203892h; Xi LJ, 2009, ENVIRON TOXICOL, V24, P211, DOI 10.1002/tox.20418; Xie YL, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-14; Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8; Zhao JX, 2009, NEUROTOXICOLOGY, V30, P220, DOI 10.1016/j.neuro.2008.12.005	54	37	40	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91360	10.1371/journal.pone.0091360	http://dx.doi.org/10.1371/journal.pone.0091360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625829	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300077
J	Ran, S; Liu, YJ; Zhang, L; Pei, YF; Yang, TL; Hai, R; Han, YY; Lin, Y; Tian, Q; Deng, HW				Ran, Shu; Liu, Yong-Jun; Zhang, Lei; Pei, Yufang; Yang, Tie-Lin; Hai, Rong; Han, Ying-Ying; Lin, Yong; Tian, Qing; Deng, Hong-Wen			Genome-Wide Association Study Identified Copy Number Variants Important for Appendicular Lean Mass	PLOS ONE			English	Article							ALTERNATIVE DEFINITIONS; STRUCTURAL VARIANTS; MUSCLE STRENGTH; GENES; POLYMORPHISMS; EXPRESSION; SARCOPENIA; FAMILY; RISK	Skeletal muscle is a major component of the human body. Age-related loss of muscle mass and function contributes to some public health problems such as sarcopenia and osteoporosis. Skeletal muscle, mainly composed of appendicular lean mass (ALM), is a heritable trait. Copy number variation (CNV) is a common type of human genome variant which may play an important role in the etiology of many human diseases. In this study, we performed genome-wide association analyses of CNV for ALM in 2,286 Caucasian subjects. We then replicated the major findings in 1,627 Chinese subjects. Two CNVs, CNV1191 and CNV2580, were detected to be associated with ALM (p = 2.26x10(-2) and 3.34x10(-3), respectively). In the Chinese replication sample, the two CNVs achieved p-values of 3.26x10(-2) and 0.107, respectively. CNV1191 covers a gene, GTPase of the immunity-associated protein family (GIMAP1), which is important for skeletal muscle cell survival/death in humans. CNV2580 is located in the Serine hydrolase-like protein (SERHL) gene, which plays an important role in normal peroxisome function and skeletal muscle growth in response to mechanical stimuli. In summary, our study suggested two novel CNVs and the related genes that may contribute to variation in ALM.	[Ran, Shu; Zhang, Lei; Pei, Yufang; Han, Ying-Ying; Lin, Yong; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Yang, Tie-Lin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ,Inst Mol Genet, Xian 710049, Peoples R China; [Hai, Rong] Inner Mongolia Peoples Hosp, Geriatr Hlth Clin, Inner Mongolia, Peoples R China; [Liu, Yong-Jun; Tian, Qing; Deng, Hong-Wen] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA	University of Shanghai for Science & Technology; Xi'an Jiaotong University; Tulane University	Deng, HW (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	hdeng2@tulane.edu	Zhang, Lei/L-1016-2016; Yang, Tie-Lin/G-8365-2014; Liu, Yong/GWQ-6163-2022	Zhang, Lei/0000-0002-1007-4834; Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	Shanghai University of Science and Technology; Shanghai Leading Academic Discipline Project [S30501]; National Institutes of Health [R01AG026564, RC2DE020756, R01AR057049, R01AR050496, R03TW008221]; SCOR (Specialized Center of Research) [P50AR055081]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Research on Women's Health (ORWH); Edward G. Schlieder Endowment; Franklin D. Dickson/Missouri Endowment; National Natural Science Foundation of China [31100902]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR059781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Shanghai University of Science and Technology; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR (Specialized Center of Research); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Edward G. Schlieder Endowment; Franklin D. Dickson/Missouri Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was partially supported by startup funding from Shanghai University of Science and Technology and Shanghai Leading Academic Discipline Project (S30501). The investigators of this work were partially supported by grants from the National Institutes of Health (R01AG026564, RC2DE020756, R01AR057049, R01AR050496 and R03TW008221), a SCOR (Specialized Center of Research) grant (P50AR055081) supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Office of Research on Women's Health (ORWH), and the Edward G. Schlieder Endowment and the Franklin D. Dickson/Missouri Endowment. Lei Zhang was also supported by the National Natural Science Foundation of China project (31100902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fisher KA, 2008, J ACOUST SOC AM, V123, P1862, DOI 10.1121/1.2839140; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hai R, 2012, J HUM GENET, V57, P33, DOI 10.1038/jhg.2011.125; Han YY, 2012, BONE, V51, P1000, DOI 10.1016/j.bone.2012.08.127; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Liaubet L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-548; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Development Core Team, 2010, R LANG ENV STAT COMP; Ravnik-Glavac M, 2012, CONSCIOUS COGN, V21, P1322, DOI 10.1016/j.concog.2012.06.003; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Sadusky TJ, 2001, GENOMICS, V73, P38, DOI 10.1006/geno.2000.6483; Saunders A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-53; Schwefel David, 2011, Small GTPases, V2, P27; Sipila S, 2006, J GERONTOL A-BIOL, V61, P92, DOI 10.1093/gerona/61.1.92; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027325; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89776	10.1371/journal.pone.0089776	http://dx.doi.org/10.1371/journal.pone.0089776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626161	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300009
J	Leisnham, PT; LaDeau, SL; Juliano, SA				Leisnham, Paul T.; LaDeau, Shannon L.; Juliano, Steven A.			Spatial and Temporal Habitat Segregation of Mosquitoes in Urban Florida	PLOS ONE			English	Article							QUINQUEFASCIATUS DIPTERA-CULICIDAE; CONDITION-SPECIFIC COMPETITION; AEDES-ALBOPICTUS DIPTERA; CULEX-PIPIENS DIPTERA; CONTAINER MOSQUITOS; SEASONAL-VARIATION; AGGREGATION MODEL; AEGYPTI DIPTERA; OVIPOSITION; COEXISTENCE	Understanding mechanisms fostering coexistence between invasive and resident species is important in predicting ecological, economic, or health impacts of invasive species. The non-native mosquitoes Aedes aegypti and Culex quinquefasciatus have been resident in the southeastern United States for over a century. They coexist at some urban sites with the more recent invasive Aedes albopictus, which is usually superior in interspecific competition. We tested predictions of temporal and spatial habitat segregation that foster coexistence of these resident species with the superior invasive competitor. We measured spatial and temporal patterns of site occupancy and abundance for all three species among standard oviposition traps in metropolitan Tampa, Florida. Consistent with the condition-specific competition hypothesis, A. albopictus and A. aegypti abundances were greater and C. quinquefasciatus abundance was lower late (September) versus early (June) in the rainy season, and the proportional increase of A. albopictus abundance was greater than that of A. aegypti. These results are postulated to result from greater dry-season egg mortality and associated greater rainy-season competitive superiority of larvae of A. albopictus, followed by A. aegypti, and C. quinquefasciatus. Spatial partitioning among landscape variables was also evident among species, with A. albopictus more likely to oviposit across a range of open grass landscapes whereas A. aegypti were mostly restricted to cemeteries. Culex quinquefasciatus showed a shift in abundance from cemeteries early in the rainy season to developed areas characterized by built environments with large proportions of impervious surfaces late in the rainy season, where A. albopictus was not in its highest abundance. These results suggest that both temporal and spatial variation, and their interaction, may contribute to local coexistence between Aedes and Culex mosquito species in urban areas.	[Leisnham, Paul T.] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA; [LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	University System of Maryland; University of Maryland College Park; Cary Institute of Ecosystem Studies; Illinois State University	Leisnham, PT (corresponding author), Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA.	leisnham@umd.edu		Juliano, Steven/0000-0002-6178-4553; Leisnham, Paul T./0000-0003-3527-8435; LaDeau, Shannon/0000-0003-4825-5435	NIAID [R01-AI-44793]; Illinois State University; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044793] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Illinois State University; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Field work was funded by NIAID grant R01-AI-44793 (Illinois State University subaward) and by a grant to SAJ from Illinois State University. Time for analyses and authorship for PTL was funded by the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2001, J THEOR BIOL, V209, P333, DOI 10.1006/jtbi.2001.2269; Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; BLAUSTEIN L, 1993, ECOL ENTOMOL, V18, P104, DOI 10.1111/j.1365-2311.1993.tb01190.x; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; CHADEE DD, 2002, ENTOMOL EXP APPL, V57, P1990; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008; Fader JE, 2013, ECOLOGY, V94, P478, DOI 10.1890/12-0123.1; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Geographic Mapping Section, 1999, FLOR LAND US COV FOR; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Ghosh SK, 2006, J STAT PLAN INFER, V136, P1360, DOI 10.1016/j.jspi.2004.10.008; Harbison JE, 2010, J MED ENTOMOL, V47, P67, DOI 10.1603/033.047.0109; Hartley S, 2002, J ANIM ECOL, V71, P651, DOI 10.1046/j.1365-2656.2002.00628.x; Hoeck PAE, 2003, J VECTOR ECOL, V28, P65; Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Juliano SA, 2008, ANN REV ENTOMOLOGY, V54; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kery M., 2010, INTRO WINBUGS ECOLOG; Lee JH, 2004, J AM MOSQUITO CONTR, V20, P248; Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI 10.1590/S0034-89102005000400006; Murrell EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043458; Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158; Serpa LLN, 2006, REV SAUDE PUBL, V40, P1101, DOI 10.1590/S0034-89102006005000008; O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; PETERS TM, 1969, MOSQ NEWS, V29, P435; Rawlins SC, 1998, J AM MOSQUITO CONTR, V14, P131; Reiter ME, 2009, J VECTOR ECOL, V34, P208, DOI [10.3376/038.034.0206, 10.1111/j.1948-7134.2009.00028.x]; Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2; Richards SL, 2006, J MED ENTOMOL, V43, P976, DOI 10.1603/0022-2585(2006)43[976:SAOAAD]2.0.CO;2; Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Schultz George W., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P369; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taniguchi Y, 2000, ECOLOGY, V81, P2027, DOI 10.2307/177290; Tilman D., 1982, Monographs in Population Biology, pi; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Workman PD, 2003, J VECTOR ECOL, V28, P213	56	44	46	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91655	10.1371/journal.pone.0091655	http://dx.doi.org/10.1371/journal.pone.0091655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621592	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300113
J	Shibata, M; Ninomiya, T; Jensen, MP; Anno, K; Yonemoto, K; Makino, S; Iwaki, R; Yamashiro, K; Yoshida, T; Imada, Y; Kubo, C; Kiyohara, Y; Sudo, N; Hosoi, M				Shibata, Mao; Ninomiya, Toshiharu; Jensen, Mark P.; Anno, Kozo; Yonemoto, Koji; Makino, Seiko; Iwaki, Rie; Yamashiro, Koji; Yoshida, Toshiyuki; Imada, Yuko; Kubo, Chiharu; Kiyohara, Yutaka; Sudo, Nobuyuki; Hosoi, Masako			Alexithymia Is Associated with Greater Risk of Chronic Pain and Negative Affect and with Lower Life Satisfaction in a General Population: The Hisayama Study	PLOS ONE			English	Article							VISUAL ANALOG SCALE; LOW-BACK-PAIN; PREVALENCE; DISEASE; COMORBIDITY; RELIABILITY; DEPRESSION; VALIDITY; GENDER; HEALTH	Introduction: Chronic pain is a significant health problem worldwide, with a prevalence in the general population of approximately 40%. Alexithymia - the personality trait of having difficulties with emotional awareness and self-regulation - has been reported to contribute to an increased risk of several chronic diseases and health conditions, and limited research indicates a potential role for alexithymia in the development and maintenance of chronic pain. However, no study has yet examined the associations between alexithymia and chronic pain in the general population. Methods: We administered measures assessing alexithymia, pain, disability, anxiety, depression, and life satisfaction to 927 adults in Hisayama, Japan. We classified the participants into four groups (low-normal alexithymia, middle-normal alexithymia, high-normal alexithymia, and alexithymic) based on their responses to the alexithymia measure. We calculated the risk estimates for the criterion measures by a logistic regression analysis. Results: Controlling for demographic variables, the odds ratio (OR) for having chronic pain was significantly higher in the high-normal (OR: 1.49, 95% CI: 1.07-2.09) and alexithymic groups (OR: 2.56, 95% CI: 1.47-4.45) compared to the low-normal group. Approximately 40% of the participants belonged to these two high-risk groups. In the subanalyses of the 439 participants with chronic pain, the levels of pain intensity, disability, depression, and anxiety were significantly increased and the degree of life satisfaction was decreased with elevating alexithymia categories. Conclusions: The findings demonstrate that, in the general population, higher levels of alexithymia are associated with a higher risk of having chronic pain. The early identification and treatment of alexithymia and negative affect may be beneficial in preventing chronic pain and reducing the clinical and economic burdens of chronic pain. Further research is needed to determine if this association is due to a causal effect of alexithymia on the prevalence and severity of chronic pain.	[Shibata, Mao; Anno, Kozo; Makino, Seiko; Iwaki, Rie; Yamashiro, Koji; Imada, Yuko; Sudo, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan; [Shibata, Mao; Kubo, Chiharu; Sudo, Nobuyuki; Hosoi, Masako] Kyushu Univ Hosp, Dept Psychosomat Med, Fukuoka 812, Japan; [Shibata, Mao; Ninomiya, Toshiharu; Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Jensen, Mark P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Yonemoto, Koji] Kurume Univ, Biostat Ctr, Fukuoka, Japan; [Yoshida, Toshiyuki] Int Univ Hlth & Welf, Dept Speech & Hearing Sci, Sch Hlth Sci Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; University of Washington; University of Washington Seattle; Kurume University; International University of Health & Welfare	Hosoi, M (corresponding author), Kyushu Univ Hosp, Dept Psychosomat Med, Fukuoka 812, Japan.	hosoi@cephal.med.kyushu-u.ac.jp		Hosoi, Masako/0000-0001-8880-5847; Sudo, Nobuyuki/0000-0002-7935-878X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590766]; Ministry of Health, Labor and Welfare of Japan [H23-Pain-Shitei-005]; Grants-in-Aid for Scientific Research [25253048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MH was supported in part by Grants-in-Aid for Scientific Research C (number 21590766) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and for the Health and Labor Sciences Research from the Ministry of Health, Labor and Welfare of Japan (H23-Pain-Shitei-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bagby RM, 1997, DISORDERS AFFECT REG, P30; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; CELIKEL F, 2006, ANN GEN PSYCHIATR, V15, P5; Cheng YH, 2002, SOC SCI MED, V55, P1415, DOI 10.1016/S0277-9536(01)00271-4; Committee on Advancing Pain Research Care and Education Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Franz M, 2008, SOC PSYCH PSYCH EPID, V43, P54, DOI 10.1007/s00127-007-0265-1; Gregory Robert J, 2005, Ann Clin Psychiatry, V17, P59, DOI 10.1080/10401230590932317; Group TITW, 2011, CLASS CHRON PAIN D 1; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hosoi M, 2010, PAIN, V149, P273, DOI 10.1016/j.pain.2010.02.012; Huber A, 2009, J PSYCHOSOM RES, V66, P425, DOI 10.1016/j.jpsychores.2008.11.009; Kano M, 2007, PAIN, V132, P252, DOI 10.1016/j.pain.2007.01.032; Kano M, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-1; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Kosturek A, 1998, PSYCHOSOMATICS, V39, P399, DOI 10.1016/S0033-3182(98)71298-8; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Lumley MA, 2005, PAIN MED, V6, P251, DOI 10.1111/j.1526-4637.2005.05036.x; Lumley MA, 1997, PSYCHOSOMATICS, V38, P497, DOI 10.1016/S0033-3182(97)71427-0; Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X; Lumley MA, 1997, COMPR PSYCHIAT, V38, P160, DOI 10.1016/S0010-440X(97)90069-9; Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698; Makino S, 2013, CLIN J PAIN, V29, P354, DOI 10.1097/AJP.0b013e3182579c63; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P57; Matsubayashi Kozo, 1994, Japanese Journal of Geriatrics, V31, P790; Mattila AK, 2006, J PSYCHOSOM RES, V61, P629, DOI 10.1016/j.jpsychores.2006.04.013; Mehling WE, 2005, J PSYCHOSOM RES, V58, P73, DOI 10.1016/j.jpsychores.2004.05.007; Mehling WE, 2007, J PSYCHOSOM RES, V62, P667, DOI 10.1016/j.jpsychores.2007.03.002; Messina A, 2011, ANN CLIN PSYCHIATRY, V23, P125; Mico JA, 2006, TRENDS PHARMACOL SCI, V27, P348, DOI 10.1016/j.tips.2006.05.004; Moriguchi Y, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-7; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Pecukonis EV, 2009, PAIN MANAG NURS, V10, P116, DOI 10.1016/j.pmn.2008.11.001; Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591; Porcelli P, 2007, PSYCHO-ONCOLOGY, V16, P644, DOI 10.1002/pon.1115; Saariaho AS, 2013, GEN HOSP PSYCHIAT, V35, P239, DOI 10.1016/j.genhosppsych.2012.11.011; Sharp John, 2005, Curr Psychiatry Rep, V7, P213, DOI 10.1007/s11920-005-0056-x; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spek V, 2008, ACTA PSYCHIAT SCAND, V118, P164, DOI 10.1111/j.1600-0447.2008.01199.x; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; Tomioka M, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-19; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Tulipani C, 2010, PSYCHOTHER PSYCHOSOM, V79, P156, DOI 10.1159/000286960; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224, DOI 10.1177/070674370805300403; Valkamo M, 2001, ACTA PSYCHIAT SCAND, V104, P391, DOI 10.1034/j.1600-0447.2001.00165.x; WISE TN, 1994, HEADACHE, V34, P362, DOI 10.1111/j.1526-4610.1994.hed3406362.x	47	64	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90984	10.1371/journal.pone.0090984	http://dx.doi.org/10.1371/journal.pone.0090984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621785	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000332845300041
J	Galvao, BPGV; Weber, BW; Rafudeen, MS; Ferreira, EO; Patrick, S; Abratt, VR				Galvao, Bruna P. G. V.; Weber, Brandon W.; Rafudeen, Mohamed S.; Ferreira, Eliane O.; Patrick, Sheila; Abratt, Valerie R.			Identification of a Collagen Type I Adhesin of Bacteroides fragilis	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; EXTRACELLULAR-MATRIX PROTEINS; EXTENSIVE DNA INVERSIONS; BINDING PROTEIN; SURFACE; SYSTEM; GLYCOSYLATION; EXPRESSION; PREDICTION; SEQUENCES	Bacteroides fragilis is an opportunistic pathogen which can cause life threatening infections in humans and animals. The ability to adhere to components of the extracellular matrix, including collagen, is related to bacterial host colonisation. Collagen Far Western analysis of the B. fragilis outer membrane protein (OMP) fraction revealed the presence two collagen adhesin bands of similar to 31 and similar to 34 kDa. The collagen adhesins in the OMP fraction were separated and isolated by two-dimensional SDS-PAGE and also purified by collagen affinity chromatography. The collagen binding proteins isolated by both these independent methods were subjected to tandem mass spectroscopy for peptide identification and matched to a single hypothetical protein encoded by B. fragilis NCTC 9343 (BF0586), conserved in YCH46 (BF0662) and 638R (BF0633) and which is designated in this study as cbp1 (collagen binding protein). Functionality of the protein was confirmed by targeted insertional mutagenesis of the cbp1 gene in B. fragilis GSH18 which resulted in the specific loss of both the similar to 31 kDa and the similar to 34 kDa adhesin bands. Purified his-tagged Cbp1, expressed in a B. fragilis wild-type and a glycosylation deficient mutant, confirmed that the cbp1 gene encoded the observed collagen adhesin, and showed that the 34 kDa band represents a glycosylated version of the similar to 31 kDa protein. Glycosylation did not appear to be required for binding collagen. This study is the first to report the presence of collagen type I adhesin proteins in B. fragilis and to functionally identify a gene encoding a collagen binding protein.	[Galvao, Bruna P. G. V.; Rafudeen, Mohamed S.; Abratt, Valerie R.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa; [Weber, Brandon W.] Univ Cape Town, Dept Clin Lab Sci, Div Med Biochem, Struct Biol Res Unit, Observatory, Western Cape, South Africa; [Ferreira, Eliane O.] Univ Fed Rio de Janeiro, Ilha Fundao, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Med, Rio de Janeiro, Brazil; [Ferreira, Eliane O.] Univ Fed Rio de Janeiro Polo Xerem, Rio De Janeiro, Brazil; [Patrick, Sheila] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland	University of Cape Town; University of Cape Town; Universidade Federal do Rio de Janeiro; Queens University Belfast	Abratt, VR (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa.	valerie.abratt@uct.ac.za	de Oliveira Ferreira, Eliane/E-4272-2019	de Oliveira Ferreira, Eliane/0000-0002-9977-6460; RAFUDEEN, MOHAMED SUHAIL/0000-0002-0364-6646	Medical Research Council of South Africa; South African National Research Foundation (NRF); NRF Africa Scholarship program; NRF Innovation Scholarship program; University of Cape Town Research Scholarship; Claude Leon Foundation	Medical Research Council of South Africa(South African Medical Research Council); South African National Research Foundation (NRF)(National Research Foundation - South Africa); NRF Africa Scholarship program; NRF Innovation Scholarship program; University of Cape Town Research Scholarship; Claude Leon Foundation	This study was supported by grants from the Medical Research Council of South Africa and the South African National Research Foundation (NRF). BPGVG acknowledges financial support from NRF Africa and Innovation Scholarship programs, University of Cape Town Research Scholarship and the Claude Leon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 1991, CELL BIOL EXTRACELLU; Barczak AK, 2009, CURR OPIN MICROBIOL, V12, P490, DOI 10.1016/j.mib.2009.06.012; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Ferreira ED, 2006, RES MICROBIOL, V157, P960, DOI 10.1016/j.resmic.2006.09.005; Ferreira ED, 2008, MEM I OSWALDO CRUZ, V103, P683, DOI 10.1590/S0074-02762008000700010; Dobrindt U, 2008, CURR OPIN MICROBIOL, V11, P409, DOI 10.1016/j.mib.2008.09.005; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Esmay PA, 2003, INFECT IMMUN, V71, P4368, DOI 10.1128/IAI.71.8.4368-4374.2003; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Galvao BPGV, 2011, ANAEROBE, V17, P142, DOI 10.1016/j.anaerobe.2011.02.009; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Houston S, 2010, MICROBIOL-SGM, V156, P2516, DOI 10.1099/mic.0.038588-0; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING LAB MANU; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Patrick S, 1996, MICROB PATHOGENESIS, V20, P191, DOI 10.1006/mpat.1996.0018; Patrick S, 2010, MICROBIOL-SGM, V156, P3255, DOI 10.1099/mic.0.042978-0; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pauer H, 2009, FEMS IMMUNOL MED MIC, V55, P388, DOI 10.1111/j.1574-695X.2009.00532.x; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Pumbwe L, 2006, ANAEROBE, V12, P211, DOI 10.1016/j.anaerobe.2006.09.004; Shoemaker NB, 2000, J BACTERIOL, V182, P928, DOI 10.1128/JB.182.4.928-936.2000; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Snydman DR, 2010, CLIN INFECT DIS, V50, pS26, DOI 10.1086/647940; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Szoke I, 1996, J MED MICROBIOL, V45, P338, DOI 10.1099/00222615-45-5-338; Szoke I, 1997, ANAEROBE, V3, P91, DOI 10.1006/anae.1997.0079; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91141	10.1371/journal.pone.0091141	http://dx.doi.org/10.1371/journal.pone.0091141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618940	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400050
J	Pan, JS; Wang, TL; Wang, L; Chen, WT; Song, M				Pan, Jinsong; Wang, Tingle; Wang, Li; Chen, Wantao; Song, Meng			Cyclic Strain-Induced Cytoskeletal Rearrangement of Human Periodontal Ligament Cells via the Rho Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DISSOCIATION-INHIBITOR-ALPHA; KINASE PATHWAY; IN-VITRO; MIGRATION; APOPTOSIS; REORGANIZATION; PROLIFERATION; PROTEIN; GTPASES	Background: Although mechanical stimulations are known have a significant impact on cytoskeletal rearrangement, little is known regarding the behavioral alteration of human periodontal ligament cells (hPDLCs) under cyclic strain. The aim of this study was to elucidate the role of the Rho signaling pathway on cyclic strain-induced cytoskeletal rearrangement of hPDLCs. Methods: Healthy hPDLCs obtained from teeth extracted for orthodontic purposes were subjected to cyclic strain with physiological loading (10%) at a frequency of 0.1 Hz for 6 h or 24 h using a FX-5000T system. Changes in cell morphology were examined by phase-contrast microscopy, while F-actin reorganization was observed by phalloidin staining and confocal microscopy. Protein expression was analyzed through western blot analysis. Results: Significant enhancement of cytoskeletal reorganization was observed following exposure to the cyclic strain. In addition, a significant increase was noted in the expression levels of GTP-Rho, Rho-associated protein kinase (ROCK) and p-cofilin, whereas the expression levels of Rho GDP dissociation inhibitors alpha (Rho-GDIa) were reduced in the hPDLCs, compared with the static control cells. More importantly, the Rock inhibitor Y-27632 suppressed cyclic strain-induced cytoskeletal rearrangement of hPDLCs. Additionally, Y-27632 and overexpression of Rho-GDIa were found to lower p-cofilin protein expressions under cyclic strain, while Rho-GDIa siRNA transfection had the opposite effect on the hPDLCs. Conclusion: Cyclic strain promotes cytoskeletal rearrangement of hPDLCs by downregulating the expression levels of Rho-GDIa and upregulating the expression levels of GTP-Rho, Rock and p-cofilin. These observations may provide valuable insight into understanding orthodontic tooth movement as well as alveolar bone remodeling.	[Pan, Jinsong; Chen, Wantao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Pan, Jinsong; Chen, Wantao] Shanghai Res Inst Stomatol, Shanghai 200030, Peoples R China; [Wang, Tingle] Cent Hosp Minhang Dist, Dept Stomatol, Shanghai, Peoples R China; [Wang, Li; Song, Meng] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Stomatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, WT (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, Shanghai 200030, Peoples R China.	chenwantao2002@hotmail.com; smgjzh160@sohu.com			National Natural Science Foundation of China [11172177, 30973343]; projects of the Shanghai Science and Technology Committee [11DZ2291800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); projects of the Shanghai Science and Technology Committee	This research was supported by grants from the National Natural Science Foundation of China (No. 11172177 and 30973343) and projects of the Shanghai Science and Technology Committee (Grant No. 11DZ2291800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2001, ARTERIOSCL THROM VAS, V21, P300, DOI 10.1161/01.ATV.21.3.300; Archambault J, 2002, J ORTHOPAED RES, V20, P36, DOI 10.1016/S0736-0266(01)00075-4; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Dhaliwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035046; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P33; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Onoue N, 2008, J CARDIOVASC PHARM, V51, P55, DOI 10.1097/FJC.0b013e31815b9d26; Pan Jin-song, 2010, Zhonghua Kou Qiang Yi Xue Za Zhi, V45, P80; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rolli-Derkinderen M, 2010, MOL CELL BIOL, V30, P4786, DOI 10.1128/MCB.00381-10; Sato R, 2002, J PERIODONTAL RES, V37, P15, DOI 10.1034/j.1600-0765.2002.90770.x; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Yamamoto M, 2012, MOL VIS, V18, P1727; Yano Y, 1997, J CELL BIOCHEM, V64, P505, DOI 10.1002/(SICI)1097-4644(19970301)64:3<505::AID-JCB17>3.0.CO;2-E; Zeichen J, 2000, AM J SPORT MED, V28, P888, DOI 10.1177/03635465000280061901; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	29	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91580	10.1371/journal.pone.0091580	http://dx.doi.org/10.1371/journal.pone.0091580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619024	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400108
J	Leithner, K; Hrzenjak, A; Trotzmuller, M; Moustafa, T; Kofeler, HC; Wohlkoenig, C; Stacher, E; Lindenmann, J; Harris, AL; Olschewski, A; Olschewski, H				Leithner, K.; Hrzenjak, A.; Troetzmueller, M.; Moustafa, T.; Koefeler, H. C.; Wohlkoenig, C.; Stacher, E.; Lindenmann, J.; Harris, A. L.; Olschewski, A.; Olschewski, H.			PCK2 activation mediates an adaptive response to glucose depletion in lung cancer	ONCOGENE			English	Article							HEPATIC ENERGY-METABOLISM; FLIGHT MASS-SPECTROMETRY; PHOSPHOENOLPYRUVATE CARBOXYKINASE; CELL METABOLISM; TUMOR-CELLS; NUTRIENT DEPRIVATION; EXPRESSION; LACTATE; GROWTH; COLON	Cancer cells are reprogrammed to utilize glycolysis at high rates, which provides metabolic precursors for cell growth. Consequently, glucose levels may decrease substantially in underperfused tumor areas. Gluconeogenesis results in the generation of glucose from smaller carbon substrates such as lactate and amino acids. The key gluconeogenic enzyme, phosphoenolpyruvate carboxykinase ( PEPCK), has been shown to provide metabolites for cell growth. Still, the role of gluconeogenesis in cancer is unknown. Here we show that the mitochondrial isoform of PEPCK (PCK2) is expressed and active in three lung cancer cell lines and in non-small cell lung cancer samples. PCK2 expression and activity were enhanced under low-glucose conditions. PEPCK activity was elevated threefold in lung cancer samples over normal lungs. To track the conversion of metabolites along the gluconeogenesis pathway, lung cancer cell lines were incubated with C-13(3)-lactate and label enrichment in the phosphoenolpyruvate (PEP) pool was measured. Under low glucose, all three carbons from C-13(3)-lactate appeared in the PEP pool, further supporting a conversion of lactate to pyruvate, via pyruvate carboxylase to oxaloacetate, and via PCK2 to phosphoenolpyruvate. PCK2 small interfering RNA and the pharmacological PEPCK inhibitor 3-mercaptopicolinate significantly enhanced glucose depletion-induced apoptosis in A549 and H23 cells, but not in H1299 cells. The growth of H23 multicellular spheroids was significantly reduced by 3-mercaptopicolinate. The results of this study suggest that lung cancer cells may utilize at least some steps of gluconeogenesis to overcome the detrimental metabolic situation during glucose deprivation and that in human lung cancers this pathway is activated in vivo.	[Leithner, K.; Hrzenjak, A.; Wohlkoenig, C.; Olschewski, H.] Med Univ Graz, Dept Internal Med, Div Pulmonol, A-8036 Graz, Austria; [Hrzenjak, A.; Olschewski, A.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Troetzmueller, M.; Koefeler, H. C.] Med Univ Graz, Core Facil Mass Spectrometry & Lipid, A-8036 Graz, Austria; [Moustafa, T.] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Stacher, E.] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Lindenmann, J.] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, A-8036 Graz, Austria; [Harris, A. L.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Olschewski, A.] Med Univ Graz, Univ Clin Anesthesiol & Intens Care Med, A-8036 Graz, Austria	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; University of Graz; Medical University of Graz; Medical University of Graz; University of Oxford; Medical University of Graz	Leithner, K (corresponding author), Med Univ Graz, Dept Internal Med, Div Pulmonol, Auenbruggerpl 15, A-8036 Graz, Austria.	katharina.leithner@medunigraz.at	Leithner, Katharina, MD, PhD/E-7662-2011; Harris, Adrian L/ABA-3343-2020; Olschewski, Horst/L-3547-2019; Moustafa, Tarek/P-9509-2016	Leithner, Katharina, MD, PhD/0000-0002-8252-9279; Harris, Adrian L/0000-0003-1376-8409; Olschewski, Horst/0000-0002-2834-7466; Moustafa, Tarek/0000-0002-6755-4687; Trotzmuller, Martin/0000-0003-0545-9892; Olschewski, Andrea/0000-0002-8189-3634; Kofeler, Harald/0000-0002-2725-9616	Oesterreichische Nationalbank (Anniversary Fund) [12713]; state government; Cancer Research UK; Inspire to Live; Cancer Research UK [11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Oesterreichische Nationalbank (Anniversary Fund); state government; Cancer Research UK(Cancer Research UK); Inspire to Live; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to Prof. Rudolf Zechner, Karl Franzens University, Graz, Austria, for his advice and valuable discussions. The excellent technical help by Astrid Knopf, Elisabeth Pollitzer and Alexandra Bertsch, and the contribution by Anna Katschnig are highly appreciated. We are grateful to Dr Guther Fauler and Christina Haas, Medical University of Graz, for their support. The study was supported by the Oesterreichische Nationalbank (Anniversary Fund, project number 12713 to HO) and by a research grant from the state government (KL). ALH is funded by Cancer Research UK and Inspire to Live.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Chun SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-293; Dang CV, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-3; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Fell DA, 2005, J EXP BOT, V56, P267, DOI 10.1093/jxb/eri011; GAUTHIER T, 1989, INT J BIOCHEM, V21, P191, DOI 10.1016/0020-711X(89)90108-0; Guenther GG, 2014, ONCOGENE, V33, P1776, DOI 10.1038/onc.2013.139; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Izuishi K, 2000, CANCER RES, V60, P6201; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee GH, 2011, ONCOL LETT, V2, P831, DOI 10.3892/ol.2011.353; MAKINEN AL, 1983, J BIOL CHEM, V258, P1654; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; SCOTT WJ, 1994, ANN THORAC SURG, V58, P698, DOI 10.1016/0003-4975(94)90730-7; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Stryer L., 1995, BIOCHEMISTRY-US, P559; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; WATFORD M, 1981, J BIOL CHEM, V256, P23; Xiong Y, 2011, COLD SH Q B, V76, P285, DOI 10.1101/sqb.2011.76.010942; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	51	119	123	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1044	1050		10.1038/onc.2014.47	http://dx.doi.org/10.1038/onc.2014.47			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632615				2022-12-25	WOS:000350121300010
J	Kurimoto, A; Kitazume, S; Kizuka, Y; Nakajima, K; Oka, R; Fujinawa, R; Korekane, H; Yamaguchi, Y; Wada, Y; Taniguchi, N				Kurimoto, Ayako; Kitazume, Shinobu; Kizuka, Yasuhiko; Nakajima, Kazuki; Oka, Ritsuko; Fujinawa, Reiko; Korekane, Hiroaki; Yamaguchi, Yoshiki; Wada, Yoshinao; Taniguchi, Naoyuki			The Absence of Core Fucose Up-regulates GnT-III and Wnt Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Glycosyltransferases; Lectin; Mass Spectrometry (MS); Oxidative Stress; Wnt Pathway; Fut8; GnT-III; Bisecting GlcNAc; Core Fucose	N-ACETYLGLUCOSAMINYLTRANSFERASE-III; TANDEM MASS-SPECTROMETRY; BETA-CATENIN; E-CADHERIN; GLYCOPROTEIN-SYNTHESIS; DEFICIENT MICE; CELL-ADHESION; CDNA CLONING; LUNG-CANCER; PURIFICATION	Background: Little is known about how loss of a given glycan causes adaptive regulation of other glycosylation. Results: Deficiency in core 1,6-fucose specifically up-regulates bisecting GlcNAc by enhanced gene expression of a biosynthetic enzyme GnT-III. Conclusion: Wnt signaling pathway regulates the expression of GnT-III. Significance: Wnt-mediated GnT-III up-regulation may be an adaptive response to the loss of core fucose. Glycans play key roles in a variety of protein functions under normal and pathological conditions, but several glycosyltransferase-deficient mice exhibit no or only mild phenotypes due to redundancy or compensation of glycan functions. However, we have only a limited understanding of the underlying mechanism for these observations. Our previous studies indicated that 70% of Fut8-deficient (Fut8(-/-)) mice that lack core fucose structure die within 3 days after birth, but the remainder survive for up to several weeks although they show growth retardation as well as emphysema. In this study, we show that, in mouse embryonic fibroblasts (MEFs) from Fut8(-/-) mice, another N-glycan branching structure, bisecting GlcNAc, is specifically up-regulated by enhanced gene expression of the responsible enzyme N-acetylglucosaminyltransferase III (GnT-III). As candidate target glycoproteins for bisecting GlcNAc modification, we confirmed that level of bisecting GlcNAc on 1-integrin and N-cadherin was increased in Fut8(-/-) MEFs. Moreover using mass spectrometry, glycan analysis of IgG(1) in Fut8(-/-) mouse serum demonstrated that bisecting GlcNAc contents were also increased by Fut8 deficiency in vivo. As an underlying mechanism, we found that in Fut8(-/-) MEFs Wnt/-catenin signaling is up-regulated, and an inhibitor against Wnt signaling was found to abrogate GnT-III expression, indicating that Wnt/-catenin is involved in GnT-III up-regulation. Furthermore, various oxidative stress-related genes were also increased in Fut8(-/-) MEFs. These data suggest that Fut8(-/-) mice adapted to oxidative stress, both ex vivo and in vivo, by inducing various genes including GnT-III, which may compensate for the loss of core fucose functions.	[Korekane, Hiroaki; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr, RIKEN Global Res Cluster, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yamaguchi, Yoshiki] RIKEN, RIKEN Max Planck Joint Res Ctr, RIKEN Global Res Cluster, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Wada, Yoshinao] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Izumi Ku, Osaka 5941101, Japan	RIKEN; RIKEN	Taniguchi, N (corresponding author), RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Global Res Cluster, Dis Glyc Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Yamaguchi, Yoshiki/N-5246-2015; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016	Yamaguchi, Yoshiki/0000-0003-0100-5439; Taniguchi, Naoyuki/0000-0001-5889-5968; Kizuka, Yasuhiko/0000-0002-3181-9743	RIKEN (the Systems Glycobiology Research project) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [20249018]; global Certificate of Eligibility (COE) program from the Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN (the Systems Glycobiology Research project) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global Certificate of Eligibility (COE) program from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by RIKEN (the Systems Glycobiology Research project) (to N. T.), Grant-in-Aid for Scientific Research (A) 20249018 (to N. T.), and the global Certificate of Eligibility (COE) program (to N. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ashline DJ, 2007, ANAL CHEM, V79, P3830, DOI 10.1021/ac062383a; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hedge J.E., 1962, METHODS CARBOHYDRATE, P380; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Korekane H, 2010, J BIOCHEM, V148, P359, DOI 10.1093/jb/mvq077; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; MIZUOCHI T, 1987, ARCH BIOCHEM BIOPHYS, V257, P387, DOI 10.1016/0003-9861(87)90581-9; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Nishima W, 2012, J PHYS CHEM B, V116, P8504, DOI 10.1021/jp212550z; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; SANTER UV, 1979, BIOCHEMISTRY-US, V18, P2533, DOI 10.1021/bi00579a016; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Taniguchi N, 1996, GLYCOBIOLOGY, V6, P691, DOI 10.1093/glycob/6.7.691; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wada Y, 2010, J PROTEOME RES, V9, P1367, DOI 10.1021/pr900913k; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2006, METHOD ENZYMOL, V417, P11, DOI 10.1016/S0076-6879(06)17002-0; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	48	37	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11704	11714		10.1074/jbc.M113.502542	http://dx.doi.org/10.1074/jbc.M113.502542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619415	Green Published, hybrid			2022-12-25	WOS:000335010600013
J	Cheng, XR; Yang, Q; Han, YQ; Ding, XF; Fan, Z				Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao			Capacity Limit of Simultaneous Temporal Processing: How Many Concurrent 'Clocks' in Vision?	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; NEURAL MECHANISMS; MULTIPLE TARGETS; FRONTAL-CORTEX; TIME; ATTENTION; TRACKING; NUMBER; DISCRIMINATION	A fundamental ability for humans is to monitor and process multiple temporal events that occur at different spatial locations simultaneously. A great number of studies have demonstrated simultaneous temporal processing (STP) in human and animal participants, i.e., multiple 'clocks' rather than a single 'clock'. However, to date, we still have no knowledge about the exact limitation of the STP in vision. Here we provide the first experimental measurement to this critical parameter in human vision by using two novel and complementary paradigms. The first paradigm combines merits of a temporal oddball-detection task and a capacity measurement widely used in the studies of visual working memory to quantify the capacity of STP (CSTP). The second paradigm uses a two-interval temporal comparison task with various encoded spatial locations involved in the standard temporal intervals to rule out an alternative, 'object individuation'-based, account of CSTP, which is measured by the first paradigm. Our results of both paradigms indicate consistently that the capacity limit of simultaneous temporal processing in vision is around 3 to 4 spatial locations. Moreover, the binding of the 'local clock' and its specific location is undermined by bottom-up competition of spatial attention, indicating that the time-space binding is resource-consuming. Our finding that the capacity of STP is not constrained by the capacity of visual working memory (VWM) supports the idea that the representations of STP are likely stored and operated in units different from those of VWM. A second paradigm confirms further that the limited number of location-bound 'local clocks' are activated and maintained during a time window of several hundreds milliseconds.	[Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao] CCNU, Key Lab Adolescent Cyberpsychol & Behav, Minist Educ, Wuhan, Peoples R China; [Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao] Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Fan, Z (corresponding author), CCNU, Key Lab Adolescent Cyberpsychol & Behav, Minist Educ, Wuhan, Peoples R China.	zfan@mail.edu.cn	?, ?/AAU-8474-2021; Ding, Xianfeng/B-8931-2016		SRF for ROCS, SEM; China Postdoctoral Science Foundation [20110491179]; Humanities and Social Sciences Foundation of the Ministry of Education, China [11YJC190006]; Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, China [2012A03]; National Natural Science Foundation of China [31170979]; National Social Science Foundation of China [13CSH075]	SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Humanities and Social Sciences Foundation of the Ministry of Education, China; Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This work was made possible by grants from SRF for ROCS, SEM, the China Postdoctoral Science Foundation (20110491179), the Humanities and Social Sciences Foundation of the Ministry of Education, China (11YJC190006), the open funds of Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, China (2012A03), the National Natural Science Foundation of China (31170979) and the National Social Science Foundation of China (13CSH075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayhan I, 2009, J VISION, V9, DOI 10.1167/9.11.2; Bahrami B, 2003, VISUAL COGNITION, V10; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; BERGEN JR, 1983, IEEE T SYST MAN CYB, V13, P857, DOI 10.1109/TSMC.1983.6313080; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bravo MJ, 1992, PERCEPTION PSYCHOPHY, V51; BROWN SW, 1990, ACTA PSYCHOL, V75, P103, DOI 10.1016/0001-6918(90)90081-P; Buhusi CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006268; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; COLTHEART M, 1980, PHILOS T ROY SOC B, V290, P57, DOI 10.1098/rstb.1980.0082; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dormal V, 2012, HUM BRAIN MAPP, V33, P1490, DOI 10.1002/hbm.21300; Fougnie D, 2006, PSYCHOL SCI, V17, P526, DOI 10.1111/j.1467-9280.2006.01739.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hartshorne JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002716; Helson H, 1930, Science, V71, P536, DOI 10.1126/science.71.1847.536; Hyde DC, 2011, J COGNITIVE NEUROSCI, V23, P2336, DOI 10.1162/jocn.2010.21581; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Johnston A, 2011, J VISION, V10, P1; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Klapproth F, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00071; Kline SR, 2013, ATTEN PERCEPT PSYCHO, V75, P161, DOI 10.3758/s13414-012-0370-4; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Magen H, 2009, NEUROPSYCHOLOGIA, V47, P1790, DOI 10.1016/j.neuropsychologia.2009.02.015; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; McPeek RM, 1999, VISION RES, V39, P1555, DOI 10.1016/S0042-6989(98)00228-4; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; MECK WH, 1984, J EXP PSYCHOL ANIM B, V10, P1, DOI 10.1037/0097-7403.10.1.1; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Morgan M, 2008, J VISION, V8, DOI 10.1167/8.11.9; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; New JJ, 2009, J VISION, V9, DOI 10.1167/9.2.4; OLTON DS, 1988, NEUROPSYCHOLOGIA, V26, P307, DOI 10.1016/0028-3932(88)90083-8; Pagano S, 2012, NEUROPSYCHOLOGIA, V50, P754, DOI 10.1016/j.neuropsychologia.2012.01.009; PALMER J, 1993, J EXP PSYCHOL HUMAN, V19, P108, DOI 10.1037/0096-1523.19.1.108; Pang KCH, 2001, NEUROSCIENCE, V103, P615, DOI 10.1016/S0306-4522(01)00018-5; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; PRICEWILLIAMS DR, 1954, NATURE, V173, P363, DOI 10.1038/173363a0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rousseau L, 1996, PERCEPT PSYCHOPHYS, V58, P434, DOI 10.3758/BF03206819; SAGI D, 1985, PERCEPTION, V14, pA27; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Staddon JER, 1999, J EXP ANAL BEHAV, V71, P215, DOI 10.1901/jeab.1999.71-215; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; van Rijn H, 2008, ACTA PSYCHOL, V129, P365, DOI 10.1016/j.actpsy.2008.09.002; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Yumoto N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019168	64	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91797	10.1371/journal.pone.0091797	http://dx.doi.org/10.1371/journal.pone.0091797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632675	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400089
J	Horstmann, JT; Henningsson, P; Thomas, ALR; Bomphrey, RJ				Horstmann, Jan T.; Henningsson, Per; Thomas, Adrian L. R.; Bomphrey, Richard J.			Wake Development behind Paired Wings with Tip and Root Trailing Vortices: Consequences for Animal Flight Force Estimates	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; VORTEX WAKE; KINEMATICS; BAT; REVEAL; FISH; LIFT	Recent experiments on flapping flight in animals have shown that a variety of unrelated species shed a wake behind left and right wings consisting of both tip and root vortices. Here we present an investigation using Particle Image Velocimetry (PIV) of the behaviour and interaction of trailing vortices shed by paired, fixed wings that simplify and mimic the wake of a flying animal with a non-lifting body. We measured flow velocities at five positions downstream of two adjacent NACA 0012 aerofoils and systematically varied aspect ratio, the gap between the wings (corresponding to the width of a non-lifting body), angle of attack, and the Reynolds number. The range of aspect ratios and Reynolds number where chosen to be relevant to natural fliers and swimmers, and insect flight in particular. We show that the wake behind the paired wings deformed as a consequence of the induced flow distribution such that the wingtip vortices convected downwards while the root vortices twist around each other. Vortex interaction and wake deformation became more pronounced further downstream of the wing, so the positioning of PIV measurement planes in experiments on flying animals has an important effect on subsequent force estimates due to rotating induced flow vectors. Wake deformation was most severe behind wings with lower aspect ratios and when the distance between the wings was small, suggesting that animals that match this description constitute high-risk groups in terms of measurement error. Our results, therefore, have significant implications for experimental design where wake measurements are used to estimate forces generated in animal flight. In particular, the downstream distance of the measurement plane should be minimised, notwithstanding the animal welfare constraints when measuring the wake behind flying animals.	[Horstmann, Jan T.] Bremen Univ Appl Sci, Bremen, Germany; [Horstmann, Jan T.; Henningsson, Per; Thomas, Adrian L. R.; Bomphrey, Richard J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Henningsson, Per] Lund Univ, Dept Biol, Lund, Sweden; [Bomphrey, Richard J.] Royal Vet Coll, Struct & Mot Lab, London, England	Bremen University of Applied Sciences; University of Oxford; Lund University; University of London; University of London Royal Veterinary College	Bomphrey, RJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	rbomphrey@rvc.ac.uk	Bomphrey, Richard/I-6272-2013	Bomphrey, Richard/0000-0002-4748-0510; Horstmann, Jan Tobias/0000-0001-6922-4756	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [EP/H004025/1, BB/J001244/1]; Swedish Research Council [2013-4838]; EPSRC Career Acceleration Fellowship; BBSRC [BB/J001244/1, BB/J000523/1, BB/J001244/2] Funding Source: UKRI; EPSRC [EP/H004025/2, EP/H004025/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J000523/1, BB/J001244/2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H004025/2, EP/H004025/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); EPSRC Career Acceleration Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) and the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grants to RJB (EP/H004025/1 and BB/J001244/1) and by the Swedish Research Council (www.vr.se) to PH (2013-4838). RJB holds an EPSRC Career Acceleration Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2009, EXP FLUIDS, V46, P835, DOI 10.1007/s00348-008-0602-5; Bomphrey RJ, 2012, J R SOC INTERFACE, V9, P3378, DOI 10.1098/rsif.2012.0418; Bomphrey RJ, 2012, EVOL BIOL, V39, P1, DOI 10.1007/s11692-011-9134-7; Bomphrey RJ, 2009, EXP FLUIDS, V46, P811, DOI 10.1007/s00348-009-0631-8; Bomphrey RJ, 2006, J R SOC INTERFACE, V3, P311, DOI 10.1098/rsif.2005.0090; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; Crow S. C., 1970, AIAA J, V8, P2172, DOI DOI 10.2514/3.6083; Drucker EG, 1999, J EXP BIOL, V202, P2393; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2009, EXP FLUIDS, V46, P923, DOI 10.1007/s00348-009-0634-5; Henningsson P, 2008, J EXP BIOL, V211, P717, DOI 10.1242/jeb.012146; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Henningsson P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0099; Henningsson P, 2012, J R SOC INTERFACE, V9, P1177, DOI 10.1098/rsif.2011.0749; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; Hubel TY, 2009, EXP FLUIDS, V46, P933, DOI 10.1007/s00348-009-0624-7; Johansson LC, 2009, J EXP BIOL, V212, P3365, DOI 10.1242/jeb.034454; Kundu PK, 2012, FLUID MECHANICS, 5TH EDITION, P1; Lack D., 1956, SWIFTS TOWER; MILNETHOMPSON LM, 1966, THEORETICAL AERODYNA; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Muijres FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037335; Muijres FT, 2011, EXP FLUIDS, V51, P511, DOI 10.1007/s00348-011-1067-5; Muller UK, 1997, J EXP BIOL, V200, P2893; Nauen JC, 2002, J EXP BIOL, V205, P3271; Nauen JC, 2002, J EXP BIOL, V205, P1709; Ortega JM, 2002, AIAA J, V40, P709, DOI 10.2514/2.1703; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; RAYNER JMV, 1979, J FLUID MECH, V91, P731, DOI 10.1017/S0022112079000422; Rosen M, 2004, J EXP BIOL, V207, P4255, DOI 10.1242/jeb.01283; SPEDDING GR, 1984, J EXP BIOL, V111, P81; Stepniewski WZ, 1979, ROTARY WING AERODYNA; Taylor GI, 1938, PROC R SOC LON SER-A, V164, P0476, DOI 10.1098/rspa.1938.0032; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; THOMAS PJ, 1994, J FLUID MECH, V265, P289, DOI 10.1017/S0022112094000844; Waldman RM, 2012, EXP FLUIDS, V53, P1487, DOI 10.1007/s00348-012-1368-3	36	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91040	10.1371/journal.pone.0091040	http://dx.doi.org/10.1371/journal.pone.0091040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632825	gold, Green Submitted, Green Published			2022-12-25	WOS:000332858400037
J	Kendall, EJ; Flynn, MT				Kendall, Edward J.; Flynn, Matthew T.			Automated Breast Image Classification Using Features from Its Discrete Cosine Transform	PLOS ONE			English	Article							COMPUTER-AIDED DETECTION; DIAGNOSIS CAD; PERFORMANCE	Purpose: This work aimed to improve breast screening program accuracy using automated classification. The goal was to determine if whole image features represented in the discrete cosine transform would provide a basis for classification. Priority was placed on avoiding false negative findings. Methods: Online datasets were used for this work. No informed consent was required. Programs were developed in Mathematica and, where necessary to improve computational performance ported to C++. The use of a discrete cosine transform to separate normal from cancerous breast tissue was tested. Features (moments of the mean) were calculated in square sections of the transform centered on the origin. K-nearest neighbor and naive Bayesian classifiers were tested. Results: Forty-one features were generated and tested singly, and in combination of two or three. Using a k-nearest neighbor classifier, sensitivities as high as 98% with a specificity of 66% were achieved. With a naive Bayesian classifier, sensitivities as high as 100% were achieved with a specificity of 64%. Conclusion: Whole image classification based on discrete cosine transform (DCT) features was effectively implemented with a high level of sensitivity and specificity achieved. The high sensitivity attained using the DCT generated feature set implied that these classifiers could be used in series with other methods to increase specificity. Using a classifier with near 100% sensitivity, such as the one developed in this project, before applying a second classifier could only boost the accuracy of that classifier.	[Kendall, Edward J.; Flynn, Matthew T.] Mem Univ Newfoundland, Discipline Radiol, St John, NF, Canada	Memorial University Newfoundland	Kendall, EJ (corresponding author), Mem Univ Newfoundland, Discipline Radiol, St John, NF, Canada.	edward.kendall@mun.ca			Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was funded in part by the Canadian Breast Cancer Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azavedo E, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-22; BIRD RE, 1992, RADIOLOGY, V184, P613, DOI 10.1148/radiology.184.3.1509041; Coldman AJ, 2006, RADIOLOGY, V238, P809, DOI 10.1148/radiol.2382041684; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dromain C, 2013, EUR J RADIOL, V82, P417, DOI 10.1016/j.ejrad.2012.03.005; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Gur D, 2004, RADIOLOGY, V233, P418, DOI 10.1148/radiol.2332040277; Gur D, 2003, RADIOLOGY, V228, P10, DOI 10.1148/radiol.2281020709; Gur D, 2008, RADIOLOGY, V249, P47, DOI 10.1148/radiol.2491072025; Heath M, 1998, COMP IMAG VIS, V13, P457; Heath M., 2000, P 5 INT WORKSH DIG M, P212; Houssami N, 2009, J MED IMAG RADIAT ON, V53, P171, DOI 10.1111/j.1754-9485.2009.02062.x; Houssami N, 2009, MED J AUSTRALIA, V190, P493, DOI 10.5694/j.1326-5377.2009.tb02526.x; Jiang YL, 2006, ACAD RADIOL, V13, P84, DOI 10.1016/j.acra.2005.09.086; Kendall EJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-43; Liu S, 1998, 1998 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL 1, P727, DOI 10.1109/ICIP.1998.723599; Liu S, 2001, IEEE T IMAGE PROCESS, V10, P874, DOI 10.1109/83.923284; Oliver A, 2010, MED IMAGE ANAL, V14, P87, DOI 10.1016/j.media.2009.12.005; Pisano ED, 2001, IWDM 2000: 5TH INTERNATIONAL WORKSHOP ON DIGITAL MAMMOGRAPHY, P504; Sato M, 2012, BREAST CANC; Scott HJ, 2005, P SOC PHOTO-OPT INS, V5749, P557, DOI 10.1117/12.596892; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Suckling J, 1994, MAMMOGRAPHIC IMAGE A; Taylor-Phillips S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3279; The Breast Cancer Surveillance Consortium, 2005, NCI FUND BREAST CANC; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066	31	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91015	10.1371/journal.pone.0091015	http://dx.doi.org/10.1371/journal.pone.0091015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632807	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400034
J	Mittal, R; Grati, M; Gerring, R; Blackwelder, P; Yan, D; Li, JD; Liu, XZ				Mittal, Rahul; Grati, M'hamed; Gerring, Robert; Blackwelder, Patricia; Yan, Denise; Li, Jian-Dong; Liu, Xue Zhong			In Vitro Interaction of Pseudomonas aeruginosa with Human Middle Ear Epithelial Cells	PLOS ONE			English	Article							SUPPURATIVE OTITIS-MEDIA; SENSORINEURAL HEARING-LOSS; OUTER-MEMBRANE PROTEINS; SENSITIVITY PATTERN; HOST INNATE; INVASION; DEATH; COMPLICATIONS; MANIPULATION; PATHOGENESIS	Background: Otitis media (OM) is an inflammation of the middle ear which can be acute or chronic. Acute OM is caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis whereas Pseudomonas aeruginosa is a leading cause of chronic suppurative otitis media (CSOM). CSOM is a chronic inflammatory disorder of the middle ear characterized by infection and discharge. The survivors often suffer from hearing loss and neurological sequelae. However, no information is available regarding the interaction of P. aeruginosa with human middle ear epithelial cells (HMEECs). Methodology and Findings: In the present investigation, we demonstrate that P. aeruginosa is able to enter and survive inside HMEECs via an uptake mechanism that is dependent on microtubule and actin microfilaments. The actin microfilament disrupting agent as well as microtubule inhibitors exhibited significant decrease in invasion of HMEECs by P. aeruginosa. Confocal microscopy demonstrated F-actin condensation associated with bacterial entry. This recruitment of F-actin was transient and returned to normal distribution after bacterial internalization. Scanning electron microscopy demonstrated the presence of bacteria on the surface of HMEECs, and transmission electron microscopy confirmed the internalization of P. aeruginosa located in the plasma membrane-bound vacuoles. We observed a significant decrease in cell invasion of OprF mutant compared to the wild-type strain. P. aeruginosa induced cytotoxicity, as demonstrated by the determination of lactate dehydrogenase levels in culture supernatants of infected HMEECs and by a fluorescent dye-based assay. Interestingly, OprF mutant showed little cell damage compared to wild-type P. aeruginosa. Conclusions and Significance: This study deciphered the key events in the interaction of P. aeruginosa with HMEECs in vitro and highlighted the role of bacterial outer membrane protein, OprF, in this process. Understanding the molecular mechanisms in the pathogenesis of CSOM will help in identifying novel targets to design effective therapeutic strategies and to prevent hearing loss.	[Mittal, Rahul; Grati, M'hamed; Gerring, Robert; Yan, Denise; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Blackwelder, Patricia] Univ Miami, Ctr Adv Microscopy, Coral Gables, FL 33124 USA; [Blackwelder, Patricia] RSMAS, Key Biscayne, FL USA; [Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Li, Jian-Dong] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA	University of Miami; University of Miami; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University of Miami	Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.	xliu@med.miami.edu		Li, Jian-Dong/0000-0002-5593-050X; Grati, Mhamed/0000-0001-5149-3245; Grati, M'hamed/0000-0002-4490-1682; Blackwelder, Patricia/0000-0003-0989-2976	National Institutes of Health [R01DC005575, R01DC012546, R01DC012115]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC012546, R01DC005843, R01DC005575, R01DC012115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research work in Dr. Liu's laboratory is supported by the National Institutes of Health grants R01DC005575, R01DC012546, and R01DC012115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi OA, 2012, AFR HEALTH SCI, V12, P362, DOI 10.4314/ahs.v12i3.18; Alberts B, 2002, MOL BIOL CELL; Allen Matthew, 1994, Clinical Materials, V16, P189; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bluestone C.D, 1996, PEDIAT OTOLARYNGOLOG; Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X; Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Carayol N, 2013, CURR OPIN MICROBIOL, V16, P32, DOI 10.1016/j.mib.2012.11.010; Chew Yok Kuan, 2012, Ear Nose Throat J, V91, P430; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Cureoglu S, 2004, LARYNGOSCOPE, V114, P622, DOI 10.1097/00005537-200404000-00006; da Costa SS, 2009, EUR ARCH OTO-RHINO-L, V266, P221, DOI 10.1007/s00405-008-0739-0; Dayasena RP, 2011, AUSTRALAS MED J, V4, P101, DOI 10.4066/AMJ.2011.549; FINNEN RL, 1992, J BACTERIOL, V174, P4977, DOI 10.1128/JB.174.15.4977-4985.1992; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Horsington J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003239; Huang M, 1990, Ann Otol Rhinol Laryngol Suppl, V148, P35; JANDA JM, 1991, INFECT IMMUN, V59, P154, DOI 10.1128/IAI.59.1.154-161.1991; Jensen RG, 2013, INT J PEDIATR OTORHI, V77, P1530, DOI 10.1016/j.ijporl.2013.06.025; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kim BG, 2014, LARYNGOSCOPE, V124, pE27, DOI 10.1002/lary.24397; Kolo ES, 2012, INDIAN J OTOLARYNGOL, V64, P59, DOI 10.1007/s12070-011-0251-5; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lim DJ, 2012, ADV EXP MED BIOL, V720, P15, DOI 10.1007/978-1-4614-0254-1_2; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Madana J, 2011, INT J PEDIATR OTORHI, V75, P1104, DOI 10.1016/j.ijporl.2011.05.025; Matz G, 2004, OTOLARYNG HEAD NECK, V130, pS79, DOI 10.1016/j.otohns.2003.12.007; McClean S, 2012, PROTEIN PEPTIDE LETT, V19, P1013, DOI 10.2174/092986612802762688; MILIOTIS MD, 1995, INFECT IMMUN, V63, P4959, DOI 10.1128/IAI.63.12.4959-4963.1995; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; MORIZONO T, 1991, OTOLARYNG CLIN N AM, V24, P835; Morris P, 2013, AM FAM PHYSICIAN, V88, P694; Morris Peter S, 2009, Pediatr Clin North Am, V56, P1383, DOI 10.1016/j.pcl.2009.09.007; Mujeeb A, 2013, ACTA BIOMATER, V9, P4609, DOI 10.1016/j.actbio.2012.08.044; Nair MKM, 2009, FOODBORNE PATHOG DIS, V6, P495, DOI 10.1089/fpd.2008.0228; Navarro-Garcia F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/374395; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Oelschlaeger Tobias A, 2000, BACTERIAL INVASION E, DOI [10.1007/978-1-4757-4580-1, DOI 10.1007/978-1-4757-4580-1]; Olatoke Fatai, 2008, Ear Nose Throat J, V87, pE19; Park HY, 2012, INT J PEDIATR OTORHI, V76, P475, DOI 10.1016/j.ijporl.2011.12.028; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Posselt G, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-77; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Qureishi A, 2014, INFECT DRUG RESIST, V7, P15, DOI 10.2147/IDR.S39637; RAWLING EG, 1995, INFECT IMMUN, V63, P38, DOI 10.1128/IAI.63.1.38-42.1995; RICHARDSON WP, 1988, INFECT IMMUN, V56, P2512, DOI 10.1128/IAI.56.9.2512-2514.1988; Saini Santosh, 2005, Indian J Pathol Microbiol, V48, P413; Sattar A, 2012, JCPSP-J COLL PHYSICI, V22, P128, DOI 02.2012/JCPSP.128129; STGEME JW, 1990, INFECT IMMUN, V58, P4036, DOI 10.1128/IAI.58.12.4036-4044.1990; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Villenave R, 2013, TRENDS MICROBIOL, V21, P238, DOI 10.1016/j.tim.2013.02.004; WOODRUFF WA, 1988, J BACTERIOL, V170, P2592, DOI 10.1128/jb.170.6.2592-2598.1988; Wu HH, 2009, J NEUROPATH EXP NEUR, V68, P677, DOI 10.1097/NEN.0b013e3181a77d1e; Wu J, 2013, DIGEST DIS SCI, V58, P1830, DOI 10.1007/s10620-013-2589-x; Wu JF, 2012, ACTA OTO-LARYNGOL, V132, P261, DOI 10.3109/00016489.2011.643239; Yeo SG, 2007, ACTA OTO-LARYNGOL, V127, P1062, DOI 10.1080/00016480601126978; Yorgancilar E, 2013, B-ENT, V9, P17; Yorgancilar E, 2013, EUR ARCH OTO-RHINO-L, V270, P69, DOI 10.1007/s00405-012-1924-8; Zou YN, 2013, BIOSCI BIOTECH BIOCH, V77, P345, DOI 10.1271/bbb.120764	75	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91885	10.1371/journal.pone.0091885	http://dx.doi.org/10.1371/journal.pone.0091885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632826	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400116
J	O'Mara, ML; Mark, AE				O'Mara, Megan L.; Mark, Alan E.			Structural Characterization of Two Metastable ATP-Bound States of P-Glycoprotein	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG ABC TRANSPORTER; TRANSMEMBRANE SEGMENTS; CROSS-LINKING; DRUG-BINDING; CASSETTE TRANSPORTER; CRYSTAL-STRUCTURE; LINKER REGION; ENVIRONMENT	ATP Binding Cassette (ABC) transporters couple the binding and hydrolysis of ATP to the transport of substrate molecules across the membrane. The mechanism by which ATP binding and/or hydrolysis drives the conformational changes associated with substrate transport has not yet been characterized fully. Here, changes in the conformation of the ABC export protein P-glycoprotein on ATP binding are examined in a series of molecular dynamics simulations. When one molecule of ATP is placed at the ATP binding site associated with each of the two nucleotide binding domains (NBDs), the membrane-embedded P-glycoprotein crystal structure adopts two distinct metastable conformations. In one, each ATP molecule interacts primarily with the Walker A motif of the corresponding NBD. In the other, the ATP molecules interacts with both Walker A motif of one NBD and the Signature motif of the opposite NBD inducing the partial dimerization of the NBDs. This interaction is more extensive in one of the two ATP binding site, leading to an asymmetric structure. The overall conformation of the transmembrane domains is not altered in either of these metastable states, indicating that the conformational changes associated with ATP binding observed in the simulations in the absence of substrate do not lead to the outward-facing conformation and thus would be insufficient in themselves to drive transport. Nevertheless, the metastable intermediate ATP-bound conformations observed are compatible with a wide range of experimental cross-linking data demonstrating the simulations do capture physiologically important conformations. Analysis of the interaction between ATP and its cofactor Mg2+ with each NBD indicates that the coordination of ATP and Mg2+ differs between the two NBDs. The role structural asymmetry may play in ATP binding and hydrolysis is discussed. Furthermore, we demonstrate that our results are not heavily influenced by the crystal structure chosen for initiation of the simulations.	[O'Mara, Megan L.; Mark, Alan E.] Univ Queensland, IMB, SCMB, Brisbane, Qld, Australia; [O'Mara, Megan L.] Univ Queensland, IMB, SMB, Brisbane, Qld, Australia; [Mark, Alan E.] Univ Queensland, IMB, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	O'Mara, ML (corresponding author), Univ Queensland, IMB, SCMB, Brisbane, Qld, Australia.	m.omara@uq.edu.au	O'Mara, Megan/ABF-8913-2020; O'Mara, Megan/AAY-5934-2021; Mark, Alan E/A-8799-2011; O'Mara, Megan L/A-4962-2011	O'Mara, Megan/0000-0002-8764-1585; Mark, Alan E/0000-0001-5880-4798; O'Mara, Megan L/0000-0002-8764-1585	Australian Research Council [DP110100327]; National Health and Medical Research Council [APP1049685]; Merit Allocation Scheme on the NCI National Facility at the ANU	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Merit Allocation Scheme on the NCI National Facility at the ANU	This work was supported by grants from the Australian Research Council (DP110100327), the National Health and Medical Research Council (APP1049685) and the Merit Allocation Scheme on the NCI National Facility at the ANU. MLO is an ARC Discovery Early Career Researcher (DE120101550). AEM is an ARC Discovery Outstanding Researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AN, 2012, PROTEIN SCI, V21, P107, DOI 10.1002/pro.767; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Callaghan R, 2006, FEBS LETT, V580, P1056, DOI 10.1016/j.febslet.2005.11.083; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Ferreira RJ, 2012, J CHEM THEORY COMPUT, V8, P1853, DOI 10.1021/ct300083m; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Liang J, 2012, BIOCH BIOPHYSICA ACT; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loo TW, 2007, BIOCHEMISTRY-US, V46, P9328, DOI 10.1021/bi700837y; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, J BIOL CHEM, V279, P38395, DOI 10.1074/jbc.M405623200; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LOO TW, 1994, J BIOL CHEM, V269, P7750; Ma J, 2013, PROTEINS, V81, P1653, DOI 10.1002/prot.24324; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modok S, 2004, J LIPID RES, V45, P1910, DOI 10.1194/jlr.M400220-JLR200; Nuti SL, 2000, BIOCHEMISTRY-US, V39, P3424, DOI 10.1021/bi992392w; Nuti SL, 2002, J BIOL CHEM, V277, P29417, DOI 10.1074/jbc.M204054200; O'Mara ML, 2012, J CHEM THEORY COMPUT, V8, P3964, DOI 10.1021/ct300254y; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Romsicki Y, 1998, EUR J BIOCHEM, V256, P170, DOI 10.1046/j.1432-1327.1998.2560170.x; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sato T, 2009, FEBS J, V276, P3504, DOI 10.1111/j.1742-4658.2009.07072.x; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Oliveira AS, 2011, PROTEINS, V79, P1977, DOI 10.1002/prot.23023; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378	64	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91916	10.1371/journal.pone.0091916	http://dx.doi.org/10.1371/journal.pone.0091916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632881	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400120
J	Celton, JM; Kelner, JJ; Martinez, S; Bechti, A; Touhami, AK; James, MJ; Durel, CE; Laurens, F; Costes, E				Celton, Jean-Marc; Kelner, Jean-Jacques; Martinez, Sebastien; Bechti, Abdel; Touhami, Amina Khelifi; James, Marie Jose; Durel, Charles-Eric; Laurens, Francois; Costes, Evelyne			Fruit Self-Thinning: A Trait to Consider for Genetic Improvement of Apple Tree	PLOS ONE			English	Article							X DOMESTICA BORKH.; QTL ANALYSIS; ABSCISSION ZONE; WOOD FORMATION; CROP LOAD; MALUS; GROWTH; REVEALS; EXPRESSION; SIZE	In apple (Malusxdomestica Borkh), as in many fruiting crops, fruit maintenance vs abscission is a major criteria for production profitability. Growers routinely make use of chemical thinning agents to control total fruit load. However, serious threats for the environment lead to the demand for new apple cultivars with self-thinning properties. In this project, we studied the genetic determinism of this trait using a F-1 progeny derived from the cross between the hybrid INRA X3263, assumed to possess the self-thinning trait, and the cultivar 'Belrene'. Both counting and percentage variables were considered to capture the fruiting behaviour on different shoot types and over three consecutive years. Besides low to moderate but significant genetic effects, mixed models showed considerable effects of the year and the shoot type, as well as an interaction effect. Year effect resulted mainly from biennial fruiting. Eight Quantitative Trait Locus (QTL) were detected on several linkage groups (LG), either independent or specific of the year of observation or the shoot type. The QTL with highest LOD value was located on the top third of LG10. The screening of three QTL zones for candidate genes revealed a list of transcription factors and genes involved in fruit nutrition, xylem differentiation, plant responses to starvation and organ abscission that open new avenues for further molecular investigations. The detailed phenotyping performed revealed the dependency between the self-thinning trait and the fruiting status of the trees. Despite a moderate genetic control of the self-thinning trait, QTL and candidate genes were identified which will need further analyses involving other progenies and molecular investigations.	[Celton, Jean-Marc; Kelner, Jean-Jacques; Martinez, Sebastien; Touhami, Amina Khelifi; Costes, Evelyne] INRA, Montpellier SupAgro Team Architecture & Fonctionn, UMR 1334, AGAP,CIRAD, Montpellier, France; [Bechti, Abdel; James, Marie Jose] Pepinieres & Roseraies G Delbard, Commentry, France; [Celton, Jean-Marc; Durel, Charles-Eric; Laurens, Francois] Univ Angers, INRA, UMR1345, IRHS,AgroCampus Ouest,QUASAV,SFR 4207, Beaucouze, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers	Costes, E (corresponding author), INRA, Montpellier SupAgro Team Architecture & Fonctionn, UMR 1334, AGAP,CIRAD, Montpellier, France.	costes@supagro.inra.fr	Kelner, Jean-Jacques/AAE-6210-2020	Kelner, Jean-Jacques/0000-0003-4694-6662; Celton, Jean-Marc/0000-0002-1452-4812	INRA (National Institute for Agronomical Research); department BAP (Plant Biology and Breeding)	INRA (National Institute for Agronomical Research); department BAP (Plant Biology and Breeding)	Funding was provided by INRA (National Institute for Agronomical Research), department BAP (Plant Biology and Breeding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DL, 1960, ANN APPL BIOL, V48, P434, DOI 10.1111/j.1744-7348.1960.tb03546.x; Agusti J, 2008, J EXP BOT, V59, P2717, DOI 10.1093/jxb/ern138; Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Alonso-Cantabrana H, 2007, DEVELOPMENT, V134, P2663, DOI 10.1242/DEV.02864; Baldi P, 2013, MOL BREEDING, V31, P429, DOI 10.1007/s11032-012-9800-1; Bangerth F, 2000, PLANT GROWTH REGUL, V31, P43, DOI 10.1023/A:1006398513703; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; BERUTER J, 1991, SCI HORTIC-AMSTERDAM, V46, P201, DOI 10.1016/0304-4238(91)90043-X; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Butler DG, 2009, TRAINING SERIES; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Calenge F, 2006, MOL BREEDING, V17, P329, DOI 10.1007/s11032-006-9004-7; Calenge F, 2004, PHYTOPATHOLOGY, V94, P370, DOI 10.1094/PHYTO.2004.94.4.370; Celton JM, 2011, NEW PHYTOL, V192, P378, DOI 10.1111/j.1469-8137.2011.03823.x; Conner PJ, 1998, THEOR APPL GENET, V96, P1027, DOI 10.1007/s001220050835; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Costes E, 2003, ANN BOT-LONDON, V91, P91, DOI 10.1093/aob/mcg010; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dal Cin V, 2009, GENE, V442, P26, DOI 10.1016/j.gene.2009.04.009; Davey MW, 2006, PLANT PHYSIOL, V142, P343, DOI 10.1104/pp.106.083279; Dennis FG, 2000, PLANT GROWTH REGUL, V31, P1, DOI 10.1023/A:1006330009160; Durand JB, 2013, J EXP BOT, V64, P5099, DOI 10.1093/jxb/ert297; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Estornell LH, 2013, PLANT SCI, V199, P48, DOI 10.1016/j.plantsci.2012.10.008; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gallais A, 1989, THEORIE SELECTION AM, P45; Gould N, 2012, PLANT SCI, V188, P97, DOI 10.1016/j.plantsci.2011.12.018; GREENE DW, 1992, J AM SOC HORTIC SCI, V117, P775, DOI 10.21273/JASHS.117.5.775; Guitton B, 2012, J EXP BOT, V63, P131, DOI 10.1093/jxb/err261; Ireland HS, 2013, PLANT J, V73, P1044, DOI 10.1111/tpj.12094; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Ji HS, 2006, GENETICS, V173, P995, DOI 10.1534/genetics.105.054031; Kenis K, 2007, MOL BREEDING, V19, P193, DOI 10.1007/s11032-006-9022-5; Krost C, 2013, PLANT MOL BIOL, V81, P211, DOI 10.1007/s11103-012-9992-0; Lakso AN, 2008, ACTA HORTIC, V903, P733; Lauri PE, 1995, SCI HORTIC-AMSTERDAM, V64, P265, DOI 10.1016/0304-4238(95)00836-5; Lauri PE, 1997, J HORTIC SCI, V72, P519, DOI 10.1080/14620316.1997.11515539; Lauri PE, 2004, NEW PHYTOL, V163, P533, DOI 10.1111/j.1469-8137.2004.01136.x; LESPINASSE JM, 1977, CONDUITE POMMIER TYP; Lespinasse Y., 1992, Amelioration des especes vegetales cultivees: objectifs et criteres de selection., P579; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Looney NE., 1984, ACTA HORTIC, P31, DOI DOI 10.17660/ACTAH0RTIC.1984.146.2; Luckwill LC, 1969, PHYSL TREE CROPS, P123; Luckwill LC, 1970, PHYSL TREE CROPS, P237; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Miller S. S., 1988, Horticultural Reviews, V10, P309, DOI 10.1002/9781118060834.ch9; Monselise S. P., 1984, Horticultural Reviews, V4, P128, DOI 10.1002/9781118060773.ch5; Moriya S, 2012, PLANT BREEDING, V131, P641, DOI 10.1111/j.1439-0523.2012.01985.x; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Paul S, 2007, ENVIRONMETRICS, V18, P421, DOI 10.1002/env.849; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; R Development Core Team, 2009, R FDN STAT COMP; ROBERTS JA, 2009, STEWART POSTHARVEST, V5, P1, DOI DOI 10.2212/spr.2009.1.2; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Segura V, 2007, GENOME, V50, P159, DOI 10.1139/G07-002; Segura V, 2009, TREE GENET GENOMES, V5, P165, DOI 10.1007/s11295-008-0181-x; Segura V, 2008, NEW PHYTOL, V178, P302, DOI 10.1111/j.1469-8137.2007.02374.x; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Sun LX, 2009, EUPHYTICA, V165, P55, DOI 10.1007/s10681-008-9754-x; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Tustin DS, 2012, ACTA HORTIC, V932, P195, DOI 10.17660/ActaHortic.2012.932.28; Untiedt R, 2001, PLANT GROWTH REGUL, V35, P1, DOI 10.1023/A:1013894901621; van Dyk MM, 2010, TREE GENET GENOMES, V6, P489, DOI 10.1007/s11295-009-0266-1; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voorrips R.E., 2001, MAPCHART VERSION 2 0; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055238; WESTWOOD MN, 1967, P AM SOC HORTIC SCI, V91, P51; Williams M. W., 1979, Horticultural Reviews, V1, P270; Wu BH, 2005, J HORTIC SCI BIOTECH, V80, P340, DOI 10.1080/14620316.2005.11511941; Wunsche JN, 2000, J AM SOC HORTIC SCI, V125, P93, DOI 10.21273/JASHS.125.1.93; Zheng XY, 2002, THEOR APPL GENET, V105, P397, DOI 10.1007/s00122-002-0880-x; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhu H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-138	80	22	23	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91016	10.1371/journal.pone.0091016	http://dx.doi.org/10.1371/journal.pone.0091016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625529	Green Published, gold			2022-12-25	WOS:000332851300051
J	Chen, G; Hou, F; Yan, FF; Zhang, P; Xi, J; Zhou, YF; Lu, ZL; Huang, CB				Chen, Ge; Hou, Fang; Yan, Fang-Fang; Zhang, Pan; Xi, Jie; Zhou, Yifeng; Lu, Zhong-Lin; Huang, Chang-Bing			Noise Provides New Insights on Contrast Sensitivity Function	PLOS ONE			English	Article							VISUAL SIGNAL-DETECTION; SPATIAL-FREQUENCY; LETTER IDENTIFICATION; PSYCHOMETRIC FUNCTION; AMBLYOPIA; VISION; ORIENTATION; MECHANISMS; LUMINANCE; GRATINGS	Sensitivity to luminance difference, or contrast sensitivity, is critical for animals to survive in and interact with the external world. The contrast sensitivity function (CSF), which measures visual sensitivity to spatial patterns over a wide range of spatial frequencies, provides a comprehensive characterization of the visual system. Despite its popularity and significance in both basic research and clinical practice, it hasn't been clear what determines the CSF and how the factors underlying the CSF change in different conditions. In the current study, we applied the external noise method and perceptual template model to a wide range of external noise and spatial frequency (SF) conditions, and evaluated how the various sources of observer inefficiency changed with SF and determined the limiting factors underlying the CSF. We found that only internal additive noise and template gain changed significantly with SF, while the transducer non-linearity and coefficient for multiplicative noise were constant. The 12-parameter model provided a very good account of all the data in the 200 tested conditions (86.5%, 86.2%, 89.5%, and 96.4% for the four subjects, respectively). Our results suggest a re-consideration of the popular spatial vision model that employs the CSF as the front-end filter and constant internal additive noise across spatial frequencies. The study will also be of interest to scientists and clinicians engaged in characterizing spatial vision deficits and/or developing rehabilitation methods to restore spatial vision in clinical populations.	[Chen, Ge; Yan, Fang-Fang; Zhang, Pan; Xi, Jie; Huang, Chang-Bing] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Ge] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hou, Fang; Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Ctr Cognit & Brain Sci, Columbus, OH 43210 USA; [Zhou, Yifeng] Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China; [Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Ohio; Ohio State University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, CB (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	huangcb@psych.ac.cn	Huang, Chang-Bing/AAE-2909-2020	huang, chang bing/0000-0003-4694-0834; Hou, Fang/0000-0003-4811-5918; Lu, Zhong-Lin/0000-0002-7295-727X	National Natural Science Foundation of China [NSFC 31230032]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y3CX102003]; Institute of Psychology [Y1CX201006]; National Eye Institute [EY021553]; NATIONAL EYE INSTITUTE [R01EY021553] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Institute of Psychology; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundation of China (NSFC 31230032 to YZ), the Knowledge Innovation Program of the Chinese Academy of Sciences (Y3CX102003 to CBH), Institute of Psychology (Y1CX201006 to CBH), and the National Eye Institute (EY021553 to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS MS, 1988, J OPT SOC AM A, V5, P2059, DOI 10.1364/JOSAA.5.002059; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; Bednarek DB, 2002, NEUROREPORT, V13, P2521, DOI 10.1097/00001756-200212200-00028; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bubl E, 2010, BIOL PSYCHIAT, V68, P205, DOI 10.1016/j.biopsych.2010.02.009; Burgess A.E., 1979, P SPIE, V0173, P34, DOI [10.1117/12.957121, DOI 10.1117/12.957121]; BURGESS AE, 1988, J OPT SOC AM A, V5, P617, DOI 10.1364/JOSAA.5.000617; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Chung STL, 2002, VISION RES, V42, P1571, DOI 10.1016/S0042-6989(02)00065-2; Chung STL, 2002, VISION RES, V42, P2137, DOI 10.1016/S0042-6989(02)00092-5; Chung STL, 2009, J VISION, V9, DOI 10.1167/9.9.16; Dao DY, 2006, J VISION, V6, P739, DOI 10.1167/6.7.6; Eckstein MP, 1997, J OPT SOC AM A, V14, P2406, DOI 10.1364/JOSAA.14.002406; ELLIOTT DB, 1990, EYE, V4, P712, DOI 10.1038/eye.1990.100; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Golomb JD, 2009, J NEUROSCI, V29, P9072, DOI 10.1523/JNEUROSCI.1003-09.2009; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; Griffiths JWR, 1963, RADIO ELECT ENG, V25, P225; Hallum LE, 2011, J NEUROPHYSIOL, V105, P2121, DOI 10.1152/jn.01007.2010; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; HESS RF, 1978, PFLUG ARCH EUR J PHY, V377, P201, DOI 10.1007/BF00584273; Hou F, 2010, INVEST OPHTH VIS SCI, V51, P5365, DOI 10.1167/iovs.10-5468; HOWELL ER, 1983, INVEST OPHTH VIS SCI, V24, P782; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; Huang CB, 2009, J VISION, V9, DOI 10.1167/9.3.17; KERSTEN D, 1988, CLIN VISION SCI, V2, P143; Kornowski JA, 2003, J GEN PSYCHOL, V130, P229, DOI 10.1080/00221300309601156; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Lesmes LA, 2010, J VISION, V10, DOI 10.1167/10.3.17; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Lu ZL, 2014, VISUAL PSYCHOPHYSICS: FROM LABORATORY TO THEORY, P1; McAnany JJ, 2010, VISION RES, V50, P1957, DOI 10.1016/j.visres.2010.07.006; MOVSHON JA, 1988, J OPT SOC AM A, V5, P2166, DOI 10.1364/JOSAA.5.002166; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; NAVARRO R, 1993, J OPT SOC AM A, V10, P201, DOI 10.1364/JOSAA.10.000201; Oruc I, 2009, J VISION, V9, DOI 10.1167/9.9.4; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pelli DG, 1981, THESIS CAMBRIDGE; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; REGAN D, 1983, OPHTHALMOLOGY, V90, P1192; Regan David, 2000, HUMAN PERCEPTION OBJ; ROVAMO J, 1992, VISION RES, V32, P631, DOI 10.1016/0042-6989(92)90179-M; SAMPLE PA, 1991, AM J OPHTHALMOL, V112, P308, DOI 10.1016/S0002-9394(14)76732-7; Slaghuis WL, 1999, VISION RES, V39, P651, DOI 10.1016/S0042-6989(98)00151-5; Souza Givago da Silva, 2011, Psychol. Neurosci., V4, P29, DOI 10.3922/j.psns.2011.1.005; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Stuart GW, 2001, VISION RES, V41, P3205, DOI 10.1016/S0042-6989(01)00176-6; Tjan BS, 2002, J VISION, V2, P31, DOI DOI 10.1167/2.7.31; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; WILSON HR, 1988, VISION RES, V28, P611; Xu P, 2006, VISION RES, V46, P3748, DOI 10.1016/j.visres.2006.06.013; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031	64	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90579	10.1371/journal.pone.0090579	http://dx.doi.org/10.1371/journal.pone.0090579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626135	gold, Green Submitted, Green Published			2022-12-25	WOS:000332851300026
J	Chi, PD; Liu, W; Chen, H; Zhang, JP; Lin, YH; Zheng, X; Liu, WL; Dai, SQ				Chi, Pei-Dong; Liu, Wen; Chen, Hao; Zhang, Jing-Ping; Lin, Yuehao; Zheng, Xin; Liu, Wanli; Dai, Shuqin			High-Density Lipoprotein Cholesterol Is a Favorable Prognostic Factor and Negatively Correlated with C-Reactive Protein Level in Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INHIBIT TUMOR-DEVELOPMENT; HDL-CHOLESTEROL; METABOLIC SYNDROME; APOA-I; CANCER; SERUM; RISK; INFLAMMATION; BIOMARKER	Background: Although the alterations of lipid profile in lung cancer have been documented, the prognostic value of serum HDL-C level and its correlation with inflammation in NSCLC remain unknown. Subjects and Methods: Levels of preoperative serum lipid concentrations (including HDL-C, LDL-C, TC, and TG) and the inflammatory biomarker C-reactive protein level (CRP) were retrospectively analyzed in 228 patients with NSCLC and in 300 healthy controls. The serum lipid levels in these two populations were compared. Univariate and multivariate cox hazards analyses were performed to investigate the prognostic value of serum lipid levels in NSCLC. The correlation between CRP and lipid profile were also analyzed. Results: Compared with those in normal controls, the serum HDL-C, LDL-C, and TC levels were statistically decreased and the TG levels were significantly increased in 228 NSCLC patients. The patients with decreased levels of HDL-C had significantly lower 5-year survival rates than those with normal HDL-C, not only in the whole NSCLC cohort but also in the subgroups stratified according to the disease T, N classifications, and metastasis, whereas the other lipid components were not independent prognostic factors for NSCLC. Of the lipid components, a lower HDL-C level was observed more often in patients with a high CRP level than in those with a normal CRP level. Spearman's rank correlation analysis revealed that the HDL-C level presented a negative correlation with the CRP level (r = -0.360, p<0.001). Conclusions: A decreased level of preoperative HDL-C was found to be associated with poor survival in patients with NSCLC. Serum HDL-C level may be a clinical prognosis factor for NSCLC patients. In addition, a negative correlation was present between the levels of HDL-C and CRP, the well-known inflammation biomarker.	[Chi, Pei-Dong; Liu, Wen; Chen, Hao; Zhang, Jing-Ping; Lin, Yuehao; Zheng, Xin; Liu, Wanli; Dai, Shuqin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Chi, Pei-Dong; Liu, Wen; Chen, Hao; Zhang, Jing-Ping; Lin, Yuehao; Zheng, Xin; Liu, Wanli; Dai, Shuqin] Sun Yat Sen Univ, Ctr Canc, Dept Clin Lab Med, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Dai, SQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	daisq@sysucc.org.cn	ZHANG, JINGPING/AAT-8229-2021; zhang, jingping/AAM-2751-2021	zhang, jingping/0000-0003-0090-6710				Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; ALEXOPOULOS CG, 1987, CANCER-AM CANCER SOC, V60, P3065, DOI 10.1002/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO;2-Q; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Baker M, 2004, NAT BIOTECHNOL, V22, P641, DOI 10.1038/nbt0604-641; Boutsikou E, 2013, ONCOTARGETS THER, V6, P125, DOI 10.2147/OTT.S42245; Brower V, 2009, J NATL CANCER I, V101, P11, DOI 10.1093/jnci/djn483; Cheng Xiansheng, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P749; Cohen MH, 2005, ONCOLOGIST, V10, P461, DOI 10.1634/theoncologist.10-7-461; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gazdar AF, 2010, CANCER METAST REV, V29, P37, DOI 10.1007/s10555-010-9201-z; Giusti RM, 2008, CLIN CANCER RES, V14, P1296, DOI 10.1158/1078-0432.CCR-07-1354; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Guo EQ, 2007, ANN SURG ONCOL, V14, P2528, DOI 10.1245/s10434-007-9401-0; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Italiano A, 2007, B CANCER, V94, pF177; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeon JH, 2010, LUNG CANCER, V69, P165, DOI 10.1016/j.lungcan.2009.10.014; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Kotani K, 2013, J EPIDEMIOL, V23, P313, DOI 10.2188/jea.JE20130006; Kucharska-Newton AM, 2008, LUNG CANCER, V61, P292, DOI 10.1016/j.lungcan.2008.01.015; LEVY E, 1993, PEDIATR RES, V34, P162, DOI 10.1203/00006450-199308000-00011; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lim U, 2007, CANCER RES, V67, P5569, DOI 10.1158/0008-5472.CAN-07-0212; Mizia-Stec K, 2003, ACTA CARDIOL, V58, P9, DOI 10.2143/AC.58.1.2005253; Moorman PG, 1998, CANCER EPIDEM BIOMAR, V7, P483; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Siemianowicz K, 2000, INT J MOL MED, V6, P307; Su F, 2012, MOL CANCER THER, V11, P1311, DOI 10.1158/1535-7163.MCT-11-0905; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Tietge UJF, 2002, ARTERIOSCL THROM VAS, V22, P1213, DOI 10.1161/01.ATV.0000023228.90866.29; UMEKI S, 1993, RESPIRATION, V60, P178; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; WallbergJonsson S, 1996, J INTERN MED, V240, P373, DOI 10.1046/j.1365-2796.1996.53873000.x	47	49	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91080	10.1371/journal.pone.0091080	http://dx.doi.org/10.1371/journal.pone.0091080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625581	gold, Green Submitted, Green Published			2022-12-25	WOS:000332851300054
J	Gergs, A; Preuss, TG; Palmqvist, A				Gergs, Andre; Preuss, Thomas G.; Palmqvist, Annemette			Double Trouble at High Density: Cross-Level Test of Resource-Related Adaptive Plasticity and Crowding-Related Fitness	PLOS ONE			English	Article							DAPHNIA-MAGNA; FEEDING RATE; POPULATION-DYNAMICS; AMPLITUDE CYCLES; OFFSPRING SIZE; FILTER SCREENS; BODY-SIZE; FOOD; MODEL; REPRODUCTION	Population size is often regulated by negative feedback between population density and individual fitness. At high population densities, animals run into double trouble: they might concurrently suffer from overexploitation of resources and also from negative interference among individuals regardless of resource availability, referred to as crowding. Animals are able to adapt to resource shortages by exhibiting a repertoire of life history and physiological plasticities. In addition to resource-related plasticity, crowding might lead to reduced fitness, with consequences for individual life history. We explored how different mechanisms behind resource-related plasticity and crowding-related fitness act independently or together, using the water flea Daphnia magna as a case study. For testing hypotheses related to mechanisms of plasticity and crowding stress across different biological levels, we used an individual-based population model that is based on dynamic energy budget theory. Each of the hypotheses, represented by a sub-model, is based on specific assumptions on how the uptake and allocation of energy are altered under conditions of resource shortage or crowding. For cross-level testing of different hypotheses, we explored how well the sub-models fit individual level data and also how well they predict population dynamics under different conditions of resource availability. Only operating resource-related and crowding-related hypotheses together enabled accurate model predictions of D. magna population dynamics and size structure. Whereas this study showed that various mechanisms might play a role in the negative feedback between population density and individual life history, it also indicated that different density levels might instigate the onset of the different mechanisms. This study provides an example of how the integration of dynamic energy budget theory and individual-based modelling can facilitate the exploration of mechanisms behind the regulation of population size. Such understanding is important for assessment, management and the conservation of populations and thereby biodiversity in ecosystems.	[Gergs, Andre; Palmqvist, Annemette] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Preuss, Thomas G.] Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany	Roskilde University; RWTH Aachen University	Gergs, A (corresponding author), Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark.	andre.gergs@bio5.rwth-aachen.de	; Preuss, Thomas G./A-7926-2009	Palmqvist, Annemette/0000-0003-3422-0063; Preuss, Thomas G./0000-0001-6249-6003	European Union [266712: ModNanoTox]	European Union(European Commission)	AG has received funding by the European Union (project no 266712: ModNanoTox). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Alvarez OA, 2006, ENVIRON TOXICOL CHEM, V25, P3230, DOI 10.1897/06-097R.1; Bassar RD, 2013, AM NAT, V181, P25, DOI 10.1086/668590; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Boersma M, 1997, EVOL ECOL, V11, P439, DOI 10.1023/A:1018484824003; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Bohrer RN, 1988, FUNCT ECOL, V2, P463, DOI 10.2307/2389389; BRADLEY MC, 1991, OECOLOGIA, V86, P414, DOI 10.1007/BF00317610; BRAND GW, 1985, MAR BIOL, V88, P67, DOI 10.1007/BF00393045; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BURNS CW, 1995, OECOLOGIA, V101, P234, DOI 10.1007/BF00317289; Burns CW, 2000, FRESHWATER BIOL, V43, P19, DOI 10.1046/j.1365-2427.2000.00510.x; Chamberlin TC, 1931, J GEOL, V39, P155, DOI 10.1086/623804; Cleuvers M, 1997, OECOLOGIA, V110, P337, DOI 10.1007/s004420050167; DODSON SI, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432405; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; Gergs A, 2014, J ANIM ECOL, V83, P758, DOI 10.1111/1365-2656.12195; GLAZIER DS, 1992, ECOLOGY, V73, P910, DOI 10.2307/1940168; GOPHEN M, 1984, OECOLOGIA, V64, P408, DOI 10.1007/BF00379140; GOSER B, 1994, OECOLOGIA, V98, P354, DOI 10.1007/BF00324224; GOSER B, 1997, DICHTEABHANGIGE ANDE; GOULDEN CE, 1980, P NATL ACAD SCI-BIOL, V77, P1716, DOI 10.1073/pnas.77.3.1716; GUISANDE C, 1992, J PLANKTON RES, V14, P997, DOI 10.1093/plankt/14.7.997; Hammers-Wirtz M, 2003, 36003024 FKZ FED ENV; HAYWARD RS, 1976, ARCH HYDROBIOL, V77, P139; Hazlerigg CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037550; HELGEN JC, 1987, HYDROBIOLOGIA, V154, P113, DOI 10.1007/BF00026835; HOBAEK A, 1990, ECOLOGY, V71, P2255, DOI 10.2307/1938637; Jager T, 2013, ECOL MODEL, DOI [10.1016/j.ecolmodel.2013.06.024, DOI 10.1016/J.EC0LM0DEL.2013.06.024]; Jager T, 2013, MAKING SENSE CHEM ST; Jager T, 2011, J SEA RES, V66, P456, DOI 10.1016/j.seares.2011.04.003; Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Kirk KL, 1998, ECOLOGY, V79, P2456, DOI 10.2307/176835; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; Lampert W, 1996, LIMNOL OCEANOGR, V41, P216, DOI 10.4319/lo.1996.41.2.0216; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P997, DOI 10.4319/lo.1994.39.5.0997; Lampert W, 2006, POL J ECOL, V54, P607; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; Marshall DJ, 2009, ECOLOGY, V90, P487, DOI 10.1890/08-0320.1; Martin BT, 2013, AM NAT, V181, P506, DOI 10.1086/669904; MATVEEV V, 1993, FRESHWATER BIOL, V29, P99, DOI 10.1111/j.1365-2427.1993.tb00748.x; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; MCCAULEY E, 1990, ECOLOGY, V71, P703, DOI 10.2307/1940324; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; MCMAHON JW, 1963, CAN J ZOOLOG, V41, P321, DOI 10.1139/z63-027; MILLER RICHARD S., 1967, ADVAN ECOL RESADVANCES IN ECOLOGICAL, V4, P1, DOI 10.1016/S0065-2504(08)60319-0; Moe SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2133, DOI 10.1098/rspb.2005.3184; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Nisbet RM, 2010, PHILOS T R SOC B, V365, P3541, DOI 10.1098/rstb.2010.0167; Plath K, 1998, LIMNOL OCEANOGR, V43, P593, DOI 10.4319/lo.1998.43.4.0593; POP M, 1991, HYDROBIOLOGIA, V225, P169, DOI 10.1007/BF00028394; Post JR, 1997, CAN J FISH AQUAT SCI, V54, P867, DOI 10.1139/cjfas-54-4-867; Preuss TG, 2009, ECOL MODEL, V220, P310, DOI 10.1016/j.ecolmodel.2008.09.018; Renault D, 2003, J ZOOL, V259, P381, DOI 10.1017/S0952836902003382; Repka S, 1999, J PLANKTON RES, V21, P971, DOI 10.1093/plankt/21.5.971; Ricklefs RE., 1999, ECOLOGY; RIGLER FH, 1961, CAN J ZOOLOG, V39, P857, DOI 10.1139/z61-080; Roff DA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P358, DOI 10.1086/518012; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; SEITZ A, 1984, OECOLOGIA, V62, P94, DOI 10.1007/BF00377380; Semlitsch RD, 2000, OECOLOGIA, V125, P179, DOI 10.1007/s004420000443; Sibly RM, 1999, ECOL APPL, V9, P496, DOI 10.1890/1051-0761(1999)009[0496:EEDFSS]2.0.CO;2; Siehoff S, 2009, FRESHWATER BIOL, V54, P15, DOI 10.1111/j.1365-2427.2008.02087.x; SOKULLKLUETTGEN B, 1998, KOMBINIERTE WIRKUNG; Sousa T, 2012, PHILOS T ROY SOC LON, V365, P3413; Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stelzer CP, 2012, FUNCT ECOL, V26, P180, DOI 10.1111/j.1365-2435.2011.01918.x; THRELKELD ST, 1976, FRESHWATER BIOL, V6, P489, DOI 10.1111/j.1365-2427.1976.tb01640.x; Urabe J, 2001, FUNCT ECOL, V15, P165, DOI 10.1046/j.1365-2435.2001.00511.x; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; Wogram J, 2001, B ENVIRON CONTAM TOX, V67, P360	83	17	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91503	10.1371/journal.pone.0091503	http://dx.doi.org/10.1371/journal.pone.0091503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626228	Green Published, gold			2022-12-25	WOS:000332851300092
J	Cheng, JS; Gao, PP; Zhou, IY; Chan, RW; Chan, QN; Mak, HK; Khong, PL; Wu, EX				Cheng, Joe S.; Gao, Patrick P.; Zhou, Iris Y.; Chan, Russell W.; Chan, Queenie; Mak, Henry K.; Khong, Pek L.; Wu, Ed X.			Resting-State fMRI Using Passband Balanced Steady-State Free Precession	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; BOLD FMRI; RAT-BRAIN; SSFP FMRI; NETWORKS; RESOLUTION; MRI; CORTEX	Objective: Resting-state functional MRI (rsfMRI) has been increasingly used for understanding brain functional architecture. To date, most rsfMRI studies have exploited blood oxygenation level-dependent (BOLD) contrast using gradient-echo (GE) echo planar imaging (EPI), which can suffer from image distortion and signal dropout due to magnetic susceptibility and inherent long echo time. In this study, the feasibility of passband balanced steady-state free precession (bSSFP) imaging for distortion-free and high-resolution rsfMRI was investigated. Methods: rsfMRI was performed in humans at 3 T and in rats at 7 T using bSSFP with short repetition time (TR = 4/2.5 ms respectively) in comparison with conventional GE-EPI. Resting-state networks (RSNs) were detected using independent component analysis. Results and Significance: RSNs derived from bSSFP images were shown to be spatially and spectrally comparable to those derived from GE-EPI images with considerable intra-and inter-subject reproducibility. High-resolution bSSFP images corresponded well to the anatomical images, with RSNs exquisitely co-localized to the gray matter. Furthermore, RSNs at areas of severe susceptibility such as human anterior prefrontal cortex and rat piriform cortex were proved accessible. These findings demonstrated for the first time that passband bSSFP approach can be a promising alternative to GE-EPI for rsfMRI. It offers distortion-free and high-resolution RSNs and is potentially suited for high field studies.	[Cheng, Joe S.; Gao, Patrick P.; Zhou, Iris Y.; Chan, Russell W.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Cheng, Joe S.; Gao, Patrick P.; Zhou, Iris Y.; Chan, Russell W.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Mak, Henry K.; Khong, Pek L.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Chan, Queenie] Philips Healthcare, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Philips; Philips Healthcare	Wu, EX (corresponding author), Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China.	ewu@eee.hku.hk	Zhou, Iris Yuwen/A-2089-2017; Wu, Ed Xuekui/C-1579-2009	Zhou, Iris Yuwen/0000-0002-4351-7398; Chan, Russell/0000-0002-7680-9231; Wu, Ed Xuekui/0000-0001-5581-1546	Hong Kong Research Grants Council [HKU7837/11M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by Hong Kong Research Grants Council (HKU7837/11M). The authors have declared that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Kir ABM, 2013, P INT SOC MAGN RES M, P2280; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bowen CV., 2005, P 13 ANN M ISMRM MIA, P119; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chan KC, 2010, NEUROIMAGE, V49, P2013, DOI 10.1016/j.neuroimage.2009.10.069; Chappell M, 2011, MAGN RESON IMAGING, V29, P1, DOI 10.1016/j.mri.2010.07.007; Cheung MM, 2012, NEUROIMAGE, V61, P978, DOI 10.1016/j.neuroimage.2012.03.031; Cheung MM, 2012, NEUROIMAGE, V60, P1205, DOI 10.1016/j.neuroimage.2012.01.087; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; de Zwart JA, 2006, NMR BIOMED, V19, P342, DOI 10.1002/nbm.1043; Dharmakumar R, 2005, MAGN RESON MED, V53, P574, DOI 10.1002/mrm.20393; Duong TQ, 2008, NMR BIOMED, V21, P978, DOI 10.1002/nbm.1311; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Foxall DL, 2002, MAGN RESON MED, V48, P502, DOI 10.1002/mrm.10225; Glover GH, 1999, MAGNET RESON MED, V42, P290, DOI 10.1002/(SICI)1522-2594(199908)42:2<290::AID-MRM11>3.0.CO;2-N; Glover GH, 2004, MAGN RESON MED, V51, P863, DOI 10.1002/mrm.20016; GOLANOV EV, 1994, AM J PHYSIOL, V266, pR204, DOI 10.1152/ajpregu.1994.266.1.R204; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; JOHNSON G, 1985, J MAGN RESON, V63, P14, DOI 10.1016/0022-2364(85)90149-0; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kim TS, 2012, INT J IMAG SYST TECH, V22, P23, DOI 10.1002/ima.21296; Koopmans PJ, 2012, NEUROIMAGE, V62, P1939, DOI 10.1016/j.neuroimage.2012.05.080; Lau C, 2011, NEUROIMAGE, V58, P878, DOI 10.1016/j.neuroimage.2011.06.055; Lee JH, 2008, MAGN RESON MED, V59, P1099, DOI 10.1002/mrm.21576; Lee J, 2007, MAGN RESON MED, V57, P905, DOI 10.1002/mrm.21195; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Miller KL, 2008, MAGN RESON MED, V60, P661, DOI 10.1002/mrm.21690; Miller KL, 2007, NEUROIMAGE, V37, P1227, DOI 10.1016/j.neuroimage.2007.06.024; Miller KL, 2012, NEUROIMAGE, V62, P713, DOI 10.1016/j.neuroimage.2011.10.040; Miller KL, 2006, MAGN RESON MED, V55, P161, DOI 10.1002/mrm.20753; Miller KL, 2003, MAGNET RESON MED, V50, P675, DOI 10.1002/mrm.10602; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Parrish T, 2008, P INT SOC MAGN RES M, P3567; Patterson S, 2011, P INT SOC MAGN RES M, P1630; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peltier SJ, 2002, NEUROIMAGE, V16, P985, DOI 10.1006/nimg.2002.1141; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Scheffler K, 2001, NMR BIOMED, V14, P490, DOI 10.1002/nbm.726; Scremin O. U., 2004, RAT NERVOUS SYSTEM, P1167; Shipley M. T., 2004, RAT NERVOUS SYSTEM, P923; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; WEBB P, 1991, MAGNET RESON MED, V20, P113, DOI 10.1002/mrm.1910200112; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhong K, 2007, MAGN RESON MED, V57, P67, DOI 10.1002/mrm.21103; Zhou IY, 2012, MAGN RESON MED, V68, P65, DOI 10.1002/mrm.23202	69	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91075	10.1371/journal.pone.0091075	http://dx.doi.org/10.1371/journal.pone.0091075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622278	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300048
J	Ge, XX; Chen, HW; Wang, HL; Shi, AP; Liu, KF				Ge, Xiuxiu; Chen, Hongwei; Wang, Hongli; Shi, Aiping; Liu, Kefeng			De Novo Assembly and Annotation of Salvia splendens Transcriptome Using the Illumina Platform	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SSR-MARKERS; RNA-SEQ; GENES; MICROSATELLITES; STRIGOLACTONE; TOOL; ARABIDOPSIS; GENERATION; DISCOVERY	Background: As an important perennial herbaceous flower, Salvia splendens possesses high ornamental value. Understanding its branching processes may help scientists select the best plant type. Although Salvia splendens is a frequently-used horticultural flower, only limited transcriptomic or genomic research is available in public databases. In the present study, we, for the first time, constructed a comprehensive dataset for Salvia splendens through de novo high-throughput transcriptome sequencing. Methodology/Principal Findings: We performed de novo transcriptome sequencing on two different branching type plants (Strain 35 and Cailinghong) using the Illumina paired-end sequencing technology. For Strain 35, a total of 16,488,829 reads were generated and assembled into 38,498 unigenes, with a mean length of approximately 779 bp. For Cailinghong, 16,464,713 reads were generated and assembled into 34,302 unigenes, with a mean length of approximately 812 bp. Moreover, a total of 49,310 unigenes for Salvia splendens were identified, among them 33,925 (68.80%) were annotated in the non-redundant NCBI database, 25,371 (51.45%) were annotated in the Swiss-Prot database, while 24,888 (50.47%) and 9,896 (20.07%) unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. Using the Kyoto Encyclopedia of Genes and Genomes pathway database, we identified 134 differently expressed unigenes between Strain 35 and Cailinghong, and then these unigenes were mapped to 79 pathways. In addition, we detected 2,453 simple sequence repeats (SSRs). Conclusions: We obtained a comprehensive transcriptomic information from this work and provided a valuable resource of transcript sequences of Salvia splendens in public databases. Moreover, some candidate genes potentially involved in branching were identified. Furthermore, numerous obtained SSRs might contribute to marker-assisted selection. These data could be further utilized in functional genomics studies on Salvia splendens.	[Ge, Xiuxiu] Beijing Agr Univ, Coll Biol Sci & Engn, Beijing 100094, Peoples R China; [Chen, Hongwei; Liu, Kefeng] Beijing Agr Univ, Coll Urban & Rural Dev, Beijing 100094, Peoples R China; [Wang, Hongli; Shi, Aiping] Beijing Agr Univ, Coll Hort, Beijing 100094, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Beijing University of Agriculture	Ge, XX (corresponding author), Beijing Agr Univ, Coll Biol Sci & Engn, Beijing 100094, Peoples R China.	liukefeng@sohu.com			National Science Foundation for Distinguished Young Scholars of China [31100509]; Science and Technology Development Project of Beijing Municipal Institutions [KM 201210020005]; Beijing Gardening and Greening Bureau [YLHH201200202, YLHH201200120]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [PXM201010]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Science and Technology Development Project of Beijing Municipal Institutions; Beijing Gardening and Greening Bureau; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This study was supported by the National Science Foundation for Distinguished Young Scholars of China (Grant No. 31100509), Science and Technology Development Project of Beijing Municipal Institutions (KM 201210020005), Beijing Gardening and Greening Bureau (YLHH201200202 and YLHH201200120) and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (PXM201010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; ArguelloAstorga GR, 1996, PLANT PHYSIOL, V112, P1151, DOI 10.1104/pp.112.3.1151; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dun EA, 2012, PLANT PHYSIOL, V158, P487, DOI 10.1104/pp.111.186783; Eckert KA, 2002, BIOCHEMISTRY-US, V41, P10490, DOI 10.1021/bi025918c; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lokanathan Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-76; Luo HM, 2010, PHYSIOL PLANTARUM, V139, P1, DOI 10.1111/j.1399-3054.2009.01339.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Park S, 2006, PLANT PHYSIOL, V141, P811, DOI 10.1104/pp.106.080994; Pauli S, 2004, J VIROL, V78, P12120, DOI 10.1128/JVI.78.22.12120-12128.2004; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]	44	28	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e87693	10.1371/journal.pone.0087693	http://dx.doi.org/10.1371/journal.pone.0087693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622329	gold, Green Submitted, Green Published			2022-12-25	WOS:000332845300003
J	Gorniak, T; Haraszti, T; Garamus, VM; Buck, AR; Senkbeil, T; Priebe, M; Hedberg-Buenz, A; Koehn, D; Salditt, T; Grunze, M; Anderson, MG; Rosenhahn, A				Gorniak, Thomas; Haraszti, Tamas; Garamus, Vasyl M.; Buck, Andreas R.; Senkbeil, Tobias; Priebe, Marius; Hedberg-Buenz, Adam; Koehn, Demelza; Salditt, Tim; Grunze, Michael; Anderson, Michael G.; Rosenhahn, Axel			Nano-Scale Morphology of Melanosomes Revealed by Small-Angle X-Ray Scattering	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; BROWN LOCUS; MELANIN; HAIR; MELANOGENESIS; DIFFRACTION; MICROSCOPY; INSIGHTS; POWER; BONE	Melanosomes are highly specialized organelles that produce and store the pigment melanin, thereby fulfilling essential functions within their host organism. Besides having obvious cosmetic consequences-determining the color of skin, hair and the iris-they contribute to photochemical protection from ultraviolet radiation, as well as to vision (by defining how much light enters the eye). Though melanosomes can be beneficial for health, abnormalities in their structure can lead to adverse effects. Knowledge of their ultrastructure will be crucial to gaining insight into the mechanisms that ultimately lead to melanosome-related diseases. However, due to their small size and electron-dense content, physiologically intact melanosomes are recalcitrant to study by common imaging techniques such as light and transmission electron microscopy. In contrast, X-ray-based methodologies offer both high spatial resolution and powerful penetrating capabilities, and thus are well suited to study the ultrastructure of electron-dense organelles in their natural, hydrated form. Here, we report on the application of small-angle X-ray scattering-a method effective in determining the three-dimensional structures of biomolecules - to whole, hydrated murine melanosomes. The use of complementary information from the scattering signal of a large ensemble of suspended organelles and from single, vitrified specimens revealed a melanosomal sub-structure whose surface and bulk properties differ in two commonly used inbred strains of laboratory mice. Whereas melanosomes in C57BL/6J mice have a well-defined surface and are densely packed with 40-nm units, their counterparts in DBA/2J mice feature a rough surface, are more granular and consist of 60-nm building blocks. The fact that these strains have different coat colors and distinct susceptibilities to pigment-related eye disease suggest that these differences in size and packing are of biological significance.	[Gorniak, Thomas; Buck, Andreas R.; Senkbeil, Tobias; Grunze, Michael; Rosenhahn, Axel] Karlsruhe Inst Technol KIT, Inst Funct Interfaces IFG, Eggenstein Leopoldshafen, Germany; [Gorniak, Thomas; Haraszti, Tamas; Buck, Andreas R.; Senkbeil, Tobias; Grunze, Michael; Rosenhahn, Axel] Heidelberg Univ, Heidelberg, Germany; [Gorniak, Thomas; Buck, Andreas R.; Rosenhahn, Axel] Ruhr Univ Bochum, Bochum, Germany; [Haraszti, Tamas] Max Planck Inst Intelligent Syst, Stuttgart, Germany; [Garamus, Vasyl M.] Zentrum Mat & Kustenforsch GmbH, Helmholtz Zentrum Geesthacht, Geesthacht, Germany; [Priebe, Marius; Salditt, Tim] Univ Gottingen, Inst Xray Phys, D-37073 Gottingen, Germany; [Hedberg-Buenz, Adam; Koehn, Demelza; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Hedberg-Buenz, Adam; Anderson, Michael G.] Iowa City Vet Affairs VA Hlth Care Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Ruhr University Bochum; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Gottingen; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Gorniak, T (corresponding author), Karlsruhe Inst Technol KIT, Inst Funct Interfaces IFG, Eggenstein Leopoldshafen, Germany.	thomas.gorniak@kit.edu	Grunze, Michael/O-2912-2019; Grunze, Michael H/H-1600-2013; Rosenhahn, Axel/F-7319-2011; Anderson, Michael/B-4580-2009	Rosenhahn, Axel/0000-0001-9393-7190; Anderson, Michael/0000-0001-5730-6105; Haraszti, Tamas/0000-0002-7095-4358; Salditt, Tim/0000-0003-4636-0813	Helmholtz society, under the virtual institute [VH-VI-403]; BMBF [05K10VH4, FSP 301 FLASH]; National Eye Institute [EY017673]; NATIONAL EYE INSTITUTE [R01EY017673] Funding Source: NIH RePORTER	Helmholtz society, under the virtual institute; BMBF(Federal Ministry of Education & Research (BMBF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors gratefully acknowledge the funding of this work by the Helmholtz society, under the virtual institute VH-VI-403 and by the BMBF (05K10VH4, FSP 301 FLASH). Contributions of MGA were supported by National Eye Institute Grant EY017673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Anderson MG, 2006, MICRON, V37, P689, DOI 10.1016/j.micron.2006.03.008; Avdeev MV, 2009, J PHYS CHEM C, V113, P9473, DOI 10.1021/jp900424p; Avdeev MV, 2006, CARBON, V44, P954, DOI 10.1016/j.carbon.2005.10.010; Beaucage G, 1995, J APPL CRYSTALLOGR, V28, P717, DOI 10.1107/S0021889895005292; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Beaucage G, 2004, J APPL CRYSTALLOGR, V37, P523, DOI 10.1107/S0021889804008969; BIRBECK MSC, 1963, ANN NY ACAD SCI, V100, P540, DOI 10.1111/j.1749-6632.1963.tb42871.x; Blanton TN, 2000, J APPL CRYSTALLOGR, V33, P172, DOI 10.1107/S0021889899012388; BOROVANSKY J, 1991, NEOPLASMA, V38, P393; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P1; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P343; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Burger C, 2012, POLYM SCI COMPREHENS, P363; CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x; CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x; Clancy CMR, 2000, J PHYS CHEM B, V104, P7871, DOI 10.1021/jp001630q; Clancy CMR, 2001, BIOCHEMISTRY-US, V40, P13353, DOI 10.1021/bi010786t; Dell'Angelica EC, 2003, TRENDS CELL BIOL, V13, P503, DOI 10.1016/j.tcb.2003.08.001; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Gallas JM, 1999, BIOPHYS J, V77, P1135, DOI 10.1016/S0006-3495(99)76964-X; Giewekemeyer K, 2013, J SYNCHROTRON RADIAT, V20, P490, DOI 10.1107/S0909049513005372; Granke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058043; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Haraszti T, 2011, PIGM CELL MELANOMA R, V24, P187, DOI 10.1111/j.1755-148X.2010.00788.x; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; Kalbfleisch S, 2011, AIP CONF PROC, V1365, P96, DOI 10.1063/1.3625313; Kasas S, 2003, J MICROSC-OXFORD, V211, P48, DOI 10.1046/j.1365-2818.2003.01193.x; Kaulich B, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/8/083002; Krauss S, 2011, J STRUCT BIOL, V175, P457, DOI 10.1016/j.jsb.2011.06.005; Kumagai K, 2009, ULTRAMICROSCOPY, V109, P368, DOI 10.1016/j.ultramic.2009.01.005; Lamoreux ML, 2010, INTRO MUTANT PIGMENT, P51; Littrell KC, 2003, PHOTOCHEM PHOTOBIOL, V77, P115, DOI 10.1562/0031-8655(2003)077<0115:SSOBMB>2.0.CO;2; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P135, DOI 10.1562/2004-08-03-RA-259.1; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Okulicz JF, 2003, J EUR ACAD DERMATOL, V17, P251, DOI 10.1046/j.1468-3083.2003.00767.x; PAWELEK JM, 1978, NATURE, V276, P627, DOI 10.1038/276627a0; Peles DN, 2009, J PHYS CHEM B, V113, P11346, DOI 10.1021/jp904138n; Petoukhov MV, 2013, INT J BIOCHEM CELL B, V45, P429, DOI 10.1016/j.biocel.2012.10.017; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Prem P, 2003, J COSMET SCI, V54, P395; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; SCHMIDT PW, 1982, J APPL CRYSTALLOGR, V15, P567, DOI 10.1107/S002188988201259X; SCHMIDT PW, 1991, J APPL CRYSTALLOGR, V24, P414, DOI 10.1107/S0021889891003400; SCHMIDT PW, 1986, PHYS REV A, V33, P560, DOI 10.1103/PhysRevA.33.560; Schraermeyer U, 1996, PIGM CELL RES, V9, P248, DOI 10.1111/j.1600-0749.1996.tb00114.x; Simon JD, 2008, J PHYS CHEM B, V112, P13201, DOI 10.1021/jp804248h; SMIT NPM, 2000, ROLE CATECHOL QUINON, P191; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Tello C, 2010, GLAUCOMA BOOK: A PRACTICAL, EVIDENCE-BASED APPROACH TO PATIENT CARE, P499, DOI 10.1007/978-0-387-76700-0_38; Tivol WF, 2008, IMPROVED CRYOGEN PLU, P14; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375; Wilke RN, 2012, OPT EXPRESS, V20, P19232, DOI 10.1364/OE.20.019232; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105	58	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90884	10.1371/journal.pone.0090884	http://dx.doi.org/10.1371/journal.pone.0090884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621581	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300034
J	Froslie, KF; Roislien, J; Qvigstad, E; Godang, K; Bollerslev, J; Henriksen, T; Veierod, MB				Froslie, Kathrine Frey; Roislien, Jo; Qvigstad, Elisabeth; Godang, Kristin; Bollerslev, Jens; Henriksen, Tore; Veierod, Marit B.			Shape Information in Repeated Glucose Curves during Pregnancy Provided Significant Physiological Information for Neonatal Outcomes	PLOS ONE			English	Article							AMERICAN-DIABETES-ASSOCIATION; STUDY-GROUPS RECOMMENDATIONS; INTERNATIONAL ASSOCIATION; POSTPRANDIAL GLUCOSE; CARBOHYDRATE-METABOLISM; FETAL MACROSOMIA; BIRTH-WEIGHT; INSULIN; WOMEN; TOLERANCE	Objective: To use multilevel functional principal component analysis to exploit the information inherent in the shape of longitudinally sampled glucose curves during pregnancy, and to analyse the impact of glucose curve characteristics on neonatal birth weight, percentage fat and cord blood C-peptide. Study Design and Setting: A cohort study of healthy, pregnant women (n = 884). They underwent two oral glucose tolerance tests (gestational weeks 14-16 and 30-32), which gave two glucose curves per woman. Results: Glucose values were higher, and peaked later in third trimester than in early pregnancy. The curve characteristic "general glucose level'' accounted for 91% of the variation across visits, and 72% within visits. The curve characteristics "timing of postprandial peak'', and "oscillating glucose levels'' accounted for a larger part of the variation within visits (15% and 8%), than across visits (7% and <2%). A late postprandial peak during pregnancy, and high general glucose levels in third trimester had significant, positive effects on birth weight (p<0.05). Generally high glucose levels during pregnancy had a significant, positive impact on neonatal percentage fat (p = 0.04). High general glucose level in third trimester had a significant, positive impact on cord blood C-peptide (p = 0.004). Conclusion: Shape information in entire OGTT curves provides significant physiological information of importance for several outcomes, and may contribute to the understanding of the metabolic changes during pregnancy.	[Froslie, Kathrine Frey; Roislien, Jo; Veierod, Marit B.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Froslie, Kathrine Frey] Univ Oslo, Rikshosp, Norwegian Resource Ctr Womens Hlth, Div Obstet & Gynaecol,Oslo Univ Hosp, N-0027 Oslo, Norway; [Qvigstad, Elisabeth; Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Med, Sect Specialised Endocrinol, Oslo, Norway; [Bollerslev, Jens; Henriksen, Tore] Univ Oslo, Fac Clin Med, Oslo, Norway; [Henriksen, Tore] Univ Oslo, Rikshosp, Oslo Univ Hosp, Div Obstet & Gynaecol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Froslie, KF (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway.	k.f.froslie@medisin.uio.no	Røislien, Jo/AAF-2265-2020; Veierød, Marit B/J-8229-2019	Røislien, Jo/0000-0002-7168-2833; Veierød, Marit B/0000-0002-2083-2758; Qvigstad, Elisabeth/0000-0002-9119-9187	Norwegian Health Association; Faculty of Medicine, University of Oslo; Department of Obstetrics and Gynaecology, Oslo University Hospital Rikshospitalet; National Resource Centre for Women's Health, Oslo University Hospital Rikshospitalet	Norwegian Health Association; Faculty of Medicine, University of Oslo; Department of Obstetrics and Gynaecology, Oslo University Hospital Rikshospitalet; National Resource Centre for Women's Health, Oslo University Hospital Rikshospitalet	Funding for the study was provided by the Norwegian Health Association; Faculty of Medicine, University of Oslo; Department of Obstetrics and Gynaecology and the National Resource Centre for Women's Health, Oslo University Hospital Rikshospitalet. Roche Diagnostics, Norway supplied glucometers and test strips free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2013, R FDN STAT COMPUTING; Aparicio NJ, 1998, AM J OBSTET GYNECOL, V178, P1059, DOI 10.1016/S0002-9378(98)70548-4; Beardsall K, 2008, BEST PRACT RES CL EN, V22, P41, DOI 10.1016/j.beem.2007.10.001; Buhling KJ, 2005, J PERINAT MED, V33, P125, DOI 10.1515/JPM.2005.024; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Chitayat L, 2009, DIABETES TECHNOL THE, V11, pS105, DOI 10.1089/dia.2008.0136; Clapp JF, 1998, DIABETES CARE, V21, pB107; COUSINS L, 1980, AM J OBSTET GYNECOL, V136, P483, DOI 10.1016/0002-9378(80)90675-4; Coustan DR, 2012, CLIN CHEM, V58, P1094, DOI 10.1373/clinchem.2012.186239; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Crainiceanu C, 2010, J STAT SOFTW, V32, P1; Di CZ, 2009, ANN APPL STAT, V3, P458, DOI 10.1214/08-AOAS206; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ferrara A, 2007, DIABETOLOGIA, V50, P298, DOI 10.1007/s00125-006-0517-8; Froslie KF, 2011, CLIN BIOCHEM, V44, P1483, DOI 10.1016/j.clinbiochem.2011.08.1150; Froslie KF, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-6; Godang K, 2013, EUR J ENDOCRINOL, V168, P371, DOI 10.1530/EJE-12-0531; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Gumbiner B, 1996, J CLIN ENDOCR METAB, V81, P2061, DOI 10.1210/jc.81.6.2061; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; Hernandez TL, 2011, DIABETES CARE, V34, P1660, DOI 10.2337/dc11-0241; Hod M., 2008, TXB DIABETES PREGNAN; Jeffery AN, 2004, MIDWIFERY, V20, P281, DOI 10.1016/j.midw.2004.01.002; JOVANOVICPETERSON L, 1991, AM J OBSTET GYNECOL, V164, P103, DOI 10.1016/0002-9378(91)90637-7; Katon J, 2011, PAEDIATR PERINAT EP, V25, P265, DOI 10.1111/j.1365-3016.2011.01195.x; Langer O, 2013, J MATERN-FETAL NEO M, V26, P111, DOI 10.3109/14767058.2012.734874; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; LIND T, 1973, J OBSTET GYN BR COMM, V80, P1033; Long H, 2013, CURR DIABETES REP, V13, P43, DOI 10.1007/s11892-012-0330-3; McGowan CA, 2010, BRIT J NUTR, V104, P153, DOI 10.1017/S0007114510000425; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Mills JL, 1998, METABOLISM, V47, P1140, DOI 10.1016/S0026-0495(98)90290-6; Ong KK, 2008, DIABETES CARE, V31, P2193, DOI 10.2337/dc08-1111; Parretti E, 2001, DIABETES CARE, V24, P1319, DOI 10.2337/diacare.24.8.1319; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ramsay J.O., 2006, FUNCTIONAL DATA ANAL; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Siegmund T, 2008, EUR J OBSTET GYN R B, V139, P46, DOI 10.1016/j.ejogrb.2007.12.006; Sivan E, 1997, DIABETES CARE, V20, P1470, DOI 10.2337/diacare.20.9.1470; Stotland NE, 2004, INT J GYNECOL OBSTET, V87, P220, DOI 10.1016/j.ijgo.2004.08.010; Trujillo-Arriaga HM, 2008, COMPUT BIOL MED, V38, P185, DOI 10.1016/j.compbiomed.2007.09.004; Voldner N, 2010, THESIS U OSLO OSLO; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Voldner N, 2010, J MATERN-FETAL NEO M, V23, P74, DOI 10.3109/14767050903121472; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organization, 2006, DEF DIAGN DIAB MELL; Young BC, 2013, CURR DIABETES REP, V13, P12, DOI 10.1007/s11892-012-0338-8	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90798	10.1371/journal.pone.0090798	http://dx.doi.org/10.1371/journal.pone.0090798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619030	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400030
J	Wang, Q; Shen, B; Chen, L; Zheng, P; Feng, H; Hao, Q; Liu, X; Liu, L; Xu, S; Chen, J; Teng, J				Wang, Q.; Shen, B.; Chen, L.; Zheng, P.; Feng, H.; Hao, Q.; Liu, X.; Liu, L.; Xu, S.; Chen, J.; Teng, J.			Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis	ONCOGENE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR-CLONING; PROTEIN; EXPRESSION; CANCER; PROGRESSION; FIBRONECTIN; MECHANISM; CLEAVAGE; ADHESION	Extracellular proteins are vital for cell activities, such as cell migration. Calumenin is highly conserved among eukaryotes, but its functions are largely unclear. Here, we identify extracellular calumenin as a suppressor of cell migration and tumor metastasis. Calumenin binds to and stabilizes fibulin-1, leading to inactivation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling. We further identify the minimal functional domain of calumenin (amino acids 74-138 and 214-280). Depletion of calumenin induces fibulin-1-and phospho-ERK1/2 (pERK1/2)-dependent promotion of cell migration. Consistently, in hepatocellular and pancreatic carcinoma, both calumenin and fibulin-1 are downregulated. Furthermore, we show that matrix metalloproteinase13 (MMP-13) proteolyzes fibulin-1 and that calumenin protects fibulin-1 from cleavage by MMP-13. Calumenin, together with fibulin-1, also interacts with fibronectin and depends on both syndecan-4 and a5a1-integrin to suppress ERK1/2 signaling and inhibit cell migration. Thus, extracellular calumenin regulates fibulin-1 to have crucial roles in ERK1/2 signaling and cell migration.	[Wang, Q.; Shen, B.; Chen, L.; Zheng, P.; Feng, H.; Hao, Q.; Liu, X.; Liu, L.; Xu, S.; Chen, J.; Teng, J.] Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat, Minist Educ,Coll Life Sci,Dept Cell Biol & Genet, Beijing 100871, Peoples R China; [Chen, J.] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, J (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat, Minist Educ,Coll Life Sci, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	chenjg@pku.edu.cn; junlinteng@pku.edu.cn		Wang, Qiao/0000-0001-6416-1733; Shen, Birong/0000-0002-1208-506X; Zheng, Pengli/0000-0002-3797-4023	National Natural Science Foundation of China [31271424]; Major State Basic Research Development Program of China (973 program) [2010CB833705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China)	We thank Dr W Scott Argraves at the Medical University of South Carolina for kindly providing anti-fibulin-1 antibody (3A11). The lentivirus system is a kind gift from Dr Jincai Luo at Peking University. We also thank Dr Li Yu and Dr Xiaofeng Wang at Tsinghua University, and Dr Zhengfan Jiang at Peking University for helpful discussion. We also thank Dr IC Bruce at Zhejiang University and Dr Xiaolei Su at the University of California, San Francisco, for reading the manuscript. This work was supported by the National Natural Science Foundation of China (31271424) and the Major State Basic Research Development Program of China (973 program) (2010CB833705).	Cooley MA, 2012, DEV DYNAM, V241, P303, DOI 10.1002/dvdy.23716; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Ding SJ, 2004, PROTEOMICS, V4, P982, DOI 10.1002/pmic.200300653; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Feng H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.403; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hseu MJ, 1999, FEBS LETT, V445, P440, DOI 10.1016/S0014-5793(99)00177-5; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Julovi SM, 2011, J ORTHOP RES, V29, P258, DOI 10.1002/jor.21216; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Labat-Robert J, 2012, PATHOL BIOL, V60, P15, DOI 10.1016/j.patbio.2011.10.003; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mikula M, 2010, FUNCT INTEGR GENOMIC; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PAN TC, 1993, EUR J BIOCHEM, V215, P733, DOI 10.1111/j.1432-1033.1993.tb18086.x; Pupa SM, 2004, ONCOGENE, V23, P2153, DOI 10.1038/sj.onc.1207323; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; Roger P, 1998, AM J PATHOL, V153, P1579, DOI 10.1016/S0002-9440(10)65746-X; Shen CY, 2002, LUNG CANCER, V38, P235, DOI 10.1016/S0169-5002(02)00300-8; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Twal WO, 2001, J CELL SCI, V114, P4587; Vandenbroucke RE, 2013, EMBO MOL MED, V5, P1000, DOI 10.1002/emmm.201202100; Vizoso FJ, 2006, SCAND J GASTROENTERO, V41, P1050, DOI 10.1080/00365520600554667; Voisin SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016352; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035344; Wang Qiao, 2012, Front Biosci (Elite Ed), V4, P998, DOI 10.2741/E435; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Williams SA, 2009, MOL BIOL CELL, V20, P1141, DOI 10.1091/mbc.E08-06-0621; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yabe D, 1998, GENOMICS, V49, P331, DOI 10.1006/geno.1998.5245; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Zhang H, 2008, ACTA BIOCH BIOPH SIN, V40, P375, DOI 10.1111/j.1745-7270.2008.00420.x; Zhang XR, 2012, CARTILAGE, V3, P267, DOI 10.1177/1947603511435273; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	55	27	30	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2015	34	8					1006	1018		10.1038/onc.2014.52	http://dx.doi.org/10.1038/onc.2014.52			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RT	24632605				2022-12-25	WOS:000350121300007
J	Alaimo, A; Gorojod, RM; Beauquis, J; Munoz, MJ; Saravia, F; Kotler, ML				Alaimo, Agustina; Gorojod, Roxana M.; Beauquis, Juan; Munoz, Manuel J.; Saravia, Flavia; Kotler, Monica L.			Deregulation of Mitochondria-Shaping Proteins Opa-1 and Drp-1 in Manganese-Induced Apoptosis	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION; FISSION; FUSION; FRAGMENTATION; CRISTAE; NEURODEGENERATION; MODULATION; INHIBITION	Mitochondria are dynamic organelles that undergo fusion and fission processes. These events are regulated by mitochondria-shaping proteins. Changes in the expression and/or localization of these proteins lead to a mitochondrial dynamics impairment and may promote apoptosis. Increasing evidence correlates the mitochondrial dynamics disruption with the occurrence of neurodegenerative diseases. Therefore, we focused on this topic in Manganese (Mn)-induced Parkinsonism, a disorder associated with Mn accumulation preferentially in the basal ganglia where mitochondria from astrocytes represent an early target. Using MitoTracker Red staining we observed increased mitochondrial network fission in Mn-exposed rat astrocytoma C6 cells. Moreover, Mn induced a marked decrease in fusion protein Opa-1 levels as well as a dramatic increase in the expression of fission protein Drp-1. Additionally, Mn provoked a significant release of high MW Opa-1 isoforms from the mitochondria to the cytosol as well as an increased Drp-1 translocation to the mitochondria. Both Mdivi-1, a pharmacological Drp-1 inhibitor, and rat Drp-1 siRNA reduced the number of apoptotic nuclei, preserved the mitochondrial network integrity and prevented cell death. CsA, an MPTP opening inhibitor, prevented mitochondrial Delta psi m disruption, Opa-1 processing and Drp-1 translocation to the mitochondria therefore protecting Mn-exposed cells from mitochondrial disruption and apoptosis. The histological analysis and Hoechst 33258 staining of brain sections of Mn-injected rats in the striatum showed a decrease in cellular mass paralleled with an increase in the occurrence of apoptotic nuclei. Opa-1 and Drp-1 expression levels were also changed by Mn-treatment. Our results demonstrate for the first time that abnormal mitochondrial dynamics is implicated in both in vitro and in vivo Mn toxicity. In addition we show that the imbalance in fusion/fission equilibrium might be involved in Mn-induced apoptosis. This knowledge may provide new therapeutic tools for the treatment of Manganism and other neurodegenerative diseases.	[Alaimo, Agustina; Gorojod, Roxana M.; Kotler, Monica L.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Apoptosis El Sistema Nervioso & Nanooncol, Buenos Aires, DF, Argentina; [Alaimo, Agustina; Gorojod, Roxana M.; Kotler, Monica L.] Inst Quim Biol Ciencias Exactas Nat IQUIBICEN CON, Buenos Aires, DF, Argentina; [Beauquis, Juan; Saravia, Flavia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Neurobiol Lab, Buenos Aires, DF, Argentina; [Beauquis, Juan; Saravia, Flavia] Inst Biol & Med Expt IBYME CONICET, Buenos Aires, DF, Argentina; [Munoz, Manuel J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Munoz, Manuel J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias IFIBYNE CONI, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires	Kotler, ML (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Apoptosis El Sistema Nervioso & Nanooncol, Buenos Aires, DF, Argentina.	moniquekotler@gmail.com	Beauquis, Juan/AAT-5042-2020	Beauquis, Juan/0000-0003-1404-5632; Saravia, Flavia/0000-0002-0781-0140; Kotler, Monica Lidia/0000-0002-3555-7621; Munoz, Manuel J./0000-0002-1152-5449; Gorojod, Roxana Mayra/0000-0002-9820-3978	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP) [5406, 0356]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP No 5406 and 0356, www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2011, NEUROCHEM INT, V59, P297, DOI 10.1016/j.neuint.2011.06.001; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; ASCHNER M, 1992, J NEUROCHEM, V58, P730, DOI 10.1111/j.1471-4159.1992.tb09778.x; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Corrado Mauro, 2012, Int J Cell Biol, V2012, P729290, DOI 10.1155/2012/729290; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Ganapathy PS, 2011, INVEST OPHTH VIS SCI, V52, P5551, DOI 10.1167/iovs.11-7256; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Gonzalez LE, 2008, NEUROCHEM INT, V53, P408, DOI 10.1016/j.neuint.2008.09.008; Gray JJ, 2013, BRAIN RES, V1494, P28, DOI 10.1016/j.brainres.2012.12.001; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Gunter TE, 2006, NEUROTOXICOLOGY, V27, P765, DOI 10.1016/j.neuro.2006.05.002; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jain P, 2011, P NATL ACAD SCI USA, V108, P16032, DOI 10.1073/pnas.1105175108; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Ju WK, 2005, J COMP NEUROL, V488, P1, DOI 10.1002/cne.20586; Ju WK, 2008, INVEST OPHTH VIS SCI, V49, P4903, DOI 10.1167/iovs.07-1661; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Landes T, 2011, BBA-MOL CELL RES, V1813, P540, DOI 10.1016/j.bbamcr.2011.01.021; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Loucks FA, 2009, BRAIN RES, V1250, P63, DOI 10.1016/j.brainres.2008.10.081; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Maltecca F, 2012, HUM MOL GENET, V21, P3858, DOI 10.1093/hmg/dds214; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quintanar L, 2012, EXP NEUROL, V233, P182, DOI 10.1016/j.expneurol.2011.09.032; Rao KVR, 2004, J BIOL CHEM, V279, P32333, DOI 10.1074/jbc.M402096200; Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; SUZUKI H, 1983, TOXICOL APPL PHARM, V71, P422, DOI 10.1016/0041-008X(83)90030-3; Tan AR, 2011, CELL CALCIUM, V49, P108, DOI 10.1016/j.ceca.2010.12.002; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xu B, 2009, NEUROTOXICOLOGY, V30, P941, DOI 10.1016/j.neuro.2009.07.011; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yin ZB, 2008, BRAIN RES, V1203, P1, DOI 10.1016/j.brainres.2008.01.079; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213	66	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91848	10.1371/journal.pone.0091848	http://dx.doi.org/10.1371/journal.pone.0091848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632637	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400108
J	Rao, W; Xie, GH; Zhang, Y; Wang, SJ; Wang, Y; Zhang, HZ; Song, FF; Zhang, RF; Yin, QQ; Shen, LS; Ge, HL				Rao, Wei; Xie, Guohua; Zhang, Yong; Wang, Shujun; Wang, Ying; Zhang, Huizhen; Song, Feifei; Zhang, Renfeng; Yin, Qinqin; Shen, Lisong; Ge, Hailiang			OVA66, a Tumor Associated Protein, Induces Oncogenic Transformation of NIH3T3 Cells	PLOS ONE			English	Article							ANTIGEN; PROLIFERATION; KINASE; CML66	The tumor associated antigen OVA66 has been demonstrated to be highly expressed in malignant tumors and implicated in various cellular processes. To further elucidate its oncogenic character, we established an OVA66 stably overexpressed NIH3T3 cell line and a vector transfected control, named NIH3T3-flagOVA66 and NIH3T3-mock, respectively. NIH3T3-flagOVA66 cells showed faster cell cycling, proliferation, cell migration and more resistance to 5-fluorouracil-induced apoptosis. When NIH3T3-flagOVA66 and NIH3T3-mock cells were injected into nude mice for xenograft tumorigenicity assays, the NIH3T3-flagOVA66 cells formed tumors whereas no tumors were observed in mice inoculated with NIH3T3-mock cells. Analysis of PI3K/AKT and ERK1/2 MAPK signaling pathways by serum stimulation indicated hyperactivation of AKT and ERK1/2 in NIH3T3-flagOVA66 cells compared with NIH3T3-mock cells, while a decreased level of p-AKT and p-ERK1/2 were observed in OVA66 knocked down HeLa cells. To further validate if the p-AKT or p-ERK1/2 is essential for OVA66 induced oncogenic transformation, we treated the cells with the PI3K/AKT specific inhibitor LY294002 and the ERK1/2 MAPK specific inhibitor PD98059 and found either inhibitor can attenuate the cell colony forming ability in soft agar and the cell viability of NIH3T3-flagOVA66 cells, suggesting aberrantly activated AKT and ERK1/2 signaling be indispensible of the tumorigenic role of OVA66. Our results indicate that OVA66 is important in oncogenic transformation, promoting proliferation, cell migration and reducing apoptosis via hyperactivating PI3K/AKT and ERK1/2 MAPK signaling pathway. Thus, OVA66 might be a novel target for early detection, prevention and treatment of tumors in the future.	[Rao, Wei; Zhang, Yong; Wang, Shujun; Wang, Ying; Zhang, Huizhen; Song, Feifei; Zhang, Renfeng; Yin, Qinqin; Ge, Hailiang] Shanghai Jiaotong Univ SJTU, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Xie, Guohua; Shen, Lisong] Shanghai Jiaotong Univ SJTU, Sch Med, Xinhua Hosp, Dept Clin Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ge, HL (corresponding author), Shanghai Jiaotong Univ SJTU, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.	gehl@shsmu.edu.cn	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022; rao, wei/AAM-1288-2021	, wei/0000-0002-2975-7045	National Natural Science Foundation of China [30371598, 81272328]; Scientific Research Project of Shanghai Institute of Immunology [08A03]; Innovative Program of Shanghai Municipal Education Commission [08YZ39]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Shanghai Institute of Immunology; Innovative Program of Shanghai Municipal Education Commission	This study was supported by grants from the National Natural Science Foundation of China (Nos. 30371598, 81272328), Scientific Research Project of Shanghai Institute of Immunology (No. 08A03) and Innovative Program of Shanghai Municipal Education Commission (No. 08YZ39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chari NS, 2009, APOPTOSIS, V14, P336, DOI 10.1007/s10495-009-0327-9; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jin S, 2008, CANCER SCI, V99, P1670, DOI 10.1111/j.1349-7006.2008.00860.x; Jin Shu, 2005, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V21, P233; Kadomatsu K, 1997, BRIT J CANCER, V75, P354, DOI 10.1038/bjc.1997.58; Li Mei-xing, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P185; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liu MY, 2002, CANCER RES, V62, P6475; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mufson RA, 2006, FRONT BIOSCI-LANDMRK, V11, P337, DOI 10.2741/1801; [荣婷婷 Rong Tingting], 2011, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V31, P1129; Sahin U, 1997, CURR OPIN IMMUNOL, V9, P709, DOI 10.1016/S0952-7915(97)80053-2; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; Yang XF, 2001, P NATL ACAD SCI USA, V98, P7492, DOI 10.1073/pnas.131590998; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e85705	10.1371/journal.pone.0085705	http://dx.doi.org/10.1371/journal.pone.0085705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633332	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400001
J	Kato, N; Sejima, H; Ueda, Y; Mori, K; Satoh, S; Dansako, H; Ikeda, M				Kato, Nobuyuki; Sejima, Hiroe; Ueda, Youki; Mori, Kyoko; Satoh, Shinya; Dansako, Hiromichi; Ikeda, Masanori			Genetic Characterization of Hepatitis C Virus in Long-Term RNA Replication Using Li23 Cell Culture Systems	PLOS ONE			English	Article							ADAPTIVE MUTATIONS; IN-VITRO; SEQUENCE VARIATION; MOLECULAR-CLONING; GENOME; INFECTION; PERSISTENT; STRAIN; IDENTIFICATION; RESISTANCE	Background: The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and variation. To understand this feature, we previously performed genetic analysis of HCV in the long-term culture of human hepatoma HuH-7-derived HCV RNA-replicating cell lines. On the other hand, we newly established HCV RNA-replicating cell lines using human hepatoma Li23 cells, which were distinct from HuH-7 cells. Methodology/Principal Findings: Li23-derived HCV RNA-replicating cells were cultured for 4 years. We performed genetic analysis of HCVs recovered from these cells at 0, 2, and 4 years in culture. Most analysis was performed in two separate parts: one part covered from the 5'-terminus to NS2, which is mostly nonessential for RNA replication, and the other part covered from NS3 to NS5B, which is essential for RNA replication. Genetic mutations in both regions accumulated in a timedependent manner, and the mutation rates in the 5'-terminus-NS2 and NS3-NS5B regions were 4.0-9.0x10(-3) and 2.7-4.0x10(-3) base substitutions/site/year, respectively. These results suggest that the variation in the NS3-NS5B regions is affected by the pressure of RNA replication. Several in-frame deletions (3-105 nucleotides) were detected in the structural regions of HCV RNAs obtained from 2-year or 4-year cultured cells. Phylogenetic tree analyses clearly showed that the genetic diversity of HCV was expanded in a time-dependent manner. The GC content of HCV RNA was significantly increased in a time-dependent manner, as previously observed in HuH-7-derived cell systems. This phenomenon was partially due to the alterations in codon usages for codon optimization in human cells. Furthermore, we demonstrated that these long-term cultured cells were useful as a source for the selection of HCV clones showing resistance to anti-HCV agents. Conclusions/Significance: Long-term cultured HCV RNA-replicating cells are useful for the analysis of evolutionary dynamics and variations of HCV and for drug-resistance analysis.	[Kato, Nobuyuki; Sejima, Hiroe; Ueda, Youki; Mori, Kyoko; Satoh, Shinya; Dansako, Hiromichi; Ikeda, Masanori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Shikata, Okayama, Japan	Okayama University	Kato, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Shikata, Okayama, Japan.	nkato@md.okayama-u.ac.jp	Ueda, Youki/J-3529-2015; DANSAKO, Hiromichi/B-2025-2011; Dansako, Hiromichi/M-1421-2019; Dansako, Hiromichi/N-3109-2019	Ueda, Youki/0000-0002-2627-8524; DANSAKO, Hiromichi/0000-0002-2353-3024; Dansako, Hiromichi/0000-0002-2353-3024	Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for research on hepatitis from the Ministry of Health, Labor, and Welfare of Japan; and by a grant-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS). Y.U. was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartenschlager R, 2005, J HEPATOL, V43, P210, DOI 10.1016/j.jhep.2005.05.013; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Kang JI, 2009, VIRUS RES, V144, P107, DOI 10.1016/j.virusres.2009.04.002; Kato N, 2005, J GEN VIROL, V86, P645, DOI 10.1099/vir.0.80479-0; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kato N, 2009, ARCH VIROL, V154, P77, DOI 10.1007/s00705-008-0282-8; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kliman RM, 2005, GENE, V352, P92, DOI 10.1016/j.gene.2005.04.001; Koutsoudakis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052651; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu SY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036406, 10.1371/journal.pone.0030349]; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mori K, 2010, HEPATOL RES, V40, P1248, DOI 10.1111/j.1872-034X.2010.00730.x; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Sejima H, 2012, VIRUS RES, V167, P74, DOI 10.1016/j.virusres.2012.04.008; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0; Tan S. L., 2006, HEPATITIS C VIRUSES; TANAKA T, 1992, VIRUS RES, V23, P39; Thomas DL, 2000, CURR TOP MICROBIOL, V242, P25; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Ueda Y, 2011, BIOCHEM BIOPH RES CO, V409, P663, DOI 10.1016/j.bbrc.2011.05.061; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755; Zhao Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084346; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	47	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91156	10.1371/journal.pone.0091156	http://dx.doi.org/10.1371/journal.pone.0091156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625789	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300059
J	Rauer, C; Ringseis, R; Rothe, S; Wen, GP; Eder, K				Rauer, Christine; Ringseis, Robert; Rothe, Susanne; Wen, Gaiping; Eder, Klaus			Sterol Regulatory Element-Binding Proteins Are Regulators of the Rat Thyroid Peroxidase Gene in Thyroid Cells	PLOS ONE			English	Article							LEUCINE ZIPPER PROTEIN; COENZYME-A REDUCTASE; PROMOTER ANALYSIS; NA+/I-SYMPORTER; EXPRESSION; TRANSCRIPTION; IDENTIFICATION; THYROTROPIN; RECEPTOR; CHOLESTEROL	Sterol regulatory element-binding proteins (SREBPs)-1c and -2, which were initially discovered as master transcriptional regulators of lipid biosynthesis and uptake, were recently identified as novel transcriptional regulators of the sodium-iodide symporter gene in the thyroid, which is essential for thyroid hormone synthesis. Based on this observation that SREBPs play a role for thyroid hormone synthesis, we hypothesized that another gene involved in thyroid hormone synthesis, the thyroid peroxidase (TPO) gene, is also a target of SREBP-1c and -2. Thyroid epithelial cells treated with 25-hydroxycholesterol, which is known to inhibit SREBP activation, had about 50% decreased mRNA levels of TPO. Similarly, the mRNA level of TPO was reduced by about 50% in response to siRNA mediated knockdown of both, SREBP-1 and SREBP-2. Reporter gene assays revealed that overexpression of active SREBP-1c and -2 causes a strong transcriptional activation of the rat TPO gene, which was localized to an approximately 80 bp region in the intron 1 of the rat TPO gene. In vitro-and in vivo-binding of both, SREBP-1c and SREBP-2, to this region in the rat TPO gene could be demonstrated using gel-shift assays and chromatin immunoprecipitation. Mutation analysis of the 80 bp region of rat TPO intron 1 revealed two isolated and two overlapping SREBP-binding elements from which one, the overlapping SRE+609/InvSRE+614, was shown to be functional in reporter gene assays. In connection with recent findings that the rat NIS gene is also a SREBP target gene in the thyroid, the present findings suggest that SREBPs may be possible novel targets for pharmacological modulation of thyroid hormone synthesis.	[Rauer, Christine; Ringseis, Robert; Rothe, Susanne; Wen, Gaiping; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Ringseis, R (corresponding author), Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany.	robert.ringseis@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021		Deutsche Forschungsgemeinschaft [RI 1537/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (Grant. no. RI 1537/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOJ SM, 1990, MOL ENDOCRINOL, V4, P611, DOI 10.1210/mend-4-4-611; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; BIFULCO M, 1995, J BIOL CHEM, V270, P15231, DOI 10.1074/jbc.270.25.15231; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Colin IM, 2013, ENDOCR REV, V34, P209, DOI 10.1210/er.2012-1015; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Gerard AC, 2002, J CLIN ENDOCR METAB, V87, P1291, DOI 10.1210/jc.87.3.1291; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; GRIECO D, 1990, J BIOL CHEM, V265, P19343; Guan GM, 1997, J BIOL CHEM, V272, P10295; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Inoue SI, 2011, MOL PHARMACOL, V79, P148, DOI 10.1124/mol.110.068577; Laglia G, 1996, ENDOCRINOLOGY, V137, P3170, DOI 10.1210/en.137.8.3170; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Nara TY, 2002, BIOCHEM BIOPH RES CO, V296, P111, DOI 10.1016/S0006-291X(02)00851-3; Nazar M, 2012, ENDOCRINOLOGY, V153, P6114, DOI 10.1210/en.2012-1567; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nicola JP, 2010, MOL ENDOCRINOL, V24, P1846, DOI 10.1210/me.2010-0102; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ringseis R, 2013, MOL ENDOCRINOL, V27, P781, DOI 10.1210/me.2012-1269; Rozman D, 1999, MOL ENDOCRINOL, V13, P1951, DOI 10.1210/me.13.11.1951; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wen GP, 2010, BIOCHEM PHARMACOL, V79, P768, DOI 10.1016/j.bcp.2009.10.002; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91265	10.1371/journal.pone.0091265	http://dx.doi.org/10.1371/journal.pone.0091265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625548	Green Submitted, Green Published, gold			2022-12-25	WOS:000332851300069
J	Tucker, K; Hodges, PW; Van den Hoorn, W; Nordez, A; Hug, F				Tucker, Kylie; Hodges, Paul W.; Van den Hoorn, Wolbert; Nordez, Antoine; Hug, Francois			Does Stress within a Muscle Change in Response to an Acute Noxious Stimulus?	PLOS ONE			English	Article							MOTOR UNIT RECRUITMENT; SHEAR ELASTIC-MODULUS; FIRING RATE; PAIN; CONTRACTIONS; STRATEGIES; FATIGUE; FORCE; ELASTOGRAPHY; STIMULATION	Background: Altered muscle activation during pain is thought to redistribute stress within muscles and ultimately decrease the load on painful structures. However, change in muscle stress during pain has not been directly tested. The aim of the present study is to determine whether stress within muscle tissue is reduced during local acute experimental pain. Methods and Results: Ten participants attended 2 experimental sessions that each involved isometric knee extension tasks in 2 series of control trials and 1 series of test trials at similar to 10%MVC. Shear elastic modulus was measured from vastus lateralis using a shear wave elastographic technique (Supersonic Shear Imaging). Prior to the test contractions, a bolus of hypertonic (Pain) or isotonic saline (No-pain) was injected into vastus lateralis. Pain intensity was 5.2+/-1.0 during the painful contractions. The intra-session repeatability of the shear elastic modulus determined between control trials was good (ICC: 0.95 and 0.99; SEM: 5.1 and 9.3 kPa for No-pain and Pain, respectively). Muscle shear elastic modulus did not change systematically during Pain or No-pain contractions (all main effects and interaction P>0.14). Examination of data for individual participants showed that stress either increased or decreased. If the absolute change in modulus is considered between the control and the test trials, the change during Pain (16.2+/-9.5 kPa) was double that observed with No pain (7.9+/-5.9 kPa; P = 0.046). Conclusion: This is the first study to directly determine the change in stress within a muscle (change in shear elastic modulus) during pain. We conclude that experimental pain induced by hypertonic saline does not induce a systematic reduction in muscle stress during a single-joint isometric task. Therefore, the changes in muscle activity reported previously during similar tasks are unlikely to systematically reduce load in the painful region. Whether the individual-specific increase and decrease are physiologically relevant or purposeful requires further investigation.	[Tucker, Kylie; Hodges, Paul W.; Van den Hoorn, Wolbert; Hug, Francois] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia; [Tucker, Kylie] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Nordez, Antoine; Hug, Francois] Univ Nantes, Lab Motricite Interact Performance EA 4334, Nantes, France	University of Queensland; University of Queensland; Nantes Universite	Hug, F (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia.	f.hug@uq.edu.au	Hug, François/AAV-2415-2020; Tucker, Kylie/M-4887-2013; van den Hoorn, Wolbert/F-6894-2010; Hodges, Paul W/B-6578-2008	Hug, François/0000-0002-6432-558X; Tucker, Kylie/0000-0003-4976-7483; van den Hoorn, Wolbert/0000-0002-9658-2388; Hodges, Paul W/0000-0002-1206-9107	National Health and Medical Research Council [ID401599, ID1009410]; Queensland Government Research Travel Fellowship; European Regional Development Fund (FEDER) [37400]; NHMRC Program grant [ID631717]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Research Travel Fellowship; European Regional Development Fund (FEDER)(European Commission); NHMRC Program grant(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council provided research fellowships for PH: ID401599 and KT: ID1009410. Financial support for KT was also provided by a Queensland Government Research Travel Fellowship, 2012; Project support was provided by a grant from the European Regional Development Fund (FH and AN, FEDER No 37400), and NHMRC Program grant (PH: ID631717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2002, J APPL PHYSIOL, V92, P679, DOI 10.1152/japplphysiol.00267.2001; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Ciubotariu A, 2004, EUR J APPL PHYSIOL, V91, P604, DOI 10.1007/s00421-003-1026-9; Del Santo F, 2007, BRAIN RES, V1128, P91, DOI 10.1016/j.brainres.2006.09.039; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Fadiga L, 2004, NEUROSCI LETT, V361, P250, DOI 10.1016/j.neulet.2003.12.016; Falla D, 2009, CLIN NEUROPHYSIOL, V120, P150, DOI 10.1016/j.clinph.2008.10.148; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2004, J NEUROPHYSIOL, V91, P1250, DOI 10.1152/jn.00620.2003; GravenNielsen T, 1997, ELECTROMYOGR MOTOR C, V105, P156, DOI 10.1016/S0924-980X(96)96554-6; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hodges PW, 2008, J PAIN, V9, P1169, DOI 10.1016/j.jpain.2008.06.012; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hug F, 2013, J ELECTROMY IN PRESS; Hug F, 2014, EUR J APPL IN PRESS; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Kouzaki M, 2006, J APPL PHYSIOL, V101, P715, DOI 10.1152/japplphysiol.01309.2005; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Madeleine P, 2005, J ELECTROMYOGR KINES, V15, P27, DOI 10.1016/j.jelekin.2004.06.006; Madeleine P, 2006, CLIN NEUROPHYSIOL, V117, P2436, DOI 10.1016/j.clinph.2006.06.753; Minami I, 2013, J DENT RES, V92, P143, DOI 10.1177/0022034512470832; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Peck CC, 2008, AUST DENT J, V53, P201, DOI 10.1111/j.1834-7819.2008.00050.x; RIEK S, 1992, J NEUROPHYSIOL, V68, P100, DOI 10.1152/jn.1992.68.1.100; ROMENY BMT, 1982, EXP NEUROL, V78, P360, DOI 10.1016/0014-4886(82)90054-1; Smith M, 2005, EXP BRAIN RES, V166, P109, DOI 10.1007/s00221-005-2352-4; Svensson P, 1996, PAIN, V64, P241, DOI 10.1016/0304-3959(95)00133-6; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; THOMAS JS, 1978, EXP NEUROL, V59, P384, DOI 10.1016/0014-4886(78)90230-3; Tucker K J, 2013, CHIN J PAIN IN PRESS; Tucker K, 2012, PAIN, V153, P636, DOI 10.1016/j.pain.2011.11.024; Tucker K, 2009, J NEUROSCI, V29, P10820, DOI 10.1523/JNEUROSCI.5211-08.2009; Tucker KJ, 2010, EUR J PAIN, V14, P932, DOI 10.1016/j.ejpain.2010.03.006; Tucker KJ, 2009, PAIN, V141, P151, DOI 10.1016/j.pain.2008.10.029; Yang D, 1998, SURG RADIOL ANAT, V20, P307, DOI 10.1007/BF01630610	41	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91899	10.1371/journal.pone.0091899	http://dx.doi.org/10.1371/journal.pone.0091899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626150	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300144
J	Zhang, FB; Hao, WW; Zhao, WG; Zheng, C; Chu, YJ; Xu, F				Zhang Fangbin; Hao Weiwei; Zhao Wugan; Zheng Cong; Chu Yanjun; Xu Feng			The Analysis of Factors Associated with Progression of Isolated Terminal Ileal Lesions	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; FECAL CALPROTECTIN; ASYMPTOMATIC ILEITIS; CLINICAL-ASSESSMENT; DIAGNOSTIC-VALUE; CHRONIC DIARRHEA; CROHNS-DISEASE; FOLLOW-UP; SYMPTOMS	Objective: To assess the factors associated with the progression of isolated terminal ileal lesions (ITILs) at colonoscopy in Chinese patients. Methods: Patients diagnosed with ITILs were enrolled. The ileoscopy was performed by two experienced gastroenterologists every 52 weeks. A logistic regression analysis was used to elucidate the factors associated with Crohn's disease (CD) and mucosal healing. A log rank test was used to assess the differences of the cumulative proportion of CD and mucosal healing in different groups at different times. Results: (1) A total of 34 patients were included and no patient had taken nonsteroidal anti-inflammatory drug in the last 6 months; eight (23.5%) patients had a clinical diagnosis of CD, 14 (41.2%) patients achieved mucosal healing, and 12 (35.3%) patients showed no significant changes in the lesions at last follow-up. (2) The logistic regression analysis showed that only abdominal pain was a factor in the ITIL disease outcomes. (3) The cumulative proportion of CD in the abdominal pain group after 3 years was statistically higher than that in the non-abdominal pain group (42.7% vs. 6.2%, chi(2) = 10.129, P = 0.001). However, the cumulative proportion of mucosal healing in the non-abdominal pain group was statistically higher than that in the abdominal pain group (73.3% vs. 5.6%, chi(2) = 5.225, P = 0.022). (4) The numbers of lesions observed on the initial colonoscopy exams and the initial histologic findings were not related to the ITIL disease outcomes. Conclusions: Clinical symptoms may be related to ITIL disease outcomes. Patients with abdominal pain had a high likelihood of CD, whereas those without abdominal pain had a high likelihood of mucosal healing.	[Zhang Fangbin; Hao Weiwei; Zheng Cong; Chu Yanjun; Xu Feng] Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, Zhengzhou 450052, Peoples R China; [Zhao Wugan] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, FB (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, Zhengzhou 450052, Peoples R China.	dr_mingren@163.com			research funding for the doctoral program of higher education of China; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	research funding for the doctoral program of higher education of China; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	This study was sponsored by research funding for the doctoral program of higher education of China and the Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar A, 2010, GUT, V59, P767, DOI 10.1136/gut.2009.194449; Berrill JW, 2013, ALIMENT PHARM THER, V38, P44, DOI 10.1111/apt.12335; BJERKE K, 1993, GUT, V34, P1357, DOI 10.1136/gut.34.10.1357; Canani RB, 2004, DIGEST LIVER DIS, V36, P467, DOI 10.1016/j.dld.2004.02.009; Carroccio A, 2003, CLIN CHEM, V49, P861, DOI 10.1373/49.6.861; Chang HS, 2010, GASTROINTEST ENDOSC, V72, P1226, DOI 10.1016/j.gie.2010.08.029; Courville EL, 2009, AM J SURG PATHOL, V33, P1341, DOI 10.1097/PAS.0b013e3181ad25b6; Geboes K, 1998, AM J GASTROENTEROL, V93, P201, DOI 10.1111/j.1572-0241.1998.00201.x; Geboes K, 2007, AM J GASTROENTEROL, V102, P1090, DOI 10.1111/j.1572-0241.2007.01190.x; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P838, DOI 10.1309/4PK0G68M2G1L6X47; Greaves ML, 2006, J CLIN GASTROENTEROL, V40, P281, DOI 10.1097/01.mcg.0000210104.59370.66; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; HIZAWA K, 1994, RADIOLOGY, V190, P451, DOI 10.1148/radiology.190.2.8284398; Keohane J, 2010, AM J GASTROENTEROL, V105, P1789, DOI 10.1038/ajg.2010.156; Lengeling RW, 2003, CLIN GASTROENTEROL H, V1, P160, DOI 10.1053/jcgh.2003.50024; Limburg PJ, 2000, AM J GASTROENTEROL, V95, P2831, DOI 10.1016/S0002-9270(00)01987-0; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Matsumoto T, 2000, BRIT J RADIOL, V73, P1046, DOI 10.1259/bjr.73.874.11271896; McHugh JB, 2007, AM J GASTROENTEROL, V102, P1084, DOI 10.1111/j.1572-0241.2007.01194.x; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Porter CK, 2011, DIGEST DIS SCI, V56, P3262, DOI 10.1007/s10620-011-1762-3; Singh S, 2009, AM J GASTROENTEROL, V104, P1298, DOI 10.1038/ajg.2009.15; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Stavlo PL, 2003, J PEDIATR SURG, V38, P935, DOI 10.1016/S0022-3468(03)00127-1; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Villani AC, 2010, GASTROENTEROLOGY, V138, P1502, DOI 10.1053/j.gastro.2009.12.049; Vivinus-Nebot M, 2013, GUT; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017; Zucchelli M, 2011, GUT, V60, P1671, DOI 10.1136/gut.2011.241877	34	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90797	10.1371/journal.pone.0090797	http://dx.doi.org/10.1371/journal.pone.0090797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625578	gold, Green Submitted, Green Published			2022-12-25	WOS:000332851300035
J	Barnea, O; Huppert, A; Katriel, G; Stone, L				Barnea, Oren; Huppert, Amit; Katriel, Guy; Stone, Lewi			Spatio-Temporal Synchrony of Influenza in Cities across Israel: The "Israel Is One City'' Hypothesis	PLOS ONE			English	Article							SEASONAL INFLUENZA; UNITED-STATES; TRANSMISSION; EPIDEMIC; SPREAD; AUSTRALIA; FRANCE; TRENDS	We analysed an 11-year dataset (1998-2009) of Influenza-Like Illness (ILI) that was based on surveillance of (similar to)23% of Israel's population. We examined whether the level of synchrony of ILI epidemics in Israel's 12 largest cities is high enough to view Israel as a single epidemiological unit. Two methods were developed to assess the synchrony: (1) City-specific attack rates were fitted to a simple model in order to estimate the temporal differences in attack rates and spatial differences in reporting rates of ILI. The model showed good fit to the data (R-2 = 0.76) and revealed considerable differences in reporting rates of ILI in different cities (up to a factor of 2.2). (2) A statistical test was developed to examine the null hypothesis (H0) that ILI incidence curves in two cities are essentially identical, and was tested using ILI data. Upon examining all possible pairs of incidence curves, 77.4% of pairs were found not to be different (H0 was not rejected). It was concluded that all cities generally have the same attack rate and follow the same epidemic curve each season, although the attack rate changes from season to season, providing strong support for the "Israel is one city'' hypothesis. The cities which were the most out of synchronization were Bnei Brak, Beersheba and Haifa, the latter two being geographically remote from all other cities in the dataset and the former geographically very close to several other cities but socially separate due to being populated almost exclusively by ultra-orthodox Jews. Further evidence of assortative mixing of the ultra-orthodox population can be found in the 2001-2002 season, when ultra-orthodox cities and neighborhoods showed distinctly different incidence curves compared to the general population.	[Barnea, Oren; Stone, Lewi] Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Huppert, Amit] Chaim Sheba Med Ctr, Gertner Inst, IL-52621 Tel Hashomer, Israel; [Katriel, Guy] ORT Braude Coll, Dept Math, Karmiel, Israel; [Stone, Lewi] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia	Tel Aviv University; Chaim Sheba Medical Center; Royal Melbourne Institute of Technology (RMIT)	Stone, L (corresponding author), Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il		Stone, Lewi/0000-0002-6465-579X; Katriel, Guy/0000-0001-7411-4789	EU-FP7 Epiwork grant; Israel science Foundation; Israel National Institute for Health Policy and Health Services Research [91168]; Israeli Ministry of Health	EU-FP7 Epiwork grant; Israel science Foundation(Israel Science Foundation); Israel National Institute for Health Policy and Health Services Research; Israeli Ministry of Health	EU-FP7 Epiwork grant; The Israel science Foundation; The Israel National Institute for Health Policy and Health Services Research, http://www.israelhpr.org.il/e/, Grant number: 91168; The Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Barnea O, 2011, MATH BIOSCI ENG, V8, P561, DOI 10.3934/mbe.2011.8.561; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Centeral Bureau of Statistics, 2013, STAT ABSTR ISR; Charland KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017207, 10.1371/journal.pone.0024047]; Choshen M., 2012, JERUSALEM FACTS TREN; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Gurovich N., 2004, ULTRAORTHODOX JEWS G; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huppert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045107; Israel Center for Disease Control, 2013, SURV INFL LIK ILLN I; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Roll U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-92; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Stein-Zamir C, 2009, EUROSURVEILLANCE, V14, P12; Stein-Zamir C, 2008, EURO SURVEILLANCE, V13; Truscott J, 2011, J ROYAL SOC INTERFAC, DOI DOI 10.1098/RSIF.2011.0309.ACCESSED; van Noort SP, 2012, J THEOR BIOL, V298, P131, DOI 10.1016/j.jtbi.2011.12.020; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Yaari R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0298	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91909	10.1371/journal.pone.0091909	http://dx.doi.org/10.1371/journal.pone.0091909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622820	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300139
J	Davis, KE; Fox, S; Gigg, J				Davis, Katherine E.; Fox, Sarah; Gigg, John			Increased Hippocampal Excitability in the 3xTgAD Mouse Model for Alzheimer's Disease In Vivo	PLOS ONE			English	Article							EPISODIC-LIKE MEMORY; DENTATE GYRUS; SYNAPTIC PLASTICITY; AMYLOID-BETA; ENTORHINAL CORTEX; ELECTROPHYSIOLOGICAL CHARACTERIZATION; TRANSGENIC MODEL; A-BETA; RAT; ORGANIZATION	Mouse Alzheimer's disease (AD) models develop age-and region-specific pathology throughout the hippocampal formation. One recently established pathological correlate is an increase in hippocampal excitability in vivo. Hippocampal pathology also produces episodic memory decline in human AD and we have shown a similar episodic deficit in 3xTg AD model mice aged 3-6 months. Here, we tested whether hippocampal synaptic dysfunction accompanies this cognitive deficit by probing dorsal CA1 and DG synaptic responses in anaesthetized, 4-6 month-old 3xTgAD mice. As our previous reports highlighted a decline in episodic performance in aged control mice, we included aged cohorts for comparison. CA1 and DG responses to low-frequency perforant path stimulation were comparable between 3xTgAD and controls at both age ranges. As expected, DG recordings in controls showed paired-pulse depression; however, paired-pulse facilitation was observed in DG and CA1 of young and old 3xTgAD mice. During stimulus trains both short-latency (presumably monosynaptic: 'direct') and long-latency (presumably polysynaptic: 're-entrant') responses were observed. Facilitation of direct responses was modest in 3xTgAD animals. However, re-entrant responses in DG and CA1 of young 3xTgAD mice developed earlier in the stimulus train and with larger amplitude when compared to controls. Old mice showed less DG paired-pulse depression and no evidence for re-entrance. In summary, DG and CA1 responses to low-frequency stimulation in all groups were comparable, suggesting no loss of synaptic connectivity in 3xTgAD mice. However, higher-frequency activation revealed complex change in synaptic excitability in DG and CA1 of 3xTgAD mice. In particular, short-term plasticity in DG and CA1 was facilitated in 3xTgAD mice, most evidently in younger animals. In addition, re-entrance was facilitated in young 3xTgAD mice. Overall, these data suggest that the episodic-like memory deficit in 3xTgAD mice could be due to the development of an abnormal hyper-excitable state in the hippocampal formation.	[Davis, Katherine E.; Fox, Sarah; Gigg, John] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Gigg, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	j.gigg@manchester.ac.uk		Gigg, John/0000-0001-8253-1582	BBSRC [BB/D011159/1]; Royal Society [RSRG 24519]; Biotechnology and Biological Sciences Research Council [BB/D011159/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for RCUK funding to KED (BBSRC PhD studentship), SF (BBSRC CASE PhD studentship) and JG (BBSRC grant BB/D011159/1; Royal Society grant RSRG 24519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Backman L, 2001, BRAIN, V124, P96, DOI 10.1093/brain/124.1.96; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Bampton ETW, 1999, BRAIN RES, V841, P123, DOI 10.1016/S0006-8993(99)01811-9; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blaise JH, 2000, ANN BIOMED ENG, V28, P128, DOI 10.1114/1.261; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BROWN RE, 1995, NEUROSCI LETT, V196, P17, DOI 10.1016/0304-3940(95)11825-H; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Davis KE, 2013, BEHAV BRAIN RES, V254, P73, DOI 10.1016/j.bbr.2013.03.009; Davis KE, 2013, J ALZHEIMERS DIS, V33, P681, DOI 10.3233/JAD-2012-121543; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Golby A, 2005, BRAIN, V128, P773, DOI 10.1093/brain/awh400; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hwang DY, 2006, EPILEPSY BEHAV, V8, P115, DOI 10.1016/j.yebeh.2005.09.009; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Kloosterman F, 2004, HIPPOCAMPUS, V14, P1026, DOI 10.1002/hipo.20022; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LAMBERT NA, 1994, J NEUROPHYSIOL, V72, P121, DOI 10.1152/jn.1994.72.1.121; Lee H, 2004, ACTA NEUROBIOL EXP, V64, P89; LEUNG LS, 1995, J NEUROPHYSIOL, V73, P2392, DOI 10.1152/jn.1995.73.6.2392; Loreth D, 2012, NEUROBIOL DIS, V47, P1, DOI 10.1016/j.nbd.2012.03.011; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paxinos G, 2001, MOUSE BRAIN INSTEREO; Phillips T, 2000, NEUROSCIENCE, V95, P1139; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sloviter R S, 1991, Hippocampus, V1, P31, DOI 10.1002/hipo.450010105; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Tamamaki N, 1997, EXP BRAIN RES, V116, P250, DOI 10.1007/PL00005753; Townsend G, 2002, BRAIN RES PROTOC, V9, P122, DOI 10.1016/S1385-299X(02)00139-3; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; VANHOESEN GW, 1990, PROG BRAIN RES, V83, P445; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Witter MP, 2003, INT CONGR SER, V1250, P131, DOI 10.1016/S0531-5131(03)01014-8; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	62	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91203	10.1371/journal.pone.0091203	http://dx.doi.org/10.1371/journal.pone.0091203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621690	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300062
J	Du, YC; Zhang, Q; Zhang, JX				Du, Yingchun; Zhang, Qin; Zhang, John X.			Does N200 Reflect Semantic Processing?-An ERP Study on Chinese Visual Word Recognition	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TIME-COURSE; NEUROPHYSIOLOGICAL EVIDENCE; REPETITION; MEMORY; IDENTIFICATION; ACTIVATION; FACE; REPRESENTATIONS; CATEGORIZATION	Recent event-related potential research has reported a N200 response or a negative deflection peaking around 200 ms following the visual presentation of two-character Chinese words. This N200 shows amplitude enhancement upon immediate repetition and there has been preliminary evidence that it reflects orthographic processing but not semantic processing. The present study tested whether this N200 is indeed unrelated to semantic processing with more sensitive measures, including the use of two tasks engaging semantic processing either implicitly or explicitly and the adoption of a within-trial priming paradigm. In Exp. 1, participants viewed repeated, semantically related and unrelated prime-target word pairs as they performed a lexical decision task judging whether or not each target was a real word. In Exp. 2, participants viewed high-related, low-related and unrelated word pairs as they performed a semantic task judging whether each word pair was related in meaning. In both tasks, semantic priming was found from both the behavioral data and the N400 ERP responses. Critically, while repetition priming elicited a clear and large enhancement on the N200 response, semantic priming did not show any modulation effect on the same response. The results indicate that the N200 repetition enhancement effect cannot be explained with semantic priming and that this specific N200 response is unlikely to reflect semantic processing.	[Du, Yingchun] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhang, Qin] Capital Normal Univ, Dept Psychol, Beijing, Peoples R China; [Zhang, John X.] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Capital Normal University; Fudan University	Zhang, JX (corresponding author), Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China.	zhangxuexinjohn@gmail.com			National Nature Science Foundation of China (NSFC) [31100815, 30670702, 31271110]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Nature Science Foundation of China (NSFC #31100815, #30670702, and #31271110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RP, 2003, BRAIN LANG, V87, P290, DOI 10.1016/S0093-934X(03)00108-1; Badecker W, 2007, BRAIN LANG, V103, P16, DOI 10.1016/j.bandl.2007.07.008; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BENTIN S, 1990, Q J EXP PSYCHOL-A, V42, P693, DOI 10.1080/14640749008401245; Besner D, 1991, BASIC PROCESSES READ, P264; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Czigler I, 1996, BIOL PSYCHOL, V43, P27, DOI 10.1016/0301-0511(95)05173-2; Douglas LM, 2000, PSYCHOL LEARN MOTIV, P121; Evans KM, 2007, NEUROPSYCHOLOGIA, V45, P1777, DOI 10.1016/j.neuropsychologia.2006.12.014; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Folstein JR, 2004, J EXP PSYCHOL LEARN, V30, P1026, DOI 10.1037/0278-7393.30.5.1026; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Ganis G, 2008, NEUROIMAGE, V42, P1714, DOI 10.1016/j.neuroimage.2008.07.004; Guillaume C, 2009, BRAIN RES, V1248, P149, DOI 10.1016/j.brainres.2008.10.069; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Heinze HJ, 1994, COGNITIVE ELECTROPHY, P124; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Holcomb PJ, 2007, BRAIN RES, V1180, P39, DOI 10.1016/j.brainres.2007.06.110; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; HOLCOMB PJ, 1988, BRAIN LANG, V35, P66, DOI 10.1016/0093-934X(88)90101-0; Hu W, 2013, NEUROSCI LETT, V552, P151, DOI 10.1016/j.neulet.2013.07.041; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Jia XF, 2013, NEUROPSYCHOLOGIA, V51, P1296, DOI 10.1016/j.neuropsychologia.2013.03.024; Kuperberg GR, 2008, HUM BRAIN MAPP, V29, P544, DOI 10.1002/hbm.20419; Lebreton K, 2001, J COGNITIVE NEUROSCI, V13, P670, DOI 10.1162/089892901750363226; Libben G., 2006, REPRESENTATION PROCE; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; MUSEN G, 1990, J EXP PSYCHOL LEARN, V16, P127, DOI 10.1037/0278-7393.16.1.127; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; NOBRE AC, 1995, J NEUROSCI, V15, P1090; Olichney JM, 2000, BRAIN, V123, P1948, DOI 10.1093/brain/123.9.1948; Pesciarelli F, 2007, BIOL PSYCHOL, V76, P21, DOI 10.1016/j.biopsycho.2007.05.003; Pylkkanen L, 2003, TRENDS COGN SCI, V7, P187, DOI 10.1016/S1364-6613(03)00092-5; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; Rugg MD, 1997, PSYCHOPHYSIOLOGY, V34, P572, DOI 10.1111/j.1469-8986.1997.tb01744.x; Schendan HE, 2007, J COGNITIVE NEUROSCI, V19, P734, DOI 10.1162/jocn.2007.19.5.734; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; Schendan HE, 2003, J COGNITIVE NEUROSCI, V15, P111, DOI 10.1162/089892903321107864; Schendan HE, 2002, NEUROPSYCHOLOGIA, V40, P931, DOI 10.1016/S0028-3932(01)00176-2; Segaert K, 2013, NEUROPSYCHOLOGIA, V51, P59, DOI 10.1016/j.neuropsychologia.2012.11.006; Segalowitz SJ, 2009, BIOL PSYCHOL, V80, P122, DOI 10.1016/j.biopsycho.2008.04.009; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Swick D, 1998, COGNITIVE BRAIN RES, V7, P143, DOI 10.1016/S0926-6410(98)00019-6; Trenner MU, 2004, COGNITIVE BRAIN RES, V21, P388, DOI 10.1016/j.cogbrainres.2004.06.017; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; VANPETTEN C, 1991, J COGNITIVE NEUROSCI, V3, P131, DOI 10.1162/jocn.1991.3.2.131; Xu GF, 2008, THESIS TIANJIN NORMA; Zhang J. X., 2011, J S CHINA NORMAL U S, V4, P5; Zhang JX, 2012, CHINESE SCI BULL, V57, P1516, DOI 10.1007/s11434-011-4932-y	57	20	20	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90794	10.1371/journal.pone.0090794	http://dx.doi.org/10.1371/journal.pone.0090794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622389	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300029
J	King, DT; Barnes, M; Thomsen, D; Lee, CH				King, Dustin T.; Barnes, Mark; Thomsen, Dana; Lee, Chow H.			Assessing Specific Oligonucleotides and Small Molecule Antibiotics for the Ability to Inhibit the CRD-BP-CD44 RNA Interaction	PLOS ONE			English	Article							PROTEIN CRD-BP; MYC MESSENGER-RNA; NUCLEIC-ACID BINDING; C-MYC; CODING REGION; CELL-PROLIFERATION; EXPRESSION; CANCER; GROWTH; IMP1	Studies on Coding Region Determinant-Binding Protein (CRD-BP) and its orthologs have confirmed their functional role in mRNA stability and localization. CRD-BP is present in extremely low levels in normal adult tissues, but it is over-expressed in many types of aggressive human cancers and in neonatal tissues. Although the exact role of CRD-BP in tumour progression is unclear, cumulative evidence suggests that its ability to physically associate with target mRNAs is an important criterion for its oncogenic role. CRD-BP has high affinity for the 3'UTR of the oncogenic CD44 mRNA and depletion of CRD-BP in cells led to destabilization of CD44 mRNA, decreased CD44 expression, reduced adhesion and disruption of invadopodia formation. Here, we further characterize the CRD-BP-CD44 RNA interaction and assess specific antisense oligonucleotides and small molecule antibiotics for their ability to inhibit the CRD-BP-CD44 RNA interaction. CRD-BP has a high affinity for binding to CD44 RNA nts 2862-3055 with a K-d of 645 nM. Out of ten antisense oligonucleotides spanning nts 2862-3055, only three antisense oligonucleotides (DD4, DD7 and DD10) were effective in competing with CRD-BP for binding to P-32-labeled CD44 RNA. The potency of DD4, DD7 and DD10 in inhibiting the CRD-BP-CD44 RNA interaction in vitro correlated with their ability to specifically reduce the steady-state level of CD44 mRNA in cells. The aminoglycoside antibiotics neomycin, paramomycin, kanamycin and streptomycin effectively inhibited the CRD-BP-CD44 RNA interaction in vitro. Assessing the potential inhibitory effect of aminoglycoside antibiotics including neomycin on the CRD-BP-CD44 mRNA interaction in cells proved difficult, likely due to their propensity to non-specifically bind nucleic acids. Our results have important implications for future studies in finding small molecules and nucleic acid-based inhibitors that interfere with protein-RNA interactions.	[King, Dustin T.; Barnes, Mark; Thomsen, Dana; Lee, Chow H.] Univ No British Columbia, Chem Program, Prince George, BC V2L 5P2, Canada	University of Northern British Columbia	Lee, CH (corresponding author), Univ No British Columbia, Chem Program, Prince George, BC V2L 5P2, Canada.	chow.lee@unbc.ca		King, Dustin/0000-0003-1775-2885	Natural Sciences & Engineering Research Council (NSERC) [227158]; NSERC; BC Cancer Agency Summer Studentship	Natural Sciences & Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BC Cancer Agency Summer Studentship	This work was supported by a Discovery Grant (grant number 227158) from Natural Sciences & Engineering Research Council (NSERC) to C. H. L. D. T. K. was a recipient of NSERC Undergraduate Student Research Awards and a BC Cancer Agency Summer Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya DP, 2003, J AM CHEM SOC, V125, P8070, DOI 10.1021/ja034241t; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bergstrom K, 2006, J CELL BIOCHEM, V98, P519, DOI 10.1002/jcb.20726; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Craig EA, 2012, J CELL SCI, V125, P5950, DOI 10.1242/jcs.115204; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Dinesh CU, 2003, SMALL MOL DNA RNA BI, P58; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Gu W, 2009, J CELL SCI, V122, P1895, DOI 10.1242/jcs.045278; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Hsieh YT, 2013, GYNECOL ONCOL, V131, P182, DOI 10.1016/j.ygyno.2013.07.106; Hwang S, 1999, P NATL ACAD SCI USA, V96, P12997, DOI 10.1073/pnas.96.23.12997; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Ioannidis P, 2004, CANCER LETT, V209, P245, DOI 10.1016/j.canlet.2003.12.015; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kato T, 2007, CLIN CANCER RES, V13, P434, DOI 10.1158/1078-0432.CCR-06-1297; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Liao BS, 2004, J BIOL CHEM, V279, P48716, DOI 10.1074/jbc.M405853200; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; LUEDTKE NW, 2003, SMALL MOL DNA RNA BI, P18; Mao CJ, 2006, ANAL BIOCHEM, V350, P222, DOI 10.1016/j.ab.2005.12.010; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Prayle A, 2010, THORAX, V65, P654, DOI 10.1136/thx.2009.131532; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider PN, 2011, GENESIS, V49, P117, DOI 10.1002/dvg.20689; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Tok JBH, 2003, CURR TOP MED CHEM, V3, P1001, DOI 10.2174/1568026033452131; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Xue LA, 2011, BIOCHEMISTRY-US, V50, P2838, DOI 10.1021/bi1017304; Xue LA, 2010, BIOCHEMISTRY-US, V49, P5540, DOI 10.1021/bi100071j; Yang G, 2006, J MED CHEM, V49, P5478, DOI 10.1021/jm060288o; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zuker M, 2003, NUCLEIC ACIDS RES, V15, P3046	55	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91585	10.1371/journal.pone.0091585	http://dx.doi.org/10.1371/journal.pone.0091585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622399	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300108
J	Veronez, CL; Nascimento, FD; Melo, KRB; Nader, HB; Tersariol, ILS; Motta, G				Veronez, Camila Lopes; Nascimento, Fabio D.; Melo, Katia R. B.; Nader, Helena B.; Tersariol, Ivarne L. S.; Motta, Guacyara			The Involvement of Proteoglycans in the Human Plasma Prekallikrein Interaction with the Cell Surface	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; HEPARAN-SULFATE PROTEOGLYCANS; HEPATOCYTE GROWTH-FACTOR; VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; ADIPOCYTE DIFFERENTIATION; BRADYKININ FORMATION; CONTACT ACTIVATION; H-KININOGEN; MAST-CELLS	Introduction: The aim of this work was to evaluate the role of human plasma prekallikrein assembly and processing in cells and to determine whether proteoglycans, along with high molecular weight kininogen (H-kininogen), influence this interaction. Methods: We used the endothelial cell line ECV304 and the epithelial cell lines CHO-K1 (wild type) and CHO-745 (deficient in proteoglycans). Prekallikrein endocytosis was studied using confocal microscopy, and prekallikrein cleavage/activation was determined by immunoblotting using an antibody directed to the prekallikrein sequence C364TTKTSTR371 and an antibody directed to the entire H-kininogen molecule. Results: At 37 degrees C, prekallikrein endocytosis was assessed in the absence and presence of exogenously applied H-kininogen and found to be 1,418.4 +/- 0.010 and 1,070.3 +/- 0.001 pixels/cell, respectively, for ECV304 and 1,319.1 +/- 0.003 and 631.3 +/- 0.001 pixels/cell, respectively, for CHO-K1. No prekallikrein internalization was observed in CHO-745 in either condition. Prekallikrein colocalized with LysoTracker in the absence and presence of exogenous H-kininogen at levels of 76.0% and 88.5%, respectively, for ECV304 and at levels of 40.7% and 57.0%, respectively, for CHO-K1. After assembly on the cell surface, a plasma kallikrein fragment of 53 kDa was predominant in the incubation buffer of all the cell lines studied, indicating specific proteolysis; plasma kallikrein fragments of 48-44 kDa and 34-32 kDa were also detected in the incubation buffer, indicating non-specific cleavage. Bradykinin free H-kininogen internalization was not detected in CHO-K1 or CHO-745 cells at 37 degrees C. Conclusion: The prekallikrein interaction with the cell surface is temperature-dependent and independent of exogenously applied H-kininogen, which results in prekallikrein endocytosis promoted by proteoglycans. Prekallikrein proteolysis/activation is influenced by H-kininogen/glycosaminoglycans assembly and controls plasma kallikrein activity.	[Veronez, Camila Lopes; Melo, Katia R. B.; Nader, Helena B.; Tersariol, Ivarne L. S.; Motta, Guacyara] Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Sao Paulo, Brazil; [Nascimento, Fabio D.] Univ Bandeirante Sao Paulo, Biomat & Biotechnol Res Grp, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Bandeirante de Sao Paulo	Tersariol, ILS (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Sao Paulo, Brazil.	ivarne.tersariol@gmail.com; guacyara.motta05@unifesp.br	Veronez, Camila Lopes/O-6134-2015; Nascimento, Fabio Dupart/ABB-8295-2020; Nascimento, Fabio D/A-5115-2010; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; MOTTA, GUACYARA/C-4429-2015; Nader, Helena Bonciani/D-9253-2012	Veronez, Camila Lopes/0000-0001-9565-1911; Nascimento, Fabio Dupart/0000-0001-6672-3373; Nascimento, Fabio D/0000-0001-6672-3373; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; MOTTA, GUACYARA/0000-0001-5427-1795; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 09/51319-1, 09/13160-0, FAPESP 13/05822-9, FAPESP 2012/50219-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 472403/2007-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: fellowship to C. L. Veronez(FAPESP 09/51319-1 and 09/13160-0), grant to F. D. Nascimento(FAPESP 13/05822-9) and grant to I. L. S. Tersariol (FAPESP 2012/50219-6); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant to G. Motta(CNPq 472403/2007-9); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah RT, 2010, J BIOL CHEM, V285, P35206, DOI 10.1074/jbc.M110.171769; Akita K, 2002, GASTROENTEROLOGY, V123, P352, DOI 10.1053/gast.2002.34234; Andrezza JG, 2002, INT IMMUNOPHARMACOL, V2, P1861, DOI 10.1016/S1567-5769(02)00145-5; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; BURGER D, 1986, J BIOL CHEM, V261, P324; Cerf M, 1999, IMMUNOPHARMACOLOGY, V44, P75, DOI 10.1016/S0162-3109(99)00112-5; Chee J, 2007, BIOL CHEM, V388, P1235, DOI 10.1515/BC.2007.139; Colman RW, 2006, CURR PHARM DESIGN, V12, P2599, DOI 10.2174/138161206777698710; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; della Vergiliana JFV, 2010, BIOL CHEM, V391, P1067, DOI 10.1515/BC.2010.102; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Fernando AN, 2005, AM J PHYSIOL-HEART C, V289, pH251, DOI 10.1152/ajpheart.00206.2004; Fink E, 2007, BIOL CHEM, V388, P957, DOI 10.1515/BC.2007.104; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gozzo AJ, 2006, BIOL CHEM, V387, P1129, DOI 10.1515/BC.2006.139; Gozzo AJ, 2011, BIOCHIMIE, V93, P1839, DOI 10.1016/j.biochi.2011.07.003; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Lilla JN, 2009, J BIOL CHEM, V284, P13792, DOI 10.1074/jbc.M900508200; Melo KRB, 2009, BIOL CHEM, V390, P145, DOI 10.1515/BC.2009.016; Motta G, 1992, Agents Actions Suppl, V36, P200; Motta G, 1992, Agents Actions Suppl, V38 ( Pt 2), P265; Motta G, 1989, Adv Exp Med Biol, V247B, P239; Motta G, 2001, THROMB HAEMOSTASIS, V86, P840; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Oliva M.L.V., 1982, AGENTS ACTIONS S, V9, P52; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2002, INT IMMUNOPHARMACOL, V2, P1867, DOI 10.1016/S1567-5769(02)00170-4; Renne T, 2001, FEBS LETT, V500, P36, DOI 10.1016/S0014-5793(01)02570-4; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	42	6	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91280	10.1371/journal.pone.0091280	http://dx.doi.org/10.1371/journal.pone.0091280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621563	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300072
J	Buss, MC; Remke, M; Lee, J; Gandhi, K; Schniederjan, MJ; Kool, M; Northcott, PA; Pfister, SM; Taylor, MD; Castellino, RC				Buss, M. C.; Remke, M.; Lee, J.; Gandhi, K.; Schniederjan, M. J.; Kool, M.; Northcott, P. A.; Pfister, S. M.; Taylor, M. D.; Castellino, R. C.			The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants	ONCOGENE			English	Article							CXCR4 ACTIVATION; P53 FUNCTION; CHK2 KINASE; PPM1D; PHOSPHATASE; PATHWAY; EXPRESSION; MUTATIONS; CHILDREN; SUBGROUP	Recent studies suggest that medulloblastoma, the most common malignant brain tumor of childhood, is comprised of four disease variants. The WIP1 oncogene is overexpressed in Group 3 and 4 tumors, which contain medulloblastomas with the most aggressive clinical behavior. Our data demonstrate increased WIP1 expression in metastatic medulloblastomas, and inferior progression-free and overall survival of patients with WIP1 high-expressing medulloblastoma. Microarray analysis identified upregulation of genes involved in tumor metastasis, including the G protein-coupled receptor CXCR4, in medulloblastoma cells with high WIP1 expression. Stimulation with the CXCR4 ligand SDF1a activated PI-3 kinase signaling, and promoted growth and invasion of WIP1 highexpressing medulloblastoma cells in a p53-dependent manner. When xenografted into the cerebellum of immunodeficient mice, medulloblastoma cells with stable or endogenous high WIP1 expression exhibited strong expression of CXCR4 and activated AKT in primary and invasive tumor cells. WIP1 or CXCR4 knockdown inhibited medulloblastoma growth and invasion. WIP1 knockdown also improved the survival of mice xenografted with WIP1 high-expressing medulloblastoma cells. WIP1 knockdown inhibited cell surface localization of CXCR4 by suppressing expression of the G protein receptor kinase 5, GRK5. Restoration of wild-type GRK5 promoted Ser339 phosphorylation of CXCR4 and inhibited the growth of WIP1-stable medulloblastoma cells. Conversely, GRK5 knockdown inhibited Ser339 phosphorylation of CXCR4, increased cell surface localization of CXCR4 and promoted the growth of medulloblastoma cells with low WIP1 expression. These results demonstrate crosstalk among WIP1, CXCR4 and GRK5, which may be important for the aggressive phenotype of a subclass of medulloblastomas in children.	[Buss, M. C.; Lee, J.; Castellino, R. C.] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Remke, M.; Taylor, M. D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Program Dev & Stem Cell Biol,Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Gandhi, K.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA; [Schniederjan, M. J.] Emory Univ, Childrens Healthcare Atlanta, Dept Pathol, Sch Med, Atlanta, GA 30322 USA; [Kool, M.; Northcott, P. A.; Pfister, S. M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Pfister, S. M.] Univ Heidelberg Hosp, Dept Pediat Hematol Oncol & Immunol, Heidelberg, Germany	Children's Healthcare of Atlanta (CHOA); Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Castellino, RC (corresponding author), Emory Univ, Dept Pediat, Sch Med, 1760 Haygood Dr NE,Room E394, Atlanta, GA 30322 USA.	rccaste@emory.edu	Northcott, Paul A/N-4022-2018; Pfister, Stefan M/F-6860-2013; Castellino, Robert/GRF-7847-2022	Northcott, Paul A/0000-0002-1220-5252; Pfister, Stefan M/0000-0002-5447-5322; Remke, Marc/0000-0002-9404-9993; Taylor, Michael/0000-0001-7009-3466	NIH [1R01CA172392-01, CA159859]; St Baldrick's Foundation; CURE Childhood Cancer Foundation; Southeastern Brain Tumor Foundation; Emory Egleston Children's Research Center; Dr Mildred-Scheel Foundation; NIH/NCI [P30CA138292]; NATIONAL CANCER INSTITUTE [R01CA172392, P30CA138292, R01CA159859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St Baldrick's Foundation; CURE Childhood Cancer Foundation; Southeastern Brain Tumor Foundation; Emory Egleston Children's Research Center; Dr Mildred-Scheel Foundation(Deutsche Krebshilfe); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Jeffrey Benovic, Lawrence Donehower, H Trent Spencer, Laurent Brault, Jurg Schwaller and Rita Nahta for gene expression constructs, Gregory Doho for assistance with analysis of microarrays, and Dr Rita Nahta for editorial assistance. This work was supported by grants from the NIH (1R01CA172392-01, RCC; CA159859, MD Taylor), St Baldrick's Foundation (RCC), CURE Childhood Cancer Foundation (RCC), Southeastern Brain Tumor Foundation (RCC), the Emory Egleston Children's Research Center (RCC) and the Dr Mildred-Scheel Foundation (MR). Research reported in this publication was supported in part by the NIH/NCI under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barker BL, 2011, BIOCHEMISTRY-US, V50, P6933, DOI 10.1021/bi2005202; BELZA MG, 1991, J NEUROSURG, V75, P575, DOI 10.3171/jns.1991.75.4.0575; Bian XW, 2007, NEUROSURGERY, V61, P570, DOI 10.1227/01.NEU.0000290905.53685.A2; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Buss MC, 2012, NEURO-ONCOLOGY, V14, P440, DOI 10.1093/neuonc/nos001; Calatozzolo C, 2006, CANCER BIOL THER, V5, P827, DOI 10.4161/cbt.5.7.2838; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dudgeon C, 2013, CELL CYCLE, V12, P2656, DOI 10.4161/cc.25694; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Ellison DW, 2011, J CLIN ONCOL, V29, P1400, DOI 10.1200/JCO.2010.30.2810; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gajjar AJ, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.cra9501; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Gessi M, 2012, J NEURO-ONCOL, V106, P135, DOI 10.1007/s11060-011-0648-8; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lamont JM, 2004, CLIN CANCER RES, V10, P5482, DOI 10.1158/1078-0432.CCR-03-0721; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; McNeil DE, 2002, MED PEDIATR ONCOL, V39, P190, DOI 10.1002/mpo.10121; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Mumert M, 2012, CANCER RES, V72, P4944, DOI 10.1158/0008-5472.CAN-12-1629; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pan E, 2005, CLIN CANCER RES, V11, P4733; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Pfister S, 2012, ACTA NEUROPATHOL, V123, P463, DOI 10.1007/s00401-012-0966-8; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Remke M, 2011, J CLIN ONCOL, V29, P2717, DOI 10.1200/JCO.2011.34.9373; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Siu IM, 2003, CANCER RES, V63, P4773; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; TORRES CF, 1994, NEW ENGL J MED, V330, P892, DOI 10.1056/NEJM199403313301303; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; von Hoff K, 2009, EUR J CANCER, V45, P1209, DOI 10.1016/j.ejca.2009.01.015; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200	69	34	35	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 26	2015	34	9					1126	1140		10.1038/onc.2014.37	http://dx.doi.org/10.1038/onc.2014.37			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC1RY	24632620	Green Accepted			2022-12-25	WOS:000350122100006
J	Kronert, WA; Melkani, GC; Melkani, A; Bernstein, SI				Kronert, William A.; Melkani, Girish C.; Melkani, Anju; Bernstein, Sanford I.			Mapping Interactions between Myosin Relay and Converter Domains That Power Muscle Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Drosophila; Electron Microscopy (EM); Myosin; Skeletal Muscle; Myofibril	DROSOPHILA INDIRECT FLIGHT; HEAVY-CHAIN; MOLECULAR MOTOR; RECOVERY STROKE; ATP HYDROLYSIS; CONFORMATIONAL-CHANGES; LEVER ARM; MELANOGASTER; MECHANISM; DICTYOSTELIUM	Background: Dissecting the molecular mechanism of muscle myosin function in vivo has proved difficult. Results: Transgenic fruit flies expressing mutant myosin and potential suppressor mutations suggest interacting amino acids. Conclusion: Communication between a relay domain residue and one in the converter is likely critical to myosin motor function. Significance: The transgenic system allows mapping of putative protein interactions essential for muscle contraction. Intramolecular communication within myosin is essential for its function as motor, but the specific amino acid residue interactions required are unexplored within muscle cells. Using Drosophila melanogaster skeletal muscle myosin, we performed a novel in vivo molecular suppression analysis to define the importance of three relay loop amino acid residues (Ile(508), Asn(509), and Asp(511)) in communicating with converter domain residue Arg(759). We found that the N509K relay mutation suppressed defects in myosin ATPase, in vitro motility, myofibril stability, and muscle function associated with the R759E converter mutation. Through molecular modeling, we define a mechanism for this interaction and suggest why the I508K and D511K relay mutations fail to suppress R759E. Interestingly, I508K disabled motor function and myofibril assembly, suggesting that productive relay-converter interaction is essential for both processes. We conclude that the putative relay-converter interaction mediated by myosin residues 509 and 759 is critical for the biochemical and biophysical function of skeletal muscle myosin and the normal ultrastructural and mechanical properties of muscle.	[Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Bernstein, SI (corresponding author), San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA.	sbernstein@mail.sdsu.edu		Melkani, Girish/0000-0003-0353-4633; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [R01 GM32443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM32443 (to S. I. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Baumketner A, 2012, PROTEINS, V80, P2701, DOI 10.1002/prot.24155; BECKER KD, 1992, J CELL BIOL, V116, P669, DOI 10.1083/jcb.116.3.669; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Bloemink MJ, 2011, J BIOL CHEM, V286, P28435, DOI 10.1074/jbc.M111.258228; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Caldwell JT, 2012, METHODS, V56, P25, DOI 10.1016/j.ymeth.2011.12.002; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; Cripps RM, 1999, EMBO J, V18, P1793, DOI 10.1093/emboj/18.7.1793; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEORGE EL, 1989, MOL CELL BIOL, V9, P2957, DOI 10.1128/MCB.9.7.2957; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Highsmith S, 2000, BIOCHEMISTRY-US, V39, P12330, DOI 10.1021/bi001146d; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Kronert WA, 2008, J MOL BIOL, V379, P443, DOI 10.1016/j.jmb.2008.04.010; Kronert WA, 2010, J MOL BIOL, V398, P625, DOI 10.1016/j.jmb.2010.03.049; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; ODONNELL PT, 1989, GENE DEV, V3, P1233, DOI 10.1101/gad.3.8.1233; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Ramanath S, 2011, BIOPHYS J, V101, P1114, DOI 10.1016/j.bpj.2011.07.045; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Suzuki Y, 2000, METHODS, V22, P355, DOI 10.1006/meth.2000.1087; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2001, J BIOL CHEM, V276, P15117, DOI 10.1074/jbc.M008379200; Swank DM, 2012, METHODS, V56, P69, DOI 10.1016/j.ymeth.2011.10.015; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Wang Y, 2012, MOL BIOL CELL, V23, P2057, DOI 10.1091/mbc.E12-02-0120; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Yang CX, 2008, BIOPHYS J, V95, P5228, DOI 10.1529/biophysj.108.136192; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Zhang SX, 2001, MECH DEVELOP, V101, P35, DOI 10.1016/S0925-4773(00)00549-9	45	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12779	12790		10.1074/jbc.M114.550673	http://dx.doi.org/10.1074/jbc.M114.550673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627474	Green Published, hybrid			2022-12-25	WOS:000335581400047
J	Vangala, JR; Dudem, S; Jain, N; Kalivendi, SV				Vangala, Janakiram Reddy; Dudem, Srikanth; Jain, Nishant; Kalivendi, Shasi V.			Regulation of PSMB5 Protein and beta Subunits of Mammalian Proteasome by Constitutively Activated Signal Transducer and Activator of Transcription 3 ( STAT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Chemoresistance; Epidermal Growth Factor (EGF); Proteasome; STAT3	PROSTATE-CANCER CELLS; NF-KAPPA-B; BORTEZOMIB RESISTANCE; GENE-EXPRESSION; NUCLEAR FACTOR; MULTIPLE-MYELOMA; INHIBITOR; APOPTOSIS; PATHWAY; DEGRADATION	Background: Malignancies are frequently associated with altered abundance of proteasome and elevated proteasome activity. Results: EGF-induced PSMB5 expression requires STAT3 activation. Conclusion: The catalytic subunits and activities of the mammalian proteasome are regulated by STAT3. Significance: Proteasome function is regulated by oncogenic signaling. The ubiquitin-proteasome system facilitates the degradation of ubiquitin-tagged proteins and performs a regulatory role in cells. Elevated proteasome activity and subunit expression are found in several cancers. However, the inherent molecular mechanisms responsible for increased proteasome function in cancers remain unclear despite the well investigated and defined role of the mammalian proteasome. This study was initiated to elucidate the mechanisms involved in the regulation of subunits of the mammalian proteasome. Suppression of STAT3 tyrosine phosphorylation coordinately decreased the mRNA and protein levels of the subunits of the 20 S core complex in DU145 cells. Notably, PSMB5, a molecular target of bortezomib, was shown to be a target of STAT3. Knockdown of STAT3 decreased PSMB5 protein. Inhibition of phospho-STAT3 substantially reduced PSMB5 protein levels in cells expressing constitutively active-STAT3. Accumulation of activated STAT3 resulted in the induction of PSMB5 promoter and protein levels. In addition, a direct correlation was observed between the endogenous levels of PSMB5 and constitutively active STAT3. PSMB5 and STAT3 protein levels remained unaltered following the inhibition of proteasome activity. The EGF-induced concerted increase of subunits was blocked by inhibition of the EGF receptor or STAT3 but not by the PI3K/AKT or MEK/ERK pathways. Decreased proteasome activities were due to reduced protein levels of catalytic subunits of the proteasome in STAT3-inhibited cells. Combined treatments with bortezomib and inhibitor of STAT3 abrogated proteasome activity and enhanced cellular apoptosis. Overall, we demonstrate that aberrant activation of STAT3 regulates the expression of subunits, in particular PSMB5, and the catalytic activity of the proteasome.	[Vangala, Janakiram Reddy; Dudem, Srikanth; Jain, Nishant; Kalivendi, Shasi V.] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad 500607, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Jain, N (corresponding author), Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Uppal Rd, Hyderabad 500607, Andhra Pradesh, India.	nishant@iict.res.in; kalivendi@iict.res.in		Dudem, Srikanth/0000-0003-4601-2771; Jain, Nishant/0000-0003-3260-2543	Department of Science and Technology, India; Council of Scientific and Industrial Research (CSIR) SMiLE Project, India [CSC-0111]; Indian Council of Medical Research	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR) SMiLE Project, India; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Science and Technology, India (to S. V. K.); by Council of Scientific and Industrial Research (CSIR) SMiLE Project CSC-0111, India (to S. V. K.); and by a senior research fellowship from the Indian Council of Medical Research (to V. J. R.).	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; de Wilt LHAM, 2012, BIOCHEM PHARMACOL, V83, P207, DOI 10.1016/j.bcp.2011.10.009; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jain N, 2005, J BIOL CHEM, V280, P36664, DOI 10.1074/jbc.M413261200; Jain N, 2007, FEBS J, V274, P4396, DOI 10.1111/j.1742-4658.2007.05969.x; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Kraus M, 2007, LEUKEMIA, V21, P84, DOI 10.1038/sj.leu.2404414; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Li CY, 2009, MOL CANCER THER, V8, P2211, DOI 10.1158/1535-7163.MCT-09-0327; Lichter DI, 2012, BLOOD, V120, P4513, DOI 10.1182/blood-2012-05-426924; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Lu SQ, 2009, EXP HEMATOL, V37, P831, DOI 10.1016/j.exphem.2009.04.001; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Mora LB, 2002, CANCER RES, V62, P6659; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Politou M, 2006, LEUKEMIA RES, V30, P240, DOI 10.1016/j.leukres.2005.06.014; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Xie YM, 2010, CANCER METAST REV, V29, P687, DOI 10.1007/s10555-010-9255-y; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhou J, 2010, BIOCHEM PHARMACOL, V79, P1242, DOI 10.1016/j.bcp.2009.12.014	51	47	49	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12612	12622		10.1074/jbc.M113.542829	http://dx.doi.org/10.1074/jbc.M113.542829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627483	hybrid, Green Published			2022-12-25	WOS:000335581400033
J	Nadkarni, MA; Chen, ZL; Wilkins, MR; Hunter, N				Nadkarni, Mangala A.; Chen, Zhiliang; Wilkins, Marc R.; Hunter, Neil			Comparative Genome Analysis of Lactobacillus rhamnosus Clinical Isolates from Initial Stages of Dental Pulp Infection: Identification of a New Exopolysaccharide Cluster	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COLLAGEN-BINDING PROTEIN; GENE CLUSTERS; MOLECULAR CHARACTERIZATION; LISTERIA-MONOCYTOGENES; ADHESION; CASEI; GG; BIOSYNTHESIS; EVOLUTION	The human oral microbiome has a major role in oral diseases including dental caries. Our studies on progression of caries infection through dentin and more recently, the invasion of vital dental pulp, detected Lactobacillus rhamnosus in the initial stages of infection of vital pulp tissue. In this study employing current high-throughput next generation sequencing technology we sought to obtain insight into genomic traits of tissue invasive L. rhamnosus, to recognise biomarkers that could provide an understanding of pathogenic potential of lactobacilli, generally regarded as safe. Roche GS FLX+ technology was used to generate whole genome sequences of two clinical isolates of L. rhamnosus infecting vital pulp. Detailed genome-wide comparison of the genetic profiles of tissue invasive L. rhamnosus with probiotic L. rhamnosus was performed to test the hypothesis that specific strains of L. rhamnosus possessing a unique gene complement are selected for the capacity to invade vital pulp tissue. Analysis identified 264 and 258 genes respectively, from dental pulp-invasive L. rhamnosus strains LRHMDP2 and LRHMDP3 isolated from two different subjects that were not present in the reference probiotic L. rhamnosus strain ATCC 53103 (GG). Distinct genome signatures identified included the presence of a modified exopolysaccharide cluster, a characteristic confirmed in a further six clinical isolates. Additional features of LRHMDP2 and LRHMDP3 were altered transcriptional regulators from RpoN, NtrC, MutR, ArsR and zinc-binding Cro/CI families, as well as changes in the two-component sensor kinase response regulator and ABC transporters for ferric iron. Both clinical isolates of L. rhamnosus contained a single SpaFED cluster, as in L. rhamnosus Lc705, instead of the two Spa clusters (SpaCBA and SpaFED) identified in L. rhamnosus ATCC 53103 (GG). Genomic distance analysis and SNP divergence confirmed a close relationship of the clinical isolates but segregation from the reference probiotic L. rhamnosus strain ATCC 53103 (GG).	[Nadkarni, Mangala A.; Hunter, Neil] Westmead Ctr Oral Hlth, Inst Dent Res, Westmead, NSW, Australia; [Nadkarni, Mangala A.; Hunter, Neil] Westmead Millennium Inst, Westmead, NSW, Australia; [Nadkarni, Mangala A.; Hunter, Neil] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia; [Chen, Zhiliang; Wilkins, Marc R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of New South Wales Sydney	Nadkarni, MA (corresponding author), Westmead Ctr Oral Hlth, Inst Dent Res, Westmead, NSW, Australia.	mangala.nadkarni@sydney.edu.au			NIDCR [R01 DE015272-07]; Westmead Centre for Oral Health; Australian Government Super Science Scheme; New South Wales State Government Science Leveraging Fund (SLF); University of New South Wales; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015272] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Westmead Centre for Oral Health; Australian Government Super Science Scheme(Australian Government); New South Wales State Government Science Leveraging Fund (SLF); University of New South Wales; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported partially by NIDCR grant R01 DE015272-07, by the Westmead Centre for Oral Health, by the Australian Government Super Science Scheme, the New South Wales State Government Science Leveraging Fund (SLF) and by the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Chen Z, 2013, GENOME ANNOUNC, V1; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Fiocco D, 2010, J BACTERIOL, V192, P896, DOI 10.1128/JB.01122-09; Francl AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-77; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Jolly L, 2001, INT DAIRY J, V11, P733, DOI 10.1016/S0958-6946(01)00117-0; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Laws A, 2001, BIOTECHNOL ADV, V19, P597, DOI 10.1016/S0734-9750(01)00084-2; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171, DOI 10.1177/154411130201300207; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Monedero V, 2007, J MOL MICROB BIOTECH, V12, P20, DOI 10.1159/000096456; Nadkarni MA, 2010, J CLIN MICROBIOL, V48, P1732, DOI 10.1128/JCM.01912-09; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Paster BJ, 2009, PERIODONTOL 2000, V51, P38, DOI 10.1111/j.1600-0757.2009.00316.x; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Schaudinn C, 2009, J MICROSC-OXFORD, V235, P124, DOI 10.1111/j.1365-2818.2009.03201.x; Schroeder K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007567; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Welman AD, 2003, TRENDS BIOTECHNOL, V21, P269, DOI 10.1016/S0167-7799(03)00107-0; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	48	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90643	10.1371/journal.pone.0090643	http://dx.doi.org/10.1371/journal.pone.0090643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632842	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400017
J	Pilipow, K; Basso, V; Migone, N; Mondino, A				Pilipow, Karolina; Basso, Veronica; Migone, Nicola; Mondino, Anna			Monoallelic Germline TSC1 Mutations Are Permissive for T Lymphocyte Development and Homeostasis in Tuberous Sclerosis Complex Individuals	PLOS ONE			English	Article							GENE INACTIVATION; ALLELIC LOSS; MOUSE MODEL; PATHOGENESIS; TUMORS; QUIESCENCE; MAINTAINS; SURVIVAL; LESIONS	Germline and somatic biallelic mutations of the Tuberous sclerosis complex (TSC) 1 and TSC2 gene products cause TSC, an autosomal dominant multifocal hamartomatosis with variable neurological manifestations. The consequences of TSC1 or TSC2 loss in cells of hematopoietic origin have recently started to be unveiled in mice and showed to hinder the development of proper T cell immunity. To date, the consequences of germline TSC1 mutations and/or its loss in mature human T cells remain to be determined. To address these issues, we analyzed subset representation, phenotype and responsiveness to mitogens in T cells from patients with inherited monoallelic TSC1 mutations, and induced shRNA-mediated TSC1 down-regulation in primary and transformed human T cells. We report that, the distribution of peripheral CD4 and CD8 T cell subsets, their cytokine-secretion profile, and responsiveness to in vitro stimulation were largely preserved in TSC subjects with monoallelic TSC1 germline mutations when compared to healthy controls. Sufficient levels of hamartin and tuberin and proper control of mTOR-dependent signaling in primary T cells from TSC subjects best explained this. In contrast, shRNA-induced down-regulation of TSC1, likely mimicking biallelic inactivation of TSC1, compromised hamartin and tuberin expression and mTORC2/AKT/FoxO1/3 signaling causing both primary and transformed T cells to die by apoptosis. Thus, our results indicate that, while one functional TSC1 allele preserves human T lymphocytes development and homeostasis, TSC1 acute down-regulation is detrimental to the survival of both primary and transformed T cells.	[Pilipow, Karolina; Basso, Veronica; Mondino, Anna] Ist Sci San Raffaele, Immunol Transplantat & Infect Dis Div, Lymphocyte Activat Unit, I-20132 Milan, Italy; [Pilipow, Karolina] Univ Vita Salute San Raffaele, Milan, Italy; [Migone, Nicola] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Migone, Nicola] Univ San Giovanni Battista, Azienda Osped, Turin, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Turin	Mondino, A (corresponding author), Ist Sci San Raffaele, Immunol Transplantat & Infect Dis Div, Lymphocyte Activat Unit, I-20132 Milan, Italy.	anna.mondino@hsr.it	Basso, Veronica/AAC-8131-2019; Mondino, Anna/K-9434-2016	Mondino, Anna/0000-0003-0833-6927; basso, veronica/0000-0003-1880-8406	Associazione Italiana Ricerca sul Cancro; San Raffaele Vita-Salute University; FIRC	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); San Raffaele Vita-Salute University; FIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana Ricerca sul Cancro to AM. KP benefited of fellowships from the San Raffaele Vita-Salute University (2010-2012) and from FIRC (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLSEN G, 1994, ARCH NEUROL-CHICAGO, V51, P76, DOI 10.1001/archneur.1994.00540130110018; Borkowska J, 2011, INT J DERMATOL, V50, P13, DOI 10.1111/j.1365-4632.2010.04727.x; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Colombetti S, 2002, J IMMUNOL, V169, P6178, DOI 10.4049/jimmunol.169.11.6178; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hayashi T, 2010, MODERN PATHOL, V23, P1251, DOI 10.1038/modpathol.2010.114; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hoogeveen-Westerveld M, 2010, BBA-MOL BASIS DIS, V1802, P774, DOI 10.1016/j.bbadis.2010.06.004; Jentarra GM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-29; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; O'Brien TF, 2011, EUR J IMMUNOL, V41, P3361, DOI 10.1002/eji.201141411; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz RA, 2007, J AM ACAD DERMATOL, V57, P189, DOI 10.1016/j.jaad.2007.05.004; Song W, 2012, J NEUROCHEM, V123, P325, DOI 10.1111/j.1471-4159.2012.07914.x; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tucker T, 2002, CLIN GENET, V62, P345, DOI 10.1034/j.1399-0004.2002.620501.x; Weiner DM, 1998, J AM COLL SURGEONS, V187, P548, DOI 10.1016/S1072-7515(98)00239-7; Wolf HK, 1997, ACTA NEUROPATHOL, V93, P93, DOI 10.1007/s004010050587; Wu Q, 2011, J IMMUNOL, V187, P1106, DOI 10.4049/jimmunol.1003968; Yang K, 2011, NAT IMMUNOL; Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91952	10.1371/journal.pone.0091952	http://dx.doi.org/10.1371/journal.pone.0091952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633152	Green Published, gold, Green Submitted			2022-12-25	WOS:000332858400124
J	Sigurgeirsson, B; Emanuelsson, O; Lundeberg, J				Sigurgeirsson, Benjamin; Emanuelsson, Olof; Lundeberg, Joakim			Sequencing Degraded RNA Addressed by 3 ' Tag Counting	PLOS ONE			English	Article							SEQ; QUANTIFICATION; TRANSCRIPTION; DEGRADATION; INTEGRITY	RNA sequencing has become widely used in gene expression profiling experiments. Prior to any RNA sequencing experiment the quality of the RNA must be measured to assess whether or not it can be used for further downstream analysis. The RNA integrity number (RIN) is a scale used to measure the quality of RNA that runs from 1 (completely degraded) to 10 (intact). Ideally, samples with high RIN (>8) are used in RNA sequencing experiments. RNA, however, is a fragile molecule which is susceptible to degradation and obtaining high quality RNA is often hard, or even impossible when extracting RNA from certain clinical tissues. Thus, occasionally, working with low quality RNA is the only option the researcher has. Here we investigate the effects of RIN on RNA sequencing and suggest a computational method to handle data from samples with low quality RNA which also enables reanalysis of published datasets. Using RNA from a human cell line we generated and sequenced samples with varying RINs and illustrate what effect the RIN has on the basic procedure of RNA sequencing; both quality aspects and differential expression. We show that the RIN has systematic effects on gene coverage, false positives in differential expression and the quantification of duplicate reads. We introduce 3' tag counting (3TC) as a computational approach to reliably estimate differential expression for samples with low RIN. We show that using the 3TC method in differential expression analysis significantly reduces false positives when comparing samples with different RIN, while retaining reasonable sensitivity.	[Sigurgeirsson, Benjamin; Emanuelsson, Olof; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Solna, Sweden	Royal Institute of Technology	Lundeberg, J (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Solna, Sweden.	joakim.lundeberg@scilifelab.se	Sigurgeirsson, Bárður/B-6130-2011	Sigurgeirsson, Bardur/0000-0002-9733-9742	Swedish Research Council; Knut and Alice Wallenberg Foundation; Science for Life Laboratories, National Genomics Infrastructure (NGI), Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Science for Life Laboratories, National Genomics Infrastructure (NGI), Sweden	This work was supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, and Science for Life Laboratories, National Genomics Infrastructure (NGI), Sweden. The computations were performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NATURE METHODS; Anders S, 2013, HTSEQ COUNT; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brisco MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks588; Derti A, 2012, GENOME RES; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Felix K., 2013, TRIM GALORE; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Li W, 2012, BIOINFORMATICS, V28, P2914, DOI 10.1093/bioinformatics/bts559; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Solnestam BW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-574; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan L, 2012, BIOSTATISTICS, V13, P734, DOI 10.1093/biostatistics/kxs001; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu ZP, 2011, BIOINFORMATICS, V27, P502, DOI 10.1093/bioinformatics/btq696; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16	29	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91851	10.1371/journal.pone.0091851	http://dx.doi.org/10.1371/journal.pone.0091851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632678	Green Published, Green Submitted, gold			2022-12-25	WOS:000332858400109
J	Dasgupta, B; Kasahara, K; Kamiya, N; Nakamura, H; Kinjo, AR				Dasgupta, Bhaskar; Kasahara, Kota; Kamiya, Narutoshi; Nakamura, Haruki; Kinjo, Akira R.			Specific Non-Local Interactions Are Not Necessary for Recovering Native Protein Dynamics	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; DISULFIDE-BOND ISOMERASE; CARBONIC-ANHYDRASE-II; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE; CONFORMATIONAL-CHANGE; ADENYLATE KINASE; GLOBULAR PROTEIN	The elastic network model (ENM) is a widely used method to study native protein dynamics by normal mode analysis (NMA). In ENM we need information about all pairwise distances, and the distance between contacting atoms is restrained to the native value. Therefore ENM requires O(N-2) information to realize its dynamics for a protein consisting of N amino acid residues. To see if (or to what extent) such a large amount of specific structural information is required to realize native protein dynamics, here we introduce a novel model based on only O(N) restraints. This model, named the ` contact number diffusion' model (CND), includes specific distance restraints for only local (along the amino acid sequence) atom pairs, and semi-specific non-local restraints imposed on each atom, rather than atom pairs. The semi-specific non-local restraints are defined in terms of the non-local contact numbers of atoms. The CND model exhibits the dynamic characteristics comparable to ENM and more correlated with the explicit-solvent molecular dynamics simulation than ENM. Moreover, unrealistic surface fluctuations often observed in ENM were suppressed in CND. On the other hand, in some ligand-bound structures CND showed larger fluctuations of buried protein atoms interacting with the ligand compared to ENM. In addition, fluctuations from CND and ENM show comparable correlations with the experimental B-factor. Although there are some indications of the importance of some specific non-local interactions, the semi-specific non-local interactions are mostly sufficient for reproducing the native protein dynamics.	[Dasgupta, Bhaskar; Kasahara, Kota; Kamiya, Narutoshi; Nakamura, Haruki; Kinjo, Akira R.] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kinjo, AR (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	akinjo@protein.osaka-u.ac.jp	Kamiya, Narutoshi/C-4548-2016; Dasgupta, Bhaskar/AAY-4599-2020	Kamiya, Narutoshi/0000-0002-0527-6968; Dasgupta, Bhaskar/0000-0003-0630-4593; Kinjo, Akira/0000-0002-4006-8208; Kasahara, Kota/0000-0003-0207-6271	JSPS [23370071, 25440070]; Grants-in-Aid for Scientific Research [25440070] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (B) (23370071) and Grant-in-Aid for Scientific Research (C) (25440070) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2010, PROTEINS, V78, P3341, DOI 10.1002/prot.22841; Anderson E., 1999, LAPACK USERS GUIDE; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Atilgan C, 2010, PROTEINS, V78, P3363, DOI 10.1002/prot.22843; Bahar I, 1998, J MOL BIOL, V281, P871, DOI 10.1006/jmbi.1998.1978; Banaszak K, 2004, ACTA CRYSTALLOGR D, V60, P1747, DOI 10.1107/S0907444904018359; Beattie JF, 2003, BIOORG MED CHEM LETT, V13, P2955, DOI 10.1016/S0960-894X(03)00202-6; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Brylinski M, 2008, PROTEINS, V70, P363, DOI 10.1002/prot.21510; Chaudhuri BN, 1999, J MOL BIOL, V286, P1519, DOI 10.1006/jmbi.1999.2571; Chikenji G, 2006, P NATL ACAD SCI USA, V103, P3141, DOI 10.1073/pnas.0508195103; Choe JY, 1999, BIOCHEMISTRY-US, V38, P6953, DOI 10.1021/bi990159s; Dasgupta B, 2014, PROTEINS, V82, P77, DOI 10.1002/prot.24371; Dasgupta B, 2013, PROTEIN SCI, V22, P168, DOI 10.1002/pro.2195; DIAMOND R, 1988, ACTA CRYSTALLOGR A, V44, P211, DOI 10.1107/S0108767387010535; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinsen K, 1999, J CHEM PHYS, V111, P10766, DOI 10.1063/1.480441; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang JW, 2004, BIOCHEMISTRY-US, V43, P6415, DOI 10.1021/bi030213b; Hubbard S. J., 1993, NACCESS; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabakcioglu A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041904; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinjo AR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-401; Kinjo AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001963; Kinjo AR, 2005, BIOINFORMATICS, V21, P2167, DOI 10.1093/bioinformatics/bti330; Kinjo AR, 2005, PROTEINS, V58, P158, DOI 10.1002/prot.20300; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; Kondrashov DA, 2006, BIOPHYS J, V91, P2760, DOI 10.1529/biophysj.106.085894; Li DW, 2009, BIOPHYS J, V96, P3074, DOI 10.1016/j.bpj.2009.01.011; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Ming DM, 2006, BIOPHYS J, V90, P3382, DOI 10.1529/biophysj.105.071902; Momma K, 2005, BIOCHEMISTRY-US, V44, P5053, DOI 10.1021/bi047781r; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4; NISHIKAWA K, 1986, J BIOCHEM-TOKYO, V100, P1043, DOI 10.1093/oxfordjournals.jbchem.a121783; NISHIKAWA K, 1980, INT J PEPT PROT RES, V16, P19; Park H, 2004, MOL MICROBIOL, V51, P963, DOI 10.1046/j.1365-2958.2003.03885.x; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; R Core Team, 2016, R FDN STAT COMP; Reuter K, 2002, J BIOL CHEM, V277, P5378, DOI 10.1074/jbc.M109500200; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Seeliger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000634; Selvaraj S, 2003, BIOPHYS J, V84, P1919, DOI 10.1016/S0006-3495(03)75000-0; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; SMITH GM, 1994, PROTEIN SCI, V3, P118, DOI 10.1002/pro.5560030115; Standley DM, 2008, BRIEF BIOINFORM, V9, P276, DOI 10.1093/bib/bbn015; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wako H, 2011, BIOPHYS CHEM, V159, P257, DOI 10.1016/j.bpc.2011.07.004; Wang J, 2005, P NATL ACAD SCI USA, V102, P8881, DOI 10.1073/pnas.0503742102	66	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91347	10.1371/journal.pone.0091347	http://dx.doi.org/10.1371/journal.pone.0091347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625758	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300075
J	Reckhenrich, AK; Kirsch, BM; Wahl, EA; Schenck, TL; Rezaeian, F; Harder, Y; Foehr, P; Machens, HG; Egana, JT				Reckhenrich, Ann Katharin; Kirsch, Bianca Manuela; Wahl, Elizabeth Ann; Schenck, Thilo Ludwig; Rezaeian, Farid; Harder, Yves; Foehr, Peter; Machens, Hans-Guenther; Tomas Egana, Jose			Surgical Sutures Filled with Adipose-Derived Stem Cells Promote Wound Healing	PLOS ONE			English	Article							GROWTH-FACTORS; TENDON REPAIR; DIFFERENTIATION; MARROW; PROLIFERATION; INFLAMMATION; MECHANISMS; DELIVERY; MURINE; MODEL	Delayed wound healing and scar formation are among the most frequent complications after surgical interventions. Although biodegradable surgical sutures present an excellent drug delivery opportunity, their primary function is tissue fixation. Mesenchymal stem cells (MSC) act as trophic mediators and are successful in activating biomaterials. Here biodegradable sutures were filled with adipose-derived mesenchymal stem cells (ASC) to provide a pro-regenerative environment at the injured site. Results showed that after filling, ASCs attach to the suture material, distribute equally throughout the filaments, and remain viable in the suture. Among a broad panel of cytokines, cell-filled sutures constantly release vascular endothelial growth factor to supernatants. Such conditioned media was evaluated in an in vitro wound healing assay and showed a significant decrease in the open wound area compared to controls. After suturing in an ex vivo wound model, cells remained in the suture and maintained their metabolic activity. Furthermore, cell-filled sutures can be cryopreserved without losing their viability. This study presents an innovative approach to equip surgical sutures with pro-regenerative features and allows the treatment and fixation of wounds in one step, therefore representing a promising tool to promote wound healing after injury.	[Reckhenrich, Ann Katharin; Kirsch, Bianca Manuela; Wahl, Elizabeth Ann; Schenck, Thilo Ludwig; Rezaeian, Farid; Harder, Yves; Machens, Hans-Guenther; Tomas Egana, Jose] Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-80290 Munich, Germany; [Tomas Egana, Jose] Univ Chile, Fac Ciencias, FONDAP Ctr Genome Regulat, Santiago, Chile; [Foehr, Peter] Tech Univ Munich, Klinikum Rechts Isar, Chair Orthopaed & Sport Orthopaed, D-80290 Munich, Germany	Technical University of Munich; Universidad de Chile; Technical University of Munich	Egana, JT (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-80290 Munich, Germany.	tomasega@gmail.com		Wahl, Elizabeth/0000-0002-1367-7921; Foehr, Peter/0000-0003-1042-546X; Harder, Yves/0000-0002-2557-249X; Egana, Jose Tomas/0000-0003-2624-6992	CIRM-BMBF Early Translational II Award; Hans und Klementia Langmatz Stiftung	CIRM-BMBF Early Translational II Award; Hans und Klementia Langmatz Stiftung	This work was supported by the CIRM-BMBF Early Translational II Award and the Hans und Klementia Langmatz Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Braun S, 2004, PHILOS T R SOC B, V359, P753, DOI 10.1098/rstb.2004.1464; Brower J, 2011, ADV SKIN WOUND CARE, V24, P524, DOI 10.1097/01.ASW.0000407648.89961.a6; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053; Dines JS, 2007, J SHOULDER ELB SURG, V16, p215S, DOI 10.1016/j.jse.2007.03.001; ETHICON, 2008, GES NAHTM IMPL; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Fuchs TF, 2012, SCI WORLD J, DOI 10.1100/2012/109216; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Georgiev-Hristov T, 2012, EUR J CARDIO-THORAC, V42, pE40, DOI 10.1093/ejcts/ezs357; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Guyette JP, 2012, J BIOMED MAT RES A; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Justinger C, 2012, SURGERY, V151, P398, DOI 10.1016/j.surg.2011.08.004; Li HH, 2012, CELL TISSUE RES, V348, P371, DOI 10.1007/s00441-012-1393-9; Li Y, 2012, LANGMUIR, V28, P12134, DOI 10.1021/la302732w; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Mantovani C, 2012, EXP CELL RES, V318, P2034, DOI 10.1016/j.yexcr.2012.05.008; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; Nozaki K, 2012, CLIN BIOMECH, V27, P506, DOI 10.1016/j.clinbiomech.2011.11.005; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Siggers K, 2010, J BIOMED MATER RES A, V94A, P877, DOI 10.1002/jbm.a.32766; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Sorrell JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt30; Tobita M, 2011, DISCOV MED, V11, P160; Tziotzios C, 2012, J AM ACAD DERMATOL, V66, P13, DOI 10.1016/j.jaad.2011.08.035; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835	34	28	28	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91169	10.1371/journal.pone.0091169	http://dx.doi.org/10.1371/journal.pone.0091169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625821	Green Published, Green Submitted, gold			2022-12-25	WOS:000332851300060
J	Wong, HR; Weiss, SL; Giuliano, JS; Wainwright, MS; Cvijanovich, NZ; Thomas, NJ; Allen, GL; Anas, N; Bigham, MT; Hall, M; Freishtat, RJ; Sen, A; Meyer, K; Checchia, PA; Shanley, TP; Nowak, J; Quasney, M; Chopra, A; Fitzgerald, JC; Gedeit, R; Banschbach, S; Beckman, E; Harmon, K; Lahni, P; Lindsell, CJ				Wong, Hector R.; Weiss, Scott L.; Giuliano, John S., Jr.; Wainwright, Mark S.; Cvijanovich, Natalie Z.; Thomas, Neal J.; Allen, Geoffrey L.; Anas, Nick; Bigham, Michael T.; Hall, Mark; Freishtat, Robert J.; Sen, Anita; Meyer, Keith; Checchia, Paul A.; Shanley, Thomas P.; Nowak, Jeffrey; Quasney, Michael; Chopra, Arun; Fitzgerald, Julie C.; Gedeit, Rainer; Banschbach, Sharon; Beckman, Eileen; Harmon, Kelli; Lahni, Patrick; Lindsell, Christopher J.			The Temporal Version of the Pediatric Sepsis Biomarker Risk Model	PLOS ONE			English	Article							SEPTIC SHOCK; EXPRESSION PROFILES; IDENTIFICATION; MORTALITY	Background: PERSEVERE is a risk model for estimating mortality probability in pediatric septic shock, using five biomarkers measured within 24 hours of clinical presentation. Objective: Here, we derive and test a temporal version of PERSEVERE (tPERSEVERE) that considers biomarker values at the first and third day following presentation to estimate the probability of a "complicated course'', defined as persistence of >= 2 organ failures at seven days after meeting criteria for septic shock, or death within 28 days. Methods: Biomarkers were measured in the derivation cohort (n = 225) using serum samples obtained during days 1 and 3 of septic shock. Classification and Regression Tree (CART) analysis was used to derive a model to estimate the risk of a complicated course. The derived model was validated in the test cohort (n = 74), and subsequently updated using the combined derivation and test cohorts. Results: A complicated course occurred in 23% of the derivation cohort subjects. The derived model had a sensitivity for a complicated course of 90% (95% CI 78-96), specificity was 70% (62-77), positive predictive value was 47% (37-58), and negative predictive value was 96% (91-99). The area under the receiver operating characteristic curve was 0.85 (0.79-0.90). Similar test characteristics were observed in the test cohort. The updated model had a sensitivity of 91% (81-96), a specificity of 70% (64-76), a positive predictive value of 47% (39-56), and a negative predictive value of 96% (92-99). Conclusions: tPERSEVERE reasonably estimates the probability of a complicated course in children with septic shock. tPERSEVERE could potentially serve as an adjunct to physiological assessments for monitoring how risk for poor outcomes changes during early interventions in pediatric septic shock.	[Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Harmon, Kelli; Lahni, Patrick] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Harmon, Kelli; Lahni, Patrick] Cincinnati Childrens Res Fdn, Cincinnati, OH USA; [Wong, Hector R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Weiss, Scott L.; Fitzgerald, Julie C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Giuliano, John S., Jr.] Yale Univ, Sch Med, Dept Pediat, Div Crit Care Med, New Haven, CT 06510 USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Cvijanovich, Natalie Z.] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Thomas, Neal J.] Penn State Hershey Childrens Hosp, Hershey, PA USA; [Allen, Geoffrey L.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Anas, Nick] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Bigham, Michael T.] Akron Childrens Hosp, Akron, OH USA; [Hall, Mark] Nationwide Childrens Hosp, Columbus, OH USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sen, Anita] Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp, New York, NY USA; [Meyer, Keith] Miami Childrens Hosp, Miami, FL USA; [Checchia, Paul A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Shanley, Thomas P.; Quasney, Michael] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Nowak, Jeffrey] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Chopra, Arun] St Christophers Hosp Children, Philadelphia, PA 19133 USA; [Gedeit, Rainer] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Lindsell, Christopher J.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Children's Mercy Hospital; Childrens Hospital of Orange County; Akron Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Baylor College of Medicine; University of Michigan System; University of Michigan; Children's Hospitals & Clinics of Minnesota; Children's Hospital of Wisconsin; University System of Ohio; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	Chopra, Arun/AAA-6983-2019; Hall, Mark/E-3193-2011	Giuliano, John/0000-0003-2753-8460; Freishtat, Robert/0000-0002-7411-2342; Meyer, Keith/0000-0001-7354-5552; Chopra, Arun/0000-0002-1418-6470; Shanley, Thomas/0000-0001-8936-377X; Gedeit, Rainer/0000-0003-2420-9493; Thomas, Neal/0000-0002-7991-7510; Weiss, Scott/0000-0002-7040-3281; Wong, Hector/0000-0001-7989-1173; Fitzgerald, Julie/0000-0001-9936-9569	National Institutes of Health [RC1HL100474, RO1GM064619, RO1GM099773]; Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR [8UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099773, R01GM064619, T32GM008478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants RC1HL100474, RO1GM064619, RO1GM099773, and an Innovation Award from the Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation. Supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR 8UL1 TR000077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulebda K, 2014, CRIT CARE MED, V42, P397, DOI 10.1097/CCM.0b013e3182a64607; Basu RK, 2011, CRIT CARE, V15, DOI 10.1186/cc10554; Che DS, 2011, ADV EXP MED BIOL, V696, P191, DOI 10.1007/978-1-4419-7046-6_19; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; Giuliano Jr JS, 2013, PEDIAT CRIT CARE MED; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hanna W, 2013, CRIT CARE CLIN, V29, P203, DOI 10.1016/j.ccc.2012.11.003; Kaplan JM, 2011, PEDIATR CRIT CARE ME, V12, P165, DOI 10.1097/PCC.0b013e3181e28876; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; Muller R, 2008, CLIN CHIM ACTA, V394, P1, DOI 10.1016/j.cca.2008.04.007; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Typpo KV, 2009, PEDIATR CRIT CARE ME, V10, P562, DOI 10.1097/PCC.0b013e3181a64be1; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; Wong HR, 2011, CRIT CARE MED, V39, P2511, DOI 10.1097/CCM.0b013e3182257675; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Wong HR, 2014, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0086242, DOI 10.1371/J0URNAL.P0NE.0086242)]; Wong HR, 2013, CRIT CARE MED; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	27	36	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e92121	10.1371/journal.pone.0092121	http://dx.doi.org/10.1371/journal.pone.0092121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626215	Green Published, gold, Green Submitted			2022-12-25	WOS:000332851300146
J	Bose, U; Hewavitharana, AK; Vidgen, ME; Ng, YK; Shaw, PN; Fuerst, JA; Hodson, MP				Bose, Utpal; Hewavitharana, Amitha K.; Vidgen, Miranda E.; Ng, Yi Kai; Shaw, P. Nicholas; Fuerst, John A.; Hodson, Mark P.			Discovering the Recondite Secondary Metabolome Spectrum of Salinispora Species: A Study of Inter-Species Diversity	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MASS-SPECTROMETRY; MARINE BACTERIUM; DRUG DISCOVERY; SP NOV.; ACTINOMYCETE; GENOME; RIFAMYCINS; ARENICOLA; EVOLUTION	Patterns of inter-species secondary metabolite production by bacteria can provide valuable information relating to species ecology and evolution. The complex nature of this chemical diversity has previously been probed via directed analyses of a small number of compounds, identified through targeted assays rather than more comprehensive biochemical profiling approaches such as metabolomics. Insights into ecological and evolutionary relationships within bacterial genera can be derived through comparative analysis of broader secondary metabolite patterns, and this can also eventually assist biodiscovery search strategies for new natural products. Here, we investigated the species-level chemical diversity of the two marine actinobacterial species Salinispora arenicola and Salinispora pacifica, isolated from sponges distributed across the Great Barrier Reef (GBR), via their secondary metabolite profiles using LC-MS-based metabolomics. The chemical profiles of these two species were obtained by UHPLC-QToF-MS based metabolic profiling. The resultant data were interrogated using multivariate data analysis methods to compare their (bio)chemical profiles. We found a high level of inter-species diversity in strains from these two bacterial species. We also found rifamycins and saliniketals were produced exclusively by S. arenicola species, as the main secondary metabolites differentiating the two species. Furthermore, the discovery of 57 candidate compounds greatly increases the small number of secondary metabolites previously known to be produced by these species. In addition, we report the production of rifamycin O and W, a key group of ansamycin compounds, in S. arenicola for the first time. Species of the marine actinobacteria harbour a much wider spectrum of secondary metabolites than suspected, and this knowledge may prove a rich field for biodiscovery as well as a database for understanding relationships between speciation, evolution and chemical ecology.	[Bose, Utpal; Hewavitharana, Amitha K.; Shaw, P. Nicholas] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Vidgen, Miranda E.; Ng, Yi Kai; Fuerst, John A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Hodson, Mark P.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Metabol Australia, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Hodson, MP (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Metabol Australia, Brisbane, Qld, Australia.	m.hodson1@uq.edu.au	Bose, Utpal/A-1785-2019; Hewavitharana, Amitha K/A-5533-2008; Bose, Utpal/AAU-5241-2020; Hodson, Mark P/J-7609-2013; Fuerst, John/I-8649-2012; Shaw, Paul N/G-4418-2010; Shaw, Paul/Q-8454-2019	Bose, Utpal/0000-0003-1156-6504; Hewavitharana, Amitha K/0000-0003-2935-9941; Bose, Utpal/0000-0003-1156-6504; Hodson, Mark P/0000-0002-5436-1886; Fuerst, John/0000-0002-6451-8533; Shaw, Paul N/0000-0001-7154-592X; Shaw, Paul/0000-0001-7154-592X; Vidgen, Miranda/0000-0003-4131-0390	CRC Reef Research Centre; Fisheries Research and Development Corporation; National Oceans Office; University of Queensland International Scholarship; University of Queensland Research Scholarship; Australian Research Council	CRC Reef Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Fisheries Research and Development Corporation; National Oceans Office; University of Queensland International Scholarship; University of Queensland Research Scholarship(University of Queensland); Australian Research Council(Australian Research Council)	This paper is an output from the Great Barrier Reef Seabed Biodiversity Project, a collaboration between the Australian Institute of Marine Science (AIMS), the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Queensland Department of Primary Industries & Fisheries (QDPIF), and the Queensland Museum (QM); funded by the CRC Reef Research Centre, the Fisheries Research and Development Corporation, and the National Oceans Office; and led by R. Pitcher (Principal Investigator, CSIRO), P. Doherty (AIMS), J. Hooper (QM) and N. Gribble (QDPIF). Utpal Bose was supported by a University of Queensland International Scholarship. Yi Kai Ng was supported by the University of Queensland Research Scholarship. Miranda Vidgen was supported by an Australian Research Council Linkage Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed L, 2013, ANTON LEEUW INT J G, V103, P1069, DOI 10.1007/s10482-013-9886-4; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; BANERJEE UC, 1992, BIOTECHNOL ADV, V10, P577, DOI 10.1016/0734-9750(92)91454-M; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Doolittle WF, 1999, TRENDS BIOCHEM SCI, V24, pM5, DOI 10.1016/S0968-0004(99)01471-1; Dunn WB, 2011, BIOANALYSIS, V3, P2205, DOI [10.4155/BIO.11.223, 10.4155/bio.11.223]; Edlund A, 2011, APPL ENVIRON MICROB, V77, P5916, DOI 10.1128/AEM.00611-11; Ejje N, 2013, METALLOMICS, V5, P1519, DOI 10.1039/c3mt00230f; Eustaquio AS, 2011, CHEMBIOCHEM, V12, P61, DOI 10.1002/cbic.201000564; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fenical W, 2009, BIOORGAN MED CHEM, V17, P2175, DOI 10.1016/j.bmc.2008.10.075; Freel KC, 2011, APPL ENVIRON MICROB, V77, P7261, DOI 10.1128/AEM.05943-11; Hewavitharana AK, 2007, J CHROMATOGR B, V852, P362, DOI 10.1016/j.jchromb.2007.01.042; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; Hornung A, 2007, CHEMBIOCHEM, V8, P757, DOI 10.1002/cbic.200600375; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Jensen PR, 2005, ANTON LEEUW INT J G, V87, P43, DOI 10.1007/s10482-004-6540-1; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim TK, 2006, ENVIRON MICROBIOL, V8, P1460, DOI 10.1111/j.1462-2920.2006.01040.x; Kim TK, 2006, APPL ENVIRON MICROB, V72, P2118, DOI 10.1128/AEM.72.3.2118-2125.2006; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Krug D, 2008, ANAL CHIM ACTA, V624, P97, DOI 10.1016/j.aca.2008.06.036; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; Larsen TO, 2005, NAT PROD REP, V22, P672, DOI 10.1039/b404943h; Macel M, 2010, MOL ECOL RESOUR, V10, P583, DOI 10.1111/j.1755-0998.2010.02854.x; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Ng YK, 2013, APPL MICROBIOL BIOT, V97, P3097, DOI 10.1007/s00253-012-4479-0; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; SCHUPP T, 1981, J ANTIBIOT, V34, P965, DOI 10.7164/antibiotics.34.965; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Vidgen M, 2011, ANTON LEEUW INT J G, V101, P603; Wilson MC, 2010, J AM CHEM SOC, V132, P12757, DOI 10.1021/ja105891a; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051; Zhao W, 2010, CELL RES, V20, P1096, DOI 10.1038/cr.2010.87; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105	44	23	23	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91488	10.1371/journal.pone.0091488	http://dx.doi.org/10.1371/journal.pone.0091488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621594	gold, Green Published, Green Submitted			2022-12-25	WOS:000332845300095
J	Hasan, S; Singh, K; Danisuddin, M; Verma, PK; Khan, AU				Hasan, Sadaf; Singh, Kunal; Danisuddin, Mohd; Verma, Praveen K.; Khan, Asad U.			Inhibition of Major Virulence Pathways of Streptococcus mutans by Quercitrin and Deoxynojirimycin: A Synergistic Approach of Infection Control	PLOS ONE			English	Article							VITRO ANTIMICROBIAL ACTIVITY; IN-VITRO; BIOFILM FORMATION; BINDING-SITES; ADHERENCE; ANTIBIOTICS; PROTEIN; GENES; DEHYDROGENASE; ADAPTATION	Objectives: To evaluate the synergistic effect of Quercitrin and Deoxynojirimycin (DNJ) together with their individual inhibitory effect against virulence pathways of Streptococcus mutans. Methodology: MICs of both the compounds were determined by the microdilution method, followed by their in vitrosynergy using checkerboard and time kill assay. The nature of interaction was classified as synergistic on the basis of fractional inhibitory concentration index (FICI) value of <= 0.5. Furthermore, the activity of Quercitrin and DNJ was evaluated individually and in combination against various cariogenic properties of S. mutans UA159 such as acidogenesis, aciduracity, glucan production, hydrophobicity, biofilm and adherence. Moreover, expression of virulent genes in S. mutans was analysed by quantitative RT-PCR (qRT-PCR) and inhibition of F1F0-ATPase, lactate dehydrogenase and enolase was also evaluated. Finally, scanning electron microscopy (SEM) was used to investigate structural obliteration of biofilm. Results: The in vitro synergism between Quercitrin and DNJ was observed, with a FICI of 0.313. Their MIC values were found to be 64 mu g/ml and 16 mu g/ml respectively. The synergistic combination consistently showed best activity against all the virulence factors as compared to Quercitrin and DNJ individually. A reduction in glucan synthesis and biofilm formation was observed at different phases of growth. The qRT-PCR revealed significant downregulation of various virulent genes. Electron micrographs depicted the obliteration of biofilm as compared to control and the activity of cariogenic enzymes was also inhibited. Conclusions: The whole study reflects a prospective role of Quercitrin and DNJ in combination as a potent anticariogenic agent against S. mutans.	[Hasan, Sadaf; Danisuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India; [Singh, Kunal; Verma, Praveen K.] Natl Inst Plant Genome Res, New Delhi, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	hasan, sadaf/J-4050-2019; Singh, Kunal/AAS-1975-2021; Khan, Asad U/K-8157-2013	Singh, Kunal/0000-0001-9375-1070; Khan, Asad U/0000-0001-9191-9423	Interdisciplinary Biotechnology Unit, Aligarh Muslim University; Indian Councel of Medical Research [59/6/2009/BMS/TRM]	Interdisciplinary Biotechnology Unit, Aligarh Muslim University; Indian Councel of Medical Research	This study was supported by internal funds of Interdisciplinary Biotechnology Unit, Aligarh Muslim University and Indian Councel of Medical Research grant no. 59/6/2009/BMS/TRM to AUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban SH, 2012, MOLECULES, V17, P9231, DOI 10.3390/molecules17089231; BELLI WA, 1995, CAN J MICROBIOL, V41, P785, DOI 10.1139/m95-108; BENCINI DA, 1983, ANAL BIOCHEM, V132, P259, DOI 10.1016/0003-2697(83)90005-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Celenza G, 2012, PHYTOMEDICINE, V19, P596, DOI 10.1016/j.phymed.2012.02.010; CHEN AP, 1994, J BACTERIOL, V176, P1542, DOI 10.1128/jb.176.5.1542-1545.1994; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; CROW VL, 1977, J BACTERIOL, V131, P82, DOI 10.1128/JB.131.1.82-91.1977; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gregoire S, 2007, J APPL MICROBIOL, V103, P1960, DOI 10.1111/j.1365-2672.2007.03441.x; HAMADA S, 1978, INFECT IMMUN, V20, P592, DOI 10.1128/IAI.20.3.592-599.1978; HAMILTON IR, 1991, ORAL MICROBIOL IMMUN, V6, P65, DOI 10.1111/j.1399-302X.1991.tb00453.x; Hasan S, 2013, FUTURE MICROBIOL, V8, P939, DOI 10.2217/fmb.13.54; Hasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040319; Hong CO, 2013, BIOSCI BIOTECH BIOCH, V77, P58, DOI 10.1271/bbb.120562; Islam B, 2008, J ANTIMICROB CHEMOTH, V62, P751, DOI 10.1093/jac/dkn253; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; KOBAYASHI H, 1986, J BIOL CHEM, V261, P627; Koo H, 2000, ARCH ORAL BIOL, V45, P141, DOI 10.1016/S0003-9969(99)00117-X; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Levesque CM, 2005, INFECT IMMUN, V73, P3773, DOI 10.1128/IAI.73.6.3773-3777.2005; Li Y., 2013, INT J ANTENN PROPAG, V2013; Liu C, 2011, ANTIMICROB AGENTS CH, V55, P2679, DOI 10.1128/AAC.01496-10; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MCBRIDE BC, 1984, INFECT IMMUN, V44, P68, DOI 10.1128/IAI.44.1.68-75.1984; Miller-Torbert TA, 2008, MICROB PATHOGENESIS, V45, P53, DOI 10.1016/j.micpath.2008.02.001; Muller P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057679; Muzitano MF, 2006, PLANTA MED, V72, P81, DOI 10.1055/s-2005-873183; Nakano K, 2007, J MED MICROBIOL, V56, P1413, DOI 10.1099/jmm.0.47335-0; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; SERVICE RF, 1995, SCIENCE, V270, P724, DOI 10.1126/science.270.5237.724; Stipp RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058271; Timokhova A V, 2012, Mol Biol (Mosk), V46, P644; Tsuduki T, 2013, FOOD CHEM, V139, P16, DOI 10.1016/j.foodchem.2013.02.025; Wagner C, 2006, BRAIN RES, V1107, P192, DOI 10.1016/j.brainres.2006.05.084; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Yin YQ, 2013, TOXICOL APPL PHARM, V269, P89, DOI 10.1016/j.taap.2013.03.015	45	42	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91736	10.1371/journal.pone.0091736	http://dx.doi.org/10.1371/journal.pone.0091736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622055	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300122
J	Jia, ZJ; Hong, B; Chen, DM; Huang, QH; Yang, ZG; Yin, C; Deng, XQ; Liu, JM				Jia, Ze-jun; Hong, Bo; Chen, Da-ming; Huang, Qing-hai; Yang, Zhi-gang; Yin, Cha; Deng, Xiao-qun; Liu, Jian-min			China's Growing Contribution to Global Intracranial Aneurysm Research (1991-2012): A Bibliometric Study	PLOS ONE			English	Article							ENDOVASCULAR APPROACH; SACCULAR ANEURYSMS; ELECTROTHROMBOSIS; INDEX	Background: We sought to analyze the growing worldwide trends of intracranial aneurysm research, investigate China's recent contribution, and compare the contributions of mainland China, Taiwan, and Hong Kong. Methods: Global and China intracranial aneurysm-related publications were retrieved from the Web of Science database from 1991 to 2012. Excel 2007, Matlab, and Thomson Data Analyzer (TDA) software were used to analyze the search results for number of publications, cited frequency, h-index, and organization contributions. Results: 16468 global papers were identified that were cited 273500 times until 2013-08-15. The United States accounted for 31.497% of the articles, 58.64% of the citations, and the highest h-index (127). Japan and Germany followed in frequency. China's articles ranked eighth (third in 2012) in total number, with most of the contributions occurring since 2002 (91.33%). China was at the early stage of the logic growth curve (exponential growth), with the citation frequency and h-index per year increasing. The quality of the publications was low. The main research centers were located in Beijing, Shanghai, Taiwan, and Hong Kong. The main Asian funding body was the National Natural Science Foundation of China. The number of publications and frequency of citations of papers from mainland China was greater than that of Taiwan or Hong Kong. Conclusion: Global intracranial aneurysm research has been developing swiftly since 1991, with the United States making the largest contribution. Research in China started later, in 2002. Since then, China has increased its rate of publication, and became the third largest contributor by 2012.	[Jia, Ze-jun; Hong, Bo; Huang, Qing-hai; Yang, Zhi-gang; Liu, Jian-min] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Jia, Ze-jun; Yin, Cha; Deng, Xiao-qun] Second Mil Med Univ, Dept Res, Editorial Dept Acad Journal, Shanghai, Peoples R China; [Chen, Da-ming] Chinese Acad Sci, SIBS, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Deng, XQ (corresponding author), Second Mil Med Univ, Dept Res, Editorial Dept Acad Journal, Shanghai, Peoples R China.	xqdeng_jane@163.com; chstroke@163.com			National Natural Science Foundation of China [31370810]; Foundation of General Administration of Press and Publication of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of General Administration of Press and Publication of the People's Republic of China	This work was supported by the National Natural Science Foundation of China (31370810) at http://www.nsfc.gov.cn, and Foundation of General Administration of Press and Publication of the People's Republic of China (2013) at http://www.gapp.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2002, NATURE, V415, P726, DOI 10.1038/415726a; Asplund K, 2012, STROKE, V43, P830, DOI 10.1161/STROKEAHA.111.637249; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; BROOKES BC, 1969, NATURE, V224, P953, DOI 10.1038/224953a0; Elango B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081094; Glynn RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013902; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; GUGLIELMI G, 1991, J NEUROSURG, V75, P8, DOI 10.3171/jns.1991.75.1.0008; Haeffner-Cavaillon N, 2009, ARCH IMMUNOL THER EX, V57, P33, DOI 10.1007/s00005-009-0004-2; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Lai DYF, 2011, NATURE, V476, P152, DOI 10.1038/476152b; Lenoir T, 2009, J BIOMED DISCOV COLL, V4; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042200; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057371; Nalimov VV, 1974, SYNTHESE, V27, P211; Peng J, 2011, INT NURS REV, V58, P21, DOI 10.1111/j.1466-7657.2010.00873.x; Rosas SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017428; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vioque J, 2010, OBES REV, V11, P603, DOI 10.1111/j.1467-789X.2009.00647.x; Xu GL, 2013, STROKE, V44, P1775, DOI 10.1161/STROKEAHA.113.001238; Yao XB, 2013, NAT REV MOL CELL BIO, V14, P600, DOI 10.1038/nrm3638; Zhang JF, 2013, STROKE, V44, P2891, DOI 10.1161/STROKEAHA.113.002599; Zhang WJ, 2012, ANN PLAS SURG, V68, P328, DOI 10.1097/SAP.0b013e318214e6dd	26	19	20	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91594	10.1371/journal.pone.0091594	http://dx.doi.org/10.1371/journal.pone.0091594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622581	Green Submitted, Green Published, gold			2022-12-25	WOS:000332845300109
J	Lada, H; Thomson, JR; Cunningham, SC; Mac Nally, R				Lada, Hania; Thomson, James R.; Cunningham, Shaun C.; Mac Nally, Ralph			Relating Demographic Characteristics of a Small Mammal to Remotely Sensed Forest-Stand Condition	PLOS ONE			English	Article							MARSUPIAL ANTECHINUS-FLAVIPES; SOUTH-EASTERN AUSTRALIA; CLIMATE-CHANGE; RIVER; FLOW; BIODIVERSITY; LANDSCAPE; IMPACTS; STRESS	Many ecological systems around the world are changing rapidly in response to direct (land-use change) and indirect (climate change) human actions. We need tools to assess dynamically, and over appropriate management scales, condition of ecosystems and their responses to potential mitigation of pressures. Using a validated model, we determined whether stand condition of floodplain forests is related to densities of a small mammal (a carnivorous marsupial, Antechinus flavipes) in 60 000 ha of extant river red gum (Eucalyptus camaldulensis) forests in south-eastern Australia in 2004, 2005 and 2011. Stand condition was assessed remotely using models built from ground assessments of stand condition and satellite-derived reflectance. Other covariates, such as volumes of fallen timber, distances to floods, rainfall and life stages were included in the model. Trapping of animals was conducted at 272 plots (0.25 ha) across the region. Densities of second-year females (i.e. females that had survived to a second breeding year) and of second-year females with suckled teats (i.e. inferred to have been successful mothers) were higher in stands with the highest condition. There was no evidence of a relationship with stand condition for males or all females. These outcomes show that remotely-sensed estimates of stand condition (here floodplain forests) are relatable to some demographic characteristics of a small mammal species, and may provide useful information about the capacity of ecosystems to support animal populations. Over-regulation of large, lowland rivers has led to declines in many facets of floodplain function. If management of water resources continues as it has in recent decades, then our results suggest that there will be further deterioration in stand condition and a decreased capacity for female yellow-footed antechinuses to breed multiple times.	[Lada, Hania; Thomson, James R.; Cunningham, Shaun C.; Mac Nally, Ralph] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Monash University	Lada, H (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	hania.lada@monash.edu	Cunningham, Shaun/J-7669-2015; Thomson, Jim/W-2950-2019; Cunningham, Shaun/I-1116-2012	Cunningham, Shaun/0000-0002-1447-312X; Cunningham, Shaun/0000-0002-1447-312X	Australian Research Council [DP0984170, DP120100797]	Australian Research Council(Australian Research Council)	The Australian Research Council supported this research (DP0984170, DP120100797); http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger A, 2005, FRESHWATER BIOL, V50, P1190, DOI 10.1111/j.1365-2427.2005.01391.x; BREN LJ, 1987, AUST FOREST RES, V17, P127; Buehler DA, 2006, J WILDLIFE MANAGE, V70, P1763, DOI 10.2193/0022-541X(2006)70[1763:PCWHUI]2.0.CO;2; Bureau of Meteorology, 2011, CLIM DAT ONL; Chisholm RA, 2007, ECOL APPL, V17, P317, DOI 10.1890/05-1580; Close A., 1990, MURRAY, P61; COATES T, 1995, REPROD ECOLOGY YELLO; Cunningham SC, 2009, ECOSYSTEMS, V12, P207, DOI 10.1007/s10021-008-9218-0; Cunningham SC, 2011, MAPPING CONDITION RI; Cunningham SC, 2007, AUST J BOT, V55, P692, DOI 10.1071/BT07031; Cunningham SC, 2011, FRESHWATER BIOL, V56, P1494, DOI 10.1111/j.1365-2427.2011.02585.x; DEXTER B D, 1978, Proceedings of the Royal Society of Victoria, V90, P175; Fahey C, 1988, BARMAH FOREST HIST; Gelman A., 1006, BAYESIAN ANAL, V1, P515, DOI [10.1214/06-BA117AQ6, DOI 10.1214/06-BA117AQ6]; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gonzalez E, 2010, ENVIRON MANAGE, V45, P669, DOI 10.1007/s00267-010-9441-2; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Kingsford RT, 2009, CONSERV BIOL, V23, P834, DOI 10.1111/j.1523-1739.2009.01287.x; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Lada H, 2008, J APPL ECOL, V45, P1732, DOI 10.1111/j.1365-2664.2008.01563.x; Lada H, 2008, BIOL J LINN SOC, V94, P303, DOI 10.1111/j.1095-8312.2008.00970.x; Lada H, 2008, J MAMMAL, V89, P398, DOI 10.1644/07-MAMM-A-080R.1; Lada H, 2007, MOL ECOL, V16, P2934, DOI 10.1111/j.1365-294X.2007.03327.x; Lada H, 2007, BIOL CONSERV, V134, P527, DOI 10.1016/j.biocon.2006.09.003; Lada H, 2013, AUSTRAL ECOL, V38, P581, DOI 10.1111/aec.12002; Lee A.K., 1982, P1; LUNN DJ, 2005, GENERIC REVERSIBLE J; Mac Nally R, 2008, BASIC APPL ECOL, V9, P458, DOI 10.1016/j.baae.2007.05.003; Mac Nally R, 2007, J ANIM ECOL, V76, P643, DOI 10.1111/j.1365-2656.2007.01247.x; Mac Nally R, 2014, GLOBAL ECOL BIOGEOGR, V23, P191, DOI 10.1111/geb.12091; Mac Nally R, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010383; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Marchesan D, 2004, WILDLIFE RES, V31, P273, DOI 10.1071/WR02038; Margules, 1990, RIP VEG RIV MURR; Mcalpine CA, 2009, GLOBAL CHANGE BIOL, V15, P2206, DOI 10.1111/j.1365-2486.2009.01939.x; Menkhorst P., 1995, MAMMALS VICTORIA DIS; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nicholls N, 2004, CLIMATIC CHANGE, V63, P323, DOI 10.1023/B:CLIM.0000018515.46344.6d; Page K, 2005, RIVER RES APPL, V21, P567, DOI 10.1002/rra.828; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Pillay D, 2010, MAR ECOL PROG SER, V415, P35, DOI 10.3354/meps08733; Rood SB, 2003, TREE PHYSIOL, V23, P1113, DOI 10.1093/treephys/23.16.1113; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Specht R.L., 1981, ECOLOGICAL BIOGEOGRA, P163; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Treitz PM, 1999, PROG PHYS GEOG, V23, P359, DOI 10.1177/030913339902300303; VEAC, 2008, RIV RED GUM FOR INV	47	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91731	10.1371/journal.pone.0091731	http://dx.doi.org/10.1371/journal.pone.0091731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621967	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300121
J	Shahaf, G; Shweiki, D				Shahaf, Guy; Shweiki, Dorit			Nonsense-Mediated mRNA Decay Immunity Can Help Identify Human Polycistronic Transcripts	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; OPEN READING FRAMES; EXON JUNCTION COMPLEX; TRANSLATION INITIATION; MAMMALIAN-CELLS; NUCLEOTIDE RESOLUTION; UPF1 PHOSPHORYLATION; EXPRESSION; SURVEILLANCE; SEQUENCES	Eukaryotic polycistronic transcription units are rare and only a few examples are known, mostly being the outcome of serendipitous discovery. We claim that nonsense-mediated mRNA decay (NMD) immune structure is a common characteristic of polycistronic transcripts, and that this immunity is an emergent property derived from all functional CDSs. The human RefSeq transcriptome was computationally screened for transcripts capable of eliciting NMD, and which contain an additional ORF(s) potentially capable of rescuing the transcript from NMD. Transcripts were further analyzed implementing domain-based strategies in order to estimate the potential of the candidate ORF to encode a functional protein. Consequently, we predict the existence of forty nine novel polycistronic transcripts. Experimental verification was carried out utilizing two different types of analyses. First, five Gene Expression Omnibus (GEO) datasets from published NMD-inhibition studies were used, aiming to explore whether a given mRNA is indeed insensitive to NMD. All known bicistronic transcripts and eleven out of the twelve predicted genes that were analyzed, displayed NMD insensitivity using various NMD inhibitors. For three genes, a mixed expression pattern was observed presenting both NMD sensitivity and insensitivity in different cell types. Second, we used published global translation initiation sequencing data from HEK293 cells to verify the existence of translation initiation sites in our predicted polycistronic genes. In five of our genes, the predicted rescuing uORFs are indeed identified as translation initiation sites, and in two additional genes, one of two predicted rescuing uORF is verified. These results validate our computational analysis and reinforce the possibility that NMD-immune architecture is a parameter by which polycistronic genes can be identified. Moreover, we present evidence for NMD-mediated regulation controlling the production of one or more proteins encoded in the polycistronic transcript.	[Shahaf, Guy; Shweiki, Dorit] Acad Coll Tel Aviv Yaffo, Sch Comp Sci, Bioinformat Program, Tel Aviv, Israel		Shweiki, D (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Comp Sci, Bioinformat Program, Tel Aviv, Israel.	dorits@mta.ac.il						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anczukow O, 2008, HUM MUTAT, V29, P65, DOI 10.1002/humu.20590; Bailleul B, 1997, NUCLEIC ACIDS RES, V25, P2752, DOI 10.1093/nar/25.14.2752; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Buisson M, 2006, HUM MUTAT, V27, P1024, DOI 10.1002/humu.20384; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Durand S, 2013, NAT STRUCT MOL BIOL, V20, P702, DOI 10.1038/nsmb.2575; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Gilat R, 2007, BIOCHEM BIOPH RES CO, V353, P487, DOI 10.1016/j.bbrc.2006.12.052; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Han A, 2007, BIOINFORMATICS, V23, P397, DOI 10.1093/bioinformatics/btl593; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matsui M, 2007, FEBS LETT, V581, P4184, DOI 10.1016/j.febslet.2007.07.057; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; MILLER PF, 1989, GENE DEV, V3, P1217, DOI 10.1101/gad.3.8.1217; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Pesole G, 2002, NUCLEIC ACIDS RES, V30, P335, DOI 10.1093/nar/30.1.335; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Rufener SC, 2013, NAT STRUCT MOL BIOL, V20, P710, DOI 10.1038/nsmb.2576; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; Wu TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-160; Xiong Z, 2006, J IMMUNOL, V177, P4907, DOI 10.4049/jimmunol.177.7.4907; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91535	10.1371/journal.pone.0091535	http://dx.doi.org/10.1371/journal.pone.0091535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621851	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300101
J	Magdoom, KN; Pishko, GL; Rice, L; Pampo, C; Siemann, DW; Sarntinoranont, M				Magdoom, Kulam Najmudeen; Pishko, Gregory L.; Rice, Lori; Pampo, Chris; Siemann, Dietmar W.; Sarntinoranont, Malisa			MRI-Based Computational Model of Heterogeneous Tracer Transport following Local Infusion into a Mouse Hind Limb Tumor	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; INTERSTITIAL FLUID PRESSURE; INTRATUMORAL INFUSION; DRUG-DELIVERY; HYDRAULIC CONDUCTIVITY; THERAPEUTIC AGENTS; BRAIN-TUMORS; SOLID TUMOR; VASCULATURE; MICROENVIRONMENT	Systemic drug delivery to solid tumors involving macromolecular therapeutic agents is challenging for many reasons. Amongst them is their chaotic microvasculature which often leads to inadequate and uneven uptake of the drug. Localized drug delivery can circumvent such obstacles and convection-enhanced delivery (CED) - controlled infusion of the drug directly into the tissue - has emerged as a promising delivery method for distributing macromolecules over larger tissue volumes. In this study, a three-dimensional MR image-based computational porous media transport model accounting for realistic anatomical geometry and tumor leakiness was developed for predicting the interstitial flow field and distribution of albumin tracer following CED into the hind-limb tumor (KHT sarcoma) in a mouse. Sensitivity of the model to changes in infusion flow rate, catheter placement and tissue hydraulic conductivity were investigated. The model predictions suggest that 1) tracer distribution is asymmetric due to heterogeneous porosity; 2) tracer distribution volume varies linearly with infusion volume within the whole leg, and exponentially within the tumor reaching a maximum steady-state value; 3) infusion at the center of the tumor with high flow rates leads to maximum tracer coverage in the tumor with minimal leakage outside; and 4) increasing the tissue hydraulic conductivity lowers the tumor interstitial fluid pressure and decreases the tracer distribution volume within the whole leg and tumor. The model thus predicts that the interstitial fluid flow and drug transport is sensitive to porosity and changes in extracellular space. This image-based model thus serves as a potential tool for exploring the effects of transport heterogeneity in tumors.	[Magdoom, Kulam Najmudeen; Pishko, Gregory L.; Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Rice, Lori; Pampo, Chris; Siemann, Dietmar W.] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sarntinoranont, M (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	msarnt@ufl.edu		Siemann, Dietmar/0000-0002-5190-5761	National Institutes of Health [R21NS05270, R01NS063360]; National Cancer Institute (Public Health Service Grant) [CA084408]; NATIONAL CANCER INSTITUTE [R01CA084408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (Public Health Service Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was partly funded by grants from the National Institutes of Health (Grant Nos. R21NS05270 and R01NS063360; http://www.nih.gov/) and National Cancer Institute (Public Health Service Grant CA084408; http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard E, 2009, BIOMATERIALS, V30, P2302, DOI 10.1016/j.biomaterials.2009.01.003; ARUNYAWONGSAKORN U, 1985, ANAL BIOCHEM, V146, P265, DOI 10.1016/0003-2697(85)90425-7; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Boucher Y, 1998, BRIT J CANCER, V78, P1442, DOI 10.1038/bjc.1998.705; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOUCHER Y, 1991, CANCER RES, V51, P6691; Debinski W, 2009, EXPERT REV NEUROTHER, V9, P1519, DOI 10.1586/ERN.09.99; Dickinson PJ, 2010, NEURO-ONCOLOGY, V12, P928, DOI 10.1093/neuonc/noq046; Engebraaten O, 2002, INT J CANCER, V97, P846, DOI 10.1002/ijc.10137; Fu N.J.A., 2008, ANTIANGIOGENIC AGENT, P205; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Grathwohl P, 1998, DIFFUSION NATURAL PO, P31; Guerin C, 2004, INVEST NEW DRUG, V22, P27, DOI 10.1023/B:DRUG.0000006172.65135.3e; GUTMANN R, 1992, CANCER RES, V52, P1993; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Huang GC, 2008, CANCER BIOTHER RADIO, V23, P661, DOI 10.1089/cbr.2008.0492; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; JAIN RK, 1988, CANCER RES, V48, P2641; Kim JH, 2010, MED BIOL ENG COMPUT, V48, P203, DOI 10.1007/s11517-009-0564-7; Kim JH, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3169248; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Linninger AA, 2008, J THEOR BIOL, V250, P125, DOI 10.1016/j.jtbi.2007.09.009; MacKay JA, 2005, BRAIN RES, V1035, P139, DOI 10.1016/j.brainres.2004.12.007; Magdoom KN, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007096; McGuire S, 2001, AM J PHYSIOL-HEART C, V281, pH715, DOI 10.1152/ajpheart.2001.281.2.H715; Mow VC., 2004, BASIC ORTHOPAEDIC BI; NATHANSON SD, 1994, ANN SURG ONCOL, V1, P333, DOI 10.1007/BF03187139; Nield D.A., 2006, CONVECTION POROUS ME; Perlstein B, 2008, NEURO-ONCOLOGY, V10, P153, DOI 10.1215/15228517-2008-002; Pishko GL, 2011, ANN BIOMED ENG, V39, P2360, DOI 10.1007/s10439-011-0349-7; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; Sampson JH, 2007, NEUROSURGERY, V60, P89, DOI 10.1227/01.NEU.0000249256.09289.5F; Secomb TW, 2012, BASIC CLIN PHARMACOL, V110, P63, DOI 10.1111/j.1742-7843.2011.00815.x; Smith JH, 2007, MICROVASC RES, V73, P58, DOI 10.1016/j.mvr.2006.07.001; Soltani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067025; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; Truskey GA, 2004, TRANSPORT PHENOMENA, P473; Vazquez L, 2012, J MATER SCI-MATER M, P1; WALTER KA, 1995, NEUROSURGERY, V37, P1129, DOI 10.1227/00006123-199512000-00013; Wang Y, 2006, MOL CANCER THER, V5, P362, DOI 10.1158/1535-7163.MCT-05-0266; Wang Y, 2003, MOL CANCER THER, V2, P1233; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; YOUNG JS, 1950, J PATHOL BACTERIOL, V62, P313, DOI 10.1002/path.1700620303; Zhang XY, 2000, AM J PHYSIOL-HEART C, V279, pH2726, DOI 10.1152/ajpheart.2000.279.6.H2726; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003	50	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e89594	10.1371/journal.pone.0089594	http://dx.doi.org/10.1371/journal.pone.0089594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619021	gold, Green Published			2022-12-25	WOS:000332842400006
J	Zhao, Y; Zhou, W; Xue, LY; Zhang, WM; Zhan, QM				Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin			Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; DUCT EPITHELIAL-CELLS; ACETYLCHOLINE-RECEPTOR; CANDIDATE ONCOGENE; STEM-LIKE; KINASE-C; POPULATION; CARCINOMA; PATHWAY; CATENIN	Cigarette smoking is an established risk factor for esophageal cancers. Yes-associated protein 1 (YAP1), the key transcription factor of the mammalian Hippo pathway, has been reported to be an oncogenic factor for many cancers. In this study, we find nicotine administration can induce nuclear translocation and activation of YAP1 in ESCC. Consistently, we observed nuclear translocation and activation of YAP1 by knockdown of CHRNA3, which is a negative regulator of nicotine signaling in bronchial and esophageal cancer cells. Nicotine administration or CHRNA3 depletion substantially increased proliferation and migration in esophageal cancer cells. Interestingly, we find that YAP1 physically interacts with nAChRs, and nAChRs-signaling dissociates YAP1 from its negative regulatory complex composed with alpha-catenin, beta-catenin and 14-3-3 in the cytoplasm, leading to upregulation and nuclear translocation of YAP1. This process likely requires PKC activation, as PKC specific inhibitor Enzastaurin can block nicotine induced YAP1 activation. In addition, we find nicotine signaling also inhibits the interaction of YAP1 with P63, which contributes to the inhibitory effect of nicotine on apoptosis. Using immunohistochemistry analysis we observed upregulation of YAP1 in a significant portion of esophageal cancer samples. Consistently, we have found a significant association between YAP1 upregulation and cigarette smoking in the clinical esophageal cancer samples. Together, these findings suggest that the nicotine activated nAChRs signaling pathway which further activates YAP1 plays an important role in the development of esophageal cancer, and this mechanism may be of a general significance for the carcinogenesis of smoking related cancers.	[Zhao, Yue; Zhou, Wei; Zhang, Weimin; Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Liyan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by the funds from the 973 National Key Fundamental Research Program of China (2009CB521801) and the National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029915; Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; An Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047919; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Brown EN, 2003, AM J PHYSIOL-GASTR L, V285, pG37, DOI 10.1152/ajpgi.00053.2003; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; He JQ, 2000, J PHYSIOL-LONDON, V524, P807, DOI 10.1111/j.1469-7793.2000.00807.x; Hirata N, 2010, BIOCHEM BIOPH RES CO, V403, P138, DOI 10.1016/j.bbrc.2010.10.134; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Krais AM, 2011, CARCINOGENESIS, V32, P1388, DOI 10.1093/carcin/bgr090; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nallet-Staub F, 2013, J INVEST DERMATOL; Onoda N, 2001, HEAD NECK-J SCI SPEC, V23, P860, DOI 10.1002/hed.1125; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Takeuchi H, 2010, J DENT RES, V89, P34, DOI 10.1177/0022034509353403; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yamada K, 2010, CELL PHYSIOL BIOCHEM, V26, P247, DOI 10.1159/000320524; Yeo MK, 2012, ANTICANCER RES, V32, P3835; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051967; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	41	56	56	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90836	10.1371/journal.pone.0090836	http://dx.doi.org/10.1371/journal.pone.0090836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	25093675	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300031
J	Liang, XH; Chen, J; Liu, YX; He, CL; Li, TY				Liang, Xiaohua; Chen, Jie; Liu, Youxue; He, Chunling; Li, Tingyu			The Effect of Hypertension and Diabetes Management in Southwest China: A Before- and After-Intervention Study	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SYSTEMATIC ANALYSIS; HUMAN-RESOURCES; HEALTH; CARE; CHOLESTEROL; PREVALENCE; BURDEN; TRENDS	Background: Non-communicable diseases are leading causes of disease burden in middle income countries. Little evidence exists to determine if the primary healthcare system can effectively manage non-communicable diseases. The purpose of this study was to examine the effectiveness of hypertension and diabetes management by the primary healthcare system. Methods: We used individual level data from the 2009 National Basic Public Health Services System to assess the effectiveness of hypertension and diabetes interventions on fasting plasma glucose, and blood pressure. We analyzed the associations between fasting plasma glucose, systolic or diastolic blood pressure and risk factors. The estimated average intervention effect on data balanced with confounding variables was assessed. Results: 9543 individuals who had data for fasting plasma glucose, systolic blood pressure and diastolic blood pressure were included in this analysis. This study included 6681 patients with hypertension and 2222 with diabetes. The intervention lowered mean fasting plasma glucose by 0.5 mmol/L (0.4-0.6), lowered mean systolic blood pressure by 3.5 mm Hg (3.2-3.7), and lowered diastolic blood pressure by 2.9 mm Hg (2.7-3.2). Individuals who received medicinal treatment had 1.3 mmHg (0.8 to 1.8, P<0.01) lower diastolic blood pressure and 0.6 mmol/L (0.5-0.8, P<0.01) lower fasting plasma glucose than those who did not receive medicine. Generalized linear model indicated that medicinal treatment and baseline systolic blood pressure were significant positive predictors of change in systolic blood pressure. Age, living in urban areas and diabetic complications were significant negative predictors of change for systolic blood pressure. Conclusion: The National Basic Public Health Services System in China using trained community healthcare workers and well-established guidelines can be effectively implement non-communicable disease prevention and management care paradigms.	[Liang, Xiaohua; Chen, Jie; Liu, Youxue; Li, Tingyu] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China; [Liang, Xiaohua; He, Chunling] Ctr Dis Control & Prevent Jiulongpo Dist, Chongqing, Peoples R China	Chongqing Medical University	Li, TY (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China.	tyli@vip.sina.com		Liu, Youxue/0000-0003-4493-4350	Chongqing Municipal Health Bureau [2012-2-453, 2012-2-518, 2009-1-39]; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission [2012-1, 2013-1]	Chongqing Municipal Health Bureau; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission	This work was supported by three grants [2012-2-453/2012-2-518/2009-1-39, http://www.cqwsj.gov.cn/] from Chongqing Municipal Health Bureau, and by two grants [2012-1/2013-1] of Biomedical Project from Chongqing Jiulongpo Science and Technology Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JK, 2013, J CARDIOVASC NURS; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Cuddy Mary Linda Stotter, 2005, J Pract Nurs, V55, P17; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Frankenberg E, 1995, Health Transit Rev, V5, P143; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Huizinga MM, 2006, INDIAN J MED RES, V124, P481; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Linnet K, 1999, CLIN CHEM, V45, P314; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Low W H H, 2013, Med J Malaysia, V68, P129; Mitchell AD, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-29; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Omboni S, 2013, J HYPERTENS, V31, P455, DOI 10.1097/HJH.0b013e32835ca8dd; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Schmidt B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1017; Stewart S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7156; Thyregod HMaP, 2011, INTR GEN GEN LIN MOD; Tussing-Humphreys L, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120286; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	33	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91801	10.1371/journal.pone.0091801	http://dx.doi.org/10.1371/journal.pone.0091801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632720	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400090
J	Liang, XS; Gao, YA; Zhang, XY; Tian, YQ; Zhang, ZX; Gao, LH				Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong			Effect of Optimal Daily Fertigation on Migration of Water and Salt in Soil, Root Growth and Fruit Yield of Cucumber (Cucumis sativus L.) in Solar-Greenhouse	PLOS ONE			English	Article							USE EFFICIENCY; PHOSPHORUS LEVEL; NITROGEN; IRRIGATION; NITRATE; FREQUENCY; TOMATO; ARCHITECTURE; MANAGEMENT; CHLORIDE	Inappropriate and excessive irrigation and fertilization have led to the predominant decline of crop yields, and water and fertilizer use efficiency in intensive vegetable production systems in China. For many vegetables, fertigation can be applied daily according to the actual water and nutrient requirement of crops. A greenhouse study was therefore conducted to investigate the effect of daily fertigation on migration of water and salt in soil, and root growth and fruit yield of cucumber. The treatments included conventional interval fertigation, optimal interval fertigation and optimal daily fertigation. Generally, although soil under the treatment optimal interval fertigation received much lower fertilizers than soil under conventional interval fertigation, the treatment optimal interval fertigation did not statistically decrease the economic yield and fruit nutrition quality of cucumber when compare to conventional interval fertigation. In addition, the treatment optimal interval fertigation effectively avoided inorganic nitrogen accumulation in soil and significantly (P < 0.05) increased the partial factor productivity of applied nitrogen by 88% and 209% in the early-spring and autumn-winter seasons, respectively, when compared to conventional interval fertigation. Although soils under the treatments optimal interval fertigation and optimal daily fertigation received the same amount of fertilizers, the treatment optimal daily fertigation maintained the relatively stable water, electrical conductivity and mineral nitrogen levels in surface soils, promoted fine root (< 1.5 mm diameter) growth of cucumber, and eventually increased cucumber economic yield by 6.2% and 8.3% and partial factor productivity of applied nitrogen by 55% and 75% in the early-spring and autumn-winter seasons, respectively, when compared to the treatment optimal interval fertigation. These results suggested that optimal daily fertigation is a beneficial practice for improving crop yield and the water and fertilizers use efficiency in solar greenhouse.	[Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong] China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University	Gao, LH (corresponding author), China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China.	gaolh@cau.edu.cn		Liu, Youxue/0000-0003-4493-4350	earmarked fund for Modern Agro-industry Technology Research System in China [CARS-25]; Chinese Ministry of Water Resources [201001061]	earmarked fund for Modern Agro-industry Technology Research System in China; Chinese Ministry of Water Resources	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System in China (CARS-25) and the Special Fund for Research in the Public Interest provided by the Chinese Ministry of Water Resources (201001061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2010, ACTA AGR BOREALI OCC, P188; Belder P, 2005, FIELD CROP RES, V93, P169, DOI 10.1016/j.fcr.2004.09.022; Boomsma CR, 2009, AGRON J, V101, P1426, DOI 10.2134/agronj2009.0082; Cabello MJ, 2009, AGR WATER MANAGE, V96, P866, DOI 10.1016/j.agwat.2008.11.006; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chen Qing, 2005, China Vegetables, P57; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; Gao LH, 2010, HORTTECHNOLOGY, V20, P626, DOI 10.21273/HORTTECH.20.3.626; [高艳明 Gao Yanming], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P121; Garnett T, 2009, PLANT CELL ENVIRON, V32, P1272, DOI 10.1111/j.1365-3040.2009.02011.x; Guo RY, 2008, ENVIRON POLLUT, V151, P443, DOI 10.1016/j.envpol.2007.04.008; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; JACKSON TL, 1966, SOIL SCI SOC AM PRO, V30, P70, DOI 10.2136/sssaj1966.03615995003000010026x; Jokinen K, 2011, SCI HORTIC-AMSTERDAM, V130, P808, DOI 10.1016/j.scienta.2011.09.008; KOCH GW, 1988, PLANT CELL ENVIRON, V11, P755, DOI 10.1111/j.1365-3040.1988.tb01160.x; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2012, PHILOS T R SOC B, V367, P1598, DOI 10.1098/rstb.2011.0243; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Matsuo N, 2009, PLANT PROD SCI, V12, P514, DOI 10.1626/pps.12.514; Mi GH, 2010, SCI CHINA LIFE SCI, V53, P1369, DOI 10.1007/s11427-010-4097-y; Pei XB, 2002, ZHONGGUO NONG YE KE, V35, P1510; Rajput TBS, 2006, AGR WATER MANAGE, V79, P293, DOI 10.1016/j.agwat.2005.03.009; Shen J, 2012, J EXP BOT; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Silber A, 2005, PLANT SOIL, V270, P135, DOI 10.1007/s11104-004-1311-3; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; [孙丽萍 SUN Liping], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P173; Thompson RB, 2007, AGR WATER MANAGE, V89, P261, DOI 10.1016/j.agwat.2007.01.013; Tian YQ, 2010, NUTR CYCL AGROECOSYS, V88, P429, DOI 10.1007/s10705-010-9367-3; Wang H, 2006, CRIT REV PLANT SCI, V25, P279, DOI 10.1080/07352680600709917; [汪建飞 Wang Jianfei], 2005, [土壤通报, Journal of Soil Science], V36, P708; WANG XZ, 1991, CHINESE B BOT, V8, P34; Wang YS, 2010, FUNCT PLANT BIOL, V37, P175, DOI 10.1071/FP09181; Wei Yan, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P67; Xu G, 2004, PLANT SOIL, V263, P297, DOI 10.1023/B:PLSO.0000047743.19391.42; Yoshida Chie, 2011, Horticultural Research (Japan), V10, P325, DOI 10.2503/hrj.10.325; Yu ShuFang, 2000, China Vegetables, P10; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang LD, 2012, SCI HORTIC-AMSTERDAM, V138, P43, DOI 10.1016/j.scienta.2012.02.003; Zhao ShuMei, 2001, Transactions of the Chinese Society of Agricultural Engineering, V17, P171; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	46	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86975	10.1371/journal.pone.0086975	http://dx.doi.org/10.1371/journal.pone.0086975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24632720	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300122
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-25	WOS:000330240500068
